PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Busker, M; Neidhardt, I; Behrends, S				Busker, Mareike; Neidhardt, Inga; Behrends, Soenke			Nitric Oxide Activation of Guanylate Cyclase Pushes the alpha(1) Signaling Helix and the beta(1) Heme-binding Domain Closer to the Substrate-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Fluorescence Resonance Energy Transfer (FRET); Guanylate Cyclase (Guanylyl Cyclase); Nitric Oxide; Signal Transduction; Ciguate	CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CATALYTIC DOMAINS; MECHANISM; SUBUNIT; RECEPTOR; NO; TRANSDUCTION; INHIBITION; EXPRESSION	The complete structure of the assembled domains of nitric oxide-sensitive guanylate cyclase (NOsGC) remains to be determined. It is also unknown how binding of NO to heme in guanylate cyclase is communicated to the catalytic domain. In the current study the conformational change of guanylate cyclase on activation by NO was studied using FRET. Endogenous tryptophan residues were used as donors, the substrate analog 2-Mant-3-dGTP as acceptor. The enzyme contains five tryptophan residues distributed evenly over all four functional domains. This provides a unique opportunity to detect the movement of the functional domains relative to the substrate-binding catalytic region. FRET measurements indicate that NO brings tryptophan 22 in the B helix of the (1) heme NO binding domain and tryptophan 466 in the second short helix of the (1) coiled-coil domain closer to the catalytic domain. We propose that the respective domains act as a pair of tongs forcing the catalytic domain into the nitric oxide-activated conformation.	[Busker, Mareike; Neidhardt, Inga; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Behrends, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Mendelssohnstr 1, D-38106 Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010	Behrends, Sönke/0000-0002-9068-0729	Deutsche Forschungsgemeinschaft [BE 1865/5-1]; European Cooperation in Science and Technology Program [BM1005]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology Program	This work was supported by the Deutsche Forschungsgemeinschaft (BE 1865/5-1) and the European Cooperation in Science and Technology Program BM1005.	Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Gille A, 2004, J BIOL CHEM, V279, P19955, DOI 10.1074/jbc.M312560200; Gille A, 2003, J BIOL CHEM, V278, P12672, DOI 10.1074/jbc.M211292200; Goettle M, 2007, MOL PHARMACOL, V72, P526, DOI 10.1124/mol.107.034413; Haase N, 2010, BIOCHEM PHARMACOL, V80, P1676, DOI 10.1016/j.bcp.2010.08.007; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Koglin M, 2000, BBA-GENE STRUCT EXPR, V1494, P286, DOI 10.1016/S0167-4781(00)00211-6; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Kraehling JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025772; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P63; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Mou TC, 2006, MOL PHARMACOL, V70, P878, DOI 10.1124/mol.106.026427; Newton M, 2010, ANAL BIOCHEM, V402, P129, DOI 10.1016/j.ab.2010.03.041; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Schultz G., 1984, METHOD ENZYMAT AN, P379; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	34	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					476	484		10.1074/jbc.M113.504472	http://dx.doi.org/10.1074/jbc.M113.504472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220034	Green Published, hybrid			2022-12-25	WOS:000329370900041
J	Finger, JD; Tylleskar, T; Lampert, T; Mensink, GBM				Finger, Jonas D.; Tylleskar, Thorkild; Lampert, Thomas; Mensink, Gert B. M.			Dietary Behaviour and Socioeconomic Position: The Role of Physical Activity Patterns	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; NUTRITION SURVEY; NATIONAL-HEALTH; HEART-DISEASE; UNITED-STATES; SOCIAL-CLASS; ADULTS; WOMEN; CONSUMPTION; VALIDATION	Background: The positive association between education level and health outcomes can be partly explained by dietary behaviour. We investigated the associations between education and several indices of food intake and potential influencing factors, placing special emphasis on physical-activity patterns, using a representative sample of the German adult population. Methods: The German National Health Interview and Examination Survey 1998 (GNHIES98) involved 7,124 participants aged between 18 and 79. Complete information on the exposure (education) and outcome (nutrition) variables was available for 6,767 persons. The associations between 'education' and indices of 'sugar-rich food', 'fat-rich food', 'fruit-and-vegetable' and 'alcohol' intake were analysed separately for men and women using multivariate logistic regression analysis. Odds ratios (OR) of education level on nutrition outcomes were calculated and adjusted for age, region (former East/West Germany), occupation, income and other influencing factors such as physical activity indicators. Results: Men and women with only a primary education had a more frequent intake of sugar-rich and fat-rich foods and a less frequent intake of fruit and vegetables and alcohol than people with a tertiary education. 'Physical work activity' partly explained the associations between education and sugar-rich food intake. The interference with physical work activity was stronger among men than women. No significant associations between education and energy-dense food intake were observed in the retirement-age group of persons aged 65+ and among persons with low energy expenditure. Conclusions: In Germany, adults with a low level of education report that they consume energy-dense foods more frequently - and fruit and vegetables and alcohol less frequently - than adults with a high education level. High levels of physical work activity among adults with a low education level may partly explain why they consume more energy-dense foods.	[Finger, Jonas D.; Lampert, Thomas; Mensink, Gert B. M.] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway	Robert Koch Institute; University of Bergen	Finger, JD (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	FingerJ@rki.de	Mensink, Gert B/B-2447-2009; Tylleskär, Thorkild/S-5529-2017	Mensink, Gert B/0000-0001-6268-5998; Tylleskär, Thorkild/0000-0003-4801-4324; Finger, Jonas David/0000-0003-3697-6649	German Federal Ministry of Health	German Federal Ministry of Health	The study was financed by the German Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amine E, 2011, DIET NUTR PREV CHRON; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59; Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Erkkila AT, 1999, EUR J CLIN NUTR, V53, P662, DOI 10.1038/sj.ejcn.1600829; FEHILY AM, 1984, AM J CLIN NUTR, V40, P827, DOI 10.1093/ajcn/40.4.827; Finger JD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1079; Fransson EIM, 2003, SCAND J PUBLIC HEALT, V31, P324, DOI 10.1080/14034940210165055; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Gillman MW, 2001, PREV MED, V32, P295, DOI 10.1006/pmed.2000.0812; Girois SB, 2001, AM J PUBLIC HEALTH, V91, P418, DOI 10.2105/AJPH.91.3.418; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Haftenberger M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-36; Hoffmeyer-Zlotnik J.H., 2003, ZUMA NACHRICHTEN, V27, P125; Howley ET, 2001, MED SCI SPORT EXER, V33, pS364, DOI 10.1097/00005768-200106001-00005; Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503; King NA, 1997, MED SCI SPORT EXER, V29, P1076, DOI 10.1097/00005768-199708000-00014; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Lu N, 2002, J HEALTH CARE POOR U, V13, P241; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marks GC, 2006, J NUTR, V136, P459, DOI 10.1093/jn/136.2.459; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923; Mishra G, 2011, EUROPEAN J CLIN NUTR, V56, P687; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; Murakami K, 2009, NUTR RES, V29, P164, DOI 10.1016/j.nutres.2009.02.002; OECD, 2011, OECD PROJ INC DISTR; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Popkin BM, 1996, NEW ENGL J MED, V335, P716, DOI 10.1056/NEJM199609053351006; Schroedter JH, 2006, ZUMA METHODENBERICHT, V12, P1; SMITH AM, 1992, J EPIDEMIOL COMMUN H, V46, P409, DOI 10.1136/jech.46.4.409; Sternfeld B, 1999, PREV MED, V28, P313, DOI 10.1006/pmed.1998.0470; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019	42	27	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78390	10.1371/journal.pone.0078390	http://dx.doi.org/10.1371/journal.pone.0078390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223150	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200042
J	Garzon-Ospina, D; Lopez, C; Cadavid, LF; Patarroyo, ME; Patarroyo, MA				Garzon-Ospina, Diego; Lopez, Carolina; Cadavid, Luis F.; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Identification and Diversity of Killer Cell Ig-Like Receptors in Aotus vociferans, a New World Monkey	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; RAPID EVOLUTION; KIR GENES; MHC; RECOGNITION; DNA; RECOMBINATION; SUBSTITUTIONS; MECHANISM; EXPANSION	Previous BAC clone analysis of the Platyrrhini owl monkey KIRs have shown an unusual genetic structure in some loci. Therefore, cDNAs encoding KIR molecules from eleven Aotus vociferans monkeys were characterized here; ten putative KIR loci were found, some of which encoded atypical proteins such as KIR4DL and transcripts predicted to encode a D0+D1 configuration (AOTVOKIR2DL1*01v1) which appear to be unique in the Aotus genus. Furthermore, alternative splicing was found as a likely mechanism for producing activator receptors in A. vociferans species. KIR proteins from New World monkeys may be split into three new lineages according to domain by domain phylogenetic analysis. Although the A. vociferans KIR family displayed a high divergence among paralogous genes, individual loci were limited in their genetic polymorphism. Selection analysis showed that both constrained and rapid evolution may operate within the AvKIR family. The frequent alternative splicing (as a likely mechanism generating activator receptors), the presence of KIR4DL and KIR2DL1 (D0+D1) molecules and other data reported here suggest that the KIR family in Aotus has had a rapid evolution, independent from its Catarrhini counterparts.	[Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Cadavid, Luis F.] Univ Nacl Colombia, Inst Genet, Bogota, Colombia; [Cadavid, Luis F.] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	Universidad del Rosario; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Garzón-Ospina, Diego/AFS-7704-2022; Garzón-Ospina, Diego/L-8585-2016; López-Santana, Carolina/L-8580-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Garzón-Ospina, Diego/0000-0003-3829-6719; López-Santana, Carolina/0000-0003-1313-7607; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Cadavid, Luis F./0000-0002-6778-7958				Bimber BN, 2008, J IMMUNOL, V181, P6301, DOI 10.4049/jimmunol.181.9.6301; Boyington JC, 2002, MOL IMMUNOL, V38, P1007, DOI 10.1016/S0161-5890(02)00030-5; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Cadavid LF, 2009, IMMUNOGENETICS, V61, P27, DOI 10.1007/s00251-008-0342-y; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chwae YJ, 1999, IMMUNOL LETT, V68, P267, DOI 10.1016/S0165-2478(99)00062-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Goodridge JP, 2007, EUR J IMMUNOL, V37, P199, DOI 10.1002/eji.200636316; Guethlein LA, 2002, J IMMUNOL, V169, P220, DOI 10.4049/jimmunol.169.1.220; Guethlein LA, 2007, J IMMUNOL, V179, P491, DOI 10.4049/jimmunol.179.1.491; Hao L, 2005, GENE, V347, P149, DOI 10.1016/j.gene.2004.12.012; Hershberger KL, 2005, EUR J IMMUNOL, V35, P922, DOI 10.1002/eji.200425408; Hershberger KL, 2001, J IMMUNOL, V166, P4380, DOI 10.4049/jimmunol.166.7.4380; Hughes AL, 2002, MOL PHYLOGENET EVOL, V25, P330, DOI 10.1016/S1055-7903(02)00255-5; Isakov N, 1997, J LEUKOCYTE BIOL, V61, P6, DOI 10.1002/jlb.61.1.6; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mager DL, 2001, CURR BIOL, V11, P626, DOI 10.1016/S0960-9822(01)00148-8; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; National Research Council, 2011, GUIDE CARE USE LAB A, DOI [10.17226/12910, DOI 10.17226/12910]; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Palacios C, 2011, GENE, V474, P39, DOI 10.1016/j.gene.2010.12.006; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Rajalingam R, 2004, J IMMUNOL, V172, P356, DOI 10.4049/jimmunol.172.1.356; Rajalingam Raja, 2011, Korean J Hematol, V46, P216, DOI 10.5045/kjh.2011.46.4.216; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79731	10.1371/journal.pone.0079731	http://dx.doi.org/10.1371/journal.pone.0079731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223188	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200081
J	Xu, JL; Yin, ZQ; Shen, H; Gao, W; Qian, YY; Pei, D; Liu, LX; Shu, YQ				Xu, Jiali; Yin, Zhiqiang; Shen, Hong; Gao, Wen; Qian, Yingying; Pei, Dong; Liu, Lingxiang; Shu, Yongqian			A Genetic Polymorphism in pre-miR-27a Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ONCOGENIC MICRORNA-27A; METFORMIN; EXPRESSION; SURVIVAL; SUSCEPTIBILITY; CHEMOTHERAPY; METAANALYSIS; MECHANISM; IMPACT	Background: Recent evidence indicates that microRNAs (miRNAs) can function as tumor suppressors and oncogenes. Single nucleotide polymorphisms (SNPs) at miRNA genes can influence the maturation of miRNAs or miRNA-mediated transcriptional regulation. Our objective was to investigate the association of SNPs in deregulated miRNAs with clinical outcome in patients with non-small cell lung cancer (NSCLC) in a Chinese population. Methods: Deregulated miRNAs in NSCLC and their SNPs were identified through public databases. A single SNP, rs895819 in pre-miR-27a, was found suitable for selection. TaqMan assays were performed for genotyping and to assess the effect on the overall survival (OS) and chemotherapy response in 576 NSCLC patients. Results: Log-rank test and Cox regression analysis indicated that the G allele of rs895819 was associated with shorter survival and increased risk of death in NSCLC [dominant model: 22.0 vs. 46.0 months, P<0.001; adjusted hazard ratio (HR) = 1.71, 95% confidential interval (CI): 1.12-2.26]. Further stepwise regression analysis suggested that this SNP was an independently unfavorable factor for the prognosis of NSCLC and the effect remained significant in subgroup analysis stratified by clinical parameters and treatment status. Moreover, multivariate logistic regression analysis showed that the subjects with AG/GG genotypes of rs895819 had significantly decreased response rate to platinum-based chemotherapy compared to those with the AA genotype. Conclusion: Our results suggest that the pre-miR-27a rs895819 polymorphism may influence NSCLC patients' clinical outcome. Further large sample studies should be used to validate our findings.	[Xu, Jiali; Shen, Hong; Gao, Wen; Qian, Yingying; Pei, Dong; Liu, Lingxiang; Shu, Yongqian] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yin, Zhiqiang] Nanjing Med Univ, Dept Dermatol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn	Liu, Lingxiang/I-7538-2016; Shu, Yongqian/ABD-5698-2021	Liu, Lingxiang/0000-0001-8689-1788; 	National Natural Science Foundation of China [81172140, 81272532]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (81172140, 81272532) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bahl A, 2001, BRIT J CANCER, V84, P1143, DOI 10.1054/bjoc.2000.1740; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hatlen P, 2011, J THORAC ONCOL, V6, P1810, DOI 10.1097/JTO.0b013e31822a75be; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hong MJ, 2013, J THORAC ONCOL, V8, P703, DOI 10.1097/JTO.0b013e318288dc0a; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jiang Y, 2013, INT J CANC; Kao S, 2012, NUCLEIC ACIDS RES, V40, pD972, DOI 10.1093/nar/gkr1183; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shi DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046566; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Sun QM, 2009, ONCOL REP, V22, P563, DOI 10.3892/or_00000472; Sweeney C, 2003, CANCER EPIDEM BIOMAR, V12, P527; Tan BX, 2011, CANCER-AM CANCER SOC, V117, P5103, DOI 10.1002/cncr.26151; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xu L, 2013, ANTICANCER AGENTS ME; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang Q, 2012, ONCOGENE; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	56	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79135	10.1371/journal.pone.0079135	http://dx.doi.org/10.1371/journal.pone.0079135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223174	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200066
J	Augis, V; Airiau, K; Josselin, M; Turcq, B; Mahon, FX; Belloc, F				Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis			A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; DOWN-REGULATION; BIM; RESISTANCE; APOPTOSIS; MUTATIONS; SUPPRESSOR; GENES; CELLS; BCL-2	Purpose: BIM is essential for the response to tyrosine-kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) patients. Recently, a deletion polymorphism in intron 2 of the BIM gene was demonstrated to confer an intrinsic TKI resistance in Asian patients. The present study aimed at identifying mutations in the BIM sequence that could lead to imatinib resistance independently of BCR-ABL mutations. Experimental Design: BIM coding sequence analysis was performed in 72 imatinib-treated CML patients from a French population of our centre and in 29 healthy controls (reference population) as a case-control study. Real-time quantitative PCR (RT qPCR) was performed to assess Bim expression in our reference population. Results: No mutation with amino-acid change was found in the BIM coding sequence. However, we observed a silent single nucleotide polymorphism (SNP) c465C>T (rs724710). A strong statistical link was found between the presence of the T allele and the high Sokal risk group (p = 0.0065). T allele frequency was higher in non responsive patients than in the reference population (p = 0.0049). Similarly, this T allele was associated with the mutation frequency on the tyrosine kinase domain of BCR-ABL (p<0.001) and the presence of the T allele significantly lengthened the time to achieve a major molecular response (MMR). Finally, the presence of the T allele was related to a decreased basal expression of the Bim mRNA in the circulating mononuclear cells of healthy controls. Conclusion: These results suggest that the analysis of the c465C>T SNP of BIM could be useful for predicting the outcome of imatinib-treated CML patients.	[Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis] Univ Bordeaux Segalen, Bordeaux, France; [Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis] INSERM U1035 Bordeaux, Bordeaux, France; [Augis, Vanessa; Mahon, Francois-Xavier; Belloc, Francis] Ctr Hosp Univ Bordeaux, Hematol Lab, Bordeaux, France; [Mahon, Francois-Xavier] Ctr Hosp Univ Bordeaux, Serv Malad Sang, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Augis, V (corresponding author), Univ Bordeaux Segalen, Bordeaux, France.	vanessa.augis@chu-bordeaux.fr		Turcq, Beatrice/0000-0003-2235-8540	La Ligue contre le Cancer Aquitaine	La Ligue contre le Cancer Aquitaine	La Ligue contre le Cancer Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airiau K, 2012, EXP HEMATOL, V40, P367, DOI 10.1016/j.exphem.2012.01.004; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; BARAN Y, 2007, HEMATOLOGY; Belloc F, 2007, CANCER BIOL THER, V6, P912, DOI 10.4161/cbt.6.6.4101; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Branford S, 2006, METH MOLEC MED, V125, P93; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575	25	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78582	10.1371/journal.pone.0078582	http://dx.doi.org/10.1371/journal.pone.0078582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223824	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400033
J	Khanna, S; Santos, MJ; Ustin, SL; Koltunov, A; Kokaly, RF; Roberts, DA				Khanna, Shruti; Santos, Maria J.; Ustin, Susan L.; Koltunov, Alexander; Kokaly, Raymond F.; Roberts, Dar A.			Detection of Salt Marsh Vegetation Stress and Recovery after the Deepwater Horizon Oil Spill in Barataria Bay, Gulf of Mexico Using AVIRIS Data	PLOS ONE			English	Article							LOUISIANA CRUDE-OIL; SPECTRAL REFLECTANCE; HYDROCARBON POLLUTION; REMOTE ESTIMATION; SAUDI-ARABIA; BRACKISH; IMPACT; COAST; CLASSIFICATION; SPECTROSCOPY	The British Petroleum Deepwater Horizon Oil Spill in the Gulf of Mexico was the biggest oil spill in US history. To assess the impact of the oil spill on the saltmarsh plant community, we examined Advanced Visible Infrared Imaging Spectrometer (AVIRIS) data flown over Barataria Bay, Louisiana in September 2010 and August 2011. Oil contamination was mapped using oil absorption features in pixel spectra and used to examine impact of oil along the oiled shorelines. Results showed that vegetation stress was restricted to the tidal zone extending 14 m inland from the shoreline in September 2010. Four indexes of plant stress and three indexes of canopy water content all consistently showed that stress was highest in pixels next to the shoreline and decreased with increasing distance from the shoreline. Index values along the oiled shoreline were significantly lower than those along the oil-free shoreline. Regression of index values with respect to distance from oil showed that in 2011, index values were no longer correlated with proximity to oil suggesting that the marsh was on its way to recovery. Change detection between the two dates showed that areas denuded of vegetation after the oil impact experienced varying degrees of re-vegetation in the following year. This recovery was poorest in the first three pixels adjacent to the shoreline. This study illustrates the usefulness of high spatial resolution airborne imaging spectroscopy to map actual locations where oil from the spill reached the shore and then to assess its impacts on the plant community. We demonstrate that post-oiling trends in terms of plant health and mortality could be detected and monitored, including recovery of these saltmarsh meadows one year after the oil spill.	[Khanna, Shruti; Ustin, Susan L.; Koltunov, Alexander] Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Santos, Maria J.] Stanford Univ, Ctr Spatial & Textual Anal CESTA, Stanford, CA 94305 USA; [Kokaly, Raymond F.] US Geol Survey, Denver, CO 80225 USA; [Roberts, Dar A.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; Stanford University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Khanna, S (corresponding author), Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA.	shrkhanna@ucdavis.edu	Kokaly, Raymond/A-6817-2017; Khanna, Shruti/AAI-5171-2020; Santos, Maria Joao/M-5034-2013	Kokaly, Raymond/0000-0003-0276-7101; Khanna, Shruti/0000-0003-1724-248X; Santos, Maria Joao/0000-0002-6558-7477; Ustin, Susan/0000-0001-8551-0461	NSF [1058134]; Chevron Corp. [201118134]; Chevron	NSF(National Science Foundation (NSF)); Chevron Corp.; Chevron	This work has been partially funded by an NSF Macroecosystems program for a Rapid grant (#1058134) and Chevron Corp. (#201118134). The authors project for Chevron is primarily to provide advice on when to use different types of remote sensing data, mostly to identify land cover types using different types of statistical classification methods. The objective of their funding from Chevron has been to identify cost effective data types and methods of analysis that can be applied under a range of environmental conditions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDOR E, 1990, APPL SPECTROSC, V44, P1064, DOI 10.1366/0003702904086821; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; Bianchi R, 1995, P SOC PHOTO-OPT INS, V2585, P352, DOI 10.1117/12.227199; Brekke C, 2005, REMOTE SENS ENVIRON, V95, P1, DOI 10.1016/j.rse.2004.11.015; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; CLARK RN, 1984, J GEOPHYS RES, V89, P6329, DOI 10.1029/JB089iB07p06329; CLOUTIS EA, 1989, SCIENCE, V245, P165, DOI 10.1126/science.245.4914.165; CROSS AM, 1992, INT J REMOTE SENS, V13, P781, DOI 10.1080/01431169208904152; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; DEDOMENICO L, 1994, MAR POLLUT BULL, V28, P587, DOI 10.1016/0025-326X(94)90359-X; DeLaune RD, 2011, SOIL SCI SOC AM J, V75, P1602, DOI 10.2136/sssaj2011.0168; DELAUNE RD, 1984, ENVIRON POLLUT A, V36, P207, DOI 10.1016/0143-1471(84)90003-5; Fingas MF, 1997, SPILL SCI TECHNOL B, V4, P199, DOI 10.1016/S1353-2561(98)00023-1; Gaffey S.J., 1993, REMOTE GEOCHEMICAL A, P43; GAFFEY SJ, 1986, AM MINERAL, V71, P151; Gerrard A.J., 1981, SOILS LANDFORMS INTE; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286, DOI 10.1016/S0176-1617(11)81633-0; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; GOODMAN R, 1994, SPILL SCI TECHNOL B, V1, P11, DOI 10.1016/1353-2561(94)90004-3; GUNDLACH ER, 1978, MAR TECHNOL SOC J, V12, P18; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hester MW, 2000, MAR ENVIRON RES, V49, P233, DOI 10.1016/S0141-1136(99)00071-9; Horig B, 2001, INT J REMOTE SENS, V22, P1413, DOI 10.1080/01431160010013450; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; Houborg R, 2007, REMOTE SENS ENVIRON, V106, P39, DOI 10.1016/j.rse.2006.07.016; Howari FM, 2004, J COASTAL RES, V20, P1089, DOI 10.2112/03-0023R.1; Hu CM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047184; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Irani M, 2002, INT J COMPUT VISION, V48, P173, DOI 10.1023/A:1016372015744; JACKSON JBC, 1989, SCIENCE, V243, P37, DOI 10.1126/science.243.4887.37; Jurgens C, 1997, INT J REMOTE SENS, V18, P3583, DOI 10.1080/014311697216810; KENWORTHY WJ, 1993, MAR POLLUT BULL, V27, P213, DOI 10.1016/0025-326X(93)90027-H; Khanna S, 2007, REMOTE SENS ENVIRON, V109, P154, DOI 10.1016/j.rse.2006.12.018; Khanna S, 2011, INT J REMOTE SENS, V32, P1067, DOI 10.1080/01431160903505328; Ko JY, 2004, OCEAN COAST MANAGE, V47, P597, DOI 10.1016/j.ocecoaman.2004.12.004; Kokaly R. F., 2011, SHORELINE SURVEYS OI; Kokaly RF, 2013, REMOTE SENS ENVIRON, V129, P210, DOI 10.1016/j.rse.2012.10.028; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Koltunov A, 2009, INT J REMOTE SENS, V30, P57, DOI 10.1080/01431160802220193; Koltunov A., 2012, P ASPRS ANN C SACR C; Leifer I, 2012, REMOTE SENS ENVIRON, V124, P185, DOI 10.1016/j.rse.2012.03.024; Li L, 2005, REMOTE SENS ENVIRON, V94, P1, DOI 10.1016/j.rse.2004.08.010; Lin B, 2004, LECT NOTES COMPUT SC, V3173, P977; Lin QX, 1996, MAR POLLUT BULL, V32, P202, DOI 10.1016/0025-326X(95)00118-7; Liu P, 2011, MAR POLLUT BULL, V62, P2611, DOI 10.1016/j.marpolbul.2011.09.036; Liu Y, 2011, COMBINING NUMERICAL; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Merton R, 1998, MONITORING COMMUNITY; MILTON NM, 1991, REMOTE SENS ENVIRON, V36, P121, DOI 10.1016/0034-4257(91)90034-4; Mishra DR, 2012, REMOTE SENS ENVIRON, V118, P176, DOI 10.1016/j.rse.2011.11.007; Moss L, 2010, 13 LARGEST OIL SPILL; Nagler PL, 2000, REMOTE SENS ENVIRON, V71, P207, DOI 10.1016/S0034-4257(99)00082-6; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Ramsey E, 2011, REMOTE SENS-BASEL, V3, P2630, DOI 10.3390/rs3122630; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; SMITH CJ, 1981, ENVIRON POLLUT A, V26, P297, DOI 10.1016/0143-1471(81)90051-9; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Svejkovsky J, 2012, PHOTOGRAMME IN PRESS; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; van der Meer F, 2002, TERRA NOVA, V14, P1, DOI 10.1046/j.1365-3121.2002.00390.x; Volckaert FAM, 2000, MAR POLLUT BULL, V40, P1051, DOI 10.1016/S0025-326X(00)00056-4; Yang H, 1998, TERRA NOVA, V10, P231; Zar J. H., 2009, BIOSTATISTICAL ANAL; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9	66	52	54	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78989	10.1371/journal.pone.0078989	http://dx.doi.org/10.1371/journal.pone.0078989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223872	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400044
J	Namdar, M; Biaggi, P; Stahli, B; Butler, B; Casado-Arroyo, R; Ricciardi, D; Rodriguez-Manero, M; Steffel, J; Hurlimann, D; Schmied, C; de Asmundis, C; Chierchia, GB; Sarkozy, A; Luscher, TF; Jenni, R; Duru, F; Paulus, WJ; Brugada, P				Namdar, Mehdi; Biaggi, Patric; Staehli, Barbara; Buetler, Bernhard; Casado-Arroyo, Ruben; Ricciardi, Danilo; Rodriguez-Manero, Moises; Steffel, Jan; Huerlimann, David; Schmied, Christian; de Asmundis, Carlo; Chierchia, Gian-Battista; Sarkozy, Andrea; Luescher, Thomas F.; Jenni, Rolf; Duru, Firat; Paulus, Walter J.; Brugada, Pedro			A Novel Electrocardiographic Index for the Diagnosis of Diastolic Dysfunction	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; WALL-MOTION ABNORMALITY; HEART-FAILURE; NATRIURETIC PEPTIDE; EJECTION FRACTION; DOPPLER-ECHOCARDIOGRAPHY; HYPERTENSIVE PATIENTS; QT DISPERSION; HIGH-RISK; T-WAVE	Background: Although the assessment of diastolic dysfunction (DD) is an integral part of routine cardiologic examinations, little is known about associated electrocardiographic (ECG) changes. Our aim was to investigate a potential role of ECG indices for the recognition of patients with DD. Methods and Results: ECG parameters correlating with echocardiographic findings of DD were retrospectively assessed in a derivation group of 172 individuals (83 controls with normal diastolic function, 89 patients with DD) and their diagnostic performance was tested in a validation group of 50 controls and 50 patients. The patient group with a DD Grade 1 and 2 showed longer QTc (422 +/- 24ms and 434 +/- 32ms vs. 409 +/- 25ms, p<0.0005) and shorter Tend-P and Tend-Q intervals, reflecting the electrical and mechanical diastole (240 +/- 78ms and 276 +/- 108ms vs. 373 +/- 110ms, p<0.0001; 409 +/- 85ms and 447 +/- 115ms vs. 526 +/- 119ms, p<0.0001). The PQ-interval was significantly longer in the patient group (169 +/- 28ms and 171 +/- 38ms vs. 153 +/- 22ms, p<0.005). After adjusting for possible confounders, a novel index (Tend-P/[PQxAge]) showed a high performance for the recognition of DD, stayed robust in the validation group (sensitivity 82%, specificity 93%, positive predictive value 93%, negative predictive value 82%, accuracy 88%) and proved a substantial added value when combined with the indexed left atrial volume (LAESVI, sensitivity 90%, specificity 92%, positive predictive value 95%, negative predictive value 86%, accuracy 91%). Conclusions: A novel electrocardiographic index Tend-P/(PQxAge) demonstrates a high diagnostic accuracy for the diagnosis of DD and yields a substantial added value when combined with the LAESVI.	[Namdar, Mehdi; Casado-Arroyo, Ruben; Ricciardi, Danilo; Rodriguez-Manero, Moises; de Asmundis, Carlo; Chierchia, Gian-Battista; Sarkozy, Andrea; Brugada, Pedro] VUB, UZ Brussel, Heart Rhythm Management Ctr, Div Cardiovasc, Brussels, Belgium; [Namdar, Mehdi; Biaggi, Patric; Staehli, Barbara; Buetler, Bernhard; Steffel, Jan; Huerlimann, David; Schmied, Christian; Luescher, Thomas F.; Jenni, Rolf; Duru, Firat] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Paulus, Walter J.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Namdar, Mehdi] Hop Univ Geneve, Serv Cardiol, Geneva, Switzerland	University Hospital Brussels; Vrije Universiteit Brussel; University of Zurich; University Zurich Hospital; Vrije Universiteit Amsterdam; University of Geneva	Namdar, M (corresponding author), VUB, UZ Brussel, Heart Rhythm Management Ctr, Div Cardiovasc, Brussels, Belgium.	mehdi.namdar@hcuge.ch	Rodríguez-Mañero, Moisés/R-6110-2019; Sarkozy, Andrea/C-4939-2017; rolf jenni, MSEE/B-2334-2015; Arroyo, Ruben Casado/L-7726-2019	Rodríguez-Mañero, Moisés/0000-0001-7566-9321; Sarkozy, Andrea/0000-0001-6327-0487; Arroyo, Ruben Casado/0000-0002-3876-6074; de Asmundis, Carlo/0000-0001-9351-0760; Duru, Firat/0000-0002-4748-0158; Namdar, Mehdi/0000-0002-5779-7431; Jenni, Rolf/0000-0002-2609-6915				Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; [Anonymous], [No title captured]; Antzelevitch C, 1997, J ELECTROCARDIOL, V30, P168; Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; Antzelevitch C, 2007, HEART RHYTHM, V4, P1114, DOI 10.1016/j.hrthm.2007.05.028; Bombardini T, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-15; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chiladakis J, 2009, PACING CLIN ELECTROP, V33, P553, DOI DOI 10.1111/J.1540-8159.2009.02657.X.PUBMED:20025715; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DEFERRARI GM, 1994, CIRCULATION, V89, P2126, DOI 10.1161/01.CIR.89.5.2126; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Engel G, 2004, CURR PROB CARDIOLOGY, V29, P365, DOI 10.1016/j.cpcardiol.2004.02.007; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; FREEDMAN RA, 1986, J AM COLL CARDIOL, V7, P595, DOI 10.1016/S0735-1097(86)80470-3; Grewal J, 2008, AM J CARDIOL, V102, P733, DOI 10.1016/j.amjcard.2008.04.048; Haugaa KH, 2009, EUR HEART J, V30, P330, DOI 10.1093/eurheartj/ehn466; Hnatkova K, 2010, J ELECTROCARDIOL, V43, P588, DOI 10.1016/j.jelectrocard.2010.06.003; Hummel YM, 2011, EUR J HEART FAIL, V13, P698, DOI 10.1093/eurjhf/hfr061; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1741, DOI 10.1152/ajpheart.00759.2010; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; LAKATTA EG, 1975, CIRC RES, V36, P262, DOI 10.1161/01.RES.36.2.262; Ledwidge M, 2013, JAMA-J AM MED ASSOC, V310, P66, DOI 10.1001/jama.2013.7588; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; LEV M, 1964, AM J MED, V37, P742, DOI 10.1016/0002-9343(64)90022-1; Mayet J, 1996, HYPERTENSION, V28, P791, DOI 10.1161/01.HYP.28.5.791; McGrady M, 2013, EUR J HEART FAIL, V15, P573, DOI 10.1093/eurjhf/hft001; Muntinga HJ, 1997, NUCL MED COMMUN, V18, P642, DOI 10.1097/00006231-199707000-00008; NADOR F, 1991, CIRCULATION, V84, P1530, DOI 10.1161/01.CIR.84.4.1530; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nakayama K, 1998, HEART, V80, P245, DOI 10.1136/hrt.80.3.245; Nussinovitch U, 2012, ANN NONINVAS ELECTRO, V17, P28, DOI 10.1111/j.1542-474X.2011.00478.x; Oikarinen L, 2001, J HYPERTENS, V19, P1883, DOI 10.1097/00004872-200110000-00025; Okin PM, 2001, J AM COLL CARDIOL, V38, P514, DOI 10.1016/S0735-1097(01)01378-X; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Savoye C, 2003, Eur J Echocardiogr, V4, P209, DOI 10.1016/S1525-2167(03)00011-8; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2; Shuai XX, 2011, EUR J HEART FAIL, V13, P737, DOI 10.1093/eurjhf/hfr053; SIMPSON RJ, 1982, AM J CARDIOL, V50, P1331, DOI 10.1016/0002-9149(82)90471-4; Truong QA, 2011, J ELECTROCARDIOL, V44, P257, DOI 10.1016/j.jelectrocard.2010.04.011; Truong QA, 2011, INT J CARDIOL, V146, P171, DOI 10.1016/j.ijcard.2009.06.029; Tsao CW, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-7; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Vaidean GD, 2005, J ELECTROCARDIOL, V38, P139, DOI 10.1016/j.jelectrocard.2004.09.020; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Vyas H, 2008, J AM SOC ECHOCARDIOG, V21, DOI 10.1016/j.echo.2007.08.001; Wilcox JE, 2011, AM J CARDIOL, V108, P1760, DOI 10.1016/j.amjcard.2011.07.050; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928; YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	51	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79152	10.1371/journal.pone.0079152	http://dx.doi.org/10.1371/journal.pone.0079152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223898	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400048
J	Van Doornik, DM; Berejikian, BA; Campbell, LA				Van Doornik, Donald M.; Berejikian, Barry A.; Campbell, Lance A.			Gene Flow between Sympatric Life History Forms of Oncorhynchus mykiss Located above and below Migratory Barriers	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; RESIDENT RAINBOW-TROUT; FRESH-WATER; POPULATION-STRUCTURE; MICROSATELLITE LOCI; ANADROMOUS STEELHEAD; MATING SYSTEM; CONSERVATION; DIFFERENTIATION; RIVER	Oncorhynchus mykiss have a diverse array of life history types, and understanding the relationship among types is important for management of the species. Patterns of gene flow between sympatric freshwater resident O. mykiss, commonly known as rainbow trout, and anadromous O. mykiss, commonly known as steelhead, populations are complex and poorly understood. In this study, we attempt to determine the occurrence and pathways of gene flow and the degree of genetic similarity between sympatric resident and anadromous O. mykiss in three river systems, and investigate whether resident O. mykiss are producing anadromous offspring in these rivers, two of which have complete barriers to upstream migration. We found that the population structure of the O. mykiss in these rivers appears to be influenced more by the presence of a barrier to upstream migration than by life history type. The sex ratio of resident O. mykiss located above a barrier, and smolts captured in screw traps was significantly skewed in favor of females, whereas the reverse was true below the barriers, suggesting that male resident O. mykiss readily migrate downstream over the barrier, and that precocious male maturation may be occurring in the anadromous populations. Through paternity analyses, we also provide direct confirmation that resident O. mykiss can produce offspring that become anadromous. Most (89%) of the resident O. mykiss that produced anadromous offspring were males. Our results add to the growing body of evidence that shows that gene flow does readily occur between sympatric resident and anadromous O. mykiss life history types, and indicates that resident O. mykiss populations may be a potential repository of genes for the anadromous life history type.	[Van Doornik, Donald M.; Berejikian, Barry A.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Manchester, WA 98353 USA; [Campbell, Lance A.] Washington Dept Fish & Wildlife, Olympia, WA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW)	Van Doornik, DM (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Manchester, WA 98353 USA.	don.vandoornik@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	National Oceanic and Atmospheric Administration; Hood Canal Salmon Enhancement Group, Long Live the Kings; Skokomish Tribal Nation; U.S. Fish and Wildlife Service; Washington Department of Fish and Wildlife	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Hood Canal Salmon Enhancement Group, Long Live the Kings; Skokomish Tribal Nation; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Washington Department of Fish and Wildlife	Primary funding for this work was provided by the National Oceanic and Atmospheric Administration. Additional support was provided by the Hood Canal Salmon Enhancement Group, Long Live the Kings, the Skokomish Tribal Nation, the U.S. Fish and Wildlife Service, and the Washington Department of Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; [Anonymous], 2002, FSTAT VERSION 2 9 3; Araki H, 2007, MOL ECOL, V16, P953, DOI 10.1111/j.1365-294X.2006.03206.x; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Behnke RJ, 2002, TROUT SALMON N AM; Berejikian BA, 2008, CAN J FISH AQUAT SCI, V65, P754, DOI 10.1139/F08-014; Berejikian BA, 2013, CAN J FISH AQUAT SCI, V70, P756, DOI 10.1139/cjfas-2012-0491; Berejikian BA, 2012, ENVIRON BIOL FISH, V94, P29, DOI 10.1007/s10641-011-9788-0; Brunelli JP, 2008, GENOME, V51, P739, DOI 10.1139/G08-060; Buchholz W., 1999, 991 US FISH WILDL SE; BUSBY PJ, 1996, NMFSNWFSC27 NAT OC A; Cairney M, 2000, MOL ECOL, V9, P2175, DOI 10.1046/j.1365-294X.2000.105312.x; Christie MR, 2011, MOL ECOL, V20, P1263, DOI 10.1111/j.1365-294X.2010.04994.x; Clemento AJ, 2009, CONSERV GENET, V10, P1321, DOI 10.1007/s10592-008-9712-0; Condrey MJ, 1998, MOL ECOL, V7, P787; CURRENS KP, 1990, COPEIA, P730; Docker MF, 2003, CONSERV GENET, V4, P227, DOI 10.1023/A:1023355114612; Donohoe CJ, 2008, CAN J FISH AQUAT SCI, V65, P1060, DOI 10.1139/F08-029; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FOOTE CJ, 1988, BEHAVIOUR, V106, P43, DOI 10.1163/156853988X00089; Good TP, 2005, NMFSNWFSC66 NAT OC A; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Hayes SA, 2012, N AM J FISH MANAGE, V32, P772, DOI 10.1080/02755947.2012.686953; Heath DD, 2008, T AM FISH SOC, V137, P1268, DOI 10.1577/T05-278.1; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hendry Andrew P., 2004, P92; Holecek DE, 2012, T AM FISH SOC, V141, P68, DOI 10.1080/00028487.2011.651550; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kuligowski DR, 2005, T AM FISH SOC, V134, P1202, DOI 10.1577/T04-187.1; MAEKAWA K, 1994, ENVIRON BIOL FISH, V39, P109, DOI 10.1007/BF00004927; McConnell S, 1995, AQUACULTURE, V137, P19, DOI 10.1016/0044-8486(95)01111-0; McMillan JR, 2007, T AM FISH SOC, V136, P736, DOI 10.1577/T06-016.1; McPhee MV, 2007, ECOL FRESHW FISH, V16, P539, DOI 10.1111/j.1600-0633.2007.00248.x; Meka JM, 2003, T AM FISH SOC, V132, P717, DOI 10.1577/T01-166; Moore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049645; Morris DB, 1996, CAN J FISH AQUAT SCI, V53, P120, DOI 10.1139/cjfas-53-1-120; Narum SR, 2004, J FISH BIOL, V65, P471, DOI 10.1111/j.0022-1112.2004.00461.x; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; OConnell M, 1997, CAN J FISH AQUAT SCI, V54, P1391, DOI 10.1139/cjfas-54-6-1391; Olsen JB, 1998, MOL ECOL, V7, P1087; Olsen JB, 2006, CONSERV GENET, V7, P613, DOI 10.1007/s10592-005-9099-0; Pascual M, 2001, T AM FISH SOC, V130, P53, DOI 10.1577/1548-8659(2001)130<0053:FDCOAI>2.0.CO;2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2009, J HERED, V100, P515, DOI 10.1093/jhered/esp040; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rundio DE, 2012, ECOL FRESHW FISH, V21, P293, DOI 10.1111/j.1600-0633.2011.00547.x; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; Seamons TR, 2007, EVOL ECOL RES, V9, P409; Seamons TR, 2004, ENVIRON BIOL FISH, V69, P333, DOI 10.1023/B:EBFI.0000022893.88086.8f; Smith CT, 1998, MOL ECOL, V7, P1614; Spies IB, 2005, MOL ECOL NOTES, V5, P278, DOI 10.1111/j.1471-8286.2005.00900.x; Thibault I, 2010, ECOL FRESHW FISH, V19, P348, DOI 10.1111/j.1600-0633.2010.00417.x; Thrower F, 2004, ENVIRON BIOL FISH, V69, P111, DOI 10.1023/B:EBFI.0000022880.52256.92; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Thrower FP, 2009, CONSERV GENET, V10, P1299, DOI 10.1007/s10592-008-9709-8; Van Doornik DM, 2010, CAN J FISH AQUAT SCI, V67, P1449, DOI 10.1139/F10-073; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WDFW (Washington Department of Fish and Wildlife), 2012, SPAWN GROUND SURV DA; Winans GA, 2008, NORTHWEST SCI, V82, P128, DOI 10.3955/0029-344X-82.S.I.128; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152; Zimmerman CE, 2009, T AM FISH SOC, V138, P280, DOI 10.1577/T08-044.1	69	13	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79931	10.1371/journal.pone.0079931	http://dx.doi.org/10.1371/journal.pone.0079931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224023	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400096
J	Ma, YH; Kang, WJ; Bao, YX; Jiao, FB; Ma, YR				Ma, Yinghuan; Kang, Wanjun; Bao, Yongxin; Jiao, Fubin; Ma, Yiran			Clinical Significance of Ischemia-Modified Albumin in the Diagnosis of Doxorubicin-Induced Myocardial Injury in Breast Cancer Patients	PLOS ONE			English	Article							COBALT-BINDING TEST; ADRIAMYCIN NSC-123127; CARDIOTOXICITY; BIOMARKERS; MARKER; CARDIOMYOPATHY; MECHANISMS; MANAGEMENT	Background: Ischemia-modified albumin is an altered serum albumin that forms under conditions of oxidative stress, a state also associated with doxorubicin-induced myocardial injury. Objective: The aim of this study was to better assess diagnostic and prognostic significance of ischemia-modified albumin in patients with breast cancer undergoing doxorubicin chemotherapy. Methods: Blood samples were collected from 152 breast cancer patients before and after each cycle of doxorubicin chemotherapy to measure the serum levels of ischemia-modified albumin, cardiac troponin T and creatine kinase-MB. We also monitored cardiac function during a 12 month follow-up. Results: There was a significant difference in ischemia-modified albumin levels before and after each cycle of chemotherapy and the ischemia-modified albumin concentration positively correlated with the cumulative dose of doxorubicin (r = 0.212, P < 0.05). The combination of ischemia-modified albumin with cardiac troponin T and creatine kinase-MB increased the sensitivity to 0.920 and the specificity to 0.830 in the diagnosis of doxorubicin-induced myocardial injury. The optimal cutoff for ischemia-modified albumin concentration was 112.09 U/ml. The rate of change for ischemia-modified albumin levels correlated negatively with the rate of change for left ventricular ejection fraction at one year (r = -0.221, P < 0.05). Conclusion: Ischemia-modified albumin may be a clinically potential new marker for diagnosing doxorubicin-induced myocardial injury, and is helpful to predict long-term impairment of cardiac function.	[Ma, Yinghuan; Kang, Wanjun; Bao, Yongxin] 463rd Hosp Chinese PLA, Dept Canc, Shenyang, Liaoning, Peoples R China; [Jiao, Fubin] Gen Advisor Off Chinese PLA, Bur Guard, Div Hlth, Beijing, Peoples R China; [Ma, Yiran] China Med Univ, Hosp 1, Dept Transfus, Shenyang, Liaoning, Peoples R China	China Medical University	Ma, YR (corresponding author), China Med Univ, Hosp 1, Dept Transfus, Shenyang, Liaoning, Peoples R China.	yiransmile@hotmail.com			Shenyang Science and Technology Project [F11-264-1-12]; 463rd Hospital of the Chinese PLA Medical Research Project [070106]; First hospital of China Medical University; 463rd Hospital of the Chinese PLA	Shenyang Science and Technology Project; 463rd Hospital of the Chinese PLA Medical Research Project; First hospital of China Medical University; 463rd Hospital of the Chinese PLA	This work was supported by research grants from Shenyang Science and Technology Project (No. F11-264-1-12) and the 463rd Hospital of the Chinese PLA Medical Research Project (No. 070106). The authors wish to thank the First hospital of China Medical University and the 463rd Hospital of the Chinese PLA for their research grants.	Apple FS, 2002, CLIN CHEM, V48, P1097; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Bar-Or D, 2001, EUR J BIOCHEM, V268, P42, DOI 10.1046/j.1432-1327.2001.01846.x; Barry E, 2007, EXPERT OPIN PHARMACO, V8, P1039, DOI 10.1517/14656566.8.8.1039; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Biskup Piotr, 2006, Pol Arch Med Wewn, V115, P551; BONADONNA G, 1970, CANCER RES, V30, P2572; Christenson RH, 2001, CLIN CHEM, V47, P464; Collinson PO, 2005, SCAND J CLIN LAB INV, V65, P86, DOI 10.1080/00365510500236002; Dawie Jelal, 2011, Ethiop Med J, V49, P25; DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33; Dominguez-Rodriguez A, 2008, CLIN CHIM ACTA, V388, P196, DOI 10.1016/j.cca.2007.10.030; Dong Shi-Yong, 2012, Asian Cardiovasc Thorac Ann, V20, P252, DOI 10.1177/0218492311434947; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; GOORMAGHTIGH E, 1980, BIOCHEM PHARMACOL, V29, P3003, DOI 10.1016/0006-2952(80)90050-7; Govender R, 2008, CARDIOVASC J AFR, V19, P141; Gunduz A, 2008, AM J EMERG MED, V26, P874, DOI 10.1016/j.ajem.2007.11.023; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HAQ MM, 1985, CANCER-AM CANCER SOC, V56, P1361, DOI 10.1002/1097-0142(19850915)56:6<1361::AID-CNCR2820560624>3.0.CO;2-S; Hjortshoj S, 2009, CLIN CHIM ACTA, V403, P114, DOI 10.1016/j.cca.2009.01.033; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kehl DW, 2012, TRANSL RES, V159, P252, DOI 10.1016/j.trsl.2011.11.002; Khattry N, 2009, MED PEDIATR ONCOL, V30, P9, DOI [10.4103/0971-5851.56329, DOI 10.4103/0971-5851.56329]; Mentese A, 2008, EMERG MED J, V25, P811, DOI 10.1136/emj.2007.056614; Montagnana M, 2006, CLIN BIOCHEM, V39, P913, DOI 10.1016/j.clinbiochem.2006.03.016; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Quiles JL, 2002, TOXICOLOGY, V180, P79, DOI 10.1016/S0300-483X(02)00383-9; Rathe M, 2010, PEDIATR BLOOD CANCER, V54, P444, DOI 10.1002/pbc.22302; Roy D, 2006, HEART, V92, P113, DOI 10.1136/hrt.2004.049643; Sbarouni E, 2011, CLIN CHEM LAB MED, V49, P177, DOI 10.1515/CCLM.2011.037; Sinha MK, 2004, EMERG MED J, V21, P29, DOI 10.1136/emj.2003.006007; Sliwinska J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/890826; Stoodley PW, 2011, HEART LUNG CIRC, V20, P3, DOI 10.1016/j.hlc.2010.09.007; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Talwalkar SS, 2008, ANN CLIN LAB SCI, V38, P132; Turedi S, 2009, AM J EMERG MED, V27, P635, DOI 10.1016/j.ajem.2008.05.002; Ukinc K, 2009, ENDOCRINE, V36, P425, DOI 10.1007/s12020-009-9236-5; Zapico-Muniz E, 2004, CLIN CHEM, V50, P1063, DOI 10.1373/clinchem.2003.027789; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhou SY, 2001, CANCER RES, V61, P771	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79426	10.1371/journal.pone.0079426	http://dx.doi.org/10.1371/journal.pone.0079426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223946	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400113
J	Vondenhoff, GH; Pugach, K; Gadakh, B; Carlier, L; Rozenski, J; Froeyen, M; Severinov, K; Van Aerschot, A				Vondenhoff, Gaston H.; Pugach, Ksenia; Gadakh, Bharat; Carlier, Laurence; Rozenski, Jef; Froeyen, Mathy; Severinov, Konstantin; Van Aerschot, Arthur			N-Alkylated Aminoacyl sulfamoyladenosines as Potential Inhibitors of Aminoacylation Reactions and Microcin C Analogues Containing D-Amino Acids	PLOS ONE			English	Article							D-TYR-TRNA(TYR) DEACYLASE; RESISTANCE; BIOSYNTHESIS; RECOGNITION; MECHANISM; PEPTIDE; COLI; CELL; FORM	Microcin C analogues were recently envisaged as important compounds for the development of novel antibiotics. Two issues that may pose problems to these potential antibiotics are possible acquisition of resistance through acetylation and in vivo instability of the peptide chain. N-methylated aminoacyl sulfamoyladenosines were synthesized to investigate their potential as aminoacyl tRNA synthetase inhibitors and to establish whether these N-alkylated analogues would escape the natural inactivation mechanism via acetylation of the alpha amine. It was shown however, that these compounds are not able to effectively inhibit their respective aminoacyl tRNA synthetase. In addition, we showed that (D)-aspartyl-sulfamoyladenosine (i.e. with a (D)-configuration for the aspartyl moiety), is a potent inhibitor of aspartyl tRNA synthetase. However, we also showed that the inhibitory effect of (D)-aspartyl-sulfamoyladenosine is relatively short-lasting. Microcin C analogues with (D)-amino acids throughout from positions two to six proved inactive. They were shown to be resistant against metabolism by the different peptidases and therefore not able to release the active moiety. This observation could not be reversed by incorporation of (L)-amino acids at position six, showing that none of the available peptidases exhibit endopeptidase activity.	[Vondenhoff, Gaston H.; Pugach, Ksenia; Gadakh, Bharat; Carlier, Laurence; Rozenski, Jef; Froeyen, Mathy; Van Aerschot, Arthur] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, Piscataway, NJ USA; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	KU Leuven; Universite Catholique Louvain; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Van Aerschot, A (corresponding author), Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, Minderbroedersstr 10, B-3000 Louvain, Belgium.	Arthur.VanAerschot@rega.kuleuven.be	Severinov, Konstantin/C-8545-2016; Gadakh, Bharat K./F-9886-2014; Froeyen, Mathy MC/I-1665-2014	Gadakh, Bharat K./0000-0001-6814-4818; Froeyen, Mathy MC/0000-0002-8675-6540; Rozenski, Jef/0000-0001-9624-5536; Van Aerschot, Arthur/0000-0003-3528-8588	Belgian IWT fellowship [SB81117]; Hercules Foundation of the Flemish Government [20100225-7]; Russian Academy of Sciences; Erasmus Mundus External Cooperation Window lot 13 fellowship	Belgian IWT fellowship; Hercules Foundation of the Flemish Government; Russian Academy of Sciences(Russian Academy of Sciences); Erasmus Mundus External Cooperation Window lot 13 fellowship	GV was recipient of a Belgian IWT fellowship (SB81117). MS was made possible by the Hercules Foundation of the Flemish Government (grant 20100225-7). KS was supported by a Russian Academy of Sciences Presidium Nanotechnology Program grant. Bharat Gadakh received an Erasmus Mundus External Cooperation Window lot 13 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik SD, 2010, J PHYS CHEM B, V114, P2301, DOI 10.1021/jp910730s; Banik SD, 2013, TOP CURR CHEM, V333, P255, DOI 10.1007/128_2012_369; Banik SD, 2012, J BIOMOL STRUCT DYN, V30, P701, DOI 10.1080/07391102.2012.689701; Beautement K, 1999, N ALPHA AMINOACYL 5, P288; BENZ G, 1984, LIEBIGS ANN CHEM, P1408, DOI 10.1002/jlac.198419840803; Chacon O, 2009, MICROBIOL-SGM, V155, P1440, DOI 10.1099/mic.0.024901-0; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Malde AK, 2009, J AM CHEM SOC, V131, P3848, DOI 10.1021/ja9002124; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Rink R, J PHARMACOL TOX MET, V61, P210, DOI [10.1016/j.vascn.2010.02.010, DOI 10.1016/J.VASCN.2010.02.010.PUBMED:20176117]; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Thompson D, 2007, J BIOL CHEM, V282, P30856, DOI 10.1074/jbc.M704788200; Tikhonov A, 2010, J BIOL CHEM, V285, P37944, DOI 10.1074/jbc.M110.179135; Van de Vijver P, 2009, BIOORGAN MED CHEM, V17, P260, DOI 10.1016/j.bmc.2008.11.054; Van de Vijver P, 2009, J BACTERIOL, V191, P6273, DOI 10.1128/JB.00829-09; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Vondenhoff GHM, 2011, NUCLEOS NUCLEOT NUCL, V30, P465, DOI 10.1080/15257770.2011.583972; Vondenhoff GHM, 2011, BIOORGAN MED CHEM, V19, P5462, DOI 10.1016/j.bmc.2011.07.052; Vondenhoff GHM, 2011, J BACTERIOL, V193, P3618, DOI 10.1128/JB.00172-11; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Wydau S, 2009, J BIOL CHEM, V284, P14096, DOI 10.1074/jbc.M808173200; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79234	10.1371/journal.pone.0079234	http://dx.doi.org/10.1371/journal.pone.0079234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223911	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400104
J	Lee, DE; Kim, SY; Lim, JH; Park, SY; Ryu, HM				Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee			Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma	PLOS ONE			English	Article							CELL-FREE DNA; FETAL DNA; SERUM; DIAGNOSIS; ORIGIN; MASPIN; WOMEN; GENE	Background: Quantification of cell-free fetal DNA by methylation-based DNA discrimination has been used in non-invasive prenatal testing of fetal chromosomal aneuploidy. The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells. The objective of this study was to evaluate the accuracy of non-invasive detection of fetal trisomy 18 using the unmethylated-maspin (U-maspin) gene as a cell-free fetal DNA marker and the methylated-maspin (M-maspin) gene as a cell-free total DNA marker in the first trimester of pregnancy. Methodology/Principal Findings: A nested case-control study was conducted using maternal plasma collected from 66 pregnant women, 11 carrying fetuses with trisomy 18 and 55 carrying normal fetuses. Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001). Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001). The specificities of U-maspin and M-maspin concentrations for non-invasive fetal trisomy 18 detection were 96.4% and 74.5%, respectively, with a sensitivity of 90.9%. Conclusions: Our results suggest that U-maspin and M-maspin concentrations may be useful as potential biomarkers for non-invasive detection of fetal trisomy 18 in the first trimester of pregnancy, irrespective of the sex and genetic variations of the fetus.	[Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Lee, Da Eun; Kim, Shin Young; Lim, Ji Hyae; Park, So Yeon; Ryu, Hyun Mee] Womens Healthcare Ctr, Seoul, South Korea; [Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Ryu, Hyun Mee] Kwandong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea	Catholic Kwandong University	Ryu, HM (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Lim, Ji Hyae/N-4634-2013	Lim, Ji Hyae/0000-0002-1105-7235	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111550]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This project was supported by the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Bianchi DW, 2012, OBSTET GYNECOLOGY, V119, P1; Brojer E, 2005, TRANSFUSION, V45, P1473, DOI 10.1111/j.1537-2995.2005.00559.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cereda A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-81; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dokras A, 2002, PLACENTA, V23, P274, DOI 10.1053/plac.2001.0784; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Herman JG, 1996, CANCER RES, V56, P722; Leung TN, 2001, CLIN CHEM, V47, P137; Lim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056787; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Lui YNYN, 2002, CLIN CHEM, V48, P421; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; PALOMAKI GE, 1995, PRENATAL DIAG, V15, P713, DOI 10.1002/pd.1970150806; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Spencer K, 2003, PRENATAL DIAG, V23, P580, DOI 10.1002/pd.647; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Zhong XY, 2006, PRENATAL DIAG, V26, P1272, DOI 10.1002/pd	27	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78136	10.1371/journal.pone.0078136	http://dx.doi.org/10.1371/journal.pone.0078136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223769	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300025
J	Bee, C; Abdiche, YN; Pons, J; Rajpal, A				Bee, Christine; Abdiche, Yasmina N.; Pons, Jaume; Rajpal, Arvind			Determining the Binding Affinity of Therapeutic Monoclonal Antibodies towards Their Native Unpurified Antigens in Human Serum	PLOS ONE			English	Article							PROTEIN; EQUILIBRIUM; PROGRANULIN; CHOLESTEROL	Monoclonal antibodies (mAbs) are a growing segment of therapeutics, yet their in vitro characterization remains challenging. While it is essential that a therapeutic mAb recognizes the native, physiologically occurring epitope, the generation and selection of mAbs often rely on the use of purified recombinant versions of the antigen that may display non-native epitopes. Here, we present a method to measure both, the binding affinity of a therapeutic mAb towards its native unpurified antigen in human serum, and the antigen's endogenous concentration, by combining the kinetic exclusion assay and Biacore's calibration free concentration analysis. To illustrate the broad utility of our method, we studied a panel of mAbs raised against three disparate soluble antigens that are abundant in the serum of healthy donors: proprotein convertase subtilisin/kexin type 9 (PCSK9), progranulin (PGRN), and fatty acid binding protein (FABP4). We also determined the affinity of each mAb towards its purified recombinant antigen and assessed whether the interactions were pH-dependent. Of the six mAbs studied, three did not appear to discriminate between the serum and recombinant forms of the antigen; one mAb bound serum antigen with a higher affinity than recombinant antigen; and two mAbs displayed a different affinity for serum antigen that could be explained by a pH-dependent interaction. Our results highlight the importance of taking pH into account when measuring the affinities of mAbs towards their serum antigens, since the pH of serum samples becomes increasingly alkaline upon aerobic handling.	[Bee, Christine; Abdiche, Yasmina N.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat, San Francisco, CA USA	Pfizer	Abdiche, YN (corresponding author), Pfizer Inc, Rinat, San Francisco, CA USA.	Yasmina.Abdiche@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	All research was funded by Pfizer Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2011, ANAL BIOCHEM, V411, P139, DOI 10.1016/j.ab.2010.12.020; Bee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036261; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day YSN, 2002, PROTEIN SCI, V11, P1017, DOI 10.1110/ps.4330102; Drake AW, 2012, ANAL BIOCHEM, V429, P58, DOI 10.1016/j.ab.2012.06.024; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Myszka D G, 2003, J Biomol Tech, V14, P247; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Rathanaswami P, 2011, ANAL BIOCHEM, V414, P7, DOI 10.1016/j.ab.2011.02.034; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Tkaczuk KR, 2011, BREAST CANCER-BASIC, V5, P155, DOI 10.4137/BCBCR.S7224	15	22	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80501	10.1371/journal.pone.0080501	http://dx.doi.org/10.1371/journal.pone.0080501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223227	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200120
J	Siami, S; Polito, A; Porcher, R; Hissem, T; Blanchard, A; Boucly, C; Carlier, R; Annane, D; Haymann, JP; Sharshar, T				Siami, Shidasp; Polito, Andrea; Porcher, Raphael; Hissem, Tarik; Blanchard, Anne; Boucly, Catherine; Carlier, Robert; Annane, Djillali; Haymann, Jean-Philippe; Sharshar, Tarek			Thirst Perception and Osmoregulation of Vasopressin Secretion Are Altered During Recovery From Septic Shock	PLOS ONE			English	Article							ANTIDIURETIC-HORMONE; RELEASE; PNEUMONIA; EXCRETION; FAILURE; NEURONS; HUMANS; BRAIN; SCORE; RATS	Objective: Vasopressin (AVP) secretion during an osmotic challenge is frequently altered in the immediate post-acute phase of septic shock. We sought to determine if this response is still altered in patients recovering from septic shock. Design: Prospective interventional study Setting: Intensive care unit (ICU) at Raymond Poincare and Etampes Hospitals. Patients: Normonatremic patients at least 5 days post discontinuation of catecholamines given for a septic shock. Intervention: Osmotic challenge involved infusing 500 mL of hypertonic saline solution (with cumulative amount of sodium not exceeding 24 g) over 120 minutes. Measurements and main results: Plasma AVP levels were measured 15 minutes before the infusion and then every 30 minutes for two hours. Non-responders were defined as those with a slope of the relation between AVP and plasma sodium levels less than < 0.5 ng/mEq. Among the 30 included patients, 18 (60%) were non-responders. Blood pressure and plasma sodium and brain natriuretic peptide levels were similar in both responders and non-responders during the course of the test. Critical illness severity, hemodynamic alteration, electrolyte disturbances, treatment and outcome did not differ between the two groups. Responders had more severe gas exchange abnormality. Thirst perception was significantly diminished in non-responders. The osmotic challenge was repeated in 4 non-responders several months after discharge and the abnormal response persisted. Conclusion: More than half of patients recovering from septic shock have an alteration of osmoregulation characterised by a dramatic decrease in vasopressin secretion and thirst perception during osmotic challenge. The mechanisms of this alteration but also of the relationship between haematosis and normal response remain to be elucidated.	[Siami, Shidasp; Hissem, Tarik] Sud Essonne Hosp, Dept Intens Care Med, Etampes, France; [Polito, Andrea; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Garches, France; [Porcher, Raphael] St Louis Teaching Hosp, Biostat & Med Comp Sci Dept, Paris, France; [Blanchard, Anne] Univ Paris 05, European Georges Pompidou Teaching Hosp, AP HP, Clin Invest Ctr, Paris, France; [Blanchard, Anne] INSERM, CIC9201, Paris, France; [Boucly, Catherine] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Dept Biochem, Garches, France; [Carlier, Robert] Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Dept Radiol, Garches, France; [Haymann, Jean-Philippe] Univ Paris 06, Tenon Teaching Hosp, AP HP, Dept Funct Invest, Paris, France; [Haymann, Jean-Philippe] INSERM, U702, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sharshar, T (corresponding author), Univ Versailles St Quentin En Yvelines, Raymond Poincare Hosp, AP HP, Garches, France.	tarek.sharshar@rpc.aphp.fr	Sharshar, Tarek/ABF-4117-2021; Annane, Djillali/R-7947-2019	BLANCHARD, Anne/0000-0002-0815-0586; Porcher, Raphael/0000-0002-5277-4679	Programme Hospitalier de Recherche Clinique [AOR 05047]	Programme Hospitalier de Recherche Clinique	The study was supported, in part, by Grant AOR 05047 from the Programme Hospitalier de Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2009, CHEST; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; BAERTSCHI AJ, 1981, J PHYSIOL-LONDON, V315, P217, DOI 10.1113/jphysiol.1981.sp013743; BAYLIS PH, 1987, AM J PHYSIOL, V253, pR671, DOI 10.1152/ajpregu.1987.253.5.R671; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; CAILLENS H, 1982, ANN PHARM FR, V40, P113; Carlson SH, 1997, AM J PHYSIOL-REG I, V272, pR750, DOI 10.1152/ajpregu.1997.272.3.R750; Darmon M, 2010, NEPHROL DIAL TRANSPL, V25, P2510, DOI 10.1093/ndt/gfq067; DREYFUSS D, 1988, AM REV RESPIR DIS, V138, P583, DOI 10.1164/ajrccm/138.3.583; Giltinan, 1995, MONOGRAPHS STAT APPL; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Hussy N, 1997, J PHYSIOL-LONDON, V502, P609, DOI 10.1111/j.1469-7793.1997.609bj.x; Ishikawa S, 1996, ENDOCR J, V43, P101, DOI 10.1507/endocrj.43.101; Landry DW, 1997, CIRCULATION, V95, P1122; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P845; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; PHILLIPS PA, 1985, AM J PHYSIOL, V248, pR645, DOI 10.1152/ajpregu.1985.248.6.R645; Pinheiro J, 2001, MIXED EFFECTS MODELS; PRUSZCZYNSKI W, 1984, CLIN SCI, V67, P307, DOI 10.1042/cs0670307; Richard D, 1996, J NEUROSCI, V16, P7526; ROSENOW EC, 1972, MAYO CLIN PROC, V47, P169; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharshar T, 2003, CRIT CARE MED, V31, P1752, DOI 10.1097/01.CCM.0000063046.82359.4A; Sharshar T, 2002, CRIT CARE MED, V30, P497, DOI 10.1097/00003246-200203000-00001; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Sharshar T, 2008, BEST PRACT RES-CLIN, V22, P265, DOI 10.1016/j.bpa.2008.02.005; Siami S, 2010, CRIT CARE MED, V38, P1962, DOI 10.1097/CCM.0b013e3181eb9acf; THIBONNIER M, 1984, KIDNEY INT, V25, P411, DOI 10.1038/ki.1984.32; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199	33	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80190	10.1371/journal.pone.0080190	http://dx.doi.org/10.1371/journal.pone.0080190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223220	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200113
J	Trombetta-eSilva, J; Eadie, EP; Zhang, YH; Norris, RA; Borg, TK; Bradshaw, AD				Trombetta-eSilva, Jessica; Eadie, Erik P.; Zhang, Yuhua; Norris, Russell A.; Borg, Thomas K.; Bradshaw, Amy D.			The Effects of Age and the Expression of SPARC on Extracellular Matrix Production by Cardiac Fibroblasts in 3-D Cultures	PLOS ONE			English	Article							FIBRILLAR COLLAGEN CONTENT; DIASTOLIC FUNCTION ROLE; CONNECTIVE-TISSUE; IN-VITRO; NETWORK; HEART; BIOLOGY; MUSCLE; TENDON	Fibrillar collagen is the primary component of the cardiac interstitial extracellular matrix. This extracellular matrix undergoes dramatic changes from birth to adulthood and then into advanced age. As evidence, fibrillar collagen content was compared in sections from neonates, adult, and old hearts and was found to increase at each respective age. Cardiac fibroblasts are the principle cell type that produce and control fibrillar collagen content. To determine whether fibroblast production, processing, and deposition of collagen differed with age, primary cardiac fibroblasts from neonate, adult, and old mice were isolated and cultured in 3-dimensional (3D) fibrin gels. Fibroblasts from each age aligned in fibrin gels along points of tension and deposited extracellular matrix. By confocal microscopy, wild-type neonate fibroblasts appeared to deposit less collagen into fibrillar structures than fibroblasts from adults. However, by immunoblot analysis, differences in procollagen production and processing of collagen I were not detected in neonate versus adult fibroblasts. In contrast, fibroblasts from old mice demonstrated increased efficiency of procollagen processing coupled with decreased production of total collagen. SPARC is a collagen-binding protein previously shown to affect cardiac collagen deposition. Accordingly, in the absence of SPARC, less collagen appeared to be associated with fibroblasts of each age grown in fibrin gels. In addition, the increased efficiency of procollagen alpha 1(I) processing in old wild-type fibroblasts was not detected in old SPARC-null fibroblasts. Increased levels of fibronectin were detected in wild-type neonate fibroblasts over that of adult and old fibroblasts but not in SPARC-null neonate fibroblasts versus older ages. Immunostaining of SPARC overlapped with that of collagen I but not to that of fibronectin in 3D cultures. Hence, whereas increases in procollagen processing, influenced by SPARC expression, plausibly contribute to increased collagen deposition in old hearts, other cellular mechanisms likely affect differential collagen deposition by neonate fibroblasts.	[Trombetta-eSilva, Jessica; Bradshaw, Amy D.] Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Eadie, Erik P.; Norris, Russell A.; Borg, Thomas K.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Zhang, Yuhua; Bradshaw, Amy D.] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Bradshaw, Amy D.] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Bradshaw, AD (corresponding author), Med Univ S Carolina, Dept Craniofacial Biol, Charleston, SC 29425 USA.	bradshad@musc.edu			Research Service of the Department of Veterans Affairs [1I01BX001385-01A1]; National Heart, Lung, and Blood Institute [HL085847]; National Institute of Dental and Craniofacial Research [DE023009-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023009] Funding Source: NIH RePORTER	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Research Service of the Department of Veterans Affairs (Dr. Bradshaw: 1I01BX001385-01A1) and grants from the National Heart, Lung, and Blood Institute (Dr. Borg: HL085847) and the National Institute of Dental and Craniofacial Research (Ms Trombetta-eSilva: DE023009-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; BORG TK, 1982, SCAN ELECTRON MICROS, P1775; BORG TK, 1982, AM J ANAT, V165, P435, DOI 10.1002/aja.1001650407; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; CAULFIELD JB, 1979, LAB INVEST, V40, P364; EGHBALI M, 1989, CARDIOVASC RES, V23, P723, DOI 10.1093/cvr/23.8.723; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Moxham B J, 1995, Connect Tissue Res, V33, P31, DOI 10.3109/03008209509016978; Nehls V, 1998, CELL TISSUE RES, V293, P479, DOI 10.1007/s004410051140; Ngo P, 2006, METH MOL B, V341, P103; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Robinson PS, 2008, TISSUE ENG PT A, V14, P83, DOI 10.1089/ten.a.2007.0148; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341	22	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79715	10.1371/journal.pone.0079715	http://dx.doi.org/10.1371/journal.pone.0079715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223185	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200078
J	Xing, L; Niu, MJ; Zhao, X; Kleiman, L				Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence			Roles of the Linker Region of RNA Helicase A in HIV-1 RNA Metabolism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TAT PROTEIN; VIRAL-RNA; IN-VITRO; BINDING; TRANSCRIPTION; REPLICATION; EXPRESSION; CELLS; REQUIREMENT	RNA helicase A (RHA) promotes multiple steps in HIV-1 production including transcription and translation of viral RNA, annealing of primer tRNA(Lys3) to viral RNA, and elevating the ratio of unspliced to spliced viral RNA. At its amino terminus are two double-stranded RNA binding domains (dsRBDs) that are essential for RHA-viral RNA interaction. Linking the dsRBDs to the core helicase domain is a linker region containing 6 predicted helices. Working in vitro with purified mutant RHAs containing deletions of individual helices reveals that this region may regulate the enzyme's helicase activity, since deletion of helix 2 or 3 reduces the rate of unwinding RNA by RHA. The biological significance of this finding was then examined during HIV-1 production. Deletions in the linker region do not significantly affect either RHA-HIV-1 RNA interaction in vivo or the incorporation of mutant RHAs into progeny virions. While the partial reduction in helicase activity of mutant RHA containing a deletion of helices 2 or 3 does not reduce the ability of RHA to stimulate viral RNA synthesis, the promotion of tRNA(Lys3) annealing to viral RNA is blocked. In contrast, deletion of helices 4 or 5 does not affect the ability of RHA to promote tRNA(Lys3) annealing, but reduces its ability to stimulate viral RNA synthesis. Additionally, RHA stimulation of viral RNA synthesis results in an increased ratio of unspliced to spliced viral RNA, and this increase is not inhibited by deletions in the linker region, nor is the pattern of splicing changed within the similar to 4.0 kb or similar to 1.8 kb HIV-1 RNA classes, suggesting that RHA's effect on suppressing splicing is confined mainly to the first 5'-splice donor site. Overall, the differential responses to the mutations in the linker region of RHA reveal that RHA participates in HIV-1 RNA metabolism by multiple distinct mechanisms.	[Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ, Canada; [Xing, Li; Niu, Meijuan; Zhao, Xia; Kleiman, Lawrence] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Xing, L (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	xingli107@gmail.com; lawrence.kleiman@mcgill.ca	Xing, Li/ABH-3898-2020	Xing, Li/0000-0002-1405-3459	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; CACHIANES G, 1993, BIOTECHNIQUES, V15, P255; CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128; Cordin O, 2012, RNA BIOL, P10; Das AT, 2011, J VIROL, V85, P9506, DOI 10.1128/JVI.00650-11; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; Guo F, 2009, J VIROL, V83, P8099, DOI 10.1128/JVI.00488-09; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Kameoka M, 2002, J VIROL, V76, P3637, DOI 10.1128/JVI.76.8.3637-3645.2002; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kuciak M, 2008, NUCLEIC ACIDS RES, V36, P3389, DOI 10.1093/nar/gkn177; LEE CG, 1992, J BIOL CHEM, V267, P4398; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Mandal D, 2010, J VIROL, V84, P12790, DOI 10.1128/JVI.01257-10; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; NEUMANN M, 1994, AIDS RES HUM RETROV, V10, P1531, DOI 10.1089/aid.1994.10.1531; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Xing L, 2012, J VIROL, V86, P13272, DOI 10.1128/JVI.01993-12; Xing L, 2011, J VIROL, V85, P8929, DOI 10.1128/JVI.00336-11; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang SS, 1997, J BIOL CHEM, V272, P11487	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78596	10.1371/journal.pone.0078596	http://dx.doi.org/10.1371/journal.pone.0078596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223160	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200052
J	Featherstone, CR; Morrison, CM; Waterman, MG; MacGregor, LJ				Featherstone, Cara R.; Morrison, Catriona M.; Waterman, Mitch G.; MacGregor, Lucy J.			Semantics, Syntax or Neither? A Case for Resolution in the Interpretation of N500 and P600 Responses to Harmonic Incongruities	PLOS ONE			English	Article							ELECTRIC BRAIN RESPONSES; FUNCTIONAL-ANATOMY; MUSIC PERCEPTION; LANGUAGE AREAS; POTENTIALS; MELODIES; TENSION; TIME	The processing of notes and chords which are harmonically incongruous with their context has been shown to elicit two distinct late ERP effects. These effects strongly resemble two effects associated with the processing of linguistic incongruities: a P600, resembling a typical response to syntactic incongruities in language, and an N500, evocative of the N400, which is typically elicited in response to semantic incongruities in language. Despite the robustness of these two patterns in the musical incongruity literature, no consensus has yet been reached as to the reasons for the existence of two distinct responses to harmonic incongruities. This study was the first to use behavioural and ERP data to test two possible explanations for the existence of these two patterns: the musicianship of listeners, and the resolved or unresolved nature of the harmonic incongruities. Results showed that harmonically incongruous notes and chords elicited a late positivity similar to the P600 when they were embedded within sequences which started and ended in the same key (harmonically resolved). The notes and chords which indicated that there would be no return to the original key (leaving the piece harmonically unresolved) were associated with a further P600 in musicians, but with a negativity resembling the N500 in non-musicians. We suggest that the late positivity reflects the conscious perception of a specific element as being incongruous with its context and the efforts of musicians to integrate the harmonic incongruity into its local context as a result of their analytic listening style, while the late negativity reflects the detection of the absence of resolution in non-musicians as a result of their holistic listening style.	[Featherstone, Cara R.; Morrison, Catriona M.; Waterman, Mitch G.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [MacGregor, Lucy J.] Cognit & Brain Sci Unit, Med Res Council, Cambridge, England	University of Leeds; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Featherstone, CR (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	c.r.featherstone@leeds.ac.uk		Waterman, Mitch/0000-0003-0168-0426; MacGregor, Lucy/0000-0002-1062-9529	Economic and Social Research Council	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by an Economic and Social Research Council +3 Open Competition Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSON M, 1994, NEUROSCI LETT, V168, P101, DOI 10.1016/0304-3940(94)90426-X; Besson M, 1998, CAH PSYCHOL COGN, V17, P921; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; Besson M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00094; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Ducreux D, 2003, J NEURORADIOLOGY, V30, P18; Featherstone CR, 2012, BEHAV RES METHODS, V44, P81, DOI 10.3758/s13428-011-0137-1; Hantz EC, 1997, MUSIC PERCEPT, V15, P69; Jentschke S, 2005, ANN NY ACAD SCI, V1060, P231, DOI 10.1196/annals.1360.016; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2003, NEUROREPORT, V14, P709, DOI 10.1097/00001756-200304150-00010; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Koelsch S, 2010, J COGNITIVE NEUROSCI, V22, P2251, DOI 10.1162/jocn.2009.21338; Kreutz G, 2008, MUSIC PERCEPT, V26, P57, DOI 10.1525/MP.2008.26.1.57; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Levitin DJ, 2005, MUSIC PERCEPT, V22, P563, DOI 10.1525/mp.2005.22.3.563; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lovelock W, 1957, RUDIMENTS MUSIC; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Mirz F, 1999, SCAND AUDIOL, V28, P161, DOI 10.1080/010503999424734; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Piston W., 1978, HARMONY; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Regnault P, 1998, CAH PSYCHOL COGN, V17, P1069; Rogalsky C, 2011, J NEUROSCI, V31, P3843, DOI 10.1523/JNEUROSCI.4515-10.2011; Schmithorst VJ, 2005, NEUROIMAGE, V25, P444, DOI 10.1016/j.neuroimage.2004.12.006; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Stoesz BM, 2007, MUSIC PERCEPT, V25, P153, DOI 10.1525/MP.2007.25.2.153; Tillmann B, 2012, TOP COGN SCI, V4, P568, DOI 10.1111/j.1756-8765.2012.01209.x; Vuust P, 2006, NEUROIMAGE, V31, P832, DOI 10.1016/j.neuroimage.2005.12.037	45	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76600	10.1371/journal.pone.0076600	http://dx.doi.org/10.1371/journal.pone.0076600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223704	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400003
J	Ito, G; Okamoto, R; Murano, T; Shimizu, H; Fujii, S; Nakata, T; Mizutani, T; Yui, S; Akiyama-Morio, J; Nemoto, Y; Okada, E; Araki, A; Ohtsuka, K; Tsuchiya, K; Nakamura, T; Watanabe, M				Ito, Go; Okamoto, Ryuichi; Murano, Tatsuro; Shimizu, Hiromichi; Fujii, Satoru; Nakata, Toru; Mizutani, Tomohiro; Yui, Shiro; Akiyama-Morio, Junko; Nemoto, Yasuhiro; Okada, Eriko; Araki, Akihiro; Ohtsuka, Kazuo; Tsuchiya, Kiichiro; Nakamura, Tetsuya; Watanabe, Mamoru			Lineage-Specific Expression of Bestrophin-2 and Bestrophin-4 in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							BICARBONATE SECRETION; CYSTIC-FIBROSIS; ULCERATIVE-COLITIS; MACULAR DYSTROPHY; GENE-EXPRESSION; ION-TRANSPORT; HUMAN COLON; FAMILY; DIFFERENTIATION; IDENTIFICATION	Intestinal epithelial cells (IECs) regulate the absorption and secretion of anions, such as HCO3(-) or Cl-. Bestrophin genes represent a newly identified group of calcium-activated Cl- channels (CaCCs). Studies have suggested that, among the four human bestrophin-family genes, bestrophin-2 (BEST2) and bestrophin-4 (BEST4) might be expressed within the intestinal tissue. Consistently, a study showed that BEST2 is expressed by human colonic goblet cells. However, their precise expression pattern along the gastrointestinal tract, or the lineage specificity of the cells expressing these genes, remains largely unknown. Here, we show that BEST2 and BEST4 are expressed in vivo, each in a distinct, lineage-specific manner, in human IECs. While BEST2 was expressed exclusively in colonic goblet cells, BEST4 was expressed in the absorptive cells of both the small intestine and the colon. In addition, we found that BEST2 expression is significantly down-regulated in the active lesions of ulcerative colitis, where goblet cells were depleted, suggesting that BEST2 expression is restricted to goblet cells under both normal and pathologic conditions. Consistently, the induction of goblet cell differentiation by a Notch inhibitor, LY411575, significantly up-regulated the expression of not BEST4 but BEST2 in MUC2-positive HT-29 cells. Conversely, the induction of absorptive cell differentiation up-regulated the expression of BEST4 in villin-positive Caco-2 cells. In addition, we found that the up- or down-regulation of Notch activity leads to the preferential expression of either BEST4 or BEST2, respectively, in LS174T cells. These results collectively confirmed that BEST2 and BEST4 could be added to the lineage-specific genes of humans IECs due to their abilities to clearly identify goblet cells of colonic origin and a distinct subset of absorptive cells, respectively.	[Ito, Go; Okamoto, Ryuichi; Murano, Tatsuro; Shimizu, Hiromichi; Fujii, Satoru; Nakata, Toru; Mizutani, Tomohiro; Yui, Shiro; Akiyama-Morio, Junko; Nemoto, Yasuhiro; Okada, Eriko; Araki, Akihiro; Ohtsuka, Kazuo; Tsuchiya, Kiichiro; Nakamura, Tetsuya; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Okamoto, Ryuichi; Tsuchiya, Kiichiro; Nakamura, Tetsuya] Tokyo Med & Dent Univ, Grad Sch, Dept Adv GI Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Okamoto, R (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo, Japan.	rokamoto.gast@tmd.ac.jp	Tsuchiya, Kiichiro/AAB-1769-2020; Okamoto, Ryuichi/I-1130-2019; Watanabe, Mamoru/AHE-0489-2022; Mizutani, Tomohiro/AAX-5650-2021	Tsuchiya, Kiichiro/0000-0002-1977-8707; Okamoto, Ryuichi/0000-0002-7047-571X; Mizutani, Tomohiro/0000-0002-8373-7969; Yui, Shiro/0000-0003-4268-647X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [25293170, 25460945] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Young Scientists (B) (to RO and JA-M), Scientific Research (C) (to KI), Scientific Research (B) (to TN), Scientific Research (S) (to MW), Exploratory Research (to MW) and Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (to RO and TN) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labor Sciences Research Grant (to RO and MW) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2010, BIOCHEM BIOPH RES CO, V393, P662, DOI 10.1016/j.bbrc.2010.02.048; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; CARPENTER CC, 1972, J INFECT DIS, V126, P551, DOI 10.1093/infdis/126.5.551; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; De Lisle RC, 2009, J CLIN INVEST, V119, P2535, DOI 10.1172/JCI40598; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Ito T, 2000, DEVELOPMENT, V127, P3913; Iwasaki M, 2011, J GASTROENTEROL, V46, P191, DOI 10.1007/s00535-010-0346-x; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Murayama M, 2009, J GASTROENTEROL, V44, P173, DOI 10.1007/s00535-008-2284-4; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nemeth ZH, 2002, AM J PHYSIOL-GASTR L, V283, pG122, DOI 10.1152/ajpgi.00015.2002; Okada S, 2003, FEBS LETT, V540, P157, DOI 10.1016/S0014-5793(03)00256-4; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611	35	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79693	10.1371/journal.pone.0079693	http://dx.doi.org/10.1371/journal.pone.0079693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223998	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400082
J	Wang, LL; Hatem, A; Catalyurek, UV; Morrison, M; Yu, ZT				Wang, Lingling; Hatem, Ayat; Catalyurek, Umit V.; Morrison, Mark; Yu, Zhongtang			Metagenomic Insights into the Carbohydrate-Active Enzymes Carried by the Microorganisms Adhering to Solid Digesta in the Rumen of Cows	PLOS ONE			English	Article							HERBIVORE GASTROINTESTINAL-TRACT; RNA GENE-SEQUENCES; REAL-TIME PCR; BOVINE RUMEN; CELLULOLYTIC BACTERIA; DIVERSITY; PREVOTELLA; BIOMASS; ADAPTATION; ABUNDANCE	The ruminal microbial community is a unique source of enzymes that underpin the conversion of cellulosic biomass. In this study, the microbial consortia adherent on solid digesta in the rumen of Jersey cattle were subjected to an activity-based metagenomic study to explore the genetic diversity of carbohydrolytic enzymes in Jersey cows, with a particular focus on cellulases and xylanases. Pyrosequencing and bioinformatic analyses of 120 carbohydrate-active fosmids identified genes encoding 575 putative Carbohydrate-Active Enzymes (CAZymes) and proteins putatively related to transcriptional regulation, transporters, and signal transduction coupled with polysaccharide degradation and metabolism. Most of these genes shared little similarity to sequences archived in databases. Genes that were predicted to encode glycoside hydrolases (GH) involved in xylan and cellulose hydrolysis (e. g., GH3, 5, 9, 10, 39 and 43) were well represented. A new subfamily (S-8) of GH5 was identified from contigs assigned to Firmicutes. These subfamilies of GH5 proteins also showed significant phylum-dependent distribution. A number of polysaccharide utilization loci (PULs) were found, and two of them contained genes encoding Sus-like proteins and cellulases that have not been reported in previous metagenomic studies of samples from the rumens of cows or other herbivores. Comparison with the large metagenomic datasets previously reported of other ruminant species (or cattle breeds) and wallabies showed that the rumen microbiome of Jersey cows might contain differing CAZymes. Future studies are needed to further explore how host genetics and diets affect the diversity and distribution of CAZymes and utilization of plant cell wall materials.	[Wang, Lingling; Morrison, Mark; Yu, Zhongtang] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Hatem, Ayat; Catalyurek, Umit V.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hatem, Ayat; Catalyurek, Umit V.] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Morrison, Mark] CSIRO Livestock Ind, St Lucia, Qld, Australia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yu, ZT (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	yu.226@osu.edu	Yu, Zhongtang/B-3987-2012; Morrison, Mark/C-9707-2013; Catalyurek, Umit/A-2454-2008	Yu, Zhongtang/0000-0002-6165-8522; Morrison, Mark/0000-0001-9257-9133; Catalyurek, Umit/0000-0002-5625-3758				An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Firkins J. L., 2006, P19; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; KWON KS, 1994, APPL ENVIRON MICROB, V60, P4584, DOI 10.1128/AEM.60.12.4584-4586.1994; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Mackenzie AK, 2012, APPL ENVIRON MICROB, V78, P5935, DOI 10.1128/AEM.01164-12; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Michalet-Doreau B, 2001, REPROD NUTR DEV, V41, P187, DOI 10.1051/rnd:2001122; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Sambrook J, 2001, MOL CLONING LAB MANU; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; Wood J, 1998, APPL ENVIRON MICROB, V64, P3683; Yang SL, 2010, MOL BIOL REP, V37, P2063, DOI 10.1007/s11033-009-9664-6; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	40	77	79	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78507	10.1371/journal.pone.0078507	http://dx.doi.org/10.1371/journal.pone.0078507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223817	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400031
J	Ferrando, M; Wan, XH; Meiss, R; Yang, J; De Siervi, A; Navone, N; Vazquez, E				Ferrando, Mercedes; Wan, Xinhai; Meiss, Roberto; Yang, Jun; De Siervi, Adriana; Navone, Nora; Vazquez, Elba			Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; UP-REGULATION; BETA-CATENIN; OSTEOCLASTOGENESIS; STRESS; ACTIVATION; GROWTH	Prostate cancer (PCa) is a leading cause of death among males. It is currently estimated that inflammatory responses are linked to 15-20% of all deaths from cancer worldwide. PCa is dominated by complications arising from metastasis to the bone where the tumor cells interact with the bone microenvironment impairing the balance between bone formation and degradation. However, the molecular nature of this interaction is not completely understood. Heme oxygenase-1 (HO-1) counteracts oxidative damage and inflammation. Previous studies from our laboratory showed that HO-1 is implicated in PCa, demonstrating that endogenous HO-1 inhibits bone derived-prostate cancer cells proliferation, invasion and migration and decreases tumor growth and angiogenesis in vivo. The aim of this work was to analyze the impact of HO-1 modulated PCa cells on osteoblasts proliferation in vitro and on bone remodeling in vivo. Using a co-culture system of PC3 cells with primary mice osteoblasts (PMOs), we demonstrated that HO-1 pharmacological induction (hemin treatment) abrogated the diminution of PMOs proliferation induced by PCa cells and decreased the expression of osteoclast-modulating factors in osteoblasts. No changes were detected in the expression of genes involved in osteoblasts differentiation. However, co-culture of hemin pre-treated PC3 cells (PC3 Hem) with PMOs provoked an oxidative status and activated FoxO signaling in osteoblasts. The percentage of active osteoblasts positive for HO-1 increased in calvarias explants co-cultured with PC3 Hem cells. Nuclear HO-1 expression was detected in tumors generated by in vivo bone injection of HO-1 stable transfected PC3 (PC3HO-1) cells in the femur of SCID mice. These results suggest that HO-1 has the potential to modify the bone microenvironment impacting on PCa bone metastasis.	[Ferrando, Mercedes; De Siervi, Adriana; Vazquez, Elba] Univ Buenos Aires, Dept Biol Chem, Sch Sci, IQUIBICEN CONICET, Buenos Aires, DF, Argentina; [Wan, Xinhai; Yang, Jun; Navone, Nora] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Meiss, Roberto] Natl Acad Med Buenos Aires, Inst Oncol Studies, Dept Pathol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Texas System; UTMD Anderson Cancer Center; Buenos Aires National Academy of Medicine	Vazquez, E (corresponding author), Univ Buenos Aires, Dept Biol Chem, Sch Sci, IQUIBICEN CONICET, Buenos Aires, DF, Argentina.	elba@qb.fcen.uba.ar	De Siervi, Adriana/AAC-7177-2020; Vazquez, Elba/D-5134-2019	De Siervi, Adriana/0000-0002-1524-8063; Vazquez, Elba/0000-0002-0460-0236	University of Buenos Aires, Argentina; UBACyT [20020100100179]; ANPCYT [PICT RAICES 2010-0431]; CONICET; UICC International Cancer Technology Transfer Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	University of Buenos Aires, Argentina(University of Buenos Aires); UBACyT; ANPCYT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UICC International Cancer Technology Transfer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of Buenos Aires, Argentina, UBACyT (20020100100179) and ANPCYT (PICT RAICES 2010-0431). M. F. held fellowships from CONICET and UICC International Cancer Technology Transfer Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2011, BONE, V49, P319, DOI 10.1016/j.bone.2011.05.023; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Battisti V, 2011, BIOMED PHARMACOTHER, V65, P516, DOI 10.1016/j.biopha.2011.06.003; Clerigues V, 2012, BIOCHEM PHARMACOL, V83, P395, DOI 10.1016/j.bcp.2011.11.024; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Feller L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-24; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Freshney RI, 1994, CULTURE ANIMAL CELLS; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Goldring SR, 2002, J RHEUMATOL, V29, P44; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kido J, 1997, J CELL BIOCHEM, V67, P248; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Martinez J, 1996, J CELL BIOCHEM, V61, P18, DOI 10.1002/(SICI)1097-4644(19960401)61:1<18::AID-JCB3>3.0.CO;2-5; Pratap J, 2003, CANCER RES, V63, P5357; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Yang J, 2001, CANCER RES, V61, P5652; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	37	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80315	10.1371/journal.pone.0080315	http://dx.doi.org/10.1371/journal.pone.0080315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224047	gold, Green Published			2022-12-25	WOS:000326503400153
J	Hsu, HC; Chiou, JF; Wang, YH; Chen, CH; Mau, SY; Ho, CT; Chang, PJ; Liu, TZ; Chen, CH				Hsu, Hung-Chih; Chiou, Jeng-Fong; Wang, Yu-Huei; Chen, Chia-Hui; Mau, Shin-Yi; Ho, Chun-Te; Chang, Pey-Jium; Liu, Tsan-Zon; Chen, Ching-Hsein			Folate Deficiency Triggers an Oxidative-Nitrosative Stress-Mediated Apoptotic Cell Death and Impedes Insulin Biosynthesis in RINm5F Pancreatic Islet beta-Cells: Relevant to the Pathogenesis of Diabetes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ENZYME GENE-EXPRESSION; CASPASE-3 ACTIVATION; REDUCED GLUTATHIONE; HYDROGEN-PEROXIDE; DEFENSE STATUS; MOUSE-TISSUES; NITRIC-OXIDE; RESISTANCE; ALLOXAN	It has been postulated that folic acid (folate) deficiency (FD) may be a risk factor for the pathogenesis of a variety of oxidative stress-triggered chronic degenerative diseases including diabetes, however, the direct evidence to lend support to this hypothesis is scanty. For this reason, we set out to study if FD can trigger the apoptotic events in an insulin-producing pancreatic RINm5F islet beta cells. When these cells were cultivated under FD condition, a time-dependent growth impediment was observed and the demise of these cells was demonstrated to be apoptotic in nature proceeding through a mitochondria-dependent pathway. In addition to evoke oxidative stress, FD condition could also trigger nitrosative stress through a NF-kappa B-dependent iNOS-mediated overproduction of nitric oxide (NO). The latter compound could then trigger depletion of endoplasmic reticulum (ER) calcium (Ca2+) store leading to cytosolic Ca2+ overload and caused ER stress as evidence by the activation of CHOP expression. Furthermore, FD-induced apoptosis of RINm5F cells was found to be correlated with a time-dependent depletion of intracellular gluthathione (GSH) and a severe down-regulation of Bcl-2 expression. Along the same vein, we also demonstrated that FD could severely impede RINm5F cells to synthesize insulin and their abilities to secret insulin in response to glucose stimulation were appreciably hampered. Even more importantly, we found that folate replenishment could not restore the ability of RINm5F cells to resynthesize insulin. Taken together, our data provide strong evidence to support the hypothesis that FD is a legitimate risk factor for the pathogenesis of diabetes.	[Hsu, Hung-Chih; Chang, Pey-Jium] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsu, Hung-Chih] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ & Hosp, Ctr Canc, Taipei, Taiwan; [Chiou, Jeng-Fong] Taipei Med Univ & Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Wang, Yu-Huei; Chen, Chia-Hui; Mau, Shin-Yi; Ho, Chun-Te; Liu, Tsan-Zon] Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chen, Ching-Hsein] Natl Chiayi Univ, Collage Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Chiayi University	Liu, TZ (corresponding author), Taipei Med Univ & Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan.	tzliu@tmuh.org.tw; chench@mail.ncyu.edu.tw		Chang, Pey-Jium/0000-0002-6492-0346	National Science Council, Taiwan [NSC 99-2314-B-038-026-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC 99-2314-B-038-026-MY3; National Science Council's Web site: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari MY, 2012, NUTRITION, V28, P23; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; Chen Y. H., 2001, J BIOMED LAB SCI, V13, P52; Chern CL, 2001, BIOMED PHARMACOTHER, V55, P434, DOI 10.1016/S0753-3322(01)00095-6; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Honda T, 2004, CANCER GENE THER, V11, P249, DOI 10.1038/sj.cgt.7700684; Huang RFS, 2001, LIFE SCI, V68, P2799, DOI 10.1016/S0024-3205(01)01066-9; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kim JS, 2011, BIOCHEM BIOPH RES CO, V413, P105, DOI 10.1016/j.bbrc.2011.08.063; Kim SJ, 2007, J NEUROSCI RES, V85, P139, DOI 10.1002/jnr.21106; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Lee DH, 2009, ENVIRON HEALTH PERSP, V117, P1799, DOI 10.1289/ehp.0900741; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Park JH, 2008, FOOD CHEM TOXICOL, V46, P3684, DOI 10.1016/j.fct.2008.09.056; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Scullion SMJ, 2012, J ENDOCRINOL, V214, P233, DOI 10.1530/JOE-11-0461; Setola E, 2004, EUR J ENDOCRINOL, V151, P483, DOI 10.1530/eje.0.1510483; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shils ME, 2006, MODERN NUTR HLTH DIS, P550; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Watson D, 2009, BRIT J BIOMED SCI, V66, P208, DOI 10.1080/09674845.2009.11730278; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444; Woltjer RL, 2005, J NEUROCHEM, V93, P1047, DOI 10.1111/j.1471-4159.2005.03109.x; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	35	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77931	10.1371/journal.pone.0077931	http://dx.doi.org/10.1371/journal.pone.0077931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223745	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400024
J	Kida, T; Kakigi, R				Kida, Tetsuo; Kakigi, Ryusuke			Task-Related Changes in Functional Properties of the Human Brain Network Underlying Attentional Control	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SPATIAL ATTENTION; PREPARATORY STATES; CONNECTIVITY; EVENT; STIMULUS; LINKS; DESYNCHRONIZATION; SYNCHRONIZATION; MODULATION	Previous studies have demonstrated task-related changes in brain activation and inter-regional connectivity but the temporal dynamics of functional properties of the brain during task execution is still unclear. In the present study, we investigated task-related changes in functional properties of the human brain network by applying graph-theoretical analysis to magnetoencephalography (MEG). Subjects performed a cue-target attention task in which a visual cue informed them of the direction of focus for incoming auditory or tactile target stimuli, but not the sensory modality. We analyzed the MEG signal in the cue-target interval to examine network properties during attentional control. Cluster-based non-parametric permutation tests with the Monte-Carlo method showed that in the cue-target interval, beta activity was desynchronized in the sensori-motor region including premotor and posterior parietal regions in the hemisphere contralateral to the attended side. Graph-theoretical analysis revealed that, in beta frequency, global hubs were found around the sensori-motor and prefrontal regions, and functional segregation over the entire network was decreased during attentional control compared to the baseline. Thus, network measures revealed task-related temporal changes in functional properties of the human brain network, leading to the understanding of how the brain dynamically responds to task execution as a network.	[Kida, Tetsuo] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Kida, Tetsuo; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	Waseda University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kida, T (corresponding author), Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.	tkida@aoni.waseda.jp	Kida, Tetsuo/GSD-8744-2022	Kida, Tetsuo/0000-0003-3499-0762	Waseda University [2012A-935]; Japan Society for the Promotion of Science (JSPS) [25705021]; National Institute for Physiological Sciences	Waseda University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS))	This study was supported by a Waseda University Grant for Special Research Projects (No. 2012A-935) and Grants-in-Aid for Young Scientists(A)(No. 25705021) from the Japan Society for the Promotion of Science (JSPS) to T.K., and the Cooperative Study Program of National Institute for Physiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Akaishi R, 2010, J NEUROSCI, V30, P4295, DOI 10.1523/JNEUROSCI.6198-09.2010; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Bastiaansen MCM, 2001, CLIN NEUROPHYSIOL, V112, P393, DOI 10.1016/S1388-2457(00)00537-X; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chambers CD, 2004, NEURON, V44, P925, DOI 10.1016/j.neuron.2004.12.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; Dodel S, 2002, NEUROCOMPUTING, V44, P1065, DOI 10.1016/S0925-2312(02)00416-2; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; Gherri E, 2008, CLIN NEUROPHYSIOL, V119, P2587, DOI 10.1016/j.clinph.2008.07.214; Gili T, 2013, J NEUROSCI, V33, P4024, DOI 10.1523/JNEUROSCI.3480-12.2013; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hinrichs H, 2008, HUM BRAIN MAPP, V29, P193, DOI 10.1002/hbm.20382; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Kida T, 2011, J NEUROPHYSIOL, V105, P674, DOI 10.1152/jn.00807.2009; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Macaluso E, 2003, EXP BRAIN RES, V149, P62, DOI 10.1007/s00221-002-1335-y; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Macaluso E, 2001, EXP BRAIN RES, V137, P445, DOI 10.1007/s002210000656; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Seiss E, 2009, CLIN NEUROPHYSIOL, V120, P1087, DOI 10.1016/j.clinph.2009.03.016; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Stam CJ, 2012, NEUROIMAGE, V62, P1415, DOI 10.1016/j.neuroimage.2012.05.050; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Supp GG, 2011, CURR BIOL, V21, P1988, DOI 10.1016/j.cub.2011.10.017; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053	45	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79023	10.1371/journal.pone.0079023	http://dx.doi.org/10.1371/journal.pone.0079023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223876	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400096
J	Sanjurjo, L; Amezaga, N; Vilaplana, C; Caceres, N; Marzo, E; Valeri, M; Cardona, PJ; Sarrias, MR				Sanjurjo, Lucia; Amezaga, Nuria; Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Valeri, Marta; Cardona, Pere-Joan; Sarrias, Maria-Rosa			The Scavenger Protein Apoptosis Inhibitor of Macrophages (AIM) Potentiates the Antimicrobial Response against Mycobacterium tuberculosis by Enhancing Autophagy	PLOS ONE			English	Article							CELL-BINDING CHARACTERISTICS; LIVER-X-RECEPTORS; VITAMIN-D; SP-ALPHA; MOLECULAR-CLONING; NITRIC-OXIDE; SURVIVAL; MURINE; EXPRESSION; DOMAIN	Apoptosis inhibitor of macrophages (AIM), a scavenger protein secreted by tissue macrophages, is transcriptionally regulated by the nuclear receptor Liver X Receptor (LXR) and Retinoid X Receptor (RXR) heterodimer. Given that LXR exerts a protective immune response against M. tuberculosis, here we analyzed whether AIM is involved in this response. In an experimental murine model of tuberculosis, AIM serum levels peaked dramatically early after infection with M. tuberculosis, providing an in vivo biological link to the disease. We therefore studied the participation of AIM in macrophage response to M. tuberculosis in vitro. For this purpose, we used the H37Rv strain to infect THP-1 macrophages transfected to stably express AIM, thereby increasing infected macrophage survival. Furthermore, the expression of this protein enlarged foam cell formation by enhancing intracellular lipid content. Phagocytosis assays with FITC-labeled M. tuberculosis bacilli indicated that this protein was not involved in bacterial uptake; however, AIM expression decreased the number of intracellular cfus by up to 70% in bacterial killing assays, suggesting that AIM enhances macrophage mycobactericidal activity. Accordingly, M. tuberculosis-infected AIM-expressing cells upregulated the production of reactive oxygen species. Moreover, real-time PCR analysis showed increased mRNA levels of the antimicrobial peptides cathelicidin and defensin 4B. These increases were concomitant with greater cellular concentrations of the autophagy-related molecules Beclin 1 and LC3II, as well as enhanced acidification of mycobacterial phagosomes and LC3 co-localization. In summary, our data support the notion that AIM contributes to key macrophage responses to M. tuberculosis.	[Sanjurjo, Lucia; Amezaga, Nuria; Sarrias, Maria-Rosa] Fundacio Inst Invest Ciencies Salut Germans Trias, Innate Immun Grp, Badalona, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Fundacio Inst Invest Ciencies Salut Germans Trias, UTE, Badalona, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Univ Autonoma Barcelona, Bellaterra, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Palma de Mallorca, Spain; [Valeri, Marta] Vall Hebron Res Inst VHIR, Barcelona, Spain; [Sarrias, Maria-Rosa] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Barcelona, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Sarrias, MR (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, Innate Immun Grp, Badalona, Spain.	mrsarrias@igtp.cat	sarrias, maria rosa/D-6205-2014; Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012; Marzo, Elena/AAG-7662-2020; Sanjurjo, Lucía/K-9221-2015	sarrias, maria rosa/0000-0001-6929-8069; Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270; Sanjurjo, Lucía/0000-0003-4006-8010	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS PI10/1565, FIS CP08/124]; Fundacio Marato de TV3 [MTV308932]; Spanish Ministry of Science and Innovation; Miguel Servet Research Program [CP08/124]	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacio Marato de TV3; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Miguel Servet Research Program	This work was supported by grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FIS PI10/1565 and FIS CP08/124 as well as Fundacio Marato de TV3, MTV308932. CV is supported by the program CIBER Enfermedades Respiratorias from the Spanish Ministry of Science and Innovation. MRS is supported by Miguel Servet Research Program (CP08/124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bowdish DME, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-47; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HART P D, 1974, Infection and Immunity, V10, P742; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klug-Micu GM, 2013, IMMUNOLOGY, V139, P121, DOI 10.1111/imm.12062; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Kuwata K, 2003, AM J PATHOL, V162, P837, DOI 10.1016/S0002-9440(10)63880-1; Li Y, 2011, CANCER RES, V71, P5488, DOI 10.1158/0008-5472.CAN-10-4225; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Miller J, 2010, NY TIMES BK REV, P6; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Sarrias MR, 2005, J BIOL CHEM, V280, P35391, DOI 10.1074/jbc.M505042200; Sarrias MR, 2004, TISSUE ANTIGENS, V63, P335, DOI 10.1111/j.0001-2815.2004.00193.x; Sever-Chroneos Z, 2011, TUBERCULOSIS, V91, pS69, DOI 10.1016/j.tube.2011.10.014; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; WEINBERG JB, 1995, BLOOD, V86, P1184; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yu HR, 2009, PEDIAT ALLERG IMM-UK, V20, P699, DOI 10.1111/j.1399-3038.2008.00844.x; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Yusa S, 1999, EUR J IMMUNOL, V29, P1086, DOI 10.1002/(SICI)1521-4141(199904)29:04<1086::AID-IMMU1086>3.3.CO;2-O; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	72	34	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79670	10.1371/journal.pone.0079670	http://dx.doi.org/10.1371/journal.pone.0079670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223991	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400136
J	Souza, MFVR; Ferreira, RL				Villela Rezende Souza, Maysa Fernanda; Ferreira, Rodrigo Lopes			Two New Species of the Enigmatic Leptokoenenia (Eukoeneniidae: Palpigradi) from Brazil: First Record of the Genus Outside Intertidal Environments	PLOS ONE			English	Article							CAVES; ARACHNIDA	Two new species of Leptokoenenia Conde 1965 (Eukoeneniidae: Palpigradi), Leptokoenenia pelada sp. nov. and Leptokoenenia thalassophobica sp. nov., are described based on both male and female specimens collected in iron ore caves from the Brazilian Amazon. This is the first record of the genus for the Americas. Furthermore, a new combination is stated for Eukoenenia gallii based on its morphology.	[Villela Rezende Souza, Maysa Fernanda] Univ Fed Lavras, Programa Posgrad Ecol Aplicada, Lavras, MG, Brazil; [Villela Rezende Souza, Maysa Fernanda; Ferreira, Rodrigo Lopes] Univ Fed Lavras, Dept Biol, Setor Zool, Lab Ecol Subterranea, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras	Ferreira, RL (corresponding author), Univ Fed Lavras, Dept Biol, Setor Zool, Lab Ecol Subterranea, Lavras, MG, Brazil.	drops@dbi.ufla.br	Ferreira, RL/L-8419-2014	Ferreira, RL/0000-0003-3288-4405	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq) [301061/2011-4]	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Conselho Nacional do desenvolvimento Cientifico e Tecnologico (CNPq grant 301061/2011-4), (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barranco P, 2007, J ARACHNOL, V35, P318, DOI 10.1636/H05-23.1; Christian E, 2010, REV SUISSE ZOOL, V117, P829; Christian E, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2136.1.5; CONDE B, 1993, REV SUISSE ZOOL, V100, P279, DOI 10.5962/bhl.part.79861; CONDE B, 1965, CR HEBD ACAD SCI, V261, P1898; Conde B, 1955, NOTES BIOSPELEOL, V9, P145; Conde B., 1990, B SOC EUROPEENNE ARA, V1, P64; Conde B, 1998, INTRO STUDY MEIOFAUN, p425 ; Enghoff H, 2013, J NAT HIST, V47, P1613, DOI 10.1080/00222933.2012.759289; Ferreira RL, 2011, J ARACHNOL, V39, P409, DOI 10.1636/Ha11-03.1; Hansen HJ, 1901, ENTOMOL TIDSKR, V22, P193; Harvey M.S, 2003, CATALOGUE SMALLER AR; Krantz G., 2009, MANUAL ACAROLOGY; Mello-Lietao C. de, 1935, Ann Acad Bras Sci Rio T, V7, P339; Monniot F., 1966, Rev Ecol Biol Sci, V3, P41; ROWLAND JM, 1980, J ARACHNOL, V8, P69; Rucker A, 1901, AM NAT, V35, P615, DOI 10.1086/277979; Silvestri F, 1913, B LAB ZOOL GEN AGR P, V7, P211; Souza MFVR, 2012, ZOOTAXA, P59, DOI 10.11646/zootaxa.3295.1.3; Souza MFVR, 2011, ZOOTAXA, P31, DOI 10.11646/zootaxa.2886.1.3; Souza MFVR, 2012, J ARACHNOL, V40, P151, DOI 10.1636/Ha11-26.1; Souza MFVR, 2011, J ARACHNOL, V39, P185, DOI 10.1636/Ha10-43.1; Souza MFVR, 2010, J ARACHNOL, V38, P415, DOI 10.1636/Ha09-112.1; van der Hammen L., 1982, ZOOL VERH, V196, P1	24	10	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77840	10.1371/journal.pone.0077840	http://dx.doi.org/10.1371/journal.pone.0077840			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223731	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400017
J	Visser, K; Mortimer, M; Louw, A				Visser, Koch; Mortimer, Morne; Louw, Ann			Cyclopia Extracts Act as ER alpha Antagonists and ER beta Agonists, In Vitro and In Vivo	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; NF-KAPPA-B; HUMAN-BREAST-CANCER; INTERLEUKIN-6 GENE-EXPRESSION; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; SELECTIVE LIGANDS; HONEYBUSH TEA; ASPALATHUS-LINEARIS; ANIMAL-MODELS	Hormone replacement therapy associated risks, and the concomitant reluctance of usage, has instigated the search for new generations of estrogen analogues that would maintain estrogen benefits without associated risks. Furthermore, if these analogues display chemo-preventative properties in breast and endometrial tissues it would be of great value. Both the selective estrogen receptor modulators as well as the selective estrogen receptor subtype modulators have been proposed as estrogen analogues with improved risk profiles. Phytoestrogen containing extracts of Cyclopia, an indigenous South African fynbos plant used to prepare Honeybush tea may serve as a source of new estrogen analogues. In this study three extracts, P104, SM6Met, and cup-of-tea, from two species of Cyclopia, C. genistoides and C. subternata, were evaluated for ER subtype specific agonism and antagonism both in transactivation and transrepression. For transactivation, the Cyclopia extracts displayed ER alpha antagonism and ER beta agonism when ER subtypes were expressed separately, however, when co-expressed only agonism was uniformly observed. In contrast, for transrepression, this uniform behavior was lost, with some extracts (P104) displaying uniform agonism, while others (SM6Met) displayed antagonism when subtypes were expressed separately and agonism when co-expressed. In addition, breast cancer cell proliferation assays indicate that extracts antagonize cell proliferation in the presence of estrogen at lower concentrations than that required for proliferation. Furthermore, lack of uterine growth and delayed vaginal opening in an immature rat uterotrophic model validates the ERa antagonism of extracts observed in vitro and supports the potential of the Cyclopia extracts as a source of estrogen analogues with a reduced risk profile.	[Visser, Koch; Mortimer, Morne; Louw, Ann] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	al@sun.ac.za	Louw, Ann/A-7620-2012	Louw, Ann/0000-0002-1021-6732	Medical Research Council (MRC); Cancer Association of South Africa (CANSA)	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa (CANSA)	The authors would like to thank the Medical Research Council (MRC) and the Cancer Association of South Africa (CANSA) for financial support to A.L. (grant for projects entitled "Cyclopia Phytoestrogens" and "Cyclopia and breast cancer") and for financial support to K. V. and M. M. the National Research Foundation (NRF) and the Harry Crossley foundation is acknowledged. Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and therefore the funders do not accept any liability in regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Ball LJ, 2009, MOL CELL ENDOCRINOL, V299, P204, DOI 10.1016/j.mce.2008.10.050; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzezinski A, 1999, EUR J OBSTET GYN R B, V85, P47, DOI 10.1016/S0301-2115(98)00281-4; Burger HG, 2008, MENOPAUSE, V15, P603, DOI 10.1097/gme.0b013e318174ea4d; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2863(03)00056-1; Choi EM, 2012, INT IMMUNOPHARMACOL, V12, P139, DOI 10.1016/j.intimp.2011.11.003; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; Cranney A, 2005, DRUG SAFETY, V28, P721, DOI 10.2165/00002018-200528080-00006; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; D'Amelio P, 2013, EXPERT OPIN PHARMACO, V14, P949, DOI 10.1517/14656566.2013.782002; de Beer D, 2012, MOLECULES, V17, P14602, DOI 10.3390/molecules171214602; DELIMA, 2008, PHYTOMEDICINE, V15, P31, DOI DOI 10.1016/J.PHYMED.2007.06.006; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Denger S, 2001, MOL CELL ENDOCRINOL, V178, P155, DOI 10.1016/S0303-7207(01)00417-8; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; du Toit J, 1998, J SUSTAIN AGR, V12, P67, DOI 10.1300/J064v12n02_06; Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1016/S1521-690X(02)00103-3; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; Flototto T, 2004, J STEROID BIOCHEM, V88, P131, DOI 10.1016/j.jsbmb.2003.11.004; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Fong CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-151; Fong CJ, 2010, J MOL ENDOCRINOL, V45, P161, DOI 10.1677/JME-09-0158; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; FRIEND DR, 1984, J MED CHEM, V27, P261, DOI 10.1021/jm00369a005; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Glazier MG, 2001, ARCH INTERN MED, V161, P1161, DOI 10.1001/archinte.161.9.1161; Gosselin D, 2011, CELL, V145, P495, DOI 10.1016/j.cell.2011.04.018; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; HABEL LA, 1993, EPIDEMIOL REV, V15, P209, DOI 10.1093/oxfordjournals.epirev.a036107; HALL J, 2008, MENOPAUSAL MED, P16; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Han DH, 2002, BIOSCI BIOTECH BIOCH, V66, P1479, DOI 10.1271/bbb.66.1479; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hertrampf T, 2008, BRIT J PHARMACOL, V153, P1432, DOI 10.1038/sj.bjp.0707664; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Hiremath SP, 2000, EUR J PHARMACOL, V391, P193, DOI 10.1016/S0014-2999(99)00723-2; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; JORDAN VC, 1988, CANCER INVEST, V6, P589, DOI 10.3109/07357908809082124; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Kamara BI, 2004, J AGR FOOD CHEM, V52, P5391, DOI 10.1021/jf040097z; Kamara BI, 2003, J AGR FOOD CHEM, V51, P3874, DOI 10.1021/jf0210730; Kanno J, 2001, ENVIRON HEALTH PERSP, V109, P785, DOI 10.2307/3454820; KIES P., 1951, BOTHALIA, V6, P161; KNABBE C, 1987, CELL, V48, P417, DOI 10.1016/0092-8674(87)90193-0; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lattrich C, 2013, STEROIDS, V78, P195, DOI 10.1016/j.steroids.2012.10.014; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; LERNER LJ, 1990, CANCER RES, V50, P4177; LI H, 2013, TOXICOL APPL PHARM; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lindsay R, 1996, OBSTET GYNECOL, V87, pS16, DOI 10.1016/0029-7844(95)00430-0; Louw A, 2013, PLANTA MED, V79, P580, DOI 10.1055/s-0032-1328463; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mfenyana C, 2008, J STEROID BIOCHEM, V112, P74, DOI 10.1016/j.jsbmb.2008.08.005; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Nand SL, 1998, OBSTET GYNECOL, V91, P678, DOI 10.1016/S0029-7844(98)00038-6; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Regan RM, 2002, LANCET ONCOL, V3, P207, DOI 10.1016/S1470-2045(02)00711-8; Odum J, 1997, REGUL TOXICOL PHARM, V25, P176, DOI 10.1006/rtph.1997.1100; Oseni T, 2008, PLANTA MED, V74, P1656, DOI 10.1055/s-0028-1088304; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Palmieri C, 2002, ENDOCR-RELAT CANCER, V9, P1, DOI 10.1677/erc.0.0090001; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Primiano T, 2001, PHARM BIOL, V39, P83, DOI 10.1076/phbi.39.2.83.6256; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Romas E, 1997, OSTEOPOROSIS INT, V7, P47, DOI 10.1007/BF03194342; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rymer J, 2003, BRIT MED J, V326, P322, DOI 10.1136/bmj.326.7384.322; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Scafonas A, 2008, J STEROID BIOCHEM, V110, P197, DOI 10.1016/j.jsbmb.2007.10.013; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Schreurs R, 2002, ARCH TOXICOL, V76, P257, DOI 10.1007/s00204-002-0348-4; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Shaaban AM, 2003, AM J SURG PATHOL, V27, P1502, DOI 10.1097/00000478-200312000-00002; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; Slavin JL, 1998, AM J CLIN NUTR, V68, p1492S, DOI 10.1093/ajcn/68.6.1492S; Snijman PW, 2007, MUTAT RES-GEN TOX EN, V631, P111, DOI 10.1016/j.mrgentox.2007.03.009; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Stroheker T, 2003, REPROD TOXICOL, V17, P421, DOI 10.1016/S0890-6238(03)00044-3; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Tikkanen MJ, 2000, BIOCHEM PHARMACOL, V60, P1, DOI 10.1016/S0006-2952(99)00409-8; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Trock BJ, 2006, JNCI-J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; Tu SH, 2013, FOOD CHEM, V141, P1553, DOI 10.1016/j.foodchem.2013.04.077; Verhoog NJD, 2007, S AFR J SCI, V103, P13; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Vosse M, 2002, EUR J OBSTET GYN R B, V101, P58, DOI 10.1016/S0301-2115(01)00516-4; Wardell SE, 2013, CLIN CANCER RES, V19, P2420, DOI 10.1158/1078-0432.CCR-12-3771; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yeh WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060889; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z	143	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79223	10.1371/journal.pone.0079223	http://dx.doi.org/10.1371/journal.pone.0079223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223909	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400103
J	Wang, B; Zhao, BF; North, P; Kong, A; Huang, J; Miao, QR				Wang, Bei; Zhao, Baofeng; North, Paula; Kong, Amanda; Huang, Jian; Miao, Qing Robert			Expression of NgBR Is Highly Associated with Estrogen Receptor Alpha and Survivin in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; NOGO-B; PROTEIN EXPRESSION; APOPTOSIS; CELLS; INHIBITOR; CARCINOMAS; SUBTYPES; CLASSIFICATION	NgBR is a type I receptor with a single transmembrane domain and was identified as a specific receptor for Nogo-B. Our recent findings demonstrated that NgBR binds farnesylated Ras and recruits Ras to the plasma membrane, which is a critical step required for the activation of Ras signaling in human breast cancer cells and tumorigenesis. Here, we first use immunohistochemistry and real-time PCR approaches to examine the expression patterns of Nogo-B and NgBR in both normal and breast tumor tissues. Then, we examine the relationship between NgBR expression and molecular subtypes of breast cancer, and the roles of NgBR in estrogen-dependent survivin signaling pathway. Results showed that NgBR and Nogo-B protein were detected in both normal and breast tumor tissues. However, the expression of Nogo-B and NgBR in breast tumor tissue was much stronger than in normal breast tissue. The statistical analysis demonstrated that NgBR is highly associated with ER-positive/HER2-negative breast cancer. We also found that the expression of NgBR has a strong correlation with the expression of survivin, which is a well-known apoptosis inhibitor. The correlation between NgBR and survivin gene expression was further confirmed by real-time PCR. In vitro results also demonstrated that estradiol induces the expression of survivin in ER-positive T47D breast tumor cells but not in ER-negative MDA-MB-468 breast tumor cells. NgBR knockdown with siRNA abolishes estradiol-induced survivin expression in ER-positive T47D cells but not in ERnegative MDA-MB-468 cells. In addition, estradiol increases the expression of survivin and cell growth in ER-positive MCF-7 and T47D cells whereas knockdown of NgBR with siRNA reduces estradiol-induced survivin expression and cell growth. In summary, these results indicate that NgBR is a new molecular marker for breast cancer. The data suggest that the expression of NgBR may be essential in promoting ER-positive tumor cell proliferation via survivin induction in breast cancer.	[Wang, Bei] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China; [Wang, Bei; Zhao, Baofeng; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Wang, Bei; Zhao, Baofeng; North, Paula; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA; [Kong, Amanda] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Huang, Jian] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Huang, Jian] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	China-Japan Friendship Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine	Huang, J (corresponding author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.	jihuang@mcw.edu; qmiao@mcw.edu	Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); Division of Pediatric Pathology, Medical College of Wisconsin (MCW); Advancing a Healthier Wisconsin endowment; American Cancer Society; MCW Cancer Center pilot grant; NIH [R01HL108938]; Wisconsin Breast Cancer Showhouse (WBCS); Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW; Women's Health Research Program (WHRP) at MCW; Falk Medical Research; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108938] Funding Source: NIH RePORTER	Division of Pediatric Surgery, Medical College of Wisconsin (MCW); Division of Pediatric Pathology, Medical College of Wisconsin (MCW); Advancing a Healthier Wisconsin endowment; American Cancer Society(American Cancer Society); MCW Cancer Center pilot grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Breast Cancer Showhouse (WBCS); Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW; Women's Health Research Program (WHRP) at MCW; Falk Medical Research; AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by start-up funds from Division of Pediatric Surgery and Division of Pediatric Pathology, Medical College of Wisconsin (MCW) and Advancing a Healthier Wisconsin endowment to MCW, the American Cancer Society and MCW Cancer Center pilot grant, and NIH R01HL108938 to R.Q.M., and the Wisconsin Breast Cancer Showhouse (WBCS) to R.Q.M and J.H., the Independent Seed Grant for Breast Cancer Research in the Cancer Center at MCW to J.H., the Women's Health Research Program (WHRP) at MCW and the Falk Medical Research to J.H., AHA postdoctoral fellowship to B.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheung HH, 2006, CLIN CANCER RES, V12, P3238, DOI 10.1158/1078-0432.CCR-06-0817; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Grandpre T, 2001, NEUROSCIENTIST, V7, P377, DOI 10.1177/107385840100700507; Ho TF, 2009, TOXICOL APPL PHARM, V235, P253, DOI 10.1016/j.taap.2008.12.009; Huber AB, 2002, J NEUROSCI, V22, P3553; Jha K, 2012, SURG ONCOL, V21, P125, DOI 10.1016/j.suronc.2011.01.001; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; KASSIS JA, 1981, J BIOL CHEM, V256, P7378; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kuang E, 2006, EXP CELL RES, V312, P1983, DOI 10.1016/j.yexcr.2006.02.024; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li Q, 2001, ONCOGENE, V20, P3929, DOI 10.1038/sj.onc.1204536; Ma Jian, 2009, Zhonghua Zhongliu Zazhi, V31, P250, DOI 10.3760/cma.j.issn.0253-3766.2009.04.003; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Oertle T, 2003, ONCOGENE, V22, P1390, DOI 10.1038/sj.onc.1206278; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reilly CE, 2000, J NEUROL, V247, P239; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh M, 2004, APPL IMMUNOHISTO M M, V12, P296, DOI 10.1097/00129039-200412000-00003; Song J, 2013, TUMOR BIOL, V34, P2053, DOI 10.1007/s13277-013-0848-2; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Tanaka K, 2000, CLIN CANCER RES, V6, P127; TAVASSOLI FA, 2003, WHO CLASSIFICATION T, P9; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Xiong HH, 2007, J HUAZHONG UNIV SCI, V27, P65, DOI 10.1007/s11596-007-0119-9; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577	44	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78083	10.1371/journal.pone.0078083	http://dx.doi.org/10.1371/journal.pone.0078083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223763	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400034
J	Wearn, OR; Rowcliffe, JM; Carbone, C; Bernard, H; Ewers, RM				Wearn, Oliver R.; Rowcliffe, J. Marcus; Carbone, Chris; Bernard, Henry; Ewers, Robert M.			Assessing the Status of Wild Felids in a Highly-Disturbed Commercial Forest Reserve in Borneo and the Implications for Camera Trap Survey Design	PLOS ONE			English	Article							LEOPARD NEOFELIS-DIARDI; SMALL CARNIVORES; TROPICAL FOREST; CATOPUMA-BADIA; SABAH; DIVERSITY; CONSERVATION; LOCALITY; DENSITY; MAMMALS	The proliferation of camera-trapping studies has led to a spate of extensions in the known distributions of many wild cat species, not least in Borneo. However, we still do not have a clear picture of the spatial patterns of felid abundance in Southeast Asia, particularly with respect to the large areas of highly-disturbed habitat. An important obstacle to increasing the usefulness of camera trap data is the widespread practice of setting cameras at non-random locations. Non-random deployment interacts with non-random space-use by animals, causing biases in our inferences about relative abundance from detection frequencies alone. This may be a particular problem if surveys do not adequately sample the full range of habitat features present in a study region. Using camera-trapping records and incidental sightings from the Kalabakan Forest Reserve, Sabah, Malaysian Borneo, we aimed to assess the relative abundance of felid species in highly-disturbed forest, as well as investigate felid space-use and the potential for biases resulting from non-random sampling. Although the area has been intensively logged over three decades, it was found to still retain the full complement of Bornean felids, including the bay cat Pardofelis badia, a poorly known Bornean endemic. Camera-trapping using strictly random locations detected four of the five Bornean felid species and revealed inter-and intra-specific differences in space-use. We compare our results with an extensive dataset of >1,200 felid records from previous camera-trapping studies and show that the relative abundance of the bay cat, in particular, may have previously been underestimated due to the use of non-random survey locations. Further surveys for this species using random locations will be crucial in determining its conservation status. We advocate the more wide-spread use of random survey locations in future camera-trapping surveys in order to increase the robustness and generality of inferences that can be made.	[Wearn, Oliver R.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Wearn, Oliver R.; Rowcliffe, J. Marcus; Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia	Imperial College London; Zoological Society of London; Universiti Malaysia Sabah	Wearn, OR (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	oliver.wearn08@imperial.ac.uk	Rowcliffe, Marcus/G-3713-2018	Rowcliffe, Marcus/0000-0002-4286-6887; Wearn, Oliver/0000-0001-8258-3534	Sime Darby Foundation	Sime Darby Foundation	This work was funded by the Sime Darby Foundation (http://www.yayasansimedarby.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; [Anonymous], 2012, BORNEO POST     1121; [Anonymous], 2011, BORNEO POST     0104; [Anonymous], 2011, BORNEO POST     0826; Azlan JM, 2006, ORYX, V40, P36, DOI 10.1017/S0030605306000147; Bashir T., 2011, NeBIO, V2, P1; Bernard Henry, 2012, Cat News, V56, P4; Brodie Jedediah, 2012, Cat News, V56, P8; Brodie J, 2012, ORYX, V46, P427, DOI 10.1017/S0030605312000087; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Cheyne SM, 2011, ORYX, V45, P119, DOI 10.1017/S003060531000133X; Cochran WG., 1963, SAMPLING TECHNIQUES; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Didham RK, 2011, BIOTROPICA, V43, P393, DOI 10.1111/j.1744-7429.2011.00790.x; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hearn A, 2008, IUCN 2012 IUCN RED L; Hearn AJ, 2009, FLAT HEADED CAT PHOT; Hunter L, 2011, CARNIVORES WORLD; IUCN and UNEP, 2012, WORLD DAT PROT AR WD; Johnson A, 2009, ORYX, V43, P626, DOI 10.1017/S0030605309990238; Karanth KU, 1998, ECOLOGY, V79, P2852; Kays Roland, 2011, International Journal of Research and Reviews in Wireless Sensor Networks, V1, P19; Kitchener AC, 2004, MAMM BIOL, V69, P349, DOI 10.1078/1616-5047-00154; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Lhota S, 2012, AM J PRIMATOL, V74, P193, DOI 10.1002/ajp.21983; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Mathai John, 2010, Small Carnivore Conservation, V42, P1; Matsubayashi Hisashi, 2011, Small Carnivore Conservation, V45, P18; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Meek P, 2012, INTRO CAMERA TRAPPIN; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mohamed A, 2009, CAT NEWS, V51, P12; Mohd-Azlan J, 2007, ORYX, V41, P394, DOI 10.1017/S0030605307000516; Olsen AR, 1999, ENVIRON MONIT ASSESS, V54, P1, DOI 10.1023/A:1005823911258; Osseweijer M., 2008, REFLECTIONS HEART BO; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pinard M. A., 2000, International Forestry Review, V2, P33; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Rustam, 2012, MAMM STUDY, V37, P299, DOI 10.3106/041.037.0404; Samejima Hiromitsu, 2012, Small Carnivore Conservation, V46, P1; Samejima H, 2012, FOREST ECOL MANAG, V270, P248, DOI 10.1016/j.foreco.2012.01.013; Scott DM, 2004, CAN HUMAN MODIFIED L; Sunquist ME, 2002, WILD CATS WORLD; Thompson W.L., 1998, MONITORING VERTEBRAT; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilting A, 2010, WILDLIFE SURVEYS SEG; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694; Wilting Andreas, 2010, Small Carnivore Conservation, V42, P10; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Wilting Andreas, 2006, BMC Ecology, V6, P16, DOI 10.1186/1472-6785-6-16; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; WWF, 2012, HEART BORN NAT PRIOR; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	62	61	68	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77598	10.1371/journal.pone.0077598	http://dx.doi.org/10.1371/journal.pone.0077598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223717	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400011
J	Li, JZ; Chen, X; Gong, XL; Hu, HY; Shi, D; Lu, YM; Qiu, L; Lu, F; Hu, ZL; Zhang, JP				Li, Jian-Zhong; Chen, Xia; Gong, Xue-Lian; Hu, Hong-Yuan; Shi, Duo; Lu, Yi-Ming; Qiu, Lei; Lu, Fa; Hu, Zhen-Lin; Zhang, Jun-Ping			Identification of a Functional Nuclear Localization Signal Mediating Nuclear Import of the Zinc Finger Transcription Factor ZNF24	PLOS ONE			English	Article							DNA-BINDING; NUCLEOCYTOPLASMIC TRANSPORT; CELL-PROLIFERATION; DOMAIN; PROTEINS; GENE; REPRESSION; SEQUENCE	ZNF24 is a member of the SCAN domain family of Kruppel-like zinc finger (ZF) transcription factors, which plays a critical role in cell proliferation and differentiation. However, how ZNF24 enters the nucleus in order to exert its function remains unclear since its nuclear localization signal(s) (NLS) has not been identified. Here, we generated a series of GFP-tagged deletion and point mutants and assessed their subcellular localization. Our results delimit the NLS to ZF1-2. Deletion of ZF1-2 caused cytoplasmic accumulation of ZNF24. Fusion of the ZF1-2 to green fluorescent protein (GFP) targeted GFP to the nucleus, demonstrating that the ZF1-2 is both necessary and sufficient for nuclear localization. ZNF24 containing histidine to leucine mutations that disrupt the structure of ZF1 or/and ZF2 retains appropriate nuclear localization, indicating that neither the tertiary structure of the zinc fingers nor specific DNA binding are necessary for nuclear localization. K286A and R290A mutation led to partial cytoplasmic accumulation. Co-immunoprecipitation demonstrated that ZNF24 interacted with importin-beta and this interaction required the ZF motifs. The beta-Catenin (CTNNB1) luciferase assays showed that the ZNF24 mutants defective in nuclear localization could not promote CTNNB1promoter activation as the wild-type ZNF24 did. Taken together, these results suggest that consecutive ZF1-2 is critical for the regulation of ZNF24 nuclear localization and its transactivation function.	[Li, Jian-Zhong; Gong, Xue-Lian; Hu, Hong-Yuan; Shi, Duo; Lu, Yi-Ming; Qiu, Lei; Lu, Fa; Hu, Zhen-Lin; Zhang, Jun-Ping] Second Mil Med Univ, Dept Biochem Pharm, Shanghai, Peoples R China; [Chen, Xia] Second Mil Med Univ, Inst Canc, Shanghai, Peoples R China; [Gong, Xue-Lian] Second Mil Med Univ, Dept Hlth Toxicol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Li, JZ (corresponding author), Second Mil Med Univ, Dept Biochem Pharm, Shanghai, Peoples R China.	466186272@qq.com; jpzhang08@hotmail.com			National Natural Science Foundation of China [30871353, 30901322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30871353 and No. 30901322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Corbi N, 2004, BIOCHEM CELL BIOL, V82, P428, DOI 10.1139/O04-047; Dono R, 1998, ONCOGENE, V16, P2151, DOI 10.1038/sj.onc.1201746; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; Harper J, 2007, CANCER RES, V67, P8736, DOI 10.1158/0008-5472.CAN-07-1617; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Howng SYB, 2010, GENE DEV, V24, P301, DOI 10.1101/gad.1864510; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Li J, J CELL BIOCH; Li JZ, 2006, EXP CELL RES, V312, P3990, DOI 10.1016/j.yexcr.2006.08.020; Li JZ, 2010, BIOCHEM BIOPH RES CO, V397, P318, DOI 10.1016/j.bbrc.2010.05.110; Li JZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-241; Liu GY, 2012, HEPATOLOGY, V55, P1830, DOI 10.1002/hep.25564; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHALOWSKI CB, 1990, MOL GEN GENET, V224, P222, DOI 10.1007/BF00271555; Nam K, 2004, PROTEINS, V56, P685, DOI 10.1002/prot.20170; NEDVED ML, 1994, NUCLEIC ACIDS RES, V22, P4705, DOI 10.1093/nar/22.22.4705; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; ROUSSEAUMERCK MF, 1991, GENOMICS, V9, P154, DOI 10.1016/0888-7543(91)90233-5; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SANDER G, 1976, EUR J BIOCHEM, V61, P317, DOI 10.1111/j.1432-1033.1976.tb10024.x; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Shi S L, 1998, Shi Yan Sheng Wu Xue Bao, V31, P21; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Takei Y, 1999, FEBS LETT, V447, P292, DOI 10.1016/S0014-5793(99)00306-3; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wali A, 2007, ANN HUM GENET, V71, P570, DOI 10.1111/j.1469-1809.2007.00362.x; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	40	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79910	10.1371/journal.pone.0079910	http://dx.doi.org/10.1371/journal.pone.0079910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224020	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300096
J	Lyn, RK; Hope, G; Sherratt, AR; McLauchlan, J; Pezacki, JP				Lyn, Rodney K.; Hope, Graham; Sherratt, Allison R.; McLauchlan, John; Pezacki, John Paul			Bidirectional Lipid Droplet Velocities Are Controlled by Differential Binding Strengths of HCV Core DII Protein	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SIGNAL PEPTIDE PEPTIDASE; TUG-OF-WAR; CARS MICROSCOPY; IN-VIVO; INFECTIOUS VIRUS; MOLECULAR MOTORS; TRANSPORT; DYNEIN; REPLICATION	Host cell lipid droplets (LD) are essential in the hepatitis C virus (HCV) life cycle and are targeted by the viral capsid core protein. Core-coated LDs accumulate in the perinuclear region and facilitate viral particle assembly, but it is unclear how mobility of these LDs is directed by core. Herein we used two-photon fluorescence, differential interference contrast imaging, and coherent anti-Stokes Raman scattering microscopies, to reveal novel core-mediated changes to LD dynamics. Expression of core protein's lipid binding domain II (DII-core) induced slower LD speeds, but did not affect directionality of movement on microtubules. Modulating the LD binding strength of DII-core further impacted LD mobility, revealing the temporal effects of LD-bound DII-core. These results for DII-core coated LDs support a model for core-mediated LD localization that involves core slowing down the rate of movement of LDs until localization at the perinuclear region is accomplished where LD movement ceases. The guided localization of LDs by HCV core protein not only is essential to the viral life cycle but also poses an interesting target for the development of antiviral strategies against HCV.	[Lyn, Rodney K.; Sherratt, Allison R.; Pezacki, John Paul] Natl Res Council Canada, Ottawa, ON, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Hope, Graham; McLauchlan, John] Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland	National Research Council Canada; University of Ottawa; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow	McLauchlan, J (corresponding author), Univ Glasgow, Ctr Virus Res, Med Res Council, Glasgow, Lanark, Scotland.	john.mclauchlan@glasgow.ac.uk; john.pezacki@nrc-cnrc.gc.ca			National Research Council of Canada; Canadian Institutes for Health Research (CIHR); Ontario Graduate Scholarship; Medical Research Council [MC_UU_12014/1] Funding Source: researchfish; MRC [MC_UU_12014/1] Funding Source: UKRI	National Research Council of Canada; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Research Council of Canada and a grant from the Canadian Institutes for Health Research (CIHR). R. K. L. was the recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Alsaleh K, 2010, J VIROL, V84, P12515, DOI 10.1128/JVI.01393-10; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Clement S, 2007, J HEPATOL, V46, P985, DOI 10.1016/j.jhep.2007.03.005; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Erhardt A, 2002, VIROLOGY, V292, P272, DOI 10.1006/viro.2001.1227; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hayashi J, 2000, HEPATOLOGY, V32, P958, DOI 10.1053/jhep.2000.19343; Henry T, 2006, CELL MICROBIOL, V8, P23, DOI 10.1111/j.1462-5822.2005.00649.x; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mazumder N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066738; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pegoraro AF, 2009, OPT EXPRESS, V17, P20700, DOI 10.1364/OE.17.020700; Pegoraro AF, 2009, OPT EXPRESS, V17, P2984, DOI 10.1364/OE.17.002984; Perez-Berna AJ, 2008, J VIRAL HEPATITIS, V15, P346, DOI 10.1111/j.1365-2893.2007.00948.x; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Roingeard P, 2011, BIOL CELL, V103, P223, DOI 10.1042/BC20100119; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836	77	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78065	10.1371/journal.pone.0078065	http://dx.doi.org/10.1371/journal.pone.0078065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223760	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300020
J	Pathak, SK; Tavares, R; de Klerk, N; Spetz, AL; Jonsson, AB				Pathak, Sushil Kumar; Tavares, Raquel; de Klerk, Nele; Spetz, Anna-Lena; Jonsson, Ann-Beth			Helicobacter pylori Protein JHP0290 Binds to Multiple Cell Types and Induces Macrophage Apoptosis via Tumor Necrosis Factor (TNF)-Dependent and Independent Pathways	PLOS ONE			English	Article							KAPPA-B ACTIVATION; FACTOR-ALPHA; GASTRIC-CANCER; INCREASED RISK; INFECTION; RELEASE; TNF; INTERLEUKIN-1-BETA; EXPRESSION; INDUCTION	Activated macrophages at the sub-mucosal space play a major role in generating innate immune responses during H. pylori infection. Final disease outcome largely depends on how H. pylori and bacterium-derived products modulate macrophage responses. Here, we report that JHP0290, a functionally unknown protein from H. pylori, regulates macrophage functions. Recombinant purified JHP0290 (rJHP0290) had the ability to bind to several cell types including macrophages, human gastric epithelial cell lines, human monocyte-derived dendritic cells (MoDC) and human neutrophils. Exposure to rJHP0290 induced apoptosis in macrophages concurrent with release of proinflammatory cytokine tumor necrosis factor (TNF). A mutant strain of H. pylori disrupted in the jhp0290 gene was significantly impaired in its ability to induce apoptosis and TNF in macrophages confirming the role of endogenous protein in regulating macrophage responses. Intracellular signaling involving Src family of tyrosine kinases (SFKs) and ERK MAPK were required for rJHP0290-induced TNF release and apoptosis in macrophages. Furthermore, rJHP0290-induced TNF release was partly dependent on activation of nuclear transcription factor-kappa B (NF-kappa B). Neutralizing antibodies against TNF partially blocked rJHP0290-induced macrophage apoptosis indicating TNF-independent pathways were also involved. These results provide mechanistic insight into the potential role of the protein JHP0290 during H. pylori-associated disease development. By virtue of its ability to induce TNF, an acid suppressive proinflammatory cytokine and induction of macrophage apoptosis, JHP0290 possibly helps in persistent survival of the bacterium inside the stomach.	[Pathak, Sushil Kumar; Tavares, Raquel; de Klerk, Nele; Jonsson, Ann-Beth] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Spetz, Anna-Lena] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska University Hospital	Pathak, SK (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	sushil.pathak@su.se; ann-beth.jonsson@su.se	Spetz, Anna-Lena/C-3543-2016	Spetz, Anna-Lena/0000-0003-3964-9512	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council (www.vr.se) and the Swedish Cancer Society (www.cancerfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022530; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Catrina AI, 2005, ARTHRITIS RHEUM-US, V52, P61, DOI 10.1002/art.20764; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Epplein M, 2012, CANCER EPIDEM BIOMAR, V21, P2185, DOI 10.1158/1055-9965.EPI-12-0792-T; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Harris PR, 1998, J INFECT DIS, V178, P1516, DOI 10.1086/314426; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Li X, 2009, TOXICOL MECH METHOD, V19, P51, DOI 10.1080/15376510802354201; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Parker H, 2012, MICROBES INFECT, V14, P9, DOI 10.1016/j.micinf.2011.08.007; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207	43	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77872	10.1371/journal.pone.0077872	http://dx.doi.org/10.1371/journal.pone.0077872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223737	gold, Green Submitted, Green Published			2022-12-25	WOS:000326499300012
J	Poon, AFY; Walker, LW; Murray, H; McCloskey, RM; Harrigan, PR; Liang, RH				Poon, Art F. Y.; Walker, Lorne W.; Murray, Heather; McCloskey, Rosemary M.; Harrigan, P. Richard; Liang, Richard H.			Mapping the Shapes of Phylogenetic Trees from Human and Zoonotic RNA Viruses	PLOS ONE			English	Article							EVOLUTIONARY; DIVERSIFICATION; PERFORMANCE; PYTHON	A phylogeny is a tree-based model of common ancestry that is an indispensable tool for studying biological variation. Phylogenies play a special role in the study of rapidly evolving populations such as viruses, where the proliferation of lineages is constantly being shaped by the mode of virus transmission, by adaptation to immune systems, and by patterns of human migration and contact. These processes may leave an imprint on the shapes of virus phylogenies that can be extracted for comparative study; however, tree shapes are intrinsically difficult to quantify. Here we present a comprehensive study of phylogenies reconstructed from 38 different RNA viruses from 12 taxonomic families that are associated with human pathologies. To accomplish this, we have developed a new procedure for studying phylogenetic tree shapes based on the 'kernel trick', a technique that maps complex objects into a statistically convenient space. We show that our kernel method outperforms nine different tree balance statistics at correctly classifying phylogenies that were simulated under different evolutionary scenarios. Using the kernel method, we observe patterns in the distribution of RNA virus phylogenies in this space that reflect modes of transmission and pathogenesis. For example, viruses that can establish persistent chronic infections (such as HIV and hepatitis C virus) form a distinct cluster. Although the visibly 'star-like' shape characteristic of trees from these viruses has been well-documented, we show that established methods for quantifying tree shape fail to distinguish these trees from those of other viruses. The kernel approach presented here potentially represents an important new tool for characterizing the evolution and epidemiology of RNA viruses.	[Poon, Art F. Y.; Murray, Heather; McCloskey, Rosemary M.; Harrigan, P. Richard; Liang, Richard H.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Poon, Art F. Y.; Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Walker, Lorne W.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego	Poon, AFY (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	apoon@cfenet.ubc.ca	Poon, Art/W-9811-2019; Murray, Heather/GQY-8016-2022	Poon, Art/0000-0003-3779-154X; Walker, Lorne/0000-0002-2500-0504	Canadian Institutes of Health Research (CIHR) [HOP-111406]; Michael Smith Foundation for Health Research (MSFHR)/St. similar toPaul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI); CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research; Simon Fraser University; University of British Columbia; CIHR/GSK Research Chair in Clinical Virology	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)/St. similar toPaul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI); CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research(Canadian Institutes of Health Research (CIHR)); Simon Fraser University; University of British Columbia; CIHR/GSK Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (HOP-111406) awarded to AFYP. AFYP is supported by a Scholar Award from the Michael Smith Foundation for Health Research (MSFHR)/St. similar to Paul's Hospital Foundation-Providence Health Care Research Institute (SPHF-PHCRI) Career Investigator program, and by a New Investigator Award from the CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery and Social Research. RMM was supported by a Vice President Research Undergraduate Student Research Award (VPR-USRA) from Simon Fraser University. HM was supported by a Centre for Blood Research Summer Studentship from the University of British Columbia. PRH is supported by a CIHR/GSK Research Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821, DOI DOI 10.1234/12345678; Bernhard S., 2004, KERNEL METHODS COMPU, P35; Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Collins M., 2002, ADV NEURAL INFORM PR, V14; Dalcin L, 2008, J PARALLEL DISTR COM, V68, P655, DOI 10.1016/j.jpdc.2007.09.005; Drake JW, 1998, GENETICS, V148, P1667; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Karatzoglou A., 2004, R J STAT SOFTW, V11, P1; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Moschitti A., 2006, P 11 C EUR CHAPT ASS, P113; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Pompei S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044849; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purvis A, 2002, J THEOR BIOL, V214, P99, DOI 10.1006/jtbi.2001.2443; Ratmann O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002835; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Scholkopf B, 2000, NEURAL COMPUTATION, V12, P1207; Sharp PM, 2002, CELL, V108, P305, DOI 10.1016/S0092-8674(02)00639-6; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weston J, 2003, ANN I STAT MATH, V55, P391, DOI 10.1023/A:1026338322729; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107	42	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78122	10.1371/journal.pone.0078122	http://dx.doi.org/10.1371/journal.pone.0078122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223766	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300023
J	Wang, M; Wang, F; Wang, YN; Ma, XN; Zhao, M; Zhao, CJ				Wang, Miao; Wang, Fei; Wang, Yinan; Ma, Xiaonan; Zhao, Min; Zhao, Chunjie			Metabonomics Study of the Therapeutic Mechanism of Gynostemma pentaphyllum and Atorvastatin for Hyperlipidemia in Rats	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DIET-INDUCED HYPERLIPIDEMIA; NMR-SPECTROSCOPY; METABOLOMICS; URINE; SERUM; BERBERINE; SAPONINS	Gynostemma pentaphyllum (GP) is widely used for the treatment of diseases such as hyperlipidemia, fatty liver and obesity in China, and atorvastatin is broadly used as an anti-hyperlipidemia drug. This research focuses on the plasma and liver metabolites in the following four groups of rats: control, a hyperlipidemia model, a hyperlipidemia model treated with GP and a hyperlipidemia model treated with atorvastatin. Using H-1-NMR-based metabonomics, we elucidated the therapeutic mechanisms of GP and atorvastatin. Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) plotting of the metabolic state and analysis of potential biomarkers in the plasma and liver correlated well with the results of biochemical assays. GP can effectively affect lipid metabolism, and it exerts its anti-hyperlipidemia effect by elevating the level of phosphatidylcholine and decreasing the level of trimethylamine N-oxide (TMAO). In contrast, atorvastatin affects hyperlipidemia mainly during lipid metabolism and protein metabolism in vivo.	[Wang, Miao; Wang, Yinan; Zhao, Min; Zhao, Chunjie] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Wang, Fei] Northeastern Univ, Coll Informat Sci & Eng, Shenyang, Peoples R China; [Wang, Miao; Ma, Xiaonan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Northeastern University - China; Shenyang Pharmaceutical University	Zhao, CJ (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	zcjjljj@sina.com						Azmi J, 2005, BIOMARKERS, V10, P401, DOI 10.1080/13547500500309259; BALES JR, 1984, CLIN CHEM, V30, P426; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bollard ME, 2000, MAGNET RESON MED, V44, P201, DOI 10.1002/1522-2594(200008)44:2<201::AID-MRM6>3.0.CO;2-5; CHEN HZ, 2004, J CHINESE INTEG 0302, V2, P81; DONALD V, 2000, FUNDAMENTALS BIOCH; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Gu Y, 2010, TALANTA, V81, P766, DOI 10.1016/j.talanta.2010.01.015; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Huyen VTT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/452313; JEAN CM, 2009, ATHEROSCLEROSIS, V206, P127, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2009.01.040; Kao TH, 2008, ANAL CHIM ACTA, V626, P200, DOI 10.1016/j.aca.2008.07.049; LACOUR B, 1995, J ETHNOPHARMACOL, V46, P125, DOI 10.1016/0378-8741(95)01234-5; Li N, 2012, EUR J MED CHEM, V50, P173, DOI 10.1016/j.ejmech.2012.01.052; Liang SX, 2002, SPECTROSC SPECT ANAL, V22, P847; Liang XP, 2011, J PROTEOME RES, V10, P790, DOI 10.1021/pr1009299; Lindon JC, 2004, EXPERT REV MOL DIAGN, V4, P189, DOI 10.1586/14737159.4.2.189; Liu F, 2012, ANAL BIOANAL CHEM, V403, P847, DOI 10.1007/s00216-012-5923-9; Naoumova RP, 1997, J LIPID RES, V38, P1496; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Qin RA, 2012, ARCH PHARM RES, V35, P1241, DOI 10.1007/s12272-012-0715-5; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watkins SM, 2002, CURR OPIN MOL THER, V4, P224; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Yang XB, 2008, J AGR FOOD CHEM, V56, P6905, DOI 10.1021/jf801101u; Zha WB, 2009, BIOMARKERS, V14, P372, DOI 10.1080/13547500903026401; Zhang AH, 2012, PHARMAZIE, V67, P667, DOI 10.1691/ph.2012.2511; Zhang Q, 2010, BIOMARKERS, V15, P205, DOI 10.3109/13547500903419049; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173	36	17	22	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78731	10.1371/journal.pone.0078731	http://dx.doi.org/10.1371/journal.pone.0078731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223845	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300032
J	Yam, PT; Pincus, Z; Gupta, GD; Bashkurov, M; Charron, F; Pelletier, L; Colman, DR				Yam, Patricia T.; Pincus, Zachary; Gupta, Gagan D.; Bashkurov, Mikhail; Charron, Frederic; Pelletier, Laurence; Colman, David R.			N-Cadherin Relocalizes from the Periphery to the Center of the Synapse after Transient Synaptic Stimulation in Hippocampal Neurons	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; BETA-CATENIN; CELL; ADHESION; ORGANIZATION; SYNAPTOGENESIS; PLASTICITY; MICROSCOPY; JUNCTIONS; COMPLEX	N-cadherin is a cell adhesion molecule which is enriched at synapses. Binding of N-cadherin molecules to each other across the synaptic cleft has been postulated to stabilize adhesion between the presynaptic bouton and the postsynaptic terminal. N-cadherin is also required for activity-induced changes at synapses, including hippocampal long term potentiation and activity-induced spine expansion and stabilization. We hypothesized that these activity-dependent changes might involve changes in N-cadherin localization within synapses. To determine whether synaptic activity changes the localization of N-cadherin, we used structured illumination microscopy, a superresolution approach which overcomes the conventional resolution limits of light microscopy, to visualize the localization of N-cadherin within synapses of hippocampal neurons. We found that synaptic N-cadherin exhibits a spectrum of localization patterns, ranging from puncta at the periphery of the synapse adjacent to the active zone to an even distribution along the synaptic cleft. Furthermore, the N-cadherin localization pattern within synapses changes during KCl depolarization and after transient synaptic stimulation. During KCl depolarization, N-cadherin relocalizes away from the central region of the synaptic cleft to the periphery of the synapse. In contrast, after transient synaptic stimulation with KCl followed by a period of rest in normal media, fewer synapses have N-cadherin present as puncta at the periphery and more synapses have N-cadherin present more centrally and uniformly along the synapse compared to unstimulated cells. This indicates that transient synaptic stimulation modulates N-cadherin localization within the synapse. These results bring new information to the structural organization and activity-induced changes occurring at synapses, and suggest that N-cadherin relocalization may contribute to activity dependent changes at synapses.	[Yam, Patricia T.; Colman, David R.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Yam, Patricia T.; Charron, Frederic; Colman, David R.] McGill Univ, Program Neuroengn, Montreal, PQ, Canada; [Pincus, Zachary] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Gupta, Gagan D.; Bashkurov, Mikhail; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Charron, Frederic] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Charron, Frederic] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Charron, Frederic] McGill Univ, Dept Biol, Dept Anat & Cell Biol, Div Expt Med, Montreal, PQ H3A 1B1, Canada; [Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	McGill University; McGill University; Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; University of Toronto	Yam, PT (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	patricia.yam@gmail.com	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Pelletier, Laurence/F-8858-2013	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Gupta, Gagan/0000-0002-1089-965X; Yam, Patricia/0000-0002-3631-3151; Pincus, Zachary/0000-0001-9785-5977	Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR); McGill Program in Neuroengineering; NSERC; CIHR; Rio Tinto Alcan; Molson Foundation; Ontario Research Fund GL2; Canadian Cancer Society; NIH [1K99AG042487]; NATIONAL INSTITUTE ON AGING [R00AG042487, K99AG042487] Funding Source: NIH RePORTER	Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Rio Tinto Alcan; Molson Foundation; Ontario Research Fund GL2; Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR) to D. R. C., by grants obtained via the McGill Program in Neuroengineering, which is supported by NSERC, CIHR, Rio Tinto Alcan and the Molson Foundation, grants from the Ontario Research Fund GL2 and the Canadian Cancer Society to L. P., a grant from CIHR to F. C. and NIH 1K99AG042487 grant to Z.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rubio ME, 2005, MOL CELL NEUROSCI, V30, P118, DOI 10.1016/j.mcn.2005.06.005; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SANTAMARIA F, PLOS COMPUT BIOL, V6, P780, DOI DOI 10.1371/J0URNAL.PCBI.1000780.PUBMED:20485563; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Sigrist SJ, 2012, CURR OPIN NEUROBIOL, V22, P86, DOI 10.1016/j.conb.2011.10.014; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; TRILLER A, 1985, J NEUROCYTOL, V14, P177, DOI 10.1007/BF01258446; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vitureira N, 2012, NAT NEUROSCI, V15, P81, DOI 10.1038/nn.2995; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	52	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79679	10.1371/journal.pone.0079679	http://dx.doi.org/10.1371/journal.pone.0079679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223993	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300093
J	Cui, YX; Xia, XY; Zhou, Y; Gao, L; Shang, XJ; Ni, T; Wang, WP; Fan, XB; Yin, HL; Jiang, SJ; Yao, B; Hu, YA; Wang, G; Li, XJ				Cui, Ying-Xia; Xia, Xin-Yi; Zhou, Yang; Gao, Lin; Shang, Xue-Jun; Ni, Tong; Wang, Wei-Ping; Fan, Xiao-Buo; Yin, Hong-Lin; Jiang, Shao-Jun; Yao, Bing; Hu, Yu-An; Wang, Gang; Li, Xiao-Jun			Novel Mutations of ABCB6 Associated with Autosomal Dominant Dyschromatosis Universalis Hereditaria	PLOS ONE			English	Article							TRANSPORTER; IDENTIFICATION	Objective: Dyschromatosis universalis hereditaria (DUH) is a rare heterogeneous pigmentary genodermatosis, which was first described in 1933. The genetic cause has recently been discovered by the discovery of mutations in ABCB6. Here we investigated a Chinese family with typical features of autosomal dominant DUH and 3 unrelated patients with sporadic DUH. Methods: Skin tissues were obtained from the proband, of this family and the 3 sporadic patients. Histopathological examination and immunohistochemical analysis of ABCB6 were performed. Peripheral blood DNA samples were obtained from 21 affected, 14 unaffected, 11 spouses in the family and the 3 sporadic patients. A genome-wide linkage scan for the family was carried out to localize the causative gene. Exome sequencing was performed from 3 affected and 1 unaffected in the family. Sanger sequencing of ABCB6 was further used to identify the causative gene for all samples obtained from available family members, the 3 sporadic patients and a panel of 455 ethnically-matched normal Chinese individuals. Results: Histopathological analysis showed melanocytes in normal control's skin tissue and the hyperpigmented area contained more melanized, mature melanosomes than those within the hypopigmented areas. Empty immature melanosomes were found in the hypopigmented melanocytes. Parametric multipoint linkage analysis produced a HLOD score of 4.68, with markers on chromosome 2q35-q37.2. A missense mutation (c.1663 C>A, p.Gln555Lys) in ABCB6 was identified in this family by exome and Sanger sequencing. The mutation perfectly cosegregated with the skin phenotype. An additional mutation (g. 776 delC, c. 459 delC) in ABCB6 was found in an unrelated sporadic patient. No mutation in ABCB6 was discovered in the other two sporadic patients. Neither of the two mutations was present in the 455 controls. Melanocytes showed positive immunoreactivity to ABCB6. Conclusion: Our data add new variants to the repertoire of ABCB6 mutations with DUH.	[Cui, Ying-Xia; Xia, Xin-Yi; Zhou, Yang; Shang, Xue-Jun; Wang, Wei-Ping; Fan, Xiao-Buo; Yao, Bing; Hu, Yu-An; Li, Xiao-Jun] Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Gao, Lin; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Ni, Tong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Dermatol, Nanjing 210008, Jiangsu, Peoples R China; [Yin, Hong-Lin; Jiang, Shao-Jun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Air Force Military Medical University; Nanjing University; Nanjing University	Li, XJ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	Lixiaojun1962@gmail.com	Xia, Xin-Yi/C-3744-2014; Wang, Gang/H-6710-2019	Wang, Gang/0000-0002-5842-8080	National Natural Science Foundation of China [30901652, 81071419]; Natural Science Foundation of Jiangsu Province [BK2011660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This sdudy is supported in part by the National Natural Science Foundation of China (30901652,81071419) and the Natural Science Foundation of Jiangsu Province (BK2011660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hawsawi K, 2002, PEDIATR DERMATOL, V19, P523, DOI 10.1046/j.1525-1470.2002.00225.x; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Bukhari IA, 2006, J EUR ACAD DERMATOL, V20, P628, DOI 10.1111/j.1468-3083.2006.01522.x; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Ichigawa T, 1933, JAPANESE J DERMATOLO, V34, P360; Kenani N, 2008, Dermatol Online J, V14, P16; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Nuber UA, 2004, AM J MED GENET A, V125A, P261, DOI 10.1002/ajmg.a.20519; Reddy Shruthi Geedipalley, 2011, Dermatol Online J, V17, P3; Sethuraman G, 2002, CLIN EXP DERMATOL, V27, P477, DOI 10.1046/j.1365-2230.2002.01129.x; Steel KP, 1998, NAT GENET, V20, P319, DOI 10.1038/3781; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; SUENAGA M, 1952, Tohoku J Exp Med, V55, P373; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Udayashankar Carounanidy, 2011, Dermatol Online J, V17, P2; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Yusuf SM, 2009, INT J DERMATOL, V48, P749, DOI 10.1111/j.1365-4632.2009.03290.x; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	23	18	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79808	10.1371/journal.pone.0079808	http://dx.doi.org/10.1371/journal.pone.0079808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224009	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400090
J	Dohms, KM; Burg, TM				Dohms, Kimberly M.; Burg, Theresa M.			Molecular Markers Reveal Limited Population Genetic Structure in a North American Corvid, Clark's Nutcracker (Nucifraga columbiana)	PLOS ONE			English	Article							MICROSATELLITE LOCI; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; POSTGLACIAL COLONIZATION; PINE; DISPERSAL; PATTERNS; DIVERSITY; SEQUENCES; SOFTWARE	The genetic impact of barriers and Pleistocene glaciations on high latitude resident species has not been widely investigated. The Clark's nutcracker is an endemic North American corvid closely associated with Pinus-dominated forests. The nutcracker's encompasses known barriers to dispersal for other species, and glaciated and unglaciated areas. Clark's nutcrackers also irruptively disperse long distances in search of pine seed crops, creating the potential for gene flow among populations. Using the highly variable mitochondrial DNA control region, seven microsatellite loci, and species distribution modeling, we examined the effects of glaciations and dispersal barriers on population genetic patterns and population structure of nutcrackers. We sequenced 900 bp of mitochondrial control region for 169 individuals from 15 populations and analysed seven polymorphic microsatellite loci for 13 populations across the Clark's nutcracker range. We used species distribution modeling and a range of phylogeographic analyses to examine evolutionary history. Clark's nutcracker populations are not highly differentiated throughout their range, suggesting high levels of gene flow among populations, though we did find some evidence of isolation by distance and peripheral isolation. Our analyses suggested expansion from a single refugium after the last glacial maximum, but patterns of genetic diversity and paleodistribution modeling of suitable habitat were inconclusive as to the location of this refugium. Potential barriers to dispersal (e. g. mountain ranges) do not appear to restrict gene flow in Clark's nutcracker, and postglacial expansion likely occurred quickly from a single refugium located south of the ice sheets.	[Dohms, Kimberly M.; Burg, Theresa M.] Univ Lethbridge, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Dohms, KM (corresponding author), Univ Lethbridge, Lethbridge, AB T1K 3M4, Canada.	kim.dohms@uleth.ca			Natural Science and Engineering Research Council (NSERC); Alberta Innovates (AI)	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates (AI)	The work was supported by the following: Natural Science and Engineering Research Council (NSERC) Discovery Grant (TMB) and Post-Graduate Scholarship D (KMD), http://www.nserc-crsng.gc.ca/; Alberta Innovates (AI) New Faculty Award (TMB) and Graduate Scholarship (KMD), http://www.albertatechfutures.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Avise J.C., 2004, MOL MARKERS NATURAL, P684; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burg TM, 2006, MOL ECOL, V15, P2409, DOI 10.1111/j.1365-294X.2006.02957.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burg TM, 2003, P ROY SOC B-BIOL SCI, V270, P979, DOI 10.1098/rspb.2002.2322; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; EARL DA, 2012, CONSERV GENET RESOUR, V4, P1, DOI DOI 10.1007/S12686-011-9460-1; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ernest HB, 2008, MOL ECOL RESOUR, V8, P196, DOI 10.1111/j.1471-8286.2007.01921.x; Ersts P, 2011, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Graham BA, 2012, J AVIAN BIOL, V43, P198, DOI 10.1111/j.1600-048X.2012.05604.x; Haring E, 2007, MOL PHYLOGENET EVOL, V45, P840, DOI 10.1016/j.ympev.2007.06.016; Hasumi H., 2004, 1 U TOK CTR CLIM SYS; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johansen AD, 2003, MOL ECOL, V12, P293, DOI 10.1046/j.1365-294X.2003.01723.x; Jorgensen S, 2002, AM J BOT, V89, P792, DOI 10.3732/ajb.89.5.792; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kim MS, 2011, TREE GENET GENOMES, V7, P11, DOI 10.1007/s11295-010-0311-0; Klicka J, 2011, AUK, V128, P346, DOI 10.1525/auk.2011.10264; Koopman ME, 2007, AUK, V124, P690, DOI 10.1642/0004-8038(2007)124[690:HCAMGS]2.0.CO;2; Lait LA, 2012, J AVIAN BIOL, V43, P541, DOI 10.1111/j.1600-048X.2012.05761.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Lorenz TJ, 2010, J FIELD ORNITHOL, V81, P430, DOI 10.1111/j.1557-9263.2010.00299.x; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Marthinsen G, 2008, MOL PHYLOGENET EVOL, V47, P1005, DOI 10.1016/j.ympev.2008.03.027; MCKINNEY ST, 2011, FUTURE HIGH ELEVATIO, P376; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Milot E, 2000, MOL ECOL, V9, P667, DOI 10.1046/j.1365-294x.2000.00897.x; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Newton I, 2006, ARDEA, V94, P433; Oyler-McCance SJ, 2013, CONSERV GENET RESOUR, V5, P303, DOI 10.1007/s12686-012-9789-0; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pielou E.C., 1991, ICE AGE RETURN LIFE; Piertney SB, 2001, P ROY SOC B-BIOL SCI, V268, P1511, DOI 10.1098/rspb.2001.1015; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pritchard JK, 2000, GENETICS, V155, P945; Pulgarin-R PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040412; Pyle P., 1997, IDENTIFICATION GUI 1; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saunders MA, 2000, J MOL EVOL, V51, P97, DOI 10.1007/s002390010070; SLATKIN M, 1991, GENETICS, V129, P555; Spellman GM, 2007, MOL ECOL, V16, P1729, DOI 10.1111/j.1365-294X.2007.03237.x; Spellman GM, 2006, P ROY SOC B-BIOL SCI, V273, P3057, DOI 10.1098/rspb.2006.3682; Stenzler LM, 2009, CONDOR, V111, P470, DOI 10.1525/cond.2009.080052; Stenzler LM, 2002, MOL ECOL NOTES, V2, P547, DOI 10.1046/j.1471-8286.2002.00312.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; TOMBACK DF, 1998, BIRDS N AM, V24; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Williams JW, 2003, GLOBAL PLANET CHANGE, V35, P1, DOI 10.1016/S0921-8181(02)00088-7; Wright S., 1978, EVOLUTION GENETICS P, V4; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink Robert M., 1997, P301, DOI 10.1016/B978-012498315-1/50017-0	78	9	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79621	10.1371/journal.pone.0079621	http://dx.doi.org/10.1371/journal.pone.0079621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223982	Green Published, gold			2022-12-25	WOS:000326503400132
J	Inoue, Y; Tomiya, T; Nishikawa, T; Ohtomo, N; Tanoue, Y; Ikeda, H; Koike, K				Inoue, Yukiko; Tomiya, Tomoaki; Nishikawa, Takako; Ohtomo, Natsuko; Tanoue, Yasushi; Ikeda, Hitoshi; Koike, Kazuhiko			Induction of p53-Dependent p21 Limits Proliferative Activity of Rat Hepatocytes in the Presence of Hepatocyte Growth Factor	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-SYNTHESIS; LIVER; P53; PROTEIN; ARREST; EXPRESSION; INHIBITOR; INVOLVEMENT; G(1)	Background: Hepatocyte growth factor (HGF), a potent mitogen for hepatocytes, enhances hepatocyte function without stimulating proliferation, depending on the physiological conditions. p53, a transcription factor, suppresses the cell proliferation by expressing p21(WAF1/CIP1) in various tissues. Aim: To investigate the mechanism through which the hepatocytes maintain mitotically quiescent even in the presence of HGF. Methods: We studied the relationship between p53 and p21 expression and the effect of p53-p21 axis on hepatocyte proliferation in primary cultured rat hepatocytes stimulated by HGF. Hepatic p21 levels are determined serially after partial hepatectomy or sham operation in rats. Results: DNA synthesis was markedly increased by HGF addition in rat hepatocytes cultured at low density but not at high density. Cellular p53 levels increased in the hepatocytes cultured at both the densities. p21 levels were increased and correlated with cellular p53 levels in hepatocytes cultured at high density but not at low density. When the activity of p53 was suppressed by a chemical inhibitor for p53, cellular p21 levels were reduced, and DNA synthesis was increased. Similarly, p21 antisense oligonucleotide increased the DNA synthesis. In rats after partial hepatectomy, transient elevation of hepatic p21 levels was observed. In contrast, in sham-operated rats, hepatic p21 levels were increased on sustained time scales. Conclusion: p53-related induction of p21 may suppress hepatocyte proliferation in the presence of HGF in the setting that mitogenic activity of HGF is not elicitable.	[Inoue, Yukiko; Tomiya, Tomoaki; Nishikawa, Takako; Ohtomo, Natsuko; Tanoue, Yasushi; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Ikeda, Hitoshi] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Tomiya, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tomiya-1im@h.u-tokyo.ac.jp						Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Albrecht JH, 1999, AM J PHYSIOL-GASTR L, V277, pG1207, DOI 10.1152/ajpgi.1999.277.6.G1207; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN WH, 1995, ENDOCRINOLOGY, V136, P5240, DOI 10.1210/en.136.11.5240; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chou WW, 2008, TOXICOLOGY, V243, P1, DOI 10.1016/j.tox.2007.09.003; Conner EA, 1997, BIOCHEM BIOPH RES CO, V236, P396, DOI 10.1006/bbrc.1997.6938; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faletto D L, 1993, EXS, V65, P107; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; FUJIWARA K, 1993, HEPATOLOGY, V18, P1443, DOI 10.1016/0270-9139(93)90237-H; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Han JH, 2005, J BIOL CHEM, V280, P31548, DOI 10.1074/jbc.M503431200; HARPER JW, 1993, CELL, V75, P805; Inoue Y, 2002, HEPATOLOGY, V36, P336, DOI 10.1053/jhep.2002.34942; Israsena N, 2002, J NEUROSCI RES, V69, P803, DOI 10.1002/jnr.10362; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MICHIELI P, 1994, CANCER RES, V54, P3391; MILNE DM, 1994, J BIOL CHEM, V269, P9253; Mizuno S, 2007, REGEN MED, V2, P161, DOI 10.2217/17460751.2.2.161; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shima N, 1998, J CELL PHYSIOL, V177, P130, DOI 10.1002/(SICI)1097-4652(199810)177:1<130::AID-JCP14>3.3.CO;2-O; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; TAKEHARA T, 1992, J BIOCHEM-TOKYO, V112, P330, DOI 10.1093/oxfordjournals.jbchem.a123900; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TOMIYA T, 1992, HEPATOLOGY, V15, P1, DOI 10.1002/hep.1840150102; Tomiya T, 2000, AM J PATHOL, V157, P1693, DOI 10.1016/S0002-9440(10)64806-7; TOMIYA T, 1992, GASTROENTEROLOGY, V103, P1621, DOI 10.1016/0016-5085(92)91186-8; Tomiya T, 1996, NEPHRON, V73, P735; Tomiya T, 1998, AM J PATHOL, V153, P955, DOI 10.1016/S0002-9440(10)65637-4; Tomiya T, 2004, BIOCHEM BIOPH RES CO, V322, P772, DOI 10.1016/j.bbrc.2004.07.191; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wierod L, 2008, ONCOGENE, V27, P2763, DOI 10.1038/sj.onc.1210937; Yamaoka M, 1998, LIVER, V18, P52; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78346	10.1371/journal.pone.0078346	http://dx.doi.org/10.1371/journal.pone.0078346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223793	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400053
J	Iwajomo, OH; Finn, A; Ogunniyi, AD; Williams, NA; Heyderman, RS				Iwajomo, Oluwadamilola H.; Finn, Adam; Ogunniyi, Abiodun D.; Williams, Neil A.; Heyderman, Robert S.			Impairment of Pneumococcal Antigen Specific Isotype-Switched Igg Memory B-Cell Immunity in HIV Infected Malawian Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; AFRICAN CHILDREN; RESPONSES; DISEASE; IMMUNIZATION; INDIVIDUALS; PROTEIN; PNEUMOLYSIN; EXPRESSION; PROTECTION	Pneumococcal disease is associated with a particularly high morbidity and mortality amongst adults in HIV endemic countries. Our previous findings implicating a B-cell defect in HIV-infected children from the same population led us to comprehensively characterize B-cell subsets in minimally symptomatic HIV-infected Malawian adults and investigate the isotype-switched IgG memory B-cell immune response to the pneumococcus. We show that similar to vertically acquired HIV-infected Malawian children, horizontally acquired HIV infection in these adults is associated with IgM memory B-cell (CD19(+) CD27(+) IgM(+) IgD(+)) depletion, B-cell activation and impairment of specific IgG B-cell memory to a range of pneumococcal proteins. Our data suggest that HIV infection affects both T-cell independent and T-cell dependent B-cell maturation, potentially leading to impairment of humoral responses to extracellular pathogens such as the pneumococcus, and thus leaving this population susceptible to invasive disease.	[Iwajomo, Oluwadamilola H.; Finn, Adam; Williams, Neil A.; Heyderman, Robert S.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Iwajomo, Oluwadamilola H.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Ogunniyi, Abiodun D.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Bristol; University of Malawi; University of Adelaide	Iwajomo, OH (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	damilola.iwajomo@gmail.com		Finn, Adam/0000-0003-1756-5668; Heyderman, Robert/0000-0003-4573-449X; Ogunniyi, Abiodun/0000-0001-9308-5629	Joan Franklin-Adams Trust; David Baum Memorial Appeal; Wellcome Trust MLW core grant; Wellcome Trust project grant	Joan Franklin-Adams Trust; David Baum Memorial Appeal; Wellcome Trust MLW core grant; Wellcome Trust project grant(Wellcome Trust)	This work was supported by the Joan Franklin-Adams Trust (scholarship to OHI), David Baum Memorial Appeal (grant to AF and RSH), Wellcome Trust MLW core grant (funding to RSH) and a Wellcome Trust project grant (funding to RSH and NAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clarke ET, 2013, MUCOSAL IMMUNOL, V6, P288, DOI 10.1038/mi.2012.70; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ogunniyi AD, 2008, VACCINE, V26, P4676, DOI 10.1016/j.vaccine.2008.06.099; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Ogunniyi AD, 2001, INFECT IMMUN, V69, P5997, DOI 10.1128/IAI.69.10.5997-6003.2001; Pilling PA, 1998, ACTA CRYSTALLOGR D, V54, P1464, DOI 10.1107/S0907444998005812; Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; World Health Organization, 2009, RAP ADV ANT THER HIV; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617	31	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78592	10.1371/journal.pone.0078592	http://dx.doi.org/10.1371/journal.pone.0078592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223825	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400074
J	Wang, HX; Fan, WJ; Li, H; Yang, J; Huang, JR; Zhang, P				Wang, Hongxia; Fan, Weijuan; Li, Hong; Yang, Jun; Huang, Jirong; Zhang, Peng			Functional Characterization of Dihydroflavonol-4-Reductase in Anthocyanin Biosynthesis of Purple Sweet Potato Underlies the Direct Evidence of Anthocyanins Function against Abiotic Stresses	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PROANTHOCYANIDIN BIOSYNTHESIS; FLAVONOID BIOSYNTHESIS; ACYLATED ANTHOCYANINS; CHALCONE SYNTHASE; MOLECULAR-CLONING; 4-REDUCTASE GENE; MALUS-DOMESTICA; STORAGE ROOT; CELL-LINE	Dihydroflavonol-4-reductase (DFR) is a key enzyme in the catalysis of the stereospecific reduction of dihydroflavonols to leucoanthocyanidins in anthocyanin biosynthesis. In the purple sweet potato (Ipomoea batatas Lam.) cv. Ayamurasaki, expression of the IbDFR gene was strongly associated with anthocyanin accumulation in leaves, stems and roots. Overexpression of the IbDFR in Arabidopsis tt3 mutants fully complemented the pigmentation phenotype of the seed coat, cotyledon and hypocotyl. Downregulation of IbDFR expression in transgenic sweet potato (DFRi) using an RNAi approach dramatically reduced anthocyanin accumulation in young leaves, stems and storage roots. In contrast, the increase of flavonols quercetin-3-O-hexose-hexoside and quercetin-3-O-glucoside in the leaves and roots of DFRi plants is significant. Therefore, the metabolic pathway channeled greater flavonol influx in the DFRi plants when their anthocyanin and proanthocyanidin accumulation were decreased. These plants also displayed reduced antioxidant capacity compared to the wild type. After 24 h of cold treatment and 2 h recovery, the wild-type plants were almost fully restored to the initial phenotype compared to the slower recovery of DFRi plants, in which the levels of electrolyte leakage and hydrogen peroxide accumulation were dramatically increased. These results provide direct evidence of anthocyanins function in the protection against oxidative stress in the sweet potato. The molecular characterization of the IbDFR gene in the sweet potato not only confirms its important roles in flavonoid metabolism but also supports the protective function of anthocyanins of enhanced scavenging of reactive oxygen radicals in plants under stressful conditions.	[Wang, Hongxia; Fan, Weijuan; Li, Hong; Huang, Jirong; Zhang, Peng] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Hongxia; Fan, Weijuan; Li, Hong; Huang, Jirong; Zhang, Peng] Chinese Acad Sci, Natl Ctr Plant Gene Res Shanghai, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Jun; Zhang, Peng] Chinese Acad Sci, Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, P (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	zhangpeng@sibs.ac.cn	Peng Zhang, Dr./A-6423-2008	Peng Zhang, Dr./0000-0002-4868-1306; wang, hong xia/0000-0003-1433-3693	National Basic Research Program [2013CB127000]; National High Technology Research and Development Program of China [2012AA101204]; Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration [G102410, F132427]	National Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration	This work was supported by grants from the National Basic Research Program (Grant No. 2013CB127000), the National High Technology Research and Development Program of China (2012AA101204), and Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration (G102410, F132427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Andersen M, 2010, ENCY LIFE SCI, P1; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chang H, 2010, NUTR CANCER, V62, P1128, DOI 10.1080/01635581.2010.494821; Davies KM, 2007, MUTAT RES-FUND MOL M, V622, P122, DOI 10.1016/j.mrfmmm.2007.02.003; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Ghasemzadeh A, 2012, INT J MOL SCI, V13, P14828, DOI 10.3390/ijms131114828; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goda Y, 1997, PHYTOCHEMISTRY, V44, P183, DOI 10.1016/S0031-9422(96)00533-X; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Gould K., 2009, ANTHOCYANINS BIOSYNT; Han KH, 2007, BRIT J NUTR, V98, P914, DOI 10.1017/S0007114507761792; Hisatomi Y, 1997, THEOR APPL GENET, V95, P509, DOI 10.1007/s001220050591; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030364; Ju JH, 2011, J MED FOOD, V14, P1097, DOI 10.1089/jmf.2010.1450; Kano N, 2005, BIOSCI BIOTECH BIOCH, V69, P979, DOI 10.1271/bbb.69.979; Konczak-Islam I, 2000, PLANT CELL REP, V19, P472, DOI 10.1007/s002990050758; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Lalusin AG, 2006, MOL GENET GENOMICS, V275, P44, DOI 10.1007/s00438-005-0080-x; Li HH, 2012, MOL BIOL REP, V39, P2991, DOI 10.1007/s11033-011-1061-2; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Luceri C, 2008, FOOD CHEM TOXICOL, V46, P1213, DOI 10.1016/j.fct.2007.10.007; Luo CY, 2013, FOOD CHEM, V141, P2697, DOI 10.1016/j.foodchem.2013.05.009; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; MELDGAARD M, 1992, THEOR APPL GENET, V83, P695, DOI 10.1007/BF00226687; Mendoza-Diaz S, 2012, PLANT FOOD HUM NUTR, V67, P442, DOI 10.1007/s11130-012-0326-9; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Montilla EC, 2010, J AGR FOOD CHEM, V58, P9899, DOI 10.1021/jf101898j; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Muller PY, 2002, BIOTECHNIQUES, V33, P514; Mylona P.V., 2010, REACTIVE OXYGEN SPEC, P1; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pelletier MK, 1999, PLANT MOL BIOL, V40, P45, DOI 10.1023/A:1026414301100; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Philpott M, 2004, J AGR FOOD CHEM, V52, P1511, DOI 10.1021/jf034593j; Pourcel L, 2013, PLANT J, V74, P383, DOI 10.1111/tpj.12129; Pourcel L, 2012, REC ADV POLYPHEN RES, V3, P143; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Rosati C, 1997, PLANT MOL BIOL, V35, P303, DOI 10.1023/A:1005881032409; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Schieber A, 2001, J CHROMATOGR A, V910, P265, DOI 10.1016/S0021-9673(00)01217-6; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Szankowski I, 2009, ACTA HORTIC, V814, P511; Tanaka M, 2004, DNA SEQUENCE, V15, P277, DOI 10.1080/10425170400004120; Terahara N, 2000, PHYTOCHEMISTRY, V54, P919, DOI 10.1016/S0031-9422(00)00099-6; Terahara N, 2004, J BIOMED BIOTECHNOL, P279, DOI 10.1155/S1110724304406056; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian QG, 2005, J AGR FOOD CHEM, V53, P6503, DOI 10.1021/jf050671m; White BL, 2011, J AGR FOOD CHEM, V59, P4692, DOI 10.1021/jf200149a; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2005, PHYTOCHEMISTRY, V66, P2127, DOI 10.1016/j.phytochem.2005.01.008; Yang J, 2011, PLANT SCI, V181, P701, DOI 10.1016/j.plantsci.2011.01.005; Yoshida K, 2010, J PLANT RES, V123, P801, DOI 10.1007/s10265-010-0325-6; Yu B, 2007, PLANT CELL TISS ORG, V90, P265, DOI 10.1007/s11240-007-9265-9; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhu F, 2010, J AGR FOOD CHEM, V58, P7588, DOI 10.1021/jf101867t	68	105	119	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78484	10.1371/journal.pone.0078484	http://dx.doi.org/10.1371/journal.pone.0078484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223813	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400067
J	Wu, SX; Liu, B; Zhang, QY; Liu, J; Zhou, W; Wang, C; Li, MY; Bao, ST; Zhu, RH				Wu, Shixing; Liu, Bin; Zhang, Qingyu; Liu, Jie; Zhou, Wei; Wang, Chang; Li, Mingyi; Bao, Shiting; Zhu, Runzhi			Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							CYCLE ARREST; DNA-DAMAGE; MUTANT P53; BAX/BCL-2 RATIO; UP-REGULATION; APOPTOSIS; INHIBITION; ACTIVATION; PATHWAYS; DEATH	Dihydromyricetin (DHM) is a major active ingredient of flavonoids compounds. It exhibited anticancer activity and induced apoptosis in human hepatocellular carcinoma HepG2 cells according to our previous data. In this study, we investigated whether p53 is involved in DHM-triggered viability inhibition and apoptosis induction in cancer cells. MTT [3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay was employed to evaluate the viability of HepG2 cells after DHM treatment. Meanwhile, p53 small interfering RNA (siRNA) was adopted to silence p53 expression. Protein level of p53 and Bax/Bcl-2 were evaluated by western blot analysis. Cell counting assay showed that DHM inhibited HepG2 cell growth effectively in a time- and dose-dependent manner. P53 expression was significantly increased after DHM treatment, whereas Bcl-2 was reduced potently. Furthermore, after co-treatment with Pifithrin-alpha (PFT-alpha, p53 inhibitor), Bcl-2 expression was reversed. The expression of Bax was no significant change, which was also observed after p53 silence. These findings defined and supported a novel function that DHM could induce human hepatocellular carcinoma HepG2 cells apoptosis by up-regulating Bax/Bcl-2 expression via p53 signal pathway.	[Wu, Shixing; Liu, Bin; Zhang, Qingyu; Liu, Jie; Zhou, Wei; Li, Mingyi; Bao, Shiting; Zhu, Runzhi] Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Lab Regenerat Med, Zhanjiang, Peoples R China; [Wang, Chang] Fujian Med Univ, Affiliated Hosp, Ningde Hosp, Emergency Dept, Ningde, Peoples R China	Guangdong Medical University; Fujian Medical University	Li, MY (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Lab Regenerat Med, Zhanjiang, Peoples R China.	hepatolab@163.com; handuney@163.com; hepatolab@gmail.com			National Natural Science Funds, China; Guangdong Province Natural Science Funds, China	National Natural Science Funds, China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Funds, China	This work was supported in part by the following grants: The National Natural Science Funds (http://www.nsfc.gov.cn/) and Guangdong Province Natural Science Funds (http://gdsf.gdstc.gov.cn/), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, J CLIN PHARMACOL, V53, P228, DOI 10.1177/0091270011436344; Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Burmakin M, 2013, CLIN CANC RES; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chee JLY, 2013, CELL CYCLE, V12, P278, DOI 10.4161/cc.23054; Del Poeta G, 2010, BRIT J HAEMATOL, V149, P383, DOI 10.1111/j.1365-2141.2010.08098.x; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Goeman Frauke, 2013, Methods Mol Biol, V962, P211, DOI 10.1007/978-1-62703-236-0_18; Gu HY, 2009, J CANCER RES CLIN, V135, P1777, DOI 10.1007/s00432-009-0624-2; Huang FF, 2012, MAR DRUGS, V10, P2153, DOI 10.3390/md10102153; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Hussein MR, 2009, EXP MOL PATHOL, V87, P63, DOI 10.1016/j.yexmp.2009.03.005; Jeon SH, 2008, ARCH PHARM RES, V31, P978, DOI 10.1007/s12272-001-1255-9; Kou XJ, 2012, PHYTOTHER RES, V26, P988, DOI 10.1002/ptr.3671; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kundakovic T, 2008, ARCH BIOL SCI, V60, P641, DOI 10.2298/ABS0804641K; Lee JH, 2013, CANCER RES, V73, P785, DOI 10.1158/0008-5472.CAN-12-1994; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038802; Qi SM, 2012, INT IMMUNOPHARMACOL, V12, P278, DOI 10.1016/j.intimp.2011.12.001; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Tasyriq M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/765316; Tian Z, 2008, INT J CANCER, V122, P31, DOI 10.1002/ijc.23048; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Voskamp P, 2013, CANCER PREV RES, V6, P129, DOI 10.1158/1940-6207.CAPR-12-0361; Woo HJ, 2012, ENZYME MICROB TECH, V51, P311, DOI 10.1016/j.enzmictec.2012.07.014; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Ye JT, 2008, PLANTA MED, V74, P252, DOI 10.1055/s-2008-1034317; Yeudall W Andrew, 2013, Methods Mol Biol, V962, P135, DOI 10.1007/978-1-62703-236-0_11; Zhang BL, 2012, ANTI-CANCER DRUG, V23, P590, DOI 10.1097/CAD.0b013e32835019f9; Zhou WM, 2010, MOLECULES, V15, P2114, DOI 10.3390/molecules15042114; Zhu HB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-22	34	21	35	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76886	10.1371/journal.pone.0076886	http://dx.doi.org/10.1371/journal.pone.0076886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223706	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400007
J	Kshirsagar, AV; Freburger, JK; Ellis, AR; Wang, L; Winkelmayer, WC; Brookhart, MA				Kshirsagar, Abhijit V.; Freburger, Janet K.; Ellis, Alan R.; Wang, Lily; Winkelmayer, Wolfgang C.; Brookhart, M. Alan			Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients	PLOS ONE			English	Article							ANEMIA MANAGEMENT; MORTALITY; THERAPY; PRODUCTS; PATTERNS; OUTCOMES; DISEASE; ALPHA	Background & Objectives: Intravenous iron supplementation is widespread in the hemodialysis population, but there is uncertainty about the safest dosing strategy. We compared the safety of different intravenous iron dosing practices on the risk of adverse cardiovascular outcomes in a large population of hemodialysis patients. Design settings, participants, & measurements: A retrospective cohort was created from the clinical database of a large dialysis provider (years 2004-2008) merged with administrative data from the United States Renal Data System. Dosing comparisons were (1) bolus (consecutive doses >= 100 mg exceeding 600 mg during one month) versus maintenance (all other iron doses during the month); and (2) high (> 200 mg over 1 month) versus low dose (<= 200 mg over 1 month). We established a 6-month baseline period (to identify potential confounders and effect modifiers), a one-month iron exposure period, and a three-month follow-up period. Outcomes were myocardial infarction, stroke, and death from cardiovascular disease. Results: 117,050 patients contributed 776,203 unique iron exposure/follow-up periods. After adjustment, we found no significant associations of bolus dose versus maintenance, hazards ratio for composite outcome, 1.03 (95% C. I. 0.99, 1.07), or high dose versus low dose intravenous iron, hazards ratio for composite outcome, 0.99 (95% C. I. 0.96, 1.03). There were no consistent associations of either high or bolus dose versus low or maintenance respectively among pre-specified subgroups. Conclusions: Strategies favoring large doses of intravenous iron were not associated with increased short-term cardiovascular morbidity and mortality. Investigation of the long-term safety of the various intravenous iron supplementation strategies may still be warranted.	[Kshirsagar, Abhijit V.] Univ N Carolina, Sch Med, Kidney Ctr, Chapel Hill, NC 27515 USA; [Freburger, Janet K.; Ellis, Alan R.; Wang, Lily] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Winkelmayer, Wolfgang C.] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA; [Brookhart, M. Alan] UNC, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Kshirsagar, AV (corresponding author), Univ N Carolina, Sch Med, Kidney Ctr, Chapel Hill, NC 27515 USA.	sagar@med.unc.edu			Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program [HHSA290200500401]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090181] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded under contract number HHSA290200500401 from the Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Brewster UC, 2006, SEMIN DIALYSIS, V19, P285, DOI 10.1111/j.1525-139X.2006.00174.x; *CTR MED MED SERV, 2012, FED REGISTER, V77, P133; *CTR MED MED SERV, 2011, FED REGISTER, V76, P218; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *FDA, 2011, DRUG SAF COMM MOD DO; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Fishbane S, 1999, AM J KIDNEY DIS, V34, pS47, DOI 10.1053/ajkd.1999.v34.aajkd0344b0047; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KSHIRSAGAR AV, 2013, AM J MED IN PRESS, P97800; LIN DY, 1994, BIOMETRIKA, V81, P61, DOI 10.1093/biomet/81.1.61; *NAT I HLTH, 2011, RES GUID USRDS DAT 2; Parkkinen J, 2000, NEPHROL DIAL TRANSPL, V15, P1827, DOI 10.1093/ndt/15.11.1827; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Reis KA, 2005, INT HEART J, V46, P255, DOI 10.1536/ihj.46.255; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh N, 2012, CLIN NEPHROL, V77, P188, DOI 10.5414/CN107266; Spiegel DM, 2009, CLIN J AM SOC NEPHRO, V4, P1009, DOI 10.2215/CJN.00270109; Thakuria M, 2011, SEMIN DIALYSIS, V24, P597, DOI 10.1111/j.1525-139X.2011.00975.x; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009; Yong K, 2010, NEPHROLOGY, V15, P288, DOI 10.1111/j.1440-1797.2009.01184.x; Zanen AL, 1996, NEPHROL DIAL TRANSPL, V11, P820, DOI 10.1093/oxfordjournals.ndt.a027405	34	54	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78930	10.1371/journal.pone.0078930	http://dx.doi.org/10.1371/journal.pone.0078930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223866	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300043
J	Woon, AP; Tohidpour, A; Alonso, H; Saijo-Hamano, Y; Kwok, T; Roujeinikova, A				Woon, Amanda P.; Tohidpour, Abolghasem; Alonso, Hernan; Saijo-Hamano, Yumiko; Kwok, Terry; Roujeinikova, Anna			Conformational Analysis of Isolated Domains of Helicobacter pylori CagA	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; IV SECRETION; SECONDARY STRUCTURE; GAB FAMILY; PROTEIN; PHOSPHORYLATION; POLYPROLINE; VIRULENCE; ONCOPROTEIN; PREDICTION	The CagA protein of Helicobacter pylori is associated with increased virulence and gastric cancer risk. CagA is translocated into the host cell by a H. pylori type IV secretion system via mechanisms that are poorly understood. Translocated CagA interacts with numerous host factors, altering a variety of host signalling pathways. The recently determined crystal structure of C-terminally-truncated CagA indicated the presence of two domains: the smaller, flexible N-terminal domain and the larger, middle domain. In this study, we have investigated the conformation, oligomeric state and stability of the N-terminal, middle and glutamate-proline-isoleucine-tyrosine-alanine (EPIYA)-repeats domains. All three domains are monomeric, suggesting that the multimerisation of CagA observed in infected cells is likely to be mediated not by CagA itself but by its interacting partners. The middle and the C-terminal domains, but not the N-terminal domain, are capable of refolding spontaneously upon heat denaturation, lending support to the hypothesis that unfolded CagA is threaded C-terminus first through the type IV secretion channel with its N-terminal domain, which likely requires interactions with other domains to refold, being threaded last. Our findings also revealed that the C-terminal EPIYA-repeats domain of CagA exists in an intrinsically disordered premolten globule state with regions in PPII conformation - a feature that is shared by many scaffold proteins that bind multiple protein components of signalling pathways. Taken together, these results provide a deeper understanding of the physicochemical properties of CagA that underpin its complex cellular and oncogenic functions.	[Woon, Amanda P.; Kwok, Terry; Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Tohidpour, Abolghasem; Alonso, Hernan; Kwok, Terry; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Saijo-Hamano, Yumiko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	Monash University; Monash University; Osaka University	Roujeinikova, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Anna.Roujeinikova@monash.edu		Woon, Amanda/0000-0002-4781-0356; Kwok, Terry/0000-0002-5905-3233; Roujeinikova, Anna/0000-0001-8478-4751	Monash University Strategic Grant Scheme	Monash University Strategic Grant Scheme(Monash University)	This work was supported by the Monash University Strategic Grant Scheme, www.monash.edu. AR is an Australian Research Council Research Fellow (DP1094619), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Berisio R, 2012, CURR PROTEIN PEPT SC, V13, P855, DOI 10.2174/138920312804871157; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Hatakeyama M, 2003, MICROBES INFECT, V5, P143, DOI 10.1016/S1286-4579(02)00085-0; Hayashi T, 2013, CELL MICROBIOL, V15, P377, DOI 10.1111/cmi.12040; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jones KR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00115; Kabanov VA, 2004, J PHYS CHEM B, V108, P1485, DOI 10.1021/jp035821f; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lai CH, 2011, FEMS MICROBIOL LETT, V323, P155, DOI 10.1111/j.1574-6968.2011.02372.x; MAKAROV AA, 1994, BIOPOLYMERS, V34, P1123, DOI 10.1002/bip.360340816; MARSHALL BJ, 1984, LANCET, V1, P1311; Murata-Kamiya N, 2011, MICROBES INFECT, V13, P799, DOI 10.1016/j.micinf.2011.03.011; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Nagase L, 2011, J BIOL CHEM, V286, P33622, DOI 10.1074/jbc.M111.258673; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Pelz C, 2011, J BIOL CHEM, V286, P8999, DOI 10.1074/jbc.M110.166504; Race PR, 2007, BIOPHYS J, V93, P586, DOI 10.1529/biophysj.106.101766; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tompa P, 2010, STRUCTURE AND FUNCTI, P43; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zafra-Ruano A, 2012, FEBS LETT, V586, P2619, DOI 10.1016/j.febslet.2012.04.057	54	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79367	10.1371/journal.pone.0079367	http://dx.doi.org/10.1371/journal.pone.0079367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223932	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300077
J	Artelle, KA; Anderson, SC; Cooper, AB; Paquet, PC; Reynolds, JD; Darimont, CT				Artelle, Kyle A.; Anderson, Sean C.; Cooper, Andrew B.; Paquet, Paul C.; Reynolds, John D.; Darimont, Chris T.			Confronting Uncertainty in Wildlife Management: Performance of Grizzly Bear Management	PLOS ONE			English	Article							CONSERVATION; POPULATION; FISHERIES; MORTALITY	Scientific management of wildlife requires confronting the complexities of natural and social systems. Uncertainty poses a central problem. Whereas the importance of considering uncertainty has been widely discussed, studies of the effects of unaddressed uncertainty on real management systems have been rare. We examined the effects of outcome uncertainty and components of biological uncertainty on hunt management performance, illustrated with grizzly bears (Ursus arctos horribilis) in British Columbia, Canada. We found that both forms of uncertainty can have serious impacts on management performance. Outcome uncertainty alone - discrepancy between expected and realized mortality levels - led to excess mortality in 19% of cases (population-years) examined. Accounting for uncertainty around estimated biological parameters (i.e., biological uncertainty) revealed that excess mortality might have occurred in up to 70% of cases. We offer a general method for identifying targets for exploited species that incorporates uncertainty and maintains the probability of exceeding mortality limits below specified thresholds. Setting targets in our focal system using this method at thresholds of 25% and 5% probability of overmortality would require average target mortality reductions of 47% and 81%, respectively. Application of our transparent and generalizable framework to this or other systems could improve management performance in the presence of uncertainty.	[Artelle, Kyle A.; Anderson, Sean C.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Artelle, Kyle A.; Paquet, Paul C.; Darimont, Chris T.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Paquet, Paul C.; Darimont, Chris T.] Univ Victoria, Dept Geog, Victoria, BC, Canada	Simon Fraser University; Simon Fraser University; University of Victoria	Artelle, KA (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	kartelle@sfu.ca	Anderson, Sean C./AFN-3267-2022; Reynolds, John D/L-6345-2015	Anderson, Sean C./0000-0001-9563-1937; Reynolds, John D/0000-0002-0459-0074; Artelle, Kyle/0000-0002-8399-5693	David Suzuki Foundation; Raincoast Conservation Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]); C. D. Nelson Memorial Foundation; Anne Vallee Ecological Fund; Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; NSERC PGSA; Fulbright Canada award; Wilburforce Foundation; NSERC [341481, 435683]; Tom Buell endowment; Pacific Salmon Foundation; BC Leading Edge Fund	David Suzuki Foundation; Raincoast Conservation Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]); C. D. Nelson Memorial Foundation; Anne Vallee Ecological Fund; Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; NSERC PGSA; Fulbright Canada award; Wilburforce Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tom Buell endowment; Pacific Salmon Foundation; BC Leading Edge Fund	The authors thank the David Suzuki Foundation, the Raincoast Conservation Foundation, and the Tula Foundation for financial support. KAA was supported by Natural Sciences and Engineering Research Council of Canada (NSERC CGSA [Alexander Graham Bell Supplement]), C. D. Nelson Memorial Foundation, Anne Vallee Ecological Fund, and a scholarship funded by the Tula Foundation through the Hakai Network for Coastal Peoples and Ecosystems; SCA was supported by an NSERC PGSA and a Fulbright Canada award; PCP by the Wilburforce Foundation; JDR by an NSERC Discovery Grant (341481), the Tom Buell endowment, the Pacific Salmon Foundation, and the BC Leading Edge Fund; and CTD by an NSERC Discovery Grant (435683) as well as the Tula and Wilburforce Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins J. L., 2012, INVASIVE LIONFISH GU, P24; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Austin M. A., 2004, GRIZZLY BEAR URSUS A; Bolker B.M, 2011, ECOLOGICAL MODELS DA; British Columbia Ministry of Environment Fish Wildlife and Habitat Branch, 2010, GRIZZL BEAR HUNT FRE; Caddy J. F., 1996, North American Journal of Fisheries Management, V16, P479, DOI 10.1577/1548-8675(1996)016&lt;0479:TOLFMO&gt;2.3.CO;2; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Darimont CT, 2012, FALTERING LIGHT; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Hamilton AN, 2004, ESTIMATING GRIZZLY B; HAMILTON AN, 2002, GRIZZLY BEAR HARVEST; Harris RB, 1986, MODELING SUSTA UNPUB; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Hilborn Ray, 1997, V28; Holt CA, 2006, CAN J FISH AQUAT SCI, V63, P2722, DOI 10.1139/F06-155; Knapp A, 2007, REV EUROPEAN UNIONS; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Levi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001303; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Lunn K, 2007, GRIZZLY BEAR HARVEST; Mattson DJ, 1996, CONSERV BIOL, V10, P1013, DOI 10.1046/j.1523-1739.1996.10041013.x; McLoughlin PD, 2004, CONSERV BIOL, V18, P1665, DOI 10.1111/j.1523-1739.2004.00500.x; McLoughlin PD, 2003, MANAGING RISKS DECLI; Miller S, 1990, INT C BEAR, V8; Milner-Gulland EJ, 2001, ANIM CONSERV, V4, P157, DOI 10.1017/S1367943001001184; Ministry of Forests Lands and Natural Resource Operations, 2012, BRIT COL GRIZZL BEAR; Paquet PC, 2010, ANIM WELFARE, V19, P177; Peek J, 2003, MANAGEMENT GRI UNPUB; PEEK JM, 1987, WILDLIFE SOC B, V15, P160; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Phillis CC, 2013, CONSERV LETT, V6, P98, DOI 10.1111/j.1755-263X.2012.00294.x; Prager MH, 2003, N AM J FISH MANAGE, V23, P349, DOI 10.1577/1548-8675(2003)023<0349:TALFMO>2.0.CO;2; RECKHOW KH, 1994, ENVIRON MANAGE, V18, P161, DOI 10.1007/BF02393758; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Reynolds JD, 2003, MACROECOLOGY, P195; Ross PI, 1996, WILDLIFE SOC B, V24, P490; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3	41	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78041	10.1371/journal.pone.0078041	http://dx.doi.org/10.1371/journal.pone.0078041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223134	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200026
J	Behr, ER; Ritchie, MD; Tanaka, T; Kaab, S; Crawford, DC; Nicoletti, P; Floratos, A; Sinner, MF; Kannankeril, PJ; Wilde, AAM; Bezzina, CR; Schulze-Bahr, E; Zumhagen, S; Guicheney, P; Bishopric, NH; Marshall, V; Shakir, S; Dalageorgou, C; Bevan, S; Jamshidi, Y; Bastiaenen, R; Myerburg, RJ; Schott, JJ; Camm, AJ; Steinbeck, G; Norris, K; Altman, RB; Tatonetti, NP; Jeffery, S; Kubo, M; Nakamura, Y; Shen, YF; George, AL; Roden, DM				Behr, Elijah R.; Ritchie, Marylyn D.; Tanaka, Toshihiro; Kaeaeb, Stefan; Crawford, Dana C.; Nicoletti, Paola; Floratos, Aris; Sinner, Moritz F.; Kannankeril, Prince J.; Wilde, Arthur A. M.; Bezzina, Connie R.; Schulze-Bahr, Eric; Zumhagen, Sven; Guicheney, Pascale; Bishopric, Nanette H.; Marshall, Vanessa; Shakir, Saad; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Myerburg, Robert J.; Schott, Jean-Jacques; Camm, A. John; Steinbeck, Gerhard; Norris, Kris; Altman, Russ B.; Tatonetti, Nicholas P.; Jeffery, Steve; Kubo, Michiaki; Nakamura, Yusuke; Shen, Yufeng; George, Alfred L., Jr.; Roden, Dan M.			Genome Wide Analysis of Drug-Induced Torsades de Pointes: Lack of Common Variants with Large Effect Sizes	PLOS ONE			English	Article							QT INTERVAL DURATION; INDUCED LIVER-INJURY; SUDDEN-INFANT-DEATH; ATRIAL-FIBRILLATION; DISEASE GENES; ASSOCIATION; POPULATION; LINKAGE; SCN5A; RISK	Marked prolongation of the QT interval on the electrocardiogram associated with the polymorphic ventricular tachycardia Torsades de Pointes is a serious adverse event during treatment with antiarrhythmic drugs and other culprit medications, and is a common cause for drug relabeling and withdrawal. Although clinical risk factors have been identified, the syndrome remains unpredictable in an individual patient. Here we used genome-wide association analysis to search for common predisposing genetic variants. Cases of drug-induced Torsades de Pointes (diTdP), treatment tolerant controls, and general population controls were ascertained across multiple sites using common definitions, and genotyped on the Illumina 610k or 1M-Duo BeadChips. Principal Components Analysis was used to select 216 Northwestern European diTdP cases and 771 ancestry-matched controls, including treatment-tolerant and general population subjects. With these sample sizes, there is 80% power to detect a variant at genome-wide significance with minor allele frequency of 10% and conferring an odds ratio of >= 2.7. Tests of association were carried out for each single nucleotide polymorphism (SNP) by logistic regression adjusting for gender and population structure. No SNP reached genome wide-significance; the variant with the lowest P value was rs2276314, a non-synonymous coding variant in C18orf21 (p = 3 x 10(-7), odds ratio = 2, 95% confidence intervals: 1.5-2.6). The haplotype formed by rs2276314 and a second SNP, rs767531, was significantly more frequent in controls than cases (p = 3 x 10(-9)). Expanding the number of controls and a gene-based analysis did not yield significant associations. This study argues that common genomic variants do not contribute importantly to risk for drug-induced Torsades de Pointes across multiple drugs.	[Behr, Elijah R.; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Camm, A. John; Jeffery, Steve] St Georges Univ London, Cardiovasc Sci Ctr, London, England; [Behr, Elijah R.; Dalageorgou, Chrysoula; Bevan, Steve; Jamshidi, Yalda; Bastiaenen, Rachel; Camm, A. John; Jeffery, Steve] St Georges Univ London, Genet Res Ctr, London, England; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Kannankeril, Prince J.; Norris, Kris; George, Alfred L., Jr.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ritchie, Marylyn D.] Penn State Univ, Eberly Coll Sci, Huck Inst Life Sci, University Pk, PA 16802 USA; [Tanaka, Toshihiro; Kubo, Michiaki; Nakamura, Yusuke] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Kaeaeb, Stefan; Sinner, Moritz F.] Univ Munich, Dept Med 1, Univ Hosp Munich, Munich, Germany; [Nicoletti, Paola; Floratos, Aris; Tatonetti, Nicholas P.; Shen, Yufeng] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Wilde, Arthur A. M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Hosp Munster, Inst Genet Heart Dis, Dept Cardiovasc Med, Munster, Germany; [Guicheney, Pascale] Univ Paris 06, INSERM, UMRS 956, Paris, France; [Bishopric, Nanette H.; Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Med Cardiol, Miami, FL 33136 USA; [Marshall, Vanessa; Shakir, Saad] Drug Safety Res Unit, Southampton, Hants, England; [Schott, Jean-Jacques] Univ Nantes, CNRS, INSERM, UMR1087,UMR 6291, Nantes, France; [Schott, Jean-Jacques] CHU Nantes, F-44035 Nantes 01, France; [Steinbeck, Gerhard] Hosp Starnberg, Ctr Cardiol, Starnberg, Germany; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Nakamura, Yusuke] Univ Chicago, Chicago, IL 60637 USA; [Tanaka, Toshihiro; Kubo, Michiaki] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kaeaeb, Stefan] Deutsch Zentrum Herz Kreislauf Forsch eV, Munich, Germany; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Munster, IZKF, D-48149 Munster, Germany; [Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Physiol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA	St Georges University London; St Georges University London; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tokyo Medical & Dental University (TMDU); University of Munich; Columbia University; University of Amsterdam; Academic Medical Center Amsterdam; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Miami; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Stanford University; University of Chicago; RIKEN; German Centre for Cardiovascular Research; University of Munster; University of Miami; University of Miami; University of Miami	Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	dan.roden@Vanderbilt.Edu	Sinner, Moritz/AAW-5043-2020; Crawford, Dana/O-5578-2019; Jamshidi, Yalda/AAL-1377-2020; Guicheney, Pascale/D-1034-2017; Kaab, Stefan/H-3915-2012; Tanaka, Toshihiro/J-9310-2014; Kubo, Michiaki/N-7947-2015; Schott, jean-Jacques/F-8842-2013; Roden, Dan/ABD-5412-2021	Crawford, Dana/0000-0002-6437-6248; Jamshidi, Yalda/0000-0003-0151-6482; Guicheney, Pascale/0000-0002-7663-2050; Tanaka, Toshihiro/0000-0001-6201-9784; Schott, jean-Jacques/0000-0002-9578-9475; Bastiaenen, Rachel/0000-0002-5018-8035; Bezzina, Connie/0000-0002-0633-3514; Behr, Elijah/0000-0002-8731-2853; Bevan, Steve/0000-0003-0490-6830; Tatonetti, Nicholas/0000-0002-2700-2597	Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network; Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death'') [05 CVD 01]; BioBank Japan Project; Japanese Ministry of Education, Culture, Sports, Science and Technology; British Heart Foundation [SP/02/001]; Abbott; Amgen; Astra-Zeneca; Cerner; Daiichi-Sankyo; GlaxoSmithKline; Merck; Novartis; Pfizer; Takeda; Welcome Trust;  [U01HL65962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, U19HL065962] Funding Source: NIH RePORTER; British Heart Foundation [PG/12/38/29615] Funding Source: researchfish	Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network; Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death''); BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation); Abbott(Abbott Laboratories); Amgen(Amgen); Astra-Zeneca(AstraZeneca); Cerner; Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Welcome Trust(Wellcome Trust); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	This study was supported by U01HL65962, the Pharmacogenomics of Arrhythmia Therapy site of the Pharmacogenetics Research Network, and by a grant from the Fondation Leducq (Trans-Atlantic Network of Excellence "Alliance Against Sudden Cardiac Death'', 05 CVD 01). Genotyping the Leducq samples described in the text was performed by the RIKEN Center for Genomic Medicine, Yokohama, Japan, which is supported in part by the BioBank Japan Project funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The DARE study was funded by the British Heart Foundation under special project grant SP/02/001. The DARE samples were genotyped at Gene Expression Ltd. Further support was provided by a collaboration with the International Serious Adverse Events Consortium, whose membership currently includes Abbott, Amgen, Astra-Zeneca, Cerner, Daiichi-Sankyo, GlaxoSmithKline, Merck, Novartis, Pfizer, Takeda, and the Welcome Trust. Portions of the Leducq dataset have been deposited at dbGaP at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id = phs000331.v1.p1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; ARAKAWA M, 1992, AM J CARDIOL, V70, P550, DOI 10.1016/0002-9149(92)91211-L; Carter N, 2000, J HUM HYPERTENS, V14, P389, DOI 10.1038/sj.jhh.1001026; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Darbar D, 2007, J CARDIOVASC ELECTR, V18, P636, DOI 10.1111/j.1540-8167.2007.00817.x; Fenichel RR, 2004, J CARDIOVASC ELECTR, V15, P475, DOI 10.1046/j.1540-8167.2004.03534.x; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; Hoppe UC, 2001, P NATL ACAD SCI USA, V98, P5335, DOI 10.1073/pnas.091239098; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Jamshidi Y, 2012, J AM COLL C IN PRESS; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril PJ, 2005, HEART RHYTHM, V2, P134, DOI 10.1016/j.hrthm.2004.10.039; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pirmohamed M, 2011, CLIN PHARMACOL THER, V89, P784, DOI 10.1038/clpt.2011.30; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2007, EUROPACE, V9, P1, DOI 10.1093/europace/eum165; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SALERNO DM, 1993, PACE, V16, P1862, DOI 10.1111/j.1540-8159.1993.tb01821.x; Sanguinetti MC, 2003, CIRC RES, V93, P491, DOI 10.1161/01.RES.0000091829.63501.A8; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tatonetti NP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S9; The Psychiatrist, 2004, PSYCHIATRIST, V28, P431; Van Norstrand DW, 2008, HEART RHYTHM, V5, P712, DOI 10.1016/j.hrthm.2008.02.012; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C	43	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78511	10.1371/journal.pone.0078511	http://dx.doi.org/10.1371/journal.pone.0078511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223155	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326656200047
J	Brisson, CD; Lukewich, MK; Andrew, RD				Brisson, C. Devin; Lukewich, Mark K.; Andrew, R. David			A Distinct Boundary between the Higher Brain's Susceptibility to Ischemia and the Lower Brain's Resistance	PLOS ONE			English	Article							SPREADING DEPRESSION; ANOXIC DEPOLARIZATION; NEURONAL DAMAGE; RAT; STEM; HETEROGENEITY; DEPRIVATION; FOREBRAIN; GLUTAMATE; FAILURE	Higher brain regions are more susceptible to global ischemia than the brainstem, but is there a gradual increase in vulnerability in the caudal-rostral direction or is there a discrete boundary? We examined the interface between 'higher' thalamus and the hypothalamus the using live brain slices where variation in blood flow is not a factor. Whole-cell current clamp recording of 18 thalamic neurons in response to 10 min O-2/glucose deprivation (OGD) revealed a rapid anoxic depolarization (AD) from which thalamic neurons do not recover. Newly acquired neurons could not be patched following AD, confirming significant regional thalamic injury. Coinciding with AD, light transmittance (LT) imaging during whole-cell recording showed an elevated LT front that initiated in midline thalamus and that propagated into adjacent hypothalamus. However, hypothalamic neurons patched in paraventricular nucleus (PVN, n= 8 magnocellular and 12 parvocellular neurons) and suprachiasmatic nucleus (SCN, n= 18) only slowly depolarized as AD passed through these regions. And with return to control aCSF, hypothalamic neurons repolarized and recovered their input resistance and action potential amplitude. Moreover, newly acquired hypothalamic neurons could be readily patched following exposure to OGD, with resting parameters similar to neurons not previously exposed to OGD. Thalamic susceptibility and hypothalamic resilience were also observed following ouabain exposure which blocks the Na+/K+ pump, evoking depolarization similar to OGD in all neuronal types tested. Finally, brief exposure to elevated [K+](o) caused spreading depression (SD, a milder, AD-like event) only in thalamic neurons so SD generation is regionally correlated with strong AD. Therefore the thalamus-hypothalamus interface represents a discrete boundary where neuronal vulnerability to ischemia is high in thalamus (like more rostral neocortex, striatum, hippocampus). In contrast hypothalamic neurons are comparatively resistant, generating weaker and recoverable anoxic depolarization similar to brainstem neurons, possibly the result of a Na/K pump that better functions during ischemia.	[Brisson, C. Devin; Lukewich, Mark K.; Andrew, R. David] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Andrew, RD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	andrewd@queensu.ca		Lukewich, Mark/0000-0001-7738-4688	Heart and Stroke Foundation of Ontario [T-4478]; Faculty of Health Sciences, Queen's University	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Faculty of Health Sciences, Queen's University	This work was supported by the Heart and Stroke Foundation of Ontario (grant T-4478) and the Faculty of Health Sciences, Queen's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew R. D., 2012, Society for Neuroscience Abstract Viewer and Itinerary Planner, V42; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; BURES J, 1981, J NEUROBIOL, V12, P211, DOI 10.1002/neu.480120303; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Erdemli G, 1998, J NEUROSCI, V18, P5212, DOI 10.1523/JNEUROSCI.18-14-05212.1998; Falini A, 1998, AM J NEURORADIOL, V19, P648; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; FIFKOVA E, 1964, EXPERIENTIA, V20, P635, DOI 10.1007/BF02144834; Funke F, 2009, J NEUROPHYSIOL, V101, P2395, DOI 10.1152/jn.91260.2008; Gottron MA, 2009, CONTEMP NEUROSCI, P129, DOI 10.1007/978-1-60761-280-3_8; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Kaminogo M, 1998, NEUROL RES, V20, P343, DOI 10.1080/01616412.1998.11740529; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; KIM YI, 1993, J PHYSIOL-LONDON, V464, P229, DOI 10.1113/jphysiol.1993.sp019632; Kolaj M, 2000, NEUROSCIENCE, V98, P129, DOI 10.1016/S0306-4522(00)00094-4; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Longstreth WT, 2008, NEUROLOGY GEN MED, P163; Luigetti M, 2012, ACTA NEUROL BELG, V112, P105, DOI 10.1007/s13760-012-0007-3; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Richter F, 2012, J CEREBR BLOOD F MET, V32, P1535, DOI 10.1038/jcbfm.2012.40; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Senatorov VV, 1997, J PHYSIOL-LONDON, V502, P387, DOI 10.1111/j.1469-7793.1997.387bk.x; SIEBER FE, 1995, STROKE, V26, P2091, DOI 10.1161/01.STR.26.11.2091; Tanaka E, 1999, J NEUROPHYSIOL, V81, P1872, DOI 10.1152/jn.1999.81.4.1872; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; WYTRZES LM, 1989, ARCH NEUROL-CHICAGO, V46, P93, DOI 10.1001/archneur.1989.00520370095028; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Yuill EA, 2007, EUR J NEUROSCI, V25, P425, DOI 10.1111/j.1460-9568.2006.05293.x	45	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79589	10.1371/journal.pone.0079589	http://dx.doi.org/10.1371/journal.pone.0079589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223181	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200073
J	Liu, L; Karmakar, S; Dhar, R; Mahajan, M; Choudhury, A; Weissman, S; Pace, BS				Liu, Li; Karmakar, Subhradip; Dhar, Ruby; Mahajan, Milind; Choudhury, Alina; Weissman, Sherman; Pace, Betty S.			Regulation of G gamma-Globin Gene by ATF2 and Its Associated Proteins through the cAMP-Response Element	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; CHROMATIN REMODELING COMPLEX; FETAL-HEMOGLOBIN EXPRESSION; LOCUS-CONTROL REGION; BETA; TRANSCRIPTION; INDUCTION; BCL11A; ACTIVATION; PROMOTER	The upstream G gamma-globin cAMP-response element (G-CRE) plays an important role in regulating G gamma-globin expression through binding of ATF2 and its DNA-binding partners defined in this study. ATF2 knockdown resulted in a significant reduction of gamma-globin expression accompanied by decreased ATF2 binding to the G-CRE. By contrast, stable ATF2 expression in K562 cells increased gamma-globin transcription which was reduced by ATF2 knockdown. Moreover, a similar effect of ATF2 on gamma-globin expression was observed in primary erythroid progenitors. To understand the role of ATF2 in gamma-globin expression, chromatographically purified G-CRE/ATF2-interacting proteins were subjected to mass spectrometry analysis; major binding partners included CREB1, cJun, Brg1, and histone deacetylases among others. Immunoprecipitation assays demonstrated interaction of these proteins with ATF2 and in vivo GCRE binding in CD34(+) cells undergoing erythroid differentiation which was correlated with gamma-globin expression during development. These results suggest synergism between developmental stage-specific recruitments of the ATF2 protein complex and expression of gamma-globin during erythropoiesis. Microarray studies in K562 cells support ATF2 plays diverse roles in hematopoiesis and chromatin remodeling.	[Liu, Li] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA; [Karmakar, Subhradip; Dhar, Ruby; Choudhury, Alina] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Mahajan, Milind] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Weissman, Sherman] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA	University of Texas System; University of Texas Dallas; University of Chicago; Icahn School of Medicine at Mount Sinai; Yale University; University System of Georgia; Augusta University	Pace, BS (corresponding author), Georgia Regents Univ, Dept Pediat, Augusta, GA USA.	bpace@georgiahealth.edu	Karmakar, Subhradip/AAF-7678-2021; Karmakar, Subhradip/AAP-6043-2020	Karmakar, Subhradip/0000-0002-4757-8729; Pace, Betty/0000-0002-1275-4112	National Heart, Lung, and Blood Institute [HL69234]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069234] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant HL69234 from the National Heart, Lung, and Blood Institute to Dr. Betty Pace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano H, 1999, MOL CELL BIOL, V19, P3571; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kalra IS, 2011, BRIT J HAEMATOL, V154, P248, DOI 10.1111/j.1365-2141.2011.08710.x; Karmakar S, 2010, EMBO J, V29, P3260, DOI 10.1038/emboj.2010.204; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kodeboyina S, 2009, BLOOD CELLS MOL DIS; Kodeboyina S, 2010, BLOOD CELL MOL DIS, V44, P7, DOI 10.1016/j.bcmd.2009.10.002; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee CH, 1999, P NATL ACAD SCI USA, V96, P12311, DOI 10.1073/pnas.96.22.12311; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Li BR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-153; Liu L, 2006, J BIOL CHEM, V281, P1506, DOI 10.1074/jbc.M510402200; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Mahajan MC, 2009, EXP HEMATOL, V37, P1143, DOI 10.1016/j.exphem.2009.07.001; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Pace BS, 2006, DEV DYNAM, V235, P1727, DOI 10.1002/dvdy.20802; Pace BS, 2003, EXP HEMATOL, V31, P1089, DOI 10.1016/S0301-472X(03)00235-2; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; PISSARD S, 1994, BLOOD, V84, P331; Ramakrishnan V, 2011, BLOOD CELL MOL DIS, V47, P12, DOI 10.1016/j.bcmd.2011.03.003; Sangerman J, 2006, BLOOD, V108, P3590, DOI 10.1182/blood-2006-01-023713; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DIS; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; Yu T, 2002, BLOOD, V99, P1082, DOI 10.1182/blood.V99.3.1082; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78253	10.1371/journal.pone.0078253	http://dx.doi.org/10.1371/journal.pone.0078253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223142	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200034
J	Polacek, M; Griggio, M; Bartikova, M; Hoi, H				Polacek, Miroslav; Griggio, Matteo; Bartikova, Michaela; Hoi, Herbert			Nest Sanitation as the Evolutionary Background for Egg Ejection Behaviour and the Role of Motivation for Object Removal	PLOS ONE			English	Article							CONSPECIFIC BROOD PARASITISM; EXTRA-PAIR PATERNITY; GREAT-REED WARBLERS; CUCULUS-CANORUS; EUROPEAN PASSERINES; LIFE-HISTORY; CLUTCH SIZE; CUCKOO; REJECTION; RECOGNITION	Higher interclutch colour variation can evolve under the pressure of brood parasitism to increase the detection of parasitic eggs. Nest sanitation could be a prerequisite for the evolution of anti-parasite defence in terms of egg ejection. In this respect, we used nest sanitation behaviour as a tool to identify: i) motivation and its underlying function and, ii) which features provoke ejection behaviour. Therefore, we experimentally tested whether size, colour or shape may influence ejection behaviour using artificial flat objects. We found a high interclutch variation in egg colouration and egg size in our tree sparrow (Passer montanus) population. Using colour and size we were in fact able to predict clutch affiliation for each egg. Our experiments further revealed the existence of direct anti-parasite behaviours and birds are able to recognise conspecific eggs, since only experimentally-deposited eggs have been removed. Moreover, experiments with different objects revealed that the motivation of tree sparrows to remove experimental objects from their nests was highest during egg laying for objects of varying size, most likely because of parasitism risk at this breeding stage. In contrary, motivation to remove white objects and objects with edges was higher during incubation stage as behavioural patterns connected to hatching started to emerge. The fact that rejection rate of our flat objects was higher than real egg ejection, suggests that egg ejection in tree sparrows and probably more general in small passerines, to be limited by elevated costs to eject eggs with their beaks. The presence of anti-parasite behaviour supports our suggestion that brood parasitism causes variation in egg features, as we have found that tree sparrows can recognise and reject conspecific eggs in their clutch. In conclusion, in tree sparrows it seems that nest sanitation plays a key role in the evolution of the removal of parasitic eggs.	[Polacek, Miroslav; Bartikova, Michaela] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Polacek, Miroslav; Griggio, Matteo; Bartikova, Michaela; Hoi, Herbert] Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria	Slovak Academy of Sciences; University of Veterinary Medicine Vienna	Hoi, H (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	Herbert.hoi@vetmeduni.ac.at	Polacek, Miroslav/AGI-5698-2022	Polacek, Miroslav/0000-0003-0786-7849; Griggio, Matteo/0000-0002-3298-2905	University of Veterinary Medicine, Vienna; Slovak Academy of Sciences	University of Veterinary Medicine, Vienna; Slovak Academy of Sciences(Slovak Academy of Sciences)	The funding for this work was provided by University of Veterinary Medicine, Vienna and the Slovak Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Bartol I, 2003, ACTA ZOOL ACAD SCI H, V49, P111; BROOKE MD, 1988, NATURE, V335, P630; Cordero PJ, 1999, J AVIAN BIOL, V30, P97, DOI 10.2307/3677248; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; de Hierro MDGL, 2008, BEHAVIOUR, V145, P949, DOI 10.1163/156853908784089270; DERRICKSON KC, 1991, CONDOR, V93, P757, DOI 10.2307/1368210; Engstrand SM, 2002, FUNCT ECOL, V16, P782, DOI 10.1046/j.1365-2435.2002.00681.x; Fenske B, 1995, AUK, V112, P415; Floerchinger Stefan, 2002, Vogelwarte, V41, P279; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Guigueno MF, 2012, J ORNITHOL, V153, P35, DOI 10.1007/s10336-011-0731-0; Guigueno MF, 2009, ETHOLOGY, V115, P247, DOI 10.1111/j.1439-0310.2008.01597.x; Hauber ME, 2003, AUK, V120, P860, DOI 10.1642/0004-8038(2003)120[0860:EIACPB]2.0.CO;2; Hoi H, 2004, AUK, V121, P557, DOI 10.1642/0004-8038(2004)121[0557:CEILGS]2.0.CO;2; Hoi H, 2010, BEHAVIOUR, V147, P1533, DOI 10.1163/000579510X511060; Honza M, 2007, BIOL J LINN SOC, V92, P269, DOI 10.1111/j.1095-8312.2007.00848.x; Horak P, 1997, OIKOS, V78, P592, DOI 10.2307/3545622; HOYT DF, 1979, AUK, V96, P73; KENDRA PE, 1988, WILSON BULL, V100, P80; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Kruger O, 2007, PHILOS T R SOC B, V362, P1873, DOI 10.1098/rstb.2006.1849; Lienert G.A., 1978, VERTEILUNGSFREIE MET; Lopez-de-Hierro MDG, 2010, BEHAV ECOL SOCIOBIOL, V64, P317, DOI 10.1007/s00265-009-0811-9; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; MARCHETTI K, 1992, P ROY SOC B-BIOL SCI, V248, P41, DOI 10.1098/rspb.1992.0040; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; Moller A.P., 1991, P1041; MOLLER AP, 1987, ANIM BEHAV, V35, P247, DOI 10.1016/S0003-3472(87)80230-0; Moskat C, 2003, J AVIAN BIOL, V34, P16, DOI 10.1034/j.1600-048X.2003.02919.x; Moskat C, 2008, BEHAV ECOL SOCIOBIOL, V62, P1885, DOI 10.1007/s00265-008-0618-0; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; OIEN IJ, 1995, BEHAV ECOL, V6, P166, DOI 10.1093/beheco/6.2.166; Payne Robert B., 1997, P338; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Poysa H, 2007, AM NAT, V169, P94, DOI 10.1086/509943; Prochazka P, 2003, J ORNITHOL, V144, P354, DOI 10.1007/BF02465635; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; REID WV, 1990, EVOLUTION, V44, P1780, DOI 10.1111/j.1558-5646.1990.tb05248.x; Rothstein S, 1998, PARASITIC BIRDS THEI, P444; ROTHSTEIN SI, 1976, AUK, V93, P675; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1982, BEHAV ECOL SOCIOBIOL, V11, P229, DOI 10.1007/BF00299299; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; Ruxton GD, 2002, P ROY SOC B-BIOL SCI, V269, P1989, DOI 10.1098/rspb.2002.2125; SEALY SG, 1995, ANIM BEHAV, V49, P877, DOI 10.1006/anbe.1995.0120; Servedio MR, 2006, J EVOLUTION BIOL, V19, P1585, DOI 10.1111/j.1420-9101.2006.01124.x; Soler JJ, 1996, BEHAV ECOL, V7, P89, DOI 10.1093/beheco/7.1.89; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stokke BG, 2002, BEHAVIOUR, V139, P629, DOI 10.1163/15685390260136744; Stokke BG, 2002, EVOLUTION, V56, P199; Stokke BG, 1999, P ROY SOC B-BIOL SCI, V266, P1483, DOI 10.1098/rspb.1999.0804; Summers-Smith JD, 1995, TREE SPARROW, P205; Therneau T, 2012, PACKAGE SURVIVAL SUR; TINBERGEN N., 1962, BEHAVIOUR, V19, P74, DOI 10.1163/156853961X00213; Underwood TJ, 2006, ETHOLOGY, V112, P164, DOI 10.1111/j.1439-0310.2006.01143.x; Veiga JP, 2000, J AVIAN BIOL, V31, P237, DOI 10.1034/j.1600-048X.2000.310215.x; Welbergen J, 2001, BEHAV ECOL, V12, P8, DOI 10.1093/oxfordjournals.beheco.a000382; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x; YOMTOV Y, 1980, BIOL REV, V55, P93, DOI 10.1111/j.1469-185X.1980.tb00689.x; Zolei A, 2012, BEHAVIOUR, V149, P391, DOI 10.1163/156853912X638445	70	22	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78771	10.1371/journal.pone.0078771	http://dx.doi.org/10.1371/journal.pone.0078771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223165	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200057
J	Xu, S; Santini, GC; De Veirman, K; Vande Broek, I; Leleu, X; De Becker, A; Van Camp, B; Vanderkerken, K; Van Riet, I				Xu, Song; Santini, Gaia Cecilia; De Veirman, Kim; Vande Broek, Isabelle; Leleu, Xavier; De Becker, Ann; Van Camp, Ben; Vanderkerken, Karin; Van Riet, Ivan			Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; LINEAGE; MIRNA; PROLIFERATION; PROGRAM; PATHWAY; PROFILE; PCR; RNA	Previous studies have demonstrated that mesenchymal stem cells from multiple myeloma (MM) patients (MM-hMSCs) display a distinctive gene expression profile, an enhanced production of cytokines and an impaired osteogenic differentiation ability compared to normal donors (ND-hMSCs). However, the underlying molecular mechanisms are unclear. In the present study, we observed that MM-hMSCs exhibited an abnormal upregulation of miR-135b, showing meanwhile an impaired osteogenic differentiation and a decrease of SMAD5 expression, which is the target of miR-135b involved in osteogenesis. By gain and loss of function studies we confirmed that miR-135b negatively regulated hMSCs osteogenesis. We also found that MM cell-produced factors stimulated ND-hMSCs to upregulate the expression of miR-135b. Importantly, treatment with a miR-135b inhibitor promoted osteogenic differentiation in MM-hMSCs. Finally, we observed that MM cell-derived soluble factors could induce an upregulation of miR-135b expression in ND-hMSCs in an indirect coculture system and the miR-135b expression turned to normal level after the removal of MM cells. Collectively, we provide evidence that miR-135b is involved in the impaired osteogenic differentiation of MSCs derived from MM patients and might therefore be a promising target for controlling bone disease.	[Xu, Song] Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Dept Lung Canc Surg, Tianjin, Peoples R China; [Xu, Song; Santini, Gaia Cecilia; De Veirman, Kim; De Becker, Ann; Van Riet, Ivan] Univ Ziekenhuis Brussel UZ Brussel, Div Clin Hematol, Stem Cell Lab, Brussels, Belgium; [Xu, Song; De Veirman, Kim; Vande Broek, Isabelle; Van Camp, Ben; Vanderkerken, Karin; Van Riet, Ivan] Vrije Univ Brussel, Myeloma Ctr Brussels, Dept Hematol & Immunol, Brussels, Belgium; [Leleu, Xavier] CHU Lille, Serv Hematol, F-59037 Lille, France	Tianjin Medical University; University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite de Lille - ISITE; CHU Lille	Van Riet, I (corresponding author), Univ Ziekenhuis Brussel UZ Brussel, Div Clin Hematol, Stem Cell Lab, Brussels, Belgium.	ivan.vanriet@uzbrussel.be	De Veirman, Kim/ADT-0689-2022	De Veirman, Kim/0000-0002-1313-6121; Vanderkerken, Karin/0000-0002-2137-7179; De Becker, Ann/0000-0003-0947-8708	FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren); Vrije Universiteit Brussel (HOA); Scientific Foundation Willy Gepts (WFWG) UZ Brussel; CSC-VUB scholarship	FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren); Vrije Universiteit Brussel (HOA); Scientific Foundation Willy Gepts (WFWG) UZ Brussel; CSC-VUB scholarship	This work was supported by grants from the FWO-Vlaanderen, "Vlaamse Liga tegen Kanker" (Stichting Emmanuel Van der Shueren), the Vrije Universiteit Brussel (HOA) and the Scientific Foundation Willy Gepts (WFWG) UZ Brussel. SX is supported by CSC-VUB scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Gutierrez NC, 2010, LEUKEMIA, V24, P629, DOI 10.1038/leu.2009.274; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu W, 2012, MOL MED REP, DOI [10.3892/mmr.2012: 1207, DOI 10.3892/MMR.2012:1207]; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Jo DH, 2011, J PEDIAT HEMATOL ONC, V33, P529, DOI 10.1097/MPH.0b013e318228280a; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Lv SQ, 2012, BRAIN PATHOL, V22, P230, DOI 10.1111/j.1750-3639.2011.00523.x; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Menu E, 2004, BRIT J CANCER, V90, P1076, DOI 10.1038/sj.bjc.6601613; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wu TT, 2012, BONE, V51, P498, DOI 10.1016/j.bone.2012.05.013; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Xu S, 2012, STEM CELLS, V30, P266, DOI 10.1002/stem.787; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	31	59	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79752	10.1371/journal.pone.0079752	http://dx.doi.org/10.1371/journal.pone.0079752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223191	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200084
J	Cheng, CX; Xu, XZ; Singer, SD; Li, J; Zhang, HJ; Gao, M; Wang, L; Song, JY; Wang, XP				Cheng, Chenxia; Xu, Xiaozhao; Singer, Stacy D.; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping			Effect of GA(3) Treatment on Seed Development and Seed-Related Gene Expression in Grape	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; GIBBERELLIC-ACID; LIPID-PEROXIDATION; OVULE DEVELOPMENT; MATERNAL CONTROL; FERTILIZATION; STRESS; MEDEA; FRUIT; ELONGATION	Background: The phytohormone gibberellic acid (GA(3)) is widely used in the table grape industry to induce seedlessness in seeded varieties. However, there is a paucity of information concerning the mechanisms by which GAs induce seedlessness in grapes. Methodology/Principal Findings: In an effort to systematically analyze the cause of this GA(3)-induced seed abortion, we conducted an in depth characterization of two seeded grape cultivars ('Kyoho' and 'Red Globe'), along with a seedless cultivar (Thompson Seedless'), following treatment with GA(3). In a similar fashion to the seedless control, which exhibited GA(3)-induced abortion of the seeds 9 days after full bloom (DAF), both 'Kyoho' and 'Red Globe' seeded varieties exhibited complete abortion of the seeds 15 DAF when treated with GA(3). Morphological analyses indicated that while fertilization appeared to occur normally following GA(3) treatment, as well as in the untreated seedless control cultivar, seed growth eventually ceased. In addition, we found that GA(3) application had an effect on redox homeostasis, which could potentially cause cell damage and subsequent seed abortion. Furthermore, we carried out an analysis of antioxidant enzyme activities, as well as transcript levels from various genes believed to be involved in seed development, and found several differences between GA(3)-treated and untreated controls. Conclusion: Therefore, it seems that the mechanisms driving GA(3)-induced seedlessness are similar in both seeded and seedless cultivars, and that the observed abortion of seeds may result at least in part from a GA(3)-induced increase in cell damage caused by reactive oxygen species, a decrease in antioxidant enzymatic activities, and an alteration of the expression of genes related to seed development.	[Cheng, Chenxia; Xu, Xiaozhao; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cheng, Chenxia; Xu, Xiaozhao; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping] Northwest A&F Univ, Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat North, Yangling, Shaanxi, Peoples R China; [Singer, Stacy D.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Alberta	Wang, XP (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wangxiping@nwsuaf.edu.cn	程, 晨霞/HDO-7321-2022; 宋, 军阳/A-3567-2017	宋, 军阳/0000-0002-3529-8113; Li, Jun/0000-0003-2845-2351	National Natural Science Foundation of China [31071782]; Ministry of Agriculture of China [2012-S12]; Chinese Universities Scientific Fund [QN2011056]; Program for Innovative Research Team of Grape Germplasm Resources and Breeding [2013KCT-25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Chinese Universities Scientific Fund; Program for Innovative Research Team of Grape Germplasm Resources and Breeding	This work was supported by the National Natural Science Foundation of China (31071782), 948 Project from Ministry of Agriculture of China (2012-S12), Chinese Universities Scientific Fund (QN2011056), as well as the Program for Innovative Research Team of Grape Germplasm Resources and Breeding (2013KCT-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguero C, 2000, PLANT GROWTH REGUL, V30, P9, DOI 10.1023/A:1006207614388; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Beppu K, 2001, J JPN SOC HORTIC SCI, V70, P157, DOI 10.2503/jjshs.70.157; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Colombo L, 2008, TRENDS PLANT SCI, V13, P444, DOI 10.1016/j.tplants.2008.04.011; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Dreni L, 2013, MOL PLANT, V6, P650, DOI 10.1093/mp/sst019; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Hanania U, 2009, PLANT CELL REP, V28, P1033, DOI 10.1007/s00299-009-0715-1; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; IWAHORI S, 1968, PLANT PHYSIOL, V43, P333, DOI 10.1104/pp.43.3.333; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Kimura PH, 1996, AM J ENOL VITICULT, V47, P152; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mesejo C, 2008, PLANT SCI, V175, P267, DOI 10.1016/j.plantsci.2008.04.008; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Okamoto G, 2005, VITIS, V44, P157; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schwechheimer C, 2009, CURR OPIN PLANT BIOL, V12, P57, DOI 10.1016/j.pbi.2008.09.004; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; Stout AB, 1936, SEEDLESSNESS GRAPES, P1; SUGIURA A., 1966, Engei Gakkai Zasshi = Journal of the Japanese Society of Horticultural Science, V35, P233; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Swain SM, 1997, PLANT J, V12, P1329, DOI 10.1046/j.1365-313x.1997.12061329.x; Tang DM, 2009, SCI HORTIC-AMSTERDAM, V120, P51, DOI 10.1016/j.scienta.2008.09.018; Tian SF, 2011, ACTA PHYSIOL PLANT, V33, P2467, DOI 10.1007/s11738-011-0791-z; Varoquaux F, 2000, TRENDS BIOTECHNOL, V18, P233, DOI 10.1016/S0167-7799(00)01448-7; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang Z, 2012, PROTEOMICS, V12, P86, DOI 10.1002/pmic.201000668; Xu XZ, 2013, PLANT CELL TISS ORG, V114, P187, DOI 10.1007/s11240-013-0314-2; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Ye WJ, 2009, PLANT SCI, V177, P19, DOI 10.1016/j.plantsci.2009.03.005; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zhou BY, 2006, PLANT GROWTH REGUL, V49, P113, DOI 10.1007/s10725-006-9000-2	56	44	55	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80044	10.1371/journal.pone.0080044	http://dx.doi.org/10.1371/journal.pone.0080044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224035	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400107
J	Dixit, S; Upadhyay, SK; Singh, H; Sidhu, OP; Verma, PC; Chandrashekar, K				Dixit, Sameer; Upadhyay, Santosh Kumar; Singh, Harpal; Sidhu, Om Prakash; Verma, Praveen Chandra; Chandrashekar, K.			Enhanced Methanol Production in Plants Provides Broad Spectrum Insect Resistance	PLOS ONE			English	Article							PECTIN METHYLESTERASE; BACILLUS-THURINGIENSIS; DROUGHT-RESISTANCE; BEMISIA-TABACI; BT COTTON; EXPRESSION; TOBACCO; WHITEFLIES; MOVEMENT; EMISSION	Plants naturally emit methanol as volatile organic compound. Methanol is toxic to insect pests; but the quantity produced by most of the plants is not enough to protect them against invading insect pests. In the present study, we demonstrated that the over-expression of pectin methylesterase, derived from Arabidopsis thaliana and Aspergillus niger, in transgenic tobacco plants enhances methanol production and resistance to polyphagous insect pests. Methanol content in the leaves of transgenic plants was measured using proton nuclear spectroscopy (1H NMR) and spectra showed up to 16 fold higher methanol as compared to control wild type (WT) plants. A maximum of 100 and 85% mortality in chewing insects Helicoverpa armigera and Spodoptera litura larvae was observed, respectively when fed on transgenic plants leaves. The surviving larvae showed less feeding, severe growth retardation and could not develop into pupae. In-planta bioassay on transgenic lines showed up to 99 and 75% reduction in the population multiplication of plant sap sucking pests Myzus persicae (aphid) and Bemisia tabaci (whitefly), respectively. Most of the phenotypic characters of transgenic plants were similar to WT plants. Confocal microscopy showed no deformities in cellular integrity, structure and density of stomata and trichomes of transgenic plants compared to WT. Pollen germination and tube formation was also not affected in transgenic plants. Cell wall enzyme transcript levels were comparable with WT. This study demonstrated for the first time that methanol emission can be utilized for imparting broad range insect resistance in plants.	[Dixit, Sameer; Upadhyay, Santosh Kumar; Singh, Harpal; Sidhu, Om Prakash; Verma, Praveen Chandra; Chandrashekar, K.] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Dixit, Sameer] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Upadhyay, Santosh Kumar] Natl Agrifood Biotechnol Inst, Dept Biotechnol, Minist Sci & Technol, Mohali, Punjab, India; [Chandrashekar, K.] Indian Agr Res Inst, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Verma, PC (corresponding author), CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India.	praveencverma@nbri.res.in; kc_shekar2001@yahoo.com	Upadhyay, Santosh/ABD-2302-2020; Chadrashekar, K/AAX-4996-2021; Verma, Praveen C/F-9709-2010	Upadhyay, Santosh/0000-0001-6991-0502; Verma, Praveen C/0000-0002-3732-0564	CSIR, INDIA	CSIR, INDIA(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abro G. H., 2004, Biotechnology, V3, P75; Aktar M.S., 2009, INTERDISCIPLINARY TO, V2, P1; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Baldwin IT, 2001, CURR OPIN PLANT BIOL, V4, P351, DOI 10.1016/S1369-5266(00)00184-9; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carvalho AB, 2009, INT J FOOD SCI NUTR, V60, P255, DOI 10.1080/09637480701752244; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; de Maagd RA, 1999, TRENDS PLANT SCI, V4, P9, DOI 10.1016/S1360-1385(98)01356-9; Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640; Dutt U., 2007, MEALY BUG INFESTATIO; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; FLEMING R, 1985, J ECON ENTOMOL, V78, P1179, DOI 10.1093/jee/78.6.1179; Frenkel C, 1998, J BIOL CHEM, V273, P4293, DOI 10.1074/jbc.273.8.4293; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Jirschitzka J, 2012, CURRENT OPINION BIOT, V24, P1; Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu XH, 2003, J EXP BIOL, V206, P2221, DOI 10.1242/jeb.00420; Mangos TJ, 1997, ANAL BIOCHEM, V244, P357, DOI 10.1006/abio.1996.9908; Marty P, 1997, PHYTOCHEMISTRY, V44, P1435, DOI 10.1016/S0031-9422(96)00766-2; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P948, DOI 10.1016/j.bbabio.2007.05.003; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; NONOMURA AM, 1992, P NATL ACAD SCI USA, V89, P9794, DOI 10.1073/pnas.89.20.9794; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Virla EG, 2010, CROP PROT, V29, P635, DOI 10.1016/j.cropro.2009.12.019; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu Wen-hua, 2008, Journal of Ecology and Rural Environment, V24, P32; Yarasi B, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-102; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhao HW, 2000, ACTA BOT SIN, V42, P616	45	30	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79664	10.1371/journal.pone.0079664	http://dx.doi.org/10.1371/journal.pone.0079664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223989	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400080
J	Haagensen, AMJ; Klein, AB; Ettrup, A; Matthews, LR; Sorensen, DB				Haagensen, Annika Maria Juul; Klein, Anders Bue; Ettrup, Anders; Matthews, Lindsay R.; Sorensen, Dorte Bratbo			Cognitive Performance of Gottingen Minipigs Is Affected by Diet in a Spatial Hole-Board Discrimination Test	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HIGH-ENERGY DIET; NEUROTROPHIC FACTOR; HIGH-FAT; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; SATURATED FAT; MEMORY; SUCROSE; OBESITY	Consumption of a high energy diet, containing high amounts of saturated fat and refined sugar has been associated with impairment of cognitive function in rodents and humans. We sought to contrast the effect of a high fat/cholesterol, low carbohydrate diet and a low fat, high carbohydrate/sucrose diet, relative to a standard low fat, high carbohydrate minipig diet on spatial cognition with regards to working memory and reference memory in 24 male Gottingen minipigs performing in a spatial hole-board discrimination test. We found that both working memory and reference memory were impaired by both diets relative to a standard minipig diet high in carbohydrate, low in fat and sugar. The different diets did not impact levels of brain-derived neurotrophic factor in brain tissue and neither did they affect circulatory inflammation measured by concentrations of C-reactive protein and haptoglobin in serum. However, higher levels of triglycerides were observed for minipigs fed the diets with high fat/cholesterol, low carbohydrate and low fat, high carbohydrate/sucrose compared to minipigs fed a standard minipig diet. This might explain the observed impairments in spatial cognition. These findings suggest that high dietary intake of both fat and sugar may impair spatial cognition which could be relevant for mental functioning in humans.	[Haagensen, Annika Maria Juul; Sorensen, Dorte Bratbo] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg, Denmark; [Klein, Anders Bue] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Frederiksberg, Denmark; [Ettrup, Anders] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Copenhagen, Denmark; [Matthews, Lindsay R.] Lindsay R Matthews & Associates Res Int, Scerne Di Pineto, Italy; [Matthews, Lindsay R.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Auckland	Haagensen, AMJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg, Denmark.	amjh@sund.ku.dk		Sorensen, Dorte Bratbo/0000-0002-6144-1710; Ettrup, Anders/0000-0002-8926-3012; Klein, Anders Bue/0000-0002-0236-3089	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research [2101-06-0034]	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Centre for Applied Laboratory Animal Research and the Danish Council for Strategic Research (Grant Number: 2101-06-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Abargouei AS, 2012, PUBLIC HEALTH NUTR, V15, P1925, DOI 10.1017/S1368980011003302; Acuna E, 2004, ST CLASS DAT ANAL, P639; Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bollen PJA, 2002, 32 SCAND LAS S GARD; Brown LA, 2013, FOOD FUNCT, V4, P770, DOI 10.1039/c3fo30243a; Bruggeman EC, 2011, PHARMACOL BIOCHEM BE, V99, P356, DOI 10.1016/j.pbb.2011.05.014; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Carvalho C, 2012, DIABETES, V61, P1234, DOI 10.2337/db11-1186; Chepulis LM, 2009, PHYSIOL BEHAV, V97, P359, DOI 10.1016/j.physbeh.2009.03.001; Cserjesi R, 2009, APPETITE, V52, P535, DOI 10.1016/j.appet.2009.01.003; Eagan Danielle E, 2012, Cardiovasc Psychiatry Neurol, V2012, P120540, DOI 10.1155/2012/120540; Elias MF, 2005, NEUROBIOL AGING, V26, pS11, DOI 10.1016/j.neurobiolaging.2005.08.019; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Gieling ET, 2012, PEDIATR RES, V71, P71, DOI 10.1038/pr.2011.5; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Haagensen AMJ, 2013, BEHAV PHARMACOL, V24, P172, DOI 10.1097/FBP.0b013e32836104fd; HEILMAN KM, 1974, ARCH NEUROL-CHICAGO, V31, P67, DOI 10.1001/archneur.1974.00490370093018; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Karczewska-Kupczewska M, 2012, DIABETES CARE, V35, P358, DOI 10.2337/dc11-1295; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; Manton J, 2010, REPROD TOXICOL, V30, P233; MATHEW NT, 1976, EUR NEUROL, V14, P370, DOI 10.1159/000114761; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Northstone K, 2012, J EPIDEMIOL COMMUN H, V66, P624, DOI 10.1136/jech.2010.111955; OADES RD, 1978, BEHAV BIOL, V24, P327, DOI 10.1016/S0091-6773(79)90184-6; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; Perlmuter L C, 1988, J Diabet Complications, V2, P210, DOI 10.1016/S0891-6632(88)80011-4; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Ross AP, 2009, NEUROBIOL LEARN MEM, V92, P410, DOI 10.1016/j.nlm.2009.05.007; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Svendsen O, 2006, EXP TOXICOL PATHOL, V57, P335, DOI 10.1016/j.etp.2006.03.003; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; van der Borght K, 2011, REGUL PEPTIDES, V167, P26, DOI 10.1016/j.regpep.2010.11.002; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yamada-Goto N, 2012, J NEUROENDOCRINOL, V24, P1120, DOI 10.1111/j.1365-2826.2012.02327.x; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	55	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79429	10.1371/journal.pone.0079429	http://dx.doi.org/10.1371/journal.pone.0079429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223947	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400065
J	Hisatomi, Y; Asakura, K; Kugino, K; Kurokawa, M; Asakura, T; Nakata, K				Hisatomi, Yuko; Asakura, Kyo; Kugino, Kenji; Kurokawa, Mamoru; Asakura, Tomiko; Nakata, Keiko			Changes in Brain Tissue and Behavior Patterns Induced by Single Short-Term Fasting in Mice	PLOS ONE			English	Article							OREXIN NEURONS; APPARATUS; AROUSAL	In humans, emaciation from long-term dietary deficiencies, such as anorexia, reportedly increases physical activity and brain atrophy. However, the effects of single short-term fasting on brain tissue or behavioral activity patterns remain unclear. To clarify the impact of malnutrition on brain function, we conducted a single short-term fasting study as an anorexia model using male adult mice and determined if changes occurred in migratory behavior as an expression of brain function and in brain tissue structure. Sixteen-week-old C57BL/6J male mice were divided into either the fasted group or the control group. Experiments were conducted in a fixed indoor environment. We examined the effects of fasting on the number of nerve cells, structural changes in the myelin and axon density, and brain atrophy. For behavior observation, the amount of food and water consumed, ingestion time, and the pattern of movement were measured using a time-recording system. The fasted mice showed a significant increase in physical activity and their rhythm of movement was disturbed. Since the brain was in an abnormal state after fasting, mice that were normally active during the night became active regardless of day or night and performed strenuous exercise at a high frequency. The brain weight did not change by a fast, and brain atrophy was not observed. Although no textural change was apparent by fasting, the neuronal neogenesis in the subventricular zone and hippocampus was inhibited, causing disorder of the brain function. A clear association between the suppression of encephalic neuropoiesis and overactivity was not established. However, it is interesting that the results of this study suggest that single short-term fasting has an effect on encephalic neuropoiesis.	[Hisatomi, Yuko; Nakata, Keiko] Nishikyushu Univ, Fac Hlth & Social Welf Sci, Dept Hlth & Nutr Sci, Kanzaki, Saga, Japan; [Asakura, Kyo] Special Nursing Home Aged Social Welf Jurid Perso, Dietary Dept, Bungo Ono, Ooita, Japan; [Kugino, Kenji] Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki 852, Japan; [Kurokawa, Mamoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Med & Dent Sci, Nagasaki 852, Japan; [Asakura, Tomiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Nagasaki University; Nagasaki University; University of Tokyo	Kugino, K (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki 852, Japan.	kugino@mxa.cncm.ne.jp						ARTMANN H, 1985, NEURORADIOLOGY, V27, P304, DOI 10.1007/BF00339562; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; HEINZ ER, 1977, J COMPUT ASSIST TOMO, V1, P415, DOI 10.1097/00004728-197710000-00006; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Ida T, 2000, BIOCHEM BIOPH RES CO, V270, P318, DOI 10.1006/bbrc.2000.2412; Kurokawa M, 2000, PHYSIOL BEHAV, V70, P105, DOI 10.1016/S0031-9384(00)00226-2; Kurokawa M, 2003, CELL MOL NEUROBIOL, V23, P121, DOI 10.1023/A:1022956403708; Kurokawa M, 2005, COLOR ATLAS MOUSE IL, P169; Matsuda Motoko, 2000, Congenital Anomalies, V40, P14, DOI 10.1111/j.1741-4520.2000.tb00904.x; Mukai M, 2008, NIPPON TOSEKI IGAKKA, V41, P421, DOI 10.4009/jsdt.41.421; Nagai J, 2007, J PHARMACOL EXP THER, V321, P195, DOI 10.1124/jpet.106.115121; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; NUSSBAUM M, 1980, J PEDIATR-US, V96, P867, DOI 10.1016/S0022-3476(80)80561-0; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Watanabe Seiji, 2009, No To Hattatsu, V41, P43; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	20	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80085	10.1371/journal.pone.0080085	http://dx.doi.org/10.1371/journal.pone.0080085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224039	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400111
J	Yang, HX; Chu, JM				Yang, Hongxiao; Chu, Jianmin			Persistence of Coastal Vegetation in Supratidal Zones of Northern China	PLOS ONE			English	Article							STORM-SURGE; SEED-DISPERSAL; ECOSYSTEMS; COMMUNITY; RESERVE; PLANTS; IMPACT	Coastal vegetation comprises a number of coastal specialists and terrestrial generalists. It remains unclear how they persist on disturbed and undisturbed coastal conditions. We tested the hypothesis that coastal specialists may be superior to terrestrial generalists on supratidal zones of coasts, but their superiority can be influenced by human disturbances. Eight separate sandy coasts of the Shandong Peninsula were sampled, representing for disturbed and undisturbed sandy coasts. Plants growing on their supratidal zones were surveyed. On this basis, we compared the relative dominances, niche widths, and commonness of all species, and also analyzed species diversities of the coasts. Coastal specialists were found to be more common and widespread on supratidal zones of the sandy coasts than terrestrial generalists haphazardly invading from hinterlands. Coastal specialists exhibited lower Sorensen dissimilarities than terrestrial generalists among the coasts. Tourist trampling seemed more detrimental than pond fishery to coastal vegetation. Relative to terrestrial generalists, coastal specialists responded to human disturbances more deterministically, with steady decreases in species diversities. These evidences verify that coastal specialists are intrinsically superior to terrestrial generalists on supratidal zones of coasts, especially of undisturbed coasts, because their dispersal among coasts adapts well to local storm surge regime. They also validate that human disturbances can depress the superiority of coastal specialists, partly by inducing invasion of terrestrial generalists.	[Yang, Hongxiao] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China; [Chu, Jianmin] State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China; [Chu, Jianmin] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Chu, JM (corresponding author), State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China.	cjmcaf@163.com			Qingdao Agricultural University	Qingdao Agricultural University	This work was supported by the funds of Qingdao Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2005, APPL VEG SCI, V8, P133, DOI 10.1111/j.1654-109X.2005.tb00638.x; Acosta A, 2007, J COASTAL RES, V23, P1518, DOI 10.2112/05-0589.1; Ai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046164; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bird E.C., 2011, COASTAL GEOMORPHOLOG; Blaber SJM, 2000, ICES J MAR SCI, V57, P590, DOI 10.1006/jmsc.2000.0723; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Breitbach N, 2012, J ECOL, V100, P1349, DOI 10.1111/1365-2745.12001; Chen Hanbin, 1990, FLORA SHANDONG; Christenhusz MJM, 2013, BOT J LINN SOC, V171, P277, DOI 10.1111/j.1095-8339.2012.01301.x; de Juan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065575; Fan SJ, 2003, FLORA LAOSHAN; Guimaraes JTF, 2013, EARTH SURF PROC LAND, V38, P1535, DOI 10.1002/esp.3396; Fenner M., 2005, ECOLOGY SEEDS; Foxcroft LC, 2011, PERSPECT PLANT ECOL, V13, P89, DOI 10.1016/j.ppees.2011.03.004; Gormsem E., 1997, GeoJournal, V42, P39, DOI 10.1023/A:1006840622450; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Guja LK, 2010, FUNCT PLANT BIOL, V37, P1175, DOI 10.1071/FP10166; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HAYDEN BP, 1995, GEOMORPHOLOGY, V13, P283, DOI 10.1016/0169-555X(95)00032-Z; Kreitler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056670; Lee TL, 2009, ADV ENG SOFTW, V40, P1200, DOI 10.1016/j.advengsoft.2007.06.005; Leithead M, 2012, J VEG SCI, V23, P339, DOI 10.1111/j.1654-1103.2011.01351.x; LEVINS RICHARD, 1968; Li PS, 1994, MARINE FORECASTS, V11, P47; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2006, PC ORD MULTIVARIATE; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Rodgers JC, 2009, ESTUAR COAST, V32, P496, DOI 10.1007/s12237-009-9138-z; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Savage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042708; Shannon C., 1964, MATH THEORY COMMUNIC; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Tate AS, 2013, J VEG SCI, V24, P46, DOI 10.1111/j.1654-1103.2012.01447.x; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; VELLINGA P, 1982, COAST ENG, V6, P361, DOI 10.1016/0378-3839(82)90007-2; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wilson JB, 2012, J VEG SCI, V23, P1013, DOI 10.1111/j.1654-1103.2012.01430.x; Yang HX, 2012, FLORA, V207, P701, DOI 10.1016/j.flora.2012.08.001; Yang HongXiao, 2010, Acta Prataculturae Sinica, V19, P228; Yang HX, 2011, CHIN B BOT, V46, P50, DOI [10.3724/SP.J.1259.2011.00050, DOI 10.3724/SP.J.1259.2011.00050]	42	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79964	10.1371/journal.pone.0079964	http://dx.doi.org/10.1371/journal.pone.0079964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224026	Green Submitted, gold, Green Published			2022-12-25	WOS:000326597400100
J	Zawistowski, JS; Sabouri-Ghomi, M; Danuser, G; Hahn, KM; Hodgson, L				Zawistowski, Jon S.; Sabouri-Ghomi, Mohsen; Danuser, Gaudenz; Hahn, Klaus M.; Hodgson, Louis			A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; GTPASE ACTIVITIES; EXCHANGE FACTOR; STRESS FIBERS; INVASION; DOWNSTREAM; MOTILITY; METASTASIS; DYNAMICS; DRIVES	RhoA and RhoC GTPases share 92% amino acid sequence identity, yet play different roles in regulating cell motility and morphology. To understand these differences, we developed and validated a biosensor of RhoC activation (RhoC FLARE). This was used together with a RhoA biosensor to compare the spatio-temporal dynamics of RhoA and RhoC activity during cell protrusion/retraction and macropinocytosis. Both GTPases were activated similarly at the cell edge, but in regions more distal from the edge RhoC showed higher activation during protrusion. The two isoforms differed markedly in the kinetics of activation. RhoC was activated concomitantly with RhoA at the cell edge, but distally, RhoC activation preceded RhoA activation, occurring before edge protrusion. During macropinocytosis, differences were observed during vesicle closure and in the area surrounding vesicle formation.	[Zawistowski, Jon S.; Hahn, Klaus M.; Hodgson, Louis] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Zawistowski, Jon S.; Hahn, Klaus M.; Hodgson, Louis] Univ N Carolina, Sch Med, Lineberger Canc Ctr, Chapel Hill, NC USA; [Sabouri-Ghomi, Mohsen; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute	Hahn, KM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	khahn@med.unc.edu; louis.hodgson@einstein.yu.edu		Hahn, Klaus/0000-0002-1970-7562; Hodgson, Louis/0000-0001-9188-7580; Danuser, Gaudenz/0000-0001-8583-2014	American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship [PF-07-102-01-TBE]; The Sinsheimer Foundation Young Investigator Award; NIH [RO1 GM090317, RO1 GM093121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317, R01GM093121] Funding Source: NIH RePORTER	American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship; The Sinsheimer Foundation Young Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship #PF-07-102-01-TBE (J.S.Z.); The Sinsheimer Foundation Young Investigator Award (L.H.); NIH RO1 GM090317 (G. D. and K. M. H.); and NIH RO1 GM093121 (L.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bravo-Cordero JJ, 2013, J CELL SCI, V126, P3356, DOI 10.1242/jcs.123547; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Chang KW, 2013, ORAL ONCOL, V49, P27, DOI 10.1016/j.oraloncology.2012.07.003; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Danuser G, 1999, J MICROSC-OXFORD, V193, P62, DOI 10.1046/j.1365-2818.1999.00425.x; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Efron B., 1993, INTRO BOOTSTRAP, Vxvi; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Korkina O, 2013, J BIOL CHEM, V288, P5364, DOI 10.1074/jbc.M112.414060; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lim JI, 2010, EXP CELL RES, V316, P2027, DOI 10.1016/j.yexcr.2010.04.011; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Spiering D, 2012, METHODS MOL BIOL, V827, P215, DOI 10.1007/978-1-61779-442-1_15; Unsal-Kacmaz K, 2012, MOL ONCOL, V6, P284, DOI 10.1016/j.molonc.2011.12.001; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vilela M, 2013, METHOD ENZYMOL, V519, P253, DOI 10.1016/B978-0-12-405539-1.00009-9; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79877	10.1371/journal.pone.0079877	http://dx.doi.org/10.1371/journal.pone.0079877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400093
J	Bhat, HS; Vaz, GJ				Bhat, Harish S.; Vaz, Garnet J.			Frequency Response and Gap Tuning for Nonlinear Electrical Oscillator Networks	PLOS ONE			English	Article							TRANSMISSION-LINES; GENERATION; SOLITONS; LATTICE; SYNCHRONIZATION; PRINCIPLES; DYNAMICS	We study nonlinear electrical oscillator networks, the smallest example of which consists of a voltage-dependent capacitor, an inductor, and a resistor driven by a pure tone source. By allowing the network topology to be that of any connected graph, such circuits generalize spatially discrete nonlinear transmission lines/lattices that have proven useful in high-frequency analog devices. For such networks, we develop two algorithms to compute the steady-state response when a subset of nodes are driven at the same fixed frequency. The algorithms we devise are orders of magnitude more accurate and efficient than stepping towards the steady-state using a standard numerical integrator. We seek to enhance a given network's nonlinear behavior by altering the eigenvalues of the graph Laplacian, i.e., the resonances of the linearized system. We develop a Newton-type method that solves for the network inductances such that the graph Laplacian achieves a desired set of eigenvalues; this method enables one to move the eigenvalues while keeping the network topology fixed. Running numerical experiments using three different random graph models, we show that shrinking the gap between the graph Laplacian's first two eigenvalues dramatically improves a network's ability to (i) transfer energy to higher harmonics, and (ii) generate large-amplitude signals. Our results shed light on the relationship between a network's structure, encoded by the graph Laplacian, and its function, defined in this case by the presence of strongly nonlinear effects in the frequency response.	[Bhat, Harish S.; Vaz, Garnet J.] Univ Calif Merced, Appl Math Unit, Merced, CA 95344 USA	University of California System; University of California Merced	Bhat, HS (corresponding author), Univ Calif Merced, Appl Math Unit, Merced, CA 95344 USA.	hbhat@ucmerced.edu		Bhat, Dr. Shijaatt Hussain/0000-0002-8735-6792; Bhat, Harish/0000-0001-7631-1831				Afshari E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2174126; Afshari E, 2005, IEEE J SOLID-ST CIRC, V40, P744, DOI 10.1109/JSSC.2005.843639; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhat HS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066602; Bhat HS, 2009, PHYSICA D, V238, P1216, DOI 10.1016/j.physd.2009.04.009; Bhat HS, 2011, IEEE T ANTENN PROPAG, V59, P3772, DOI 10.1109/TAP.2011.2163787; Bhat HS, 2011, IEEE T COMPUT AID D, V30, P1483, DOI 10.1109/TCAD.2011.2159605; Bhat HS, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/20/205101; Bhat HS, 2013, FINITE VOLUME UNPUB; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brede M, 2008, EUR PHYS J B, V62, P87, DOI 10.1140/epjb/e2008-00126-9; Brede M, 2008, PHYS LETT A, V372, P5305, DOI 10.1016/j.physleta.2008.06.017; CASE M, 1991, APPL PHYS LETT, V58, P173, DOI 10.1063/1.104963; CASE M, 1992, APPL PHYS LETT, V60, P3019, DOI 10.1063/1.106795; Dadashi M, 2010, CHAOS, V20, DOI 10.1063/1.3515170; DiDonna BA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066619; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Han RN, 2013, ISSCC DIG TECH PAP I, V56, P138, DOI 10.1109/ISSCC.2013.6487671; Han RN, 2013, IEEE T MICROW THEORY, V61, P1150, DOI 10.1109/TMTT.2013.2243465; Jalili M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016105; Kelly D, 2011, CHAOS, V21, DOI 10.1063/1.3590855; Kori H, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066115; LANDAUER R, 1960, IBM J RES DEV, V4, P391, DOI 10.1147/rd.44.0391; LANDAUER R, 1960, J APPL PHYS, V31, P479, DOI 10.1063/1.1735612; Lee W, 2012, IEEE T MICROW THEORY, V60, P370, DOI 10.1109/TMTT.2011.2178255; Lee W, 2012, IEEE T MICROW THEORY, V60, P329, DOI 10.1109/TMTT.2011.2178318; Lilis GN, 2010, IEEE T MICROW THEORY, V58, P1713, DOI 10.1109/TMTT.2010.2049678; Momeni O, 2011, IEEE J SOLID-ST CIRC, V46, P2966, DOI 10.1109/JSSC.2011.2162469; Monthus C, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/8/085001; OSTROVSKY LA, 1980, ZH EKSP TEOR FIZ+, V78, P831; Park K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026211; STEPANYANTS YA, 1981, WAVE MOTION, V3, P335, DOI 10.1016/0165-2125(81)90025-1; Stepanyants Yu. A., 1983, Radiophysics and Quantum Electronics, V26, P601, DOI 10.1007/BF01034871; Tighe BP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168303; Togashi Y, 2007, P NATL ACAD SCI USA, V104, P8697, DOI 10.1073/pnas.0702950104; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501; Yanagita T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056206	42	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78009	10.1371/journal.pone.0078009	http://dx.doi.org/10.1371/journal.pone.0078009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223751	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400028
J	de Groot, GA; During, H				de Groot, G. Arjen; During, Heinjo			Fern Spore Longevity in Saline Water: Can Sea Bottom Sediments Maintain a Viable Spore Bank?	PLOS ONE			English	Article							GENETIC DIVERSITY; DIASPORE BANK; COLONIZATION; POPULATIONS; GERMINATION; DISPERSAL; NACL	Freshwater and marine sediments often harbor reservoirs of plant diaspores, from which germination and establishment may occur whenever the sediment falls dry. Therewith, they form valuable records of historical inter- and intraspecific diversity, and are increasingly exploited to facilitate diversity establishment in new or restored nature areas. Yet, while ferns may constitute a considerable part of a vegetation's diversity and sediments are known to contain fern spores, little is known about their longevity, which may suffer from inundation and - in sea bottoms - salt stress. We tested the potential of ferns to establish from a sea or lake bottom, using experimental studies on spore survival and gametophyte formation, as well as a spore bank analysis on sediments from a former Dutch inland sea. Our experimental results revealed clear differences among species. For Asplenium scolopendrium and Gymnocarpium dryopteris, spore germination was not affected by inundated storage alone, but decreased with rising salt concentrations. In contrast, for Asplenium trichomanes subsp. quadrivalens germination decreased following inundation, but not in response to salt. Germination rates decreased with time of storage in saline water. Smaller and less viable gametophytes were produced when saline storage lasted for a year. Effects on germination and gametophyte development clearly differed among genotypes of A. scolopendrium. Spore bank analyses detected no viable spores in marine sediment layers. Only two very small gametophytes (identified as Thelypteris palustris via DNA barcoding) emerged from freshwater sediments. Both died before maturation. We conclude that marine, and likely even freshwater sediments, will generally be of little value for long-term storage of fern diversity. The development of any fern vegetation on a former sea floor will depend heavily on the deposition of spores onto the drained land by natural or artificial means of dispersal.	[de Groot, G. Arjen] Alterra Wageningen UR, Wageningen, Netherlands; [de Groot, G. Arjen; During, Heinjo] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	de Groot, GA (corresponding author), Alterra Wageningen UR, Wageningen, Netherlands.	g.a.degroot@wur.nl						Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ballesteros D, 2011, WORKING WITH FERNS: ISSUES AND APPLICATIONS, P165, DOI 10.1007/978-1-4419-7162-3_12; Bogdanovic M, 2011, AUST J BOT, V59, P734, DOI 10.1071/BT11059; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Bremer P., 2007, The colonisation of a former sea-floor by ferns; Chen ShaSha, 2012, African Journal of Biotechnology, V11, P9572, DOI 10.5897/AJB12.320; Cremer H, 2006, 2006UR0133B TNO BOUW; Cremer H, 2009, HYDROBIOLOGIA, V631, P279, DOI 10.1007/s10750-009-9816-7; Dalen Linda, 1999, Lindbergia, V24, P49; de Groot GA, 2008, GORTERIA, V33, P59; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; de Groot GA, 2012, AM J BOT, V99, P1375, DOI 10.3732/ajb.1100482; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; De Groot GA, 2011, THESIS UTRECHT U UTR, P197; During Heinjo J., 2007, LINDBERGIA, V32, P55; During HJ, 1997, ADV BRYOLOG, V6, P103; During HJ, 2001, BRYOLOGIST, V104, P92, DOI 10.1639/0007-2745(2001)104[0092:DB]2.0.CO;2; Dyer A. F., 1979, EXPT BIOL FERNS, P253; DYER AF, 1994, BIODIVERS CONSERV, V3, P160, DOI 10.1007/BF02291886; DYER AF, 1992, AM FERN J, V82, P89, DOI 10.2307/1547792; Erkkila HMJB, 1998, CAN J BOT, V76, P1188, DOI 10.1139/cjb-76-7-1188; Furness SB, 1981, BRID J BRYOL, V4, P733; Guan B, 2009, J ARID ENVIRON, V73, P135, DOI 10.1016/j.jaridenv.2008.08.009; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hock Z, 2008, AM J BOT, V95, P542, DOI 10.3732/ajb.2007283; Hock Z, 2006, PLANT ECOL, V187, P289, DOI 10.1007/s11258-006-9142-3; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jansen AJM, 2004, APPL VEG SCI, V7, P243, DOI 10.1111/j.1654-109X.2004.tb00616.x; Johansson ME, 1996, J VEG SCI, V7, P593, DOI 10.2307/3236309; Khan MA, 1998, SEED SCI TECHNOL, V26, P107; Klekowski EJ, 1969, BOT J LINN SOC, V62; Kochanek J, 2009, AUST J BOT, V57, P123, DOI 10.1071/BT09023; Lindsay Stuart, 1992, P285; LLOYD R M, 1986, Fern Gazette, V13, P97; Nishihiro J, 2007, ENVIRON RES, V11, P171, DOI [10.1007/s11355-006-0005-9, DOI 10.1007/S11355-006-0005-9]; ONR, 2013, OC WAT SAL OFF NAV R; Pangua E, 2009, FLORA, V204, P673, DOI 10.1016/j.flora.2008.09.007; Quintanilla LG, 2002, ANN BOT-LONDON, V90, P461, DOI 10.1093/aob/mcf224; Stuurman RJ, 2007, 2007UR0225B TNO BOUW; Sun WQ, 1999, PHYSIOL PLANTARUM, V105, P51, DOI 10.1034/j.1399-3054.1999.105109.x; Ungar I.A., 1995, SEED DEV GERMINATION, P529; Ungar Irwin A., 2001, Wetlands Ecology and Management, V9, P499, DOI 10.1023/A:1012236829474; Urrego LE, 2009, REV PALAEOBOT PALYNO, V156, P358, DOI 10.1016/j.revpalbo.2009.04.004; WARNE TR, 1995, INT J PLANT SCI, V156, P374, DOI 10.1086/297259; WEINBERG ES, 1969, P NATL ACAD SCI USA, V64, P835, DOI 10.1073/pnas.64.3.835; Wilmshurst JM, 2005, J PALEOLIMNOL, V34, P503, DOI 10.1007/s10933-005-5476-4; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157	48	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79470	10.1371/journal.pone.0079470	http://dx.doi.org/10.1371/journal.pone.0079470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223951	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400116
J	Yang, CC; Lin, CY; Wang, HS; Lyu, SR				Yang, Chih-Chang; Lin, Cheng-Yu; Wang, Hwai-Shi; Lyu, Shaw-Ruey			Matrix Metalloproteases and Tissue Inhibitors of Metalloproteinases in Medial Plica and Pannus-like Tissue Contribute to Knee Osteoarthritis Progression	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; RHEUMATOID-ARTHRITIS; CELL-MIGRATION; FOLLOW-UP; DEGRADATION; COMPARTMENT; EXPRESSION; ANGIOGENESIS; INFLAMMATION; DESTRUCTION	Osteoarthritis (OA) is characterized by degradation of the cartilage matrix, leading to pathologic changes in the joints. However, the pathogenic effects of synovial tissue inflammation on OA knees are not clear. To investigate whether the inflammation caused by the medial plica is involved in the pathogenesis of osteoarthritis, we examined the expression of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), interleukin (IL)-1 beta, and tumor necrosis factor (TNF)-alpha in the medial plica and pannus-like tissue in the knees of patients with medial compartment OA who underwent either arthroscopic medial release (stage II; 15 knee joints from 15 patients) or total knee replacement (stage IV; 18 knee joints from 18 patients). MMP-2, MMP-3, MMP-9, IL-1 beta, and TNF-alpha mRNA and protein levels measured, respectively, by quantitative real-time PCR and Quantibody human MMP arrays, were highly expressed in extracts of medial plica and pannus-like tissue from stage IV knee joints. Immunohistochemical staining also demonstrated high expression of MMP-2, MMP-3, and MMP-9 in plica and pannus-like tissue of stage IV OA knees and not in normal cartilage. Some TIMP/MMP ratios decreased significantly in both medial plica and pannus-like tissue as disease progressed from stage II to stage IV. Furthermore, the migration of cells from the pannus-like tissue was enhanced by IL-1 beta, while plica cell migration was enhanced by TNF-alpha. The results suggest that medial plica and pannus-like tissue may be involved in the process of cartilage degradation in medial compartment OA of the knee.	[Yang, Chih-Chang; Lin, Cheng-Yu; Wang, Hwai-Shi] Natl Yang Ming Univ, Dept Anat, Taipei, Taiwan; [Lyu, Shaw-Ruey] Tzu Chi Dalin Gen Hosp, Joint Ctr, Chiayi, Taiwan; [Lyu, Shaw-Ruey] Tzu Chi Univ, Hualien, Taiwan	National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Tzu Chi University	Wang, HS (corresponding author), Natl Yang Ming Univ, Dept Anat, Taipei, Taiwan.	hswang@ym.edu.tw; srlyu@seed.net.tw	Lyu, Shaw-Ruey/AAC-5480-2022; Lyu, Shaw-Ruey/AAD-9397-2022	Lyu, Shaw-Ruey/0000-0003-3797-4848; Lin, Cheng-Yu/0000-0001-9959-140X	Tzu-Chi Dalin General Hospital, Chiayi, Taiwan; National Science Council, Taiwan [NSC100-2320-B-010-013]; Ministry of Education, Taiwan, Aim for the Top University Plan	Tzu-Chi Dalin General Hospital, Chiayi, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Aim for the Top University Plan	Supported by the Tzu-Chi Dalin General Hospital, Chiayi, Taiwan (S.-R. Lyu) and by a grant from the National Science Council, Taiwan (NSC100-2320-B-010-013) to H.-S. Wang, and a grant from the Ministry of Education, Taiwan, Aim for the Top University Plan (H.-S. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainola MM, 2005, CLIN EXP RHEUMATOL, V23, P644; Akhavani MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2689; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BROOM MJ, 1986, ORTHOP CLIN N AM, V17, P279; DANDY D J, 1990, Arthroscopy, V6, P79, DOI 10.1016/0749-8063(90)90002-U; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DEAN DD, 1987, J RHEUMATOL, V14, P43; DEAN DD, 1984, BIOCHEM J, V218, P277, DOI 10.1042/bj2180277; Duerr S, 2004, CLIN EXP RHEUMATOL, V22, P603; Dupont JY, 1997, CLIN SPORT MED, V16, P87, DOI 10.1016/S0278-5919(05)70009-0; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fassbender HG, 1975, PATHOLOGY RHEUMATIC, P279; FLANAGAN JP, 1994, ACTA ORTHOP SCAND, V65, P408, DOI 10.3109/17453679408995480; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314; Ikeuchi M, 2005, ARTHROSCOPY, V21, P1457, DOI 10.1016/j.arthro.2005.09.011; JACKSON RW, 1982, ORTHOP CLIN N AM, V13, P307; Katerinaki E, 2003, BRIT J CANCER, V89, P1123, DOI 10.1038/sj.bjc.6601257; KLEIN W, 1983, ARCH ORTHOP TRAUM SU, V102, P67, DOI 10.1007/BF02498717; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Kontogiorgis CA, 2005, CURR MED CHEM, V12, P339, DOI 10.2174/0929867053363243; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Lyu SR, 2008, J BONE JOINT SURG BR, V90B, P1186, DOI 10.1302/0301-620X.90B9.20584; Lyu SR, 2007, CLIN BIOMECH, V22, P1013, DOI 10.1016/j.clinbiomech.2007.08.001; Lyu SR, 2006, CLIN BIOMECH, V21, P860, DOI 10.1016/j.clinbiomech.2006.03.010; Lyu SR, 2010, KNEE SURG SPORT TR A, V18, P769, DOI 10.1007/s00167-009-0946-2; Lyu SR, 2006, ARTHROSCOPY, V22, P17, DOI 10.1016/j.arthro.2005.08.039; MEACHIM G, 1970, J PATHOL, V102, P1, DOI 10.1002/path.1711020102; Mitchell MD, 2007, AM J PHYSIOL-HEART C, V292, pH1139, DOI 10.1152/ajpheart.00881.2005; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nakata K, 1986, Nihon Seikeigeka Gakkai Zasshi, V60, P763; NOTTAGE WM, 1983, AM J SPORT MED, V11, P211, DOI 10.1177/036354658301100405; OGATA S, 1990, Arthroscopy, V6, P315, DOI 10.1016/0749-8063(90)90063-J; OKADA Y, 1992, LAB INVEST, V66, P680; Patwari P, 2003, ARTHRITIS RHEUM-US, V48, P1292, DOI 10.1002/art.10892; Sakata K, 2000, INT J ONCOL, V17, P673; SCHULITZ KP, 1983, ARCH ORTHOP TRAUM SU, V102, P37, DOI 10.1007/BF00443037; Shibakawa A, 2003, OSTEOARTHR CARTILAGE, V11, P133, DOI 10.1053/joca.2002.0871; Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976; TASKER T, 1982, J BONE JOINT SURG BR, V64, P486, DOI 10.1302/0301-620X.64B4.7096428; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Wang HS, 2011, HISTOPATHOLOGY, V58, P593, DOI 10.1111/j.1365-2559.2011.03783.x; Yuan GH, 2004, OSTEOARTHR CARTILAGE, V12, P38, DOI 10.1016/j.joca.2003.08.004	50	49	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79662	10.1371/journal.pone.0079662	http://dx.doi.org/10.1371/journal.pone.0079662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223987	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400133
J	Helms, N; Kowalski, M; Illes, P; Riedel, T				Helms, Nick; Kowalski, Maria; Illes, Peter; Riedel, Thomas			Agonist Antagonist Interactions at the Rapidly Desensitizing P2X3 Receptor	PLOS ONE			English	Article							P2X(2/3) RECEPTORS; P2X(3) RECEPTORS; ION-CHANNEL; PURINERGIC RECEPTORS; SENSORY NEURONS; ATP; PAIN; RAT; SUBUNITS; KINETICS	P2X3 receptors (P2XRs), as members of the purine receptor family, are deeply involved in chronic pain sensation and therefore, specific, competitive antagonists are of great interest for perspective pain management. Heretofore, Schild plot analysis has been commonly used for studying the interaction of competitive antagonists and the corresponding receptor. Unfortunately, the steady-state between antagonist and agonist, as a precondition for this kind of analysis, cannot be reached at fast desensitizing receptors like P2X3R making Schild plot analysis inappropriate. The aim of this study was to establish a new method to analyze the interaction of antagonists with their binding sites at the rapidly desensitizing human P2X3R. The patch-clamp technique was used to investigate the structurally divergent, preferential antagonists A317491, TNP-ATP and PPADS. The P2X1,3-selective alpha,beta-methylene ATP (alpha,beta-meATP) was used as an agonist to induce current responses at the wild-type (wt) P2X3R and several agonist binding site mutants. Afterwards a Markov model combining sequential transitions of the receptor from the closed to the open and desensitized mode in the presence or absence of associated antagonist molecules was developed according to the measured data. The P2X3R-induced currents could be fitted correctly with the help of this Markov model allowing identification of amino acids within the binding site which are important for antagonist binding. In conclusion, Markov models are suitable to simulate agonist antagonist interactions at fast desensitizing receptors such as the P2X3R. Among the antagonists investigated, TNP-ATP and A317491 acted in a competitive manner, while PPADS was identified as a (pseudo) irreversible blocker.	[Helms, Nick; Kowalski, Maria; Illes, Peter; Riedel, Thomas] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany	Leipzig University	Riedel, T (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany.	Thomas.Riedel@medizin.uni-leipzig.de		Kowalski-Jahn, Maria/0000-0003-1442-3656	Deutsche Forschungsgemeinschaft [FOR748, RI 2092/1-2, IL 20/18-2]; University of Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Leipzig	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de/ (FOR748; RI 2092/1-2 and IL 20/18-2) and the University of Leipzig, http://www.uniklinikum-leipzig.de/r-promotionsfoerderung-a-768.html (Promotionsforderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Brown SG, 2001, DRUG DEVELOP RES, V53, P281, DOI 10.1002/ddr.1197; Browne L.E., 2012, WIRES MEMBR TRANSP S, V1, P56, DOI DOI 10.1002/WMTS.24; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burgard EC, 2000, MOL PHARMACOL, V58, P1502, DOI 10.1124/mol.58.6.1502; Burnstock G, 2011, PROG NEUROBIOL; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chizh BA, 2001, PHARMACOL REV, V53, P553; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Hattori M, 2012, NATURE, DOI DOI 10.HTML#/SUPPLEMENTARY-INF0RMATI0N.ACCESSED; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kennedy C, 2003, J PHYSIOL-LONDON, V553, P683, DOI 10.1113/jphysiol.2003.049114; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koles L, 2008, N-S ARCH PHARMACOL, V377, P1, DOI 10.1007/s00210-007-0222-2; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Neelands TR, 2003, BRIT J PHARMACOL, V140, P202, DOI 10.1038/sj.bjp.0705411; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Riedel T, 2012, MOL PHARM; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; Spelta V, 2002, BRIT J PHARMACOL, V135, P1524, DOI 10.1038/sj.bjp.0704591; Syed N.I., 2012, WILEY INTERDISCIPLIN, V1, P16, DOI DOI 10.1002/WMTS.1; Virginio C, 1998, MOL PHARMACOL, V53, P969; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wolf C, 2011, MOL PHARMACOL, V79, P649, DOI 10.1124/mol.110.068700	36	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79213	10.1371/journal.pone.0079213	http://dx.doi.org/10.1371/journal.pone.0079213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223907	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300066
J	Mehlhorn, J; Steinocher, H; Beck, S; Kennis, JTM; Hegemann, P; Mathes, T				Mehlhorn, Jennifer; Steinocher, Helena; Beck, Sebastian; Kennis, John T. M.; Hegemann, Peter; Mathes, Tilo			A Set of Engineered Escherichia coli Expression Strains for Selective Isotope and Reactivity Labeling of Amino Acid Side Chains and Flavin Cofactors	PLOS ONE			English	Article							INDUCED STRUCTURAL-CHANGES; COUPLED ELECTRON-TRANSFER; BLUE-LIGHT PHOTORECEPTOR; INFRARED-SPECTROSCOPY; CRYSTAL-STRUCTURES; FAD BLUF; APPA; PROTEIN; DOMAIN; SIGNAL	Biological reactions are facilitated by delicate molecular interactions between proteins, cofactors and substrates. To study and understand their dynamic interactions researchers have to take great care not to influence or distort the object of study. As a non-invasive alternative to a site-directed mutagenesis approach, selective isotope labeling in combination with vibrational spectroscopy may be employed to directly identify structural transitions in wild type proteins. Here we present a set of customized Escherichia coli expression strains, suitable for replacing both the flavin cofactor and/or selective amino acids with isotope enriched or chemically modified substrates. For flavin labeling we report optimized auxotrophic strains with significantly enhanced flavin uptake properties. Labeled protein biosynthesis using these strains was achieved in optimized cultivation procedures using high cell density fermentation. Finally, we demonstrate how this approach is used for a clear assignment of vibrational spectroscopic difference signals of apoprotein and cofactor of a flavin containing photoreceptor of the BLUF (Blue Light receptors Using FAD) family.	[Mehlhorn, Jennifer; Steinocher, Helena; Hegemann, Peter; Mathes, Tilo] Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany; [Beck, Sebastian] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Kennis, John T. M.; Mathes, Tilo] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, Amsterdam, Netherlands	Humboldt University of Berlin; Humboldt University of Berlin; Vrije Universiteit Amsterdam	Mathes, T (corresponding author), Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany.	mathes@vu.nl	Beck, Sebastian/C-8159-2017; Mathes, Tilo/C-5715-2011	Beck, Sebastian/0000-0001-6440-693X; Mathes, Tilo/0000-0002-9694-748X	German Research Organisation (DFG) [HE3824/24-1]; Netherlands Organization for Scientific Research (NWO)-DFG [HE3824/25-1]; NWO-Chemical Sciences Section (CW); NWO	German Research Organisation (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)-DFG(Netherlands Organization for Scientific Research (NWO)); NWO-Chemical Sciences Section (CW); NWO(Netherlands Organization for Scientific Research (NWO))	The research presented here was funded by the German Research Organisation (DFG) (HE3824/24-1) and the Netherlands Organization for Scientific Research (NWO)-DFG Bilateral Cooperation program (HE3824/25-1). JTM Kennis was supported by the NWO-Chemical Sciences Section (CW) through a VICI and Echo grant. Funding for open access publication was from NWO through the Incentive Fund Open Access publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BANDRIN SV, 1979, GENETIKA+, V15, P2063; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; Bonetti C, 2008, BIOPHYS J, V95, P4790, DOI 10.1529/biophysj.108.139246; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Dragnea V, 2009, BIOCHEMISTRY-US, V48, P9969, DOI 10.1021/bi9009067; Eberhardt S, 1997, J BACTERIOL, V179, P2938, DOI 10.1128/jb.179.9.2938-2943.1997; Fiedler S, 2007, GENET ENG BIOTECHN, V27, P54; Gauden M, 2005, BIOCHEMISTRY-US, V44, P3653, DOI 10.1021/bi047359a; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Goldbourt A, 2007, J MAGN RESON, V189, P157, DOI 10.1016/j.jmr.2007.07.011; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Grage SL, 2007, ANNU REP NMR SPECTRO, V60, P191, DOI 10.1016/S0066-4103(06)60005-7; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Hamm P, 2008, ANNU REV PHYS CHEM, V59, P291, DOI 10.1146/annurev.physchem.59.032607.093757; Hashimoto S, 2002, BIOCHEMISTRY-US, V41, P6495, DOI 10.1021/bi012190b; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Hertwig S, 2003, J MOL BIOL, V331, P605, DOI 10.1016/S0022-2836(03)00763-0; Hong M, 1999, J BIOMOL NMR, V14, P71, DOI 10.1023/A:1008334930603; Husain M, 1978, Methods Enzymol, V53, P429; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Khrenova MG, 2013, J PHYS CHEM B, V117, P2369, DOI 10.1021/jp312775x; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Lin MT, 2011, METHODS, V55, P370, DOI 10.1016/j.ymeth.2011.08.019; Majerus T, 2007, CHEMPHYSCHEM, V8, P1787, DOI 10.1002/cphc.200700248; Masuda S, 2005, PLANT CELL PHYSIOL, V46, P1894, DOI 10.1093/pcp/pci208; Masuda S, 2005, BIOCHEMISTRY-US, V44, P1215, DOI 10.1021/bi047876t; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2008, PLANT CELL PHYSIOL, V49, P1600, DOI 10.1093/pcp/pcn132; Mathes T, 2012, J BIOL CHEM, V287, P31725, DOI 10.1074/jbc.M112.391896; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Mathes T, 2011, J PHYS CHEM B, V115, P7963, DOI 10.1021/jp201296m; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; O'Grady C, 2012, ANAL BIOCHEM, V426, P126, DOI 10.1016/j.ab.2012.04.019; Rathod R, 2012, PROTEIN EXPRES PURIF, V85, P125, DOI 10.1016/j.pep.2012.06.011; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; Stelling AL, 2007, J AM CHEM SOC, V129, P15556, DOI 10.1021/ja074074n; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Toh KC, 2008, BIOPHYS J, V95, P312, DOI 10.1529/biophysj.107.117788; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tyagi A, 2010, J PHOTOCH PHOTOBIO B, V101, P76, DOI 10.1016/j.jphotobiol.2010.06.014; Uchida T, 2004, J BIOL CHEM, V279, P53613, DOI 10.1074/jbc.M409719200; Udvarhelyi A, 2013, J PHYS CHEM B, V117, P2888, DOI 10.1021/jp400437x; Unno M, 2005, J PHYS CHEM B, V109, P12620, DOI 10.1021/jp0522664; Unno M, 2010, BIOPHYS J, V98, P1949, DOI 10.1016/j.bpj.2010.01.007; Vogel R, 2000, CURR OPIN CHEM BIOL, V4, P518, DOI 10.1016/S1367-5931(00)00125-3; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; Warscheid B, 2008, VIB SPECTROSC, V48, P28, DOI 10.1016/j.vibspec.2007.11.003; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Yuan H, 2011, BIOCHEMISTRY-US, V50, P6365, DOI 10.1021/bi200701d; Zirak P, 2009, J PHOTOCH PHOTOBIO B, V97, P61, DOI 10.1016/j.jphotobiol.2009.08.002; Zscherp C, 2001, BIOCHEMISTRY-US, V40, P1875, DOI 10.1021/bi002567y	68	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79006	10.1371/journal.pone.0079006	http://dx.doi.org/10.1371/journal.pone.0079006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223875	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300047
J	Vigna, SR; Shahid, RA; Liddle, RA				Vigna, Steven R.; Shahid, Rafiq A.; Liddle, Rodger A.			Ethanol contributes to neurogenic pancreatitis by activation of TRPV1	FASEB JOURNAL			English	Article						acute pancreatitis; AMG9801; palmitoleic acid; TRP channel	ALCOHOLIC PANCREATITIS; VANILLOID RECEPTOR; INFLAMMATION; METABOLITES; TOXICITY; INJURY; RATS; MICE	Alcohol abuse is a major cause of pancreatitis in people, but the mechanism is unknown. It has been recently demonstrated that transient receptor potential vanilloid 1 (TRPV1) activation causes neurogenic inflammation and plays an important role in acute pancreatitis. Moreover, TRPV1 is activated by ethanol. We examined the direct effects of ethanol on acute pancreatitis. Acute inflammation of the pancreas was produced by injection of ethanol and palmitoleic acid (POA), a nonoxidative metabolite of ethanol, in wild-type C57BL/6J mice and Trpv1-knockout C57BL/6J mice. Inflammatory indexes were analyzed 24 h later. Injection of ethanol + POA produced acute pancreatitis indicated by significant increases in histopathological damage, serum amylase levels, and pancreatic MPO concentrations (P<0.05-0.001). All parameters of pancreatitis were blocked by pretreatment with the TRPV1 antagonist drug AMG9810. In addition, ethanol + POA administration to Trpv1knockout mice did not produce pancreatic inflammation. Treatment with vehicle, ethanol alone, or POA alone had no inflammatory effects. TRPV1 partially mediates inflammation induced by ethanol + POA in the mouse pancreas, consistent with the ability of ethanol to activate TRPV1. We propose that ethanol may contribute to alcohol-induced pancreatitis by a neurogenic mechanism.Vigna, S. R., Shahid, R. A., and Liddle, R. A. Ethanol contributes to neurogenic pancreatitis by activation of TRPV1.	[Vigna, Steven R.; Shahid, Rafiq A.; Liddle, Rodger A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Vigna, Steven R.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Liddle, Rodger A.] Durham Vet Affairs Med Ctr, Durham, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Liddle, RA (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 103211, Durham, NC 27710 USA.	rodger.liddle@duke.edu			U.S. National Institutes of Health [R01 DK-064213]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064213] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. D. Julius (University of California, San Francisco, CA, USA) for the generous gift of Trpv1<SUP>-/-</SUP> mice. This work was supported by U.S. National Institutes of Health grant R01 DK-064213.	BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Dawra R, 2008, PANCREAS, V37, P62, DOI 10.1097/MPA.0b013e3181607761; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Huang W, 2010, PANCREAS, V39, P1324; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Liddle RA, 2004, PANCREATOLOGY, V4, P551, DOI 10.1159/000082180; Liddle RA, 2007, BBA-MOL BASIS DIS, V1772, P869, DOI 10.1016/j.bbadis.2007.02.012; Long D. J., J PHARM EXP THER, V332, P525; Nathan JD, 2005, GASTROENTEROLOGY, V128, P717, DOI 10.1053/j.gastro.2004.11.052; Romac JMJ, 2008, PANCREAS, V36, P394, DOI 10.1097/MPA.0b013e318160222a; SPORMANN H, 1989, PATHOL RES PRACT, V184, P507, DOI 10.1016/S0344-0338(89)80143-8; Szallasi A, 2000, TRENDS NEUROSCI, V23, P491, DOI 10.1016/S0166-2236(00)01630-1; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; Werner J, 2002, AM J PHYSIOL-GASTR L, V283, pG65, DOI 10.1152/ajpgi.00419.2001; Werner J, 2001, SURGERY, V129, P736, DOI 10.1067/msy.2001.113891	23	17	18	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					891	896		10.1096/fj.13-236208	http://dx.doi.org/10.1096/fj.13-236208			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24221085	Green Published			2022-12-25	WOS:000331072200034
J	Abe, K; Ohno, Y; Sassa, T; Taguchi, R; Caliskan, M; Ober, C; Kihara, A				Abe, Kensuke; Ohno, Yusuke; Sassa, Takayuki; Taguchi, Ryo; Caliskan, Minal; Ober, Carole; Kihara, Akio			Mutation for Nonsyndromic Mental Retardation in the trans-2-Enoyl-CoA Reductase TER Gene Involved in Fatty Acid Elongation Impairs the Enzyme Activity and Stability, Leading to Change in Sphingolipid Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Fatty Acid Metabolism; Lipids; Membrane; Sphingolipid	IDENTIFICATION; ELOVL4; DELETION; SYSTEM; TSC13P	Background: The P182L mutation in the trans-2-enoyl-CoA reductase (TER) gene required for very long-chain fatty acid (VLCFA) synthesis causes nonsyndromic mental retardation. Results: This mutation reduces the activity and stability of the TER enzyme. Conclusion: The impaired TER function affects VLCFA synthesis and thereby alters the cellular sphingolipid profile. Significance: Maintenance of a proper VLCFA level may be important for neural function. Very long-chain fatty acids (VLCFAs, chain length >C20) exist in tissues throughout the body and are synthesized by repetition of the fatty acid (FA) elongation cycle composed of four successive enzymatic reactions. In mammals, the TER gene is the only gene encoding trans-2-enoyl-CoA reductase, which catalyzes the fourth reaction in the FA elongation cycle. The TER P182L mutation is the pathogenic mutation for nonsyndromic mental retardation. This mutation substitutes a leucine for a proline residue at amino acid 182 in the TER enzyme. Currently, the mechanism by which the TER P182L mutation causes nonsyndromic mental retardation is unknown. To understand the effect of this mutation on the TER enzyme and VLCFA synthesis, we have biochemically characterized the TER P182L mutant enzyme using yeast and mammalian cells transfected with the TER P182L mutant gene and analyzed the FA elongation cycle in the B-lymphoblastoid cell line with the homozygous TER P182L mutation (TERP182L/P182L B-lymphoblastoid cell line). We have found that TER P182L mutant enzyme exhibits reduced trans-2-enoyl-CoA reductase activity and protein stability, thereby impairing VLCFA synthesis and, in turn, altering the sphingolipid profile (i.e. decreased level of C24 sphingomyelin and C24 ceramide) in the TERP182L/P182L B-lymphoblastoid cell line. We have also found that in addition to the TER enzyme-catalyzed fourth reaction, the third reaction in the FA elongation cycle is affected by the TER P182L mutation. These findings provide new insight into the biochemical defects associated with this genetic mutation.	[Abe, Kensuke; Ohno, Yusuke; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taguchi, Ryo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Caliskan, Minal; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Hokkaido University; Chubu University; University of Chicago	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; Ohno, Yusuke/B-5621-2014; KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/Q-3285-2019	SASSA, Takayuki/0000-0003-3145-9829; Ohno, Yusuke/0000-0003-3702-1043; KIHARA, AKIO/0000-0001-5889-0788; Ohno, Yusuke/0000-0003-3702-1043; Caliskan, Minal/0000-0002-0942-7073; Ober, Carole/0000-0003-4626-9809	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [BY25598]; Grants-in-Aid for Scientific Research [25116701, 24619007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The yeast strain for the AID system (BY25598) was provided by the National Bio-Resource Project (NBRP) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We are grateful to Dr. K. Obara for technical support and Dr. T. Toyokuni for scientific editing of the manuscript.	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Brachmann CB, 1998, YEAST, V14, P115; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Muhammad E., 2013, HUM MOL GEN IN PRESS; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Paul S, 2007, J BIOL CHEM, V282, P19237, DOI 10.1074/jbc.M701774200; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	30	17	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36741	36749		10.1074/jbc.M113.493221	http://dx.doi.org/10.1074/jbc.M113.493221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24220030	Green Published, hybrid			2022-12-25	WOS:000328883400051
J	Hashimoto, T; Igarashi, J; Hasan, AU; Ohmori, K; Kohno, M; Nagai, Y; Yamashita, T; Kosaka, H				Hashimoto, Takeshi; Igarashi, Junsuke; Hasan, Arif U.; Ohmori, Koji; Kohno, Masakazu; Nagai, Yukiko; Yamashita, Tetsuo; Kosaka, Hiroaki			Mifepristone Promotes Adiponectin Production and Improves Insulin Sensitivity in a Mouse Model of Diet-Induced-Obesity	PLOS ONE			English	Article							3T3-L1 ADIPOCYTES; LIPID-METABOLISM; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; RESISTANCE; EXPRESSION; INDUCTION; RU486; MICE; PIOGLITAZONE	The steroid receptor antagonist mifepristone is used as an anti-cancer agent, eliciting both cytostatic and cytotoxic effects on malignant cells. However, the metabolic effects of long-term treatment with mifepristone have remained unclear. The effects of mifepristone on insulin sensitivity and adiponectin secretion were evaluated both in in vivo and in vitro. First, we explored the effects of mifepristone, on metabolic functions in obese mice receiving a high-fat diet. When these mice were fed mifepristone, they exhibited a marked improvement in insulin sensitivity, attenuated hepatic injury, and decreased adipocyte size, compared with mice that received only the high-fat diet. Intriguingly, mifepristone-treated mice showed significantly elevated plasma adiponectin levels. Second, we tested the effects of mifepristone on differentiated 3T3-L1 adipocytes in vitro. When differentiated adipocytes were treated with mifepristone for 48 h, adiponectin was upregulated at both mRNA and protein levels. Collectively, these results reveal novel actions of mifepristone on metabolic functions, in vivo and in vitro, in which the drug exerts antidiabetic effects associated with an upregulation in adiponectin-secretion.	[Hashimoto, Takeshi; Igarashi, Junsuke; Yamashita, Tetsuo; Kosaka, Hiroaki] Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa, Japan; [Hasan, Arif U.; Ohmori, Koji; Kohno, Masakazu] Kagawa Univ, Dept Cardiorenal & Cerebrovasc Med, Kagawa, Japan; [Nagai, Yukiko] Kagawa Univ, Life Sci Res Ctr, Kagawa, Japan	Kagawa University; Kagawa University; Kagawa University	Hashimoto, T (corresponding author), Kagawa Univ, Fac Med, Dept Cardiovasc Physiol, Kagawa, Japan.	hasimoty@med.kagawa-u.ac.jp	Hasan, Arif Ul/J-1062-2019	Hasan, Arif Ul/0000-0002-6491-347X; Tetsuo, Yamashita/0000-0002-4076-991X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kagawa University Faculty of Medicine Specially Promoted Research Fund; Fund for Kagawa University Young Scientists	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. H., Kagawa, Japan). This work was also supported by grants from the Kagawa University Faculty of Medicine Specially Promoted Research Fund 2011 (to T. H., Kagawa, Japan), the Fund for Kagawa University Young Scientists 2012 (to T. H., Kagawa, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Cadepond F, 1997, ANNU REV MED, V48, P129; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FELDMAN D, 1976, J CLIN INVEST, V57, P1, DOI 10.1172/JCI108249; Gross C, 2010, OBESITY, V18, P2295, DOI 10.1038/oby.2010.51; Gross C, 2009, ADV THER, V26, P959, DOI 10.1007/s12325-009-0070-1; Hasan AU, 2011, BIOCHEM BIOPH RES CO, V411, P375, DOI 10.1016/j.bbrc.2011.06.152; Hashimoto T, 2009, J LIPID RES, V50, P602, DOI 10.1194/jlr.M800206-JLR200; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Hosoe T, 2005, J HEALTH SCI, V51, P75, DOI 10.1248/jhs.51.75; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; KUSUNOKI M, 1995, DIABETES, V44, P718, DOI 10.2337/diabetes.44.6.718; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; LAHTEENMAKI P, 1980, FERTIL STERIL, V34, P246; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Lin SC, 2012, CELL RES, V22, P746, DOI 10.1038/cr.2011.162; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Moriuchi A, 2007, BIOCHEM BIOPH RES CO, V356, P1024, DOI 10.1016/j.bbrc.2007.03.084; Musgrove EA, 1997, MOL ENDOCRINOL, V11, P54, DOI 10.1210/me.11.1.54; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Sacco M, 2002, J Endocrinol Invest, V25, P81; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharma AM, 2006, AM J MED, V119, p17S, DOI 10.1016/j.amjmed.2006.01.010; Taylor AI, 2009, HORM METAB RES, V41, P899, DOI 10.1055/s-0029-1234071; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Wang Y, 2011, DIABETOLOGIA, V54, P440, DOI 10.1007/s00125-010-1956-9; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang Baichun, 2008, BMC Pharmacology, V8, P7, DOI 10.1186/1471-2210-8-7	46	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79724	10.1371/journal.pone.0079724	http://dx.doi.org/10.1371/journal.pone.0079724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223187	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200080
J	Hughes, JA; Phillips, G; Reed, P				Hughes, J. Antony; Phillips, Gordon; Reed, Phil			Brief Exposure to a Self-Paced Computer-Based Reading Programme and How It Impacts Reading Ability and Behaviour Problems	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; LITERACY; INTERVENTION; CHILDHOOD; STRENGTHS; READERS; SKILLS	Basic literacy skills underlie much future adult functioning, and are targeted in children through a variety of means. Children with reading problems were exposed either to a self-paced computer programme that focused on improving phonetic ability, or underwent a classroom-based reading intervention. Exposure was limited to 3 40-min sessions a week, for six weeks. The children were assessed in terms of their reading, spelling, and mathematics abilities, as well as for their externalising and internalising behaviour problems, before the programme commenced, and immediately after the programme terminated. Relative to the control group, the computer-programme improved reading by about seven months in boys (but not in girls), but had no impact on either spelling or mathematics. Children on the programme also demonstrated fewer externalising and internalising behaviour problems than the control group. The results suggest that brief exposure to a self-paced phonetic computer-teaching programme had some benefits for the sample.	[Hughes, J. Antony; Reed, Phil] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Phillips, Gordon] Glen Care Ctr, London, England	Swansea University	Reed, P (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	p.reed@swansea.ac.uk	Reed, Phil/H-7999-2019	Reed, Phil/0000-0002-8157-0747	Glen Care Centre	Glen Care Centre	The Glen Care Centre is a commercial business, and this commercial funder provided the funding for the employment of J. Antony Hughes to collect these data. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BOSTOCK S, 2012, BMJ OPEN, V344, pe1602, DOI DOI 10.1136/BMJ.E1602; Brooks G, 2006, EDUC STUD-UK, V32, P133, DOI 10.1080/03055690500416116; Cowling H, 1998, TOE TOE MULTISENSORY; Daly EJ, 2005, J APPL BEHAV ANAL, V38, P485, DOI 10.1901/jaba.2005.113-04; Department for Education and Skills, 2006, NAT PRIM STRAT; Department for Education and Skills. Skills for Life Survey, 2003, SKILLS LIF SURV NAT; Dugdale G., 2008, LITERACY CHANGES LIV; Eisenberger R, 1996, AM PSYCHOL, V51, P1153, DOI 10.1037/0003-066X.51.11.1153; Elliot C. D., 1996, BRIT ABILITY SCALES; Flora SR, 1999, PSYCHOL REC, V49, P3, DOI 10.1007/BF03395303; Given BK, 2008, BRAIN LANG, V106, P83, DOI 10.1016/j.bandl.2007.12.001; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Harford DP, 1994, J LEARNING DISABILIT, V27, P647; Hatcher P, 2001, SOUND LINKAGE; Hatcher PJ, 2004, J CHILD PSYCHOL PSYC, V45, P338, DOI 10.1111/j.1469-7610.2004.00225.x; Holmes W, 2012, PROCEDIA SOCIAL BEHA; Huffstetter M, 2010, J EDUC STUDENTS PLAC, V15, P279, DOI 10.1080/10824669.2010.532415; Johnston RS, 2003, INSIGHT, V17; Kohn A., 1993, PUNISHED REWARDS; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Lingard A. W., 1996, SUPPORT LEARNING, V11, P25; Macdonald P, 2010, SUPPORT LEARN, V25, P15, DOI 10.1111/j.1467-9604.2009.01434.x; Malmberg M, 2003, NORD J PSYCHIAT, V57, P357, DOI 10.1080/08039480310002697; MANN VA, 1993, J LEARN DISABIL, V26, P259, DOI 10.1177/002221949302600406; Morgan P. L., 2000, J LEARNING DISABILIT, V41, P417; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; National Center for Education Statistics, FAST FACTS DIST LEAR; O'Connor RE, 2000, READ WRIT, V13, P159, DOI 10.1023/A:1008134818771; Pool, 2006, ALPHA OMEGA; Rose J, 2006, ROSE REPORT; Saine NL, 2010, LEARN INDIVID DIFFER, V20, P402, DOI 10.1016/j.lindif.2010.06.004; Sattler JM, 1998, ASSESSMENT CHILDREN; Sharpies J, 2011, EFFECTIVE CLASSROOM; Skinner BF, 1954, HARVARD EDUC REV, V24, P86; Snowling MJ, 2012, INT J LANG COMM DIS, V47, P27, DOI 10.1111/j.1460-6984.2011.00081.x; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; van Lier PAC, 2012, CHILD DEV, V83, P1775, DOI 10.1111/j.1467-8624.2012.01802.x; WAGNER RK, 1993, J EDUC PSYCHOL, V85, P83, DOI 10.1037/0022-0663.85.1.83; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wigfield A, 1997, J EDUC PSYCHOL, V89, P420, DOI 10.1037/0022-0663.89.3.420	41	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77867	10.1371/journal.pone.0077867	http://dx.doi.org/10.1371/journal.pone.0077867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223125	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200017
J	Li, SN; Yu, W; Lai, CTM; Wong, SJ; Cheung, YF				Li, Shu-na; Yu, Wei; Lai, Clare Tik-man; Wong, Sophia J.; Cheung, Yiu-fai			Left Ventricular Mechanics in Repaired Tetralogy of Fallot with and without Pulmonary Valve Replacement: Analysis by Three-Dimensional Speckle Tracking Echocardiography	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; WALL-MOTION ANALYSIS; SURGICAL REPAIR; MYOCARDIAL MECHANICS; TWIST MECHANICS; STRAIN; ADULTS; HEART; REGURGITATION; DYSSYNCHRONY	Background: Altered septal curvature and left ventricular (LV) geometry secondary to right ventricular (RV) dilation render two-dimensional assessment of LV mechanics difficult in repaired tetralogy of Fallot (TOF) patients. The novel three-dimensional (3D) speckle tracking echocardiography enables comprehensive evaluation of true 3D LV mechanics. Methods and Results: Seventy-six patients aged 23.6 +/- 8.3 years, 55 with isolated repair (group I) and 21 with subsequent pulmonary valve replacement (group II), and 34 healthy controls were studied. Three-dimensional volume datasets were acquired for assessment of LV global and regional 3D strain, systolic dyssynchrony index (SDI), twist, twist gradient (twist/LV length), and ejection fraction. A global performance index was calculated as (global 3D strain.twist gradient)/SDI. The septal curvature and LV eccentricity were determined from the mid-ventricular short-axis. Compared with controls, group I and II patients had significantly reduced LV global 3D strain, LV twist, twist gradient, septal curvature, and global performance index, and greater LV systolic and diastolic eccentricity and SDI (all p<0.05). All but the four apical LV segments in patients had reduced regional 3D strain compared with controls (all p<0.05). Septal curvature correlated with LV global 3D strain (r = 0.41, p<0.001), average septal strain (r = 0.38, p<0.001), twist (r = 0.32, p<0.001), twist gradient (r = 0.33, p<0.001), and global performance index (r = 0.43, p<0.001). Conclusions: Adverse 3D LV mechanics as characterized by impaired global and regional 3D systolic strain, mechanical dyssynchrony, and reduced twist is related to reduced septal curvature in repaired TOF patients with and without pulmonary valve replacement.	[Li, Shu-na; Yu, Wei; Lai, Clare Tik-man; Wong, Sophia J.; Cheung, Yiu-fai] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992	Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China [HKU 763710M]	Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China	The study was funded by Research Grants Council General Research Fund of the Hong Kong Special Administrative Region, China (Project no. HKU 763710M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman MY, 2005, J AM COLL CARDIOL, V45, P915, DOI 10.1016/j.jacc.2004.11.049; Ashraf M, 2010, JACC-CARDIOVASC IMAG, V3, P227, DOI 10.1016/j.jcmg.2009.09.027; Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chalard A, 2012, AM J CARDIOL, V110, P1828, DOI 10.1016/j.amjcard.2012.08.017; Cheung EWY, 2009, AM J CARDIOL, V104, P1264, DOI 10.1016/j.amjcard.2009.06.043; Cheung EWY, 2010, AM J CARDIOL, V106, P552, DOI 10.1016/j.amjcard.2010.03.065; Cheung YF, 2012, NAT REV CARDIOL, V9, P644, DOI 10.1038/nrcardio.2012.128; Cheung YF, 2011, CIRC J, V75, P1735, DOI 10.1253/circj.CJ-10-1253; Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4; DELORGERIL M, 1984, BRIT HEART J, V52, P536; Diller GP, 2012, CIRCULATION, V125, P2440, DOI 10.1161/CIRCULATIONAHA.111.086983; Fernandes FP, 2012, J AM SOC ECHOCARDIOG, V25, P494, DOI 10.1016/j.echo.2012.01.014; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Hayabuchi Y, 2011, J AM SOC ECHOCARDIOG, V24, P1205, DOI 10.1016/j.echo.2011.06.016; Henson RE, 2000, AM J PHYSIOL-HEART C, V278, pH1117, DOI 10.1152/ajpheart.2000.278.4.H1117; Hristov N, 2006, EUR J CARDIO-THORAC, V29, pS115, DOI 10.1016/j.ejcts.2006.02.041; Kim HK, 2006, AM J CARDIOL, V98, P236, DOI 10.1016/j.amjcard.2006.01.082; Li SN, 2011, J AM SOC ECHOCARDIOG, V24, P819, DOI 10.1016/j.echo.2011.03.020; Li W, 2004, AM HEART J, V147, P165, DOI 10.1016/S0002-8703(03)00527-1; Liang XC, 2008, AM J CARDIOL, V102, P1731, DOI 10.1016/j.amjcard.2008.07.062; Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056; Moiduddin N, 2012, CONGENIT HEART DIS, V7, P361, DOI 10.1111/j.1747-0803.2012.00680.x; Moses DA, 2004, MAGN RESON MED, V52, P154, DOI 10.1002/mrm.20105; Muzzarelli S, 2011, RADIOLOGY, V259, P375, DOI 10.1148/radiol.10100895; Nakasato M, 1997, INT J CARDIOL, V58, P127, DOI 10.1016/S0167-5273(96)02868-9; Niezen RA, 1999, HEART, V82, P697, DOI 10.1136/hrt.82.6.697; de Isla LP, 2009, J AM SOC ECHOCARDIOG, V22, P325, DOI 10.1016/j.echo.2009.01.001; Raedle-Hurst TM, 2009, AM HEART J, V157, P791, DOI 10.1016/j.ahj.2008.12.015; Roeleveld RJ, 2005, RADIOLOGY, V234, P710, DOI 10.1148/radiol.2343040151; Santamore WP, 1998, PROG CARDIOVASC DIS, V40, P289, DOI 10.1016/S0033-0620(98)80049-2; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Takayasu H, 2011, ECHOCARDIOGR-J CARD, V28, P720, DOI 10.1111/j.1540-8175.2011.01417.x; Tanaka H, 2010, AM J CARDIOL, V105, P235, DOI 10.1016/j.amjcard.2009.09.010; Thebault C, 2011, EUR J ECHOCARDIOGR, V12, P26, DOI 10.1093/ejechocard/jeq095; Tobler D, 2012, INT J CARDIOL, V160, P165, DOI 10.1016/j.ijcard.2011.04.007; Tzemos N, 2009, AM J CARDIOL, V103, P420, DOI 10.1016/j.amjcard.2008.09.101; van der Hulst AE, 2010, AM J CARDIOL, V106, P723, DOI 10.1016/j.amjcard.2010.04.032; Weidemann F, 2002, AM J CARDIOL, V90, P133, DOI 10.1016/S0002-9149(02)02435-9	44	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78826	10.1371/journal.pone.0078826	http://dx.doi.org/10.1371/journal.pone.0078826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223166	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200058
J	Lin, YC; Lu, MC; Lin, CJ; Chiang, MK; Jan, MS; Tang, HL; Liu, HC; Lin, WL; Huang, CY; Chen, CM; Lai, YC				Lin, Yi-Chun; Lu, Min-Chi; Lin, Chingju; Chiang, Ming-Ko; Jan, Ming-Shiou; Tang, Hui-Ling; Liu, Hsu-Chung; Lin, Wea-Lung; Huang, Chih-Yang; Chen, Chuan-Mu; Lai, Yi-Chyi			Activation of IFN-gamma/STAT/IRF-1 in Hepatic Responses to Klebsiella pneumoniae Infection	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GAMMA-INDUCED APOPTOSIS; IFN-GAMMA; LIVER-ABSCESS; INTERFERON-GAMMA; INJURY; GENES; K1; SUPPRESSION; VIRULENCE	Background: Klebsiella pneumoniae-caused liver abscess (KLA) has become a health problem in Taiwan and is continually reported in other countries. Diabetes mellitus, the most common metabolic disorder, underlies half of the KLA patients in Taiwan. The clinical impact of KLA has been well-documented. Nevertheless, the molecular basis regarding how K. pneumoniae causes liver infection, particularly in diabetic individuals, remains unclear. Methodology/Principle Findings: Auto-bioluminescence-expressing K. pneumoniae was inoculated into diabetic mice and age-match naive control. With the use of in vivo imaging system, translocation of the bioluminescence-expressing K. pneumoniae from intestine to extraintestinal organs, mainly the liver, was noted in 80% of the diabetic mice, whereas the same bacteria causes extraintestinal infections in only 31% of naive mice. Besides increased morbidity, the severity of hepatic tissue injury was also enhanced in the K. pneumoniae-infected diabetic mice. Upon K. pneumoniae infection, IFN-gamma production was significantly evoked in the liver. To mediate IFN-gamma signal, STAT (signal transducers and activators of transcription) 1 and 3 were activated in hepatocytes, and so was the expression of IRF (interferon regulatory factor)-1. Moreover, accumulation of neutrophils which was triggered by prolonged production of IL-1 beta and MIP-2, and significant increases in the level of active caspase 3 and phospho-eIF2 alpha, were exclusively revealed in the K. pneumoniae-infected diabetic mice. Conclusion: The activation of IFN-gamma/STAT/IRF-1 signaling demonstrated by this work emphasizes the role of IFN-gamma for mediating the hepatic response to K. pneumoniae infection.	[Lin, Yi-Chun; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan; [Lu, Min-Chi; Jan, Ming-Shiou; Lai, Yi-Chyi] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Lin, Chingju] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan; [Chiang, Ming-Ko] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Tang, Hui-Ling] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Tang, Hui-Ling] China Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taichung, Taiwan; [Liu, Hsu-Chung; Lin, Wea-Lung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Liu, Hsu-Chung] Chung Shan Med Univ Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Lin, Wea-Lung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; National Chung Cheng University; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Lu, MC (corresponding author), Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan.	luminchi@csmu.edu.tw; chchen1@dragon.nchu.edu.tw; yclai@csmu.edu.tw	Yuang, Chih-Yang/O-5111-2015; Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; LAI, YICHYI/0000-0003-2396-1827	National Science Council of Taiwan [NSC 101-2320-B-040-013-, NSC 101-2314-B -040-009-]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan, NSC 101-2320-B-040-013- to Yi-Chyi Lai, and NSC 101-2314-B -040-009- to Min-Chi Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebien M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002812; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; DECHAMPS C, 1989, J CLIN MICROBIOL, V27, P2887, DOI 10.1128/JCM.27.12.2887-2890.1989; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; EASTGATE JA, 1995, J BACTERIOL, V177, P932, DOI 10.1128/jb.177.4.932-937.1995; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fung CP, 2012, EMERG INFECT DIS, V18, P1322, DOI 10.3201/eid1808.111053; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; HEWETT JA, 1992, LAB INVEST, V66, P347; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Kanki K, 2009, APOPTOSIS, V14, P309, DOI 10.1007/s10495-009-0318-x; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Karama Edison Mutsinzi, 2008, International Ophthalmology, V28, P111, DOI 10.1007/s10792-007-9111-4; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Korrapati MC, 2012, J PHARMACOL EXP THER, V343, P34, DOI 10.1124/jpet.112.196964; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lin YC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-50; Liu CY, 2003, J CELL SCI, V116, P1861, DOI 10.1242/jcs.00408; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; Moore TA, 2002, INFECT IMMUN, V70, P6310, DOI 10.1128/IAI.70.11.6310-6318.2002; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; POZZILLI P, 1994, DIABETIC MED, V11, P935, DOI 10.1111/j.1464-5491.1994.tb00250.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Shen KZ, 2008, AM J PHYSIOL-GASTR L, V294, pG1070, DOI 10.1152/ajpgi.00554.2007; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Sunahara KKS, 2012, J LEUKOCYTE BIOL, V91, P871, DOI 10.1189/jlb.0911488; Tagawa Y, 1997, J IMMUNOL, V159, P1418; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; Vadrot N, 2006, J INTERF CYTOK RES, V26, P901, DOI 10.1089/jir.2006.26.901; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; WETZSTEIN M, 1990, FEMS MICROBIOL LETT, V72, P55, DOI 10.1111/j.1574-6968.1990.tb03861.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Yang CS, 2007, OPHTHALMOLOGY, V114, P876, DOI 10.1016/j.ophtha.2006.12.035; Yeh CC, 2007, J BIOMED SCI, V14, P183, DOI 10.1007/s11373-006-9139-x	52	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79961	10.1371/journal.pone.0079961	http://dx.doi.org/10.1371/journal.pone.0079961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223208	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200101
J	Meehan, TD; Gratton, C; Diehl, E; Hunt, ND; Mooney, DF; Ventura, SJ; Barham, BL; Jackson, RD				Meehan, Timothy D.; Gratton, Claudio; Diehl, Erica; Hunt, Natalie D.; Mooney, Daniel F.; Ventura, Stephen J.; Barham, Bradford L.; Jackson, Randall D.			Ecosystem-Service Tradeoffs Associated with Switching from Annual to Perennial Energy Crops in Riparian Zones of the US Midwest	PLOS ONE			English	Article							LAND-USE; AGRICULTURE; BIODIVERSITY; LANDSCAPE; BIOENERGY; ETHANOL; CARBON	Integration of energy crops into agricultural landscapes could promote sustainability if they are placed in ways that foster multiple ecosystem services and mitigate ecosystem disservices from existing crops. We conducted a modeling study to investigate how replacing annual energy crops with perennial energy crops along Wisconsin waterways could affect a variety of provisioning and regulating ecosystem services. We found that a switch from continuous corn production to perennial-grass production decreased annual income provisioning by 75%, although it increased annual energy provisioning by 33%, decreased annual phosphorous loading to surface water by 29%, increased below-ground carbon sequestration by 30%, decreased annual nitrous oxide emissions by 84%, increased an index of pollinator abundance by an average of 11%, and increased an index of biocontrol potential by an average of 6%. We expressed the tradeoffs between income provisioning and other ecosystem services as benefit-cost ratios. Benefit-cost ratios averaged 12.06 GJ of additional net energy, 0.84 kg of avoided phosphorus pollution, 18.97 Mg of sequestered carbon, and 1.99 kg of avoided nitrous oxide emissions for every $ 1,000 reduction in income. These ratios varied spatially, from 2- to 70-fold depending on the ecosystem service. Benefit-cost ratios for different ecosystem services were generally correlated within watersheds, suggesting the presence of hotspots - watersheds where increases in multiple ecosystem services would come at lower-than-average opportunity costs. When assessing the monetary value of ecosystem services relative to existing conservation programs and environmental markets, the overall value of enhanced services associated with adoption of perennial energy crops was far lower than the opportunity cost. However, when we monitized services using estimates for the social costs of pollution, the value of enhanced services far exceeded the opportunity cost. This disparity between recoverable costs and social value represents a fundamental challenge to expansion of perennial energy crops and sustainable agricultural landscapes.	[Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Hunt, Natalie D.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Mooney, Daniel F.; Barham, Bradford L.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Ventura, Stephen J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Meehan, Timothy D.; Gratton, Claudio; Barham, Bradford L.; Jackson, Randall D.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Diehl, Erica] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Meehan, TD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	tmeehan@wisc.edu	Mooney, Daniel/AAC-5566-2022; Mooney, Daniel F/E-6264-2011; Jackson, Randall/AAE-5573-2022	Gratton, Claudio/0000-0001-6262-9670; Hunt, Natalie/0000-0002-0782-0488	Sun Grant Initiative (DOE EERE) [3TC162]; Hatch Act Formula Fund [WISO1503]; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2011-67009-3002, 2012-67009-19715]	Sun Grant Initiative (DOE EERE)(United States Department of Energy (DOE)); Hatch Act Formula Fund; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture	This project was funded in part by the Sun Grant Initiative (DOE EERE Subaward 3TC162), the Hatch Act Formula Fund (WISO1503), the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494), the DOE OBP Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830), and the Agriculture and Food Research Initiative (Competitive Grants 2011-67009-3002 and 2012-67009-19715) of the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB BIOGEOCHEM CYCL; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; CHAVAS JP, 1993, J AGR RESOUR ECON, V18, P1; Costello C, 2009, ENVIRON SCI TECHNOL, V43, P7985, DOI 10.1021/es9011433; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; GANTZER CJ, 1990, J SOIL WATER CONSERV, V45, P641; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Horowitz J., 2010, EC INFORM B, V70; IWGSCC, 2013, ECHN UPD SOC COST CA; Jackson-Smith D, 2000, RES RUR SOC, V8, P115, DOI 10.1016/S1057-1922(00)80008-6; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Johnson KA, 2012, ECOL ECON, V79, P71, DOI 10.1016/j.ecolecon.2012.04.020; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Lathrop RC, 1998, CAN J FISH AQUAT SCI, V55, P1169, DOI 10.1139/cjfas-55-5-1169; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Ma Z, 2001, BIOMASS BIOENERG, V20, P413, DOI 10.1016/S0961-9534(01)00008-3; Meehan TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041728; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; NAS, 2009, LIQ TRANSP FUELS COA; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; NRCS Soil survey staff natural resources conservation service United States department of agriculture, 2010, SOIL SURVEY PAGE COU; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Prince SD, 2001, ECOL APPL, V11, P1194, DOI 10.1890/1051-0761(2001)011[1194:NPPOUS]2.0.CO;2; PRISM Climate Group, 2012, US PREC NORM 1981 20; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reckhow KH, 1980, ODELING PHOSPHORUS L; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Seely R, 2012, DANE COUNTY ANNOUNCE; Sissine F, 2007, ENERGY INDEPENDENCE; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Soranno PA, 1996, ECOL APPL, V6, P865, DOI 10.2307/2269490; Swinton SM, 2007, ECOL ECON, V64, P245, DOI 10.1016/j.ecolecon.2007.09.020; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; U.S. DOE, 2011, US BILLION TON UPDAT; Un FAO, 2012, GLOB MAP MONTHL REF; USDA ERS, 2011, FEED GRAINS DAT YB T; USDA ERS, 2012, SDA AGR PROJ 2021; USDA ERS, 2012, COMM COSTS RET WISC; USDA NASS, 2007, QUICKSTATS QUER TOOL; USDA NASS, 2007, ENS AGR; USDA NASS, 2007, CROPL DAT LAYER; UW CDP, 2012, AGR FIN ADV DAT; WDNR, 2012, HYDR GEOD; WDNR, 2012, PHOSPH RED WISC WAT; West TO, 2008, SOIL SCI SOC AM J, V72, P285, DOI 10.2136/sssaj2007.0113; Wisconsin DNR, 2013, OLL LOAD RAT EST TOO; Wolf Amy T., 2008, Great Lakes Entomologist, V41, P129; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	68	70	80	5	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80093	10.1371/journal.pone.0080093	http://dx.doi.org/10.1371/journal.pone.0080093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223215	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200108
J	Ohyama, Y; Imai, M; Kurabayashi, M				Ohyama, Yoshiaki; Imai, Masahiko; Kurabayashi, Masahiko			Estimated Glomerular Filtration Rate and Proteinuria Are Separately and Independently Associated with the Prevalence of Atrial Fibrillation in General Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK; EQUATION; HEART	Background: Both, proteinuria and a decline in glomerular filtration rate (GFR) are associated with greater cardiovascular mortality. However, few studies have explored that proteinuria and lower GFR are related with prevalent atrial fibrillation (AF). Methods: This cross-sectional study was based on annual health check-up program of community-based population in Gunma, Japan from April 2011 to March 2012. A total of 20,019 adult participants were included. AF was ascertained by a standard 12-lead electrocardiogram. Cross-sectional association and correlates with prevalent AF were examined using multivariable logistic regression analysis. Results: The overall prevalence of AF was 0.6% (2.2 % in participants with eGFR < 60 mL. min(-1). 1.73m(-2), 0.4% and 0.2% in those with eGFR 60 to 89 and >= 90 mL.min(-1).1.73m(-2), p for trend < 0.001). The multivariable odds ratio (OR) for AF was 2.86 (95 % CI 1.16-7.08, p<0.001) for eGFR<60 mL. min(-1). 1.73m-2 versus eGFR. 90 mL. min-1. 1.73m-2. This association remained significant with further adjustment for proteinuria. In addition, proteinuria was also strongly associated with increased prevalence of AF (OR 2.96, 95 % CI 1.55-5.68, p<0.001), an association that remained significant after adjustment for eGFR. Conclusions: Proteinuria and lower eGFR are separately and significantly associated with prevalence of AF independent of well-established risk factors for AF in general population.	[Ohyama, Yoshiaki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan; [Ohyama, Yoshiaki] Gunma Univ Hosp, Clin Investigat & Res Unit, Maebashi, Gunma, Japan; [Imai, Masahiko] Gunma Chuo Gen Hosp, Dept Cardiol, Maebashi, Gunma, Japan	Gunma University; Gunma University	Ohyama, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 371, Japan.	yoshiaki-ohyama@gunma-u.ac.jp			Grants-in-Aid for Scientific Research [23590661] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Fabbian F, 2000, CLIN NEPHROL, V54, P234; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McManus DD, 2009, AM J CARDIOL, V104, P1551, DOI 10.1016/j.amjcard.2009.07.026; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Takahashi Y, 2011, CIRCULATION, V124, P2380, DOI 10.1161/CIRCULATIONAHA.111.047266; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471	19	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79717	10.1371/journal.pone.0079717	http://dx.doi.org/10.1371/journal.pone.0079717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223186	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200079
J	Papolu, PK; Gantasala, NP; Kamaraju, D; Banakar, P; Sreevathsa, R; Rao, U				Papolu, Pradeep Kumar; Gantasala, Nagavara Prasad; Kamaraju, Divya; Banakar, Prakash; Sreevathsa, Rohini; Rao, Uma			Utility of Host Delivered RNAi of Two FMRF Amide Like Peptides, flp-14 and flp-18, for the Management of Root Knot Nematode, Meloidogyne incognita	PLOS ONE			English	Article							FMRFAMIDE-RELATED PEPTIDES; PHARYNGEAL GLAND-CELL; DOUBLE-STRANDED-RNA; HETERODERA-GLYCINES; CAENORHABDITIS-ELEGANS; ASCARIS-SUUM; GENE-EXPRESSION; NERVOUS-SYSTEM; NEUROPEPTIDES; INTERFERENCE	Root knot nematode, Meloidogyne incognita, is an obligate sedentary endoparasite that infects a large number of crop species and causes substantial yield losses. Non-chemical based control strategies for these nematodes are gaining importance. In the present study, we have demonstrated the significance of two FMRFamide like peptide genes (flp-14 and flp-18) for infection and development of resistance to M. incognita through host-derived RNAi. The study demonstrated both in vitro and in planta validation of RNAi-induced silencing of the two genes cloned from J2 stage of M. incognita. In vitro silencing of both the genes interfered with nematode migration towards the host roots and subsequent invasion into the roots. Transgenic tobacco lines were developed with RNAi constructs of flp-14 and flp-18 and evaluated against M. incognita. The transformed plants did not show any visible phenotypic variations suggesting the absence of any off-target effects. Bioefficacy studies with deliberate challenging of M. incognita resulted in 50-80% reduction in infection and multiplication confirming the silencing effect. We have provided evidence for in vitro and in planta silencing of the genes by expression analysis using qRT-PCR. Thus the identified genes and the strategy can be used as a potential tool for the control of M. incognita. This is the first ever report that has revealed the utility of host delivered RNAi of flps to control M. incognita. The strategy can also be extended to other crops and nematodes.	[Papolu, Pradeep Kumar; Gantasala, Nagavara Prasad; Kamaraju, Divya; Banakar, Prakash; Rao, Uma] Indian Agr Res Inst, Div Nematol, New Delhi 110012, India; [Sreevathsa, Rohini] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB)	Rao, U (corresponding author), Indian Agr Res Inst, Div Nematol, New Delhi 110012, India.	umarao@iari.res.in	banakar, prakash/Q-1204-2019	Sreevathsa, Rohini/0000-0003-4171-6956	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; Bakhetia M, 2008, INT J PARASITOL, V38, P1589, DOI 10.1016/j.ijpara.2008.05.003; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Brownlee DJA, 1996, PARASITOL TODAY, V12, P343, DOI 10.1016/0169-4758(96)10052-1; BYBD DW, 1983, J NEMATOL, V15, P142; Chen PC, 2003, NEMATOLOGY, V5, P687, DOI 10.1163/156854103322746869; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Dalzell JJ, 2009, INT J PARASITOL, V39, P1503, DOI 10.1016/j.ijpara.2009.05.006; Day TA, 1999, PEPTIDES, V20, P999, DOI 10.1016/S0196-9781(99)00093-5; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; Fellowes RA, 1998, PARASITOLOGY, V116, P277, DOI 10.1017/S0031182097002229; Fellowes RA, 2000, PARASITOLOGY, V121, P325, DOI 10.1017/S0031182099006290; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Geary TG, 1999, ANN NY ACAD SCI, V897, P212, DOI 10.1111/j.1749-6632.1999.tb07893.x; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Johnston MJG, 2010, J HELMINTHOL, V84, P253, DOI 10.1017/S0022149X09990630; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Kimber MJ, 2001, MOL BIOCHEM PARASIT, V116, P199, DOI 10.1016/S0166-6851(01)00323-1; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Lilley CJ, 2005, INT J PARASITOL, V35, P1577, DOI 10.1016/j.ijpara.2005.07.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maule Aaron G., 2002, Current Topics in Medicinal Chemistry, V2, P733, DOI 10.2174/1568026023393697; McVeigh P, 2006, TRENDS PARASITOL, V22, P385, DOI 10.1016/j.pt.2006.06.010; Moffett CL, 2003, INT J PARASITOL, V33, P859, DOI 10.1016/S0020-7519(03)00109-7; Mousley A, 2005, INT J PARASITOL, V35, P1557, DOI 10.1016/j.ijpara.2005.08.002; Niu JH, 2012, EUR J PLANT PATHOL, V134, P131, DOI 10.1007/s10658-012-9971-y; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; SASSER JN, 1980, PLANT DIS, V64, P36, DOI 10.1094/PD-64-36; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xue BY, 2013, PHYTOPATHOLOGY, V103, P175, DOI 10.1094/PHYTO-07-12-0173-R; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013	55	67	68	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80603	10.1371/journal.pone.0080603	http://dx.doi.org/10.1371/journal.pone.0080603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223228	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200121
J	Schueler, J; Wider, D; Klingner, K; Siegers, GM; May, AM; Wasch, R; Fiebig, HH; Engelhardt, M				Schueler, Julia; Wider, Dagmar; Klingner, Kerstin; Siegers, Gabrielle M.; May, Annette M.; Waesch, Ralph; Fiebig, Heinz-Herbert; Engelhardt, Monika			Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2R gamma(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; MODEL; TUMOR; ENGRAFTMENT; LEUKEMIA; THERAPY; GROWTH	Background: We systematically analyzed multiple myeloma (MM) cell lines and patient bone marrow cells for their engraftment capacity in immunodeficient mice and validated the response of the resulting xenografts to antimyeloma agents. Design and Methods: Using flow cytometry and near infrared fluorescence in-vivo-imaging, growth kinetics of MM cell lines L363 and RPMI8226 and patient bone marrow cells were investigated with use of a murine subcutaneous bone implant, intratibial and intravenous approach in NOD/SCID, NOD/SCID treated with CD122 antibody and NOD/SCID IL-2R gamma(null) mice (NSG). Results: Myeloma growth was significantly increased in the absence of natural killer cell activity (NSG or alpha CD122-treated NOD/SCID). Comparison of NSG and alpha CD122-treated NOD/SCID revealed enhanced growth kinetics in the former, especially with respect to metastatic tumor sites which were exclusively observed therein. In NSG, MM cells were more tumorigenic when injected intratibially than intravenously. In NOD/SCID in contrast, the use of juvenile long bone implants was superior to intratibial or intravenous cancer cell injection. Using the intratibial NSG model, mice developed typical disease symptoms exclusively when implanted with human MM cell lines or patient-derived bone marrow cells, but not with healthy bone marrow cells nor in mock-injected animals. Bortezomib and dexamethasone delayed myeloma progression in L363- as well as patient-derived MM cell bearing NSG. Antitumor activity could be quantified via flow cytometry and in vivo imaging analyses. Conclusions: Our results suggest that the intratibial NSG MM model mimics the clinical situation of the disseminated disease and serves as a valuable tool in the development of novel anticancer strategies.	[Schueler, Julia; Wider, Dagmar; Waesch, Ralph; Engelhardt, Monika] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Schueler, Julia; Klingner, Kerstin; Fiebig, Heinz-Herbert] Oncotest, Dept Invivo Tumorbiol, Freiburg, Germany; [Siegers, Gabrielle M.] Univ Western Ontario, Schulich Sch Med, Dept Anat & Cell Biol, London, ON, Canada; [May, Annette M.] Univ Freiburg, Med Ctr, Dept Pathol, Freiburg, Germany	University of Freiburg; Oncotest GmbH; Western University (University of Western Ontario); University of Freiburg	Engelhardt, M (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.	monika.engelhardt@uniklinik-freiburg.de	Waesch, Ralph/F-6282-2019; Siegers, Gabrielle M/M-2042-2017	Siegers, Gabrielle M/0000-0003-2154-0279	Biothera Stiftung [1/2009]	Biothera Stiftung	This study was funded by the "Biothera Stiftung (http://www.cancer.de/main.htm); 1/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012487; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Castano AP, 2006, BRIT J CANCER, V94, P391, DOI 10.1038/sj.bjc.6602953; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P2006, DOI 10.3109/10428194.2010.516378; Froyland M, 2011, EUR J HAEMATOL, V86, P385, DOI 10.1111/j.1600-0609.2011.01590.x; Fryer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057641; Gado K, 2001, HAEMATOLOGICA, V86, P227; Garg TK, 2012, HAEMATOL-HEMATOL J, V97, P1348, DOI 10.3324/haematol.2011.056747; Ghosh N, 2009, CANCER LETT, V277, P1, DOI 10.1016/j.canlet.2008.08.005; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Kleber M, 2012, LEUKEMIA LYMPHOMA, V53, P1057, DOI 10.3109/10428194.2011.644548; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Medioni J, 2012, CONTEMP CLIN TRIALS, V33, P178, DOI 10.1016/j.cct.2011.09.010; Meyer LH, 2011, CANCER RES, V71, P7141, DOI 10.1158/0008-5472.CAN-11-1732; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Pesnel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030690; Riedel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052398; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Schuler J, 2013, EXPERT OPIN BIOL TH, V13, pS111, DOI 10.1517/14712598.2013.799131; Swift BE, 2012, HAEMATOL-HEMATOL J, V97, P1020, DOI 10.3324/haematol.2011.054254; Udi J, 2013, BRIT J HAEMATOL, V161, P104, DOI 10.1111/bjh.12226; van Rhee F, 2009, MOL CANCER THER, V8, P2616, DOI 10.1158/1535-7163.MCT-09-0483; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zlei M, 2007, EXP HEMATOL, V35, P1550, DOI 10.1016/j.exphem.2007.06.016	29	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79939	10.1371/journal.pone.0079939	http://dx.doi.org/10.1371/journal.pone.0079939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223204	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200097
J	Allareddy, V; Allareddy, V; Nalliah, RP; Rampa, S; Lee, MK				Allareddy, Veerajalandhar; Allareddy, Veerasathpurush; Nalliah, Romesh P.; Rampa, Sankeerth; Lee, Min Kyeong			Infection Related Never Events in Pediatric Patients Undergoing Spinal Fusion Procedures in United States: Prevalence and Predictors	PLOS ONE			English	Article							SURGICAL-SITE INFECTION; RISK-FACTORS; DEPRESSION; SCOLIOSIS; OUTCOMES; SURGERY; STRESS	Objective: To examine the prevalence and predictors of infection related never events (NE) associated with spinal fusion procedures (SFP) in children (age < = 18 years) in the United States. Methods: We performed a retrospective analysis of the Nationwide Inpatient Sample for the years 2004 to 2008. All pediatric hospitalizations that underwent SFP were selected for analysis. The main outcomes measures include occurrence of certain NE's. The association between the occurrence of a NE and factors (patient & hospital related) were examined using multivariable logistic regression analysis. Results: Of 56,465 hospitalizations, 61.7% occurred among females. The average age was 13.7 y and two-thirds were whites. The major insurance payer was private insurance (67.4%). About 82% of all hospitalizations occurred on an elective basis. Teaching hospitals accounted for a majority of hospitalizations (87.9%). Two-thirds were posterior fusion techniques, 52.3% had underlying musculoskeletal deformities, and the most frequently present co-morbid conditions (CMC) included paralysis (10.9%), chronic pulmonary disease (9.7%), and fluid/electrolyte disorders (7.6%). Overall rate of occurrence of a NE was 4.8%. Post-operative pneumonia was the most frequently occurring NE (2.9%). Female gender (OR = 0.78) and elective admissions (OR = 0.66) were associated with lower risk of NE occurrence. Medicaid coverage (OR = 1.46), primary diagnosis of other acquired deformities (OR = 1.82), spinal cord injury (OR = 6.94), other nervous system disorders (OR = 2.84) were associated with higher risk of NE occurrence. Among CMC, those with chronic blood loss anemia (OR = 2.57), coagulopathy (OR = 1.97), depression (OR = 2), drug abuse (OR = 3.71), fluid/electrolyte disorders (OR = 2.62), neurological disorders (OR = 1.72), paralysis (OR = 1.75), renal failure (OR = 5.45), and weight loss (OR = 4.61) were risk factors for higher odds of a NE occurrence. Hospital teaching status, region, hospital size, and patient race did not influence the occurrence of NE. Conclusion: The never events examined in the current study occurred in 4.8% of children hospitalized with SFP. Certain predictors of NE are identified in this study.	[Allareddy, Veerajalandhar] Case Western Reserve Univ, Dept Pediat Crit Care, Cleveland, OH 44106 USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA; [Nalliah, Romesh P.; Lee, Min Kyeong] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Rampa, Sankeerth] Texas A&M Univ, College Stn, TX USA	Case Western Reserve University; University of Iowa; Harvard University; Harvard School of Dental Medicine; Texas A&M University System; Texas A&M University College Station	Allareddy, V (corresponding author), Case Western Reserve Univ, Dept Pediat Crit Care, Cleveland, OH 44106 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656				Agency for Healthcare Research and Quality, HEALTHC COST UT PROJ; Aleissa S, 2011, CAN J SURG, V54, P263, DOI 10.1503/cjs.008210; Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P31, DOI 10.1086/502112; Bhamidipati CM, 2011, SURGERY, V150, P626, DOI 10.1016/j.surg.2011.07.056; Business Wire, 2008, REUTERS; Canturk Z, 2003, OBES RES, V11, P769, DOI 10.1038/oby.2003.107; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Centers for Medicare & Medicaid Services, 2008, CMS IMPR PAT SAF MED; CHOBAN PS, 1995, AM SURGEON, V61, P1001; Engel AM, 2009, ANN THORAC SURG, V88, P1793, DOI 10.1016/j.athoracsur.2009.07.077; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Fry DE, 2007, ANN SURG, V246, P875, DOI 10.1097/SLA.0b013e3180cc2e7a; Fry DE, 2010, ARCH SURG-CHICAGO, V145, P148, DOI 10.1001/archsurg.2009.277; Jain A, 2012, SPINE, V37, P1683, DOI 10.1097/BRS.0b013e318254168f; Labbe AC, 2003, INFECT CONT HOSP EP, V24, P591, DOI 10.1086/502259; Linam WM, 2009, INFECT CONT HOSP EP, V30, P109, DOI 10.1086/593952; Marawar S, 2010, SPINE, V35, P1454, DOI 10.1097/BRS.0b013e3181bef3cb; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb; Reiche EMV, 2006, INT REV PSYCHIATR, V17, P515, DOI 10.1080/02646830500382102; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Smith S., 2008, BOSTON GLOBE; Tsirikos AI, 2008, SPINE, V33, P1133, DOI 10.1097/BRS.0b013e31816f63cf; Veeravagu A, 2009, SPINE, V34, P1869, DOI 10.1097/BRS.0b013e3181adc989; Zeidman SM, 1997, J SPINAL DISORD, V10, P523	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77540	10.1371/journal.pone.0077540	http://dx.doi.org/10.1371/journal.pone.0077540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223715	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400008
J	Lee, EJ; Kamli, MR; Pokharel, S; Malik, A; Tareq, KMA; Bhat, AR; Park, HB; Lee, YS; Kim, SH; Yang, B; Chung, KY; Choi, I				Lee, Eun Ju; Kamli, Majid Rasool; Pokharel, Smritee; Malik, Adeel; Tareq, K. M. A.; Bhat, Abdul Roouf; Park, Hee-Bok; Lee, Yong Seok; Kim, SangHoon; Yang, Bohsuk; Chung, Ki Young; Choi, Inho			Expressed Sequence Tags for Bovine Muscle Satellite Cells, Myotube Formed-Cells and Adipocyte-Like Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; NITRIC-OXIDE; BINDING PROTEIN; DIFFERENTIATION; GROWTH; TRANSDIFFERENTIATION; FAMILY; PROFILES; S100A4; THROMBOSPONDIN-1	Background: Muscle satellite cells (MSCs) represent a devoted stem cell population that is responsible for postnatal muscle growth and skeletal muscle regeneration. An important characteristic of MSCs is that they encompass multi potential mesenchymal stem cell activity and are able to differentiate into myocytes and adipocytes. To achieve a global view of the genes differentially expressed in MSCs, myotube formed-cells (MFCs) and adipocyte-like cells (ALCs), we performed large-scale EST sequencing of normalized cDNA libraries developed from bovine MSCs. Results: A total of 24,192 clones were assembled into 3,333 clusters, 5,517 singletons and 3,842contigs. Functional annotation of these unigenes revealed that a large portion of the differentially expressed genes are involved in cellular and signaling processes. Database for Annotation, Visualization and Integrated Discovery (DAVID) functional analysis of three subsets of highly expressed gene lists (MSC233, MFC258, and ALC248) highlighted some common and unique biological processes among MSC, MFC and ALC. Additionally, genes that may be specific to MSC, MFC and ALC are reported here, and the role of dimethylarginine dimethylaminohydrolase2 (DDAH2) during myogenesis and hemoglobin subunit alpha2 (HBA2) during transdifferentiation in C2C12 were assayed as a case study. DDAH2 was up-regulated during myognesis and knockdown of DDAH2 by siRNA significantly decreased myogenin (MYOG) expression corresponding with the slight change in cell morphology. In contrast, HBA2 was up-regulated during ALC formation and resulted in decreased intracellular lipid accumulation and CD36 mRNA expression upon knockdown assay. Conclusion: In this study, a large number of EST sequences were generated from the MSC, MFC and ALC. Overall, the collection of ESTs generated in this study provides a starting point for the identification of novel genes involved in MFC and ALC formation, which in turn offers a fundamental resource to enable better understanding of the mechanism of muscle differentiation and transdifferentiation.	[Lee, Eun Ju; Kamli, Majid Rasool; Pokharel, Smritee; Malik, Adeel; Tareq, K. M. A.; Bhat, Abdul Roouf; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Lee, Eun Ju; Lee, Yong Seok; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea; [Park, Hee-Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea; [Kim, SangHoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Yang, Bohsuk; Chung, Ki Young] Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Seoul, South Korea	Yeungnam University; Yeungnam University; Gyeongsang National University; Soonchunhyang University; Kyung Hee University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Chung, KY (corresponding author), Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Seoul, South Korea.	cky95@korea.kr; inhochoi@ynu.ac.kr	Kamli, Majid Rasool/AAN-6151-2020; Malik, Adeel/ABD-4831-2020; kamli, majid/AFS-7216-2022; Kim, Sang Hoon/AAJ-7334-2020; LEE, YONGSEOK/AAF-3965-2020	Kamli, Majid Rasool/0000-0003-0553-0046; Malik, Adeel/0000-0002-3453-6001; Lee, Yongseok/0000-0002-8687-589X; Kim, Sanghoon/0000-0002-4078-6269	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ907099]; Republic of Korea; National Research Foundation of Korea (MEST) [2008-0060480]; Yeungnam University	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Republic of Korea; National Research Foundation of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Yeungnam University	This work was supported by a grant from the BioGreen 21 Program (project no. PJ907099), Rural Development Administration, Republic of Korea, as well as a grant from the Republic of Korea and National Research Foundation of Korea (MEST) (grant no. 2008-0060480). This study was supported by the 2011 Yeungnam University research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bentzinger CF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt27; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandan E, 1996, EUR J CELL BIOL, V71, P170; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; De Coppi P, 2006, DIABETOLOGIA, V49, P1962, DOI 10.1007/s00125-006-0304-6; De Palma C, 2012, MOL NEUROBIOL, V46, P682, DOI 10.1007/s12035-012-8311-8; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fruhbeck G, 2009, TRENDS CELL BIOL, V19, P141, DOI 10.1016/j.tcb.2009.01.007; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; Gao Y, 2007, MEAT SCI, V77, P36, DOI 10.1016/j.meatsci.2007.03.026; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Guerin Colleen M, 2009, Commun Integr Biol, V2, P452; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HIGGS DR, 1989, BLOOD, V73, P1081; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUEHNS E R, 1965, J Med Genet, V2, P48, DOI 10.1136/jmg.2.1.48; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Kelley JM, 1999, NUCLEIC ACIDS RES, V27, P1539, DOI 10.1093/nar/27.6.1539; Kunes P, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/920517; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee DM, 2012, GENES GENOM, V34, P125, DOI 10.1007/s13258-011-0075-4; Lee DM, 2011, IN VITRO CELL DEV-AN, V47, P438, DOI 10.1007/s11626-011-9427-2; Lee EJ, 2010, ASIAN AUSTRAL J ANIM, V23, P649, DOI 10.5713/ajas.2010.90227; Lee EJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063617, DOI 10.1371/J0URNAL.P0NE.0063617.PUBMED:23717454]; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; LEE KH, 1994, J BIOL CHEM, V269, P14371; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Liang F, 2000, NUCLEIC ACIDS RES, V28, P3657, DOI 10.1093/nar/28.18.3657; Maile LA, 2010, EXP DIABETES RES, DOI 10.1155/2010/617052; Mirko V, 2010, J BIOMED BIOTECHNOL; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578; SANTERRE RF, 1993, MOL CELL BIOL, V13, P6044, DOI 10.1128/MCB.13.10.6044; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Su Y, 2010, ELECTROPHORESIS, V31, P2913, DOI 10.1002/elps.201000034; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Velleman SG, 2013, COMP BIOCHEM PHYS A, V164, P36, DOI 10.1016/j.cbpa.2012.10.007; Wride MA, 2003, MOL VIS, V9, P360; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	77	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79780	10.1371/journal.pone.0079780	http://dx.doi.org/10.1371/journal.pone.0079780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224006	Green Submitted, gold, Green Published			2022-12-25	WOS:000326597400087
J	Wu, LJ; Tang, ZH; Sun, XH; Feng, XY; Qian, W; Wang, J; Jin, LX				Wu, Lingjie; Tang, Zuohua; Sun, Xinghuai; Feng, Xiaoyuan; Qian, Wen; Wang, Jie; Jin, Lixin			Metabolic Changes in the Visual Cortex of Binocular Blindness Macaque Monkeys: A Proton Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; IN-VIVO; RAT-BRAIN; MONOCULAR ENUCLEATION; N-ACETYLASPARTATE; MRS; NMR	Purpose: To evaluate proton magnetic resonance spectroscopy (H-1-MRS) in a study of cross-modal plasticity in the visual cortex of binocular blindness macaque monkeys. Materials and Methods: Four healthy neonatal macaque monkeys were randomly divided into 2 groups, with 2 in each group. Optic nerve transection was performed in both monkeys in the experimental group (group B) to obtain binocular blindness. Two healthy macaque monkeys served as a control group (group A). After sixteen months post-procedure, H-1-MRS was performed in the visual cortex of all monkeys. We compared the peak areas of NAA, Cr, Cho, Glx and Ins and the ratios of NAA/Cr, Cho/Cr, Glx/Cr and Ins/Cr of each monkey in group B with group A. Results: The peak area of NAA and the NAA/Cr ratio in the visual cortex of monkey 4 in group B were found to be dramatically decreased, the peak area of NAA slightly decreased and the NAA/Cr ratio clearly decreased in visual cortex of monkey 3 in group B than those in group A. The peak area of Ins and the Ins/Cr ratio in the visual cortex of monkey 4 in group B slightly increased. The peak area of Cho and the Cho/Cr ratio in the visual cortex of all monkeys in group B dramatically increased compared with group A. The peak area of Glx in the visual cortex of all monkeys in group B slightly increased compared with group A. Conclusions: 1H-MRS could detect biochemical and metabolic changes in the visual cortex and therefore this technique can be used to provide valuable information for investigating the mechanisms of cross-modal plasticity of binocular blindness in a macaque monkey model.	[Wu, Lingjie; Tang, Zuohua; Qian, Wen; Wang, Jie] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Eye & ENT Hosp,Dept Ophthalmol, Shanghai 200433, Peoples R China; [Feng, Xiaoyuan] Fudan Univ, Shanghai Med Sch, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Jin, Lixin] Siemens Ltd, Healthcare Sect, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Siemens AG	Tang, ZH (corresponding author), Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	tzh518sunny@163.com; xhsun@shmu.edu.cn			Grant of Science and Technology Commission of Shanghai Municipality [09ZR1405600]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [81020108017]	Grant of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Grant of Science and Technology Commission of Shanghai Municipality (No. 09ZR1405600), http://www.stcsm.gov.cn/; The Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81020108017), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Choi JK, 2007, NMR BIOMED, V20, P216, DOI 10.1002/nbm.1145; Chow AM, 2011, INT J DEV NEUROSCI, V29, P25, DOI 10.1016/j.ijdevneu.2010.10.002; Desgent S, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/590725; Dowling C, 2001, AM J NEURORADIOL, V22, P604; FONT C, 1982, REV ESP FISIOL, V38, P317; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; HOWE FA, 1993, MAGN RESON QUART, V9, P31; Karlen SJ, 2009, CEREB CORTEX, V19, P1360, DOI 10.1093/cercor/bhn176; Larvaron P, 2006, NMR BIOMED, V19, P180, DOI 10.1002/nbm.997; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; Mountford C, 2006, J MAGN RESON IMAGING, V24, P459, DOI 10.1002/jmri.20668; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Newton JR, 2002, EXP BRAIN RES, V144, P423, DOI 10.1007/s00221-002-1087-8; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; RIBAK CE, 1986, EXP BRAIN RES, V62, P203; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; VIZUETE ML, 1992, BRAIN RES, V575, P231, DOI 10.1016/0006-8993(92)90084-M; Xu S, 2005, NEUROIMAGE, V28, P401, DOI 10.1016/j.neuroimage.2005.06.016; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073197	34	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80073	10.1371/journal.pone.0080073	http://dx.doi.org/10.1371/journal.pone.0080073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224037	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400109
J	Zhan, T; Zhang, K; Chen, YY; Lin, YJ; Wu, GB; Zhang, LL; Yao, P; Shao, ZZ; Liu, ZD				Zhan, Tao; Zhang, Kai; Chen, Yangyan; Lin, Yongjun; Wu, Gaobing; Zhang, Lili; Yao, Pei; Shao, Zongze; Liu, Ziduo			Improving Glyphosate Oxidation Activity of Glycine Oxidase from Bacillus cereus by Directed Evolution	PLOS ONE			English	Article							HERBICIDE GLYPHOSATE; FLUORESCENS ESTERASE; TOLERANCE; MUTATIONS; ENANTIOSELECTIVITY; PREDICTION; RESISTANCE; SUBTILIS; SYNTHASE	Glyphosate, a broad spectrum herbicide widely used in agriculture all over the world, inhibits 5-enolpyruvylshikimate-3-phosphate synthase in the shikimate pathway, and glycine oxidase (GO) has been reported to be able to catalyze the oxidative deamination of various amines and cleave the C-N bond in glyphosate. Here, in an effort to improve the catalytic activity of the glycine oxidase that was cloned from a glyphosate-degrading marine strain of Bacillus cereus (BceGO), we used a bacteriophage T7 lysis-based method for high-throughput screening of oxidase activity and engineered the gene encoding BceGO by directed evolution. Six mutants exhibiting enhanced activity toward glyphosate were screened from two rounds of error-prone PCR combined with site directed mutagenesis, and the beneficial mutations of the six evolved variants were recombined by DNA shuffling. Four recombinants were generated and, when compared with the wild-type BceGO, the most active mutant B3S1 showed the highest activity, exhibiting a 160-fold increase in substrate affinity, a 326-fold enhancement in catalytic efficiency against glyphosate, with little difference between their pH and temperature stabilities. The role of these mutations was explored through structure modeling and molecular docking, revealing that the Arg(51) mutation is near the active site and could be an important residue contributing to the stabilization of glyphosate binding, while the role of the remaining mutations is unclear. These results provide insight into the application of directed evolution in optimizing glycine oxidase function and have laid a foundation for the development of glyphosate-tolerant crops.	[Zhan, Tao; Zhang, Kai; Chen, Yangyan; Lin, Yongjun; Wu, Gaobing; Yao, Pei; Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhang, Lili] Tarim Univ, Coll Life Sci, Key Lab Protect & Utilizat Biol Resources Tarim B, Alar, Xinjiang, Peoples R China; [Shao, Zongze] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian, Peoples R China	Huazhong Agricultural University; Tarim University; State Oceanic Administration	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	lzd@mail.hzau.edu.cn			National Natural Science Foundation of China [u1170303]; Genetically Modified Organisms Breeding Major Projects of China [2011zx08001-001]; Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps [BRZD1101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China; Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps	This work was supported by grants from the National Natural Science Foundation of China (number u1170303), the Genetically Modified Organisms Breeding Major Projects of China (2011zx08001-001), and the opening project of the Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps (number BRZD1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Barry G.F., 1995, U.S. Patent, Patent No. [5-463,175, 5463175]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; ELSNER HI, 1989, DNA-J MOLEC CELL BIO, V8, P697, DOI 10.1089/dna.1989.8.697; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Franz JE, 1997, AM CHEM SOC MONOGRAP, V189; GOLDSBROUGH PB, 1990, PLANT SCI, V72, P53, DOI 10.1016/0168-9452(90)90186-R; Harrison LA, 1996, J NUTR, V126, P728, DOI 10.1093/jn/126.3.728; Horsman GP, 2003, CHEM-EUR J, V9, P1933, DOI 10.1002/chem.200204551; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; Joern JM, 2002, J MOL BIOL, V316, P643, DOI 10.1006/jmbi.2001.5349; Larguinho M, 2010, TALANTA, V81, P881, DOI 10.1016/j.talanta.2010.01.032; Martinez-Martinez I, 2008, PROTEINS, V70, P1429, DOI 10.1002/prot.21690; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meilan R, 2002, CAN J FOREST RES, V32, P967, DOI 10.1139/X02-015; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Nandula VK, 2007, J AGR FOOD CHEM, V55, P3540, DOI 10.1021/jf063568l; Nishiya Y, 1998, FEBS LETT, V438, P263, DOI 10.1016/S0014-5793(98)01313-1; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Park S, 2005, CHEM BIOL, V12, P45, DOI 10.1016/j.chembiol.2004.10.012; Pedotti M, 2009, J BIOL CHEM, V284, P36415, DOI 10.1074/jbc.M109.051631; Pollegioni L, 2011, FEBS J, V278, P2753, DOI 10.1111/j.1742-4658.2011.08214.x; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; Siehl DL, 2005, PEST MANAG SCI, V61, P235, DOI 10.1002/ps.1014; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; STEINRUCKEN HC, 1986, ARCH BIOCHEM BIOPHYS, V244, P169, DOI 10.1016/0003-9861(86)90106-2; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stierand K, 2011, MOL INFORM, V30, P12, DOI 10.1002/minf.201000167; TARAHOVSKY YS, 1994, FEMS MICROBIOL LETT, V122, P195, DOI 10.1111/j.1574-6968.1994.tb07164.x; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Weiner M, 1994, GENOME RES, V4, P131, DOI [10.1101/gr.4.3.S131, DOI 10.1101/GR.4.3.S131]; Zhao HM, 1997, CURR OPIN STRUC BIOL, V7, P480, DOI 10.1016/S0959-440X(97)80110-8	41	20	23	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79175	10.1371/journal.pone.0079175	http://dx.doi.org/10.1371/journal.pone.0079175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223901	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400051
J	Glover, JD; Taylor, L; Sherman, A; Zeiger-Poli, C; Sang, HM; McGrew, MJ				Glover, James D.; Taylor, Lorna; Sherman, Adrian; Zeiger-Poli, Caroline; Sang, Helen M.; McGrew, Michael J.			A Novel Piggybac Transposon Inducible Expression System Identifies a Role for Akt Signalling in Primordial Germ Cell Migration	PLOS ONE			English	Article							CONDITIONAL RNA INTERFERENCE; PLURIPOTENT STEM-CELLS; STUDYING GENE-FUNCTION; MAMMALIAN-CELLS; FLUORESCENT PROTEINS; TRANSGENIC CHICKENS; MICE; MOUSE; EMBRYO; TOOL	In this work, we describe a single piggyBac transposon system containing both a tet-activator and a doxycycline-inducible expression cassette. We demonstrate that a gene product can be conditionally expressed from the integrated transposon and a second gene can be simultaneously targeted by a short hairpin RNA contained within the transposon, both in vivo and in mammalian and avian cell lines. We applied this system to stably modify chicken primordial germ cell (PGC) lines in vitro and induce a reporter gene at specific developmental stages after injection of the transposon-modified germ cells into chicken embryos. We used this vector to express a constitutively-active AKT molecule during PGC migration to the forming gonad. We found that PGC migration was retarded and cells could not colonise the forming gonad. Correct levels of AKT activation are thus essential for germ cell migration during early embryonic development.	[McGrew, Michael J.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	McGrew, MJ (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh EH8 9YL, Midlothian, Scotland.	mike.mcgrew@roslin.ed.ac.uk		Glover, James/0000-0003-4678-5643	Biotechnology and Biological Sciences Research Council; BBSRC [BB/H023593/1]; BBSRC [BBS/E/D/20320000, BBS/E/R/00001607, BBS/E/D/20221658] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001607, BB/H023593/1, BBS/E/D/20320000, BBS/E/D/20221658] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Institute Strategic Grant funding from the Biotechnology and Biological Sciences Research Council and BBSRC grant no. BB/H023593/1 to H. M. S. and M.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Glover JD, 2012, J POULT SCI, V49, P155, DOI 10.2141/jpsa.011161; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hunter CV, 2005, TRENDS MOL MED, V11, P293, DOI 10.1016/j.molmed.2005.04.001; Jang CW, 2007, CSH PROTOC; Kappel S, 2007, NAT PROTOC, V2, P3257, DOI 10.1038/nprot.2007.458; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Serralbo O, 2013, GENESIS, V51, P372, DOI 10.1002/dvg.22388; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman A, 1998, NAT BIOTECHNOL, V16, P1050, DOI 10.1038/3497; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sisson TH, 2006, AM J RESP CELL MOL, V34, P552, DOI 10.1165/rcmb.2005-0378OC; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Takahashi Y, 2008, METHOD CELL BIOL, V87, P271, DOI 10.1016/S0091-679X(08)00214-8; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wick G, 2006, ADV IMMUNOL, V92, P71, DOI 10.1016/S0065-2776(06)92002-1; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028	54	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77222	10.1371/journal.pone.0077222	http://dx.doi.org/10.1371/journal.pone.0077222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223709	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400009
J	Hsu, YL; Shi, SF; Wu, WL; Ho, LJ; Lai, JH				Hsu, Yu-Lin; Shi, Shao-Fu; Wu, Wan-Lin; Ho, Ling-Jun; Lai, Jenn-Haung			Protective Roles of Interferon-Induced Protein with Tetratricopeptide Repeats 3 (IFIT3) in Dengue Virus Infection of Human Lung Epithelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STIMULATED GENES; ANTIVIRAL RESPONSE; IDENTIFICATION; EXPRESSION; EFFECTORS; FAMILY; ALPHA; INHIBITION; INFLUENZA	Interferons (IFNs) are critical cytokines that regulate immune response against virus infections. Dengue virus (DV) infections are a major public health concern worldwide, and especially in Asia. In the present study, we investigated the effects and mechanisms of action of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in human lung epithelial cells. The results demonstrated that DV infection induced expression of several IFITs, including IFIT1, IFIT2, IFIT3, and IFIT5 in A549 cells. Induction of IFIT3 by DV infection was also observed in human dendritic cells. In a knockdown study, we showed that a signal transducer and activator of transcription 2 (STAT2), but not STAT1 or STAT3, regulated DV-induced IFIT3 production. By using several different methods to evaluate cell death, we demonstrated that knockdown of IFIT3 led to cellular apoptosis. Furthermore, knockdown of IFIT3 induced the expression of several apoptotic regulators such as caspase 3, caspase 8, caspase 9, and Bcl-2-associated X protein (BAX). Such apoptotic effects and mechanisms were synergistically enhanced after DV infection. Moreover, under conditions of IFIT3 deficiency, viral production increased, suggesting an anti-viral effect of IFIT3. Interestingly, DV could suppress IFN-alpha-induced but not IFN-gamma-induced IFIT3 expression, a phenomenon similar to the regulation of STATs by DV. In conclusion, this study revealed some mechanisms of IFIT3 induction, and also demonstrated the protective roles of IFIT3 following IFN-alpha production in DV infection of human lung epithelial cells.	[Hsu, Yu-Lin; Lai, Jenn-Haung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shi, Shao-Fu] Natl Def Med Ctr, Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Wu, Wan-Lin; Ho, Ling-Jun] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ho, Ling-Jun] China Med Univ, PhD Program Aging, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lai, Jenn-Haung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Rheumatol Allergy & Immunol, Tao Yuan, Taiwan	National Defense Medical Center; National Defense Medical Center; National Health Research Institutes - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Lai, JH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	laiandho@gmail.com	Ho, Ling-Jun/B-1087-2010	Ho, Ling-Jun/0000-0003-3453-2913	Chang Gung Memorial Hospital [CMRPG3B1751E]; National Science Council, Taiwan. R.O.C.	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan. R.O.C.(Ministry of Science and Technology, Taiwan)	The study was supported by a research grant from Chang Gung Memorial Hospital (CMRPG3B1751E) and National Science Council, Taiwan. R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Bordignon J, 2008, VIROLOGY, V377, P319, DOI 10.1016/j.virol.2008.04.033; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Despres P, 1996, J VIROL, V70, P4090; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmeisser H, 2010, J VIROL, V84, P10671, DOI 10.1128/JVI.00818-10; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103	36	45	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79518	10.1371/journal.pone.0079518	http://dx.doi.org/10.1371/journal.pone.0079518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223959	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400120
J	Kinouchi, K; Ichihara, A; Sano, M; Sun-Wada, GH; Wada, Y; Ochi, H; Fukuda, T; Bokuda, K; Kurosawa, H; Yoshida, N; Takeda, S; Fukuda, K; Itoh, H				Kinouchi, Kenichiro; Ichihara, Atsuhiro; Sano, Motoaki; Sun-Wada, Ge-Hong; Wada, Yoh; Ochi, Hiroki; Fukuda, Toru; Bokuda, Kanako; Kurosawa, Hideaki; Yoshida, Naohiro; Takeda, Shu; Fukuda, Keiichi; Itoh, Hiroshi			The Role of Individual Domains and the Significance of Shedding of ATP6AP2/(pro)renin Receptor in Vacuolar H+-ATPase Biogenesis	PLOS ONE			English	Article							PRO RENIN RECEPTOR; ENDOPLASMIC-RETICULUM; PRORENIN RECEPTOR; (PRO)RENIN RECEPTOR; ANGIOTENSIN-II; V-ATPASE; OSTEOCLAST DIFFERENTIATION; NONPROTEOLYTIC ACTIVATION; SACCHAROMYCES-CEREVISIAE; MEMBRANE SECTOR	The ATPase 6 accessory protein 2 (ATP6AP2)/(pro)renin receptor (PRR) is essential for the biogenesis of active vacuolar H+-ATPase (V-ATPase). Genetic deletion of ATP6AP2/PRR causes V-ATPase dysfunction and compromises vesicular acidification. Here, we characterized the domains of ATP6AP2/PRR involved in active V-ATPase biogenesis. Three forms of ATP6AP2/PRR were found intracellularly: full-length protein and the N- and C-terminal fragments of furin cleavage products, with the N-terminal fragment secreted extracellularly. Genetic deletion of ATP6AP2/PRR did not affect the protein stability of V-ATPase subunits. The extracellular domain (ECD) and transmembrane domain (TM) of ATP6AP2/PRR were indispensable for the biogenesis of active V-ATPase. A deletion mutant of ATP6AP2/PRR, which lacks exon 4-encoded amino acids inside the ECD (Delta 4M) and causes X-linked mental retardation Hedera type (MRXSH) and X-linked parkinsonism with spasticity (XPDS) in humans, was defective as a V-ATPase-associated protein. Prorenin had no effect on the biogenesis of active V-ATPase. The cleavage of ATP6AP2/PRR by furin seemed also dispensable for the biogenesis of active V-ATPase. We conclude that the N-terminal ECD of ATP6AP2/PRR, which is also involved in binding to prorenin or renin, is required for the biogenesis of active V-ATPase. The V-ATPase assembly occurs prior to its delivery to the trans-Golgi network and hence shedding of ATP6AP2/PRR would not affect the biogenesis of active V-ATPase.	[Kinouchi, Kenichiro; Ochi, Hiroki; Fukuda, Toru; Bokuda, Kanako; Kurosawa, Hideaki; Takeda, Shu; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan; [Ichihara, Atsuhiro; Yoshida, Naohiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan; [Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Sun-Wada, Ge-Hong] Doshisha Womens Coll, Fac Pharmaceut Sci, Dept Biochem, Kyoto, Japan; [Wada, Yoh] Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Osaka, Japan	Keio University; Tokyo Women's Medical University; Keio University; Osaka University	Ichihara, A (corresponding author), Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan.	atzichi@endm.twmu.ac.jp	Sano, Motoaki/L-3405-2013; Kinouchi, Kenichiro/AAW-8471-2021; Fukuda, Keiichi/L-3777-2013	Kinouchi, Kenichiro/0000-0003-4743-2583; 	JSPS KAKENHI [25293198]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25650066, 25293198] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI Grant Number 25293198 (to A.I.), a Grant-in-Aid for JSPS fellows (to K. K.), notable awards for research achievements in science and technology (Takeda Science Foundation), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Burckle C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; HILL KJ, 1994, MOL BIOL CELL, V5, P1039, DOI 10.1091/mbc.5.9.1039; HIRATA R, 1993, J BIOL CHEM, V268, P961; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Ichihara A, 2006, J AM SOC NEPHROL, V17, P2495, DOI 10.1681/ASN.2005121278; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; KANE PM, 1992, J BIOL CHEM, V267, P447; Kinouchi K, 2011, FRONT BIOSCI-LANDMRK, V16, P3216, DOI 10.2741/3907; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Korvatska O, 2013, HUM MOL GENET; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nakamura N, 2001, J BIOCHEM-TOKYO, V130, P765, DOI 10.1093/oxfordjournals.jbchem.a003047; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Takahashi H, 2007, J AM SOC NEPHROL, V18, P2054, DOI 10.1681/ASN.2006080820; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284	42	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78603	10.1371/journal.pone.0078603	http://dx.doi.org/10.1371/journal.pone.0078603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223829	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400077
J	Koo, KC; Shim, DH; Yang, CM; Lee, SB; Kim, SM; Shin, TY; Kim, KH; Yoon, HG; Rha, KH; Lee, JM; Hong, SJ				Koo, Kyo Chul; Shim, Doo Hee; Yang, Chang Mo; Lee, Saet-Byul; Kim, Shi Mun; Shin, Tae Young; Kim, Kwang Hyun; Yoon, Ho Geun; Rha, Koon Ho; Lee, Jae Myun; Hong, Sung Joon			Reduction of the CD16(-)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; DENDRITIC CELLS; TUMOR-CELLS; IN-VIVO; CARCINOMA; INFECTION; PROLIFERATION; CYTOTOXICITY	Background: Natural cytotoxicity, mediated by natural killer (NK) cells plays an important role in the inhibition and elimination of malignant tumor cells. To investigate the immunoregulatory role of NK cells and their potential as diagnostic markers, NK cell activity (NKA) was analyzed in prostate cancer (PCa) patients with particular focus on NK cell subset distribution. Methods: Prospective data of NKA and NK cell subset distribution patterns were measured from 51 patients initially diagnosed with PCa and 54 healthy controls. NKA was represented by IFN-gamma levels after stimulation of the peripheral blood with Promoca (R). To determine the distribution of NK cell subsets, PBMCs were stained with fluorochrome-conjugated monoclonal antibodies. Then, CD16(+)CD56(dim) and CD16(-)CD56(bright) cells gated on CD56(+)CD3(-) cells were analyzed using a flow-cytometer. Results: NKA and the proportion of CD56(bright) cells were significantly lower in PCa patients compared to controls (430.9 pg/ml vs. 975.2 pg/ml and 2.3% vs. 3.8%, respectively; p<0.001). Both tended to gradually decrease according to cancer stage progression (p for trend = 0.001). A significantly higher CD56(dim) (-)to-CD56(bright) cell ratio was observed in PCa patients (41.8 vs. 30.3; p<0.001) along with a gradual increase according to cancer stage progression (p for trend = 0.001), implying a significant reduction of CD56(bright) cells in relation to the alteration of CD56(dim) cells. The sensitivity and the specificity of NKA regarding PCa detection were 72% and 74%, respectively (best cut-off value at 530.9 pg/ml, AUC = 0.786). Conclusions: Reduction of CD56(bright) cells may precede NK cell dysfunction, leading to impaired cytotoxicity against PCa cells. These observations may explain one of the mechanisms behind NK cell dysfunction observed in PCa microenvironment and lend support to the development of future cancer immunotherapeutic strategies.	[Koo, Kyo Chul; Shin, Tae Young; Kim, Kwang Hyun; Rha, Koon Ho; Hong, Sung Joon] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Koo, Kyo Chul; Shin, Tae Young; Kim, Kwang Hyun; Rha, Koon Ho; Hong, Sung Joon] Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea; [Shim, Doo Hee; Yang, Chang Mo; Lee, Saet-Byul; Lee, Jae Myun] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Yang, Chang Mo; Lee, Saet-Byul; Yoon, Ho Geun; Lee, Jae Myun] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Kim, Shi Mun] ATgen, Songnam, South Korea; [Yoon, Ho Geun] Yonsei Univ, Coll Med, Severance Med Res Inst, Dept Biochem & Mol Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JM (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	jaemyun@yuhs.ac; sjhong346@yuhs.ac	rchnds, rchnds/D-7595-2016	Lee, Jae Myun/0000-0002-5273-3113; Koo, Kyo Chul/0000-0001-7303-6256; Rha, Koon Ho/0000-0001-8588-7584; Hong, Sung Joon/0000-0001-9869-065X; Shim, Doo Hee/0000-0002-6696-7199; Yoon, Ho-Geun Yoon/0000-0003-2718-3372	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0000807]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0000807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch E, 2012, J CLIN ONCOL, V30, P3020, DOI 10.1200/JCO.2012.43.3441; Bauernhofer T, 2003, EUR J IMMUNOL, V33, P119, DOI 10.1002/immu.200390014; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dowell AC, 2012, CANCER IMMUNOL IMMUN, V61, P615, DOI 10.1007/s00262-011-1122-3; Ebelt K, 2008, PROSTATE, V68, P1, DOI 10.1002/pros.20661; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Harlin H, 2007, J IMMUNOL, V179, P4513, DOI 10.4049/jimmunol.179.7.4513; Izawa S, CANC IMMUNOL IMMUNOT, V60, P1801; KASTELAN M, 1992, PROSTATE, V21, P111; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Klein EA, 2008, CURR OPIN UROL, V18, P315, DOI 10.1097/MOU.0b013e3282f9b3b7; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lin CT, 2010, CANCER LETT, V291, P39, DOI 10.1016/j.canlet.2009.09.019; Oikawa T, 2003, BJU INT, V92, P1009, DOI 10.1111/j.1464-410X.2003.04509.x; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Schroder FH, 2012, BJU INT, V110, P3, DOI 10.1111/j.1464-410X.2012.011428.x; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Sheikhi A, 2011, IMMUNOPHARM IMMUNOT, V33, P700, DOI 10.3109/08923973.2011.561437; Sotosek S, 2011, WIEN KLIN WOCHENSCHR, V123, P718, DOI 10.1007/s00508-011-0096-7; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; Takeuchi H, 2001, AM J GASTROENTEROL, V96, P574; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wagenlehner FME, 2007, BJU INT, V100, P733, DOI 10.1111/j.1464-410X.2007.07091.x; Watanabe M, 2010, DIS ESOPHAGUS, V23, P675, DOI 10.1111/j.1442-2050.2010.01073.x; Yamaguchi Y, 1994, In Vivo, V8, P279; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	31	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78049	10.1371/journal.pone.0078049	http://dx.doi.org/10.1371/journal.pone.0078049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223759	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400031
J	Merritt, KE; Bachtell, RK				Merritt, Kathryn E.; Bachtell, Ryan K.			Initial D-2 Dopamine Receptor Sensitivity Predicts Cocaine Sensitivity and Reward in Rats	PLOS ONE			English	Article							INDUCED LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS NEURONS; CHRONIC MILD STRESS; INDIVIDUAL-DIFFERENCES; BINDING CHARACTERISTICS; SEEKING BEHAVIOR; DRUG-ABUSE; VULNERABILITY; SENSITIZATION; AGONISTS	The activation of dopamine receptors within the mesolimbic dopamine system is known to be involved in the initiation and maintenance of cocaine use. Expression of the D-2 dopamine receptor subtype has been implicated as both a predisposing factor and consequence of chronic cocaine use. It is unclear whether there is a predictive relationship between D-2 dopamine receptor function and cocaine sensitivity that would enable cocaine abuse. Therefore, we exploited individual differences in behavioral responses to D2 dopamine receptor stimulation to test its relationship with cocaine-mediated behaviors. Outbred, male Sprague-Dawley rats were initially characterized by their locomotor responsiveness to the D-2 dopamine receptor agonist, quinpirole, in a within-session ascending dose-response regimen (0, 0.1, 0.3 & 1.0 mg/kg, sc). Rats were classified as high or low quinpirole responders (HD2 and LD2, respectively) by a median split of their quinpirole-induced locomotor activity. Rats were subsequently tested for differences in the psychostimulant effects of cocaine by measuring changes in cocaine-induced locomotor activity (5 and 15 mg/kg, ip). Rats were also tested for differences in the development of conditioned place preference to a low dose of cocaine (7.5mg/kg, ip) that does not reliably produce a cocaine conditioned place preference. Finally, rats were tested for acquisition of cocaine self-administration and maintenance responding on fixed ratio 1 and 5 schedules of reinforcement, respectively. Results demonstrate that HD2 rats have enhanced sensitivity to the locomotor stimulating properties of cocaine, display greater cocaine conditioned place preference, and self-administer more cocaine compared to LD2 animals. These findings suggest that individual differences in D-2 dopamine receptor sensitivity may be predictive of cocaine sensitivity and reward.	[Merritt, Kathryn E.; Bachtell, Ryan K.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Bachtell, Ryan K.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Bachtell, Ryan K.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Bachtell, RK (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	Ryan.Bachtell@Colorado.edu	Bachtell, Ryan/H-7436-2013	Bachtell, Ryan/0000-0001-5268-5927; Merritt, Kathryn/0000-0002-5016-1510	CU Innovative Seed Grant;  [R03 DA 029420]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA029240] Funding Source: NIH RePORTER	CU Innovative Seed Grant; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by R03 DA 029420; CU Innovative Seed Grant. The funders had no role in study design, data collection and analysis, decision	Allen RM, 2007, PHARMACOL BIOCHEM BE, V86, P37, DOI 10.1016/j.pbb.2006.12.005; Anderson SM, 2005, PHARMACOL THERAPEUT, V106, P389, DOI 10.1016/j.pharmthera.2004.12.004; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Bachtell RK, 2008, EUR J NEUROSCI, V27, P2229, DOI 10.1111/j.1460-9568.2008.06199.x; Bailey A, 2008, EUR J NEUROSCI, V28, P759, DOI 10.1111/j.1460-9568.2008.06369.x; Briand LA, 2008, EUR NEUROPSYCHOPHARM, V18, P551, DOI 10.1016/j.euroneuro.2008.01.002; Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Carr KD, 2001, PSYCHOPHARMACOLOGY, V154, P420, DOI 10.1007/s002130000674; Collins GT, 2011, PSYCHOPHARMACOLOGY, V215, P609, DOI 10.1007/s00213-010-2154-7; De Vries TJ, 1999, PSYCHOPHARMACOLOGY, V143, P254, DOI 10.1007/s002130050944; Del Arco A, 2004, PSYCHOPHARMACOLOGY, V171, P148, DOI 10.1007/s00213-003-1578-8; DEMINIERE JM, 1989, NEUROSCI BIOBEHAV R, V13, P141, DOI 10.1016/S0149-7634(89)80023-5; Dias C, 2004, PSYCHOPHARMACOLOGY, V175, P414, DOI 10.1007/s00213-004-1839-1; Dziedzicka-Wasylewska M, 1997, BEHAV PHARMACOL, V8, P607, DOI 10.1097/00008877-199711000-00017; Edwards S, 2007, NEUROPSYCHOPHARMACOL, V32, P354, DOI 10.1038/sj.npp.1301062; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; Fattore L, 2009, NEUROPSYCHOPHARMACOL, V34, P1091, DOI 10.1038/npp.2008.43; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Giorgi O, 2007, NEUROSCI BIOBEHAV R, V31, P148, DOI 10.1016/j.neubiorev.2006.07.008; Grant KA, 1998, SYNAPSE, V29, P80, DOI 10.1002/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7; Gulley JM, 2003, NEUROPSYCHOPHARMACOL, V28, P2089, DOI 10.1038/sj.npp.1300279; HENRY C, 1995, BRAIN RES, V685, P179, DOI 10.1016/0006-8993(95)00430-X; HOOKS MS, 1994, J NEUROSCI, V14, P6144; HOOKS MS, 1991, PHARMACOL BIOCHEM BE, V38, P467, DOI 10.1016/0091-3057(91)90308-O; HOOKS MS, 1994, PSYCHOPHARMACOLOGY, V116, P217; HU XT, 1988, BRAIN RES, V444, P389, DOI 10.1016/0006-8993(88)90953-5; Khroyan TV, 2000, J PHARMACOL EXP THER, V294, P680; KOSTRZEWA RM, 1991, LIFE SCI, V48, pPL129; KURASHIMA M, 1995, PHARMACOL BIOCHEM BE, V52, P503, DOI 10.1016/0091-3057(95)00103-4; Mandt B, 2008, PSYCHOPHARMACOLOGY, V201, P195, DOI 10.1007/s00213-008-1265-x; Marinelli M, 2000, J NEUROSCI, V20, P8876; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; O'Neill CE, 2012, NEUROPSYCHOPHARMACOL, V37, P1245, DOI 10.1038/npp.2011.312; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; PAPP M, 1993, PSYCHOPHARMACOLOGY, V110, P152, DOI 10.1007/BF02246965; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; PUGLISIALLEGRA S, 1991, LIFE SCI, V48, P1263, DOI 10.1016/0024-3205(91)90521-C; RILKE O, 1995, PHARMACOL BIOCHEM BE, V52, P23, DOI 10.1016/0091-3057(95)00093-C; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Schramm-Sapyta NL, 2011, PSYCHOPHARMACOLOGY, V215, P493, DOI 10.1007/s00213-011-2216-5; Seeman P, 2005, P NATL ACAD SCI USA, V102, P3513, DOI 10.1073/pnas.0409766102; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Thanos PK, 2008, SYNAPSE, V62, P481, DOI 10.1002/syn.20523; UJIKE H, 1990, PSYCHOPHARMACOLOGY, V102, P459, DOI 10.1007/BF02247125; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; WHITE FJ, 1986, J NEUROSCI, V6, P274	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78258	10.1371/journal.pone.0078258	http://dx.doi.org/10.1371/journal.pone.0078258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223783	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400045
J	Nelson, RM; Pettersson, ME; Li, XD; Carlborg, O				Nelson, Ronald M.; Pettersson, Mats E.; Li, Xidan; Carlborg, Orjan			Variance Heterogeneity in Saccharomyces cerevisiae Expression Data: Trans-Regulation and Epistasis	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN; TRANSCRIPTION; PATHWAY; TRAITS; ARCHITECTURE; VARIABILITY; DISSECTION; LANDSCAPE; RIM101	Here, we describe the results from the first variance heterogeneity Genome Wide Association Study (VGWAS) on yeast expression data. Using this forward genetics approach, we show that the genetic regulation of gene-expression in the budding yeast, Saccharomyces cerevisiae, includes mechanisms that can lead to variance heterogeneity in the expression between genotypes. Additionally, we performed a mean effect association study (GWAS). Comparing the mean and variance heterogeneity analyses, we find that the mean expression level is under genetic regulation from a larger absolute number of loci but that a higher proportion of the variance controlling loci were trans-regulated. Both mean and variance regulating loci cluster in regulatory hotspots that affect a large number of phenotypes; a single variance-controlling locus, mapping close to DIA2, was found to be involved in more than 10% of the significant associations. It has been suggested in the literature that variance-heterogeneity between the genotypes might be due to genetic interactions. We therefore screened the multi-locus genotype-phenotype maps for several traits where multiple associations were found, for indications of epistasis. Several examples of two and three locus genetic interactions were found to involve variance-controlling loci, with reports from the literature corroborating the functional connections between the loci. By using a new analytical approach to re-analyze a powerful existing dataset, we are thus able to both provide novel insights to the genetic mechanisms involved in the regulation of gene-expression in budding yeast and experimentally validate epistasis as an important mechanism underlying genetic variance-heterogeneity between genotypes.	[Nelson, Ronald M.; Pettersson, Mats E.; Li, Xidan; Carlborg, Orjan] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Nelson, RM (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	ronnie.nelson@slu.se	Pettersson, Mats E/E-4523-2011	Pettersson, Mats/0000-0002-7372-9076; Carlborg, Orjan/0000-0002-2722-5264	Swedish Foundation for Strategic Research; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); EURYI	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS)(Swedish Research Council Formas); EURYI(European Science Foundation (ESF))	This study was funded by the Swedish Foundation for Strategic Research; by Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); and by a EURYI Award to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; BLOOM JS, 2013, NATURE; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fichtner L, 2007, MOL MICROBIOL, V66, P1276, DOI 10.1111/j.1365-2958.2007.06014.x; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Flynn PJ, 1999, MOL CELL BIOL, V19, P882; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pettersson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002180; Reece RJ, 2000, CELL MOL LIFE SCI, V57, P1161, DOI 10.1007/PL00000756; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; ROY A, 1990, MOL CELL BIOL, V10, P5257, DOI 10.1128/MCB.10.10.5257; Shen X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002839; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Sorensen D, 2003, GENET RES, V82, P207, DOI 10.1017/S0016672303006426; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; TEUNISSEN AWRH, 1995, YEAST, V11, P1001, DOI 10.1002/yea.320111102; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	41	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79507	10.1371/journal.pone.0079507	http://dx.doi.org/10.1371/journal.pone.0079507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223957	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400119
J	Pelchovich, G; Omer-Bendori, S; Gophna, U				Pelchovich, Gidi; Omer-Bendori, Shira; Gophna, Uri			Menaquinone and Iron Are Essential for Complex Colony Development in Bacillus subtilis	PLOS ONE			English	Article							FRUITING BODY FORMATION; VITAMIN-K MENAQUINONE; STREPTOMYCES-COELICOLOR; BACTERIAL COLONIES; MYXOCOCCUS-XANTHUS; SELF-ORGANIZATION; AERIAL HYPHAE; COOPERATIVE ORGANIZATION; ISOCHORISMATE SYNTHASE; CAROTENOID SYNTHESIS	Cells of undomesticated species of Bacillus subtilis frequently form complex colonies during spreading on agar surfaces. Given that menaquinone is involved in another form of coordinated behavior, namely, sporulation, we looked for a possible role for menaquinone in complex colony development (CCD) in the B. subtilis strain NCIB 3610. Here we show that inhibition of menaquinone biosynthesis in B. subtilis indeed abolished its ability to develop complex colonies. Additionally some mutations of B. subtilis which confer defective CCD could be suppressed by menaquinone derivatives. Several such mutants mapped to the dhb operon encoding the genes responsible for the biosynthesis of the iron siderophore, bacillibactin. Our results demonstrate that both menaquinone and iron are essential for CCD in B. subtilis.	[Pelchovich, Gidi; Omer-Bendori, Shira; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Pelchovich, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	gidi78@gmail.com	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652	Tauber Fund at Tel-Aviv University; DIP grant from the Deutsche Forschungsgemeinschaft	Tauber Fund at Tel-Aviv University; DIP grant from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research was supported in large part by a grant from the Tauber Fund at Tel-Aviv University. UG is supported by a DIP grant from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Ben-Jacob E, 2003, PHILOS T R SOC A, V361, P1283, DOI 10.1098/rsta.2003.1199; Ben-Jacob E, 2000, PHYSICA A, V282, P247, DOI 10.1016/S0378-4371(00)00093-5; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Ben-Jacob E, 2009, ANN NY ACAD SCI, V1178, P78, DOI 10.1111/j.1749-6632.2009.05022.x; BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899; BENJACOB E, 1992, PHYSICA A, V187, P378, DOI 10.1016/0378-4371(92)90002-8; BenJacob E, 1997, CONTEMP PHYS, V38, P205, DOI 10.1080/001075197182405; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Curtis PD, 2007, J BACTERIOL, V189, P9126, DOI 10.1128/JB.01008-07; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Daruwala R, 1996, FEMS MICROBIOL LETT, V140, P159, DOI 10.1016/0378-1097(96)00173-5; Degering C, 2010, APPL ENVIRON MICROB, V76, P6370, DOI 10.1128/AEM.01146-10; DOY CH, 1965, BIOCHIM BIOPHYS ACTA, V104, P377, DOI 10.1016/0304-4165(65)90343-0; EMMONS GT, 1985, BIOCHEM BIOPH RES CO, V131, P956, DOI 10.1016/0006-291X(85)91332-4; Fall R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-31; FARRAND SK, 1974, J BACTERIOL, V117, P324, DOI 10.1128/JB.117.1.324-326.1974; FARRAND SK, 1973, J BACTERIOL, V115, P1035, DOI 10.1128/JB.115.3.1035-1044.1973; Ferland G, 2012, ANN NUTR METAB, V61, P213, DOI 10.1159/000343108; Fu QS, 2009, BIODEGRADATION, V20, P109, DOI 10.1007/s10532-008-9204-4; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; FUJIKAWA H, 1994, FEMS MICROBIOL ECOL, V13, P159, DOI 10.1111/j.1574-6941.1994.tb00062.x; HAMMOND RK, 1970, J BACTERIOL, V103, P611, DOI 10.1128/JB.103.3.611-615.1970; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hamze K, 2011, MICROBIOL-SGM, V157, P2456, DOI 10.1099/mic.0.047159-0; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; HUANG L, 1974, J BIOL CHEM, V249, P4467; HUANG L, 1974, J BIOL CHEM, V249, P4473; IKEDA H, 1990, EUR J BIOCHEM, V192, P219, DOI 10.1111/j.1432-1033.1990.tb19218.x; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; KAKUTANI Y, 1967, J BIOCHEM-TOKYO, V61, P193, DOI 10.1093/oxfordjournals.jbchem.a128531; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kelemen GH, 1996, MOL MICROBIOL, V21, P593, DOI 10.1111/j.1365-2958.1996.tb02567.x; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; KOCH GLE, 1971, BIOCHIM BIOPHYS ACTA, V229, P795, DOI 10.1016/0005-2795(71)90298-4; KoikeTakeshita A, 1997, J BIOL CHEM, V272, P12380, DOI 10.1074/jbc.272.19.12380; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; MATSUSHITA M, 1990, PHYSICA A, V168, P498, DOI 10.1016/0378-4371(90)90402-E; MAY BK, 1968, BIOCHIM BIOPHYS ACTA, V157, P607, DOI 10.1016/0005-2787(68)90158-5; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; MCCANDLISS RJ, 1978, P NATL ACAD SCI USA, V75, P4810, DOI 10.1073/pnas.75.10.4810; Meganathan R, 2001, VITAM HORM, V61, P173; Mendelson NH, 1996, J BACTERIOL, V178, P1980, DOI 10.1128/jb.178.7.1980-1989.1996; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; POPP JL, 1989, ANAL BIOCHEM, V178, P306, DOI 10.1016/0003-2697(89)90643-X; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rowland BM, 1996, GENE, V178, P119, DOI 10.1016/0378-1119(96)00349-6; SCHOLES PB, 1965, BIOCHEM J, V97, P766, DOI 10.1042/bj0970766; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SLECHTA L, 1958, NATURE, V181, P268, DOI 10.1038/181268b0; Sliusarenko O, 2007, J BACTERIOL, V189, P611, DOI 10.1128/JB.01206-06; Sogaard-Andersen L, 2003, MOL MICROBIOL, V48, P1, DOI 10.1046/j.1365-2958.2003.03399.x; STEINMETZ M, 1994, J BACTERIOL, V176, P1761, DOI 10.1128/jb.176.6.1761-1763.1994; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; TABER HW, 1981, J BACTERIOL, V145, P321, DOI 10.1128/JB.145.1.321-327.1981; Tcherpakov M, 1999, INT J SYST BACTERIOL, V49, P239, DOI 10.1099/00207713-49-1-239; VICSEK T, 1994, FRACTALS, V2, P15, DOI DOI 10.1142/S0218348X9400003X; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; Wallin R, 2008, VITAM HORM, V78, P227, DOI 10.1016/S0083-6729(07)00011-8; Yamamoto Y, 2006, BIOMETALS, V19, P205, DOI 10.1007/s10534-005-5419-6; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x; YOUNG IG, 1975, BIOCHEMISTRY-US, V14, P399, DOI 10.1021/bi00673a029	91	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79488	10.1371/journal.pone.0079488	http://dx.doi.org/10.1371/journal.pone.0079488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223955	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400118
J	Sin, YY; Ballantyne, LL; Mukherjee, K; Amand, TS; Kyriakopoulou, L; Schulze, A; Funk, CD				Sin, Yuan Yan; Ballantyne, Laurel L.; Mukherjee, Kamalika; Amand, Tim St.; Kyriakopoulou, Lianna; Schulze, Andreas; Funk, Colin D.			Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid Metabolism	PLOS ONE			English	Article							HUMAN-LIVER ARGINASE; GUANIDINO COMPOUNDS; GENE-THERAPY; MOUSE MODEL; BRAIN; EXPRESSION; CLONING; ARGININEMIA; SEQUENCE; PROLINE	Arginase deficiency is a rare autosomal recessive disorder resulting from a loss of the liver arginase isoform, arginase 1 (ARG1), which is the final step in the urea cycle for detoxifying ammonia. ARG1 deficiency leads to hyperargininemia, characterized by progressive neurological impairment, persistent growth retardation and infrequent episodes of hyperammonemia. Using the Cre/loxP-directed conditional gene knockout system, we generated an inducible Arg1-deficient mouse model by crossing "floxed'' Arg1 mice with CreER(T2) mice. The resulting mice (Arg-Cre) die about two weeks after tamoxifen administration regardless of the starting age of inducing the knockout. These treated mice were nearly devoid of Arg1 mRNA, protein and liver arginase activity, and exhibited symptoms of hyperammonemia. Plasma amino acid analysis revealed pronounced hyperargininemia and significant alterations in amino acid and guanidino compound metabolism, including increased citrulline and guanidinoacetic acid. Despite no alteration in ornithine levels, concentrations of other amino acids such as proline and the branched-chain amino acids were reduced. In summary, we have generated and characterized an inducible Arg1-deficient mouse model exhibiting several pathologic manifestations of hyperargininemia. This model should prove useful for exploring potential treatment options of ARG1 deficiency.	[Sin, Yuan Yan; Ballantyne, Laurel L.; Mukherjee, Kamalika; Amand, Tim St.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Kyriakopoulou, Lianna; Schulze, Andreas] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Kyriakopoulou, Lianna; Schulze, Andreas] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada	Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Schulze, Andreas/I-5706-2019; Mukherjee, Kamalika/O-5148-2019	Schulze, Andreas/0000-0001-8491-1095; Sin, Yuan Yan/0000-0001-6537-5266; Funk, Colin/0000-0001-7029-4233	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	CDF holds a Tier I Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Crombez EA, 2005, MOL GENET METAB, V84, P243, DOI 10.1016/j.ymgme.2004.11.004; Deignan JL, 2008, MOL GENET METAB, V93, P172, DOI 10.1016/j.ymgme.2007.09.016; Deignan JL, 2010, MOL GENET METAB, V100, pS31, DOI 10.1016/j.ymgme.2010.01.012; DIZIKES GJ, 1986, SOMAT CELL MOLEC GEN, V12, P375, DOI 10.1007/BF01570732; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FEIL S, 2009, METHOD MOL BIOL, V530, P1; FELDMAN JM, 1971, AM J PHYSIOL, V221, P1027, DOI 10.1152/ajplegacy.1971.221.4.1027; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; GRODY WW, 1993, HUM GENET, V91, P1; HARAGUCHI Y, 1987, P NATL ACAD SCI USA, V84, P412, DOI 10.1073/pnas.84.2.412; HARPER AE, 1989, J NUTR, V119, P677, DOI 10.1093/jn/119.5.677; Holecek M, 2011, AMINO ACIDS, V40, P575, DOI 10.1007/s00726-010-0679-z; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lee EK, 2013, GENE THER, V20, P785, DOI 10.1038/gt.2012.99; Lee EK, 2012, MOL THER, V20, P1844, DOI 10.1038/mt.2012.129; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; MIZUTANI N, 1987, TOHOKU J EXP MED, V153, P197, DOI 10.1620/tjem.153.197; Morris SM, 1997, GENE, V193, P157, DOI 10.1016/S0378-1119(97)00099-1; Prasad AN, 1997, J CHILD NEUROL, V12, P301, DOI 10.1177/088307389701200502; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPARKES RS, 1986, AM J HUM GENET, V39, P186; TAKIGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8789, DOI 10.1093/nar/16.18.8789; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606	35	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80001	10.1371/journal.pone.0080001	http://dx.doi.org/10.1371/journal.pone.0080001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224027	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000326503400149
J	Tajiri, N; Kellogg, SL; Shimizu, T; Arendash, GW; Borlongan, CV				Tajiri, Naoki; Kellogg, S. Leilani; Shimizu, Toru; Arendash, Gary W.; Borlongan, Cesar V.			Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular A beta Aggregation in Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; OLDER-ADULTS; RISK; ENCEPHALOPATHY; DAMAGE; ABNORMALITIES; HIPPOCAMPUS; PERFORMANCE	Traumatic brain injury (TBI) has become a signature wound of the wars in Iraq and Afghanistan. Many American soldiers, even those undiagnosed but likely suffering from mild TBI, display Alzheimer's disease (AD)-like cognitive impairments, suggesting a pathological overlap between TBI and AD. This study examined the cognitive and neurohistological effects of TBI in presymptomatic APP/PS1 AD-transgenic mice. AD mice and non-transgenic (NT) mice received an experimental TBI on the right parietal cortex using the controlled cortical impact model. Animals were trained in a water maze task for spatial memory before TBI, and then reevaluated in the same task at two and six weeks post-TBI. The results showed that AD mice with TBI made significantly more errors in the task than AD mice without TBI and NT mice regardless of TBI. A separate group of AD mice and NT mice were evaluated neurohistologically at six weeks after TBI. The number of extracellular beta-amyloid (A beta)-deposits significantly increased by at least one fold in the cortex of AD mice that received TBI compared to the NT mice that received TBI or the AD and NT mice that underwent sham surgery. A significant decrease in MAP2 positive cells, indicating neuronal loss, was observed in the cortex of both the AD and NT mice that received TBI compared to the AD and NT mice subjected to sham surgery. Similar changes in extracellular A beta deposits and MAP2 positive cells were also seen in the hippocampus. These results demonstrate for the first time that TBI precipitates cognitive impairment in presymptomatic AD mice, while also confirming extracellular A beta deposits following TBI. The recognition of this pathological link between TBI and AD should aid in developing novel treatments directed at abrogating cellular injury and extracellular A beta deposition in the brain.	[Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA; [Kellogg, S. Leilani; Shimizu, Toru] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Arendash, Gary W.] NeuroEM Therapeut Inc, Scottsdale, AZ USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782	University of South Florida Department of Neurosurgery; Brain Repair funds; James and Esther King Biomedical Research Foundation [1KG01-33966, NIH 5U01NS055914-04, NIH 1R01NS071956-01A1]; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	University of South Florida Department of Neurosurgery; Brain Repair funds; James and Esther King Biomedical Research Foundation; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Borroni B, 2002, J NEUROL SCI, V203, P189, DOI 10.1016/S0022-510X(02)00289-7; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Davies TA, 2000, AMYLOID, V7, P153, DOI 10.3109/13506120009146830; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jantaratnotai Nattinee, 2011, Int J Alzheimers Dis, V2011, P918280, DOI 10.4061/2011/918280; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Mlekusch R, 2009, NEUROSCI LETT, V466, P135, DOI 10.1016/j.neulet.2009.09.043; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Palmer JC, 2010, NEUROPATH APPL NEURO, V36, P487, DOI 10.1111/j.1365-2990.2010.01084.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sarmiento K, 2008, J HEAD TRAUMA REHAB, V23, P164, DOI 10.1097/01.HTR.0000319933.22709.61; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; Yesil Y, 2012, ARCH GERONTOL GERIAT, V55, P257, DOI 10.1016/j.archger.2011.09.016; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	37	50	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78851	10.1371/journal.pone.0078851	http://dx.doi.org/10.1371/journal.pone.0078851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223856	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400091
J	Zehender, G; Ebranati, E; Shkjezi, R; Papa, A; Luzzago, C; Gabanelli, E; Lo Presti, A; Lai, A; Rezza, G; Galli, M; Bino, S; Ciccozzi, M				Zehender, Gianguglielmo; Ebranati, Erika; Shkjezi, Renata; Papa, Anna; Luzzago, Camilla; Gabanelli, Elena; Lo Presti, Alessandra; Lai, Alessia; Rezza, Giovanni; Galli, Massimo; Bino, Silvia; Ciccozzi, Massimo			Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe	PLOS ONE			English	Article							CLINICAL-FEATURES; SPREAD; EPIDEMIOLOGY; TRANSMISSION; INFERENCE; DYNAMICS; OUTBREAK; PATTERNS; DISEASES; STRAINS	Crimean-Congo hemorrhagic fever (CCHF) is a zoonosis mainly transmitted by ticks that causes severe hemorrhagic fever and has a mortality rate of 5-60%. The first outbreak of CCHF occurred in the Crimean peninsula in 1944-45 and it has recently emerged in the Balkans and eastern Mediterranean. In order to reconstruct the origin and pathway of the worldwide dispersion of the virus at global and regional (eastern European) level, we investigated the phylogeography of the infection by analysing 121 publicly available CCHFV S gene sequences including two recently characterised Albanian isolates. The spatial and temporal phylogeny was reconstructed using a Bayesian Markov chain Monte Carlo approach, which estimated a mean evolutionary rate of 2.96 x 10(-4) (95% HPD=1.6 and 4.7 x 10(-4)) substitutions/site/year for the analysed fragment. All of the isolates segregated into seven highly significant clades that correspond to the known geographical clades: in particular the two new isolates from northern Albania clustered significantly within the Europe 1 clade. Our phylogeographical reconstruction suggests that the global CCHFV clades originated about one thousand years ago from a common ancestor probably located in Africa. The virus then spread to Asia in the XV century and entered Europe on at least two occasions: the first in the early 1800s, when a still circulating but less or non-pathogenic virus emerged in Greece and Turkey, and the second in the early 1900s, when a pathogenic CCHFV strain began to spread in eastern Europe. The most probable location for the origin of this European clade 1 was Russia, but Turkey played a central role in spreading the virus throughout Europe. Given the close proximity of the infected areas, our data suggest that the movement of wild and domestic ungulates from endemic areas was probably the main cause of the dissemination of the virus in eastern Europe.	[Zehender, Gianguglielmo; Ebranati, Erika; Gabanelli, Elena; Lai, Alessia; Galli, Massimo] Univ Milan, Dept Clin Sci Luigi Sacco, Infect Dis Sect, Milan, Italy; [Shkjezi, Renata] Catholic Univ Our Lady Good Council, Fac Med, Tirana, Albania; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Thessaloniki, Greece; [Luzzago, Camilla] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Lo Presti, Alessandra; Rezza, Giovanni; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediate Dis, Epidemiol Unit, Rome, Italy; [Bino, Silvia] Natl Inst Hlth, Control Infect Dis Dept, Tirana, Albania	University of Milan; Luigi Sacco Hospital; Aristotle University of Thessaloniki; University of Milan; Istituto Superiore di Sanita (ISS)	Zehender, G (corresponding author), Univ Milan, Dept Clin Sci Luigi Sacco, Infect Dis Sect, Milan, Italy.	gianguglielmo.zehender@unimi.it	CICCOZZI, MASSIMO/C-6484-2016; Lo Presti, Alessandra/K-1451-2016; Luzzago, Camilla/G-2829-2011; rezza, giovanni/D-4393-2016; Ciccozzi, Massimo/AAC-3271-2022; LAI, ALESSIA/AAR-1300-2021; GALLI, MASSIMO/L-7282-2017	CICCOZZI, MASSIMO/0000-0003-3866-9239; Lo Presti, Alessandra/0000-0001-7611-5021; Luzzago, Camilla/0000-0001-9236-2049; rezza, giovanni/0000-0003-0268-6790; Ciccozzi, Massimo/0000-0003-3866-9239; LAI, ALESSIA/0000-0002-3174-5721; GALLI, MASSIMO/0000-0001-8887-6215	European Commission [260427]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no 260427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou V, 2009, INFECT GENET EVOL, V9, P948, DOI 10.1016/j.meegid.2009.06.018; [Anonymous], 2012, EFSA J, V10, P2635; Aradaib IE, 2010, EMERG INFECT DIS, V16, P837, DOI 10.3201/eid1605.091815; Bakir M, 2005, J MED MICROBIOL, V54, P385, DOI 10.1099/jmm.0.45865-0; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Carroll SA, 2010, MOL PHYLOGENET EVOL, V55, P1103, DOI 10.1016/j.ympev.2010.01.006; Chinikar S, 2010, J CLIN VIROL, V47, P110, DOI 10.1016/j.jcv.2009.10.014; Chumakov M. P., 1945, MEDITSINSKA PARAZITOLOGI[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P18; Ciccozzi M, 2013, INFECT GENET EVOL, V17, P46, DOI 10.1016/j.meegid.2013.03.034; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EFSA, 2010, EFSA J, V8, P1703; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada-Pena A, 2012, EMERG INFECT DIS, V18, P179, DOI 10.3201/eid1801.111040; Gargili A, 2011, VECTOR-BORNE ZOONOT, V11, P747, DOI 10.1089/vbz.2010.0030; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Han Na, 2011, Virologica Sinica, V26, P229, DOI 10.1007/s12250-011-3211-z; Hewson R, 2004, VIRUS RES, V102, P185, DOI 10.1016/j.virusres.2003.12.035; HOOGSTRAAL H, 1981, ANNU REV ENTOMOL, V26, P75, DOI 10.1146/annurev.en.26.010181.000451; Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1; Jameson LJ, 2012, VECTOR-BORNE ZOONOT, V12, P753, DOI 10.1089/vbz.2011.0773; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KONDRATENKO V F, 1976, Parazitologiya (St. Petersburg), V10, P297; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Kunchev A, 2008, EUROSURVEILLANCE, V13; Leblebicioglu H, 2010, INT J ANTIMICROB AG, V36, pS43, DOI 10.1016/j.ijantimicag.2010.06.020; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Mahzounieh M, 2012, VECTOR-BORNE ZOONOT, V12, P782, DOI 10.1089/vbz.2011.0928; Midilli K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-54; Mild M, 2010, J GEN VIROL, V91, P199, DOI 10.1099/vir.0.014878-0; Nabeth P, 2007, EMERGING VIRUSES HUM, VS0168-7069, P16012; Ozkaya E, 2010, VIRUS RES, V149, P64, DOI 10.1016/j.virusres.2009.12.014; Papa A, 2008, EUROSURVEILLANCE, V13; Papa A, 2011, EMERG INFECT DIS, V17, P141, DOI 10.3201/eid1701.100073; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Roeder PL, 2006, RINDERPEST 20 21 CEN; Schmaljohn C.S., 2001, FIELDS VIROLOGY; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHEPHERD AJ, 1987, T ROY SOC TROP MED H, V81, P1004, DOI 10.1016/0035-9203(87)90379-8; Sherman DM, 2011, REV SCI TECH OIE, V30, P207; SLATKIN M, 1989, GENETICS, V123, P603; Slingenbergh J, 2004, REV SCI TECH OIE, V23, P467, DOI 10.20506/rst.23.2.1492; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDEWAL BW, 1985, S AFR MED J, V68, P729; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003	50	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79663	10.1371/journal.pone.0079663	http://dx.doi.org/10.1371/journal.pone.0079663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223988	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400134
J	Berg, A; Zelano, J; Pekna, M; Wilhelmsson, U; Pekny, M; Cullheim, S				Berg, Alexander; Zelano, Johan; Pekna, Marcela; Wilhelmsson, Ulrika; Pekny, Milos; Cullheim, Staffan			Axonal Regeneration after Sciatic Nerve Lesion Is Delayed but Complete in GFAP- and Vimentin-Deficient Mice	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; SPINAL MOTONEURONS; ASTROCYTE ACTIVATION; SYNAPTIC TERMINALS; NEUROMUSCULAR-JUNCTION; FUNCTIONAL RECOVERY; CELL-PROLIFERATION; SCHWANN-CELLS; GLIAL-CELLS	Peripheral axotomy of motoneurons triggers Wallerian degeneration of injured axons distal to the lesion, followed by axon regeneration. Centrally, axotomy induces loss of synapses (synaptic stripping) from the surface of lesioned motoneurons in the spinal cord. At the lesion site, reactive Schwann cells provide trophic support and guidance for outgrowing axons. The mechanisms of synaptic stripping remain elusive, but reactive astrocytes and microglia appear to be important in this process. We studied axonal regeneration and synaptic stripping of motoneurons after a sciatic nerve lesion in mice lacking the intermediate filament (nanofilament) proteins glial fibrillary acidic protein (GFAP) and vimentin, which are upregulated in reactive astrocytes and Schwann cells. Seven days after sciatic nerve transection, ultrastructural analysis of synaptic density on the somata of injured motoneurons revealed more remaining boutons covering injured somata in GFAP(-/-)Vim(-/-) mice. After sciatic nerve crush in GFAP(-/-)Vim(-/-) mice, the fraction of reinnervated motor endplates on muscle fibers of the gastrocnemius muscle was reduced 13 days after the injury, and axonal regeneration and functional recovery were delayed but complete. Thus, the absence of GFAP and vimentin in glial cells does not seem to affect the outcome after peripheral motoneuron injury but may have an important effect on the response dynamics.	[Berg, Alexander; Cullheim, Staffan] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Zelano, Johan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Pekna, Marcela; Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Pekna, Marcela; Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Karolinska Institutet; Uppsala University; University of Gothenburg; Florey Institute of Neuroscience & Mental Health	Berg, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	alexander.berg@ki.se	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021; Zelano, Johan/AAF-1708-2021	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Zelano, Johan/0000-0001-9445-4545; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research Council; AFA Research Foundation; ALF Goteborg [11392]; Sten A. Olsson Foundation for Research and Culture; Soderberg Foundations; Hjarnfonden; Hagstromer's Foundation Millennium; Swedish Stroke Foundation; Swedish Society for Medical Research; Free Mason Foundation; Amlov's Foundation; E. Jacobson's Donation Fund; NanoNet COST Action [BM1002]; EU [237956, 279017]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA Research Foundation; ALF Goteborg; Sten A. Olsson Foundation for Research and Culture; Soderberg Foundations; Hjarnfonden; Hagstromer's Foundation Millennium; Swedish Stroke Foundation; Swedish Society for Medical Research; Free Mason Foundation; Amlov's Foundation; E. Jacobson's Donation Fund; NanoNet COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission)	This work was supported by the Swedish Medical Research Council, AFA Research Foundation, ALF Goteborg (project 11392), Sten A. Olsson Foundation for Research and Culture, Soderberg Foundations, Hjarnfonden, Hagstromer's Foundation Millennium, the Swedish Stroke Foundation, the Swedish Society for Medical Research, the Free Mason Foundation, Amlov's Foundation, E. Jacobson's Donation Fund, NanoNet COST Action (BM1002), the EU FP 7 Program EduGlia (237956), and the EU FP 7 Program TargetBraIn (279017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Alvarez FJ, 2011, J NEUROPHYSIOL; Barron K, 1983, SPINAL CORD RECONSTR, P7; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Carlstedt T, 2000, Prog Brain Res, V127, P501; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; COPE TC, 1994, J NEUROPHYSIOL, V71, P817, DOI 10.1152/jn.1994.71.2.817; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koirala S, 2000, J NEUROBIOL, V44, P343, DOI 10.1002/1097-4695(20000905)44:3<343::AID-NEU5>3.0.CO;2-O; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lago N, 2006, J NEUROTRAUM, V23, P227, DOI 10.1089/neu.2006.23.227; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Linda H, 2000, J COMP NEUROL, V425, P10; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Ludwin S K, 1988, Adv Neurol, V47, P215; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mor D, 2010, NEUROSCIENCE, V166, P1167, DOI 10.1016/j.neuroscience.2010.01.045; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; STEFANSSON K, 1982, BRAIN RES, V234, P309, DOI 10.1016/0006-8993(82)90871-X; SUGIMURA K, 1989, MUSCLE NERVE, V12, P929, DOI 10.1002/mus.880121109; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; SUMNER BEH, 1975, EXP NEUROL, V49, P406, DOI 10.1016/0014-4886(75)90097-7; SVENSSON M, 1993, BRAIN RES BULL, V30, P499, DOI 10.1016/0361-9230(93)90284-I; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vardjan N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-144; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	51	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79395	10.1371/journal.pone.0079395	http://dx.doi.org/10.1371/journal.pone.0079395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223940	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300080
J	Dobigny, G; Tatard, C; Gauthier, P; Ba, K; Duplantier, JM; Granjon, L; Kergoat, GJ				Dobigny, Gauthier; Tatard, Caroline; Gauthier, Philippe; Ba, Khalilou; Duplantier, Jean-Marc; Granjon, Laurent; Kergoat, Gael J.			Mitochondrial and Nuclear Genes-Based Phylogeography of Arvicanthis niloticus (Murinae) and Sub-Saharan Open Habitats Pleistocene History	PLOS ONE			English	Article							CLIMATE-CHANGE; RODENTIA MURIDAE; WEST-AFRICA; POPULATION-GENETICS; COMPLEX RODENTIA; EAST-AFRICA; EVOLUTION; REFUGIA; CONSERVATION; BIODIVERSITY	A phylogeographic study was conducted on the Nile grass rat, Arvicanthis niloticus, a rodent species that is tightly associated with open grasslands from the Sudano-Sahelian regions. Using one mitochondrial (cytochrome b) and one nuclear (intron 7 of Beta Fibrinogen) gene, robust patterns were retrieved that clearly show that (i) the species originated in East Africa concomitantly with expanding grasslands some 2 Ma, and (ii) four parapatric and genetically well-defined lineages differentiated essentially from East to West following Pleistocene bioclimatic cycles. This strongly points towards allopatric genetic divergence within savannah refuges during humid episodes, then dispersal during arid ones; secondary contact zones would have then stabilized around geographic barriers, namely, Niger River and Lake Chad basins. Our results pertinently add to those obtained for several other African rodent as well as non-rodent species that inhabit forests, humid zones, savannahs and deserts, all studies that now allow one to depict a more comprehensive picture of the Pleistocene history of the continent south of the Sahara. In particular, although their precise location remains to be determined, at least three Pleistocene refuges are identified within the West and Central African savannah biome.	[Dobigny, Gauthier; Gauthier, Philippe; Duplantier, Jean-Marc; Granjon, Laurent] IRD, CBGP, INRA, CIRAD,Montpellier SupAgro, Montferrier Sur Lez, France; [Dobigny, Gauthier] Ctr Reg Agrhymet, Niamey, Niger; [Tatard, Caroline; Kergoat, Gael J.] INRA, CBGP, IRD, CIRAD,Montpellier SupAgro, Montferrier Sur Lez, France; [Ba, Khalilou; Granjon, Laurent] IRD, CBGP, INRA, CIRAD,Montpellier SupAgro, Dakar, Senegal	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Kergoat, GJ (corresponding author), INRA, CBGP, IRD, CIRAD,Montpellier SupAgro, Campus Baillarguet, Montferrier Sur Lez, France.	kergoat@supagro.inra.fr	Granjon, Laurent/K-2111-2016; Kergoat, Gael J./AAW-6505-2020	Granjon, Laurent/0000-0003-1182-3793; Kergoat, Gael J./0000-0002-8284-6215; GAUTHIER, Philippe/0000-0001-8363-6845				Ahmed EHAR, 2008, BIOL J LINN SOC, V93, P641, DOI 10.1111/j.1095-8312.2007.00895.x; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow A, 2013, MOL ECOL, V22, P1134, DOI 10.1111/mec.12157; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Baskevich M. I., 2000, BONN ZOOL MONOGR, V46, P209; Beatty GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-29; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Ben Faleh A, 2012, BIOL J LINN SOC, V107, P27, DOI 10.1111/j.1095-8312.2012.01920.x; Bobe R, 2004, PAL PAL PAL, V207, P309; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Bryja J, 2010, MOL ECOL, V19, P4783, DOI 10.1111/j.1365-294X.2010.04847.x; Castiglia R, 2006, J ZOOL SYST EVOL RES, V44, P223, DOI 10.1111/j.1439-0469.2006.00356.x; Castiglia R, 2003, GENETICA, V118, P33, DOI 10.1023/A:1022903112274; Colangelo P, 2012, BIOL J LINN SOC, V108, P901; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dobigny G, 2005, HEREDITY, V95, P358, DOI 10.1038/sj.hdy.6800730; Dobigny G, 2002, MAMMALIA, V66, P495, DOI 10.1515/mamm.2002.66.4.495; Dobigny G, 2001, COLLOQ SEMI, P445; Dobigny G, 2010, HEREDITY, V104, P378, DOI 10.1038/hdy.2009.119; Dobigny G, 2011, MAMM BIOL, V76, P417, DOI 10.1016/j.mambio.2010.10.002; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ducroz J. F., 2001, Journal of Mammalian Evolution, V8, P173, DOI 10.1023/A:1012277012303; Ducroz JF, 1997, J ZOOL, V241, P709, DOI 10.1111/j.1469-7998.1997.tb05743.x; Ducroz JF, 1998, MOL PHYLOGENET EVOL, V10, P104, DOI 10.1006/mpev.1997.0477; DUCROZ JF, 1998, THESIS MUSEUM NATL H; Duplantier JM, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P527, DOI 10.1007/978-4-431-36025-4_24; Dupont L, 2011, QUATERNARY SCI REV, V30, P3589, DOI 10.1016/j.quascirev.2011.09.019; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Fontaine C, 2004, HEREDITY, V93, P639, DOI 10.1038/sj.hdy.6800591; Fu YX, 1997, GENETICS, V147, P915; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; GITHURE JI, 1986, ANN TROP MED PARASIT, V80, P501, DOI 10.1080/00034983.1986.11812056; Gomez C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-167; GRANJON L, 1992, ISRAEL J ZOOL, V38, P263; Granjon L, 2003, MAMMAL REV, V33, P77, DOI 10.1046/j.1365-2907.2003.00007.x; Granjon L., 2009, RONGEURS AFRIQUE SAH; Granjon L., 2013, MAMMALS AFRICA, VIII, P387; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, HEREDITY, V92, P1, DOI 10.1038/sj.hdy.6800365; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hima K, 2011, J ZOOL, V284, P276, DOI 10.1111/j.1469-7998.2011.00803.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Jacobs Louis L., 1994, National Science Museum Monographs, V8, P149; Julvez J, 1997, Med Trop (Mars), V57, P153; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lecompte E, 2002, J ZOOL SYST EVOL RES, V40, P8, DOI 10.1046/j.1439-0469.2002.00172.x; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; LEHOUEROU HN, 1992, J ARID ENVIRON, V22, P3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Lorenzen ED, 2007, MOL ECOL, V16, P3241, DOI 10.1111/j.1365-294X.2007.03382.x; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Maley J., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P68; Maley J., 1980, SAHARA NILE PP, P63; Mardsen CD, 2012, MOL ECOL, V21, P1379; Matthee CA, 2002, MOL ECOL, V11, P465, DOI 10.1046/j.0962-1083.2001.01458.x; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Mercier A, 2013, MEM I OSWALDO CRUZ, V108, P399, DOI 10.1590/S0074-0276108042013002; Miller JM, 2011, CONSERV GENET, V12, P423, DOI 10.1007/s10592-010-0149-x; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; Morales-Hojas R, 2008, MOL ECOL, V17, P2910, DOI 10.1111/j.1365-294X.2008.03796.x; Mouline K, 2008, MOL ECOL, V17, P1036, DOI 10.1111/j.1365-294X.2007.03610.x; Musser GG, 2005, MAMMALS WORLD TAXONO, V2, P1285; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nicolas V, 2008, MOL ECOL, V17, P5118, DOI 10.1111/j.1365-294X.2008.03974.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nicolas V, 2012, AFR ZOOL, V47, P100, DOI 10.3377/004.047.0119; Nicolas V, 2009, BIOL J LINN SOC, V98, P29, DOI 10.1111/j.1095-8312.2009.01273.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Poelchau MF, 2013, J BIOGEOGR, V40, P618, DOI 10.1111/j.1365-2699.2011.02599.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rohland N, 2005, MOL BIOL EVOL, V22, P2435, DOI 10.1093/molbev/msi244; SEBEK Z, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P337; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sezonlin M, 2006, MOL ECOL, V15, P407, DOI 10.1111/j.1365-294X.2005.02761.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; TAJIMA F, 1989, GENETICS, V123, P585; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Trape JF, 1996, AM J TROP MED HYG, V54, P289, DOI 10.4269/ajtmh.1996.54.289; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Volobouev VT, 2002, CYTOGENET GENOME RES, V96, P261, DOI 10.1159/000063049; Volobouev VT, 2002, CYTOGENET GENOME RES, V96, P250, DOI 10.1159/000063041; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Winkler AJ, 2002, J HUM EVOL, V42, P237, DOI 10.1006/jhev.2001.0501; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	121	32	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77815	10.1371/journal.pone.0077815	http://dx.doi.org/10.1371/journal.pone.0077815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223730	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300009
J	Gautam, S; Kirschnek, S; Wiesmeier, M; Vier, J; Hacker, G				Gautam, Sanjivan; Kirschnek, Susanne; Wiesmeier, Michael; Vier, Juliane; Haecker, Georg			Roscovitine-induced Apoptosis in Neutrophils and Neutrophil Progenitors Is Regulated by the Bcl-2-Family Members Bim, Puma, Noxa and Mcl-1	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; BCL-2 PROTEIN FAMILY; R-ROSCOVITINE; CANCER THERAPEUTICS; SELICICLIB CYC202; BH3-ONLY PROTEINS; MULTIPLE-MYELOMA; DOWN-REGULATION; BH3 DOMAINS; CELL-DEATH	Neutrophil granulocyte (neutrophil) apoptosis plays a key role in determining inflammation in infectious and noninfectious settings. Recent work has shown that inhibitors of cyclin-dependent kinases (cdk) such as roscovitine can potently induce neutrophil apoptosis and reduce inflammation. Using a conditional Hoxb8-expression system we tested the participation of Bcl-2-family proteins to roscovitine-induced apoptosis in mouse neutrophils and in neutrophil progenitor cells. Bcl-2 strongly protected against roscovitine-induced apoptosis in neutrophils. The isolated loss of either Bim or noxa provided significant, partial protection while protection through combined loss of Bim and noxa or Bim and Puma was only slightly greater than this individual loss. The only substantial change in protein levels observed was the loss of Mcl-1, which was not transcriptional and was inhibited by proteasome blockade. In progenitor cells there was no protection by the loss of Bim alone but substantial protection by the loss of both Bim and Puma; surprisingly, strongest protection was seen by the isolated loss of noxa. The pattern of protein expression and Mcl-1-regulation in progenitor cells was very similar to the one observed in differentiated neutrophils. In addition, roscovitine strongly inhibited proliferation in progenitor cells, associated with an accumulation of cells in G2/M-phase.	[Gautam, Sanjivan; Kirschnek, Susanne; Wiesmeier, Michael; Vier, Juliane; Haecker, Georg] Univ Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	University of Freiburg	Hacker, G (corresponding author), Univ Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany.	georg.haecker@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 620, TP A12]; Spemann Graduate School, Excellence Initiative of German Government; MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg; Else Kroner Fresenius-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Spemann Graduate School, Excellence Initiative of German Government; MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg; Else Kroner Fresenius-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB 620, TP A12), grant to GH, S. G was supported by Spemann Graduate School, Excellence Initiative of German Government and M. W was supported by MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg funded by Else Kroner Fresenius-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Craxton A, 2012, CELL DEATH DIFFER, V19, P1424, DOI 10.1038/cdd.2012.16; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Hoogendijk AJ, 2012, MOL MED, V18, P1086, DOI 10.2119/molmed.2012.00033; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Leitch AE, 2012, CELL DEATH DIFFER, V19, P1950, DOI 10.1038/cdd.2012.80; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Ren Y, 2008, J IMMUNOL, V180, P4978, DOI 10.4049/jimmunol.180.7.4978; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tofts PS, 2011, BLOOD, V117, P6050, DOI 10.1182/blood-2010-10-310532; Turner SM, 2011, BLOOD, V117, P6052, DOI 10.1182/blood-2010-12-322271; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	34	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79352	10.1371/journal.pone.0079352	http://dx.doi.org/10.1371/journal.pone.0079352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223929	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300076
J	Robert, JA; Pitt, C; Bonnett, TR; Yuen, MMS; Keeling, CI; Bohlmann, J; Huber, DPW				Robert, Jeanne A.; Pitt, Caitlin; Bonnett, Tiffany R.; Yuen, Macaire M. S.; Keeling, Christopher I.; Bohlmann, Joerg; Huber, Dezene P. W.			Disentangling Detoxification: Gene Expression Analysis of Feeding Mountain Pine Beetle Illuminates Molecular-Level Host Chemical Defense Detoxification Mechanisms	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE HOPKINS; GLUTATHIONE-S-TRANSFERASE; BARK BEETLE; PYREARINUS-TERMITILLUMINANS; HETEROLOGOUS EXPRESSION; INSECTICIDE RESISTANCE; FUNCTIONAL EXPRESSION; GROSMANNIA-CLAVIGERA; COLEOPTERA; IDENTIFICATION	The mountain pine beetle, Dendroctonus ponderosae, is a native species of bark beetle (Coleoptera: Curculionidae) that caused unprecedented damage to the pine forests of British Columbia and other parts of western North America and is currently expanding its range into the boreal forests of central and eastern Canada and the USA. We conducted a large-scale gene expression analysis (RNA-seq) of mountain pine beetle male and female adults either starved or fed in male-female pairs for 24 hours on lodgepole pine host tree tissues. Our aim was to uncover transcripts involved in coniferophagous mountain pine beetle detoxification systems during early host colonization. Transcripts of members from several gene families significantly increased in insects fed on host tissue including: cytochromes P450, glucosyl transferases and glutathione S-transferases, esterases, and one ABC transporter. Other significantly increasing transcripts with potential roles in detoxification of host defenses included alcohol dehydrogenases and a group of unexpected transcripts whose products may play an, as yet, undiscovered role in host colonization by mountain pine beetle.	[Robert, Jeanne A.; Pitt, Caitlin; Bonnett, Tiffany R.; Huber, Dezene P. W.] Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada; [Yuen, Macaire M. S.; Keeling, Christopher I.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of Northern British Columbia; University of British Columbia	Robert, JA (corresponding author), Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada.	jrobert@unbc.ca	Keeling, Christopher I./I-3371-2012; Huber, Dezene P.W./AAG-9638-2019	Keeling, Christopher I./0000-0001-7885-8558; Huber, Dezene P.W./0000-0002-6495-1759	Natural Science and Engineering Research Council of Canada (NSERC); Genome Canada; Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program; Canada Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program(Canada Research Chairs); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF)	This work was supported by the following: Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (http://www.nserc-crsng.gc.ca/index_eng.asp); Genome Canada (http://www.genomecanada.ca); Genome British Columbia (http://www.genomebc.ca); Genome Alberta (http://genomealberta.ca); Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca); Canada Foundation for Innovation (CFI) (http://www.innovation.ca; and British Columbia Knowledge Development Fund (BCKDF) (http://www.aved.gov.bc.ca/researchandinnovation/Funding/BCKDF/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aw T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-215; Barkawi LS, 2003, INSECT BIOCHEM MOLEC, V33, P773, DOI 10.1016/S0965-1748(03)00069-9; Barros MP, 1998, FREE RADICAL BIO MED, V24, P767, DOI 10.1016/S0891-5849(97)00335-3; Barros MP, 2001, INSECT BIOCHEM MOLEC, V31, P393, DOI 10.1016/S0965-1748(00)00132-6; Barros MP, 2000, PHOTOCHEM PHOTOBIOL, V71, P648, DOI 10.1562/0031-8655(2000)071&lt;0648:LAUMAA&gt;2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; BRATTSTEN LB, 1977, SCIENCE, V196, P1349, DOI 10.1126/science.196.4296.1349; British Columbia Ministry of Lands Forests and Natural Resource Operations, 2012, HIST BATTL MOUNT PIN; BUESA C, 1994, J BIOL CHEM, V269, P11707; Cano-Ramirez C, 2013, GENE, V520, P47, DOI 10.1016/j.gene.2012.11.059; Clark EL, 2012, ENVIRON ENTOMOL, V41, P392, DOI 10.1603/EN11295; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Day JC, 2004, LUMINESCENCE, V19, P8, DOI 10.1002/bio.749; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Feng QL, 2001, J INSECT PHYSIOL, V47, P1, DOI 10.1016/S0022-1910(00)00093-7; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Figueroa-Teran R, 2012, INSECT BIOCHEM MOLEC, V42, P81, DOI 10.1016/j.ibmb.2011.10.009; Francke W, 1996, BIOORGAN MED CHEM, V4, P363, DOI 10.1016/0968-0896(96)00013-2; Fraser JD, 2011, THESIS U N BRIT COLU; Gilg AB, 2005, P NATL ACAD SCI USA, V102, P9760, DOI 10.1073/pnas.0503277102; Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200; Huang HS, 1998, INSECT BIOCHEM MOLEC, V28, P651, DOI 10.1016/S0965-1748(98)00049-6; Huber DPW, 2007, INSECT MOL BIOL, V16, P335, DOI 10.1111/j.1365-2583.2007.00731.x; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Keeling CI, 2006, INSECT MOL BIOL, V15, P207, DOI 10.1111/j.1365-2583.2006.00629.x; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee S, 2006, CAN J FOREST RES, V36, P2864, DOI 10.1139/X06-194; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; LIBBEY LM, 1985, Z ANGEW ENTOMOL, V100, P381; Lopez MF, 2013, INSECT BIOCHEM MOLEC, V43, P417, DOI 10.1016/j.ibmb.2013.02.004; LYON R. L., 1958, CANADIAN ENT, V90, P582; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Nealis V, 2009, BC10417 CAN FOR SERV; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; REID R. W., 1958, CANADIAN ENT, V90, P464; Roth CW, 2003, MOL CELLS, V15, P150; Sandstrom P, 2006, INSECT BIOCHEM MOLEC, V36, P835, DOI 10.1016/j.ibmb.2006.08.004; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schneider R. R., 2010, International Journal of Forestry Research, V2010, P417595, DOI 10.1155/2010/417595; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SHRIMPTON DM, 1973, CAN J BOT, V51, P527, DOI 10.1139/b73-064; Song MM, 2013, INSECT BIOCHEM MOLEC, V43, P336, DOI 10.1016/j.ibmb.2013.01.003; Syvanen M, 1996, J MOL EVOL, V43, P236, DOI 10.1007/PL00006082; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; VANDERWEL D, 1992, J CHEM ECOL, V18, P1389, DOI 10.1007/BF00994364; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; VONRUDLOFF E, 1987, CAN J FOREST RES, V17, P1013; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	67	46	47	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77777	10.1371/journal.pone.0077777	http://dx.doi.org/10.1371/journal.pone.0077777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223726	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300006
J	Sarmiento, L; Frisk, G; Anagandula, M; Cabrera-Rode, E; Roivainen, M; Cilio, CM				Sarmiento, Luis; Frisk, Gun; Anagandula, Mahesh; Cabrera-Rode, Eduardo; Roivainen, Merja; Cilio, Corrado M.			Expression of Innate Immunity Genes and Damage of Primary Human Pancreatic Islets by Epidemic Strains of Echovirus: Implication for Post-Virus Islet Autoimmunity	PLOS ONE			English	Article							BETA-CELLS; ENTEROVIRUS INFECTION; PATHOGENESIS; MECHANISMS; ANTIBODIES; CYTOKINE; CHILDREN; RNA	Three large-scale Echovirus (E) epidemics (E4, E16, E30), each differently associated to the acute development of diabetes related autoantibodies, have been documented in Cuba. The prevalence of islet cell autoantibodies was moderate during the E4 epidemic but high in the E16 and E30 epidemic. The aim of this study was to evaluate the effect of epidemic strains of echovirus on beta-cell lysis, beta-cell function and innate immunity gene expression in primary human pancreatic islets. Human islets from non-diabetic donors (n = 7) were infected with the virus strains E4, E16 and E30, all isolated from patients with aseptic meningitis who seroconverted to islet cell antibody positivity. Viral replication, degree of cytolysis, insulin release in response to high glucose as well as mRNA expression of innate immunity genes (IFN-b, RANTES, RIG-I, MDA5, TLR3 and OAS) were measured. The strains of E16 and E30 did replicate well in all islets examined, resulting in marked cytotoxic effects. E4 did not cause any effects on cell lysis, however it was able to replicate in 2 out of 7 islet donors. Beta-cell function was hampered in all infected islets (P<0.05); however the effect of E16 and E30 on insulin secretion appeared to be higher than the strain of E4. TLR3 and IFN-beta mRNA expression increased significantly following infection with E16 and E30 (P<0.033 and P<0.039 respectively). In contrast, the expression of none of the innate immunity genes studied was altered in E4-infected islets. These findings suggest that the extent of the epidemic-associated islet autoimmunity may depend on the ability of the viral strains to damage islet cells and induce pro-inflammatory innate immune responses within the infected islets.	[Sarmiento, Luis; Cilio, Corrado M.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden; [Sarmiento, Luis] Pedro Kouri Trop Med Inst, Dept Virol, Havana, Cuba; [Frisk, Gun; Anagandula, Mahesh] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Cabrera-Rode, Eduardo] Natl Inst Endocrinol, Dept Immunol & Genet Diabet, Havana, Cuba; [Roivainen, Merja] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Div Hlth Protect, Intestinal Viruses Unit, Helsinki, Finland	Lund University; Skane University Hospital; Uppsala University; Finland National Institute for Health & Welfare	Cilio, CM (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden.	corrado.cilio@med.lu.se		Sarmiento, Luis/0000-0002-3694-1211	Swedish Medical Research Council; Swedish Diabetes Association	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Association	This work was supported by Swedish Medical Research Council and Swedish Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hello H, 2009, J MED VIROL, V81, P296, DOI 10.1002/jmv.21391; Al-Hello H, 2008, J GEN VIROL, V89, P1949, DOI 10.1099/vir.0.83474-0; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Cabrera-Rode E, 2005, J MED VIROL, V76, P373, DOI 10.1002/jmv.20368; Cabrera-Rode E, 2003, DIABETOLOGIA, V46, P1348, DOI 10.1007/s00125-003-1179-4; Cabrera-Rode E, 2013, DIABETES VIRUSES, P195; Chehadeh W, 2000, J VIROL, V74, P10153, DOI 10.1128/JVI.74.21.10153-10164.2000; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Elshebani A, 2007, VIRUS RES, V124, P193, DOI 10.1016/j.virusres.2006.11.004; Frisk G, 2000, Int J Exp Diabetes Res, V1, P165, DOI 10.1155/EDR.2000.165; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Klemola P, 2008, ANN NY ACAD SCI, V1150, P210, DOI 10.1196/annals.1447.012; Lennette EH, 1969, DIAGNOSTIC PROCEDURE, P1; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Otonkoski T, 2000, DIABETOLOGIA, V43, P1235, DOI 10.1007/s001250051518; Paananen A, 2007, J MED VIROL, V79, P945, DOI 10.1002/jmv.20922; Paananen A, 2003, J MED VIROL, V69, P529, DOI 10.1002/jmv.10341; Perez LS, 2004, FOCUS ON MENINGITIS RESEARCH, P1; Richer MJ, 2009, J INNATE IMMUN, V1, P421, DOI 10.1159/000226247; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Roivainen M, 2002, DIABETOLOGIA, V45, P693, DOI 10.1007/s00125-002-0805-x; Roivainen M, 2000, J CLIN ENDOCR METAB, V85, P432, DOI 10.1210/jc.85.1.432; Sarmiento L, 2001, EMERG INFECT DIS, V7, P887; Sarmiento L, 2007, AUTOIMMUNITY, V40, P540, DOI 10.1080/08916930701523429; Sarmiento L, 2013, MEDICC REV, V15, P29, DOI 10.37757/MR2013V15.N1.7; Schulte BM, 2010, DIABETES, V59, P1182, DOI 10.2337/db09-1071; Skog O, 2011, J MED VIROL, V83, P658, DOI 10.1002/jmv.21924; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szopa Teresa M., 1992, Biochemical Society Transactions, V20, p315S; SZOPA TM, 1990, DIABETOLOGIA, V33, P325, DOI 10.1007/BF00404634; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; URIARTE A, 1987, DIABETOLOGIA, V30, pA590; Uriarte A, 1991, REV CUB ENDOCRINOL, V2, P34; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; von Herrath M, 2009, DIABETES, V58, P2, DOI 10.2337/db08-9027; Williams CH, 2006, J CLIN MICROBIOL, V44, P441, DOI 10.1128/JCM.44.2.441-448.2006; Ylipaasto P, 2005, DIABETOLOGIA, V48, P1510, DOI 10.1007/s00125-005-1839-7; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Ylipaasto P, 2012, DIABETOLOGIA, V55, P3273, DOI 10.1007/s00125-012-2713-z	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77850	10.1371/journal.pone.0077850	http://dx.doi.org/10.1371/journal.pone.0077850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223733	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300010
J	Seliger, C; Leukel, P; Moeckel, S; Jachnik, B; Lottaz, C; Kreutz, M; Brawanski, A; Proescholdt, M; Bogdahn, U; Bosserhoff, AK; Vollmann-Zwerenz, A; Hau, P				Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Lottaz, Claudio; Kreutz, Marina; Brawanski, Alexander; Proescholdt, Martin; Bogdahn, Ulrich; Bosserhoff, Anja-Katrin; Vollmann-Zwerenz, Arabel; Hau, Peter			Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro	PLOS ONE			English	Article							CANCER STEM-CELLS; LATENT TGF-BETA; MATRIX METALLOPROTEINASE-2; THROMBOSPONDIN-1; EXPRESSION; GLIOBLASTOMA; MALIGNANCY; PROTEINS; MOTILITY; BINDING	Background: An important phenomenon observed in glioma metabolism is increased aerobic glycolysis in tumor cells, which is generally referred to as the Warburg effect. Transforming growth factor (TGF)-beta2, which we previously showed to be induced by lactic acid, is a key pathophysiological factor in glioblastoma, leading to increased invasion and severe local immunosuppression after proteolytic cleavage from its latency associated peptide. In this study we tested the hypothesis, that lactate regulates TGF-beta2 expression and glioma cell migration via induction of Thrombospondin-1 (THBS-1), a TGF-beta activating protein. Methods: Lactate levels were reduced by knockdown of LDH-A using specific small interfering RNA (siRNA) and competitive inhibition of LDH-A by sodium oxamate. Knockdown of THBS-1 was performed using specific siRNA. Western Blot, qRT-PCR, and ELISA were used to investigate expression levels of LDH-A, LDH-B, TGF-beta2 and THBS-1. Migration of cells was examined by Spheroid, Scratch and Boyden Chamber assays. Results: Knockdown of LDH-A with subsequent decrease of lactate concentration leads to reduced levels of THBS-1 and TGF-beta2 in glioma cells. Lactate addition increases THBS-1 protein, leading to increased activation of TGF-beta2. Inhibition of THBS-1 reduces TGF-beta2 protein and migration of glioma cells. Addition of synthetic THBS-1 can rescue reduced TGF-beta2 protein levels and glioma cell migration in siLDH-A treated cells. Conclusion: We define a regulatory cascade between lactate, THBS-1 and TGF-beta2, leading to enhanced migration of glioma cells. Our results demonstrate a specific interaction between tumor metabolism and migration and provide a better understanding of the mechanisms underlying glioma cell invasion.	[Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Kreutz, Marina] Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany; [Brawanski, Alexander; Proescholdt, Martin] Univ Regensburg, Sch Med, Dept Neurosurg, D-93053 Regensburg, Germany; [Lottaz, Claudio] Inst Funct Genom, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hau, P (corresponding author), Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany.	Peter.Hau@ukr.de		Hau, Peter/0000-0003-3894-5053; Lottaz, Claudio/0000-0003-0781-4827; Bosserhoff, Anja/0000-0001-8147-394X	University Hospital Regensburg (ReForM-C)	University Hospital Regensburg (ReForM-C)	Part of the work was funded by an internal grant of the University Hospital Regensburg (ReForM-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Amagasaki K, 2001, INT J CANCER, V94, P508, DOI 10.1002/ijc.1497; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bouche M, 2000, FASEB J, V14, P1147, DOI 10.1096/fasebj.14.9.1147; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; DERDA DF, 1980, J BIOL CHEM, V255, P1112; Formby B, 2003, BIOCHEM BIOPH RES CO, V305, P203, DOI 10.1016/S0006-291X(03)00723-X; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; FULHAM MJ, 1992, RADIOLOGY, V185, P675, DOI 10.1148/radiology.185.3.1438744; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; HAWKINS RA, 1992, J NUCL MED, V33, P339; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; Kawataki T, 2000, NEUROPATHOLOGY, V20, P161, DOI 10.1046/j.1440-1789.2000.00327.x; Kim SA, 2001, MOL CELL BIOCHEM, V216, P21, DOI 10.1023/A:1011022822077; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nickl-Jockschat T, 2007, INT J ONCOL, V30, P499; Ramm P, 2011, STEM CELLS DEV, V20, P2189, DOI 10.1089/scd.2010.0567; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Sasaki A, 2001, NEUROL MED-CHIR, V41, P253, DOI 10.2176/nmc.41.253; Schlingensiepen KH, 2006, CYTOKINE GROWTH F R, V17, P129, DOI 10.1016/j.cytogfr.2005.09.002; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SILVERSTEIN RL, 1986, J BIOL CHEM, V261, P9959; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; STUBBS M, 1994, CANCER RES, V54, P4011; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Theriault BL, 2011, CANCER LETT, V313, P108, DOI 10.1016/j.canlet.2011.08.033; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629	46	58	60	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78935	10.1371/journal.pone.0078935	http://dx.doi.org/10.1371/journal.pone.0078935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223867	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300044
J	Tanwar, AS; Goyal, VD; Choudhary, D; Panjikar, S; Anand, R				Tanwar, Ajay Singh; Goyal, Venuka Durani; Choudhary, Deepanshu; Panjikar, Santosh; Anand, Ruchi			Importance of Hydrophobic Cavities in Allosteric Regulation of Formylglycinamide Synthetase: Insight from Xenon Trapping and Statistical Coupling Analysis	PLOS ONE			English	Article							RIBONUCLEOTIDE AMIDOTRANSFERASE; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; PHOSPHATE SYNTHETASE; SEQUENCE STATISTICS; THERMOTOGA-MARITIMA; BACILLUS-SUBTILIS; PROTEIN; EVOLUTION; GLUTAMINE	Formylglycinamide ribonucleotide amidotransferase (FGAR-AT) is a 140 kDa bi-functional enzyme involved in a coupled reaction, where the glutaminase active site produces ammonia that is subsequently utilized to convert FGAR to its corresponding amidine in an ATP assisted fashion. The structure of FGAR-AT has been previously determined in an inactive state and the mechanism of activation remains largely unknown. In the current study, hydrophobic cavities were used as markers to identify regions involved in domain movements that facilitate catalytic coupling and subsequent activation of the enzyme. Three internal hydrophobic cavities were located by xenon trapping experiments on FGAR-AT crystals and further, these cavities were perturbed via site-directed mutagenesis. Biophysical characterization of the mutants demonstrated that two of these three voids are crucial for stability and function of the protein, although being,20 A from the active centers. Interestingly, correlation analysis corroborated the experimental findings, and revealed that amino acids lining the functionally important cavities form correlated sets (co-evolving residues) that connect these regions to the amidotransferase active center. It was further proposed that the first cavity is transient and allows for breathing motion to occur and thereby serves as an allosteric hotspot. In contrast, the third cavity which lacks correlated residues was found to be highly plastic and accommodated steric congestion by local adjustment of the structure without affecting either stability or activity.	[Tanwar, Ajay Singh; Goyal, Venuka Durani; Choudhary, Deepanshu; Anand, Ruchi] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University	Anand, R (corresponding author), Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.	ruchi@chem.iitb.ac.in	Panjikar, Santosh/D-2709-2012; Choudhary, Deepanshu/ABB-8869-2020; Goyal, Venuka/AAR-7525-2020	Panjikar, Santosh/0000-0001-7429-3879; Choudhary, Deepanshu/0000-0002-2912-1610; Goyal, Venuka/0000-0001-7838-572X	Council of Scientific and Industrial Research (CSIR) [01/2329/09/EMR-II]; DAAD; CSIR	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR) grant 01/2329/09/EMR-II. DAAD research stay fellowship for providing financial support during data collection, CSIR for fellowship of AST, and IIT Bombay for providing infrastructure and also fellowship for VDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Anand R, 2004, BIOCHEMISTRY-US, V43, P10343, DOI 10.1021/bi0491292; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; Baker P, 2012, BIOCHEMISTRY-US, V51, P1942, DOI 10.1021/bi201832a; Batey S, 2008, HFSP J, V2, P365, DOI 10.2976/1.2991513; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; Durani V, 2013, METHOD ENZYMOL, V523, P237, DOI 10.1016/B978-0-12-394292-0.00011-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Gassner NC, 1996, P NATL ACAD SCI USA, V93, P12155, DOI 10.1073/pnas.93.22.12155; GUILLOU F, 1992, BIOCHEMISTRY-US, V31, P1656, DOI 10.1021/bi00121a012; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hoskins AA, 2004, BIOCHEMISTRY-US, V43, P10314, DOI 10.1021/bi049127h; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173; Kallenbach N, 2001, P NATL ACAD SCI USA, V98, P2958, DOI 10.1073/pnas.071051798; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Li QA, 2011, J BIOL CHEM, V286, P18213, DOI 10.1074/jbc.M110.183418; List F, 2012, CHEM BIOL, V19, P1589, DOI 10.1016/j.chembiol.2012.10.012; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Morar M, 2008, BIOCHEMISTRY-US, V47, P7816, DOI 10.1021/bi800329p; Morar M, 2006, BIOCHEMISTRY-US, V45, P14880, DOI 10.1021/bi061591u; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers RS, 2005, BIOCHEMISTRY-US, V44, P11974, DOI 10.1021/bi050706b; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Panjikar S, 2002, J APPL CRYSTALLOGR, V35, P261, DOI 10.1107/S0021889802002509; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e; Silverman JA, 2001, P NATL ACAD SCI USA, V98, P3092, DOI 10.1073/pnas.041613598; Sullivan BJ, 2012, J MOL BIOL, V420, P384, DOI 10.1016/j.jmb.2012.04.025; Sullivan BJ, 2011, J MOL BIOL, V413, P195, DOI 10.1016/j.jmb.2011.08.001; Tanwar AS, 2012, ACTA CRYSTALLOGR D, V68, P627, DOI 10.1107/S0907444912006543; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	45	19	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77781	10.1371/journal.pone.0077781	http://dx.doi.org/10.1371/journal.pone.0077781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223728	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300008
J	Zheng, H; Zhang, LN; Zhao, YR; Yang, D; Song, FJ; Wen, Y; Hao, Q; Hu, ZB; Zhang, W; Chen, KX				Zheng, Hong; Zhang, Lina; Zhao, Yanrui; Yang, Da; Song, Fengju; Wen, Yang; Hao, Quan; Hu, Zhibin; Zhang, Wei; Chen, Kexin			Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; SERUM; LET-7; EXPRESSION; TARGETS; MARKER; CHEMOTHERAPY; REPRESSION; CARCINOMA; PROFILES	Background: Most (70%) epithelial ovarian cancers (EOCs) are diagnosed late. Non-invasive biomarkers that facilitate disease detection and predict outcome are needed. The microRNAs (miRNAs) represent a new class of biomarkers. This study was to identify and validate plasma miRNAs as biomarkers in EOC. Methodology/Principal Findings: We evaluated plasma samples of 360 EOC patients and 200 healthy controls from two institutions. All samples were grouped into screening, training and validation sets. We scanned the circulating plasma miRNAs by TaqMan low-density array in the screening set and identified/validated miRNA markers by real-time polymerase chain reaction assay in the training set. Receiver operating characteristic and logistic regression analyses established the diagnostic miRNA panel, which were confirmed in the validation sets. We found higher plasma miR-205 and lower let-7f expression in cases than in controls. MiR-205 and let-7f together provided high diagnostic accuracy for EOC, especially in patients with stage I disease. The combination of these two miRNAs and carbohydrate antigen-125 (CA-125) further improved the accuracy of detection. MiR-483-5p expression was elevated in stages III and IV compared with in stages I and II, which was consistent with its expression pattern in tumor tissues. Furthermore, lower levels of let-7f were predictive of poor prognosis in EOC patients. Conclusions/Significance: Our findings indicate that plasma miR-205 and let-7f are biomarkers for ovarian cancer detection that complement CA-125; let-7f may be predictive of ovarian cancer prognosis.	[Zheng, Hong; Zhao, Yanrui; Song, Fengju; Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Zheng, Hong; Zhang, Lina; Zhao, Yanrui; Song, Fengju; Hao, Quan; Chen, Kexin] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Lina] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Oncol, Tianjin, Peoples R China; [Yang, Da; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wen, Yang; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Hao, Quan] Tianjin Med Univ Canc Inst & Hosp, Dept Gynaecol Oncol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center; Nanjing Medical University; Tianjin Medical University	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	wzhang@mdanderson.org; chenkexin1963@yahoo.com		Chen, Kexin/0000-0003-4248-7681; Yang, Da/0000-0002-8336-9457	National Natural Science Foundation of China [81072363]; program for Changjiang Scholars and Innovative Research Team at the University in China [IRT1076]; National Key Scientific and Technological Project [2011ZX09307-001-04]; Tianjin Science and Technology Committee Foundation [09ZCZDSF04700]; Tianjin Center; US National Foundation for Cancer Research; Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship; Harold C. and Mary L. Daily Endowment Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team at the University in China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Scientific and Technological Project; Tianjin Science and Technology Committee Foundation; Tianjin Center; US National Foundation for Cancer Research; Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship; Harold C. and Mary L. Daily Endowment Fund	This work was supported partially by the National Natural Science Foundation of China (Grants 81072363), the program for Changjiang Scholars and Innovative Research Team at the University in China (Grant IRT1076), the National Key Scientific and Technological Project (Grant 2011ZX09307-001-04), and the Tianjin Science and Technology Committee Foundation (Grant 09ZCZDSF04700). The tissue bank is jointly supported by the Tianjin Center and the US National Foundation for Cancer Research. D.Y. is an Odyssey Fellow at MD Anderson Cancer Center, and supported by The Diane Denson Tobola Fellowship in Ovarian Cancer Research fellowship and The Harold C. and Mary L. Daily Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; Bakouboula B, 2008, AM J RESP CRIT CARE, V177, P536, DOI 10.1164/rccm.200706-840OC; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Eisenhauer EA, 1997, ANN ONCOL, V8, P963, DOI 10.1023/A:1008240421028; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kong XY, 2010, WORLD J GASTROENTERO, V16, P4599, DOI 10.3748/wjg.v16.i36.4599; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moss EL, 2005, J CLIN PATHOL, V58, P308, DOI 10.1136/jcp.2004.018077; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Rustin GJS, 1996, J CLIN ONCOL, V14, P1545, DOI 10.1200/JCO.1996.14.5.1545; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105	54	137	148	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77853	10.1371/journal.pone.0077853	http://dx.doi.org/10.1371/journal.pone.0077853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223734	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300011
J	Berecki-Gisolf, J; Sheldon, A; Wieling, W; van Dijk, N; Costantino, G; Furlan, R; Shen, WK; Sheldon, R				Berecki-Gisolf, Janneke; Sheldon, Aaron; Wieling, Wouter; van Dijk, Nynke; Costantino, Giorgio; Furlan, Raffaello; Shen, Win-Kuang; Sheldon, Robert			Identifying Cardiac Syncope Based on Clinical History: A Literature-Based Model Tested in Four Independent Datasets	PLOS ONE			English	Article							TERM SERIOUS OUTCOMES; RISK-STRATIFICATION; EMERGENCY-DEPARTMENT; VASOVAGAL SYNCOPE; HEART-DISEASE; VENTRICULAR-TACHYCARDIA; MEDICAL-STUDENTS; TRANSIENT LOSS; GUIDELINES; MECHANISM	Background: We aimed to develop and test a literature-based model for symptoms that associate with cardiac causes of syncope. Methods and Results: Seven studies (the derivation sample) reporting >= 2 predictors of cardiac syncope were identified (4 Italian, 1 Swiss, 1 Canadian, and 1 from the United States). From these, 10 criteria were identified as diagnostic predictors. The conditional probability of each predictor was calculated by summation of the reported frequencies. A model of conditional probabilities and a priori probabilities of cardiac syncope was constructed. The model was tested in four datasets of patients with syncope (the test sample) from Calgary (n=670; 21% had cardiac syncope), Amsterdam (n=503; 9%), Milan (n=689; 5%) and Rochester (3877; 11%). In the derivation sample ten variables were significantly associated with cardiac syncope: age, gender, structural heart disease, low number of spells, brief or absent prodrome, supine syncope, effort syncope, and absence of nausea, diaphoresis and blurred vision. Fitting the test datasets to the full model gave C- statistics of 0.87 (Calgary), 0.84 (Amsterdam), 0.72 (Milan) and 0.71 (Rochester). Model sensitivity and specificity were 92% and 68% for Calgary, 86% and 67% for Amsterdam, 76% and 59% for Milan, and 73% and 52% for Rochester. A model with 5 variables (age, gender, structural heart disease, low number of spells, and lack of prodromal symptoms) was as accurate as the total set. Conclusion: A simple literature-based Bayesian model of historical criteria can distinguish patients with cardiac syncope from other patients with syncope with moderate accuracy.	[Berecki-Gisolf, Janneke; Sheldon, Robert] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Sheldon, Aaron] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Wieling, Wouter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Nynke] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Costantino, Giorgio; Furlan, Raffaello] Univ Milan, Syncope Unit, L Sacco Hosp, Milan, Italy; [Shen, Win-Kuang] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; Luigi Sacco Hospital; Mayo Clinic	Berecki-Gisolf, J (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	janneke.berecki-gisolf@monash.edu	costantino, giorgio/AAC-6441-2022; Furlan, Raffaello/AAH-3167-2021	costantino, giorgio/0000-0002-6391-3849; Furlan, Raffaello/0000-0001-5209-6786; van Dijk, Nynke/0000-0001-7959-5649				Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Brignole M, 2005, EUROPACE, V7, P14, DOI 10.1016/j.eupc.2004.11.001; Brignole M, 2001, CIRCULATION, V104, P2045, DOI 10.1161/hc4201.097837; CALKINS H, 1995, AM J MED, V98, P365, DOI 10.1016/S0002-9343(99)80315-5; Chen LY, 2003, MAYO CLIN PROC, V78, P414, DOI 10.4065/78.4.414; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Costantino G, 2008, J AM COLL CARDIOL, V51, P276, DOI 10.1016/j.jacc.2007.08.059; Del Rosso A, 2008, HEART, V94, P1620, DOI 10.1136/hrt.2008.143123; Del Rosso A, 2005, AM J CARDIOL, V96, P1431, DOI 10.1016/j.amjcard.2005.07.047; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, J AM MED ASS, V285, P2486; Galizia G, 2009, J AM GERIATR SOC, V57, P18, DOI 10.1111/j.1532-5415.2008.02070.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; Grossman SA, 2007, J EMERG MED, V33, P233, DOI 10.1016/j.jemermed.2007.04.001; Iglesias JF, 2009, PACE, V32, pS202, DOI 10.1111/j.1540-8159.2008.02291.x; Krahn AD, 2012, J CARDIOVASC ELECTR, V23, P60, DOI 10.1111/j.1540-8167.2011.02185.x; Martin TP, 1997, ANN EMERG MED, V29, P459, DOI 10.1016/S0196-0644(97)70217-8; Menozzi C, 2002, CIRCULATION, V105, P2741, DOI 10.1161/01.CIR.0000018125.31973.87; Moya A, 2001, CIRCULATION, V104, P1261, DOI 10.1161/hc3601.095708; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Quinn JV, 2004, ANN EMERG MED, V43, P224, DOI 10.1016/S0196-0644(03)00823-0; Reed MJ, 2007, EMERG MED J, V24, P270, DOI 10.1136/emj.2006.042739; Reed MJ, 2010, J AM COLL CARDIOL, V55, P713, DOI 10.1016/j.jacc.2009.09.049; Saccilotto RT, 2011, CAN MED ASSOC J, V183, pE1116, DOI 10.1503/cmaj.101326; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Sheldon R, 2006, EUR HEART J, V27, P344, DOI 10.1093/eurheartj/ehi584; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; Sheldon R, 2010, J CARDIOVASC ELECTR, V21, P1358, DOI 10.1111/j.1540-8167.2010.01835.x; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Sud S, 2009, HEART RHYTHM, V6, P238, DOI 10.1016/j.hrthm.2008.10.035; Sun BC, 2012, ACAD EMERG MED, V19, P694, DOI 10.1111/j.1553-2712.2012.01375.x; Thijs RD, 2008, NEUROLOGY, V71, P1713, DOI 10.1212/01.wnl.0000335165.68893.b0; van Dijk N, 2008, J CARDIOVASC ELECTR, V19, P48, DOI 10.1111/j.1540-8167.2007.00984.x	33	26	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75255	10.1371/journal.pone.0075255	http://dx.doi.org/10.1371/journal.pone.0075255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24223233	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200032
J	Padhi, S; Khan, N; Jameel, S; Priyakumar, UD				Padhi, Siladitya; Khan, Nabab; Jameel, Shahid; Priyakumar, U. Deva			Molecular Dynamics Simulations Reveal the HIV-1 Vpu Transmembrane Protein to Form Stable Pentamers	PLOS ONE			English	Article							ION-CHANNEL ACTIVITY; 3-DIMENSIONAL STRUCTURE; U VPU; VIRUS; DOMAIN; CHARMM; AMILORIDE; HELIX; OLIGOMERIZATION; IDENTIFICATION	The human immunodeficiency virus type I (HIV-1) Vpu protein is 81 residues long and has two cytoplasmic and one transmembrane (TM) helical domains. The TM domain oligomerizes to form a monovalent cation selective ion channel and facilitates viral release from host cells. Exactly how many TM domains oligomerize to form the pore is still not understood, with experimental studies indicating the existence of a variety of oligomerization states. In this study, molecular dynamics (MD) simulations were performed to investigate the propensity of the Vpu TM domain to exist in tetrameric, pentameric, and hexameric forms. Starting with an idealized a-helical representation of the TM domain, a thorough search for the possible orientations of the monomer units within each oligomeric form was carried out using replica-exchange MD simulations in an implicit membrane environment. Extensive simulations in a fully hydrated lipid bilayer environment on representative structures obtained from the above approach showed the pentamer to be the most stable oligomeric state, with interhelical van der Waals interactions being critical for stability of the pentamer. Atomic details of the factors responsible for stable pentamer structures are presented. The structural features of the pentamer models are consistent with existing experimental information on the ion channel activity, existence of a kink around the Ile17, and the location of tetherin binding residues. Ser23 is proposed to play an important role in ion channel activity of Vpu and possibly in virus propagation.	[Padhi, Siladitya; Priyakumar, U. Deva] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India; [Khan, Nabab; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi, India	International Institute of Information Technology Hyderabad; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Priyakumar, UD (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India.	deva@iiit.ac.in	khan, Nabab/Z-3970-2019; Priyakumar, Deva/F-6793-2010	khan, Nabab/0000-0002-8563-5341; Padhi, Siladitya/0000-0002-4272-6040	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12729/BID/07/297/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/; grant no. BT/PR12729/BID/07/297/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; CORDES FS, 2001, BIOCHIM BIOPHYS ACTA, V1512, P29; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Ewart GD, 2004, ANTIMICROB AGENTS CH, V48, P2325, DOI 10.1128/AAC.48.6.2325-2330.2004; Federau T, 1996, INT J PEPT PROT RES, V47, P297; Fischer WB, 2000, BIOPOLYMERS, V53, P529, DOI 10.1002/(SICI)1097-0282(200006)53:7<529::AID-BIP1>3.0.CO;2-6; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Grice AL, 1997, FEBS LETT, V405, P299, DOI 10.1016/S0014-5793(97)00198-1; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim CG, 2006, ANAL BIOANAL CHEM, V386, P2213, DOI 10.1007/s00216-006-0832-4; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kruger J, 2010, EUR BIOPHYS J BIOPHY, V39, P1069, DOI 10.1007/s00249-009-0487-0; Kruger J, 2009, J CHEM THEORY COMPUT, V5, P2503, DOI 10.1021/ct900185n; Kukol A, 1999, BIOPHYS J, V77, P1594, DOI 10.1016/S0006-3495(99)77007-4; Lemaitre V, 2004, FEBS LETT, V563, P75, DOI 10.1016/S0014-5793(04)00251-0; Liu F, 2004, BIOPHYS J, V87, P2470, DOI 10.1529/biophysj.104.046342; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Lu JX, 2010, PROTEIN SCI, V19, P1877, DOI 10.1002/pro.474; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Moore PB, 1998, FEBS LETT, V431, P143, DOI 10.1016/S0014-5793(98)00714-5; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2009, J BIOMOL STRUCT DYN, V27, P1; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saiz L, 2004, J PHYS CHEM B, V108, P2608, DOI 10.1021/jp0369793; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Ulmschneider JP, 2007, J CHEM THEORY COMPUT, V3, P2335, DOI 10.1021/ct700103k; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; WRAY V, 1995, INT J PEPT PROT RES, V45, P35; Wray V, 1999, BIOCHEMISTRY-US, V38, P5272, DOI 10.1021/bi982755c; ZHANG YP, 1993, BIOCHEMISTRY-US, V32, P3942, DOI 10.1021/bi00066a014	64	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79779	10.1371/journal.pone.0079779	http://dx.doi.org/10.1371/journal.pone.0079779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223193	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200086
J	Whitehouse, J; Micheletta, J; Powell, LE; Bordier, C; Waller, BM				Whitehouse, Jamie; Micheletta, Jerome; Powell, Lauren E.; Bordier, Celia; Waller, Bridget M.			The Impact of Cognitive Testing on the Welfare of Group Housed Primates	PLOS ONE			English	Article							SOCIAL-INTERACTION PATTERNS; DISPLACEMENT ACTIVITIES; RHESUS-MONKEYS; MACAQUES; RECIPROCITY; CHALLENGE; CONFLICT; EMOTIONS; SULAWESI; BEHAVIOR	Providing cognitive challenges to zoo-housed animals may provide enriching effects and subsequently enhance their welfare. Primates may benefit most from such challenges as they often face complex problems in their natural environment and can be observed to seek problem solving opportunities in captivity. However, the extent to which welfare benefits can be achieved through programmes developed primarily for cognitive research is unknown. We tested the impact of voluntary participation cognitive testing on the welfare of a socially housed group of crested macaques (Macaca nigra) at the Macaque Study Centre (Marwell Zoo). First, we compared the rate of self-directed and social behaviours on testing and non-testing days, and between conditions within testing days. Minimal differences in behaviour were found when comparing testing and non-testing days, suggesting that there was no negative impact on welfare as a result of cognitive testing. Lipsmacking behaviours were found to increase and aggressive interaction was found to decrease in the group as a result of testing. Second, social network analysis was used to assess the effect of testing on associations and interactions between individuals. The social networks showed that testing subjects increased their association with others during testing days. One interpretation of this finding could be that providing socially housed primates with an opportunity for individuals to separate from the group for short periods could help mimic natural patterns of sub-group formation and reunion in captivity. The findings suggest, therefore, that the welfare of captive primates can be improved through the use of cognitive testing in zoo environments.	[Whitehouse, Jamie; Micheletta, Jerome; Powell, Lauren E.; Bordier, Celia; Waller, Bridget M.] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Dept Psychol, Portsmouth PO1 2UP, Hants, England; [Micheletta, Jerome; Waller, Bridget M.] Marwell Wildlife, Winchester, Hants, England	University of Portsmouth	Whitehouse, J (corresponding author), Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Dept Psychol, Portsmouth PO1 2UP, Hants, England.	jamie.whitehouse@port.ac.uk	Micheletta, Jérôme/E-4699-2014	Micheletta, Jérôme/0000-0002-4480-6781; Waller, Bridget/0000-0001-6303-7458; Whitehouse, Jamie/0000-0003-2607-5492				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; [Anonymous], ENCY MEASUREMENTS ST; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; BLOOMSTRAND M, 1986, ZOO BIOL, V5, P293, DOI 10.1002/zoo.1430050307; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Borgatti S., 2002, UCINET WINDOWS SOFTW; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Brent LJN, 2013, BEHAV ECOL SOCIOBIOL, V67, P349, DOI 10.1007/s00265-012-1455-8; Clark FE, 2013, AM J PRIMATOL, V75, P807, DOI 10.1002/ajp.22141; Clark FE, 2011, APPL ANIM BEHAV SCI, V135, P1, DOI 10.1016/j.applanim.2011.10.010; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; Duboscq J, 2013, AM J PRIMATOL, V75, P361, DOI 10.1002/ajp.22114; Fagot J, 2013, AM J PRIMATOLOGY; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fernandez EJ, 2008, ZOO BIOL, V27, P470, DOI 10.1002/zoo.20215; Flack J.C., 2004, MACAQUE SOC, P157; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; FUKUDA F, 1989, INT J PRIMATOL, V10, P419, DOI 10.1007/BF02736369; Gazes RP, 2013, ANIM COGN, V16, P445, DOI 10.1007/s10071-012-0585-8; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Herrelko ES, 2012, AM J PRIMATOL, V74, P828, DOI 10.1002/ajp.22036; JANSON CH, 1988, BEHAVIOUR, V105, P165, DOI 10.1163/156853988X00502; JUDGE PG, 1993, ANIM BEHAV, V46, P221, DOI 10.1006/anbe.1993.1184; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Melfi VA, 2002, ANIM WELFARE, V11, P213; MENARD N, 1990, FOLIA PRIMATOL, V55, P166, DOI 10.1159/000156512; Micheletta J, 2012, P ROY SOC B-BIOL SCI, V279, P4042, DOI 10.1098/rspb.2012.1470; NOVAK MA, 1991, LAB ANIM SCI, V41, P308; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Paulus A, 2009, THESIS U PLYMOUTH PL; Perdue BM, 2012, ZOO BIOL, V31, P27, DOI 10.1002/zoo.20378; Rosenthal Robert., 1991, META ANALYTIC PROCED; Schel AM, 2013, AM J PRIMATOL, V75, P254, DOI 10.1002/ajp.22101; Schino G, 1996, ANXIETY, V2, P186; SCUCCHI S, 1991, PRIMATES, V32, P115, DOI 10.1007/BF02381606; Smith M., 2010, NODEXL FREE OPEN NET; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Thierry B., 2000, Primate Research, V16, P203; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; Waller BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044680; Wasserman EA, 2009, COMP COGNITION EXPT, P1	48	32	32	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78308	10.1371/journal.pone.0078308	http://dx.doi.org/10.1371/journal.pone.0078308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223146	Green Published, gold			2022-12-25	WOS:000326656200038
J	Wolnicka-Glubisz, A; Pecio, A; Podkowa, D; Plonka, PM; Grabacka, M				Wolnicka-Glubisz, Agnieszka; Pecio, Anna; Podkowa, Dagmara; Plonka, Przemyslaw Mieszko; Grabacka, Maja			HGF/SF Increases Number of Skin Melanocytes but Does Not Alter Quality or Quantity of Follicular Melanogenesis	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; INFLAMMATORY RESPONSE; COMPREHENSIVE GUIDE; UV-RADIATION; TELOGEN SKIN; HAIR CYCLE; MICE; DEFICIENT; MELANIN; GROWTH	Melanins are an important factor determining the vulnerability of mammalian skin to UV radiation and thus to UV-induced skin cancers. Transgenic mice overexpressing hepatocyte growth factor/scatter factor (HGF/SF) have extra-follicular dermal melanocytes, notably in the papillary upper dermis, and are susceptible to UV-induced melanoma. Pigmented HGF/SF neonatal mice are more susceptible than albino HGF/SF animals to UVA-induced melanoma, indicating an involvement of melanin in melanoma formation. This raises the question of the effect of transgenic HGF/SF on melanization. We developed a methodology to accurately quantitate both the production of melanin and the efficiency of melanogenesis in normal, and HGF/SF transgenic mice in vivo. Skin and hair shafts of 5 day old and adult (3 week old) C57BL/6-HGF/SF and corresponding C57BL/6 wild type mice were investigated by electron paramagnetic resonance spectroscopy (EPR) to quantitate melanin, by transmission electron microscopy (TEM) for the presence of melanosomes, and by standard histology and by Western blotting and zymography to determine the expression and activity of melanogenesis-related proteins. Eumelanin but no phaeomelanin was detected in transgenic C57BL/6-HGF and C57BL/6 wild type mice. Transgenic HGF/SF overexpression did not change the type of melanin produced in the skin or hair, did not affect the terminal content of melanin production in standard samples of hair and did not influence hair cycle/morphogenesis-related changes in skin thickness. No melanocytes were found in the epidermis and no melanosomes were found in epidermal keratinocytes. HGF/SF transgenic mice thus lack the epidermal melanin UV-protection found in constitutively dark human skin. We conclude that melanocytes in the HGF/SF transgenic mouse, particularly in the papillary dermis, are vulnerable to UVA which interacts with eumelanin but not phaeomelanin to induce melanoma.	[Wolnicka-Glubisz, Agnieszka; Plonka, Przemyslaw Mieszko] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland; [Pecio, Anna; Podkowa, Dagmara] Jagiellonian Univ, Inst Zool, Dept Comparat Anat, PL-30060 Krakow, Poland; [Grabacka, Maja] Univ Agr, Dept Food Biotechnol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Agricultural University Krakow	Wolnicka-Glubisz, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland.	a.wolnicka-glubisz@uj.edu.pl	Grabacka, Maja/ABE-5286-2021	Grabacka, Maja/0000-0003-4407-8814; Wolnicka-Glubisz, Agnieszka/0000-0003-3070-6349; Pecio, Anna/0000-0001-9052-5844; Plonka, Przemyslaw/0000-0002-0261-3439	Foundation for Polish Science-POMOST program; European Union with in European Regional Development Fund; Faculty BBBt, UJ, BW	Foundation for Polish Science-POMOST program; European Union with in European Regional Development Fund; Faculty BBBt, UJ, BW	M.G. is supported by the Foundation for Polish Science-POMOST program co-financed by the European Union with in European Regional Development Fund. A.W-G. was supported by Faculty BBBt, UJ, BW-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hill HZ, 1997, PHOTOCHEM PHOTOBIOL, V65, P983, DOI 10.1111/j.1751-1097.1997.tb07958.x; JIMBOW K, 1975, J INVEST DERMATOL, V64, P50, DOI 10.1111/1523-1747.ep12540914; JIMENEZCERVANTES C, 1993, PIGM CELL RES, V6, P394, DOI 10.1111/j.1600-0749.1993.tb00621.x; JINDO T, 1994, J INVEST DERMATOL, V103, P306, DOI 10.1111/1523-1747.ep12394731; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Mizuno S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/909350; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Noonan FP, 2012, NAT COMMUN, V6, P3; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; PLONKA P, 1995, ARCH DERMATOL RES, V287, P687, DOI 10.1007/BF00371744; Plonka PM, 2008, J DERMATOL SCI, V49, P227, DOI 10.1016/j.jdermsci.2007.09.010; Plonka PM, 2009, EXP DERMATOL, V18, P472, DOI 10.1111/j.1600-0625.2009.00883.x; Sarna Tadeusz, 2005, V23, P125, DOI 10.1007/0-387-26741-7_7; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Thong HY, 2003, BRIT J DERMATOL, V149, P498, DOI 10.1046/j.1365-2133.2003.05473.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wolnicka A, 1998, FOLIA BIOL-KRAKOW, V46, P7; Wolnicka-Glubisz A, 2007, J LEUKOCYTE BIOL, V81, P1352, DOI 10.1189/jlb.1206729; Wolnicka-Glubisz A, 2013, EXP DERMATOL, V22, P226, DOI 10.1111/exd.12100; Wolnicka-Glubisz A, 2012, EXP DERMATOL, V21, P537, DOI 10.1111/j.1600-0625.2012.01511.x; Yamazaki F, 2004, J INVEST DERMATOL, V123, P220, DOI 10.1111/j.0022-202X.2004.22710.x	38	13	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e74883	10.1371/journal.pone.0074883	http://dx.doi.org/10.1371/journal.pone.0074883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223113	Green Published, gold			2022-12-25	WOS:000326656200005
J	Cruaud, A; Underhill, JG; Huguin, M; Genson, G; Jabbour-Zahab, R; Tolley, KA; Rasplus, JY; van Noort, S				Cruaud, Astrid; Underhill, Jenny G.; Huguin, Mailis; Genson, Gwenaelle; Jabbour-Zahab, Roula; Tolley, Krystal A.; Rasplus, Jean-Yves; van Noort, Simon			A Multilocus Phylogeny of the World Sycoecinae Fig Wasps (Chalcidoidea: Pteromalidae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; HYMENOPTERA CHALCIDOIDEA; AGAONIDAE; SYSTEMATICS; FICUS; EVOLUTION; GENE; TREE; INFORMATIVENESS; NUCLEAR	The Sycoecinae is one of five chalcid subfamilies of fig wasps that are mostly dependent on Ficus inflorescences for reproduction. Here, we analysed two mitochondrial (COI, Cytb) and four nuclear genes (ITS2, EF-1 alpha, RpL27a, mago nashi) from a worldwide sample of 56 sycoecine species. Various alignment and partitioning strategies were used to test the stability of major clades. All topologies estimated using maximum likelihood and Bayesian methods were similar and well resolved but did not support the existing classification. A high degree of morphological convergence was highlighted and several species appeared best described as species complexes. We therefore proposed a new classification for the subfamily. Our analyses revealed several cases of probable speciation on the same host trees (up to 8 closely related species on one single tree of F. sumatrana), which raises the question of how resource partitioning occurs to avoid competitive exclusion. Comparisons of our results with fig phylogenies showed that, despite sycoecines being internally ovipositing wasps host-switches are common incidents in their evolutionary history. Finally, by studying the evolutionary properties of the markers we used and profiling their phylogenetic informativeness, we predicted their utility for resolving phylogenetic relationships of Chalcidoidea at various taxonomic levels.	[Cruaud, Astrid; Huguin, Mailis; Genson, Gwenaelle; Jabbour-Zahab, Roula; Rasplus, Jean-Yves] INRA, CBGP, UMR1062, Montferrier Sur Lez, France; [Underhill, Jenny G.; Tolley, Krystal A.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [van Noort, Simon] Iziko Museums Cape Town, S African Museum, Nat Hist Div, Cape Town, South Africa; [Tolley, Krystal A.; van Noort, Simon] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa	INRAE; Institut de Recherche pour le Developpement (IRD); South African National Biodiversity Institute; University of Cape Town	Cruaud, A (corresponding author), INRA, CBGP, UMR1062, Montferrier Sur Lez, France.	cruaud@supagro.inra.fr	van Noort, Simon/C-4006-2017; Rasplus, Jean-Yves/O-2873-2017	van Noort, Simon/0000-0001-6930-9741; Rasplus, Jean-Yves/0000-0001-8614-6665; Tolley, Krystal/0000-0002-7778-1963	South African National Research Foundation [GUN 61497]; French National Research Agency (ANR); South African National Biodiversity Institute; network Bibliotheque du Vivant; CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope)	South African National Research Foundation(National Research Foundation - South Africa); French National Research Agency (ANR)(French National Research Agency (ANR)); South African National Biodiversity Institute; network Bibliotheque du Vivant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; INRA; CEA (Genoscope)	This work is based upon financial support received from the South African National Research Foundation grant GUN 61497 to SvN and from the French National Research Agency (ANR) grant that supports the "BioFigs" project. This research was also supported by the South African National Biodiversity Institute. Sequencing was supported by the network Bibliotheque du Vivant founded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Genoscope). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Auger-Rozenberg MA, 2006, SYST ENTOMOL, V31, P47, DOI 10.1111/j.1365-3113.2005.00310.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Berg C. C., 2005, FLORA MALESIANA 1; Boucek Z., 1988, P1; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Burks RA, 2011, CLADISTICS, V27, P581, DOI 10.1111/j.1096-0031.2011.00358.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen Y, 2004, MOL PHYLOGENET EVOL, V31, P300, DOI 10.1016/S1055-7903(03)00282-3; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cognato AI, 2001, SYST BIOL, V50, P758, DOI 10.1080/106351501753462803; Compton S.G., 1994, PARASITOID COMMUNITY, P323; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Corner E. J. H., 1978, Philosophical Transactions of the Royal Society of London, B, V281, P347, DOI 10.1098/rstb.1978.0002; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Cruaud A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-178; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Danforth BN, 2002, P NATL ACAD SCI USA, V99, P286, DOI 10.1073/pnas.012387999; Drummond AJ, 2010, ENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; GALIL J, 1977, NEW PHYTOL, V79, P163, DOI 10.1111/j.1469-8137.1977.tb02192.x; GARDINER A J, 1987, Tijdschrift voor Entomologie, V130, P129; Gauthier N, 2000, SYST ENTOMOL, V25, P521, DOI 10.1046/j.1365-3113.2000.00134.x; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson AP, 2004, BIOL REV, V79, P751, DOI 10.1017/S1464793104006463; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jiang ZF, 2006, J EVOLUTION BIOL, V19, P1157, DOI 10.1111/j.1420-9101.2006.01087.x; Jousselin E, 2001, OIKOS, V94, P287, DOI 10.1034/j.1600-0706.2001.940209.x; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kjellberg Finn, 2005, P539; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lohse K, 2011, MOL ECOL RESOUR, V11, P521, DOI 10.1111/j.1755-0998.2010.02956.x; Lohse K, 2010, EVOLUTION, V64, P2664, DOI 10.1111/j.1558-5646.2010.01024.x; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Marussich WA, 2007, MOL ECOL, V16, P1925, DOI 10.1111/j.1365-294X.2007.03278.x; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Nylander J.A.A., 2004, MRAIC PL; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Ronsted N, 2007, MOL PHYLOGENET EVOL, V43, P190, DOI 10.1016/j.ympev.2006.12.010; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt S, 2007, SYST ENTOMOL, V32, P81, DOI 10.1111/j.1365-3113.2006.00364.x; Schulte JA, 2008, MOL PHYLOGENET EVOL, V47, P700, DOI 10.1016/j.ympev.2008.01.010; Segar ST, 2012, MOL PHYLOGENET EVOL, V65, P116, DOI 10.1016/j.ympev.2012.05.030; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Stamatakis A., 2006, P 20 INT PAR DISTR P, DOI DOI 10.1109/IPDPS.2006.1639535; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Van Noort S, 2005, ZOOTAXA, P1; van Noort S, 1992, THESIS RHODES U GRAH; Van Noort S, 2006, ZOOTAXA, P39, DOI 10.11646/zootaxa.1337.1.2; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; VANNOORT S, 1993, P K NED AKAD WETENSC, V96, P233; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P341; VANNOORT S, 1993, P K NED AKAD WETENSC, V96, P449; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P311; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P83; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; Warren M, 2010, ECOGRAPHY, V33, P148, DOI 10.1111/j.1600-0587.2009.06041.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES J T, 1977, Zoologische Mededelingen (Leiden), V52, P137; WIEBES JT, 1974, P K NED AKAD C BIOL, V77, P295; WIEBES JT, 1968, P K NED AKAD C BIOL, V71, P346; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang FP, 2009, NATURWISSENSCHAFTEN, V96, P543, DOI 10.1007/s00114-008-0502-9	93	5	6	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79291	10.1371/journal.pone.0079291	http://dx.doi.org/10.1371/journal.pone.0079291			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223925	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400061
J	Kriebel, K; Biedermann, A; Kreikemeyer, B; Lang, H				Kriebel, Katja; Biedermann, Anne; Kreikemeyer, Bernd; Lang, Hermann			Anaerobic Co-Culture of Mesenchymal Stem Cells and Anaerobic Pathogens - A New In Vitro Model System	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PERIODONTAL PATHOGENS; ENDOTHELIAL-CELLS; CYTOKINE RESPONSE; IMMUNE-RESPONSE; INVASION; HYPOXIA	Background: Human mesenchymal stem cells (hMSCs) are multipotent by nature and are originally isolated from bone marrow. In light of a future application of hMSCs in the oral cavity, a body compartment with varying oxygen partial pressures and an omnipresence of different bacterial species i. e. periodontitis pathogens, we performed this study to gain information about the behavior of hMSC in an anaerobic system and the response in interaction with oral bacterial pathogens. Methodology/Principal Findings: We established a model system with oral pathogenic bacterial species and eukaryotic cells cultured in anaerobic conditions. The facultative anaerobe bacteria Fusobacterium nucleatum, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans were studied. Their effects on hMSCs and primary as well as permanent gingival epithelial cells (Ca9-22, HGPEC) were comparatively analyzed. We show that hMSCs cope with anoxic conditions, since 40% vital cells remain after 72 h of anaerobic culture. The Ca9-22 and HGPEC cells are significantly more sensitive to lack of oxygen. All bacterial species reveal a comparatively low adherence to and internalization into hMSCs (0.2% and 0.01% of the initial inoculum, respectively). In comparison, the Ca9-22 and HGPEC cells present better targets for bacterial adherence and internalization. The production of the pro-inflammatory chemokine IL-8 is higher in both gingival epithelial cell lines compared to hMSCs and Fusobacterium nucleatum induce a time-dependent cytokine secretion in both cell lines. Porphyromonas gingivalis is less effective in stimulating secretion of IL-8 in the co-cultivation experiments. Conclusions/significance: HMSCs are suitable for use in anoxic regions of the oral cavity. The interaction with local pathogenic bacteria does not result in massive pro-inflammatory cytokine responses. The test system established in this study allowed further investigation of parameters prior to set up of oral hMSC in vivo studies.	[Kriebel, Katja] Univ Rostock, Katja Kriebel Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Biedermann, Anne] Univ Rostock, Anne Biedermann Dept Operat Dent & Periodontol, D-18055 Rostock, Germany; [Kreikemeyer, Bernd] Univ Rostock, Bernd Kreikemeyer Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany; [Lang, Hermann] Univ Rostock, Hermann Lang Dept Operat Dent & Periodontol, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Lang, H (corresponding author), Univ Rostock, Hermann Lang Dept Operat Dent & Periodontol, D-18055 Rostock, Germany.	hermann.lang@uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098				Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Crisostomo PR, 2006, SHOCK, V26, P571, DOI 10.1097/01.shk.0000233195.63859.ef; Dabija-Wolter G, 2009, J PERIODONTOL, V80, P1174, DOI 10.1902/jop.2009.090051; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Diaz PI, 2000, FEMS MICROBIOL LETT, V187, P31, DOI 10.1016/S0378-1097(00)00174-9; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; DUNCAN MJ, 1993, INFECT IMMUN, V61, P2260, DOI 10.1128/IAI.61.5.2260-2265.1993; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Ellen RP, 1999, MICROBES INFECT, V1, P621, DOI 10.1016/S1286-4579(99)80062-8; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hirose K, 1996, ORAL MICROBIOL IMMUN, V11, P402, DOI 10.1111/j.1399-302X.1996.tb00202.x; Horikoshi M, 1974, Nihon Koku Geka Gakkai Zasshi, V20, P100; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Jain Manu, 2005, Proc Am Thorac Soc, V2, P202, DOI 10.1513/pats.200501-006AC; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Madianos PN, 1996, INFECT IMMUN, V64, P660, DOI 10.1128/IAI.64.2.660-664.1996; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Meyer DH, 1996, INFECT IMMUN, V64, P2988, DOI 10.1128/IAI.64.8.2988-2997.1996; Meyer DH, 1997, CRIT REV ORAL BIOL M, V8, P389, DOI 10.1177/10454411970080040301; Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x; Nasef A, 2007, GENE EXPRESSION, V13, P217; Njoroge T, 1997, INFECT IMMUN, V65, P1980, DOI 10.1128/IAI.65.5.1980-1984.1997; Pan YP, 2009, MICROB PATHOGENESIS, V46, P73, DOI 10.1016/j.micpath.2008.10.012; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rudney JD, 2001, INFECT IMMUN, V69, P2700, DOI 10.1128/IAI.69.4.2700-2707.2001; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Saito A, 2008, FEMS IMMUNOL MED MIC, V54, P349, DOI 10.1111/j.1574-695X.2008.00481.x; Scheres N, 2010, J PERIODONTAL RES, V45, P262, DOI 10.1111/j.1600-0765.2009.01229.x; Shi Y, 2012, TRENDS IMMUNOLOGY; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318	47	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78226	10.1371/journal.pone.0078226	http://dx.doi.org/10.1371/journal.pone.0078226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223777	Green Published, gold			2022-12-25	WOS:000326503400040
J	Lidster, K; Jackson, SJ; Ahmed, Z; Munro, P; Coffey, P; Giovannoni, G; Baker, MD; Baker, D				Lidster, Katie; Jackson, Samuel J.; Ahmed, Zubair; Munro, Peter; Coffey, Pete; Giovannoni, Gavin; Baker, Mark D.; Baker, David			Neuroprotection in a Novel Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSGENIC MICE; NEUROMYELITIS-OPTICA; SODIUM-CHANNELS; VISUAL-ACUITY; ANIMAL-MODELS; ANTIBODIES; DISEASE; MECHANISMS	Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease that currently lacks any neuroprotective treatments. Innovative neuroprotective trial designs are required to hasten the translational process of drug development. An ideal target to monitor the efficacy of strategies aimed at treating multiple sclerosis is the visual system, which is the most accessible part of the human central nervous system. A novel C57BL/6 mouse line was generated that expressed transgenes for a myelin oligodendrocyte glycoprotein-specific T cell receptor and a retinal ganglion cell restricted-Thy1 promoter-controlled cyan fluorescent protein. This model develops spontaneous or induced optic neuritis, in the absence of paralytic disease normally associated with most rodent autoimmune models of multiple sclerosis. Demyelination and neurodegeneration could be monitored longitudinally in the living animal using electrophysiology, visual sensitivity, confocal scanning laser ophthalmoscopy and optical coherence tomography all of which are relevant to human trials. This model offers many advantages, from a 3Rs, economic and scientific perspective, over classical experimental autoimmune encephalomyelitis models that are associated with substantial suffering of animals. Optic neuritis in this model led to inflammatory damage of axons in the optic nerve and subsequent loss of retinal ganglion cells in the retina. This was inhibited by the systemic administration of a sodium channel blocker (oxcarbazepine) or intraocular treatment with siRNA targeting caspase-2. These novel approaches have relevance to the future treatment of neurodegeneration of MS, which has so far evaded treatment.	[Lidster, Katie; Jackson, Samuel J.; Giovannoni, Gavin; Baker, Mark D.; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Ahmed, Zubair] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Munro, Peter; Coffey, Pete] UCL, Inst Ophthalmol, London, England	University of London; Queen Mary University London; University of Birmingham; University of London; University College London	Lidster, K (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	katie.lidster@nc3rs.org.uk		Coffey, Peter/0000-0002-5427-2939	Barts and the London Charity; Multiple Sclerosis Society of Great Britain and Northern Ireland; National Multiple Sclerosis Society, USA; National Centre for the Replacement, Refinement & Reduction of Animals in Research; Wellcome Trust [092539]; National Centre for the Replacement [G1000094/1] Funding Source: researchfish	Barts and the London Charity; Multiple Sclerosis Society of Great Britain and Northern Ireland; National Multiple Sclerosis Society, USA(National Multiple Sclerosis Society); National Centre for the Replacement, Refinement & Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	The authors acknowledge the support of the Barts and the London Charity, the Multiple Sclerosis Society of Great Britain and Northern Ireland, the National Multiple Sclerosis Society, USA, notably the National Centre for the Replacement, Refinement & Reduction of Animals in Research, and the Wellcome Trust (grant no. 092539 to ZA). The siRNA was provided by Quark Pharmaceuticals. The funders and Quark Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2002, AM J PATHOL, V161, P1577, DOI 10.1016/S0002-9440(10)64436-7; Al-Izki S, 2011, MULT SCLER J, V17, pS209; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Bechtold DA, 2006, J NEUROL, V253, P1542, DOI 10.1007/s00415-006-0204-1; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Black JA, 2012, EXP NEUROL, V234, P302, DOI 10.1016/j.expneurol.2011.09.030; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fernandes DB, 2012, J NEURO-OPHTHALMOL, V32, P102, DOI 10.1097/WNO.0b013e31823a9ebc; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Gnanapavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070019; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Guan YT, 2006, J NEUROIMMUNOL, V178, P40, DOI 10.1016/j.jneuroim.2006.05.019; Hafezi F, 2000, BRIT J OPHTHALMOL, V84, P922, DOI 10.1136/bjo.84.8.922; Hampton DW, 2008, J NEUROIMMUNOL, V201, P200, DOI 10.1016/j.jneuroim.2008.05.034; Hayton T, 2011, J NEUROL, V258, P1; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Leung CKS, 2009, BRIT J OPHTHALMOL, V93, P964, DOI 10.1136/bjo.2008.150482; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; Morris-Downes MM, 2002, J NEUROIMMUNOL, V125, P114, DOI 10.1016/S0165-5728(02)00040-1; O'Neill JK, 1998, J NEUROIMMUNOL, V82, P210, DOI 10.1016/S0165-5728(97)00203-8; Oh J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/460825; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; Wang X, 2010, NEUROSCI LETT, V468, P110, DOI 10.1016/j.neulet.2009.10.077; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735	40	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79188	10.1371/journal.pone.0079188	http://dx.doi.org/10.1371/journal.pone.0079188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223903	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400101
J	Sun, X; Kay, AD; Kang, HZ; Small, GE; Liu, GF; Zhou, X; Yin, S; Liu, CJ				Sun, Xiao; Kay, Adam D.; Kang, Hongzhang; Small, Gaston E.; Liu, Guofang; Zhou, Xuan; Yin, Shan; Liu, Chunjiang			Correlated Biogeographic Variation of Magnesium across Trophic Levels in a Terrestrial Food Chain	PLOS ONE			English	Article							LEAF-LITTER; STOICHIOMETRY; SOIL; TEMPERATURE; PHOSPHORUS; PATTERNS; CALCIUM; NUTRIENTS; GRADIENT; CLIMATE	Using samples from eastern China (c. 25 - 41 degrees N and 99 - 123 degrees E) and from a common garden experiment, we investigate how Mg concentration varies with climate across multiple trophic levels. In soils, plant tissue (Oriental oak leaves and acorns), and a specialist acorn predator (the weevil Curculio davidi), Mg concentration increased significantly with different slopes from south to north, and generally decreased with both mean annual temperature (MAT) and precipitation (MAP). In addition, soil, leaf, acorn and weevil Mg showed different strengths of association and sensitivity with climatic factors, suggesting that distinct mechanisms may drive patterns of Mg variation at different trophic levels. Our findings provide a first step toward determining whether anticipated changes in temperature and precipitation due to climate change will have important consequences for the bioavailability and distribution of Mg in food chain.	[Sun, Xiao; Kang, Hongzhang; Zhou, Xuan; Yin, Shan; Liu, Chunjiang] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Kay, Adam D.; Small, Gaston E.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Liu, Guofang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yin, Shan; Liu, Chunjiang] Shanghai Jiao Tong Univ, Res Ctr Low Carbon Agr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of St Thomas Minnesota; Chinese Academy of Sciences; Institute of Botany, CAS; Shanghai Jiao Tong University	Liu, CJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	chjliu@sjtu.edu.cn	zhou, xuan/GZA-8157-2022	Kang, Hongzhang/0000-0003-4026-3588; Small, Gaston/0000-0002-9018-7555	National Natural Science Foundation of China [NSFC 31070532, 30800138, 30671674]; Science and Technology Commission of Shanghai Municipality [10JC1407000]; U.S. National Science Foundation [NSF-DEB 0842038]; Direct For Biological Sciences [0842038] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by the National Natural Science Foundation of China (NSFC 31070532, 30800138 and 30671674), and the Science and Technology Commission of Shanghai Municipality (10JC1407000). A. D. Kay was supported by the U.S. National Science Foundation (NSF-DEB 0842038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Agren GI, 2012, NEW PHYTOL, V194, P944, DOI 10.1111/j.1469-8137.2012.04114.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bohonak A. J., 2004, RMA SOFTWARE REDUCED; De Frenne P, 2011, PLANT BIOLOGY, V13, P493, DOI 10.1111/j.1438-8677.2010.00404.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; ERICSSON T, 1988, PHYSIOL PLANTARUM, V72, P227, DOI 10.1111/j.1399-3054.1988.tb05827.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Hermans C, 2004, PLANTA, V220, P344, DOI 10.1007/s00425-004-1340-4; Huang NH, 2009, J FIRE SCI, V27, P235, DOI 10.1177/0734904108099334; JOHANSSON MB, 1995, FORESTRY, V68, P49, DOI 10.1093/forestry/68.1.49; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2004, BIODIVERS CONSERV, V13, P659; Mayland H.F., 1988, RUMINANT ANIMAL DIGE, P511; MAYLAND HF, 1989, J ANIM SCI, V67, P3437; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; NOWELL NW, 1963, J APPL PHYSIOL, V18, P967, DOI 10.1152/jappl.1963.18.5.967; Pratihar Suman, 2009, South American Journal of Herpetology, V4, P51, DOI 10.2994/057.004.0106; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; REINBOTT TM, 1994, AGRON J, V86, P523, DOI 10.2134/agronj1994.00021962008600030013x; Riedesel ML, 1956, SERUM MAGNESIUM CHAN; Sardans J, 2008, BIOGEOCHEMISTRY, V87, P49, DOI 10.1007/s10533-007-9167-2; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sun X, 2013, J INSECT PHYSL; Wang L, 1985, J BEIJING FOR COLL, V3, P57	34	11	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78444	10.1371/journal.pone.0078444	http://dx.doi.org/10.1371/journal.pone.0078444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223807	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400061
J	Hus, I; Bojarska-Junak, A; Chocholska, S; Tomczak, W; Wos, J; Dmoszynska, A; Rolinski, J				Hus, Iwona; Bojarska-Junak, Agnieszka; Chocholska, Sylwia; Tomczak, Waldemar; Wos, Justyna; Dmoszynska, Anna; Rolinski, Jacek			Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity	PLOS ONE			English	Article							REGULATORY T-CELLS; NECROSIS-FACTOR-ALPHA; HELPER 17 CELLS; TH17 CELLS; PERIPHERAL-BLOOD; B-CELLS; INTERLEUKIN-10 LEVELS; CLINICAL-SIGNIFICANCE; DISEASE PROGRESSION; T(H)17 CELLS	Th17 cells, a recently discovered subset of T helper cells that secrete IL-17A, can affect the inflammation process autoimmune and cancer diseases development. The purpose of this study was to evaluate the role of Th17 cells and IL17A in biology of CLL. The study group included 294 untreated CLL patients in different clinical stages. Here, we show that higher Th17 and IL-17A values were associated with less advanced clinical stage of CLL. Th17 cells' percentages in PB were lower in patients who died due to CLL during follow-up due to CLL (as compared to surviving patients) and in patients responding to first-line therapy with fludarabine-based regimens (as compared to non-responders). IL-17A inversely correlated with the time from CLL diagnosis to the start of therapy and was lower in patients who required treatment during follow-up. Th-17 and IL-17A values were lower in patients with adverse prognostic factors (17p and 11q deletion, CD38 and ZAP-70 expression). CLL patients with detectable IL-17A mRNA in T cells were in Rai Stage 0 and negative for both ZAP-70 and CD38 expression. Th17 percentages positively correlated with iNKT and adversely with Treg cells. The results of this study suggest that Th17 may play a beneficial role in CLL immunity.	[Hus, Iwona; Chocholska, Sylwia; Tomczak, Waldemar; Dmoszynska, Anna] Med Univ Lublin, Dept Haematooncol & Bone Marrow Transplantat, Lublin, Poland; [Bojarska-Junak, Agnieszka; Wos, Justyna; Rolinski, Jacek] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Bojarska-Junak, A (corresponding author), Med Univ Lublin, Dept Clin Immunol, Lublin, Poland.	agnieszkajunak@poczta.onet.pl	Hus, Iwona/AAB-2809-2020; Bojarska-Junak, Agnieszka/AAK-3714-2021	Hus, Iwona/0000-0002-6096-4093; Bojarska-Junak, Agnieszka/0000-0003-2340-9442; Tomczak, Waldemar/0000-0002-3205-5781; Chocholska, Sylwia/0000-0002-5001-9258; Rolinski, Jacek/0000-0003-4841-6120; wos, justyna/0000-0002-9597-5331; Rolinski, Jacek Mariusz/0000-0001-5596-2651	State Funds for Scientific Research of National Science Centre (NCN) [GR831];  [N N402 351438];  [N N404 682440];  [N N402 439139];  [N N402 683140]	State Funds for Scientific Research of National Science Centre (NCN); ; ; ; 	This work was supported by research grants: N N402 351438, N N404 682440, N N402 439139, N N402 683140 and Development Grant GR831 from State Funds for Scientific Research of National Science Centre (NCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Bojarska-Junak A, 2002, HAEMATOLOGICA, V87, P490; Bojarska-Junak A, 2008, LEUKEMIA RES, V32, P225, DOI 10.1016/j.leukres.2007.06.007; Chong SY, 2001, GENES IMMUN, V2, P239, DOI 10.1038/sj.gene.6363773; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; D'Arena G, 2011, LEUKEMIA RES, V35, P363, DOI 10.1016/j.leukres.2010.08.010; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; de Jong E, 2010, CLIN EXP IMMUNOL, V159, P148, DOI 10.1111/j.1365-2249.2009.04041.x; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Furman RR, 2010, HEMATOL-AM SOC HEMAT, P77, DOI 10.1182/asheducation-2010.1.77; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hus I, 2006, ANN ONCOL, V17, P683, DOI 10.1093/annonc/mdj120; Jadidi-Niaragh F, 2013, TUMOR BIOL, V34, P929, DOI 10.1007/s13277-012-0628-4; Jain P, 2012, HAEMATOL-HEMATOL J, V97, P599, DOI 10.3324/haematol.2011.047316; Ji YQ, 2010, CANCER IMMUNOL IMMUN, V59, P979, DOI 10.1007/s00262-010-0849-6; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lech-Maranda E, 2012, ARCH IMMUNOL THER EX, V60, P477, DOI 10.1007/s00005-012-0197-7; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Mellstedt H, 2006, CANCER IMMUNOL IMMUN, V55, P210, DOI 10.1007/s00262-005-0675-4; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Palmer S, 2008, BRIT J HAEMATOL, V141, P607, DOI 10.1111/j.1365-2141.2008.07070.x; Podhorecka M, 2002, LEUKEMIA RES, V26, P657, DOI 10.1016/S0145-2126(01)00194-1; Podhorecka Monika, 2004, Postepy Hig Med Dosw (Online), V58, P236; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Scrivener S, 2003, LEUKEMIA LYMPHOMA, V44, P383, DOI 10.1080/1042819021000029993; Seino K, 2006, CANCER SCI, V97, P807, DOI 10.1111/j.1349-7006.2006.00257.x; Tinhofer I, 2006, BLOOD, V108, P2950, DOI 10.1182/blood-2006-03-010553; Wang J, 2011, J INT MED RES, V39, P691, DOI 10.1177/147323001103900301; Weinkove R, 2013, HAEMATOLOGICA, V98, P376, DOI 10.3324/haematol.2012.072835; Wilke CM, 2011, CARCINOGENESIS, V32, P643, DOI 10.1093/carcin/bgr019; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Ye ZJ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-77; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhou P, 2010, J INT MED RES, V38, P611, DOI 10.1177/147323001003800223; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	44	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78091	10.1371/journal.pone.0078091	http://dx.doi.org/10.1371/journal.pone.0078091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223764	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300021
J	Zhong, M; Kawaguchi, R; Ter-Stepanian, M; Kassai, M; Sun, H				Zhong, Ming; Kawaguchi, Riki; Ter-Stepanian, Mariam; Kassai, Miki; Sun, Hui			Vitamin A Transport and the Transmembrane Pore in the Cell-Surface Receptor for Plasma Retinol Binding Protein	PLOS ONE			English	Article							LARGE-SCALE MUTAGENESIS; POTASSIUM CHANNELS; MEMBRANE-RECEPTOR; MOLECULAR-BASIS; VISUAL CYCLE; MICE LACKING; MUTATIONS; ACID; DEFICIENCY; STRA6	Vitamin A and its derivatives (retinoids) play diverse and crucial functions from embryogenesis to adulthood and are used as therapeutic agents in human medicine for eye and skin diseases, infections and cancer. Plasma retinol binding protein (RBP) is the principal and specific vitamin A carrier in the blood and binds vitamin A at 1:1 ratio. STRA6 is the high-affinity membrane receptor for RBP and mediates cellular vitamin A uptake. STRA6 null mice have severely depleted vitamin A reserves for vision and consequently have vision loss, even under vitamin A sufficient conditions. STRA6 null humans have a wide range of severe pathological phenotypes in many organs including the eye, brain, heart and lung. Known membrane transport mechanisms involve transmembrane pores that regulate the transport of the substrate (e.g., the gating of ion channels). STRA6 represents a new type of membrane receptor. How this receptor interacts with its transport substrate vitamin A and the functions of its nine transmembrane domains are still completely unknown. These questions are critical to understanding the molecular basis of STRA6's activities and its regulation. We employ acute chemical modification to introduce chemical side chains to STRA6 in a site-specific manner. We found that modifications with specific chemicals at specific positions in or near the transmembrane domains of this receptor can almost completely suppress its vitamin A transport activity. These experiments provide the first evidence for the existence of a transmembrane pore, analogous to the pore of ion channels, for this new type of cell-surface receptor.	[Sun, Hui] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020		National Institutes of Health [R01EY018144]; NATIONAL EYE INSTITUTE [R01EY018144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grant R01EY018144. H.S. is an Early Career Scientist of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; BEZANILLA F, 1974, SCIENCE, V183, P753, DOI 10.1126/science.183.4126.753; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chivot M, 2005, AM J CLIN DERMATOL, V6, P13, DOI 10.2165/00128071-200506010-00002; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; Evans R M, 1994, Harvey Lect, V90, P105; Folli C, 2005, BIOCHEM BIOPH RES CO, V336, P1017, DOI 10.1016/j.bbrc.2005.08.227; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; HELLER J, 1973, J BIOL CHEM, V248, P6308; HELLER J, 1975, J BIOL CHEM, V250, P3613; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2013, JOVE-J VIS EXP, DOI 10.3791/50169; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nau H., 1994, Vitamin A in health and disease., P615; Nau H, 2001, J AM ACAD DERMATOL, V45, pS183, DOI 10.1067/mjd.2001.113720; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Orfanos CE, 1997, DRUGS, V53, P358, DOI 10.2165/00003495-199753030-00003; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; RASK L, 1976, J BIOL CHEM, V251, P6360; RASK L, 1980, SCAND J CLIN LAB INV, V40, P45; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; SOMMER A, 1993, LANCET, V342, P1420, DOI 10.1016/0140-6736(93)92776-P; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sun H, 2011, INT REV CEL MOL BIO, V288, P1, DOI 10.1016/B978-0-12-386041-5.00001-7; Szeto W, 2001, CANCER RES, V61, P4197; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8; Zhong M, 2012, NUTRIENTS, V4, P2069, DOI 10.3390/nu4122069; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	68	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e73838	10.1371/journal.pone.0073838	http://dx.doi.org/10.1371/journal.pone.0073838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223695	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300001
J	Aven, L; Paez-Cortez, J; Achey, R; Krishnan, R; Ram-Mohan, S; Cruikshank, WW; Fine, A; Ai, XB				Aven, Linh; Paez-Cortez, Jesus; Achey, Rebecca; Krishnan, Ramaswamy; Ram-Mohan, Sumati; Cruikshank, William W.; Fine, Alan; Ai, Xingbin			An NT4/TrkB-dependent increase in innervation links early-life allergen exposure to persistent airway hyperreactivity	FASEB JOURNAL			English	Article						smooth muscle; ASM; childhood asthma; innervation; contractility; lung slice	TRK RECEPTORS; MURINE MODEL; ASTHMA; CELLS; HYPERRESPONSIVENESS; INFLAMMATION; INDUCTION; SIGNALS; MUSCLE; MICE	Children who are exposed to environmental respiratory insults often develop asthma that persists into adulthood. In this study, we used a neonatal mouse model of ovalbumin (OVA)-induced allergic airway inflammation to understand the long-term effects of early childhood insults on airway structure and function. We showed that OVA sensitization and challenge in early life led to a 2-fold increase in airway smooth muscle (ASM) innervation (P<0.05) and persistent airway hyperreactivity (AHR). In contrast, OVA exposure in adult life elicited short-term AHR without affecting innervation levels. We found that postnatal ASM innervation required neurotrophin (NT)-4 signaling through the TrkB receptor and that early-life OVA exposure significantly elevated NT4 levels and TrkB signaling by 5- and 2-fold, respectively, to increase innervation. Notably, blockade of NT4/TrkB signaling in OVA-exposed pups prevented both acute and persistent AHR without affecting baseline airway function or inflammation. Furthermore, biophysical assays using lung slices and isolated cells demonstrated that NT4 was necessary for hyperreactivity of ASM induced by early-life OVA exposure. Together, our findings show that the NT4/TrkB-dependent increase in innervation plays a critical role in the alteration of the ASM phenotype during postnatal growth, thereby linking early-life allergen exposure to persistent airway dysfunction.Aven, L., Paez-Cortez, J., Achey, R., Krishnan, R., Ram-Mohan, S., Cruikshank, W. W., Fine, A., Ai X. An NT4/TrkB-dependent increase in innervation links early-life allergen exposure to persistent airway hyperreactivity.	[Aven, Linh; Paez-Cortez, Jesus; Achey, Rebecca; Cruikshank, William W.; Fine, Alan; Ai, Xingbin] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Krishnan, Ramaswamy; Ram-Mohan, Sumati] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center	Ai, XB (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 72 East Concord St, Boston, MA 02118 USA.	aix@bu.edu			U.S. National Institutes of Health [HL112619, CA122737, HL007035]; Parker Francis Foundation; American Asthma Foundation [12-0086]; NATIONAL CANCER INSTITUTE [R01CA122737] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116163, T32HL007035, R21HL112619] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Francis Foundation; American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. David Ginty (Johns Hopkins University, Baltimore, MD, USA) for the TrkB<SUP>F616A/F616A</SUP> mouse line; Dr. Janice Weinberg for statistical analysis; Kavon Kaboli for airway resistance assay by Flexivent; and Kelsi Radzikinas, Kruti Patel, and Kavitha Rajendran for technical assistance. This work was supported by grants to X. A. and A. F. (HL112619) and W. C. (CA122737) and a T32 training grant to L. A. (HL007035) from the U.S. National Institutes of Health; a grant from The Parker Francis Foundation to R. K.; and a grant to X. A. from the American Asthma Foundation (12-0086). The authors declare no conflicts of interest.	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Aven L, 2013, ORGANOGENESIS, V9, P194, DOI 10.4161/org.24842; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; Bisgaard H, 2010, J ALLERGY CLIN IMMUN, V126, P187, DOI 10.1016/j.jaci.2010.07.011; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Chevrel G, 2006, MUSCLE NERVE, V33, P462, DOI 10.1002/mus.20444; de Vries A, 2006, CLIN EXP ALLERGY, V36, P1192, DOI 10.1111/j.1365-2222.2006.02549.x; Fischer A, 1996, J CLIN INVEST, V98, P2284, DOI 10.1172/JCI119039; Garcia-Suarez O, 2009, RESP PHYSIOL NEUROBI, V167, P281, DOI 10.1016/j.resp.2009.06.001; Gelfand EW, 2012, CURR OPIN IMMUNOL, V24, P713, DOI 10.1016/j.coi.2012.08.011; Ghosh S, 2011, J BIOL CHEM, V286, P22678, DOI 10.1074/jbc.M111.241224; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kc P, 2010, RESP PHYSIOL NEUROBI, V173, P213, DOI 10.1016/j.resp.2010.03.020; Kerzel S, 2003, AM J RESP CELL MOL, V28, P170, DOI 10.1165/rcmb.4811; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Langsdorf A, 2011, AM J RESP CELL MOL, V44, P293, DOI 10.1165/rcmb.2009-0462OC; Larson SD, 2004, TOXICOL APPL PHARM, V194, P211, DOI 10.1016/j.taap.2003.09.025; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Luther JA, 2009, AUTON NEUROSCI-BASIC, V151, P46, DOI 10.1016/j.autneu.2009.08.009; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Martinez FD, 2009, ALLERGOL IMMUNOPATH, V37, P249, DOI 10.1016/j.aller.2009.06.008; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Nassenstein C, 2006, J ALLERGY CLIN IMMUN, V118, P597, DOI 10.1016/j.jaci.2006.04.052; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Paez-Cortez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074469; Radzikinas K, 2011, J NEUROSCI, V31, P15407, DOI 10.1523/JNEUROSCI.2745-11.2011; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Shuler MG, 2004, J COMP NEUROL, V472, P183, DOI 10.1002/cne.11017; SPRINGALL DR, 1987, J AUTONOM NERV SYST, V20, P155, DOI 10.1016/0165-1838(87)90113-5; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Szczepankiewicz A, 2012, EUR RESPIR J, V39, P1035, DOI 10.1183/09031936.00136611; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Wu ZX, 2012, AM J PHYSIOL-LUNG C, V302, pL152, DOI 10.1152/ajplung.00071.2011; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	43	31	34	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					897	907		10.1096/fj.13-238212	http://dx.doi.org/10.1096/fj.13-238212			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24221086	Green Published			2022-12-25	WOS:000331072200035
J	Zhou, Y; Paull, TT				Zhou, Yi; Paull, Tanya T.			DNA-dependent Protein Kinase Regulates DNA End Resection in Concert with Mre11-Rad50-Nbs1 (MRN) and Ataxia Telangiectasia-mutated (ATM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Damage Response; DNA Enzymes; DNA Recombination; DNA Repair; Protein Kinases	DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; REPAIR; AUTOPHOSPHORYLATION; COMPLEX; BINDING; CTIP; EXO1	The resection of DNA double strand breaks initiates homologous recombination (HR) and is critical for genomic stability. Using direct measurement of resection in human cells and reconstituted assays of resection with purified proteins in vitro, we show that DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a classic nonhomologous end joining factor, antagonizes double strand break resection by blocking the recruitment of resection enzymes such as exonuclease 1 (Exo1). Autophosphorylation of DNA-PKcs promotes DNA-PKcs dissociation and consequently Exo1 binding. Ataxia telangiectasia-mutated kinase activity can compensate for DNA-PKcs autophosphorylation and promote resection under conditions where DNA-PKcs catalytic activity is inhibited. The Mre11-Rad50-Nbs1 (MRN) complex further stimulates resection in the presence of Ku and DNA-PKcs by recruiting Exo1 and enhancing DNA-PKcs autophosphorylation, and it also inhibits DNA ligase IV/XRCC4-mediated end rejoining. This work suggests that, in addition to its key role in nonhomologous end joining, DNA-PKcs also acts in concert with MRN and ataxia telangiectasia-mutated to regulate resection and thus DNA repair pathway choice.	Univ Texas Austin, Dept Mol Biosci, Howard Hughes Med Inst, Austin, TX 78712 USA; [Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Dept Mol Biosci, 2500 Speedway,MBB 2-448, Austin, TX 78712 USA.	tpaull@utexas.edu	Zhou, Yi/P-1039-2015	Zhou, Yi/0000-0002-1650-4591; Paull, Tanya/0000-0002-2991-651X	CPRIT [RP110465-P4]	CPRIT	This work was supported by CPRIT Grant RP110465-P4.	Allen C, 2003, MOL CANCER RES, V1, P913; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Costanzo V, 2011, DNA REPAIR, V10, P1060, DOI 10.1016/j.dnarep.2011.07.009; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Davidson D, 2012, INVEST NEW DRUG, V30, P1248, DOI 10.1007/s10637-010-9626-9; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lee BS, 2013, MOL CELL BIOL, V33, P3568, DOI 10.1128/MCB.00308-13; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Long MJC, 2012, CHEM BIOL, V19, P629, DOI 10.1016/j.chembiol.2012.04.008; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Trovesi C, 2013, J MOL BIOL, V425, P4756, DOI 10.1016/j.jmb.2013.04.013; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang H., 2013, PLOS GENET, V9; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	60	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37112	37125		10.1074/jbc.M113.514398	http://dx.doi.org/10.1074/jbc.M113.514398			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220101	Green Published, hybrid			2022-12-25	WOS:000329189700031
J	Hassan, S; Karpova, Y; Flores, A; D'Agostino, R; Kulik, G				Hassan, Sazzad; Karpova, Yelena; Flores, Anabel; D'Agostino, Ralph, Jr.; Kulik, George			Surgical Stress Delays Prostate Involution in Mice	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; BICALUTAMIDE; CELLS; METASTASIS; PROMOTION; SURGERY; THERAPY	Androgens control growth of prostate epithelial cells and androgen deprivation induces apoptosis, leading to prostate involution. We investigated the effects of surgical stress on prostate involution induced by androgen ablation and determined the underlying mechanisms. Androgen ablation in mice was induced by surgical castration and administration of the anti-androgenic drugs bicalutamide and MDV3100. Surgical stress was induced by sham castration under isoflurane anesthesia. Surgical stress delayed apoptosis and prostate involution induced by anti-androgenic drugs. These effects of stress were prevented by administering the selective beta2-adrenoreceptor antagonist ICI118,551 and were also blocked in BAD 3SA/WT mice expressing phosphorylation-deficient mutant BAD3SA. These results indicate that apoptosis and prostate involution in response to androgen ablation therapy could be delayed by surgical stress via the beta2-adrenoreceptor/BAD signaling pathway. Thus, surgery could interfere with androgen ablation therapy, whereas administration of beta2-adrenoreceptor antagonists may enhance its efficacy.	[Hassan, Sazzad; Karpova, Yelena; Flores, Anabel; Kulik, George] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA; [D'Agostino, Ralph, Jr.; Kulik, George] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Kulik, George] Alfaisal Univ, Coll Sci, Riyadh, Saudi Arabia	Wake Forest University; Wake Forest University; Alfaisal University	Kulik, G (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27106 USA.	gkulik@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	Department of Defense [PC073548]; National Cancer Institute [R01CA118329]; NCI Cancer Center Support Grant (CCSG) [P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA118329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064249] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Project described was supported by PC073548 award from the Department of Defense and Award Number R01CA118329 from the National Cancer Institute to George Kulik. Biostatistical support was made possible by NCI Cancer Center Support Grant (CCSG) P30CA012197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales GT, 1996, UROLOGY, V47, P38, DOI 10.1016/S0090-4295(96)80007-0; Ben-Eliyahu S, 2003, BRAIN BEHAV IMMUN, V17, pS27; CARTER HB, 1990, PROG CLIN BIOL RES, V350, P129; Da Costa ML, 1998, SURGERY, V124, P516, DOI 10.1067/msy.1998.89410; EGGERMONT AMM, 1988, CANCER DETECT PREV, V12, P421; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guerrero J, 2013, PROSTATE; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hofer SOP, 1999, EUR J SURG ONCOL, V25, P231, DOI 10.1053/ejso.1998.0634; ISAACS JT, 1992, J ANDROL, V13, P457; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; KYPRIANOU N, 1991, CANCER SURV, V11, P265; Lee JW, 2009, CLIN CANCER RES, V15, P2695, DOI 10.1158/1078-0432.CCR-08-2966; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Nickerson T, 1999, UROLOGY, V54, P1120, DOI 10.1016/S0090-4295(99)00421-5; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Scattoni V, 2006, BJU INT, V98, P54, DOI 10.1111/j.1464-410X.2006.06204.x; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; WEESE JL, 1986, SURGERY, V100, P273	20	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78175	10.1371/journal.pone.0078175	http://dx.doi.org/10.1371/journal.pone.0078175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223137	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200029
J	Major, E; Rigo, K; Hague, T; Berces, A; Juhos, S				Major, Endre; Rigo, Krisztina; Hague, Tim; Berces, Attila; Juhos, Szilveszter			HLA Typing from 1000 Genomes Whole Genome and Whole Exome Illumina Data	PLOS ONE			English	Article							CLASS-I; HIGH-THROUGHPUT; GENETICS; PROJECT	Specific HLA genotypes are known to be linked to either resistance or susceptibility to certain diseases or sensitivity to certain drugs. In addition, high accuracy HLA typing is crucial for organ and bone marrow transplantation. The most widespread high resolution HLA typing method used to date is Sanger sequencing based typing (SBT), and next generation sequencing (NGS) based HLA typing is just starting to be adopted as a higher throughput, lower cost alternative. By HLA typing the HapMap subset of the public 1000 Genomes paired Illumina data, we demonstrate that HLA-A, B and C typing is possible from exome sequencing samples with higher than 90% accuracy. The older 1000 Genomes whole genome sequencing read sets are less reliable and generally unsuitable for the purpose of HLA typing. We also propose using coverage % (the extent of exons covered) as a quality check (QC) measure to increase reliability.	[Major, Endre; Rigo, Krisztina; Hague, Tim; Berces, Attila; Juhos, Szilveszter] Omixon Biocomp, Budapest, Hungary		Juhos, S (corresponding author), Omixon Biocomp, Budapest, Hungary.	szilveszter.juhos@omixon.com		Juhos, Szilveszter/0000-0001-6280-4643	Swiss Contribution scheme	Swiss Contribution scheme	Supported by the Swiss Contribution scheme http://www.contribution-enlargement.admin.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; De Santis D, 2013, INT J IMMUNOGENET, V40, P72, DOI 10.1111/iji.12024; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Kilpinen H, 2013, TRENDS GENET, V29, P23, DOI 10.1016/j.tig.2012.10.001; Lank SM, 2010, HUM IMMUNOL, V71, P1011, DOI 10.1016/j.humimm.2010.07.012; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Mack SJ, 2013, TISSUE ANTIGENS, V81, P194, DOI 10.1111/tan.12093; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; R Core Team, 2012, R LANG ENV STAT COMP; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396	21	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78410	10.1371/journal.pone.0078410	http://dx.doi.org/10.1371/journal.pone.0078410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223151	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200043
J	Inoshita, H; Kim, BG; Yamashita, M; Choi, SH; Tomino, Y; Letterio, JJ; Emancipator, SN				Inoshita, Hiroyuki; Kim, Byung-Gyu; Yamashita, Michifumi; Choi, Sung Hee; Tomino, Yasuhiko; Letterio, John J.; Emancipator, Steven N.			Disruption of Smad4 Expression in T Cells Leads to IgA Nephropathy-Like Manifestations	PLOS ONE			English	Article							MURINE B-CELLS; TGF-BETA; IMMUNE-COMPLEXES; O-GLYCOSYLATION; KNOCKOUT MICE; RENAL-DISEASE; GLOMERULONEPHRITIS; COMPLEMENT; ACTIVATION; DIFFERENTIATION	The link between glomerular IgA nephropathy (IgAN) and T helper 2 (Th2) response has been implicated, however, the mechanisms are poorly defined because of the lack of an appropriate model. Here we report a novel murine model characterized by lineage-restricted deletion of the gene encoding MAD homologue 4 (Smad4) in T cells (Smad4(co/co;Lck-cre)). Loss of Smad4 expression in T cells results in overproduction of Th2 cytokines and high serum IgA levels. We found that Smad4(co/co;Lck-cre) mice exhibited massive glomerular IgA deposition, increased albumin creatinine ratio, aberrant glycosylated IgA, IgA complexed with IgG1 and IgG2a, and polymeric IgA, all known features of IgAN in humans. Furthermore, we examined the beta 1, 4-galactosyltransferases (beta 4GalT) enzyme which is involved in the synthesis of glycosylated murine IgA, and we found reduced beta 4GalT2 and beta 4GalT4 mRNA levels in B cells. These findings indicate that Smad4(co/co;Lck-cre) mice could be a useful model for studying the mechanisms between IgAN and Th2 response, and further, disruption of Smad4-dependent signaling in T cells may play an important role in the pathogenesis of human IgAN and contributing to a Th2 T cell phenotype.	[Inoshita, Hiroyuki; Yamashita, Michifumi; Emancipator, Steven N.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kim, Byung-Gyu; Choi, Sung Hee; Letterio, John J.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Inoshita, Hiroyuki; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol,Bunkyo Ku, Tokyo, Japan; [Emancipator, Steven N.] Louis Stokes Dept Vet Affairs, Med Ctr, Pathol & Lab Med Serv, Cleveland, OH USA; Univ Hosp Cleveland, Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Juntendo University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University Hospitals of Cleveland	Inoshita, H (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	inoshitahiroyuki@gmail.com	YAMASHITA, Michifumi/AFT-3479-2022	Kim, Byung-Gyu/0000-0002-8921-5061; Yamashita, Michifumi/0000-0001-6221-8900	Department of Veteran Affairs [BLRD-5I01 BX000376-04]	Department of Veteran Affairs(US Department of Veterans Affairs)	This research was supported by a Merit grant from the Department of Veteran Affairs (BLRD-5I01 BX000376-04). Dr. Letterio is endowed as the Jane and Lee Seidman Chair in Pediatric Cancer Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; Chintalacharuvu SR, 2008, CLIN EXP IMMUNOL, V153, P456, DOI 10.1111/j.1365-2249.2008.03703.x; Chintalacharuvu SR, 1997, J IMMUNOL, V159, P2327; Chintalacharuvu SR, 2000, CYTOKINE, V12, P1182, DOI 10.1006/cyto.2000.0699; Chintalacharuvu SR, 2001, CLIN EXP IMMUNOL, V126, P326, DOI 10.1046/j.1365-2249.2001.01678.x; Couser WG, 1999, LANCET, V353, P1509, DOI 10.1016/S0140-6736(98)06195-9; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; EMANCIPATOR SN, 1990, KIDNEY INT, V38, P1216, DOI 10.1038/ki.1990.337; EMANCIPATOR SN, 1987, LAB INVEST, V57, P269; Emancipator SN, 2007, HEPTINSTALLS PATHOLO; FRIEDBERG M, 1978, LANCET, V1, P498; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HOGG R J, 1982, Kidney International, V22, P643; HUBERT D, 1984, PRESSE MED, V13, P1083; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kotani N, 2001, BIOCHEM J, V357, P827, DOI 10.1042/0264-6021:3570827; Kusaba G, 2012, MED MOL MORPHOL, V45, P29, DOI 10.1007/s00795-011-0538-3; LAI KN, 1994, CLIN EXP IMMUNOL, V96, P116; LEE HS, 1989, KIDNEY INT, V35, P880, DOI 10.1038/ki.1989.68; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; NAKAZAWA K, 1988, J BIOCHEM-TOKYO, V104, P165, DOI 10.1093/oxfordjournals.jbchem.a122434; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCIVITTARO V, 1994, CLIN NEPHROL, V42, P1; Sharmin S, 2004, J NEPHROL, V17, P504; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki Y, 2008, SEMIN NEPHROL, V28, P66, DOI 10.1016/j.semnephrol.2007.10.008; VANES LA, 1988, AM J KIDNEY DIS, V12, P397, DOI 10.1016/S0272-6386(88)80033-7; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; YOSHIKAWA N, 1990, CLIN NEPHROL, V33, P160; YOSHIMURA M, 1987, AM J KIDNEY DIS, V9, P404, DOI 10.1016/S0272-6386(87)80143-9; ZHANG W, 1994, IMMUNOLOGY, V81, P137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	45	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78736	10.1371/journal.pone.0078736	http://dx.doi.org/10.1371/journal.pone.0078736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223846	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400086
J	Taina, M; Vanninen, R; Hedman, M; Jakala, P; Karkkainen, S; Tapiola, T; Sipola, P				Taina, Mikko; Vanninen, Ritva; Hedman, Marja; Jakala, Pekka; Karkkainen, Satu; Tapiola, Tero; Sipola, Petri			Left Atrial Appendage Volume Increased in More Than Half of Patients with Cryptogenic Stroke	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ISCHEMIC-STROKE; CARDIAC CT; FIBRILLATION; RISK; ECHOCARDIOGRAPHY; MORPHOLOGY; TELEMETRY; FORMS	Background: Ischemic strokes without a well-defined etiology are labeled as cryptogenic, and account for 30-40% of strokes in stroke registries. The left atrial appendage (LAA) is the most typical origin for intracardiac thrombus formation when associated with atrial fibrillation. Here, we examined whether increased LAA volume detected with cardiac computed tomography (cCT) constitutes a risk factor in cryptogenic stroke patients. Methods: This study included 82 stroke/TIA patients (57 males; mean age, 58 years) with a diagnosis of cryptogenic stroke after extensive radiological and cardiological investigations. Cases were classified using the TOAST criteria modified by European Association of Echocardiography recommendations for defining cardiac sources of embolism. Forty age- and gender-matched control subjects without cardiovascular diseases were selected for pair-wise comparisons (21 males; mean age, 54 years). LAA volume adjusted for body surface area was measured three dimensionally by tracing the LAA borders on electrocardiogram-gated CT slices. Results: In control subjects, mean LAA volume was 3.4 +/- 1.1 mL/m(2). Mean+2SD, which was considered the upper limit for normal LAA volume was 5.6 mL/m(2). In paired Student t-test between the patient group and matched controls, LAA volume was 67% larger in cryptogenic stroke/TIA patients (5.7 +/- 2.0 mL/m(2) vs. 3.4 +/- 1.1 mL/m(2); P<0.001). Forty-five (55%) patients with cryptogenic stroke/TIA had enlarged LAA. Conclusion: LAA is significantly enlarged in more than half of patients with cryptogenic stroke/TIA. LAA thrombosis may contribute to the pathogenesis of stroke in patients considered to have cryptogenic stroke after conventional evaluation.	[Taina, Mikko; Vanninen, Ritva; Hedman, Marja; Sipola, Petri] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Vanninen, Ritva; Sipola, Petri] Univ Eastern Finland, Radiol Unit, Inst Clin Med, Kuopio, Finland; [Hedman, Marja; Karkkainen, Satu] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Neurol Unit, Inst Clin Med, Kuopio, Finland; [Tapiola, Tero] North Kymi Hosp, Dept Neurol, Kouvola, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519). Kuopio University Hospital web site: www.kuh.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, CEREBROVASC DIS, V27, P97, DOI 10.1159/000200446; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; BURRELL LD, 2013, AM J CARDIOL; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Dion F, 2010, J INTERV CARD ELECTR, V28, P101, DOI 10.1007/s10840-010-9485-5; DOLHABERRIAGUE L, 1989, STROKE, V20, P1648, DOI 10.1161/01.STR.20.12.1648; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Etgen T, 2013, STROKE, V44, P2007, DOI 10.1161/STROKEAHA.113.001340; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; Flint AC, 2012, STROKE, V43, P2788, DOI 10.1161/STROKEAHA.112.665844; Gladstone DJ, 2008, STROKE, V39, pE78, DOI 10.1161/STROKEAHA.107.513002; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Knebel F, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-15; Lacomis JM, 2007, EUROPACE, V9, P1134, DOI 10.1093/europace/eum227; Leschka S, 2006, EUR RADIOL, V16, P1964, DOI 10.1007/s00330-006-0262-x; MANINA G, 2012, INTERN EMERG MED; Miller DJ, 2013, J NEUROL SCI, V324, P57, DOI 10.1016/j.jns.2012.10.001; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Pan NH, 2009, J CARDIOVASC ELECTR, V20, P153, DOI 10.1111/j.1540-8167.2008.01290.x; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Tayal AH, 2008, NEUROLOGY, V71, P1696, DOI 10.1212/01.wnl.0000325059.86313.31; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Whisenant BK, 2013, J AM COLL CARDIOL, V61, pE279, DOI 10.1016/S0735-1097(13)60279-X; Wolber Thomas, 2007, J Stroke Cerebrovasc Dis, V16, P1, DOI 10.1016/j.jstrokecerebrovasdis.2006.07.002; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	43	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79519	10.1371/journal.pone.0079519	http://dx.doi.org/10.1371/journal.pone.0079519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223960	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400121
J	Dvorak, J; Mancikova, V; Pizl, V; Elhottova, D; Silerova, M; Roubalova, R; Skanta, F; Prochazkova, P; Bilej, M				Dvorak, Jiri; Mancikova, Veronika; Pizl, Vaclav; Elhottova, Dana; Silerova, Marcela; Roubalova, Radka; Skanta, Frantisek; Prochazkova, Petra; Bilej, Martin			Microbial Environment Affects Innate Immunity in Two Closely Related Earthworm Species Eisenia andrei and Eisenia fetida	PLOS ONE			English	Article							CELOMIC FLUID; TRANSPLANTATION IMMUNITY; LUMBRICUS-TERRESTRIS; PROTEIN; IDENTIFICATION; LYSOZYME; DNA; CLONING; RECOGNITION; EXPRESSION	Survival of earthworms in the environment depends on their ability to recognize and eliminate potential pathogens. This work is aimed to compare the innate defense mechanisms of two closely related earthworm species, Eisenia andrei and Eisenia fetida, that inhabit substantially different ecological niches. While E. andrei lives in a compost and manure, E. fetida can be found in the litter layer in forests. Therefore, the influence of environment-specific microbiota on the immune response of both species was followed. Firstly, a reliable method to discern between E. andrei and E. fetida based on species-specific primers for cytochrome c oxidase I (COI) and stringent PCR conditions was developed. Secondly, to analyze the immunological profile in both earthworm species, the activity and expression of lysozyme, pattern recognition protein CCF, and antimicrobial proteins with hemolytic function, fetidin and lysenins, have been assessed. Whereas, CCF and lysozyme showed only slight differences in the expression and activity, fetidin/lysenins expression as well as the hemolytic activity was considerably higher in E. andrei as compared to E. fetida. The expression of fetidin/lysenins in E. fetida was not affected upon the challenge with compost microbiota, suggesting more substantial changes in the regulation of the gene expression. Genomic DNA analyses revealed significantly higher level of fetidin/lysenins (determined using universal primer pairs) in E. andrei compared to E. fetida. It can be hypothesized that E. andrei colonizing compost as a new habitat acquired an evolutionary selection advantage resulting in a higher expression of antimicrobial proteins.	[Dvorak, Jiri; Mancikova, Veronika; Silerova, Marcela; Roubalova, Radka; Skanta, Frantisek; Prochazkova, Petra; Bilej, Martin] Acad Sci Czech Republ, Inst Microbiol, Lab Cellular & Mol Immunol, VVI, Prague, Czech Republic; [Pizl, Vaclav; Elhottova, Dana] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, Dept Soil Zool & Soil Microstruct,VVI, CR-37005 Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Bilej, M (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Cellular & Mol Immunol, VVI, Prague, Czech Republic.	mbilej@biomed.cas.cz	Roubalová, Radka/H-2501-2014; Dvořák, Jiří/I-1145-2014; Bilej, Martin/I-4564-2014; Prochazkova, Petra/H-2529-2014; Pizl, Vaclav/B-2636-2009; Škanta, František/H-7931-2014; Elhottová, Dana/G-1168-2014	Roubalová, Radka/0000-0002-9298-4734; Dvořák, Jiří/0000-0002-3714-7781; Pizl, Vaclav/0000-0003-2216-3137	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; Institutional Research Concepts [RVO 61388971, RVO 60077344]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concepts	This research was supported by the Ministry of Education, Youth and Sports (CZ.1.07/2.3.00/20.0055 for PP and CZ.1.07/2.3.00/30.0003 for RR), and the Institutional Research Concepts RVO 61388971 and RVO 60077344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1963, B BIOL FR BELG, V97, P1; BAILEY S, 1971, IMMUNOLOGY, V21, P81; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; Beschin A, 2001, CELL MOL LIFE SCI, V58, P801, DOI 10.1007/PL00000901; BILEJ M, 1995, IMMUNOL LETT, V45, P123, DOI 10.1016/0165-2478(94)00248-P; Bouche MB, 1972, I N R A PUBL ANN ZOO, V72; BRUCE KD, 1992, APPL ENVIRON MICROB, V58, P3413, DOI 10.1128/AEM.58.10.3413-3416.1992; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; COOPER EL, 1968, TRANSPLANTATION, V6, P322, DOI 10.1097/00007890-196805000-00002; COTUK A, 1984, COMP BIOCHEM PHYS A, V78, P469, DOI 10.1016/0300-9629(84)90580-2; Dominguez J, 2005, PEDOBIOLOGIA, V49; DUPASQUI.L, 1968, CR ACAD SCI D NAT, V266, P538; Gregory TR, 2002, CAN J ZOOL, V80, P1485, DOI 10.1139/Z02-145; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jolles P, 1996, EXS, V75, P3; Joskova R, 2009, DEV COMP IMMUNOL, V33, P932, DOI 10.1016/j.dci.2009.03.002; Kauschke E, 1997, COMP BIOCHEM PHYS B, V116, P235, DOI 10.1016/S0305-0491(96)00248-9; Kohlerova P, 2004, DEV COMP IMMUNOL, V28, P701, DOI 10.1016/j.dci.2004.01.001; Kyselkova M, 2012, MICROBES ENVIRON, V27, P413, DOI 10.1264/jsme2.ME12028; Lassegues M, 1997, EUR J BIOCHEM, V246, P756, DOI 10.1111/j.1432-1033.1997.00756.x; LAVELLE P, 1988, BIOL FERT SOILS, V6, P237, DOI 10.1007/BF00260820; LIE O, 1986, ACTA VET SCAND, V27, P23; Milochau A, 1997, BBA-PROTEIN STRUCT M, V1337, P123, DOI 10.1016/S0167-4838(96)00160-4; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Pil V, 2002, SBORNIK PRIRODOVED S, V9, P1; Prochazkova P, 2006, DEV COMP IMMUNOL, V30, P381, DOI 10.1016/j.dci.2005.06.014; Prochazkova P, 2013, J INVERTEBR PATHOL, V114, P217, DOI 10.1016/j.jip.2013.08.003; ROCH P, 1991, DEV COMP IMMUNOL, V15, P27, DOI 10.1016/0145-305X(91)90044-Y; ROCH P, 1981, COMP BIOCHEM PHYS B, V69, P829, DOI 10.1016/0305-0491(81)90390-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sekizawa Y, 1997, GENE, V191, P97, DOI 10.1016/S0378-1119(97)00047-4; Silerova M, 2006, DEV COMP IMMUNOL, V30, P765, DOI 10.1016/j.dci.2005.11.002; Valembois P., 1986, P74; Vitturi R, 2000, HEREDITY, V85, P203, DOI 10.1046/j.1365-2540.2000.00709.x	35	18	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79257	10.1371/journal.pone.0079257	http://dx.doi.org/10.1371/journal.pone.0079257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223917	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300071
J	Lallemand, M; Login, FH; Guschinskaya, N; Pineau, C; Effantin, G; Robert, X; Shevchik, VE				Lallemand, Mathilde; Login, Frederic H.; Guschinskaya, Natalia; Pineau, Camille; Effantin, Geraldine; Robert, Xavier; Shevchik, Vladimir E.			Dynamic Interplay between the Periplasmic and Transmembrane Domains of GspL and GspM in the Type II Secretion System	PLOS ONE			English	Article							VIBRIO-CHOLERAE; PSEUDOMONAS-AERUGINOSA; ERWINIA-CHRYSANTHEMI; MEMBRANE-PROTEIN; MULTIPLE INTERACTIONS; SCANNING MUTAGENESIS; INTERACTION NETWORK; CYTOPLASMIC DOMAIN; CROSS-LINKING; COMPLEX	The type II secretion system (T2SS) is a multiprotein nanomachine that transports folded proteins across the outer membrane of gram-negative bacteria. The molecular mechanisms that govern the secretion process remain poorly understood. The inner membrane components GspC, GspL and GspM possess a single transmembrane segment (TMS) and a large periplasmic region and they are thought to form a platform of unknown function. Here, using two-hybrid and pull-down assays we performed a systematic mapping of the GspC/GspL/GspM interaction regions in the plant pathogen Dickeya dadantii. We found that the TMS of these components interact with each other, implying a complex interaction network within the inner membrane. We also showed that the periplasmic, ferredoxin-like, domains of GspL and GspM drive homo- and heterodimerizations of these proteins. Disulfide bonding analyses revealed that the respective domain interfaces include the equivalent secondary-structure elements, suggesting alternating interactions of the periplasmic domains, L/L and M/M versus L/M. Finally, we found that displacements of the periplasmic GspM domain mediate coordinated shifts or rotations of the cognate TMS. These data suggest a plausible mechanism for signal transmission between the periplasmic and the cytoplasmic portions of the T2SS machine.	[Login, Frederic H.; Guschinskaya, Natalia; Robert, Xavier; Shevchik, Vladimir E.] Univ Lyon 1, F-69365 Lyon, France; [Lallemand, Mathilde; Pineau, Camille; Shevchik, Vladimir E.] INSA Lyon, Villeurbanne, France; [Lallemand, Mathilde; Login, Frederic H.; Guschinskaya, Natalia; Pineau, Camille; Effantin, Geraldine; Shevchik, Vladimir E.] CNRS, UMR5240, Lyon, France; [Robert, Xavier] CNRS, Lab Biocrystallog & Struct Biol Therapeut Targets, UMR5086, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Shevchik, VE (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	vladimir.shevchik@insa-lyon.fr	ROBERT, Xavier/C-3879-2015	ROBERT, Xavier/0000-0002-6174-8595; Shevchik, Vladimir/0000-0002-8031-8638; Effantin, Geraldine/0000-0002-7296-0831	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-2010-BLANC-1531]; LyonBioPole	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); LyonBioPole	This work was supported by the Centre National de la Recherche Scientifique, by a grant from the Agence Nationale de la Recherche (ANR-2010-BLANC-1531) and a grant from LyonBioPole to V. E. S. C. P. was supported by the ANR-2010-BLANC-1531 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chami M., 2005, J BIOL CHEM, V280, P2703; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Dunstan RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003117; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai WC, 2007, METHOD ENZYMOL, V423, P299, DOI 10.1016/S0076-6879(07)23013-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Michel G, 1998, MICROBIOL-SGM, V144, P3379, DOI 10.1099/00221287-144-12-3379; Miller JH., 1972, EXPT MOL GENETICS; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robert V, 2002, J BACTERIOL, V184, P1779, DOI 10.1128/JB.184.6.1779-1782.2002; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 2000, J BACTERIOL, V182, P742, DOI 10.1128/JB.182.3.742-748.2000; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tosi T, 2011, MOL MICROBIOL, V82, P1422, DOI 10.1111/j.1365-2958.2011.07896.x; Tsai RT, 2002, BIOCHEM J, V367, P865, DOI 10.1042/BJ20020909; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Zhang XYZ, 2011, J BIOL CHEM, V286, P11756, DOI 10.1074/jbc.M110.192773	62	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79562	10.1371/journal.pone.0079562	http://dx.doi.org/10.1371/journal.pone.0079562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223969	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300089
J	Mojardin, L; Botet, J; Quintales, L; Moreno, S; Salas, M				Mojardin, Laura; Botet, Javier; Quintales, Luis; Moreno, Sergio; Salas, Margarita			New Insights into the RNA-Based Mechanism of Action of the Anticancer Drug 5 '-Fluorouracil in Eukaryotic Cells	PLOS ONE			English	Article							GENOME-WIDE SCREEN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; THYMIDYLATE SYNTHASE; PREMESSENGER RNA; SACCHAROMYCES-CEREVISIAE; COLORECTAL-CANCER; MODIFYING ENZYMES; SMALL-SUBUNIT; IN-VIVO	5-Fluorouracil (5FU) is a chemotherapeutic drug widely used in treating a range of advanced, solid tumours and, in particular, colorectal cancer. Here, we used high-density tiling DNA microarray technology to obtain the specific transcriptome-wide response induced by 5FU in the eukaryotic model Schizosaccharomyces pombe. This approach combined with real-time quantitative PCR analysis allowed us to detect splicing defects of a significant number of intron-containing mRNA, in addition to identify some rRNA and tRNA processing defects after 5FU treatment. Interestingly, our studies also revealed that 5FU specifically induced the expression of certain genes implicated in the processing of mRNA, tRNA and rRNA precursors, and in the post-transcriptional modification of uracil residues in RNA. The transcription of several tRNA genes was also significantly induced after drug exposure. These transcriptional changes might represent a cellular response mechanism to counteract 5FU damage since deletion strains for some of these up-regulated genes were hypersensitive to 5FU. Moreover, most of these RNA processing genes have human orthologs that participate in conserved pathways, suggesting that they could be novel targets to improve the efficacy of 5FU-based treatments.	[Mojardin, Laura; Salas, Margarita] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, CSIC, Madrid, Spain; [Botet, Javier; Quintales, Luis; Moreno, Sergio] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Mojardin, L (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, CSIC, Madrid, Spain.	lmojardin@cbm.uam.es; msalas@cbm.uam.es	Quintales, Luis/K-8150-2014; Salas, Margarita/J-9873-2014; Moreno, Sergio/K-3671-2014	Salas, Margarita/0000-0001-5939-3441; Moreno, Sergio/0000-0002-8039-1413; Quintales, Luis/0000-0003-3553-2237	Spanish Ministry of Economy and Competitiveness [BFU2011-23645, BFU2011-28274, BFU2011-28804]; Spanish Ministry of Science and Innovation [CSD2007-00015]; Fundacion Mutua Madrilena; Fundacion Ramon Areces	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces	This work was supported by the Spanish Ministry of Economy and Competitiveness (BFU2011-23645 to MS and BFU2011-28274 to SM), the CONSOLIDER-INGENIO from the Spanish Ministry of Science and Innovation CSD2007-00015 (MS and SM), the Fundacion Mutua Madrilena (MS) and an Institutional Grant from Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa". Funding for LQ research come from the Spanish Ministry of Economy and Competitiveness (BFU2011-28804); LM was holder of a CONSOLIDER-INGENIO contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2012, MOL CANCER THER, V11, P119, DOI 10.1158/1535-7163.MCT-11-0510; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Das BK, 1999, MOL CELL BIOL, V19, P6796; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; DOONG SL, 1988, J BIOL CHEM, V263, P4467; Edler D, 1997, EUR J CANCER, V33, P2278, DOI 10.1016/S0959-8049(97)00306-7; ENGELBRECHT C, 1984, BIOCHEM PHARMACOL, V33, P745, DOI 10.1016/0006-2952(84)90457-X; GHOSHAL K, 1994, CANCER RES, V54, P632; GLAZER RI, 1982, MOL PHARMACOL, V21, P468; Good L, 1997, EUR J BIOCHEM, V247, P314, DOI 10.1111/j.1432-1033.1997.00314.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Grivicich I, 2007, INT J COLORECTAL DIS, V22, P1201, DOI 10.1007/s00384-007-0307-x; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Han S, 2013, BIOCHEM BIOPH RES CO, V436, P613, DOI 10.1016/j.bbrc.2013.05.138; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; HERRICK D, 1984, MOL PHARMACOL, V26, P135; Hoang T, 2005, MOL CELL BIOL, V25, P5523, DOI 10.1128/MCB.25.13.5523-5534.2005; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kadota K, 2011, INT J ONCOL, V38, P355, DOI 10.3892/ijo.2010.880; KUFE DW, 1981, J BIOL CHEM, V256, P9802; LENZ HJ, 1994, J BIOL CHEM, V269, P31962; Li MH, 2004, ORAL ONCOL, V40, P63, DOI 10.1016/S1368-8375(03)00136-2; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moy TI, 2002, MICROBIOL-SGM, V148, P1081, DOI 10.1099/00221287-148-4-1081; Oltra E, 2004, J CELL SCI, V117, P967, DOI 10.1242/jcs.00946; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Quintales L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-136; Ren LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016719; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; Salonga D, 2000, CLIN CANCER RES, V6, P1322; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; SANTI DV, 1987, BIOCHEMISTRY-US, V26, P8599, DOI 10.1021/bi00400a016; SANTI DV, 1974, BIOCHEMISTRY-US, V13, P471, DOI 10.1021/bi00700a012; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sharma A, 2009, CANCER BIOL THER, V8, P2106, DOI 10.4161/cbt.8.22.9687; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; SIERAKOWSKA H, 1989, J BIOL CHEM, V264, P19185; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sturgeon Christopher M., 2006, Biotechnology Journal, V1, P289, DOI 10.1002/biot.200500039; Suzuki T, 2010, FEBS LETT, V584, P272, DOI 10.1016/j.febslet.2009.11.085; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Webb CJ, 2004, MOL CELL BIOL, V24, P4229, DOI 10.1128/MCB.24.10.4229-4240.2004; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; WU XP, 1993, MOL PHARMACOL, V44, P22; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Zembutsu H, 2002, CANCER RES, V62, P518; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	62	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78172	10.1371/journal.pone.0078172	http://dx.doi.org/10.1371/journal.pone.0078172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223771	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300026
J	DeLuca, TH; Zackrisson, O; Bergman, I; Diez, B; Bergman, B				DeLuca, Thomas H.; Zackrisson, Olle; Bergman, Ingela; Diez, Beatriz; Bergman, Birgitta			Diazotrophy in Alluvial Meadows of Subarctic River Systems	PLOS ONE			English	Article							NITROGEN-FIXATION; FLOW REGULATION; BOREAL FORESTS; N-2 FIXATION; ECOSYSTEMS; FLUXES; FRAGMENTATION; COMMUNITIES; FLOODPLAIN; STREAMS	There is currently limited understanding of the contribution of biological N-2 fixation (diazotrophy) to the N budget of large river systems. This natural source of N in boreal river systems may partially explain the sustained productivity of river floodplains in Northern Europe where winter fodder was harvested for centuries without fertilizer amendments. In much of the world, anthropogenic pollution and river regulation have nearly eliminated opportunities to study natural processes that shaped early nutrient dynamics of large river systems; however, pristine conditions in northern Fennoscandia allow for the retrospective evaluation of key biochemical processes of historical significance. We investigated biological N-2 fixation (diazotrophy) as a potential source of nitrogen fertility at 71 independent floodplain sites along 10 rivers and conducted seasonal and intensive analyses at a subset of these sites. Biological N-2 fixation occurred in all floodplains, averaged 24.5 kg N ha(-1) yr(-1) and was down regulated from over 60 kg N ha(-1) yr(-1) to 0 kg N ha(-1) yr(-1) by river N pollution. A diversity of N-2-fixing cyanobacteria was found to colonize surface detritus in the floodplains. The data provide evidence for N-2 fixation to be a fundamental source of new N that may have sustained fertility at alluvial sites along subarctic rivers. Such data may have implications for the interpretation of ancient agricultural development and the design of contemporary low-input agroecosystems.	[DeLuca, Thomas H.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [DeLuca, Thomas H.; Zackrisson, Olle; Bergman, Ingela] Inst Subarctic Landscape Res, Arjeplog, Sweden; [Diez, Beatriz] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol Genet & Microbiol, Santiago 6513677, Chile; [Bergman, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	University of Washington; University of Washington Seattle; Pontificia Universidad Catolica de Chile; Stockholm University	DeLuca, TH (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	deluca@uw.edu	DeLuca, Thomas Henry/B-4547-2012; DeLuca, Thomas/GYU-3468-2022; Díez, Beatriz/AAG-2244-2021	DeLuca, Thomas Henry/0000-0003-1561-9597; Díez, Beatriz/0000-0002-9371-8083	European Regional Development Fund; Bank of Sweden Tercentenary Foundation	European Regional Development Fund(European Commission); Bank of Sweden Tercentenary Foundation	The authors thank the European Regional Development Fund and the Bank of Sweden Tercentenary Foundation for their financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Brown A.G., 1997, ALLUVIAL GEOARCHAEOL; CAMPBELL A, 1982, FRAN VILDMARK BYGD E; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Diebel MW, 2009, ECOL APPL, V19, P1127, DOI 10.1890/08-0327.1; Diez B, 2007, APPL ENVIRON MICROB, V73, P3656, DOI 10.1128/AEM.02067-06; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ellenberg H., 1988, VEGETATION ECOLOGY C; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Helton AM, 2011, FRONT ECOL ENVIRON, V9, P229, DOI 10.1890/080211; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; Humborg C, 2004, LIMNOL OCEANOGR, V49, P1871, DOI 10.4319/lo.2004.49.5.1871; Lisuzzo NJ, 2008, ECOSCIENCE, V15, P366, DOI 10.2980/15-3-2998; Malmqvist B, 2009, RIVERS OF EUROPE, 1ST EDITION, P297, DOI 10.1016/B978-0-12-369449-2.00008-4; Marcarelli AM, 2008, J N AM BENTHOL SOC, V27, P186, DOI 10.1899/07-027.1; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Olson JB, 1998, MICROBIAL ECOL, V36, P231, DOI 10.1007/s002489900110; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Reisinger AJ, 2013, FRESHWATER BIOL, V58, P938, DOI 10.1111/fwb.12098; Rudberg S, 1959, GEOGR ANN, V4, P261; SCHOLLHORN R, 1967, P NATL ACAD SCI USA, V58, P213, DOI 10.1073/pnas.58.1.213; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Tockner K, 1999, FRESHWATER BIOL, V41, P521, DOI 10.1046/j.1365-2427.1999.00399.x; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Walter H, 1989, ECOLOGICAL SYSTEMS G, DOI DOI 10.1007/978-3-642-70160-3; Wassen G, 1966, KUNGLIGA SVENSKA VET, V2, P1; Wassen MJ, 2006, APPL VEG SCI, V9, P213, DOI 10.1658/1402-2001(2006)9[213:CONAPF]2.0.CO;2; Yasuda Y, 2000, BIRTH RIVERINE CIVIL; Zackrisson O., 1976, EARLY NORRLAND, V9, P7; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	43	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77342	10.1371/journal.pone.0077342	http://dx.doi.org/10.1371/journal.pone.0077342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223119	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200011
J	Matsushima-Nishiwaki, R; Kumada, T; Nagasawa, T; Suzuki, M; Yasuda, E; Okuda, S; Maeda, A; Kaneoka, Y; Toyoda, H; Kozawa, O				Matsushima-Nishiwaki, Rie; Kumada, Takashi; Nagasawa, Tomoaki; Suzuki, Mariko; Yasuda, Eisuke; Okuda, Seiji; Maeda, Atsuyuki; Kaneoka, Yuji; Toyoda, Hidenori; Kozawa, Osamu			Direct Association of Heat Shock Protein 20 (HSPB6) with Phosphoinositide 3-kinase (PI3K) in Human Hepatocellular Carcinoma: Regulation of the PI3K Activity	PLOS ONE			English	Article							GROWTH-FACTOR; NEGATIVE REGULATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; SMOOTH-MUSCLE; HUMAN CANCER; P85-ALPHA; TARGET; HSP20; ACTIVATION	HSP20 (HSPB6), one of small heat shock proteins (HSPs), is constitutively expressed in various tissues and has several functions. We previously reported that the expression levels of HSP20 in human hepatocellular carcinoma (HCC) cells inversely correlated with the progression of HCC, and that HSP20 suppresses the growth of HCC cells via the AKT and mitogen-activated protein kinase signaling pathways. However, the exact mechanism underlying the effect of HSP20 on the regulation of these signaling pathways remains to be elucidated. To clarify the details of this effect in HCC, we explored the direct targets of HSP20 in HCC using human HCC-derived HuH7 cells with HSP20 overexpression. HSP20 proteins in the HuH7 cells were coimmunoprecipitated with the p85 regulatory subunit and p110 catalytic subunit of phosphoinositide 3-kinase (PI3K), an upstream kinase of AKT. Although HSP20 overexpression in HCC cells failed to affect the expression levels of PI3K, the activity of PI3K in the unstimulated cells and even in the transforming growth factor-alpha stimulated cells were downregulated by HSP20 overexpression. The association of HSP20 with PI3K was also observed in human HCC tissues in vivo. These findings strongly suggest that HSP20 directly associates with PI3K and suppresses its activity in HCC, resulting in the inhibition of the AKT pathway, and subsequently decreasing the growth of HCC.	[Matsushima-Nishiwaki, Rie; Nagasawa, Tomoaki; Suzuki, Mariko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Kumada, Takashi; Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan; [Yasuda, Eisuke] Suzuka Univ Med Sci, Dept Radiol Technol, Suzuka, Mie, Japan; [Okuda, Seiji] Ogaki Municipal Hosp, Dept Med Technol, Ogaki, Gifu, Japan; [Maeda, Atsuyuki; Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Ogaki, Gifu, Japan	Gifu University; Ogaki Municipal Hospital; Ogaki Municipal Hospital; Ogaki Municipal Hospital	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [22590726]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (22590726) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Brophy CM, 1999, J VASC SURG, V29, P326, DOI 10.1016/S0741-5214(99)70385-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YW, 2012, J CELL PHYSIOL, V227, P2818, DOI 10.1002/jcp.23038; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Daveau M, 2003, MOL CARCINOGEN, V36, P130, DOI 10.1002/mc.10103; Fan GC, 2008, CIRC RES, V103, P1270, DOI 10.1161/CIRCRESAHA.108.182832; Fan GC, 2011, J MOL CELL CARDIOL, V51, P574, DOI 10.1016/j.yjmcc.2010.09.013; Flynn CR, 2005, J APPL PHYSIOL, V98, P1836, DOI 10.1152/japplphysiol.01043.2004; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Noda T, 2007, ONCOL REP, V17, P1309; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Seit-Nebi AS, 2010, CELL STRESS CHAPERON, V15, P233, DOI 10.1007/s12192-009-0141-x; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tanaka K, 2001, JPN J CANCER RES, V92, P959, DOI 10.1111/j.1349-7006.2001.tb01187.x; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Viahos CJ, 1994, J BIOL CHEM, V269, P5241; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2011, MOL CELL, V41, P499, DOI 10.1016/j.molcel.2011.02.017; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wang Y, 2001, DIABETES, V50, P1821, DOI 10.2337/diabetes.50.8.1821; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	39	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78440	10.1371/journal.pone.0078440	http://dx.doi.org/10.1371/journal.pone.0078440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223153	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200045
J	Preuss, UW; Winham, SJ; Biernacka, JM; Geske, JR; Bakalkin, G; Koller, G; Zill, P; Soyka, M; Karpyak, VM				Preuss, Ulrich W.; Winham, Stacey J.; Biernacka, Joanna M.; Geske, Jennifer R.; Bakalkin, Georgy; Koller, Gabriele; Zill, Peter; Soyka, Michael; Karpyak, Victor M.			PDYN rs2281285 Variant Association with Drinking to Avoid Emotional or Somatic Discomfort	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTOR; ALCOHOL DEPENDENCE; GENE; SITUATIONS; INVENTORY; SYSTEM; MODEL	Introduction: One of the proposed psychobiological pathways of craving attributes the desire for drinking in the context of tension, discomfort or unpleasant emotions, to "negative'' (or "relief'') craving. The aim of this study was to replicate a previously reported association of the PDYN rs2281285 variant with negative craving using a different phenotyping approach. Methods: The TaqMan (R) Genotyping Assay was used to genotype the rs2281285 variant in 417 German alcohol-dependent subjects. The presence of negative/relief craving was assessed by asking if participants ever ingested alcohol to avoid unwanted emotional or somatic discomfort. Results: The minor allele of rs2281285 was associated with an increased risk of drinking to avoid/escape unwanted emotional or somatic events (OR = 2.29, 95% CI = 1.08-4.85, p = 0.0298). Discussion: Despite the use of a different phenotyping approach to the measurement of negative craving, our results confirm the association between negative craving and PDYN rs2281285. Genetic markers of negative craving may help to identify subgroups of alcohol-dependent individuals vulnerable to relapse in the context of negative emotions or somatic discomfort, leading to the development of specifically tailored treatment strategies.	[Preuss, Ulrich W.; Koller, Gabriele; Zill, Peter; Soyka, Michael] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Preuss, Ulrich W.] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Winham, Stacey J.; Biernacka, Joanna M.; Geske, Jennifer R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Biernacka, Joanna M.; Karpyak, Victor M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden; [Soyka, Michael] Private Hosp Meiringen, Meiringen, Switzerland	University of Munich; Martin Luther University Halle Wittenberg; Mayo Clinic; Mayo Clinic; Uppsala University	Karpyak, VM (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.	karpyak.victor@mayo.edu	Karpyak, Victor M./AGJ-2595-2022	Karpyak, Victor M./0000-0002-9552-6130; Winham, Stacey/0000-0002-8492-9102; Bakalkin, Georgy/0000-0002-8074-9833	St. Marys Hospital; Samuel C. Johnson Genomics of Addiction Program; NIH/NIAAA [P20 AA17830Z]; Swedish Council for Working Life and Social Research; Swedish Science Research Council; Swedish Research Council FORMAS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830] Funding Source: NIH RePORTER	St. Marys Hospital; Samuel C. Johnson Genomics of Addiction Program; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Science Research Council; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the St. Marys Hospital Sponsorship Award (VMK), Samuel C. Johnson Genomics of Addiction Program (VMK, JMB), NIH/NIAAA P20 AA17830Z (VMK, JMB), and the Swedish Council for Working Life and Social Research, Swedish Science Research Council and Swedish Research Council FORMAS (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis H.M., 1985, INVENTORY DRUG TAKIN; Annis H.M., 1997, INVENTORY DRUG TAKIN; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Edenberg HJ, 2008, HUM MOL GENET, V17, P1783, DOI 10.1093/hmg/ddn068; Falk D, 2010, ALCOHOL CLIN EXP RES, V34, P2022, DOI 10.1111/j.1530-0277.2010.01290.x; Galeote L, 2008, J NEUROCHEM, V105, P1358, DOI 10.1111/j.1471-4159.2008.05247.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Heinz A, 2003, ALCOHOL ALCOHOLISM, V38, P35, DOI 10.1093/alcalc/agg005; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Ji Y, 2013, PHARMACOGENOMICS J, V13, P456, DOI 10.1038/tpj.2012.32; Karpyak VM, 2013, INT J NEUROPSYCHOPH, V16, P975, DOI 10.1017/S1461145712001137; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; Nikoshkov A, 2005, FASEB J, V19, P1543, DOI 10.1096/fj.05-3743fje; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Todtenkopf MS, 2004, PSYCHOPHARMACOLOGY, V172, P463, DOI 10.1007/s00213-003-1680-y; Turner NE, 1997, BEHAV RES THER, V35, P465, DOI 10.1016/S0005-7967(96)00119-2; Verheul R, 1999, ALCOHOL ALCOHOLISM, V34, P197, DOI 10.1093/alcalc/34.2.197; VictorioEstrada A, 1997, ADDICT BEHAV, V22, P557, DOI 10.1016/S0306-4603(96)00061-5; VictorioEstrada A, 1996, DRUG ALCOHOL DEPEN, V41, P75, DOI 10.1016/0376-8716(96)01241-0; Wadenberg MLG, 2003, CNS DRUG REV, V9, P187; Walsh SL, 2001, PSYCHOPHARMACOLOGY, V157, P151, DOI 10.1007/s002130100788; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Williams TJ, 2007, ADDICT BIOL, V12, P496, DOI 10.1111/j.1369-1600.2007.00069.x; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; Wittchen HU, 1997, SKID STRUCTURED CLIN; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zywiak WH, 2006, J SUBST ABUSE TREAT, V30, P349, DOI 10.1016/j.jsat.2006.03.004; Zywiak WH, 2003, J SUBST ABUSE TREAT, V25, P287, DOI 10.1016/S0740-5472(03)00118-1	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78688	10.1371/journal.pone.0078688	http://dx.doi.org/10.1371/journal.pone.0078688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223163	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200055
J	Sakurai, A; Takayama, K; Nomura, N; Munakata, T; Yamamoto, N; Tamura, T; Yamada, J; Hashimoto, M; Kuwahara, K; Sakoda, Y; Suda, Y; Kobayashi, Y; Sakaguchi, N; Kida, H; Kohara, M; Shibasaki, F				Sakurai, Akira; Takayama, Katsuyoshi; Nomura, Namiko; Munakata, Tsubasa; Yamamoto, Naoki; Tamura, Tsuruki; Yamada, Jitsuho; Hashimoto, Masako; Kuwahara, Kazuhiko; Sakoda, Yoshihiro; Suda, Yoshihiko; Kobayashi, Yukuharu; Sakaguchi, Nobuo; Kida, Hiroshi; Kohara, Michinori; Shibasaki, Futoshi			Broad-Spectrum Detection of H5 Subtype Influenza A Viruses with a New Fluorescent Immunochromatography System	PLOS ONE			English	Article							SOUTHERN CHINA; WATER BIRDS; NOMENCLATURE; GENERATION; EVOLUTION; INFECTION; DIAGNOSIS; CHICKENS; STRAINS; ANTIGEN	Immunochromatography (IC) is an antigen-detection assay that plays an important role in the rapid diagnosis of influenza virus because the protocol is short time and easy to use. Despite the usability of IC, the sensitivity is approximately 10(3) pfu per reaction. In addition, antigen-antibody interaction-based method cannot be used for the detection of influenza viruses with major antigenic change. In this study, we established the use of fluorescent immunochromatography (FLIC) to detect a broad spectrum of H5 subtype influenza A viruses. This method has improved sensitivity 10-100 fold higher than traditional IC because of the use of fluorescent conjugated beads. Our Type-E FLIC kit detected all of the H5 subtype influenza viruses that were examined, as well as recombinant hemagglutinin (HA) proteins (rHAs) belonging to the Eurasian H5 subtype viruses and the Type-N diagnosed North American H5 subtype influenza A viruses. Thus, this kit has the improved potential to detect H5 subtype influenza viruses of different clades with both Type-E and Type-N FLIC kits. Compared with PCR-based diagnosis, FLIC has a strong advantage in usability, because the sample preparation required for FLIC is only mix-and-drop without any additional steps such as RNA extraction. Our results can provide new strategies against the spread and transmission of HPAI H5N1 viruses in birds and mammals including humans.	[Sakurai, Akira; Nomura, Namiko; Hashimoto, Masako; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan; [Takayama, Katsuyoshi; Kobayashi, Yukuharu] ADTEC Co LTD, Usa City, Oita, Japan; [Munakata, Tsubasa; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Yamamoto, Naoki; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab,Kita Ku, Sapporo, Hokkaido, Japan; [Tamura, Tsuruki; Yamada, Jitsuho; Suda, Yoshihiko] Konica Minolta Inc, Hino, Tokyo, Japan; [Kuwahara, Kazuhiko; Sakaguchi, Nobuo] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol, Chuo Ku, Kumamoto, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Konica Minolta Inc.; Kumamoto University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Ministry of Economy, Trade, and Industry, Japan [2010FY]; Japan Society for the Promotion of Science KAKENHI [23659069, 23659314]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT); Target-driven R&D (Japan Science and Technology Agency); Grants-in-Aid for Scientific Research [24659224] Funding Source: KAKEN	Ministry of Economy, Trade, and Industry, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target-driven R&D (Japan Science and Technology Agency); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Ministry of Economy, Trade, and Industry, Japan as a part of "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs'' (supplementary budget, 2010FY), Japan Society for the Promotion of Science KAKENHI (Grant Numbers 23659069 and 23659314), a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a contract research fund from the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (MEXT) to N.S. and partly by a grant for the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (Japan Science and Technology Agency) to K. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assiri A, 2013, LANCET INFECT DIS; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Khan K, 2013, PLOS CURR, V5; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Sakurai A, 2012, VIRUSES-BASEL, V4, P1235, DOI 10.3390/v4081235; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soda K, 2008, ARCH VIROL, V153, P2041, DOI 10.1007/s00705-008-0226-3; Soda K, 2008, JPN J VET RES, V55, P93; Soda K, 2011, J VET MED SCI, V73, P767, DOI 10.1292/jvms.10-0532; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsuda Y, 2007, MICROBIOL IMMUNOL, V51, P903, DOI 10.1111/j.1348-0421.2007.tb03973.x; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2013, CUM NUMB CONF HUM CA; WHO, 2020, PAND INFL RISK MAN W; World Health Organization, 2011, ANT GEN CHAR ZOON IN; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao SH, 2012, J VIROL, V86, P13836, DOI 10.1128/JVI.02595-12	38	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76753	10.1371/journal.pone.0076753	http://dx.doi.org/10.1371/journal.pone.0076753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223117	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200009
J	Tomlinson, LA; Abel, GA; Chaudhry, AN; Tomson, CR; Wilkinson, IB; Roland, MO; Payne, RA				Tomlinson, Laurie A.; Abel, Gary A.; Chaudhry, Afzal N.; Tomson, Charles R.; Wilkinson, Ian B.; Roland, Martin O.; Payne, Rupert A.			ACE Inhibitor and Angiotensin Receptor-II Antagonist Prescribing and Hospital Admissions with Acute Kidney Injury: A Longitudinal Ecological Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONVERTING ENZYME-INHIBITORS; RISK; COMBINATIONS; MORTALITY; BLOCKERS	Background: ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness. Rates of hospitalization with AKI are increasing. We aimed to determine whether hospital AKI admission rates are associated with increased ACE-I/ARA prescribing. Methods and Findings: English NHS prescribing data for ACE-I/ARA prescriptions were matched at the level of the general practice to numbers of hospital admissions with a primary diagnosis of AKI. Numbers of prescriptions were weighted for the demographic characteristics of general practices by expressing prescribing as rates where the denominator is Age, Sex, and Temporary Resident Originated Prescribing Units (ASTRO-PUs). We performed a mixed-effect Poisson regression to model the number of admissions for AKI occurring in each practice for each of 4 years from 1/4/2007. From 2007/8-2010/11, crude AKI admission rates increased from 0.38 to 0.57 per 1000 patients (51.6% increase), and national annual ACE-I/ARA prescribing rates increased by 0.032 from 0.202 to 0.234 (15.8% increase). There was strong evidence (p<0.001) that increases in practice-level prescribing of ACE-I/ARA over the study period were associated with an increase in AKI admission rates. The increase in prescribing seen in a typical practice corresponded to an increase in admissions of approximately 5.1% (rate ratio = 1.051 for a 0.03 per ASTRO-PU increase in annual prescribing rate, 95% CI 1.047-1.055). Using the regression model we predict that 1,636 (95% CI 1,540-1,780) AKI admissions would have been avoided if prescribing rates were at the 2007/8 level, equivalent to 14.8% of the total increase in AKI admissions. Conclusion: In this ecological analysis, up to 15% of the increase in AKI admissions in England over a 4-year time period is potentially attributable to increased prescribing of ACE-I and ARAs. However, these findings are limited by the lack of patient level data such as indication for prescribing and patient characteristics.	[Tomlinson, Laurie A.; Wilkinson, Ian B.] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge, England; [Abel, Gary A.; Roland, Martin O.; Payne, Rupert A.] Cambridge Ctr Hlth Serv Res, Inst Publ Hlth, Cambridge, England; [Chaudhry, Afzal N.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Dept Nephrol, Cambridge, England; [Tomson, Charles R.] North Bristol Natl Hlth Serv Trust, Richard Bright Renal Unit, Bristol, Avon, England	University of Cambridge; University of Cambridge	Tomlinson, LA (corresponding author), Univ Cambridge, Cambridge Clin Trials Unit, Cambridge, England.	lat42@cam.ac.uk	Abel, Gary/ABE-1765-2021	Abel, Gary/0000-0003-2231-5161; wilkinson, ian/0000-0001-6598-9399; Tomson, Charles/0000-0002-0224-8726; Tomlinson, Laurie/0000-0001-8848-9493; Roland, Martin/0000-0002-8533-3060	Cambridge Biomedical Research Institute; British Heart Foundation; British Heart Foundation [FS/12/8/29377] Funding Source: researchfish; National Institute for Health Research [CL-2010-14-003] Funding Source: researchfish	Cambridge Biomedical Research Institute; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	ANC is supported by the Cambridge Biomedical Research Institute and IBW by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2012, INEQUALITIES OUTCOME; Adhiyaman V, 2001, J ROY SOC MED, V94, P512, DOI 10.1177/014107680109401005; Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Fournier JP, 2012, FUNDAM CLIN PHARM; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; National Health Service, 2011, PRESCR COST AN; National Health Service. The Information Centre, QUAL OUTC FRAM; National Health Service. The Information Centre, HOSP EP STAT; National Institute for Health and Clinical Excellence, 2011, CHRON KIDN DIS QUAL; Okunola O, 2012, Afr J Med Med Sci, V41, P119; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Rifkin DE, 2012, J AM SOC NEPHROL, V23, P979, DOI 10.1681/ASN.2011121185; Rim MY, 2012, AM J KIDNEY DIS, V60, P576, DOI 10.1053/j.ajkd.2012.04.017; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; Smets HLE, 2008, PHARMACOEPIDEM DR S, V17, P1014, DOI 10.1002/pds.1641; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wheeler DC, 2013, KIDNEY INT, V83, P377, DOI 10.1038/ki.2012.425; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 1990, INT CLASS DIS, V10th	29	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78465	10.1371/journal.pone.0078465	http://dx.doi.org/10.1371/journal.pone.0078465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223154	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200046
J	Reisberg, EE; Hildebrandt, U; Riederer, M; Hentschel, U				Reisberg, Eva E.; Hildebrandt, Ulrich; Riederer, Markus; Hentschel, Ute			Distinct Phyllosphere Bacterial Communities on Arabidopsis Wax Mutant Leaves	PLOS ONE			English	Article							TRANSPIRATION BARRIER PROPERTIES; PLANT-MICROBE INTERACTIONS; CUTICULAR WAXES; PSEUDOMONAS-SYRINGAE; ECERIFERUM MUTANTS; EPICUTICULAR WAXES; LEAF; COLONIZATION; DIVERSITY; TOMATO	The phyllosphere of plants is inhabited by diverse microorganisms, however, the factors shaping their community composition are not fully elucidated. The plant cuticle represents the initial contact surface between microorganisms and the plant. We thus aimed to investigate whether mutations in the cuticular wax biosynthesis would affect the diversity of the phyllosphere microbiota. A set of four Arabidopsis thaliana eceriferum mutants (cer1, cer6, cer9, cer16) and their respective wild type (Landsberg erecta) were subjected to an outdoor growth period and analysed towards this purpose. The chemical distinctness of the mutant wax phenotypes was confirmed by gas chromatographic measurements. Next generation amplicon pyrosequencing of the bacterial communities showed distinct community patterns. This observation was supported by denaturing gradient gel electrophoresis experiments. Microbial community analyses revealed bacterial phylotypes that were ubiquitously present on all plant lines (termed "core" community) while others were positively or negatively affected by the wax mutant phenotype (termed "plant line-specific" community). We conclude from this study that plant cuticular wax composition can affect the community composition of phyllosphere bacteria.	[Reisberg, Eva E.; Hildebrandt, Ulrich; Riederer, Markus; Hentschel, Ute] Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany	University of Wurzburg	Hentschel, U (corresponding author), Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany.	ute.hentschel@uni-wuerzburg.de	Riederer, Markus/B-5540-2008; Hentschel, Ute/ABD-6624-2021; Hentschel, Ute/H-8343-2013	Riederer, Markus/0000-0001-7081-1456; Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X	DFG Graduiertenkolleg 1342 "Lipid Signalling" [TP A8]; German Research Foundation (DFG); University of Wuerzburg	DFG Graduiertenkolleg 1342 "Lipid Signalling"; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This project was financially supported by the DFG Graduiertenkolleg 1342 "Lipid Signalling" (TP A8) to U. Hentschel/M. Riederer. URLs: http://www.dfg.de/en/; http://www.gk-1342.uni-wuerzburg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (The publication fee will be funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.) URL: http://www.bibliothek.uni-wuerzburg.de/en/homepage/.	Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; Beattie GA, 2002, PHYLLOSPHERE MICROBIOLOGY, P3; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Brandl MT, 1998, APPL ENVIRON MICROB, V64, P3256; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burch AY, 2013, APPL ENVIRON MICROB, V79, P845, DOI 10.1128/AEM.02791-12; Burch AY, 2011, ENVIRON MICROBIOL, V13, P2681, DOI 10.1111/j.1462-2920.2011.02534.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CURSTEDT T, 1974, BIOCHIM BIOPHYS ACTA, V360, P12, DOI 10.1016/0005-2760(74)90176-3; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ensikat HJ, 2011, BEILSTEIN J NANOTECH, V2, P152, DOI 10.3762/bjnano.2.19; Finkel OM, 2012, APPL ENVIRON MICROB, V78, P6187, DOI 10.1128/AEM.00888-12; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANKIN L, 1968, J GEN MICROBIOL, V51, P457, DOI 10.1099/00221287-51-3-457; Hansjakob A, 2010, NEW PHYTOL, V188, P1039, DOI 10.1111/j.1469-8137.2010.03419.x; Hartmann A, 2012, J CHEM ECOL, V38, P704, DOI 10.1007/s10886-012-0141-7; Huang TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042124; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Jenks MA, 1996, PHYTOCHEMISTRY, V42, P29, DOI 10.1016/0031-9422(95)00898-5; Jenks MA, 2002, ARABIDOPSIS BOOK, V1, pe0016; Jetter R, 2006, ANNU PLANT REV, V23, P145; Kadivar H, 2003, MICROBIAL ECOL, V45, P353, DOI 10.1007/s00248-002-1065-5; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Knoll D, 2000, MICROB ECOL, V40, P33, DOI 10.1007/s002480000012; KOORNNEEF M, 1989, J HERED, V80, P118, DOI 10.1093/oxfordjournals.jhered.a110808; Krimm U, 2005, FEMS MICROBIOL ECOL, V53, P483, DOI 10.1016/j.femsec.2005.02.004; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; Leveau JHJ, 2006, ANNU PLANT REV, V23, P334; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lu SY, 2012, PLANT PHYSIOL, V159, P930, DOI 10.1104/pp.112.198697; Marcell LM, 2002, MOL PLANT MICROBE IN, V15, P1236, DOI 10.1094/MPMI.2002.15.12.1236; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Monier JM, 2005, APPL ENVIRON MICROB, V71, P5484, DOI 10.1128/AEM.71.9.5484-5493.2005; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; OBRIEN RD, 1989, PHYTOPATHOLOGY, V79, P619, DOI 10.1094/Phyto-79-619; Okamura K, 2009, J GEN APPL MICROBIOL, V55, P43, DOI 10.2323/jgam.55.43; Oksanen JF, 2012, PACKAGE VEGAN; PODILA GK, 1993, PLANT PHYSIOL, V103, P267, DOI 10.1104/pp.103.1.267; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Riederer M, 2006, ANNU PLANT REV, V23, P1; Ryan MP, 2007, J APPL MICROBIOL, V103, P754, DOI 10.1111/j.1365-2672.2007.03361.x; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Schulz S, 2012, ISME J, V6, P1763, DOI 10.1038/ismej.2012.17; Shanker KS, 2007, PHYTOCHEM ANALYSIS, V18, P7, DOI 10.1002/pca.942; Shepherd T, 1997, PHYTOCHEMISTRY, V46, P83, DOI 10.1016/S0031-9422(97)00272-0; SHEPHERD T, 1995, PHYTOCHEMISTRY, V40, P407, DOI 10.1016/0031-9422(95)00281-B; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Shin DH, 2012, J MICROBIOL BIOTECHN, V22, P448, DOI 10.4014/jmb.1108.08087; Truyens S, 2012, PLANT BIOL IN PRESS; Tsuba M, 2002, PHYSIOL MOL PLANT P, V60, P51, DOI 10.1006/pmpp.2002.0376; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes G., 2012, PACKAGE GPLOTS	81	58	62	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78613	10.1371/journal.pone.0078613	http://dx.doi.org/10.1371/journal.pone.0078613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223831	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400035
J	Acevedo, N; Mohr, J; Zakzuk, J; Samonig, M; Briza, P; Erler, A; Pomes, A; Huber, CG; Ferreira, F; Caraballo, L				Acevedo, Nathalie; Mohr, Jens; Zakzuk, Josefina; Samonig, Martin; Briza, Peter; Erler, Anja; Pomes, Anna; Huber, Christian G.; Ferreira, Fatima; Caraballo, Luis			Proteomic and Immunochemical Characterization of Glutathione Transferase as a New Allergen of the Nematode Ascaris lumbricoides	PLOS ONE			English	Article							HOUSE-DUST-MITE; IGE ANTIBODY-RESPONSES; COCKROACH BLATTELLA-GERMANICA; S-TRANSFERASE; ONCHOCERCA-VOLVULUS; CROSS-REACTIVITY; DERMATOPHAGOIDES-PTERONYSSINUS; TROPICAL ENVIRONMENT; MOLECULAR-CLONING; IMMUNOGLOBULIN-E	Helminth infections and allergy have evolutionary and clinical links. Infection with the nematode Ascaris lumbricoides induces IgE against several molecules including invertebrate pan-allergens. These antibodies influence the pathogenesis and diagnosis of allergy; therefore, studying parasitic and non-parasitic allergens is essential to understand both helminth immunity and allergy. Glutathione transferases (GSTs) from cockroach and house dust mites are clinically relevant allergens and comparative studies between them and the GST from A. lumbricoides (GSTA) are necessary to evaluate their allergenicity. We sought to analyze the allergenic potential of GSTA in connection with the IgE response to non-parasitic GSTs. IgE to purified GSTs from Ascaris (nGSTA and rGSTA), house dust mites (rDer p 8, nBlo t 8 and rBlo t 8), and cockroach (rBla g 5) was measured by ELISA in subjects from Cartagena, Colombia. Also, multidimensional proteomic approaches were used to study the extract of A. lumbricoides and investigate the existence of GST isoforms. We found that among asthmatics, the strength of IgE levels to GSTA was significantly higher than to mite and cockroach GSTs, and there was a strong positive correlation between IgE levels to these molecules. Specific IgE to GSTA was found in 13.2% of controls and 19.5% of asthmatics. In addition nGSTA induced wheal and flare in skin of sensitized asthmatics indicating that it might be of clinical relevance for some patients. Frequency and IgE levels to GSTA were higher in childhood and declined with age. At least six GST isoforms in A. lumbricoides bind human IgE. Four isoforms were the most abundant and several amino acid substitutions were found, mainly on the N-terminal domain. In conclusion, a new allergenic component of Ascaris has been discovered; it could have clinical impact in allergic patients and influence the diagnosis of mite and cockroach allergy in tropical environments.	[Acevedo, Nathalie; Zakzuk, Josefina; Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Acevedo, Nathalie; Zakzuk, Josefina; Caraballo, Luis] Fdn Dev Med & Biol Sci, Cartagena, Colombia; [Mohr, Jens; Samonig, Martin; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria; [Briza, Peter; Erler, Anja; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Div Allergy & Immunol, A-5020 Salzburg, Austria; [Pomes, Anna] Indoor Biotechnol Inc, Charlottesville, VA USA	Universidad de Cartagena; Salzburg University; Salzburg University; INDOOR Biotechnologies	Caraballo, L (corresponding author), Univ Cartagena, Immunol Res Inst, Cartagena, Colombia.	lcaraballog@unicartagena.edu.co	Huber, Christian G./E-5445-2011; Ferreira, Fatima/E-4889-2011; Briza, Peter/D-7309-2012; Ferreira, Fatima/AAB-4321-2019; Pomés, Anna/H-7010-2019	Huber, Christian G./0000-0001-8358-1880; Ferreira, Fatima/0000-0003-0989-2335; Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335; Pomés, Anna/0000-0002-8729-1829; Acevedo, Nathalie/0000-0002-5154-2964	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) [602-2009]; University of Cartagena (Colombia); University of Salzburg (Austria); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI077653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia); University of Cartagena (Colombia); University of Salzburg (Austria); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Administrative Department of Science, Technology and Innovation (Colciencias, Colombia), Contract 602-2009; the University of Cartagena (Colombia); the University of Salzburg (Austria) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI077653 (to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2011, PARASITE IMMUNOL, V33, P309, DOI 10.1111/j.1365-3024.2011.01288.x; Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Acevedo N, 2009, CLIN EXP IMMUNOL, V157, P282, DOI 10.1111/j.1365-2249.2009.03948.x; Acevedo N, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-13; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; Arruda LK, 1997, J BIOL CHEM, V272, P20907, DOI 10.1074/jbc.272.33.20907; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; AURIAULT C, 1990, J CLIN MICROBIOL, V28, P1918, DOI 10.1128/JCM.28.9.1918-1924.1990; Caraballo L, 1996, J ALLERGY CLIN IMMUN, V98, P573, DOI 10.1016/S0091-6749(96)70091-X; Caraballo L, 2011, WORLD ALLERGY ORGAN, V4, P77, DOI 10.1097/WOX.0b013e3182167e04; Cooper PJ, 2009, CURR OPIN ALLERGY CL, V9, P29, DOI 10.1097/ACI.0b013e32831f44a6; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P339, DOI 10.1111/j.1365-2222.2009.03345.x; Haahtela T, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-3; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Hong SJ, 2002, EXP PARASITOL, V101, P231, DOI 10.1016/S0014-4894(02)00112-1; Huang CH, 2006, CLIN EXP ALLERGY, V36, P369, DOI 10.1111/j.1365-2222.2006.02447.x; Jeong KY, 2009, INT ARCH ALLERGY IMM, V148, P59, DOI 10.1159/000151506; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jimenez S, 2007, ALLERGY CLIN IMMUNOL, V19, P233, DOI 10.1027/0838-1925.19.6.233; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Liebau E, 1997, BIOCHEM J, V324, P659, DOI 10.1042/bj3240659; Liebau E, 2008, FEBS J, V275, P3438, DOI 10.1111/j.1742-4658.2008.06494.x; Mohr J, 2010, PROTEOMICS, V10, P3598, DOI 10.1002/pmic.201000341; Nakazawa T, 2013, BIOSCI BIOTECH BIOCH, V77, P145, DOI 10.1271/bbb.120626; ONeill GM, 1995, IMMUNOL LETT, V48, P103, DOI 10.1016/0165-2478(95)02452-2; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Perbandt M, 2005, J BIOL CHEM, V280, P12630, DOI 10.1074/jbc.M413551200; Salinas G, 1996, PARASITE IMMUNOL, V18, P377, DOI 10.1046/j.1365-3024.1996.d01-124.x; Santiago HC, 2012, J ALLERGY CLIN IMMUN, V130, P248, DOI 10.1016/j.jaci.2012.02.045; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sommer A, 2001, INFECT IMMUN, V69, P7718, DOI 10.1128/IAI.69.12.7718-7728.2001; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Zhan B, 2010, INFECT IMMUN, V78, P1552, DOI 10.1128/IAI.00848-09	39	42	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78353	10.1371/journal.pone.0078353	http://dx.doi.org/10.1371/journal.pone.0078353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223794	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400054
J	Fujita, A; Koinuma, S; Yasuda, S; Nagai, H; Kamiguchi, H; Wada, N; Nakamura, T				Fujita, Akane; Koinuma, Shingo; Yasuda, Sayaka; Nagai, Hiroyuki; Kamiguchi, Hiroyuki; Wada, Naoyuki; Nakamura, Takeshi			GTP Hydrolysis of TC10 Promotes Neurite Outgrowth through Exocytic Fusion of Rab11-and L1-Containing Vesicles by Releasing Exocyst Component Exo70	PLOS ONE			English	Article							AXONAL GROWTH CONES; PLASMA-MEMBRANE; PC12 CELLS; RHO FAMILY; N-WASP; MAMMALIAN-CELLS; SMALL GTPASES; T-SNARE; PROTEIN; COMPLEX	The use of exocytosis for membrane expansion at nerve growth cones is critical for neurite outgrowth. TC10 is a Rho family GTPase that is essential for specific types of vesicular trafficking to the plasma membrane. Recent studies have shown that TC10 and its effector Exo70, a component of the exocyst tethering complex, contribute to neurite outgrowth. However, the molecular mechanisms of the neuritogenesis-promoting functions of TC10 remain to be established. Here, we propose that GTP hydrolysis of vesicular TC10 near the plasma membrane promotes neurite outgrowth by accelerating vesicle fusion by releasing Exo70. Using Forster resonance energy transfer (FRET)-based biosensors, we show that TC10 activity at the plasma membrane decreased at extending growth cones in hippocampal neurons and nerve growth factor (NGF)-treated PC12 cells. In neuronal cells, TC10 activity at vesicles was higher than its activity at the plasma membrane, and TC10-positive vesicles were found to fuse to the plasma membrane in NGF-treated PC12 cells. Therefore, activity of TC10 at vesicles is presumed to be inactivated near the plasma membrane during neuronal exocytosis. Our model is supported by functional evidence that constitutively active TC10 could not rescue decrease in NGF-induced neurite outgrowth induced by TC10 depletion. Furthermore, TC10 knockdown experiments and colocalization analyses confirmed the involvement of Exo70 in TC10-mediated trafficking in neuronal cells. TC10 frequently resided on vesicles containing Rab11, which is a key regulator of recycling pathways and implicated in neurite outgrowth. In growth cones, most of the vesicles containing the cell adhesion molecule L1 had TC10. Exocytosis of Rab11- and L1-positive vesicles may play a central role in TC10-mediated neurite outgrowth. The combination of this study and our previous work on the role of TC10 in EGF-induced exocytosis in HeLa cells suggests that the signaling machinery containing TC10 proposed here may be broadly used for exocytosis.	[Fujita, Akane; Koinuma, Shingo; Yasuda, Sayaka; Nagai, Hiroyuki; Nakamura, Takeshi] Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Noda, Chiba 278, Japan; [Nagai, Hiroyuki] RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama, Japan; [Wada, Naoyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo University of Science; RIKEN; Tokyo University of Science	Nakamura, T (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Noda, Chiba 278, Japan.	tnakamr@rs.noda.tus.ac.jp	Kamiguchi, Hiroyuki/N-5409-2015	Kamiguchi, Hiroyuki/0000-0003-1802-6324; Koinuma, Shingo/0000-0001-8653-0501	Japan Society for the Promotion of Science [23300134, 24657094]; Yamada Science Foundation; Grants-in-Aid for Scientific Research [24657094] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamada Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (23300134 and 24657094) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) and the Yamada Science Foundation (http://www.yamadazaidan.jp/english.html) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bridges D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042451; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Goslin K., 1998, CULTURING NERVE CELL, P339; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hazuka CD, 1999, J NEUROSCI, V19, P1324; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; HIGASHIDA H, 1983, BRAIN RES, V279, P363, DOI 10.1016/0006-8993(83)90211-1; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mohammadi S, 2013, J CELL BIOL, V200, P81, DOI 10.1083/jcb.201204090; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; PFENNINGER KH, 1981, J CELL BIOL, V89, P547, DOI 10.1083/jcb.89.3.547; Pommereit D, 2007, J CELL SCI, V120, P2694, DOI 10.1242/jcs.03475; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuermer CAO, 2010, TRENDS CELL BIOL, V20, P6, DOI 10.1016/j.tcb.2009.10.003; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tanabe K, 2000, J NEUROSCI, V20, P4138; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Walsh FS, 1997, SOC GEN PHY, V52, P221; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	68	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79689	10.1371/journal.pone.0079689	http://dx.doi.org/10.1371/journal.pone.0079689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223996	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400139
J	Laycock, I; Cresswell, JE				Laycock, Ian; Cresswell, James E.			Repression and Recuperation of Brood Production in Bombus terrestris Bumble Bees Exposed to a Pulse of the Neonicotinoid Pesticide Imidacloprid	PLOS ONE			English	Article							DECREASES FORAGING SUCCESS; APIS-MELLIFERA; LEARNING PERFORMANCES; COLONY GROWTH; HONEY-BEES; SURVIVAL; INSECTICIDES; ABUNDANCE; DECLINES; QUEENS	Currently, there is concern about declining bee populations and some blame the residues of neonicotinoid pesticides in the nectar and pollen of treated crops. Bumble bees are important wild pollinators that are widely exposed to dietary neonicotinoids by foraging in agricultural environments. In the laboratory, we tested the effect of a pulsed exposure (14 days 'on dose' followed by 14 days 'off dose') to a common neonicotinoid, imidacloprid, on the amount of brood (number of eggs and larvae) produced by Bombus terrestris L. bumble bees in small, standardised experimental colonies (a queen and four adult workers). During the initial 'on dose' period we observed a dose-dependent repression of brood production in colonies, with productivity decreasing as dosage increased up to 98 mu g kg(-1) dietary imidacloprid. During the following 'off dose' period, colonies showed a dose-dependent recuperation such that total brood production during the 28-day pulsed exposure was not correlated with imidacloprid up to 98 mu g kg(-1). Our findings raise further concern about the threat to wild bumble bees from neonicotinoids, but they also indicate some resilience to a pulsed exposure, such as that arising from the transient bloom of a treated mass-flowering crop.	[Laycock, Ian; Cresswell, James E.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Cresswell, James E.] Univ Calcutta, Ctr Pollinat Studies, Kolkata, India	University of Exeter; University of Calcutta	Laycock, I (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	il219@exeter.ac.uk			Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	IL was supported by a studentship from the Natural Environment Research Council (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreage, 2012, ACR; Ak?akaya H.R., 2008, DEMOGRAPHIC TOXICITY, P3; Amin MR, 2012, J INSECT BEHAV, V25, P362, DOI 10.1007/s10905-011-9306-4; [Anonymous], LATE LESSONS EARLY W; Azevedo-Pereira HMVS, 2011, WATER AIR SOIL POLL, V219, P215, DOI 10.1007/s11270-010-0700-x; Beekman M, 1998, ENTOMOL EXP APPL, V89, P207, DOI 10.1023/A:1003595306816; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DEFRA, 2012, AGR UK 2011; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; FERA, 2013, PEST US SURV; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; He YX, 2011, J ECON ENTOMOL, V104, P833, DOI 10.1603/EC10281; Heinrich B, 2004, BUMBLEBEE EC, P7; Henry M, 2012, SCIENCE, V337, DOI 10.1126/science.1224930; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hoyle M, 2007, ECOL APPL, V17, P2123, DOI 10.1890/06-1972.1; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; NAUEN R, 1995, PESTIC SCI, V44, P145, DOI 10.1002/ps.2780440207; OWEN RE, 1980, BEHAV ECOL SOCIOBIOL, V7, P287, DOI 10.1007/BF00300669; PLOWRIGHT RC, 1968, INSECT SOC, V15, P171, DOI 10.1007/BF02223465; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pyke GH, 2011, ECOL ENTOMOL, V36, P511, DOI 10.1111/j.1365-2311.2011.01295.x; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rennich K., 2012, 2011 2012 NATL HONEY; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Shardlow M, 2012, REV RECENT RES RELAT; Statistics Canada, 2012, 2011 CENS AGR; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Vogt FD, 1998, CAN J ZOOL, V76, P2026, DOI 10.1139/cjz-76-11-2026; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025	56	36	36	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79872	10.1371/journal.pone.0079872	http://dx.doi.org/10.1371/journal.pone.0079872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224015	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400146
J	Retana, C; Sanchez, EI; Gonzalez, S; Perez-Lopez, A; Cruz, A; Lagunas-Munoz, J; Alfaro-Cruz, C; Vital-Flores, S; Reyes, JL				Retana, Carmen; Sanchez, Elsa I.; Gonzalez, Sirenia; Perez-Lopez, Alejandro; Cruz, Armando; Lagunas-Munoz, Jesus; Alfaro-Cruz, Carmen; Vital-Flores, Socorro; Reyes, Jose L.			Retinoic Acid Improves Morphology of Cultured Peritoneal Mesothelial Cells from Patients Undergoing Dialysis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HIGH GLUCOSE; MESENCHYMAL TRANSITION; FACTOR-BETA; SURFACE; EXPRESSION; SINUS; DIFFERENTIATION; MICROVILLI; INDUCTION	Patients undergoing continuous ambulatory peritoneal dialysis are classified according to their peritoneal permeability as low transporter (low solute permeability) or High transporter (high solute permeability). Factors that determine the differences in permeability between them have not been fully disclosed. We investigated morphological features of cultured human peritoneal mesothelial cells from low or high transporter patients and its response to All trans retinoic Acid (ATRA, vitamin A active metabolite), as compared to non-uremic human peritoneal mesothelial cells. Control cells were isolated from human omentum. High or low transporter cells were obtained from dialysis effluents. Cells were cultured in media containing ATRA (0, 50, 100 or 200 nM). We studied length and distribution of microvilli and cilia (scanning electron microscopy), epithelial (cytokeratin, claudin-1, ZO-1 and occludin) and mesenchymal (vimentin and alpha-smooth muscle actin) transition markers by immunofluorescence and Western blot, and transforming growth factor beta 1 expression by Western blot. Low and high transporter exhibited hypertrophic cells, reduction in claudin-1, occludin and ZO-1 expression, cytokeratin and vimentin disorganization and positive alpha-smooth muscle actin label. Vimentin, alpha-smooth muscle actin and transforming growth factor- beta 1 were overexpressed in low transporter. Ciliated cells were diminished in low and high transporters. Microvilli number and length were severely reduced in high transporter. ATRA reduced hypertrophic cells number in low transporter. It also improved cytokeratin and vimentin organization, decreased vimentin and alpha-smooth muscle actin expression, and increased claudin 1, occludin and ZO-1 expression, in low and high transporter. In low transporter, ATRA reduced transforming growth factor-beta 1 expression. ATRA augmented percentage of ciliated cells in low and high transporter. It also augmented cilia length in high transporter. Alterations in structure, epithelial mesenchymal markers and transforming growth factor-beta 1expression were differential between low and high transporter. Beneficial effects of ATRA were improved human peritoneal mesothelial cells morphology tending to normalize structures.	[Retana, Carmen] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City, DF, Mexico; [Sanchez, Elsa I.; Reyes, Jose L.] Natl Polytech Inst, Ctr Res & Adv Studies, Physiol Biophys & Neurosci Dept, Mexico City, DF, Mexico; [Gonzalez, Sirenia] Natl Polytech Inst, Ctr Res & Adv Studies, Cent Labs, Mexico City, DF, Mexico; [Perez-Lopez, Alejandro] Hosp Cent Norte Petr Mexicanos, Dept Nephrol, Mexico City, DF, Mexico; [Cruz, Armando; Lagunas-Munoz, Jesus] Hosp Gen Raza, Inst Mexicano Seguro Social, Dept Nephrol, Unidad Med Alta Especialidad, Mexico City, DF, Mexico; [Cruz, Armando; Lagunas-Munoz, Jesus] Hosp Gen Raza, Inst Mexicano Seguro Social, Dept Gynecol, Unidad Med Alta Especialidad, Mexico City, DF, Mexico; [Alfaro-Cruz, Carmen] Hosp Reg 1, Inst Mexicano Seguro Social, Dept Nephrol, Mexico City, DF, Mexico; [Vital-Flores, Socorro] Hosp Juarez Mexico, Dept Nephrol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Reyes, JL (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Physiol Biophys & Neurosci Dept, Mexico City, DF, Mexico.	jreyes@fisio.cinvestav.mx	Retana Contreras, Maria del Carmen/Q-8946-2018	Retana Contreras, Maria del Carmen/0000-0003-0457-8478	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [0179870];  [CONACYT 176602]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	Study partially supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico (Grant 0179870). Carmen Retana had a postgraduate fellowship (CONACYT 176602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird SD, 2004, CELL BIOL INT, V28, P79, DOI 10.1016/j.cellbi.2003.11.014; BOMAN BM, 1983, LAB INVEST, V48, P199; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chan TM, 2003, NEPHROL DIAL TRANSPL, V18, P1086, DOI 10.1093/ndt/gfg096; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; COHEN PS, 1995, CANCER RES, V55, P2380; Correa-Rotter R, 2001, PERITON DIALYSIS INT, V21, pS75; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; Diaz C, 1998, ADV PERIT D, V14, P19; Erickson VR, 2008, AM J RHINOL, V22, P334, DOI 10.2500/ajr.2008.22.3176; Fang W, 2004, CHINESE MED J-PEKING, V117, P862; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; GOTLOIB L, 1989, NEPHRON, V51, P77, DOI 10.1159/000185247; GuerreroBarrera AL, 1996, MICROBIOL-SGM, V142, P1133, DOI 10.1099/13500872-142-5-1133; Hill EM, 1998, AM J RESP CELL MOL, V18, P662, DOI 10.1165/ajrcmb.18.5.2985; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; HONG WK, 1994, LEUKEMIA, V8, pS33; Hwang PH, 2006, LARYNGOSCOPE, V116, P1080, DOI 10.1097/01.mlg.0000224352.50256.99; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang DH, 1999, PERITON DIALYSIS INT, V19, P221; KIM KH, 1987, J CELL BIOL, V105, P3039, DOI 10.1083/jcb.105.6.3039; Ksiazek K, 2007, LAB INVEST, V87, P345, DOI 10.1038/labinvest.3700519; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lange K, 2001, AM J PHYSIOL-CELL PH, V281, pC369, DOI 10.1152/ajpcell.2001.281.2.C369; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Lee EA, 2001, PERITON DIALYSIS INT, V21, P245; Lee HB, 2007, J KOREAN MED SCI, V22, P943, DOI 10.3346/jkms.2007.22.6.943; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Leung MK, 2007, AM J RHINOL, V21, P271, DOI 10.2500/ajr.2007.21.3035; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Million K, 2001, AM J RESP CELL MOL, V25, P744, DOI 10.1165/ajrcmb.25.6.4549; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Mutsaers SE, 1996, J PATHOL, V180, P333; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Wang Gui-hua, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P575; Wang T, 1998, NEPHROL DIAL TRANSPL, V13, P1242, DOI 10.1093/ndt/13.5.1242; Witowski J, 2008, NEPHRON EXP NEPHROL, V108, pE69, DOI 10.1159/000126920; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; YANEZ MM, 2003, N ENGL MED, P403; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Yung S, 2007, PERITON DIALYSIS INT, V27, pS110; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; Zhong H, 2009, INT J HEMATOL, V89, P438, DOI 10.1007/s12185-009-0293-6	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79678	10.1371/journal.pone.0079678	http://dx.doi.org/10.1371/journal.pone.0079678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223992	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400137
J	Arora, S; Saini, S; Fukuhara, S; Majid, S; Shahryari, V; Yamamura, S; Chiyomaru, T; Deng, GR; Tanaka, Y; Dahiya, R				Arora, Sumit; Saini, Sharanjot; Fukuhara, Shinichiro; Majid, Shahana; Shahryari, Varahram; Yamamura, Soichiro; Chiyomaru, Takeshi; Deng, Guoren; Tanaka, Yuichiro; Dahiya, Rajvir			MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases	PLOS ONE			English	Article							ABL EXPRESSION; METASTASIS; PREDICTION; DASATINIB; MECP2; DIFFERENTIATION; PROLIFERATION; MECHANISMS; COMPONENTS; RESISTANT	The Abelson (c-Abl) proto-oncogene encodes a highly conserved nonreceptor protein tyrosine kinase that plays a role in cell proliferation, differentiation, apoptosis and cell adhesion. c-Abl represents a specific anti-cancer target in prostate cancer as aberrant activity of this kinase has been implicated in the stimulation of prostate cancer growth and progression. However, the mechanism of regulation of c-Abl is not known. Here we report that Abl kinases are regulated by a novel microRNA, miR-4723, in prostate cancer. Expression profiling of miR-4723 expression in a cohort of prostate cancer clinical specimens showed that miR-4723 expression is widely attenuated in prostate cancer. Low miR-4723 expression was significantly correlated with poor survival outcome and our analyses suggest that miR-4723 has significant potential as a disease biomarker for diagnosis and prognosis in prostate cancer. To evaluate the functional significance of decreased miR-4723 expression in prostate cancer, miR-4723 was overexpressed in prostate cancer cell lines followed by functional assays. miR-4723 overexpression led to significant decreases in cell growth, clonability, invasion and migration. Importantly, miR-4723 expression led to dramatic induction of apoptosis in prostate cancer cell lines suggesting that miR-4723 is a pro-apoptotic miRNA regulating prostate carcinogenesis. Analysis of putative miR-4723 targets showed that miR-4723 targets integrin alpha 3 and Methyl CpG binding protein in addition to Abl1 and Abl2 kinases. Further, we found that the expression of Abl kinase is inversely correlated with miR-4723 expression in prostate cancer clinical specimens. Also, Abl1 knockdown partially phenocopies miR-4723 reexpression in prostate cancer cells suggesting that Abl is a functionally relevant target of miR-4723 in prostate cancer. In conclusion, we have identified a novel microRNA that mediates regulation of Abl kinases in prostate cancer. This study suggests that miR-4723 may be an attractive target for therapeutic intervention in prostate cancer.	[Dahiya, Rajvir] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Dahiya, R (corresponding author), Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health (NIH) [RO1CA 138642, RO1CA160079, T32DK007790]; VA Merit Review and VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review and VA Program Project(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health (NIH) through Grant Number RO1CA 138642, RO1CA160079, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balan V, 2012, J BIOL CHEM, V287, P5192, DOI 10.1074/jbc.C111.331686; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; Faber J, 2008, CANCER CELL, V13, P467, DOI 10.1016/j.ccr.2008.05.013; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iijima Y, 2000, BLOOD, V95, P2126; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lopotova T, 2011, LEUKEMIA RES, V35, P974, DOI 10.1016/j.leukres.2011.03.029; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Nguyen CT, 2012, ASIAN J ANDROL, V14, P349, DOI 10.1038/aja.2011.140; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; ONeill AJ, 1997, J PATHOL, V183, P325, DOI 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Rabbani SA, 2010, MOL CANCER THER, V9, P1147, DOI 10.1158/1535-7163.MCT-09-0962; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Saini S, 2010, PHARM RES-DORDR, V27, P1014, DOI 10.1007/s11095-010-0086-x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Scholl V, 2012, LEUKEMIA RES, V36, P119, DOI 10.1016/j.leukres.2011.08.023; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Yaqinuddin A, 2008, BIOSCIENCE REP, V28, P319, DOI 10.1042/BSR20080032; Ye L, 2007, INT J MOL MED, V20, P103; Yu EY, 2011, UROLOGY, V77, P1166, DOI 10.1016/j.urology.2011.01.006; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691	49	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78023	10.1371/journal.pone.0078023	http://dx.doi.org/10.1371/journal.pone.0078023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223753	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300018
J	Rajayer, SR; Jacob, A; Yang, WL; Zhou, MA; Chaung, WN; Wang, P				Rajayer, Salil R.; Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping			Cold-Inducible RNA-Binding Protein Is an Important Mediator of Alcohol-Induced Brain Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; MICROGLIAL CELLS; BINGE DRINKING; ETHANOL; NEUROINFLAMMATION; CONSUMPTION; ACTIVATION; SENSOR; CIRP	Binge drinking has been associated with cerebral dysfunction. Ethanol induced microglial activation initiates an inflammatory process that causes upregulation of proinflammatory cytokines which in turn creates neuronal inflammation and damage. However, the molecular mechanism is not fully understood. We postulate that cold-inducible RNA-binding protein (CIRP), a novel proinflammatory molecule, can contribute to alcohol-induced neuroinflammation. To test this theory male wild-type (WT) mice were exposed to alcohol at concentrations consistent to binge drinking and blood and brain tissues were collected. At 5 h after alcohol, a significant increase of 53% in the brain of CIRP mRNA was observed and its expression remained elevated at 10 h and 15 h. Brain CIRP protein levels were increased by 184% at 10 h and remained high at 15 h. We then exposed male WT and CIRP knockout (CIRP-/-) mice to alcohol, and blood and brain tissues were collected at 15 h post-alcohol infusion. Serum levels of tissue injury markers (AST, ALT and LDH) were significantly elevated in alcohol-exposed WT mice while they were less increased in the CIRP-/- mice. Brain TNF-alpha mRNA and protein expressions along with IL-1 beta protein levels were significantly increased in WT mice, which was not seen in the CIRP-/- mice. In cultured BV2 cells (mouse microglia), ethanol at 100 mM showed an increase of CIRP mRNA by 274% and 408% at 24 h and 48 h respectively. Corresponding increases in TNF-alpha and IL-1 beta were also observed. CIRP protein levels were markedly increased in the medium, suggesting that CIRP was secreted by the BV2 cells. From this we conclude that alcohol exposure activates microglia to produce and secrete CIRP and possibly induce pro-inflammatory response and thereby causing neuroinflammation. CIRP could be a novel mediator of alcohol-induced brain inflammation.	[Rajayer, Salil R.; Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY USA; [Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Hofstra University; Northwell Health; Northwell Health	Wang, P (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R21 AA021496]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by National Institutes of Health (NIH) grant, R21 AA021496 to P. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Anderson ML, 2012, NEUROSCIENCE, V224, P202, DOI 10.1016/j.neuroscience.2012.08.018; Appel S H, 2011, Acta Myol, V30, P4; Archie S, 2012, ALCOHOL, V46, P165, DOI 10.1016/j.alcohol.2011.07.001; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bleich S, 2003, NEUROSCI LETT, V335, P179, DOI 10.1016/S0304-3940(02)01194-1; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Carson EJ, 1996, ALCOHOL CLIN EXP RES, V20, P132, DOI 10.1111/j.1530-0277.1996.tb01055.x; Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018; Chung YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370526; Climent E, 2002, J NEUROSCI RES, V68, P213, DOI 10.1002/jnr.10208; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Niemela O, 2001, FREE RADICAL BIO MED, V31, P1533, DOI 10.1016/S0891-5849(01)00744-4; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Saito M, 2002, NEUROCHEM RES, V27, P1221, DOI 10.1023/A:1020937728506; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Spear L, 2011, ALCOHOL DEV BRAIN; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Theoharides TC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-46; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Xue JH, 1999, FREE RADICAL BIO MED, V27, P1238, DOI 10.1016/S0891-5849(99)00158-6; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x	44	34	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79430	10.1371/journal.pone.0079430	http://dx.doi.org/10.1371/journal.pone.0079430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223948	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300084
J	Gulshan, K; Brubaker, G; Wang, SH; Hazen, SL; Smith, JD				Gulshan, Kailash; Brubaker, Gregory; Wang, Shuhui; Hazen, Stanley L.; Smith, Jonathan D.			Sphingomyelin Depletion Impairs Anionic Phospholipid Inward Translocation and Induces Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Apolipoproteins; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylserine; Sphingolipid; Sphingomyelinase	APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER A1; HAMSTER OVARY CELLS; APOE-DEFICIENT MICE; CELLULAR CHOLESTEROL; TANGIER-DISEASE; KNOCKOUT MICE; LIPID EFFLUX; ACCELERATES ATHEROSCLEROSIS	The phosphatidylserine (PS) floppase activity (outward translocation) of ABCA1 leads to plasma membrane remodeling that plays a role in lipid efflux to apolipoprotein A-I (apoAI) generating nascent high density lipoprotein. The Tangier disease W590S ABCA1 mutation has defective PS floppase activity and diminished cholesterol efflux activity. Here, we report that depletion of sphingomyelin by inhibitors or sphingomyelinase caused plasma membrane remodeling, leading to defective flip (inward translocation) of PS, higher PS exposure, and higher cholesterol efflux from cells by both ABCA1-dependent and ABCA1-independent mechanisms. Mechanistically, sphingomyelin was connected to PS translocation in cell-free liposome studies that showed that sphingomyelin increased the rate of spontaneous PS flipping. Depletion of sphingomyelin in stably transfected HEK293 cells expressing the Tangier disease W590S mutant ABCA1 isoform rescued the defect in PS exposure and restored cholesterol efflux to apoAI. Liposome studies showed that PS directly increased cholesterol accessibility to extraction by cyclodextrin, providing the mechanistic link between cell surface PS and cholesterol efflux. We conclude that altered plasma membrane environment conferred by depleting sphingomyelin impairs PS flip and promotes cholesterol efflux in ABCA1-dependent and -independent manners.	[Gulshan, Kailash; Brubaker, Gregory; Wang, Shuhui; Hazen, Stanley L.; Smith, Jonathan D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.; Smith, Jonathan D.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Smith, JD (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Box NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	smithj4@ccf.org	Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [PO1 HL098055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL098055 (to J. D. S. and S. L. H.).	Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cary LA, 2000, NATURE, V404, P945, DOI 10.1038/35010257; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chiantia Salvatore, 2013, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-7091-1368-4_2; Christian AE, 1997, J LIPID RES, V38, P2264; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Drobnik W, 2002, TRAFFIC, V3, P268, DOI 10.1034/j.1600-0854.2002.030404.x; Durbin DM, 1999, J LIPID RES, V40, P2293; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Ghering AB, 2006, J LIPID RES, V47, P2781, DOI 10.1194/jlr.M600380-JLR200; Glaros EN, 2008, J LIPID RES, V49, P324, DOI 10.1194/jlr.M700261-JLR200; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Hidaka H, 2008, CLIN BIOCHEM, V41, P1211, DOI 10.1016/j.clinbiochem.2008.06.010; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Li ZQ, 2009, BBA-MOL CELL BIOL L, V1791, P297, DOI 10.1016/j.bbalip.2009.01.010; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nagao K, 2009, J LIPID RES, V50, P1165, DOI 10.1194/jlr.M800597-JLR200; Ohvo H, 1997, BBA-LIPID LIPID MET, V1349, P131, DOI 10.1016/S0005-2760(97)00126-4; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Smith JD, 2002, J BIOL CHEM, V277, P17797, DOI 10.1074/jbc.M201594200; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Worgall TS, 2011, ADV EXP MED BIOL, V721, P139, DOI 10.1007/978-1-4614-0650-1_9; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	64	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37166	37179		10.1074/jbc.M113.512244	http://dx.doi.org/10.1074/jbc.M113.512244			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220029	Green Published, hybrid			2022-12-25	WOS:000329189700035
J	Dalesman, S; Sunada, H; Teskey, ML; Lukowiak, K				Dalesman, Sarah; Sunada, Hiroshi; Teskey, Morgan Lee; Lukowiak, Ken			Combining Stressors That Individually Impede Long-Term Memory Blocks All Memory Processes	PLOS ONE			English	Article							AERIAL RESPIRATORY BEHAVIOR; SNAIL LYMNAEA-STAGNALIS; ALTERS ADAPTIVE BEHAVIORS; ENVIRONMENTAL CALCIUM; SYNAPTIC PLASTICITY; PREDATOR EXPOSURE; PREFRONTAL CORTEX; MODEL SYSTEM; L.; HIPPOCAMPUS	The effects of stress on memory are typically assessed individually; however, in reality different stressors are often experienced simultaneously. Here we determined the effect that two environmentally relevant stressors, crowding and low calcium availability, have on memory and neural activity following operant conditioning of aerial respiration in the pond snail, Lymnaea stagnalis. We measured aerial breathing behaviour and activity of a neuron necessary for memory formation, right pedal dorsal 1 (RPeD1), in the central pattern generator (CPG) that drives aerial respiration in untrained animals, and assessed how these traits changed following training. In naive animals both crowding and combined stressors significantly depressed burst activity in RPeD1 which correlated with a depression in aerial breathing behaviour, whereas low calcium availability had no effect on RPeD1 activity. Following training, changes in burst activity in RPeD1 correlated with behavioural changes, decreasing relative to their naive state at 3 h and 24 h in control conditions when both intermediate-term memory (ITM: 3 h) and long-term memory (LTM: 24 h) are formed, at 3 h but not 24 h when exposed to individual stressors when only ITM is formed, and did not change in combined stressors (i.e. when no memory is formed). Additionally, we also found that Lymnaea formed short-term memory (STM: 10 min) in the presence of individual stressors or under control conditions, but failed to do so in the presence of combined stressors. Our data demonstrate that by combining stressors that individually block LTM only we can block all memory processes. Therefore the effects of two stressors with similar individual affects on memory phenotype may be additive when experienced in combination.	[Dalesman, Sarah; Sunada, Hiroshi; Teskey, Morgan Lee; Lukowiak, Ken] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Dalesman, S (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	S.Dalesman@exeter.ac.uk		Dalesman, Sarah/0000-0001-8548-3096	Alberta Innovates - Health Solutions; Hotchkiss Brain Institute; Canadian Institutes of Health Research	Alberta Innovates - Health Solutions; Hotchkiss Brain Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Alberta Innovates - Health Solutions provided financial support for S. D., the Hotchkiss Brain Institute supports H. S. and Canadian Institutes of Health Research supports K. L. and the laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun MH, 2012, NEUROBIOL LEARN MEM, V97, P173, DOI 10.1016/j.nlm.2011.11.005; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; BROWN KM, 1979, EVOLUTION, V33, P417, DOI 10.1111/j.1558-5646.1979.tb04695.x; Dalesman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032334; Dalesman S, 2011, J EXP BIOL, V214, P4179, DOI 10.1242/jeb.064857; Dalesman S, 2011, J EXP BIOL, V214, P2528, DOI 10.1242/jeb.058024; Dalesman S, 2011, NEUROBIOL LEARN MEM, V95, P393, DOI 10.1016/j.nlm.2010.11.017; Dalesman S, 2010, J EXP BIOL, V213, P1471, DOI 10.1242/jeb.040493; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; De Caigny P, 2008, J EXP BIOL, V211, P2678, DOI 10.1242/jeb.020347; DeBoer PACM, 1997, J EXP BIOL, V200, P941; DUSSART G B J, 1976, Journal of Molluscan Studies, V42, P181; Ebanks SC, 2010, J COMP PHYSIOL B, V180, P953, DOI 10.1007/s00360-010-0469-7; Hermann PM, 2009, J EXP BIOL, V212, P3164, DOI 10.1242/jeb.030031; Karnik V, 2012, J EXP BIOL, V215, P536, DOI 10.1242/jeb.061432; Kavushansky Alexandra, 2009, Stress, V12, P412, DOI 10.1080/10253890802556081; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knezevic B, 2011, J EXP BIOL, V214, P2118, DOI 10.1242/jeb.054635; Lukowiak K, 2003, J PHYSIOL-PARIS, V97, P69, DOI 10.1016/j.jphysparis.2003.10.008; Lukowiak K, 1991, Curr Opin Neurobiol, V1, P577, DOI 10.1016/S0959-4388(05)80031-5; Lukowiak K, 1996, J EXP BIOL, V199, P683; Lukowiak K, 2008, J EXP BIOL, V211, P1747, DOI 10.1242/jeb.014886; Lukowiak K, 2010, BEHAV BRAIN RES, V214, P18, DOI 10.1016/j.bbr.2010.05.011; MANN KH, 1958, LIMNOL OCEANOGR, V3, P418, DOI 10.4319/lo.1958.3.4.0418; McComb C, 2003, J NEUROPHYSIOL, V90, P983, DOI 10.1152/jn.00263.2003; Orr MV, 2008, J NEUROSCI, V28, P2726, DOI 10.1523/JNEUROSCI.5132-07.2008; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Sangha S, 2004, ADV EXP MED BIOL, V551, P311; Scheibenstock A, 2002, J NEUROPHYSIOL, V88, P1584, DOI 10.1152/jn.2002.88.4.1584; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Spencer GE, 2000, J NEUROSCI, V20, P8077; Spencer GE, 1999, J NEUROSCI, V19, P1836; Spencer SJ, 2004, EUR J NEUROSCI, V20, P1008, DOI 10.1111/j.1460-9568.2004.03569.x; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613; Zoladz PR, 2012, HIPPOCAMPUS, V22, P577, DOI 10.1002/hipo.20922	36	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79561	10.1371/journal.pone.0079561	http://dx.doi.org/10.1371/journal.pone.0079561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223180	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200072
J	Alves, CCD; Collison, A; Hatchwell, L; Plank, M; Morten, M; Foster, PS; Johnston, SL; da Costa, CF; de Almeida, MV; Teixeira, HC; Ferreira, AP; Mattes, J				de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Johnston, Sebastian L.; da Costa, Cristiane Franca; de Almeida, Mauro Vieira; Teixeira, Henrique Couto; Ferreira, Ana Paula; Mattes, Joerg			Inhibiting AKT Phosphorylation Employing Non-Cytotoxic Anthraquinones Ameliorates T(H)2 Mediated Allergic Airways Disease and Rhinovirus Exacerbation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-CELLS; SEVERE ASTHMA; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIPLE-SCLEROSIS; TOPOISOMERASE-II; ANTI-IGE; INFLAMMATION; MITOXANTRONE; ACTIVATION	Background: Severe asthma is associated with T helper (T-H) 2 and 17 cell activation, airway neutrophilia and phosphoinositide-3-kinase (PI3K) activation. Asthma exacerbations are commonly caused by rhinovirus (RV) and also associated with PI3K-driven inflammation. Anthraquinone derivatives have been shown to reduce PI3K-mediated AKT phosphorylation in-vitro. Objective: To determine the anti-inflammatory potential of anthraquinones in-vivo. Methods: BALB/c mice were sensitized and challenged with crude house dust mite extract to induce allergic airways disease and treated with mitoxantrone and a novel non-cytotoxic anthraquinone derivative. Allergic mice were also infected with RV1B to induce an exacerbation. Results: Anthraquinone treatment reduced AKT phosphorylation, hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression, and ameliorated allergen-and RV-induced airways hyprereactivity, neutrophilic and eosinophilic inflammation, cytokine/chemokine expression, mucus hypersecretion, and expression of T(H)2 proteins in the airways. Anthraquinones also boosted type 1 interferon responses and limited RV replication in the lung. Conclusion: Non-cytotoxic anthraquinone derivatives may be of therapeutic benefit for the treatment of severe and RV-induced asthma by blocking pro-inflammatory pathways regulated by PI3K/AKT.	[de Souza Alves, Caio Cesar; Teixeira, Henrique Couto; Ferreira, Ana Paula] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Sao Pedro, MG, Brazil; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Morten, Matthew; Mattes, Joerg] Univ Newcastle, Experimental& Translat Resp Grp, Newcastle, NSW 2300, Australia; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Mattes, Joerg] Hunter Med Res Inst, Newcastle, NSW, Australia; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Mattes, Joerg] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, Airway Dis Infect Sect, Natl Heart & Lung Inst, London, England; [Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [da Costa, Cristiane Franca; de Almeida, Mauro Vieira] Univ Fed Juiz de Fora, Dept Chem, Sao Pedro, MG, Brazil; [Mattes, Joerg] Newcastle Childrens Hosp, Paediat Resp & Sleep Med Unit, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Imperial College London; Imperial College London; University of London; King's College London	Ferreira, AP (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Sao Pedro, MG, Brazil.	ana.paula@ufjf.edu.br; Joerg.mattes@newcastle.edu.au	Johnston, Sebastian Lennox/I-2423-2012; Da Costa, Cristiane F/C-3710-2016; Foster, Paul/G-5057-2013; Teixeira, Henrique C/R-2133-2019; Almeida, Mauro/U-8931-2019; Ferreira, Ana Paula/C-5259-2013; De Souza Alves, Caio Cesar/B-9428-2013; MATTES, JOERG/M-5179-2019	Johnston, Sebastian Lennox/0000-0003-3009-9200; Teixeira, Henrique C/0000-0002-0172-9720; De Souza Alves, Caio Cesar/0000-0001-9765-8527; 	National Health Medical Research Council (NHMRC); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Professional Research Fellowship; CAPES; CNPq; FAPEMIG; Asthma UK [CH1155]; MRC Centre grant [G1000758]; ERC [233015]; Medical Research Council [G1000758] Funding Source: researchfish	National Health Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Professional Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Asthma UK; MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the National Health Medical Research Council (NH&MRC) (J.M., P. F.), the Hunter Medical Research Institute (J.M., P. F.), the Hunter Children's Research Foundation (J.M., P. F.) and an NH&MRC Health Professional Research Fellowship (J.M.). C. C. S. A., C. F. C., H. C. T., M. V. A. and A. P. F. were supported by CAPES, CNPq and FAPEMIG grants. S.L.J. was supported by a Chair from Asthma UK (CH1155). This work was supported in part by MRC Centre grant G1000758 and ERC FP7 Advanced Grant 233015 (to S.L.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101; ALRAMLI W, 2009, J ALLERGY CLIN IMMUN, V123; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; BOCHNER BS, 1994, ANNU REV IMMUNOL, V12, P295; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CORREN J, 2011, NEW ENGL J MED, V3, P3; Corrigan CJ, 2011, P NATL ACAD SCI USA, V108, P1579, DOI 10.1073/pnas.1014241108; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dunn JJ, 2004, J CLIN MICROBIOL, V42, P79, DOI 10.1128/JCM.42.1.79-82.2004; FAULDS D, 1991, DRUGS, V41, P400, DOI 10.2165/00003495-199141030-00007; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Fox EJ, 2006, CLIN THER, V28, P461, DOI 10.1016/j.clinthera.2006.04.013; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Grunberg K, 2001, AM J RESP CRIT CARE, V164, P1816; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Kim JH, 2008, BIOCHEM BIOPH RES CO, V377, P195, DOI 10.1016/j.bbrc.2008.09.095; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee Chun Geun, 2011, Proc Am Thorac Soc, V8, P512, DOI 10.1513/pats.201102-018MW; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P403, DOI 10.1016/j.jaci.2006.04.041; Leung DYM, 1998, PEDIATR ALLERGY IMMU, V9, P3, DOI 10.1111/j.1399-3038.1998.tb00293.x; Leung DYM, 1997, CLIN CHEST MED, V18, P611, DOI 10.1016/S0272-5231(05)70405-6; Lloyd C, 2002, IMMUNOLOGY, V105, P144, DOI 10.1046/j.1365-2567.2002.01344.x; Lu Y, 2012, MOL CELL BIOCHEM, V365, P333, DOI 10.1007/s11010-012-1273-3; Lu Y, 2011, BIOCHEM PHARMACOL, V82, P1700, DOI 10.1016/j.bcp.2011.08.022; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miller EK, 2010, IMMUNOL ALLERGY CLIN, V30, P541, DOI 10.1016/j.iac.2010.08.007; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Neuhaus O, 2004, J NEUROL SCI, V223, P25, DOI 10.1016/j.jns.2004.04.015; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; SMITH IE, 1983, CANCER TREAT REV, V10, P103, DOI 10.1016/0305-7372(83)90008-7; Thomson NC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-102; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	65	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79565	10.1371/journal.pone.0079565	http://dx.doi.org/10.1371/journal.pone.0079565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223970	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400073
J	Zhang, HB; Sachdev, PS; Wen, W; Kochan, NA; Crawford, JD; Brodaty, H; Slavin, MJ; Reppermund, S; Kang, K; Trollor, JN				Zhang, Haobo; Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.; Crawford, John D.; Brodaty, Henry; Slavin, Melissa J.; Reppermund, Simone; Kang, Kristan; Trollor, Julian N.			Grey Matter Correlates of Three Language Tests in Non-demented Older Adults	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MINI-MENTAL-STATE; VERBAL FLUENCY; SEMANTIC MEMORY; WORKING-MEMORY; ALZHEIMERS-DISEASE; PHONEMIC FLUENCY; FUNCTIONAL MRI; WORD RETRIEVAL; BRAIN	Language has been extensively investigated by functional neuroimaging studies. However, only a limited number of structural neuroimaging studies have examined the relationship between language performance and brain structure in healthy adults, and the number is even less in older adults. The present study sought to investigate correlations between grey matter volumes and three standardized language tests in late life. The participants were 344 non-demented, community-dwelling adults aged 70-90 years, who were drawn from the population-based Sydney Memory and Ageing Study. The three language tests included the Controlled Oral Word Association Task (COWAT), Category Fluency (CF), and Boston Naming Test (BNT). Correlation analyses between voxel-wise GM volumes and language tests showed distinctive GM correlation patterns for each language test. The GM correlates were located in the right frontal and left temporal lobes for COWAT, in the left frontal and temporal lobes for CF, and in bilateral temporal lobes for BNT. Our findings largely corresponded to the neural substrates of language tasks revealed in fMRI studies, and we also observed a less hemispheric asymmetry in the GM correlates of the language tests. Furthermore, we divided the participants into two age groups (70-79 and 80-90 years old), and then examined the correlations between structural laterality indices and language performance for each group. A trend toward significant difference in the correlations was found between the two age groups, with stronger correlations in the group of 70-79 years old than those in the group of 80-90 years old. This difference might suggest a further decline of language lateralization in different stages of late life.	[Zhang, Haobo; Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.; Crawford, John D.; Reppermund, Simone; Kang, Kristan; Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry; Slavin, Melissa J.] Univ New S Wales, Sch Psychiat, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Trollor, JN (corresponding author), Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia.	J.Trollor@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Zhang, Haobo/0000-0002-7220-8957	National Health and Medical Research Council of Australia Program Grant [350833]; Project Grant [ID 510175]; Australian Research Council Discovery Grant [ID DP0774213]	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Project Grant(Wellcome Trust); Australian Research Council Discovery Grant(Australian Research Council)	The current study was financially supported by the National Health and Medical Research Council of Australia Program Grant (ID 350833) and Project Grant (ID 510175) (http://www.nhmrc.gov.au/grants), as well as by an Australian Research Council Discovery Grant (ID DP0774213) (http://www.arc.gov.au/ncgp/dp/dp_default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benton A.L., 1967, CORTEX, V3, P32, DOI [10.1016/s0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4, 10.1016/S0010-9452(67)80005-4]; Bernard FA, 2004, NEUROIMAGE, V22, P1704, DOI 10.1016/j.neuroimage.2004.03.036; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Blaizot X, 2010, CEREB CORTEX, V20, P2198, DOI 10.1093/cercor/bhp289; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chee MWL, 2009, NEUROIMAGE, V46, P257, DOI 10.1016/j.neuroimage.2009.01.036; Chee MWL, 2002, NEUROIMAGE, V16, P259, DOI 10.1006/nimg.2002.1061; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Corbett F, 2009, BRAIN, V132, P2593, DOI 10.1093/brain/awp146; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foundas AL, 1996, P NATL ACAD SCI USA, V93, P719, DOI 10.1073/pnas.93.2.719; Frenck-Mestre C, 2005, NEUROREPORT, V16, P761, DOI 10.1097/00001756-200505120-00021; Gauger LM, 1997, J SPEECH LANG HEAR R, V40, P1272, DOI 10.1044/jslhr.4006.1272; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Grogan A, 2009, CEREB CORTEX, V19, P2690, DOI 10.1093/cercor/bhp023; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hirshorn EA, 2006, NEUROPSYCHOLOGIA, V44, P2547, DOI 10.1016/j.neuropsychologia.2006.03.035; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Hoeppner J, 2009, EUR ARCH PSY CLIN N, V259, P92, DOI 10.1007/s00406-008-0840-9; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jefferies E, 2007, NEUROPSYCHOLOGIA, V45, P1065, DOI 10.1016/j.neuropsychologia.2006.09.009; Josse G, 2003, COGNITIVE BRAIN RES, V18, P1, DOI 10.1016/j.cogbrainres.2003.08.007; Josse G, 2009, J NEUROSCI, V29, P13516, DOI 10.1523/JNEUROSCI.1680-09.2009; Kaplan E, 2001, BOSTON NAMING TEST; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Koelsch S, 2009, HUM BRAIN MAPP, V30, P859, DOI 10.1002/hbm.20550; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; McGeown WJ, 2009, PSYCHIAT RES-NEUROIM, V173, P218, DOI 10.1016/j.pscychresns.2008.10.005; Meinzer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033631; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Melrose RJ, 2009, INT J GERIATR PSYCH, V24, P885, DOI 10.1002/gps.2229; MILLER BL, 1991, NEUROLOGY, V41, P1374, DOI 10.1212/WNL.41.9.1374; Moser D, 2009, NEUROIMAGE, V46, P549, DOI 10.1016/j.neuroimage.2009.01.015; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Newman LM, 2007, BRAIN IMAGING BEHAV, V1, P3, DOI 10.1007/s11682-007-9000-5; NICHOLAS M, 1985, CORTEX, V21, P595, DOI 10.1016/S0010-9452(58)80007-6; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.band1.2010.03.001, 10.1016/j.bandl.2010.03.001]; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Phelps EA, 1997, NEUROREPORT, V8, P561, DOI 10.1097/00001756-199701200-00036; Pihlajamaki M, 2000, ANN NEUROL, V47, P470, DOI 10.1002/1531-8249(200004)47:4<470::AID-ANA10>3.3.CO;2-D; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Richardson FM, 2009, BRAIN STRUCT FUNCT, V213, P511, DOI 10.1007/s00429-009-0211-y; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Sharp DJ, 2010, HUM BRAIN MAPP, V31, P365, DOI 10.1002/hbm.20871; Somers M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00031; Spreen O., 1969, NEUROSENSORY CTR COM; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Venneri A, 2008, NEUROPSYCHOLOGIA, V46, P497, DOI 10.1016/j.neuropsychologia.2007.08.026; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Whitney C, 2011, CEREB CORTEX, V21, P831, DOI 10.1093/cercor/bhq148; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wildgruber D, 2001, NEUROIMAGE, V13, P101, DOI 10.1006/nimg.2000.0672; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Zhang HB, 2011, DEMENT GERIATR COGN, V32, P216, DOI 10.1159/000333372; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324; Ziegler DA, 2010, NEUROBIOL AGING, V31, P1912, DOI 10.1016/j.neurobiolaging.2008.10.015	98	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80215	10.1371/journal.pone.0080215	http://dx.doi.org/10.1371/journal.pone.0080215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224044	Green Published, gold			2022-12-25	WOS:000326597400114
J	Barutta, F; Tricarico, M; Corbelli, A; Annaratone, L; Pinach, S; Grimaldi, S; Bruno, G; Cimino, D; Taverna, D; Deregibus, MC; Rastaldi, MP; Perin, PC; Gruden, G				Barutta, Federica; Tricarico, Marinella; Corbelli, Alessandro; Annaratone, Laura; Pinach, Silvia; Grimaldi, Serena; Bruno, Graziella; Cimino, Daniela; Taverna, Daniela; Deregibus, Maria Chiara; Rastaldi, Maria Pia; Perin, Paolo Cavallo; Gruden, Gabriella			Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY GLOMERULI; EXPRESSION; CELLS; MICROALBUMINURIA; TGF-BETA-1; MIR-145; PLASMA	MicroRNAs (miRNAs), a class of small non-protein-encoding RNAs, regulate gene expression via suppression of target mRNAs. MiRNAs are present in body fluids in a remarkable stable form as packaged in microvesicles of endocytic origin, named exosomes. In the present study, we have assessed miRNA expression in urinary exosomes from type 1 diabetic patients with and without incipient diabetic nephropathy. Results showed that miR-130a and miR-145 were enriched, while miR-155 and miR-424 reduced in urinary exosomes from patients with microalbuminuria. Similarly, in an animal model of early experimental diabetic nephropathy, urinary exosomal miR-145 levels were increased and this was paralleled by miR-145 overexpression within the glomeruli. Exposure of cultured mesangial cells to high glucose increased miR-145 content in both mesangial cells and mesangial cells-derived exosomes, providing a potential mechanism for diabetes-induced miR-145 overexpression. In conclusion, urinary exosomal miRNA content is altered in type 1 diabetic patients with incipient diabetic nephropathy and miR-145 may represent a novel candidate biomarker/player in the complication.	[Barutta, Federica; Tricarico, Marinella; Pinach, Silvia; Grimaldi, Serena; Bruno, Graziella; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Diabet Nephropathy Lab, Turin, Italy; [Corbelli, Alessandro] Osped Maggiore Policlin, Fdn IRCCS, Renal Res Lab, Milan, Italy; [Corbelli, Alessandro] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Corbelli, Alessandro] Milano Bicocca Univ, MIA Consortium Image Anal, Milan, Italy; [Annaratone, Laura] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Cimino, Daniela; Taverna, Daniela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Deregibus, Maria Chiara] Univ Turin, Dept Med Sci, Lab Renal & Vasc Pathophysiol, Turin, Italy	University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; University of Turin; University of Turin; University of Turin	Barutta, F (corresponding author), Univ Turin, Dept Med Sci, Diabet Nephropathy Lab, Turin, Italy.	federica.barutta@unito.it	taverna, daniela/J-8358-2016; Corbelli, Alessandro/ABG-3900-2020; Pinach, Silvia/AAC-7490-2022; Annaratone, Laura/J-9261-2016	taverna, daniela/0000-0002-6365-527X; Corbelli, Alessandro/0000-0001-8545-8050; Pinach, Silvia/0000-0002-3234-9990; Annaratone, Laura/0000-0001-5750-1445; BRUNO, Graziella/0000-0002-3011-8304	EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant	EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant	This work was supported by a EFSD & Sanofi European Research Programme in Micro- and Macrovascular Complications of Diabetes Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; El Andaloussi S, 2012, ADV DRUG DELIV REV; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Giunti S, 2008, DIABETOLOGIA, V51, P198, DOI 10.1007/s00125-007-0837-3; Glassock RJ, 2010, AM J NEPHROL, V31, P462, DOI 10.1159/000313553; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; HE L, 2004, NAT REV GENET, V5, P522, DOI DOI 10.1038/NRG1379.PUBMED:15211354; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lambers Heerspink HJ, 2010, AM J NEPHROL, V31, P458, DOI 10.1159/000292501; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu MC, 2013, CLIN EXP IMMUNOL, V171, P91, DOI 10.1111/j.1365-2249.2012.04676.x; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; MANGILI R, 1992, ACTA DIABETOL, V29, P156, DOI 10.1007/BF00573481; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stevens LA, 2006, CLIN J AM SOC NEPHRO, V1, P874, DOI 10.2215/CJN.00600206; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tarabra E, 2009, DIABETES, V58, P2109, DOI 10.2337/db08-0895; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Wang G, 2007, NEPHROLOGY, V12, P494, DOI 10.1111/j.1440-1797.2007.00836.x; Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703, DOI 10.1681/ASN.V124703	39	221	235	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e73798	10.1371/journal.pone.0073798	http://dx.doi.org/10.1371/journal.pone.0073798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223694	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400002
J	Fenske, N; Burns, J; Hothorn, T; Rehfuess, EA				Fenske, Nora; Burns, Jacob; Hothorn, Torsten; Rehfuess, Eva A.			Understanding Child Stunting in India: A Comprehensive Analysis of Socio-Economic, Nutritional and Environmental Determinants Using Additive Quantile Regression	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; RISK-FACTORS; MULTISECTOR INTERVENTION; ACCELERATE REDUCTIONS; RESPIRATORY MORBIDITY; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; PRESCHOOL-CHILDREN; DIETARY DIVERSITY; POPULATION HEALTH	Background: Most attempts to address undernutrition, responsible for one third of global child deaths, have fallen behind expectations. This suggests that the assumptions underlying current modelling and intervention practices should be revisited. Objective: We undertook a comprehensive analysis of the determinants of child stunting in India, and explored whether the established focus on linear effects of single risks is appropriate. Design: Using cross-sectional data for children aged 0-24 months from the Indian National Family Health Survey for 2005/2006, we populated an evidence-based diagram of immediate, intermediate and underlying determinants of stunting. We modelled linear, non-linear, spatial and age-varying effects of these determinants using additive quantile regression for four quantiles of the Z-score of standardized height-for-age and logistic regression for stunting and severe stunting. Results: At least one variable within each of eleven groups of determinants was significantly associated with height-for-age in the 35% Z-score quantile regression. The non-modifiable risk factors child age and sex, and the protective factors household wealth, maternal education and BMI showed the largest effects. Being a twin or multiple birth was associated with dramatically decreased height-for-age. Maternal age, maternal BMI, birth order and number of antenatal visits influenced child stunting in non-linear ways. Findings across the four quantile and two logistic regression models were largely comparable. Conclusions: Our analysis confirms the multifactorial nature of child stunting. It emphasizes the need to pursue a systems-based approach and to consider non-linear effects, and suggests that differential effects across the height-for-age distribution do not play a major role.	[Fenske, Nora; Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Burns, Jacob; Rehfuess, Eva A.] Univ Munich, Inst Med Informationsverarbeitung Biometrie & Epi, Munich, Germany	University of Munich; University of Munich	Fenske, N (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	nora.fenske@stat.uni-muenchen.de	Rehfuess, Eva Annette/ABD-8167-2021		Munich Center of Health Sciences (MC-Health)	Munich Center of Health Sciences (MC-Health)	This work was supported by the Munich Center of Health Sciences (MC-Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 1997, J NUTR, V127, P314, DOI 10.1093/jn/127.2.314; Agee MD, 2010, SOC SCI MED, V71, P1973, DOI 10.1016/j.socscimed.2010.09.020; Anekwe TD, 2012, J PUBLIC HEALTH-UK, V34, P489, DOI 10.1093/pubmed/fds032; ANGELES IT, 1993, AM J CLIN NUTR, V58, P339, DOI 10.1093/ajcn/58.3.339; [Anonymous], 2008, LANCET, DOI DOI 10.1016/S0140-6736(07)61693-6; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Best CM, 2007, NUTRITION, V23, P731, DOI 10.1016/j.nut.2007.06.014; Bhandari N, 2008, MATERN CHILD NUTR, V4, P5, DOI 10.1111/j.1740-8709.2007.00126.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Clemens MA, 2012, AM J CLIN NUTR, V95, P774, DOI 10.3945/ajcn.111.031278; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; De-Regil LM, 2011, COCHRANE DB SYST REV, V9; Dekker LH, 2010, FOOD NUTR BULL, V31, P242, DOI 10.1177/156482651003100207; Delpeuch F, 2000, PUBLIC HEALTH NUTR, V3, P39, DOI 10.1017/S1368980000000069; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fenske N, 2011, J AM STAT ASSOC, V106, P494, DOI 10.1198/jasa.2011.ap09272; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Garg A, 2009, J HEALTH POPUL NUTR, V27, P763; Ghosh R, 2011, ARCH PEDIAT ADOL MED, V165, P492, DOI 10.1001/archpediatrics.2010.294; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Habicht JP, 2004, ADV EXP MED BIOL, V554, P79; Haddad L, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6687; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Hofner B, 2011, J COMPUT GRAPH STAT, V20, P956, DOI 10.1198/jcgs.2011.09220; Hothorn T, 2013, MBOOST MODEL BASED B; Hothorn T, 2010, J MACH LEARN RES, V11, P2109; Huy ND, 2009, FOOD NUTR BULL, V30, pS506, DOI 10.1177/15648265090304S405; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; International Institute for Population Sciences, 2013, NAT FAM HLTH SURV; International Institute for Population Sciences and Macro International, 2007, NAT FAM HLTH SURV NF, P517; Jayasinghe S, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-2; Joffe M, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-1; Jones AD, 2012, SOC SCI MED, V75, P1673, DOI 10.1016/j.socscimed.2012.06.025; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Kimani-Murage EW, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-23; Kneib T, 2009, BIOMETRICS, V65, P626, DOI 10.1111/j.1541-0420.2008.01112.x; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Kyu HH, 2009, INT J EPIDEMIOL, V38, P1342, DOI 10.1093/ije/dyp253; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Magadi MA, 2011, SOC SCI MED, V73, P436, DOI 10.1016/j.socscimed.2011.05.042; Markovitz AR, 2012, INT J EPIDEMIOL, V41, P504, DOI 10.1093/ije/dyr194; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; McMichael AJ, 2001, P NUTR SOC, V60, P195, DOI 10.1079/PNS200090; Medhin G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-27; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Nalwoga A, 2010, TROP MED INT HEALTH, V15, P414, DOI 10.1111/j.1365-3156.2010.02476.x; Osei A, 2010, FOOD NUTR BULL, V31, P221, DOI 10.1177/156482651003100205; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; Pearce N, 2011, INT J EPIDEMIOL, V40, P503, DOI 10.1093/ije/dyq257; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, P191, DOI 10.3945/ajcn.2008.26862; Reddy KS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7188; Remans R, 2011, AM J CLIN NUTR, V94, P1632, DOI 10.3945/ajcn.111.020099; Rosado JL, 1999, J NUTR, V129, p531S, DOI 10.1093/jn/129.2.531S; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; Rue H., 2005, GAUSSIAN MARKOV RAND; Ruel MT, 2002, J NUTR, V132, P1180, DOI 10.1093/jn/132.6.1180; Ruel MT, 2002, 143 INT FOOD POL RES, P53; Semba RD, 2008, AM J CLIN NUTR, V87, P438, DOI 10.1093/ajcn/87.2.438; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Semba RD, 2010, J NUTR, V140, p208S, DOI 10.3945/jn.109.110700; Sguassero Y., 2012, COCHRANE DB SYST REV, V6; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Smith GD, 2001, J CLIN EPIDEMIOL, V54, P325, DOI 10.1016/S0895-4356(00)00334-6; Smith LC, 2003, 131 IFPRI, P163; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Subramanian SV, 2010, PEDIATRICS, V126, pE663, DOI 10.1542/peds.2010-0222; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Svedberg P, 2006, INT J EPIDEMIOL, V35, P1336, DOI 10.1093/ije/dyl157; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; UNICEF, 1998, STAT WORLDS CHILDR 1; UNICEF WHO The World Bank and United Nations DESA/Population Division, 2011, LEV TRENDS CHILD MOR, P19; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Varela-Silva MI, 2009, AM J HUM BIOL, V21, P657, DOI 10.1002/ajhb.20883; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; WHO, 2003, INF YOUNG CHILD FEED, P140; WHO Multicentre Growth Reference Study Group, 2006, WHO GUID DRINK WAT Q, P138; WHO UNICEF, 2005, HDB INT MAN CHILDH I, P163; World Health Organization, GLOB DAT CHILD GROWT; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	102	108	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78692	10.1371/journal.pone.0078692	http://dx.doi.org/10.1371/journal.pone.0078692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223839	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400082
J	Fertig, EJ; Markovic, A; Danilova, LV; Gaykalova, DA; Cope, L; Chung, CH; Ochs, MF; Califano, JA				Fertig, Elana J.; Markovic, Ana; Danilova, Ludmila V.; Gaykalova, Daria A.; Cope, Leslie; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A.			Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis	PLOS ONE			English	Article							NECK-CANCER; HUMAN-PAPILLOMAVIRUS; EXPRESSION DIFFERENCES; HEAD; PATTERNS; METHYLATION; RESISTANCE; DISCOVERY; SURVIVAL; REVEALS	Head and neck squamous cell carcinoma (HNSCC) is largely divided into two groups based on their etiology, human papillomavirus (HPV)-positive and -negative. Global DNA methylation changes are known to drive oncogene and tumor suppressor expression in primary HNSCC of both types. However, significant heterogeneity in DNA methylation within the groups results in different transcriptional profiles and clinical outcomes. We applied a meta-pathway analysis to link gene expression changes to DNA methylation in distinguishing HNSCC subtypes. This approach isolated specific epigenetic changes controlling expression in HPV- HNSCC that distinguish it from HPV+ HNSCC. Analysis of genes identified Hedgehog pathway activation specific to HPV- HNSCC. We confirmed that GLI1, the primary Hedgehog target, showed higher expression in tumors compared to normal samples with HPV- tumors having the highest GLI1 expression, suggesting that increased expression of GLI1 is a potential driver in HPV- HNSCC. Our algorithm for integration of DNA methylation and gene expression can infer biologically significant molecular pathways that may be exploited as therapeutics targets. Our results suggest that therapeutics targeting the Hedgehog pathway may be of benefit in HPV- HNSCC. Similar integrative analysis of high-throughput coupled DNA methylation and expression datasets may yield novel insights into deregulated pathways in other cancers.	[Fertig, Elana J.; Danilova, Ludmila V.; Cope, Leslie; Chung, Christine H.; Ochs, Michael F.; Califano, Joseph A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA; [Markovic, Ana] Univ Calif San Francisco, Hellen Diller Family Comprehens Canc Ctr, Dept Hematopoiet Malignancies, San Francisco, CA 94143 USA; [Gaykalova, Daria A.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Hlth Sci Informat, Baltimore, MD USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Greater Baltimore Medical Center	Fertig, EJ (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA.	ejfertig@jhmi.edu		Fertig, Elana/0000-0003-3204-342X	NCI [CA1410503]; NLM [LM001100]; NIH/NIDCR [DE020324]; CCSG; Johns Hopkins University Head and Neck Cancer SPORE [5P50DE019032]; Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University; NATIONAL CANCER INSTITUTE [K25CA141053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011000] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CCSG; Johns Hopkins University Head and Neck Cancer SPORE; Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The following funding sources supported this research: NCI (CA1410503), NLM (LM001100), NIH/NIDCR (DE020324), CCSG, the Johns Hopkins University Head and Neck Cancer SPORE (5P50DE019032). This project was also partly funded by Flight Attendant Medical Research Institute Center of Excellence at Johns Hopkins University. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2002, CANCER RES, V62, P7350; Bidaut G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-99; Bidaut G, 2004, BIOINFORMATICS, V20, P2869, DOI 10.1093/bioinformatics/bth307; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Chung CH, 2011, J CLIN ONCOL, V29, P1326, DOI 10.1200/JCO.2010.32.3295; Dimitrova K, 2013, ONKOLOGIE, V36, P279, DOI 10.1159/000350322; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Fertig EJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-160; Fertig EJ, 2010, BIOINFORMATICS, V26, P2792, DOI 10.1093/bioinformatics/btq503; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Kossenkov A, 2003, BIOINFORMATICS, V19, P675, DOI 10.1093/bioinformatics/btg056; Kossenkov AV, 2009, METHOD ENZYMOL, V467, P59, DOI 10.1016/S0076-6879(09)67003-8; Langendijk JA, 2010, ANN ONCOL, V21, P1931, DOI 10.1093/annonc/mdq439; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Ochs M F, 2003, ANAL GENE EXPRESSION, P388; Ochs MF, 2004, ANN NY ACAD SCI, V1020, P212, DOI 10.1196/annals.1310.018; Ochs Michael F, 2012, IEEE Symp Comput Intell Bioinforma Comput Biol Proc, V2012, P387, DOI 10.1109/CIBCB.2012.6217256; Ochs MF, 2009, CANCER RES, V69, P9125, DOI 10.1158/0008-5472.CAN-09-1709; Pishvaian Michael J., 2007, Cancer Biomarkers, V3, P263; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rickman DS, 2008, ONCOGENE, V27, P6607, DOI 10.1038/onc.2008.251; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sartor MA, 2011, EPIGENETICS-US, V6, P777, DOI 10.4161/epi.6.6.16216; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei Y, 2011, CANC OUTLIER GENE PR; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322	49	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78127	10.1371/journal.pone.0078127	http://dx.doi.org/10.1371/journal.pone.0078127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223768	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400035
J	Gusberti, M; Gessler, C; Broggini, GAL				Gusberti, Michele; Gessler, Cesare; Broggini, Giovanni A. L.			RNA-Seq Analysis Reveals Candidate Genes for Ontogenic Resistance in Malus-Venturia Pathosystem	PLOS ONE			English	Article							AGE-RELATED RESISTANCE; APPLE SCAB; DISEASE MANAGEMENT; ALPHA-TOCOPHEROL; DEFENSE RESPONSE; FUNGAL PATHOGEN; TOBACCO-LEAVES; FRUIT-QUALITY; PLANT DEFENSE; GRAPE BERRIES	Ontogenic scab resistance in apple leaves and fruits is a horizontal resistance against the plant pathogen Venturia inaequalis and is expressed as a decrease in disease symptoms and incidence with the ageing of the leaves. Several studies at the biochemical level tried to unveil the nature of this resistance; however, no conclusive results were reported. We decided therefore to investigate the genetic origin of this phenomenon by performing a full quantitative transcriptome sequencing and comparison of young (susceptible) and old (ontogenic resistant) leaves, infected or not with the pathogen. Two time points at 72 and 96 hours post-inoculation were chosen for RNA sampling and sequencing. Comparison between the different conditions (young and old leaves, inoculated or not) should allow the identification of differentially expressed genes which may represent different induced plant defence reactions leading to ontogenic resistance or may be the cause of a constitutive (uninoculated with the pathogen) shift toward resistance in old leaves. Differentially expressed genes were then characterised for their function by homology to A. thaliana and other plant genes, particularly looking for genes involved in pathways already suspected of appertaining to ontogenic resistance in apple or other hosts, or to plant defence mechanisms in general. In this work, five candidate genes putatively involved in the ontogenic resistance of apple were identified: a gene encoding an "enhanced disease susceptibility 1 protein'' was found to be down-regulated in both uninoculated and inoculated old leaves at 96 hpi, while the other four genes encoding proteins (metallothionein3-like protein, lipoxygenase, lipid transfer protein, and a peroxidase 3) were found to be constitutively up-regulated in inoculated and uninoculated old leaves. The modulation of the five candidate genes has been validated using the real-time quantitative PCR. Thus, ontogenic resistance may be the result of the corresponding up-and down-regulation of these genes.	[Gusberti, Michele; Gessler, Cesare; Broggini, Giovanni A. L.] Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gessler, C (corresponding author), Swiss Fed Inst Technol, Plant Pathol Grp, Inst Integrat Biol Zurich, Zurich, Switzerland.	cesare.gessler@usys.ethz.ch	Broggini, Giovanni/N-7034-2016	Broggini, Giovanni/0000-0002-1011-4090	EnviroChange project of the Autonomous Province of Trento, Italy	EnviroChange project of the Autonomous Province of Trento, Italy	Research was partially financed by the EnviroChange project (http://www.envirochange.eu) of the Autonomous Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Aderhold R, 1900, LANDW JB, V29, P541; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BARNES EH, 1961, CAN J MICROBIOL, V7, P525, DOI 10.1139/m61-062; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Bringe K, 2006, PHYTOCHEMISTRY, V67, P161, DOI 10.1016/j.phytochem.2005.10.018; Bus VGM, 2005, NEW PHYTOL, V166, P1035, DOI 10.1111/j.1469-8137.2005.01395.x; Bus VGM, 2005, MOL BREEDING, V15, P103, DOI 10.1007/s11032-004-3609-5; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Choi HW, 2012, PLANTA, V235, P1369, DOI 10.1007/s00425-011-1580-z; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Collakova E, 2003, PLANT PHYSIOL, V133, P930, DOI 10.1104/pp.103.026138; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Degenhardt J, 2005, MOL GENET GENOMICS, V273, P326, DOI 10.1007/s00438-005-1136-7; Degenhardt J, 2006, THESIS GW LEIBNIZ U; Erdin N, 2006, GENOME, V49, P1238, DOI 10.1139/G06-096; Ficke A, 2003, PHYTOPATHOLOGY, V93, P556, DOI 10.1094/PHYTO.2003.93.5.556; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; FOTHERGILL PG, 1955, J GEN MICROBIOL, V12, P387, DOI 10.1099/00221287-12-3-387; Galiana E, 1997, PLANT PHYSIOL, V115, P1557, DOI 10.1104/pp.115.4.1557; Garcia-Ruiz H, 2001, ANN APPL BIOL, V139, P307, DOI 10.1111/j.1744-7348.2001.tb00144.x; GESSLER C, 1984, PHYTOPATHOL Z, V110, P119; Gessler C, 2012, TREES-STRUCT FUNCT, P1, DOI [10.1007/s00468-011-0618-y, DOI 10.1007/S00468-011-0618-Y:1-14]; Goethe R, 1887, GARTENFLORA, V36, P293; Gusberti M, 2012, PLANT DIS, V96, P1791, DOI 10.1094/PDIS-12-11-1058-RE; Gygax M, 2004, THEOR APPL GENET, V109, P1702, DOI 10.1007/s00122-004-1803-9; Hao W, 2011, PLANT DIS PESTS, V2, P9; Holb IJ, 2003, J PHYTOPATHOL, V151, P335, DOI 10.1046/j.1439-0434.2003.00728.x; Hrazdina G, 2003, PHYTOCHEMISTRY, V64, P485, DOI 10.1016/S0031-9422(03)00150-X; Hugot K, 1999, PLANT J, V20, P163, DOI 10.1046/j.1365-313x.1999.00587.x; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Juen YC, 1991, J PHYTOPATHOL BERL, V131, P40; Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z; Keitt G. W., 1926, RES B, V73, P104; Kennelly MM, 2005, PHYTOPATHOLOGY, V95, P1445, DOI 10.1094/PHYTO-95-1445; Kirubakaran SI, 2008, PLANT PHYSIOL BIOCH, V46, P918, DOI 10.1016/j.plaphy.2008.05.007; Kollar A, 1996, EUR J PLANT PATHOL, V102, P773, DOI 10.1007/BF01877152; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; LEBEN C, 1948, AM J BOT, V35, P337, DOI 10.2307/2437747; Li B, 2002, J PHYTOPATHOL, V150, P687, DOI 10.1046/j.1439-0434.2002.00824.x; Lindhagen M, 1996, SCI HORTIC-AMSTERDAM, V67, P65, DOI 10.1016/S0304-4238(96)00944-2; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; MacHardy WE, 2001, PLANT DIS, V85, P1036, DOI 10.1094/PDIS.2001.85.10.1036; MacHardy WE, 1996, APPLE SCAB BIOL EPID, P117; MACHARDY WE, 1996, APPLE SCAB BIOL EPID, P104; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noga G, 2000, ACTA HORTIC, P111, DOI 10.17660/ActaHortic.2000.527.12; Pagliarani G, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-51; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Patocchi A, 2005, GENOME, V48, P630, DOI 10.1139/G05-036; Patocchi A, 2004, THEOR APPL GENET, V109, P1087, DOI 10.1007/s00122-004-1723-8; PERIES OS, 1962, ANN APPL BIOL, V50, P225, DOI 10.1111/j.1744-7348.1962.tb06005.x; Petre B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044408; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; RAA J, 1968, Netherlands Journal of Plant Pathology, V74, P37, DOI 10.1007/BF01977511; RAA J, 1968, PHYTOCHEMISTRY, V7, P721, DOI 10.1016/S0031-9422(00)84824-4; Rence I, 1998, PNAS, V95, P6554; RISE M, 1989, PLANT PHYSIOL, V89, P1028, DOI 10.1104/pp.89.4.1028; Sabri N, 1997, PHYSIOL MOL PLANT P, V50, P321, DOI 10.1006/pmpp.1997.0095; Savory EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035796; Schmitz M, 1998, ACTA HORTIC, P89, DOI 10.17660/ActaHortic.1998.466.15; Spann TM, 2010, MINERAL NUTR CONTRIB; Stadler B, 1988, THESIS SWISS FEDERAL, V8685, P72; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Treutter D, 2001, PLANT GROWTH REGUL, V34, P71, DOI 10.1023/A:1013378702940; VALSANGIACOMO C, 1988, PHYTOPATHOLOGY, V78, P1066, DOI 10.1094/Phyto-78-1066; VAUGHN SF, 1993, J CHEM ECOL, V19, P2337, DOI 10.1007/BF00979668; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wanderley-Nogueira A. C., 2012, FUNCT PLANT SCI BIOT, V6, P134; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; WYATT SE, 1991, PHYSIOL MOL PLANT P, V39, P433, DOI 10.1016/0885-5765(91)90009-7; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245	83	40	41	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78457	10.1371/journal.pone.0078457	http://dx.doi.org/10.1371/journal.pone.0078457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223809	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400063
J	Kolahdooz, F; Barr, A; Roache, C; Sheehy, T; Corriveau, A; Sharma, S				Kolahdooz, Fariba; Barr, Alison; Roache, Cindy; Sheehy, Tony; Corriveau, Andre; Sharma, Sangita			Dietary Adequacy of Vitamin D and Calcium among Inuit and Inuvialuit Women of Child-Bearing Age in Arctic Canada: A Growing Concern	PLOS ONE			English	Article							D DEFICIENCY; LIFE-STYLE; NUTRITION TRANSITION; RAPID TRANSITION; FOOD INSECURITY; POPULATION; HEALTH; RISK; DISEASE; DETERMINANTS	Background: Arctic populations are at an increased risk of vitamin D inadequacy due to geographic latitude and a nutrition transition. This study aimed to assess the adequacy of dietary vitamin D and calcium among women of child-bearing age in Arctic Canada. Methods: This study collected data from 203 randomly selected women of child-bearing age (19-44 years) in Nunavut and the Northwest Territories of Arctic Canada. Cross-sectional surveys using a validated quantitative food frequency questionnaire were analysed to determine the dietary adequacy of vitamin D and calcium and summarize the top foods contributing to vitamin D and calcium intake among traditional food eaters (TFE) and non-traditional food eaters (NTFE). Results: The response rate was between 69-93% depending on the community sampled. Mean BMIs for both TFE and NTFE were above the normal range. Traditional food eaters had a significantly higher median vitamin D intake compared with non-traditional eaters (TFE = 5.13 +/- 5.34 mu g/day; NTFE = 3.5 +/- 3.22 mu g/day, p = 0.004). The majority of women (87%) were below the Estimated Average Requirements (EAR) for vitamin D. Despite adequate median daily calcium intake in both TFE (1299 +/- 798 mg/day) and NTFE (992 +/- 704 mg/day; p = 0.0005), 27% of the study population fell below the EAR for calcium. Dairy products contributed the most to intake of vitamin D (TFE = 30.7%; NTFE = 39.1%) and calcium (TFE = 25.5%; NTFE = 34.5%). Conclusions: Inadequate dietary vitamin D intake is evident among Inuit and Inuvialuit women of child-bearing age in Arctic Canada. Promotion of nutrient-rich sources of traditional foods, supplementation protocols and/or expanded food fortification should be considered to address this nutrition concern.	[Kolahdooz, Fariba; Barr, Alison; Roache, Cindy; Sharma, Sangita] Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada; [Sheehy, Tony] Natl Univ Ireland Univ Coll Cork, Dept Food & Nutr Sci, Cork, Ireland; [Corriveau, Andre] Govt Northwest Territories, Dept Hlth & Social Serv, Yellowknife, NT, Canada	University of Alberta; University College Cork	Sharma, S (corresponding author), Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada.	gita.sharma@ualberta.ca		Sharma, Sangita/0000-0002-4995-0010	American Diabetes Association Clinical Research award [1-08-CR-57]	American Diabetes Association Clinical Research award(American Diabetes Association)	This project was supported by the American Diabetes Association Clinical Research award 1-08-CR-57. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2010, J NUTR, V140, P1864, DOI 10.3945/jn.109.117770; Berti PR, 2008, INT J CIRCUMPOL HEAL, V67, P349, DOI 10.3402/ijch.v67i4.18340; Brenner DR, 2011, CLIN INVEST MED, V34, pE377; Buppasiri P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007079.pub2; Calvo MS, 2004, AM J CLIN NUTR, V80, p1710S, DOI 10.1093/ajcn/80.6.1710S; Cashman KD, 2012, SCAND J CLIN LAB INV, V72, P136, DOI 10.3109/00365513.2012.682891; Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006; Erber E, 2010, J HUM NUTR DIET, V23, P35, DOI 10.1111/j.1365-277X.2010.01098.x; Gittelsohn J, 2006, J NUTR EDUC BEHAV, V38, P163, DOI 10.1016/j.jneb.2005.12.004; Glendenning P, 2012, PATHOLOGY, V44, P160, DOI 10.1097/PAT.0b013e32834e8df6; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Hopping BN, 2010, J HUM NUTR DIET, V23, P27, DOI 10.1111/j.1365-277X.2010.01099.x; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Lewis S, 2010, MOL NUTR FOOD RES, V54, P1092, DOI 10.1002/mnfr.201000044; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Mason RS, 2011, EUR J CLIN NUTR, V65, P986, DOI 10.1038/ejcn.2011.105; McGrath J, 2001, MED HYPOTHESES, V56, P367, DOI 10.1054/mehy.2000.1226; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Morabia A, 2000, EUR J CLIN NUTR, V54, P684, DOI 10.1038/sj.ejcn.1601074; Norman AW, 2011, PUBLIC HEALTH NUTR, V14, P744, DOI 10.1017/S1368980011000280; Nwosu BU, 2011, J PEDIATR ENDOCR MET, V24, P619, DOI 10.1515/JPEM.2011.300; Pakseresht M, 2010, J HUM NUTR DIET, V23, P67, DOI 10.1111/j.1365-277X.2010.01104.x; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Sharma S, 2010, J HUM NUTR DIET, V23, P5, DOI 10.1111/j.1365-277X.2010.01093.x; Sharma S, 2011, NUTR REV, V69, P468, DOI 10.1111/j.1753-4887.2011.00406.x; Sharma S, 2010, BRIT J NUTR, V103, P749, DOI 10.1017/S0007114509992224; Sharma S, 2009, CAN J PUBLIC HEALTH, V100, P442, DOI 10.1007/BF03404341; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Vanga SR, 2010, AM J CARDIOL, V106, P798, DOI 10.1016/j.amjcard.2010.04.042; Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Weiler HA, 2007, J NUTR, V137, P461, DOI 10.1093/jn/137.2.461; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199	36	14	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78987	10.1371/journal.pone.0078987	http://dx.doi.org/10.1371/journal.pone.0078987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223871	gold, Green Published			2022-12-25	WOS:000326503400095
J	Marciniak, A; Selck, C; Friedrich, B; Speier, S				Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan			Mouse Pancreas Tissue Slice Culture Facilitates Long-Term Studies of Exocrine and Endocrine Cell Physiology in situ	PLOS ONE			English	Article							ACINAR-CELLS; ANIMAL-MODELS; AMYLASE RELEASE; DUCT CELLS; BETA-CELLS; INSULIN; ACTIVATION; ADULT; HETEROGENEITY; EXPRESSION	Studies on pancreatic cell physiology rely on the investigation of exocrine and endocrine cells in vitro. Particularly, in the case of the exocrine tissue these studies have suffered from a reduced functional viability of acinar cells in culture. As a result not only investigations on dispersed acinar cells and isolated acini were limited in their potential, but also prolonged studies on pancreatic exocrine and endocrine cells in an intact pancreatic tissue environment were unfeasible. To overcome these limitations, we aimed to establish a pancreas tissue slice culture platform to allow long-term studies on exocrine and endocrine cells in the intact pancreatic environment. Mouse pancreas tissue slice morphology was assessed to determine optimal long-term culture settings for intact pancreatic tissue. Utilizing optimized culture conditions, cell specificity and function of exocrine acinar cells and endocrine beta cells were characterized over a culture period of 7 days. We found pancreas tissue slices cultured under optimized conditions to have intact tissue specific morphology for the entire culture period. Amylase positive intact acini were present at all time points of culture and acinar cells displayed a typical strong cell polarity. Amylase release from pancreas tissue slices decreased during culture, but maintained the characteristic bell-shaped dose-response curve to increasing caerulein concentrations and a ca. 4-fold maximal over basal release. Additionally, endocrine beta cell viability and function was well preserved until the end of the observation period. Our results show that the tissue slice culture platform provides unprecedented maintenance of pancreatic tissue specific morphology and function over a culture period for at least 4 days and in part even up to 1 week. This analytical advancement now allows mid-to long-term studies on the cell biology of pancreatic disorder pathogenesis and therapy in an intact surrounding in situ.	[Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan] Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan] German Ctr Diabet Res DZD, Paul Langerhans Inst Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Speier, S (corresponding author), Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.	stephan.speier@crt-dresden.de	Speier, Stephan/E-8525-2010	Speier, Stephan/0000-0002-4561-7085; Selck, Claudia/0000-0002-1831-752X	Emmy Noether Program of the German Research Foundation (DFG); CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence; German Ministry for Education and Research (BMBF); Network of Competence for Diabetes (KKNDm)	Emmy Noether Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Network of Competence for Diabetes (KKNDm)	This work was supported with funds from the Emmy Noether Program of the German Research Foundation (DFG; www.dfg.de), the CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence (www.crt-dresden.de), and the German Ministry for Education and Research (BMBF; www.bmbf.de) to the German Centre for Diabetes Research (DZD-e.v.) and the Network of Competence for Diabetes (KKNDm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; AMSTERDA.A, 1974, J CELL BIOL, V63, P1037, DOI 10.1083/jcb.63.3.1037; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bhagat L, 2000, J CLIN INVEST, V106, P81, DOI 10.1172/JCI8706; Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; BOSCO D, 1994, J CELL PHYSIOL, V160, P378, DOI 10.1002/jcp.1041600219; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chen N, 2011, J CLIN GASTROENTEROL, V45, P850, DOI 10.1097/MCG.0b013e31822a2ae5; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Esni F, 2005, METH MOLEC MED, V103, P259; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huang YC, 2013, DIABETES, V62, P519, DOI 10.2337/db11-0786; Huang YC, 2011, J PHYSIOL-LONDON, V589, P395, DOI 10.1113/jphysiol.2010.200345; Irving-Rodgers HF, 2012, CELL TRANSPLANT; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; LOGSDON CD, 1986, AM J PHYSIOL, V250, pG440, DOI 10.1152/ajpgi.1986.250.4.G440; LOGSDON CD, 1983, AM J PHYSIOL, V244, pG675, DOI 10.1152/ajpgi.1983.244.6.G675; MALHOTRA R, 1992, REGUL PEPTIDES, V41, P149, DOI 10.1016/0167-0115(92)90044-U; Meisterfeld R, 2008, EXP CLIN ENDOCR DIAB, V116, pS7, DOI 10.1055/s-2008-1080918; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; OLIVER C, 1980, IN VITRO CELL DEV B, V16, P297; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; PIPELEERS D, 1982, P NATL ACAD SCI-BIOL, V79, P7322, DOI 10.1073/pnas.79.23.7322; do Amaral ASR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055288; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Speier S, 2005, MOL CELL ENDOCRINOL, V230, P51, DOI 10.1016/j.mce.2004.11.002; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; Tatarkiewicz K, 2010, AM J PHYSIOL-ENDOC M, V299, pE1076, DOI 10.1152/ajpendo.00479.2010; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	36	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78706	10.1371/journal.pone.0078706	http://dx.doi.org/10.1371/journal.pone.0078706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223842	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400084
J	Bontell, I; Sarker, MS; Rahman, M; Afrad, MH; Sonnerborg, A; Azim, T				Bontell, Irene; Sarker, Md. Safiullah; Rahman, Mustafizur; Afrad, Mokibul Hassan; Sonnerborg, Anders; Azim, Tasnim			Molecular Dating of HIV-1 Subtype C from Bangladesh	PLOS ONE			English	Article							PREVALENCE; SYPHILIS	Bangladesh has an overall low HIV prevalence of <0.1% in the general population and <1% among key affected populations, but it is one of few Asian countries that has yet to reverse the epidemic. In order to do this, it is important to understand the transmission dynamics in this country. The aim of this study was to investigate the phylogenetic relationships of HIV-1 subtype C strains from Bangladesh and related strains from other countries, and thereby clarify when and from where subtype C was introduced in the country and how it subsequently spread within Bangladesh. The phylogenetic analysis included 118 Bangladeshi gag sequences and 128 sequences from other countries and was performed using the BEAST package. Our analysis revealed that the vast majority of Bangladeshi sequences (97/118, 82%) fall into a large regional cluster of samples from Bangladesh, India, China and Myanmar, which dates back to the early 1960's. Following its establishment in the region, this strain has entered Bangladesh multiple times from around 1975 and onwards, but extensive in-country transmission could only be detected among drug users and not through sexual transmission. In addition, there have been multiple (at least ten) introductions of subtype C to Bangladesh from outside this region, but no extensive spread could be detected for any of these. Since many HIV-infections remain undetected while asymptomatic, the true extent of the transmission of each strain remains unknown, especially among hard to reach groups such as clients of sex workers and returning migrants with families.	[Bontell, Irene; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Solna, Sweden; [Sarker, Md. Safiullah; Rahman, Mustafizur; Afrad, Mokibul Hassan; Azim, Tasnim] Icddr B, Virol Lab, Dhaka, Bangladesh; [Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Microbiol, Solna, Sweden	Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet	Bontell, I (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Solna, Sweden.	irene.bontell@ki.se	rahman, mustafizur/E-6918-2010; Afrad, Mokibul/C-4149-2011; Sarker, Safiullah/E-7587-2010; Sönnerborg, Anders/W-2011-2019; Sarker, Safiullah/N-3014-2019; Afrad, Mokibul Hassan/H-6904-2012	Afrad, Mokibul/0000-0002-9627-7877; Sönnerborg, Anders/0000-0001-8928-3374; Afrad, Mokibul Hassan/0000-0002-9627-7877; Sarker, Md. Safiullah/0000-0002-5320-1274	UNAIDS; Department of International Development (DfID), UK [BGH 9800 552/582/002]; Govt. of Bangladesh/DfID/IDA [3441 BD]; World Health Organization (WHO) [SE/01/257693]; Family Health International; icddr, b; EU [246599]; Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh; Canadian International Development Agency CIDA), Government of Japa; Government of the Netherlands; Swedish International Development Cooperative Agency (SIDA); Swiss Development Cooperation (SDC); Department for International Development, UK (DFID)	UNAIDS; Department of International Development (DfID), UK; Govt. of Bangladesh/DfID/IDA; World Health Organization (WHO)(World Health Organization); Family Health International; icddr, b; EU(European Commission); Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh; Canadian International Development Agency CIDA), Government of Japa; Government of the Netherlands(Netherlands Government); Swedish International Development Cooperative Agency (SIDA); Swiss Development Cooperation (SDC); Department for International Development, UK (DFID)	This surveillance was conducted by icddr,b on behalf of the Govt. of Bangladesh, with support of grants from UNAIDS, from the Department of International Development (DfID), UK grant number BGH 9800 552/582/002 and Govt. of Bangladesh/DfID/IDA, credit number 3441 BD. The VCT Unit was supported by UNAIDS, Family Health International, and icddr, b. The HIV survey on tuberculosis patients was supported by World Health Organization (WHO), grant number SE/01/257693. The icddr, b acknowledges with gratitude the commitment of the different development partners to the Centre's research efforts. The icddr, b also gratefully acknowledges those donors who provide unrestricted support to the Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh, Canadian International Development Agency CIDA), Government of Japan, Government of the Netherlands, Swedish International Development Cooperative Agency (SIDA), Swiss Development Cooperation (SDC) and Department for International Development, UK (DFID). IB is thankful for funding from the EU FP7 program Marie Curie ERG (#246599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; [Anonymous], MOL EV PHYL EP; Azim T, 2000, AIDS, V14, P210, DOI 10.1097/00002030-200001280-00022; Badreddine S, 2007, AIDS RES HUM RETROV, V23, P667, DOI 10.1089/aid.2007.0185; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Foss AM, 2007, ADDICTION, V102, P114, DOI 10.1111/j.1360-0443.2006.01637.x; Ghys PD, 2001, AIDS, V15, pS91, DOI 10.1097/00002030-200100005-00012; Government of Bangladesh IEDCR and icddrb, 2011, AT HIV SER SURV 2011; Nepal B, 2007, J HEALTH POPUL NUTR, V25, P267; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rich JD, 1997, AIDS, V11, P703; Sarker MS, 2008, VIRUS RES, V135, P89, DOI 10.1016/j.virusres.2008.02.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNAIDS, 2012, LOB REP UNAIDS REP G; Zaidi A, 2004, 15 INT AIDS C BANGK	16	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79193	10.1371/journal.pone.0079193	http://dx.doi.org/10.1371/journal.pone.0079193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223905	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300065
J	Fusinatto, LA; Alexandrino, J; Haddad, CFB; Brunes, TO; Rocha, CFD; Sequeira, F				Fusinatto, Luciana A.; Alexandrino, Joao; Haddad, Celio F. B.; Brunes, Tuliana O.; Rocha, Carlos F. D.; Sequeira, Fernando			Cryptic Genetic Diversity Is Paramount in Small-Bodied Amphibians of the Genus Euparkerella (Anura: Craugastoridae) Endemic to the Brazilian Atlantic Forest	PLOS ONE			English	Article							BAYESIAN SPECIES DELIMITATION; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; RELATIVE RATES; BODY-SIZE; FROGS; INFERENCE; TREES; DIVERSIFICATION; UNDERESTIMATION	Morphological similarity associated to restricted distributions and low dispersal abilities make the direct developing "Terrarana" frogs of the genus Euparkerella a good model for examining diversification processes. We here infer phylogenetic relationships within the genus Euparkerella, using DNA sequence data from one mitochondrial and four nuclear genes coupled with traditional Bayesian phylogenetic reconstruction approaches and more recent coalescent methods of species tree inference. We also used Bayesian clustering analysis and a recent Bayesian coalescent-based approach specifically to infer species delimitation. The analysis of 39 individuals from the four known Euparkerella species uncovered high levels of genetic diversity, especially within the two previously morphologically-defined E. cochranae and E. brasiliensis. Within these species, the gene trees at five independent loci and trees from combined data (concatenated dataset and the species tree) uncovered six deeply diverged and geographically coherent evolutionary units, which may have diverged between the Miocene and the Pleistocene. These six units were also uncovered in the Bayesian clustering analysis, and supported by the Bayesian coalescent-based species delimitation (BPP), and Genealogical Sorting Index (GSI), providing thus strong evidence for underestimation of the current levels of diversity within Euparkerella. The cryptic diversity now uncovered opens new opportunities to examine the origins and maintenance of microendemism in the context of spatial heterogeneity and/or human induced fragmentation of the highly threatened Brazilian Atlantic forest hotspot.	[Fusinatto, Luciana A.; Rocha, Carlos F. D.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Alexandrino, Joao] UNIFESP Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Alexandrino, Joao; Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Brunes, Tuliana O.; Sequeira, Fernando] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO UP, Vairao, Portugal; [Brunes, Tuliana O.] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade do Porto; Universidade do Porto	Fusinatto, LA (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil.	lufusinatto@gmail.com	Brunes, Tuliana O./L-7916-2013; Sequeira, Fernando/C-3119-2012; Haddad, Célio F. B./C-4267-2012; Rocha, Carlos Frederico D/A-6225-2013; Alexandrino, João/B-7603-2012; Fusinatto, Luciana A/K-3517-2013	Brunes, Tuliana O./0000-0002-3665-030X; Sequeira, Fernando/0000-0003-0740-7981; Haddad, Célio F. B./0000-0002-7044-5764; Rocha, Carlos Frederico D/0000-0003-3000-1242; Alexandrino, João/0000-0003-2427-0964; Fusinatto, Luciana A/0000-0001-9354-1698	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [proc. 0378/11-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 142823/2009-0]; "Productivity in Research" grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2005/52727-5, proc. 2006/56938-3]; CFBH [proc. 2008/50928-1]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [proc. E-26/102.404765-2012]; Fundacao Para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/87721/2012];  [304791/2010-5];  [472287/2012-5]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Productivity in Research" grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CFBH; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This research was founded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) as sandwich doctorate grant to LAF (proc. 0378/11-9); by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) as doctorate grant (proc. 142823/2009-0) to LAF, "Productivity in Research" grant to CFBH, and grants (proc. 304791/2010-5 and 472287/2012-5) to CFDR; by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as grants to JA (proc. 2005/52727-5 and proc. 2006/56938-3) and CFBH (proc. 2008/50928-1); by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) as grants to CFDR (proc. E-26/102.404765-2012); and by Fundacao Para a Ciencia e a Tecnologia (FCT) as postdoctoral grant to FS (SFRH/BPD/87721/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alonso R, 2012, J BIOGEOGR, V39, P434, DOI 10.1111/j.1365-2699.2011.02594.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Brumfield RT, 2008, SYST BIOL, V57, P719, DOI 10.1080/10635150802422290; Brunes TO, 2010, MOL PHYLOGENET EVOL, V57, P1120, DOI 10.1016/j.ympev.2010.08.026; Campbell JA, 2000, HERPETOL MONOGR, V14, P186, DOI 10.2307/1467048; Canedo C, 2012, MOL PHYLOGENET EVOL, V65, P610, DOI 10.1016/j.ympev.2012.07.016; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2013, BIOL J LINN SOC, V109, P737, DOI 10.1111/bij.12093; CHERRY LM, 1977, AM ZOOL, V17, P910; Chiari Y, 2004, MOL ECOL, V13, P3763, DOI 10.1111/j.1365-294X.2004.02367.x; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DELARIVA I, 2007, HERPETOL MONOGR, P241, DOI DOI 10.1655/07-011.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SV, 2000, EVOLUTION, V54, P1839; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2013, AMPHIBIAN SPECIES WO; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Glaw F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031314; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HANKEN J, 1994, COPEIA, P573; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hanken J, 2001, HERPETOLOGICA, V57, P515; Harvey MB, 2013, ZOOTAXA, V3635, P1, DOI 10.11646/zootaxa.3635.1.1; Hedges S.B., 1989, P305; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Heinicke MP, 2009, ZOOTAXA, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; IZECKSOHN E, 1988, Revista Brasileira de Biologia, V48, P59; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kieswetter CM, 2013, MOL PHYLOGENET EVOL, V69, P417, DOI 10.1016/j.ympev.2013.08.007; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2010, MOL PHYLOGENET EVOL, V54, P162, DOI 10.1016/j.ympev.2009.09.006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lynch JD, 1976, SPECIES GROUPS S AM, P1; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pasachnik SA, 2010, CONSERV GENET, V11, P1767, DOI 10.1007/s10592-010-0070-3; Pritchard JK, 2000, GENETICS, V155, P945; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2007, TRACER V1 4; Rittmeyer EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029797; Rodriguez A, 2010, MOL PHYLOGENET EVOL, V54, P179, DOI 10.1016/j.ympev.2009.08.023; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sakalidis ML, 2011, MOL PHYLOGENET EVOL, V60, P333, DOI 10.1016/j.ympev.2011.04.026; Savage J.M., 1987, FIELDIANA ZOOL, V33, P1; Sequeira F, 2006, AMPHIBIA-REPTILIA, V27, P409, DOI 10.1163/156853806778190114; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stuart BL, 2008, MOL PHYLOGENET EVOL, V46, P49, DOI 10.1016/j.ympev.2007.09.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome MTC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-242; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Veloso HP, 1991, CLASSIFICACAO VEGETA; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; Wiens JJ, 2008, BIOSCIENCE, V58, P297, DOI 10.1641/B580405; Wiens JJ, 2010, BIOL J LINN SOC, V99, P445, DOI 10.1111/j.1095-8312.2009.01342.x; Wilson E. O., 2003, FUTURE LIFE; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	83	28	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79504	10.1371/journal.pone.0079504	http://dx.doi.org/10.1371/journal.pone.0079504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223956	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300087
J	Hazra, S; Stepps, V; Bhatwadekar, AD; Caballero, S; Boulton, ME; Higgins, PJ; Nikonova, EV; Pepine, CJ; Thut, C; Finney, EM; Stone, DJ; Bartelmez, SH; Grant, MB				Hazra, Sugata; Stepps, Valerie; Bhatwadekar, Ashay D.; Caballero, Sergio; Boulton, Michael E.; Higgins, Paul J.; Nikonova, Elena V.; Pepine, Carl J.; Thut, Catherine; Finney, Eva M.; Stone, David J.; Bartelmez, Stephen H.; Grant, Maria B.			Enhancing the Function of CD34(+) Cells by Targeting Plasminogen Activator Inhibitor-1	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; MOBILIZATION; EXPRESSION; TYPE-1; GENE; OVEREXPRESSION; ANGIOGENESIS; RECEPTOR; STEM	Previously, we showed that transient inhibition of TGF-beta 1 resulted in correction of key aspects of diabetes-induced CD34(+) cell dysfunction. In this report, we examine the effect of transient inhibition of plasminogen activator inhibitor-1 (PAI-1), a major gene target of TGF-beta 1 activation. Using gene array studies, we examined CD34(+) cells isolated from a cohort of longstanding diabetic individuals, free of microvascular complications despite suboptimal glycemic control, and found that the cells exhibited reduced transcripts of both TGF-beta 1 and PAI-1 compared to age, sex, and degree of glycemic control-matched diabetic individuals with microvascular complications. CD34(+) cells from diabetic subjects with microvascular complications consistently exhibited higher PAI-1 mRNA than age-matched non-diabetic controls. TGF-beta 1 phosphorodiamidate morpholino oligo (PMO) reduced PAI-1 mRNA in diabetic (p<0.01) and non-diabetic (p=0.05) CD34(+) cells. To reduce PAI-1 in human CD34(+) cells, we utilized PAI-1 siRNA, lentivirus expressing PAI-1 shRNA or PAI-1 PMO. We found that inhibition of PAI-1 promoted CD34(+) cell proliferation and migration in vitro, likely through increased PI3(K) activity and increased cGMP production. Using a retinal ischemia reperfusion injury model in mice, we observed that recruitment of diabetic CD34(+) cells to injured acellular retinal capillaries was greater after PAI-1-PMO treatment compared with control PMO-treated cells. Targeting PAI-1 offers a promising therapeutic strategy for restoring vascular reparative function in defective diabetic progenitors.	[Hazra, Sugata; Bhatwadekar, Ashay D.; Caballero, Sergio; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Stepps, Valerie; Bartelmez, Stephen H.] BetaStem Therapeut Inc, San Francisco, CA USA; [Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Higgins, Paul J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Nikonova, Elena V.; Thut, Catherine; Finney, Eva M.; Stone, David J.] Merck & Co Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA; [Pepine, Carl J.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Albany Medical College; Merck & Company; State University System of Florida; University of Florida	Grant, MB (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	grantma@ufl.edu	Bhatwadekar, Ashay/AAT-5933-2020	Pepine, Carl/0000-0002-6011-681X	NIH [EY007739, EY012601, U01 HL087366, DK090730, 1R43HL093955, DK48708]; AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA); Center for Cancer Research, National Cancer Institute, NIH; FWR [GM057242]; NATIONAL EYE INSTITUTE [R01EY007739, R01EY012601, R44EY028070, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366, R43HL093955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048708, R01DK090730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FWR; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants EY007739, EY012601, U01 HL087366, DK090730 to MBG, 1R43HL093955 to SB and MBG, DK48708 (SB), and AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA). This research was also supported in part by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, NIH and GM057242 and GM057242 (FWR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Basu A, 2009, INVEST OPHTH VIS SCI, V50, P4974, DOI 10.1167/iovs.09-3619; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Calzi SL, 2008, DIABETES, V57, P2488, DOI 10.2337/db08-0381; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Das A, 1999, INVEST OPHTH VIS SCI, V40, P809; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Glowinska B, 2003, ATHEROSCLEROSIS, V167, P275, DOI 10.1016/S0021-9150(03)00003-0; Grant MB, 1996, EXP EYE RES, V63, P233, DOI 10.1006/exer.1996.0112; Grant MB, 2000, INVEST OPHTH VIS SCI, V41, P2296; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarajapu YPR, 2013, DIABETES, V62, P1258, DOI 10.2337/db12-0808; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; JARAJAPU YP, 2010, FASEB J, V24, P571; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Nagi DK, 1997, DIABETES CARE, V20, P1304, DOI 10.2337/diacare.20.8.1304; Pandolfi A, 2001, ACTA DIABETOL, V38, P71, DOI 10.1007/s005920170016; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; Rufaihah AJ, 2010, REGEN MED, V5, P231, DOI 10.2217/RME.09.83; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Uchiyama T, 2000, ARTERIOSCL THROM VAS, V20, P1155, DOI 10.1161/01.ATV.20.4.1155; Xiang GS, 2004, J EXP MED, V200, P1657, DOI 10.1084/jem.20040221; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79067	10.1371/journal.pone.0079067	http://dx.doi.org/10.1371/journal.pone.0079067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223881	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300051
J	DeBerge, MP; Ely, KH; Cheng, GS; Enelow, RI				DeBerge, Matthew P.; Ely, Kenneth H.; Cheng, Guang-Shing; Enelow, Richard I.			ADAM17-Mediated Processing of TNF-alpha Expressed by Antiviral Effector CD8(+) T Cells Is Required for Severe T-Cell-Mediated Lung Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFLUENZA-VIRUS INFECTION; INFLAMMATORY RESPONSE; CONVERTING-ENZYME; VIRAL CLEARANCE; INNATE IMMUNE; CUTTING EDGE; IN-VIVO; MICE; IMMUNOPATHOLOGY	Influenza infection in humans evokes a potent CD8(+) T-cell response, which is important for clearance of the virus but may also exacerbate pulmonary pathology. We have previously shown in mice that CD8(+) T-cell expression of TNF-alpha is required for severe and lethal lung injury following recognition of an influenza antigen expressed by alveolar epithelial cells. Since TNF-alpha is first expressed as a transmembrane protein that is then proteolytically processed to release a soluble form, we sought to characterize the role of TNF-alpha processing in CD8(+) T-cell-mediated injury. In this study we observed that inhibition of ADAM17-mediated processing of TNF-alpha by CD8(+) T cells significantly attenuated the diffuse alveolar damage that occurs after T-cell transfer, resulting in enhanced survival. This was due in part to diminished chemokine expression, as TNF-alpha processing was required for lung epithelial cell expression of CXCL2 and the subsequent inflammatory infiltration. We confirmed the importance of CXCL2 expression in acute lung injury by transferring influenza-specific CD8(+) T cells into transgenic mice lacking CXCR2. These mice exhibited reduced airway infiltration, attenuated lung injury, and enhanced survival. Theses studies describe a critical role for TNF-alpha processing by CD8(+) T cells in the initiation and severity of acute lung injury, which may have important implications for limiting immunopathology during influenza infection and other human infectious or inflammatory diseases.	[DeBerge, Matthew P.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA; [Ely, Kenneth H.; Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Cheng, Guang-Shing] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Enelow, Richard I.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA	Dartmouth College; Dartmouth College; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Dartmouth College	DeBerge, MP (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA.	matthew.deberge@dartmouth.edu			Public Health Service [T32 A107363, T32HL007778, RO1AI 069360, U19AI 083024]; Ira Jerome Brody '44 Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363, U19AI083024, R01AI069360] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ira Jerome Brody '44 Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants T32 A107363 (MPD), T32HL007778 (GSC), RO1AI 069360 and U19AI 083024 (RIE). The authors gratefully acknowledge the generous support of the Ira Jerome Brody '44 Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2006, EUR J IMMUNOL, V36, P2768, DOI 10.1002/eji.200635921; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Enelow RI, 1998, J CLIN INVEST, V102, P1653, DOI 10.1172/JCI4174; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Liu AN, 1999, AM J RESP CELL MOL, V20, P849, DOI 10.1165/ajrcmb.20.5.3585; Liu J, 2005, AM J RESP CELL MOL, V33, P463, DOI 10.1165/rcmb.2005-0204OC; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ramana CV, 2006, J INTERF CYTOK RES, V26, P318, DOI 10.1089/jir.2006.26.318; Ramana CV, 2009, MOL IMMUNOL, V47, P623, DOI 10.1016/j.molimm.2009.09.001; Slifman NR, 2003, ARTHRITIS RHEUM, V48, P319, DOI 10.1002/art.10758; Small BA, 2001, J EXP MED, V194, P1835, DOI 10.1084/jem.194.12.1835; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wareing MD, 2007, VIRAL IMMUNOL, V20, P369, DOI 10.1089/vim.2006.0101; WELLS MA, 1981, J IMMUNOL, V126, P1036; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zhao MQ, 2000, J CLIN INVEST, V106, pR49, DOI 10.1172/JCI9786; Zhou J, 2008, J IMMUNOL, V180, P25, DOI 10.4049/jimmunol.180.1.25	39	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79340	10.1371/journal.pone.0079340	http://dx.doi.org/10.1371/journal.pone.0079340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223177	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200069
J	Hu, JZ; Nomura, Y; Bashir, A; Fernandez-Hernandez, H; Itzkowitz, S; Pei, ZH; Stone, J; Loudon, H; Peter, I				Hu, Jianzhong; Nomura, Yoko; Bashir, Ali; Fernandez-Hernandez, Heriberto; Itzkowitz, Steven; Pei, Zhiheng; Stone, Joanne; Loudon, Holly; Peter, Inga			Diversified Microbiota of Meconium Is Affected by Maternal Diabetes Status	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TOLERANCE TEST VALUE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; AMNIOTIC-FLUID; PRETERM LABOR; PREGNANCY; INFANTS; NEWBORNS; BACTERIA	Objectives: This study was aimed to assess the diversity of the meconium microbiome and determine if the bacterial community is affected by maternal diabetes status. Methods: The first intestinal discharge (meconium) was collected from 23 newborns stratified by maternal diabetes status: 4 mothers had pre-gestational type 2 diabetes mellitus (DM) including one mother with dizygotic twins, 5 developed gestational diabetes mellitus (GDM) and 13 had no diabetes. The meconium microbiome was profiled using multi-barcode 16S rRNA sequencing followed by taxonomic assignment and diversity analysis. Results: All meconium samples were not sterile and contained diversified microbiota. Compared with adult feces, the meconium showed a lower species diversity, higher sample-to-sample variation, and enrichment of Proteobacteria and reduction of Bacteroidetes. Among the meconium samples, the taxonomy analyses suggested that the overall bacterial content significantly differed by maternal diabetes status, with the microbiome of the DM group showing higher alpha-diversity than that of no-diabetes or GDM groups. No global difference was found between babies delivered vaginally versus via Cesarean-section. Regression analysis showed that the most robust predictor for the meconium microbiota composition was the maternal diabetes status that preceded pregnancy. Specifically, Bacteroidetes (phyla) and Parabacteriodes (genus) were enriched in the meconium in the DM group compared to the no-diabetes group. Conclusions: Our study provides evidence that meconium contains diversified microbiota and is not affected by the mode of delivery. It also suggests that the meconium microbiome of infants born to mothers with DM is enriched for the same bacterial taxa as those reported in the fecal microbiome of adult DM patients.	[Hu, Jianzhong; Bashir, Ali; Fernandez-Hernandez, Heriberto; Peter, Inga] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Nomura, Yoko] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Itzkowitz, Steven] Icahn Sch Med Mt Sinai, Dept Med, Div Gastroenterol, New York, NY USA; [Pei, Zhiheng] Dept Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, NYU Langone Med Ctr, Dept Pathol, New York, NY USA; [Stone, Joanne; Loudon, Holly] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai	Hu, JZ (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA.	jianzhong.hu@mssm.edu	Hu, Jianzhong/ABE-4311-2020; Hu, Jianzhong/P-6305-2014	Hu, Jianzhong/0000-0001-8546-5111; Hu, Jianzhong/0000-0001-8546-5111; Pei, Zhiheng/0000-0001-8570-6747	CCFA Career Development Award; The Chemotherapy Foundation; National Cancer Institute [UH3CA140233, R01CA159036, R03CA159414]; National Institute of Mental Health [K01MH080062-03]; NATIONAL CANCER INSTITUTE [R01CA159036, R03CA159414, UH3CA140233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080062] Funding Source: NIH RePORTER	CCFA Career Development Award; The Chemotherapy Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by a CCFA Career Development Award (JH) and grants from The Chemotherapy Foundation (SI), the National Cancer Institute UH3CA140233, R01CA159036, and R03CA159414 (ZP) and the National Institute of Mental Health K01MH080062-03 (YN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bell R, 2012, DIABETOLOGIA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Buchanan TA, 1995, PREGNANCY PREEXISTIN, P719; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Guarino A, 2012, J MATERN-FETAL NEO M, V25, P63, DOI 10.3109/14767058.2012.663231; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; LANGER O, 1987, AM J OBSTET GYNECOL, V157, P758, DOI 10.1016/S0002-9378(87)80045-5; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LINDSAY MK, 1989, OBSTET GYNECOL, V73, P103; Ma YF, 2009, APPL ENVIRON MICROB, V75, P6812, DOI 10.1128/AEM.00933-09; Madan JC, 2012, ARCH DIS CHILD FETAL; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Oh KJ, 2010, J PERINAT MED, V38, P261, DOI [10.1515/JPM.2010.040, 10.1515/jpm.2010.040]; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oksanen J, 2007, MULTIVARIATE ANAL EC; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yap GC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-193	48	142	161	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78257	10.1371/journal.pone.0078257	http://dx.doi.org/10.1371/journal.pone.0078257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223144	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200036
J	Sriyani, KA; Wasalathanthri, S; Hettiarachchi, P; Prathapan, S				Sriyani, Kumarasinghe A.; Wasalathanthri, Sudharshani; Hettiarachchi, Priyadharshika; Prathapan, Shamini			Predictors of Diabetic Foot and Leg Ulcers in a Developing Country with a Rapid Increase in the Prevalence of Diabetes Mellitus	PLOS ONE			English	Article							SEMMES-WEINSTEIN MONOFILAMENT; DIFFERENT SCREENING-TESTS; RISK-FACTORS; PERIPHERAL NEUROPATHY; CARE; ULCERATION; POLYNEUROPATHY; ASSOCIATION; COMMUNITY; PEOPLE	Objective: To identify the socio demographic, life style and foot examination related predictors of diabetic foot and leg ulcers with a view to develop a screening tool appropriate for the use in an outpatient setting. Research design and methods: This cross sectional study included type 2 diabetes mellitus (DM) patients; 88 subjects with leg and foot ulcers and 80 non ulcer controls. Socio demographic data and life style factors were documented. Foot was examined for skin changes and structural abnormalities. Distal peripheral neuropathy was assessed by pressure sense, vibration sense and joint position sense. Multivariate analysis by logistic regression was used to determine the significant predictors in screening for foot ulcers. Results: Education of grade 6 and below (OR - 1.41, 95% CI; 1.03 - 4.68), low income (OR -23.3, 95% CI; 1.5 - 34.0), impaired vibration sense (OR - 24.79, 95% CI; 9.3 - 66.2), abnormal monofilament test on first (OR - 1.69, 95% CI; 1.36 - 16.6), third (OR - 3.4, 95% CI; 1.1 - 10.6) and fifth (OR - 1.8, 95% CI; 1.61-12.6) toes are found to be predictors of increased risk whereas incidental diagnosis of DM (OR - 0.03, 95% CI; 0.003 - 0.28), wearing covered shoes (OR - 0.003, 95% CI; 0.00 - 0.28), presence of normal skin color (OR - 0.01, 95% CI; 0.001 - 0.14) and normal monofilament test on first metatarsal head (OR - 0.10, 95% CI; 0.00 - 0.67) are protective factors for ulcers. Conclusions: Ten independent risk and protective factors identified in this study are proposed as a simple screening tool to predict the risk of developing leg and foot ulcers in patients with DM.	[Sriyani, Kumarasinghe A.] Open Univ Sri Lanka, Dept Hlth Sci, Nawala, Sri Lanka; [Wasalathanthri, Sudharshani] Univ Colombo, Dept Physiol, Colombo, Sri Lanka; [Hettiarachchi, Priyadharshika] Univ Sri Jayewardenepura, Dept Physiol, Nugegoda, Sri Lanka; [Prathapan, Shamini] Univ Sri Jayewardenepura, Dept Community Med, Nugegoda, Sri Lanka	Open University Sri Lanka; University of Colombo; University Sri Jayewardenepura; University Sri Jayewardenepura	Wasalathanthri, S (corresponding author), Univ Colombo, Dept Physiol, Colombo, Sri Lanka.	sudharshaniw@gmail.com			University of Sri Jayewardenepura [ASP/06/RE/MED/2012/35]	University of Sri Jayewardenepura	The study was funded by the University of Sri Jayewardenepura - Grant number ASP/06/RE/MED/2012/35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Al-Geffari M, 2012, INT J HEALTH SCI-IJH, V6, P127, DOI 10.12816/0005988; Al-Maskari F, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-59; ALGEFFARI M, 2012, INT J HLTH SCI, V609, P109; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Asad Ambreen, 2009, JPMA Journal of the Pakistan Medical Association, V59, P594; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Boulton AJ, 2005, DIABETES VOICE, V50, P5; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Chalya Phillipo L, 2011, BMC Res Notes, V4, P365, DOI 10.1186/1756-0500-4-365; Dutta A, 2005, INT J DIABETES DEV C, V25, P30, DOI [10.4103/0973-3930.26756, DOI 10.4103/0973-3930.26756]; Fernando D. J. S., 1996, Ceylon Medical Journal, V41, P96; Forouzandeh F, 2005, ACTA NEUROL SCAND, V112, P409, DOI 10.1111/j.1600-0404.2005.00494.x; Franse LV, 2000, DIABETIC MED, V17, P105, DOI 10.1046/j.1464-5491.2000.00223.x; Giacomozzi C, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-99; IKEM RT, 2009, MERA DIABETES INT, P15; Illangasekera U, 2004, J R SOC PROMO HEALTH, V124, P92, DOI 10.1177/146642400412400214; Jayasinghe Saroj A, 2007, Rural Remote Health, V7, P692; Katulanda P, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-21; Kerr M., 2012, FOOT CARE PEOPLE DIA; Kiani J, 2013, ARCH IRAN MED, V16, P17, DOI 013161/AIM.006; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Lee SY, 2003, J KOREAN MED SCI, V18, P103; Margolis DJ, 2011, DATA POINTS PUBLICAT; Mayfield JA, 1998, DIABETES CARE, V21, P2161, DOI 10.2337/diacare.21.12.2161; McGill M, 1999, DIABETES CARE, V22, P598, DOI 10.2337/diacare.22.4.598; Meijer JWG, 2005, DIABETES CARE, V28, P2201, DOI 10.2337/diacare.28.9.2201; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Murray HJ, 1996, DIABETIC MED, V13, P979, DOI 10.1002/(SICI)1096-9136(199611)13:11<979::AID-DIA267>3.3.CO;2-1; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; RIAZ M, 2012, DIABETES CARE; Shin JB, 2000, J KOREAN MED SCI, V15, P78, DOI 10.3346/jkms.2000.15.1.78; Tan LS, 2010, DIABETES RES CLIN PR, V90, P1, DOI 10.1016/j.diabres.2010.06.021; Weerasuriya N, 1998, QJM-INT J MED, V91, P439, DOI 10.1093/qjmed/91.6.439; Wijewardene K., 2005, Ceylon Medical Journal, V50, P62; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557	39	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80856	10.1371/journal.pone.0080856	http://dx.doi.org/10.1371/journal.pone.0080856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223231	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200124
J	Yu, F; Du, F; Wang, YZ; Huang, SP; Miao, RD; Major, AS; Murphy, EA; Fu, MG; Fan, DP				Yu, Fang; Du, Fen; Wang, Yuzhen; Huang, Shengping; Miao, Ruidong; Major, Amy S.; Murphy, E. Angela; Fu, Mingui; Fan, Daping			Bone Marrow Deficiency of MCPIP1 Results in Severe Multi-Organ Inflammation but Diminishes Atherogenesis in Hyperlipidemic Mice	PLOS ONE			English	Article							T-CELLS; ATHEROSCLEROSIS; IMMUNITY; ACTIVATION; ANTIBODIES; RATIONALE; PROTEIN; PLAQUE; RNASE	Objective: MCPIP1 is a newly identified protein that profoundly impacts immunity and inflammation. We aim to test if MCPIP1 deficiency in hematopoietic cells results in systemic inflammation and accelerates atherogenesis in mice. Approach and Results: After lethally irradiated, LDLR-/- mice were transplanted with bone marrow cells from either wildtype or MCPIP1(-/-) mice. These chimeric mice were fed a western-type diet for 7 weeks. We found that bone marrow MCPIP1(-/-) mice displayed a phenotype similar to that of whole body MCPIP1(-/-) mice, with severe systemic and multi-organ inflammation. However, MCPIP1(-/-) bone marrow recipients developed >10-fold less atherosclerotic lesions in the proximal aorta than WT bone marrow recipients, and essentially no lesions in en face aorta. The diminishment in atherosclerosis in bone marrow MCPIP1(-/-) mice may be partially attributed to the slight decrease in their plasma lipids. Flow cytometric analysis of splenocytes showed that bone marrow MCPIP1(-/-) mice contained reduced numbers of T cells and B cells, but increased numbers of regulatory T cells, Th17 cells, CD11b+/Gr1+ cells and CD11b+/Ly6C(low) cells. This overall anti-atherogenic leukocyte profile may also contribute to the reduced atherogenesis. We also examined the cholesterol efflux capability of MCPIP1 deficient macrophages, and found that MCPIP1 deficiency increased cholesterol efflux to apoAI and HDL, due to increased protein levels of ABCA1 and ABCG1. Conclusions: Hematopoietic deficiency of MCPIP1 resulted in severe systemic and multi-organ inflammation but paradoxically diminished atherogenesis in mice. The reduced atheroegensis may be explained by the decreased plasma cholesterol levels, the anti-atherogenic leukocyte profile, as well as enhanced cholesterol efflux capability. This study suggests that, while atherosclerosis is a chronic inflammatory disease, the mechanisms underlying atherogenesis-associated inflammation in arterial wall versus the inflammation in solid organs may be substantially different.	[Yu, Fang] Fourth Mil Med Univ, Dept Nutr & Food Hyg, Xian 710032, Shaanxi, Peoples R China; [Yu, Fang; Du, Fen; Wang, Yuzhen; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Du, Fen] Wuhan Univ, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan 430072, Peoples R China; [Huang, Shengping; Miao, Ruidong; Fu, Mingui] Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA; [Huang, Shengping; Miao, Ruidong; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Major, Amy S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA; [Murphy, E. Angela] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	Air Force Military Medical University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wuhan University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	daping.fan@uscmed.sc.edu			American Heart Association [SDG4110005]; National Institutes of Health [HL106325, HL116626, R01HL088364, R01HL089310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089310, R01HL116626, R01HL088364, R21HL106325] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Heart Association (SDG4110005 to DF), and National Institutes of Health (HL106325 and HL116626 to DF; R01HL088364 and R01HL089310 to ASM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Binder CJ, 2008, CURR DRUG TARGETS, V9, P190; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Fazio S, 2002, J LIPID RES, V43, P1602, DOI 10.1194/jlr.M200108-JLR200; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Kong YY, 2013, CURR MED CHEM, V20, P1437, DOI 10.2174/0929867311320110006; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Suthers B, 2012, VACCINE, V30, P3983, DOI 10.1016/j.vaccine.2012.03.084; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taleb S, 2008, J INTERN MED, V263, P489, DOI 10.1111/j.1365-2796.2008.01944.x; Xu JW, 2012, PROTEIN CELL, V3, P903, DOI 10.1007/s13238-012-2075-9; Yu F, 2013, MOL CANCER RES, V11, P923, DOI 10.1158/1541-7786.MCR-12-0686; Zhou XH, 2000, CIRCULATION, V102, P2919	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80089	10.1371/journal.pone.0080089	http://dx.doi.org/10.1371/journal.pone.0080089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223214	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200107
J	Jang, TH; Park, JH; Park, HH				Jang, Tae-ho; Park, Jin Hee; Park, Hyun Ho			Novel Disulfide Bond-Mediated Dimerization of the CARD Domain Was Revealed by the Crystal Structure of CARMA1 CARD	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE-RECRUITMENT DOMAIN; CHROMOSOMAL TRANSLOCATION; ANTIGEN RECEPTOR; ACTIVATION; BCL10; DEATH; MALT1; PHOSPHORYLATION; SUPERFAMILY	CARMA1, BCL10 and MALT1 form a large molecular complex known as the CARMA1 signalosome during lymphocyte activation. Lymphocyte activation via the CARMA1 signalosome is critical to immune response and linked to many immune diseases. Despite the important role of the CARMA1 signalosome during lymphocyte activation and proliferation, limited structural information is available. Here, we report the dimeric structure of CARMA1 CARD at a resolution of 3.2 angstrom. Interestingly, although CARMA1 CARD has a canonical six helical-bundles structural fold similar to other CARDs, CARMA1 CARD shows the first homo-dimeric structure of CARD formed by a disulfide bond and reveals a possible biologically important homo-dimerization mechanism.	[Park, Hyun Ho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea	Yeungnam University; Yeungnam University	Park, HH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [2013-009083]	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (2013-009083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dzivenu OK, 2004, PROTEIN EXPRES PURIF, V38, P1, DOI 10.1016/j.pep.2004.07.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Handa N, 2006, ACTA CRYSTALLOGR D, V62, P1502, DOI 10.1107/S0907444906039369; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Jang TH, 2011, J BIOTECHNOL, V151, P335, DOI 10.1016/j.jbiotec.2011.01.003; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042775; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park JH, 2013, ACTA CRYSTALLOGR F, V69, P435, DOI 10.1107/S1744309113005642; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen LJ, 2003, BLOOD, V102, P1553, DOI 10.1182/blood-2003-04-1286; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WEGENER E, 2007, SCI STKE, pE21; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79778	10.1371/journal.pone.0079778	http://dx.doi.org/10.1371/journal.pone.0079778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224005	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400086
J	Li, P; Shen, Y; Sui, X; Chen, CM; Feng, TY; Li, H; Holroyd, C				Li, Peng; Shen, Yue; Sui, Xue; Chen, Changming; Feng, Tingyong; Li, Hong; Holroyd, Clay			The Neural Basis of Responsibility Attribution in Decision-Making	PLOS ONE			English	Article							RIGHT TEMPOROPARIETAL JUNCTION; DIFFUSION; REWARD; REGRET; BRAIN; MINDS; PSYCHOLOGY; MOTIVATION; FEEDBACK; SYSTEM	Social responsibility links personal behavior with societal expectations and plays a key role in affecting an agent's emotional state following a decision. However, the neural basis of responsibility attribution remains unclear. In two previous event-related brain potential (ERP) studies we found that personal responsibility modulated outcome evaluation in gambling tasks. Here we conducted a functional magnetic resonance imaging (fMRI) study to identify particular brain regions that mediate responsibility attribution. In a context involving team cooperation, participants completed a task with their teammates and on each trial received feedback about team success and individual success sequentially. We found that brain activity differed between conditions involving team success vs. team failure. Further, different brain regions were associated with reinforcement of behavior by social praise vs. monetary reward. Specifically, right temporoparietal junction (RTPJ) was associated with social pride whereas dorsal striatum and dorsal anterior cingulate cortex (ACC) were related to reinforcement of behaviors leading to personal gain. The present study provides evidence that the RTPJ is an important region for determining whether self-generated behaviors are deserving of praise in a social context.	[Li, Peng; Sui, Xue; Li, Hong] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Peoples R China; [Li, Peng; Sui, Xue; Li, Hong] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Shen, Yue] Dalian Univ Technol, Inst Neuroinformat, Dalian, Peoples R China; [Chen, Changming; Feng, Tingyong] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Holroyd, Clay] Univ Victoria, Dept Psychol, Victoria, BC, Canada	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Southwest University - China; University of Victoria	Li, H (corresponding author), Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Peoples R China.	lihong@lnnu.edu.cn; holroyd@uvic.ca		Holroyd, Clay/0000-0003-3084-8574; Feng, Tingyong/0000-0001-9278-6474	National Natural Science Foundation of China [NSFC31300872, 81171289]; Special Public-welfare Project of the Ministry of Health [201002003]; Natural Sciences and Engineering Research Council Discovery Grant [RGPIN 312409-05]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Public-welfare Project of the Ministry of Health; Natural Sciences and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); MOE (Ministry of Education in China) Project of Humanities and Social Sciences	This research was supported by the National Natural Science Foundation of China (NSFC31300872, 81171289), and the Special Public-welfare Project of the Ministry of Health (201002003) and a Natural Sciences and Engineering Research Council Discovery Grant (RGPIN 312409-05), and MOE (Ministry of Education in China) Project of Humanities and Social Sciences (13YJC190013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 1971, ATTRIBUTION PERCEIV; Blackwood NJ, 2003, NEUROIMAGE, V20, P1076, DOI 10.1016/S1053-8119(03)00331-8; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Forsyth DR, 2002, PERS SOC PSYCHOL B, V28, P54, DOI 10.1177/0146167202281005; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; JONES EE, 1976, AM SCI, V64, P300; KASARI C, 1993, J CHILD PSYCHOL PSYC, V34, P353, DOI 10.1111/j.1469-7610.1993.tb00997.x; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Li P, 2011, PSYCHOPHYSIOLOGY, V48, P1129, DOI 10.1111/j.1469-8986.2011.01182.x; Li P, 2010, NEUROIMAGE, V52, P1727, DOI 10.1016/j.neuroimage.2010.04.275; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; MYNATT C, 1975, J PERS SOC PSYCHOL, V32, P1111; Nicolle A, 2011, SOC NEUROSCI-UK, V6, P178, DOI 10.1080/17470919.2010.506128; Nicolle A, 2011, J COGNITIVE NEUROSCI, V23, P845, DOI 10.1162/jocn.2010.21510; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schlenker BR, 2009, PERSONALITY, IDENTITY, AND CHARACTER: EXPLORATIONS IN MORAL PSYCHOLOGY, P316, DOI 10.1017/CBO9780511627125.015; SCHLENKER BR, 1994, PSYCHOL REV, V101, P632, DOI 10.1037/0033-295X.101.4.632; SILLARS AL, 1980, COMMUN MONOGR, V47, P180, DOI 10.1080/03637758009376031; Talairach J., 1988, COPLANAR STEREOTAXIC; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; Yates D., 1999, PRACTICE STAT; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2011, SOC NEUROSCI-UK, V6, P302, DOI 10.1080/17470919.2010.529712; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107; Zeelenberg M, 2000, ACTA PSYCHOL, V104, P303, DOI 10.1016/S0001-6918(00)00034-2	47	6	7	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80389	10.1371/journal.pone.0080389	http://dx.doi.org/10.1371/journal.pone.0080389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224053	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400119
J	Pipoly, I; Bokony, V; Seress, G; Szabo, K; Liker, A				Pipoly, Ivett; Bokony, Veronika; Seress, Gabor; Szabo, Krisztian; Liker, Andras			Effects of Extreme Weather on Reproductive Success in a Temperate-Breeding Songbird	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION DECLINES; INCUBATION PERIOD; HOUSE SPARROWS; SEX; SIZE; EVOLUTIONARY; RESPONSES; FOOD; PATTERNS	The frequency of extreme meteorological events such as heat waves and rainstorms is predicted to increase with climate change. However, there is still little information about how extreme weather influences reproduction in animals. It may not only affect breeding success but might also alter offspring sex ratio if males and females are differentially sensitive to meteorological conditions during development. We investigated the relationship between meteorological conditions and reproductive success over 6 years in a house sparrow population in central Europe. We found that hatching success increased with the number of extremely hot days (daily maximum >31 degrees C) and decreased with the number of extremely cold days (<16 degrees C) during incubation, although the latter effect held only for clutches with relatively short incubation periods. Fledging success was unrelated to weather variables. However, the frequency of extremely hot days had a negative effect on fledglings' body mass and tarsus length, although both of these traits were positively related to average temperature. Additionally, fledglings' body mass increased with the length of period without rainfall before fledging. Male to female ratio among fledglings did not differ from 1: 1 and did not vary with weather variables. The magnitude of the effects of extreme meteorological events was usually small, although in some cases comparable to those of ecologically relevant predictors of reproductive success. Our results indicate that meteorological conditions have complex effects on breeding success, as the effects of extreme weather can differ between different aspects of reproduction and also from the effects of overall meteorological conditions.	[Pipoly, Ivett; Bokony, Veronika; Seress, Gabor; Liker, Andras] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Szabo, Krisztian] Szent Istvan Univ, Dept Ecol, Budapest, Hungary	University of Pannonia; Hungarian University of Agriculture & Life Sciences	Pipoly, I (corresponding author), Univ Pannonia, Dept Limnol, Veszprem, Hungary.	pipoly.ivett@gmail.com	Bókony, Veronika/AAH-7679-2020	Bókony, Veronika/0000-0002-2136-5346; Pipoly, Ivett/0000-0002-4541-6056; Seress, Gabor/0000-0001-9828-4934	Hungarian Scientific Research Fund [OTKA K72827, K84132]; European Union; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0064]; Marie Curie Intra-European Fellowship	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); Marie Curie Intra-European Fellowship(European Commission)	The study was supported by Hungarian Scientific Research Fund (OTKA K72827, K84132) and was realized with the support of the European Union, with the co-funding of the European Social Fund (TAMOP-4.2.2.A-11/1/KONV-2012-0064). A. L. was supported by a Marie Curie Intra-European Fellowship during a part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Arbuckle J, 2011, IBM SPSS AMOS 20 USE; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brzek P, 2009, J EXP BIOL, V212, P1284, DOI 10.1242/jeb.023911; Chalfoun AD, 2007, ANIM BEHAV, V73, P579, DOI 10.1016/j.anbehav.2006.09.010; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Crick QP, 2006, ACTA ZOOL SINICA, V52, P154; Csorgo Tibor, 2009, Termeszetvedelmi Kozlemenyek, V15, P1; Dawson RD, 2008, CAN J ZOOL, V86, P843, DOI 10.1139/Z08-065; Deeming DC, 2008, J THERM BIOL, V33, P345, DOI 10.1016/j.jtherbio.2008.05.002; Deschenes O, 2007, XTREME WEA EVENTS MO, P1; Dijkstra C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1393, DOI 10.1007/s00265-010-0954-8; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Elkins N., 2004, WEATHER BIRD BEHAV; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hegyi G, 2013, OECOLOGIA, V172, P279, DOI 10.1007/s00442-012-2487-5; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hoi H, 2003, FOLIA ZOOL, V52, P299; Holm E., 1973, Ecology, V54, P45; Hungarian, 2013, MET SERV; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Kovacs S, 2011, J ORNITHOL, V152, P365, DOI 10.1007/s10336-010-0596-7; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Ligon RA, 2010, ANIM BEHAV, V79, P727, DOI 10.1016/j.anbehav.2009.12.028; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; McDonald PG, 2004, J ANIM ECOL, V73, P683; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Mock DW, 2010, WILSON J ORNITHOL, V122, P207, DOI 10.1676/09-206.1; Moller AP, 2011, CURR ZOOL, V57, P351, DOI 10.1093/czoolo/57.3.351; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MURPHY MT, 1985, ECOLOGY, V66, P162, DOI 10.2307/1941316; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Pipoly I, 2011, ALLATTANI KOZLEMENYE, V96, P97; R Core Team, 2021, R LANG ENV STAT COMP; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, BEHAV ECOL SOCIOBIOL, V51, P255, DOI 10.1007/S00265-001-0435-1; Ringsby TH, 1998, J AVIAN BIOL, V29, P241, DOI 10.2307/3677106; Rosivall B, 2010, BEHAV ECOL SOCIOBIOL, V64, P1555, DOI 10.1007/s00265-010-0969-1; Salido L, 2012, ECOGRAPHY, V35, P604, DOI 10.1111/j.1600-0587.2011.06797.x; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Strausberger BM, 1998, AUK, V115, P843, DOI 10.2307/4089503; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; Torres R, 2009, OECOLOGIA, V161, P447, DOI 10.1007/s00442-009-1378-x; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Vincze O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060998; Weatherhead PJ, 2005, OECOLOGIA, V144, P168, DOI 10.1007/s00442-005-0009-4; Westneat DF, 2002, CONDOR, V104, P598, DOI 10.1650/0010-5422(2002)104[0598:POSRVI]2.0.CO;2; Winkler DW, 2013, OECOLOGIA, V173, P129, DOI 10.1007/s00442-013-2605-z; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208	68	38	38	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80033	10.1371/journal.pone.0080033	http://dx.doi.org/10.1371/journal.pone.0080033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224033	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400105
J	Toki, W; Takahashi, Y; Togashi, K				Toki, Wataru; Takahashi, Yukiko; Togashi, Katsumi			Fungal Garden Making inside Bamboos by a Non-Social Fungus-Growing Beetle	PLOS ONE			English	Article							COLEOPTERA EROTYLIDAE LANGURIINAE; PHYLOGENETIC-RELATIONSHIPS; ASCOMYCETOUS YEASTS; AGRICULTURE; MUTUALISM; PICHIA; PLANTS; ANT	In fungus-growing mutualism, it is indispensable for host animals to establish gardens of the symbiotic fungus as rapidly as possible. How to establish fungal gardens has been well-documented in social fungus-farming insects, whereas poorly documented in non-social fungus-farming insects. Here we report that the non-social, fungus-growing lizard beetle Doubledaya bucculenta (Coleoptera: Erotylidae: Languriinae) transmits the symbiotic yeast Wickerhamomyces anomalus from the ovipositor-associated mycangium into bamboo internode cavities and disperses the yeast in the cavities to make gardens. Microbial isolation and cryo-scanning electron microscopy observation revealed that W. anomalus was constantly located on the posterior ends of eggs, where larvae came out, and on the inner openings of oviposition holes. Direct observation of oviposition behavior inside internodes revealed that the distal parts of ovipositors showed a peristaltic movement when they were in contact with the posterior ends of eggs. Rearing experiments showed that W. anomalus was spread much more rapidly and widely on culture media and internodes in the presence of the larvae than in the absence. These results suggest that the ovipositors play a critical role in vertical transmission of W. anomalus and that the larvae contribute actively to the garden establishment, providing a novel case of fungal garden founding in non-social insect-fungus mutualism.	[Toki, Wataru; Togashi, Katsumi] Univ Tokyo, Dept Forest Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan; [Takahashi, Yukiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Toki, W (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	watarutoki@08.alumni.u-tokyo.ac.jp	Takahashi, Yukiko/N-6194-2019; Takahashi, Yukiko/F-4561-2014	Takahashi, Yukiko/0000-0003-2810-316X; Takahashi, Yukiko/0000-0003-2810-316X	Sasakawa Scientific Research Grant from The Japan Science Society; Japan Society for the Promotion of Science KAKENHI Grant [25840153]	Sasakawa Scientific Research Grant from The Japan Science Society; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	WT was supported by the Sasakawa Scientific Research Grant from The Japan Science Society and the Japan Society for the Promotion of Science KAKENHI Grant (no. 25840153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATRA LEKH R., 1963, TRANS KANAS ACAD SCI, V66, P213, DOI 10.2307/3626562; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; BORKENT A, 1985, Symbiosis, V1, P185; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P909; COUTTS MP, 1969, FOREST SCI, V15, P412; Francke-Grosmann H., 1967, P141; Grebennikov VV, 2010, ENTOMOL SCI, V13, P81, DOI 10.1111/j.1479-8298.2009.00351.x; Groenewald M, 2010, INT J SYST EVOL MICR, V60, P2675, DOI 10.1099/ijs.0.018580-0; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; Hayashi N., 1974, NAT INSECT, V9, P17; Holldobler B., 1990, pi; Kobayashi C, 2008, EVOL ECOL, V22, P711, DOI 10.1007/s10682-007-9196-2; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2011, ANTON LEEUW INT J G, V99, P13, DOI 10.1007/s10482-010-9505-6; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Li XQ, 2012, J INSECT PHYSIOL, V58, P867, DOI 10.1016/j.jinsphys.2012.03.011; MORGAN FD, 1968, ANNU REV ENTOMOL, V13, P239, DOI 10.1146/annurev.en.13.010168.001323; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Norris D.M., 1979, P53; QUINLAN RJ, 1978, INSECT SOC, V25, P237, DOI 10.1007/BF02224744; R Development Core Team, 2012, R LANG ENV STAT COMP; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Schultz TR, 2005, ECOLOGICAL EVOLUTION, P149; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Swada Y., 1986, Science Bulletin of the Faculty of Agriculture Kyushu University, V40, P197; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanahashi M, 2010, NATURWISSENSCHAFTEN, V97, P311, DOI 10.1007/s00114-009-0643-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toki W., 2012, ELYTRA, V1, P253; Toki W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041893; Toki W, 2011, ZOOL SCI, V28, P348, DOI 10.2108/zsj.28.348; Toki Wataru, 2009, Biogeography, V11, P109; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	37	14	15	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79515	10.1371/journal.pone.0079515	http://dx.doi.org/10.1371/journal.pone.0079515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223958	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400069
J	Fang, Z; Lu, BX; Liu, MY; Zhang, MX; Yi, ZH; Wen, CP; Shi, TL				Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Zhang, Meixia; Yi, Zhenghui; Wen, Chengping; Shi, Tieliu			Evaluating the Pharmacological Mechanism of Chinese Medicine Si-Wu-Tang through Multi-Level Data Integration	PLOS ONE			English	Article							DREAM; GENE; CONSTITUENTS; POLYMORPHISM; ASSOCIATION; CYTOSCAPE; ABUNDANCE; NETWORKS; RECEPTOR; DENSITY	Si-Wu-Tang (SWT) is a Traditional Chinese Medicine (TCM) formula widely used for the treatments of gynecological diseases. To explore the pharmacological mechanism of SWT, we incorporated microarray data of SWT with our herbal target database TCMID to analyze the potential activity mechanism of SWT's herbal ingredients and targets. We detected 2,405 differentially expressed genes in the microarray data, 20 of 102 proteins targeted by SWT were encoded by these DEGs and can be targeted by 2 FDA-approved drugs and 39 experimental drugs. The results of pathway enrichment analysis of the 20 predicted targets were consistent with that of 2,405 differentially expressed genes, elaborating the potential pharmacological mechanisms of SWT. Further study from a perspective of protein-protein interaction (PPI) network showed that the predicted targets of SWT function cooperatively to perform their multi-target effects. We also constructed a network to combine herbs, ingredients, targets and drugs together which bridges the gap between SWT and conventional medicine, and used it to infer the potential mechanisms of herbal ingredients. Moreover, based on the hypothesis that the same or similar effects between different TCM formulae may result from targeting the same proteins, we analyzed 27 other TCM formulae which can also treat the gynecological diseases, the subsequent result provides additional insight to understand the potential mechanisms of SWT in treating amenorrhea. Our bioinformatics approach to detect the pharmacology of SWT may shed light on drug discovery for gynecological diseases and could be utilized to investigate other TCM formulae as well.	[Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Fang, Zhao; Lu, Bingxin; Liu, Mingyao; Shi, Tieliu] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Meixia] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Yi, Zhenghui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Schizophrenia Program, Shanghai 200030, Peoples R China; [Wen, Chengping] Zhejiang Univ Chinese Med, TCM Clin Basis Inst, Hangzhou, Zhejiang, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	East China Normal University; East China Normal University; Sichuan University; Shanghai Jiao Tong University; Zhejiang Chinese Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, TL (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	tieliushi01@gmail.com		LU, BINGXIN/0000-0002-0606-5150; Liu, Mingyao/0000-0001-7339-5048; chengping, Wen/0000-0001-9254-6235	National 973 Key Basic Research Program [2013CB127000, 2010CB945401]; National Natural Science Foundation of China [31240038, 31071162, 31000590]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National 973 Key Basic Research Program (Grant No. 2013CB127000 and 2010CB945401), the National Natural Science Foundation of China (Grant No. 31240038, 31071162, and 31000590), the Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen ZW, 2010, CHINA OCCUPATIONAL M, V37, P279; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Dai Y, 2002, BIOL PHARM BULL, V25, P1175, DOI 10.1248/bpb.25.1175; Debnath B, 2010, DRUG NEWS PERSPECT, V23, P670, DOI 10.1358/dnp.2010.23.10.1506088; Gao Y, 2003, TIANJIN J TRADIT CHI, V20, P47; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hinke V, 2001, CALCIFIED TISSUE INT, V69, P315, DOI 10.1007/s002230020024; [华永庆 HUA Yongqing], 2008, [中国药科大学学报, Journal of China Pharmaceutical University], V39, P72; Leng F, 2012, SCI CHINA LIFE SCI, V55, P1022; Li GB, 2012, SCI CHINA LIFE SCI, V55, P1022, DOI 10.1007/s11427-012-4397-5; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Li Y, 2008, NEUROCHEM RES, V33, P2070, DOI 10.1007/s11064-008-9686-9; Liang QD, 2006, BIOL PHARM BULL, V29, P1378, DOI 10.1248/bpb.29.1378; [刘立 Liu Li], 2012, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V28, P2; Liu L, 2012, BIOORG MED CHEM LETT, V22, P154, DOI 10.1016/j.bmcl.2011.11.041; Ma Zeng-chun, 2003, Zhongguo Zhongyao Zazhi, V28, P1050; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; Narvekar N, 2006, HUM REPROD, V21, P2312, DOI 10.1093/humrep/del182; OHTA H, 1993, PHARMACOL BIOCHEM BE, V45, P719, DOI 10.1016/0091-3057(93)90530-7; Os I, 2002, J INTERN MED, V251, P223, DOI 10.1046/j.1365-2796.2002.00950.x; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang L, 2011, INT J PHARMACEUT, V406, P99, DOI 10.1016/j.ijpharm.2011.01.001; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Watanabe Hiroshi, 1998, Journal of Toxicological Sciences, V23, P234; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao X., 2002, TRADITIONAL CHINESE, V13, P11; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Yan Shi-Kai, 2009, Chinese Journal of Natural Medicines, V7, P249, DOI 10.3724/SP.J.1009.2009.00249; Yeh LLL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000719; Yue G., 2010, WORLD SCI TECHNOLOGY, V12, P211; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747; Zhang CB, 2007, PHARM CLIN RES, V15, P459; Zhang HJ, 2004, J PHARMACEUT BIOMED, V34, P705, DOI 10.1016/S0731-7085(03)00650-2; Zhang T, 2000, J BEIJING U TRADIT C, V23, P36; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063	48	44	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e72334	10.1371/journal.pone.0072334	http://dx.doi.org/10.1371/journal.pone.0072334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223693	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400001
J	Huang, CH; Chen, CCV; Siow, TY; Hsu, SHS; Hsu, YH; Jaw, FS; Chang, C				Huang, Chien-Hsiang; Chen, Chiao-Chi V.; Siow, Tiing-Yee; Hsu, Sheng-Hsiou S.; Hsu, Yi-Hua; Jaw, Fu-Shan; Chang, Chen			High-Resolution Structural and Functional Assessments of Cerebral Microvasculature Using 3D Gas Delta R-2*-mMRA	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; BLOOD-VOLUME; IN-VIVO; VASCULAR ARCHITECTURE; CONTRAST AGENTS; DYNAMIC CHANGES; MR-ANGIOGRAPHY; VESSEL SIZE; BRAIN; ISCHEMIA	The ability to evaluate the cerebral microvascular structure and function is crucial for investigating pathological processes in brain disorders. Previous angiographic methods based on blood oxygen level-dependent (BOLD) contrast offer appropriate visualization of the cerebral vasculature, but these methods remain to be optimized in order to extract more comprehensive information. This study aimed to integrate the advantages of BOLD MRI in both structural and functional vascular assessments. The BOLD contrast was manipulated by a carbogen challenge, and signal changes in gradient-echo images were computed to generate Delta R-2* maps. Simultaneously, a functional index representing the regional cerebral blood volume was derived by normalizing the Delta R-2* values of a given region to those of vein-filled voxels of the sinus. This method is named 3D gas Delta R-2*-mMRA (microscopic MRA). The advantages of using 3D gas Delta R-2*-mMRA to observe the microvasculature include the ability to distinguish air-tissue interfaces, a high vessel-to-tissue contrast, and not being affected by damage to the blood-brain barrier. A stroke model was used to demonstrate the ability of 3D gas Delta R-2*-mMRA to provide information about poststroke revascularization at 3 days after reperfusion. However, this technique has some limitations that cannot be overcome and hence should be considered when it is applied, such as magnifying vessel sizes and predominantly revealing venous vessels.	[Huang, Chien-Hsiang; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Huang, Chien-Hsiang; Chen, Chiao-Chi V.; Siow, Tiing-Yee; Hsu, Sheng-Hsiou S.; Hsu, Yi-Hua; Chang, Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw; bmcchen@ibms.sinica.edu.tw	Chang, Chen/B-5079-2009		National Science Council, Taiwan [NSC102-2321-B-001-062]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (NSC102-2321-B-001-062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyagari AL, 2006, MAGN RESON MED, V55, P1023, DOI 10.1002/mrm.20846; Beckmann N, 1999, J MAGN RESON, V140, P442, DOI 10.1006/jmre.1999.1864; Blockley NP, 2012, NEUROIMAGE, V59, P3266, DOI 10.1016/j.neuroimage.2011.11.041; Bolan PJ, 2006, NEUROIMAGE, V32, P62, DOI 10.1016/j.neuroimage.2006.03.027; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Bulte D, 2007, J MAGN RESON IMAGING, V26, P894, DOI 10.1002/jmri.21096; Cai KJ, 2012, NMR BIOMED, V25, P1125, DOI 10.1002/nbm.2780; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Dashner RA, 2004, J MAGN RESON IMAGING, V19, P303, DOI 10.1002/jmri.20006; Du YP, 2008, MAGN RESON MED, V59, P954, DOI 10.1002/mrm.21581; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; HAACKE EM, 1994, NMR BIOMED, V7, P54, DOI 10.1002/nbm.1940070109; Jochimsen TH, 2010, NEUROIMAGE, V51, P765, DOI 10.1016/j.neuroimage.2010.02.037; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Lin CY, 2013, ANGIOGENESIS, V16, P785, DOI 10.1007/s10456-013-9355-8; Lin CY, 2009, NEUROIMAGE, V45, P824, DOI 10.1016/j.neuroimage.2008.12.030; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Losert C, 2002, MAGN RESON MED, V48, P271, DOI 10.1002/mrm.10215; Madore B, 2001, MAGN RESON MED, V45, P1103, DOI 10.1002/mrm.1145; Mendichovszky I, 2011, BRIT J RADIOL, V84, pS145, DOI 10.1259/bjr/82292521; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Pathak AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022643; Perles-Barbacaru AT, 2012, J CEREBR BLOOD F MET, V32, P489, DOI 10.1038/jcbfm.2011.151; Petrella JR, 2000, AM J ROENTGENOL, V175, P207, DOI 10.2214/ajr.175.1.1750207; PHELPS ME, 1979, J NUCL MED, V20, P328; Pipe J G, 2001, Top Magn Reson Imaging, V12, P163, DOI 10.1097/00002142-200106000-00003; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Quarles CC, 2012, MAGN RESON IMAGING, V30, P944, DOI 10.1016/j.mri.2012.03.008; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Reese T, 1999, NMR BIOMED, V12, P189, DOI 10.1002/(SICI)1099-1492(199906)12:4<189::AID-NBM557>3.0.CO;2-O; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Renkin EM, 1989, TXB PHYSL, P860; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Robinson SP, 2001, MAGN RESON IMAGING, V19, P161, DOI 10.1016/S0730-725X(01)00230-2; Ross J, 1991, CARDIOVASCULAR SYSTE; Santosh C, 2008, J CEREBR BLOOD F MET, V28, P1742, DOI 10.1038/jcbfm.2008.56; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; SCHMIDT B, 1989, THROMB HAEMOSTASIS, V62, P1074; Sedlacik J, 2008, NEUROIMAGE, V40, P11, DOI 10.1016/j.neuroimage.2007.11.046; Shen YJ, 2011, NEUROIMAGE, V55, P1063, DOI 10.1016/j.neuroimage.2010.12.084; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Vovenko E, 1999, PFLUG ARCH EUR J PHY, V437, P617, DOI 10.1007/s004240050825; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wise RG, 2010, MAGN RESON IMAGING, V28, P1129, DOI 10.1016/j.mri.2010.06.002; Xu YB, 2001, J MAGN RESON IMAGING, V14, P628, DOI 10.1002/jmri.1228; Xu YB, 2008, MAGN RESON IMAGING, V26, P1406, DOI 10.1016/j.mri.2008.04.008; Zerbi V, 2012, BRAIN STRUCT FUNCT	55	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78186	10.1371/journal.pone.0078186	http://dx.doi.org/10.1371/journal.pone.0078186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223773	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400037
J	Morohaku, K; Hoshino, Y; Sasada, H; Sato, E				Morohaku, Kanako; Hoshino, Yumi; Sasada, Hiroshi; Sato, Eimei			Incorporation of Phosphatase Inhibitor in Culture Prompts Growth Initiation of Isolated Non-Growing Oocytes	PLOS ONE			English	Article							STEM-CELL FACTOR; PHOSPHOINOSITIDE 3-KINASE PATHWAY; MOUSE OVARIAN-FOLLICLES; IN-VITRO DEVELOPMENT; PRIMORDIAL FOLLICLES; KIT-LIGAND; PREANTRAL FOLLICLES; FOLLICULAR DEVELOPMENT; TUMOR-SUPPRESSOR; ACTIVATION	In vitro folliculogenesis of primordial and early preantral follicles is necessary for increment of reproductive efficiency in domestic animals, humans and endangered species. Recent study in phosphatase and tensin homolog (Pten) - knockout mice has revealed that this phosphatase acts as an inhibitory factor in follicle activation of primordial pool with the resultant inhibition of oocyte growth. To test in vitro effect of a phosphatase inhibitor on growth initiation of isolated non-growing oocytes in neonatal ovaries, we applied a specific inhibitor (bpV (HOpic)) for PTEN in culturing system. Non-growing oocytes isolated from the ovaries of newborn BDF1 (C57BL/6 x DBA/2) pups were divided to four culture groups. Five days after culture, the oocytes in 14 mu mol/l bpV only, 14 mu mol/l bpV plus 100 ng/ml Kit Ligand (KL), and 100 ng/ml KL groups showed significantly (P<0.05) growth (19.3+/-0.55, 25.8+/-0.53 and 21.6+/-0.29 mu m, respectively) compared with that of the control (no additive) (16.9+/-0.53 mu m). In addition, western blotting in those groups showed enhanced expression of phosphorylated Akt. In conclusion, we clearly demonstrate that isolated non-growing oocytes develop in phosphatase inhibitor, especially to PTEN, incorporated culturing system, and show first as we know that oocytes with zona Pellucidae can be obtained in vitro from isolated non-growing oocytes.	[Morohaku, Kanako; Hoshino, Yumi; Sasada, Hiroshi; Sato, Eimei] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Morohaku, Kanako; Sasada, Hiroshi] Kitasato Univ, Sch Vet Med, Lab Anim Reprod, Towada, Aomori, Japan	Tohoku University; Kitasato University	Morohaku, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan.	km592@cornell.edu			JSPS Research Fellowships for Young Scientists [09J0513]	JSPS Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported from the JSPS Research Fellowships for Young Scientists (Grant number 09J0513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; BORUM K, 1967, EXP CELL RES, V45, P39, DOI 10.1016/0014-4827(67)90110-3; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cortvrindt R, 1996, HUM REPROD, V11, P2656; Cuncic C, 1999, BIOCHEM PHARMACOL, V58, P1859, DOI 10.1016/S0006-2952(99)00284-1; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fortune JE, 1998, THERIOGENOLOGY, V49, P441, DOI 10.1016/S0093-691X(97)00416-0; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; Hu Y, 2002, MOL REPROD DEV, V61, P549, DOI 10.1002/mrd.10107; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; KOHSAKA T, 1992, J REPROD FERTIL, V95, P397, DOI 10.1530/jrf.0.0950397; Kohsaka T, 2007, CELL TISSUE RES, V330, P303, DOI 10.1007/s00441-007-0492-5; Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415; Li J, 1998, CANCER RES, V58, P5667; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; LINTERNMOORE S, 1979, BIOL REPROD, V20, P773, DOI 10.1095/biolreprod20.4.773; Liu K, 2006, FRONT BIOSCI-LANDMRK, V11, P126, DOI 10.2741/1785; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; NEAL P, 1974, J REPROD FERTIL, V37, P399, DOI 10.1530/jrf.0.0370399; Nilsson EE, 2004, MOL CELL ENDOCRINOL, V214, P19, DOI 10.1016/j.mce.2003.12.001; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Smitz J, 1998, MATURITAS, V30, P171, DOI 10.1016/S0378-5122(98)00071-1; Smitz JEJ, 2002, REPRODUCTION, V123, P185, DOI 10.1530/rep.0.1230185; Stokoe D, 2005, P NATL ACAD SCI USA, V102, P2677, DOI 10.1073/pnas.0500089102; Stokoe David, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009361; TELFER E, 1990, J REPROD FERTIL, V89, P565	44	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77533	10.1371/journal.pone.0077533	http://dx.doi.org/10.1371/journal.pone.0077533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223714	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400010
J	Rosolowski, M; Lauter, J; Abramov, D; Drexler, HG; Hummel, M; Klapper, W; MacLeod, RAF; Pellissery, S; Horn, F; Siebert, R; Loeffler, M				Rosolowski, Maciej; Laeuter, Juergen; Abramov, Dmitriy; Drexler, Hans G.; Hummel, Michael; Klapper, Wolfram; MacLeod, Roderick A. F.; Pellissery, Shoji; Horn, Friedemann; Siebert, Reiner; Loeffler, Markus			Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							GENE-EXPRESSION; BURKITT-LYMPHOMA; SOMATIC MUTATIONS; C-MYC; SIGNATURES; DIAGNOSIS; SURVIVAL; SUBTYPES; TARGETS; GENOME	Based on the assumption that molecular mechanisms involved in cancerogenesis are characterized by groups of coordinately expressed genes, we developed and validated a novel method for analyzing transcriptional data called Correlated Gene Set Analysis (CGSA). Using 50 extracted gene sets we identified three different profiles of tumors in a cohort of 364 Diffuse large B-cell (DLBCL) and related mature aggressive B-cell lymphomas other than Burkitt lymphoma. The first profile had high level of expression of genes related to proliferation whereas the second profile exhibited a stromal and immune response phenotype. These two profiles were characterized by a large scale gene activation affecting genes which were recently shown to be epigenetically regulated, and which were enriched in oxidative phosphorylation, energy metabolism and nucleoside biosynthesis. The third and novel profile showed only low global gene activation similar to that found in normal B cells but not cell lines. Our study indicates novel levels of complexity of DLBCL with low or high large scale gene activation related to metabolism and biosynthesis and, within the group of highly activated DLBCLs, differential behavior leading to either a proliferative or a stromal and immune response phenotype.	[Rosolowski, Maciej; Laeuter, Juergen; Loeffler, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Laeuter, Juergen] Univ Magdeburg, D-39106 Magdeburg, Germany; [Abramov, Dmitriy; Klapper, Wolfram] Univ Kiel, Dept Pathol, Hematopathol Sect, Kiel, Germany; [Abramov, Dmitriy; Klapper, Wolfram] Univ Kiel, Lymph Node Registry, Kiel, Germany; [Abramov, Dmitriy] Russian Fed Res Ctr, Dept Pathol, Moscow, Russia; [Drexler, Hans G.; MacLeod, Roderick A. F.] DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Hummel, Michael] Charite, Inst Pathol, D-13353 Berlin, Germany; [Pellissery, Shoji; Siebert, Reiner] Univ Kiel, Univ Hosp Schleswig Holstein Campus Kiel, Inst Human Genet, Kiel, Germany; [Horn, Friedemann] Univ Leipzig, Fac Med, Inst Clin Immunol, D-04109 Leipzig, Germany	Leipzig University; Otto von Guericke University; University of Kiel; University of Kiel; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Leipzig University	Rosolowski, M (corresponding author), Univ Leipzig, IMISE, D-04109 Leipzig, Germany.	maciej.rosolowski@imise.uni-leipzig.de	Klapper, Wolfram/S-6314-2016; Siebert, Reiner/A-8049-2010	Hummel, Michael/0000-0001-6717-605X; Abramov, Dmitry/0000-0003-3664-2876	Deutsche Krebshilfe [70-3173-Tr3]; BMBF grant HaematoSYS [0315452A]; German Minster of Education and Science (BMBF)	Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF grant HaematoSYS(Federal Ministry of Education & Research (BMBF)); German Minster of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	The experimental work was carried out within the framework of the research network "Molecular Mechanisms in Malignant Lymphoma" (MMML), supported by the Deutsche Krebshilfe (70-3173-Tr3). Bioinformatic analysis was supported by the BMBF grant HaematoSYS (No. 0315452A, Markus Loeffler, Reiner Siebert, Jurgen Lauter, Maciej Rosolowski) granted by the German Minster of Education and Science (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2010, R LANG ENV STAT COMP; Bentink S, 2008, LEUKEMIA, V22, P1746, DOI 10.1038/leu.2008.166; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Kostka D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040022; Kreuz M, 2007, METHOD INFORM MED, V46, P608, DOI 10.1160/ME9064; Lauter J, 2009, BIOMETRICAL J, V51, P235, DOI 10.1002/bimj.200800207; Lauter J, 2012, ARXIV12022045V1STATM; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salaverria I, 2011, BLOOD, V118, P139, DOI 10.1182/blood-2011-01-330795; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76287	10.1371/journal.pone.0076287	http://dx.doi.org/10.1371/journal.pone.0076287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223701	Green Published, gold			2022-12-25	WOS:000326503400006
J	Saint-Criq, V; Kim, SH; Katzenellenbogen, JA; Harvey, BJ				Saint-Criq, Vinciane; Kim, Sung Hoon; Katzenellenbogen, John A.; Harvey, Brian J.			Non-Genomic Estrogen Regulation of Ion Transport and Airway Surface Liquid Dynamics in Cystic Fibrosis Bronchial Epithelium	PLOS ONE			English	Article							PROTEIN-KINASE-C; RAT DISTAL COLON; CHLORIDE SECRETION; PSEUDOMONAS-AERUGINOSA; STEROID-HORMONES; RECEPTOR-ALPHA; LUNG-DISEASE; GENDER-GAP; 17-BETA-ESTRADIOL; CELLS	Male cystic fibrosis (CF) patients survive longer than females and lung exacerbations in CF females vary during the estrous cycle. Estrogen has been reported to reduce the height of the airway surface liquid (ASL) in female CF bronchial epithelium. Here we investigated the effect of 17 beta-estradiol on the airway surface liquid height and ion transport in normal (NuLi-1) and CF (CuFi-1) bronchial epithelial monolayers. Live cell imaging using confocal microscopy revealed that airway surface liquid height was significantly higher in the non-CF cells compared to the CF cells. 17 beta-estradiol (0.1-10 nM) reduced the airway surface liquid height in non-CF and CF cells after 30 min treatment. Treatment with the nuclear-impeded Estrogen Dendrimer Conjugate mimicked the effect of free estrogen by reducing significantly the airway surface liquid height in CF and non-CF cells. Inhibition of chloride transport or basolateral potassium recycling decreased the airway surface liquid height and 17 beta-estradiol had no additive effect in the presence of these ion transporter inhibitors. 17 beta-estradiol decreased bumetanide-sensitive transepithelial short-circuit current in non-CF cells and prevented the forskolin-induced increase in ASL height. 17 beta-estradiol stimulated an amiloride-sensitive transepithelial current and increased ouabain-sensitive basolateral short-circuit current in CF cells. 17 beta-estradiol increased PKC delta activity in CF and non-CF cells. These results demonstrate that estrogen dehydrates CF and non-CF ASL, and these responses to 17 beta-estradiol are non-genomic rather than involving the classical nuclear estrogen receptor pathway. 17 beta-estradiol acts on the airway surface liquid by inhibiting cAMP-mediated chloride secretion in non-CF cells and increasing sodium absorption via the stimulation of PKC delta, ENaC and the Na+/K+ ATPase in CF cells.	[Saint-Criq, Vinciane; Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland; [Kim, Sung Hoon; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL USA	Royal College of Surgeons - Ireland; University of Illinois System; University of Illinois Urbana-Champaign	Harvey, BJ (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland.	bjpharvey@rcsi.ie	Saint-Criq, Vinciane/A-6602-2010; Harvey, Brian/AAJ-4085-2020; Harvey, Brian J/A-5120-2010	Saint-Criq, Vinciane/0000-0003-0042-3735; Harvey, Brian/0000-0002-7388-8034; Harvey, Brian J/0000-0002-7388-8034	Marie Curie fellowship CEMP; National Biophotonics Imaging Platform Ireland HEA PRTLI 4; National Institutes of Health [DK015556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556, R01DK015556] Funding Source: NIH RePORTER	Marie Curie fellowship CEMP; National Biophotonics Imaging Platform Ireland HEA PRTLI 4; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Marie Curie fellowship CEMP (VSC), the National Biophotonics Imaging Platform Ireland HEA PRTLI 4 (BJH), and the National Institutes of Health DK015556 (JAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Alzamora R, 2011, STEROIDS, V76, P867, DOI 10.1016/j.steroids.2011.04.016; Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5; Beers KW, 1996, BIOCHEM BIOPH RES CO, V221, P442, DOI 10.1006/bbrc.1996.0614; Block JK, 2006, THORAX, V61, P969, DOI 10.1136/thx.2006.061366; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chotirmall SH, 2012, NEW ENGL J MED, V366, P1978, DOI 10.1056/NEJMoa1106126; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Condliffe SB, 2001, J PHYSIOL-LONDON, V530, P47, DOI 10.1111/j.1469-7793.2001.0047m.x; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Corey M, 1996, PEDIATR PULM, V21, P149, DOI 10.1002/1099-0496(199603)21:3<149::AID-PPUL1950210302>3.0.CO;2-C; Doolan CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1935, DOI 10.1152/ajpcell.1996.271.6.C1935; Doolan CM, 2000, BRIT J PHARMACOL, V129, P1375, DOI 10.1038/sj.bjp.0703193; Doolan CM, 1996, J BIOL CHEM, V271, P8763, DOI 10.1074/jbc.271.15.8763; Gerlach U, 2001, J MED CHEM, V44, P3831, DOI 10.1021/jm0109255; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Kim SH, 2006, ANGEW CHEM INT EDIT, V45, P7243, DOI 10.1002/anie.200601923; Lam RS, 2003, J PHYSIOL-LONDON, V548, P475, DOI 10.1113/jphysiol.2002.036806; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MOHRMANN M, 1987, AM J PHYSIOL, V253, pF372, DOI 10.1152/ajprenal.1987.253.2.F372; Moro L, 2005, BLOOD, V105, P115, DOI 10.1182/blood-2003-11-3840; Musselman TM, 2010, STEROIDS, V75, P760, DOI 10.1016/j.steroids.2010.05.014; O'Mahony F, 2007, J BIOL CHEM, V282, P24563, DOI 10.1074/jbc.M611682200; O'Mahony F, 2009, MOL ENDOCRINOL, V23, P1885, DOI 10.1210/me.2008-0248; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; ROCHWERGER L, 1993, ENDOCRINOLOGY, V133, P921, DOI 10.1210/en.133.2.921; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Saint-Criq V, 2012, STEROIDS, V77, P918, DOI 10.1016/j.steroids.2012.02.017; Santanam N, 1998, J LIPID RES, V39, P2111; Singh AK, 2000, J PHARMACOL EXP THER, V295, P195; Soukup B, 2012, AM J PHYSIOL-LUNG C, V302, pL133, DOI 10.1152/ajplung.00031.2011; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Sweezey NB, 1997, AM J PHYSIOL-LUNG C, V272, pL844, DOI 10.1152/ajplung.1997.272.5.L844; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Tam A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-24; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Verma N, 2005, CHEST, V128, P2824, DOI 10.1016/S0012-3692(15)52709-8; Verriere V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037746; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]; Yang GZ, 2011, CELL MOL BIOL, V57, P1480, DOI 10.1170/170; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	57	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78593	10.1371/journal.pone.0078593	http://dx.doi.org/10.1371/journal.pone.0078593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223826	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400075
J	Zimolzak, AJ; Spettell, CM; Fernandes, J; Fusaro, VA; Palmer, NP; Saria, S; Kohane, IS; Jonikas, MA; Mandl, KD				Zimolzak, Andrew J.; Spettell, Claire M.; Fernandes, Joaquim; Fusaro, Vincent A.; Palmer, Nathan P.; Saria, Suchi; Kohane, Isaac S.; Jonikas, Magdalena A.; Mandl, Kenneth D.			Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance	PLOS ONE			English	Article							THERAPY; INTERVENTIONS; PATIENT	Background: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. Methods: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. Results: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. Conclusions: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection.	[Zimolzak, Andrew J.; Kohane, Isaac S.; Jonikas, Magdalena A.; Mandl, Kenneth D.] Boston Childrens Hosp, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol Hlth Sci & Tec, Boston, MA USA; [Spettell, Claire M.; Fernandes, Joaquim] Aetna, Blue Bell, PA USA; [Fusaro, Vincent A.; Palmer, Nathan P.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Saria, Suchi] Johns Hopkins Univ, Div Hlth Sci & Informat, Baltimore, MD USA; [Zimolzak, Andrew J.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol Hlth Sci & Tec, Boston, MA USA.	kenneth_mandl@harvard.edu	Zimolzak, Andrew/K-8237-2019	Zimolzak, Andrew/0000-0003-0973-5639	National Library of Medicine [5-T15-LM007092-20, 5R01LM007677]; Office of the National Coordinator of Health Information Technology [90TR0001/01]; NICHD [5T32HD040128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092, R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Office of the National Coordinator of Health Information Technology; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant 5-T15-LM007092-20 and 5R01LM007677 from the National Library of Medicine, by 90TR0001/01 from the Office of the National Coordinator of Health Information Technology and 5T32HD040128 from the NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Centers for Medicare and Medicaid Services, 2012, MED HLTH DRUG PLAN Q; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jacobson G, 2011, MEDICARE ADVANTAGE P; Jonikas MA, 2012, J AM MED INFORM ASSN, V19, P649, DOI 10.1136/amiajnl-2011-000416; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; *NEW ENGL HEALLTHC, 2009, THINK OUTS PILLB SYS; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Reid RO, 2013, JAMA-J AM MED ASSOC, V309, P267, DOI 10.1001/jama.2012.173925; Simpson RJ, 2010, J CLIN LIPIDOL, V4, P462, DOI 10.1016/j.jacl.2010.08.026; Steiner JF, 2012, ANN INTERN MED, V157, P580, DOI 10.7326/0003-4819-157-8-201210160-00013; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538	17	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79611	10.1371/journal.pone.0079611	http://dx.doi.org/10.1371/journal.pone.0079611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223977	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400128
J	Chalan, P; Kroesen, BJ; van der Geest, KSM; Huitema, MG; Abdulahad, WH; Bijzet, J; Brouwer, E; Boots, AMH				Chalan, Paulina; Kroesen, Bart-Jan; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Circulating CD4+CD161+T Lymphocytes Are Increased in Seropositive Arthralgia Patients but Decreased in Patients with Newly Diagnosed Rheumatoid Arthritis	PLOS ONE			English	Article							T-CELL SUBSETS; TH17 CELLS; HUMAN NKR-P1A; CUTTING EDGE; EXPRESSION; LIGAND; CLASSIFICATION; STRATEGIES; SYNOVITIS; CYTOKINES	Improved understanding of the immune events discriminating between seropositive arthralgia and clinical synovitis is of key importance in rheumatology research. Ample evidence suggests a role for Th17 cells in rheumatoid arthritis. We hypothesized that CD4+CD161+ cells representing Th17 lineage cells may be modulated prior to or after development of clinical synovitis. Therefore, in a cross-sectional study, we investigated the occurrence of CD4+CD161+ T-cells in seropositive arthralgia patients who are at risk for developing rheumatoid arthritis and in newly diagnosed rheumatoid arthritis patients. In a prospective study, we evaluated the effect of methotrexate treatment on circulating CD4+CD161+ T-cells. Next, we assessed if these cells can be detected at the level of the RA joints. Precursor Th17 lineage cells bearing CD161 were found to be increased in seropositive arthralgia patients. In contrast, circulating CD4+CD161+ T-cells were decreased in newly diagnosed rheumatoid arthritis patients. The decrease in CD4+CD161+ T-cells correlated inversely with C-reactive protein and with the 66 swollen joint count. Methotrexate treatment led to normalization of CD4+CD161+ T-cells and reduced disease activity. CD4+CD161+ T cells were readily detected in synovial tissues from both early and late-stage rheumatoid arthritis. In addition, synovial fluid from late-stage disease was found to be enriched for CD4+CD161+ T-cells. Notably, synovial fluid accumulated CD4+CD161+ T-cells showed skewing towards the Th1 phenotype as evidenced by increased interferon-gamma expression. The changes in peripheral numbers of CD4+CD161+ T-cells in seropositive arthralgia and early rheumatoid arthritis and the enrichment of these cells at the level of the joint predict a role for CD4+CD161+ T-cells in the early immune events leading to clinical synovitis. Our findings may add to the development of RA prediction models and provide opportunities for early intervention.	[Chalan, Paulina; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands; [Chalan, Paulina; Kroesen, Bart-Jan; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Hlth Ageing & Immune Longev, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Boots, AMH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands.	m.boots@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020	Brouwer, Elisabeth/0000-0002-5652-4423; /0000-0003-3109-4487; van der Geest, Kornelis/0000-0003-2798-6765	University Medical Center Groningen (UMCG)	University Medical Center Groningen (UMCG)	The project was funded by University Medical Center Groningen (UMCG). The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Annunziato F, 2013, ANN NY ACAD SCI, V1284, P66, DOI 10.1111/nyas.12075; Annunziato F, 2012, TRENDS IMMUNOL, V33, P505, DOI 10.1016/j.it.2012.05.004; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Burgoyne CH, 2008, ANN RHEUM DIS, V67, P750, DOI 10.1136/ard.2007.073833; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Church LD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3152; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P502; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1039, DOI 10.1136/ard.2010.141234; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; LANIER LL, 1994, J IMMUNOL, V153, P2417; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Maggi L, 2012, EUR J IMMUNOL, V42, P3180, DOI 10.1002/eji.201242648; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Miao J, 2013, MOD RHEUMATOL; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Page G, 2004, J PATHOL, V204, P28, DOI 10.1002/path.1607; Poggi A, 1997, EUR J IMMUNOL, V27, P2345, DOI 10.1002/eji.1830270932; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Smith MD, 2001, RHEUMATOLOGY, V40, P965, DOI 10.1093/rheumatology/40.9.965; Tanida S, 2009, CYTOKINE, V47, P112, DOI 10.1016/j.cyto.2009.05.009; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; van de Stadt LA, 2012, ANN RHEUM DIS; VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM-US, V35, P26; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341	37	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79370	10.1371/journal.pone.0079370	http://dx.doi.org/10.1371/journal.pone.0079370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223933	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300078
J	Elder, AM; Henderson, DM; Nalls, AV; Wilham, JM; Caughey, BW; Hoover, EA; Kincaid, AE; Bartz, JC; Mathiason, CK				Elder, Alan M.; Henderson, Davin M.; Nalls, Amy V.; Wilham, Jason M.; Caughey, Byron W.; Hoover, Edward A.; Kincaid, Anthony E.; Bartz, Jason C.; Mathiason, Candace K.			In Vitro Detection of prionemia in TSE-Infected Cervids and Hamsters	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE VIRUS-INFECTION; CHRONIC WASTING DISEASE; BLOOD-TRANSFUSION; CYCLIC AMPLIFICATION; SEEDED CONVERSION; PROTEIN; TRANSMISSION; TISSUES; DEER	Blood-borne transmission of infectious prions during the symptomatic and asymptomatic stages of disease occurs for both human and animal transmissible spongiform encephalopathies (TSEs). The geographical distribution of the cervid TSE, chronic wasting disease (CWD), continues to spread across North America and the prospective number of individuals harboring an asymptomatic infection of human variant Creutzfeldt-Jakob Disease (vCJD) in the United Kingdom has been projected to be similar to 1 in 3000 residents. Thus, it is important to monitor cervid and human blood products to ensure herd health and human safety. Current methods for detecting blood-associated prions rely primarily upon bioassay in laboratory animals. While bioassay provides high sensitivity and specificity, it requires many months, animals, and it is costly. Here we report modification of the real time quaking-induced conversion (RT-QuIC) assay to detect blood-borne prions in whole blood from prion-infected preclinical white-tailed deer, muntjac deer, and Syrian hamsters, attaining sensitivity of > 90% while maintaining 100% specificity. Our results indicate that RT-QuIC methodology as modified can provide consistent and reliable detection of blood-borne prions in preclinical and symptomatic stages of two animal TSEs, offering promise for prionemia detection in other species, including humans.	[Elder, Alan M.; Henderson, Davin M.; Nalls, Amy V.; Hoover, Edward A.; Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wilham, Jason M.; Caughey, Byron W.] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Kincaid, Anthony E.; Bartz, Jason C.] Creighton Univ, Omaha, NE 68178 USA	Colorado State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Creighton University	Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	candace.mathiason@colostate.edu	Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017	Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556; Bartz, Jason/0000-0003-4081-7886; Elder, Alan/0000-0002-0386-1792; Kincaid, Anthony/0000-0002-5700-5887	Morris Animal Foundation [D12ZO-045];  [NIH-RO1 093634-01];  [NIH-R01 N5061902];  [NIAID-NO1-AI-25491];  [RO1 NS061994];  [RO1 NS061994-03S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112956, N01AI025491, R01AI093634, ZIAAI001086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902, R01NS061994] Funding Source: NIH RePORTER	Morris Animal Foundation; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work at Colorado State University was supported by NIH-RO1 093634-01, NIH-R01 N5061902, NIAID-NO1-AI-25491 and Morris Animal Foundation D12ZO-045. Work done at Creighton University was supported by RO1 NS061994 and RO1 NS061994-03S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bannach O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036620; Barria MA, 2012, METHODS MOL BIOL, V849, P199, DOI 10.1007/978-1-61779-551-0_14; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Denkers ND, 2011, J VIROL, V85, P1396, DOI 10.1128/JVI.01655-10; Dominguez K, 2009, SYST BIOL REPROD MED, V55, P193, DOI 10.3109/19396360903234052; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Glier H, 2012, J IMMUNOL METHODS, V380, P65, DOI 10.1016/j.jim.2012.04.002; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; KITAMOTO T, 1989, J GEN VIROL, V70, P3371, DOI 10.1099/0022-1317-70-12-3371; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Lacroux C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042019; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; LOVELOCK JE, 1954, NATURE, V173, P659, DOI 10.1038/173659a0; LOVELOCK JE, 1955, BRIT J HAEMATOL, V1, P117, DOI 10.1111/j.1365-2141.1955.tb05493.x; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Morales R, 2008, BIOCHEM BIOPH RES CO, V377, P373, DOI 10.1016/j.bbrc.2008.09.141; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Nalls AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071844; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; PATTISON IH, 1962, J COMP PATHOL THERAP, V72, P233, DOI 10.1016/S0368-1742(62)80026-5; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peden Alexander H, 2008, Expert Opin Med Diagn, V2, P207, DOI 10.1517/17530059.2.2.207; Prowse CV, 2000, VOX SANG, V79, P248, DOI 10.1046/j.1423-0410.2000.7940248.x; RACE RE, 1992, J GEN VIROL, V73, P3319, DOI 10.1099/0022-1317-73-12-3319; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa Paula, 2004, V299, P53; Team E, 2007, EUROSURVEILLANCE, V12; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	60	66	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80203	10.1371/journal.pone.0080203	http://dx.doi.org/10.1371/journal.pone.0080203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224043	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300097
J	Hao, RX; Bondesson, M; Singh, AV; Riu, A; McCollum, CW; Knudsen, TB; Gorelick, DA; Gustafsson, JA				Hao, Ruixin; Bondesson, Maria; Singh, Amar V.; Riu, Anne; McCollum, Catherine W.; Knudsen, Thomas B.; Gorelick, Daniel A.; Gustafsson, Jan-Ake			Identification of Estrogen Target Genes during Zebrafish Embryonic Development through Transcriptomic Analysis	PLOS ONE			English	Article							CANCER-CELL-LINES; DANIO-RERIO; RECEPTOR-ALPHA; BREAST-CANCER; ER-BETA; RETINOIC ACID; DIFFERENTIAL REGULATION; REGULATES EXPRESSION; POSTMENOPAUSAL WOMEN; VITELLOGENIN GENES	Estrogen signaling is important for vertebrate embryonic development. Here we have used zebrafish (Danio rerio) as a vertebrate model to analyze estrogen signaling during development. Zebrafish embryos were exposed to 1 mu M 17 beta-estradiol (E2) or vehicle from 3 hours to 4 days post fertilization (dpf), harvested at 1, 2, 3 and 4 dpf, and subjected to RNA extraction for transcriptome analysis using microarrays. Differentially expressed genes by E2-treatment were analyzed with hierarchical clustering followed by biological process and tissue enrichment analysis. Markedly distinct sets of genes were up and down-regulated by E2 at the four different time points. Among these genes, only the well-known estrogenic marker vtg1 was co-regulated at all time points. Despite this, the biological functional categories targeted by E2 were relatively similar throughout zebrafish development. According to knowledge-based tissue enrichment, estrogen responsive genes were clustered mainly in the liver, pancreas and brain. This was in line with the developmental dynamics of estrogen-target tissues that were visualized using transgenic zebrafish containing estrogen responsive elements driving the expression of GFP (Tg(5xERE: GFP)). Finally, the identified embryonic estrogen-responsive genes were compared to already published estrogen-responsive genes identified in male adult zebrafish (Gene Expression Omnibus database). The expressions of a few genes were co-regulated by E2 in both embryonic and adult zebrafish. These could potentially be used as estrogenic biomarkers for exposure to estrogens or estrogenic endocrine disruptors in zebrafish. In conclusion, our data suggests that estrogen effects on early embryonic zebrafish development are stage-and tissue-specific.	[Hao, Ruixin; Bondesson, Maria; Riu, Anne; McCollum, Catherine W.; Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Singh, Amar V.; Knudsen, Thomas B.] US EPA, Off Res & Dev, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Gorelick, Daniel A.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; [Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	University of Houston System; University of Houston; United States Environmental Protection Agency; Carnegie Institution for Science; Karolinska Institutet	Bondesson, M (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA.	mbondessonbolin@uh.edu	Bondesson, Maria/H-3027-2012	Bondesson, Maria/0000-0001-6358-5788; McCollum, Catherine/0000-0002-2238-803X	Environmental Protection Agency [R834289]; Emerging Technology Fund of Texas; Robert A Welch Foundation [E-0004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD061119] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); Emerging Technology Fund of Texas; Robert A Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Environmental Protection Agency (grant number R834289), the Emerging Technology Fund of Texas and the Robert A Welch Foundation (E-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 1997, ENDOCRINOLOGY, V138, P978, DOI 10.1210/en.138.3.978; Armenti AE, 2008, TOXICOL APPL PHARM, V233, P286, DOI 10.1016/j.taap.2008.09.010; Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x; Bardet PL, 2002, J MOL ENDOCRINOL, V28, P153, DOI 10.1677/jme.0.0280153; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Callard GV, 2011, J STEROID BIOCHEM, V127, P176, DOI 10.1016/j.jsbmb.2011.03.022; Celeghin A, 2011, GEN COMP ENDOCR, V172, P120, DOI 10.1016/j.ygcen.2010.12.020; Chandrasekar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009678; Chen GJ, 2011, J PHYSIOL-LONDON, V589, P1061, DOI 10.1113/jphysiol.2010.203398; Chung JK, 2002, J NUCL MED, V43, P1188; Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009; De Geeter F, 2011, HELL J NUCL MED, V14, P76; Deb S, 2004, J CLIN ENDOCR METAB, V89, P4018, DOI 10.1210/jc.2004-0127; Deng L, 2003, J CLIN ENDOCR METAB, V88, P2157, DOI 10.1210/jc.2002-021844; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Dormire SL, 2009, BIOL RES NURS, V10, P241, DOI 10.1177/1099800408324558; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Elgort MG, 1996, MOL ENDOCRINOL, V10, P477, DOI 10.1210/me.10.5.477; Fan XT, 2010, PROG BRAIN RES, V181, P233, DOI 10.1016/S0079-6123(08)81013-8; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Froehlicher M, 2009, DEV BIOL, V330, P32, DOI 10.1016/j.ydbio.2009.03.005; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Gorelick DA, 2011, ENDOCRINOLOGY, V152, P2690, DOI 10.1210/en.2010-1257; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Guo TL, 2005, J NUTR, V135, P2449, DOI 10.1093/jn/135.10.2449; Hamad A, 2007, CURR EYE RES, V32, P819, DOI 10.1080/02713680701573712; Han QX, 1997, DIAGN MOL PATHOL, V6, P42, DOI 10.1097/00019606-199702000-00007; Hart CD, 1998, AM J RESP CELL MOL, V19, P63, DOI 10.1165/ajrcmb.19.1.2859; HASHIMOTO S, 1991, MATURITAS, V13, P23, DOI 10.1016/0378-5122(91)90282-U; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hinfray N, 2006, ENVIRON TOXICOL, V21, P332, DOI 10.1002/tox.20203; Jansson I, 2001, PHARMACOGENETICS, V11, P793, DOI 10.1097/00008571-200112000-00007; Jennings BL, 2012, HYPERTENSION, V59, P348, DOI 10.1161/HYPERTENSIONAHA.111.183301; Jones DR, 2002, J LIPID RES, V43, P383; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Karpuzoglu-Sahin E, 2001, J REPROD IMMUNOL, V52, P113, DOI 10.1016/S0165-0378(01)00117-6; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kim R, 2005, INT J ONCOL, V26, P1025; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; KUSHWAHA RS, 1990, METABOLISM, V39, P544, DOI 10.1016/0026-0495(90)90015-5; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lam SH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-41; Lamon-Fava S, 1999, ARTERIOSCL THROM VAS, V19, P2960, DOI 10.1161/01.ATV.19.12.2960; Lamon-Fava S, 2006, ARTERIOSCL THROM VAS, V26, P385, DOI 10.1161/01.ATV.0000199248.53590.e1; Larsen MG, 2009, ENVIRON TOXICOL CHEM, V28, P1783, DOI 10.1897/08-563.1; Lassiter CS, 2002, GENE, V299, P141, DOI 10.1016/S0378-1119(02)01050-8; Le Saux M, 2006, J NEUROSCI RES, V84, P1076, DOI 10.1002/jnr.21007; Lee O, 2012, ENVIRON HEALTH PERSP, V120, P990, DOI 10.1289/ehp.1104433; Lengi AJ, 2007, J LEUKOCYTE BIOL, V81, P1065, DOI 10.1189/jlb.0606391; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Levi L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-141; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu XC, 2009, BIOL REPROD, V80, P1253, DOI 10.1095/biolreprod.108.070250; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Medina RA, 2004, J ENDOCRINOL, V182, P467, DOI 10.1677/joe.0.1820467; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Murthy AR, 2012, J HUM GENET, V57, P523, DOI 10.1038/jhg.2012.62; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Nelson BP, 2008, BRAIN RES, V1222, P118, DOI 10.1016/j.brainres.2008.05.049; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Pantschenko AG, 2005, J BONE MINER RES, V20, P1414, DOI 10.1359/JBMR.050315; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Ruggeri B, 2008, GEN COMP ENDOCR, V158, P138, DOI 10.1016/j.ygcen.2008.05.012; Sanchez-Criado JE, 2006, J ENDOCRINOL, V188, P167, DOI 10.1677/joe.1.06377; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; Schultz JR, 2005, J BIOL CHEM, V280, P347, DOI 10.1074/jbc.M407879200; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; Stoilov I, 2004, MOL VIS, V10, P629; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Thongngarm T, 2003, AM J REPROD IMMUNOL, V49, P129, DOI 10.1034/j.1600-0897.2003.00015.x; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tong Y, 2004, GENE, V328, P25, DOI 10.1016/j.gene.2003.12.001; Trukhacheva E, 2009, J CLIN ENDOCR METAB, V94, P615, DOI 10.1210/jc.2008-1466; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Uzumcu M, 2006, J ENDOCRINOL, V191, P549, DOI 10.1677/joe.1.06592; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wilkins HR, 2010, TUMOR BIOL, V31, P16, DOI 10.1007/s13277-009-0003-2; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Xu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1317, DOI 10.1152/ajpgi.00172.2003; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061	85	76	77	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79020	10.1371/journal.pone.0079020	http://dx.doi.org/10.1371/journal.pone.0079020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223173	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200065
J	Niedworok, C; Rock, K; Kretschmer, I; Freudenberger, T; Nagy, N; Szarvas, T; Dorp, F; Reis, H; Rubben, H; Fischer, JW				Niedworok, Christian; Roeck, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Szarvas, Tibor; vom Dorp, Frank; Reis, Henning; Ruebben, Herbert; Fischer, Jens W.			Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer	PLOS ONE			English	Article							ADVANCED UROTHELIAL CANCER; GROWTH-FACTOR; TOLL-LIKE; IN-VITRO; DOWN-REGULATION; EXPRESSION; DECORIN; MATRIX; CELLS; SORAFENIB	Background: Urothelial bladder cancer is the ninth most common cancer. Despite surgical and chemotherapeutic treatment the prognosis is still poor once bladder cancer progresses to a muscle-invasive state. Discovery of new diagnostic markers and pathophysiologic effectors might help to contribute to novel diagnostic and therapeutic options. The extracellular matrix microenvironment shaped by the extracellular matrix critically affects tumor cell and stroma cell functions. Therefore, aim of the present study was to assess the possible implication of the small leucine-rich proteoglycan biglycan in progression of human urothelial bladder cancer. Methods and Results: For this purpose tumor biopsies of 76 bladder cancer patients with different tumor stages (pTa, pT1-T4) were investigated with respect to biglycan expression and correlated with a long-term (10 years) clinical follow-up. Interestingly, higher biglycan mRNA expression was associated with higher tumor stages and muscle invasiveness. In vitro knock-down of endogenous biglycan in human urothelial carcinoma cells (J82 cells) increased proliferation, whereas addition of recombinant biglycan and overexpression of biglycan inhibited tumor cell proliferation. In line with this growth-inhibitory effect of biglycan, transplantation of J82 cells after knock-down of biglycan resulted in significantly increased growth of subcutaneous xenograft tumors in nude mice in vivo. Furthermore, treatment with two anti-proliferative, multi-receptor tyrosine kinase inhibitors-sunitinib and sorafenib-strongly upregulated biglycan expression. Collectively, the experimental data suggest that high biglycan expression is associated with reduced tumor cell proliferation. In accordance, Kaplan-Meier analysis revealed higher 10-year survival in patients with high biglycan mRNA expression in tumor biopsies. Conclusion: In conclusion, the present data suggest that biglycan is an endogenous inhibitor of bladder cancer cell proliferation that is upregulated in response to anti-proliferative tyrosine kinase inhibitors. In addition, high biglycan expression is associated with favorable prognosis.	[Niedworok, Christian; vom Dorp, Frank; Ruebben, Herbert] Univ Duisburg Essen, Essen Med Sch, Dept Urol, Essen, Germany; [Roeck, Katharina; Kretschmer, Inga; Freudenberger, Till; Nagy, Nadine; Fischer, Jens W.] Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany; [Reis, Henning] Univ Duisburg Essen, Essen Med Sch, Dept Pathol, Essen, Germany; [Szarvas, Tibor] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Duisburg Essen; Medical University of Vienna	Fischer, JW (corresponding author), Univ Klinikum Dusseldorf, Inst Pharmakol & Klin Pharmakol, Dusseldorf, Germany.	Jens.Fischer@uni-duesseldorf.de	SZARVAS, t./L-4422-2017; Reis, Henning/AAX-9545-2020	SZARVAS, t./0000-0002-6321-0799; Reis, Henning/0000-0003-1373-5295	Ifores Programm of the University Clinics Essen [D107-10800]; Deutsche Forschungsgemeinschaft, DFG [FI 682/4-1]	Ifores Programm of the University Clinics Essen; Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	The study was funded in part by the Ifores Programm of the University Clinics Essen (D107-10800; http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml) and by the Deutsche Forschungsgemeinschaft, DFG (FI 682/4-1; http://gepris.dfg.de/gepris/OCTOPUS/;jsessionid=E43949FD6A49E805D72DE1129F1DB078?context=person&displayMode=print&findButton=Finden&id=1433803&keywords_criterion=Jens+Fischer&module=gepris&nurProjekteMitAB=false&task=showDetail). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Agarwal N, 2009, DRUGS, V69, P1173, DOI 10.2165/00003495-200969090-00003; Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Aprile G, 2013, TUMOR BIOL, V34, P131, DOI 10.1007/s13277-012-0520-2; Ayari C, 2011, J UROLOGY, V185, P1915, DOI 10.1016/j.juro.2010.12.097; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Dreicer R, 2009, CANCER-AM CANCER SOC, V115, P4090, DOI 10.1002/cncr.24467; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Gu XH, 2012, CLIN EXP MED, V12, P195, DOI 10.1007/s10238-011-0155-4; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Inkson CA, 2009, CELLS TISSUES ORGANS, V189, P153, DOI 10.1159/000151377; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; KINSELLA MG, 1988, J BIOL CHEM, V263, P19222; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Niedworok C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075681; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Recktenwald CV, 2012, J BIOL CHEM, V287, P24320, DOI 10.1074/jbc.M111.334425; Rock K, 2012, J BIOL CHEM, V287, P20056, DOI 10.1074/jbc.M112.353151; Rose A, 2010, BRIT J PHARMACOL, V160, P1690, DOI 10.1111/j.1476-5381.2010.00838.x; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shabbir M, 2009, INT J UROL, V16, P143, DOI 10.1111/j.1442-2042.2008.02207.x; Singh V, 2012, ARCH MED RES; Sridhar SS, 2011, INVEST NEW DRUG, V29, P1045, DOI 10.1007/s10637-010-9408-4; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Tepeli E, 2012, MOL BIOL REP, V39, P335, DOI 10.1007/s11033-011-0743-0; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Tzai TS, 1998, ANTICANCER RES, V18, P1585; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Wang B, 2011, EXP BIOL MED, V236, P1247, DOI 10.1258/ebm.2011.011124; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu ZW, 2012, ANTI-CANCER AGENT ME, V12, P1081, DOI 10.2174/187152012803529673	53	37	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80084	10.1371/journal.pone.0080084	http://dx.doi.org/10.1371/journal.pone.0080084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223213	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200106
J	Ritter, S; Michalski, SG; Settele, J; Wiemers, M; Fric, ZF; Sielezniew, M; Sasic, M; Rozier, Y; Durka, W				Ritter, Sylvia; Michalski, Stefan G.; Settele, Josef; Wiemers, Martin; Fric, Zdenek F.; Sielezniew, Marcin; Sasic, Martina; Rozier, Yves; Durka, Walter			Wolbachia Infections Mimic Cryptic Speciation in Two Parasitic Butterfly Species, Phengaris teleius and P. nausithous (Lepidoptera: Lycaenidae)	PLOS ONE			English	Article							SELFISH GENETIC ELEMENTS; MALE-KILLING WOLBACHIA; MITOCHONDRIAL-DNA; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; MACULINEA-ALCON; EVOLUTIONARY; PHYLOGEOGRAPHY; DIVERSITY; PHYLOGENY	Deep mitochondrial divergence within species may result from cryptic speciation, from phylogeographic isolation or from endosymbiotic bacteria like Wolbachia that manipulate host reproduction. Phengaris butterflies are social parasites that spend most of their life in close relationship with ants. Previously, cryptic speciation has been hypothesised for two Phengaris species based on divergent mtDNA sequences. Since Phengaris species are highly endangered, the existence of cryptic species would have drastic consequences for conservation and management. We tested for cryptic speciation and alternative scenarios in P. teleius and P. nausithous based on a comprehensive sample across their Palaearctic ranges using COI gene sequences, nuclear microsatellites and tests for Wolbachia. In both species a deep mitochondrial split occurring 0.65-1.97 myrs ago was observed that did not correspond with microsatellite data but was concordant with Wolbachia infection. Haplotypes previously attributed to cryptic species were part of the Wolbachia-infected clades. In both species remaining phylogeographic structure was largely consistent between mitochondrial and nuclear genomes. In P. teleius several mitochondrial and nuclear groups were observed in East Asia while a single haplogroup and nuclear cluster prevailed across continental Eurasia. Neutrality tests suggested rapid demographic expansion into that area. In contrast, P. nausithous had several mitochondrial and nuclear groups in Europe, suggesting a complex phylogeographic history in the western part of the species range. We conclude that deep intraspecific divergences found in DNA barcode studies do not necessarily need to represent cryptic speciation but instead can be due to both infection by Wolbachia and phylogeographic structure.	[Ritter, Sylvia; Michalski, Stefan G.; Settele, Josef; Wiemers, Martin; Durka, Walter] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Settele, Josef; Durka, Walter] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Fric, Zdenek F.] Acad Sci Czech Republ, Ctr Biol, Ceske Budejovice, Czech Republic; [Sielezniew, Marcin] Univ Bialystok, Inst Biol, Dept Invertebrate Zool, Bialystok, Poland; [Sasic, Martina] Croatian Nat Hist Museum, Dept Zool, Zagreb, Croatia; [Rozier, Yves] CED Entreprises, Ctr Activ Gorge Loup, Lyon, France	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Bialystok	Wiemers, M (corresponding author), Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	martin.wiemers@ufz.de	Settele, Josef/A-6371-2009; FALTYNEK, FRIC ZDENEK/H-1468-2014; Michalski, Stefan G/O-5774-2015; Wiemers, Martin/B-5715-2011; Durka, Walter/E-4667-2010	Settele, Josef/0000-0002-8624-4983; FALTYNEK, FRIC ZDENEK/0000-0002-3611-8022; Michalski, Stefan G/0000-0002-8969-7355; Wiemers, Martin/0000-0001-5272-3903; Durka, Walter/0000-0002-6611-2246; Sasic, Martina/0000-0002-0612-5619	VolkswagenStiftung [Az 1/82 751]; Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (Germany); Natural Environment Research Council (UK); Department of Environment, Food & Rural Affairs (UK); French National Research Agency (France); Formas (Sweden); Swedish Environmental Protection Agency (Sweden); EU [226852]	VolkswagenStiftung(Volkswagen); Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (Germany); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department of Environment, Food & Rural Affairs (UK); French National Research Agency (France)(French National Research Agency (ANR)); Formas (Sweden)(Swedish Research Council Formas); Swedish Environmental Protection Agency (Sweden); EU(European Commission)	The study was financially supported by the VolkswagenStiftung (http://www.volkswagenstiftung.de/) (Sylvia Ritter, Az 1/82 751). Furthermore, research has been conducted within the project CLIMIT (Climit Change Impacts on Insects and their Mitigation; http://www.climit-project.net/) funded by Deutsches Zentrum fur Luft- und Raumfahrt-Bundesministerium fur Bildung und Forschung (www.pt-dlr.de/?) (Germany), the Natural Environment Research Council (http://www.nerc.ac.uk/) and the Department of Environment, Food & Rural Affairs (http://www.defra.gov.uk/) (UK), the French National Research Agency (http://www.agence-nationale-recherche.fr/) (France), Formas (http://www.formas.se/) (Sweden), and Swedish Environmental Protection Agency (http://www.naturvardsverket.se/) (Sweden) through the FP6 BiodivERsA Eranet (http://www.biodiversa.org/) and was also funded within the EU funded project SCALES (http://www.scales-project.net/) (FP7 grant agreement no. 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als TD, 2004, NATURE, V432, P386, DOI 10.1038/nature03020; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bordenstein Seth R., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020043; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bordenstein SR, 2000, HEREDITY, V84, P54, DOI 10.1046/j.1365-2540.2000.00637.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Cassel A, 2003, CONSERV GENET, V4, P83, DOI 10.1023/A:1021884832122; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Druce HH, 1875, CISTULA ENTOMOLOGICA, V1, P357; Duplouy A, 2010, J EVOLUTION BIOL, V23, P231, DOI 10.1111/j.1420-9101.2009.01891.x; Egas M, 2002, EVOLUTION, V56, P1101; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fiedler K, 1998, J INSECT CONSERV, V2, P3, DOI 10.1023/A:1009618721239; Fric Z, 2007, SYST ENTOMOL, V32, P558, DOI 10.1111/j.1365-3113.2007.00387.x; Fu YX, 1996, GENETICS, V143, P557; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerth M, 2011, SYST BIODIVERS, V9, P319, DOI 10.1080/14772000.2011.627953; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hatcher MJ, 2000, TRENDS ECOL EVOL, V15, P271, DOI 10.1016/S0169-5347(00)01875-9; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOFFMANN AA, 1988, GENETICS, V119, P435; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Hurst GDD, 2001, HEREDITY, V87, P220, DOI 10.1046/j.1365-2540.2001.00917.x; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kudrna O., 2011, DISTRIBUTION ATLAS B; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Lukhtanov V, 1994, HERBIPOLIANA, V3; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; MATSUMURA S., 1926, INSECTA MATSUMURANA, V1, P23; Matsumura S, 1910, ENTOMOL Z, V23, P221; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Munguira ML, 1999, ACTION PLAN MACULINE; Munoz Astrid G, 2011, BMC Evol Biol, V11, P358, DOI 10.1186/1471-2148-11-358; Murayama S, 1992, NATURE INSECTS, V27, P37; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Nice CC, 2009, BIOL CONSERV, V142, P3137, DOI 10.1016/j.biocon.2009.08.020; Novikova O, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-93; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Patricelli D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-14; Pech P, 2004, CLADISTICS, V20, P362, DOI 10.1111/j.1096-0031.2004.00031.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; R Core Team, 2016, R FDN STAT COMP; Rakosy Laszlo, 2010, Nota Lepidopterologica, V33, P31; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reynolds KT, 2003, GENETICS, V164, P1027; Roine A, 2000, LEPIBASE 2 0 BUTTERF; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Salunke BK, 2012, APPL ENVIRON MICROB, V78, P4458, DOI 10.1128/AEM.07298-11; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneider DI, 2013, J INVERTEBR PATHOL, V112, pS104, DOI 10.1016/j.jip.2012.03.024; Sibatani Atuhiro, 1994, Tyo To Ga, V44, P157; Sielezniew M, 2012, INSECT CONSERV DIVER, V5, P223, DOI 10.1111/j.1752-4598.2011.00163.x; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Staudinger O., 1892, Deutsche Entomologische Zeitschrift Lep, Vv, P300; Staudinger O, 1887, MEMOIRES LEPIDOPTERE, P126; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tagami Y, 2004, INSECT MOL BIOL, V13, P359, DOI 10.1111/j.0962-1075.2004.00492.x; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi A., 1973, Tyo to Ga, V23, P75; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Tshikolovets VV, 2009, BUTTERFLIES ALTAI SA; Tshikolovets VV, 2009, BUTTERFLIES MONGOLIA; Tshikolovets VV, 2002, BUTTERFLIES TRANSBAI; TSUKADA M, 1982, ECOLOGY, V63, P1091, DOI 10.2307/1937247; Ugelvig LV, 2011, MOL PHYLOGENET EVOL, V61, P237, DOI 10.1016/j.ympev.2011.05.016; van Swaay C, 2012, NAT CONSERV-BULGARIA, P73, DOI 10.3897/natureconservation.1.2786; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Wang M, 2010, ZOOKEYS, P21, DOI 10.3897/zookeys.48.415; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wynhoff I, 1998, J INSECT CONSERV, V2, P15, DOI 10.1023/A:1009636605309; Zeisset I, 2005, MOL ECOL NOTES, V5, P165, DOI 10.1111/j.1471-8286.2004.00872.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	108	58	61	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78107	10.1371/journal.pone.0078107	http://dx.doi.org/10.1371/journal.pone.0078107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223136	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200028
J	Thienpont, JR; Kokelj, SV; Korosi, JB; Cheng, ES; Desjardins, C; Kimpe, LE; Blais, JM; Pisaric, MFJ; Smol, JP				Thienpont, Joshua R.; Kokelj, Steven V.; Korosi, Jennifer B.; Cheng, Elisa S.; Desjardins, Cyndy; Kimpe, Linda E.; Blais, Jules M.; Pisaric, Michael F. J.; Smol, John P.			Exploratory Hydrocarbon Drilling Impacts to Arctic Lake Ecosystems	PLOS ONE			English	Article							MACKENZIE DELTA REGION; NORTHWEST-TERRITORIES; PERMAFROST; CLADOCERA; CHEMISTRY	Recent attention regarding the impacts of oil and gas development and exploitation has focused on the unintentional release of hydrocarbons into the environment, whilst the potential negative effects of other possible avenues of environmental contamination are less well documented. In the hydrocarbon-rich and ecologically sensitive Mackenzie Delta region (NT, Canada), saline wastes associated with hydrocarbon exploration have typically been disposed of in drilling sumps (i.e., large pits excavated into the permafrost) that were believed to be a permanent containment solution. However, failure of permafrost as a waste containment medium may cause impacts to lakes in this sensitive environment. Here, we examine the effects of degrading drilling sumps on water quality by combining paleolimnological approaches with the analysis of an extensive present-day water chemistry dataset. This dataset includes lakes believed to have been impacted by saline drilling fluids leaching from drilling sumps, lakes with no visible disturbances, and lakes impacted by significant, naturally occurring permafrost thaw in the form of retrogressive thaw slumps. We show that lakes impacted by compromised drilling sumps have significantly elevated lakewater conductivity levels compared to control sites. Chloride levels are particularly elevated in sump-impacted lakes relative to all other lakes included in the survey. Paleolimnological analyses showed that invertebrate assemblages appear to have responded to the leaching of drilling wastes by a discernible increase in a taxon known to be tolerant of elevated conductivity coincident with the timing of sump construction. This suggests construction and abandonment techniques at, or soon after, sump establishment may result in impacts to downstream aquatic ecosystems. With hydrocarbon development in the north predicted to expand in the coming decades, the use of sumps must be examined in light of the threat of accelerated permafrost thaw, and the potential for these industrial wastes to impact sensitive Arctic ecosystems.	[Thienpont, Joshua R.; Korosi, Jennifer B.; Cheng, Elisa S.; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Kokelj, Steven V.] Govt Northwest Terr, Northwest Terr Geosci Off, Yellowknife, NT, Canada; [Korosi, Jennifer B.; Desjardins, Cyndy; Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pisaric, Michael F. J.] Carleton Univ, Dept Geog & Environm Studies, Ottawa, ON K1S 5B6, Canada; [Pisaric, Michael F. J.] Brock Univ, Dept Geog, St Catharines, ON L2S 3A1, Canada	Queens University - Canada; University of Ottawa; Carleton University; Brock University	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Smol, John P/A-8838-2015; Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Korosi, Jennifer/0000-0002-9917-8137; Smol, John/0000-0002-2499-6696; Pisaric, Michael/0000-0003-3806-8986	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Northern Supplement	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Northern Supplement	This work was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada through Discovery grants to MFJP, JMB and JPS, and an NSERC Northern Supplement to MFJP. The Polar Continental Shelf Program (PCSP) also provided logistical support to MFJP. The cumulative impact monitoring program (CIMP) provided support for collection of water chemistry results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2005, ARCTIC CLIMATE IMPAC; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Battarbee RW, 2001, TRACKING ENV CHANGE, V3, P155, DOI DOI 10.1007/0-306-47668-1_8; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Bos DG, 1999, HYDROBIOLOGIA, V392, P129, DOI 10.1023/A:1003542709450; Burn CR, 2009, PERMAFROST PERIGLAC, V20, P83, DOI 10.1002/ppp.655; CHENGALATH R, 1982, CAN J ZOOL, V60, P2668, DOI 10.1139/z82-343; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Deasley K, 2012, J PALEOLIMNOL, V48, P287, DOI 10.1007/s10933-012-9577-6; Dixon J, 1994, BULLETIN, V474, P1; Dyke LD, 2001, POLAR REC, V37, P215, DOI DOI 10.1017/S0032247400027248; Falk M.R., 1973, CEN731 CAN DEP ENV F; FRENCH HM, 1980, ARCTIC, V33, P794; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Grimm EC, 2011, TIHA V1 6 COMPUTER P; Jenkins R, 2008, P 9 INT C PERM JUN 2, P833; Johnstone JF, 2008, ARCTIC, V61, P199; Kanigan J, 2010, GEO2010, P1473; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kokelj SV, 2010, COLD REG SCI TECHNOL, V64, P46, DOI 10.1016/j.coldregions.2010.04.009; Kokelj SV, 2009, PERMAFROST PERIGLAC, V20, P185, DOI 10.1002/ppp.641; Kokelj SV, 2005, PERMAFROST PERIGLAC, V16, P343, DOI 10.1002/ppp.536; Kokelj SV, 2005, CAN J EARTH SCI, V42, P37, DOI 10.1139/E04-089; Korosi JB, 2012, J PALEOLIMNOL, V48, P571, DOI 10.1007/s10933-012-9632-3; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; Lantz TC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032433; Mesquita PS, 2010, FRESHWATER BIOL, V55, P2347, DOI 10.1111/j.1365-2427.2010.02450.x; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Oksanen J., 2017, R PACKAGE VERSION 26; R Core Team, 2021, R LANG ENV STAT COMP; Rampton VN, 1988, GEOLOGICAL SURVEY CA; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; Smol JP, 2008, POLLUTION LAKES RIVE; Sweetman JN, 2010, J LIMNOL, V69, P76, DOI 10.4081/jlimnol.2010.76; Thienpont JR, 2013, FRESHWATER BIOL, V58, P337, DOI 10.1111/fwb.12061; Utz LRP, 2001, B ENVIRON CONTAM TOX, V66, P379, DOI 10.1007/s00128-001-0016-z	37	17	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78875	10.1371/journal.pone.0078875	http://dx.doi.org/10.1371/journal.pone.0078875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223170	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200062
J	Wang, LT; Chen, BL; Wu, CT; Huang, KH; Chiang, CK; Liu, SH				Wang, Li-Ting; Chen, Bo-Lin; Wu, Cheng-Tien; Huang, Kuo-How; Chiang, Chih-Kang; Liu, Shing Hwa			Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; REPERFUSION INJURY; CARDIAC AUTOPHAGY; ISCHEMIA; KIDNEY; MTOR; PHOSPHORYLATION; EXPRESSION; APOPTOSIS; PATHWAYS	Ischemia/reperfusion (I/R) injury is a common cause of injury to target organs such as brain, heart, and kidneys. Renal injury from I/R, which may occur in renal transplantation, surgery, trauma, or sepsis, is known to be an important cause of acute kidney injury. The detailed molecular mechanism of renal I/R injury is still not fully clear. Here, we investigate the role of AMP-activated protein kinase (AMPK)-evoked autophagy in the renal proximal tubular cell death in an in vitro I/R injury model. To mimic in vivo renal I/R injury, LLC-PK1 cells, a renal tubular cell line derived from pig kidney, were treated with antimycin A and 2-deoxyglucose to mimic ischemia injury followed by reperfusion with growth medium. This I/R injury model markedly induced apoptosis and autophagy in LLC-PK1 cells in a time-dependent manner. Autophagy inhibitor 3-methyladenine (3MA) significantly enhanced I/R injury-induced apoptosis. I/R could also up-regulate the phosphorylation of AMPK and down-regulate the phosphorylation of mammalian target of rapamycin (mTOR). Cells transfected with small hairpin RNA (shRNA) for AMPK significantly increased the phosphorylation of mTOR as well as decreased the induction of autophagy followed by enhancing cell apoptosis during I/R. Moreover, the mTOR inhibitor RAD001 significantly enhanced autophagy and attenuated cell apoptosis during I/R. Taken together, these findings suggest that autophagy induction protects renal tubular cell injury via an AMPK-regulated mTOR pathway in an in vitro I/R injury model. AMPK-evoked autophagy may be as a potential target for therapeutic intervention in I/R renal injury.	[Wang, Li-Ting; Chen, Bo-Lin; Wu, Cheng-Tien; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How] Natl Taiwan Univ, Coll Med, Dept Urol, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chiang, CK (corresponding author), Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan.	ckchiang@ntu.edu.tw; shinghwaliu@ntu.edu.tw	Wu, Cheng-Tien/ABE-9509-2022; Wu, Cheng-Tien/AAF-5177-2019	CHIANG, CHIH-KANG/0000-0001-9021-4616; Huang, Kuo-How/0000-0002-0989-0578; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC97-2314-B-002-052-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grant from the National Science Council of Taiwan (NSC97-2314-B-002-052-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2012, BMB REP, V45, P489, DOI 10.5483/BMBRep.2012.45.9.169; Andreucci M, 2003, KIDNEY INT, V64, P1189, DOI 10.1046/j.1523-1755.2003.00204.x; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Castaneda MP, 2003, TRANSPLANTATION, V76, P50, DOI 10.1097/01.TP.0000069835.95442.9F; Chiang CK, 2011, BRIT J PHARMACOL, V163, P586, DOI 10.1111/j.1476-5381.2011.01242.x; CONGER JD, 1995, J INVEST MED, V43, P431; Cryer HG, 1997, SHOCK, V8, P26, DOI 10.1097/00024382-199707000-00005; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Inal M, 2002, CELL BIOCHEM FUNCT, V20, P291, DOI 10.1002/cbf.953; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jeyaraj SC, 2006, AM J PHYSIOL-RENAL, V291, pF1255, DOI 10.1152/ajprenal.00440.2005; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Jin QR, 2004, BIOCHEM BIOPH RES CO, V315, P555, DOI 10.1016/j.bbrc.2004.01.093; Kolyada AY, 2008, AM J NEPHROL, V28, P203, DOI 10.1159/000110089; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Lee HT, 2002, J AM SOC NEPHROL, V13, P2753, DOI 10.1097/01.ASN.0000032421.79225.6E; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Matsuyama M, 2004, EXPERT OPIN BIOL TH, V4, P1931, DOI 10.1517/14712598.4.12.1931; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Molitoris BA, 2004, KIDNEY INT, V66, P871, DOI 10.1111/j.1523-1755.2004.00818.x; Munafo DB, 2001, J CELL SCI, V114, P3619; Okusa MD, 2002, AM J PHYSIOL-RENAL, V282, pF10, DOI 10.1152/ajprenal.2002.282.1.F10; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Takagi H, 2007, AUTOPHAGY, V3, P405, DOI 10.4161/auto.4281; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tilney NL, 1997, TRANSPLANTATION, V64, P945, DOI 10.1097/00007890-199710150-00001; Wolf G, 1997, J CLIN INVEST, V100, P1047, DOI 10.1172/JCI119615; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Wu CT, 2010, TOXICOL SCI, V114, P295, DOI 10.1093/toxsci/kfq006; Xie J, 2006, J AM SOC NEPHROL, V17, P3336, DOI 10.1681/ASN.2006040311; Xie ZL, 2011, AUTOPHAGY, V7, P1254, DOI 10.4161/auto.7.10.16740; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Xu M, 2011, ACTA PHARMACOL SIN, V32, P1089, DOI 10.1038/aps.2011.50; Yen YP, 2012, ARCH TOXICOL, V86, P923, DOI 10.1007/s00204-012-0864-9	47	50	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79814	10.1371/journal.pone.0079814	http://dx.doi.org/10.1371/journal.pone.0079814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223196	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200089
J	McIlroy, SK; Lind, AJ; Allen-Diaz, BH; Roche, LM; Frost, WE; Grasso, RL; Tate, KW				McIlroy, Susan K.; Lind, Amy J.; Allen-Diaz, Barbara H.; Roche, Leslie M.; Frost, William E.; Grasso, Rob L.; Tate, Kenneth W.			Determining the Effects of Cattle Grazing Treatments on Yosemite Toads (Anaxyrus [=Bufo] canorus) in Montane Meadows	PLOS ONE			English	Article							AMPHIBIAN POPULATION DECLINES; COLUMBIA SPOTTED FROG; SIERRA-NEVADA; HABITAT; CALIFORNIA; EXTINCTIONS; COMMUNITIES; FLOODPLAIN; MECHANISMS; LIVESTOCK	Amphibians are experiencing a precipitous global decline, and population stability on public lands with multiple uses is a key concern for managers. In the Sierra Nevada Mountains (California, USA), managers have specifically identified livestock grazing as an activity that may negatively affect Yosemite toads due to the potential overlap of grazing with toad habitat. Grazing exclusion from Yosemite toad breeding and rearing areas and/or entire meadows have been proposed as possible management actions to alleviate the possible impact of cattle on this species. The primary objective of this study was to determine if different fencing treatments affect Yosemite toad populations. We specifically examined the effect of three fencing treatments on Yosemite toad breeding pool occupancy, tadpoles, and young of the year (YOY). Our hypothesis was that over the course of treatment implementation (2006 through 2010), Yosemite toad breeding pool occupancy and early life stage densities would increase within two fencing treatments relative to actively grazed meadows due to beneficial changes to habitat quality in the absence of grazing. Our results did not support our hypothesis, and showed no benefit to Yosemite toad presence or early life stages in fenced or partially fenced meadows compared to standard USDA Forest Service grazing levels. We found substantial Yosemite toad variation by both meadow and year. This variation was influenced by meadow wetness, with water table depth significant in both the tadpole and YOY models.	[McIlroy, Susan K.; Allen-Diaz, Barbara H.] Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA; [Lind, Amy J.; Grasso, Rob L.] USDA Forest Serv, Pacific Southwest Res Stn, Davis, CA USA; [Roche, Leslie M.; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Frost, William E.] Agr & Nat Resources Res & Extens Ctr, Davis, CA USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	McIlroy, SK (corresponding author), USGS Forest & Rangeland Ecosyst Sci Ctr, Snake River Field Stn, Boise, ID 83706 USA.	smcilroy@usgs.gov		Roche, Leslie/0000-0003-2954-8056	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by USDA Forest Service, Pacific Southwest Region. Other than providing preliminary data, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bull EL, 2000, J RANGE MANAGE, V53, P291, DOI 10.2307/4003434; Burton EC, 2009, J WILDLIFE MANAGE, V73, P269, DOI 10.2193/2007-562; California Department of Fish and Game, 2011, CAL NAT DAT SPEC AN; Chambers JC, 1999, J RANGE MANAGE, V52, P92, DOI 10.2307/4003497; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Derlet RW, 2012, J ENV PUBLIC HLTH, V2012; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; George M, 2007, RANGELAND MANAGEMENT, V8217, P20; Healey M, 1997, AUST J ECOL, V22, P270, DOI 10.1111/j.1442-9993.1997.tb00672.x; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Interagency Technical Team, 1996, BLMRSST96004; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jennings M. R., 1994, AMPHIBIAN REPTILE SP; Jennings Mark R., 1996, P921; Jofre MB, 1999, ENVIRON TOXICOL CHEM, V18, P1806, DOI 10.1002/etc.5620180829; KARLSTROM ERNEST L., 1962, UNIV CALIFORNIA PUBL ZOO1, V62, P1; Knapp RA, 2001, ECOL MONOGR, V71, P401, DOI 10.1890/0012-9615(2001)071[0401:RAROAL]2.0.CO;2; Liang C.T., 2010, THESIS U CALIFORNIA; Lind AJ, 2011, DETERMINING EFFECTS, V5, P25; McIlroy SK, 2012, WETL ECOL MANAG, V20, P287, DOI 10.1007/s11273-012-9253-7; Mcllroy S.K., 2011, RANGELAND ECOL MANAG, V64, P187, DOI [10.2111/REM-D-09-00130.1, DOI 10.2111/REM-D-09-00130.1]; Mcllroy SK, 2008, THESIS U CALIFORNIA; Morton ML, 2010, HERPETOL CONSERV BIO, V5, P388; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Sadinsky W, 2004, FINAL REPORT YOSEMIT; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Sherman C.K., 1980, THESIS U MICHIGAN; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; SHERMAN CK, 1984, NAT HIST, V93, P72; Sparling DW, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P257; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; [USDA] US DEPARTMENT OF AGRICULTURE, 2001, SIERR NEV FOR PLAN A; USDI, 2002, FED REGISTER, V67, P75834; USDI, 2004, FED REGISTER, V69, P25876; Weixelman DA, 1996, R4ECOL9601; IUCN RED LIST THREAT	44	8	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79263	10.1371/journal.pone.0079263	http://dx.doi.org/10.1371/journal.pone.0079263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223919	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400057
J	Stein, C; Makarewicz, O; Pfeifer, Y; Brandt, C; Ramos, JC; Klinger, M; Pletz, MW				Stein, Claudia; Makarewicz, Oliwia; Pfeifer, Yvonne; Brandt, Christian; Ramos, Joao Costa; Klinger, Mareike; Pletz, Mathias W.			Direct RNA-Based Detection and Differentiation of CTX-M-Type Extended-Spectrum beta-Lactamases (ESBL)	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIMICROBIAL THERAPY; INFECTIONS; IMPACT; ENTEROBACTERIACEAE; EMERGENCE; MORTALITY	The current global spread of multi-resistant Gram-negatives, particularly extended spectrum beta-lactamases expressing bacteria, increases the likelihood of inappropriate empiric treatment of critically ill patients with subsequently increased mortality. From a clinical perspective, fast detection of resistant pathogens would allow a pre-emptive correction of an initially inappropriate treatment. Here we present diagnostic amplification-sequencing approach as proof of principal based on the fast molecular detection and correct discrimination of CTX-M-beta-lactamases, the most frequent ESBL family. The workflow consists of the isolation of total mRNA and CTX-M-specific reverse transcription (RT), amplification and pyrosequencing. Due to the high variability of the CTX-M-beta-lactamasegenes, degenerated primers for RT, qRT as well as for pyrosequencing, were used and the suitability and discriminatory performance of two conserved positions within the CTX-M genes were analyzed, using one protocol for all isolates and positions, respectively. Using this approach, no information regarding the expected CTX-M variant is needed since all sequences are covered by these degenerated primers. The presented workflow can be conducted within eight hours and has the potential to be expanded to other beta-lactamase families.	[Stein, Claudia; Makarewicz, Oliwia; Brandt, Christian; Ramos, Joao Costa; Klinger, Mareike; Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany; [Makarewicz, Oliwia; Klinger, Mareike; Pletz, Mathias W.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Pfeifer, Yvonne] Robert Koch Inst, Wernigerode, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Robert Koch Institute	Pletz, MW (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany.	Mathias.pletz@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Brandt, Christian/0000-0002-7199-3957	German Ministry of Education and Research (BMBF) [01KI1204, 01EO1002]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the German Ministry of Education and Research (BMBF); grant numbers 01KI1204 and 01EO1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; CLSI, 2012, M100MS22 CLSI; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Dalhoff K, 2012, Pneumologie, V66, P707, DOI 10.1055/s-0032-1325924; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Eller C, J ANTIMICROB CHEMOTH; European Study Group on Antibiotic Resistance, 1987, EUR J CLIN MICROBIOL, V6, P460, DOI [10.1007/BF02013111, DOI 10.1007/BF02013111]; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; Leclercq R, 2013, CLIN MICROBIOL INFEC, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11; Marra AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-24; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Novais A, 2008, ANTIMICROB AGENTS CH, V52, P2377, DOI 10.1128/AAC.01658-07; Novais A, 2006, ANTIMICROB AGENTS CH, V50, P2741, DOI 10.1128/AAC.00274-06; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2012, ANTIMICROB AGENTS CH, V56, P2125, DOI 10.1128/AAC.05315-11; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pfeifer Y, 2009, EMERG INFECT DIS, V15, P1533, DOI 10.3201/eid1509.090567; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; Reinhart K, 2010, Ger Med Sci, V8, pDoc14, DOI 10.3205/000103; Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80079	10.1371/journal.pone.0080079	http://dx.doi.org/10.1371/journal.pone.0080079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224038	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400110
J	Vega, Y; Marques, I; Castro, S; Loureiro, J				Vega, Yesenia; Marques, Isabel; Castro, Silvia; Loureiro, Joao			Outcomes of Extensive Hybridization and Introgression in Epidendrum (Orchidaceae): Can We Rely on Species Boundaries?	PLOS ONE			English	Article							GENOME SIZE; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; FLOW-CYTOMETRY; HYBRIDS; POLLINATION; DIVERGENCE; PATTERNS; BARRIERS; PROGRAM	Hybridization has the potential to contribute to phenotypic and genetic variation and can be a major evolutionary mechanism. However, when hybridization is extensive it can also lead to the blurring of species boundaries and the emergence of cryptic species (i.e., two or more species not distinguishable morphologically). In this study, we address this hypothesis in Epidendrum, the largest Neotropical genus of orchids where hybridization is apparently so common that it may explain the high levels of morphological diversity found. Nonetheless, this hypothesis is mostly based on the intermediacy of morphological characters and intermediacy by itself is not a proof of hybridization. Therefore, in this study, we first assessed the existence of hybrids using cpDNA and AFLP data gathered from a large-scale sampling comprising 1038 plants of three species of Epidendrum (E. calanthum, E. cochlidium and E. schistochilum). Subsequently, a Bayesian assignment of individuals into different genetic classes (pure species, F1, F2 or backcross generations) revealed that hybrid genotypes were prevalent in all sympatric populations. In most cases, parental species were not assigned as pure individuals, rather consisting in backcrossed genotypes or F1 hybrids. We also found that reproductive barriers are apparently very weak in Epidendrum because the three species largely overlapped in their flowering periods and interspecific crosses always produced viable seeds. Further, hybridization contributed to enhance floral variability, genome size and reproductive success since we found that these traits were always higher in hybrid classes (F1, F2 and backcrosses) than in pure parental species, and offer an explanation for the blurring of species boundaries in this genus of orchids. We hypothesize that these natural hybrids possess an evolutionary advantage, which may explain the high rates of cryptic species observed in this genus.	[Vega, Yesenia; Marques, Isabel] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador; [Marques, Isabel] Univ Zaragoza, High Polytech Sch Huesca, Dept Agr Bot, Huesca, Spain; [Castro, Silvia; Loureiro, Joao] Univ Coimbra, Dept Life Sci, CFE Ctr Funct Ecol, Coimbra, Portugal	Universidad Tecnica Particular de Loja; University of Zaragoza; Universidade de Coimbra	Marques, I (corresponding author), Univ British Columbia, UBC Bot Garden, Vancouver, BC V5Z 1M9, Canada.	isabel.ic@gmail.com	Castro, Sílvia/C-2469-2008; Marques, Isabel/G-6773-2015; loureiro, joão/GZL-6236-2022; Loureiro, João/B-4830-2008	Castro, Sílvia/0000-0002-7358-6685; Marques, Isabel/0000-0001-9788-4831; Loureiro, João/0000-0002-9068-3954	IM though a postdoctoral grant [PROY-CBCM-0021]; Portuguese Foundation for Science and Technology and European Social Funds [FCT/SFRH/BPD/41200/2007]	IM though a postdoctoral grant; Portuguese Foundation for Science and Technology and European Social Funds	UTPL financed the work of IM though a postdoctoral grant (PROY-CBCM-0021) and the Portuguese Foundation for Science and Technology and European Social Funds financed the work of SC (FCT/SFRH/BPD/41200/2007). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Anderson EC, 2002, GENETICS, V160, P1217; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; ARNOLD ML, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P115; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bures P, 2004, ANN BOT-LONDON, V94, P353, DOI 10.1093/aob/mch151; Campbell DR, 2005, OECOLOGIA, V144, P214, DOI 10.1007/s00442-005-0064-x; Chung MY, 2005, MOL ECOL, V14, P4389, DOI 10.1111/j.1365-294X.2005.02738.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Gay L, 2007, MOL ECOL, V16, P3215, DOI 10.1111/j.1365-294X.2007.03363.x; Hagsater E., 2005, GENERA ORCHIDACEARUM, P236; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; Kim SC, 1999, GENETICS, V153, P965; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 1998, EVOLUTION, V52, P503, DOI 10.1111/j.1558-5646.1998.tb01649.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mant J, 2005, MOL ECOL, V14, P3067, DOI 10.1111/j.1365-294X.2005.02659.x; Marques I, 2012, ANN BOT-LONDON, V109, P257, DOI 10.1093/aob/mcr282; Marques I, 2011, J ECOL, V99, P1508, DOI 10.1111/j.1365-2745.2011.01876.x; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Mayr E., 1942, SYSTEMATICS ORIGIN S; McMillan WO, 1999, EVOLUTION, V53, P247, DOI 10.1111/j.1558-5646.1999.tb05350.x; Muntzing A, 1932, HEREDITAS, V16, P105; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Pansarin ER, 2008, FLORA, V203, P474, DOI 10.1016/j.flora.2007.07.004; Peakall R, 1997, AUST J BOT, V45, P839, DOI 10.1071/BT96081; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; Pinheiro F, 2009, PLANT SYST EVOL, V283, P165, DOI 10.1007/s00606-009-0224-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rayburn AL, 1993, CLASSICAL MOL CYTOGE, p[110, 95]; Rencher AC, 2002, METHODS MULTIVARIATE; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scopece G, 2008, AM NAT, V171, P315, DOI 10.1086/527501; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tiffin P, 2001, P ROY SOC B-BIOL SCI, V268, P861, DOI 10.1098/rspb.2000.1578; UNEP-WCMC, 2003, UNEP WCMC SPEC DAT C; Vega Y., 2011, EVOLUCION BARRERAS R; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wendt T, 2002, PLANT SYST EVOL, V232, P201, DOI 10.1007/s006060200043; Xu SQ, 2011, EVOLUTION, V65, P2606, DOI 10.1111/j.1558-5646.2011.01323.x	57	24	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80662	10.1371/journal.pone.0080662	http://dx.doi.org/10.1371/journal.pone.0080662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224057	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400121
J	Zehendner, CM; Tsohataridis, S; Luhmann, HJ; Yang, JW				Zehendner, Christoph M.; Tsohataridis, Simeon; Luhmann, Heiko J.; Yang, Jenq-Wei			Developmental Switch in Neurovascular Coupling in the Immature Rodent Barrel Cortex	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; VIBRISSAL STIMULATION; NEURONAL-ACTIVITY; RESPONSES; CHILDREN; DENSITY; MICE	Neurovascular coupling (NVC) in the adult central nervous system (CNS) is a mechanism that provides regions of the brain with more oxygen and glucose upon increased levels of neural activation. Hemodynamic changes that go along with neural activation evoke a blood oxygen level-dependent (BOLD) signal in functional magnetic resonance imaging (fMRI) that can be used to study brain activity non-invasively. A correct correlation of the BOLD signal to neural activity is pivotal to understand this signal in neuronal development, health and disease. However, the function of NVC during development is largely unknown. The rodent whisker-to-barrel cortex is an experimentally well established model to study neurovascular interdependences. Using extracellular multi-electrode recordings and laser-Doppler-flowmetry (LDF) we show in the murine barrel cortex of postnatal day 7 (P7) and P30 mice in vivo that NVC undergoes a physiological shift during the first month of life. In the mature CNS it is well accepted that cortical sensory processing results in a rise in regional cerebral blood flow (rCBF). We show in P7 animals that rCBF decreases during prolonged multi-whisker stimulation and goes along with multi unit activity (MUA) fatigue. In contrast at P30, MUA remains stable during repetitive stimulation and is associated with an increase in rCBF. Further we characterize in both age groups the responses in NVC to single sensory stimuli. We suggest that the observed shift in NVC is an important process in cortical development that may be of high relevance for the correct interpretation of brain activity e.g. in fMRI studies of the immature central nervous system (CNS).	[Zehendner, Christoph M.; Tsohataridis, Simeon; Luhmann, Heiko J.; Yang, Jenq-Wei] Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany.	Zehendner@uni-mainz.de; YangJ@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	University Medical Center of the Johannes Gutenberg-University Mainz; Deutsche Studienstiftung	University Medical Center of the Johannes Gutenberg-University Mainz; Deutsche Studienstiftung	HJL was supported by DFG grants, CMZ is supported by a Stufe 1 grant of the University Medical Center of the Johannes Gutenberg-University Mainz, ST is supported by the Deutsche Studienstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2012, J NEUROSCI, V32, P9511, DOI 10.1523/JNEUROSCI.1212-12.2012; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayata C, 1996, J CEREBR BLOOD F MET, V16, P539, DOI 10.1097/00004647-199607000-00002; Barber PA, 2013, SENSORS-BASEL, V13, P6981, DOI 10.3390/s130606981; CHIRON C, 1992, J NUCL MED, V33, P696; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; D'Agostino RB, 1990, EST DEPARTURES NORMA, V44, P316; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Enager P, 2009, J CEREBR BLOOD F MET, V29, P976, DOI 10.1038/jcbfm.2009.23; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; FORAN DR, 1992, J NEUROSCI, V12, P4890; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kocharyan A, 2008, J CEREBR BLOOD F MET, V28, P221, DOI 10.1038/sj.jcbfm.9600558; Kozberg MG, 2013, P NATL ACAD SCI USA, V110, P4380, DOI 10.1073/pnas.1212785110; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; Lecrux C, 2011, J NEUROSCI, V31, P9836, DOI 10.1523/JNEUROSCI.4943-10.2011; Li J, 2011, EUR J NEUROSCI, V34, P1983, DOI 10.1111/j.1460-9568.2011.07927.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ma JY, 1996, AM J PHYSIOL-HEART C, V270, pH1085, DOI 10.1152/ajpheart.1996.270.3.H1085; Martin E, 1999, PEDIATR RES, V46, P135, DOI 10.1203/00006450-199908000-00001; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Roche-Labarbe N, 2013, NEUROIMAGE, DOI [10.1016/j.neuroimage.2013.01.035, DOI 10.1016/J.NEUR0IMAGE.2013.01.035.PUBMED:23370052]; Seidl AH, 2013, NEUROSCIENCE; Sengupta B, 2013, J CEREBR BLOOD F MET, V33, P1465, DOI 10.1038/jcbfm.2013.103; Takuwa H, 2013, J CEREBR BLOOD F MET, V33, P774, DOI 10.1038/jcbfm.2013.16; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Wojtkiewicz S, 2009, PHYS MED BIOL, V54, P679, DOI 10.1088/0031-9155/54/3/014; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; Yang JW, 2013, CEREB CORTEX, V23, P1299, DOI 10.1093/cercor/bhs103; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062628	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80749	10.1371/journal.pone.0080749	http://dx.doi.org/10.1371/journal.pone.0080749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224059	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400122
J	Zhu, YN; Shi, DQ; Ruan, MB; Zhang, LL; Meng, ZH; Liu, J; Yang, WC				Zhu, Ya-Na; Shi, Dong-Qiao; Ruan, Meng-Bin; Zhang, Li-Li; Meng, Zhao-Hong; Liu, Jie; Yang, Wei-Cai			Transcriptome Analysis Reveals Crosstalk of Responsive Genes to Multiple Abiotic Stresses in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; CONFERS ENHANCED TOLERANCE; DEPENDENT PROTEIN-KINASE; HIGH-SALINITY STRESSES; ABSCISIC-ACID; OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; STARCH DEGRADATION; FREEZING TOLERANCE	Abiotic stress is a major environmental factor that limits cotton growth and yield, moreover, this problem has become more and more serious recently, as multiple stresses often occur simultaneously due to the global climate change and environmental pollution. In this study, we sought to identify genes involved in diverse stresses including abscisic acid (ABA), cold, drought, salinity and alkalinity by comparative microarray analysis. Our result showed that 5790, 3067, 5608, 778 and 6148 transcripts, were differentially expressed in cotton seedlings under treatment of ABA (1 mu M ABA), cold (4 degrees C), drought (200mM mannitol), salinity (200mM NaCl) and alkalinity (pH= 11) respectively. Among the induced or suppressed genes, 126 transcripts were shared by all of the five kinds of abiotic stresses, with 64 up-regulated and 62 down-regulated. These common members are grouped as stress signal transduction, transcription factors (TFs), stress response/defense proteins, metabolism, transport facilitation, as well as cell wall/structure, according to the function annotation. We also noticed that large proportion of significant differentially expressed genes specifically regulated in response to different stress. Nine of the common transcripts of multiple stresses were selected for further validation with quantitative real time RT-PCR (qRT-PCR). Furthermore, several well characterized TF families, for example, WRKY, MYB, NAC, AP2/ERF and zinc finger were shown to be involved in different stresses. As an original report using comparative microarray to analyze transcriptome of cotton under five abiotic stresses, valuable information about functional genes and related pathways of anti-stress, and/or stress tolerance in cotton seedlings was unveiled in our result. Besides this, some important common factors were focused for detailed identification and characterization. According to our analysis, it suggested that there was crosstalk of responsive genes or pathways to multiple abiotic or even biotic stresses, in cotton. These candidate genes will be worthy of functional study under diverse stresses.	[Zhu, Ya-Na; Shi, Dong-Qiao; Ruan, Meng-Bin; Zhang, Li-Li; Meng, Zhao-Hong; Liu, Jie; Yang, Wei-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Shi, DQ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	dqshi@genetics.ac.cn; wcyang@genetics.ac.cn	Yang, Wei-Cai/AAX-7879-2021	Yang, Wei-Cai/0000-0003-0252-7079	Chinese National Major Program on Transgenic Organisms, Ministry of Agriculture of China [2013ZX08009-003]; DQS [2013ZX08009-004]	Chinese National Major Program on Transgenic Organisms, Ministry of Agriculture of China; DQS	This work was supported by Chinese National Major Program on Transgenic Organisms from Ministry of Agriculture of China to WCY (2013ZX08009-003) and DQS (2013ZX08009-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Antolin-Llovera M, 2011, PLANT SIGNAL BEHAV, V6, P1127, DOI 10.4161/psb.6.8.16363; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Cheng H, 2013, MOL BIOL REP, V40, P707, DOI 10.1007/s11033-012-2111-0; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Curtiss J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-49; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gao SQ, 2009, PLANT CELL REP, V28, P301, DOI 10.1007/s00299-008-0623-9; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Harish SR, 2011, ENVIRON RES, V111, P1070, DOI 10.1016/j.envres.2011.07.002; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Jin LG, 2010, J INTEGR PLANT BIOL, V52, P485, DOI 10.1111/j.1744-7909.2010.00914.x; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kode A, 2004, FUND CLIN PHARMACOL, V18, P565, DOI 10.1111/j.1472-8206.2004.00274.x; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotaka A, 2008, J BIOSCI BIOENG, V105, P622, DOI 10.1263/jbb.105.622; Lakhssassi N, 2012, PLANT PHYSIOL, V158, P1252, DOI 10.1104/pp.111.188920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li DD, 2013, NEW PHYTOL, V199, P695, DOI 10.1111/nph.12309; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Pais SM, 2009, PLANT SIGNAL BEHAV, V4, P1013, DOI 10.4161/psb.4.11.9783; Marrocco K, 2006, PLANT J, V45, P423, DOI 10.1111/j.1365-313X.2005.02635.x; Mathioudakis MM, 2012, VIRUS RES, V163, P28, DOI 10.1016/j.virusres.2011.08.007; Medina-Silva R, 2006, RES MICROBIOL, V157, P275, DOI 10.1016/j.resmic.2005.07.004; Meng XP, 2010, PLANT MOL BIOL REP, V28, P176, DOI 10.1007/s11105-009-0136-x; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munshi MK, 2006, PLANT PHYSIOL, V141, P737, DOI 10.1104/pp.106.080267; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ozler A, 2008, PREP BIOCHEM BIOTECH, V38, P358, DOI 10.1080/10826060802325469; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Pang Y, 2010, PLANT BIOLOGY, V12, P903, DOI 10.1111/j.1438-8677.2009.00313.x; Park W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-90; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rapala-Kozik M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-2; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; Romieu I, 2008, EUR RESPIR J, V31, P179, DOI 10.1183/09031936.00128106; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Rosado A, 2010, PLANT SIGNAL BEHAV, V5, P450, DOI 10.4161/psb.5.4.11341; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Ruan YL, 2013, J INTEGR PLANT BIOL, V55, P572, DOI 10.1111/jipb.12074; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Samajova O, 2013, BIOTECHNOL ADV, V31, P118, DOI 10.1016/j.biotechadv.2011.12.002; Samaniego R, 2006, PLANTA, V223, P1201, DOI 10.1007/s00425-005-0168-x; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Seto Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2316, DOI 10.1271/bbb.110454; Shi HT, 2013, PLANT PHYSIOL BIOCH, V67, P209, DOI 10.1016/j.plaphy.2013.03.016; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shi YT, 2013, NEW PHYTOL, V199, P135, DOI 10.1111/nph.12275; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Sun HL, 2011, J EXP BOT, V62, P5713, DOI 10.1093/jxb/err274; Suzuki K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-38; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tani T, 2008, PLANTA, V227, P517, DOI 10.1007/s00425-007-0635-7; Tonelli F, 2013, BRIT J PHARMACOL, V168, P1497, DOI 10.1111/bph.12035; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; van Ooijen G, 2010, PLANT J, V63, P563, DOI 10.1111/j.1365-313X.2010.04260.x; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; You MK, 2010, PLANT PHYSIOL, V152, P1015, DOI 10.1104/pp.109.147645; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	95	77	87	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80218	10.1371/journal.pone.0080218	http://dx.doi.org/10.1371/journal.pone.0080218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224045	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400115
J	Gajda, MJ; Zapien, DM; Uchikawa, E; Dock-Bregeon, AC				Gajda, Michal Jan; Zapien, Denise Martinez; Uchikawa, Emiko; Dock-Bregeon, Anne-Catherine			Modeling the Structure of RNA Molecules with Small-Angle X-Ray Scattering Data	PLOS ONE			English	Article							PREDICTION; RESOLUTION; PROTEINS; PROGRAM; MOTIFS; LOOPS	We propose a novel fragment assembly method for low-resolution modeling of RNA and show how it may be used along with small-angle X-ray solution scattering (SAXS) data to model low-resolution structures of particles having as many as 12 independent secondary structure elements. We assessed this model-building procedure by using both artificial data on a previously proposed benchmark and publicly available data. With the artificial data, SAXS-guided models show better similarity to native structures than ROSETTA decoys. The publicly available data showed that SAXS-guided models can be used to reinterpret RNA structures previously deposited in the Protein Data Bank. Our approach allows for fast and efficient building of de novo models of RNA using approximate secondary structures that can be readily obtained from existing bioinformatic approaches. We also offer a rigorous assessment of the resolving power of SAXS in the case of small RNA structures, along with a small multimetric benchmark of the proposed method.	[Gajda, Michal Jan] Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Niedersachsen, Germany; [Gajda, Michal Jan] European Mol Biol Labs, Hamburg, Germany; [Zapien, Denise Martinez; Uchikawa, Emiko; Dock-Bregeon, Anne-Catherine] Inst Genet & Biol Mol & Cellulaire, Lab Biol & Genom Struct, Illkirch Graffenstaden, Bas Rhin, France; [Dock-Bregeon, Anne-Catherine] Inst Biol Ecole Normale Super, Paris, Ile De France, France	Max Planck Society; European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Gajda, MJ (corresponding author), Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Niedersachsen, Germany.	miga@nmr.mpibpc.mpg.de		Dock-Bregeon, Anne-Catherine/0000-0002-6913-4061; UCHIKAWA, Emiko/0000-0003-0442-767X	SAXIER [RIDS-011934]; French Agency for Research [ANR-06-BLAN-0072]; CNRS; INSERM; University of Strasbourg; SPINE-2 European project [LSHG-CT-2006-031220]; CONACYT, Mexico; Association pour la Recherche sur le Cancer (ARC)	SAXIER; French Agency for Research(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; SPINE-2 European project; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work of MJG was partially funded by the SAXIER (RIDS-011934) grant from EU. ACDB and DMZ were funded by French Agency for Research (grant TrscrREGsnRNP ANR-06-BLAN-0072); CNRS, INSERM, University of Strasbourg and the SPINE-2 European project (Contract LSHG-CT-2006-031220). DMZ received a doctoral fellowship from CONACYT, Mexico, and Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Bothe JR, 2011, NAT METHODS, V8, P919, DOI [10.1038/NMETH.1735, 10.1038/nmeth.1735]; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Durney MA, 2010, J MOL BIOL, V404, P555, DOI 10.1016/j.jmb.2010.08.042; Ellson J, 2004, MATH VIS, P127; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Gillespie J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-369; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Jonikas MA, 2009, RNA, V15, P189, DOI 10.1261/rna.1270809; Jossinet F, 2010, BIOINFORMATICS; Karaduman R, 2006, J MOL BIOL, V356, P1248, DOI 10.1016/j.jmb.2005.12.013; Kladwang W, 2012, J AM CHEM SOC, V134, P1404, DOI 10.1021/ja2093508; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAVERY R, 1995, COMPUT PHYS COMMUN, V91, P135, DOI 10.1016/0010-4655(95)00046-I; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Parisien M, 2012, J STRUCT BIOL, V179, P252, DOI 10.1016/j.jsb.2011.12.024; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Puton T, 2012, A SERVER FOR CONTINU; Reinharz V, 2012, BIOINFORMATICS, V28, pI207, DOI 10.1093/bioinformatics/bts226; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Standley DM, 1999, J MOL BIOL, V285, P1691, DOI 10.1006/jmbi.1998.2372; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun D, 1987, STRUCTURE ANAL SMALL, DOI 10.1007/978-1-4757-6624-0_1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Yang SC, 2010, J PHYS CHEM B, V114, P10039, DOI 10.1021/jp1057308; Zhang Q, 2008, NAT METHODS, V5, P243, DOI 10.1038/NMETH.1180; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	50	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78007	10.1371/journal.pone.0078007	http://dx.doi.org/10.1371/journal.pone.0078007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223750	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400027
J	Wang, QS; Mohamed, AAM; Takeda, M				Wang, Qiushi; Mohamed, Ahmed A. M.; Takeda, Makio			Serotonin Receptor B May Lock the Gate of PTTH Release/Synthesis in the Chinese Silk Moth, Antheraea pernyi; A Diapause Initiation/Maintenance Mechanism?	PLOS ONE			English	Article							PROTHORACICOTROPIC HORMONE PTTH; CEPHALIC NERVOUS-SYSTEM; CORPUS ALLATUM COMPLEX; BOMBYX-MORI; MANDUCA-SEXTA; INSECT PHOTOPERIODISM; ECLOSION HORMONE; PUPAL DIAPAUSE; BRAIN; DROSOPHILA	The release of prothoracicotropic hormone, PTTH, or its blockade is the major endocrine switch regulating the developmental channel either to metamorphosis or to pupal diapause in the Chinese silk moth, Antheraea pernyi. We have cloned cDNAs encoding two types of serotonin receptors (5HTR(A and B)). 5HTR(A-), and 5HTR(B)-like immunohistochemical reactivities (-ir) were colocalized with PTTH-ir in two pairs of neurosecretory cells at the dorsolateral region of the protocerebrum (DL). Therefore, the causal involvement of these receptors was suspected in PTTH release/synthesis. The level of mRNA(5HTRB) responded to 10 cycles of long-day activation, falling to 40% of the original level before activation, while that of 5HTR(A) was not affected by long-day activation. Under LD 16:8 and 12:12, the injection of dsRNA(5HTRB) resulted in early diapause termination, whereas that of dsRNA(5HTRA) did not affect the rate of diapause termination. The injection of dsRNA(5HTRB) induced PTTH accumulation, indicating that 5HTR(B) binding suppresses PTTH synthesis also. This conclusion was supported pharmacologically; the injection of luzindole, a melatonin receptor antagonist, plus 5th inhibited photoperiodic activation under LD 16:8, while that of 5,7-DHT, induced emergence in a dose dependent fashion under LD 12:12. The results suggest that 5HTR(B) may lock the PTTH release/synthesis, maintaining diapause. This could also work as diapause induction mechanism.	[Wang, Qiushi; Mohamed, Ahmed A. M.; Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan	Kobe University	Takeda, M (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.	mtakeda@kobe-u.ac.jp			JSPS [15003114]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by JSPS grant (15003114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHIYAMADA T, 1994, EUR J BIOCHEM, V220, P633, DOI 10.1111/j.1432-1033.1994.tb18665.x; Bembenek J, 2004, THESIS KOBE U; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks HV, 2003, EUR J ENTOMOL, V100, P209, DOI 10.14411/eje.2003.036; HEWES RS, 1991, J COMP PHYSIOL A, V168, P697; Hiragaki S, 2009, CELL TISSUE RES, V335, P607, DOI 10.1007/s00441-008-0747-9; Hiragaki Susumu, 2009, International Journal of Wild Silkmoth & Silk, V13, P1; Ichihara N, 2000, THESIS KOBE U; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; MIZOGUCHI A, 1990, DEV GROWTH DIFFER, V32, P591; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Richter K, 2000, J PINEAL RES, V28, P129; Roy A, 2012, ZOOL SCI, V29, P333, DOI 10.2108/zsj.29.333; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; Saunders DS, 2011, ENTOMOL SCI, V14, P235, DOI 10.1111/j.1479-8298.2011.00463.x; Saunders DS, 2005, J INSECT PHYSIOL, V51, P599, DOI 10.1016/j.jinsphys.2004.12.002; Sedlak BJ, 1981, ENDOCRINOLOGIST, V44, P207; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Shao QM, 2010, J INSECT PHYSIOL, V56, P1576, DOI 10.1016/j.jinsphys.2010.05.015; Shionoya M, 2003, INSECT BIOCHEM MOLEC, V33, P795, DOI 10.1016/S0965-1748(03)00078-X; SHIRAI Y, 1994, J INSECT PHYSIOL, V40, P469, DOI 10.1016/0022-1910(94)90119-8; SHIRAI Y, 1995, COMP BIOCHEM PHYS C, V110, P143, DOI 10.1016/0742-8413(94)00101-F; Takeda M, 1997, EUR J ENTOMOL, V94, P67; Takeda Makio, 2011, International Journal of Wild Silkmoth & Silk, V16, P97; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; TOMIOKA K, 1993, NATURWISSENSCHAFTEN, V80, P137, DOI 10.1007/BF01131019; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tsugehara T, 2013, COMP BIOCHEM PHYS C, V157, P93, DOI 10.1016/j.cbpc.2012.10.003; Uno T, 2013, HISTOCHEM CELL BIOL, V139, P299, DOI 10.1007/s00418-012-1021-5; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; WILLIAMS CM, 1964, SCIENCE, V144, P569, DOI 10.1126/science.144.3618.569-c; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	39	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79381	10.1371/journal.pone.0079381	http://dx.doi.org/10.1371/journal.pone.0079381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223937	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400110
J	Xu, GD; Xin, X; Zheng, CY				Xu, Guodong; Xin, Xiu; Zheng, Congyi			GPS2 Is Required for the Association of NS5A with VAP-A and Hepatitis C Virus Replication	PLOS ONE			English	Article							RNA REPLICATION; G-PROTEIN; COMPLEX; DOMAIN; PHOSPHORYLATION; PATHWAY; BINDING	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of the replication complex associated with various cellular proteins. It has been reported that G protein pathway suppressor 2 (GPS2) is a potential NS5A-binding factor, as identified in a yeast two-hybrid screens of human cDNA library using viral proteins as baits [1]. In this study, we demonstrated the interaction between GPS2 and NS5A in mammalian cells by coimmunoprecipitation analysis and found that both exogenously and endogenously expressed GPS2 interacted with NS5A of genotype 1b and 2a. Mutagenesis study demonstrated that Domain I of NS5A and coiled-coil domain of GPS2 are responsible for the interaction. Knockdown of GPS2 in hepatoma cell lines suppressed the replication of HCV RNA, which can be rescued by the expression of an RNAi-resistant GPS2. Furthermore, overexpression of GPS2 enhanced the association of NS5A with a proviral cellular factor, human vesicle-associated membrane protein-associated protein A (VAP-A), while knockdown of GPS2 disrupted interaction between VAP-A and NS5A. Taken together, our results suggest that GPS2 acts as a bridge between NS5A and VAP-A and is required for efficient HCV replication.	[Xu, Guodong; Xin, Xiu; Zheng, Congyi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Zheng, Congyi] Wuhan Univ, China Ctr Type Culture Collect, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zheng, CY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	cctcc202@whu.edu.cn			National Basic Research Program of China [2011CB504800]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (Grant No. 2011CB504800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Christopher V, 2005, J NEUROL, V252, P855, DOI 10.1007/s00415-005-0767-2; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Kim YK, 2002, BIOCHEM BIOPH RES CO, V290, P105, DOI 10.1006/bbrc.2001.6167; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038130; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Tan SL., 2006, HEPATITIS C VIRUSES; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	35	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78195	10.1371/journal.pone.0078195	http://dx.doi.org/10.1371/journal.pone.0078195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223774	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400038
J	Zhou, MY; Wang, GL; Li, D; Zhao, DL; Qin, QL; Chen, XL; Chen, B; Zhou, BC; Zhang, XY; Zhang, YZ				Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Chen, Bo; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong			Diversity of Both the Cultivable Protease-Producing Bacteria and Bacterial Extracellular Proteases in the Coastal Sediments of King George Island, Antarctica	PLOS ONE			English	Article							DEEP-SEA; COMMUNITIES; ENZYMES	Protease-producing bacteria play a vital role in degrading sedimentary organic nitrogen. However, the diversity of these bacteria and their extracellular proteases in most regions remain unknown. In this paper, the diversity of the cultivable protease-producing bacteria and of bacterial extracellular proteases in the sediments of Maxwell Bay, King George Island, Antarctica was investigated. The cultivable protease-producing bacteria reached 10(5) cells/g in all 8 sediment samples. The cultivated protease-producing bacteria were mainly affiliated with the phyla Actinobacteria, Firmicutes, Bacteroidetes, and Proteobacteria, and the predominant genera were Bacillus (22.9%), Flavobacterium (21.0%) and Lacinutrix (16.2%). Among these strains, Pseudoalteromonas and Flavobacteria showed relatively high protease production. Inhibitor analysis showed that nearly all the extracellular proteases from the bacteria were serine proteases or metalloproteases. These results begin to address the diversity of protease-producing bacteria and bacterial extracellular proteases in the sediments of the Antarctic Sea.	[Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China	Shandong University; Shandong University; Polar Research Institute of China	Zhang, XY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangxiying@sdu.edu.cn			Hi-Tech Research and Development program of China [2012AA092105, 2012AA092103, 2011AA09070303]; National Natural Science Foundation of China [31025001, 31290231, 41106161, 31070061]; COMRA Program [DY125-15-T-05]; Special Fund of China for Marine-scientific Research in the Public Interest [201005032-6]; Independent Innovation Foundation of Shandong University [2009TS079]; Program of Shandong for Taishan Scholars [2008BS02019]; Foundation for Young Excellent Scientists in Shandong Province [BS2010SW015]	Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); COMRA Program; Special Fund of China for Marine-scientific Research in the Public Interest; Independent Innovation Foundation of Shandong University; Program of Shandong for Taishan Scholars; Foundation for Young Excellent Scientists in Shandong Province	The work was supported by Hi-Tech Research and Development program of China (2012AA092105, 2012AA092103, 2011AA09070303), National Natural Science Foundation of China (31025001, 31290231, 41106161, 31070061), COMRA Program (DY125-15-T-05), Special Fund of China for Marine-scientific Research in the Public Interest (201005032-6), Independent Innovation Foundation of Shandong University (2009TS079), Program of Shandong for Taishan Scholars, (2008BS02019), and Foundation for Young Excellent Scientists in Shandong Province (BS2010SW015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gray JP, 1996, APPL ENVIRON MICROB, V62, P4049, DOI 10.1128/AEM.62.11.4049-4059.1996; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Liao L, 2009, J ZHEJIANG UNIV-SC B, V10, P890, DOI 10.1631/jzus.B0920181; Loperena L, 2012, WORLD J MICROB BIOT, V28, P2249, DOI 10.1007/s11274-012-1032-3; Nercessian O, 2005, ENVIRON MICROBIOL, V7, P698, DOI 10.1111/j.1462-2920.2005.00744.x; Olivera NL, 2007, EXTREMOPHILES, V11, P517, DOI 10.1007/s00792-007-0064-3; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Sohrin Y, 2000, DEEP-SEA RES PT I, V47, P55, DOI 10.1016/S0967-0637(99)00049-7; Talbot V, 1997, DEEP-SEA RES PT II, V44, P1069, DOI 10.1016/S0967-0645(96)00107-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P85, DOI 10.1099/ijs.0.02857-0; Vazquez SC, 2008, REV ARGENT MICROBIOL, V40, P63; Vazquez SC, 2002, POLAR RES, V21, P63, DOI 10.1111/j.1751-8369.2002.tb00067.x; VAZQUEZ SC, 1995, POLAR BIOL, V15, P131; WHITAKER TM, 1982, PROC R SOC SER B-BIO, V214, P169, DOI 10.1098/rspb.1982.0003; Xiong HR, 2007, J IND MICROBIOL BIOT, V34, P63, DOI 10.1007/s10295-006-0165-5; [徐宏翔 Xu Hongxiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P479; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	23	28	33	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79668	10.1371/journal.pone.0079668	http://dx.doi.org/10.1371/journal.pone.0079668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223990	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400135
J	Shen, YX; Gao, L; Xia, X; Li, YH; Guan, HL				Shen, You-xin; Gao, Lei; Xia, Xue; Li, Yuhui; Guan, Huilin			Successional Distance between the Source and Recipient Influence Seed Germination and Seedling Survival during Surface Soil Replacement in SW China	PLOS ONE			English	Article							RESTORATION TOOL; FOREST; ECOSYSTEM; ESTABLISHMENT; DEGRADATION; RECRUITMENT; COMPETITION; MICROSITE; MODELS; LITTER	Adding propagules (source) to a degraded site (recipient) is a common way of manipulating secondary succession to restore diversity and services formerly provided by forests. However, heretofore no study has considered the effect of "successional distance" between source and recipient site. Four sites in the Shilin karst area of SW China were treated as different states along a secondary successional sere: grass, shrub, young secondary forest, and primary forest. Ten 1 m x 1m soil quadrats in the grass, shrub and young forest sites were replaced with 10 cm deep soil sources from corresponding later successional stage(s) in January 2009. Woody plant seed germination was monitored in the first year and seedling survival was monitored until the end of the second year. At the end of 2010, 2097 seeds of woody plants belonging to 45 taxa had germinated, and 3.9% of the seedlings and 7.8% of the species survived. Germination of most species was sensitive to ambient light (red, far-red, R:FR ratios, photosynthetically active radiation). Soil source and recipient site had a significant effect on the total number of seeds and number of species that germinated, and on the percentage of seedlings that survived through the end of the second year. Closer successional stages between recipient site and soil source had higher seed germination and seedling-survival percentages. However, a transition threshold exists in the young forest state, where seeds can germinate but not survive the second year. Our results, although based on an unreplicated chronosequence, suggest that successional distance between soil sources and recipient sites affect forest recruitment and restoration in degraded karst of SW China.	[Shen, You-xin; Gao, Lei] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Shen, You-xin; Gao, Lei; Xia, Xue] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Restorat Ecol Grp, Kunming, Peoples R China; [Li, Yuhui; Guan, Huilin] Yunnan Normal Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Normal University	Shen, YX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China.	yxshen@xtbg.ac.cn	li, yuhui/Q-1730-2019		Chinese Academy of Sciences; National Nature Scientific Foundation of China [41262013, 41371514, 41361075]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by grants from "Light in Western China" Program of Chinese Academy of Sciences and the National Nature Scientific Foundation of China (41262013, 41371514, 41361075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, J ECOL, V99, P1045, DOI 10.1111/j.1365-2745.2011.01835.x; Aronson J., 1993, Restoration Ecology, V1, P8, DOI 10.1111/j.1526-100X.1993.tb00004.x; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Brang P, 1998, CAN J FOREST RES, V28, P626, DOI 10.1139/cjfr-28-4-626; Castro-Marin G, 2011, TROP ECOL, V52, P1; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Farrell C, 2011, PLANT SOIL, V348, P397, DOI 10.1007/s11104-011-0850-7; Foster BL, 2007, RESTOR ECOL, V15, P652, DOI 10.1111/j.1526-100X.2007.00277.x; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Graae BJ, 2004, FLORA, V199, P263, DOI 10.1078/0367-2530-00154; Hall SL, 2010, RESTOR ECOL, V18, P834, DOI 10.1111/j.1526-100X.2008.00509.x; Hobbs R.J., 2007, LINKING RESTORATION, P168, DOI DOI 10.1111/J.1466-822X.2006.00212.X; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunziker U, 2005, FOREST ECOL MANAG, V210, P67, DOI 10.1016/j.foreco.2005.02.019; Jiang YJ, 2006, ENVIRON GEOL, V50, P911, DOI 10.1007/s00254-006-0262-9; King EG, 2006, RESTOR ECOL, V14, P369, DOI 10.1111/j.1526-100X.2006.00145.x; Koch JM, 2007, RESTOR ECOL, V15, pS137, DOI 10.1111/j.1526-100X.2007.00301.x; [劳文科 LAO Wenke], 2008, [地球与环境, Earth and Environment], V36, P119; Lopez DR, 2011, APPL VEG SCI, V14, P6, DOI 10.1111/j.1654-109X.2010.01095.x; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Parise M, 2003, ENVIRON GEOL, V44, P247, DOI 10.1007/s00254-003-0773-6; Pearson TRH, 2003, FUNCT ECOL, V17, P394, DOI 10.1046/j.1365-2435.2003.00747.x; Perez-Garcia EA, 2004, PLANT ECOL, V175, P147, DOI 10.1007/s11258-005-4841-8; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Prach K, 2007, LINKING RESTORATION; Sheley RL, 2006, ECOL MONOGR, V76, P365, DOI 10.1890/0012-9615(2006)076[0365:PFSTTG]2.0.CO;2; [沈有信 Shen Youxin], 2005, [广西植物, Guihaia], V25, P321; Thompson K., 2000, Seeds: the ecology of regeneration in plant communities, P215, DOI 10.1079/9780851994321.0215; Travlos IS, 2007, J FOOD AGRIC ENVIRON, V5, P153; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; VAZQUEZYANES C, 1990, ECOLOGY, V71, P1952, DOI 10.2307/1937603; Zhang F.M., 1997, STUDY LUNAN STONE FO	36	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79125	10.1371/journal.pone.0079125	http://dx.doi.org/10.1371/journal.pone.0079125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223891	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300060
J	Paco, S; Kalko, SG; Jou, C; Rodriguez, MA; Corbera, J; Muntoni, F; Feng, L; Rivas, E; Torner, F; Gualandi, F; Gomez-Foix, AM; Ferrer, A; Ortez, C; Nascimento, A; Colomer, J; Jimenez-Mallebrera, C				Paco, Sonia; Kalko, Susana G.; Jou, Cristina; Rodriguez, Maria A.; Corbera, Joan; Muntoni, Francesco; Feng, Lucy; Rivas, Eloy; Torner, Ferran; Gualandi, Francesca; Gomez-Foix, Anna M.; Ferrer, Anna; Ortez, Carlos; Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia			Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; MEMBRANE ATTACK COMPLEX; SKELETAL-MUSCLE; MITOCHONDRIAL DYSFUNCTION; MYOGENIC DIFFERENTIATION; BIGLYCAN EXPRESSION; ALPHA-6 CHAINS; S100B PROTEIN; ULLRICH; DISEASE	Ullrich congenital muscular dystrophy (UCMD), caused by collagen VI deficiency, is a common congenital muscular dystrophy. At present, the role of collagen VI in muscle and the mechanism of disease are not fully understood. To address this we have applied microarrays to analyse the transcriptome of UCMD muscle and compare it to healthy muscle and other muscular dystrophies. We identified 389 genes which are differentially regulated in UCMD relative to controls. In addition, there were 718 genes differentially expressed between UCMD and dystrophin deficient muscle. In contrast, only 29 genes were altered relative to other congenital muscular dystrophies. Changes in gene expression were confirmed by real-time PCR. The set of regulated genes was analysed by Gene Ontology, KEGG pathways and Ingenuity Pathway analysis to reveal the molecular functions and gene networks associated with collagen VI defects. The most significantly regulated pathways were those involved in muscle regeneration, extracellular matrix remodelling and inflammation. We characterised the immune response in UCMD biopsies as being mainly mediated via M2 macrophages and the complement pathway indicating that anti-inflammatory treatment may be beneficial to UCMD as for other dystrophies. We studied the immunolocalisation of ECM components and found that biglycan, a collagen VI interacting proteoglycan, was reduced in the basal lamina of UCMD patients. We propose that biglycan reduction is secondary to collagen VI loss and that it may be contributing towards UCMD pathophysiology. Consequently, strategies aimed at over-expressing biglycan and restore the link between the muscle cell surface and the extracellular matrix should be considered.	[Paco, Sonia; Rodriguez, Maria A.; Ortez, Carlos; Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] Hosp Maternoinfantil St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain; [Kalko, Susana G.] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Bioinformat Core Facil, Barcelona, Spain; [Jou, Cristina; Corbera, Joan] Hosp Maternoinfantil St Joan de Deu, Dept Pathol, Barcelona, Spain; [Muntoni, Francesco; Feng, Lucy] UCL, Inst Child Hlth, MRC Ctr Neuromuscular Dis, Dubowitz Neuromuscular Ctr, London, England; [Rivas, Eloy] Hosp Virgen del Rocio, Dept Pathol, Seville, Spain; [Torner, Ferran] Hosp Maternoinfantil St Joan de Deu, Orthopaed Surg & Traumatol Dept, Barcelona, Spain; [Gualandi, Francesca] Azienda Osped Univ SAnna, UO Genet Med, Dipartimento Riprod & Accrescimento, Ferrara, Italy; [Gomez-Foix, Anna M.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Gomez-Foix, Anna M.] Univ Barcelona, Ctr Biomed Res Diabet & Metab Disorders CIBERDEM, Barcelona, Spain; [Ferrer, Anna] Ctr Regulac Genom, Microarray Unit, Barcelona, Spain; [Nascimento, Andres; Colomer, Jaume; Jimenez-Mallebrera, Cecilia] ISCIII, CIBERER, Ctr Biomed Res Rare Dis, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; Virgen del Rocio University Hospital; University of Ferrara; Arcispedale Sant'Anna; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Jimenez-Mallebrera, C (corresponding author), Hosp Maternoinfantil St Joan de Deu, Fdn St Joan de Deu, Dept Neurol, Neuromuscular Unit, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Gualandi, Francesca/K-7513-2016; Ferrer-Salvador, Anna/K-6001-2015; Jiménez-Mallebrera, Cecilia/F-5030-2016; IBIS, NEUROCIENCIAS/C-2262-2016	Gualandi, Francesca/0000-0001-9551-057X; Ferrer-Salvador, Anna/0000-0001-5507-0733; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Kalko, Susana/0000-0002-6701-0233	Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS) [PI10/00177]; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by the Ministerio de Ciencia e Innovacion & Instituto de Salud Carlos III (FIS grant PI10/00177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Angelini Corrado, 2012, Acta Myol, V31, P9; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Collins J, 2012, NEUROLOGY, V79, P2158, DOI 10.1212/WNL.0b013e3182752ebc; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Connolly AM, 2002, J NEUROIMMUNOL, V127, P80, DOI 10.1016/S0165-5728(02)00104-2; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; ENGEL AG, 1982, ANN NEUROL, V12, P289, DOI 10.1002/ana.410120314; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Higuchi I, 2003, NEUROMUSCULAR DISORD, V13, P310, DOI 10.1016/S0960-8966(02)00282-1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Ishmukhametova A, 2012, EUR J HUM GENET, V20, P1096, DOI 10.1038/ejhg.2012.51; Kawahara G, 2007, NEUROLOGY, V69, P1043, DOI 10.1212/01.wnl.0000271386.89878.22; Kawahara G, 2008, MUSCLE NERVE, V38, P1192, DOI 10.1002/mus.21030; Keira Y, 2007, NEUROSCI RES, V57, P513, DOI 10.1016/j.neures.2006.12.010; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; Krahn M, 2011, CLIN GENET, V80, P398, DOI 10.1111/j.1399-0004.2010.01620.x; Lechner BE, 2006, MUSCLE NERVE, V34, P347, DOI 10.1002/mus.20596; Lethias C, 2006, FEBS LETT, V580, P6281, DOI 10.1016/j.febslet.2006.10.037; Margaron Y, 2010, BIOPHYS CHEM, V147, P87, DOI 10.1016/j.bpc.2009.12.011; Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007; Matsumoto K, 2004, EXP CELL RES, V297, P404, DOI 10.1016/j.yexcr.2004.03.041; MDEL B, 2012, ACTA MYOL, V31, P4; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Merlini L, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/139194; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Nakajima I, 2002, BIOL CELL, V94, P197, DOI 10.1016/S0248-4900(02)01189-9; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Noguchi S, 2005, NEUROLOGY, V65, P732, DOI 10.1212/01.wnl.0000174625.67484.4d; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Rafii MS, 2006, J CELL PHYSIOL, V209, P439, DOI 10.1002/jcp.20740; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Riuzzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028700; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sabatelli P, 2011, J INVEST DERMATOL, V131, P99, DOI 10.1038/jid.2010.284; Saenz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003750; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Spuler S, 1998, NEUROLOGY, V50, P41, DOI 10.1212/WNL.50.1.41; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Young MF, 2012, CURR OPIN GENET DEV, V22, P398, DOI 10.1016/j.gde.2012.07.008; Zanotti S, 2005, BRAIN, V128, P2546, DOI 10.1093/brain/awh635; Zanotti S, 2006, THESCIENTIFICWORLDJO, V6, P446, DOI 10.1100/tsw.2006.88; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7	76	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77430	10.1371/journal.pone.0077430	http://dx.doi.org/10.1371/journal.pone.0077430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24223098	Green Published, gold			2022-12-25	WOS:000325819400117
J	Sato, S; Fukagawa, T; Tachibanaki, S; Yamano, Y; Wada, A; Kawamura, S				Sato, Shinya; Fukagawa, Takashi; Tachibanaki, Shuji; Yamano, Yumiko; Wada, Akimori; Kawamura, Satoru			Substrate Specificity and Subcellular Localization of the Aldehyde-Alcohol Redox-coupling Reaction in Carp Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photoreceptors; Retinal Metabolism; Retinoid; Vision; Vitamin A; Cones; Muller Cells; Retinoid Cycle	VISUAL-PIGMENT; VITAMIN-A; CYCLE; ROD; REGENERATION; METABOLISM; OXIDATION; RPE65; ISOMEROHYDROLASE; PHOSPHORYLATION	Background: In carp cones, 11-cis-retinal and all-trans-retinol are formed with 11-cis-retinol and all-trans-retinal present. Results: The substrate specificity, reaction mechanism, and subcellular localization of this reaction were determined. Conclusion: Substrate specificity is high for retinol but low for retinal, and the activity is present in the cone inner segment. Significance: The possible contribution to efficient pigment regeneration in cones is suggested. Our previous study suggested the presence of a novel cone-specific redox reaction that generates 11-cis-retinal from 11-cis-retinol in the carp retina. This reaction is unique in that 1) both 11-cis-retinol and all-trans-retinal were required to produce 11-cis-retinal; 2) together with 11-cis-retinal, all-trans-retinol was produced at a 1:1 ratio; and 3) the addition of enzyme cofactors such as NADP(H) was not necessary. This reaction is probably part of the reactions in a cone-specific retinoid cycle required for cone visual pigment regeneration with the use of 11-cis-retinol supplied from Muller cells. In this study, using purified carp cone membrane preparations, we first confirmed that the reaction is a redox-coupling reaction between retinals and retinols. We further examined the substrate specificity, reaction mechanism, and subcellular localization of this reaction. Oxidation was specific for 11-cis-retinol and 9-cis-retinol. In contrast, reduction showed low specificity: many aldehydes, including all-trans-, 9-cis-, 11-cis-, and 13-cis-retinals and even benzaldehyde, supported the reaction. On the basis of kinetic studies of this reaction (aldehyde-alcohol redox-coupling reaction), we found that formation of a ternary complex of a retinol, an aldehyde, and a postulated enzyme seemed to be necessary, which suggested the presence of both the retinol- and aldehyde-binding sites in this enzyme. A subcellular fractionation study showed that the activity is present almost exclusively in the cone inner segment. These results suggest the presence of an effective production mechanism of 11-cis-retinal in the cone inner segment to regenerate visual pigment.	[Sato, Shinya; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan; [Fukagawa, Takashi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamano, Yumiko; Wada, Akimori] Kobe Pharmaceut Univ, Dept Organ Chem Life Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Osaka University; Osaka University; Kobe Pharmaceutical University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Sato, Shinya/0000-0002-5978-0975	Japan Society for the Promotion of Science [20370060, 23227002, 22770150, 24570085]; Human Frontier Science Program grant; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program grant(Human Frontier Science Program); Naito Foundation(Naito Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science Grants 20370060 and 23227002 (to S. K.) and 22770150 and 24570085 (to S. T.), a Human Frontier Science Program grant (to S. K.), and the Naito Foundation (to S. T.).	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Bisswanger H., 2008, ENZYME KINETICS, P124; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Collery R, 2008, INVEST OPHTH VIS SCI, V49, P3812, DOI 10.1167/iovs.08-1957; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Irie T, 2002, COMP BIOCHEM PHYS B, V131, P209, DOI 10.1016/S1096-4959(01)00496-1; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; LIU RSH, 1984, TETRAHEDRON, V40, P1931, DOI 10.1016/S0040-4020(01)88435-0; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; Pazos Y, 2001, J ORG CHEM, V66, P8483, DOI 10.1021/jo010711v; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reinheckel T, 1998, FREE RADICAL RES, V29, P297, DOI 10.1080/10715769800300331; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Schenkels P, 2000, MICROBIOL-SGM, V146, P775, DOI 10.1099/00221287-146-4-775; SUZUKI T, 1983, ANAL BIOCHEM, V129, P111, DOI 10.1016/0003-2697(83)90059-3; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; TREHAN A, 1990, BIOORG CHEM, V18, P30, DOI 10.1016/0045-2068(90)90013-U; Wada A, 2004, BIOORGAN MED CHEM, V12, P3931, DOI 10.1016/j.bmc.2004.04.047; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; ZONTA F, 1984, J CHROMATOGR, V301, P65, DOI 10.1016/S0021-9673(01)89179-2	39	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36589	36597		10.1074/jbc.M113.521153	http://dx.doi.org/10.1074/jbc.M113.521153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217249	Green Published, hybrid			2022-12-25	WOS:000328883400039
J	Robbins, AM; Gray, M; Basabose, A; Uwingeli, P; Mburanumwe, I; Kagoda, E; Robbins, MM				Robbins, Andrew M.; Gray, Maryke; Basabose, Augustin; Uwingeli, Prosper; Mburanumwe, Innocent; Kagoda, Edwin; Robbins, Martha M.			Impact of Male Infanticide on the Social Structure of Mountain Gorillas	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BERINGEI-BERINGEI; FEMALE DISPERSAL; SOCIOECOLOGICAL INFLUENCES; POPULATION-DYNAMICS; COLOBUS-VELLEROSUS; SEXUAL SELECTION; HABITAT USE; PRIMATES; STRATEGIES	Infanticide can be a major influence upon the social structure of species in which females maintain long-term associations with males. Previous studies have suggested that female mountain gorillas benefit from residing in multimale groups because infanticide occurs when one-male groups disintegrate after the dominant male dies. Here we measure the impact of infanticide on the reproductive success of female mountain gorillas, and we examine whether their dispersal patterns reflect a strategy to avoid infanticide. Using more than 40 years of data from up to 70% of the entire population, we found that only 1.7% of the infants that were born in the study had died from infanticide during group disintegrations. The rarity of such infanticide mainly reflects a low mortality rate of dominant males in one-male groups, and it does not dispel previous observations that infanticide occurs during group disintegrations. After including infanticide from causes other than group disintegrations, infanticide victims represented up to 5.5% of the offspring born during the study, and they accounted for up to 21% of infant mortality. The overall rates of infanticide were 2-3 times higher in one-male groups than multimale groups, but those differences were not statistically significant. Infant mortality, the length of interbirth intervals, and the age of first reproduction were not significantly different between one-male versus multimale groups, so we found no significant fitness benefits for females to prefer multimale groups. In addition, we found limited evidence that female dispersal patterns reflect a preference for multimale groups. If the strength of selection is modest for females to avoid group disintegrations, than any preference for multimale groups may be slow to evolve. Alternatively, variability in male strength might give some one-male groups a lower infanticide risk than some multimale groups, which could explain why both types of groups remain common.	[Robbins, Andrew M.; Robbins, Martha M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Gray, Maryke; Basabose, Augustin] Int Gorilla Conservat Programme, Kigali, Kigali Province, Rwanda; [Uwingeli, Prosper] Rwanda Dev Board, Parc Natl Volcans, Kigali, Kigali Province, Rwanda; [Mburanumwe, Innocent] Inst Congolais Conservat Nat, Int Gorilla Conservat Programme, Parc Natl Virunga Sud, Gisenyi, Western Provinc, Rwanda; [Kagoda, Edwin] Bwindi Mgahinga Conservat Area, Uganda Wildlife Author, Kampala, Uganda	Max Planck Society	Robbins, MM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	robbins@eva.mpg.de						Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; ALTMANN SA, 1977, ANIM BEHAV, V25, P364, DOI 10.1016/0003-3472(77)90011-2; Bellemain E, 2006, ETHOLOGY, V112, P238, DOI 10.1111/j.1439-0310.2006.01152.x; BLAFFERHRDY S, 1977, AM SCI, V65, P40; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Breuer T, 2012, J HUM EVOL, V62, P466, DOI 10.1016/j.jhevol.2012.01.006; Breuer T, 2010, BEHAV ECOL SOCIOBIOL, V64, P515, DOI 10.1007/s00265-009-0867-6; BUTYNSKI TM, 1990, ECOL MONOGR, V60, P1, DOI 10.2307/1943024; Clarke Parry, 2009, P42; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Ebensperger Luis A., 2007, P267; Fossey D., 1984, P217; FOSSEY D, 1983, GORILLAS MIST; Gerald CN, 1995, THESIS PRINCETON U P, P81; Gray M, 2005, BIODIVERS CONSERV, V14, P2723, DOI 10.1007/s10531-005-8406-x; Gray M, 2009, J AFRICAN ECOLOGY, V48, P588; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harcourt A.H., 2007, GORILLA SOC CONFLICT; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; HARCOURT AH, 1976, NATURE, V263, P226, DOI 10.1038/263226a0; HARCOURT AH, 1978, Z TIERPSYCHOL, V48, P401; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harcourt Alexander H., 1995, Evolutionary Anthropology, V4, P121, DOI 10.1002/evan.1360040404; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Janson Charles H., 2000, P469, DOI 10.1017/CBO9780511542312.021; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kappeler Peter M., 2012, P3; Knornschild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025001; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Korstjens AH, 2002, BEHAVIOUR, V139, P203, DOI 10.1163/156853902760102654; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Palombit Ryne A., 2012, P432; Pluhacek J, 2006, J MAMMAL, V87, P35, DOI 10.1644/05-MAMM-A-126R2.1; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Robbins AM, 2006, AM J PHYS ANTHROPOL, V131, P511, DOI 10.1002/ajpa.20474; Robbins AM, 2009, BEHAVIOUR, V146, P525, DOI 10.1163/156853909X426354; Robbins AM, 2009, BEHAV ECOL SOCIOBIOL, V63, P477, DOI 10.1007/s00265-008-0679-0; Robbins AM, 2009, ANIM BEHAV, V77, P831, DOI 10.1016/j.anbehav.2008.12.005; Robbins MM, 2007, BEHAV ECOL SOCIOBIOL, V61, P919, DOI 10.1007/s00265-006-0321-y; Robbins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019788; Robbins MM, 2004, AM J PRIMATOL, V63, P201, DOI 10.1002/ajp.20052; ROBBINS MM, 1995, BEHAVIOUR, V132, P21, DOI 10.1163/156853995X00261; Robbins MM, 2001, MOUNTAIN GORILLAAS 3; Robbins MM, 2009, BIOL CONSERVATION, V142; Setchell JM, 2005, BEHAV ECOL SOCIOBIOL, V58, P474, DOI 10.1007/s00265-005-0946-2; Sholley C, 1989, 1989 CENSUS MOUNTAIN, P7; Sicotte P, 2000, PRIMATES, V41, P93, DOI 10.1007/BF02557465; SICOTTE P, 1993, AM J PRIMATOL, V30, P21, DOI 10.1002/ajp.1350300103; Sterck EHM, 1998, AM J PRIMATOL, V44, P235, DOI 10.1002/(SICI)1098-2345(1998)44:4<235::AID-AJP1>3.0.CO;2-X; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Stoinski TS, 2009, ANIM BEHAV, V77, P1155, DOI 10.1016/j.anbehav.2008.12.030; Teichroeb JA, 2008, BEHAVIOUR, V145, P727, DOI 10.1163/156853908783929160; Teichroeb JA, 2009, BEHAVIOUR, V146, P551, DOI 10.1163/156853909X426363; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik C.P., 2000, INFANTICIDE MALES IT; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 1999, Cambridge Studies in Biological Anthropology, V22, P204; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; Van Schaik CP, 2000, PRIMATE MALES, P34; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WATTS DP, 1989, ETHOLOGY, V81, P1; Watts DP, 2000, PRIMATE MALES, P169; WATTS DP, 1994, PRIMATES, V35, P35, DOI 10.1007/BF02381484; Watts DP, 1998, INT J PRIMATOL, V19, P651, DOI 10.1023/A:1020324909101; WEBER AW, 1983, BIOL CONSERV, V26, P341, DOI 10.1016/0006-3207(83)90096-4; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3; Williamson E.A., 2001, AFR PRIMATES, V5, P48; Yamagiwa J., 2001, MOUNTAIN GORILLAS 3, P89, DOI [10.1017/CBO9780511661631.005, DOI 10.1017/CBO9780511661631.005]; Yamagiwa Juichi, 2004, Gorilla Journal, V29, P6; Yamagiwa J, 2009, PRIMATES, V50, P293, DOI 10.1007/s10329-009-0163-0; Zhao Q, 2011, BEHAV ECOL SOCIOBIOL, V65, P1535, DOI 10.1007/s00265-011-1163-9	75	47	48	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78256	10.1371/journal.pone.0078256	http://dx.doi.org/10.1371/journal.pone.0078256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223143	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200035
J	Gao, X; Cao, DH; Liu, J; Wang, XP; Geng, SJ; Liu, B; Shi, DC				Gao, Xiang; Cao, Donghui; Liu, Jie; Wang, Xiaoping; Geng, Shujuan; Liu, Bao; Shi, Decheng			Tissue-Specific and Cation/Anion-Specific DNA Methylation Variations Occurred in C. virgata in Response to Salinity Stress	PLOS ONE			English	Article							ABIOTIC-STRESS; CYTOSINE METHYLATION; RICE; PLANTS; AFLP; SALT; HYPERMETHYLATION; DEMETHYLATION; ARABIDOPSIS; ADAPTATION	Salinity is a widespread environmental problem limiting productivity and growth of plants. Halophytes which can adapt and resist certain salt stress have various mechanisms to defend the higher salinity and alkalinity, and epigenetic mechanisms especially DNA methylation may play important roles in plant adaptability and plasticity. In this study, we aimed to investigate the different influences of various single salts (NaCl, Na2SO4, NaHCO3, Na2CO3) and their mixed salts on halophyte Chloris. virgata from the DNA methylation prospective, and discover the underlying relationships between specific DNA methylation variations and specific cations/anions through the methylation-sensitive amplification polymorphism analysis. The results showed that the effects on DNA methylation variations of single salts were ranked as follows: Na2CO3 > NaHCO3 > Na2SO4 > NaCl, and their mixed salts exerted tissue-specific effects on C. virgata seedlings. Eight types of DNA methylation variations were detected and defined in C. virgata according to the specific cations/anions existed in stressful solutions; in addition, mix-specific and higher pH-specific bands were the main type in leaves and roots independently. These findings suggested that mixed salts were not the simple combination of single salts. Furthermore, not only single salts but also mixed salts showed tissue-specific and cations/anions-specific DNA methylation variations.	[Gao, Xiang] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Cao, Donghui; Liu, Jie; Wang, Xiaoping; Geng, Shujuan; Liu, Bao; Shi, Decheng] NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet, MOE, Changchun, Peoples R China; [Liu, Jie] Weifang Univ Sci & Technol, Shouguang, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Shi, DC (corresponding author), NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet, MOE, Changchun, Peoples R China.	shidc274@gmail.com	Liu, Jie/AAH-5117-2020; Wang, Xiaoping/P-1077-2017	Wang, Xiaoping/0000-0002-5032-3671; zakaria, seyed moein/0000-0002-0086-1279; Liu, Bao/0000-0001-5481-1675	National Natural Science Foundation of China [31072078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31072078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto-Kobayashi S, 2007, MUTAT RES-GEN TOX EN, V632, P111, DOI 10.1016/j.mrgentox.2007.05.001; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cao DH, 2012, PLANT MOL BIOL REP, V30, P1102, DOI 10.1007/s11105-012-0420-z; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2008, HEREDITY, V100, P171, DOI 10.1038/sj.hdy.6800939; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Law JA, 2009, SCIENCE, V323, P1568, DOI 10.1126/science.1172782; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Marden JH, 2008, HEREDITY, V100, P111, DOI 10.1038/sj.hdy.6800904; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nishiuchi S, 2010, PLANT PHYSIOL BIOCH, V48, P247, DOI 10.1016/j.plaphy.2010.01.024; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yang CW, 2009, PHOTOSYNTHETICA, V47, P79, DOI 10.1007/s11099-009-0013-8; Yang CW, 2010, AGRON J, V102, P1081, DOI 10.2134/agronj2009.0471; Zhang X, 2011, PLANT MOL BIOL REP, V29, P626, DOI 10.1007/s11105-010-0269-y; Zluvova J, 2001, J EXP BOT, V52, P2265, DOI 10.1093/jexbot/52.365.2265	34	9	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78426	10.1371/journal.pone.0078426	http://dx.doi.org/10.1371/journal.pone.0078426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223802	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400025
J	Hijaz, FM; Manthey, JA; Folimonova, SY; Davis, CL; Jones, SE; Reyes-De-Corcuera, JI				Hijaz, Faraj M.; Manthey, John A.; Folimonova, Svetlana Y.; Davis, Craig L.; Jones, Shelley E.; Reyes-De-Corcuera, Jose I.			An HPLC-MS Characterization of the Changes in Sweet Orange Leaf Metabolite Profile following Infection by the Bacterial Pathogen Candidatus Liberibacter asiaticus	PLOS ONE			English	Article							HUANGLONGBING DISEASE; PHENOLIC-COMPOUNDS; TOMATO LEAVES; CITRUS; ACID; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION; DIAGNOSIS; DEFENSE	Huanglongbing (HLB) presumably caused by Candidatus Liberibacter asiaticus (CLas) threatens the commercial U.S. citrus crop of an annual value of $3 billion. The earliest shift in metabolite profiles of leaves from greenhouse-grown sweet orange trees infected with Clas, and of healthy leaves, was characterized by HPLC-MS concurrently with PCR testing for the presence of Clas bacteria and observation of disease symptoms. Twenty, 8-month-old 'Valencia' and 'Hamlin' trees were grafted with budwood from PCR-positive HLB source trees. Five graft-inoculated trees of each variety and three control trees were sampled biweekly and analyzed by HPLC-MS and PCR. Thirteen weeks after inoculation, Clas was detected in newly growing flushes in 33% and 55% of the inoculated 'Hamlin' and 'Valencia' trees, respectively. Inoculated trees remained asymptomatic in the first 20 weeks, but developed symptoms 30 weeks after grafting. No significant differences in the leaf metabolite profiles were detected in Clas-infected trees 23 weeks after inoculation. However, 27 weeks after inoculation, differences in metabolite profiles between control leaves and those of Clas-infected trees were evident. Affected compounds were identified with authentic standards or structurally classified by their UV and mass spectra. Included among these compounds are flavonoid glycosides, polymethoxylated flavones, and hydroxycinnamates. Four structurally related hydroxycinnamate compounds increased more than 10-fold in leaves from 'Hamlin' and 'Valencia' sweet orange trees in response to Clas infection. Possible roles of these hydroxycinnamates as plant defense compounds against the Clas infection are discussed.	[Hijaz, Faraj M.; Davis, Craig L.; Reyes-De-Corcuera, Jose I.] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL USA; [Manthey, John A.] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA; [Folimonova, Svetlana Y.; Davis, Craig L.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Reyes-De-Corcuera, JI (corresponding author), Univ Georgia, Dept Food Sci & Technol, CAES, Athens, GA 30602 USA.	jireyes@ufl.edu	Folimonova, Svetlana/T-2592-2019	Hijaz, Faraj/0000-0002-8079-161X	USDA CSREES NIFA [2009-34446-20228]	USDA CSREES NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was funded by the USDA CSREES NIFA project number 2009-34446-20228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin E, 2010, J AGR FOOD CHEM, V58, P1247, DOI 10.1021/jf9031958; Batool A, 2007, HORTIC SCI, V34, P159, DOI 10.17221/1897-HORTSCI; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Cevallos-Cevallos JM, 2009, ELECTROPHORESIS, V30, P1240, DOI 10.1002/elps.200800594; Coletta HD, 2010, EUR J PLANT PATHOL, V126, P53, DOI 10.1007/s10658-009-9523-2; Daayf F, 2000, J CHEM ECOL, V26, P1579, DOI 10.1023/A:1005578510954; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Duenas M, 2005, J SCI FOOD AGR, V85, P297, DOI 10.1002/jsfa.1924; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HOOKER ME, 1993, PLANT DIS, V77, P174, DOI 10.1094/PD-77-0174; KANES K, 1993, PHYTOCHEMISTRY, V32, P967, DOI 10.1016/0031-9422(93)85237-L; Lin H, 2013, PHYTOPATHOLOGY, V103, P524, DOI 10.1094/PHYTO-09-12-0238-RVW; Manthey J, 2008, P FLA STATE HORT SOC, V12, P285; Manthey JA, 2001, J AGR FOOD CHEM, V49, P3268, DOI 10.1021/jf010011r; Manthey JA, 2000, PLANT PHYSIOL BIOCH, V38, P333, DOI 10.1016/S0981-9428(00)00748-8; Cevallos-Cevallos JM, 2008, PROC FL STATE HORTIC, V121, P85; Belles JM, 2008, PLANT SCI, V174, P524, DOI 10.1016/j.plantsci.2008.02.008; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Pearce G, 1998, PHYTOCHEMISTRY, V47, P659, DOI 10.1016/S0031-9422(97)00620-1; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Rashed A, 2013, PHYTOPATHOLOGY, V103, P419, DOI 10.1094/PHYTO-09-12-0244-R; RISCH B, 1987, PHYTOCHEMISTRY, V26, P509, DOI 10.1016/S0031-9422(00)81444-2; RISCH B, 1988, PHYTOCHEMISTRY, V27, P3327, DOI 10.1016/0031-9422(88)80059-1; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; STRACK D, 1986, PHYTOCHEMISTRY, V25, P2605, DOI 10.1016/S0031-9422(00)84518-5; Takushi T., 2007, Japanese Journal of Phytopathology, V73, P3, DOI 10.3186/jjphytopath.73.3; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; von Roepenack-Lahaye E, 2003, J BIOL CHEM, V278, P43373, DOI 10.1074/jbc.M305084200; Wallis CM, 2012, PHYTOPATHOLOGY, V102, P816, DOI 10.1094/PHYTO-04-12-0074-R; WHEATON TA, 1965, NATURE, V206, P620, DOI 10.1038/206620a0; WHEATON TA, 1965, ANAL BIOCHEM, V12, P585, DOI 10.1016/0003-2697(65)90226-5	36	39	42	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79485	10.1371/journal.pone.0079485	http://dx.doi.org/10.1371/journal.pone.0079485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223954	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400068
J	Oohashi, H; Watanabe, H; Taga, G				Oohashi, Hiroki; Watanabe, Hama; Taga, Gentaro			Development of a Serial Order in Speech Constrained by Articulatory Coordination	PLOS ONE			English	Article							MOTOR CONTROL; CONSONANT SEQUENCES; GESTURAL OVERLAP; INFANTS; MODEL; ORGANIZATION; MOVEMENTS; PATTERNS; ORIGIN; VOWELS	Universal linguistic constraints seem to govern the organization of sound sequences in words. However, our understanding of the origin and development of these constraints is incomplete. One possibility is that the development of neuromuscular control of articulators acts as a constraint for the emergence of sequences in words. Repetitions of the same consonant observed in early infancy and an increase in variation of consonantal sequences over months of age have been interpreted as a consequence of the development of neuromuscular control. Yet, it is not clear how sequential coordination of articulators such as lips, tongue apex and tongue dorsum constrains sequences of labial, coronal and dorsal consonants in words over the course of development. We examined longitudinal development of consonant-vowel-consonant(-vowel) sequences produced by Japanese children between 7 and 60 months of age. The sequences were classified according to places of articulation for corresponding consonants. The analyses of individual and group data show that infants prefer repetitive and fronting articulations, as shown in previous studies. Furthermore, we reveal that serial order of different places of articulations within the same organ appears earlier and then gradually develops, whereas serial order of different articulatory organs appears later and then rapidly develops. In the same way, we also analyzed the sequences produced by English children and obtained similar developmental trends. These results suggest that the development of intra-and inter-articulator coordination constrains the acquisition of serial orders in speech with the complexity that characterizes adult language.	[Oohashi, Hiroki; Watanabe, Hama; Taga, Gentaro] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Oohashi, Hiroki] Koujimachi Business Ctr, Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Oohashi, H (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	hiro084@gmail.com			Japan Society for the Promotion of Science [12J08436];  [20670001];  [24119002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	The study was supported by a grant for the Fellows of the Japan Society for the Promotion of Science (No. 12J08436) awarded to H.O. and a Grant-in-Aid for Scientific Research (No. 20670001 and No. 24119002) awarded to G. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2006, J ACOUST SOC AM, V119, P1636, DOI 10.1121/1.2161443; Amano S, 2009, SPEECH COMMUN, V51, P510, DOI 10.1016/j.specom.2009.01.009; Bishop C.M., 2006, PATTERN RECOGNITION; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; Byrd D, 1996, J PHONETICS, V24, P209, DOI 10.1006/jpho.1996.0012; Chitoran I, 2002, PHONOL PHONET, V4-1, P419; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Davis B, 2007, PHONBANK ENGLISH DAV; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; de Boysson-Bardies B., 1999, LANGUAGE COMES CHILD; Fikkert P, 2008, PHONOL PHONET, V13, P231; FUJIMURA O, 1981, PHONETICA, V38, P66, DOI 10.1159/000260015; Giulivi S, 2011, LANG LEARN DEV, V7, P202, DOI 10.1080/15475441.2011.564569; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Green JR, 2000, J SPEECH LANG HEAR R, V43, P239, DOI 10.1044/jslhr.4301.239; Grimme B, 2011, MOTOR CONTROL, V15, P5, DOI 10.1123/mcj.15.1.5; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Ingram D, 1974, J CHILD LANG, Vi, P233, DOI DOI 10.1017/S0305000900000672; Ishizuka K, 2007, J ACOUST SOC AM, V121, P2272, DOI 10.1121/1.2535806; Kajikawa S, 2004, J CHILD LANG, V31, P215, DOI 10.1017/S0305000903005968; KELSO JAS, 1984, J EXP PSYCHOL HUMAN, V10, P812, DOI 10.1037/0096-1523.10.6.812; Kent RD, 2004, CLIN LINGUIST PHONET, V18, P495, DOI 10.1080/02699200410001703600; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Locke J., 1983, PHONOLOGICAL ACQUISI, DOI DOI 10.2307/414500; MacNeilage P.F., 2008, ORIGIN SPEECH; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MacNeilage PF, 1999, PSYCHOL SCI, V10, P459, DOI 10.1111/1467-9280.00187; MacWhinney B., 2000, CHILDES PROJECT, V3rd; Matyear CL, 1998, PHONETICA, V55, P1, DOI 10.1159/000028422; Nam H, 2009, PHONOL PHONET, V16, P299; Nazzi T, 2009, J ACOUST SOC AM, V126, P1440, DOI 10.1121/1.3158931; Nip ISB, 2009, J COMMUN DISORD, V42, P286, DOI 10.1016/j.jcomdis.2009.03.008; NITTROUER S, 1993, J SPEECH HEAR RES, V36, P959, DOI 10.1044/jshr.3605.959; Rochet-Capellan A, 2007, J ACOUST SOC AM, V121, P3740, DOI 10.1121/1.2734497; Serkhane JE, 2007, J PHONETICS, V35, P321, DOI 10.1016/j.wocn.2006.10.002; Smith A, 2004, DEV PSYCHOL, V45, P1077; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Tsuji S, 2012, COGNITION, V125, P413, DOI 10.1016/j.cognition.2012.07.017; Vihman M. M., 1978, UNIVERSALS HUMAN LAN, V2, P281; Vilain A., 1999, P 14 INT C PHON SCI, V3, P2497; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Walker JF, 2006, INT J LANG COMM DIS, V41, P541, DOI 10.1080/10428190500343043; Wilson Erin M., 2008, Seminars in Speech and Language, V29, P257, DOI 10.1055/s-0028-1103389; ZSIGA EC, 1994, J PHONETICS, V22, P121, DOI 10.1016/S0095-4470(19)30189-5	45	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78600	10.1371/journal.pone.0078600	http://dx.doi.org/10.1371/journal.pone.0078600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223827	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400034
J	Yamada, T; Azuma, K; Muta, E; Kim, J; Sugawara, S; Zhang, GL; Matsueda, S; Kasama-Kawaguchi, Y; Yamashita, Y; Yamashita, T; Nishio, K; Itoh, K; Hoshino, T; Sasada, T				Yamada, Teppei; Azuma, Koichi; Muta, Emi; Kim, Jintaek; Sugawara, Shunichi; Zhang, Guang Lan; Matsueda, Satoko; Kasama-Kawaguchi, Yuri; Yamashita, Yuichi; Yamashita, Takuto; Nishio, Kazuto; Itoh, Kyogo; Hoshino, Tomoaki; Sasada, Tetsuro			EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; LUNG-CANCER; ACQUIRED-RESISTANCE; CLINICAL-RESPONSE; PEPTIDE COMPLEX; POINT MUTATION; HIGH-AFFINITY; GEFITINIB; LYMPHOCYTES	Treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, has achieved high clinical response rates in patients with non-small cell lung cancers (NSCLCs). However, over time, most tumors develop acquired resistance to EGFR-TKIs, which is associated with the secondary EGFR T790M resistance mutation in about half the cases. Currently there are no effective treatment options for patients with this resistance mutation. Here we identified two novel HLA-A*0201 (A2)-restricted T cell epitopes containing the mutated methionine residue of the EGFR T790M mutation, T790M-5 (MQLMPFGCLL) and T790M-7 (LIMQLMPFGCL), as potential targets for EGFR-TKI-resistant patients. When peripheral blood cells were repeatedly stimulated in vitro with these two peptides and assessed by antigen-specific IFN-gamma secretion, T cell lines responsive to T790M-5 and T790M-7 were established in 5 of 6 (83%) and 3 of 6 (50%) healthy donors, respectively. Additionally, the T790M-5- and T790M-7-specific T cell lines displayed an MHC class I-restricted reactivity against NSCLC cell lines expressing both HLA-A2 and the T790M mutation. Interestingly, the NSCLC patients with antigen-specific T cell responses to these epitopes showed a significantly less frequency of EGFR-T790M mutation than those without them [1 of 7 (14%) vs 9 of 15 (60%); chi-squared test, p = 0.0449], indicating the negative correlation between the immune responses to the EGFR-T790M-derived epitopes and the presence of EGFR-T790M mutation in NSCLC patients. This finding could possibly be explained by the hypothesis that immune responses to the mutated neo-antigens derived from T790M might prevent the emergence of tumor cell variants with the T790M resistance mutation in NSCLC patients during EGFR-TKI treatment. Together, our results suggest that the identified T cell epitopes might provide a novel immunotherapeutic approach for prevention and/or treatment of EGFR-TKI resistance with the secondary EGFR T790M resistance mutation in NSCLC patients.	[Yamada, Teppei; Muta, Emi; Kim, Jintaek; Matsueda, Satoko; Kasama-Kawaguchi, Yuri; Itoh, Kyogo; Sasada, Tetsuro] Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 830, Japan; [Yamada, Teppei; Yamashita, Yuichi] Fukuoka Univ, Sch Med, Dept Surg, Fukuoka 81401, Japan; [Azuma, Koichi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Zhang, Guang Lan] Boston Univ, Metropolitan Coll, Boston, MA 02215 USA; [Zhang, Guang Lan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Yamashita, Takuto] Kurume Univ, Grad Sch Med, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan	Kurume University; Fukuoka University; Kurume University; Sendai Kousei Hospital; Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kurume University; Kindai University (Kinki University)	Sasada, T (corresponding author), Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 830, Japan.	tsasada@med.kurume-u.ac.jp			JSPS [23591913]; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [23591913] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS Grant-in-Aid for Scientific Research (C) 23591913 and the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Bernatchez C, 2011, VACCINE, V29, P3021, DOI 10.1016/j.vaccine.2011.01.115; Buettner R, 2013, J CLIN ONCOL, V31, P1858, DOI 10.1200/JCO.2012.45.9867; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; CHEN Y, 1994, J IMMUNOL, V152, P2874; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Echchakir H, 2001, CANCER RES, V61, P4078; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hogan KT, 1998, CANCER RES, V58, P5144; Ichiki Y, 2004, J IMMUNOL, V172, P4844, DOI 10.4049/jimmunol.172.8.4844; Jin M, 2008, CANCER SCI, V99, P1656, DOI 10.1111/j.1349-7006.2008.00866.x; Karanikas V, 2001, CANCER RES, V61, P3718; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; La Rosa C, 2001, BLOOD, V97, P1776; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McKee MD, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-35; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Sasada T, 2004, CANCER RES, V64, P2882, DOI 10.1158/0008-5472.CAN-03-3549; Sasada T, 2010, EUR J CANCER, V46, P1514, DOI 10.1016/j.ejca.2010.03.013; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; SHICHIO S, 1995, INT J CANCER, V64, P158, DOI 10.1002/ijc.2910640303; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; Takenoyama M, 2006, INT J CANCER, V118, P1992, DOI 10.1002/ijc.21594; Toubaji A, 2008, CANCER IMMUNOL IMMUN, V57, P1413, DOI 10.1007/s00262-008-0477-6; Weden S, 2011, INT J CANCER, V128, P1120, DOI 10.1002/ijc.25449; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x	49	17	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78389	10.1371/journal.pone.0078389	http://dx.doi.org/10.1371/journal.pone.0078389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223798	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400023
J	Zhang, TT; Bai, XH; Mao, XH				Zhang, Tiantian; Bai, Xuehua; Mao, Xiaohua			Systemic Delivery of Small Interfering RNA Targeting the Interleukin-2/15 Receptor beta Chain Prevents Disease Progression in Experimental Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; MURINE ARTHRITIS; QUANTUM DOTS; FACTOR-ALPHA; TNF-ALPHA; IN-VIVO; CYTOKINE; IL-15	The role of interleukin (IL)-15 in the pathogenesis of rheumatoid arthritis (RA) is well established; however, systemic knockdown of IL-15 receptor (IL-15R) for reduction in inflammation at local sites has not been demonstrated. In this study, the therapeutic effect of intravenously administered siRNA targeting the beta chain of IL-15R which is shared by the receptor for IL-2 was examined in rats with adjuvant-induced arthritis (AA). Polyethylenimine (PEI)-complexed siRNA nanoparticles could easily accumulate in arthritic paws of AA rats. In the paws, the nanoparticles were avidly taken up by macrophages and to a lesser extent by T cells. Weekly administered IL-2/15R beta siRNA polyplexes were capable of decreasing disease progression in AA rats, with striking inhibition of clinical, radiologic, and histologic features of RA. The observed therapeutic effect was associated with reduced expression of proinflammatory mediators in the inflamed joints. Thus, this study provides evidence that IL-2/15R beta could be targeted for the treatment of RA.	[Zhang, Tiantian; Bai, Xuehua; Mao, Xiaohua] Southeast Univ, Sch Life Sci, Minist Educ Dev Genes & Human Dis, Key Lab, Nanjing, Jiangsu, Peoples R China; [Mao, Xiaohua] Southeast Univ, Sch Med, Dept Biochem, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Mao, XH (corresponding author), Southeast Univ, Sch Life Sci, Minist Educ Dev Genes & Human Dis, Key Lab, Nanjing, Jiangsu, Peoples R China.	xmao@seu.edu.cn			National Natural Science Foundation of China [81071445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81071445). The URL of the funder's website is www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Andersson AK, 2008, SCAND J IMMUNOL, V68, P103, DOI 10.1111/j.1365-3083.2008.02118.x; Arend WP, 2001, ARTHRIT RHEUM-ARTHR, V45, P101; Asquith DL, 2007, CURR OPIN RHEUMATOL, V19, P246, DOI 10.1097/BOR.0b013e3280eec78c; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Choi HS, 2009, NANO LETT, V9, P2354, DOI 10.1021/nl900872r; Depis F, 2012, ARTHRITIS RHEUM-US, V64, P3189, DOI 10.1002/art.34497; Ernestam S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1871; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ferrari-Lacraz S, 2004, J IMMUNOL, V173, P5818, DOI 10.4049/jimmunol.173.9.5818; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Gao J, 2011, BIOMATERIALS, V32, P3459, DOI 10.1016/j.biomaterials.2011.01.034; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Howard KA, 2009, MOL THER, V17, P162, DOI 10.1038/mt.2008.220; Khoury M, 2006, ARTHRITIS RHEUM, V54, P1867, DOI 10.1002/art.21876; Khoury M, 2008, ARTHRITIS RHEUM-US, V58, P2356, DOI 10.1002/art.23660; Knevel R, 2012, ANN RHEUM DIS, V71, P1651, DOI 10.1136/annrheumdis-2011-200724; Kurreeman FAS, 2009, ANN RHEUM DIS, V68, P1789, DOI 10.1136/ard.2008.106393; Kuuliala A, 2006, ANN RHEUM DIS, V65, P26, DOI 10.1136/ard.2004.034728; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mitragotri S, 2011, ARCH PHARM RES, V34, P1887, DOI 10.1007/s12272-011-1109-9; Naeye B, 2013, BIOMATERIALS, V34, P2350, DOI 10.1016/j.biomaterials.2012.11.058; Ogata Y, 1999, J IMMUNOL, V162, P2754; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wang DL, 2010, MOL IMMUNOL, V47, P1535, DOI 10.1016/j.molimm.2010.01.023; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Ye C, 2013, SCAND J RHEUMATOL, V42, P266, DOI 10.3109/03009742.2013.777779; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109	39	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78619	10.1371/journal.pone.0078619	http://dx.doi.org/10.1371/journal.pone.0078619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223832	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400036
J	Chen, X; Chen, Y; Yang, Q; Kong, HS; Yu, F; Han, DS; Zheng, SF; Cui, DW; Li, LJ				Chen, Xiao; Chen, Yu; Yang, Qing; Kong, Haishen; Yu, Fei; Han, Dongsheng; Zheng, Shufa; Cui, Dawei; Li, Lanjuan			Plesiomonas shigelloides Infection in Southeast China	PLOS ONE			English	Article							DIARRHEAL DISEASE; CDC DEFINITIONS; ETIOLOGY; FISH	Background: Plesiomonas shigelloides can cause gastroenteritis and extra-intestinal diseases in humans. However, the prevalence of P. shigelloides infections has not been investigated in China. Methods: Consecutive fecal specimens from outpatients with acute diarrhea and non-diarrheal patients at nine sentinel hospitals in southeast China were collected from March 2010 to May 2012. Bacterial pathogens were detected by culture, and P. shigelloides isolates were subjected to antimicrobial susceptibility testing. We also retrospectively reviewed the hospital microbiology laboratory and infection-control databases for all P. shigelloides isolates identified from 2001-2012 at our institution in addition to data on the patients' clinical and demographic characteristics. Results: A total of 3,536 outpatients with acute diarrhea were enrolled in the study. P. shigelloides was isolated from 104 (2.9%) patients and accounted for 7.3% of bacterial isolates. Single-pathogen infections with P. shigelloides were present in 76 (73.1%) patients. No strain of P. shigelloides was isolated from the 478 non-diarrheal patients. Based on 444,684 nonfecal specimens, eight patients developed P. shigelloides-related extra-intestinal infections over the 12-year period. All eight patients had underlying diseases, including four with biliary tract diseases and three with liver diseases. Six cases were classified as nosocomial, and five cases were polymicrobial. P. shigelloides was sensitive to most antimicrobial drugs, except ampicillin. Conclusions: In southeast China, P. shigelloides has significant clinical relevance, although the isolation rate is low.	[Chen, Xiao; Chen, Yu; Yang, Qing; Kong, Haishen; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Fei; Han, Dongsheng; Zheng, Shufa; Cui, Dawei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Chen, Yu/Y-3292-2019	Han, Dongsheng/0000-0002-1892-8603	National Key Programs for Infectious Diseases of China [2012ZX10004-210]; National Key Clinical Specialist Construction Project	National Key Programs for Infectious Diseases of China; National Key Clinical Specialist Construction Project	This work was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004-210) and National Key Clinical Specialist Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 1980, J HYG-CAMBRIDGE, V84, P203, DOI 10.1017/S002217240002670X; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; Chen Y, 2013, CLIN MICROB IN PRESS; CLSI, 2011, M100S20 CLSI, P172; Escobar JC, 2012, EMERG INFECT DIS, V18, P322, DOI 10.3201/eid1802.110562; FLOCH MH, 1970, GASTROENTEROLOGY, V59, P70; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Herrera FC, 2006, INT J FOOD MICROBIOL, V108, P233, DOI 10.1016/j.ijfoodmicro.2005.12.008; HOLMBERG SD, 1986, ANN INTERN MED, V105, P690, DOI [10.7326/0003-4819-105-5-690, 10.7326/0003-4819-105-5-683]; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; HUQ MI, 1983, INDIAN J MED RES, V77, P793; Janda JM, 2005, BERGEYS MANUAL SYSTE, V2, P740; KAIN KC, 1989, J CLIN MICROBIOL, V27, P998, DOI 10.1128/JCM.27.5.998-1001.1989; Klatte JM, 2012, PEDIATR INFECT DIS J, V31, P1200, DOI 10.1097/INF.0b013e318266b61f; KUO CH, 1991, LIVER, V11, P334; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Nweze EI, 2010, J HEALTH POPUL NUTR, V28, P245; Ozdemir O, 2010, J MICROBIOL IMMUNOL, V43, P344, DOI 10.1016/S1684-1182(10)60053-9; RUTALA WA, 1982, LANCET, V1, P739; Schneider F, 2009, MED MALADIES INFECT, V39, P397, DOI 10.1016/j.medmal.2008.11.010; SOWEID AM, 1995, AM J GASTROENTEROL, V90, P2235; Stock I, 2001, J ANTIMICROB CHEMOTH, V48, P803, DOI 10.1093/jac/48.6.803; SUNG JY, 1992, J GASTROEN HEPATOL, V7, P240, DOI 10.1111/j.1440-1746.1992.tb00971.x; VANDAMME LR, 1980, APPL ENVIRON MICROB, V39, P475, DOI 10.1128/AEM.39.3.475-479.1980; Wong T. Y., 2000, Hong Kong Medical Journal, V6, P375; Woo PCY, 2005, MICROBIOLOGICA, V28, P45; Woo PCY, 2004, J CLIN MICROBIOL, V42, P933, DOI 10.1128/JCM.42.2.933-935.2004	27	20	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77877	10.1371/journal.pone.0077877	http://dx.doi.org/10.1371/journal.pone.0077877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223738	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400019
J	Saman, DM; Kavanagh, KT				Saman, Daniel M.; Kavanagh, Kevin T.			Assessing the Necessity of the Standardized Infection Ratio for Reporting Central Line-Associated Bloodstream Infections	PLOS ONE			English	Article								This brief article presents results that support the contention that risk adjustment via the standardized infection ratio (SIR) for the reporting of central line-associated bloodstream infections (CLABSIs) may be no more predictive than standard rate adjustments utilizing CLABSIs per central line days (i.e., CLABSI rates). Recent data posted on the U. S. Department of Health and Human Services' Hospital Compare website showed that nearly 70% of 1721 reporting hospitals with at least 1000 central line days had five or fewer infections during 2011. These hospitals had 39.3% of the total central line days and a significantly lower SIR than poorer performing hospitals with six or more CLABSIs (p<0.0001). In addition, 19 hospitals are presented which had central line days between 9000 to over 22,000 that also had zero to three CLABSIs. Some of these hospitals were university referral centers and inner city facilities. There was great variation of CLABSI cases among US hospitals. Evidence is mounting that all hospitals should be able to achieve a near zero incidence of CLABSIs and that these infections may in fact be near 'never events', which begs whether risk adjustment with the SIR is needed and whether it adds more information than does rate adjustment using CLABSI rates.	[Saman, Daniel M.] Essentia Inst Rural Hlth, Div Res, Duluth, MN USA; [Saman, Daniel M.; Kavanagh, Kevin T.] Hlth Watch USA, Somerset, KY USA		Saman, DM (corresponding author), Essentia Inst Rural Hlth, Div Res, Duluth, MN USA.	dmsaman@eirh.org		Saman, Daniel/0000-0002-8372-4615; Kavanagh, Kevin/0000-0002-4588-6509				Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Center for Disease Control and Prevention, 2011, NAT STAT HEALTHC ASS; Centers for Disease Control and Prevention, 2012, NAT STAT HEALTHC ASS; Centers for Medicare & Medicaid Services, 2012, HOSOP COMP RETR OUTP; Centre for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases, 2009, NAT HEALTHC ASS INF; Consumer Reports Health, 2013, CONSUMER REPORTS HLT; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Harnage SA, 2012, INNOVATION TECHNOLOG; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Lipitz-Snyderman A, 2011, ARCH INTERN MED, V171, P856, DOI 10.1001/archinternmed.2011.161; Margolin F. S., 2011, GETTING ZERO REDUCIN; Mayer J, 2012, CLIN INFECT DIS, V55, P364, DOI 10.1093/cid/cis410; Pronovost Peter, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Saman DM, 2013, J PATIENT SAF, V9, P55, DOI 10.1097/PTS.0b013e3182809f31; Silow-Carroll S, 2011, BRONSON METHODIST	16	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79554	10.1371/journal.pone.0079554	http://dx.doi.org/10.1371/journal.pone.0079554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223966	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400124
J	Sarikonda, G; Pettus, J; Sachithanantham, S; Phatak, S; Miller, JF; Ganesan, L; Chae, J; Mallios, R; Edelman, S; Peters, B; von Herrath, M				Sarikonda, Ghanashyam; Pettus, Jeremy; Sachithanantham, Sowbarnika; Phatak, Sonal; Miller, Jacqueline F.; Ganesan, Lakshmi; Chae, Ji; Mallios, Ronna; Edelman, Steve; Peters, Bjoern; von Herrath, Matthias			Temporal Intra-Individual Variation of Immunological Biomarkers in Type 1 Diabetes Patients: Implications for Future Use in Cross-Sectional Assessment	PLOS ONE			English	Article							T-CELL RESPONSES; THERAPY; COMPLICATIONS; EUROPE; TRENDS	Multiple immune parameters such as frequencies of autoreactive CD4(+), CD8(+) T-cells and CD4(+)CD25(+)Foxp3(+) T-cells have been explored as biomarkers in human T1D. However, intra-individual temporal variation of these parameters has not been assessed systematically over time. We determined the variation in each of these parameters in a cohort of T1D and healthy donors (HDs), at monthly intervals for one year. Despite low intra- and inter-assay co-efficient of variation (CV), mean CVs for each of the immune parameters were 119.1% for CD4(+) T-cell-derived IFN-gamma, 50.44% for autoreactive CD8(+) T-cells, and 31.24% for CD4(+)CD25(+)Foxp3(+) T-cells. Further, both HDs and T1D donors had similar CVs. The variation neither correlated with BMI, age, disease duration or insulin usage, nor were there detectable cyclical patterns of variation. However, averaging results from multiple visits for an individual provided a better estimate of the CV between visits. Based on our data we predict that by averaging values from three visits a treatment effect on these parameters with a 50% effect size could be detected with the same power using 1.8-4-fold fewer patients within a trial compared to using values from a single visit. Thus, our present data contribute to a more robust, accurate endpoint design for future clinical trials in T1D and aid in the identification of truly efficacious therapies.	[Sarikonda, Ghanashyam; Pettus, Jeremy; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Ganesan, Lakshmi; Chae, Ji; Mallios, Ronna; Peters, Bjoern; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA USA; [Pettus, Jeremy; Phatak, Sonal; Ganesan, Lakshmi; Chae, Ji; Edelman, Steve] Univ Calif San Diego, San Diego, CA 92103 USA; [von Herrath, Matthias] Novo Nordisk Inc, Type Diabet R&D Ctr 1, Seattle, WA USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Novo Nordisk	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA USA.	matthias@liai.org			T1D center of San Diego; University of Michigan, Ann Arbor (UMich) [3002074563]; NIH [3UL1RR024986-05S1]	T1D center of San Diego; University of Michigan, Ann Arbor (UMich); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	GS was supported by a postdoctoral fellowship from the T1D center of San Diego. This work was supported by a subaward number 3002074563 from University of Michigan, Ann Arbor (UMich), to MvH, issued under NIH award number 3UL1RR024986-05S1 to UMich under the direction of Dr. Thomas P. Shanley, P. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Buchhave P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006294; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Lachin JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026471; Lebastchi J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007708; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Martinuzzi E, 2008, J IMMUNOL METHODS, V333, P61, DOI 10.1016/j.jim.2008.01.003; Oseroff C, 2012, J IMMUNOL, V189, P1800, DOI 10.4049/jimmunol.1200850; Palmer Jerry P., 2004, Diabetes, V53, P250; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Sanda S, 2008, CLIN IMMUNOL, V127, P138, DOI 10.1016/j.clim.2007.12.003; Sarikonda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054712; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wood JR, 2013, DIABETES CARE	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79383	10.1371/journal.pone.0079383	http://dx.doi.org/10.1371/journal.pone.0079383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223938	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400111
J	Bakouche, N; Vandenbroucke, AT; Goubau, P; Ruelle, J				Bakouche, Nordine; Vandenbroucke, Anne-Therese; Goubau, Patrick; Ruelle, Jean			Study of the HIV-2 Env Cytoplasmic Tail Variability and Its Impact on Tat, Rev and Nef	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TERMINAL TAIL; CELL-CELL FUSION; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE PROTEIN; HTLV-III; INTRACYTOPLASMIC TAIL; CLATHRIN ADAPTER; ATOMIC-STRUCTURE; POINT MUTATIONS	Background: The HIV-2 env's 3' end encodes the cytoplasmic tail (CT) of the Env protein. This genomic region also encodes the rev, Tat and Nef protein in overlapping reading frames. We studied the variability in the CT coding region in 46 clinical specimens and in 2 reference strains by sequencing and by culturing. The aims were to analyse the variability of Env CT and the evolution of proteins expressed from overlapping coding sequences. Results: A 70% reduction of the length of the CT region affected the HIV-2 ROD and EHO strains in vitro due to a premature stop codon in the env gene. In clinical samples this wasn't observed, but the CT length varied due to insertions and deletions. We noted 3 conserved and 3 variable regions in the CT. The conserved regions were those containing residues involved in Env endocytosis, the potential HIV-2 CT region implicated in the NF-kB activation and the potential end of the lentiviral lytic peptide one. The variable regions were the potential HIV-2 Kennedy region, the potential lentiviral lytic peptide two and the beginning of the potential lentiviral lytic peptide one. A very hydrophobic region was coded downstream of the premature stop codon observed in vitro, suggesting a membrane spanning region. Interestingly, the nucleotides that are responsible for the variability of the CT don't impact rev and Nef. However, in the Kennedy-like coding region variability resulted only from nucleotide changes that impacted Env and Tat together. Conclusion: The HIV-2 Env, Tat and Rev C-terminal part are subject to major length variations in both clinical samples and cultured strains. The HIV-2 Env CT contains variable and conserved regions. These regions don't affect the rev and Nef amino acids composition which evolves independently. In contrast, Tat co-evolves with the Env CT.	[Bakouche, Nordine; Vandenbroucke, Anne-Therese; Goubau, Patrick; Ruelle, Jean] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium	Universite Catholique Louvain	Ruelle, J (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	jean.ruelle@uclouvain.be			Fonds de la Recherche Scientifique (a public funding)	Fonds de la Recherche Scientifique (a public funding)	NB is financed by the Fonds de la Recherche Scientifique (a public funding) url: http://www.frs-fnrs.be/. The funders (FNRS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; EISENBERG D, 1990, BIOPOLYMERS, V29, P171, DOI 10.1002/bip.360290122; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LEE SJ, 1989, AIDS RES HUM RETROV, V5, P441, DOI 10.1089/aid.1989.5.441; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; MILLER MA, 1993, VIROLOGY, V196, P89, DOI 10.1006/viro.1993.1457; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Noble B, 2006, J VIROL, V80, P2924, DOI 10.1128/JVI.80.6.2924-2932.2006; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; PAUWELS R, 1987, J VIROL METHODS, V16, P171, DOI 10.1016/0166-0934(87)90002-4; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Postler TS, 2012, CELL HOST MICROBE, V11, P181, DOI 10.1016/j.chom.2011.12.005; REY MA, 1989, VIROLOGY, V173, P258, DOI 10.1016/0042-6822(89)90242-0; Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005; ROWELL JF, 1995, J IMMUNOL, V155, P473; Schmitt AO, 1997, J THEOR BIOL, V188, P369, DOI 10.1006/jtbi.1997.0493; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Sung JH, 2001, J NEUROVIROL, V7, P454; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; VENABLE RM, 1989, AIDS RES HUM RETROV, V5, P7, DOI 10.1089/aid.1989.5.7; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Waheed AA, 2010, J VIROL, V84, P3121, DOI 10.1128/JVI.02002-09; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; YU XF, 1993, J VIROL, V67, P213, DOI 10.1128/JVI.67.1.213-221.1993	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79129	10.1371/journal.pone.0079129	http://dx.doi.org/10.1371/journal.pone.0079129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223892	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300062
J	Estes, AM; Hearn, DJ; Snell-Rood, EC; Feindler, M; Feeser, K; Abebe, T; Hotopp, JCD; Moczek, AP				Estes, Anne M.; Hearn, David J.; Snell-Rood, Emilie C.; Feindler, Michele; Feeser, Karla; Abebe, Tselotie; Hotopp, Julie C. Dunning; Moczek, Armin P.			Brood Ball-Mediated Transmission of Microbiome Members in the Dung Beetle, Onthophagus taurus (Coleoptera: Scarabaeidae)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LARVAE COLEOPTERA; BACTERIA; GUT; IDENTIFICATION; ENDOSYMBIONTS; COMMUNITY; HINDGUT; INSECT; GENES	Insects feeding on plant sap, blood, and other nutritionally incomplete diets are typically associated with mutualistic bacteria that supplement missing nutrients. Herbivorous mammal dung contains more than 86% cellulose and lacks amino acids essential for insect development and reproduction. Yet one of the most ecologically necessary and evolutionarily successful groups of beetles, the dung beetles (Scarabaeinae) feeds primarily, or exclusively, on dung. These associations suggest that dung beetles may benefit from mutualistic bacteria that provide nutrients missing from dung. The nesting behaviors of the female parent and the feeding behaviors of the larvae suggest that a microbiome could be vertically transmitted from the parental female to her offspring through the brood ball. Using sterile rearing and a combination of molecular and culture-based techniques, we examine transmission of the microbiome in the bull-headed dung beetle, Onthophagus taurus. Beetles were reared on autoclaved dung and the microbiome was characterized across development. A similar to 1425 bp region of the 16S rRNA identified Pseudomonadaceae, Enterobacteriaceae, and Comamonadaceae as the most common bacterial families across all life stages and populations, including cultured isolates from the 3rd instar digestive system. Finer level phylotyping analyses based on lepA and gyrB amplicons of cultured isolates placed the isolates closest to Enterobacter cloacae, Providencia stuartii, Pusillimonas sp., Pedobacter heparinus, and Lysinibacillus sphaericus. Scanning electron micrographs of brood balls constructed from sterile dung reveals secretions and microbes only in the chamber the female prepares for the egg. The use of autoclaved dung for rearing, the presence of microbes in the brood ball and offspring, and identical 16S rRNA sequences in both parent and offspring suggests that the O. taurus female parent transmits specific microbiome members to her offspring through the brood chamber. The transmission of the dung beetle microbiome highlights the maintenance and likely importance of this newly-characterized bacterial community.	[Estes, Anne M.; Hearn, David J.; Feindler, Michele; Feeser, Karla; Abebe, Tselotie] Towson Univ, Dept Biol Sci, Baltimore, MD USA; [Estes, Anne M.; Hotopp, Julie C. Dunning] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Snell-Rood, Emilie C.; Moczek, Armin P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Hotopp, Julie C. Dunning] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Hearn, David J.] J Craig Venter Inst Inc, Plant Genom, Rockville, MD USA	University System of Maryland; Towson University; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; University System of Maryland; University of Maryland Baltimore	Estes, AM (corresponding author), Towson Univ, Dept Biol Sci, Baltimore, MD USA.	anneestes@gmail.com		Feeser, Karla/0000-0003-0030-9449; Estes, Anne/0000-0002-8775-2656	Towson University Fisher College; Towson University; Orchid Society of Arizona; NSF REU [DBI0552654]; NSF IOS [0445661, 0718522]; State of Maryland	Towson University Fisher College; Towson University; Orchid Society of Arizona; NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF IOS(National Science Foundation (NSF)); State of Maryland	This research was supported in part through funds from: the Towson University Fisher College Undergraduate Research Awards (KF, TA), a Towson University Undergraduate Research Award (KF), Orchid Society of Arizona funding (AME), NSF REU DBI0552654 (MF), NSF IOS 0445661 (AM), NSF IOS 0718522 (AM), and State of Maryland internal funds (JDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Balmand S, 2013, J INVERTEBR PATHOL, V112, pS116, DOI 10.1016/j.jip.2012.04.002; Baumann L, 1999, J MOL EVOL, V48, P77, DOI 10.1007/PL00006447; BELDA E, 2010, BMC GENOMICS, V11, P1, DOI DOI 10.1186/1471-2164-11-S5-S1.PUBMED:20044946; Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Beninati T, 2009, FEMS MICROBIOL LETT, V299, P241, DOI 10.1111/j.1574-6968.2009.01757.x; Bressan A, 2009, ENVIRON MICROBIOL, V11, P3265, DOI 10.1111/j.1462-2920.2009.02055.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Castrillo LA, 2000, J ECON ENTOMOL, V93, P226, DOI 10.1603/0022-0493-93.2.226; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Delalibera I, 2007, SYMBIOSIS, V43, P97; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Estes AM, 2012, ENVIRON ENTOMOL, V41, P265, DOI 10.1603/EN11245; Estes AM, 2009, APPL ENVIRON MICROB, V75, P7097, DOI 10.1128/AEM.00778-09; FINCHER TG, 1975, COLEOPT B, V29, P349; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; GOIDANICH A, 1964, ANN FACOLTA SCI AGRA, V2, P213; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GREENBERG B, 1959, AM J TROP MED HYG, V8, P613, DOI 10.4269/ajtmh.1959.8.613; Halffter G, 1982, NESTING BEHAV DUNG B, P1; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hoebeke ER, 1997, ENTOMOL NEWS, V108, P345; Holter P, 2009, J ARID ENVIRON, V73, P1090, DOI 10.1016/j.jaridenv.2009.04.009; Holter P, 2013, J MORPHOL, V274, P657, DOI 10.1002/jmor.20123; HOWDEN H F, 1986, Coleopterists Bulletin, V40, P313; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Huang SW, 2010, INSECT SCI, V17, P175, DOI 10.1111/j.1744-7917.2010.01320.x; Huang SW, 2012, INT J MOL SCI, V13, P2563, DOI 10.3390/ijms13032563; HUNTER JS, 1985, J ENTOMOL SCI, V20, P24, DOI 10.18474/0749-8004-20.1.24; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kellner RLL, 2002, CHEMOECOLOGY, V12, P133, DOI 10.1007/s00012-002-8338-1; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; KRELL FT, 2006, COLEOPT SOC MONO DEC, P120, DOI DOI 10.1649/0010-065X(2006)60[; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Kuczynski Justin, 2011, Curr Protoc Bioinformatics, VChapter 10, DOI [10.1002/9780471729259.mc01e05s27, 10.1002/0471250953.bi1007s36]; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Martinez-Sanudo I, 2011, CAN J MICROBIOL, V57, P969, DOI [10.1139/W11-057, 10.1139/w11-057]; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Muller Z., 1980, FAO ANIMAL PRODUCTIO; NALEPA CA, 1984, BEHAV ECOL SOCIOBIOL, V14, P273, DOI 10.1007/BF00299498; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Philips T. Keith, 2011, P21; Pittman GW, 2008, APPL ENVIRON MICROB, V74, P762, DOI 10.1128/AEM.01831-07; Price DL, 2012, P ENTOMOL SOC WASH, V114, P142, DOI 10.4289/0013-8797.114.1.142; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; RUPERT LLK, 2003, ENTOMOL EXP APPL, V107, P115, DOI DOI 10.1046/J.1570-7458.2003.00042.X; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi WB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003131; Simonnet F, 2011, EVOL DEV, V13, P280, DOI 10.1111/j.1525-142X.2011.00479.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoll S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-308; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; White J, 2011, ROUTL FILM GUIDEBOOK, P1; White JR, 2011, NATURE PRECEDINGS; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zhang H, 2008, J APPL MICROBIOL, V105, P1277, DOI 10.1111/j.1365-2672.2008.03867.x; Zientz E, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-reviews1032	77	54	55	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79061	10.1371/journal.pone.0079061	http://dx.doi.org/10.1371/journal.pone.0079061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223880	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300050
J	Yamazaki, T; Yamori, M; Tanaka, S; Yamamoto, K; Sumi, E; Nishimoto-Sano, M; Asai, K; Takahashi, K; Nakayama, T; Bessho, K				Yamazaki, Toru; Yamori, Masashi; Tanaka, Shiro; Yamamoto, Keiichi; Sumi, Eriko; Nishimoto-Sano, Megumi; Asai, Keita; Takahashi, Katsu; Nakayama, Takeo; Bessho, Kazuhisa			Risk Factors and Indices of Osteomyelitis of the Jaw in Osteoporosis Patients: Results from a Hospital-Based Cohort Study in Japan	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; ORAL BISPHOSPHONATES; CANCER-PATIENTS; ASSOCIATION; ZOLEDRONATE; SURGERY; DISEASE	Background: Several studies have reported osteomyelitis of the jaw (OMJ) as a side effect of bisphosphonates (BPs), and the risk of oral BPs has been recently clarified. However, other systemic risk factors of OMJ remain unclear. Importantly, the possibility of risk classification based on the clinical characteristics of patients has not been explored. Here, we clarified risk factors of OMJ and evaluate the predictive accuracy of risk indices in osteoporosis patients. Methods: We performed sub-analysis using a database developed for a retrospective cohort study in patients taking medications for osteoporosis at Kyoto University Hospital. Risk indices for OMJ were constructed using logistic regression analysis, and odds ratios (OR) for OMJ cases and 95% confidence intervals (CI) were estimated. Potential risk factors included in the statistical analysis were age; sex; diabetes; use of oral BPs, corticosteroids, cancer chemotherapy, antirheumatic drugs, and biologic agents; and their interactions. Risk indices were calculated by the sum of potential risk factors of an individual patient multiplied by the regression coefficients. The discriminatory power of the risk indices was assessed by receiver operating characteristic (ROC) analysis. Results: In analysis of all patients, oral BPs (OR: 4.98, 95% CIs: 1.94-12.75), age (OR: 1.28, 95% CI: 1.06-1.60) and sex-chemotherapy interaction (OR: 11.70, 95% CI: 1.46-93.64) were significant risk factors of OMJ. Areas under the ROC curves of these risk indices provided moderate sensitivity or specificity regardless of group (0.683 to 0.718). Conclusions: Our data suggest that oral BP use, age, and sex-chemotherapy are predictors of OMJ in osteoporosis patients. The risk indices are moderately high, and allow the prediction of OMJ incidence.	[Yamazaki, Toru; Yamori, Masashi; Nishimoto-Sano, Megumi; Asai, Keita; Takahashi, Katsu; Bessho, Kazuhisa] Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Kyoto, Japan; [Tanaka, Shiro] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Pharmacoepidemiol, Kyoto, Japan; [Yamamoto, Keiichi] Natl Cerebral & Cardiovasc Ctr, Res & Dev Initiat Ctr, Dept Prevent Med & Epidemiol Informat, Osaka, Japan; [Sumi, Eriko] Kyoto Univ, Translat Res Ctr, Dept Clin Innovat Med, Kyoto, Japan; [Nakayama, Takeo] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan	Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Kyoto University	Yamazaki, T (corresponding author), Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Kyoto, Japan.	toruy@kuhp.kyoto-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022; Yamamoto, Keiichi/AFQ-9006-2022; 田中, 司朗/GON-6916-2022	Yamamoto, Keiichi/0000-0003-3278-5001; 田中, 司朗/0000-0001-6817-5235; Nakayama, Takeo/0000-0002-7918-6252	Grants-in-Aid for Scientific Research [23790566] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Badros A, 2008, J CLIN ONCOL, V26, P5904, DOI 10.1200/JCO.2008.16.9300; Balla B, 2012, ORAL DIS, V18, P580, DOI 10.1111/j.1601-0825.2012.01912.x; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Berenson JR, 2011, AM J HEMATOL, V86, P25, DOI 10.1002/ajh.21912; Bertoldo F, 2007, NAT CLIN PRACT ONCOL, V4, P711, DOI 10.1038/ncponc1000; Boonyapakorn T, 2008, ORAL ONCOL, V44, P857, DOI 10.1016/j.oraloncology.2007.11.012; Campisi G, 2009, J RHEUMATOL, V36, P451, DOI 10.3899/jrheum.080843; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968; Etminan M, 2008, J RHEUMATOL, V35, P691; Fellows JL, 2011, J DENT RES, V90, P433, DOI 10.1177/0022034510387795; Hutchinson M, 2010, J ORAL MAXIL SURG, V68, P2232, DOI 10.1016/j.joms.2010.05.003; Junquera L, 2008, J ORAL MAXIL SURG, V66, P1516, DOI 10.1016/j.joms.2008.02.012; Khamaisi M, 2007, J CLIN ENDOCR METAB, V92, P1172, DOI 10.1210/jc.2006-2036; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kos M, 2010, INT J ORAL MAX SURG, V39, P1097, DOI 10.1016/j.ijom.2010.04.054; La Ferla F, 2012, BIOMARK MED, V6, P201, DOI [10.2217/BMM.12.14, 10.2217/bmm.12.14]; Lapi F, 2013, OSTEOPOROSIS INT, V24, P697, DOI 10.1007/s00198-012-2013-y; Mawardi H, 2009, J ORAL MAXIL SURG, V67, P593, DOI 10.1016/j.joms.2008.09.031; Miyazaki H, 2012, BJU INT, V110, pE520, DOI 10.1111/j.1464-410X.2012.11205.x; Nicoletti P, 2012, ONCOLOGIST, V17, P279, DOI 10.1634/theoncologist.2011-0202; Ortega C, 2007, ACTA ONCOL, V46, P664, DOI 10.1080/02841860601185917; Patel V, 2011, BRIT J ORAL MAX SURG, V49, P251, DOI 10.1016/j.bjoms.2010.05.007; Pazianas M, 2008, OSTEOPOROSIS INT, V19, P773, DOI 10.1007/s00198-007-0502-1; Rizzoli R, 2008, BONE, V42, P841, DOI 10.1016/j.bone.2008.01.003; Rudic JS, 2011, COCHRANE DB SYST REV; Ruggiero S, 2006, J ONCOL PRACT, V2, P7, DOI 10.1200/JOP.2.1.7; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Skrepnek Grant H, 2010, Gen Dent, V58, P484; Tennis P, 2012, PHARMACOEPIDEM DR S, V21, P810, DOI 10.1002/pds.3292; Van den Wyngaert T, 2009, ANN ONCOL, V20, P331, DOI 10.1093/annonc/mdn630; Vestergaard P, 2012, J ORAL MAXIL SURG, V70, P821, DOI 10.1016/j.joms.2011.02.093; Watters AL, 2013, OR SURG OR MED OR PA, V115, P192, DOI 10.1016/j.oooo.2012.05.017; Wessel JH, 2008, J ORAL MAXIL SURG, V66, P625, DOI 10.1016/j.joms.2007.11.032; Wilkinson GS, 2007, JNCI-J NATL CANCER I, V99, P1016, DOI 10.1093/jnci/djm025; Yamamoto K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001622; Yamazaki T, 2012, BONE, V51, P882, DOI 10.1016/j.bone.2012.08.115; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79376	10.1371/journal.pone.0079376	http://dx.doi.org/10.1371/journal.pone.0079376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223935	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300079
J	Dancevic, CM; Fraser, FW; Smith, AD; Stupka, N; Ward, AC; McCulloch, DR				Dancevic, Carolyn M.; Fraser, Fiona W.; Smith, Adam D.; Stupka, Nicole; Ward, Alister C.; McCulloch, Daniel R.			Biosynthesis and Expression of a Disintegrin-like and Metalloproteinase Domain with Thrombospondin-1 Repeats-15 A NOVEL VERSICAN-CLEAVING PROTEOGLYCANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Embryo; Extracellular Matrix; Extracellular Matrix Proteins; Metalloprotease; Proteoglycan; Skeletal Muscle	CELL-SURFACE; ADAMTS METALLOPROTEASES; IN-VIVO; CLEAVAGE; ACTIVATION; AGGRECANASE; MATRIX; GENE; LOCALIZATION; PROTEOLYSIS	The proteoglycanase clade of the ADAMTS superfamily shows preferred proteolytic activity toward the hyalectan/lectican proteoglycans as follows: aggrecan, brevican, neurocan, and versican. ADAMTS15, a member of this clade, was recently identified as a putative tumor suppressor gene in colorectal and breast cancer. However, its biosynthesis, substrate specificity, and tissue expression are poorly described. Therefore, we undertook a detailed study of this proteinase and its expression. We report propeptide processing of the ADAMTS15 zymogen by furin activity, identifying RAKR(212) as a major furin cleavage site within the prodomain. ADAMTS15 was localized on the cell surface, activated extracellularly, and required propeptide processing before cleaving V1 versican at position (441)EA(442). In the mouse embryo, Adamts15 was expressed in the developing heart at E10.5 and E11.5 days post-coitum and in the musculoskeletal system from E13.5 to E15.5 days post-coitum, where it was co-localized with hyaluronan. Adamts15 was also highly expressed in several structures within the adult mouse colon. Our findings show overlapping sites of Adamts15 expression with other members of ADAMTS proteoglycanases during embryonic development, suggesting possible cooperative roles during embryogenesis, consistent with other ADAMTS proteoglycanase combinatorial knock-out mouse models. Collectively, these data suggest a role for ADAMTS15 in a wide range of biological processes that are potentially mediated through the processing of versican.	[McCulloch, Daniel R.] Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic 3216, Australia; Deakin Univ, Mol & Med Res SRC, Waurn Ponds, Vic 3216, Australia	Deakin University; Deakin University	McCulloch, DR (corresponding author), Deakin Univ, Fac Hlth, Sch Med, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	daniel.mcculloch@deakin.edu.au		Ward, Alister/0000-0001-7945-7975; McCulloch, Daniel/0000-0003-0269-5857; , Carolyn/0000-0002-1529-8060; Stupka, Nicole/0000-0002-1000-1707	Financial Markets Foundation for Children [162-10]; Deakin University Faculty of Health, Faculty Development Research Grant [FDRG-2009]; Commonwealth Government; National Health and Medical Research Council	Financial Markets Foundation for Children; Deakin University Faculty of Health, Faculty Development Research Grant; Commonwealth Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Financial Markets Foundation for Children Grant 162-10 (to D. McC., N. S., and A. W.) and the Deakin University Faculty of Health, Faculty Development Research Grant FDRG-2009 (to D. McC.).; Supported by a Commonwealth Government-funded Australian postgraduate award.; Supported in part by a National Health and Medical Research Council Peter Doherty Fellowship.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Dupuis LE, 2013, J MOL CELL CARDIOL, V60, P50, DOI 10.1016/j.yjmcc.2013.03.010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hsu YP, 2012, INT J EXP PATHOL, V93, P70, DOI 10.1111/j.1365-2613.2011.00802.x; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kintakas C, 2011, MATRIX BIOL, V30, P311, DOI 10.1016/j.matbio.2011.05.004; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McCulloch DR, 2010, OSTEOARTHR CARTILAGE, V18, P455, DOI 10.1016/j.joca.2009.10.014; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Molokwu CN, 2010, CANCER INVEST, V28, P698, DOI 10.3109/07357907.2010.489538; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Porter S, 2006, INT J CANCER, V118, P1241, DOI 10.1002/ijc.21476; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; Thai SNM, 2002, MECH DEVELOP, V115, P181, DOI 10.1016/S0925-4773(02)00115-6; Tsai HM, 2002, INT J HEMATOL, V76, P132, DOI 10.1007/BF03165103; Viloria CG, 2009, CANCER RES, V69, P4926, DOI 10.1158/0008-5472.CAN-08-4155; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Ween MP, 2011, CLIN EXP METASTAS, V28, P113, DOI 10.1007/s10585-010-9363-7; Westling J, 2002, J BIOL CHEM, V277, P16059, DOI 10.1074/jbc.M108607200; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yokoyama H, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_9.39; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	51	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37267	37276		10.1074/jbc.M112.418624	http://dx.doi.org/10.1074/jbc.M112.418624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220035	Green Published, hybrid			2022-12-25	WOS:000329189700043
J	Chao, CT; Lin, YF; Tsai, HB; Hsu, NC; Tseng, CL; Ko, WJ				Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je		HINT Study Grp	In Nonagenarians, Acute Kidney Injury Predicts In-Hospital Mortality, while Heart Failure Predicts Hospital Length of Stay	PLOS ONE			English	Article							ELDERLY-PATIENTS; FUNCTIONAL STATUS; NUTRITIONAL-STATUS; INTERNAL-MEDICINE; PHYSICAL FUNCTION; HEALTH-INSURANCE; PROGNOSTIC INDEX; OLDER-PEOPLE; RISK-FACTORS; MORBIDITY	Background/Aims: The elderly constitute an increasing proportion of admitted patients worldwide. We investigate the determinants of hospital length of stay and outcomes in patients aged 90 years and older. Methods: We retrospectively analyzed all admitted patients aged >90 years from the general medical wards in a tertiary referral medical center between August 31, 2009 and August 31, 2012. Patients' clinical characteristics, admission diagnosis, concomitant illnesses at admission, and discharge diagnosis were collected. Each patient was followed until discharge or death. Multivariate logistic regression analysis was utilized to study factors associated with longer hospital length of stay (>7 days) and in-hospital mortality. Results: A total of 283 nonagenarian in-patients were recruited, with 118 (41.7%) hospitalized longer than one week. Nonagenarians admitted with pneumonia (p = 0.04) and those with lower Barthel Index (p = 0.012) were more likely to be hospitalized longer than one week. Multivariate logistic regression analysis revealed that patients with lower Barthel Index (odds ratio [OR] 0.98; p = 0.021) and those with heart failure (OR 3.05; p = 0.046) had hospital stays >7 days, while patients with lower Barthel Index (OR 0.93; p = 0.005), main admission nephrologic diagnosis (OR 4.83; p = 0.016) or acute kidney injury (OR 30.7; p = 0.007) had higher in-hospital mortality. Conclusion: In nonagenarians, presence of heart failure at admission was associated with longer hospital length of stay, while acute kidney injury at admission predicted higher hospitalization mortality. Poorer functional status was associated with both prolonged admission and higher in-hospital mortality.	[Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Chao, Chia-Ter; Lin, Yu-Feng; Tsai, Hung-Bin; Hsu, Nin-Chieh; Tseng, Chia-Lin; Ko, Wen-Je; HINT Study Grp] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, HB (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.	b88401084@gmail.com	Tsai, Hung-Bin/G-3761-2011; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; LIN, YU-FENG/0000-0002-4350-7755; HSU, NIN-CHIEH/0000-0002-4997-1081; Tsai, Hung-Bin/0000-0002-0689-8339				Ailshire JA, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/530534; Alarcon T, 1999, AGE AGEING, V28, P429, DOI 10.1093/ageing/28.5.429; Barba R, 2011, EUR J INTERN MED, V22, P49, DOI 10.1016/j.ejim.2010.11.001; Beckett LA, 1996, AM J EPIDEMIOL, V143, P766; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Butchart C, 2013, ARCH GERONTOL GERIAT, V56, P188, DOI 10.1016/j.archger.2012.07.005; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; Casas-Vara A, 2012, NUTRITION, V28, P616, DOI 10.1016/j.nut.2011.10.006; Cervera R, 2012, ANN THORAC SURG, V93, P1950, DOI 10.1016/j.athoracsur.2012.02.071; Chan TC, 2012, GERIATR GERONTOL INT, V12, P555, DOI 10.1111/j.1447-0594.2011.00804.x; Chao CT, 2013, J AM COLL SURGEONS, V217, P240, DOI 10.1016/j.jamcollsurg.2013.03.024; Chao CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050675; Chao CT, 2012, KIDNEY INT, V82, P920, DOI 10.1038/ki.2012.237; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chronopoulos A, 2010, NAT REV NEPHROL, V6, P141, DOI 10.1038/nrneph.2009.234; Cohen SD, 2012, CURR OPIN CRIT CARE, V18, P623, DOI 10.1097/MCC.0b013e328358d3f5; Conde-Martel A, 2012, EUR J INTERN MED, V23, P513, DOI 10.1016/j.ejim.2012.02.007; Ebrahim S, 1997, J EPIDEMIOL COMMUN H, V51, P469, DOI 10.1136/jech.51.5.469-a; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Finlayson E, 2012, J AM GERIATR SOC, V60, P967, DOI 10.1111/j.1532-5415.2012.03915.x; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gambier N, 2012, SOUTH MED J, V105, P63, DOI 10.1097/SMJ.0b013e318242d74d; Garcia-Perez L, 2011, QJM-INT J MED, V104, P639, DOI 10.1093/qjmed/hcr070; Guimaraes T, 2012, INT J INFECT DIS, V16, pE442, DOI 10.1016/j.ijid.2012.02.005; Howie-Esquivel J, 2012, AM J CRIT CARE, V21, pE65, DOI 10.4037/ajcc2012382; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7; Khan SK, 2013, AGE AGEING, V42, P76, DOI 10.1093/ageing/afs152; Kimm H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-54; Koch AM, 2009, J HOSP INFECT, V71, P269, DOI 10.1016/j.jhin.2008.10.032; Lin SJ, 2012, J NURS RES, V20, P110, DOI 10.1097/jnr.0b013e318254eac9; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Lonnroos E, 2012, DRUG AGING, V29, P395, DOI 10.2165/11631420-000000000-00000; MAHONEY F I, 1965, Md State Med J, V14, P61; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Meller I, 1999, EUR ARCH PSY CLIN N, V249, P180, DOI 10.1007/s004060050085; Menotti A, 1996, PREV MED, V25, P319, DOI 10.1006/pmed.1996.0062; Miyashita J, 2012, J HOSP MED, V7, P464, DOI 10.1002/jhm.1936; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Ponzetto M, 2003, J GERONTOL A-BIOL, V58, P1049; Robine JM, 2005, J EPIDEMIOL COMMUN H, V59, P31, DOI 10.1136/jech.2003.018663; Shu CC, 2011, J HOSP MED, V6, P378, DOI [10.1002/Thm.896, 10.1002/jhm.896]; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Toumi Z, 2010, INT J CLIN PRACT, V64, P1570, DOI 10.1111/j.1742-1241.2010.02468.x; von Stauss E, 2000, J AM GERIATR SOC, V48, P1462, DOI 10.1111/j.1532-5415.2000.tb02638.x; Walsh B, 2012, J AM GERIATR SOC, V60, P2104, DOI 10.1111/j.1532-5415.2012.04198.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Yust-Katz S, 2005, ISR MED ASSOC J, V7, P635; Zafrir B, 2010, ISR MED ASSOC J, V12, P10	50	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77929	10.1371/journal.pone.0077929	http://dx.doi.org/10.1371/journal.pone.0077929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223127	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200019
J	Harris, RMB; McQuillan, P; Hughes, L				Harris, Rebecca M. B.; McQuillan, Peter; Hughes, Lesley			Experimental Manipulation of Melanism Demonstrates the Plasticity of Preferred Temperature in an Agricultural Pest (Phaulacridium vittatum)	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; BODY TEMPERATURES; WINGLESS GRASSHOPPER; THERMAL TOLERANCE; ORTHOPTERA; THERMOREGULATION; RESPONSES; ACRIDIDAE; INVASION	Phenotypic plasticity is a key trait of successful pest species, and may increase the ability to cope with higher, more variable temperatures under climate change. We investigate the plasticity of preferred temperature in a widespread agricultural pest, the wingless grasshopper (Phaulacridium vittatum). Preferred temperature is a measure of thermoregulatory behaviour through habitat selection. It is influenced by melanism, which affects body temperature by determining the amount of radiation absorbed by the body. First we demonstrate that body temperature and preferred temperature in P. vittatum is influenced by melanism, by comparing the preferred temperature of the colour morphs in laboratory thermal gradients and field body temperatures in natural populations. We then test whether preferred temperature changes in response to changes in body temperature, by determining preferred temperature before and after manipulation of melanism by painting. When melanism was manipulated experimentally in live grasshoppers, preferred temperature changed to reflect the thermal qualities of the new colour. The preferred temperature of light grasshoppers increased after they were painted black, and decreased after being painted white. Similarly, dark individuals that were painted white behaved like a light individual, maintaining a lower body temperature. Preferred temperature in P. vittatum is a plastic thermoregulatory response to ambient temperature, mediated by the influence of melanism on body temperature.	[Harris, Rebecca M. B.] Univ Tasmania, Antarctic Climate Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [McQuillan, Peter] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas, Australia; [Hughes, Lesley] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of Tasmania; Macquarie University	Harris, RMB (corresponding author), Univ Tasmania, Antarctic Climate Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	R.M.B.Harris@acecrc.org.au	McQuillan, Peter B/C-2373-2014; Harris, Rebecca/N-2790-2013	Harris, Rebecca/0000-0002-6426-2179; Hughes, Lesley/0000-0003-0313-9780; McQuillan, Peter/0000-0001-6334-372X	Australian Postgraduate Award; ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment	Australian Postgraduate Award(Australian Government); ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment	RMH was the recipient of an Australian Postgraduate Award, and the study was partially funded by an ANZ (Australia and New Zealand Banking Group) Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker G., 2005, WINGLESS GRASSHOPPER; Brian M. V., 1965, INSECT SOC, V12, P347, DOI DOI 10.1007/BF02222724; Brian MV, 1963, INSECT SOC, V10, P91, DOI 10.1007/BF02336490; Butler A., 2001, MINITAB MACROS RESAM; Chown SL, 2007, P ROY SOC B-BIOL SCI, V274, P2531, DOI 10.1098/rspb.2007.0772; CLARK D. P., 1967, AUST J ZOOL, V15, P799, DOI 10.1071/ZO9670799; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; CRITCHLOW DE, 1991, COMMUN STAT THEORY, V20, P127, DOI 10.1080/03610929108830487; Deal J, 1941, J ANIM ECOL, V10, P323, DOI 10.2307/1316; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gvozdik L, 2012, BIOL LETTERS, V8, P262, DOI 10.1098/rsbl.2011.0960; Harris R, 2012, J BIOGEOGR, V39, P1450, DOI 10.1111/j.1365-2699.2012.02710.x; Harris RM, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.5101; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Institute SAS I, 2012, JMP VERS 10; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; KEY K H L, 1992, Invertebrate Taxonomy, V6, P197, DOI 10.1071/IT9920197; Lactin DJ, 1996, J THERM BIOL, V21, P231, DOI 10.1016/0306-4565(96)00007-1; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; MAY ML, 1979, ANNU REV ENTOMOL, V24, P313, DOI 10.1146/annurev.en.24.010179.001525; Miller GA, 2009, P ROY SOC B-BIOL SCI, V276, P3581, DOI 10.1098/rspb.2009.1030; MILNER RJ, 1994, J AUST ENTOMOL SOC, V33, P165; MiniTab I, 2010, INITAB REL 16 1 0 WI; Nyamukondiwa C, 2010, ECOL ENTOMOL, V35, P565, DOI 10.1111/j.1365-2311.2010.01215.x; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; PORTER K, 1982, OIKOS, V38, P308, DOI 10.2307/3544670; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Slabber S, 2007, J INSECT PHYSIOL, V53, P113, DOI 10.1016/j.jinsphys.2006.10.010; Smolinsky R, 2012, OECOLOGIA, V170, P47, DOI 10.1007/s00442-012-2283-2; TERBRAAK CJF, 1992, LECT NOTES ECON MATH, V376, P79; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	36	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80243	10.1371/journal.pone.0080243	http://dx.doi.org/10.1371/journal.pone.0080243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223223	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200116
J	Moy, I; Lin, ZH; Rademaker, AW; Reierstad, S; Khan, SA; Bulun, SE				Moy, Irene; Lin, Zhihong; Rademaker, Alfred W.; Reierstad, Scott; Khan, Seema A.; Bulun, Serdar E.			Expression of Estrogen-Related Gene Markers in Breast Cancer Tissue Predicts Aromatase Inhibitor Responsiveness	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; POSTMENOPAUSAL WOMEN; PROGESTERONE-RECEPTORS; IMMUNOHISTOCHEMICAL-DEMONSTRATION; TAMOXIFEN THERAPY; ANASTROZOLE; BRCA1; COMBINATION	Aromatase inhibitors (AIs) are the most effective class of drugs in the endocrine treatment of breast cancer, with an approximate 50% treatment response rate. Our objective was to determine whether intratumoral expression levels of estrogen-related genes are predictive of AI responsiveness in postmenopausal women with breast cancer. Primary breast carcinomas were obtained from 112 women who received AI therapy after failing adjuvant tamoxifen therapy and developing recurrent breast cancer. Tumor ER alpha and PR protein expression were analyzed by immunohistochemistry (IHC). Messenger RNA (mRNA) levels of 5 estrogen-related genes-AKR1C3, aromatase, ER alpha, and 2 estradiol/ER alpha target genes, BRCA1 and PR-were measured by real-time PCR. Tumor protein and mRNA levels were compared with breast cancer progression rates to determine predictive accuracy. Responsiveness to AI therapy-defined as the combined complete response, partial response, and stable disease rates for at least 6 months-was 51%; rates were 56% in ER alpha-IHC-positive and 14% in ER alpha-IHC-negative tumors. Levels of ER alpha, PR, or BRCA1 mRNA were independently predictive for responsiveness to AI. In cross-validated analyses, a combined measurement of tumor ER alpha and PR mRNA levels yielded a more superior specificity (36%) and identical sensitivity (96%) to the current clinical practice (ER alpha/PR-IHC). In patients with ER alpha/PR-IHC-negative tumors, analysis of mRNA expression revealed either non-significant trends or statistically significant positive predictive values for AI responsiveness. In conclusion, expression levels of estrogen-related mRNAs are predictive for AI responsiveness in postmenopausal women with breast cancer, and mRNA expression analysis may improve patient selection.	[Moy, Irene; Lin, Zhihong; Reierstad, Scott; Bulun, Serdar E.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rademaker, Alfred W.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Khan, Seema A.] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Bulun, SE (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	s-bulun@northwestern.edu			Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A.; Avon Foundation; Breast Cancer Research Fund, U.K.	Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A.; Avon Foundation; Breast Cancer Research Fund, U.K.	This work was supported by a Dixon Priority Research Initiative grant from the Northwestern Medical Foundation, U.S.A., Avon Foundation and Breast Cancer Research Fund, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Amin AA, 2006, MOL CELL ENDOCRINOL, V253, P44, DOI 10.1016/j.mce.2006.04.029; ANDERSEN J, 1988, J HISTOCHEM CYTOCHEM, V36, P1553, DOI 10.1177/36.12.2461414; Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; BAEHNER FL, 2006, 29 ANN SAN ANT BREAS; Baum M, 2002, LANCET, V359, P2131; Baum M, 2003, Cancer, V98, P1802; Bernhard J, 1999, J CLIN ONCOL, V17, P1672, DOI 10.1200/JCO.1999.17.6.1672; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Buzdar Aman U, 2004, Clin Breast Cancer, V5 Suppl 1, pS6, DOI 10.3816/CBC.2004.s.008; BUZDAR AU, 1982, CANCER RES, V42, P3448; Chand AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-148; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dowsett M, 2005, J CLIN ONCOL, V23, P2477, DOI 10.1200/JCO.2005.07.559; Dowsett M, 2003, SEMIN ONCOL, V30, P58, DOI 10.1016/S0093-7754(03)00300-2; Dowsett M, 2010, J CLIN ONCOL, V28, P1829, DOI 10.1200/JCO.2009.24.4798; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; KNIGHT WA, 1980, CLIN ENDOCRINOL META, V9, P361, DOI 10.1016/S0300-595X(80)80038-7; Lu ML, 2006, J CLIN ENDOCR METAB, V91, P4514, DOI 10.1210/jc.2006-1364; Ma XJ, 2006, J CLIN ONCOL, V24, P4611, DOI 10.1200/JCO.2006.06.6944; Ma YX, 2005, ONCOGENE, V24, P1831, DOI 10.1038/sj.onc.1208190; MATHEWS A. W, 2008, WALL STREET J; Milla-Santos A, 2003, AM J CLIN ONCOL-CANC, V26, P317, DOI 10.1097/00000421-200306000-00022; Miller WR, 2010, EXPERT OPIN PHARMACO, V11, P1873, DOI 10.1517/14656566.2010.487863; Miller WR, 2009, J CLIN ONCOL, V27, P1382, DOI 10.1200/JCO.2008.16.8849; Miller WR, 2003, J STEROID BIOCHEM, V86, P413, DOI 10.1016/S0960-0760(03)00352-2; Mina L, 2007, BREAST CANCER RES TR, V103, P197, DOI 10.1007/s10549-006-9366-x; Mita K, 2007, JPN J CLIN ONCOL, V37, P575, DOI 10.1093/jjco/hym066; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Paridaens R, 2003, ANN ONCOL, V14, P1391, DOI 10.1093/annonc/mdg362; Possinger K, 2004, EXPERT OPIN PHARMACO, V5, P2549, DOI 10.1517/14656566.5.12.2549; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Yamashita H, 2005, BREAST CANCER RES, V7, pR753, DOI 10.1186/bcr1285; Yamashita H, 2004, BREAST CANCER RES, V6, pR24, DOI 10.1186/bcr738; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Zhang ZH, 2003, BREAST CANCER RES, V5, pR250, DOI 10.1186/bcr657; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77543	10.1371/journal.pone.0077543	http://dx.doi.org/10.1371/journal.pone.0077543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223121	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200013
J	Vigil, JM; Rowell, LN; Chouteau, S; Chavez, A; Jaramillo, E; Neal, M; Waid, D				Vigil, Jacob M.; Rowell, Lauren N.; Chouteau, Simone; Chavez, Alexandre; Jaramillo, Elisa; Neal, Michael; Waid, David			Sex Differences in How Social Networks and Relationship Quality Influence Experimental Pain Sensitivity	PLOS ONE			English	Article							FACIAL EXPRESSION; SUPPORT; RESPONSES; WOMEN; GENDER; SPOUSE; PERCEPTION; INTENSITY; BEHAVIORS; ANALGESIA	This is the first study to examine how both structural and functional components of individuals' social networks may moderate the association between biological sex and experimental pain sensitivity. One hundred and fifty-two healthy adults (mean age = 22yrs., 53% males) were measured for cold pressor task (CPT) pain sensitivity (i.e., intensity ratings) and core aspects of social networks (e. g., proportion of friends vs. family, affection, affirmation, and aid). Results showed consistent sex differences in how social network structures and intimate relationship functioning modulated pain sensitivity. Females showed higher pain sensitivity when their social networks consisted of a higher proportion of intimate types of relationship partners (e. g., kin vs. non kin), when they had known their network partners for a longer period of time, and when they reported higher levels of logistical support from their significant other (e. g., romantic partner). Conversely, males showed distinct patterns in the opposite direction, including an association between higher levels of logistical support from one's significant other and lower CPT pain intensity. These findings show for the first time that the direction of sex differences in exogenous pain sensitivity is likely dependent on fundamental components of the individual's social environment. The utility of a social-signaling perspective of pain behaviors for examining, comparing, and interpreting individual and group differences in experimental and clinical pain reports is discussed.	[Vigil, Jacob M.; Rowell, Lauren N.; Chouteau, Simone; Chavez, Alexandre; Jaramillo, Elisa; Neal, Michael; Waid, David] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	vigilj@unm.edu			Research Allocations Committee Grant from the University of New Mexico	Research Allocations Committee Grant from the University of New Mexico	The research was supported by a Research Allocations Committee Grant from the University of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCK AR, 1980, PAIN, V9, P243, DOI 10.1016/0304-3959(80)90011-1; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Campbell P, 2013, INT ARCH OCC ENV HEA, V86, P119, DOI 10.1007/s00420-012-0804-2; Campbell P, 2012, PAIN MED, V13, P204, DOI 10.1111/j.1526-4637.2011.01298.x; Cano A, 2008, CLIN J PAIN, V24, P678, DOI 10.1097/AJP.0b013e31816753d8; Cano A, 2010, PAIN, V149, P9, DOI 10.1016/j.pain.2009.10.010; Carothers BJ, 2013, J PERS SOC PSYCHOL; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; DEWAAL FBM, 1993, SOC ECON, P285; Fillingim RB, 2003, CLIN J PAIN, V19, P217, DOI 10.1097/00002508-200307000-00004; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FLOR H, 1987, J PSYCHOSOM RES, V31, P251, DOI 10.1016/0022-3999(87)90082-1; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; Geary DC, 2002, ADV CHILD DEV BEHAV, V30, P41, DOI 10.1016/S0065-2407(02)80039-8; Gigliotti E, 2002, NURS RES, V55, P217; Gigliotti E, 2011, ISRN NURSING, V2011, P2011; Gijsbers K, 2005, PERCEPT MOTOR SKILL, V101, P803, DOI 10.2466/PMS.101.7.803-807; GIL KM, 1987, PAIN, V29, P209, DOI 10.1016/0304-3959(87)91037-2; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; IBM Corp, 2012, IBM SPSS STAT WINDOW; Kallai I, 2004, PAIN, V112, P142, DOI 10.1016/j.pain.2004.08.008; Kerns RD, 2002, ANN BEHAV MED, V24, P100, DOI 10.1207/S15324796ABM2402_06; KULIK JA, 1989, HEALTH PSYCHOL, V8, P221, DOI 10.1037/0278-6133.8.2.221; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; Lopez-Martinez AE, 2008, J PAIN, V9, P373, DOI 10.1016/j.jpain.2007.12.002; McClelland LE, 2008, J BEHAV MED, V31, P413, DOI 10.1007/s10865-008-9163-6; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Montoya P, 2004, ARTHRITIS RHEUM, V50, P4035, DOI 10.1002/art.20660; Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra; NORBECK JS, 1981, NURS RES, V30, P264; NORBECK JS, 1983, NURS RES, V32, P4; Orbach-Zinger S, 2012, ANESTH ANALG, V114, P654, DOI 10.1213/ANE.0b013e318241f4f3; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Palchykov Vasyl, 2012, Sci Rep, V2, P370, DOI 10.1038/srep00370; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Pud D, 2009, NEUROSCI LETT, V467, P237, DOI 10.1016/j.neulet.2009.10.048; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Romano JM, 1995, PAIN, V63, P353, DOI 10.1016/0304-3959(95)00062-3; Romano JM, 2000, BEHAV THER, V31, P415, DOI 10.1016/S0005-7894(00)80023-4; Romano JM, 2009, J BEHAV MED, V32, P558, DOI 10.1007/s10865-009-9234-3; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Ruau D, 2012, J PAIN, V13, P228, DOI 10.1016/j.jpain.2011.11.002; Schiavenato M, 2010, CLIN J PAIN, V26, P667, DOI 10.1097/AJP.0b013e3181e72507; TURK DC, 1992, REHABIL PSYCHOL, V37, P259, DOI 10.1037/h0079108; Vervoort T, 2008, PAIN, V138, P277, DOI 10.1016/j.pain.2007.12.013; Vigil JM, 2007, HUM NATURE-INT BIOS, V18, P143, DOI 10.1007/s12110-007-9003-3; Vigil JM, 2011, PAIN RES MANAG, V16, P317, DOI 10.1155/2011/280531; Vigil JM, 2011, PAIN, V152, P2125, DOI 10.1016/j.pain.2011.05.019; Vigil JM, 2008, EVOL PSYCHOL, V6, P506; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P408, DOI 10.1017/S0140525X09990999; Vigil JM, WORLD J ANE IN PRESS; Vigil JM, PAIN RES MA IN PRESS; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; Vowles KE, 2010, PAIN, V151, P680, DOI 10.1016/j.pain.2010.08.031; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	59	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78663	10.1371/journal.pone.0078663	http://dx.doi.org/10.1371/journal.pone.0078663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223836	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400039
J	Dol-Gleizes, F; Delesque-Touchard, N; Mares, AM; Nestor, AL; Schaeffer, P; Bono, F				Dol-Gleizes, Frederique; Delesque-Touchard, Nathalie; Mares, Anne-Marie; Nestor, Anne-Laure; Schaeffer, Paul; Bono, Francoise			A New Synthetic FGF Receptor Antagonist Inhibits Arteriosclerosis in a Mouse Vein Graft Model and Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; ANGIOGENESIS; EXPRESSION; PLAQUE; INFLAMMATION; PROGRESSION; CHEMOKINES; VEGF; ATHEROGENESIS	Objective: The role of fibroblast growth factors (FGFs) in the development of vascular diseases remains incompletely understood. The objective of this study was to examine the effects of a new small-molecule multi-FGF receptor blocker with allosteric properties, SSR128129E, on neointimal proliferation after a vein graft procedure in mice and on the development of atherosclerosis in atherosclerosis-prone apolipoprotein E (apoE)-deficient mice. Methods and Results: Vein grafts were performed in 3 month-old male C57BL6 mice. Segments of the vena cava were interposed at the level of the carotid artery. In SSR128129E (50 mg/kg/d)-treated animals, a dramatic decrease in neointimal proliferation was observed 2 and 8 weeks after the graft (72.5 %, p<0.01, and 47.8 %, p<0.05, respectively). Four-week old male apoE-deficient mice were treated with SSR128129E (50 mg/kg/d) for 3 and 5 months in comparison with a control group. SSR128129E treatment resulted in a reduction of lesion size in the aortic sinus (16.4 % (ns) at 3 months and 42.9 % (p<0.01) at 5 months, without any change in serum lipids. SSR128129 significantly reduced FGFR2 mRNA levels in the aortic sinus (p<0.05, n=5-6), but did not affect the mRNA expression levels of other FGF receptors or ligands. Conclusion: These studies indicate that FGFs have an important role in the development of vascular diseases like atherosclerosis and graft arteriosclerosis. These data suggest that inhibition of FGF receptors by compounds like SSR128129E might be useful as a new therapeutic approach for these vascular pathologies.	[Dol-Gleizes, Frederique; Delesque-Touchard, Nathalie; Mares, Anne-Marie; Nestor, Anne-Laure; Schaeffer, Paul; Bono, Francoise] Sanofi Rech, F-31036 Toulouse, France	Sanofi-Aventis; Sanofi France	Bono, F (corresponding author), Sanofi Rech, F-31036 Toulouse, France.	francoise.bono@sanofi.com	Schaeffer, Paul/AAZ-9961-2020; Schaeffer, Paul/D-7069-2014; Stefanadis, Christodoulos/ABH-2232-2020	Schaeffer, Paul/0000-0002-2835-1801; Schaeffer, Paul/0000-0002-2835-1801; Stefanadis, Christodoulos/0000-0001-5974-6454				Bono F, 2013, CANCER CELL, V23, P477, DOI 10.1016/j.ccr.2013.02.019; Che JS, 2011, AM J PHYSIOL-HEART C, V300, pH154, DOI 10.1152/ajpheart.00075.2010; Cheng C, 2013, TRENDS CARDIOVAS MED, V23, P153, DOI 10.1016/j.tcm.2012.10.004; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; FLUGELMAN MY, 1993, CIRCULATION, V88, P2493, DOI 10.1161/01.CIR.88.6.2493; Fons P, 2004, J CELL PHYSIOL, V200, P351, DOI 10.1002/jcp.20076; Fox JC, 1996, J BIOL CHEM, V271, P12578, DOI 10.1074/jbc.271.21.12578; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Gerszten RE, 2000, J LAB CLIN MED, V136, P87, DOI 10.1067/mlc.2000.108154; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Herrmann J, 2006, ARTERIOSCL THROM VAS, V26, P1948, DOI 10.1161/01.ATV.0000233387.90257.9b; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jimenez SK, 2004, CARDIOVASC RES, V62, P548, DOI 10.1016/j.cardiores.2004.01.032; Kavurma MM, 2005, J THROMB HAEMOST, V3, P465, DOI 10.1111/j.1538-7836.2005.01120.x; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Luo WS, 2004, ARTERIOSCL THROM VAS, V24, P1081, DOI 10.1161/01.ATV.0000128201.65443.ea; Martin G, 2004, J CARDIOVASC PHARM, V43, P191, DOI 10.1097/00005344-200402000-00005; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Raj T, 2006, ARTERIOSCL THROM VAS, V26, P1845, DOI 10.1161/01.ATV.0000227689.41288.5e; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; SPEIR E, 1992, CIRC RES, V71, P251, DOI 10.1161/01.RES.71.2.251; Sun L, 1999, J MED CHEM, V42, P5120, DOI 10.1021/jm9904295; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	36	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80027	10.1371/journal.pone.0080027	http://dx.doi.org/10.1371/journal.pone.0080027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224032	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400150
J	Kedir, H; Berhane, Y; Worku, A				Kedir, Haji; Berhane, Yemane; Worku, Alemayehu			Khat Chewing and Restrictive Dietary Behaviors Are Associated with Anemia among Pregnant Women in High Prevalence Rural Communities in Eastern Ethiopia	PLOS ONE			English	Article							CURRENT SITUATION; MATERNAL ANEMIA; RISK-FACTORS; HEMOGLOBIN; IRON; DETERMINANTS; NUTRITION; INFECTION; MALARIA; AFRICA	Background: Anemia affects a high proportion of pregnant women in the developing countries. Factors associated with it vary in context. This study aimed to determine the prevalence and predictors of anemia among pregnant women in the rural eastern Ethiopia. Methods: A community-based cross-sectional study was done on 1678 pregnant women who were selected by a cluster random sampling technique. A pregnant woman was identified as anemic if her hemoglobin concentration was <11 g/dl. Data were collected in a community-based setting. Multilevel mixed effect logistic regression was used to determine the adjusted odds ratios (AOR) with 95% confidence intervals (CI) for the predictors of anemia. Results: Anemia was observed among 737(43.9%) of the 1678 pregnant women studied (95% CI 41.5%-46.3%). After controlling for the confounders, the risk of anemia was 29% higher in the women who chewed khat daily than those who sometimes or never did so (AOR, 1.29; 95% CI, 1.02-1.62). The study subjects with restrictive dietary behavior (reduced either meal size or frequency) had a 39% higher risk of anemia compared to those without restrictive dietary behavior (AOR, 1.39; 95% CI, 1.02-1.88). The risk of anemia was increased by 68% (AOR, 1.68; 95% CI, 1.15-2.47), and 60% (AOR, 1.60; 95% CI, 1.08-2.37) in parity levels of 2 births and 3 births, respectively. Compared to the first trimester, the risk of anemia was higher by two-fold (AOR, 2.09; 95% CI, 1.46-3.00) in the second trimester and by four-fold (AOR, 4.23; 95% CI, 2.97-6.02) in the third trimester. Conclusion: In this study, two out of five women were anemic. Chewing khat and restrictive dietary habits that are associated with anemia in the setting should be addressed through public education programs. Interventions should also focus on the women at higher parity levels and those who are in advanced stages of pregnancy.	[Kedir, Haji] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Kedir, H (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	hajikedir2007@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	Haramaya University	Haramaya University	This study was financially supported by Haramaya University as part of PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agan TU, 2010, INT J WOMENS HEALTH, V2, P229; Al-Farsi YM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-7; Al-Motarreb A, 2010, J ETHNOPHARMACOL, V132, P540, DOI 10.1016/j.jep.2010.07.001; Alem M., 2013, J INTERDISCIP HISTOP, V1, P137, DOI [10.5455/jihp.20130122042052, DOI 10.5455/JIHP.20130122042052]; [Anonymous], 2008, WORLDW PREV AN 1993; Ayoya MA, 2006, FOOD NUTR BULL, V27, P3, DOI 10.1177/156482650602700101; BAIDOO SE, 2010, J BACTERIOL RES, V2, P9; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S; Belachew Tefera, 2006, Ethiop Med J, V44, P211; Bodeau-Livinec F, 2011, AM J TROP MED HYG, V85, P414, DOI 10.4269/ajtmh.2011.10-0599; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Central Statistical Agency [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV 20; *CTR STAT AG, 2006, ETH DEM HLTH SURV 20; DESALEGN S, 1993, ETHIOPIAN MED J, V31, P251; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Dim Cyril C, 2007, MedGenMed, V9, P11; Garg Aashima, 2006, Indian Journal of Pediatrics, V73, P687, DOI 10.1007/BF02898446; Gebissa E, 2010, J ETHNOPHARMACOL, V132, P607, DOI 10.1016/j.jep.2010.01.063; Gebremedhin S, 2011, ETHIOP J HEALTH DEV, V25, P22; Ghosh S, 2009, J BIOSOC SCI, V41, P763, DOI 10.1017/S0021932009990149; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gies S, 2003, TROP MED INT HEALTH, V8, P301, DOI 10.1046/j.1365-3156.2003.01037.x; Griffiths P, 2010, J ETHNOPHARMACOL, V132, P578, DOI 10.1016/j.jep.2010.04.046; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Hinderaker SG, 2002, EUR J CLIN NUTR, V56, P192, DOI 10.1038/sj.ejcn.1601300; Lamina S, 2010, S AFR J SCI, V106, P28, DOI 10.4102/sajs.v106i3/4.155; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Melaku Umeta, 2008, Ethiopian Journal of Health Development, V22, P252; Morris LD, 2007, VOX SANG, V93, P64, DOI 10.1111/j.1423-0410.2007.00919.x; Msuya S. E., 2011, Tanzania Journal of Health Research, V13, P40; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Nkrumah B, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-5; Odenwald M, 2010, J ETHNOPHARMACOL, V132, P615, DOI 10.1016/j.jep.2009.11.005; Robert T, 2011, AFR J HLTH SCI, V18, P96; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Stanback J, 2008, REV PANAM SALUD PUBL, V23, P116, DOI 10.1590/S1020-49892008000200007; StataCorp, 2009, STAT QUICK REF IND R; Swindale A., 2006, FHI 360FANTA; Torpey K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-249; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; Wabe N.T, 2012, J EXP INTEGR MED, V2, P29, DOI [DOI 10.5455/JEIM.221211.RW.005, 10.5455/jeim.221211.rw.005]; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 1995, PHYS STAT US INT ANT; Zhang QY, 2009, PAEDIATR PERINAT EP, V23, P282, DOI 10.1111/j.1365-3016.2009.01031.x; Zimmermann M.B., 2007, NUTR ANEMIA, P199	50	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78601	10.1371/journal.pone.0078601	http://dx.doi.org/10.1371/journal.pone.0078601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223828	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400076
J	Venturini, C; Hassan, KA; Chowdhury, PR; Paulsen, IT; Walker, MJ; Djordjevic, SP				Venturini, Carola; Hassan, Karl A.; Chowdhury, Piklu Roy; Paulsen, Ian T.; Walker, Mark J.; Djordjevic, Steven P.			Sequences of Two Related Multiple Antibiotic Resistance Virulence Plasmids Sharing a Unique IS26-Related Molecular Signature Isolated from Different Escherichia coli Pathotypes from Different Hosts	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SPECTRUM BETA-LACTAMASE; GRAM-NEGATIVE BACTERIA; SHIGA TOXIN; SOS RESPONSE; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; INCP-1 PLASMIDS; RANGE PLASMIDS; GENE	Enterohemorrhagic Escherichia coli (EHEC) and atypical enteropathogenic E. coli (aEPEC) are important zoonotic pathogens that increasingly are becoming resistant to multiple antibiotics. Here we describe two plasmids, pO26-CRL125 (125 kb) from a human O26:H- EHEC, and pO111-CRL115 (115kb) from a bovine O111 aEPEC, that impart resistance to ampicillin, kanamycin, neomycin, streptomycin, sulfathiazole, trimethoprim and tetracycline and both contain atypical class 1 integrons with an identical IS26-mediated deletion in their 3'-conserved segment. Complete sequence analysis showed that pO26-CRL125 and pO111-CRL115 are essentially identical except for a 9.7 kb fragment, present in the backbone of pO26-CRL125 but absent in pO111-CRL115, and several indels. The 9.7 kb fragment encodes IncI-associated genes involved in plasmid stability during conjugation, a putative transposase gene and three imperfect repeats. Contiguous sequence identical to regions within these pO26-CRL125 imperfect repeats was identified in pO111-CRL115 precisely where the 9.7 kb fragment is missing, suggesting it may be mobile. Sequences shared between the plasmids include a complete IncZ replicon, a unique toxin/antitoxin system, IncI stability and maintenance genes, a novel putative serine protease autotransporter, and an IncI1 transfer system including a unique shufflon. Both plasmids carry a derivate Tn21 transposon with an atypical class 1 integron comprising a dfrA5 gene cassette encoding resistance to trimethoprim, and 24 bp of the 3'-conserved segment followed by Tn6026, which encodes resistance to ampicillin, kanymycin, neomycin, streptomycin and sulfathiazole. The Tn21-derivative transposon is linked to a truncated Tn1721, encoding resistance to tetracycline, via a region containing the IncP-1 alpha oriV. Absence of the 5 bp direct repeats flanking Tn3-family transposons, indicates that homologous recombination events played a key role in the formation of this complex antibiotic resistance gene locus. Comparative sequence analysis of these closely related plasmids reveals aspects of plasmid evolution in pathogenic E. coli from different hosts.	[Venturini, Carola; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Hassan, Karl A.; Chowdhury, Piklu Roy; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Macquarie Pk, NSW, Australia; [Chowdhury, Piklu Roy] NSW Dept Primary Ind, Camden, NSW, Australia; [Chowdhury, Piklu Roy; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst Infect Immun Innovat, Sydney, NSW 2007, Australia	University of Queensland; University of Queensland; Macquarie University; NSW Department of Primary Industries; University of Technology Sydney	Djordjevic, SP (corresponding author), Univ Technol Sydney, Ithree Inst Infect Immun Innovat, Sydney, NSW 2007, Australia.	steven.djordjevic@uts.edu.au	djordjevic, steven/GNP-4000-2022; Venturini, Carola/G-6642-2018; Djordjevic, Steven/A-2024-2013; Walker, Mark J./F-6940-2011; Hassan, Karl/B-2802-2013; Paulsen, Ian/K-3832-2012	djordjevic, steven/0000-0001-9301-5372; Venturini, Carola/0000-0003-2370-8661; Djordjevic, Steven/0000-0001-9301-5372; Walker, Mark/0000-0001-7423-2769; Roy Chowdhury, Piklu/0000-0003-4352-603X; Hassan, Karl/0000-0003-2031-9679; Paulsen, Ian/0000-0001-9015-9418	Australian Research Council (ARC) [LP034885]; Australian National Health and Medical Research Council (NHMRC); UTS	Australian Research Council (ARC)(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UTS	This work was supported by of the Australian Research Council (ARC) and the Australian National Health and Medical Research Council (NHMRC). This work was partly funded by UTS start-up monies to SPD. The authors acknowledge the financial support of the Australian Research Council (ARC) for provision of a PhD scholarship to CV and research support provided through the ARC Linkage grant LP034885 and the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2003, ACTA BIOCHIM POL, V50, P425; ALLMEIER H, 1992, GENE, V111, P11, DOI 10.1016/0378-1119(92)90597-I; Althorpe NJ, 1999, MOL MICROBIOL, V31, P133, DOI 10.1046/j.1365-2958.1999.01153.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Bates S, 1999, MICROBIOL-SGM, V145, P2655, DOI 10.1099/00221287-145-10-2655; Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Buvens G, 2010, ANTIMICROB AGENTS CH, V54, P4907, DOI 10.1128/AAC.00551-10; Cain AK, 2010, MICROB DRUG RESIST, V16, P197, DOI 10.1089/mdr.2010.0042; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Djordjevic SP, 2004, APPL ENVIRON MICROB, V70, P3910, DOI 10.1128/AEM.70.7.3910-3917.2004; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Eikmeyer F, 2012, PLASMID, V68, P13, DOI 10.1016/j.plasmid.2012.01.011; FURUYA N, 1991, J BACTERIOL, V173, P6612, DOI 10.1128/jb.173.20.6612-6617.1991; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; GRINSTED J, 1982, PLASMID, V8, P276, DOI 10.1016/0147-619X(82)90065-8; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; HALFORD SE, 1985, MOL GEN GENET, V200, P169, DOI 10.1007/BF00383331; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hornitzky MA, 2005, APPL ENVIRON MICROB, V71, P3405, DOI 10.1128/AEM.71.7.3405-3412.2005; Hornitzky MA, 2002, APPL ENVIRON MICROB, V68, P6439, DOI 10.1128/AEM.68.12.6439-6445.2002; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Komano T, 1999, ANNU REV GENET, V33, P171, DOI 10.1146/annurev.genet.33.1.171; KONISKY J, 1982, ANNU REV MICROBIOL, V36, P125, DOI 10.1146/annurev.mi.36.100182.001013; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Lee JH, 2009, VET MICROBIOL, V135, P401, DOI 10.1016/j.vetmic.2008.09.076; Leyton DL, 2003, INFECT IMMUN, V71, P6307, DOI 10.1128/IAI.71.11.6307-6319.2003; Masai H, 1997, CELL, V89, P897, DOI 10.1016/S0092-8674(00)80275-5; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nordstrom L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00029; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Perron GG, 2012, P ROY SOC B-BIOL SCI, V279, P1477, DOI 10.1098/rspb.2011.1933; Pinyon JL, 2011, MICROB DRUG RESIST, V17, P339, DOI 10.1089/mdr.2010.0196; Pollock KGJ, 2011, EMERG INFECT DIS, V17, P1777, DOI 10.3201/eid1709.110199; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Ramachandran V, 2003, J CLIN MICROBIOL, V41, P5022, DOI 10.1128/JCM.41.11.5022-5032.2003; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Shiomi M, 1999, PEDIATR INT, V41, P228, DOI 10.1046/j.1442-200X.1999.4121038.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; Sota M, 2007, J BACTERIOL, V189, P3091, DOI 10.1128/JB.01906-06; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Valat C, 2012, APPL ENVIRON MICROB, V78, P1308, DOI 10.1128/AEM.06997-11; Vally H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-63; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; WALKER MJ, 1987, ARCH MICROBIOL, V146, P390, DOI 10.1007/BF00410941; Zimmerhackl LB, 2010, SEMIN THROMB HEMOST, V36, P586, DOI 10.1055/s-0030-1262880	75	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78862	10.1371/journal.pone.0078862	http://dx.doi.org/10.1371/journal.pone.0078862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223859	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400092
J	Yu, HJ; Serebryannyy, LA; Fry, M; Greene, M; Chernaya, O; Hu, WY; Chew, TL; Mahmud, N; Kadkol, SS; Glover, S; Prins, G; Strakova, Z; de Lanerolle, P				Yu, Hui-Jun; Serebryannyy, Leonid A.; Fry, Madeline; Greene, Madelyne; Chernaya, Olga; Hu, Wen-Yang; Chew, Teng-Leong; Mahmud, Nadim; Kadkol, Shrihari S.; Glover, Sarah; Prins, Gail; Strakova, Zuzana; de Lanerolle, Primal			Tumor Stiffness Is Unrelated to Myosin Light Chain Phosphorylation in Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE; CYTOKINESIS; DIFFERENTIATION; CONTRACTION; METASTASIS; EXPRESSION; MOTILITY; GENE; ROCK; MLCK	Many tumors are stiffer than their surrounding tissue. This increase in stiffness has been attributed, in part, to a Rho-dependent elevation of myosin II light chain phosphorylation. To characterize this mechanism further, we studied myosin light chain kinase (MLCK), the main enzyme that phosphorylates myosin II light chains. We anticipated that increases in MLCK expression and activity would contribute to the increased stiffness of cancer cells. However, we find that MLCK mRNA and protein levels are substantially less in cancer cells and tissues than in normal cells. Consistent with this observation, cancer cells contract 3D collagen matrices much more slowly than normal cells. Interestingly, inhibiting MLCK or Rho kinase did not affect the 3D gel contractions while blebbistatin partially and cytochalasin D maximally inhibited contractions. Live cell imaging of cells in collagen gels showed that cytochalasin D inhibited filopodia-like projections that formed between cells while a MLCK inhibitor had no effect on these projections. These data suggest that myosin II phosphorylation is dispensable in regulating the mechanical properties of tumors.	[Yu, Hui-Jun; Serebryannyy, Leonid A.; Fry, Madeline; Greene, Madelyne; Chernaya, Olga; de Lanerolle, Primal] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Chew, Teng-Leong] Univ Illinois, Dept Urol, Chicago, IL USA; [Chew, Teng-Leong] Northwestern Univ, Dept Cell Biol, Chicago, IL 60611 USA; [Mahmud, Nadim] Univ Illinois, Dept Hematol & Oncol, Chicago, IL USA; [Kadkol, Shrihari S.] Univ Illinois, Dept Pathol, Chicago, IL USA; [Glover, Sarah] Univ Illinois, Dept Med, Chicago, IL USA; [Strakova, Zuzana] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	de Lanerolle, P (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.	primal@uic.edu	HU, WENYANG/L-2026-2019	Glover, Sarah/0000-0002-9899-0473	Northwestern University Physical Sciences Oncology Center [CA143869]; National Institutes of Health [CA113975, ES018758, ES02207, CA172220, ARRA HD044713]; Leukemia and Lymphoma Society (White Plains, New York, United States of America); American Gastroenterological Association; UIC Gastrointestinal and Liver Disease fund; Office of the Vice Chancellor for Research, UIC; American Heart Association [13PRE17050060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044713] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA143869, R01CA113975, R01CA172220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018758] Funding Source: NIH RePORTER	Northwestern University Physical Sciences Oncology Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (White Plains, New York, United States of America)(Leukemia and Lymphoma Society); American Gastroenterological Association; UIC Gastrointestinal and Liver Disease fund; Office of the Vice Chancellor for Research, UIC; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by grants from Northwestern University Physical Sciences Oncology Center (CA143869) sub-award to PdeL, from National Institutes of Health to SG (CA113975), GP (ES018758, ES02207 and CA172220) and ZS (ARRA HD044713), the Leukemia and Lymphoma Society (White Plains, New York, United States of America), The American Gastroenterological Association and UIC Gastrointestinal and Liver Disease fund to SG, an Areas of Excellence Award from the Office of the Vice Chancellor for Research, UIC to NM and an American Heart Association fellowship (13PRE17050060) to LAS. The authors certify that they have no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2009, EXP HEMATOL, V37, P1084, DOI 10.1016/j.exphem.2009.05.012; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barnes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050973; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Cai XF, 2010, MICRON, V41, P257, DOI 10.1016/j.micron.2009.08.011; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; DELANEROLLE P, 1981, P NATL ACAD SCI-BIOL, V78, P4738; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Gu LZ, 2006, EUR J CANCER, V42, P948, DOI 10.1016/j.ejca.2005.12.017; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Indra I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015015; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; OBARA K, 1995, J BIOL CHEM, V270, P18734, DOI 10.1074/jbc.270.32.18734; OBARA K, 1989, PFLUG ARCH EUR J PHY, V414, P134, DOI 10.1007/BF00580954; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; REDDEL RR, 1988, CANCER RES, V48, P1904; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; SOULE HD, 1990, CANCER RES, V50, P6075; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strakova Z, 2008, CELL TISSUE RES, V332, P479, DOI 10.1007/s00441-008-0604-x; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tee SY, 2009, CURR BIOL, V19, pR745, DOI 10.1016/j.cub.2009.06.034; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Xiong D, 2012, ONCOL REP, V28, P1625, DOI 10.3892/or.2012.1965	50	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79776	10.1371/journal.pone.0079776	http://dx.doi.org/10.1371/journal.pone.0079776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224004	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400143
J	Zanaruddin, SNS; Yee, PS; Hor, SY; Kong, YH; Abd Ghani, WMNW; Mustafa, WMW; Zain, RB; Prime, SS; Abd Rahman, ZA; Cheong, SC				Zanaruddin, Sharifah Nurain Syed; Yee, Pei San; Hor, Seen Yii; Kong, Yink Heay; Abd Ghani, Wan Maria Nabillah Wan; Mustafa, Wan Mahadzir Wan; Zain, Rosnah Binti; Prime, Stephen S.; Abd Rahman, Zainal Ariff; Cheong, Sok-Ching			Common Oncogenic Mutations Are Infrequent in Oral Squamous Cell Carcinoma of Asian Origin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; P53 GENE-MUTATIONS; TP53 MUTATIONS; RAS ONCOGENE; HUMAN CANCER; PIK3CA MUTATIONS; HIGH-FREQUENCY; TOBACCO-SMOKE; HEAD; TUMOR	Objectives: The frequency of common oncogenic mutations and TP53 was determined in Asian oral squamous cell carcinoma (OSCC). Materials and Methods: The OncoCarta (TM) panel v1.0 assay was used to characterize oncogenic mutations. In addition, exons 4-11 of the TP53 gene were sequenced. Statistical analyses were conducted to identify associations between mutations and selected clinico-pathological characteristics and risk habits. Results: Oncogenic mutations were detected in PIK3CA (5.7%) and HRAS (2.4%). Mutations in TP53 were observed in 27.7% (31/112) of the OSCC specimens. Oncogenic mutations were found more frequently in nonsmokers (p = 0.049) and TP53 truncating mutations were more common in patients with no risk habits (p = 0.019). Patients with mutations had worse overall survival compared to those with absence of mutations; and patients who harbored DNA binding domain (DBD) and L2/L3/LSH mutations showed a worse survival probability compared to those patients with wild type TP53. The majority of the oncogenic and TP53 mutations were G: C > A: T and A: T > G: C base transitions, regardless of the different risk habits. Conclusion: Hotspot oncogenic mutations which are frequently present in common solid tumors are exceedingly rare in OSCC. Despite differences in risk habit exposure, the mutation frequency of PIK3CA and HRAS in Asian OSCC were similar to that reported in OSCC among Caucasians, whereas TP53 mutations rates were significantly lower. The lack of actionable hotspot mutations argue strongly for the need to comprehensively characterize gene mutations associated with OSCC for the development of new diagnostic and therapeutic tools.	[Zanaruddin, Sharifah Nurain Syed; Abd Rahman, Zainal Ariff; Cheong, Sok-Ching] Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Zanaruddin, Sharifah Nurain Syed; Yee, Pei San; Hor, Seen Yii; Kong, Yink Heay; Cheong, Sok-Ching] Canc Res Initiat Fdn, Sime Darby Med Ctr, Oral Canc Res Team, Selangor, Malaysia; [Kong, Yink Heay; Abd Ghani, Wan Maria Nabillah Wan; Zain, Rosnah Binti] Univ Malaya, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan] Hosp Kuala Lumpur, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Zain, Rosnah Binti] Univ Malaya, Fac Dent, Dept Oral Pathol Oral Med & Periodontol, Kuala Lumpur, Malaysia; [Prime, Stephen S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of London; Queen Mary University London	Cheong, SC (corresponding author), Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	sokching.cheong@carif.com.my	Zain, Rosnah/B-8054-2010	Ghani, Wan Maria Nabillah/0000-0002-6782-558X	University of Malaya [UMRG: RG159/09HTM, HIRG: UM.C/HIR/MOHE/DENT/03]; Cancer Research Initiatives Foundation(CARIF)	University of Malaya(Universiti Malaya); Cancer Research Initiatives Foundation(CARIF)	This study was funded by University of Malaya (UMRG: RG159/09HTM; HIRG: UM.C/HIR/MOHE/DENT/03), and other sponsors of the Cancer Research Initiatives Foundation(CARIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Das N, 2000, ORAL ONCOL, V36, P76, DOI 10.1016/S1368-8375(99)00058-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Ferlay J, 2010, IARC CANCERBASE; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Ghani WMN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-82; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hamid S, 2007, INT J MOL MED, V19, P453; Hsieh LL, 2001, CARCINOGENESIS, V22, P1497, DOI 10.1093/carcin/22.9.1497; Husgafvel-Pursiainen K, 2000, CANCER RES, V60, P2906; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm453; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lim KP, 2005, ONCOL REP, V14, P963; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Munirajan AK, 1996, INT J CANCER, V66, P297; Murugan AK, 2008, INT J ONCOL, V32, P101; Peltonen JK, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-20; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Qiu WL, 2006, CLIN CANCER RES, V12, P1441, DOI 10.1158/1078-0432.CCR-05-2173; Ralhan R, 2001, ORAL ONCOL, V37, P243, DOI 10.1016/S1368-8375(00)00092-0; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; SARANATH D, 1991, BRIT J CANCER, V63, P573, DOI 10.1038/bjc.1991.133; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Squarize CH, 2002, J ORAL PATHOL MED, V31, P379, DOI 10.1034/j.1600-0714.2002.00142.x; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARNAKULASURIYA KAAS, 1992, J ORAL PATHOL MED, V21, P225, DOI 10.1111/j.1600-0714.1992.tb00106.x; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; YEUDALL WA, 1993, ORAL ONCOL, V29B, P63, DOI 10.1016/0964-1955(93)90012-4; Zain RB, 2013, CELL TISSUE BANK, V14, P45, DOI 10.1007/s10561-012-9298-0; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	66	27	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80229	10.1371/journal.pone.0080229	http://dx.doi.org/10.1371/journal.pone.0080229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224046	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400152
J	Kalari, KR; Necela, BM; Tang, XJ; Thompson, KJ; Lau, M; Eckel-Passow, JE; Kachergus, JM; Anderson, SK; Sun, ZF; Baheti, S; Carr, JM; Baker, TR; Barman, P; Radisky, DC; Joseph, RW; McLaughlin, SA; Chai, HS; Camille, S; Rossell, D; Asmann, YW; Thompson, EA; Perez, EA				Kalari, Krishna R.; Necela, Brian M.; Tang, Xiaojia; Thompson, Kevin J.; Lau, Melissa; Eckel-Passow, Jeanette E.; Kachergus, Jennifer M.; Anderson, S. Keith; Sun, Zhifu; Baheti, Saurabh; Carr, Jennifer M.; Baker, Tiffany R.; Barman, Poulami; Radisky, Derek C.; Joseph, Richard W.; McLaughlin, Sarah A.; Chai, High-seng; Camille, Stephan; Rossell, David; Asmann, Yan W.; Thompson, E. Aubrey; Perez, Edith A.			An Integrated Model of the Transcriptome of HER2-Positive Breast Cancer	PLOS ONE			English	Article							PLUS ADJUVANT CHEMOTHERAPY; MONOCLONAL-ANTIBODY; 1ST-LINE TREATMENT; TRASTUZUMAB; EFFICACY; REVEALS; SAFETY; TUMORS; ALIGNMENT; VARIANTS	Our goal in these analyses was to use genomic features from a test set of primary breast tumors to build an integrated transcriptome landscape model that makes relevant hypothetical predictions about the biological and/or clinical behavior of HER2-positive breast cancer. We interrogated RNA-Seq data from benign breast lesions, ER+, triple negative, and HER2-positive tumors to identify 685 differentially expressed genes, 102 alternatively spliced genes, and 303 genes that expressed single nucleotide sequence variants (eSNVs) that were associated with the HER2-positive tumors in our survey panel. These features were integrated into a transcriptome landscape model that identified 12 highly interconnected genomic modules, each of which represents a cellular processes pathway that appears to define the genomic architecture of the HER2-positive tumors in our test set. The generality of the model was confirmed by the observation that several key pathways were enriched in HER2-positive TCGA breast tumors. The ability of this model to make relevant predictions about the biology of breast cancer cells was established by the observation that integrin signaling was linked to lapatinib sensitivity in vitro and strongly associated with risk of relapse in the NCCTG N9831 adjuvant trastuzumab clinical trial dataset. Additional modules from the HER2 transcriptome model, including ubiquitin-mediated proteolysis, TGF-beta signaling, RHO-family GTPase signaling, and M-phase progression, were linked to response to lapatinib and paclitaxel in vitro and/or risk of relapse in the N9831 dataset. These data indicate that an integrated transcriptome landscape model derived from a test set of HER2-positive breast tumors has potential for predicting outcome and for identifying novel potential therapeutic strategies for this breast cancer subtype.	[Kalari, Krishna R.; Necela, Brian M.; Tang, Xiaojia; Thompson, Kevin J.; Lau, Melissa; Kachergus, Jennifer M.; Carr, Jennifer M.; Baker, Tiffany R.; Radisky, Derek C.; Thompson, E. Aubrey] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Kalari, Krishna R.; Eckel-Passow, Jeanette E.; Anderson, S. Keith; Sun, Zhifu; Baheti, Saurabh; Barman, Poulami; Chai, High-seng; Asmann, Yan W.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Joseph, Richard W.; Perez, Edith A.] Mayo Clin, Div Hematol & Oncol, Dept Internal Med, Jacksonville, FL 32224 USA; [McLaughlin, Sarah A.] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA; [Camille, Stephan; Rossell, David] Inst Res Biomed, Barcelona, Espirito Santo, Spain	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Thompson, EA (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	thompson.aubrey@mayo.edu	Radisky, Derek/B-6569-2018; Barman, Poulami/ABG-1426-2020; Rossell, David/AAM-4292-2021	Radisky, Derek/0000-0002-1962-8784; Barman, Poulami/0000-0002-4604-9868; Rossell, David/0000-0002-7104-5789; Thompson, Kevin/0000-0002-9348-4686; Joseph, Richard/0000-0001-6102-4661; Sun, Zhifu/0000-0001-8461-7523; Kalari, Krishna/0000-0001-8944-8378; Tang, Xiaojia/0000-0003-2457-9953	Donna Foundation [26.2]; Eveleigh Family Foundation; Carmichael Family; Mayo Foundation; National Cancer Institute [CA129949, CA155129]; NATIONAL CANCER INSTITUTE [R01CA129949, R21CA155129] Funding Source: NIH RePORTER	Donna Foundation; Eveleigh Family Foundation; Carmichael Family; Mayo Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported in part by funds from the 26.2 With Donna Foundation, the Eveleigh Family Foundation, the Carmichael Family, and the Mayo Foundation. Additional support was obtained from National Cancer Institute grants CA129949 (to EAP) and CA155129 (to EAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Efron B, 2010, TESTING SIGNIFICANCE; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Kalari KR, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00012; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Menon R, 2010, CANCER RES, V70, P3440, DOI 10.1158/0008-5472.CAN-09-2631; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Perez EA, 2012, CANC RES S, V72, p145s; Perez EAE-P, 2012, CANC RES, V72; Perez EA, 2012, JNCI-J NATL CANCER I, V104, P159, DOI 10.1093/jnci/djr490; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sjogren S, 1998, J CLIN ONCOL, V16, P462; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	34	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79298	10.1371/journal.pone.0079298	http://dx.doi.org/10.1371/journal.pone.0079298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223926	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300073
J	Wolfensberger, A; Sax, H; Weber, R; Zbinden, R; Kuster, SP; Hombach, M				Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Zbinden, Reinhard; Kuster, Stefan P.; Hombach, Michael			Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms	PLOS ONE			English	Article							CLINICAL BREAKPOINT CHANGES; INFECTIOUS-DISEASES; SOCIETY; UNIT; SURVEILLANCE; RESISTANCE; SELECTION	Objective: We studied whether the change in antibiotic susceptibility testing (AST) guidelines from CLSI to EUCAST influenced cumulative antibiograms in a tertiary care hospital in Switzerland. Methods: Antibiotic susceptibilities of non-duplicate isolates collected within a one-year period before (period A) and after (period B) changing AST interpretation from CLSI 2009 to EUCAST 1.3 (2011) guidelines were analysed. In addition, period B isolates were reinterpreted according to the CLSI 2009, CLSI 2013 and EUCAST 3.1 (2013) guidelines. Results: The majority of species/drug combinations showed no differences in susceptibility rates comparing periods A and B. However, in some gram-negative bacilli, decreased susceptibility rates were observed when comparing CLSI 2009 with EUCAST 1.3 within period B: Escherichia coli / cefepime, 95.8% (CLSI 2009) vs. 93.1% (EUCAST 1.3), P = 0.005; Enterobacter cloacae /cefepime, 97.0 (CLSI 2009) vs. 90.5% (EUCAST 1.3), P = 0.012; Pseudomonas aeruginosa / meropenem, 88.1% (CLSI 2009) vs. 78.3% (EUCAST 1.3), P = 0.002. These differences were still evident when comparing susceptibility rates according to the CLSI 2013 guideline with EUCAST 3.1 guideline. For P. aeruginosa and imipenem, a trend towards a lower antibiotic susceptibility rate in ICUs compared to general wards turned into a significant difference after the change to EUCAST: 87.9% vs. 79.8%, P = 0.08 (CLSI 2009) and 86.3% vs. 76.8%, P = 0.048 (EUCAST 1.3). Conclusions: The change of AST guidelines from CLSI to EUCAST led to a clinically relevant decrease of susceptibility rates in cumulative antibiograms for defined species/drug combinations, particularly in those with considerable differences in clinical susceptibility breakpoints between the two guidelines.	[Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Kuster, Stefan P.] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Kuster, Stefan P.] Univ Zurich, Zurich, Switzerland; [Zbinden, Reinhard; Hombach, Michael] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Wolfensberger, A (corresponding author), Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland.	aline.wolfensberger@usz.ch	Wolfensberger, Aline/T-1740-2017; Kuster, Stefan/T-7388-2019; Weber, Rainer/D-5175-2012; Sax, Hugo S/A-9377-2016	Wolfensberger, Aline/0000-0001-9028-0007; Kuster, Stefan/0000-0002-0525-6529; Sax, Hugo S/0000-0002-1532-2198				Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; Binkley S, 2006, INFECT CONT HOSP EP, V27, P682, DOI 10.1086/505921; Clinical and Laboratory Standards Insitute, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2008, M23A3 CLSI, Vthird; Clinical and Laboratory Standards Institute (CLSI), 2010, PERF STAND ANT SUSC; CLSI, 2011, M100S20 CLSI, P172; CLSI, 2013, PERFORMANCE STANDARD; CLSI, 2012, M02A11 CLSI; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; European Committee on Antimicrobial Susceptibility Testing, 2010, SETT BREAKP NEW AG; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hawser SP, 2010, INT J ANTIMICROB AG, V36, P293, DOI 10.1016/j.ijantimicag.2010.05.012; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hombach M, 2013, CLIN MICROBIOL INFEC, V19, pE59, DOI 10.1111/1469-0691.12090; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P145, DOI 10.1093/jac/dkg312; Kronvall G, 2011, INT J ANTIMICROB AG, V38, P281, DOI 10.1016/j.ijantimicag.2011.04.006; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marchese A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-181; Pakyz AL, 2007, PHARMACOTHERAPY, V27, P1306, DOI 10.1592/phco.27.9.1306; Rhomberg PR, 2006, DIAGN MICR INFEC DIS, V56, P57, DOI 10.1016/j.diagmicrobio.2005.12.009; Rodriguez-Bano J, 2012, CLIN MICROBIOL INFEC, V18, P894, DOI 10.1111/j.1469-0691.2011.03673.x; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x	24	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79130	10.1371/journal.pone.0079130	http://dx.doi.org/10.1371/journal.pone.0079130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223893	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326499300063
J	Liu, X; Xiao, W; Wang, XD; Li, YF; Han, JH; Li, YQ				Liu, Xin; Xiao, Wei; Wang, Xu-Dong; Li, Yue-Fang; Han, Jiahuai; Li, Yingqiu			The p38-interacting Protein (p38IP) Regulates G(2)/M Progression by Promoting alpha-Tubulin Acetylation via Inhibiting Ubiquitination-induced Degradation of the Acetyltransferase GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Cycle; Cell Signaling; Gene Silencing; Molecular Cell Biology; Protein Degradation; -Tubulin; Acetylation; gcn5; p38IP	TATA-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CELL-CYCLE; YEAST; COMPLEX; ACTIVATION; ATAC	Background: The role of p38IP in cell cycle regulation remains unclear. Results: p38IP inhibits ubiquitination-induced GCN5 degradation and therefore promotes -tubulin acetylation, facilitating spindle formation and G(2)/M progression. Conclusion: p38IP is required for G(2)/M progression. Significance: This study reveals the necessity of p38IP for GCN5 stability and for G(2)/M progression. p38-interacting protein (p38IP) is a component of the GCN5 histone acetyltransferase-containing coactivator complex (GCN5-SAGA complex). It remains unclear whether p38IP or GCN5-SAGA is involved in cell cycle regulation. Using RNA interference to knock down p38IP, we observed that cells were arrested at the G(2)/M phase, exhibiting accumulation of cyclins, shrunken spindles, and hypoacetylation of -tubulin. Further analysis revealed that knockdown of p38IP led to proteasome-dependent degradation of GCN5. GCN5 associated with and acetylated -tubulin, and recovering GCN5 protein levels in p38IP knockdown cells by ectopic expression of GCN5 efficiently reversed -tubulin hypoacetylation and G(2)/M arrest. During the G(2)/M transition, the association of -tubulin with GCN5 increased, and the acetylation of -tubulin reached a peak. Biochemical analyses demonstrated that the interaction between p38IP and GCN5 depended on the p38IP N terminus (1-381 amino acids) and GCN5 histone acetyltransferase domain and bromodomain. The p38IP N terminus could effectively reverse p38IP depletion-induced GCN5 degradation, thus recovering -tubulin acetylation and G(2)/M progression. p38IP-mediated suppression of GCN5 ubiquitination most likely occurs via nuclear sequestration of GCN5. Our data indicate that the GCN5-SAGA complex is required for G(2)/M progression, mainly because p38IP promotes the acetylation of -tubulin by preventing the degradation of GCN5, in turn facilitating the formation of the mitotic spindle.	[Liu, Xin; Xiao, Wei; Wang, Xu-Dong; Li, Yue-Fang; Li, Yingqiu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Han, Jiahuai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China	Sun Yat Sen University; Xiamen University	Li, YQ (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, 135 Xingang Xi Rd, Guangzhou 510275, Guangdong, Peoples R China.	lsslyq@mail.sysu.edu.cn	Han, J/G-4671-2010; Wang, Xu-Dong/Z-1721-2019	Wang, Xu-Dong/0000-0002-8265-1485	Ministry of Science and Technology of China [2009CB522200, 2013CB835300]; National Natural Science Foundation of China [31170846]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (Grants 2009CB522200 and 2013CB835300) and the National Natural Science Foundation of China (Grant 31170846).	Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Candau R, 1996, MOL CELL BIOL, V16, P593; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Lin W, 2007, DEV DYNAM, V236, P1547, DOI 10.1002/dvdy.21160; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Welihinda AA, 1997, P NATL ACAD SCI USA, V94, P4289, DOI 10.1073/pnas.94.9.4289; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	41	21	21	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36648	36661		10.1074/jbc.M113.486910	http://dx.doi.org/10.1074/jbc.M113.486910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24220028	Green Published, hybrid			2022-12-25	WOS:000328883400044
J	Joshi, A; Vaidyanathan, S; Mondol, S; Edgaonkar, A; Ramakrishnan, U				Joshi, Aditya; Vaidyanathan, Srinivas; Mondol, Samrat; Edgaonkar, Advait; Ramakrishnan, Uma			Connectivity of Tiger (Panthera tigris) Populations in the Human-Influenced Forest Mosaic of Central India	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; COMPUTER-PROGRAM; NATAL DISPERSAL; GENE FLOW; LANDSCAPE; DENSITY; INFERENCE; COUGAR; MIGRATION; IDENTIFICATION	Today, most wild tigers live in small, isolated Protected Areas within human dominated landscapes in the Indian subcontinent. Future survival of tigers depends on increasing local population size, as well as maintaining connectivity between populations. While significant conservation effort has been invested in increasing tiger population size, few initiatives have focused on landscape-level connectivity and on understanding the effect different landscape elements have on maintaining connectivity. We combined individual-based genetic and landscape ecology approaches to address this issue in six protected areas with varying tiger densities and separation in the Central Indian tiger landscape. We non-invasively sampled 55 tigers from different protected areas within this landscape. Maximum-likelihood and Bayesian genetic assignment tests indicate long-range tiger dispersal (on the order of 650 km) between protected areas. Further geo-spatial analyses revealed that tiger connectivity was affected by landscape elements such as human settlements, road density and host-population tiger density, but not by distance between populations. Our results elucidate the importance of landscape and habitat viability outside and between protected areas and provide a quantitative approach to test functionality of tiger corridors. We suggest future management strategies aim to minimize urban expansion between protected areas to maximize tiger connectivity. Achieving this goal in the context of ongoing urbanization and need to sustain current economic growth exerts enormous pressure on the remaining tiger habitats and emerges as a big challenge to conserve wild tigers in the Indian subcontinent.	[Joshi, Aditya] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Mondol, Samrat; Ramakrishnan, Uma] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Edgaonkar, Advait] Indian Inst Forest Management, Bhopal, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Forest Management	Ramakrishnan, U (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	uramakri@ncbs.res.in		Mondol, Samrat/0000-0003-3034-9396; Joshi, Aditya/0000-0002-9335-8508; Vaidyanathan, Srinivas/0000-0003-3642-0309	Department of Science and Technology, Government of India; Tata Institute of Fundamental Research; Wildlife Conservation society- India Program	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Wildlife Conservation society- India Program	This research was funded by the Department of Science and Technology, Government of India, Tata Institute of Fundamental Research and the Wildlife Conservation society- India Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bhagat R.B., 2009, ASIAN POPUL STUD, V5, P5, DOI [10.1080/17441730902790024, DOI 10.1080/17441730902790024]; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Carr D, 2007, OIKOS, V116, P629, DOI 10.1111/j.2007.0030-1299.15568.x; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Gubbi S, 2012, CURR SCI INDIA, V102, P1047; Jhala Y. V., 2011, STATUS TIGERS COPRED; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2011, CONSERV LETT, V4, P137, DOI 10.1111/j.1755-263X.2010.00154.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Luque S, 2012, LANDSCAPE ECOL, V27, P153, DOI 10.1007/s10980-011-9700-5; Maehr DS, 2002, BIOL CONSERV, V106, P187, DOI 10.1016/S0006-3207(01)00245-2; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; MINCH E, 1995, MICROSAT VERSION 1 5; Mondol S, 2012, CONSERV GENET RESOUR, V4, P63, DOI 10.1007/s12686-011-9475-7; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Mukherjee N, 2007, CONSERV GENET, V8, P1465, DOI 10.1007/s10592-007-9289-z; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patil N, 2011, ORYX, V45, P472, DOI 10.1017/S0030605311001591; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Sanderson E, 2006, SETTING PRIORITIES C; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Singleton PH, 2004, URSUS, V15, P90, DOI 10.2192/1537-6176(2004)015<0090:LPFGBM>2.0.CO;2; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Stoner DC, 2008, J WILDLIFE MANAGE, V72, P933, DOI 10.2193/2007-219; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Sutton PC, 2010, REMOTE SENS DIGIT IM, V10, P329, DOI 10.1007/978-1-4020-4385-7_17; Team RDC, 2008, LANG ENV STAT COMP; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Thompson DJ, 2005, J WILDLIFE MANAGE, V69, P818, DOI 10.2193/0022-541X(2005)069[0818:LDBASM]2.0.CO;2; TREWHELLA WJ, 1988, J APPL ECOL, V25, P423, DOI 10.2307/2403834; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vounatsou P, 2000, Biostatistics, V1, P177, DOI 10.1093/biostatistics/1.2.177; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wilson GA, 2003, GENETICS, V163, P1177; Yang M., 2009, JOINT URBAN REMOTE S, DOI [10.1109/URS.2009.5137530, DOI 10.1109/URS.2009.5137530]	71	69	71	1	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77980	10.1371/journal.pone.0077980	http://dx.doi.org/10.1371/journal.pone.0077980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223132	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200024
J	Lalor, MK; Greig, J; Allamuratova, S; Althomsons, S; Tigay, Z; Khaemraev, A; Braker, K; Telnov, O; du Cros, P				Lalor, Maeve K.; Greig, Jane; Allamuratova, Sholpan; Althomsons, Sandy; Tigay, Zinaida; Khaemraev, Atadjan; Braker, Kai; Telnov, Oleksander; du Cros, Philipp			Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis	PLOS ONE			English	Article							TREATMENT OUTCOMES; PROGRAM; TB	Background: The Medecins Sans Frontieres project of Uzbekistan has provided multidrug-resistant tuberculosis treatment in the Karakalpakstan region since 2003. Rates of default from treatment have been high, despite psychosocial support, increasing particularly since programme scale-up in 2007. We aimed to determine factors associated with default in multi- and extensively drug-resistant tuberculosis patients who started treatment between 2003 and 2008 and thus had finished approximately 2 years of treatment by the end of 2010. Methods: A retrospective cohort analysis of multi- and extensively drug-resistant tuberculosis patients enrolled in treatment between 2003 and 2008 compared baseline demographic characteristics and possible risk factors for default. Default was defined as missing >= 60 consecutive days of treatment (all drugs). Data were routinely collected during treatment and entered in a database. Potential risk factors for default were assessed in univariate analysis using chi-square test and in multivariate analysis with logistic regression. Results: 20% (142/710) of patients defaulted after a median of 6 months treatment (IQR 2.6-9.9). Factors associated with default included severity of resistance patterns (pre-extensively drug-resistant/extensively drug-resistant tuberculosis adjusted odds ratio 0.52, 95% CI: 0.31-0.86), previous default (2.38, 1.09-5.24) and age >45 years (1.77, 1.10-2.87). The default rate was 14% (42/294) for patients enrolled 2003-2006 and 24% (100/416) for 2007-2008 enrolments (p = 0.001). Conclusions: Default from treatment was high and increased with programme scale-up. It is essential to ensure scale-up of treatment is accompanied with scale-up of staff and patient support. A successful first course of tuberculosis treatment is important; patients who had previously defaulted were at increased risk of default and death. The protective effect of severe resistance profiles suggests that understanding disease severity or fear may motivate against default. Targeted health education and support for at-risk patients after 5 months of treatment when many begin to feel better may decrease default.	[Lalor, Maeve K.; Allamuratova, Sholpan; Althomsons, Sandy; Telnov, Oleksander] Med Sans Frontieres, Nukus, Karakalpakstan, Uzbekistan; [Greig, Jane; du Cros, Philipp] Med Sans Frontieres, London, England; [Tigay, Zinaida; Khaemraev, Atadjan] Minist Hlth, Karakalpakstan, Uzbekistan; [Braker, Kai] Med Sans Frontieres, Berlin, Germany	Doctors Without Borders; Doctors Without Borders	Lalor, MK (corresponding author), Med Sans Frontieres, Nukus, Karakalpakstan, Uzbekistan.	maeve_lalor@yahoo.com		du Cros, Philipp/0000-0002-3599-029X; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA009-42] Funding Source: researchfish	M�decins Sans Fronti�res		Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; [Anonymous], 2008, GUID PROGR MAN DRUG; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Gler MT, 2012, INT J TUBERC LUNG D, V16, P955, DOI 10.5588/ijtld.11.0502; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Ministry of Health Uzbekistan, 2009, TUB DAT UZB; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2012, TUB COUNTR WORK SUMM; World Health Organization, 2011, WHO PROGRESS REPORT; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10	20	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78364	10.1371/journal.pone.0078364	http://dx.doi.org/10.1371/journal.pone.0078364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223148	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200040
J	Martinez, A; Halliez, MCM; Aliouat, E; Chabe, M; Standaert-Vitse, A; Frealle, E; Gantois, N; Pottier, M; Pinon, A; Dei-Cas, E; Aliouat-Denis, CM				Martinez, Anna; Halliez, Marie C. M.; Aliouat, El Moukhtar; Chabe, Magali; Standaert-Vitse, Annie; Frealle, Emilie; Gantois, Nausicaa; Pottier, Muriel; Pinon, Anthony; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie			Growth and Airborne Transmission of Cell-Sorted Life Cycle Stages of Pneumocystis carinii	PLOS ONE			English	Article							F-SP HOMINIS; SP MURIS; IMMUNOCOMPETENT; INFECTION; DIAGNOSIS; MODELS; MOUSE; HOSTS; RAT	Pneumocystis organisms are airborne opportunistic pathogens that cannot be continuously grown in culture. Consequently, the follow-up of Pneumocystis stage-to-stage differentiation, the sequence of their multiplication processes as well as formal identification of the transmitted form have remained elusive. The successful high-speed cell sorting of trophic and cystic forms is paving the way for the elucidation of the complex Pneumocystis life cycle. The growth of each sorted Pneumocystis stage population was followed up independently both in nude rats and in vitro. In addition, by setting up a novel nude rat model, we attempted to delineate which cystic and/or trophic forms can be naturally aerially transmitted from host to host. The results showed that in axenic culture, cystic forms can differentiate into trophic forms, whereas trophic forms are unable to evolve into cystic forms. In contrast, nude rats inoculated with pure trophic forms are able to produce cystic forms and vice versa. Transmission experiments indicated that 12 h of contact between seeder and recipient nude rats was sufficient for cystic forms to be aerially transmitted. In conclusion, trophic-to cystic-form transition is a key step in the proliferation of Pneumocystis microfungi because the cystic forms (but not the trophic forms) can be transmitted by aerial route from host to host.	[Martinez, Anna; Halliez, Marie C. M.; Aliouat, El Moukhtar; Chabe, Magali; Standaert-Vitse, Annie; Frealle, Emilie; Gantois, Nausicaa; Pottier, Muriel; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204,EA 4547, Lille, France; [Martinez, Anna] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Halliez, Marie C. M.] Univ Calgary, Dept Biol Sci, Inflammat Res Network, Calgary, AB T2N 1N4, Canada; [Pinon, Anthony] Inst Pasteur, Unite Securite Microbiol, F-59019 Lille, France; [Frealle, Emilie; Dei-Cas, Eduardo] Ctr Reg Hosp Univ, Biol & Pathol Ctr, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; RIKEN; University of Calgary; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille	Aliouat-Denis, CM (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204,EA 4547, Lille, France.	cecile.aliouat@univ-lille2.fr	Standaert, Annie/R-5826-2018; Martinez, Anna/AAI-6447-2021; Fréalle, Emilie/AAF-5162-2020; Aliouat, El Moukhtar/D-2859-2018; Standaert, Annie/AAD-8209-2020; Aliouat-Denis, Cecile-Marie/P-1934-2016; Chabe, Magali/H-6045-2017	Standaert, Annie/0000-0002-7752-3964; Aliouat, El Moukhtar/0000-0003-2905-7126; Standaert, Annie/0000-0002-7752-3964; Pinon, Anthony/0000-0001-7048-3085; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Martinez, Anna/0000-0001-7245-9687; Frealle, Emilie/0000-0003-3129-979X; Chabe, Magali/0000-0002-6732-6772	ANR-ERA-NET 'Pneumocystis' PathoGenoMics [ANR-06-PATHO-009-01]; Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL) [IFR142]	ANR-ERA-NET 'Pneumocystis' PathoGenoMics(French National Research Agency (ANR)); Lille-Nord-de-France University; Pasteur Institute of Lille; microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL)	This work was supported by ANR-ERA-NET 'Pneumocystis' PathoGenoMics (ANR-06-PATHO-009-01). We also thank the Lille-Nord-de-France University, the Pasteur Institute of Lille and the microscopy and flow cytometry platform of the BioImaging Center of Lille Nord de France (BiCeL, IFR142) for their support. The funders (ANR-ERA-NET, Lille Nord de France University and Pasteur Institute of Lille) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat E, 1999, J EUKARYOT MICROBIOL, V46, p116S; Aliouat EM, 1998, EUR RESPIR J, V11, P542; ALIOUAT EM, 1993, J PROTOZOOL RES, V3, P94; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Aliouat-Denis CM, 2009, MEM I OSWALDO CRUZ, V104, P419, DOI 10.1590/S0074-02762009000300004; Ambrose HE, 2004, MICROBIOL-SGM, V150, P293, DOI 10.1099/mic.0.26539-0; An CL, 2003, INFECT IMMUN, V71, P2065, DOI 10.1128/IAI.71.4.2065-2070.2003; Aviles P, 2000, ANTIMICROB AGENTS CH, V44, P1284, DOI 10.1128/AAC.44.5.1284-1290.2000; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Cushion MT, 2010, ANNU REV MICROBIOL, V64, P431, DOI 10.1146/annurev.micro.112408.134335; Cushion MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001009; Cushion MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008524; Dei-Cas E, 1998, FEMS IMMUNOL MED MIC, V22, P163, DOI [10.1111/j.1574-695X.1998.tb01201.x, 10.1111/j.1574-695X.1998.tb01203.x]; DeiCas E, 1996, PARASITOL TODAY, V12, P245, DOI 10.1016/0169-4758(96)80812-X; DEICAS E, 2004, PNEUMOCYSTIS PNEUMON, P61; Dumoulin A, 2000, EUR J CLIN MICROBIOL, V19, P671, DOI 10.1007/s100960000354; Durand-Joly I, 2005, FEMS IMMUNOL MED MIC, V45, P405, DOI 10.1016/j.femsim.2005.06.006; Durand-Joly I, 2002, J CLIN MICROBIOL, V40, P1862, DOI 10.1128/JCM.40.5.1862-1865.2002; Garry S, 2003, MUTAT RES-GEN TOX EN, V538, P19, DOI 10.1016/S1383-5718(03)00082-2; Gigliotti F, 2003, INFECT IMMUN, V71, P3852, DOI 10.1128/IAI.71.7.3852-3856.2003; HUGHES WT, 1982, J INFECT DIS, V145, P842, DOI 10.1093/infdis/145.6.842; ITATANI CA, 1994, J PARASITOL, V80, P644, DOI 10.2307/3283204; Martinez A, 2009, J EUKARYOT MICROBIOL, V56, P446, DOI 10.1111/j.1550-7408.2009.00423.x; SCHMATZ DM, 1992, ANTIMICROB AGENTS CH, V36, P1964, DOI 10.1128/AAC.36.9.1964; SOULEZ B, 1991, J PARASITOL, V77, P449, DOI 10.2307/3283134; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996; WALZER PD, 1977, SCIENCE, V197, P177, DOI 10.1126/science.301657; YOSHIDA Y, 1989, J PROTOZOOL, V36, P53	32	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79958	10.1371/journal.pone.0079958	http://dx.doi.org/10.1371/journal.pone.0079958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223207	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200100
J	Zhao, M; Zang, BC; Cheng, MJ; Ma, Y; Yang, YH; Yang, NH				Zhao, Min; Zang, Baocai; Cheng, Mengjie; Ma, Yan; Yang, Yanhong; Yang, Nianhong			Differential Responses of Hepatic Endoplasmic Reticulum Stress and Inflammation in Diet-Induced Obese Rats with High-Fat Diet Rich in Lard Oil or Soybean Oil	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ER STRESS; REGULATOR GRP78/BIP; OXIDATIVE STRESS; SKELETAL-MUSCLE; CRUCIAL ROLE; CELL FATE; LIVER	Scopes: To investigate the effects of high-fat diet enriched with lard oil or soybean oil on liver endoplasmic reticulum (ER) stress and inflammation markers in diet-induced obese (DIO) rats and estimate the influence of following low-fat diet feeding. Methods and Results: Male SD rats were fed with standard low-fat diet (LF, n = 10) and two isoenergentic high-fat diets enriched with lard (HL, n = 45) or soybean oil (HS, n = 45) respectively for 10 weeks. Then DIO rats from HL and HS were fed either high-fat diet continuously (HL/HL, HS/HS) or switched to low-fat diet (HL/LF, HS/LF) for another 8 weeks. Rats in control group were maintained with low-fat diet. Body fat, serum insulin level, HOMA-IR and ectopic lipid deposition in liver were increased in HL/HL and HS/HS compared to control, but increased to a greater extent in HL/HL compared to HS/HS. Markers of ER stress including PERK and CHOP protein expression and phosphorylation of eIF2 alpha were significantly elevated in HL/HL group while phosphorylation of IRE1 alpha and GRP78 protein expression were suppressed in both HL/HL and HS/HS. Besides, inflammatory signals (OPN, TLR2, TLR4 and TNF-alpha) expressions significantly increased in HL/HL compared to others. Switching to low-fat diet reduced liver fat deposition, HOMA-IR, mRNA expression of TLR4, TNF-alpha, PERK in both HL/LF and HS/LF, but only decreased protein expression of OPN, PERK and CHOP in HL/LF group. In addition, HL/LF and HS/LF exhibited decreased phosphorylation of eIF2 alpha and increased phosphorylation of IRE1 alpha and GRP78 protein expression when compared with HL/HL and HS/HS respectively. Conclusions: Lard oil was more deleterious in insulin resistance and hepatic steatosis via promoting ER stress and inflammation responses in DIO rats, which may be attributed to the enrichment of saturated fatty acid. Low-fat diet was confirmed to be useful in recovering from impaired insulin sensitivity and liver fat deposition in this study.	[Zhao, Min; Zang, Baocai; Cheng, Mengjie; Ma, Yan; Yang, Yanhong; Yang, Nianhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan 430074, Hubei Province, Peoples R China; [Zhao, Min; Zang, Baocai; Yang, Nianhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ Key Lab Environm & Hlth, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, NH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan 430074, Hubei Province, Peoples R China.	zynh@mails.tjmu.edu.cn			National Natural Science Foundation of China [30671765]; Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China [20101561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by National Natural Science Foundation of China (No. 30671765; http://www.nsfc.gov.cn/Portal0/default152.htm) and Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China (No. 20101561; http://www.cscse.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Foreyt JP, 2002, AM J MED, V113, P60, DOI 10.1016/S0002-9343(01)00993-7; Golay A, 1997, INT J OBESITY, V21, pS2; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kim SJ, 2010, MOL NUTR FOOD RES, V54, P1014, DOI 10.1002/mnfr.200800512; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li J, 2012, J HEPATOL, V56, P900, DOI 10.1016/j.jhep.2011.10.018; Liao FH, 2010, INT J OBESITY, V34, P1608, DOI 10.1038/ijo.2010.88; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin M, 2013, KIDNEY INT; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nivala AM, 2013, METABOLISM CLIN EXPT; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pacana T, 2012, CURR OPIN CLIN NUTR, V15, P641, DOI 10.1097/MCO.0b013e328357f747; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Vinayagamoorthi R, 2008, J ENDOCRINOL, V197, P287, DOI 10.1677/JOE-08-0061; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang X, 2012, EUROPEAN J NUTR; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312	70	25	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78620	10.1371/journal.pone.0078620	http://dx.doi.org/10.1371/journal.pone.0078620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223162	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200054
J	Chen, J; Zhang, XY; Zhang, H; Lin, J; Zhang, C; Wu, Q; Ding, XQ				Chen, Jing; Zhang, Xiaoyan; Zhang, Han; Lin, Jing; Zhang, Chen; Wu, Qing; Ding, Xiaoqiang			Elevated Klotho Promoter Methylation Is Associated with Severity of Chronic Kidney Disease	PLOS ONE			English	Article							REDUCES APOPTOSIS; RENAL-DISEASE; GENE; EXPRESSION; PROTEIN; URINARY; STRESS; INJURY; FGF23	Klotho (KL) expression is down-regulated in the renal tissues of chronic kidney disease (CKD) animal models and patients with end-stage renal disease. The putative role of KL promoter hypermethylation in the progression of CKD remains unclear. The present study aimed to determine renal and peripheral blood mononuclear cells (PBMC) levels of KL promoter methylation and analyze their relationship with clinical and histological severity in patients with CKD. Using bisulfite pyrosequencing, renal and PBMC levels of KL promoter methylation were quantified in 47 patients with CKD. 47 nephrectomy specimens of patients with renal cell carcinoma and 48 PBMC specimens of healthy volunteers were used as renal tissue and PBMC controls, respectively. Renal expression of KL protein was assayed by immunohistochemistry staining. Receiver operating characteristic (ROC) curve was used to identify the optimal cut-off value of PBMC KL promoter methylation level for renal KL promoter hypermethylation. Higher levels of KL promoter methylation were observed in renal tissue and PBMC in patients with CKD compared with controls (8.79 +/- 3.24 vs. 5.17 +/- 1.11%, P<0.001; 7.20 +/- 2.79 vs. 3.27 +/- 0.79%, P<0.001). In these patients, renal KL methylation level correlated inversely with renal KL immunostaining intensity (rho=-0.794, P<0.001). Estimated glomerular filtration rate correlated inversely with renal and PBMC levels of KL promoter methylation (r=-0.829, P<0.001; r=-0.645, P<0.001), while tubulointerstistial fibrosis score correlated positively (rho=0.826, P<0.001; rho=0.755, P<0.001). PBMC KL promoter methylation level correlated positively with renal KL promoter methylation level in patients with CKD (r=0.787, P<0.001). In ROC curve, the area under curve was 0.964 (P<0.001) and the optimal cut-off value was 5.83% with a sensitivity of 93.8% and specificity of 86.7% to predict renal KL promoter hypermethylation. The degree of KL promoter methylation is associated with clinical and histological severity of CKD. PBMC KL promoter methylation level may act as a potential biomarker of renal KL promoter hypermethylation.	[Chen, Jing; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Lab Kidney Dis, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Zhang, Han; Lin, Jing; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Nephrol, Shanghai 200433, Peoples R China; [Zhang, Chen; Wu, Qing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, XY (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Nephrol, Shanghai 200433, Peoples R China.	zhang.xiaoyan@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			Ministry of Science and Technology of People's Republic of China [2011BAI10B03]; young physician training program by Shanghai Health and Family Planning Commission	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); young physician training program by Shanghai Health and Family Planning Commission	This study was supported by research grant by the Ministry of Science and Technology of People's Republic of China (2011BAI10B03) and young physician training program by Shanghai Health and Family Planning Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Rao M, 2007, KIDNEY INT, V72, P549, DOI 10.1038/sj.ki.5002391; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tan Y, 2009, CLIN EXP IMMUNOL, V156, P111, DOI 10.1111/j.1365-2249.2008.03868.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang YH, 2009, HYPERTENSION, V54, P810, DOI 10.1161/HYPERTENSIONAHA.109.134320; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P261, DOI 10.1016/j.bbrc.2009.11.046; Zhang C, 2013, TOXICOL APPL PHARM, V271, P78, DOI 10.1016/j.taap.2013.04.025	31	29	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79856	10.1371/journal.pone.0079856	http://dx.doi.org/10.1371/journal.pone.0079856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224012	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400091
J	Diegelmann, J; Czamara, D; Le Bras, E; Zimmermann, E; Olszak, T; Bedynek, A; Goke, B; Franke, A; Glas, J; Brand, S				Diegelmann, Julia; Czamara, Darina; Le Bras, Emmanuelle; Zimmermann, Eva; Olszak, Torsten; Bedynek, Andrea; Goeke, Burkhard; Franke, Andre; Glas, Juergen; Brand, Stephan			Intestinal DMBT1 Expression Is Modulated by Crohn's Disease- Associated IL23R Variants and by a DMBT1 Variant Which Influences Binding of the Transcription Factors CREB1 and ATF-2	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SCAVENGER RECEPTOR GP340; ULCERATIVE-COLITIS; SUSCEPTIBILITY LOCI; FRAMESHIFT MUTATION; GERMAN POPULATION; EPITHELIAL-CELLS; GENE-EXPRESSION; GENOTYPE STATUS	Objectives: DMBT is an antibacterial pattern recognition and scavenger receptor. In this study, we analyzed the role of DMBT1 single nucleotide polymorphisms (SNPs) regarding inflammatory bowel disease (IBD) susceptibility and examined their functional impact on transcription factor binding and downstream gene expression. Methods: Seven SNPs in the DMBT1 gene region were analyzed in 2073 individuals including 818 Crohn's disease (CD) patients and 972 healthy controls in two independent case-control panels. Comprehensive epistasis analyses for the known CD susceptibility genes NOD2, IL23R and IL27 were performed. The influence of IL23R variants on DMBT1 expression was analyzed. Functional analysis included siRNA transfection, quantitative PCR, western blot, electrophoretic mobility shift and luciferase assays. Results: IL-22 induces DMBT1 protein expression in intestinal epithelial cells dependent on STAT3, ATF-2 and CREB1. IL-22 expression-modulating, CD risk-associated IL23R variants influence DMBT1 expression in CD patients and DMBT1 levels are increased in the inflamed intestinal mucosa of CD patients. Several DMBT1 SNPs were associated with CD susceptibility. SNP rs2981804 was most strongly associated with CD in the combined panel (p = 3.06 x 10(-7), OR 1.42; 95% CI 1.24-1.63). All haplotype groups tested showed highly significant associations with CD (including omnibus P-values as low as 6.16 x 10(-18)). The most strongly CD risk-associated, non-coding DMBT1 SNP rs2981804 modifies the DNA binding sites for the transcription factors CREB1 and ATF-2 and the respective genomic region comprising rs2981804 is able to act as a transcriptional regulator in vitro. Intestinal DMBT1 expression is decreased in CD patients carrying the rs2981804 CD risk allele. Conclusion: We identified novel associations of DMBT1 variants with CD susceptibility and discovered a novel functional role of rs2981804 in regulating DMBT1 expression. Our data suggest an important role of DMBT1 in CD pathogenesis.	[Diegelmann, Julia; Le Bras, Emmanuelle; Olszak, Torsten; Goeke, Burkhard; Glas, Juergen; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Diegelmann, Julia; Zimmermann, Eva; Glas, Juergen] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Czamara, Darina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Bedynek, Andrea] Univ Munich, Dept Clin Chem, Munich, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany	University of Munich; University of Munich; Max Planck Society; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Munich; University of Kiel; RWTH Aachen University	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Franke, Andre/B-2151-2010	Franke, Andre/0000-0003-1530-5811	Ludwig-Maximilians-University of Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung [Else Kroner-Exzellenzstipendium 2010_EKES.32]; Ludwig-Maximilians-University of Munich (Excellence Initiative); Ludwig-Maximilians-University of Munich (Investment funds); Ludwig-Maximilians-University of Munich (FoFoLe); DFG [Ol 324/1-1]; German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft (German Research Foundation) [EXC 1010 SyNergy]	Ludwig-Maximilians-University of Munich (Promotionsstipendium); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; Ludwig-Maximilians-University of Munich (Excellence Initiative); Ludwig-Maximilians-University of Munich (Investment funds); Ludwig-Maximilians-University of Munich (FoFoLe); DFG(German Research Foundation (DFG)); German Ministry of Education and Research through the National Genome Research Network; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	JD was supported by a grant from the Ludwig-Maximilians-University of Munich (Promotionsstipendium). SB was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR 1912/6-1), the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32) and by grants from the Ludwig-Maximilians-University of Munich (Excellence Initiative, Investment funds 2008 and FoFoLe). TO was supported by DFG grant Ol 324/1-1. AF was supported by the German Ministry of Education and Research through the National Genome Research Network and receives infrastructure support through the DFG cluster of excellence 'Inflammation at Interfaces'. DC was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Browning BL, 2008, J MED GENET, V45, P36, DOI 10.1136/jmg.2007.050773; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Lisle RC, 2008, AM J PHYSIOL-GASTR L, V294, pG717, DOI 10.1152/ajpgi.00525.2007; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043035; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; End C, 2009, EUR J IMMUNOL, V39, P833, DOI 10.1002/eji.200838689; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Glas J, 2010, PLOS ONE, V5; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054338; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Loimaranta V, 2009, J BIOL CHEM, V284, P18614, DOI 10.1074/jbc.M900581200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007	51	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77773	10.1371/journal.pone.0077773	http://dx.doi.org/10.1371/journal.pone.0077773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223725	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400013
J	Feigenbutz, M; Garland, W; Turner, M; Mitchell, P				Feigenbutz, Monika; Garland, William; Turner, Martin; Mitchell, Phil			The Exosome Cofactor Rrp47 Is Critical for the Stability and Normal Expression of Its Associated Exoribonuclease Rrp6 in Saccharomyces cerevisiae	PLOS ONE			English	Article							HUMAN PM-SCL; YEAST EXOSOME; RIBOSOMAL-RNA; NUCLEAR-RNA; BIDIRECTIONAL PROMOTERS; QUALITY-CONTROL; DEGRADATION; POLYADENYLATION; TRANSCRIPTION; SURVEILLANCE	Rrp6 is a conserved catalytic subunit of the eukaryotic nuclear exosome ribonuclease complex that functions in the productive 3' end maturation of stable RNAs, the degradation of transiently expressed noncoding transcripts and in discard pathways that eradicate the cell of incorrectly processed or assembled RNAs. The function of Rrp6 in these pathways is at least partially dependent upon its interaction with a small nuclear protein called Rrp47/Lrp1, but the underlying mechanism(s) by which Rrp47 functions in concert with Rrp6 are not established. Previous work on yeast grown in rich medium has suggested that Rrp6 expression is not markedly reduced in strains lacking Rrp47. Here we show that Rrp6 expression in rrp47 Delta. mutants is substantially reduced during growth in minimal medium through effects on both transcript levels and protein stability. Exogenous expression of Rrp6 enables normal levels to be attained in rrp47 Delta. mutants. Strikingly, exogenous expression of Rrp6 suppresses many, but not all, of the RNA processing and maturation defects observed in an rrp47. mutant and complements the synthetic lethality of rrp47. mpp6 Delta and rrp47 rex1 Delta. double mutants. Increased Rrp6 expression in the resultant rrp47. rex1 Delta. double mutant suppresses the defect in the 3' maturation of box C/D snoRNAs. In contrast, increased Rrp6 expression in the rrp47. mpp6. double mutant diminishes the block in the turnover of CUTs and in the degradation of the substrates of RNA discard pathways. These results demonstrate that a principal function of Rrp47 is to facilitate appropriate expression levels of Rrp6 and support the conclusion that the Rrp6/Rrp47 complex and Rex1 provide redundant exonuclease activities for the 3' end maturation of box C/D snoRNAs.	[Feigenbutz, Monika; Garland, William; Turner, Martin; Mitchell, Phil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Mitchell, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	p.j.mitchell@shef.ac.uk		Mitchell, Phil/0000-0002-3178-0439; Garland, William/0000-0001-5167-8004	Wellcome Trust [08836/Z/09/Z]; BBSRC-funded PhD studentships	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC-funded PhD studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grant 08836/Z/09/Z from the Wellcome Trust (www.wellcome.ac.uk) and BBSRC-funded PhD studentships to WG and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Cairrao F, 2001, MOL MICROBIOL, V39, P1550, DOI 10.1046/j.1365-2958.2001.02342.x; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; GARLAND W, 2013, RNA, P6327; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moreira RN, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-268; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Ozanick SG, 2009, NUCLEIC ACIDS RES, V37, P298, DOI 10.1093/nar/gkn925; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; SIKORSKI RS, 1989, GENETICS, V122, P19; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; STUPAREVIC I, 2013, J BIOL CHEM, P47896; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	64	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80752	10.1371/journal.pone.0080752	http://dx.doi.org/10.1371/journal.pone.0080752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224060	Green Published, Green Accepted, gold			2022-12-25	WOS:000326597400123
J	Jin, MJ; Chen, BB; Mao, YY; Zhu, YM; Yu, YX; Wu, YY; Zhang, MW; Zhu, SK; Chen, K				Jin, Ming-Juan; Chen, Bing-Bing; Mao, Ying-Ying; Zhu, Yi-Min; Yu, Yun-Xian; Wu, Yin-Yin; Zhang, Ming-Wu; Zhu, Shan-Kuan; Chen, Kun			Prevalence of Overweight and Obesity and Their Associations with Socioeconomic Status in a Rural Han Chinese Adult Population	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; ABDOMINAL OBESITY; PREVENTION; GENDER	Background: The purpose of this study is to describe the prevalence of overweight, general obesity, and abdominal obesity and examine their associations with socioeconomic status in a rural Chinese adult population. Methods: This cross-sectional study was performed on 15,236 participants >= 35 years of age (6,313 men [41.4%] and 8,923 women [58.6%]). Each participant's weight, height, waist circumference (WC), and hipline circumference (HC) were measured, and demographic and socioeconomic data were collected using questionnaires. Results: The mean body mass index (BMI) values were 23.31 +/- 2.96 and 23.89 +/- 3.23 kg m(-2) and the mean WC values were 79.13 +/- 8.43 and 79.54 +/- 8.27 cm for men and women, respectively. The age-standardized prevalence rates of overweight (BMI >= 24.0 kg m(-2)), general obesity (BMI >= 28.0 kg m(-2)), and abdominal obesity (WC >= 85 cm for men and >= 80 cm for women) were 32.0%, 6.7%, and 27.0% for men and 35.1%, 9.7%, and 48.3% for women, respectively. All gender differences were statistically significant (p < 0.001). In addition, the age-specific prevalence rates of general and abdominal obesity slowly decreased among men but sharply increased among women as age increased (p < 0.001). In subsequent logistic regression analysis, educational level was negatively associated with both general obesity and abdominal obesity among women but positively associated with abdominal obesity among men. No significant correlation was found between obesity and income. Conclusions: These results suggest a high prevalence of obesity which might differ by gender and age, and an inverse association among women and a mixed association among men noted between education and obesity in our locality. Preventive and therapeutic programs are warranted to control this serious public health problem. The gender-specific characteristics of populations at high-risk of developing obesity should be taken into consideration when designing interventional programs.	[Jin, Ming-Juan; Chen, Bing-Bing; Mao, Ying-Ying; Zhu, Yi-Min; Yu, Yun-Xian; Wu, Yin-Yin; Zhang, Ming-Wu; Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Yin-Yin] Hangzhou Normal Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ming-Wu] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shan-Kuan] Zhejiang Univ, Sch Publ Hlth, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University	Chen, K (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	Zhu, Yimin/D-6387-2017; Mao, Yingying/Q-9996-2018	Zhu, Yimin/0000-0001-8409-7636; Mao, Yingying/0000-0003-3644-9160	Ministry of Science and Technology, China [2012BAI02B03]; Natural Science Foundation of Zhejiang Province, China [LY12H26004]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Twelfth Five-Year Plan Key Projects of the Ministry of Science and Technology, China (No. 2012BAI02B03) and Natural Science Foundation of Zhejiang Province, China (No. LY12H26004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayatollahi SMT, 2010, OBES REV, V11, P335, DOI 10.1111/j.1467-789X.2010.00725.x; Booth ML, 2000, INT J OBESITY, V24, P1058, DOI 10.1038/sj.ijo.0801359; *BUR DIS MOH, 2006, GUID OV OB CONTR CHI; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Haap M, 2011, J CLIN ENDOCR METAB, V96, pE958, DOI 10.1210/jc.2010-2682; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; National Bureau of Statistics of China, 2012, CHINA STAT PRESS; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olatunbosun ST, 2011, OBES REV, V12, P233, DOI 10.1111/j.1467-789X.2010.00801.x; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; SCHWARZ PE, 2012, NAT REV ENDOCRINOL, V8, P363, DOI [DOI 10.1038/NRENDO.2011.232, DOI 10.1038/nrendo.2011.232]; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Spence-Jones Gregory, 2003, Crit Care Nurs Q, V26, P83; *UN DEV PROGR CHIN, 2010, HUM DEV REP 2010; *UN DEV PROGR CHIN, 2010, CHIN HUM DEV REP 200; WHO, 2004, LANCET, V363, P902; Yoo S, 2010, PREV MED, V51, P460, DOI 10.1016/j.ypmed.2010.10.004	33	21	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79946	10.1371/journal.pone.0079946	http://dx.doi.org/10.1371/journal.pone.0079946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224024	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400098
J	Mehling, M; Fritz, S; Hafner, P; Eichin, D; Yonekawa, T; Klimkait, T; Lindberg, RLP; Kappos, L; Hess, C				Mehling, Matthias; Fritz, Stefanie; Hafner, Patricia; Eichin, Dominik; Yonekawa, Tomomi; Klimkait, Thomas; Lindberg, Raija L. P.; Kappos, Ludwig; Hess, Christoph			Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFN beta-Therapy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; SEARCHING BEHAVIOR; NEURONS; PROTEIN; THERMOTAXIS; CHEMOTAXIS; SIMILARITY; OLFACTION	Background: Interferon-beta (IFN beta) regulates the expression of a complex set of pro-as well as anti-inflammatory genes. In cohorts of MS patients unstratified for therapeutic response to IFN beta, normal vaccine-specific immune responses have been observed. Data capturing antigen-specific immune responses in cohorts of subjects defined by response to IFN beta-therapy are not available. Objective: To assess antigen-specific immune responses in a cohort of MS patients responding clinically and radiologically to IFN beta. Methods: In 26 MS patients, clinical and MRI disease activity were assessed before and under treatment with IFN beta. Humoral and cellular immune response to influenza vaccine was prospectively characterized in these individuals, and 33 healthy controls by influenza-specific Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme Linked Immuno Spot Technique (ELISPOT). Results: Related to pre-treatment disease activity, IFN beta reduced clinical and radiological MS disease-activity. Following influenza vaccination, frequencies of influenza-specific T cells and concentrations of anti-influenza A and B IgM and IgG increased comparably in MS-patients and in healthy controls. Conclusions: By showing in a cohort of MS-patients responding to IFN beta vaccine-specific immune responses comparable to controls, this study indicates that antigen-specific immune responses can be preserved under successful IFN beta-therapy.	[Mehling, Matthias; Fritz, Stefanie; Eichin, Dominik; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Mehling, Matthias; Fritz, Stefanie; Eichin, Dominik; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, Med Outpatient Dept, CH-4031 Basel, Switzerland; [Mehling, Matthias; Hafner, Patricia; Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Mehling, Matthias; Hafner, Patricia; Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Clin Neuroimmunol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Yonekawa, Tomomi] Univ Basel Hosp, Med Image Anal Ctr, CH-4031 Basel, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Dept Biomed, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Kappos, L (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch; chess@uhbs.ch		Eichin, Dominik/0000-0002-6772-1086; Klimkait, Thomas/0000-0003-4945-6511; Mehling, Matthias/0000-0001-8599-1226	Novartis AG, Basel, Switzerland; Swiss National Science Foundation [PP00B-114850, 31003A_135677]; Swiss MS Society	Novartis AG, Basel, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society	This investigator initiated and sponsored study was supported by Novartis AG, Basel, Switzerland. C. Hess is supported by the Swiss National Science Foundation (PP00B-114850 and 31003A_135677), and L. Kappos and M. Mehling by the Swiss MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1972, HDB MATH FUNCTIONS F; Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; [Anonymous], 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/W0RMB00K.1.123.1.AVAILABLE:HTTP://WWW.W0RMB00K.0RG]; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BEUKEMA JJ, 1968, BEHAVIOUR, V31, P1, DOI 10.1163/156853968X00018; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DETHIER VG, 1957, SCIENCE, V125, P331, DOI 10.1126/science.125.3243.331; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; JANDER R, 1975, ANNU REV ECOL SYST, V6, P171, DOI 10.1146/annurev.es.06.110175.001131; JONES RE, 1977, BEHAVIOUR, V60, P236; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Li W, 2009, NATURE, V440, P684; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MCBRIDE JM, 1966, NATURE, V211, P545, DOI 10.1038/211545b0; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Priess JR, 1997, C ELEGANS; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ryu WS, 2002, J NEUROSCI, V22, P5727; Schtickzelle N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-4; Sliusarenko O, 2006, P NATL ACAD SCI USA, V103, P1534, DOI 10.1073/pnas.0507720103; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Stephens GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013914; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	51	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78532	10.1371/journal.pone.0078532	http://dx.doi.org/10.1371/journal.pone.0078532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223820	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400032
J	Bogino, P; Abod, A; Nievas, F; Giordano, W				Bogino, Pablo; Abod, Ayelen; Nievas, Fiorela; Giordano, Walter			Water-Limiting Conditions Alter the Structure and Biofilm-Forming Ability of Bacterial Multispecies Communities in the Alfalfa Rhizosphere	PLOS ONE			English	Article							PEANUT ARACHIS-HYPOGAEA; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; PSEUDOMONAS-AERUGINOSA; DESICCATION TOLERANCE; MICROBIAL COMMUNITY; SOIL TYPE; PLANT; DIVERSITY; GROWTH	Biofilms are microbial communities that adhere to biotic or abiotic surfaces and are enclosed in a protective matrix of extracellular compounds. An important advantage of the biofilm lifestyle for soil bacteria (rhizobacteria) is protection against water deprivation (desiccation or osmotic effect). The rhizosphere is a crucial microhabitat for ecological, interactive, and agricultural production processes. The composition and functions of bacterial biofilms in soil microniches are poorly understood. We studied multibacterial communities established as biofilm-like structures in the rhizosphere of Medicago sativa (alfalfa) exposed to 3 experimental conditions of water limitation. The whole biofilm-forming ability (WBFA) for rhizospheric communities exposed to desiccation was higher than that of communities exposed to saline or nonstressful conditions. A culture-dependent ribotyping analysis indicated that communities exposed to desiccation or saline conditions were more diverse than those under the nonstressful condition. 16S rRNA gene sequencing of selected strains showed that the rhizospheric communities consisted primarily of members of the Actinobacteria and alpha- and gamma-Proteobacteria, regardless of the water-limiting condition. Our findings contribute to improved understanding of the effects of environmental stress factors on plant-bacteria interaction processes and have potential application to agricultural management practices.	[Bogino, Pablo; Abod, Ayelen; Nievas, Fiorela; Giordano, Walter] Univ Nacl Rio Cuarto, Dept Biol Mol, Fac Ciencias Exactas Fis Quim & Nat, Rio Cuarto, Cordoba, Argentina	Universidad Nacional Rio Cuarto	Giordano, W (corresponding author), Univ Nacl Rio Cuarto, Dept Biol Mol, Fac Ciencias Exactas Fis Quim & Nat, Rio Cuarto, Cordoba, Argentina.	wgiordano@exa.unrc.edu.ar		Bogino, Pablo/0000-0001-7841-6119	Secretaria de Ciencia y Tecnica de la UNRC; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET); CONICET	Secretaria de Ciencia y Tecnica de la UNRC; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Secretaria de Ciencia y Tecnica de la UNRC, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET). AA and FN were supported by a fellowship from the CONICET. PB and WG are Career Members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaras B, 2012, APPL SOIL ECOL, V61, P305, DOI 10.1016/j.apsoil.2011.11.016; Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An DS, 2006, INT J SYST EVOL MICR, V56, P443, DOI 10.1099/ijs.0.63942-0; Andreote FD, 2008, ANTON LEEUW INT J G, V93, P415, DOI 10.1007/s10482-007-9219-6; ANGLE JS, 1996, SOIL BIOCH, V9, P233; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Bailly X, 2006, MOL ECOL, V15, P2719, DOI 10.1111/j.1365-294X.2006.02969.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Balzarini M., 2003, INFOGEN SOFTWARE ANA; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bhattacharya I, 2003, MICROBIOL RES, V158, P187, DOI 10.1078/0944-5013-00195; Billi D, 2000, CE MO RE ST, P181; Bogino P, 2006, ANN APPL BIOL, V148, P207, DOI 10.1111/j.1744-7348.2006.00055.x; Bogino P, 2011, EUR J SOIL BIOL, V47, P188, DOI 10.1016/j.ejsobi.2011.01.005; Bradshaw A.D., 1980, RESTORATION LAND ECO; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Burmolle M, 2006, SOIL BIOL, V8, P397; Burmolle M, 2007, MICROB ECOL, V54, P352, DOI 10.1007/s00248-007-9222-5; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; Carelli M, 2000, APPL ENVIRON MICROB, V66, P4785, DOI 10.1128/AEM.66.11.4785-4789.2000; Castellanos T, 2009, EUR J SOIL BIOL, V45, P383, DOI 10.1016/j.ejsobi.2009.07.006; Catroux G, 2001, PLANT SOIL, V230, P21, DOI 10.1023/A:1004777115628; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Conrad JC, 2012, RES MICROBIOL, V163, P619, DOI 10.1016/j.resmic.2012.10.016; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dardanelli MS, 2008, SOIL BIOL BIOCHEM, V40, P2713, DOI 10.1016/j.soilbio.2008.06.016; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Dell'Amico E, 2005, FEMS MICROBIOL ECOL, V52, P153, DOI 10.1016/j.femsec.2004.11.005; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Farina R, 2012, APPL SOIL ECOL, V55, P44, DOI 10.1016/j.apsoil.2011.12.011; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI [10.1007/978-90-481-2666-8_12, 10.1051/agro:2008021]; Farrand SK, 2002, METHOD ENZYMOL, V358, P452; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fujishige NA, 2006, BOT J LINN SOC, V150, P79, DOI 10.1111/j.1095-8339.2006.00492.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Garbeva P, 2004, FEMS MICROBIOL ECOL, V47, P51, DOI 10.1016/S0168-6496(03)00234-4; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Griffiths RI, 2003, APPL ENVIRON MICROB, V69, P6961, DOI 10.1128/AEM.69.12.6961-6968.2003; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Han LL, 2009, J MICROBIOL, V47, P287, DOI 10.1007/s12275-009-0001-5; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Henry A, 2007, J ENVIRON QUAL, V36, P904, DOI 10.2134/jeq2006.0425sc; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Jackson CR, 2003, OIKOS, V101, P444, DOI 10.1034/j.1600-0706.2003.12254.x; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Karagoz K, 2012, EUR J SOIL BIOL, V50, P144, DOI 10.1016/j.ejsobi.2012.01.007; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; LLORET J, 1995, APPL ENVIRON MICROB, V61, P3701, DOI 10.1128/AEM.61.10.3701-3704.1995; Lloret J, 1998, APPL ENVIRON MICROB, V64, P1024; Velazquez-Hernandez ML, 2011, ARCH MICROBIOL, V193, P137, DOI 10.1007/s00203-010-0651-z; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lunsdorf H, 2000, ENVIRON MICROBIOL, V2, P161; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; MERCKX R, 1987, BIOL FERT SOILS, V5, P126, DOI 10.1007/BF00257647; Nievas F, 2012, SENSORS-BASEL, V12, P2851, DOI 10.3390/s120302851; Nievas F, 2012, APPL SOIL ECOL, V53, P74, DOI 10.1016/j.apsoil.2011.11.010; Nimnoi P, 2011, ANN MICROBIOL, V61, P237, DOI 10.1007/s13213-010-0128-y; Nogueira MA, 2006, AGR ECOSYST ENVIRON, V115, P237, DOI 10.1016/j.agee.2006.01.008; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PAPENDICK RI, 1980, WATER POTENTIAL RELA, P1; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pearce D., 1995, MICROBIAL BIOFILMS, P207; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Pongsilp N, 2012, WORLD J MICROB BIOT, V28, P615, DOI 10.1007/s11274-011-0855-7; Potera C, 1996, SCIENCE, V273, P1795, DOI 10.1126/science.273.5283.1795; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Roumiantseva ML, 2002, APPL ENVIRON MICROB, V68, P4694, DOI 10.1128/AEM.68.9.4694-4697.2002; Sambrook, 1989, MOL CLONING LAB MANU, P68; Sessitsch A, 2002, CRIT REV PLANT SCI, V21, P323, DOI 10.1080/0735-260291044278; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Shi JY, 2011, INT J MOL SCI, V12, P3770, DOI 10.3390/ijms12063770; Smalla K, 2006, FEMS MICROBIOL ECOL, V56, P165, DOI 10.1111/j.1574-6941.2006.00148.x; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorroche FG, 2012, APPL ENVIRON MICROB, V78, P4092, DOI 10.1128/AEM.07826-11; Sorroche FG, 2010, CURR MICROBIOL, V61, P465, DOI 10.1007/s00284-010-9639-9; Stach JEM, 2002, ENVIRON MICROBIOL, V4, P169, DOI 10.1046/j.1462-2920.2002.00283.x; Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Torsvik V, 1996, J IND MICROBIOL, V17, P170, DOI 10.1007/BF01574690; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Ulrich A, 2006, FEMS MICROBIOL ECOL, V56, P430, DOI 10.1111/j.1574-6941.2006.00085.x; Vanderlinde EM, 2010, FEMS MICROBIOL ECOL, V71, P327, DOI 10.1111/j.1574-6941.2009.00824.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vriezen JAC, 2007, APPL ENVIRON MICROB, V73, P3451, DOI 10.1128/AEM.02991-06; Wardle DA, 1998, SOIL BIOL BIOCHEM, V30, P1627, DOI 10.1016/S0038-0717(97)00201-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Willems A, 2001, INT J SYST EVOL MICR, V51, P111, DOI 10.1099/00207713-51-1-111; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; Yang JK, 2005, SOIL BIOL BIOCHEM, V37, P141, DOI 10.1016/j.soilbio.2004.06.016; Ying YX, 2012, BIOCHEM GENET, V50, P848, DOI 10.1007/s10528-012-9525-1; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zhang F, 2010, APPL MICROBIOL BIOT, V88, P1413, DOI 10.1007/s00253-010-2841-7	124	51	53	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79614	10.1371/journal.pone.0079614	http://dx.doi.org/10.1371/journal.pone.0079614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223979	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400130
J	Branco, R; Morais, PV				Branco, Rita; Morais, Paula V.			Identification and Characterization of the Transcriptional Regulator ChrB in the Chromate Resistance Determinant of Ochrobactrum tritici 5bvl1	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENOMIC ANALYSIS; BACTERIAL; EXPRESSION; CHROMIUM; BIOTECHNOLOGY; BIOSENSORS; PROMOTER; PROTEIN; EFFLUX	Ochrobactrum tritici 5bvl1 is able to resist to high concentrations of chromate through the expression of an inducible chromate-resistant determinant, found in a mobile element (TnOtChr), which carries the genes, chrB, chrA, chrC and chrF. The regulation of chr operon present in TnOtChr, which is controlled by a transcriptional regulator, ChrB, was characterized in the current work. Fusions of chr promoter, or chr promoter and chrB gene, upstream of a gfp reporter gene, identified the most probable promoter sequence within the tnpR-chrB intergenic region. This region contains an AT-rich imperfect inverted repeat sequence, which overlaps a part of the -10 sequence. The results of the in vitro DNA-binding assays with purified ChrB (His-or no-tagged) showed that the protein binds directly to the chr promoter region. In order to identify the ChrB functional domain for sensing chromate stress and for DNA-binding, site-directed mutagenesis of ChrB was performed. Among several single amino acid mutants, three mutants (R180; R187 and H229) prevented chromate induction without any modification to the protein's stability. Interestingly, two ChrB mutants (R18 and R23) were constitutively active, regardless of chromate stress conditions, indicating that the residues most probably belong to the protein-DNA binding site. As such, the ChrB was classified as a transcriptional regulator that recognizes a specific DNA sequence, regulating the expression of a chromate resistance determinant.	[Branco, Rita; Morais, Paula V.] IMAR CMA Marine & Environm Res Ctr, Coimbra, Portugal; [Branco, Rita] Univ Coimbra, Interdisciplinary Res Inst, Coimbra, Portugal; [Morais, Paula V.] Univ Coimbra, FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Morais, PV (corresponding author), IMAR CMA Marine & Environm Res Ctr, Coimbra, Portugal.	pvmorais@ci.uc.pt	Branco, Rita/AAQ-4007-2021; Morais, Paula Vasconcelos/C-9756-2014; Branco, Rita/Q-9573-2018	Branco, Rita/0000-0003-0291-8029; Morais, Paula Vasconcelos/0000-0002-1939-6389; Branco, Rita/0000-0003-0291-8029	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/MAR/109057/2008, SFRH/BPD/48330/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (FCT) under the PTDC/MAR/109057/2008 project. Rita Branco was supported by a grant, SFRH/BPD/48330/2008, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Barajas E, 2008, FEMS MICROBIOL LETT, V285, P97, DOI 10.1111/j.1574-6968.2008.01220.x; Aguilar-Barajas E, 2012, WORLD J MICROB BIOT, V28, P865, DOI 10.1007/s11274-011-0883-3; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Branco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054005; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; CERVANTES C, 1990, J BACTERIOL, V172, P287, DOI 10.1128/JB.172.1.287-291.1990; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; He MY, 2011, J HAZARD MATER, V185, P682, DOI 10.1016/j.jhazmat.2010.09.072; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Helmann JD, 2007, MICROBIOL MONOGR, V6, P38; Henne KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-199; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobman JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-109; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; Lin Z, 2013, BIOTECHNOL IN PRESS; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Morais PV, 2011, BIOMETALS, V24, P401, DOI 10.1007/s10534-011-9446-1; NIES A, 1990, J BIOL CHEM, V265, P5648; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Pimentel BE, 2002, FEMS MICROBIOL LETT, V212, P249, DOI 10.1111/j.1574-6968.2002.tb11274.x; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Sambrook J, 2001, MOL CLONING LAB MANU; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Tecon R, 2008, SENSORS-BASEL, V8, P4062, DOI 10.3390/s8074062; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	39	18	19	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77987	10.1371/journal.pone.0077987	http://dx.doi.org/10.1371/journal.pone.0077987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223748	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400025
J	Chang, WY; Huang, A; Yang, CY; Lee, CH; Chen, YC; Wu, TY; Chen, GS				Chang, Wen-Yu; Huang, Adam; Yang, Chung-Yi; Lee, Chien-Hung; Chen, Yin-Chun; Wu, Tian-Yau; Chen, Gwo-Shing			Computer-Aided Diagnosis of Skin Lesions Using Conventional Digital Photography: A Reliability and Feasibility Study	PLOS ONE			English	Article							PULMONARY NODULES; NEURAL-NETWORK; IMAGE-ANALYSIS; GENERAL-PRACTITIONERS; MALIGNANT-MELANOMA; CT COLONOGRAPHY; CANCER; ACCURACY; FEATURES; CLASSIFICATION	Background: Computer-aided diagnosis (CADx) software that provides a second opinion has been widely used to assist physicians with various tasks. In dermatology, however, CADx has been mostly limited to melanoma or melanocytic skin cancer diagnosis. The frequency of non-melanocytic skin cancers and the accessibility of regular digital macrographs have raised interest in developing CADx for broader applications. Objectives: To investigate the feasibility of using CADx to diagnose both melanocytic and non-melanocytic skin lesions based on conventional digital photographic images. Methods: This study was approved by an institutional review board, and the requirement to obtain informed consent was waived. In total, 769 conventional photographs of melanocytic and non-melanocytic skin lesions were retrospectively reviewed and used to develop a CADx system. Conventional and new color-related image features were developed to classify the lesions as benign or malignant using support vector machines (SVMs). The performance of CADx was compared with that of dermatologists. Results: The clinicians' overall sensitivity, specificity, and accuracy were 83.33%, 85.88%, and 85.31%, respectively. New color correlation and principal component analysis (PCA) features improved the classification ability of the baseline CADx (p = 0.001). The estimated area under the receiver operating characteristic (ROC) curve (Az) of the proposed CADx system was 0.949, with a sensitivity and specificity of 85.63% and 87.65%, respectively, and a maximum accuracy of 90.64%. Conclusions: We have developed an effective CADx system to classify both melanocytic and non-melanocytic skin lesions using conventional digital macrographs. The system's performance was similar to that of dermatologists at our institute. Through improved feature extraction and SVM analysis, we found that conventional digital macrographs were feasible for providing useful information for CADx applications. The new color-related features significantly improved CADx applications for skin cancer.	[Chang, Wen-Yu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Wen-Yu] I Shou Univ, E Da Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Huang, Adam; Wu, Tian-Yau] Natl Cent Univ, Ctr Biomarkers & Translat Med, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Huang, Adam; Wu, Tian-Yau] Natl Cent Univ, Grad Inst Biomed Engn, Jhongli, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Chen, Yin-Chun] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Chen, Yin-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Gwo-Shing] Kaohsiung Med Univ, Kaohsiung Med Univ Hospital, Coll Med, Dept Dermatol, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; National Central University; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, GS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hospital, Coll Med, Dept Dermatol, Kaohsiung, Taiwan.	d700086@kmu.edu.tw	Lee, Chien-Hung/D-4437-2009; Wu, Tian-Yau/AAK-9024-2021	Lee, Chien-Hung/0000-0002-0988-264X; Wu, Tian-Yau/0000-0002-2693-3365; Huang, Adam/0000-0001-5478-2763	National Science Council of Republic of China (Taiwan) [NSC 100-2221-E-008-009, 101-2221-E-008-021, NSC 101-2911-I-008-001, NSC 99-2627-B-008-005]	National Science Council of Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council of Republic of China (Taiwan) under Grants NSC 100-2221-E-008-009, 101-2221-E-008-021, NSC 101-2911-I-008-001, and NSC 99-2627-B-008-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kadi OS, 2010, PATTERN RECOGN, V43, P2043, DOI 10.1016/j.patcog.2010.01.005; Albanese D, 2012, MLPY MACHINE LEARNIN; Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049; Binder M, 2000, MELANOMA RES, V10, P556, DOI 10.1097/00008390-200012000-00007; Blum A, 2004, BRIT J DERMATOL, V151, P1029, DOI 10.1111/j.1365-2133.2004.06210.x; Blum A, 2008, SEMIN CUTAN MED SURG, V27, P11, DOI 10.1016/j.sder.2007.12.005; Bogoni L, 2005, BRIT J RADIOL, V78, pS57, DOI 10.1259/bjr/25777270; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Burhenne LJW, 2000, RADIOLOGY, V215, P554; Burroni M, 2004, CLIN CANCER RES, V10, P1881, DOI 10.1158/1078-0432.CCR-03-0039; Christensen JH, 2010, SKIN RES TECHNOL, V16, P98, DOI 10.1111/j.1600-0846.2009.00408.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi K, 2005, BRIT J RADIOL, V78, pS3, DOI 10.1259/bjr/82933343; DURG A, 1993, IEEE ENG MED BIOL, V12, P71, DOI 10.1109/51.232345; ERCAL F, 1994, IEEE T BIO-MED ENG, V41, P837, DOI 10.1109/10.312091; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; FUJITA H, 1992, J NUCL MED, V33, P272; Gutkowicz-Krusin D, 1997, Skin Res Technol, V3, P15, DOI 10.1111/j.1600-0846.1997.tb00154.x; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrell FE, 2001, REGRESSION MODELING; Heal CF, 2008, BRIT J DERMATOL, V159, P661, DOI 10.1111/j.1365-2133.2008.08715.x; Hoffmann K, 2003, BRIT J DERMATOL, V149, P801, DOI 10.1046/j.1365-2133.2003.05547.x; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Joel G, 2002, SKIN RES TECHNOL, V8, P240, DOI 10.1034/j.1600-0846.2002.00334.x; Jolliffe, 2002, PRINCIPAL COMPONENT; Kim JS, 2005, RADIOLOGY, V236, P295, DOI 10.1148/radiol.2361041288; LeAnder R, 2010, SKIN RES TECHNOL, V16, P297, DOI 10.1111/j.1600-0846.2010.00429.x; Lessmann B, 2007, J BIOMED INFORM, V40, P631, DOI 10.1016/j.jbi.2007.06.007; Li J, 2008, MED PHYS, V35, P3527, DOI 10.1118/1.2938517; MARCHESINI R, 1992, PHOTOCHEM PHOTOBIOL, V55, P515, DOI 10.1111/j.1751-1097.1992.tb04272.x; McKenna DB, 2004, BRIT J DERMATOL, V151, P636, DOI 10.1111/j.1365-2133.2004.06065.x; Moffatt CRM, 2006, INT J DERMATOL, V45, P656, DOI 10.1111/j.1365-4632.2006.02772.x; Morton CA, 1998, BRIT J DERMATOL, V138, P283; Perrinaud A, 2007, BRIT J DERMATOL, V157, P926, DOI 10.1111/j.1365-2133.2007.08168.x; Piccolo D, 2002, BRIT J DERMATOL, V147, P481, DOI 10.1046/j.1365-2133.2002.04978.x; Qian W, 2007, ANAL QUANT CYTOL, V29, P103; R Core Team, 2021, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Rogers HW, 2012, DERMATOL SURG; Schmid-Saugeon P, 2003, COMPUT MED IMAG GRAP, V27, P65, DOI 10.1016/S0895-6111(02)00048-4; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Shiraishi J, 2007, MED PHYS, V34, P25, DOI 10.1118/1.2401044; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sinclair R, 2013, BRIT J DERMATOL, V168, P1, DOI 10.1111/bjd.12167; Sng J, 2009, J AM ACAD DERMATOL, V61, P426, DOI 10.1016/j.jaad.2009.03.031; Su May Hsu, 2003, Lincoln Laboratory Journal, V14, P145; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; Tan E, 2010, BRIT J DERMATOL, V162, P803, DOI 10.1111/j.1365-2133.2010.09673.x; Thomson MA, 2005, BRIT J DERMATOL, V153, P453, DOI 10.1111/j.1365-2133.2005.06730.x; UMBAUGH SE, 1991, IEEE ENG MED BIOL, V10, P57, DOI 10.1109/51.107171; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Wallace VP, 2000, PHYS MED BIOL, V45, P735, DOI 10.1088/0031-9155/45/3/312; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wormanns D, 2002, EUR RADIOL, V12, P1052, DOI 10.1007/s003300101126; Youl PH, 2007, CLIN EXP DERMATOL, V32, P365, DOI 10.1111/j.1365-2230.2007.02414.x; Zagrouba E., 2004, Image Analysis & Stereology, V23, P121, DOI 10.5566/ias.v23.p121-135	60	71	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e76212	10.1371/journal.pone.0076212	http://dx.doi.org/10.1371/journal.pone.0076212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223698	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400005
J	Gandini, S; De Vries, E; Tosti, G; Botteri, E; Spadola, G; Maisonneuve, P; Martinoli, C; Joosse, A; Ferrucci, PF; Baldini, F; Cocorocchio, E; Pennacchioli, E; Cataldo, F; Bazolli, B; Clerici, A; Barberis, M; Bataille, V; Testori, A				Gandini, Sara; De Vries, Esther; Tosti, Giulio; Botteri, Edoardo; Spadola, Giuseppe; Maisonneuve, Patrick; Martinoli, Chiara; Joosse, Arjen; Ferrucci, Pier Francesco; Baldini, Federica; Cocorocchio, Emilia; Pennacchioli, Elisabetta; Cataldo, Francesco; Bazolli, Barbara; Clerici, Alessandra; Barberis, Massimo; Bataille, Veronique; Testori, Alessandro			Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; VITAMIN-D SUPPLEMENTATION; RISK-FACTORS; RECALL BIAS; EXPOSURE; MORTALITY; CANCER; METAANALYSIS; SURVIVAL; SKIN	Background: Previous studies have reported an association between sun exposure and improved cutaneous melanoma (CM) survival. We analysed the association of UV exposure with prognostic factors and outcome in a large melanoma cohort. Methods: A questionnaire was given to 289 (42%) CM patients at diagnosis (Group 1) and to 402 CM patients (58%) during follow-up (Group 2). Analyses were carried out to investigate the associations between sun exposure and melanoma prognostic factors and survival. Results: Holidays in the sun two years before CM diagnosis were significantly associated with lower Breslow thickness (p=0.003), after multiple adjustment. Number of weeks of sunny holidays was also significantly and inversely associated with thickness in a dose-dependent manner (p=0.007). However when stratifying by gender this association was found only among women (p=0.0004) the risk of CM recurrence in both sexes was significantly lower in patients (n=271) who had holidays in the sun after diagnosis, after multiple adjustment including education: HR=0.30 (95% CI: 0.10-0.87; p=0.03) conclusions: Holidays in the sun were associated with thinner melanomas in women and reduced rates of relapse in both sexes. However, these results do not prove a direct causal effect of sun exposure on survival since other confounding factors, such as vitamin D serum levels and socio-economic status, may play a role. Other factors in sun seeking individuals may also possibly affect these results.	[Gandini, Sara; Botteri, Edoardo; Maisonneuve, Patrick; Bazolli, Barbara; Clerici, Alessandra] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [De Vries, Esther; Joosse, Arjen] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Tosti, Giulio; Spadola, Giuseppe; Baldini, Federica; Pennacchioli, Elisabetta; Cataldo, Francesco; Testori, Alessandro] European Inst Oncol, Div Melanoma & Muscle Cutaneous Sarcomas, Milan, Italy; [Martinoli, Chiara; Ferrucci, Pier Francesco; Cocorocchio, Emilia] European Inst Oncol, Dept Med Oncol, Milan, Italy; [Barberis, Massimo] European Inst Oncol, Dept Pathol & Lab Med, Milan, Italy; [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England	IRCCS European Institute of Oncology (IEO); Erasmus University Rotterdam; Erasmus MC; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of London; King's College London	Gandini, S (corresponding author), European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.	sara.gandini@ieo.it	de Vries, Esther/A-6603-2009; Maisonneuve, Patrick/U-9789-2018; gandini, sara/J-4916-2018; Spadola, Giuseppe/ABI-7556-2020; cocorocchio, emilia/AAN-8263-2020; Barberis, Massimo/AAL-5446-2020; Tosti, Giulio/AAR-2056-2020; Ferrucci, Pier Francesco/AAQ-9002-2020	de Vries, Esther/0000-0002-5560-2258; Maisonneuve, Patrick/0000-0002-5309-4704; gandini, sara/0000-0002-1348-4548; Spadola, Giuseppe/0000-0001-5203-9503; cocorocchio, emilia/0000-0003-1184-6426; Ferrucci, Pier Francesco/0000-0001-6255-5851; Botteri, Edoardo/0000-0002-9023-8068; tosti, giulio/0000-0001-8231-2814; martinoli, chiara/0000-0002-8173-5046; TESTORI, ALESSANDRO/0000-0003-3685-0210	Fondazione Grazia Focacci	Fondazione Grazia Focacci	The authors thank the "Fondazione Grazia Focacci" for the financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Carnevale V, 2001, OSTEOPOROSIS INT, V12, P1026, DOI 10.1007/s001980170012; Cockburn M, 2001, AM J EPIDEMIOL, V153, P1021, DOI 10.1093/aje/153.10.1021; Davies JR, 2011, CANCER CAUSE CONTROL, V22, P1471, DOI 10.1007/s10552-011-9827-3; de Vries E, 2003, INT J CANCER, V107, P119, DOI 10.1002/ijc.11360; Egan KM, 2005, JNCI-J NATL CANCER I, V97, P161, DOI 10.1093/jnci/dji047; Gambichler T, 2013, BRIT J DERMATOL, V168, P625, DOI 10.1111/j.1365-2133.2012.11212.x; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gandini S, 2009, EUR J CANCER, V45, P634, DOI 10.1016/j.ejca.2008.10.003; Grange F, 2012, ARCH DERMATOL, V148, P1370, DOI 10.1001/archdermatol.2012.2937; Guerrieri-Gonzaga A, 2013, PIGM CELL MELANOMA R, V26, P16, DOI 10.1111/pcmr.12036; HOLMAN CDJ, 1986, J NATL CANCER I, V76, P403; Idorn LW, 2013, BRIT J DERMATOL, V168, P367, DOI 10.1111/bjd.12066; Idorn LW, 2011, BRIT J DERMATOL, V165, P164, DOI 10.1111/j.1365-2133.2011.10348.x; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Mandala M, 2011, MAYO CLIN PROC, V86, P113, DOI 10.4065/mcp.2010.0671; Newton Bishop J, 2006, MELANOMA RES, V16; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Rosso S, 2008, EUR J CANCER, V44, P1275, DOI 10.1016/j.ejca.2008.03.009; Soto E, 2010, MELANOMA RES, V20, P147, DOI 10.1097/CMR.0b013e328328f802; Tryggvadottir L, 2010, ACTA ONCOL, V49, P665, DOI 10.3109/02841861003702528; Yang L, 2011, CANCER EPIDEM BIOMAR, V20, P683, DOI 10.1158/1055-9965.EPI-10-0982	27	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78820	10.1371/journal.pone.0078820	http://dx.doi.org/10.1371/journal.pone.0078820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223851	Green Published, gold			2022-12-25	WOS:000326503400089
J	Fauchais, AL; Lise, MC; Marget, P; Lapeybie, FX; Bezanahary, H; Martel, C; Dumonteil, S; Sparsa, A; Lalloue, F; Ly, K; Essig, M; Vidal, E; Jauberteau, MO				Fauchais, Anne-Laure; Lise, Marie-Claude; Marget, Pierre; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Dumonteil, Stephanie; Sparsa, Agnes; Lalloue, Fabrice; Ly, Kim; Essig, Marie; Vidal, Elisabeth; Jauberteau, Marie-Odile			Serum and Lymphocytic Neurotrophins Profiles in Systemic Lupus Erythematosus: a Case-Control Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FACTOR INHIBITS APOPTOSIS; REGULATORY T-CELLS; DISEASE-ACTIVITY; DIFFERENTIAL REGULATION; RHEUMATOID-ARTHRITIS; CIRCULATING LEVELS; GENE-EXPRESSION; B-LYMPHOCYTES; PLASMA-LEVELS	Background: Neurotrophins play a central role in the development and maintenance of the nervous system. However, neurotrophins can also modulate B and T cell proliferation and activation, especially via autocrine loops. We hypothesized that both serum and lymphocytic neurotrophin levels may be deregulated in systemic Lupus erythematosus (SLE) and may reflect clinical symptoms of the disease. Methods: Neurotrophins in the serum (ELISA tests) and lymphocytes (flow cytometry) were measured in 26 SLE patients and 26 control subjects. Th1 (interferon-gamma) and Th2 (IL-10) profiles and serum concentration of BAFF were assessed by ELISA in the SLE and control subjects. Findings: We have demonstrated that both NGF and BDNF serum levels are higher in SLE patients than healthy controls (p=0.003 and p<0.001), independently of Th1 or Th2 profiles. Enhanced serum NT-3 levels (p=0.003) were only found in severe lupus flares (i.e. SLEDAI >= 10) and significantly correlated with complement activation (decreased CH 50, Gamma=-0.28, p=0.03). Furthermore, there was a negative correlation between serum NGF levels and the number of circulating T regulatory cells (Gamma=0.48, p=0.01). In circulating B cells, production of both NGF and BDNF was greater in SLE patients than in healthy controls. In particular, the number of NGF-secreting B cells correlated with decreased complement levels (p=0.05). One month after SLE flare treatment, BDNF levels decreased; in contrast, NGF and NT-3 levels remained unchanged. Conclusion: This study demonstrates that serum and B cell levels of both NGF and BDNF are increased in SLE, suggesting that the neurotrophin production pathway is deregulated in this disease. These results must be confirmed in a larger study with naive SLE patients, in order to avoid the potential confounding influence of prior immune-modulating treatments on neurotrophin levels.	[Fauchais, Anne-Laure; Lise, Marie-Claude; Marget, Pierre; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Sparsa, Agnes; Lalloue, Fabrice; Ly, Kim; Vidal, Elisabeth; Jauberteau, Marie-Odile] Limoges Univ Hosp, Equipe Accueil 3842, Clin Immunol Lab, Fr GEIST, Limoges, France; [Fauchais, Anne-Laure; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Dumonteil, Stephanie; Ly, Kim; Vidal, Elisabeth; Jauberteau, Marie-Odile] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Sparsa, Agnes] Limoges Univ Hosp, Dept Dermatol, Limoges, France; [Essig, Marie] Limoges Univ Hosp, Dept Nephrol, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Fauchais, AL (corresponding author), Limoges Univ Hosp, Equipe Accueil 3842, Clin Immunol Lab, Fr GEIST, Limoges, France.	anne-laure.fauchais@chu-limoges.fr	Essig, Marie/ABH-1342-2021; Essig, Marie/Q-5770-2016; Ly, Kim/AAN-4092-2021	Essig, Marie/0000-0002-2030-5616; Essig, Marie/0000-0002-2030-5616; Lalloue, Fabrice/0000-0003-0382-4948; Fauchais, Anne Laure/0000-0002-0489-8570; Jauberteau, Marie-Odile/0000-0002-8811-8948; Ly, Kim Heang/0000-0002-8511-903X				Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Abram M, 2009, J IMMUNOL, V182, P4705, DOI 10.4049/jimmunol.0802814; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Antonucci MT, 2009, NEPHRON CLIN PRACT, V111, pC21, DOI 10.1159/000178819; Barouch R, 2000, J NEUROIMMUNOL, V103, P112, DOI 10.1016/S0165-5728(99)00233-7; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Bayas A, 2003, NEUROSCI LETT, V335, P155, DOI 10.1016/S0304-3940(02)01152-7; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; BracciLaudiero L, 1996, NEUROSCI LETT, V204, P13, DOI 10.1016/0304-3940(96)12304-1; BRACCILAUDIERO L, 1993, NEUROREPORT, V4, P563, DOI 10.1097/00001756-199305000-00025; Brodie C, 1996, FEBS LETT, V394, P117, DOI 10.1016/0014-5793(96)00911-8; BRODIE C, 1994, J NEUROIMMUNOL, V52, P87, DOI 10.1016/0165-5728(94)90166-X; BRODIE C, 1992, J IMMUNOL, V148, P3492; Caggiula M, 2005, SCAND J IMMUNOL, V62, P176, DOI 10.1111/j.1365-3083.2005.01649.x; Cepika AM, 2012, CELL IMMUNOL, V276, P196, DOI 10.1016/j.cellimm.2012.05.009; Chang DM, 2002, IMMUNOL INVEST, V31, P1, DOI 10.1081/IMM-120003217; Cristofaro B, 2010, ARTERIOSCL THROM VAS, V30, P1143, DOI 10.1161/ATVBAHA.109.205468; Dagnell C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-156; Del Porto F, 2006, ANN NY ACAD SCI, V1069, P438, DOI 10.1196/annals.1351.042; di Mola FF, 2000, GUT, V46, P670, DOI 10.1136/gut.46.5.670; Dolff S, 2007, SCAND J IMMUNOL, V66, P584, DOI 10.1111/j.1365-3083.2007.02008.x; Falcini F, 1996, ANN RHEUM DIS, V55, P745, DOI 10.1136/ard.55.10.745; Falcini F, 1996, J RHEUMATOL, V23, P1798; Fauchais A, 2008, J IMMUNOL; Fauchais AL, 2009, SCAND J RHEUMATOL, V38, P50, DOI 10.1080/03009740802378832; Gomez D, 2004, SEMIN ARTHRITIS RHEU, V33, P404, DOI 10.1016/j.semarthrit.2003.11.002; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Hikawa S, 2002, HISTOCHEM CELL BIOL, V118, P51, DOI 10.1007/s00418-002-0426-y; Ikenouchi A, 2006, PROG NEURO-PSYCHOPH, V30, P1359, DOI 10.1016/j.pnpbp.2006.03.006; Ikenouchi-Sugita Atsuko, 2008, Neuropsychiatr Dis Treat, V4, P1277; Ikenouchi-Sugita A, 2010, WORLD J BIOL PSYCHIA, V11, P121, DOI 10.3109/15622970903521131; Ishii H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.106; JockersScherubl MC, 1996, LANCET, V347, P982, DOI 10.1016/S0140-6736(96)91476-2; Kalinowska-Lyszczarz A, 2011, J NEUROIMMUNOL, V240, P109, DOI 10.1016/j.jneuroim.2011.10.002; Kemi C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-18; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KIMATA H, 1991, EUR J IMMUNOL, V21, P137, DOI 10.1002/eji.1830210121; Kuhn A, 2009, ARCH DERMATOL RES, V301, P71, DOI 10.1007/s00403-008-0891-9; Lindquist S, 2011, MULT SCLER J, V17, P851, DOI 10.1177/1352458511399797; Lisak RP, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-30; Lise MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013918; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; MANNING PT, 1985, BRAIN RES, V340, P61, DOI 10.1016/0006-8993(85)90773-5; Matucci-Cerinic M, 2001, ANN RHEUM DIS, V60, P487, DOI 10.1136/ard.60.5.487; Miret C, 2001, ANTICANCER RES, V21, P3053; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Noga O, 2007, CLIN EXP ALLERGY, V37, P1701, DOI 10.1111/j.1365-2222.2007.02832.x; Ola MS, 2013, CELL MOL NEUROBIOL, V33, P359, DOI 10.1007/s10571-012-9901-8; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Ricci A, 2005, SARCOIDOSIS VASC DIF, V22, P186; Rihl M, 2005, ANN RHEUM DIS, V64, P1542, DOI 10.1136/ard.2004.032599; SANTAMBROGIO L, 1994, J IMMUNOL, V153, P4488; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Seidel MF, 2010, SEMIN ARTHRITIS RHEU, V40, P109, DOI 10.1016/j.semarthrit.2009.03.002; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Steinkamp M, 2012, MED SCI MONITOR, V18, pBR117, DOI 10.12659/MSM.882612; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THORPE LW, 1987, J NEUROSCI RES, V18, P134, DOI 10.1002/jnr.490180120; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Urshansky N, 2010, J NEUROL SCI, V295, P31, DOI 10.1016/j.jns.2010.05.019; Villoslada P, 2000, J EXP MED, V191, P1799, DOI 10.1084/jem.191.10.1799; Walz JC, 2009, J PSYCHIATR RES, V43, P721, DOI 10.1016/j.jpsychires.2008.10.005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003; Yanagida M, 1996, LIFE SCI, V59, P2075, DOI 10.1016/S0024-3205(96)00561-9; Yang ZF, 2006, ONCOL REP, V16, P1237; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79414	10.1371/journal.pone.0079414	http://dx.doi.org/10.1371/journal.pone.0079414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223945	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300083
J	Feinberg-Gorenshtein, G; Guedj, A; Shichrur, K; Jeison, M; Luria, D; Kodman, Y; Ash, S; Feinmesser, M; Edry, L; Shomron, N; Weizman, A; Yaniv, I; Avigad, S				Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Jeison, Marta; Luria, Drorit; Kodman, Yona; Ash, Shifra; Feinmesser, Meora; Edry, Liat; Shomron, Noam; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar			miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; CANCER-PATIENTS; DIFFERENTIATION; ADENOCARCINOMA; METASTASIS; PROGNOSIS; APOPTOSIS; SURVIVAL; MIRNAS	Neuroblastoma (NB) arises from the embryonic neural crest and is the most common extracranial solid tumor in children under 5 years of age. Reduced expression of Dicer1 has recently been shown to be in correlation with poor prognosis in NB patients. This study aimed to investigate the mechanisms that could lead to the down-regulation of Dicer1 in neuroblastoma. We used computational prediction to identify potential miRs down-regulating Dicer1 in neuroblastoma. One of the miRs that were predicted to target Dicer1 was miR-192. We measured the levels of miR-192 in 43 primary tumors using real time PCR. Following the silencing of miR-192, the levels of dicer1 cell viability, cell proliferation and migration capability were analyzed. Multivariate analysis identified miR-192 as an independent prognostic marker for relapse in neuroblastoma patients (p=0.04). We were able to show through a dual luciferase assay and side-directed mutational analysis that miR-192 directly binds the 3' UTR of Dicer1 on positions 1232-1238 and 2282-2288. An increase in cell viability, proliferation and migration rates were evident in NB cells transfected with miR-192-mimic. Yet, there was a significant decrease in proliferation when NB cells were transfected with an miR-192-inhibitor We suggest that miR-192 might be a key player in NB by regulating Dicer1 expression.	[Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar] Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Ash, Shifra; Feinmesser, Meora; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Jeison, Marta; Luria, Drorit; Kodman, Yona; Ash, Shifra; Yaniv, Isaac; Avigad, Smadar] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Feinmesser, Meora] Rabin Med Ctr, Inst Pathol, Petah Tiqwa, Israel; [Edry, Liat; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Avigad, S (corresponding author), Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	savigad@post.tau.ac.il	Weizman, Abraham/AAK-6450-2020	Weizman, Abraham/0000-0002-9765-8938	Rina Zaizov Memorial Fund	Rina Zaizov Memorial Fund	This work was supported by the Rina Zaizov Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin H, 2010, J MOL DIAGN, V12, P771, DOI 10.2353/jmoldx.2010.090169; Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mayr D, 2009, HISTOPATHOLOGY, V55, P716, DOI 10.1111/j.1365-2559.2009.03427.x; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187	25	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78713	10.1371/journal.pone.0078713	http://dx.doi.org/10.1371/journal.pone.0078713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223844	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300031
J	Buiting, HM; Terpstra, W; Dalhuisen, F; Gunnink-Boonstra, N; Sonke, GS; den Hartogh, G				Buiting, Hilde M.; Terpstra, Wim; Dalhuisen, Floriske; Gunnink-Boonstra, Nicolette; Sonke, Gabe S.; den Hartogh, Govert			The Facilitating Role of Chemotherapy in the Palliative Phase of Cancer: Qualitative Interviews with Advanced Cancer Patients	PLOS ONE			English	Article							SHARED DECISION-MAKING; OF-LIFE CARE; BREAST-CANCER; HEALTH-CARE; END; AGGRESSIVENESS; COMMUNICATION; PERSPECTIVES; DISCUSSIONS; PROGNOSIS	Objective: To explore the extent to which patients have a directing role in decisions about chemotherapy in the palliative phase of cancer and (want to) anticipate on the last stage of life. Design: Qualitative interview study. Methods: In depth-interviews with 15 patients with advanced colorectal or breast cancer at the medical oncology department in a Dutch teaching hospital; interviews were analysed following the principles of thematic content-analysis. Results: All patients reported to know that the chemotherapy they received was with palliative intent. Most of them did not express the wish for information about (other) treatment options and put great trust in their physicians' treatment advice. The more patients were aware of the severity of their disease, the more they seemed to 'live their life' in the present and enjoy things besides having cancer. Such living in the present seemed to be facilitated by the use of chemotherapy. Patients often considered the 'chemotherapy-free period' more stressful than periods when receiving chemotherapy despite their generally improved physical condition. Chemotherapy (regardless of side-effects) seemed to shift patients' attention away from the approaching last stage of life. Interestingly, although patients often discussed advance care planning, they were reluctant to bring on end-of-life issues that bothered them at that specific moment. Expressing real interest in people 'as a person' was considered an important element of appropriate care. Conclusions: Fearing their approaching death, patients deliberately focus on living in the present. Active (chemotherapy) treatment facilitates this focus, regardless of the perceived side-effects. However, if anxiety for what lies ahead is the underlying reason for treatment, efforts should be made in assisting patients to find other ways to cope with this fear. Simultaneously, such an approach may reduce the use of burdensome and sometimes costly treatment in the last stage of life.	[Buiting, Hilde M.; Dalhuisen, Floriske; Sonke, Gabe S.] Comprehens Canc Ctr Netherlands, Dept Registry & Res, Utrecht, Netherlands; [Buiting, Hilde M.; den Hartogh, Govert] Univ Amsterdam, Dept Philosophy, Amsterdam, Netherlands; [Terpstra, Wim; Gunnink-Boonstra, Nicolette] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Sonke, Gabe S.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	University of Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Netherlands Cancer Institute	Buiting, HM (corresponding author), Comprehens Canc Ctr Netherlands, Dept Registry & Res, Utrecht, Netherlands.	h.buiting@iknl.nl		Sonke, Gabe/0000-0001-8088-9628	ZonMw, The Netherlands Organization for Health Research and Development [70-71300-98-048]; Comprehensive Cancer Centre The Netherlands	ZonMw, The Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Comprehensive Cancer Centre The Netherlands	This study was supported by a grant from ZonMw, The Netherlands Organization for Health Research and Development. Grant number: 70-71300-98-048. The study was further supported by the Comprehensive Cancer Centre The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Balboni T, 2011, CANCER-AM CANCER SOC, V117, P5383, DOI 10.1002/cncr.26221; Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Bensing J, 2013, PATIENT EDUC COUNS, V90, P287, DOI 10.1016/j.pec.2013.01.005; Buiting HM, 2011, J PAIN SYMPTOM MANAG, V42, P32, DOI 10.1016/j.jpainsymman.2010.10.260; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Buiting HM, 2011, PALLIATIVE MED, V25, P83, DOI 10.1177/0269216310382589; Cardoso F, 2002, ANN ONCOL, V13, P197, DOI 10.1093/annonc/mdf101; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Clayton JM, 2007, J CLIN ONCOL, V25, P715, DOI 10.1200/JCO.2006.06.7827; Clayton JM, 2013, PALLIATIVE MED, V27, P236, DOI 10.1177/0269216312449683; de Kort S, 2009, THESIS; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Grant L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4859; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hughes-Davies T, 2013, NEW ENGL J MED, V368, P480, DOI 10.1056/NEJMc1214249; Kiely BE, 2011, J CLIN ONCOL, V29, P456, DOI 10.1200/JCO.2010.30.2174; Mack JW, 2012, J CLIN ONCOL, V30, P2715, DOI 10.1200/JCO.2012.42.4564; Mack JW, 2012, ANN INTERN MED, V156, P204, DOI 10.7326/0003-4819-156-3-201202070-00008; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Nappa U, 2011, ANN ONCOL, V22, P2375, DOI 10.1093/annonc/mdq778; Oostendorp LJM, 2011, LANCET ONCOL, V12, P1053, DOI 10.1016/S1470-2045(11)70045-6; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie J, 2007, QUALITATIVE RES PRAC, P336; Schuette W, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-14; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; SULMASY DP, 1994, J MED ETHICS, V20, P218, DOI 10.1136/jme.20.4.218; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; van Laarhoven HWM, 2011, J PAIN SYMPTOM MANAG, V41, P1048, DOI 10.1016/j.jpainsymman.2010.08.015; van Vliet L, 2013, PATIENT EDUC COUNS, V90, P315, DOI 10.1016/j.pec.2011.03.021; Walczak A, 2013, PATIENT EDUC COUNS, V90, P307, DOI 10.1016/j.pec.2011.08.009; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	40	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77959	10.1371/journal.pone.0077959	http://dx.doi.org/10.1371/journal.pone.0077959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223130	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200022
J	Loewen, MA; Irmis, RB; Sertich, JJW; Currie, PJ; Sampson, SD				Loewen, Mark A.; Irmis, Randall B.; Sertich, Joseph J. W.; Currie, Philip J.; Sampson, Scott D.			Tyrant Dinosaur Evolution Tracks the Rise and Fall of Late Cretaceous Oceans	PLOS ONE			English	Article							CRANIAL OSTEOLOGY; UTAH IMPLICATIONS; GEOGRAPHIC RANGE; THEROPOD; ORIGIN	The Late Cretaceous (similar to 95-66 million years ago) western North American landmass of Laramidia displayed heightened non-marine vertebrate diversity and intracontinental regionalism relative to other latest Cretaceous Laurasian ecosystems. Processes generating these patterns during this interval remain poorly understood despite their presumed role in the diversification of many clades. Tyrannosauridae, a clade of large-bodied theropod dinosaurs restricted to the Late Cretaceous of Laramidia and Asia, represents an ideal group for investigating Laramidian patterns of evolution. We use new tyrannosaurid discoveries from Utah-including a new taxon which represents the geologically oldest member of the clade-to investigate the evolution and biogeography of Tyrannosauridae. These data suggest a Laramidian origin for Tyrannosauridae, and implicate sea-level related controls in the isolation, diversification, and dispersal of this and many other Late Cretaceous vertebrate clades.	[Loewen, Mark A.; Irmis, Randall B.; Sampson, Scott D.] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA; [Loewen, Mark A.; Irmis, Randall B.; Sampson, Scott D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Sertich, Joseph J. W.; Sampson, Scott D.] Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alberta	Loewen, MA (corresponding author), Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA.	mloewen@nhmu.utah.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	National Science Foundation [EAR 0745454]; Bureau of Land Management; Natural History Museum of Utah	National Science Foundation(National Science Foundation (NSF)); Bureau of Land Management; Natural History Museum of Utah	Fieldwork and research were funded by the National Science Foundation (EAR 0745454), the Bureau of Land Management, and the Natural History Museum of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Edwards AWF, 1992, LIKELIHOOD; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Hutchison J. Howard, 2013, P295; Irmis Randall B., 2013, P424; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Kauffman E.G., 1977, Mountain Geologist, V14, P75; Kirschbaum M. A., 1995, US GEOLOGICAL SURVEY, V1561, P1; Lehman Thomas M., 1997, P223; Li D, 2009, P ROY SOC LOND B BIO, V277, P183; Liu Yongqing, 2011, Dixue Qianyuan, V18, P9; Lyson TR, 2009, J PALEONTOL, V83, P833, DOI 10.1666/09-035.1; Maddison WP, 2011, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; O'Leary MA, 2008, MORPHOBANK 2 5 WEB A; Osborn HF, 1906, B AM MUS NAT HIST, V22, P281; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Padian Kevin, 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P379; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts Eric M., 2013, P85; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Thomson TJ, 2013, CRETACEOUS RES, V43, P70, DOI 10.1016/j.cretres.2013.02.006; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; VONHUENE F, 1914, ANIMALIA FOSSILIUM C, V4, P1; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Walker J.D., 2012, GEOLOGIC TIME SCALE, DOI [10.1130/2012.CTS004R3C, DOI 10.1130/2012.CTS004R3C]; Webb L, 1981, DESERET NEWS    0903; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5	66	90	96	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79420	10.1371/journal.pone.0079420	http://dx.doi.org/10.1371/journal.pone.0079420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223179	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200071
J	Yonekura, K; Watanabe, M; Kageyama, Y; Hirata, K; Yamamoto, M; Maki-Yonekura, S				Yonekura, Koji; Watanabe, Masahiro; Kageyama, Yuko; Hirata, Kunio; Yamamoto, Masaki; Maki-Yonekura, Saori			Post-Transcriptional Regulator Hfq Binds Catalase HPII: Crystal Structure of the Complex	PLOS ONE			English	Article							RNA CHAPERONE HFQ; SM-LIKE PROTEINS; ESCHERICHIA-COLI; MOLECULAR-GRAPHICS; FLAGELLAR MOTOR; RPOS; TRANSCRIPTION; TRANSLATION; IDENTIFICATION; SEQUENCE	We report a crystal structure of Hfq and catalase HPII from Escherichia coli. The post-transcriptional regulator Hfq plays a key role in the survival of bacteria under stress. A small non-coding RNA (sRNA) DsrA is required for translation of the stationary phase sigma factor RpoS, which is the central regulator of the general stress response. Hfq facilitates efficient translation of rpoS mRNA, which encodes RpoS. Hfq helps in the function of other specific proteins involved in RNA processing, indicating its versatility in the cell. However, structural information regarding its interactions with partners is missing. Here we obtained crystals of Hfq and HPII complexes from cell lysates following attempts to overexpress a foreign membrane protein. HPII is one of two catalases in E. coli and its mRNA is transcribed by an RNA polymerase holoenzyme containing RpoS, which in turn is under positive control of small non-coding RNAs and of the RNA chaperone Hfq. This sigma factor is known to have a pronounced effect on the expression of HPII. The crystal structure reveals that a Hfq hexamer binds each subunit of a HPII tetramer. Each subunit of the Hfq hexamer exhibits a unique binding mode with HPII. The hexamer of Hfq interacts via its distal surface. The proximal and distal surfaces are known to specifically bind different sRNAs, and binding of HPII could affect Hfq function. Hfq-HPII complexation has no effect on catalase HPII activity.	[Yonekura, Koji; Watanabe, Masahiro; Kageyama, Yuko] RIKEN, SPring Ctr 8, Biostruct Mech Lab, Sayo, Hyogo, Japan; [Maki-Yonekura, Saori] RIKEN, SPring Ctr 8, Biospecimen Platform Grp, Sayo, Hyogo, Japan; [Hirata, Kunio; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Res Infrastruct Grp, Sayo, Hyogo, Japan	RIKEN; RIKEN; RIKEN	Yonekura, K (corresponding author), RIKEN, SPring Ctr 8, Biostruct Mech Lab, Sayo, Hyogo, Japan.	yone@spring8.or.jp	YONEKURA, Koji/N-5060-2015; Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768; Yonekura, Koji/0000-0001-5520-4391; Watanabe, Masahiro/0000-0001-5211-1333	Ministry of Education, Culture, Sports, Science and Technology of JAPAN [20370064, 24657111]	Ministry of Education, Culture, Sports, Science and Technology of JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grant-in-aid No. 20370064 and 24657111 by the Ministry of Education, Culture, Sports, Science and Technology of JAPAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Beich-Frandsen M, 2011, ACTA CRYSTALLOGR F, V67, P536, DOI 10.1107/S174430911100786X; Bravo J, 1999, PROTEINS, V34, P155, DOI 10.1002/(SICI)1097-0134(19990201)34:2<155::AID-PROT1>3.0.CO;2-P; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Li Yi, 2007, J Biomol Tech, V18, P185; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; LOEWEN PC, 1984, J BACTERIOL, V160, P668, DOI 10.1128/JB.160.2.668-675.1984; LOEWEN PC, 1986, BIOCHEM CELL BIOL, V64, P638, DOI 10.1139/o86-088; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Melik-Adamyan W, 2001, PROTEINS, V44, P270, DOI 10.1002/prot.1092; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Mulvey MR, 1989, NUCL ACIDS RES, V17, P9979; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Scofield DG, 2008, MOL BIOL EVOL, V25, P2255, DOI 10.1093/molbev/msn175; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vassilieva IM, 2002, MOL BIOL+, V36, P785, DOI 10.1023/A:1021621623503; Vincent HA, 2012, J MOL BIOL, V420, P56, DOI 10.1016/j.jmb.2012.03.028; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang WW, 2011, GENE DEV, V25, P2106, DOI 10.1101/gad.16746011; Yonekura K, 2006, J MOL BIOL, V357, P73, DOI 10.1016/j.jmb.2005.12.041; Yonekura K, 2011, J BACTERIOL, V193, P3863, DOI 10.1128/JB.05021-11	41	5	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78216	10.1371/journal.pone.0078216	http://dx.doi.org/10.1371/journal.pone.0078216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223139	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200031
J	Mui, LWH; Chan, AYS; Lee, A; Lee, J				Mui, Lancelot W. H.; Chan, Alvin Y. S.; Lee, Albert; Lee, John			Cross-Sectional Study on Attitudes among General Practitioners towards Pneumococcal Vaccination for Middle-Aged and Elderly Population in Hong Kong	PLOS ONE			English	Article							PHARMACEUTICAL-INDUSTRY; CLINICAL EFFECTIVENESS; MYOCARDIAL-INFARCTION; HEALTH-PROMOTION; OLDER-PEOPLE; BARRIERS; RISK; AUSTRALIA; KNOWLEDGE; COVERAGE	Objective: To study the attitudes among general practitioners towards pneumococcal vaccination for middle-aged (50-64) and elderly population (over 65) in Hong Kong and the factors affecting their decision to advise pneumococcal vaccination for those age groups. Design: Cross-sectional study of general practitioners in private practice in Hong Kong. Participants: Members of Hong Kong Medical Association delivering general practice services in private sector. Measuring Tool: Self-administered questionnaire. Main Outcome Measures: Intention to recommend pneumococcal vaccination, barriers against pneumococcal vaccination. Results: 53.4% of the respondents would actively recommend pneumococcal vaccination to elderly patients but only 18.8% would recommend for middle-aged patients. Consultation not related to pneumococcal vaccine was the main reason for not recommending pneumococcal vaccine (43.6%). Rarity of pneumonia in their daily practice was another reason with 68.4% of respondents attending five or less patients with pneumonia each year. In multivariate analysis, factors such as respondents would get vaccination when reaching age 50 (ORm 10.1), and attending 6 pneumonia cases or more per year (ORm 2.28) were found to be associated with increasing likelihood for recommending vaccination to the middle-aged. While concerns of marketing a product (ORm 0.41), consultation not related to vaccination (ORm 0.45) and limited time (ORm 0.38) were factors that reduced the likelihood. Conclusion: Public policy is needed to increase the awareness of impact of pneumococcal pneumonia and the availability of preventive measures.	[Mui, Lancelot W. H.; Lee, Albert; Lee, John] Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Alvin Y. S.] Hong Kong Med Assoc, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lee, A (corresponding author), Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	alee@cuhk.edu.hk			Hong Kong Medical Association Health Education Fund	Hong Kong Medical Association Health Education Fund	This project is supported by The Hong Kong Medical Association Health Education Fund. The Hong Kong Medical Association Task Force on Vaccination PPI is involved in the design of the questionnaire and assisted in data collection.	Achhra A, 2009, AUST FAM PHYSICIAN, V38, P605; Allender S, 2012, HEALTH PROMOT INT, V27, P261, DOI 10.1093/heapro/dar018; Andrews RM, 2005, VACCINE, V23, P2756, DOI 10.1016/j.vaccine.2004.11.039; Andrews RM, 2004, VACCINE, V23, P132, DOI 10.1016/j.vaccine.2004.06.016; Badertscher N, 2012, INT J GEN MED, V5, P967, DOI 10.2147/IJGM.S38472; Bovier PA, 2001, VACCINE, V19, P4760, DOI 10.1016/S0264-410X(01)00223-7; Breen KJ, 2004, MED J AUSTRALIA, V180, P409, DOI 10.5694/j.1326-5377.2004.tb05994.x; Brotons C, 2005, PREV MED, V40, P595, DOI 10.1016/j.ypmed.2004.07.020; Department of Health, 2012, PNEUM; Department of Health, 2011, PNEUM INF; Department of Health, 2012, HLTH FACTS HONG KONG; Forrest J M, 2000, Commun Dis Intell, V24, P89; Halsey NA, 2007, CLIN INFECT DIS, V44, pE104, DOI 10.1086/519541; Holt T, 2010, RADCLIFFE SERIES, P87; Immunisation Program, 2009, GUID IMM PRACT LOC G; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Keating KM, 2008, J ADOLESCENT HEALTH, V43, pS61, DOI 10.1016/j.jadohealth.2008.06.015; Komesaroff PA, 2002, MED J AUSTRALIA, V176, P118, DOI 10.5694/j.1326-5377.2002.tb04318.x; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Lee A, 2012, 50 ANN MULT C; Lee Albert, 2007, J Urban Health, V84, pi75; Lee Albert, 2010, Hong Kong Medical Journal, V16, P106; Lo YY., 2010, HK PRACT, V32, P17; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Nori A, 2009, AUST FAM PHYSICIAN, V38, P891; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Ridda I, 2008, VACCINE, V26, P5633, DOI 10.1016/j.vaccine.2008.07.070; Ridda I, 2009, VACCINE, V27, P3775, DOI 10.1016/j.vaccine.2009.03.075; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; Scottish Executive, 2003, PNEUM VACC PEOPL AG; Sharp Merck, 2012, PNEUM 23; Thornton H, 2010, J EPIDEMIOL COMMUN H, V64, P101, DOI 10.1136/jech.2009.090829; van Achterberg T, 2011, HEALTH PROMOT INT, V26, P148, DOI 10.1093/heapro/daq050; Vila-Corcoles A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-222; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Wyeth Pharmaceuticals Inc, 2012, PREVN 13; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112; Zimmerman RK, 2003, VACCINE, V21, P1510, DOI 10.1016/S0264-410X(02)00698-9	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78210	10.1371/journal.pone.0078210	http://dx.doi.org/10.1371/journal.pone.0078210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223775	Green Submitted, gold, Green Published			2022-12-25	WOS:000326597400019
J	Shah, SM; Carey, IM; Harris, T; DeWilde, S; Victor, CR; Cook, DG				Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Victor, Christina R.; Cook, Derek G.			Initiation of Psychotropic Medication after Partner Bereavement: A Matched Cohort Study	PLOS ONE			English	Article							OLDER-PEOPLE; HEALTH; DSM-5; DEPRESSION; VALIDATION; EXCLUSION; DATABASE	Background: Recent changes to diagnostic criteria for depression in DSM-5 remove the bereavement exclusion, allowing earlier diagnosis following bereavement. Evaluation of the potential effect of this change requires an understanding of existing psychotropic medication prescribing by non-specialists after bereavement. Aims: To describe initiation of psychotropic medication in the first year after partner bereavement. Methods: In a UK primary care database, we identified 21,122 individuals aged 60 and over with partner bereavement and no psychotropic drug use in the previous year. Prescribing (anxiolytic/hypnotic, antidepressant, antipsychotic) after bereavement was compared to age, sex and practice matched controls. Results: The risks of receiving a new psychotropic prescription within two and twelve months of bereavement were 9.5% (95% CI 9.1 to 9.9%) and 17.9% (17.3 to 18.4%) respectively; an excess risk of initiation in the first year of 12.4% compared to non-bereaved controls. Anxiolytic/hypnotic and antidepressant initiation rates were highest in the first two months. In this period, the hazard ratio for initiation of anxiolytics/hypnotics was 16.7 (95% CI 14.7 to 18.9) and for antidepressants was 5.6 (4.7 to 6.7) compared to non-bereaved controls. 13.3% of those started on anxiolytics/hypnotics within two months continued to receive this drug class at one year. The marked variation in background family practice prescribing of anxiolytics/hypnotics was the strongest determinant of their initiation in the first two months after bereavement. Conclusion: Almost one in five older people received a new psychotropic drug prescription in the year after bereavement. The early increase and trend in antidepressant use after bereavement suggests some clinicians did not adhere to the bereavement exclusion, with implications for its recent removal in DSM-5. Family practice variation in use of anxiolytics/hypnotics suggests uncertainty over their role in bereavement with the potential for inappropriate long term use.	[Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Victor, Christina R.] Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England	St Georges University London; Brunel University	Shah, SM (corresponding author), St Georges Univ London, Div Populat Hlth Sci & Educ, London, England.	sushah@sgul.ac.uk	Carey, Iain/O-6973-2014; Cook, Derek G/C-3271-2008	Carey, Iain/0000-0003-1099-8460; Cook, Derek/0000-0002-9723-5759; Harris, Tess/0000-0002-8671-1553; Victor, Christina/0000-0002-4213-3974; DeWilde, Stephen/0000-0002-4238-4474	Dunhill Medical Trust [R169/0710]; The Dunhill Medical Trust [R169/0710] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported by The Dunhill Medical Trust (grant number R169/0710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourke Alison, 2004, Inform Prim Care, V12, P171; Brown Gary, 2010, Health Stat Q, P58, DOI 10.1057/hsq.2010.21; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook JM, 2007, ARCH INTERN MED, V167, P2006, DOI 10.1001/archinte.167.18.2006; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Editorial, 2012, LANCET, V379, P589; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Forte Amanda L, 2004, BMC Palliat Care, V3, P3, DOI 10.1186/1472-684X-3-3; Fosbol EL, 2013, EUR HEART J, V34, P649, DOI 10.1093/eurheartj/ehs242; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Illich I., 1976, MED NEMESIS EXPROPRI; Joint Formulary Committee, 2012, BRIT NATL FORMULARY; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Mojtabai R, 2011, ARCH GEN PSYCHIAT, V68, P920, DOI 10.1001/archgenpsychiatry.2011.95; Moller J, 2011, AGING MENT HEALTH, V15, P259, DOI 10.1080/13607863.2010.513041; National Institute for Health and Clinical Excellence, 2009, DEPR AD TREATM MAN D; Shah SM, 2013, AM J PUBLIC HEALTH, V103, P1140, DOI 10.2105/AJPH.2012.301050; Shah SM, 2012, AM J EPIDEMIOL, V176, P689, DOI 10.1093/aje/kws162; Shah SM, 2010, AGE AGEING, V39, P617, DOI 10.1093/ageing/afq086; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; TOWNSEND P, 1998, HLTH DEPRIVATION INE; Wakefield JC, 2012, WORLD PSYCHIATRY, V11, P3, DOI 10.1016/j.wpsyc.2012.01.002; Warner J, 2001, BRIT J PSYCHIAT, V178, P36, DOI 10.1192/bjp.178.1.36; Zisook S, 2007, PSYCHOL MED, V37, P779, DOI 10.1017/S0033291707009865; Zisook S, 2012, DEPRESS ANXIETY, V29, P425, DOI 10.1002/da.21927	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77734	10.1371/journal.pone.0077734	http://dx.doi.org/10.1371/journal.pone.0077734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223722	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400011
J	Vaugeois, M; Diaz, F; Carlotti, F				Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois			A Mechanistic Individual-Based Model of the Feeding Processes for Oikopleura dioica	PLOS ONE			English	Article							FUNCTIONAL-RESPONSE; GRAZING IMPACT; APPENDICULARIAN; TUNICATA; FOOD; HOUSE; SIZE; VANHOEFFENI; WATERS; PARTICLES	A mechanistic physiological model of the appendicularian Oikopleura dioica has been built to represent its three feeding processes (filtration, ingestion and assimilation). The mathematical formulation of these processes is based on laboratory observations from the literature, and tests different hypotheses. This model accounts for house formation dynamics, the food storage capacity of the house and the gut throughput dynamics. The half-saturation coefficient for ingestion resulting from model simulations is approximately 28 mu gCl(-1) and is independent of the weight of the organism. The maximum food intake for ingestion is also a property of the model and depends on the weight of the organism. Both are in accordance with data from the literature. The model also provides a realistic representation of carbon accumulation within the house. The modelled half-saturation coefficient for assimilation is approximately 15 mu gCl(-1) and is also independent of the weight of the organism. Modelled gut throughput dynamics are based on faecal pellet formation by gut compaction. Model outputs showed that below a food concentration of 30 mu gCl(-1), the faecal pellet weight should represent a lower proportion of the body weight of the organism, meaning that the faecal pellet formation is not driven by gut filling. Simulations using fluctuating environmental food availability show that food depletion is not immediately experienced by the organism but that it occurs after a lag time because of house and gut buffering abilities. This lag time duration lasts at least 30 minutes and can reach more than 2 hours, depending on when the food depletion occurs during the house lifespan.	[Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois] Aix Marseille Univ, French Natl Ctr Sci Research, INSU, IRD,Mediterranean Inst Oceanog,UM 110, Marseille, France; [Vaugeois, Maxime; Diaz, Frederic; Carlotti, Francois] Univ Toulon & Var, CNRS, INSU, IRD,Mediterranean Inst Oceanog,UM 110, La Garde, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon	Vaugeois, M (corresponding author), Aix Marseille Univ, French Natl Ctr Sci Research, INSU, IRD,Mediterranean Inst Oceanog,UM 110, Marseille, France.	maxime.vaugeois@univ-amu.fr	Vaugeois, Maxime/ABD-6118-2020	Vaugeois, Maxime/0000-0002-3599-4506; Diaz, Frederic/0000-0002-2456-6733	Ministere de l'Education Nationale, de la Recherche et de la Technologie	Ministere de l'Education Nationale, de la Recherche et de la Technologie	MV is financed by a Ministere de l'Education Nationale, de la Recherche et de la Technologie Ph.D. grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna JL, 2000, LIMNOL OCEANOGR, V45, P608, DOI 10.4319/lo.2000.45.3.0608; ALLDREDGE AL, 1976, LIMNOL OCEANOGR, V21, P14, DOI 10.4319/lo.1976.21.1.0014; ALLDREDGE AL, 1981, LIMNOL OCEANOGR, V26, P247, DOI 10.4319/lo.1981.26.2.0247; BEDO AW, 1993, B MAR SCI, V53, P2; BELISLE CJP, 1992, J APPL PROBAB, V29, P885, DOI 10.2307/3214721; Berline L, 2011, J PLANKTON RES, V33, P855, DOI 10.1093/plankt/fbq163; Bochdansky AB, 1999, LIMNOL OCEANOGR, V44, P415, DOI 10.4319/lo.1999.44.2.0415; Broms F, 2003, J PLANKTON RES, V25, P573, DOI 10.1093/plankt/25.5.573; Burighel P, 2001, INVERTEBR BIOL, V120, P278, DOI 10.1111/j.1744-7410.2001.tb00038.x; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Capitanio FL, 2005, J APPL ICHTHYOL, V21, P414, DOI 10.1111/j.1439-0426.2005.00657.x; Cima F, 2002, MAR BIOL, V141, P479, DOI 10.1007/s00227-002-0850-5; Dagg MJ, 2004, RESPONSE MARINE ECOS, P293; Deibel, 2004, RESPONSE MARINE ECOS, P309; Deibel D., 1998, P139; DEIBEL D, 1992, MAR ECOL PROG SER, V88, P297, DOI 10.3354/meps088297; DEIBEL D, 1988, MAR BIOL, V99, P177, DOI 10.1007/BF00391979; Fenaux R., 1985, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V29, P291; FENAUX R, 1985, B MAR SCI, V37, P498; Fenaux R., 1998, P251; FENAUX R, 1986, ZOOMORPHOLOGY, V106, P224, DOI 10.1007/BF00312043; FENAUX R, 1979, ANN I OCEANOGR PARIS, V55, P195; Fernandez D, 2004, MAR ECOL PROG SER, V266, P89, DOI 10.3354/meps266089; Flood Per R., 1998, P105; Gorsky G., 1998, P161; Hansen JLS, 1996, MAR ECOL PROG SER, V141, P205, DOI 10.3354/meps141205; King KR, 1980, MAR BIOL, V27, P886; Lombard F, 2006, THESIS U PARIS 6, P6; Lombard F, 2010, DEEP-SEA RES PT I, V57, P1304, DOI 10.1016/j.dsr.2010.06.008; Lombard F, 2009, J MARINE SYST, V78, P606, DOI 10.1016/j.jmarsys.2009.01.004; Lombard F, 2009, J MARINE SYST, V78, P617, DOI 10.1016/j.jmarsys.2009.01.005; Lopez-Urrutia A, 2003, MAR ECOL PROG SER, V252, P125, DOI 10.3354/meps252125; Lopez-Urrutia A, 2003, MAR ECOL PROG SER, V252, P143, DOI 10.3354/meps252143; Lopez-Urrutia A, 1999, MAR ECOL PROG SER, V191, P195, DOI 10.3354/meps191195; PAFFENHOFER GA, 1973, MAR BIOL, V22, P183, DOI 10.1007/BF00391782; PURCELL J.E., 2004, RESPONSE MARINE ECOS, P359; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Sato R, 2001, J PLANKTON RES, V23, P415, DOI 10.1093/plankt/23.4.415; Selander E, 2003, MAR BIOL, V142, P263, DOI 10.1007/s00227-002-0949-8; Tiselius P, 2003, MAR BIOL, V142, P253, DOI 10.1007/s00227-002-0961-z; Touratier F, 2003, MAR ECOL PROG SER, V248, P141, DOI 10.3354/meps248141; Troedsson C, 2005, MAR ECOL PROG SER, V289, P165, DOI 10.3354/meps289165; Troedsson C, 2007, LIMNOL OCEANOGR, V52, P416, DOI 10.4319/lo.2007.52.1.0416; UYE S, 1995, J EXP MAR BIOL ECOL, V189, P1, DOI 10.1016/0022-0981(95)00004-B	44	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78255	10.1371/journal.pone.0078255	http://dx.doi.org/10.1371/journal.pone.0078255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223782	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400020
J	Leung, K; Elmes, MW; Glaser, ST; Deutsch, DG; Kaczocha, M				Leung, KwanNok; Elmes, Matthew W.; Glaser, Sherrye T.; Deutsch, Dale G.; Kaczocha, Martin			Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; PERIAQUEDUCTAL GRAY; BINDING PROTEINS; CLEARANCE SYSTEM; CB1 RECEPTOR; LOCALIZATION; IDENTIFICATION; ANALGESIA; SITES; CELLS	The endocannabinoid system modulates numerous physiological processes including nociception and reproduction. Anandamide (AEA) is an endocannabinoid that is inactivated by cellular uptake followed by intracellular hydrolysis by fatty acid amide hydrolase (FAAH). Recently, FAAH-like anandamide transporter (FLAT), a truncated and catalytically-inactive variant of FAAH, was proposed to function as an intracellular AEA carrier and mediate its delivery to FAAH for hydrolysis. Pharmacological inhibition of FLAT potentiated AEA signaling and produced antinociceptive effects. Given that endocannabinoids produce analgesia through central and peripheral mechanisms, the goal of the current work was to examine the expression of FLAT in the central and peripheral nervous systems. In contrast to the original report characterizing FLAT, expression of FLAT was not observed in any of the tissues examined. To investigate the role of FLAT as a putative AEA binding protein, FLAT was generated from FAAH using polymerase chain reaction and further analyzed. Despite its low cellular expression, FLAT displayed residual catalytic activity that was sensitive to FAAH inhibitors and abolished following mutation of its catalytic serine. Overexpression of FLAT potentiated AEA cellular uptake and this appeared to be dependent upon its catalytic activity. Immunofluorescence revealed that FLAT localizes primarily to intracellular membranes and does not contact the plasma membrane, suggesting that its capability to potentiate AEA uptake may stem from its enzymatic rather than transport activity. Collectively, our data demonstrate that FLAT does not serve as a global intracellular AEA carrier, although a role in mediating localized AEA inactivation in mammalian tissues cannot be ruled out.	[Leung, KwanNok; Elmes, Matthew W.; Deutsch, Dale G.; Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY USA; [Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu		Kaczocha, Martin/0000-0002-2527-1398	NIH [DA032232, DA021806, DA026953, DA016419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016419, K01DA021806, R21DA032232, R21DA026953, R01DA035923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA032232, DA021806, DA026953, and DA016419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Bouskila J, 2012, NEUROSCIENCE, V202, P117, DOI 10.1016/j.neuroscience.2011.11.041; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, ACS CHEM NEUROSCI, V3, P364, DOI 10.1021/cn300001w; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KAWAHARA H, 2010, BRIT J PHARMACOL, V163, P1214, DOI DOI 10.1111/11476-5381.2010.01157.X; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Lichtman AH, 1996, J PHARMACOL EXP THER, V276, P585; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Suplita RL, 2005, NEUROPHARMACOLOGY, V49, P1201, DOI 10.1016/j.neuropharm.2005.07.007; Tachikawa M, 2012, J PHARMACOL EXP THER, V343, P608, DOI 10.1124/jpet.112.197012; Tachikawa M, 2012, J NEUROCHEM, V123, P750, DOI 10.1111/jnc.12018; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yazulla S, 1999, J COMP NEUROL, V415, P80, DOI 10.1002/(SICI)1096-9861(19991206)415:1<80::AID-CNE6>3.0.CO;2-H	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79355	10.1371/journal.pone.0079355	http://dx.doi.org/10.1371/journal.pone.0079355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223930	gold, Green Published			2022-12-25	WOS:000326503400107
J	Okubo, N; Minami, Y; Fujiwara, H; Umemura, Y; Tsuchiya, Y; Shirai, T; Oda, R; Inokawa, H; Kubo, T; Yagita, K				Okubo, Naoki; Minami, Yoichi; Fujiwara, Hiroyoshi; Umemura, Yasuhiro; Tsuchiya, Yoshiki; Shirai, Toshiharu; Oda, Ryo; Inokawa, Hitoshi; Kubo, Toshikazu; Yagita, Kazuhiro			Prolonged Bioluminescence Monitoring in Mouse Ex Vivo Bone Culture Revealed Persistent Circadian Rhythms in Articular Cartilages and Growth Plates	PLOS ONE			English	Article							GENE-EXPRESSION; PARATHYROID-HORMONE; CLOCK; TRANSCRIPTION; OSCILLATORS; RESORPTION	The bone is a metabolically active organ which undergoes repeated remodeling cycles of bone resorption and formation. In this study, we revealed a robust and extremely long-lasting circadian rhythm in ex vivo culture maintained for over six months from the femoral bone of a PERIOD2(Luciferase) mouse. Furthermore, we also identified robust circadian clocks in flat bones. High- or low-magnification real-time bioluminescence microscopic imaging revealed that the robust circadian rhythms emanated from the articular cartilage and the epiphyseal cartilage within the growth plate of juvenile animals. Stimulation by forskolin or dexamethasone treatment caused type 0 phase resetting, indicating canonical entraining properties of the bone clock. Together, our findings from long-term ex vivo culture revealed that "tissue-autonomous'' circadian rhythm in the articular cartilage and the growth plate of femoral bone functions for several months even in an organ culture condition, and provided a useful in vitro assay system investigating the role of the biological clock in bone formation or development.	[Okubo, Naoki; Minami, Yoichi; Umemura, Yasuhiro; Tsuchiya, Yoshiki; Inokawa, Hitoshi; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan; [Okubo, Naoki; Fujiwara, Hiroyoshi; Shirai, Toshiharu; Oda, Ryo; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan; [Okubo, Naoki; Minami, Yoichi; Kubo, Toshikazu; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Musculoskeletal Chronobiol, Kyoto, Japan; [Shirai, Toshiharu] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Yagita, Kazuhiro] Japan Sci & Technol Agcy, PREST, Saitama, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kanazawa University; Japan Science & Technology Agency (JST)	Yagita, K (corresponding author), Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan.	kyagita@koto.kpu-m.ac.jp		Okubo, Naoki/0000-0001-9405-8462	PRESTO Program of the Japan Science and Technology Agency; JSPS KAKENHI [23390051, 25861335]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23390051] Funding Source: KAKEN	PRESTO Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by PRESTO Program of the Japan Science and Technology Agency (K.Y.), and by JSPS KAKENHI Grant Number 23390051 (K.Y.) and 25861335 (Y.M.). This work was also supported by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2000, GENE DEV, V14, P645; Aoshima H, 1998, BONE, V22, P73, DOI 10.1016/S8756-3282(97)00225-1; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; El-Hajj Fuleihan G, 1997, J CLIN ENDOCR METAB, V82, P281, DOI 10.1210/jc.82.1.281; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Ju HSJ, 1997, CLIN CHEM, V43, P1570; JUBIZ W, 1972, J CLIN INVEST, V51, P2040, DOI 10.1172/JCI107010; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Komoto S, 2012, CHRONOBIOL INT, V29, P66, DOI 10.3109/07420528.2011.636496; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lui JC, 2011, ENDOCR DEV, V20, P187, DOI 10.1159/000321244; Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Smith BJ, 2011, OSTEOPOROSIS INT, V22, P1633, DOI 10.1007/s00198-010-1325-z; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Swaminathan R, 2001, CLIN CHIM ACTA, V313, P95, DOI 10.1016/S0009-8981(01)00656-8; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047692; Vergely N, 2002, BONE, V30, P428, DOI 10.1016/S8756-3282(01)00677-9; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	38	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78306	10.1371/journal.pone.0078306	http://dx.doi.org/10.1371/journal.pone.0078306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223788	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400049
J	Oliveira-Sales, EB; Maquigussa, E; Semedo, P; Pereira, LG; Ferreira, VM; Camara, NO; Bergamaschi, CT; Campos, RR; Boim, MA				Oliveira-Sales, Elizabeth B.; Maquigussa, Edgar; Semedo, Patricia; Pereira, Luciana G.; Ferreira, Vanessa M.; Camara, Niels O.; Bergamaschi, Cassia T.; Campos, Ruy R.; Boim, Mirian A.			Mesenchymal Stem Cells (MSC) Prevented the Progression of Renovascular Hypertension, Improved Renal Function and Architecture	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ACUTE KIDNEY INJURY; OXIDATIVE STRESS; WATER CHANNELS; BLOOD-PRESSURE; RATS; MECHANISMS; EXPRESSION; 2-KIDNEY; THERAPY	Renovascular hypertension induced by 2 Kidney-1 Clip (2K-1C) is a renin-angiotensin-system (RAS)-dependent model, leading to renal vascular rarefaction and renal failure. RAS inhibitors are not able to reduce arterial pressure (AP) and/or preserve the renal function, and thus, alternative therapies are needed. Three weeks after left renal artery occlusion, fluorescently tagged mesenchymal stem cells (MSC) (2x10(5) cells/animal) were injected weekly into the tail vein in 2K-1C hypertensive rats. Flow cytometry showed labeled MSC in the cortex and medulla of the clipped kidney. MSC prevented a further increase in the AP, significantly reduced proteinuria and decreased sympathetic hyperactivity in 2K-1C rats. Renal function parameters were unchanged, except for an increase in urinary volume observed in 2K-1C rats, which was not corrected by MSC. The treatment improved the morphology and decreased the fibrotic areas in the clipped kidney and also significantly reduced renal vascular rarefaction typical of 2K-1C model. Expression levels of IL-1 beta, TNF-alpha angiotensinogen, ACE, and Ang II receptor AT(1) were elevated, whereas AT(2) levels were decreased in the medulla of the clipped kidney. MSC normalized these expression levels. In conclusion, MSC therapy in the 2K-1C model (i) prevented the progressive increase of AP, (ii) improved renal morphology and microvascular rarefaction, (iii) reduced fibrosis, proteinuria and inflammatory cytokines, (iv) suppressed the intrarenal RAS, iv) decreased sympathetic hyperactivity in anesthetized animals and v) MSC were detected at the CNS suggesting that the cells crossed the blood-brain barrier. This therapy may be a promising strategy to treat renovascular hypertension and its renal consequences in the near future.	[Oliveira-Sales, Elizabeth B.; Maquigussa, Edgar; Semedo, Patricia; Pereira, Luciana G.; Ferreira, Vanessa M.; Boim, Mirian A.] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Bergamaschi, Cassia T.; Campos, Ruy R.] Univ Fed Sao Paulo, Div Cardiovasc, Dept Physiol, Sao Paulo, Brazil; [Camara, Niels O.] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	mirian@nefro.epm.br	Campos, Ruy R/H-8339-2017; Bergamaschi, Cassia/AAZ-9441-2020; Boim, Mirian A/L-6574-2013; Semedo-Kuriki, Patricia/D-2429-2010; Maquigussa, Edgar/G-7685-2016; Oliveira-Sales, Elizabeth B/B-5895-2014; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Campos, Ruy R R/I-3691-2015	Campos, Ruy R/0000-0002-9404-0817; Oliveira-Sales, Elizabeth B/0000-0003-4129-8643; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Campos, Ruy R R/0000-0002-9404-0817; Maquigussa, Edgar/0000-0003-1756-1579; Bergamaschi, Cassia/0000-0002-5741-6993; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Coordenacao de Aperfeicoamento de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Coordenacao de Aperfeicoamento de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from the Coordenacao de Aperfeicoamento de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli LS, 2012, CAN J PHYSIOL PHARM, V90, P307, DOI [10.1139/Y11-130, 10.1139/y11-130]; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Braga LMGD, 2008, CLIN EXP PHARMACOL P, V35, P113, DOI 10.1111/j.1440-1681.2007.04820.x; Chade AR, 2006, FASEB J, V20, P1706, DOI 10.1096/fj.05-5680fje; Chade AR, 2010, STEM CELLS, V28, P1039, DOI 10.1002/stem.426; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Chade AR, 2003, ARTERIOSCL THROM VAS, V23, P1295, DOI 10.1161/01.ATV.0000077477.40824.52; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Glover LE, 2012, TRANSL STROKE RES, V3, P90, DOI 10.1007/s12975-011-0127-8; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Lee J, 2001, J KOREAN MED SCI, V16, P462, DOI 10.3346/jkms.2001.16.4.462; Lerman LO, 2005, J LAB CLIN MED, V146, P160, DOI 10.1016/j.lab.2005.05.005; Luan Y, 2012, AM J MED SCI, V343, P402, DOI 10.1097/MAJ.0b013e31822dc5d3; Ma SK, 2009, KIDNEY BLOOD PRESS R, V32, P411, DOI 10.1159/000264232; Maclean S., 2012, STEM CELLS INT, V2012; Mitchell Kenneth D., 1995, P1437; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Navar LG, 1998, NEWS PHYSIOL SCI, V13, P170; Oliveira-Sales EB, 2008, AM J HYPERTENS, V21, P98, DOI 10.1038/ajh.2007.12; Oliveira-Sales EB, 2010, HYPERTENSION, V56, P290, DOI 10.1161/HYPERTENSIONAHA.110.150425; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; Ploth DW, 1983, AM J PHYSIOL, V245, P131; Prieto-Carrasquero MC, 2008, HYPERTENSION, V51, P1590, DOI 10.1161/HYPERTENSIONAHA.108.110916; RABITO SF, 1981, HYPERTENSION, V3, P34, DOI 10.1161/01.HYP.3.1.34; Semedo P, 2010, LAB INVEST, V90, P685, DOI 10.1038/labinvest.2010.45; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Yerram P, 2012, MINERVA UROL NEFROL, V64, P63; Zhu XY, 2004, ARTERIOSCL THROM VAS, V24, P1854, DOI 10.1161/01.ATV.0000142443.52606.81	34	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78464	10.1371/journal.pone.0078464	http://dx.doi.org/10.1371/journal.pone.0078464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223811	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400064
J	Butcher, J; Stintzi, A				Butcher, James; Stintzi, Alain			The Transcriptional Landscape of Campylobacter jejuni under Iron Replete and Iron Limited Growth Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; HELICOBACTER-PYLORI; OXIDATIVE STRESS; GENOME SEQUENCE; REGULATOR FUR; RNA-SEQ; COLONIZATION; IDENTIFICATION; REGULON; NCTC11168	The genome-wide Campylobacter jejuni transcriptional response under iron replete and iron limited conditions was characterized using RNA-seq. We have identified 111 novel C. jejuni 5'UTRs and mapped 377 co-transcribed genes into 230 transcriptional operons. In contrast to previous microarray results, the C. jejuni iron stimulon is less extensive than previously believed and consists of 77 iron activated genes and 50 iron repressed genes. As anticipated, the iron repressed genes are primarily those involved in iron acquisition or oxidative stress defense. Interestingly, these experiments have revealed that iron is an important modulator of flagellar biogenesis with almost all the components of the flagella found to be iron activated. Given that motility is a well-known C. jejuni colonization factor, this suggests that there is an important regulatory coupling of flagellar biogenesis and iron level in C. jejuni. In addition we have identified several consensus mutations in the C. jejuni NCTC11168 strain that are widespread in the Campylobacter research community and which may explain conflicting phenotypic reports for this strain. Comparative analysis of iron responsive genes with the known Fur regulon indicates that many iron responsive genes are not Fur responsive; suggesting that additional iron regulatory factors remain to be characterized in C. jejuni. Further analysis of the RNA-seq data identified multiple novel transcripts including 19 potential ncRNAs. The expression of selected ncRNAs was confirmed and quantified with qRT-PCR. The qRT-PCR results indicate that several of these novel transcripts are either Fur and/or iron responsive. The fact that several of these ncRNAs are iron responsive or Fur regulated suggests that they may perform regulatory roles in iron homeostasis.	[Butcher, James; Stintzi, Alain] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Stintzi, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	astintzi@uottawa.ca	Butcher, James/AAC-8339-2020	Butcher, James/0000-0002-7050-1834	CIHR (MOP) [84224]; CIHR-Banting graduate scholarship	CIHR (MOP)(Canadian Institutes of Health Research (CIHR)); CIHR-Banting graduate scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR (MOP#84224) to A. S. and a CIHR-Banting graduate scholarship to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IH, 2002, MICROBIOL-SGM, V148, P1203, DOI 10.1099/00221287-148-4-1203; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Butcher J, 2012, P NATL ACAD SCI USA; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Butcher J, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P167; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; CHAN VL, 1991, GENE, V101, P51, DOI 10.1016/0378-1119(91)90223-X; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Gaasbeek EJ, 2009, J BACTERIOL, V191, P3785, DOI 10.1128/JB.01817-08; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Grabowska AD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-166; Guccione E, 2010, ENVIRON MICROBIOL, V12, P576, DOI 10.1111/j.1462-2920.2009.02096.x; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; John A, 2011, RES MICROBIOL, V162, P410, DOI 10.1016/j.resmic.2011.02.004; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kamal N, 2007, MICROBIOL-SGM, V153, P3099, DOI 10.1099/mic.0.2007/007401-0; KONKEL ME, 1994, GENE, V146, P83, DOI 10.1016/0378-1119(94)90837-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miles S, 2010, INFECT IMMUN, V78, P3073, DOI 10.1128/IAI.00190-10; Miller CE, 2008, J BACTERIOL, V190, P1900, DOI 10.1128/JB.01761-07; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; van Vliet AHM, 2000, FEMS MICROBIOL LETT, V188, P115, DOI 10.1016/S0378-1097(00)00222-6; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Verhoeff-Bakkenes L, 2008, LETT APPL MICROBIOL, V46, P377, DOI 10.1111/j.1472-765X.2008.02326.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yamasaki M, 2004, FEMS MICROBIOL LETT, V235, P57, DOI 10.1016/j.femsle.2004.04.012	53	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79475	10.1371/journal.pone.0079475	http://dx.doi.org/10.1371/journal.pone.0079475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223952	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300086
J	Lorente, E; Barriga, A; Johnstone, C; Mir, C; Jimenez, M; Lopez, D				Lorente, Elena; Barriga, Alejandro; Johnstone, Carolina; Mir, Carmen; Jimenez, Mercedes; Lopez, Daniel			Concerted In Vitro Trimming of Viral HLA-B27-Restricted Ligands by Human ERAP1 and ERAP2 Aminopeptidases	PLOS ONE			English	Article							VIRUS-INFECTED CELLS; CD8(+) T-LYMPHOCYTES; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; MOLECULES; PEPTIDES; OXYTOCINASE; MULTIPLE; EPITOPES; ER	In the classical human leukocyte antigen (HLA) class I antigen processing and presentation pathway, the antigenic peptides are generated from viral proteins by multiple proteolytic cleavages of the proteasome (and in some cases other cytosolic proteases) and transported to the endoplasmic reticulum (ER) lumen where they are exposed to aminopeptidase activity. In human cells, two different ER-resident enzymes, ERAP1 and ERAP2, can trim the N-terminally extended residues of peptide precursors. In this study, the possible cooperative effect of generating five naturally processed HLA-B27 ligands by both proteases was analyzed. We identified differences in the products obtained with increased detection of natural HLA-B27 ligands by comparing double versus single enzyme digestions by mass spectrometry analysis. These in vitro data suggest that each enzyme can use the degradation products of the other as a substrate for new N-terminal trimming, indicating concerted aminoproteolytic activity of ERAP 1 and ERAP2.	[Lorente, Elena; Barriga, Alejandro; Johnstone, Carolina; Mir, Carmen; Jimenez, Mercedes; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	dlopez@isciii.es	Johnstone, Carolina/K-9907-2014; López, Daniel/I-2632-2014; Lorente, Elena/B-1219-2019	Johnstone, Carolina/0000-0002-4966-6212; López, Daniel/0000-0003-0268-5878; Lorente, Elena/0000-0002-2246-6851; Barriga, Alejandro/0000-0001-6357-1917	Ministerio de Ciencia e Innovacion	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants to D. L. from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Infantes S, 2010, J IMMUNOL, V184, P3351, DOI 10.4049/jimmunol.0901560; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	19	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79596	10.1371/journal.pone.0079596	http://dx.doi.org/10.1371/journal.pone.0079596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223975	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300092
J	Szmydynger-Chodobska, J; Gandy, JR; Varone, A; Shan, RZ; Chodobski, A				Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam			Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury	PLOS ONE			English	Article							CHOROID-PLEXUS; VASOPRESSIN V-1A; V-2 RECEPTORS; EXPRESSION; DAMAGE; MICE; INFILTRATION; TISSUE; CELLS; RATS	Several lines of evidence indicate that the blood-cerebrospinal fluid barrier (BCSFB), which primarily resides in the choroid plexus (CP), plays a significant pathophysiological role not only in neuroinflammatory diseases, such as multiple sclerosis, but also in traumatic brain injury (TBI). Here we investigated how arginine vasopressin (AVP) regulates function of the BCSFB in the context of post-traumatic neuroinflammation. It has previously been shown that AVP exacerbates various forms of brain injury, but the mechanisms underlying this AVP action are poorly understood. Type 1A AVP receptor is highly expressed on the CP epithelium and the CP synthesizes AVP. Using the controlled cortical impact model of TBI, we demonstrated decreased post-traumatic production of proinflammatory mediators by the CP and reduced influx of inflammatory cells across the BCSFB in AVP-deficient Brattleboro rats when compared with Long-Evans rats, a parental strain for Brattleboro rats. Arginine vasopressin was also found to play an important role in post-traumatic activation of c-Jun Nterminal kinase (JNK) in the CP. In the CP epithelial cell cultures, AVP augmented the tumor necrosis factor-alpha- and interleukin-1 beta-dependent increase in synthesis of proinflammatory mediators, including neutrophil chemoattractants, an action largely dependent on the JNK signaling pathway. Under in vivo conditions, a selective JNK inhibitor decreased the post-traumatic production of neutrophil chemoattractants by the CP and reduced the influx of neutrophils across the BCSFB. These results provide evidence for the synergistic interactions between proinflammatory cytokines and AVP, a ligand for G protein-coupled receptors, and support a pathophysiological role of AVP in post-traumatic neuroinflammation.	[Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam] Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Brown University	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIH [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; Armstead WM, 2001, STROKE, V32, P1408, DOI 10.1161/01.STR.32.6.1408; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Chodobski A, 2013, VASCULAR ME IN PRESS; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; NAKAGAWA H, 1994, BIOCHEM J, V301, P545, DOI 10.1042/bj3010545; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	30	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79328	10.1371/journal.pone.0079328	http://dx.doi.org/10.1371/journal.pone.0079328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223928	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300075
J	Zhang, YW; Chen, YM; Liu, Y; Zhao, YJ; Liao, FF; Xu, HX				Zhang, Yun-Wu; Chen, Yaomin; Liu, Yun; Zhao, Yingjun; Liao, Francesca-Fang; Xu, Huaxi			APP Regulates NGF Receptor Trafficking and NGF-Mediated Neuronal Differentiation and Survival	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; INTRACELLULAR TRAFFICKING; TAU PHOSPHORYLATION; PC12 CELLS; EXPRESSION; KINASE	beta-amyloid precursor protein (APP) is a key factor in Alzheimer's disease (AD) but its physiological function is largely undetermined. APP has been found to regulate retrograde transport of nerve growth factor (NGF), which plays a crucial role in mediating neuronal survival and differentiation. Herein, we reveal the mechanism underlying APP-mediated NGF trafficking, by demonstrating a direct interaction between APP and the two NGF receptors, TrkA and p75NTR. Downregulation of APP leads to reduced cell surface levels of TrkA/p75NTR and increased endocytosis of TrkA/p75NTR and NGF. In addition, APP-deficient cells manifest defects in neurite outgrowth and are more susceptible to A beta-induced neuronal death at physiological levels of NGF. However, APP-deficient cells show better responses to NGF-stimulated differentiation and survival than control cells. This may be attributed to increased receptor endocytosis and enhanced activation of Akt and MAPK upon NGF stimulation in APP-deficient cells. Together, our results suggest that APP mediates endocytosis of NGF receptors through direct interaction, thereby regulating endocytosis of NGF and NGF-induced downstream signaling pathways for neuronal survival and differentiation.	[Zhang, Yun-Wu; Zhao, Yingjun] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China; [Zhang, Yun-Wu; Zhao, Yingjun] Xiamen Univ, Coll Med, Inst Neurosci, Xiamen, Peoples R China; [Zhang, Yun-Wu; Chen, Yaomin; Liu, Yun; Zhao, Yingjun; Xu, Huaxi] Sanford Burnham Med Res Inst, Neurodegenerat Dis Res Program, La Jolla, CA USA; [Liao, Francesca-Fang] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN USA	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; University of Tennessee System; University of Tennessee Health Science Center	Zhang, YW (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	yunzhang@xmu.edu.cn; xuh@sanfordburnham.org	Xu, Huaxi/AAV-7177-2021; Chen, Yaomin/H-5205-2013; Zhao, Yingjun/G-9173-2016	Zhang, Yun-wu/0000-0002-7152-7630; Zhao, Yingjun/0000-0003-2832-6590	National Institutes of Health [R01AG038710, R01AG021173, R01AG044420, R01NS046673, R01AG031893, R21AG041934, R21NS083908]; Alzheimer's Association; National Natural Science Foundation of China [81225008, 81161120496]; Fundamental Research Funds for the Central Universities of China; Fok Ying Tung Education Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044420, R01AG021173, R21AG041934, R01AG038710, R01AG031893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institutes of Health (R01AG038710, R01AG021173, R01AG044420, R01NS046673, R01AG031893, R21AG041934 and R21NS083908), the Alzheimer's Association, National Natural Science Foundation of China (81225008 and 81161120496), the Fundamental Research Funds for the Central Universities of China, and Fok Ying Tung Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; Binnington JC, 2007, J NEUROCHEM, V101, P422, DOI 10.1111/j.1471-4159.2006.04378.x; Cabeza C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-11; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Capsoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037555; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Cuello AC, 2007, CURR ALZHEIMER RES, V4, P351, DOI 10.2174/156720507781788774; Cuello AC, 2007, NEUROCHEM RES, V32, P1041, DOI 10.1007/s11064-006-9270-0; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; FUKUYAMA R, 1993, MOL BRAIN RES, V17, P17, DOI 10.1016/0169-328X(93)90067-Y; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Liu Y, 2009, J BIOL CHEM, V284, P12145, DOI 10.1074/jbc.M808497200; Matrone C, 2013, BIOESSAYS, V35, P847, DOI 10.1002/bies.201300041; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang X, 2006, FASEB J, V20, P1272, DOI 10.1096/fj.06-5721fje; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	39	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80571	10.1371/journal.pone.0080571	http://dx.doi.org/10.1371/journal.pone.0080571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224055	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300098
J	Igarashi, S; Izuchi, S; Ogawa, Y; Yoshimathu, M; Takizawa, K; Nakajima, Y; Tanaka, M; Ishizuka, B; Suzuki, N				Igarashi, Suguru; Izuchi, Shinichirou; Ogawa, Yukihisa; Yoshimathu, Misako; Takizawa, Kenji; Nakajima, Yasuo; Tanaka, Mamoru; Ishizuka, Bunpei; Suzuki, Nao			N-Butyl Cyanoacrylate Is Very Effective for Massive Haemorrhage during the Perinatal Period	PLOS ONE			English	Article							UTERINE ARTERY EMBOLIZATION; POSTPARTUM HEMORRHAGE; PREGNANCY; NECROSIS	Objective: The liquid embolic agent n-butyl cyanoacrylate (NBCA) is a tissue adhesive used as an immediate and permanent embolic agent when mixed with oil-based contrast medium. In this study, the preservation of fertility with TAE using NBCA for massive haemorrhage during pregnancy or the peripartum period and the utility of this therapy were investigated. Methods: Cases from January 2005 to October 2010 in which TAE was performed for massive haemorrhage in pregnant women, particularly during the peripartum period, were investigated. Results: TAE was performed in 27 pregnant women. The embolic agent used was GS only in five cases, NBCA only in 19 cases, and additional embolization with NBCA when the effect with GS was insufficient in three cases, one each of abruptio placentae, cervical pregnancy, and uterine atony. A comparison of mean blood loss when each embolic agent was used for haemostasis showed a significant difference between cases in which GS only was used and cases in which NBCA only was used. In a comparison of mean transfusion volume, a significant difference was seen between cases in which both GS and NBCA were used and cases in which NBCA only was used. In a postoperative follow-up survey, menses resumed in eight patients, including four patients who later became pregnant and three who delivered. Conclusions: TAE with NBCA, which has an embolic effect unrelated to clotting dysfunction for massive haemorrhage during the peripartum period, is a minimally invasive and very effective treatment method for patients with severe DIC.	[Igarashi, Suguru; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet, Kawasaki, Kanagawa, Japan; [Igarashi, Suguru; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Gynecol, Kawasaki, Kanagawa, Japan; [Izuchi, Shinichirou] Rose Ladies Clin, Tokyo, Japan; [Ogawa, Yukihisa; Yoshimathu, Misako; Takizawa, Kenji; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Ishizuka, Bunpei] St Marianna Univ, Sch Med, Dept Adv Reprod Med, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University; Saint Marianna University	Igarashi, S (corresponding author), St Marianna Univ, Sch Med, Dept Obstet, Kawasaki, Kanagawa, Japan.	iganosuke-10@marianna-u.ac.jp						Badawy SZA, 2001, CLIN IMAG, V25, P288, DOI 10.1016/S0899-7071(01)00307-2; BROWN BJ, 1979, OBSTET GYNECOL, V54, P361; Cheng Yung-Yi, 2003, J Chin Med Assoc, V66, P727; Igarashi S, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.04.081; Ornan D, 2003, OBSTET GYNECOL, V102, P904, DOI 10.1016/S0029-7844(03)00769-5; Pelage JP, 1998, RADIOLOGY, V208, P359, DOI 10.1148/radiology.208.2.9680559; Pirard C, 2002, FERTIL STERIL, V78, P412, DOI 10.1016/S0015-0282(02)03229-6; Porcu G, 2005, BJOG-INT J OBSTET GY, V112, P122, DOI 10.1111/j.1471-0528.2005.00306.x; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; SCHWARTZ P E, 1975, Gynecologic Oncology, V3, P276, DOI 10.1016/0090-8258(75)90035-9; StancatoPasik A, 1997, RADIOLOGY, V204, P791, DOI 10.1148/radiology.204.3.9280261; Tourne G, 2003, EUR J OBSTET GYN R B, V110, P29, DOI 10.1016/S0301-2115(03)00091-5; Tsai CC, 2006, INT J GYNECOL CANCER, V16, P439, DOI 10.1111/j.1525-1438.2006.00238.x; YAMASHITA Y, 1994, BRIT J RADIOL, V67, P530, DOI 10.1259/0007-1285-67-798-530	14	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77494	10.1371/journal.pone.0077494	http://dx.doi.org/10.1371/journal.pone.0077494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24223099	gold, Green Published, Green Submitted			2022-12-25	WOS:000325819400121
J	Boivin, B; Chaudhary, F; Dickinson, BC; Haque, A; Pero, SC; Chang, CJ; Tonks, NK				Boivin, Benoit; Chaudhary, Fauzia; Dickinson, Bryan C.; Haque, Aftabul; Pero, Stephanie C.; Chang, Christopher J.; Tonks, Nicholas K.			Receptor Protein-tyrosine Phosphatase alpha Regulates Focal Adhesion Kinase Phosphorylation and ErbB2 Oncoprotein-mediated Mammary Epithelial Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Motility; Oncogene; Phosphatase; Phosphorylation; Protein Kinases; ErbB2; FAK; PTP; Dephosphorylation	ENDOTHELIAL GROWTH-FACTOR; HUMAN BREAST-CANCER; SRC-FAMILY KINASES; PTP-ALPHA; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; RPTP-ALPHA; IN-VIVO; REVERSIBLE OXIDATION; FLUORESCENT-PROBES	We investigated the role of protein-tyrosine phosphatase (PTP) in regulating signaling by the ErbB2 oncoprotein in mammary epithelial cells. Using this model, we demonstrated that activation of ErbB2 led to the transient inactivation of PTP, suggesting that attenuation of PTP activity may contribute to enhanced ErbB2 signaling. Furthermore, RNAi-induced suppression of PTP led to increased cell migration in an ErbB2-dependent manner. The ability of ErbB2 to increase cell motility in the absence of PTP was characterized by prolonged interaction of GRB7 with ErbB2 and increased association of ErbB2 with a 1-integrin-rich complex, which depended on GRB7-SH2 domain interactions. Finally, suppression of PTP resulted in increased phosphorylation of focal adhesion kinase on Tyr-407, which induced the recruitment of vinculin and the formation of a novel focal adhesion kinase complex in response to ErbB2 activation in mammary epithelial cells. Collectively, these results reveal a new role for PTP in the regulation of motility of mammary epithelial cells in response to ErbB2 activation.	[Boivin, Benoit; Chaudhary, Fauzia; Haque, Aftabul; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Pero, Stephanie C.] Univ Vermont, Coll Med, Vermont Comprehens Canc Ctr, Dept Surg, Burlington, VT 05405 USA	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Vermont	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu		Boivin, Benoit/0000-0003-3306-5970	National Institutes of Health [CA53840, GM55989, GM79465]; Cold Spring Harbor Laboratory Cancer Centre [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R37CA053840, R01CA053840, P30CA045508, R01CA080790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Centre; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 and GM55989 (to N. K. T.) and GM79465 (to C. J. C.). This work was also supported by Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508 and by The Gladowsky Breast Cancer Foundation, The Don Monti Memorial Research Foundation, the Hansen Memorial Foundation, the West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, the Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund (to N. K. T.).	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Berndt A, 1999, HISTOCHEM CELL BIOL, V111, P399, DOI 10.1007/s004180050373; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Boivin B, 2010, METHOD ENZYMOL, V474, P35, DOI 10.1016/S0076-6879(10)74003-9; Buist A, 2000, J BIOL CHEM, V275, P20754, DOI 10.1074/jbc.M001626200; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Helmke S, 1998, J CELL SCI, V111, P2465; Huang J, 2011, EMBO J, V30, P3200, DOI 10.1038/emboj.2011.212; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Lim Y, 2007, J BIOL CHEM, V282, P10398, DOI 10.1074/jbc.M609302200; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; MANGEAT P, 1984, J CELL BIOL, V99, pS95, DOI 10.1083/jcb.99.1.95s; Matkowskyj KA, 2003, J HISTOCHEM CYTOCHEM, V51, P1041, DOI 10.1177/002215540305100807; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meyer D.S., 2013, ONCOGENE IN PRESS; Miller EW, 2007, CURR OPIN CHEM BIOL, V11, P620, DOI 10.1016/j.cbpa.2007.09.018; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Porter CJ, 2005, EUR BIOPHYS J BIOPHY, V34, P454, DOI [10.1007/s00249-005-0480-1, 10.1007/s00249-005-0480-l]; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tran KT, 2003, EXP CELL RES, V289, P359, DOI 10.1016/S0014-4827(03)00287-8; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	78	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36926	36935		10.1074/jbc.M113.527564	http://dx.doi.org/10.1074/jbc.M113.527564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217252	Green Published, hybrid			2022-12-25	WOS:000329189700015
J	Conceicao, T; Diamantino, F; Coelho, C; de Lencastre, H; Aires-de-Sousa, M				Conceicao, Teresa; Diamantino, Fernanda; Coelho, Celine; de Lencastre, Herminia; Aires-de-Sousa, Marta			Contamination of Public Buses with MRSA in Lisbon, Portugal: A Possible Transmission Route of Major MRSA Clones within the Community	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; UNITED-STATES; PCR STRATEGY; CHROMOSOME; SEQUENCE; USA300; EPIDEMIOLOGY; SURVEILLANCE	In a previous study we have shown that public buses in Oporto, the second largest city in Portugal, were highly contaminated with MRSA. Here we describe the results of a similar study performed in another urban area of Portugal-Lisbon, the capital. Between May 2011 and May 2012, hand touched surfaces of 199 public buses in Lisbon were screened for MRSA contamination. Subsequently, the hands of 575 passengers who frequently use these bus lines were also screened. All hand carriers of MRSA were further screened for nasal carriage. The isolates were characterized by PFGE, staphylococcal cassette chromosome (SCC) mec typing, spa typing, MLST and were tested for the presence of mecA, Panton-Valentine leukocidin and arginine catabolic mobile element genes. MRSA contamination was shown in 72 buses (36.2%). The majority of the isolates belonged to three major clones: Clone A was identified as EMRSA-15 defined by pattern PFGE A, spa types t2357/t747/t025/t379/t910, ST22, and SCCmec IVh (n=21; 29%). Clone B was the New York/Japan clone characterized by PFGE B-t002/t10682-ST5-II (n=15; 21%). Clone C included isolates with characteristics of the international community-acquired USA300 or related clones, PFGE C-t008-ST8-IVa/IVc/IVg/IVnt/VI (n=19; 26%). The first two clones are currently the two major lineages circulating in Portuguese hospitals. The hands of 15 individuals were contaminated with MRSA belonging to the nosocomial clones A or B. Eleven of these individuals were not nasal carriers of MRSA and all but one had travelled by public transportation, namely by bus, prior to sampling. In conclusion, public buses in two major cities in Portugal are often contaminated with MRSA representing clones dominant in hospitals in the particular geographic area. MRSA contamination of public transport and the transfer of the bacteria to the hands of passengers may represent a route through which hospital-acquired MRSA clones may spread to the community.	[Conceicao, Teresa; Coelho, Celine; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Diamantino, Fernanda] Univ Lisboa FCUL & CEAUL, Fac Ciencias, Lisbon, Portugal; [Diamantino, Fernanda] Univ Lisboa FCUL & CEAUL, Ctr Estat & Aplicacoes, Lisbon, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa ESSVP, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Rockefeller University	Aires-de-Sousa, M (corresponding author), Escola Super Saude Cruz Vermelha Portuguesa ESSVP, Lisbon, Portugal.	msousa@esscvp.eu	Conceição, Teresa/M-3449-2014	Conceição, Teresa/0000-0002-9818-2767; Aires-de-Sousa, Marta/0000-0001-5036-2446; Diamantino, Maria_Fernanda/0000-0002-9217-167X; /0000-0001-6816-8932	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-SAP/118813/2010, PEst-OE/EQB/LA0004/2011, PEst-OE/MAT/UI0006/2011]; FCT, Portugal [036/BI-BI/2012];  [SFRH/BPD/72422/2010]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); 	This work was partially supported by project PTDC/SAU-SAP/118813/2010 and grants No. PEst-OE/EQB/LA0004/2011 and PEst-OE/MAT/UI0006/2011 from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. T. Conceicao was supported by grant SFRH/BPD/72422/2010. C. Coelho was supported by grant 036/BI-BI/2012 from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Coelho C, 2011, MICROB DRUG RESIST, V17, P333, DOI 10.1089/mdr.2010.0080; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; de Lencastre H, 2011, INT J MED MICROBIOL, V301, P623, DOI 10.1016/j.ijmm.2011.09.010; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Koning S, 2006, BRIT J DERMATOL, V154, P239, DOI 10.1111/j.1365-2133.2005.06766.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mermel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017925; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nazareth R, 2012, REV PORT PNEUMOL, V18, P34, DOI 10.1016/j.rppneu.2011.05.007; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; Patel M, 2009, DRUGS, V69, P693, DOI 10.2165/00003495-200969060-00004; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares A, 2013, EUR J CLIN IN PRESS; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11	40	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77812	10.1371/journal.pone.0077812	http://dx.doi.org/10.1371/journal.pone.0077812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223124	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200016
J	Fox, NJ; Marion, G; Davidson, RS; White, PCL; Hutchings, MR				Fox, Naomi J.; Marion, Glenn; Davidson, Ross S.; White, Piran C. L.; Hutchings, Michael R.			Modelling Parasite Transmission in a Grazing System: The Importance of Host Behaviour and Immunity	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS POPULATIONS; FREE-LIVING STAGES; OSTERTAGIA-OSTERTAGI; GASTROINTESTINAL NEMATODES; FORAGING BEHAVIOR; FOOD-INTAKE; SPATIAL HETEROGENEITY; MATHEMATICAL-MODELS; INFECTIVE LARVAE; FECAL AVOIDANCE	Parasitic helminths present one of the most pervasive challenges to grazing herbivores. Many macro-parasite transmission models focus on host physiological defence strategies, omitting more complex interactions between hosts and their environments. This work represents the first model that integrates both the behavioural and physiological elements of gastro-intestinal nematode transmission dynamics in a managed grazing system. A spatially explicit, individual-based, stochastic model is developed, that incorporates both the hosts' immunological responses to parasitism, and key grazing behaviours including faecal avoidance. The results demonstrate that grazing behaviour affects both the timing and intensity of parasite outbreaks, through generating spatial heterogeneity in parasite risk and nutritional resources, and changing the timing of exposure to the parasites' free-living stages. The influence of grazing behaviour varies with the host-parasite combination, dependent on the development times of different parasite species and variations in host immune response. Our outputs include the counterintuitive finding that under certain conditions perceived parasite avoidance behaviours (faecal avoidance) can increase parasite risk, for certain host-parasite combinations. Through incorporating the two-way interaction between infection dynamics and grazing behaviour, the potential benefits of parasite-induced anorexia are also demonstrated. Hosts with phenotypic plasticity in grazing behaviour, that make grazing decisions dependent on current parasite burden, can reduce infection with minimal loss of intake over the grazing season. This paper explores how both host behaviours and immunity influence macro-parasite transmission in a spatially and temporally heterogeneous environment. The magnitude and timing of parasite outbreaks is influenced by host immunity and behaviour, and the interactions between them; the incorporation of both regulatory processes is required to fully understand transmission dynamics. Understanding of both physiological and behavioural defence strategies will aid the development of novel approaches for control.	[Fox, Naomi J.; Davidson, Ross S.; Hutchings, Michael R.] SRUC, Dis Syst Team, Edinburgh, Midlothian, Scotland; [Fox, Naomi J.; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Fox, Naomi J.; Marion, Glenn; Davidson, Ross S.] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	University of York - UK; James Hutton Institute	Marion, G (corresponding author), Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland.	glenn@bioss.ac.uk	Davidson, Ross/I-8210-2014; Marion, Glenn/J-4738-2013; Hutchings, Mike/P-6836-2019; White, Piran Crawfurd Limond/AAH-6851-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775; Marion, Glenn/0000-0002-0454-9338; Hutchings, Mike/0000-0003-3338-471X; Davidson, Ross/0000-0003-1468-5867	Scottish Government	Scottish Government	SRUC and Biomathematics and Statistics Scotland (BioSS) receive funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DB, 1981, INT J PARASITOL, V11, P381, DOI 10.1016/0020-7519(81)90009-6; ANDERSON RM, 1987, INT J PARASITOL, V17, P519, DOI 10.1016/0020-7519(87)90128-7; [Anonymous], 2003, GROSS PATHOLOGY RUMI; ARNOLD GW, 1987, J APPL ECOL, V24, P759, DOI 10.2307/2403979; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Bao J, 1998, ANIM SCI, V66, P65, DOI 10.1017/S1357729800008845; BARGER IA, 1985, INT J PARASITOL, V15, P529, DOI 10.1016/0020-7519(85)90049-9; BARGER IA, 1988, INT J PARASITOL, V18, P269, DOI 10.1016/0020-7519(88)90067-7; Basanez MG, 2001, TRENDS PARASITOL, V17, P430, DOI 10.1016/S1471-4922(01)02013-X; BLACK JL, 1984, AUST J AGR RES, V35, P565, DOI 10.1071/AR9840565; BOAG B, 1989, INT J PARASITOL, V19, P681, DOI 10.1016/0020-7519(89)90047-7; Burgess CGS, 2012, VET PARASITOL, V189, P299, DOI 10.1016/j.vetpar.2012.04.009; CALLINAN APL, 1982, AGR SYST, V9, P199, DOI 10.1016/0308-521X(82)90020-8; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Churcher TS, 2006, J ANIM ECOL, V75, P1313, DOI 10.1111/j.1365-2656.2006.01154.x; Claerebout E, 1998, VET PARASITOL, V75, P153, DOI 10.1016/S0304-4017(97)00218-5; Coop RL, 1999, VET PARASITOL, V84, P187, DOI 10.1016/S0304-4017(99)00070-9; COOP RL, 1982, J AGR SCI, V98, P247, DOI 10.1017/S0021859600041782; Cooper J, 2000, APPL ANIM BEHAV SCI, V69, P15, DOI 10.1016/S0168-1591(00)00116-7; Cornell S, 2005, TRENDS PARASITOL, V21, P542, DOI 10.1016/j.pt.2005.08.019; COYNE MJ, 1991, INT J PARASITOL, V21, P847, DOI 10.1016/0020-7519(91)90153-X; DOBSON RJ, 1990, INT J PARASITOL, V20, P365, DOI 10.1016/0020-7519(90)90153-E; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Fernandez S, 2001, VET PARASITOL, V96, P291, DOI 10.1016/S0304-4017(01)00380-6; Forbes AB, 2007, VET PARASITOL, V150, P321, DOI 10.1016/j.vetpar.2007.09.031; Forbes AB, 2000, VET PARASITOL, V90, P111, DOI 10.1016/S0304-4017(00)00218-1; FORBES TDA, 1985, GRASS FORAGE SCI, V40, P177, DOI 10.1111/j.1365-2494.1985.tb01735.x; Fox MT, 2002, VET PARASITOL, V105, P285, DOI 10.1016/S0304-4017(02)00026-2; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Gunn A, 2003, WILDLIFE SOC B, V31, P117; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; HILDERSON H, 1993, VET PARASITOL, V47, P255, DOI 10.1016/0304-4017(93)90027-K; Hutchings MR, 2000, OECOLOGIA, V124, P242, DOI 10.1007/s004420000367; Hutchings MR, 1999, J ANIM ECOL, V68, P310, DOI 10.1046/j.1365-2656.1999.00287.x; Hutchings MR, 1998, ANIM SCI, V67, P97, DOI 10.1017/S1357729800009838; Hutchings MR, 2002, OIKOS, V96, P235, DOI 10.1034/j.1600-0706.2002.960205.x; Hutchings MR, 2002, OECOLOGIA, V132, P453, DOI 10.1007/s00442-002-0971-z; Hutchings MR, 2001, ECOLOGY, V82, P1138, DOI 10.1890/0012-9658(2001)082[1138:HPSAFT]2.0.CO;2; Hutchings MR, 2001, ANIM BEHAV, V62, P955, DOI 10.1006/anbe.2001.1837; Johnson RW, 1998, DOMEST ANIM ENDOCRIN, V15, P309, DOI 10.1016/S0739-7240(98)00031-9; Kao RR, 2000, PARASITOLOGY, V121, P85, DOI 10.1017/S0031182099006095; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Langhans W, 2000, NUTRITION, V16, P996, DOI 10.1016/S0899-9007(00)00421-4; LAZO A, 1993, APPL ANIM BEHAV SCI, V36, P99, DOI 10.1016/0168-1591(93)90002-7; LEATHWICK DM, 1992, INT J PARASITOL, V22, P789, DOI 10.1016/0020-7519(92)90129-9; Louie K, 2005, PARASITOLOGY, V130, P437, DOI 10.1017/S003118200400678X; Marion G, 2008, J AGR SCI-CAMBRIDGE, V146, P507, DOI 10.1017/S0021859608008022; Marion G, 1998, IMA J MATH APPL MED, V15, P97; Marion G, 2005, J THEOR BIOL, V232, P127, DOI 10.1016/j.jtbi.2004.08.005; PANDEY VS, 1972, J PARASITOL, V58, P1037, DOI 10.2307/3278128; PANDEY VS, 1993, VET PARASITOL, V49, P219, DOI 10.1016/0304-4017(93)90121-3; Phillips C.J.C., 1993, CATTLE BEHAV WELFARE; PLOEGER HW, 1995, VET PARASITOL, V58, P61, DOI 10.1016/0304-4017(94)00711-K; Ractliffe L H, 1971, Int J Parasitol, V1, P297, DOI 10.1016/0020-7519(71)90032-4; REID GW, 1972, J AGR SCI-CAMBRIDGE, V78, P491, DOI 10.1017/S0021859600026435; ROBERTS MG, 1991, IMA J MATH APPL MED, V8, P83; ROBERTS MG, 1992, IMA J MATH APPL MED, V9, P29; SMITH G, 1988, VET PARASITOL, V27, P73, DOI 10.1016/0304-4017(88)90063-5; Smith G., 1985, Parasitology Today, V1, P76, DOI 10.1016/0169-4758(85)90047-X; SMITH G, 1986, PARASITOLOGY, V92, P471, DOI 10.1017/S0031182000064222; Smith LA, 2010, ANIM BEHAV, V80, P527, DOI 10.1016/j.anbehav.2010.06.016; Smith LA, 2009, EPIDEMIOL INFECT, V137, P630, DOI 10.1017/S0950268808001313; Stear MJ, 1997, VET J, V154, P111, DOI 10.1016/S1090-0233(97)80049-4; Swain DL, 2007, ECOL MODEL, V203, P319, DOI 10.1016/j.ecolmodel.2006.11.031; THOMAS RJ, 1982, VET PARASITOL, V11, P9, DOI 10.1016/0304-4017(82)90118-2; van der Wal R, 2000, OECOLOGIA, V124, P19, DOI 10.1007/s004420050020; Vercruysse J, 1997, VET PARASITOL, V72, P309, DOI 10.1016/S0304-4017(97)00103-9; Vlassoff A, 2001, NEW ZEAL VET J, V49, P213, DOI 10.1080/00480169.2001.36235; Waller PJ, 2006, ANIM FEED SCI TECH, V126, P277, DOI 10.1016/j.anifeedsci.2005.08.007; WallisDeVries MF, 1998, APPL ANIM BEHAV SCI, V60, P301, DOI 10.1016/S0168-1591(98)00158-0; WILLIAMS JC, 1993, VET PARASITOL, V46, P313, DOI 10.1016/0304-4017(93)90069-Y	72	27	28	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77996	10.1371/journal.pone.0077996	http://dx.doi.org/10.1371/journal.pone.0077996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223133	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200025
J	Garanto, A; van Beersum, SEC; Peters, TA; Roepman, R; Cremers, FPM; Collin, RWJ				Garanto, Alejandro; van Beersum, Sylvia E. C.; Peters, Theo A.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.			Unexpected CEP290 mRNA Splicing in a Humanized Knock-In Mouse Model for Leber Congenital Amaurosis	PLOS ONE			English	Article							RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; GENE-THERAPY; MUTATIONS; CILIOPATHIES; PHENOTYPE; MEMBRANE; ORTHOLOG; CERKL; MICE	Leber congenital amaurosis (LCA) is the most severe form of retinal dystrophy with an onset in the first year of life. The most frequent genetic cause of LCA, accounting for up to 15% of all LCA cases in Europe and North-America, is a mutation (c. 2991+1655AG) in intron 26 of CEP290. This mutation generates a cryptic splice donor site resulting in the insertion of an aberrant exon (exon X) containing a premature stop codon to CEP290 mRNA. In order to study the pathophysiology of the intronic CEP290 mutation, we generated two humanized knock-in mouse models each carrying similar to 6.3 kb of the human CEP290 gene, either with or without the intronic mutation. Transcriptional characterization of these mouse models revealed an unexpected splice pattern of CEP290 mRNA, especially in the retina. In both models, a new cryptic exon (coined exon Y) was identified in similar to 5 to 12% of all Cep290 transcripts. This exon Y was expressed in all murine tissues analyzed but not detected in human retina or fibroblasts of LCA patients. In addition, exon x that is characteristic of LCA in humans, was expressed at only very low levels in the retina of the LCA mouse model. Western blot and immunohistochemical analyses did not reveal any differences between the two transgenic models and wild-type mice. Together, our results show clear differences in the recognition of splice sites between mice and humans, and emphasize that care is warranted when generating animal models for human genetic diseases caused by splice mutations.	[Garanto, Alejandro; van Beersum, Sylvia E. C.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Garanto, Alejandro; van Beersum, Sylvia E. C.; Roepman, Ronald; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [van Beersum, Sylvia E. C.; Peters, Theo A.; Roepman, Ronald; Cremers, Frans P. M.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-6525 ED Nijmegen, Netherlands; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Collin, RWJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	rob.collin@radboudumc.nl	Garanto, Alejandro/D-5022-2014; van Beersum, Sylvia E.C./P-8653-2015; Collin, Rob/N-3575-2014; Peters, T.A./L-4571-2015; Cremers, Frans/A-5625-2014; Roepman, Ronald/B-1339-2014	Garanto, Alejandro/0000-0001-5721-1560; van Beersum, Sylvia E.C./0000-0002-4552-2908; Peters, T.A./0000-0001-8443-5500; Cremers, Frans/0000-0002-4954-5592; Roepman, Ronald/0000-0002-5178-8163	Netherlands Organisation for Scientific Research (NWO) [VENI 916.10.096]; Foundation Fighting Blindness (FFB) USA [TA-GT-0912-0582-RAD]; Stichting August F. Deutman Researchfonds Oogheelkunde; Rotterdamse Vereniging Blindenbelangen; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blindenstichting; Stichting Winckel-Sweep; Stichting Nederlands Oogheelkundig Onderzoek	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness (FFB) USA; Stichting August F. Deutman Researchfonds Oogheelkunde; Rotterdamse Vereniging Blindenbelangen; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blindenstichting; Stichting Winckel-Sweep; Stichting Nederlands Oogheelkundig Onderzoek	This work is financially supported by the Netherlands Organisation for Scientific Research (NWO) (VENI 916.10.096 to RWJC), the Foundation Fighting Blindness (FFB) USA (TA-GT-0912-0582-RAD to RWJC), the Stichting August F. Deutman Researchfonds Oogheelkunde, the Rotterdamse Vereniging Blindenbelangen, the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Gelderse Blindenstichting, the Stichting Winckel-Sweep and the Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Barbelanne M, 2013, HUM MOL GENET; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garanto A, 2012, BBA-MOL BASIS DIS, V1822, P1258, DOI 10.1016/j.bbadis.2012.04.004; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Gladman JT, 2010, HUM MOL GENET, V19, P4239, DOI 10.1093/hmg/ddq343; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kolb H, 2003, AM SCI, V91, P28, DOI 10.1511/2003.11.841; Kurth I, 2007, MOL CELL BIOL, V27, P1370, DOI 10.1128/MCB.01486-06; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Menotti-Raymond M, 2007, J HERED, V98, P211, DOI 10.1093/jhered/esm019; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; NARFSTROM K, 1985, INVEST OPHTH VIS SCI, V26, P193; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Song BJ, 2007, GENE THER MOL BIOL, V11B, P229; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Vadolas J, 2006, J BIOL CHEM, V281, P7399, DOI 10.1074/jbc.M512931200; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222	39	34	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79369	10.1371/journal.pone.0079369	http://dx.doi.org/10.1371/journal.pone.0079369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223178	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200070
J	Hou, YM; Hu, JL; Po, SS; Wang, H; Zhang, L; Zhang, F; Wang, K; Zhou, Q				Hou, Yuemei; Hu, Jialu; Po, Sunny S.; Wang, Huan; Zhang, Ling; Zhang, Feng; Wang, Kun; Zhou, Qina			Catheter-Based Renal Sympathetic Denervation Significantly Inhibits Atrial Fibrillation Induced by Electrical Stimulation of the Left Stellate Ganglion and Rapid Atrial Pacing	PLOS ONE			English	Article							DRUG-RESISTANT HYPERTENSION; SUDDEN CARDIAC DEATH; RADIOFREQUENCY ABLATION; PULMONARY VEINS; BLOOD-PRESSURE; CANINE MODEL; INNERVATION; INDUCIBILITY; TACHYCARDIA	Background: Sympathetic activity involves the pathogenesis of atrial fibrillation (AF). Renal sympathetic denervation (RSD) decreases sympathetic renal afferent nerve activity, leading to decreased central sympathetic drive. The aim of this study was to identify the effects of RSD on AF inducibility induced by hyper-sympathetic activity in a canine model. Methods: To establish a hyper-sympathetic tone canine model of AF, sixteen dogs were subjected to stimulation of left stellate ganglion (LSG) and rapid atrial pacing (RAP) for 3 hours. Then animals in the RSD group (n = 8) underwent radiofrequency ablation of the renal sympathetic nerve. The control group (n = 8) underwent the same procedure except for ablation. AF inducibility, effective refractory period (ERP), ERP dispersion, heart rate variability and plasma norepinephrine levels were measured at baseline, after stimulation and after ablation. Results: LSG stimulation combined RAP significantly induced higher AF induction rate, shorter ERP, larger ERP dispersion at all sites examined and higher plasma norepinephrine levels (P < 0.05 in all values), compared to baseline. The increased AF induction rate, shortened ERP, increased ERP dispersion and elevated plasma norepinephrine levels can be almost reversed by RSD, compared to the control group (P, 0.05). LSG stimulation combined RAP markedly shortened RR-interval and standard deviation of all RR-intervals (SDNN), Low-frequency (LF), high-frequency (HF) and LF/HF ratio (P < 0.05). These changes can be reversed by RSD, compared to the control group (P < 0.05). Conclusions: RSD significantly reduced AF inducibility and reversed the atrial electrophysiological changes induced by hyper-sympathetic activity.	[Hou, Yuemei] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Cardiovasc Dis, Shanghai 200030, Peoples R China; [Hu, Jialu] Fudan Univ, Zhongshan Hosp, Dept Cardiovasc Dis, Shanghai 200433, Peoples R China; [Po, Sunny S.] Univ Oklahoma, Hlth Sci Ctr, Heart Rhythm Inst, Oklahoma City, OK USA; [Po, Sunny S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Wang, Huan; Zhang, Ling; Zhang, Feng; Wang, Kun; Zhou, Qina] Xinjiang Med Univ, Affiliated Hosp 1, Arrhythmia Res Lab, Urumqi, Peoples R China	Shanghai Jiao Tong University; Fudan University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Xinjiang Medical University	Zhou, Q (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Arrhythmia Res Lab, Urumqi, Peoples R China.	zhouqina_5217@sina.com			International Science and Technology Cooperation Project of the Ministry of Science and Technology of China [2011DFA32860]; Shanghai Science and Technology Commission Research Projects [10411956900]	International Science and Technology Cooperation Project of the Ministry of Science and Technology of China; Shanghai Science and Technology Commission Research Projects	This study was supported by the International Science and Technology Cooperation Project of the Ministry of Science and Technology of China (2011DFA32860) and the Shanghai Science and Technology Commission Research Projects (10411956900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2012, JACC-CARDIOVASC INTE, V5, P758, DOI 10.1016/j.jcin.2012.01.027; BARAJAS L, 1978, FED PROC, V37, P1192; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Chang CM, 2001, CIRCULATION, V103, P22; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Gould PA, 2006, PACE, V29, P821, DOI 10.1111/j.1540-8159.2006.00447.x; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Ishida Yuji, 2008, Okajimas Folia Anatomica Japonica, V84, P133, DOI 10.2535/ofaj.84.133; Jayachandran JV, 2000, CIRCULATION, V101, P1185, DOI 10.1161/01.CIR.101.10.1185; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuhlkamp V, 2000, J AM COLL CARDIOL, V36, P139, DOI 10.1016/S0735-1097(00)00693-8; Lehnart SE, 2004, BIOCHEM BIOPH RES CO, V322, P1267, DOI 10.1016/j.bbrc.2004.08.032; Linz D, 2013, J CARDIOVASC ELECTRO, DOI 10:1111/jce.12284; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Lu ZB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P184, DOI 10.1161/CIRCEP.108.784272; Ogawa M, 2009, HEART RHYTHM, V6, P1772, DOI 10.1016/j.hrthm.2009.08.011; Oral H, 2008, J CARDIOVASC ELECTR, V19, P466, DOI 10.1111/j.1540-8167.2007.01089.x; Patterson E, 2006, J AM COLL CARDIOL, V47, P1196, DOI 10.1016/j.jacc.2005.12.023; Prochnau D, 2012, EUROINTERVENTION, V7, P1077, DOI 10.4244/EIJV7I9A171; Qina Z, 2012, HEART, V98, pE30; RAGER G, 1979, STAIN TECHNOL, V54, P193, DOI 10.3109/10520297909112682; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Sharifov OF, 2004, J AM COLL CARDIOL, V43, P483, DOI 10.1016/j.jacc.2003.09.030; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Swissa M, 2005, AM J PHYSIOL-HEART C, V289, pH1851, DOI 10.1152/ajpheart.00083.2005; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5; Ukena C, 2011, J AM COLL CARDIOL, V58, P1176, DOI 10.1016/j.jacc.2011.05.036; Vonend O, 2003, J HYPERTENS, V21, P1709, DOI 10.1097/00004872-200309000-00021; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y	33	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78218	10.1371/journal.pone.0078218	http://dx.doi.org/10.1371/journal.pone.0078218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223140	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200032
J	Olofsson, J; Axelsson-Olsson, D; Brudin, L; Olsen, B; Ellstrom, P				Olofsson, Jenny; Axelsson-Olsson, Diana; Brudin, Lars; Olsen, Bjorn; Ellstrom, Patrik			Campylobacter jejuni Actively Invades the Amoeba Acanthamoeba polyphaga and Survives within Non Digestive Vacuoles	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PHAGOSOME-LYSOSOME FUSION; FREE-LIVING AMEBAS; LEGIONELLA-PNEUMOPHILA; DICTYOSTELIUM-DISCOIDEUM; MYCOBACTERIUM-AVIUM; FRESH-WATER; CASTELLANII; CELLS; ASSOCIATION	The Gram-negative bacterium Campylobacter jejuni is able to enter, survive and multiply within the free living amoeba Acanthamoeba polyphaga, but the molecular mechanisms behind these events are still unclear. We have studied the uptake and intracellular trafficking of viable and heat killed bacterial cells of the C. jejuni strain 81-176 in A. polyphaga. We found that viable bacteria associated with a substantially higher proportion of Acanthamoeba trophozoites than heat killed bacteria. Furthermore, the kinetics of internalization, the total number of internalized bacteria as well as the intracellular localization of internalized C. jejuni were dramatically influenced by bacterial viability. Viable bacteria were internalized at a high rate already after 1 h of co-incubation and were observed in small vacuoles tightly surrounding the bacteria. In contrast, internalization of heat killed C. jejuni was low at early time points and did not peak until 96 h. These cells were gathered in large spacious vacuoles that were part of the degradative pathway as determined by the uptake of fluorescently labeled dextran. The amount of heat killed bacteria internalized by A. polyphaga did never reach the maximal amount of internalized viable bacteria. These results suggest that the uptake and intracellular survival of C. jejuni in A. polyphaga is bacterially induced.	[Olofsson, Jenny; Olsen, Bjorn; Ellstrom, Patrik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Olofsson, Jenny; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Axelsson-Olsson, Diana] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Brudin, Lars] Kalmar Cty Hosp, Dept Clin Physiol, Kalmar, Sweden; [Brudin, Lars] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	Uppsala University; Linnaeus University; Linnaeus University; Linkoping University	Olofsson, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	jenny.olofsson@lnu.se		Brudin, Lars/0000-0002-6278-1362; Axelsson Olsson, Diana/0000-0003-4474-8531; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council FORMAS [FORMAS 2007-438]; Royal Swedish Academy of Agriculture and Forestry [KSLA H-578]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Agriculture and Forestry	This work was supported financially by the Swedish Research Council FORMAS (FORMAS 2007-438) and the Royal Swedish Academy of Agriculture and Forestry (KSLA H-578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsam S, 2006, J MED MICROBIOL, V55, P689, DOI 10.1099/jmm.0.46497-0; Armitage P., 2002, STAT METHODS MED RES; AUBRY L, 1993, EUR J CELL BIOL, V61, P225; Axelsson-Olsson D, 2005, APPL ENVIRON MICROB, V71, P987, DOI 10.1128/AEM.71.2.987-992.2005; Axelsson-Olsson D, 2007, APPL ENVIRON MICROB, V73, P6864, DOI 10.1128/AEM.01305-07; Axelsson-Olsson D, 2010, EXP PARASITOL, V126, P59, DOI 10.1016/j.exppara.2009.12.016; Bare J, 2010, FEMS MICROBIOL ECOL, V74, P371, DOI 10.1111/j.1574-6941.2010.00955.x; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; Berk SG, 1998, APPL ENVIRON MICROB, V64, P279; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Bui XT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-232; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; First MR, 2012, J EUKARYOT MICROBIOL, V59, P12, DOI 10.1111/j.1550-7408.2011.00589.x; FREHEL C, 1986, INFECT IMMUN, V52, P252, DOI 10.1128/IAI.52.1.252-262.1986; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; KONKEL ME, 1992, INFECT IMMUN, V60, P4945, DOI 10.1128/IAI.60.11.4945-4949.1992; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lamothe J, 2004, CELL MICROBIOL, V6, P1127, DOI 10.1111/j.1462-5822.2004.00424.x; Landers P, 2000, EUR J CLIN MICROBIOL, V19, P121, DOI 10.1007/s100960050442; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Neuhaus EM, 2002, MOL BIOL CELL, V13, P1390, DOI 10.1091/mbc.01-08-0392; Nygard K, 2004, EPIDEMIOL INFECT, V132, P317, DOI 10.1017/S0950268803001900; Pickup ZL, 2007, FEMS MICROBIOL ECOL, V59, P556, DOI 10.1111/j.1574-6941.2006.00224.x; Pryor PR, 2012, METHOD ENZYMOL, V505, P145, DOI 10.1016/B978-0-12-388448-0.00016-4; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Snelling WJ, 2006, MICROBES INFECT, V8, P578, DOI 10.1016/j.micinf.2005.09.001; Snelling WJ, 2005, APPL ENVIRON MICROB, V71, P5560, DOI 10.1128/AEM.71.9.5560-5571.2005; THOM S, 1992, J MED MICROBIOL, V36, P303, DOI 10.1099/00222615-36-5-303; Thomas JM, 2011, ENVIRON SCI TECHNOL, V45, P860, DOI 10.1021/es102876y; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014	39	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78873	10.1371/journal.pone.0078873	http://dx.doi.org/10.1371/journal.pone.0078873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223169	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200061
J	Sieger, T; Bonnet, C; Serranova, T; Wild, J; Novak, D; Ruzicka, F; Urgosik, D; Ruzicka, E; Gaymard, B; Jech, R				Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Wild, Jiri; Novak, Daniel; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Gaymard, Bertrand; Jech, Robert			Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; NIGRA PARS RETICULATA; HUMAN SUBTHALAMIC NUCLEUS; CEREBRAL-BLOOD-FLOW; EXTERNALLY TRIGGERED MOVEMENTS; SUBSTANTIA-NIGRA; GLOBUS-PALLIDUS; OCULOMOTOR FUNCTIONS; MOTOR CORTEX; SACCADES	The oculomotor role of the basal ganglia has been supported by extensive evidence, although their role in scanning eye movements is poorly understood. Nineteen Parkinsons disease patients, which underwent implantation of deep brain stimulation electrodes, were investigated with simultaneous intraoperative microelectrode recordings and single channel electrooculography in a scanning eye movement task by viewing a series of colored pictures selected from the International Affective Picture System. Four patients additionally underwent a visually guided saccade task. Microelectrode recordings were analyzed selectively from the subthalamic nucleus, substantia nigra pars reticulata and from the globus pallidus by the WaveClus program which allowed for detection and sorting of individual neurons. The relationship between neuronal firing rate and eye movements was studied by crosscorrelation analysis. Out of 183 neurons that were detected, 130 were found in the subthalamic nucleus, 30 in the substantia nigra and 23 in the globus pallidus. Twenty percent of the neurons in each of these structures showed eye movement-related activity. Neurons related to scanning eye movements were mostly unrelated to the visually guided saccades. We conclude that a relatively large number of basal ganglia neurons are involved in eye motion control. Surprisingly, neurons related to scanning eye movements differed from neurons activated during saccades suggesting functional specialization and segregation of both systems for eye movement control.	[Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas; Bonnet, Cecilia; Serranova, Tereza; Ruzicka, Filip; Urgosik, Dusan; Ruzicka, Evzen; Jech, Robert] Gen Univ Hosp, Prague, Czech Republic; [Sieger, Tomas; Wild, Jiri; Novak, Daniel] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Urgosik, Dusan] Na Homolce Hosp, Dept Stereotact & Radiat Neurosurg, Prague, Czech Republic; [Gaymard, Bertrand] UPMC, Pitie Salpetriere Hosp, CRICM, INSERM UMR S975,CNRS UMR7225,ICM, Paris, France; [Gaymard, Bertrand] Univ Paris 06, Paris, France	Charles University Prague; Charles University Prague; General University Hospital Prague; Czech Technical University Prague; Na Homolce Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Jech, R (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Jech, Robert/HHY-7342-2022; Novak, Daniel/G-9231-2014; Serranová, Tereza/AAY-2386-2021; Sieger, Tomas/AAD-9342-2019; Růžička, Evžen/F-9299-2017; Urgošík, Dušan/AAA-9551-2021	Jech, Robert/0000-0002-9732-8947; Novak, Daniel/0000-0001-6996-9344; Serranová, Tereza/0000-0001-6525-3971; Růžička, Evžen/0000-0002-4893-9661; Ruzicka, Filip/0000-0003-2743-2703; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA MZ ACER NT12282-5/2011, IGA MZ ACER NT12288-5/2011]; Czech Ministry of Education [MA M 0021620849, MA M 6840770012]; Charles University in Prague [PRVOUK-P26/LF1/4]; MRC [MC_U130059811, MC_UU_12017/1, MC_EX_G0701943, MC_UU_12017/3, MC_U130015185] Funding Source: UKRI; Medical Research Council [MC_U130015185, MC_U130059811, MC_EX_G0701943, MC_UU_12017/1, MC_UU_12017/3] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Czech Science Foundation: grant project 309/09/1145, by the Czech Ministry of Health: IGA MZ ACER NT12282-5/2011, IGA MZ ACER NT12288-5/2011, by the Czech Ministry of Education: research project MA M 0021620849, MA M 6840770012 Transdisciplinary Research in the Area of Biomedical Engineering II, by the Charles University in Prague: research project PRVOUK-P26/LF1/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahyane N, 2008, CEREBELLUM, V7, P595, DOI 10.1007/s12311-008-0065-5; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antoniades CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032830; Antoniades CA, 2012, NEUROREPORT, V23, P179, DOI 10.1097/WNR.0b013e32834f6daa; Araujo C, 2001, VISION RES, V41, P3613, DOI 10.1016/S0042-6989(01)00196-1; Averbuch-Heller L, 1999, NEUROLOGY, V52, P185, DOI 10.1212/WNL.52.1.185; Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Bartanusz V, 2005, J CLIN NEUROSCI, V12, P92, DOI 10.1016/j.jocn.2004.03.033; Basso MA, 2005, EUR J NEUROSCI, V22, P448, DOI 10.1111/j.1460-9568.2005.04215.x; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; BECKSTEAD RM, 1981, J NEUROSCI, V1, P121; Blekher T, 2000, INVEST OPHTH VIS SCI, V41, P2177; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266, DOI 10.1152/jn.1994.71.3.1266; CORIN MS, 1972, J NEUROL SCI, V15, P251, DOI 10.1016/0022-510X(72)90068-8; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; DEJONG JD, 1971, EXP NEUROL, V32, P58, DOI 10.1016/0014-4886(71)90165-8; DENIAU JM, 1978, NEUROSCI LETT, V9, P117, DOI 10.1016/0304-3940(78)90058-7; Fawcett AP, 2007, CLIN NEUROPHYSIOL, V118, P155, DOI 10.1016/j.clinph.2006.09.016; Fawcett AP, 2010, NEUROMODULATION, V13, P17, DOI 10.1111/j.1525-1403.2009.00246.x; Fawcett AP, 2005, EXP BRAIN RES, V162, P357, DOI 10.1007/s00221-004-2184-7; FILION M, 1994, REV NEUROL-FRANCE, V150, P627; Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P411, DOI 10.1016/S0028-3932(01)00099-9; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; Kitama T, 1999, J NEUROPHYSIOL, V82, P2235, DOI 10.1152/jn.1999.82.5.2235; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lohnes CA, 2012, EXP NEUROL, V236, P389, DOI 10.1016/j.expneurol.2012.05.001; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nambu A, 1996, J NEUROSCI, V16, P2671; NOTON D, 1971, SCI AM, V224, P34; O'Sullivan JD, 2003, J CLIN NEUROSCI, V10, P181, DOI 10.1016/S0967-5868(02)00125-X; Pinkhardt EH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-5; Pollak P, 2002, MOVEMENT DISORD, V17, pS155, DOI 10.1002/mds.10158; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; R Core Team, 2012, R LANG ENV STAT COMP; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Rivaud-Pechoux S, 2000, J NEUROL NEUROSUR PS, V68, P381, DOI 10.1136/jnnp.68.3.381; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Sauleau P, 2008, CLIN NEUROPHYSIOL, V119, P1857, DOI 10.1016/j.clinph.2008.04.013; Sauleau P, 2007, MOVEMENT DISORD, V22, P1810, DOI 10.1002/mds.21650; SELEMON LD, 1990, J COMP NEUROL, V297, P359, DOI 10.1002/cne.902970304; SHIBASAKI H, 1979, ARCH NEUROL-CHICAGO, V36, P360, DOI 10.1001/archneur.1979.00500420070009; Shields DC, 2007, J NEUROSURG, V107, P37, DOI 10.3171/JNS-07/07/0037; Shin SY, 2010, J NEUROPHYSIOL, V103, P1874, DOI 10.1152/jn.00101.2009; Simpson DM, 2001, MED BIOL ENG COMPUT, V39, P428, DOI 10.1007/BF02345364; Temel Y, 2008, CURR BIOL, V18, pR412, DOI 10.1016/j.cub.2008.03.008; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Toh WL, 2011, COMPR PSYCHIAT, V52, P567, DOI 10.1016/j.comppsych.2010.12.005; Trukenbrod HA, 2012, J VIS, V12; TSUNODA M, 1992, SCHIZOPHR RES, V7, P159, DOI 10.1016/0920-9964(92)90046-8; VENTRE J, 1992, BRAIN, V115, P1147, DOI 10.1093/brain/115.4.1147; von Wartburg R, 2007, PERCEPTION, V36, P355, DOI 10.1068/p5552; Wark HAC, 2008, J NEUROL NEUROSUR PS, V79, P443, DOI 10.1136/jnnp.2007.117192; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Wild J, 2012, J NEUROSCI METH, V203, P369, DOI 10.1016/j.jneumeth.2011.10.013; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; Yan YJ, 2001, J NEUROPHYSIOL, V86, P3056, DOI 10.1152/jn.2001.86.6.3056; Yoshida A, 2009, CEREB CORTEX, V19, P206, DOI 10.1093/cercor/bhn069; Yugeta A, 2010, NEUROLOGY, V74, P743, DOI 10.1212/WNL.0b013e3181d31e0b; Zihl J, 1997, NEUROPSYCHOLOGIA, V35, P893, DOI 10.1016/S0028-3932(97)00006-7	75	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78581	10.1371/journal.pone.0078581	http://dx.doi.org/10.1371/journal.pone.0078581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223158	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200050
J	Du, XP; Ewert, DL; Cheng, WH; West, MB; Lu, JZ; Li, W; Floyd, RA; Kopke, RD				Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Floyd, Robert A.; Kopke, Richard D.			Effects of Antioxidant Treatment on Blast-Induced Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; IMPULSE NOISE BLAST; REDUCES OXIDATIVE STRESS; N-ACETYLCYSTEINE; C-FOS; RAT-BRAIN; INDUCED NEUROTRAUMA; COCHLEAR NUCLEUS; SPIRAL GANGLION; ANIMAL-MODEL	Blast-induced traumatic brain injury has dramatically increased in combat troops in today's military operations. We previously reported that antioxidant treatment can provide protection to the peripheral auditory end organ, the cochlea. In the present study, we examined biomarker expression in the brains of rats at different time points (3 hours to 21 days) after three successive 14 psi blast overpressure exposures to evaluate antioxidant treatment effects on blast-induced brain injury. Rats in the treatment groups received a combination of antioxidants (2,4-disulfonyl alpha-phenyl tertiary butyl nitrone and N-acetylcysteine) one hour after blast exposure and then twice a day for the following two days. The biomarkers examined included an oxidative stress marker (4-hydroxy-2-nonenal, 4-HNE), an immediate early gene (c-fos), a neural injury marker (glial fibrillary acidic protein, GFAP) and two axonal injury markers [amyloid beta (A4) precursor protein, APP, and 68 kDa neurofilament, NF-68]. The results demonstrate that blast exposure induced or up-regulated the following: 4-HNE production in the dorsal hippocampus commissure and the forceps major corpus callosum near the lateral ventricle; c-fos and GFAP expression in most regions of the brain, including the retrosplenial cortex, the hippocampus, the cochlear nucleus, and the inferior colliculus; and NF-68 and APP expression in the hippocampus, the auditory cortex, and the medial geniculate nucleus (MGN). Antioxidant treatment reduced the following: 4-HNE in the hippocampus and the forceps major corpus callosum, c-fos expression in the retrosplenial cortex, GFAP expression in the dorsal cochlear nucleus (DCN), and APP and NF-68 expression in the hippocampus, auditory cortex, and MGN. This preliminary study indicates that antioxidant treatment may provide therapeutic protection to the central auditory pathway (the DCN and MGN) and the non-auditory central nervous system (hippocampus and retrosplenial cortex), suggesting that these compounds have the potential to simultaneously treat blast-induced injuries in the brain and auditory system.	[Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Kopke, Richard D.] Hough Ear Inst, Oklahoma City, OK 73112 USA; [Floyd, Robert A.; Kopke, Richard D.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kopke, RD (corresponding author), Hough Ear Inst, Oklahoma City, OK 73112 USA.	rkopke@houghear.org			United States Department of Navy, Office of Naval Research [N00014-09-1-0999]	United States Department of Navy, Office of Naval Research	This research was supported by grant N00014-09-1-0999 from the United States Department of Navy, Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Armstrong KL, 1998, BIOCHEM BIOPH RES CO, V253, P114, DOI 10.1006/bbrc.1998.9762; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bemeur C, 2010, METAB BRAIN DIS, V25, P241, DOI 10.1007/s11011-010-9201-2; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BROWN MC, 1995, J COMP NEUROL, V357, P85, DOI 10.1002/cne.903570109; BROWN RFR, 1993, INT J EXP PATHOL, V74, P151; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chang EY, 2011, J MATERN-FETAL NEO M, V24, P732, DOI 10.3109/14767058.2010.528089; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Choi CH, 2011, FREE RADICAL RES, V45, P1162, DOI 10.3109/10715762.2011.605360; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; CORNELIUS C, 2013, ANTIOXID REDOX SIGNA; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DELLANNA ME, 1995, EXP NEUROL, V131, P144, DOI 10.1016/0014-4886(95)90016-0; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Du Xiaoping, 2011, Int J Otolaryngol, V2011, P612690, DOI 10.1155/2011/612690; Du XP, 2012, HEARING RES, V283, P1, DOI 10.1016/j.heares.2011.11.013; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; EHRET G, 1991, BRAIN RES, V567, P350, DOI 10.1016/0006-8993(91)90819-H; Elsayed NM, 2003, TOXICOLOGY, V189, P63, DOI 10.1016/S0300-483X(03)00153-7; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gleich O, 1995, NEUROREPORT, V7, P29, DOI 10.1097/00001756-199512000-00006; Gorbunov NV, 1997, AM J PHYSIOL-LUNG C, V272, pL320, DOI 10.1152/ajplung.1997.272.2.L320; Haase GM, 2011, AM J OTOLARYNG, V32, P55, DOI 10.1016/j.amjoto.2009.09.002; Han M, 2003, CELL MOL BIOL, V49, P1249; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Idrizbegovic E, 1998, BRAIN RES, V800, P86, DOI 10.1016/S0006-8993(98)00504-6; Jatana M, 2006, PEDIATR RES, V59, P684, DOI 10.1203/01.pdr.0000215045.91122.44; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; KOCHANEK PM, 2013, J NEUROTRAUMA; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; KOVESDI E, 2012, NEUROLOGIST, V3, P111, DOI DOI 10.3389/FNEUR.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Lee TF, 2008, PEDIATR RES, V64, P256, DOI 10.1203/PDR.0b013e31817cfcc0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Niu YL, 2011, ARCH BIOCHEM BIOPHYS, V515, P89, DOI 10.1016/j.abb.2011.07.016; Olucha F E, 1997, Acta Otorrinolaringol Esp, V48, P85; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Phillips Y Y, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P17; PODE D, 1989, MIL MED, V154, P288; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; ROBERTO M, 1989, ANN OTO RHINOL LARYN, V98, P23; Saint Marie RL, 1999, J COMP NEUROL, V404, P258, DOI 10.1002/(SICI)1096-9861(19990208)404:2<258::AID-CNE9>3.0.CO;2-U; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; SATO K, 1993, ACTA OTO-LARYNGOL, P18; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Sekiya T, 2009, EXP NEUROL, V218, P117, DOI 10.1016/j.expneurol.2009.04.014; Singh V, 2007, INDIAN J EXP BIOL, V45, P1037; SKOTAK M, 2013, J NEUROTRAUMA; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang XY, 2007, ANN NEUROL, V61, P263, DOI 10.1002/ana.21066; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu JA, 2011, AM J OTOLARYNG, V32, P8, DOI 10.1016/j.amjoto.2009.08.012; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Zhao ZG, 2001, BRAIN RES, V909, P46, DOI 10.1016/S0006-8993(01)02618-X	120	28	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80138	10.1371/journal.pone.0080138	http://dx.doi.org/10.1371/journal.pone.0080138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224042	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400113
J	Feng, Y; Wang, BY; Du, FY; Li, HB; Wang, SL; Hu, CH; Zhu, CH; Yu, XR				Feng, Yan; Wang, Baoying; Du, Fangying; Li, Hongbo; Wang, Shaolan; Hu, Chenghu; Zhu, Chunhui; Yu, Xiaorui			The Involvement of PI3K-Mediated and L-VGCC-Gated Transient Ca2+ Influx in 17 beta-Estradiol-Mediated Protection of Retinal Cells from H2O2-Induced Apoptosis with Ca2+ Overload	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; HYDROGEN-PEROXIDE; DEPENDENT NEURODEGENERATION; MOLECULAR-MECHANISMS; NEURONAL DEATH; SIGNAL PATHWAY; TRPC CHANNELS; ESTROGEN; RECEPTOR; EXPRESSION	Intracellular calcium concentration ([Ca2+](i)) plays an important role in regulating most cellular processes, including apoptosis and survival, but its alterations are different and complicated under diverse conditions. In this study, we focused on the [Ca2+](i) and its control mechanisms in process of hydrogen peroxide (H2O2)-induced apoptosis of primary cultured Sprague-Dawley (SD) rat retinal cells and 17 beta-estradiol (beta E2) anti-apoptosis. Fluo-3AM was used as a Ca2+ indicator to detect [Ca2+](i) through fluorescence-activated cell sorting (FACS), cell viability was assayed using MTT assay, and apoptosis was marked by Hoechst 33342 and annexin V/Propidium Iodide staining. Besides, PI3K activity was detected by Western blotting. Results showed: a) 100 mu M H2O2-induced retinal cell apoptosis occurred at 4 h after H2O2 stress and increased in a time-dependent manner, but [Ca2+](i) increased earlier at 2 h, sustained to 12 h, and then recovered at 24 h after H2O2 stress; b) 10 mu M beta E2 treatment for 0.5-24 hrs increased cell viability by transiently increasing [Ca2+](i), which appeared only at 0.5 h after beta E2 application; c) increased [Ca2+](i) under 100 mu M H2O2 treatment for 2 hrs or 10 mu M beta E2 treatment for 0.5 hrs was, at least partly, due to extracellular Ca2+ stores; d) importantly, the transiently increased [Ca2+](i) induced by 10 mu M beta E2 treatment for 0.5 hrs was mediated by the phosphatidylinositol-3-kinase (PI3K) and gated by the L-type voltage-gated Ca2+ channels (L-VGCC), but the increased [Ca2+](i) induced by 100 mu M H2O2 treatment for 2 hrs was not affected; and e) pretreatment with 10 mu M beta E2 for 0.5 hrs effectively protected retinal cells from apoptosis induced by 100 mu M H2O2, which was also associated with its transient [Ca2+](i) increase through L-VGCC and PI3K pathway. These findings will lead to better understanding of the mechanisms of beta E2-mediated retinal protection and to exploration of the novel therapeutic strategies for retina degeneration.	[Feng, Yan; Wang, Baoying; Du, Fangying; Li, Hongbo; Wang, Shaolan; Hu, Chenghu; Zhu, Chunhui; Yu, Xiaorui] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Peoples R China; [Yu, Xiaorui] Xi An Jiao Tong Univ, Sch Med, Key Lab Environm & Gene Related Dis, Minist Educ, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yu, XR (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Peoples R China.	xiaoruiy@mail.xjtu.edu.cn	Hu, Cheng-Hu/I-4210-2013	Hu, Cheng-Hu/0000-0003-2443-6485	National Natural Science Foundation of China [30672286, 81271013]; National Research Foundation for the Doctoral Program of Higher Education of China [20120201110051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No: 30672286 and No: 81271013) and the National Research Foundation for the Doctoral Program of Higher Education of China (No: 20120201110051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Arroba AI, 2009, EUR J NEUROSCI, V30, P975, DOI 10.1111/j.1460-9568.2009.06902.x; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Brzyska M, 2003, ACTA NEUROBIOL EXP, V63, P171; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen KC, 2000, P NATL ACAD SCI USA, V97, P4357, DOI 10.1073/pnas.070056097; Chen Q, 1999, EXP NEUROL, V159, P283, DOI 10.1006/exnr.1999.7135; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Darios F, 2005, J NEUROSCI, V25, P4159, DOI 10.1523/JNEUROSCI.0060-05.2005; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Duncan RS, 2010, MOLECULES, V15, P1168, DOI 10.3390/molecules15031168; Farkas I, 2012, NEUROCHEM INT, V60, P631, DOI 10.1016/j.neuint.2012.02.024; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Guarneri P, 2003, ANN NY ACAD SCI, V1007, P117, DOI 10.1196/annals.1286.012; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Herson PS, 1999, J BIOL CHEM, V274, P833, DOI 10.1074/jbc.274.2.833; Hwang JY, 2009, CELL CALCIUM, V45, P233, DOI 10.1016/j.ceca.2008.10.006; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Kobayashi K, 1998, INVEST OPHTH VIS SCI, V39, P2105; Lapanantasin S, 2006, SYNAPSE, V60, P406, DOI 10.1002/syn.20308; Lee HJ, 2005, LIFE SCI, V78, P294, DOI 10.1016/j.lfs.2005.04.043; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mo MS, 2013, NEUROSCIENCE, V228, P1, DOI 10.1016/j.neuroscience.2012.10.002; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Munaut C, 2001, BRIT J OPHTHALMOL, V85, P877, DOI 10.1136/bjo.85.7.877; Nguyen TTH, 2008, BIOL PHARM BULL, V31, P2028, DOI 10.1248/bpb.31.2028; Noguchi A, 2008, LIFE SCI, V83, P865, DOI 10.1016/j.lfs.2008.10.002; Paschen W, 2000, BRAIN RES BULL, V53, P409, DOI 10.1016/S0361-9230(00)00369-5; PRINCE RL, 1994, ENDOCR REV, V15, P301, DOI 10.1210/er.15.3.301; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Seigel G, 1999, MOL VIS, V5; Selvaraj S, 2010, CNS NEUROL DISORD-DR, V9, P94, DOI 10.2174/187152710790966650; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Wu SZ, 2009, J NEUROCHEM, V109, P1225, DOI 10.1111/j.1471-4159.2009.06037.x; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Xiang GX, 2007, J CELL PHYSIOL, V212, P126, DOI 10.1002/jcp.21008; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012; Yu XR, 2005, MECH AGEING DEV, V126, P1135, DOI 10.1016/j.mad.2005.05.005; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	55	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77218	10.1371/journal.pone.0077218	http://dx.doi.org/10.1371/journal.pone.0077218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223708	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400005
J	Han, M; Zheng, Y				Han, Miao; Zheng, Yun			Comprehensive Analysis of Single Nucleotide Polymorphisms in Human MicroRNAs	PLOS ONE			English	Article							FRAGILE SITES; GENETIC-VARIATION; LET-7; EXPRESSION; DATABASE; COMMON; VARIANTS; SNP; IDENTIFICATION; BIOGENESIS	MicroRNAs (miRNAs) are endogenous small non-coding RNAs that repress their targets at post transcriptional level. Single Nucleotide Polymorphisms (SNPs) in miRNAs can lead to severe defects to the functions of miRNAs and might result in diseases. Although several studies have tried to identify the SNPs in human miRNA genes or only in the mature miRNAs, there are only limited endeavors to explain the distribution of SNPs in these important genes. After a genome-wide scan for SNPs in human miRNAs, we totally identified 1899 SNPs in 961 out of the 1527 reported miRNA precursors of human, which is the most complete list of SNPs in human miRNAs to date. More importantly, to explain the distributions of SNPs existed in human miRNAs, we comprehensively and systematically analyzed the identified SNPs in miRNAs from several aspects. Our results suggest that conservation, genomic context, secondary structure, and functional importance of human miRNAs affect the accumulations of SNPs in these genes. Our results also show that the number of SNPs with significantly different frequencies among various populations in the HapMap and 1000 Genome Project data are consistent with the geographical distributions of these populations. These analyses provide a better insight of SNPs in human miRNAs and the spreading of the SNPs in miRNAs in different populations.	[Han, Miao] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Han, Miao] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Zheng, Yun] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China	Fudan University; Fudan University; Kunming University of Science & Technology	Zheng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	zhengyun5488@gmail.com	Zheng, Yun/I-7011-2012; Zheng, Yun/AAS-1149-2021	Zheng, Yun/0000-0003-4292-9806; Zheng, Yun/0000-0003-4292-9806	Kunming University of Science and Technology	Kunming University of Science and Technology	The research was supported by a start-up grant of Kunming University of Science and Technology to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Armengol L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007230; Arola-Arnal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025982; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhartiya D, 2011, HUM MUTAT, V32, pE2226, DOI 10.1002/humu.21482; BROWN GG, 1982, P NATL ACAD SCI-BIOL, V79, P3246, DOI 10.1073/pnas.79.10.3246; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Debacker K, 2007, HUM MOL GENET, V16, pR150, DOI 10.1093/hmg/ddm136; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; El-Murr N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031862; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kasinski AL, 2009, NUCLEIC ACIDS RES, V461, P747; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; SCHMID M, 1985, HUM GENET, V71, P342, DOI 10.1007/BF00388461; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78028	10.1371/journal.pone.0078028	http://dx.doi.org/10.1371/journal.pone.0078028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223755	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400016
J	Hong, JJ; Wu, TY; Chang, TY; Chen, CY				Hong, Jun-Jie; Wu, Tzong-Yuan; Chang, Tsair-Yuan; Chen, Chung-Yung			Viral IRES Prediction System - a Web Server for Prediction of the IRES Secondary Structure In Silico	PLOS ONE			English	Article							INDEPENDENT TRANSLATION; RNA PSEUDOKNOTS; ENTRY SITE; INITIATION; VIRUS; SEQUENCE; SUBUNIT; REGION; CODON; TOOL	The internal ribosomal entry site (IRES) functions as cap-independent translation initiation sites in eukaryotic cells. IRES elements have been applied as useful tools for bi-cistronic expression vectors. Current RNA structure prediction programs are unable to predict precisely the potential IRES element. We have designed a viral IRES prediction system (VIPS) to perform the IRES secondary structure prediction. In order to obtain better results for the IRES prediction, the VIPS can evaluate and predict for all four different groups of IRESs with a higher accuracy. RNA secondary structure prediction, comparison, and pseudoknot prediction programs were implemented to form the three-stage procedure for the VIPS. The backbone of VIPS includes: the RNAL fold program, aimed to predict local RNA secondary structures by minimum free energy method; the RNA Align program, intended to compare predicted structures; and pknotsRG program, used to calculate the pseudoknot structure. VIPS was evaluated by using UTR database, IRES database and Virus database, and the accuracy rate of VIPS was assessed as 98.53%, 90.80%, 82.36% and 80.41% for IRES groups 1, 2, 3, and 4, respectively. This advance useful search approach for IRES structures will facilitate IRES related studies. The VIPS on-line website service is available at http://140.135.61.250/vips/.	[Hong, Jun-Jie; Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan; [Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Inst Biomed Technol, Chungli, Taiwan; [Wu, Tzong-Yuan] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Chungli, Taiwan; [Chang, Tsair-Yuan] Ming Chuan Univ, Informat Management Dept, Tao Yuan, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Ming Chuan University	Chen, CY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.	cychen@cycu.edu.tw	Chen, Chung-Yung/AAJ-2111-2020		National Science Counsel of Taiwan [NSC-99-2632-M-033-001-MY3]; R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan	National Science Counsel of Taiwan(Ministry of Science and Technology, Taiwan); R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan	This project was supported by the National Science Counsel of Taiwan (NSC-99-2632-M-033-001-MY3), and the R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F., 2011, J NAT SCI BIOL MED, V2, P2; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; EVSTAFIEVA AG, 1991, NUCLEIC ACIDS RES, V19, P665, DOI 10.1093/nar/19.3.665; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193; Gao JZM, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-27; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; HALLER AA, 1993, J VIROL, V67, P7461, DOI 10.1128/JVI.67.12.7461-7471.1993; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; Jiang T, 2002, J COMPUT BIOL, V9, P371, DOI 10.1089/10665270252935511; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Shibuya N, 2003, J VIROL, V77, P12002, DOI 10.1128/JVI.77.22.12002-12010.2003; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wower IK, 2009, RNA, V15, P128, DOI 10.1261/rna.1192409; Wu TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-160; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79288	10.1371/journal.pone.0079288	http://dx.doi.org/10.1371/journal.pone.0079288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223923	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400059
J	Purdy, SJ; Bussell, JD; Nunn, CP; Smith, SM				Purdy, Sarah J.; Bussell, John D.; Nunn, Christopher P.; Smith, Steven M.			Leaves of the Arabidopsis maltose exporter1 Mutant Exhibit a Metabolic Profile with Features of Cold Acclimation in the Warm	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; FREEZING TOLERANCE; LOW-TEMPERATURES; GENE-EXPRESSION; PLANT; STARCH; PHOTOSYNTHESIS; THALIANA; CARBON; BIOSYNTHESIS	Background: Arabidopsis plants accumulate maltose from starch breakdown during cold acclimation. The Arabidopsis mutant, maltose excess1-1, accumulates large amounts of maltose in the plastid even in the warm, due to a deficient plastid envelope maltose transporter. We therefore investigated whether the elevated maltose level in mex1-1 in the warm could result in changes in metabolism and physiology typical of WT plants grown in the cold. Principal Findings: Grown at 21 degrees C, mex1-1 plants were much smaller, with fewer leaves, and elevated carbohydrates and amino acids compared to WT. However, after transfer to 4 degrees C the total soluble sugar pool and amino acid concentration was in equal abundance in both genotypes, although the most abundant sugar in mex1-1 was still maltose whereas sucrose was in greatest abundance in WT. The chlorophyll a/b ratio in WT was much lower in the cold than in the warm, but in mex1-1 it was low in both warm and cold. After prolonged growth at 4 degrees C, the shoot biomass, rosette diameter and number of leaves at bolting were similar in mex1-1 and WT. Conclusions: The mex1-1 mutation in warm-grown plants confers aspects of cold acclimation, including elevated levels of sugars and amino acids and low chlorophyll a/b ratio. This may in turn compromise growth of mex1-1 in the warm relative to WT. We suggest that elevated maltose in the plastid could be responsible for key aspects of cold acclimation.	[Purdy, Sarah J.; Bussell, John D.; Nunn, Christopher P.; Smith, Steven M.] Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, Perth, WA 6009, Australia; [Purdy, Sarah J.; Nunn, Christopher P.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Western Australia; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Purdy, SJ (corresponding author), Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, Perth, WA 6009, Australia.	sap@aber.ac.uk	Bussell, John/E-7952-2010; Smith, Steven/HDM-9496-2022; Smith, Steven M/G-7183-2015; Nunn, Chris/P-1909-2019	Smith, Steven M/0000-0001-5661-9994; Purdy, Sarah/0000-0002-6334-069X	Australian Research Council [DP0666434, FF0457721]; Centres of Excellence scheme of the Government of Western Australia	Australian Research Council(Australian Research Council); Centres of Excellence scheme of the Government of Western Australia	The authors gratefully acknowledge funding support from the Australian Research Council (grants DP0666434 and FF0457721) and the Centres of Excellence scheme of the Government of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Espinoza C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014101; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Less H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-14; Lundmark M, 2006, PLANT CELL ENVIRON, V29, P1703, DOI 10.1111/j.1365-3040.2006.01543.x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Purdy SJ, 2011, J PLANT PHYSIOL, V168, P263, DOI 10.1016/j.jplph.2010.07.001; Reyes-Diaz M, 2006, J EXP BOT, V57, P3687, DOI 10.1093/jxb/erl125; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; VANOOSTEN JJ, 1994, PLANT CELL ENVIRON, V17, P913, DOI 10.1111/j.1365-3040.1994.tb00320.x; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhan XQ, 2012, P NATL ACAD SCI USA, V109, P18198, DOI 10.1073/pnas.1216199109; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	38	18	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79412	10.1371/journal.pone.0079412	http://dx.doi.org/10.1371/journal.pone.0079412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223944	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400064
J	Campos, F; Sobrino, T; Vieites-Prado, A; Perez-Mato, M; Rodriguez-Yanez, M; Blanco, M; Castillo, J				Campos, Francisco; Sobrino, Tomas; Vieites-Prado, Alba; Perez-Mato, Maria; Rodriguez-Yanez, Manuel; Blanco, Miguel; Castillo, Jose			Hyperthermia in Human Ischemic and Hemorrhagic Stroke: Similar Outcome, Different Mechanisms	PLOS ONE			English	Article							EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BODY-TEMPERATURE; AMINO-ACIDS; THERAPIES; MORTALITY; INFARCT; INJURY	Hyperthermia is a predictor of poor outcome in ischemic (IS) and intracerebral hemorrhagic (ICH) stroke. Our aim was to study the plausible mechanisms involved in the poor outcome associated to hyperthermia in stroke. We conducted a case-control study including patients with IS (n = 100) and ICH (n = 100) within the first 12 hours from symptom onset. Specifically, IS and ICH patients were consecutively included into 2 subgroups, according to the highest body temperature within the first 24 hours: Tmax <37.5 degrees C and Tmax >= 37.5 degrees C, up to reach 50 patients per subgroup of temperature for both IS and ICH patients. Body temperature was determined at admission and every 4 hours during the first 48 hours. Main outcome variable was poor functional outcome (modified Rankin scale score >2) at 3 months. Serum levels of glutamate and active MMP-9 were measured at admission. Our results showed that Tmax >= 37.5 degrees C within the first 24 hours was independently associated with poor outcome in both IS (OR, 12.43; 95% CI, 3.73-41.48; p<0.0001) and ICH (OR, 4.29; 95% CI, 1.32-13.91; p = 0.015) after adjusting for variables with a proven biological relevance for outcome. However, when molecular markers levels were included in the logistic regression model, we observed that glutamate (OR, 1.01; 95% CI, 1.00-1.02; p = 0.001) and infarct volume (OR, 1.06; 95% CI, 1.01-1.10; p = 0.015) were the only variables independently associated to poor outcome in IS, and active MMP-9 (OR, 1.04; 95% CI, 1.00-1.08; p = 0.002) and National Institute of Health Stroke Scale (NIHSS) at admission (OR, 1.29; 95% CI, 1.13-1.49; p<0.0001) in ICH. In conclusion, these results suggest that although the outcome associated to hyperthermia is similar in human IS and ICH, the underlying mechanisms may be different.	[Campos, Francisco; Sobrino, Tomas; Vieites-Prado, Alba; Perez-Mato, Maria; Rodriguez-Yanez, Manuel; Blanco, Miguel; Castillo, Jose] Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Hosp Clin Univ, Dept Neurol,Neurovasc Area,Clin Neurosci Res Lab, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Castillo, J (corresponding author), Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Hosp Clin Univ, Dept Neurol,Neurovasc Area,Clin Neurosci Res Lab, Santiago De Compostela, Spain.	jose.castillo@usc.es	Sobrino, Tomás/D-2498-2017; Vieites-Prado, Alba/AAD-3378-2022; Rodríguez-Yáñez, Manuel/ABI-1283-2020; Vieites-Prado, Alba/GVS-3749-2022	Sobrino, Tomás/0000-0002-9760-8690; Vieites-Prado, Alba/0000-0002-8807-3321; Rodríguez-Yáñez, Manuel/0000-0002-5381-8557; Vieites-Prado, Alba/0000-0002-8807-3321; Castillo, Jose/0000-0002-6685-3001	Spanish Ministry of Economy and Competitiveness [SAF2011-30517]; Xunta de Galicia [Conselleria Economia Industria: 10PXIB918282PR, Conselleria Educacion: CN2011/010]; Instituto de Salud Carlos III [PI11/00909, CP12/03121]; Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS [RD12/0014]; COST Action "Brain Extracellular Matrix in Health and Disease'' [BM1001]; Fundacion Mutua Madrilena; European Union program FEDER; Miguel Servet Program of Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS; COST Action "Brain Extracellular Matrix in Health and Disease''; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); European Union program FEDER; Miguel Servet Program of Instituto de Salud Carlos III	This project has been partially supported by grants from the Spanish Ministry of Economy and Competitiveness SAF2011-30517, Xunta de Galicia (Conselleria Economia Industria: 10PXIB918282PR; and Conselleria Educacion: CN2011/010), Instituto de Salud Carlos III (PI11/00909 and CP12/03121), Spanish Research Network on Cerebrovascular Diseases RETICS-INVICTUS (RD12/0014), COST Action BM1001 "Brain Extracellular Matrix in Health and Disease'', Fundacion Mutua Madrilena and by the European Union program FEDER. Furthermore, T. Sobrino is recipient of a research contract from Miguel Servet Program of Instituto de Salud Carlos III. Sponsors did not participate in study design, collection, analysis and interpretation of the data, writing the report or in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Belur PK, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1317; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Campos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044191; Campos F, 2012, NEUROCHEM INT, V60, P495, DOI 10.1016/j.neuint.2012.02.003; Campos F, 2012, INT J BIOCHEM CELL B, V44, P262, DOI 10.1016/j.biocel.2011.11.003; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; CASTILLO J, 1994, CEREBROVASC DIS, V4, P66, DOI 10.1159/000108454; den Hertog HM, 2011, J NEUROL, V258, P302, DOI 10.1007/s00415-010-5756-4; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Lee ST, 2006, J CEREBR BLOOD F MET, V26, P536, DOI 10.1038/sj.jcbfm.9600213; Leira R, 2006, J INTERN MED, V260, P343, DOI 10.1111/j.1365-2796.2006.01694.x; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Rodriguez-Yanez M, 2011, STROKE, V42, P2813, DOI 10.1161/STROKEAHA.111.614503; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f	22	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78429	10.1371/journal.pone.0078429	http://dx.doi.org/10.1371/journal.pone.0078429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223804	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400060
J	Kim, CK; Lee, CH; Lee, SB; Oh, JW				Kim, Chang Kyu; Lee, Chi Ho; Lee, Seung-Bae; Oh, Jae-Wook			Simplified Large-Scale Refolding, Purification, and Characterization of Recombinant Human Granulocyte-Colony Stimulating Factor in Escherichia coli	PLOS ONE			English	Article							CELL-DENSITY CULTIVATION; G-CSF; PROTEIN; EXPRESSION; CHEMOTHERAPY; CLONING	Granulocyte-colony stimulating factor (G-CSF) is a pleiotropic cytokine that stimulates the development of committed hematopoietic progenitor cells and enhances the functional activity of mature cells. Here, we report a simplified method for fed-batch culture as well as the purification of recombinant human (rh) G-CSF. The new system for rhG-CSF purification was performed using not only temperature shift strategy without isopropyl-l-thio-beta-d-galactoside (IPTG) induction but also the purification method by a single step of prep-HPLC after the pH precipitation of the refolded samples. Through these processes, the final cell density and overall yield of homogenous rhG-CSF were obtained 42.8 g as dry cell weights, 1.75 g as purified active proteins, from 1 L culture broth, respectively. The purity of rhG-CSF was finally 99% since the isoforms of rhG-CSF could be separated through the prep-HPLC step. The result of biological activity indicated that purified rhG-CSF has a similar profile to the World Health Organization (WHO) 2nd International Standard for G-CSF. Taken together, our results demonstrate that the simple purification through a single step of prep-HPLC may be valuable for the industrial-scale production of biologically active proteins.	[Kim, Chang Kyu; Oh, Jae-Wook] Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea; [Lee, Chi Ho] Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Food Sci & Biotechnol Anim Resources, Seoul, South Korea; [Lee, Seung-Bae] Sangji Univ, Div Anim Resources & Life Sci, Wonju, South Korea	Konkuk University; Konkuk University; Sangji University	Oh, JW (corresponding author), Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea.	ohjw@konkuk.ac.kr	Oh, Jae-Wook/D-3597-2011		Konkuk University	Konkuk University	This study was supported by Konkuk University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Basu S, 2002, INT J MOL MED, V10, P3; Boubeva R, 2012, CHIMIA, V66, P281, DOI 10.2533/chimia.2012.281; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; European Directorate for the Quality of Medicines, 2009, EUR PHARM 6 3 FILGR; Gascon P, 2012, TARGET ONCOL, V7, pS29, DOI 10.1007/s11523-011-0190-9; Gomes FR, 2012, WORLD J MICROB BIOT, V28, P2593, DOI 10.1007/s11274-012-1068-4; Gravel P, 2012, TARGET ONCOL, V7, pS3, DOI 10.1007/s11523-011-0187-4; HAMMERLING U, 1995, J PHARMACEUT BIOMED, V13, P9, DOI 10.1016/0731-7085(94)00128-O; Hinderer W, 2012, Patent, Patent No. [US2012/0328560, 20120328560]; Hubel K, 2003, ONKOLOGIE, V26, P73, DOI 10.1159/000069868; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Kelker MS, 2004, J MOL BIOL, V342, P1237, DOI 10.1016/j.jmb.2004.07.089; Khalilzadeh R, 2008, J IND MICROBIOL BIOT, V35, P1643, DOI 10.1007/s10295-008-0408-8; Kim CK, 2010, FOOD SCI BIOTECHNOL, V19, P1627, DOI 10.1007/s10068-010-0230-8; LU HS, 1993, PROTEIN EXPRES PURIF, V4, P465, DOI 10.1006/prep.1993.1061; LU HS, 1989, ARCH BIOCHEM BIOPHYS, V268, P81, DOI 10.1016/0003-9861(89)90567-5; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Min CK, 2011, J BIOTECHNOL, V151, P350, DOI 10.1016/j.jbiotec.2010.12.023; Murray HD, 2003, J BACTERIOL, V185, P28, DOI 10.1128/JB.185.1.28-34.2003; NAGATA S, 1989, BIOESSAYS, V10, P113, DOI 10.1002/bies.950100405; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; Rao DVK, 2008, MOL BIOTECHNOL, V38, P221, DOI 10.1007/s12033-007-9018-3; Rao DVK, 2008, BIOTECHNOL APPL BIOC, V50, P77, DOI 10.1042/BA20070130; Rathore AS, 2003, BIOTECHNOL APPL BIOC, V37, P51, DOI 10.1042/BA20020068; Rubenstein EB, 2000, INT J ANTIMICROB AG, V16, P117, DOI 10.1016/S0924-8579(00)00214-4; Schwanke RC, 2009, INT J BIOL MACROMOL, V45, P97, DOI 10.1016/j.ijbiomac.2009.04.005; Son YJ, 2007, BIOTECHNOL BIOPROC E, V12, P556, DOI 10.1007/BF02931354; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; Thomson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049891; van Reis R, 2001, CURR OPIN BIOTECH, V12, P208, DOI 10.1016/S0958-1669(00)00201-9; Vanz ALS, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-13; Wagley Yadav, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P277, DOI 10.1089/mab.2013.0015; Wang CZ, 2012, PROCESS BIOCHEM, V47, P2262, DOI 10.1016/j.procbio.2012.09.002; WINGFIELD P, 1988, EUR J BIOCHEM, V173, P65, DOI 10.1111/j.1432-1033.1988.tb13967.x; Wittman B, 2006, CANCER TREAT REV, V32, P289, DOI 10.1016/j.ctrv.2006.03.002	37	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80109	10.1371/journal.pone.0080109	http://dx.doi.org/10.1371/journal.pone.0080109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224041	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400151
J	Miller, D; Turner, SW; Spiteri-Cornish, D; McInnes, N; Scaife, A; Danielian, PJ; Devereux, G; Walsh, GM				Miller, David; Turner, Steve W.; Spiteri-Cornish, Daniella; McInnes, Neil; Scaife, Alison; Danielian, Peter J.; Devereux, Graham; Walsh, Garry M.			Culture of Airway Epithelial Cells from Neonates Sampled within 48-Hours of Birth	PLOS ONE			English	Article							ASTHMA PATHOGENESIS; PEDIATRIC-AIRWAY; CHILDREN; NASAL; REPAIR	Introduction: Little is known about how neonatal airway epithelial cell phenotype impacts on respiratory disease in later life. This study aimed to establish a methodology to culture and characterise neonatal nasal epithelial cells sampled from healthy, non-sedated infants within 48 hours of delivery. Methods: Nasal epithelial cells were sampled by brushing both nostrils with an interdental brush, grown to confluence and sub-cultured. Cultured cells were characterised morphologically by light and electron microscopy and by immunocytochemistry. As an exemplar pro-inflammatory chemokine, IL-8 concentrations were measured in supernatants from unstimulated monolayers and after exposure to IL-1 beta/TNF-alpha a or house dust mite extract. Results: Primary cultures were successfully established in 135 (91%) of 149 neonatal samples seeded, with 79% (n = 117) successfully cultured to passage 3. The epithelial lineage of the cells was confirmed by morphological analysis and immunostaining. Constitutive IL-8 secretion was observed and was upregulated by IL-1 beta/TNF-alpha or house dust mite extract in a dose dependent manner. Conclusion: We describe a safe, minimally invasive method of culturing nasal epithelial cells from neonates suitable for functional cell analysis offering an opportunity to study "naive'' cells that may prove useful in elucidating the role of the epithelium in the early origins of asthma and/or allergic rhinitis.	[Miller, David; Turner, Steve W.; Spiteri-Cornish, Daniella; McInnes, Neil; Devereux, Graham] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Aberdeen, Scotland; [Miller, David; Spiteri-Cornish, Daniella; McInnes, Neil; Scaife, Alison; Walsh, Garry M.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Danielian, Peter J.] Aberdeen Matern Hosp, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Miller, D (corresponding author), Univ Aberdeen, Royal Aberdeen Childrens Hosp, Dept Child Hlth, Aberdeen, Scotland.	d.miller@nhs.net		Spiteri Cornish, Daniella/0000-0002-5814-2461	Chief Scientist Office, Edinburgh, UK [CAF/10/06]; Chief Scientist Office [CAF/10/06] Funding Source: researchfish	Chief Scientist Office, Edinburgh, UK; Chief Scientist Office	This study was funded by the Chief Scientist Office, Edinburgh, UK (CAF/10/06). http://www.cso.scot.nhs.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush A, 2000, ALLERGY, V55, P685, DOI 10.1034/j.1398-9995.2000.00031.x; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Devereux G, 2007, PEDIATR PULM, V42, P663, DOI 10.1002/ppul.20640; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; HOLT PG, 2006, EARLY LIFE ORIGINS A, P223; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Lane C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-53; LEE RMKW, 1984, AM REV RESPIR DIS, V129, P190; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Mosler K, 2008, J CYST FIBROS, V7, P44, DOI 10.1016/j.jcf.2007.04.005; O'Callaghan C, 1991, ARCH DIS CHILD, V66, P4431; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Prescott SL, 2003, CURR OPIN ALLERGY CL, V3, P125, DOI 10.1097/01.all.0000064776.57552.32; Pringle EJ, 2012, PEDIATR PULM, V47, P1215, DOI 10.1002/ppul.22672; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Turner SW, 2010, THORAX, V65, P391, DOI 10.1136/thx.2008.111385; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78321	10.1371/journal.pone.0078321	http://dx.doi.org/10.1371/journal.pone.0078321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223790	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400050
J	Mudgil, Y; Ghawana, S; Jones, AM				Mudgil, Yashwanti; Ghawana, Sanjay; Jones, Alan M.			N-MYC DOWN-REGULATED-LIKE Proteins Regulate Meristem Initiation by Modulating Auxin Transport and MAX2 Expression	PLOS ONE			English	Article							SUPPRESSOR GENE DRG-1; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; TUMOR-METASTASIS; BETA-SUBUNIT; CYTOKININ BIOSYNTHESIS; DEPENDENT REGULATION; BUD OUTGROWTH; BREAST-CANCER; PIN PROTEINS	Background: N-MYC DOWN-REGULATED-LIKE (NDL) proteins interact with the G beta subunit (AGB1) of the heterotrimeric G protein complex and play an important role in AGB1-dependent regulation of lateral root formation by affecting root auxin transport, auxin gradients and the steady-state levels of mRNA encoding the PIN-FORMED 2 and AUXIN 1 auxin transport facilitators. Auxin transport in aerial tissue follows different paths and utilizes different transporters than in roots; therefore, in the present study, we analyzed whether NDL proteins play an important role in AGB1-dependent, auxin-mediated meristem development. Methodology/Principal Findings: Expression levels of NDL gene family members need to be tightly regulated, and altered expression (both over-expression and down-regulation) confers ectopic growth. Over-expression of NDL1 disrupts vegetative and reproductive organ development. Reduced expression of the NDL gene family members results in asymmetric leaf emergence, twinning of rosette leaves, defects in leaf formation, and abnormal silique distribution. Reduced expression of the NDL genes in the agb1-2 (null allele) mutant rescues some of the abnormal phenotypes, such as silique morphology, silique distribution, and peduncle angle, suggesting that proper levels of NDL proteins are maintained by AGB1. We found that all of these abnormal aerial phenotypes due to altered NDL expression were associated with increases in basipetal auxin transport, altered auxin maxima and altered MAX2 expression within the inflorescence stem. Conclusion/Significance: NDL proteins, together with AGB1, act as positive regulators of meristem initiation and branching. AGB1 and NDL1 positively regulate basipetal inflorescence auxin transport and modulate MAX2 expression in shoots, which in turn regulates organ and lateral meristem formation by the establishment and maintenance of auxin gradients.	[Mudgil, Yashwanti; Ghawana, Sanjay] Univ Delhi, Dept Bot, Delhi 110007, India; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of Delhi; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mudgil, Y (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	ymudgil@botany.du.ac.in	Ariel, Pablo/AGJ-4118-2022	MUDGIL, YASHWANTI/0000-0002-0423-3499	Government of India; Department of Biotechnology-BIO-CARE grant [102/IFD/SAN/3538/2011-2012]; DST FAST-TRACK grant from SERB [SR/FT/LS-30/2011]; UGC, University of Delhi; DBT CREST award; NIGMS [R01GM065989]; DOE [DE-FG02-05er15671]; NSF [MCB-0723515, MCB-1158054, MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy; Div Of Molecular and Cellular Bioscience [1158054] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	Government of India; Department of Biotechnology-BIO-CARE grant; DST FAST-TRACK grant from SERB; UGC, University of Delhi; DBT CREST award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial source: This work was supported by the Government of India, Department of Biotechnology-BIO-CARE grant (102/IFD/SAN/3538/2011-2012), DST FAST-TRACK (SR/FT/LS-30/2011) grant from SERB, a research grant provided by UGC, University of Delhi and DBT CREST award (2011-2012) to YM. Work in the Jones Lab is supported by grants from the NIGMS (R01GM065989), DOE (DE-FG02-05er15671), and NSF (MCB-0723515, MCB-1158054, and MCB-0718202). The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy funded technical support in this study. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balla J, 2011, PLANT J, V65, P571, DOI 10.1111/j.1365-313X.2010.04443.x; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Benjamins R, 2005, BIOESSAYS, V27, P1246, DOI 10.1002/bies.20322; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Cheng Y, 2007, PLANT CELL; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Cheng ZJ, 2012, PLANT PHYSL; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; Fourquin C, 2007, ANN BOT-LONDON, V100, P651, DOI 10.1093/aob/mcm136; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J., 2009, EUR J CELL BIOL; GALAVAZI G, 1965, STAIN TECHNOL, V40, P1; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Guang RJ, 2000, CANCER RES, V60, P749; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lazar G, 2006, P NATL ACAD SCI USA, V103, P472, DOI 10.1073/pnas.0509463102; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Meister RJ, 2005, PLANT PHYSIOL, V137, P651, DOI 10.1104/pp.104.055368; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Murphy AS, 2012, CURR BIOL, V22, pR576, DOI 10.1016/j.cub.2012.06.008; Naramoto S, 2009, DEVELOPMENT, V136, P1529, DOI 10.1242/dev.030098; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peskan-Berghofer T, 2005, PLANTA, V220, P737, DOI 10.1007/s00425-004-1393-4; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Prunet N, 2009, PLANT PHYSIOL, V150, P1764, DOI 10.1104/pp.109.141812; Reinhardt D, 2005, CURR OPIN PLANT BIOL, V8, P487, DOI 10.1016/j.pbi.2005.07.012; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Santos F, 2010, PLANT BIOLOGY, V12, P3, DOI 10.1111/j.1438-8677.2010.00388.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Schmulling T, 2002, J PLANT GROWTH REGUL, V21, P40, DOI 10.1007/s003440010046; Shimizu-Sato S, 2009, PLANT MOL BIOL, V69, P429, DOI 10.1007/s11103-008-9416-3; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; SIEBURTH LE, 1995, PLANT CELL, V7, P1249, DOI 10.1105/tpc.7.8.1249; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Smith SM, 2012, CURR BIOL, V22, pR924, DOI 10.1016/j.cub.2012.09.016; Stirnberg P, 2010, BIOCHEM SOC T, V38, P717, DOI 10.1042/BST0380717; Sun J.-P., 2012, ELECT J DIFFERENTIAL, V2012, P1; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; vanBelzen N, 1997, LAB INVEST, V77, P85; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4	86	13	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77863	10.1371/journal.pone.0077863	http://dx.doi.org/10.1371/journal.pone.0077863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223735	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400018
J	Yuan, K; Jin, CW; Cheng, P; Yang, XJ; Dong, T; Bi, YZ; Xing, LH; von Deneen, KM; Yu, DH; Liu, JY; Liang, J; Cheng, TT; Qin, W; Tian, J				Yuan, Kai; Jin, Chenwang; Cheng, Ping; Yang, Xuejuan; Dong, Tao; Bi, Yanzhi; Xing, Lihong; von Deneen, Karen M.; Yu, Dahua; Liu, Junyu; Liang, Jun; Cheng, Tingting; Qin, Wei; Tian, Jie			Amplitude of Low Frequency Fluctuation Abnormalities in Adolescents with Online Gaming Addiction	PLOS ONE			English	Article							INTERNET ADDICTION; REGIONAL HOMOGENEITY	The majority of previous neuroimaging studies have demonstrated both structural and task-related functional abnormalities in adolescents with online gaming addiction (OGA). However, few functional magnetic resonance imaging (fMRI) studies focused on the regional intensity of spontaneous fluctuations in blood oxygen level-dependent (BOLD) during the resting state and fewer studies investigated the relationship between the abnormal resting-state properties and the impaired cognitive control ability. In the present study, we employed the amplitude of low frequency fluctuation (ALFF) method to explore the local features of spontaneous brain activity in adolescents with OGA and healthy controls during resting-state. Eighteen adolescents with OGA and 18 age-, education-and gender-matched healthy volunteers participated in this study. Compared with healthy controls, adolescents with OGA showed a significant increase in ALFF values in the left medial orbitofrontal cortex (OFC), the left precuneus, the left supplementary motor area (SMA), the right parahippocampal gyrus (PHG) and the bilateral middle cingulate cortex (MCC). The abnormalities of these regions were also detected in previous addiction studies. More importantly, we found that ALFF values of the left medial OFC and left precuneus were positively correlated with the duration of OGA in adolescents with OGA. The ALFF values of the left medial OFC were also correlated with the color-word Stroop test performance. Our results suggested that the abnormal spontaneous neuronal activity of these regions may be implicated in the underlying pathophysiology of OGA.	[Yuan, Kai; Cheng, Ping; Yang, Xuejuan; Dong, Tao; Bi, Yanzhi; Xing, Lihong; von Deneen, Karen M.; Yu, Dahua; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Jin, Chenwang] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Liu, Junyu; Liang, Jun; Cheng, Tingting] Baotou Heping Middle Sch, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Xi'an Jiaotong University; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Yuan, K (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	kyuan@xidian.edu.cn	Yuan, Kai/I-4150-2016; 秦, 伟/J-9770-2016; tian, jie/M-6336-2013; Yuan, Kai/M-9403-2013; Tian, Jie/H-1190-2011; Yu, Dahua/N-7242-2013	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Tian, Jie/0000-0003-0498-0432; Yu, Dahua/0000-0001-7850-7512	Project for the National Key Basic Research and Development Program (973) [2011CB707700]; National Natural Science Foundation of China [81227901, 81271644, 81271546, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81301281]; Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia [2012MS0908]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant No. 2011CB707700; the National Natural Science Foundation of China under Grant Nos. 81227901, 81271644, 81271546, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81301281; and the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia under Grant No. 2012MS0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goni J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017408; Ko CH, 2011, ADDICTION BIOL; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Liu J, 2010, CHINESE MED J-PEKING, V123, P1904, DOI 10.3760/cma.j.issn.0366-6999.2010.14.014; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Murali V, 2007, ADV PSYCHIAT TREATME, V13, P24; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Yuan K, 2011, COMMUNICATIVE INTEGR, V4; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	33	50	51	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78708	10.1371/journal.pone.0078708	http://dx.doi.org/10.1371/journal.pone.0078708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223843	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400085
J	Genova, HM; Rajagopalan, V; DeLuca, J; Das, A; Binder, A; Arjunan, A; Chiaravalloti, N; Wylie, G				Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Binder, Allison; Arjunan, Aparna; Chiaravalloti, Nancy; Wylie, Glenn			Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging	PLOS ONE			English	Article							BASAL GANGLIA; SEVERITY SCALE; POSTSTROKE FATIGUE; CORTICAL ATROPHY; IMPACT; WHITE; PERFORMANCE; IMAGES; TOOL	The present study investigated the neural correlates of cognitive fatigue in Multiple Sclerosis (MS), looking specifically at the relationship between self-reported fatigue and objective measures of cognitive fatigue. In Experiment 1, functional magnetic resonance imaging (fMRI) was used to examine where in the brain BOLD activity covaried with "state" fatigue, assessed during performance of a task designed to induce cognitive fatigue while in the scanner. In Experiment 2, diffusion tensor imaging (DTI) was used to examine where in the brain white matter damage correlated with increased "trait" fatigue in individuals with MS, assessed by the Fatigue Severity Scale (FSS) completed outside the scanning session. During the cognitively fatiguing task, the MS group had increased brain activity associated with fatigue in the caudate as compared with HCs. DTI findings revealed that reduced fractional anisotropy in the anterior internal capsule was associated with increased self-reported fatigue on the FSS. Results are discussed in terms of identifying a "fatigue-network" in MS.	[Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Chiaravalloti, Nancy; Wylie, Glenn] Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; [Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Chiaravalloti, Nancy; Wylie, Glenn] Rutgers, Dept Phys Med & Rehabil, New Jersey Med Sch, Newark, NJ USA; [Binder, Allison] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Arjunan, Aparna] Suffolk Univ, Dept Clin Psychol, Boston, MA 02114 USA	Kessler Institute for Rehabilitation; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Massachusetts System; University of Massachusetts Amherst; Suffolk University	Genova, HM (corresponding author), Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA.	hgenova@kesslerfoundation.org; gwylie@kesslerfoundation.org	Das, Abhijit/AAQ-1729-2020; R, Venkateswaran/GOV-7176-2022	R, Venkateswaran/0000-0001-9040-0785; Chiaravalloti, Nancy/0000-0003-2943-7567	National Multiple Sclerosis Society (NMSS) [PP1364]; NMSS RG [4232A1/1, 3330A1/3]	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NMSS RG	This work was supported in part by the National Multiple Sclerosis Society (NMSS) PP1364 to Glenn Wylie, NMSS RG 4232A1/1 to Helen Genova, and NMSS RG 3330A1/3 to Nancy Chiaravalloti. NMSS website: www.nationalmssociety.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman P.L., 2011, COGNITIVE FATIGUE MU; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baudewig J, 2003, MAGN RESON IMAGING, V21, P1121, DOI 10.1016/j.mri.2003.08.013; Beatty WW, 2003, CLIN NEUROPSYCHOL, V17, P551, DOI 10.1076/clin.17.4.551.27942; Benito-Leon J, 2007, MULT SCLER J, V13, P645, DOI 10.1177/1352458506073528; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; DeLuca J, 2005, ISS CLIN COGN NEUROP, P37; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; DeLuca J, 2009, PHYS MED REH CLIN N, V20, P325, DOI 10.1016/j.pmr.2008.12.007; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JENNEKENSSCHINKEL A, 1988, J NEUROL SCI, V85, P173, DOI 10.1016/0022-510X(88)90154-2; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Learmonth YC, 2013, J NEUROL SCI, V331, P102, DOI 10.1016/j.jns.2013.05.023; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; Mills RJ, 2009, MULT SCLER J, V15, P81, DOI 10.1177/1352458508096215; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Nebes RD, 2006, AGING NEUROPSYCHOL C, V13, P326, DOI 10.1080/138255890969294; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz E, 2010, RADIOLOGY, V254, P227, DOI 10.1148/radiol.2541090817; Ritvo P. G., 1977, MULTIPLE SCLEROSIS Q; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Wechsler D., 1999, WECHSLER ABBREVIATED; Weissman DH, 2002, COGNITIVE BRAIN RES, V15, P47, DOI 10.1016/S0926-6410(02)00215-X; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	88	90	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78811	10.1371/journal.pone.0078811	http://dx.doi.org/10.1371/journal.pone.0078811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223850	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300034
J	Koshkin, V; Yang, BB; Krylov, SN				Koshkin, Vasilij; Yang, Burton B.; Krylov, Sergey N.			Kinetics of MDR Transport in Tumor-Initiating Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; LASER-SCANNING CYTOMETRY; ACUTE MYELOID-LEUKEMIA; FLOW-CYTOMETRY; P-GLYCOPROTEIN; STEM-CELLS; RESISTANCE; EXPRESSION; EFFLUX; TUMORIGENICITY	Multidrug resistance (MDR) driven by ABC (ATP binding cassette) membrane transporters is one of the major causes of treatment failure in human malignancy. MDR capacity is thought to be unevenly distributed among tumor cells, with higher capacity residing in tumor-initiating cells (TIC) (though opposite finding are occasionally reported). Functional evidence for enhanced MDR of TICs was previously provided using a "side population" assay. This assay estimates MDR capacity by a single parameter - cell's ability to retain fluorescent MDR substrate, so that cells with high MDR capacity ("side population") demonstrate low substrate retention. In the present work MDR in TICs was investigated in greater detail using a kinetic approach, which monitors MDR efflux from single cells. Analysis of kinetic traces obtained allowed for the estimation of both the velocity (V-max) and affinity (K-M) of MDR transport in single cells. In this way it was shown that activation of MDR in TICs occurs in two ways: through the increase of V-max in one fraction of cells, and through decrease of K-M in another fraction. In addition, kinetic data showed that heterogeneity of MDR parameters in TICs significantly exceeds that of bulk cells. Potential consequences of these findings for chemotherapy are discussed.	[Koshkin, Vasilij; Krylov, Sergey N.] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Koshkin, Vasilij; Krylov, Sergey N.] York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 2R7, Canada; [Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	York University - Canada; York University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Krylov, SN (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	skrylov@yorku.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study has been funded only by the Natural Sciences and Engineering Research Council of Canada (NSERC). This is the government funding agency that had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Afrimzon E, 2013, J IMMUNOL METHODS, V387, P96, DOI 10.1016/j.jim.2012.10.001; [Anonymous], ABC TRANSPORTERS MUL; Aulmann S, 2010, HUM PATHOL, V41, P574, DOI 10.1016/j.humpath.2009.08.023; Bansal N, 2009, CURR PHARM BIOTECHNO, V10, P192, DOI 10.2174/138920109787315015; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan LL, 2011, CYTOM PART A, V79A, P507, DOI 10.1002/cyto.a.21071; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; DIVE C, 1990, CYTOMETRY, V11, P244, DOI 10.1002/cyto.990110205; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; FINLAY TH, 1993, ENDOCRINOLOGY, V133, P996, DOI 10.1210/en.133.3.996; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodale D, 2009, CYTOM PART A, V75A, P344, DOI 10.1002/cyto.a.20657; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta V, 2011, METHODS MOL BIOL, V716, P179, DOI 10.1007/978-1-61779-012-6_11; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583; Kars MD, 2006, ANTICANCER RES, V26, P4559; Koshkin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041368; Koslikin V, 2011, ANAL CHEM, V83, P6132, DOI 10.1021/ac201690t; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; LEARY JF, 1994, METHOD CELL BIOL, V42, P331; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; LEITH CP, 1995, BLOOD, V86, P2329, DOI 10.1182/blood.V86.6.2329.bloodjournal8662329; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Liao D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065005; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Oswald J, 2004, CYTOM PART A, V57A, P100, DOI 10.1002/cyto.a.10118; Pallis M, 2005, METH MOLEC MED, V111, P167; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Shapiro HM, 2005, PRACTICAL FLOW CYTOM; Stein WD, 1997, PHYSIOL REV, V77, P545, DOI 10.1152/physrev.1997.77.2.545; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Taylor BJ, 2001, LEUKEMIA RES, V25, P1127, DOI 10.1016/S0145-2126(01)00085-6; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wang HX, 2011, ONCOLOGIST, V16, P966, DOI 10.1634/theoncologist.2010-0230; Wong WW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100172; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xie GZ, 2012, CANCER LETT, V316, P53, DOI 10.1016/j.canlet.2011.10.018; Yan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024397; Yang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059147; Yang ZL, 2012, J BREAST CANCER, V15, P388, DOI 10.4048/jbc.2012.15.4.388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhan JF, 2011, CELL ONCOL, V34, P451, DOI 10.1007/s13402-011-0020-1; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y; Zhao LH, 2011, MED ONCOL, V28, P1188, DOI 10.1007/s12032-010-9624-y; Zhao LH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-98	53	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79222	10.1371/journal.pone.0079222	http://dx.doi.org/10.1371/journal.pone.0079222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223908	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300067
J	Xu, YY; Zhou, Y; Hong, S; Xia, ZH; Cui, DQ; Guo, JC; Xu, HX; Jiang, XY				Xu, Yuanyuan; Zhou, Yang; Hong, Sha; Xia, Zhihui; Cui, Dangqun; Guo, Jianchun; Xu, Haixia; Jiang, Xingyu			Functional Characterization of a Wheat NHX Antiporter Gene TaNHX2 That Encodes a K+/H+ Exchanger	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SALT TOLERANCE; NA+/H+ ANTIPORTERS; SACCHAROMYCES-CEREVISIAE; STRESS TOLERANCE; CATION/H+ ANTIPORTER; TRANSPORT; YEAST; HOMEOSTASIS; PLANTS	The subcellular localization of a wheat NHX antiporter, TaNHX2, was studied in Arabidopsis protoplasts, and its function was evaluated using Saccharomyces cerevisiae as a heterologous expression system. Fluorescence patterns of TaNHX2-GFP fusion protein in Arabidopsis cells indicated that TaNHX2 localized at endomembranes. TaNHX2 has significant sequence homology to NHX sodium exchangers from Arabidopsis, is abundant in roots and leaves and is induced by salt or dehydration treatments. Western blot analysis showed that TaNHX2 could be expressed in transgenic yeast cells. Expressed TaNHX2 protein suppressed the salt sensitivity of a yeast mutant strain by increasing its K+ content when exposed to salt stress. TaNHX2 also increased the tolerance of the strain to potassium stress. However, the expression of TaNHX2 did not affect the sodium concentration in transgenic cells. Western blot analysis for tonoplast proteins indicated that the TaNHX2 protein localized at the tonoplast of transgenic yeast cells. The tonoplast vesicles from transgenic yeast cells displayed enhanced K+/H+ exchange activity but very little Na+/H+ exchange compared with controls transformed with the empty vector; Na+/H+ exchange was not detected with concentrations of less than 37.5 mM Na+ in the reaction medium. Our data suggest that TaNHX2 is a endomembrane-bound protein and may primarily function as a K+/H+ antiporter, which is involved in cellular pH regulation and potassium nutrition under normal conditions. Under saline conditions, the protein mediates resistance to salt stress through the intracellular compartmentalization of potassium to regulate cellular pH and K+ homeostasis.	[Xu, Yuanyuan; Cui, Dangqun; Xu, Haixia] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Zhou, Yang; Hong, Sha; Xia, Zhihui; Jiang, Xingyu] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Zhou, Yang; Guo, Jianchun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China	Henan Agricultural University; Hainan University; Chinese Academy of Tropical Agricultural Sciences	Xu, HX (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	haixiaxu@sohu.com; jiangxingyu2002@yahoo.com			National Natural Science Foundation of China [31160185, 31101207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31160185 and No. 31101207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Carden DE, 2003, PLANT PHYSIOL, V131, P676, DOI 10.1104/pp.011445; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Jiang X, 2010, PLANT SIGNALING BEHA, V5, P1; Li HT, 2009, BIOCHEM BIOPH RES CO, V382, P637, DOI 10.1016/j.bbrc.2009.03.091; Liu H, 2010, PLANT CELL ENVIRON, V33, P1989, DOI 10.1111/j.1365-3040.2010.02200.x; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; ROBERTS CJ, 1991, METHODS ENZYMOL, V194, P644; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sychrova H, 2004, PHYSIOL RES, V53, pS91; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yu JN, 2007, J BIOSCIENCES, V32, P1153, DOI 10.1007/s12038-007-0117-x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhu J., 2007, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0001300.pub2, DOI 10.1002/9780470015902.A0001300.PUB2]	43	35	39	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78098	10.1371/journal.pone.0078098	http://dx.doi.org/10.1371/journal.pone.0078098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223765	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300022
J	Zhi, L; Chi, X; Vostal, JG				Zhi, Li; Chi, Xuan; Vostal, Jaroslav G.			In Vitro and In Vivo Characterization of Ultraviolet Light C-Irradiated Human Platelets in a 2 Event Mouse Model of Transfusion	PLOS ONE			English	Article							PATHOGEN REDUCTION TECHNOLOGY; ACUTE LUNG INJURY; BLOOD COMPONENTS; AMOTOSALEN HCL; A LIGHT; SAFETY; INACTIVATION; ACTIVATION; PLASMA; RIBOFLAVIN	UV-based pathogen reduction technologies have been developed in recent years to inactivate pathogens and contaminating leukocytes in platelet transfusion products in order to prevent transfusion-transmitted infections and alloimmunization. UVC-based technology differs from UVA or UVB-based technologies in that it uses a specific wavelength at 254 nm without the addition of any photosensitizers. Previously, it was reported that UVC irradiation induces platelet aggregation and activation. To understand if UVC-induced changes of platelet quality correlate with potential adverse events when these platelets are transfused into animals, we used a 2-event SCID mouse model in which the predisposing event was LPS treatment and the second event was infusion of UVC-irradiated platelets. We analyzed lung platelet accumulation, protein content in bronchoalveolar lavage fluid as an indication of lung injury, and macrophage inflammatory protein-2 (MIP-2) release in mice received UVC-irradiated or untreated control platelets. Our results showed UVC-irradiated platelets accumulated in lungs of the mice in a dose-dependent manner. High-doses of UVC-irradiated platelets were sequestered in the lungs to a similar level as we previously reported for UVB-irradiated platelets. Unlike UVB-platelets, UVC-platelets did not lead to lung injury or induce MIP-2 release. This could potentially be explained by our observation that although UVC treatment activated platelet surface aIIb beta 3, it failed to activate platelet cells. It also suggests lung platelet accumulation and subsequent lung damage are due to different and separate mechanisms which require further investigation.	[Zhi, Li; Chi, Xuan; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	jaroslav.vostal@fda.hhs.gov			US FDA	US FDA(United States Department of Health & Human Services)	This work was supported by Critical Path Funding from the US FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; Bashir S, 2013, TRANSFUSION, V53, P990, DOI 10.1111/j.1537-2995.2012.03854.x; Bassler N, 2007, ARTERIOSCL THROM VAS, V27, pE9, DOI 10.1161/01.ATV.0000255307.65939.59; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Cazenave JP, 2010, TRANSFUSION, V50, P2362, DOI 10.1111/j.1537-2995.2010.02694.x; Chi X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044829; Ciaravino V, 2003, VOX SANG, V85, P171, DOI 10.1046/j.1423-0410.2003.00351.x; Council of Europe, 2002, GUIDE PREPARATION US; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Harm W, 1980, BIOL EFFECTS ULTRAVI; Hillyer Christopher D, 2003, Hematology Am Soc Hematol Educ Program, P575; Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lockwood WB, TECHNICAL MANUAL; Marschner S, 2011, TRANSFUS MED HEMOTH, V38, P8, DOI 10.1159/000324160; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x; Montag T, 2008, CLIN CHEM LAB MED, V46, P926, DOI 10.1515/CCLM.2008.176; Picker SM, 2009, TRANSFUSION, V49, P2311, DOI 10.1111/j.1537-2995.2009.02316.x; Reddy HL, 2008, TRANSFUS MED REV, V22, P133, DOI 10.1016/j.tmrv.2007.12.003; Sandgren P, 2011, VOX SANG, V101, P35, DOI 10.1111/j.1423-0410.2010.01454.x; Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; TAUB R, 1989, J BIOL CHEM, V264, P259; Teitel JM, 2000, ANN MED, V32, P485, DOI 10.3109/07853890009002024; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Verhaar R, 2008, BLOOD, V112, P4935, DOI 10.1182/blood-2008-04-151043; Zhi L, 2012, TRANSFUSION	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79869	10.1371/journal.pone.0079869	http://dx.doi.org/10.1371/journal.pone.0079869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224014	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300094
J	Devalliere, J; Chang, WG; Andrejecsk, JW; Abrahimi, P; Cheng, CJ; Jane-wit, D; Saltzman, WM; Pober, JS				Devalliere, Julie; Chang, William G.; Andrejecsk, Jillian W.; Abrahimi, Parwiz; Cheng, Christopher J.; Jane-wit, Dan; Saltzman, W. Mark; Pober, Jordan S.			Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation	FASEB JOURNAL			English	Article						nanotechnology; neovascularization; controlled release; tissue engineering	PLGA-NANOPARTICLES; GENE DELIVERY; MYOCARDIAL-INFARCTION; ENDOCYTIC PATHWAYS; PROGENITOR CELLS; SKIN SUBSTITUTE; SIRNA DELIVERY; IN-VITRO; TISSUE; ANGIOGENESIS	Transplantation of endothelial cells (ECs) for therapeutic vascularization or tissue engineering is a promising method for increasing tissue perfusion. Here, we report on a new approach for enhanced EC transplantation using targeted nanoparticle transfection to deliver proangiogenic microRNA-132 (miR-132) to cultured ECs before their transplantation, thereby sensitizing cells to the effects of endogenous growth factors. We synthesized biodegradable PLGA polymer nanoparticles (NPs) that were loaded with miR-132 and coated with cyclic RGD (cRGD) peptides that target integrin v3 expressed on cultured human umbilical vein ECs (HUVECs), increasing NP uptake through clathrin-coated pits. Unlike previously reported NPs for miR delivery, these NPs slowly release RNA for several weeks. The endocytosed NPs remain in clathrin-coated vesicles from which they mediate intracellular delivery of siRNA or miRNA. Transfection of HUVECs with miR-132 enhances growth factor-induced proliferation and migration in 2D culture, producing a 1.8- and 5-fold increase, respectively. However, while the effects of conventional transfection were short-lived, NP transfection produced protein knockdown and biological effects that were significantly longer in duration (6 d). Transfection of HUVECs with miR-132 NP resulted in a 2-fold increase in the number of microvessels per square millimeter compared to lipid after transplantation into immunodeficient mice and led to a higher number of mural cell-invested vessels than control transfection. These data suggest that sustained delivery of miR-132 encapsulated in a targeted biodegradable polymer NP is a safe and efficient strategy to improve EC transplantation and vascularization.Devalliere, J., Chang, W. G., Andrejecsk, J. W., Abrahimi, P., Cheng, C. J., Jane-wit, D., Saltzman, W. M., Pober, J. S. Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation.	[Devalliere, Julie; Andrejecsk, Jillian W.; Cheng, Christopher J.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Devalliere, Julie; Abrahimi, Parwiz; Pober, Jordan S.] Yale Univ, Dept Immunobiol, New Haven, CT USA; [Chang, William G.; Jane-wit, Dan] Yale Univ, Dept Internal Med, New Haven, CT USA; [Cheng, Christopher J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Pober, JS (corresponding author), Dept Immunobiol, POB 208089, New Haven, CT 06520 USA.	jordan.pober@yale.edu		Chang, William/0000-0002-7707-9242	U.S. National Institutes of Health [HL108684, HL085416]; Clinical and Translational Science Award from the National Center for Advancing Translational Science [KL2-RR024138]; Paul and Daisy Soros Fellowship for New Americans; NATIONAL CANCER INSTITUTE [F32CA174247] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085416, T32HL007974, R21HL108684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the National Center for Advancing Translational Science; Paul and Daisy Soros Fellowship for New Americans; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Gwen Arrington and Louise Benson (Yale School of Medicine, Yale University) for provision of HUVECs and Amos Brooks (Research Histology, Department of Pathology, Yale University) for immunohistochemistry. This work was supported by grants from the U.S. National Institutes of Health (HL108684 and HL085416). W. G. C. was supported by a Clinical and Translational Science Award (KL2-RR024138) from the National Center for Advancing Translational Science, and P. A. was supported by a Paul and Daisy Soros Fellowship for New Americans.	Anand S, 2011, CURR OPIN HEMATOL, V18, P171, DOI 10.1097/MOH.0b013e328345a180; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057; Chang W. G., 2013, CARDIOVASC RES, DOI 10.1093/cvr/cvt215; Chene CJ, 2011, BIOMATERIALS, V32, P6194, DOI 10.1016/j.biomaterials.2011.04.053; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Conwell CC, 2008, MOL THER, V16, P370, DOI 10.1038/sj.mt.6300356; Costouros NG, 2002, J CELL BIOCHEM, P72, DOI 10.1002/jcb.10426; Danhier F, 2012, METHOD ENZYMOL, V508, P157, DOI 10.1016/B978-0-12-391860-4.00008-2; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; Gibot L, 2010, TISSUE ENG PT A, V16, P3199, DOI [10.1089/ten.tea.2010.0189, 10.1089/ten.TEA.2010.0189]; Gomes RSM, 2013, ACS NANO, V7, P3362, DOI 10.1021/nn400171w; Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]; Ilan N, 1998, J CELL SCI, V111, P3621; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019; Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katare R, 2011, CIRC RES, V109, P894, DOI 10.1161/CIRCRESAHA.111.251546; Khazanov E, 2006, J GENE MED, V8, P998, DOI 10.1002/jgm.933; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Liu XQ, 2011, MOL PHARMACEUT, V8, P250, DOI 10.1021/mp100315q; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Nimesh Surendra, 2012, Recent Pat DNA Gene Seq, V6, P91; Pollinger K, 2013, P NATL ACAD SCI USA, V110, P6115, DOI 10.1073/pnas.1220281110; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Yigit M., 2011, CANCER RES, V72, P2952; Zhou J, 2012, BIOMATERIALS, V33, P583, DOI 10.1016/j.biomaterials.2011.09.061	56	64	65	0	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					908	922		10.1096/fj.13-238527	http://dx.doi.org/10.1096/fj.13-238527			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24221087	Green Published			2022-12-25	WOS:000331072200036
J	Jones, AA; Vila-Rodriguez, F; Panenka, WJ; Leonova, O; Strehlau, V; Lang, DJ; Thornton, AE; Wong, H; Barr, AM; Procyshyn, RM; Smith, GN; Buchanan, T; Krajden, M; Krausz, M; Montaner, JS; MacEwan, GW; Nutt, DJ; Honer, WG				Jones, Andrea A.; Vila-Rodriguez, Fidel; Panenka, William J.; Leonova, Olga; Strehlau, Verena; Lang, Donna J.; Thornton, Allen E.; Wong, Hubert; Barr, Alasdair M.; Procyshyn, Ric M.; Smith, Geoffrey N.; Buchanan, Tari; Krajden, Mel; Krausz, Michael; Montaner, Julio S.; MacEwan, G. William; Nutt, David J.; Honer, William G.			Personalized Risk Assessment of Drug-Related Harm Is Associated with Health Outcomes	PLOS ONE			English	Article							GLOBAL BURDEN; PSYCHOTIC DISORDERS; SYSTEMATIC ANALYSIS; ILLICIT DRUGS; PREDICTORS; DEPENDENCE; MORTALITY; DISEASES; RANKING; HEROIN	Background: The Independent Scientific Committee on Drugs (ISCD) assigned quantitative scores for harm to 20 drugs. We hypothesized that a personalized, ISCD-based Composite Harm Score (CHS) would be associated with poor health outcomes in polysubstance users. Methods: A prospective community sample (n=293) of adults living in marginal housing was assessed for substance use. The CHS was calculated based on the ISCD index, and the personal substance use characteristics over four weeks. Regression models estimated the association between CHS and physical, psychological, and social health outcomes. Results: Polysubstance use was pervasive (95.8%), as was multimorbid illness (median 3, possible range 0-12). The median CHS was 2845 (interquartile range 1865-3977). Adjusting for age and sex, every 1000-unit CHS increase was associated with greater mortality (odds ratio [OR] 1.47, 95% confidence interval [CI] 1.07-2.01, p = 0.02), and persistent hepatitis C infection (OR 1.29, 95% CI 1.02-1.67, p = 0.04). The likelihood of substance-induced psychosis increased 1.39-fold (95% CI 1.13-1.67, p = 0.001). The amount spent on drugs increased 1.51-fold (1.40-1.62, p < 0.001) and the odds of having committed a crime increased 1.74-fold (1.46-2.10, p < 0.001). Multimorbid illness increased 1.43-fold (95% CI 1.26-1.63, p < 0.001). Conclusions: Greater CHS predicts poorer physical, psychological, and social health, and may be a useful quantitative, personalized measure of risk for drug-related harm.	[Jones, Andrea A.; Vila-Rodriguez, Fidel; Panenka, William J.; Leonova, Olga; Strehlau, Verena; Procyshyn, Ric M.; Smith, Geoffrey N.; Buchanan, Tari; Krausz, Michael; MacEwan, G. William; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Wong, Hubert] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Krajden, Mel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio S.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Nutt, David J.] Univ London Imperial Coll Sci Technol & Med, Ctr Neuropsychopharmacol & Mol Imaging, Div Brain Sci, London, England	University of British Columbia; University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Imperial College London	Honer, WG (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	william.honer@ubc.ca	Vila, Fidel/L-3463-2019; Lang, Donna/GVR-9040-2022; Procyshyn, Ric/AAE-5499-2019	Vila, Fidel/0000-0002-8273-8820; Barr, Alasdair/0000-0002-3407-1574; Krausz, Michael/0000-0002-3509-7274; Procyshyn, Ric/0000-0002-4348-0855; Panenka, William/0000-0001-7143-6512; Lang, Donna/0000-0001-9373-1555; nutt, david/0000-0002-1286-1401; Thornton, Allen/0000-0002-9942-0122; Wong, Hubert/0000-0001-8840-4509	Canadian Institutes of Health Research [CBG-101827]; BC Mental Health and Addictions Services; MRC [G1002226] Funding Source: UKRI; Medical Research Council [G1002226] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Addictions Services; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Canadian Institutes of Health Research (CBG-101827) and BC Mental Health and Addictions Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andrews P, 1997, J ADDICT DIS, V16, P75, DOI 10.1300/J069v16n03_08; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Canada Mortgage and Housing Corporation, 2009, FFORD COR HOUS NEED, P81; Caton CLM, 2006, SCHIZOPHRENIA BULL, V32, P618, DOI 10.1093/schbul/sbl007; Caton CLM, 2005, ARCH GEN PSYCHIAT, V62, P137, DOI 10.1001/archpsyc.62.2.137; Caulkins JP, 2011, ADDICTION, V106, P1886, DOI 10.1111/j.1360-0443.2011.03461.x; Community Health and Safety Evaluation Project Team, 2005, COMM HLTH SAF EV CHA; Connell PH, 1958, AMPHETAMINE PSYCHOSI; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Devlin RJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6166; Drake RE, 2002, J NERV MENT DIS, V190, P100, DOI 10.1097/00005053-200202000-00006; Endicott J., 1988, BEST ESTIMATE CLIN E; Fischer B, 1997, PUBLIC HEALTH, V111, P271, DOI 10.1016/S0033-3506(97)00053-X; Fox J, 2009, J STAT SOFTW, V32, P1; GOODMAN SH, 1993, COMMUNITY MENT HLT J, V29, P119, DOI 10.1007/BF00756338; Johnson J., 2008, LESSONS LEARNED SCOR; Kapadia F, 2005, ADDICTION, V100, P990, DOI 10.1111/j.1360-0443.2005.01098.x; Larney S, 2012, DRUG ALCOHOL DEPEND; LEVINE SR, 1990, NEW ENGL J MED, V323, P699, DOI 10.1056/NEJM199009133231102; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacCoun RJ., 2001, DRUG WAR HERESIES LE; Malcolm BP, 2006, SUBST USE MISUSE, V41, P729, DOI 10.1080/10826080500391803; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Mathias S, 2008, J CLIN PSYCHIAT, V69, P358, DOI 10.4088/JCP.v69n0304; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; O'Driscoll PT, 2001, AM J PUBLIC HEALTH, V91, P984, DOI 10.2105/AJPH.91.6.984; Shand FL, 2011, ADDICT BEHAV, V36, P27, DOI 10.1016/j.addbeh.2010.08.008; Sobell M. B., 1980, EVALUATING ALCOHOL D, P129, DOI DOI 10.1016/B978-0-08-022997-3.50013-2; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; Urban Health Research Initiative, 2013, DRUG SIT; van Amsterdam J, 2010, EUR ADDICT RES, V16, P202, DOI 10.1159/000317249; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whiteford HA, 2013, LANCET, P2010; Wood Evan, 2012, Open Med, V6, pe35; Wood E, 2010, LANCET, V376, P310, DOI 10.1016/S0140-6736(10)60958-0; Zhang T, 2006, REV MED VIROL, V16, P311, DOI 10.1002/rmv.508	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79754	10.1371/journal.pone.0079754	http://dx.doi.org/10.1371/journal.pone.0079754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223192	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200085
J	Li, H; Chen, TW; Zhang, XM; Li, ZL; Zhang, JL; Wang, D; Li, T; Wu, JL; Guo, X; Chen, XL; Li, L; Xie, XY; Zhang, ZS				Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Li, Zhen-lin; Zhang, Jin-ling; Wang, Dan; Li, Ting; Wu, Jian-lin; Guo, Xing; Chen, Xiao-li; Li, Li; Xie, Xian-yong; Zhang, Zi-shu			Liver Lobe Volumes and the Ratios of Liver Lobe Volumes to Spleen Volume on Magnetic Resonance Imaging for Staging Liver Fibrosis in a Minipig Model	PLOS ONE			English	Article							CARBON-TETRACHLORIDE; HEPATIC-FIBROSIS; CIRRHOSIS; BIOPSY; SIZE; MRI	Objective: To investigate liver lobe volumes and the ratios of liver lobe volumes to spleen volume measured with magnetic resonance imaging (MRI) for quantitatively monitoring and staging liver fibrosis. Methods: Animal study was approved by Institutional Animal Care and Use Committee. Sixteen minipigs were prospectively used to model liver fibrosis, and underwent abdominal gadolinium-enhanced MRI on 0, 5th, 9th, 16th and 21st weekend after modeling this disease staged by biopsy according to METAVIR classification system. On MRI, volume parameters including left lateral liver lobe volume (LLV), left medial liver lobe volume (LMV), right liver lobe volume (RV), caudate lobe volume (CV), and spleen volume (SV) were measured; and LLV/SV, LMV/SV, RV/SV and CV/SV were calculated. Statistical analyses were performed for staging this fibrosis. Results: LLV and CV increased with increasing stage of fibrosis (r = 0.711, 0.526, respectively; all P < 0.05). RV and LMV increased from stage 0 to 2 and decreased from 2 to 4; and RV/SV decreased from 0 to 1, increased from 1 to 2, and decreased from 3 to 4 (all P > 0.05). LLV/SV, LMV/SV and CV/SV decreased from stage 0 to 4 (r = -0.566, -0.748 and -0.620, respectively; all P < 0.05). LLV, CV, LLV/SV, LMV/SV, RV/SV, and CV/SV could distinguish stage 0-1 from 2-4 and 0-2 from 3-4 (all P < 0.05). Among these parameters, LLV and LMV/SV could best classify stage = 2 and = 3, respectively (area under receiver operating characteristic curve = 0.893 and 0.946, respectively). Conclusion: LLV and LMV/SV complement each other in staging liver fibrosis, and both parameters should be used to stage this disease.	[Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Wang, Dan; Li, Ting; Chen, Xiao-li] Affiliated Hosp, North Sichuan Med Coll, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Li, Hang; Chen, Tian-wu; Zhang, Xiao-ming; Wang, Dan; Li, Ting; Chen, Xiao-li] Affiliated Hosp, North Sichuan Med Coll, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Li, Hang] Sichuan Acad Med Sci, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Li, Hang] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Li, Zhen-lin] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Jin-ling] Harbin Med Univ, Affiliated Hosp 2, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Wu, Jian-lin] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Liaoning, Peoples R China; [Guo, Xing] Affiliated Hosp, North Sichuan Med Coll, Dept Ultrasonog, Nanchong, Sichuan, Peoples R China; [Li, Li; Xie, Xian-yong] Affiliated Hosp, North Sichuan Med Coll, Dept Pathol, Nanchong, Sichuan, Peoples R China; [Zhang, Zi-shu] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA	North Sichuan Medical University; North Sichuan Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Harbin Medical University; Dalian University; North Sichuan Medical University; North Sichuan Medical University; University of Michigan System; University of Michigan	Chen, TW (corresponding author), Affiliated Hosp, North Sichuan Med Coll, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	chentw@aliyun.com; cjr.wujianlin@vip.163.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; BOSMA A, 1988, J PATHOL, V156, P15, DOI 10.1002/path.1711560106; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Feng S, 2004, AM J MED, V117, P125, DOI [10.1016/j.amjmed.2004.01.026., DOI 10.1016/J.AMJMED.2004.01.026.PUBMED:15234650]; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; HENNEBRUNS D, 1989, LANGENBECK ARCH CHIR, V374, P150, DOI 10.1007/BF01261725; Hoofs JC, 1999, J NUCL MED, V40, P1745; JOHNSON CR, 1995, INT J RADIAT ONCOL, V32, P635, DOI 10.1016/0360-3016(95)00031-S; Kim AI, 2005, AM J MED, V118, P808, DOI 10.1016/j.amjmed.2005.01.073; Li H, 2012, WORLD J GASTROENTERO, V18, P7225, DOI 10.3748/wjg.v18.i48.7225; Li WX, 2010, J DIGEST DIS, V11, P215, DOI 10.1111/j.1751-2980.2010.00441.x; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Mazonakis M, 2002, J MAGN RESON IMAGING, V15, P557, DOI 10.1002/jmri.10109; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shah SHA, 1996, AM J GASTROENTEROL, V91, P2580; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; TARAO K, 1989, HEPATOLOGY, V9, P589, DOI 10.1002/hep.1840090413; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI [10.1002/hep.1840200104., DOI 10.1002/HEP.1840200104.PUBMED:8020885]; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; WITTE CL, 1974, GASTROENTEROLOGY, V67, P498; Zhang JJ, 2009, EUR SURG RES, V42, P35, DOI 10.1159/000167855	26	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79681	10.1371/journal.pone.0079681	http://dx.doi.org/10.1371/journal.pone.0079681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223184	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200077
J	Merle, BMJ; Maubaret, C; Korobelnik, JF; Delyfer, MN; Rougier, MB; Lambert, JC; Amouyel, P; Malet, F; Le Goff, M; Dartigues, JF; Barberger-Gateau, P; Delcourt, C				Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Rougier, Marie-Benedicte; Lambert, Jean-Charles; Amouyel, Philippe; Malet, Florence; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile			Association of HDL-Related Loci with Age-Related Macular Degeneration and Plasma Lutein and Zeaxanthin: the Alienor Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; HEPATIC LIPASE; RISK-FACTORS; COMMON VARIANTS; MACULOPATHY; CAROTENOIDS; LIPOPROTEIN; PREVALENCE; SMOKING	Background: Several genes implicated in high-density lipoprotein (HDL) metabolism have been reported to be associated with age-related macular degeneration (AMD). Furthermore, HDL transport the two carotenoids, lutein and zeaxanthin, which are highly suspected to play a key-role in the protection against AMD. The objective is to confirm the associations of HDL-related loci with AMD and to assess their associations with plasma lutein and zeaxanthin concentrations. Methods: Alienor study is a prospective population-based study on nutrition and age-related eye diseases performed in 963 elderly residents of Bordeaux, France. AMD was graded according to the international classification, from non-mydriatic colour retinal photographs. Plasma lutein and zeaxanthin were determined by normal-phase high-performance liquid chromatography. The following polymorphisms were studied: rs493258 and rs10468017 (LIPC), rs3764261 (CETP), rs12678919 (LPL) and rs1883025 (ABCA1). Results: After multivariate adjustment, the TT genotype of the LIPC rs493258 variant was significantly associated with a reduced risk for early and late AMD (OR=0.64, 95% CI: 0.41-0.99; p=0.049 and OR=0.26, 95% CI: 0.08-0.85; p=0.03, respectively), and with higher plasma zeaxanthin concentrations (p=0.03), while plasma lipids were not significantly different according to this SNP. Besides, the LPL variant was associated with early AMD (OR=0.67, 95% CI: 0.45-1.00; p=0.05) and both with plasma lipids and plasma lutein (p=0.047). Associations of LIPC rs10468017, CETP and ABCA1 polymorphisms with AMD did not reach statistical significance. Conclusion: These findings suggest that LIPC and LPL genes could both modify the risk for AMD and the metabolism of lutein and zeaxanthin.	[Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France; [Merle, Benedicte M. J.; Maubaret, Cecilia; Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] Univ Bordeaux, Bordeaux, France; [Korobelnik, Jean-Francois; Delyfer, Marie-Noelle; Rougier, Marie-Benedicte; Malet, Florence] CHU Bordeaux, Serv Ophtalmol, Bordeaux, France; [Lambert, Jean-Charles; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Amouyel, Philippe] Univ Lille Nord France, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille	Merle, BMJ (corresponding author), INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France.	benedicte.merle@isped.u-bordeaux2.fr	DARTIGUES, Jean François/T-4513-2019; Delyfer, Marie-Noelle/T-3304-2019; Lambert, jean-charles/A-9553-2014; Delcourt, Cecile/I-2627-2013; Merle, Benedicte MJ/F-1247-2015; Merle, Benedicte MJ/AAQ-5021-2021; lambert, jean-charles/F-8787-2013; KOROBELNIK, Jean-Francois/A-5448-2016; LE GOFF, Mélanie/A-3541-2016	Lambert, jean-charles/0000-0003-0829-7817; Delcourt, Cecile/0000-0002-2099-0481; Merle, Benedicte MJ/0000-0003-1332-0954; Merle, Benedicte MJ/0000-0003-1332-0954; lambert, jean-charles/0000-0003-0829-7817; LE GOFF, Melanie/0000-0003-2848-6287; Amouyel, Philippe/0000-0001-9088-234X	Fondation Voir et Entendre (Paris, France); Conseil Regional d'Aquitaine (Bordeaux, France) [20091301029]; Fondation pour la recherche medicale, France (FRM)	Fondation Voir et Entendre (Paris, France); Conseil Regional d'Aquitaine (Bordeaux, France)(Region Nouvelle-Aquitaine); Fondation pour la recherche medicale, France (FRM)	Laboratoires Thea participated in the design of the study, but had no role in the data collection and analysis, decision to publish or preparation of the manuscript. Others funders: Fondation Voir et Entendre (Paris, France), Conseil Regional d'Aquitaine (Convention no 20091301029, Bordeaux, France) and Fondation pour la recherche medicale, France (FRM) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalain JH, 2002, CLIN CHIM ACTA, V326, P97, DOI 10.1016/S0009-8981(02)00288-7; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1993, Arch Ophthalmol, V111, P104; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322; Borel P, 2011, ANN MED, V43, P47, DOI 10.3109/07853890.2010.531757; Borel P, 2009, BRIT J NUTR, V101, P680, DOI 10.1017/S0007114508030754; Chan D, 1998, OPTOMETRY VISION SCI, V75, P476, DOI 10.1097/00006324-199807000-00015; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; CLEVIDENCE BA, 1993, METHOD ENZYMOL, V214, P33; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2010, J NUTR HEALTH AGING, V14, P854, DOI 10.1007/s12603-010-0131-9; Delcourt C, 2012, ARCH OPHTHALMOL-CHIC, V130, P1077, DOI 10.1001/archophthalmol.2012.420; Delcourt C, 2011, INVEST OPHTH VIS SCI, V52, P5955, DOI 10.1167/iovs.10-6235; Delcourt C, 2006, INVEST OPHTH VIS SCI, V47, P2329, DOI 10.1167/iovs.05-1235; Fauser S, 2011, INVEST OPHTH VIS SCI, V52, P5525, DOI 10.1167/iovs.10-6827; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929; Hartmann D, 2004, AM J CLIN NUTR, V79, P410; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Ma L, 2012, BRIT J NUTR, V107, P350, DOI 10.1017/S0007114511004260; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Meyers KJ, 2013, INVEST OPHTH VIS SCI, V54, P2333, DOI [10.1167/iovs.12-10867, 10.1167/iovs.13-13216]; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nowak M, 2005, CLIN EXP MED, V4, P183, DOI 10.1007/s10238-004-0054-z; Peter I, 2011, AM J OPHTHALMOL, V152, P1005, DOI 10.1016/j.ajo.2011.05.016; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Seddon JM, 2010, MOL VIS, V16, P2412; Sobrin L, 2011, AM J OPHTHALMOL, V151, P345, DOI 10.1016/j.ajo.2010.08.015; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tian J, 2012, INVEST OPHTH VIS SCI, V53, P4262, DOI 10.1167/iovs.11-8542; Tyssandier V, 2002, INT J VITAM NUTR RES, V72, P300, DOI 10.1024/0300-9831.72.5.300; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wachter A, 2004, OPHTHALMOLOGE, V101, P50, DOI 10.1007/s00347-003-0868-1; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005; 2013, JAMA, P1	55	36	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79848	10.1371/journal.pone.0079848	http://dx.doi.org/10.1371/journal.pone.0079848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223199	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200092
J	Murugan, RN; Ahn, M; Lee, WC; Kim, HY; Song, JH; Cheong, C; Hwang, E; Seo, JH; Shin, SY; Choi, SH; Park, JE; Bang, JK				Murugan, Ravichandran N.; Ahn, Mija; Lee, Woo Cheol; Kim, Hye-Yeon; Song, Jung Hyun; Cheong, Chaejoon; Hwang, Eunha; Seo, Ji-Hyung; Shin, Song Yub; Choi, Sun Ho; Park, Jung-Eun; Bang, Jeong Kyu			Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1	PLOS ONE			English	Article							DISCOVERY; AFFINITY; PEPTIDE	Background: Over the years, a great deal of effort has been focused on the design and synthesis of potent, linear peptide inhibitors targeting the polo-like kinase 1 (Plk1), which is critically involved in multiple mitotic processes and has been established as an adverse prognostic marker for tumor patients. Plk1 localizes to its intracellular anchoring sites via its polo-box domain, and inhibiting the Plk1 polo-box domain has been considered as an approach to circumvent the specificity problems associated with inhibiting the conserved adenosine triphosphate-binding pocket. The polo-box domain consists of two different binding regions, such as the unique, broader pyrrolidine-binding pocket and the conserved, narrow, Tyr-rich hydrophobic channel, among the three Plk polo-box domains (Plks 1-3), respectively. Therefore, the studies that provide insights into the binding nature of the unique, broader pyrrolidine-binding pocket might lead to the development of selective Plk1-inhibitory compounds. Methodology/Principal Findings: In an attempt to retain the monospecificity by targeting the unique, broader pyrrolidine-binding pocket, here, for the first time, a systematic approach was undertaken to examine the structure-activity relationship of N-terminal-truncated PLHSpTM derivatives, to apply a site-directed ligand approach using bulky aromatic and non-aromatic systems, and to characterize the binding nature of these analogues using X-ray crystallographic studies. We have identified a new mode of binding interactions, having improved binding affinity and retaining the Plk1 polo-box domain specificity, at the pyrrolidine-binding pocket. Furthermore, our data revealed that the pyrrolidine-binding pocket was very specific to recognize a short and bulky hydrophobic ligand like adamantane, whereas the Tyr-rich hydrophobic channel was specific with lengthy and small hydrophobic groups. Conclusion/Significance: The progress made using our site-directed ligands validated this approach to specifically direct the ligand into the unique pyrrolidine-binding region, and it extends the applicability of the strategy for discovering selective protein-protein interaction inhibitors.	[Murugan, Ravichandran N.; Ahn, Mija; Lee, Woo Cheol; Kim, Hye-Yeon; Song, Jung Hyun; Cheong, Chaejoon; Hwang, Eunha; Seo, Ji-Hyung; Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chung Buk, South Korea; [Shin, Song Yub] Chosun Univ, Grad Sch, Dept Biomat, Kwangju, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea; [Choi, Sun Ho] Dong A ST, Res Labs, Yongin, Gyeonggi Do, South Korea; [Choi, Sun Ho; Park, Jung-Eun] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Korea Basic Science Institute (KBSI); Chosun University; Chosun University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Park, JE (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	parkju@mail.nih.gov; bangjk@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022		Korea Basic Science Institute's Research Program [T33418]	Korea Basic Science Institute's Research Program	This work was supported by the Korea Basic Science Institute's Research Program grant T33418 (JKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kim YK, 2004, J AM CHEM SOC, V126, P14740, DOI 10.1021/ja048170p; Liu F, 2012, CHEMBIOCHEM, V13, P1291, DOI 10.1002/cbic.201200206; Liu F, 2012, ACS CHEM BIOL, V7, P805, DOI 10.1021/cb200469a; Liu F, 2011, NAT CHEM BIOL, V7, P595, DOI 10.1038/nchembio.614; McInnes C, 2012, MOL CANCER THER, V11, P1683, DOI 10.1158/1535-7163.MCT-12-0006-T; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Qian WJ, 2012, BIOORG MED CHEM LETT, V22, P7306, DOI 10.1016/j.bmcl.2012.10.093; Qian WJ, 2013, BIOORGAN MED CHEM, V21, P3996, DOI 10.1016/j.bmc.2012.05.036; Sledz P, 2012, ANGEW CHEM INT EDIT, V51, P7680, DOI 10.1002/anie.201202660; Sledz P, 2011, ANGEW CHEM INT EDIT, V50, P4003, DOI 10.1002/anie.201008019; Ueki H, 2003, J ORG CHEM, V68, P7104, DOI 10.1021/jo0301494; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	21	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80043	10.1371/journal.pone.0080043	http://dx.doi.org/10.1371/journal.pone.0080043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223211	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200104
J	Sadler, KE; Stratton, JM; DeBerry, JJ; Kolber, BJ				Sadler, Katelyn E.; Stratton, Jarred M.; DeBerry, Jennifer J.; Kolber, Benedict J.			Optimization of a Pain Model: Effects of Body Temperature and Anesthesia on Bladder Nociception in Mice	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR 5; DORSAL-HORN NEURONS; URINARY-BLADDER; VISCEROMOTOR RESPONSES; INTERSTITIAL CYSTITIS; VISCERAL PAIN; RATS; DISTENSION; ISOFLURANE; ERK	Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating urological condition that is resistant to treatment and poorly understood. To determine novel molecular treatment targets and to elucidate the contribution of the nervous system to IC/BPS, many rodent bladder pain models have been developed. In this study we evaluated the effects of anesthesia induction and temperature variation in a mouse model of bladder pain known as urinary bladder distension (UBD). In this model compressed air is used to distend the bladder to distinct pressures while electrodes record the reflexive visceromotor response (VMR) from the overlying abdominal muscle. Two isoflurane induction models are commonly used before UBD: a short method lasting approximately 30 minutes and a long method lasting approximately 90 minutes. Animals were anesthetized with one of the methods then put through three sets of graded bladder distensions. Distensions performed following the short anesthesia protocol were significantly different from one another despite identical testing parameters; this same effect was not observed when the long anesthesia protocol was used. In order to determine the effect of temperature on VMRs, animals were put through three graded distension sets at 37.5 (normal mouse body temperature), 35.5, and 33.5 degrees C. Distensions performed at 33.5 and 35.5 degrees C were significantly lower than those performed at 37.5 degrees C. Additionally, Western blot analysis revealed significantly smaller increases in spinal levels of phosphorylated extracellular-signal regulated kinase 2 (pERK2) following bladder distension in animals whose body temperature was maintained at 33.5 degrees C as opposed to 37.5 degrees C. These results highlight the significance of the dynamic effects of anesthesia on pain-like changes and the importance of close monitoring of temperature while performing UBD. For successful interpretation of VMRs and translation to human disease, body temperature should be maintained at 37.5 degrees C and isoflurane induction should gradually decrease over the course of 90 minutes.	[Sadler, Katelyn E.; Stratton, Jarred M.; Kolber, Benedict J.] Duquesne Univ, Dept Biol Sci & Chron Pain Res Consortium, Pittsburgh, PA 15219 USA; [DeBerry, Jennifer J.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [DeBerry, Jennifer J.] Univ Pittsburgh, Ctr Pain Res, Pittsburgh, PA USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kolber, BJ (corresponding author), Duquesne Univ, Dept Biol Sci & Chron Pain Res Consortium, Pittsburgh, PA 15219 USA.	Kolberb@duq.edu		DeBerry, Jennifer/0000-0002-6613-2909; Kolber, Benedict/0000-0001-8665-1805	International Association for the Study of Pain Early Career Award; Hunkele Dreaded Disease Award	International Association for the Study of Pain Early Career Award; Hunkele Dreaded Disease Award	This work was funded by grants to BJK: International Association for the Study of Pain Early Career Award (http://www.iasp-pain.org/Content/NavigationMenu/Grants2/IASPEarlyCareerResearchGrantsProgram/default.htm); Hunkele Dreaded Disease Award (http://www.duq.edu/research/office-of-research/hunkele-dreaded-disease-competition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RH, 1987, PHYSIOL BEHAV, V41, P635, DOI 10.1016/0031-9384(87)90322-2; BERGE OG, 1988, NEUROSCI LETT, V86, P284, DOI 10.1016/0304-3940(88)90497-1; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; BIGELOW WG, 1950, ANN SURG, V132, P531, DOI 10.1097/00000658-195009000-00018; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Bon K, 2003, J UROLOGY, V170, P1008, DOI 10.1097/01.ju.0000079766.49550.94; Castroman P, 2001, NEUROSCI LETT, V306, P97, DOI 10.1016/S0304-3940(01)01886-9; Cilia J, 1998, J PHARMACOL TOXICOL, V40, P21, DOI 10.1016/S1056-8719(98)00030-6; COHN BT, 1989, AM J SPORT MED, V17, P344, DOI 10.1177/036354658901700306; Crock LW, 2012, J NEUROSCI, V32, P14217, DOI 10.1523/JNEUROSCI.1473-12.2012; Crock LW, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-20; DildyMayfield JE, 1996, J PHARMACOL EXP THER, V276, P1058; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; EGER EI, 1987, ANESTH ANALG, V66, P977; Ewald A. J., 2011, COLD SPRING HARB PRO, V2011; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1680, DOI 10.1152/jn.00341.2003; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Laboratory TSotJ, 1966, BIOL LAB MOUSE; Lai HH, 2011, PAIN, V152, P2117, DOI 10.1016/j.pain.2011.05.017; LEVY AS, 1993, CLIN ORTHOP RELAT R, P174; Luber-Narod J, 1997, UROL RES, V25, P395, DOI 10.1007/BF01268854; MCMAHON SB, 1987, PAIN, V28, P109, DOI 10.1016/0304-3959(87)91065-7; Ness TJ, 2004, J UROLOGY, V171, P1704, DOI 10.1097/01.ju.0000116430.67100.8f; Ness TJ, 2001, J UROLOGY, V165, P968, DOI 10.1016/S0022-5347(05)66586-X; Ness TJ, 1998, PAIN, V76, P61, DOI 10.1016/S0304-3959(98)00023-2; Nordmann GR, 2006, BRIT J ANAESTH, V96, P779, DOI 10.1093/bja/ael092; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rivas DA, 1997, J UROLOGY, V157, P1937, DOI 10.1016/S0022-5347(01)64905-X; Roman K, 2013, ISRN PAIN, V2013, P10; ROSLAND JH, 1991, PAIN, V45, P211, DOI 10.1016/0304-3959(91)90190-9; SCHEFFLER N M, 1992, Journal of Foot Surgery, V31, P141; Seo K, 2010, NEUROSCI LETT, V472, P1, DOI 10.1016/j.neulet.2010.01.031; Shimizu I, 1999, NEUROUROL URODYNAM, V18, P115, DOI 10.1002/(SICI)1520-6777(1999)18:2<115::AID-NAU7>3.0.CO;2-D; Simpson S, 1905, J PHYSIOL-LONDON, V32, P305; Slack SE, 2004, EUR J NEUROSCI, V20, P1769, DOI 10.1111/j.1460-9568.2004.03656.x; Stemler KM, 2013, J UROLOGY, V189, P343, DOI 10.1016/j.juro.2012.08.189; Wei F, 2006, J NEUROSCI, V26, P851, DOI 10.1523/JNEUROSCI.3292-05.2006; Yang M, 2011, AM J PHYSIOL-RENAL, V300, pF1353, DOI 10.1152/ajprenal.00009.2011	41	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79617	10.1371/journal.pone.0079617	http://dx.doi.org/10.1371/journal.pone.0079617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223980	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000326597400075
J	Aguado-Urda, M; Gibello, A; Blanco, MD; Fernandez-Garayzabal, JF; Lopez-Alonso, V; Lopez-Campos, GH				Aguado-Urda, Monica; Gibello, Alicia; Blanco, M. del Mar; Fernandez-Garayzabal, Jose F.; Lopez-Alonso, Victoria; Lopez-Campos, Guillermo H.			Global Transcriptome Analysis of Lactococcus garvieae Strains in Response to Temperature	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GENOME SEQUENCE; RNA-POLYMERASE; DELTA-SUBUNIT; STREPTOCOCCUS-PNEUMONIAE; RESPIRATION METABOLISM; MOLECULAR-COMPONENTS; STRESS RESPONSES; GENE-EXPRESSION; VIRULENCE	Lactococcus garvieae is an important fish and an opportunistic human pathogen. The genomic sequences of several L. garvieae strains have been recently published, opening the possibility of global studies on the biology of this pathogen. In this study, a whole genome DNA microarray of two strains of L. garvieae was designed and validated. This DNA microarray was used to investigate the effects of growth temperature (18 degrees C and 37 degrees C) on the transcriptome of two clinical strains of L. garvieae that were isolated from fish (Lg8831) and from a human case of septicemia (Lg21881). The transcriptome profiles evidenced a strain-specific response to temperature, which was more evident at 18 degrees C. Among the most significant findings, Lg8831 was found to up-regulate at 18 degrees C several genes encoding different cold-shock and cold-induced proteins involved in an efficient adaptive response of this strain to low-temperature conditions. Another relevant result was the description, for the first time, of respiratory metabolism in L. garvieae, whose gene expression regulation was temperature-dependent in Lg21881. This study provides new insights about how environmental factors such as temperature can affect L. garvieae gene expression. These data could improve our understanding of the regulatory networks and adaptive biology of this important pathogen.	[Aguado-Urda, Monica; Gibello, Alicia; Blanco, M. del Mar; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Sci, Dept Anim Hlth, E-28040 Madrid, Spain; [Fernandez-Garayzabal, Jose F.] Univ Complutense, Anim Hlth Surveillance Ctr VISAVET, E-28040 Madrid, Spain; [Lopez-Alonso, Victoria] Hlth Inst Carlos III, Bioinformat & Publ Hlth Dept, Madrid, Spain; [Lopez-Campos, Guillermo H.] Univ Melbourne, Sch Med, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia	Complutense University of Madrid; Complutense University of Madrid; University of Melbourne	Lopez-Campos, GH (corresponding author), Univ Melbourne, Sch Med, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia.	guillermo.lopez@unimelb.edu.au	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Gibello, Alicia/F-4140-2016; studies, IT VISAVET Account for bibliometric/C-3115-2014; Gibello, Alicia/K-6516-2019; Campos, Guillermo H Lopez/G-2883-2015; Lopez-Campos, Guillermo/O-4349-2017	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Gibello, Alicia/0000-0002-3006-8685; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Lopez Alonso, Victoria/0000-0001-8129-8352; BLANCO, MARIA DEL MAR/0000-0003-4335-4346; Lopez-Campos, Guillermo/0000-0003-3011-0940	Spanish Ministry of Economy and Competiveness [AGL2009-12447, AGL2012-35419]; Complutense University of Madrid	Spanish Ministry of Economy and Competiveness(Spanish Government); Complutense University of Madrid	This research was supported by grants AGL2009-12447 and AGL2012-35419 from the Spanish Ministry of Economy and Competiveness. MAU was recipient of a Ph.D. fellowship from the Complutense University of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Urda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040119; Aguado-Urda M, 2011, J BACTERIOL, V193, P4263, DOI 10.1128/JB.05326-11; Aguado-Urda M, 2011, J BACTERIOL, V193, P4033, DOI 10.1128/JB.05090-11; Aguado-Urda M, 2010, INT MICROBIOL, V13, P189, DOI 10.2436/20.1501.01.125; Anderson ES, 2009, INFECT IMMUN, V77, P3466, DOI 10.1128/IAI.00444-09; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Barriere C, 2005, J BACTERIOL, V187, P3752, DOI 10.1128/JB.187.11.3752-3761.2005; Florez AB, 2012, J BACTERIOL, V194, P5118, DOI 10.1128/JB.00975-12; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; den Besten HMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013746; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Dubbs James M., 2007, V44, P143; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Ferrario C, 2012, FEMS MICROBIOL LETT, V332, P153, DOI 10.1111/j.1574-6968.2012.02591.x; Gabrielsen C, 2012, J BACTERIOL, V194, P6976, DOI 10.1128/JB.01864-12; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Giangrossi M, 2007, MOL MICROBIOL, V64, P807, DOI 10.1111/j.1365-2958.2007.05699.x; Gibello A, 1999, APPL ENVIRON MICROB, V65, P4346; Ginsburg I, 2002, APMIS, V110, P753, DOI 10.1034/j.1600-0463.2002.1101101.x; Giuliodori AM, 2007, RNA, V13, P1355, DOI 10.1261/rna.455607; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Hoffmann T, 2011, J BACTERIOL, V193, P1552, DOI 10.1128/JB.01319-10; Jones AL, 2003, INFECT IMMUN, V71, P4011, DOI 10.1128/IAI.71.7.4011-4017.2003; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kocabas Pinar, 2009, Biotechnology Journal, V4, P1012, DOI 10.1002/biot.200800330; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; KUSUDA R, 1991, INT J SYST BACTERIOL, V41, P406, DOI 10.1099/00207713-41-3-406; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Marceau A, 2004, APPL ENVIRON MICROB, V70, P7260, DOI 10.1128/AEM.70.12.7260-7268.2004; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; PAPPWALLACE KM, 2000, ANNU REV MICROBIOL, V60, P187; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Perry RD, 2012, MICROBIOL-SGM, V158, P804, DOI 10.1099/mic.0.053710-0; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Pot B, 1996, SYST APPL MICROBIOL, V19, P213, DOI 10.1016/S0723-2020(96)80047-6; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rattanama P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032523; Ray MK, 2006, STRESS RESPONSE MOL, P1; Raynaud S, 2005, APPL ENVIRON MICROB, V71, P8016, DOI 10.1128/AEM.71.12.8016-8023.2005; Redon E, 2005, J BACTERIOL, V187, P3589, DOI 10.1128/JB.187.10.3589-3592.2005; Reimundo P, 2011, J BACTERIOL, V193, P3684, DOI 10.1128/JB.05210-11; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Ricci G, 2013, GENOME ANNOUNC, V1; Ricci G, 2012, J BACTERIOL, V194, P1249, DOI 10.1128/JB.06655-11; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Russo G, 2012, NEW MICROBIOL, V35, P495; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Simon R, 2007, CANCER INFORM, V3, P11; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Wick LM, 2004, ADV BIOCHEM ENG BIOT, V89, P1; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10	76	13	13	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79692	10.1371/journal.pone.0079692	http://dx.doi.org/10.1371/journal.pone.0079692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223997	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000326503400140
J	Goldenberg, G; Harris, TJC				Goldenberg, Gabrielle; Harris, Tony J. C.			Adherens Junction Distribution Mechanisms during Cell-Cell Contact Elongation in Drosophila	PLOS ONE			English	Article							E-CADHERIN; DE-CADHERIN; ENDOCYTOSIS; REARRANGEMENT; ARMADILLO; DYNAMICS; PATHWAY; BINDING; FORMS; SEC5	During Drosophila gastrulation, amnioserosa (AS) cells flatten and spread as an epithelial sheet. We used AS morphogenesis as a model to investigate how adherens junctions (AJs) distribute along elongating cell-cell contacts in vivo. As the contacts elongated, total AJ protein levels increased along their length. However, genetically blocking this AJ addition indicated that it was not essential for maintaining AJ continuity. Implicating other remodeling mechanisms, AJ photobleaching revealed non-directional lateral mobility of AJs along the elongating contacts, as well as local AJ removal from the membranes. Actin stabilization with jasplakinolide reduced AJ redistribution, and live imaging of myosin II along elongating contacts revealed fragmented, expanding and contracting actomyosin networks, suggesting a mechanism for lateral AJ mobility. Actin stabilization also increased total AJ levels, suggesting an inhibition of AJ removal. Implicating AJ removal by endocytosis, clathrin endocytic machinery accumulated at AJs. However, dynamin disruption had no apparent effect on AJs, suggesting the involvement of redundant or dynamin-independent mechanisms. Overall, we propose that new synthesis, lateral diffusion, and endocytosis play overlapping roles to populate elongating cell-cell contacts with evenly distributed AJs in this in vivo system.	[Goldenberg, Gabrielle; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	T. Harris holds a Tier 2 Canada Research Chair and the work is supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenti Stephen T, 2012, Subcell Biochem, V60, P279, DOI 10.1007/978-94-007-4186-7_12; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Boggetti Barbara, 2012, Subcell Biochem, V60, P321, DOI 10.1007/978-94-007-4186-7_14; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Bulgakova NA, 2013, J CELL BIOL, V201, P887, DOI 10.1083/jcb.201211159; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; David Daryl J V, 2012, Methods Mol Biol, V839, P1, DOI 10.1007/978-1-61779-510-7_1; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; Han Siew Ping, 2012, Subcell Biochem, V60, P111, DOI 10.1007/978-94-007-4186-7_6; Harris TJC, 2012, INT REV CEL MOL BIO, V293, P45, DOI 10.1016/B978-0-12-394304-0.00007-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Letizia Annalisa, 2012, Subcell Biochem, V60, P251, DOI 10.1007/978-94-007-4186-7_11; Levayer R, 2011, NAT CELL BIOL, V13, P734, DOI 10.1038/ncb0611-734a; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Oda H, 2001, J CELL SCI, V114, P493; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Troyanovsky Sergey, 2012, Subcell Biochem, V60, P89, DOI 10.1007/978-94-007-4186-7_5; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79613	10.1371/journal.pone.0079613	http://dx.doi.org/10.1371/journal.pone.0079613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223978	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400129
J	Zoghi, M; Galea, M; Morgan, D				Zoghi, Maryam; Galea, Mary; Morgan, David			A Brain Motor Control Assessment (BMCA) Protocol for Upper Limb Function	PLOS ONE			English	Article							SPINAL-CORD-INJURY; VOLUNTARY RESPONSE INDEX; SURFACE EMG; ARM; RELIABILITY; STROKE; SPASTICITY; SHOULDER; PATTERNS; HUMANS	The Brain Motor Control Assessment (BMCA) protocol is a surface electromyography (sEMG)-based measure of motor output from central nervous system during a variety of reflex and voluntary motor tasks performed under strictly controlled conditions. The aim of this study was to evaluate the BMCA protocol for upper limb with the addition of shoulder voluntary tasks. The voluntary response index (VRI) was calculated from quantitative analysis of sEMG data during defined voluntary movement in neurologically intact people for comparison with that of patients after neurological injuries. The BMCA protocol included one bilateral and 4 unilateral voluntary tasks at different joints of both arms. The VRI, measured from 19 neurologically intact participants, comprises the total muscle activity recorded for the voluntary motor task (magnitude). The calculated similarity index (SI) for each phase of each task show the similarity of "the distribution of activity across the recorded muscles" for that task in this group off participants. Results: The VRI magnitude values from right and left sides for different tasks showed no significant difference (ANOVA: F-Side: 0.09, P = 0.77). Therefore these values were pooled before calculating SI. SI values were higher for tasks against gravity: elbow flexion (0.99 +/- 0.03), wrist flexion with palm up (0.98 +/- 0.03) and wrist extension with palm down (0.97 +/- 0.07). On the other hand, the SI values were the lowest for bilateral shoulder abduction (0.84 +/- 0.08) and shoulder adduction (0.84 +/- 0.08). Conclusion: To validate this index for clinical use, serial studies on patients with neurological impairments should be performed. Tasks involving movement against gravity may be more suitable in future BMCAs.	[Zoghi, Maryam; Galea, Mary; Morgan, David] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne	Zoghi, M (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	mzoghi@unimelb.edu.au	Morgan, David L/B-9545-2008; , Zoghi/AAF-9536-2019; Galea, Mary/F-4242-2010	, Zoghi/0000-0002-1819-6895; Galea, Mary/0000-0003-0045-7978	Victorian Neurotrauma Initiative [D113]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative project grant no. D113: Functional electrical stimulation for hand function in quadriplegia (website: http://www.tac.vic.gov.au/about-us/research/tac-neurotrauma-research/program-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford S, 2013, CLIN REHABIL; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Barreca SR, 2005, ARCH PHYS MED REHAB, V86, P1616, DOI 10.1016/j.apmr.2005.03.017; CIONI B, 1986, APPL NEUROPHYSIOL, V49, P315; DIMITRIJEVIC MR, 1984, ANN NEUROL, V16, P216, DOI 10.1002/ana.410160208; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Grice KO, 2003, AM J OCCUP THER, V57, P570; HANSON RW, 1976, ARCH PHYS MED REHAB, V57, P291; KRONBERG M, 1990, CLIN ORTHOP RELAT R, P76; Lee DC, 2004, J ELECTROMYOGR KINES, V14, P379, DOI 10.1016/j.jelekin.2003.10.006; Lim HK, 2005, J REHABIL RES DEV, V42, P413, DOI 10.1682/JRRD.2004.07.0079; Lin JJ, 2006, J ELECTROMYOGR KINES, V16, P458, DOI 10.1016/j.jelekin.2005.09.008; McDonnell M, 2008, AUST J PHYSIOTHER, V54, P220, DOI 10.1016/S0004-9514(08)70034-5; Mckay WB, 2011, SPINAL CORD, V49, P421, DOI 10.1038/sc.2010.145; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Mulcahey Mary Jane, 2012, J Pediatr Orthop, V32 Suppl 2, pS114, DOI 10.1097/BPO.0b013e3182595423; Priebe MM, 1997, SPINAL CORD, V35, P171, DOI 10.1038/sj.sc.3100366; SHERWOOD AM, 1993, RESTOR NEUROL NEUROS, V5, P119, DOI 10.3233/RNN-1993-5202; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.3.CO;2-N; Sherwood AM, 2000, J REHABIL RES DEV, V37, P41; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; VIRJIBABUL N, 1994, EXP BRAIN RES, V99, P338; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004; Wolfe SA, 2000, PLAST RECONSTR SURG, V106, P1642, DOI 10.1097/00006534-200012000-00036	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79483	10.1371/journal.pone.0079483	http://dx.doi.org/10.1371/journal.pone.0079483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223953	Green Published, gold			2022-12-25	WOS:000326503400117
J	Obregon-Henao, A; Henao-Tamayo, M; Orme, IM; Ordway, DJ				Obregon-Henao, Andres; Henao-Tamayo, Marcela; Orme, Ian M.; Ordway, Diane J.			Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							W-BEIJING STRAINS; L-ARGININE; MOUSE MODEL; GUINEA-PIG; EXPRESSION; MECHANISMS; GRANULOMAS; GENE; RESPONSES; ARGINASE	Background: Tuberculosis is one of the world's leading killers, stealing 1.4 million lives and causing 8.7 million new and relapsed infections in 2011. The only vaccine against tuberculosis is BCG which demonstrates variable efficacy in adults worldwide. Human infection with Mycobacterium tuberculosis results in the influx of inflammatory cells to the lung in an attempt to wall off bacilli by forming a granuloma. Gr1(int)CD11b(+) cells are called myeloid-derived suppressor cells (MDSC) and play a major role in regulation of inflammation in many pathological conditions. Although MDSC have been described primarily in cancer their function in tuberculosis remains unknown. During M. tuberculosis infection it is crucial to understand the function of cells involved in the regulation of inflammation during granuloma formation. Understanding their relative impact on the bacilli and other cellular phenotypes is necessary for future vaccine and drug design. Methodology/Principal Findings: We compared the bacterial burden, lung pathology and Gr1(int)CD11b(+) myeloid-derived suppressor cell immune responses in M. tuberculosis infected NOS2-/-, RAG-/-, C3HeB/FeJ and C57/BL6 mice. Gr-1(+) cells could be found on the edges of necrotic lung lesions in NOS2-/-, RAG-/-, and C3HeB/FeJ, but were absent in wild-type mice. Both populations of Gr1(+)CD11b(+) cells expressed high levels of arginase-1, and IL-17, additional markers of myeloid derived suppressor cells. We then sorted the Gr1(hi) and Gr1(int) populations from M. tuberculosis infected NOS-/- mice and placed the sorted both Gr1(int) populations at different ratios with naive or M. tuberculosis infected splenocytes and evaluated their ability to induce activation and proliferation of CD4+ T cells. Our results showed that both Gr1(hi) and Gr1(int) cells were able to induce activation and proliferation of CD4+ T cells. However this response was reduced as the ratio of CD4(+) T to Gr1(+) cells increased. Our results illustrate a yet unrecognized interplay between Gr1(+) cells and CD4(+) T cells in tuberculosis.	[Obregon-Henao, Andres; Henao-Tamayo, Marcela; Orme, Ian M.; Ordway, Diane J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Obregon-Henao, A (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Andres.Obregon@ColoState.EDU; D.Ordway@colostate.edu	Henao-Tamayo, Marcela/D-8189-2017; Ordway, Diane/H-9732-2017	Henao-Tamayo, Marcela/0000-0002-4249-9650; Ordway, Diane/0000-0003-0003-326X	NIH [1DP2OD006450 - 01, AI081959]; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081959] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH innovator award grant number 1DP2OD006450 - 01 and AI081959. This study was also funded under the American Recovery and Reinvestment Act of 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2010, COLOR ATLAS COMP PAT; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Derive M, 2012, INTENS CARE MED, V38, P1040, DOI 10.1007/s00134-012-2574-4; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Driver ER, 2012, ANTIMICROB AGENTS CH, V56, P3181, DOI 10.1128/AAC.00217-12; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ehlers S, 2000, FRONTIERS IMMUNOLOGY, V3, P411; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gama L, 2009, J LEUKOCYTE BIOL, V91, P803; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550; Ino Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055146; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Kramnik I, 2008, CURR TOP MICROBIOL, V321, P123; Martino A, 2010, J IMMUNOL, V184, P2038, DOI 10.4049/jimmunol.0903348; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nagaraj S, 2012, SEMIN CANCER BIOL, V22, P282, DOI 10.1016/j.semcancer.2012.01.010; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Ordway DJ, 2009, CURR PROTOC IMMUNOL; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Raviglione M, 2010, LANCET, V379, P1902; Rieber N, 2013, J IMMUNOL, V190, P1276, DOI 10.4049/jimmunol.1202144; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zea AH, 2006, J INFECT DIS, V194, P1385, DOI 10.1086/508200; Zhang C, 2012, INFECT IMMUN, V80, P3634, DOI 10.1128/IAI.00668-12	53	59	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80669	10.1371/journal.pone.0080669	http://dx.doi.org/10.1371/journal.pone.0080669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224058	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300099
J	Ding, DL; Qi, WD; Yu, DZ; Jiang, HY; Han, C; Kim, MJ; Katsuno, K; Hsieh, YH; Miyakawa, T; Salvi, R; Tanokura, M; Someya, S				Ding, Dalian; Qi, Weidong; Yu, Dongzhen; Jiang, Haiyan; Han, Chul; Kim, Mi-Jung; Katsuno, Kana; Hsieh, Yun Hua; Miyakawa, Takuya; Salvi, Richard; Tanokura, Masaru; Someya, Shinichi			Addition of Exogenous NAD(+) Prevents Mefloquine-Induced Neuroaxonal and Hair Cell Degeneration through Reduction of Caspase-3-Mediated Apoptosis in Cochlear Organotypic Cultures	PLOS ONE			English	Article							AXONAL DEGENERATION; TRANSCRIPTION FACTORS; HEARING-LOSS; NICOTINAMIDE; CISPLATIN; SIRT1; DEACETYLASE; STRESS; RAT; P53	Background: Mefloquine is widely used for the treatment of malaria. However, this drug is known to induce neurological side effects including depression, anxiety, balance disorder, and sensorineural hearing loss. Yet, there is currently no treatment for these side effects. Principal Findings: In this study, we show that the coenzyme NAD(+), known to play a critical role in maintaining the appropriate cellular redox environment, protects cochlear axons and sensory hair cells from mefloquine-induced degeneration in cultured rat cochleae. Mefloquine alone destroyed hair cells and nerve fiber axons in rat cochlear organotypics cultures in a dose-dependent manner, while treatment with NAD(+) protected axons and hair cells from mefloquine-induced degeneration. Furthermore, cochlear organs treated with mefloquine showed increased oxidative stress marker levels, including superoxide and protein carbonyl, and increased apoptosis marker levels, including TUNEL-positive nuclei and caspases-3. Treatment with NAD(+) reduced the levels of these oxidative stress and apoptosis markers. Conclusions/Significance: Taken together, our findings suggest that that mefloquine disrupts the cellular redox environment and induces oxidative stress in cochlear hair cells and nerve fibers leading to caspases-3-mediated apoptosis of these structures. Exogenous NAD(+) suppresses mefloquine-induced oxidative stress and prevents the degeneration of cochlear axons and sensory hair cells caused by mefloquine treatment.	[Ding, Dalian; Jiang, Haiyan; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Ding, Dalian; Yu, Dongzhen] Shanghai Jiao Tong Univ, Shanghai Oriental Otolaryngol Inst, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ding, Dalian] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Ding, Dalian; Katsuno, Kana; Hsieh, Yun Hua; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Qi, Weidong] Fudan Univ, Huashan Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China; [Han, Chul; Kim, Mi-Jung; Someya, Shinichi] Univ Florida, Dept Aging, Gainesville, FL USA; [Han, Chul; Kim, Mi-Jung; Someya, Shinichi] Univ Florida, Dept Geriatr Res, Div Biol Aging, Gainesville, FL USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Shanghai Jiao Tong University; Central South University; University of Tokyo; Fudan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tanokura, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp; someya@ufl.edu		Yu, Dongzhen/0000-0001-9424-4855; Tanokura, Masaru/0000-0001-5072-2480	NIH [R01 DC06630-01, R01 DC06630, RO1 DC012552, RO3 DC011840-01]; AFAR Research Grant; Claude D. Pepper Older Americans Independence Center Junior Scholar Award; Japan Society for the Promotion of Science (JSPS) [23228003]; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006630, R03DC011840, R01DC012552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR Research Grant; Claude D. Pepper Older Americans Independence Center Junior Scholar Award; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grant R01 DC06630-01 (R. S), NIH grant R01 DC06630 (R. S.), NIH grant RO1 DC012552 (S. S.), NIH grant RO3 DC011840-01 (S. S.), AFAR Research Grant (S. S.), Claude D. Pepper Older Americans Independence Center Junior Scholar Award (S. S.), and Grant-in-Aid for Scientific Research (S) (23228003) from the Japan Society for the Promotion of Science (JSPS) (M. T., T. M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Barennes H, 2006, BMJ-BRIT MED J, V332, P1055, DOI 10.1136/bmj.332.7549.1055; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Crawley Jane, 2004, Semin Pediatr Infect Dis, V15, P169, DOI 10.1053/j.spid.2004.05.009; Dalian Ding, 2012, J Otol, V7, P92; Diaz-Hernandez JI, 2007, CELL DEATH DIFFER, V14, P1211, DOI 10.1038/sj.cdd.4402117; Ding D, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P510; Ding D, 2011, CISPLATIN OTOTOXICIT, V2, P39; Ding D., 2011, J OTOL, V6, P1, DOI [10.1016/S1672-2930(11)50001-7, DOI 10.1016/S1672-2930(11)50001-7, 10.1016/51672-2930(11)50001-7]; Ding D, 2013, ABSTR ASS RES OT; Ding D, 2001, JF WILLOTT HDB MOUSE, P189; Ding DL, 2007, HEARING RES, V226, P129, DOI 10.1016/j.heares.2006.07.015; Ding DL, 2012, ANAT REC, V295, P1851, DOI 10.1002/ar.22577; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; Ding DL, 2011, NEUROTOXICOLOGY, V32, P233, DOI 10.1016/j.neuro.2010.12.003; Ding DL, 2005, VOLTA REV, V105, P407; Ding DL, 2002, HEARING RES, V164, P115, DOI 10.1016/S0378-5955(01)00417-8; Dow Geoffrey S, 2003, Malar J, V2, P14, DOI 10.1186/1475-2875-2-14; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fu Y, 2012, NEUROTOX RES, V22, P158, DOI 10.1007/s12640-012-9320-0; Fusetti M, 1999, Clin Ter, V150, P379; Hipkiss Alan R, 2010, Front Aging Neurosci, V2, P10, DOI 10.3389/fnagi.2010.00010; Hood JE, 2010, NEUROTOXICOLOGY, V31, P518, DOI 10.1016/j.neuro.2010.05.005; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; Kawai Y, 2006, J PHARMACOL SCI, V100, P65, DOI 10.1254/jphs.FP0050661; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Kollaritsch H, 2000, WIEN KLIN WOCHENSCHR, V112, P441; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Milatovic D, 2011, NEUROTOXICOLOGY, V32, P578, DOI 10.1016/j.neuro.2011.01.001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Navaratnam S, 2000, J PHOTOCH PHOTOBIO B, V56, P25, DOI 10.1016/S1011-1344(00)00056-7; Oliver FJ, 1999, AM J HUM GENET, V64, P1282, DOI 10.1086/302389; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Qi W., 2009, J OTOL, V4, P29, DOI [10.1016/S1672-2930(09)50018-9, DOI 10.1016/S1672-2930(09)50018-9]; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sadanaga-Akiyoshi F, 2003, NEUROCHEM RES, V28, P1227, DOI 10.1023/A:1024236614015; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang H, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P261; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu DZ, 2011, NEUROTOX RES, V20, P51, DOI 10.1007/s12640-010-9221-z; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JG, 1996, PHARMACOL TOXICOL, V79, P191	57	35	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79817	10.1371/journal.pone.0079817	http://dx.doi.org/10.1371/journal.pone.0079817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223197	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200090
J	Hassiotou, F; Hepworth, AR; Williams, TM; Twigger, AJ; Perrella, S; Lai, CT; Filgueira, L; Geddes, DT; Hartmann, PE				Hassiotou, Foteini; Hepworth, Anna R.; Williams, Tracey M.; Twigger, Alecia-Jane; Perrella, Sharon; Lai, Ching Tat; Filgueira, Luis; Geddes, Donna T.; Hartmann, Peter E.			Breastmilk Cell and Fat Contents Respond Similarly to Removal of Breastmilk by the Infant	PLOS ONE			English	Article							ACID-COMPOSITION; FREQUENCY; VOLUME	Large inter- and intra-individual variations exist in breastmilk composition, yet factors associated with these variations in the short-term are not well understood. In this study, the effects of breastfeeding on breastmilk cellular and biochemical content were examined. Serial breastmilk samples (similar to 5 mL) were collected from both breasts of breastfeeding women before and immediately after the first morning breastfeed, and then at 30-minute intervals for up to 3 hours post-feed on 24 mornings per participant. The infant fed from one breast only at each feed. Effects of pump versus hand expression for samples were evaluated. A consistent response pattern of breastmilk cell and fat contents to breastmilk removal was observed. Maximum fat and cell levels were obtained 30 minutes post-feed (P<0.01), with up to 8-fold increase in fat and 12-fold increase in cell content compared to the pre-feed values, and then they gradually decreased. Breastmilk cell viability and protein concentration did not change with feeding (P>0.05), although large intra-individual variability was noted for protein. Expression mode for samples did not influence breastmilk composition (P>0.05). It is concluded that breastmilk fat content, and thus breast fullness, is closely associated with breastmilk cell content. This will now form the basis for standardization of sampling protocols in lactation studies and investigation of the mechanisms of milk synthesis and cell movement into breastmilk. Moreover, these findings generate new avenues for clinical interventions exploring growth and survival benefits conferred to preterm infants by providing the highest in fat and cells milk obtained at 30 min post-expression.	[Hassiotou, Foteini; Hepworth, Anna R.; Williams, Tracey M.; Twigger, Alecia-Jane; Perrella, Sharon; Lai, Ching Tat; Geddes, Donna T.; Hartmann, Peter E.] Univ Western Australia, Fac Sci, Sch Chem & Biochem, Perth, WA 6009, Australia; [Hassiotou, Foteini; Twigger, Alecia-Jane; Filgueira, Luis] Univ Western Australia, Fac Sci, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Filgueira, Luis] Univ Fribourg, Dept Med, Anat Unit, CH-1700 Fribourg, Switzerland	University of Western Australia; University of Western Australia; University of Fribourg	Hassiotou, F (corresponding author), Univ Western Australia, Fac Sci, Sch Chem & Biochem, Perth, WA 6009, Australia.	foteini.hassiotou@uwa.edu.au	Hepworth, Anna/X-6724-2019; Geddes, Donna/H-9254-2014; Lai, ching tat/M-2452-2018	Filgueira, Luis/0000-0002-2266-6650; Geddes, Donna/0000-0002-0431-7078; Perrella, Sharon/0000-0002-7727-7767; Lai, ching tat/0000-0002-9025-4922; Hartmann, Peter/0000-0002-7709-0740; Twigger, Alecia-Jane/0000-0003-4361-817X; Hepworth, Anna/0000-0003-0204-6347	Medela AG, Baar, Switzerland	Medela AG, Baar, Switzerland	Funding for this study was provided by an unrestricted research grant from Medela AG, Baar, Switzerland http://www.medela.com/IW/en/breastfeeding.html?force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR PG, 1987, J PEDIATR GASTR NUTR, V6, P758, DOI 10.1097/00005176-198709000-00017; ATWOOD CS, 1992, J DAIRY RES, V59, P287, DOI 10.1017/S0022029900030569; Buescher E. S., 1986, Human milk in infant nutrition and health, P160; BUTTE NF, 1984, AM J CLIN NUTR, V39, P296, DOI 10.1093/ajcn/39.2.296; Cregan MD, 2002, PARACELLULAR PATHWAY; Czank C, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-3; da Cunha J, 2005, EARLY HUM DEV, V81, P303, DOI 10.1016/j.earlhumdev.2004.08.004; DALY SEJ, 1993, EXP PHYSIOL, V78, P741, DOI 10.1113/expphysiol.1993.sp003722; Daly SEJ, 1996, EXP PHYSIOL, V81, P861, DOI 10.1113/expphysiol.1996.sp003982; de Mello TRB, 2000, CHARACTERIZATION MAM; DEWEY KG, 1984, J PEDIATR GASTR NUTR, V3, P713, DOI 10.1097/00005176-198411000-00014; FLEET IR, 1964, J PHYSIOL-LONDON, V175, pP15; HALL B, 1979, AM J CLIN NUTR, V32, P304, DOI 10.1093/ajcn/32.2.304; Hassiotou F, 2012, STEM CELLS; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; HO FCS, 1979, ACTA PAEDIATR SCAND, V68, P389, DOI 10.1111/j.1651-2227.1979.tb05025.x; HYTTEN FE, 1954, BMJ-BRIT MED J, V1, P175, DOI 10.1136/bmj.1.4855.175; Keenan TW, 1995, MILK FAT GLOBULE MEM; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Khan S, 2013, J HUM LACT, V29, P81, DOI 10.1177/0890334412448841; Khan S, 2012, J PEDIATR GASTR NUTR, V55, P136, DOI 10.1097/MPG.0b013e31824cf386; Martin FL, 2000, CARCINOGENESIS, V21, P799, DOI 10.1093/carcin/21.4.799; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI 10.1079/BJNBJN2002579; Neville MC, 1983, MECH MILK SECRETION, P49; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Piper KM, 2005, USE MAMMARY EPITHELI; R Development Core Team, 2009, R LANG ENV STAT COMP; RUEGG M, 1981, BIOCHIM BIOPHYS ACTA, V666, P7, DOI 10.1016/0005-2760(81)90085-0; Sarkar D., 2009, LATTICE LATTICE GRAP; WHITTLESTONE WG, 1953, J DAIRY RES, V20, P146, DOI 10.1017/S0022029900006798; Woodward D. R., 1976, Dairy Science Abstracts, V38, P137	31	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78232	10.1371/journal.pone.0078232	http://dx.doi.org/10.1371/journal.pone.0078232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223141	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200033
J	Mizushima, D; Tanuma, J; Kanaya, F; Nishijima, T; Gatanaga, H; Lam, NT; Dung, NTH; Van Kinh, N; Kikuchi, Y; Oka, S				Mizushima, Daisuke; Tanuma, Junko; Kanaya, Fumihide; Nishijima, Takeshi; Gatanaga, Hiroyuki; Nguyen Tien Lam; Nguyen Thi Hoai Dung; Nguyen Van Kinh; Kikuchi, Yoshimi; Oka, Shinichi			WHO Antiretroviral Therapy Guidelines 2010 and Impact of Tenofovir on Chronic Kidney Disease in Vietnamese HIV-Infected Patients	PLOS ONE			English	Article							DISOPROXIL FUMARATE; RENAL DYSFUNCTION; RISK-FACTORS; PREVALENCE; MORTALITY; SAFETY; COHORT; ERA	Objective: The 2010 WHO antiretroviral therapy (ART) guidelines have resulted in increased tenofovir use. Little is known about tenofovir-induced chronic kidney disease (CKD) in HIV-infected Vietnamese with mean body weight of 55 kg. We evaluated the prevalence and risk factors of CKD in this country. Design: Cross-sectional study was performed. Methods: Clinical data on HIV-infected Vietnamese cohort were collected twice a year. To evaluate the prevalence of CKD, serum creatinine was measured in 771 patients in October 2011 and April 2012. CKD was defined as creatinine clearance less than 60 ml/min at both time points. Multivariate logistic regression was used to determine the factors associated with CKD Results: Tenofovir use increased in Vietnam from 11.9% in April 2011 to 40.3% in April 2012. CKD was diagnosed in 7.3%, of which 7% was considered moderate and 0.3% was severe. Multivariate analysis of October-2011 data identified age per year-increase (OR: 1.229, 95% CI, 1.170-1.291), body weight per 1 kg-decrement (1.286, 1.193-1.386), and tenofovir use (2.715, 1.028-7.168) as risk factors for CKD. Conclusions: Older age, low body weight and tenofovir use were independent risk factors for CKD in Vietnam. Further longitudinal study is required to evaluate the impact of TDF on renal function in Vietnam and other countries with small-body weight patients.	[Mizushima, Daisuke; Tanuma, Junko; Kanaya, Fumihide; Nishijima, Takeshi; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Mizushima, Daisuke; Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Nguyen Tien Lam; Nguyen Thi Hoai Dung; Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan; Kumamoto University; National Hospital of Tropical Diseases	Mizushima, D (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	dmizushi@acc.ncgm.go.jp; oka@acc.ncgm.go.jp	Tanuma, Junko/AAE-5395-2020	Oka, Shinichi/0000-0002-9283-2167	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios A, 2004, AIDS, V18, P960, DOI 10.1097/00002030-200404090-00019; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V34, P320, DOI 10.1097/00126334-200311010-00011; Ito J, 2008, NEPHRON CLIN PRACT, V109, pC25, DOI 10.1159/000134379; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Menezes AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026042; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Soares A, 2010, AM J KIDNEY DIS, V55, P1162, DOI 10.1053/j.ajkd.2010.03.008; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Stohr W, 2008, ANTIVIR THER, V13, P761; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	26	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79885	10.1371/journal.pone.0079885	http://dx.doi.org/10.1371/journal.pone.0079885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223203	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200096
J	Zou, YF; Jiang, ZY; Yu, X; Sun, M; Zhang, YY; Zuo, Q; Zhou, J; Yang, NN; Han, P; Ge, ZP; De, W; Sun, LZ				Zou, Yanfen; Jiang, Ziyan; Yu, Xiang; Sun, Ming; Zhang, Yuanyuan; Zuo, Qing; Zhou, Jing; Yang, Nana; Han, Ping; Ge, Zhiping; De, Wei; Sun, Lizhou			Upregulation of Long Noncoding RNA SPRY4-IT1 Modulates Proliferation, Migration, Apoptosis, and Network Formation in Trophoblast Cells HTR-8SV/neo	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; NORMAL-PREGNANCY; PREECLAMPSIA; GENE; EXPRESSION; PATHOGENESIS; LIFE	SPRY4-IT1 has been reported to have extremely high expression in normal placenta tissues. It is a Long noncoding RNA (lncRNA), which is associated with cell growth, migration, invasion, and apoptosis in melanoma. A 2.8-fold increase of SPRY4-IT1 expression was validated by Real-time reverse transcription-polymerase chain reaction (qRT-PCR) in severe preeclamptic placenta as compared with that of the normal ones (n=25) in this study. Furthermore, the role of SPRY4-IT1 in proliferation, migration, apoptosis, and network formation ability of trophoblast cells HTR-8/SVneo was assessed. Suppression of SPRY4-IT1 using siRNA treatment and its overexpression using plasmid targeting SPRY4-IT1 were performed in order to explore the biological function of SPRY4-IT1 in the development and progression of trophoblast cells HTR-8/SVneo, in vitro. The results showed that SPRY4-IT1 knockdown enhanced the cell migration and proliferation, and reduced the response of cells to apoptosis. However, exogenous SPRY4-IT1 overexpression significantly decreased the cell migration and proliferation, while increased cell apoptosis. Our study showed for the first time that aberrant expression of lncRNA SPRY4-IT1 might contribute to the abnormal condition of trophoblast cells HTR-8/SVneo. Therefore, we proposed SPRY4-IT1 as a novel lncRNA molecule, which might be associated with the pathogenesis of preeclampsia and might provide a new target for its early diagnosis and treatment.	[Zou, Yanfen; Jiang, Ziyan; Zhang, Yuanyuan; Zuo, Qing; Yang, Nana; Han, Ping; Ge, Zhiping; Sun, Lizhou] Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yu, Xiang; Sun, Ming; Zhou, Jing; De, Wei] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, LZ (corresponding author), Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	lizhou_sun121@hotmail.com			National Natural Science Foundation of China [81070511, 81270710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China, grant number 81070511 (http://www.nsfc.gov.cn/Portal0/default152.htm) The National Natural Science Foundation of China, grant number 81270710 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2002, AM J OBSTET GYNECOL, V187, P735, DOI 10.1067/mob.2002.126283; Basak S, 2013, PROSTAG LEUKOTR ESS, V88, P155, DOI 10.1016/j.plefa.2012.10.001; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Cui ZL, 2013, UROL ONCOL-SEMIN ORI, V31, P1117, DOI 10.1016/j.urolonc.2011.11.030; Dewing AST, 2012, RNA BIOL, V9, P1361, DOI 10.4161/rna.22290; Dokras A, 2001, BIOL REPROD, V65, P1278, DOI 10.1095/biolreprod65.4.1278; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heazell AEP, 2008, REPROD SCI, V15, P1034, DOI 10.1177/1933719108322438; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kitroser E, 2012, PLACENTA, V33, P717, DOI 10.1016/j.placenta.2012.06.004; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Liu S, 2012, PLACENTA, V33, P712, DOI 10.1016/j.placenta.2012.06.010; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2009, BIOESSAYS, V31, P51, DOI 10.1002/bies.080099; Noris M, 2004, HYPERTENSION, V43, P614, DOI 10.1161/01.HYP.0000116220.39793.c9; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052275; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saftlas AF, 2005, OBSTET GYNECOL, V106, P162, DOI 10.1097/01.AOG.0000167389.97019.37; Stein TP, 2008, FREE RADICAL RES, V42, P841, DOI 10.1080/10715760802510069; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Waddell JM, 2011, HUM REPROD, V26, P67, DOI 10.1093/humrep/deq294; Walsh SW, 1998, SEMIN REPROD ENDOCR, V16, P93, DOI 10.1055/s-2007-1016256; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	48	71	81	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79598	10.1371/journal.pone.0079598	http://dx.doi.org/10.1371/journal.pone.0079598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223182	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200075
J	Capeness, MJ; Lambert, C; Lovering, AL; Till, R; Uchida, K; Chaudhuri, R; Alderwick, LJ; Lee, DJ; Swarbreck, D; Liddell, S; Aizawa, SI; Sockett, RE				Capeness, Michael J.; Lambert, Carey; Lovering, Andrew L.; Till, Rob; Uchida, Kaoru; Chaudhuri, Roy; Alderwick, Luke J.; Lee, David J.; Swarbreck, David; Liddell, Susan; Aizawa, Shin-Ichi; Sockett, Renee Elizabeth			Activity of Bdellovibrio Hit Locus Proteins, Bd0108 and Bd0109, Links Type IVa Pilus Extrusion/Retraction Status to Prey-Independent Growth Signalling	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE FAMILY; LIFE-CYCLE; BACTERIOVORUS; MUTANTS; SYSTEM; REVEALS; RHS; BIOGENESIS; EXPRESSION	Bdellovibrio bacteriovorus are facultatively predatory bacteria that grow within gram-negative prey, using pili to invade their periplasmic niche. They also grow prey-independently on organic nutrients after undergoing a reversible switch. The nature of the growth switching mechanism has been elusive, but several independent reports suggested mutations in the hit (host-interaction) locus on the Bdellovibrio genome were associated with the transition to prey-independent growth. Pili are essential for prey entry by Bdellovibrio and sequence analysis of the hit locus predicted that it was part of a cluster of Type IVb pilus-associated genes, containing bd0108 and bd0109. In this study we have deleted the whole bd0108 gene, which is unique to Bdellovibrio, and compared its phenotype to strains containing spontaneous mutations in bd0108 and the common natural 42 bp deletion variant of bd0108. We find that deletion of the whole bd0108 gene greatly reduced the extrusion of pili, whereas the 42 bp deletion caused greater pilus extrusion than wild-type. The pili isolated from these strains were comprised of the Type IVa pilin protein; PilA. Attempts to similarly delete gene bd0109, which like bd0108 encodes a periplasmic/secreted protein, were not successful, suggesting that it is likely to be essential for Bdellovibrio viability in any growth mode. Bd0109 has a sugar binding YD-repeat motif and an N-terminus with a putative pilin-like fold and was found to interact directly with Bd0108. These results lead us to propose that the Bd0109/Bd0108 interaction regulates pilus production in Bdellovibrio (possibly by interaction with the pilus fibre at the cell wall), and that the presence (and possibly retraction state) of the pilus feeds back to alter the growth state of the Bdellovibrio cell. We further identify a novel small RNA encoded by the hit locus, the transcription of which is altered in different bd0108 mutation backgrounds.	[Capeness, Michael J.; Lambert, Carey; Till, Rob; Sockett, Renee Elizabeth] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Lovering, Andrew L.; Alderwick, Luke J.; Lee, David J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Japan; [Chaudhuri, Roy] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Swarbreck, David] Genome Anal Ctr, Norwich, Norfolk, England; [Liddell, Susan] Univ Nottingham, Div Anim Sci, Prote Lab, Nottingham NG7 2RD, England	University of Nottingham; University of Birmingham; University of Liverpool; The Genome Analysis Centre (TGAC); University of Nottingham	Sockett, RE (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	liz.sockett@nottingham.ac.uk	Chaudhuri, Roy/E-3774-2014; Lambert, Carey/AAY-9270-2020	Chaudhuri, Roy/0000-0001-5037-2695; Lee, David/0000-0003-2395-351X; Lambert, Carey/0000-0002-1844-457X; Alderwick, Luke/0000-0002-1257-6053; Lovering, Andrew/0000-0002-1856-7975; Swarbreck, David/0000-0002-5453-1013; Aizawa, Shin-Ichi/0000-0002-9068-0825	BBSRC [G013632/1]; Butterfield award from the Sasakawa foundation; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885, BB/G013632/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G013632/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Butterfield award from the Sasakawa foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by BBSRC Grant G013632/1 to RES for CL and MJC and by a Butterfield award from the Sasakawa foundation to RES and S-IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Cahoon LA, 2013, BIOTECHNOLOGY, V9; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; COTTER TW, 1992, J BACTERIOL, V174, P6011, DOI 10.1128/JB.174.19.6011-6017.1992; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; DUPUY B, 1991, J BACTERIOL, V173, P7589, DOI 10.1128/jb.173.23.7589-7598.1991; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Fenton AK, 2010, J BACTERIOL, V192, P6329, DOI 10.1128/JB.00914-10; Fenton AK, 2010, J BACTERIOL, V192, P1299, DOI 10.1128/JB.01157-09; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FOSTER SJ, 1993, MOL MICROBIOL, V8, P299, DOI 10.1111/j.1365-2958.1993.tb01574.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; HESPELL RB, 1975, J BACTERIOL, V123, P481, DOI 10.1128/JB.123.2.481-491.1975; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hobley L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002493; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2003, ENVIRON MICROBIOL, V5, P127, DOI 10.1046/j.1462-2920.2003.00385.x; Lambert C, 2013, FEMS MICROBIOL LETT; Lambert C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-99; Lambert C, 2010, CURR MICROBIOL, V60, P419, DOI 10.1007/s00284-009-9559-8; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Lerner TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002524; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu ZY, 2012, MOL MICROBIOL, V86, P140, DOI 10.1111/j.1365-2958.2012.08178.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmoud KK, 2010, MICROBIOL-SGM, V156, P1040, DOI 10.1099/mic.0.036137-0; MATIN A, 1972, Journal of Bacteriology, V111, P664; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Minet AD, 1999, J CELL SCI, V112, P2019; Morehouse KA, 2011, J BACTERIOL, V193, P932, DOI 10.1128/JB.00941-10; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; ROBERTS RC, 1987, J GEN MICROBIOL, V133, P3065; ROGERS M, 1986, MOL GEN GENET, V205, P550, DOI 10.1007/BF00338097; Roschanski N, 2011, J BACTERIOL; Roschanski N, 2011, CURR MICROBIOL, V62, P589, DOI 10.1007/s00284-010-9748-5; SADOSKY AB, 1989, J BACTERIOL, V171, P636, DOI 10.1128/jb.171.2.636-642.1989; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schwudke D, 2005, CURR MICROBIOL, V51, P310, DOI 10.1007/s00284-005-0030-1; SEIDLER RJ, 1969, J BACTERIOL, V100, P769, DOI 10.1128/JB.100.2.769-785.1969; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THOMASHOW MF, 1979, DEV BIOL PROKARYOTES; VARON M, 1975, J BACTERIOL, V124, P1191, DOI 10.1128/JB.124.3.1191-1197.1975; Vik A, 2012, MOL MICROBIOL, V85, P1166, DOI 10.1111/j.1365-2958.2012.08166.x; VLAZNY DA, 1995, J BACTERIOL, V177, P2209, DOI 10.1128/jb.177.8.2209-2213.1995; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Woods RD, 2007, NANO LETT, V7, P1809, DOI 10.1021/nl0702968; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182	67	32	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79759	10.1371/journal.pone.0079759	http://dx.doi.org/10.1371/journal.pone.0079759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224002	Green Accepted, Green Published, gold			2022-12-25	WOS:000326597400085
J	Chorna, NE; Santos-Soto, IJ; Carballeira, NM; Morales, JL; de la Nuez, J; Catala-Valentin, A; Chornyy, AP; Vazquez-Montes, A; De Ortiz, SP				Chorna, Nataliya E.; Santos-Soto, Ivan J.; Carballeira, Nestor M.; Morales, Joan L.; de la Nuez, Janneliz; Catala-Valentin, Alma; Chornyy, Anatoliy P.; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena			Fatty Acid Synthase as a Factor Required for Exercise-Induced Cognitive Enhancement and Dentate Gyrus Cellular Proliferation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REDUCES FOOD-INTAKE; GENE-EXPRESSION; HIPPOCAMPAL NEUROGENESIS; PROTEIN PALMITOYLATION; PHYSICAL-ACTIVITY; NEURONAL DEVELOPMENT; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; MEMORY ACQUISITION	Voluntary running is a robust inducer of adult hippocampal neurogenesis. Given that fatty acid synthase (FASN), the key enzyme for de novo fatty acid biosynthesis, is critically involved in proliferation of embryonic and adult neural stem cells, we hypothesized that FASN could mediate both exercise-induced cell proliferation in the subgranular zone (SGZ) of the dentate gyrus (DG) and enhancement of spatial learning and memory. In 20 week-old male mice, voluntary running-induced hippocampal-specific upregulation of FASN was accompanied also by hippocampal-specific accumulation of palmitate and stearate saturated fatty acids. In experiments addressing the functional role of FASN in our experimental model, chronic intracerebroventricular (i.c.v.) microinfusions of C75, an irreversible FASN inhibitor, and significantly impaired exercise-mediated improvements in spatial learning and memory in the Barnes maze. Unlike the vehicle-injected mice, the C75 group adopted a non-spatial serial escape strategy and displayed delayed escape latencies during acquisition and memory tests. Furthermore, pharmacologic blockade of FASN function with C75 resulted in a significant reduction, compared to vehicle treated controls, of the number of proliferative cells in the DG of running mice as measured by immunoreactive to Ki-67 in the SGZ. Taken together, our data suggest that FASN plays an important role in exercise-mediated cognitive enhancement, which might be associated to its role in modulating exercise-induced stimulation of neurogenesis.	[Chorna, Nataliya E.] Univ Puerto Rico, Dept Biol, Metabol Res Ctr, San Juan, PR 00936 USA; [Chorna, Nataliya E.; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena] Univ Puerto Rico, Dept Biol, Funct Genom Res Core, San Juan, PR 00936 USA; [Santos-Soto, Ivan J.; Morales, Joan L.; de la Nuez, Janneliz; Catala-Valentin, Alma; Vazquez-Montes, Adrinel; De Ortiz, Sandra Pena] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Carballeira, Nestor M.] Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA; [Chornyy, Anatoliy P.] Univ Puerto Rico, Cent Adm, High Performance Comp Facil, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	De Ortiz, SP (corresponding author), Univ Puerto Rico, Dept Biol, Funct Genom Res Core, Rio Piedras Campus, San Juan, PR 00936 USA.	sandra@hpcf.upr.edu	Chorna, Nataliya/AHC-2895-2022	Chorna, Nataliya/0000-0002-7761-6802; Carballeira, Nestor/0000-0001-7404-0505	NIH-NIGMS [NIH-NIGMS/P20RR016470, P20GM103475, 5SC1MH086072, SC1GM084708, 5R25GM061151]; NIH-NIMH; UPR-Graduate Dean's Dissertation Fellowship; UPR-RP [PBDTP2010-2011]; Undergraduate Research Fellowship; NIH [8R25NS080687]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475, SC1GM084708, R25GM061151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [SC1MH086072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS080687] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UPR-Graduate Dean's Dissertation Fellowship; UPR-RP; Undergraduate Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants and fellowships to: SPO (P20GM103475 by NIH-NIGMS/P20RR016470, NIH-NIGMS & 5SC1MH086072, and NIH-NIMH); NCarballeira (SC1GM084708 by NIH-NIGMS); IJSS (Graduate Research Fellowships, 5R25GM061151 by NIH-NIGMS, UPR-Graduate Dean's Dissertation Fellowship, and PBDTP2010-2011 by UPR-RP); ACV (Undergraduate Research Fellowship, and 8R25NS080687 by NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Ambrogini P, 2004, NEUROSCI LETT, V359, P13, DOI 10.1016/j.neulet.2003.12.123; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camassei FD, 2003, INVEST OPHTH VIS SCI, V44, P2399, DOI 10.1167/iovs.02-0934; Carballeira NM, 2007, LIPIDS, V42, P1047, DOI 10.1007/s11745-007-3110-0; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colon-Cesario M, 2006, J NEUROSCI, V26, P5524, DOI 10.1523/JNEUROSCI.3050-05.2006; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Ehrmann Jiri Jr., 2002, Biomedical Papers (Olomouc), V146, P11; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Kannangara TS, 2011, NEUROBIOL AGING; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Knobloch M, 2012, NATURE; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kumar MV, 2002, P NATL ACAD SCI USA, V99, P1921, DOI 10.1073/pnas.042683699; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez M, 2007, RECENT PATENTS ENDOC, V1, P53, DOI 10.2174/187221407779814615; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Mazzola C, 2009, LEARN MEMORY, V16, P332, DOI 10.1101/lm.1145209; McNay EC, 2011, NEUROBIOL LEARN MEM, V96, P517, DOI 10.1016/j.nlm.2011.11.001; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menendez Javier A., 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P877; Morell P., 1996, HDB CLIN NEUROL, V22, P33; Nicolle MM, 2003, LEARN MEMORY, V10, P520, DOI 10.1101/lm.64803; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Ronnett GV, 2006, OBESITY, V14, P201; Saavedra-Rodriguez L, 2009, J NEUROSCI, V29, P5726, DOI 10.1523/JNEUROSCI.4033-08.2009; Schweitzer NB, 2006, NEUROCHEM INT, V48, P9, DOI 10.1016/j.neuint.2005.08.006; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sunyer B, 2007, NATURE PROTOCOLS, DOI [10.1038/nprot.2007.1390, DOI 10.1038/NPR0T.2007.1390]; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Thupari JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE97, DOI 10.1152/ajpendo.00261.2003; Tu YJ, 2005, ENDOCRINOLOGY, V146, P486, DOI 10.1210/en.2004-0976; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wang ZJ, 2006, ACTA PHARMACOL SIN, V27, P145, DOI 10.1111/j.1745-7254.2006.00259.x; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yoshii A, 2011, J NEUROSCI, V31, P11894, DOI 10.1523/JNEUROSCI.2190-11.2011	82	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77845	10.1371/journal.pone.0077845	http://dx.doi.org/10.1371/journal.pone.0077845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223732	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400014
J	Courtois, B; Audebert, A; Dardou, A; Roques, S; Ghneim-Herrera, T; Droc, G; Frouin, J; Rouan, L; Goze, E; Kilian, A; Ahmadi, N; Dingkuhn, M				Courtois, Brigitte; Audebert, Alain; Dardou, Audrey; Roques, Sandrine; Ghneim-Herrera, Thaura; Droc, Gaetan; Frouin, Julien; Rouan, Lauriane; Goze, Eric; Kilian, Andrzej; Ahmadi, Nourollah; Dingkuhn, Michael			Genome-Wide Association Mapping of Root Traits in a Japonica Rice Panel	PLOS ONE			English	Article							MIXED-MODEL APPROACH; LINKAGE DISEQUILIBRIUM; MORPHOLOGICAL TRAITS; SYSTEM ARCHITECTURE; GENOTYPIC VARIATION; DROUGHT AVOIDANCE; COMPLEX TRAITS; GROWTH; PLATFORM; QTLS	Rice is a crop prone to drought stress in upland and rainfed lowland ecosystems. A deep root system is recognized as the best drought avoidance mechanism. Genome-wide association mapping offers higher resolution for locating quantitative trait loci (QTLs) than QTL mapping in biparental populations. We performed an association mapping study for root traits using a panel of 167 japonica accessions, mostly of tropical origin. The panel was genotyped at an average density of one marker per 22.5 kb using genotyping by sequencing technology. The linkage disequilibrium in the panel was high (r(2) > 0.6, on average, for 20 kb mean distances between markers). The plants were grown in transparent 50 cm x 20 cm x 2 cm Plexiglas nailboard sandwiches filled with 1.5 mm glass beads through which a nutrient solution was circulated. Root system architecture and biomass traits were measured in 30-day-old plants. The panel showed a moderate to high diversity in the various traits, particularly for deep (below 30 cm depth) root mass and the number of deep roots. Association analyses were conducted using a mixed model involving both population structure and kinship to control for false positives. Nineteen associations were significant at P<1e-05, and 78 were significant at P<1e-04. The greatest numbers of significant associations were detected for deep root mass and the number of deep roots, whereas no significant associations were found for total root biomass or deep root proportion. Because several QTLs for different traits were co-localized, 51 unique loci were detected; several co-localized with meta-QTLs for root traits, but none co-localized with rice genes known to be involved in root growth. Several likely candidate genes were found in close proximity to these loci. Additional work is necessary to assess whether these markers are relevant in other backgrounds and whether the genes identified are robust candidates.	[Courtois, Brigitte; Audebert, Alain; Dardou, Audrey; Roques, Sandrine; Droc, Gaetan; Frouin, Julien; Rouan, Lauriane; Ahmadi, Nourollah; Dingkuhn, Michael] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, Montpellier, France; [Ghneim-Herrera, Thaura] Univ Icesi, Dept Ciencias Biol, Cali, Colombia; [Goze, Eric] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR SCA, Montpellier, France; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd DArT PL, Canberra, ACT, Australia	CIRAD; Universite de Montpellier; Universidad ICESI; CIRAD	Courtois, B (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, Montpellier, France.	brigitte.courtois@cirad.fr	COURTOIS, Brigitte/A-4004-2009; Gaetan, DROC/AAH-2616-2021	COURTOIS, Brigitte/0000-0003-2118-7102; Gaetan, DROC/0000-0003-1849-1269; Ghneim Herrera, Thaura/0000-0001-5716-0900; Kilian, Andrzej/0000-0002-2730-7462; AHMADI, Nourollah/0000-0003-0072-6285; Goze, Eric/0000-0001-9121-7835	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France)	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France)	This research was funded by the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD-France) in the framework of its Orytage project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADD, 2011, XLAST VERS 2011 4 02; [Anonymous], [No title captured]; Audebert A., 2010, 3 INT RIC C P HAN VI, P102; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Clark RT, 2013, PLANT CELL ENVIRON, V36, P454, DOI 10.1111/j.1365-3040.2012.02587.x; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Courtois B., 1999, Genetic improvement of rice for water-limited environments., P35; COURTOIS B, 1996, IRRI DISCUSSION PAPE, V16, P154; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Groleau-Renaud V, 1998, CR ACAD SCI III-VIE, V321, P63, DOI 10.1016/S0764-4469(97)89627-8; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; *INT RIC RES I, 2002, RIC ALM VERS 3; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kondo M., 1999, Genetic improvement of rice for water-limited environments., P117; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Lafitte HR, 2001, FIELD CROP RES, V71, P57, DOI 10.1016/S0378-4290(01)00150-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; MacMillan K, 2006, THEOR APPL GENET, V113, P977, DOI 10.1007/s00122-006-0356-5; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; NEMOTO K, 1995, CROP SCI, V35, P24, DOI 10.2135/cropsci1995.0011183X003500010005x; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Perrier X., 2006, DARWIN SOFTWARE; Price A, 1999, PLANT GROWTH REGUL, V29, P123, DOI 10.1023/A:1006255832479; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2008, R LANG ENV STAT COMP; Rich SM, 2013, J EXP BOT, V64, P1193, DOI 10.1093/jxb/ert043; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shen L, 2001, THEOR APPL GENET, V103, P75, DOI 10.1007/s001220100538; Singh V, 2012, EUR J AGRON, V42, P3, DOI 10.1016/j.eja.2012.04.006; STEELE K, 2009, PLANT BREEDING NEWS; Steele KA, 2006, THEOR APPL GENET, V112, P208, DOI 10.1007/s00122-005-0110-4; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang L, 2009, J EVOLUTION BIOL, V22, P751, DOI 10.1111/j.1420-9101.2009.01698.x; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	69	202	206	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78037	10.1371/journal.pone.0078037	http://dx.doi.org/10.1371/journal.pone.0078037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223758	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400017
J	Jhun, JY; Moon, SJ; Yoon, BY; Byun, JK; Kim, EK; Yang, EJ; Ju, JH; Hong, YS; Min, JK; Park, SH; Kim, HY; Cho, ML				Jhun, Joo Yeon; Moon, Su-Jin; Yoon, Bo Young; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Ju, Ji Hyeon; Hong, Yeon Sik; Min, Jun Ki; Park, Sung Hwan; Kim, Ho Youn; Cho, Mi-La			Grape Seed Proanthocyanidin Extract-Mediated Regulation of STAT3 Proteins Contributes to Treg Differentiation and Attenuates Inflammation in a Murine Model of Obesity-Associated Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; BROWN ADIPOSE-TISSUE; T-CELLS; JOINT INFLAMMATION; SELF-TOLERANCE; LEPTIN; RATS; DIET; HOMEOSTASIS; ACTIVATION	Grape seed proanthocyanidin extract (GSPE) is a natural flavonoid that exerts anti-inflammatory properties. Obesity is an inflammatory condition and inflammatory cells and their secretion of pro-inflammatory molecules contribute to the pathogenesis of obesity. Rheumatoid arthritis (RA) is a chronic autoimmune disease that is characterized by inflammation of joints lined by synovium. Previously, we demonstrated that obesity augmented arthritis severity in collagen induced arthritis (CIA), a murine model of human RA. Here, we investigated whether oral administration of GSPE showed antiobesity and anti-arthritic effects in high-fat diet-induced obese (DIO) mice and in obese CIA mice, respectively. The pathophysiologic mechanisms by which GSPE attenuates weight gain and arthritis severity in vivo were also investigated. In DIO mice, GSPE administration significantly inhibited weight gain, reduced fat infiltration in liver and improved serum lipid profiles. The antiobesity effect of GSPE was associated with increased populations of regulatory T (Treg) cells and those of decreased Th17 cells. Decrease of Th17 cells was associated with significant inhibition of their key transcriptional factors, pSTAT3(Tyr705) and pSTAT3(Ser727). On the contrary, GSPE-induced Treg induction was associated with enhanced pSTAT5 expression. To identify the anti-arthritis effects of GSPE, GSPE was given orally for 7 weeks after type II collagen immunization. GSPE treatment significantly attenuated the development of autoimmune arthritis in obese CIA model. In line with DIO mice, GSPE administration decreased Th17 cells and reciprocally increased Treg cells by regulating STAT proteins in autoimmune arthritis model. The expressions of pro-inflammatory cytokines and nitrotyrosine in synovium were significantly inhibited by GSPE treatment. Taken together, GSPE functions as a reciprocal regulator of T cell differentiation - suppression of Th17 cells and induction of Tregs in both DIO and obese CIA mice. GSPE may act as a therapeutic agent to treat immunologic diseases related with enhanced STAT3 activity such as metabolic disorders and autoimmune diseases.	[Jhun, Joo Yeon; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Cho, Mi-La] Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea; [Jhun, Joo Yeon; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Cho, Mi-La] Catholic Univ Korea, Coll Med, Rheumatism Res Ctr, Seoul, South Korea; [Moon, Su-Jin; Ju, Ji Hyeon; Hong, Yeon Sik; Min, Jun Ki; Park, Sung Hwan; Kim, Ho Youn] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Yoon, Bo Young] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Goyang, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Inje University	Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea.	iammila@catholic.ac.kr			Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government Ministry of Education, Science and Technology (MEST) [2012049783]	Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by a grant from the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government Ministry of Education, Science and Technology (MEST) (grant number 2012049783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cho ML, 2009, IMMUNOL LETT, V124, P102, DOI 10.1016/j.imlet.2009.05.001; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jhun JY, 2012, EXP MOL MED, V44, P424, DOI 10.3858/emm.2012.44.7.047; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Pajuelo D, 2012, BRIT J NUTR, V107, P170, DOI 10.1017/S0007114511002728; Park MK, 2011, IMMUNOL LETT, V135, P50, DOI 10.1016/j.imlet.2010.09.011; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rosloniec EF, 2001, CURR PROTOC IMMUNOL; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2001, ADV EXP MED BIOL, V490, P21; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Thiruchenduran M, 2011, CARDIOVASC PATHOL, V20, P361, DOI 10.1016/j.carpath.2010.09.002; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Woo YJ, 2011, EXP MOL MED, V43, P561, DOI 10.3858/emm.2011.43.10.062	37	25	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78843	10.1371/journal.pone.0078843	http://dx.doi.org/10.1371/journal.pone.0078843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223854	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400041
J	Wylie, SJ; Li, H; Jones, MGK				Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.			Donkey Orchid Symptomless Virus: A Viral 'Platypus' from Australian Terrestrial Orchids	PLOS ONE			English	Article							FAMILY FLEXIVIRIDAE; PLANT-VIRUSES; RNA VIRUSES; CONSERVATION; POTYVIRUSES; POPULATIONS; PHYLOGENY; DIVERSITY; EVOLUTION; MOVEMENT	Complete and partial genome sequences of two isolates of an unusual new plant virus, designated Donkey orchid symptomless virus (DOSV) were identified using a high-throughput sequencing approach. The virus was identified from asymptomatic plants of Australian terrestrial orchid Diuris longifolia (Common donkey orchid) growing in a remnant forest patch near Perth, western Australia. DOSV was identified from two D. longifolia plants of 264 tested, and from at least one plant of 129 Caladenia latifolia (pink fairy orchid) plants tested. Phylogenetic analysis of the genome revealed open reading frames (ORF) encoding seven putative proteins of apparently disparate origins. A 69-kDa protein (ORF1) that overlapped the replicase shared low identity with MPs of plant tymoviruses (Tymoviridae). A 157-kDa replicase (ORF2) and 22-kDa coat protein (ORF4) shared 32% and 40% amino acid identity, respectively, with homologous proteins encoded by members of the plant virus family Alphaflexiviridae. A 44-kDa protein (ORF3) shared low identity with myosin and an autophagy protein from Squirrelpox virus. A 27-kDa protein (ORF5) shared no identity with described proteins. A 14-kDa protein (ORF6) shared limited sequence identity (26%) over a limited region of the envelope glycoprotein precursor of mammal-infecting Crimea-Congo hemorrhagic fever virus (Bunyaviridae). The putative 25-kDa movement protein (MP) (ORF7) shared limited (27%) identity with 3A-like MPs of members of the plant-infecting Tombusviridae and Virgaviridae. Transmissibility was shown when DOSV systemically infected Nicotiana benthamiana plants. Structure and organization of the domains within the putative replicase of DOSV suggests a common evolutionary origin with 'potexvirus-like' replicases of viruses within the Alphaflexiviridae and Tymoviridae, and the CP appears to be ancestral to CPs of allexiviruses (Alphaflexiviridae). The MP shares an evolutionary history with MPs of dianthoviruses, but the other putative proteins are distant from plant viruses. DOSV is not readily classified in current lower order virus taxa.	[Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.] Murdoch Univ, Australian Plant Virol Lab, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia	Murdoch University	Wylie, SJ (corresponding author), Murdoch Univ, Australian Plant Virol Lab, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia.	s.wylie@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Wylie, Stephen/M-5910-2013	Jones, Michael G.K./0000-0001-5002-0227; Wylie, Stephen/0000-0002-5639-7460; Li, Hua/0000-0002-0973-5762	Australian Research Council Linkage grant [LP110200180]; Western Australian Botanic Gardens and Parks Authority; Australian Orchid Foundation	Australian Research Council Linkage grant(Australian Research Council); Western Australian Botanic Gardens and Parks Authority; Australian Orchid Foundation	This study was funded by Australian Research Council Linkage grant LP110200180 'The roles viruses play in the decline of terrestrial orchids in Australia's hotspot of global biodiversity', with financial support from the Western Australian Botanic Gardens and Parks Authority and the Australian Orchid Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; Coutts BA, 2011, ARCH VIROL, V156, P1757, DOI 10.1007/s00705-011-1046-4; Dixon KW, 2003, ORCHID CONSERVATION; DOLJA VV, 1991, VIROLOGY, V184, P79, DOI 10.1016/0042-6822(91)90823-T; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GUY PL, 1985, PLANT PATHOL, V34, P532, DOI 10.1111/j.1365-3059.1985.tb01404.x; Hall GS, 2010, PLANT PATHOL, V59, P1152, DOI 10.1111/j.1365-3059.2010.02351.x; Hoffman N, 2011, ORCHIDS S W AUSTR, P513; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Malmstrom CM, 2011, VIRUS RES, V159, P84, DOI 10.1016/j.virusres.2011.05.010; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Moyal A., 2004, PLATYPUS EXTRAORDINA; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Phillips RD, 2011, J BIOGEOGR, V38, P487, DOI 10.1111/j.1365-2699.2010.02413.x; Power AG, 2011, VIRUS RES, V159, P95, DOI 10.1016/j.virusres.2011.05.016; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; SABANADZOVIC S, 2010, PHYTOPATHOLOGY S, V100, pS112; Sabanadzovic S, 2011, ARCH VIROL, V156, P1665, DOI 10.1007/s00705-011-1015-y; SCHOLTHOF HB, 1995, VIROLOGY, V213, P425, DOI 10.1006/viro.1995.0015; Skotnicki ML, 1996, ARCH VIROL, V141, P99, DOI 10.1007/BF01718591; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Webster CG, 2007, PLANT PATHOL, V56, P729, DOI 10.1111/j.1365-3059.2007.01653.x; Wylie S, 2011, ARCH VIROL, V156, P1245, DOI 10.1007/s00705-011-0963-6; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/s00705-012-1452-2; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	42	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79587	10.1371/journal.pone.0079587	http://dx.doi.org/10.1371/journal.pone.0079587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223974	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400074
J	Yang, ZZ; Xu, YQ; Xu, L; Maccauro, G; Rossi, B; Chen, YJ; Li, HJ; Zhang, J; Sun, HP; Yang, YH; Xu, D; Liu, XF				Yang, Zuozhang; Xu, Yongqing; Xu, Lei; Maccauro, Giulio; Rossi, Barbara; Chen, Yanjin; Li, Hongjun; Zhang, Jing; Sun, Hongpu; Yang, Yihao; Xu, Da; Liu, Xuefeng			Regulation of Autophagy Via PERK-eIF2 alpha Effectively Relieve the Radiation Myelitis Induced by Iodine-125	PLOS ONE			English	Article							METASTATIC SPINAL TUMORS; RENAL-CELL CARCINOMA; PERCUTANEOUS VERTEBROPLASTY; INTERSTITIAL IMPLANTATION; TARGETING AUTOPHAGY; IN-VITRO; DEATH; PROLIFERATION; BRACHYTHERAPY; INDUCTION	Radiation myelitis is the most serious complication in clinical radiotherapy for spinal metastases. We previously showed that I-125 brachytherapy induced apoptosis of spinal cord neurons accompanied by autophagy. In this study, we further investigated the mechanism by which I-125 radiation triggered autophagy in neural cells. We found that autophagy induced by I-125 radiation was involved in endoplasmic reticulum (ER) stress and mainly dependent on PERK-eIF2 alpha pathway. The expressions of LC3II, ATG12 and PI3K were significantly suppressed in PERK knockout neural cells. Meanwhile, the expressions of phosphorylated-Akt s473 and caspase 3/8 all significantly increased in neural cells transfected with a PERK siRNA and which enhanced apoptosis of neurons after I-125 radiation. The results were consistent with that by MTT and Annexin-FITC/PT staining. In annimal model of banna pigs with radiation myelitis caused by I-125 brachytherapy, we have successfully decreased PERK expression by intrathecal administration of the lentivirus vector. The apoptosis rate was significantly higher than that in control group and which deteriorated radiation myelitis of banna pigs. Thus, autophagy caused by I-125 radiation was mainly as an attempt of cell survival at an early stage, but it would be a self-destructive process and promoted the process of apoptosis and necrosis radiated by I-125 for more than 72 hours. The study would be useful and helpful to maximize efficiency of radiation therapy in clinical therapy.	[Yang, Zuozhang; Xu, Yongqing; Xu, Lei; Chen, Yanjin; Zhang, Jing; Sun, Hongpu; Yang, Yihao; Xu, Da; Liu, Xuefeng] Kunming Med Univ, Kunming Gen Hosp Chengdu Mil Command, Affiliated Hosp 3, Dept Orthopaed, Kunming, Yunnan, Peoples R China; [Yang, Zuozhang; Maccauro, Giulio; Rossi, Barbara] Univ Cattolica Sacro Cuore, Agostino Gemelli Hosp, Dept Orthopaed Oncol, Rome, Italy; [Li, Hongjun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China	Kunming General Hospital; Kunming Medical University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College	Yang, ZZ (corresponding author), Kunming Med Univ, Kunming Gen Hosp Chengdu Mil Command, Affiliated Hosp 3, Dept Orthopaed, Kunming, Yunnan, Peoples R China.	yangzuozhang@hotmail.com		Multhoff, Gabriele/0000-0002-2616-3137; MACCAURO, Giulio/0000-0002-7359-268X	National Natural Science Foundation of China [81260322/H1606, 81372322/H1606]; Natural Science Foundation of Yunnan Province [2012FB163]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2011FB201]; Kunming Major Program of Science and Technology Development [11S030003]; specialty fund of high-level talents medical personnel training of Yunnan province [D-201242]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University; Kunming Major Program of Science and Technology Development; specialty fund of high-level talents medical personnel training of Yunnan province	This research was supported in part by grants (no. 81260322/H1606 and no. 81372322/H1606) from the National Natural Science Foundation of China, a grant (no. 2012FB163) from the Natural Science Foundation of Yunnan Province, a grant (no. 2011FB201) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University, a grant (no. 11S030003) from Kunming Major Program of Science and Technology Development, and a grant (no. D-201242) from the specialty fund of high-level talents medical personnel training of Yunnan province. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird EG, 2001, BRIT J RADIOL, V74, P56, DOI 10.1259/bjr.74.877.740056; Anbalagan S, 2012, RADIOTHER ONCOL, V103, P388, DOI 10.1016/j.radonc.2012.04.001; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BERGLER W, 1993, ORL J OTO-RHINO-LARY, V55, P230, DOI 10.1159/000276429; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Calgarotto AK, 2012, EUR J PHARMACOL, V678, P6, DOI 10.1016/j.ejphar.2011.12.031; Cetin Y, 2005, J AGR FOOD CHEM, V53, P6558, DOI 10.1021/jf051120z; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Donovan DJ, 2006, SPINE, V31, pE460, DOI 10.1097/01.brs.0000222022.67502.4e; Efeyan A, 2012, NATURE; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jaboin JJ, 2007, TECHNOL CANCER RES T, V6, P443, DOI 10.1177/153303460700600510; Jang JS, 2005, J NEUROSURG-SPINE, V2, P243, DOI 10.3171/spi.2005.2.3.0243; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee CS, 2012, ASIAN SPINE J, V6, P71, DOI 10.4184/asj.2012.6.1.71; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Mancias JD, 2011, ONCOTARGET, V2, P1302; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Merrick GS, 2003, J UROLOGY, V169, P1643, DOI 10.1097/01.ju.0000035544.25483.61; Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333; Park JH, 2012, J CLIN NEUROSCI, V19, P1573, DOI 10.1016/j.jocn.2011.12.027; Pradeep AN, 2012, CELL TISSUE RES; Roeloffzen EMA, 2011, INT J RADIAT ONCOL, V80, P76, DOI 10.1016/j.ijrobp.2010.01.022; Sahgal A, 2010, INT J RADIAT ONCOL, V77, P548, DOI 10.1016/j.ijrobp.2009.05.023; Seybold VS, 2004, METH MOLEC MED, P203; Ueda Y, 2012, BIOMATERIALS, V33, P9061, DOI 10.1016/j.biomaterials.2012.09.003; Yang ZZ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-48; Yang ZZ, 2012, ONCOL LETT, V3, P315, DOI 10.3892/ol.2011.489; Yang ZZ, 2009, ACTA RADIOL, V50, P1142, DOI 10.3109/02841850903229133	34	10	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e76819	10.1371/journal.pone.0076819	http://dx.doi.org/10.1371/journal.pone.0076819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223705	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400004
J	Zhang, T; Rong, NN; Chen, J; Zou, CW; Jing, HY; Zhu, XL; Zhang, WL				Zhang, Tao; Rong, Ningning; Chen, Juan; Zou, Chengwei; Jing, Haiyan; Zhu, Xiaolong; Zhang, Wenlong			SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; CELLS; APOPTOSIS; SENESCENCE; RADIATION; MICE; TUMORIGENESIS; DEACETYLASE; METASTASIS	Aim: The role of Sirtuin 1 (SIRT 1) in carcinogenesis is controversial. This study was to explore the association between the SIRT1 expression and the clinical characteristics, the responsiveness to chemotherapy and prognosis in Non-small cell lung cancer (NSCLC). Methods: We enrolled 295 patients with inoperable advanced stage of NSCLC, namely, stage III (A+B) and IV NSCLC. All patients had received platinum-based chemotherapy after diagnosis and the chemotherapy response were evaluated. All patients were followed up for overall survival (OS) and progression free survival (PFS). In vitro, H292 cells were tranfected with SIRT1 small interfering RNA (siRNA). The cell biological behaviors and chemosensitivity to cisplatin treatment were studied. The in vivo tumorgenesis and metastasis assays were performed in nude mice. Results: We found that the SIRT1 expressions were significantly associated with the tumor stage, tumor size and differentiation status. Patients with high SIRT 1 expressions had a significantly higher chance to be resistant to chemotherapy than those with low SIRT 1 expression. Patients with high expression of SIRT1 had significantly shorter OS and DFS than those with low expression. Cox analyses confirmed that the SIRT 1 expression was a strong predictor for a poor OS and PFS in NSCLC patients underwent Platinum-based chemotherapy. In vitro studies revealed that the reduced expression SIRT 1 by siRNA technique significantly inhibited cell proliferation, migration and invasion. More importantly, SIRT1 si-RNA significantly enhanced the chemosensitivity of H292 cells to cisplatin treatment. The in vivo tumorgenesis and metastasis assays showed that SIRT1 knockdown dramatically reduced the tumor volume and the metastatic ability in nude mice. Conclusion: Collectively, our data suggest that the SIRT1 expression may be a molecular marker associated with the NSLCLC clinical features, treatment responsiveness and prognosis of advanced NSCLC.	[Zhang, Tao; Zou, Chengwei; Zhu, Xiaolong; Zhang, Wenlong] Shandong Univ, Prov Hosp Affiliated, Dept Cardiovasc Surg, Jinan 250100, Shandong, Peoples R China; [Rong, Ningning] Shandong Prov Chest Hosp, Intens Care Unit, Jinan, Shandong, Peoples R China; [Chen, Juan] Jinan seventh peoples Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China; [Jing, Haiyan] Shandong Univ, Prov Hosp Affiliated, Dept Pathol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, WL (corresponding author), Shandong Univ, Prov Hosp Affiliated, Dept Cardiovasc Surg, Jinan 250100, Shandong, Peoples R China.	drwenlongzhang@sina.cn			Shandong University (QL) [1B-34]	Shandong University (QL)	This study was financially supported by a grant from Shandong University (QL-No. 1B-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Bae HJ, 2012, ONCOL LETT, V4, P873, DOI 10.3892/ol.2012.875; Brooks CL, 2009, AGING-US, V1, P278, DOI 10.18632/aging.100031; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V380, P236, DOI 10.1016/j.bbrc.2009.01.040; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen WY, 2013, CURR OPIN HEMATOL, V20, P308, DOI 10.1097/MOH.0b013e328360ab64; Dai CX, 2013, ENDOCRINOLOGY, V154, P1247, DOI 10.1210/en.2012-1908; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gridelli C, 2002, TUMORI J, V88, pS143, DOI 10.1177/030089160208800142; Hildebrandt MAT, 2009, EXPERT OPIN DRUG MET, V5, P745, DOI 10.1517/17425250902973711; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045119; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Kosmidis P, 2002, LUNG CANCER, V38, pS19; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Lovaas JD, 2013, PROSTATE, V73, P522, DOI 10.1002/pros.22592; Mantel C, 2008, CURR OPIN HEMATOL, V15, P326, DOI 10.1097/MOH.0b013e3283043819; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Metoyer Cheynita F, 2008, Pathophysiology, V15, P103, DOI 10.1016/j.pathophys.2008.04.002; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; REMMELE W, 1987, PATHOLOGE, V8, P138; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stuschke M, 2010, NAT REV CLIN ONCOL, V7, P613, DOI 10.1038/nrclinonc.2010.165; Subramaniam Sangeetha, 2013, J Carcinog, V12, P3, DOI 10.4103/1477-3163.107958; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Tsim S, 2010, RESP MED, V104, P1767, DOI 10.1016/j.rmed.2010.08.005; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu FL, 2012, CELL ONCOL, V35, P175, DOI 10.1007/s13402-012-0075-7; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Xie YX, 2012, J RADIAT RES, V53, P44, DOI 10.1269/jrr.11062; Zhou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063142; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	41	43	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79162	10.1371/journal.pone.0079162	http://dx.doi.org/10.1371/journal.pone.0079162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223900	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400050
J	Akinlade, KS; Atere, AD; Olaniyi, JA; Rahamon, SK; Adewale, CO				Akinlade, Kehinde Sola; Atere, Adedeji David; Olaniyi, John Ayodele; Rahamon, Sheu Kadiri; Adewale, Christiana Odunayo			Serum Copeptin and Cortisol Do Not Accurately Predict Sickle Cell Anaemia Vaso-Occlusive Crisis as C-Reactive Protein	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; STABLE PEPTIDE; VASOPRESSIN PRECURSOR; CRITICALLY-ILL; SEPTIC SHOCK; DISEASE; INFLAMMATION; MORTALITY; BIOMARKER; SEVERITY	Objective: This study assessed the diagnostic performance and prognostic properties of C-reactive protein (CRP), copeptin and cortisol in individuals with sickle cell anaemia (SCA). Design: Prospective case-control study Methods: Sixty consecutive SCA subjects (18-40 years) comprising 30 subjects in the steady state and 30 subjects in vaso-occlusive crisis (VOC) were recruited into this study. Thirty (30) apparently healthy individuals with HbAA genotype served as controls. ELISA was used for the determination of serum levels of copeptin, CRP and cortisol. Data obtained were statistically analyzed using the Student's t-test and Mann Whitney U as appropriate and P<0.05 was considered significant. Results: SCA subjects in VOC had significantly lower copeptin level and significantly higher CRP level compared with controls. However, serum levels of copeptin, cortisol and CRP were significantly higher in SCA subjects in VOC compared with SCA subjects in steady state. Furthermore, CRP had the widest Area under the ROC curve (AUROC) than copeptin and cortisol. No significant difference was observed in the levels of copeptin, CRP and cortisol when SCA subjects in VOC who were hospitalized for less <= 5 days were compared with subjects who had longer stays. Conclusion: It could be concluded that C-reactive protein has a superior diagnostic performance for vaso-occlusive crisis in individuals with sickle cell anaemia and that C-reactive protein, cortisol and copeptin are not good prognostic markers in SCA subjects in vaso-occlusive crisis.	[Akinlade, Kehinde Sola; Atere, Adedeji David; Rahamon, Sheu Kadiri; Adewale, Christiana Odunayo] Univ Ibadan, Univ Coll Hosp, Dept Chem Pathol, Ibadan, Nigeria; [Olaniyi, John Ayodele] Univ Ibadan, Univ Coll Hosp, Dept Haematol, Ibadan, Nigeria	University of Ibadan; University College Hospital, Ibadan; University of Ibadan; University College Hospital, Ibadan	Akinlade, KS (corresponding author), Univ Ibadan, Univ Coll Hosp, Dept Chem Pathol, Ibadan, Nigeria.	ksakinlade@yahoo.co.uk	Rahamon, Sheu K/C-9676-2018; Atere, Adedeji/GRE-8275-2022; Olaniyi, John/AAO-8849-2021; Olaniyi, John/H-2856-2019	Rahamon, Sheu K/0000-0003-0305-5026; Olaniyi, John/0000-0002-0048-0337; Atere, A. David/0000-0002-8802-3762; Akinlade, Kehinde Sola/0000-0002-9413-3562				Abbiyesuku F M, 1999, Afr J Med Med Sci, V28, P65; Akohoue SA, 2007, PEDIATR RES, V61, P233, DOI 10.1203/pdr.0b013e31802d7754; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Arnon B, 2005, HAEMA, V8, P462; CHRISTOU NV, 1989, ANN SURG, V210, P69, DOI 10.1097/00000658-198907000-00011; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DIXON JS, 1984, SCAND J RHEUMATOL, V13, P39, DOI 10.3109/03009748409102666; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; ELHAZMI MAF, 1992, J TROP PEDIATRICS, V38, P307, DOI 10.1093/tropej/38.6.307; HEDO CC, 1993, J INTERN MED, V233, P467, DOI 10.1111/j.1365-2796.1993.tb01000.x; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kao PC, 2006, ANN CLIN LAB SCI, V36, P163; Katan M, 2011, NEUROLOGY, V76, P563, DOI 10.1212/WNL.0b013e31820b75e6; Katan M, 2010, EUR J MED SERVICES, V140, P13101; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Krishnan S, 2010, BRIT J HAEMATOL, V148, P797, DOI 10.1111/j.1365-2141.2009.08013.x; KUSHNER I, 1991, ARTHRITIS RHEUM, V34, P1065, DOI 10.1002/art.1780340819; Latendresse G, 2008, BIOL RES NURS, V10, P54, DOI 10.1177/1099800408320970; Limper M, 2010, J INFECTION, V61, P92, DOI 10.1016/j.jinf.2010.03.029; Makis AC, 2006, ARCH INTERN MED, V166, P366, DOI 10.1001/archinte.166.3.366; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mohammed FA, 2010, BLOOD CELL MOL DIS, V45, P293, DOI 10.1016/j.bcmd.2010.08.003; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; NADEL C, 1977, NEW YORK STATE J MED, V77, P1075; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Omoti CE, 2005, ANN AFR MED, V4, P62; OSIFO BOA, 1988, ACTA HAEMATOL-BASEL, V79, P44, DOI 10.1159/000205689; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Porter L S, 2000, J Health Psychol, V5, P53, DOI 10.1177/135910530000500109; ROSENBLOOM BE, 1980, AM J HEMATOL, V9, P373; SAAD STO, 1992, TROP GEOGR MED, V44, P86; Sam S, 2004, CLIN ENDOCRINOL, V60, P29, DOI 10.1111/j.1365-2265.2004.01923.x; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Soyannwo OA, 2000, W AFR J MED, V4, P242; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; STUART J, 1994, J CLIN PATHOL, V47, P166, DOI 10.1136/jcp.47.2.166; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; van Wolfswinkel ME, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-6; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77913	10.1371/journal.pone.0077913	http://dx.doi.org/10.1371/journal.pone.0077913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223742	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400021
J	Fong, JT; Jacobs, RJ; Moravec, DN; Uppada, SB; Botting, GM; Nlend, M; Puri, N				Fong, Jason T.; Jacobs, Ryan J.; Moravec, David N.; Uppada, Srijayaprakash B.; Botting, Gregory M.; Nlend, Marie; Puri, Neelu			Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; ACQUIRED-RESISTANCE; BETA-CATENIN; CROSS-TALK; CLINICAL-RESPONSE; DUAL INHIBITION; T790M MUTATIONS; GEFITINIB; WNT	The use of tyrosine kinase inhibitors (TKIs) against EGFR/c-Met in non-small cell lung cancer (NSCLC) has been shown to be effective in increasing patient progression free survival (PFS), but their efficacy is limited due to the development of resistance and tumor recurrence. Therefore, understanding the molecular mechanisms underlying development of drug resistance in NSCLC is necessary for developing novel and effective therapeutic approaches to improve patient outcome. This study aims to understand the mechanism of EGFR/c-Met tyrosine kinase inhibitor (TKI) resistance in NSCLC. H2170 and H358 cell lines were made resistant to SU11274, a c-Met inhibitor, and erlotinib, an EGFR inhibitor, through step-wise increases in TKI exposure. The IC50 concentrations of resistant lines exhibited a 4-5 and 11-22-fold increase for SU11274 and erlotinib, respectively, when compared to parental lines. Furthermore, mTOR and Wnt signaling was studied in both cell lines to determine their roles in mediating TKI resistance. We observed a 2-4-fold upregulation of mTOR signaling proteins and a 2- to 8-fold upregulation of Wnt signaling proteins in H2170 erlotinib and SU11274 resistant cells. H2170 and H358 cells were further treated with the mTOR inhibitor everolimus and the Wnt inhibitor XAV939. H358 resistant cells were inhibited by 95% by a triple combination of everolimus, erlotinib and SU11274 in comparison to 34% by a double combination of these drugs. Parental H2170 cells displayed no sensitivity to XAV939, while resistant cells were significantly inhibited (39%) by XAV939 as a single agent, as well as in combination with SU11274 and erlotinib. Similar results were obtained with H358 resistant cells. This study suggests a novel molecular mechanism of drug resistance in lung cancer.	[Fong, Jason T.; Jacobs, Ryan J.; Moravec, David N.; Uppada, Srijayaprakash B.; Botting, Gregory M.; Puri, Neelu] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Nlend, Marie] Thermo Fisher Sci, Rockford, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Thermo Fisher Scientific	Puri, N (corresponding author), Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA.	neelupur@uic.edu	Uppada, Srijayaprakash/AAD-7728-2021		National Cancer Institute of the National Institutes of Health [R21CA158965-01A1]; NATIONAL CANCER INSTITUTE [R21CA158965] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under award number R21CA158965-01A1 http://www.nih.gov to Neelu Puri. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bianco R, 2007, CURR PHARM DESIGN, V13, P3358, DOI 10.2174/138161207782360537; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Casas-Selves M, 2012, CANC RES; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Choo AY, 2006, CELL, V126, P834, DOI 10.1016/j.cell.2006.08.025; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Coley HM, 2004, METH MOLEC MED, V88, P267; Dienstmann R, 2011, MOL ONCOL; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Goldman JW, 2012, CANCER; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; La Monica S, 2009, BIOCHEM PHARMACOL, V78, P460, DOI 10.1016/j.bcp.2009.04.033; Laux I, 2009, J CLIN ONCOL, V27, pCP46; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; Maulik G, 2002, CLIN CANCER RES, V8, P620; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Milligan SA, 2009, CLIN CANCER RES, V15, P4885, DOI 10.1158/1078-0432.CCR-09-0109; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Nakachi I, 2010, MOL CANCER RES, V8, P1142, DOI 10.1158/1541-7786.MCR-09-0388; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Puri Neelu, 2008, J Carcinog, V7, P9; Ramalingam S, 2008, J THORAC ONCOL, V3, P258, DOI 10.1097/JTO.0b013e3181653d1b; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sattler M, 2003, CANCER RES, V63, P5462; Schmid K, 2010, BRIT J CANCER, V103, P622, DOI 10.1038/sj.bjc.6605761; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Shahi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030814; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Spigel DR, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7505; Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Tahir SA, 2013, CANCER RES, V73, P1900, DOI 10.1158/0008-5472.CAN-12-3040; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wedel S, 2011, CANCER LETT, V301, P17, DOI 10.1016/j.canlet.2010.11.003; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Xu Y, 2010, CANCER BIOL THER, V9, P572, DOI 10.4161/cbt.9.8.11881; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622; Zhu H, 2011, MOL BIOL REP	64	36	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78398	10.1371/journal.pone.0078398	http://dx.doi.org/10.1371/journal.pone.0078398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223799	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400058
J	Makino, A; Klein, CJ; Beger, M; Jupiter, SD; Possingham, HP				Makino, Azusa; Klein, Carissa J.; Beger, Maria; Jupiter, Stacy D.; Possingham, Hugh P.			Incorporating Conservation Zone Effectiveness for Protecting Biodiversity in Marine Planning	PLOS ONE			English	Article							GREAT-BARRIER-REEF; RESERVES; AREAS; MANAGEMENT; FISHERIES; COSTS; PHILIPPINES; NETWORKS; DESIGN; MODEL	Establishing different types of conservation zones is becoming commonplace. However, spatial prioritization methods that can accommodate multiple zones are poorly understood in theory and application. It is typically assumed that management regulations across zones have differential levels of effectiveness ("zone effectiveness") for biodiversity protection, but the influence of zone effectiveness on achieving conservation targets has not yet been explored. Here, we consider the zone effectiveness of three zones: permanent closure, partial protection, and open, for planning for the protection of five different marine habitats in the Vatu-i-Ra Seascape, Fiji. We explore the impact of differential zone effectiveness on the location and costs of conservation priorities. We assume that permanent closure zones are fully effective at protecting all habitats, open zones do not contribute towards the conservation targets and partial protection zones lie between these two extremes. We use four different estimates for zone effectiveness and three different estimates for zone cost of the partial protection zone. To enhance the practical utility of the approach, we also explore how much of each traditional fishing ground can remain open for fishing while still achieving conservation targets. Our results show that all of the high priority areas for permanent closure zones would not be a high priority when the zone effectiveness of the partial protection zone is equal to that of permanent closure zones. When differential zone effectiveness and costs are considered, the resulting marine protected area network consequently increases in size, with more area allocated to permanent closure zones to meet conservation targets. By distributing the loss of fishing opportunity equitably among local communities, we find that 84-88% of each traditional fishing ground can be left open while still meeting conservation targets. Finally, we summarize the steps for developing marine zoning that accounts for zone effectiveness.	[Makino, Azusa; Klein, Carissa J.; Beger, Maria; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Jupiter, Stacy D.] Wildlife Conservat Soc, Fiji Country Program, Suva, Fiji; [Possingham, Hugh P.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Queensland; Imperial College London	Makino, A (corresponding author), Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, Brisbane, Qld, Australia.	azusamakino@gmail.com	Klein, Carissa J/F-1632-2011; Beger, Maria/ABC-5975-2022; Possingham, Hugh/B-1337-2008; Beger, Maria/F-9049-2013; POSSINGHAM, HUGH/R-8310-2019	Klein, Carissa J/0000-0002-6299-6451; Beger, Maria/0000-0003-1363-3571; Possingham, Hugh/0000-0001-7755-996X; Beger, Maria/0000-0003-1363-3571; POSSINGHAM, HUGH/0000-0001-7755-996X; Jupiter, Stacy/0000-0001-9742-1677	National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle"; David and Lucile Packard Foundation; John D. and Catherine T. MacArthur Foundation [0-94985-000-GSS]; Australian Research Council Centre of Excellence for Environmental Decisions; Australian Research Council Centre of Excellence for Coral Reef Studies; ITO Foundation, Japan; University of Queensland; Australian Research Council Postdoctoral Fellowship [DP110102153]; Discovery Early Career Research Award [CE110001014]	National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle"; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); John D. and Catherine T. MacArthur Foundation; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); ITO Foundation, Japan; University of Queensland(University of Queensland); Australian Research Council Postdoctoral Fellowship(Australian Research Council); Discovery Early Career Research Award(Australian Research Council)	The authors are thankful for support from the National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle", funded by the David and Lucile Packard Foundation, and a grant from the John D. and Catherine T. MacArthur Foundation (0-94985-000-GSS) to the Wildlife Conservation Society. Additional support was provided by the Australian Research Council Centre of Excellence for Environmental Decisions and the Australian Research Council Centre of Excellence for Coral Reef Studies. AM is funded by the by ITO Foundation, Japan, by the Australian Research Council Centre of Excellence for Environmental Decisions, and the University of Queensland. CJK is supported by an Australian Research Council Postdoctoral Fellowship (Project number DP110102153). MB is supported by a Discovery Early Career Research Award to the ARC Centre of Excellence for Environmental Decisions (CE110001014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agostini V.N., 2010, MARINE ZONING SAINT; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.2307/2641280; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Bruce EM, 2006, COAST MANAGE, V34, P17, DOI 10.1080/08920750500364898; Burke L., 2011, REEFS RISK REVISITED; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cinner J, 2006, ECOL SOC, V11; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Edwards HJ, 2010, BIOL CONSERV, V143, P457, DOI 10.1016/j.biocon.2009.11.013; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fernandes L, 2012, BIOPHYSICAL PRINCIPL; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Govan H., 2009, STATUS POTENTIAL LOC; Grantham HS, 2013, MAR POLICY, V38, P184, DOI 10.1016/j.marpol.2012.05.035; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Lahdelma R, 2000, ENVIRON MANAGE, V26, P595, DOI 10.1007/s002670010118; Leslie H, 2003, ECOL APPL, V13, pS185; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Merrifield MS, 2013, OCEAN COAST MANAGE, V74, P67, DOI 10.1016/j.ocecoaman.2012.06.011; Mills M, 2011, CONSERV BIOL, V25, P1155, DOI 10.1111/j.1523-1739.2011.01749.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Portman ME, 2007, OCEAN COAST MANAGE, V50, P499, DOI 10.1016/j.ocecoaman.2007.02.008; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Scholz AJ, 2011, CONSERV BIOL, V25, P485, DOI 10.1111/j.1523-1739.2010.01626.x; Sciberras M, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-4; Shahabuddin G, 2010, BIOL CONSERV, V143, P2926, DOI 10.1016/j.biocon.2010.04.040; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Teh LCL, 2009, MAR POLICY, V33, P807, DOI 10.1016/j.marpol.2009.03.001; Villa F, 2002, CONSERV BIOL, V16, P515, DOI 10.1046/j.1523-1739.2002.00425.x; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Weeks R, 2010, CONSERV BIOL, V24, P531, DOI 10.1111/j.1523-1739.2009.01340.x; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424	57	16	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78986	10.1371/journal.pone.0078986	http://dx.doi.org/10.1371/journal.pone.0078986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223870	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400094
J	Sohel, MMH; Hoelker, M; Noferesti, SS; Salilew-Wondim, D; Tholen, E; Looft, C; Rings, F; Uddin, MJ; Spencer, TE; Schellander, K; Tesfaye, D				Sohel, Md. Mahmodul Hasan; Hoelker, Michael; Noferesti, Sina Seifi; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Rings, Franca; Uddin, Muhammad Jasim; Spencer, Thomas E.; Schellander, Karl; Tesfaye, Dawit			Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence	PLOS ONE			English	Article							EXPRESSION; PATHWAY; IDENTIFICATION; MATURATION; GROWTH; CELLS; DEGRADATION; PROTEINS; MARKERS; QUALITY	Cell-cell communication within the follicle involves many signaling molecules, and this process may be mediated by secretion and uptake of exosomes that contain several bioactive molecules including extra-cellular miRNAs. Follicular fluid and cells from individual follicles of cattle were grouped based on Brilliant Cresyl Blue (BCB) staining of the corresponding oocytes. Both Exoquick precipitation and differential ultracentrifugation were used to separate the exosome and non-exosomal fraction of follicular fluid. Following miRNA isolation from both fractions, the human miRCURY LNA(TM) Universal RT miRNA PCR array system was used to profile miRNA expression. This analysis found that miRNAs were present in both exosomal and non-exosomal fraction of bovine follicular fluid. We found 25 miRNAs differentially expressed (16 up and 9 down) in exosomes and 30 miRNAs differentially expressed (21 up and 9 down) in non-exosomal fraction of follicular fluid in comparison of BCB-versus BCB+ oocyte groups. Expression of selected miRNAs was detected in theca, granulosa and cumulus oocyte complex. To further explore the potential roles of these follicular fluid derived extra-cellular miRNAs, the potential target genes were predicted, and functional annotation and pathway analysis revealed most of these pathways are known regulators of follicular development and oocyte growth. In order to validate exosome mediated cell-cell communication within follicular microenvironment, we demonstrated uptake of exosomes and resulting increase of endogenous miRNA level and subsequent alteration of mRNA levels in follicular cells in vitro. This study demonstrates for the first time, the presence of exosome or non-exosome mediated transfer of miRNA in the bovine follicular fluid, and oocyte growth dependent variation in extra-cellular miRNA signatures in the follicular environment.	[Sohel, Md. Mahmodul Hasan; Hoelker, Michael; Noferesti, Sina Seifi; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Rings, Franca; Uddin, Muhammad Jasim; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Dept Anim Breeding & Husb, Bonn, Germany; [Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Bonn; Washington State University	Tesfaye, D (corresponding author), Univ Bonn, Dept Anim Breeding & Husb, Bonn, Germany.	tesfaye@itw.uni-bonn.de	Sohel, Mahmodul Hasan/X-8820-2019; Uddin, Muhammad Jasim/N-3866-2013; Sohel, Mahmodul Hasan/I-5063-2019; Spencer, Thomas/AAD-6434-2020; Uddin, Muhammad Jasim/P-8497-2019	Sohel, Mahmodul Hasan/0000-0003-2224-085X; Uddin, Muhammad Jasim/0000-0002-6732-5534; Spencer, Thomas/0000-0003-2815-766X; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865				Araujo VR, 2011, CELL TISSUE RES, V346, P273, DOI 10.1007/s00441-011-1251-1; Armstrong D G, 1997, Rev Reprod, V2, P139, DOI 10.1530/revreprod/2.3.139; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Cortez Maria Angelica, 2012, Recent Results Cancer Res, V195, P151, DOI 10.1007/978-3-642-28160-0_13; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; da Silveira Juliano C, 2012, Biol Reprod, V86, P71, DOI 10.1095/biolreprod.111.093252; Ding F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009402; Dissen GA, 2009, SEMIN REPROD MED, V27, P24, DOI 10.1055/s-0028-1108007; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ghanem N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-90; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; GOSDEN RG, 1988, J REPROD FERTIL, V82, P813, DOI 10.1530/jrf.0.0820813; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Huo LJ, 2004, MECH DEVELOP, V121, P1275, DOI 10.1016/j.mod.2004.05.007; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; MCNATTY KP, 1978, J ENDOCRINOL, V76, P527, DOI 10.1677/joe.0.0760527; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mongan M, 2011, DEVELOPMENT, V138, P4001, DOI 10.1242/dev.065003; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patsoula E, 2001, REPRODUCTION, V121, P455, DOI 10.1530/rep.0.1210455; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Pujol M, 2004, THERIOGENOLOGY, V61, P735, DOI 10.1016/S0093-691X(03)00250-4; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Silva DS, 2011, ZYGOTE, V27, P1; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; SPANELBOROWSKI K, 1994, MOL CELL ENDOCRINOL, V104, P11, DOI 10.1016/0303-7207(94)90046-9; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sutherland JM, 2012, J CELL PHYSIOL, V227, P1188, DOI 10.1002/jcp.22837; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; TORRI AF, 1988, MOL CELL BIOL, V8, P4625, DOI 10.1128/MCB.8.11.4625; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yamaura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030250; Yokoo M, 2002, BIOL REPROD, V67, P1165, DOI 10.1095/biolreprod67.4.1165; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zheng P, 2006, MOL REPROD DEV, V73, P667, DOI 10.1002/mrd.20428; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	65	204	214	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78505	10.1371/journal.pone.0078505	http://dx.doi.org/10.1371/journal.pone.0078505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223816	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400069
J	Wu, T; Deng, SN; Li, WG; Yu, YG; Li, F; Mao, M				Wu, Ting; Deng, Shining; Li, Wei-Guang; Yu, Yongguo; Li, Fei; Mao, Meng			Maternal Obesity Caused by Overnutrition Exposure Leads to Reversal Learning Deficits and Striatal Disturbance in Rats	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; DIET-INDUCED OBESITY; FREELY MOVING RATS; FRONTAL-CORTEX; ATTENTIONAL SET; DORSOMEDIAL STRIATUM; ORBITOFRONTAL CORTEX; METABOLIC SYNDROME; LEPTIN ACTION; LESIONS	Maternal obesity caused by overnutrition during pregnancy increases susceptibility to metabolic risks in adulthood, such as obesity, insulin resistance, and type 2 diabetes; however, whether and how it affects the cognitive system associated with the brain remains elusive. Here, we report that pregnant obesity induced by exposure to excessive high fatty or highly palatable food specifically impaired reversal learning, a kind of adaptive behavior, while leaving serum metabolic metrics intact in the offspring of rats, suggesting a much earlier functional and structural defects possibly occurred in the central nervous system than in the metabolic system in the offspring born in unfavorable intrauterine nutritional environment. Mechanically, we found that above mentioned cognitive inflexibility might be associated with significant striatal disturbance including impaired dopamine homeostasis and disrupted leptin signaling in the adult offspring. These collective data add a novel perspective of understanding the adverse postnatal sequelae in central nervous system induced by developmental programming and the related molecular mechanism through which priming of risk for developmental disorders may occur during early life.	[Wu, Ting; Mao, Meng] Sichuan Univ, West China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Wu, Ting; Deng, Shining; Yu, Yongguo; Li, Fei] Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Translat Med,Sch Med, Shanghai 200030, Peoples R China; [Wu, Ting; Mao, Meng] Chengdu Womens & Childrens Cent Hosp, Chengdu, Sichuan, Peoples R China; [Deng, Shining; Yu, Yongguo; Li, Fei] Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Li, Wei-Guang] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflamm, Inst Med Sci, Dept Anat & Embryol,Sch Med, Shanghai 200030, Peoples R China; [Li, Wei-Guang] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflamm, Inst Med Sci, Dept Biochem & Mol Cell Biol,Sch Med, Shanghai 200030, Peoples R China	Sichuan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Translat Med,Sch Med, Shanghai 200030, Peoples R China.	feili@shsmu.edu.cn; dffmmao@126.com		yu, yongguo/0000-0002-4472-0910	Ministry of Education of China (NCET program); National Science Foundation of China [81000592, 81222012, 91232706]; National Basic Research Program of China (973 Project) [2013CB835100]; Science and Technology Commission of Shanghai Municipality [10DZ2272200, 09DZ2200900, 10PJ1407500, 10PJ1403500, 10231203903, 10JC1411200]; Shanghai Municipal Education Commission [11ZZ103]; Shanghai Municipal Health Bureau [2010004]; Morning Star Rewarding Fund of Shanghai Jiao Tong University; Xingbairen plan of Shanghai Jiao Tong University School of Medicine	Ministry of Education of China (NCET program)(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Municipal Health Bureau; Morning Star Rewarding Fund of Shanghai Jiao Tong University; Xingbairen plan of Shanghai Jiao Tong University School of Medicine	Ministry of Education of China (NCET program), National Science Foundation of China (81000592, 81222012, and 91232706), the National Basic Research Program of China (973 Project, 2013CB835100), Science and Technology Commission of Shanghai Municipality (10DZ2272200, 09DZ2200900, 10PJ1407500, 10PJ1403500, 10231203903 and 10JC1411200), Shanghai Municipal Education Commission (11ZZ103). Shanghai Municipal Health Bureau (2010004), Morning Star Rewarding Fund (Category B, 2011) of Shanghai Jiao Tong University and Xingbairen plan of Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basatemur E, 2013, PEDIATRICS, V131, P56, DOI 10.1542/peds.2012-0788; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Birrell JM, 2000, J NEUROSCI, V20, P4320; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Burghardt PR, 2012, J NEUROSCI, V32, P15369, DOI 10.1523/JNEUROSCI.2521-12.2012; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Couvreur O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018043; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; ELLIOTT R, 1995, PSYCHOL MED, V25, P619, DOI 10.1017/S0033291700033523; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gobert A, 1997, J NEUROCHEM, V69, P2616; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Izquierdo A, 2010, NEUROPSYCHOPHARMACOL, V35, P505, DOI 10.1038/npp.2009.155; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; Matsumoto M, 1998, EUR J PHARMACOL, V343, P165, DOI 10.1016/S0014-2999(97)01544-6; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; PAXINOS G, 2003, RAT BRAIN ATLAS STER; Peterson DA, 2009, NEUROSCIENCE, V163, P1092, DOI 10.1016/j.neuroscience.2009.07.033; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Ruager-Martin R, 2010, EARLY HUM DEV, V86, P715, DOI 10.1016/j.earlhumdev.2010.08.007; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Tait DS, 2007, ANN NY ACAD SCI, V1121, P407, DOI 10.1196/annals.1401.010; Tait DS, 2008, BEHAV BRAIN RES, V187, P100, DOI 10.1016/j.bbr.2007.08.035; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Traykov L, 2007, COGN BEHAV NEUROL, V20, P219, DOI 10.1097/WNN.0b013e31815e6254; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; Williams KW, 2009, AM J CLIN NUTR, V89, p985S, DOI 10.3945/ajcn.2008.26788D	44	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78876	10.1371/journal.pone.0078876	http://dx.doi.org/10.1371/journal.pone.0078876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223863	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400093
J	Xu, JL; Donepudi, AC; Moscovitz, JE; Slitt, AL				Xu, Jialin; Donepudi, Ajay C.; Moscovitz, Jamie E.; Slitt, Angela L.			Keap1-Knockdown Decreases Fasting-Induced Fatty Liver via Altered Lipid Metabolism and Decreased Fatty Acid Mobilization from Adipose Tissue	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; DIET-INDUCED OBESITY; HEPATOCYTE-SPECIFIC DELETION; HEPATIC STEATOSIS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; TRANSPORT PROTEIN; BINDING-PROTEIN; GENE-EXPRESSION	Aims: The purpose of this study was to determine whether Nrf2 activation, via Keap1-knockdown (Keap1-KD), regulates lipid metabolism and mobilization induced by food deprivation (e. g. fasting). Methods and Results: Male C57BL/6 (WT) and Keap1-KD mice were either fed ad libitum or food deprived for 24 hours. After fasting, WT mice exhibited a marked increase in hepatic lipid accumulation, but Keap1-KD mice had an attenuated increase of lipid accumulation, along with reduced expression of lipogenic genes (acetyl-coA carboxylase, stearoyl-CoA desaturase-1, and fatty acid synthase) and reduced expression of genes related to fatty acid transport, such as fatty acid translocase/CD36 (CD36) and Fatty acid transport protein (FATP) 2, which may attribute to the reduced induction of Peroxisome proliferator-activated receptor (Ppar) a signaling in the liver. Additionally, enhanced Nrf2 activity by Keap1-KD increased AMP-activated protein kinase (AMPK) phosphorylation in liver. In white adipose tissue, enhanced Nrf2 activity did not change the lipolysis rate by fasting, but reduced expression of fatty acid transporters - CD36 and FATP1, via a PPAR alpha-dependent mechanism, which impaired fatty acid transport from white adipose tissue to periphery circulation system, and resulted in increased white adipose tissue fatty acid content. Moreover, enhanced Nrf2 activity increased glucose tolerance and Akt phosphorylation levels upon insulin administration, suggesting Nrf2 signaling pathway plays a key role in regulating insulin signaling and enhanced insulin sensitivity in skeletal muscle. Conclusion: Enhanced Nrf2 activity via Keap1-KD decreased fasting-induced steatosis, pointing to an important function of Nrf2 on lipid metabolism under the condition of nutrient deprivation.	[Xu, Jialin; Donepudi, Ajay C.; Moscovitz, Jamie E.; Slitt, Angela L.] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Xu, Jialin] Northeastern Univ, Coll Life & Hlth Sci, Inst Biochem & Mol Biol, Shenyang, Peoples R China	University of Rhode Island; Northeastern University - China	Slitt, AL (corresponding author), Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	aslitt@uri.edu			National Institute of Health [5R01ES016042-04, 3R01ES016042-2S2, 5K22ES013782-03]; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Center for Research Resources [5P20RR016457-11]; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Institute for General Medical Science, National Institutes of Health (NIH) [8P20GM103430-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016042, K22ES013782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island IDeA Network of Biomedical Research Excellence grant from National Center for Research Resources; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Institute for General Medical Science, National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health [5R01ES016042-04; 3R01ES016042-2S2; 5K22ES013782-03], and also supported, in part, by Rhode Island IDeA Network of Biomedical Research Excellence grants from the National Center for Research Resources (5P20RR016457-11) and the National Institute for General Medical Science (8P20GM103430-11), components of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Im SS, 2006, BIOCHEM J, V399, P131, DOI 10.1042/BJ20060696; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; JENSEN MD, 1987, J CLIN INVEST, V79, P207, DOI 10.1172/JCI112785; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Morgan K, 2008, EUR J GASTROEN HEPAT, V20, P843, DOI 10.1097/MEG.0b013e3282f9b203; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nilsson PM, 2008, DIABETES CARE, V31, pS278, DOI 10.2337/dc08-s268; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rouvinen-Watt K, 2010, LIPIDS, V45, P111, DOI 10.1007/s11745-009-3377-4; Saraf N, 2012, J PHARM PHARMACOL, V64, P161, DOI 10.1111/j.2042-7158.2011.01366.x; SCHWIETERMAN W, 1988, P NATL ACAD SCI USA, V85, P359, DOI 10.1073/pnas.85.2.359; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; STREMMEL W, 1985, P NATL ACAD SCI USA, V82, P4, DOI 10.1073/pnas.82.1.4; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	62	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79841	10.1371/journal.pone.0079841	http://dx.doi.org/10.1371/journal.pone.0079841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224011	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400145
J	Liu, YW; Song, N; Ren, KX; Meng, SL; Xie, Y; Long, QD; Chen, XC; Zhao, X				Liu, Yingwei; Song, Na; Ren, Kexing; Meng, Shenglan; Xie, Yao; Long, Qida; Chen, Xiancheng; Zhao, Xia			Expression Loss and Revivification of RhoB Gene in Ovary Carcinoma Carcinogenesis and Development	PLOS ONE			English	Article							RAS TRANSFORMATION; CELL-ADHESION; CANCER; PROTEINS; GTPASES; GROWTH; FARNESYLTRANSFERASE; ADENOCARCINOMA; TRICHOSTATIN; DEGRADATION	RhoB, a member of small GTPases belonging to the Ras protein superfamily, might have a suppressive activity in cancer progression. Here, expression of RhoB gene was evaluated in human benign, borderline and malignant ovary tumors by immunostaining, with normal ovary tissue as control. Malignant tumors were assessed according to Federation Internationale de Gynecologie Obstetrique (FIGO) guidelines and classified in stage I-IV. Revivification of RhoB gene was investigated by analyzing the effect of histone deacetylase (HDAC) inhibitor trichostatin (TSA) and methyltransferase inhibitor 5-azacytidine (5-Aza) on ovarian cancer cells via RT-PCR and western blot. Apoptosis of ovary cancer cells was detected using flowcytometry and fluorescence microscopy. Subsequently, RhoB expression is detected in normal ovary epithelium, borderline tumors, and decreases significantly or lost in the majority of ovarian cancer specimen (P<0.05). RhoB expression decreases significantly from stage II (71.4%) to stage III (43.5%) to stage IV (18.2%, P<0.05). TSA can both significantly revive the RhoB gene and mediate apoptosis of ovarian cancer cells, but 5-Aza couldn't. Interference into Revivification of RhoB gene results in reduction of ovary carcinoma cell apoptosis. It is proposed that loss of RhoB expression occurs frequently in ovary carcinogenesis and progression and its expression could be regulated by histone deacetylation but not by promoter hypermethylation, which may serve as a prospective gene treatment target for the patients with ovarian malignancy not responding to standard therapies.	[Liu, Yingwei; Xie, Yao; Long, Qida; Zhao, Xia] Sichuan Univ, West China Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan, Peoples R China; [Song, Na; Ren, Kexing; Meng, Shenglan; Chen, Xiancheng] Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Song, Na; Ren, Kexing; Meng, Shenglan; Chen, Xiancheng] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Chen, XC (corresponding author), Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	chenwcrs@126.com; xia-zhao@126.com			National 973 Program of China [2010CB529905, 2011CB910702, 2011CB910703]; National Natural Science Foundation of China [NSFC81071861]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National 973 Program of China(grant nos. 2010CB529905, 2011CB910702, 2011CB910703), National Natural Science Foundation of China (NSFC81071861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Caslini C, 2006, ONCOGENE, V25, P5446, DOI 10.1038/sj.onc.1209533; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Couderc B, 2008, CANCER GENE THER, V15, P456, DOI 10.1038/cgt.2008.12; Delarue FL, 2007, ONCOGENE, V26, P633, DOI 10.1038/sj.onc.1209819; Della Ragione F, 2001, FEBS LETT, V499, P199, DOI 10.1016/S0014-5793(01)02539-X; DeWard AD, 2009, PLOS ONE, V4, P7102, DOI [10.1371/journal.pone.0007102, DOI 10.1371/J0URNAL.P0NE.0007102.PUBMED:19768111]; Eickhoff B, 2000, BIOL CHEM, V381, P107, DOI 10.1515/BC.2000.015; Ferrara FF, 2001, CANCER RES, V61, P2; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Harter P, 2007, INT J GYNECOL CANCER, V17, P1238, DOI 10.1111/j.1525-1438.2007.00931.x; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; MANT JWF, 1994, CANCER SURV, V20, P287; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Momtahen S, 2007, ASCO M, p[25, 5550]; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Weidle UH, 2000, ANTICANCER RES, V20, P1471; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	43	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78417	10.1371/journal.pone.0078417	http://dx.doi.org/10.1371/journal.pone.0078417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223801	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300028
J	Mahmoud, RS; Narisawa, K				Mahmoud, Rola S.; Narisawa, Kazuhiko			A New Fungal Endophyte, Scolecobasidium humicola, Promotes Tomato Growth under Organic Nitrogen Conditions	PLOS ONE			English	Article							DARK SEPTATE ENDOPHYTES; ARBUSCULAR MYCORRHIZAL FUNGI; CHINESE-CABBAGE; PINUS-CONTORTA; SOIL; SUPPRESSION; SYMBIOSIS; PLANT	A new fungal endophyte, Scolecobasidium humicola, was identified as a common dark septate endophytic fungal (DSE) species under both natural and agricultural conditions. This fungus was found to grow endophylically in the roots of tomato seedlings. Light microscopy of cross-sections of colonized tomato roots showed that the intercellular, pigmented hyphae of the fungus were mostly limited to the epidermal layer and formed outer mantle-like structures. Two isolates of S. humicola, H2-2 and F1-3, have shown the ability to increase plant biomass with an organic nitrogen source. This finding is the first report of S. humicola as an endophyte and could help to improve plant growth with organic nitrogen sources.	[Mahmoud, Rola S.] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan; [Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	Tokyo University of Agriculture & Technology; Ibaraki University	Mahmoud, RS (corresponding author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan.	rola_s_m@yahoo.com			Japan Society for the Promotion of Science [23380190]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23380190) from the Japan Society for the Promotion of Science; http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT E. V., 1927, MYCOLOGIA, V19, P29; Addy HD, 2000, MYCOL RES, V104, P1213, DOI 10.1017/S0953756200002896; [Anonymous], 2009, WORLD ORGANIC AGR ST; BARRON G. L., 1962, CANADIAN JOUR BOT, V40, P77, DOI 10.1139/b62-009; Caldwell BA, 2003, 4 INT C MYC MONTR CA, P312; Finlay R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P134; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; GRANDI RAP, 2002, COGN REVISTA BRASILE, V25, P79, DOI DOI 10.1590/S0100-84042002000100010; HASELWANDTER K, 1982, OECOLOGIA, V53, P352, DOI 10.1007/BF00389012; Hoberg P., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P121; Inselsbacher E, 2012, NEW PHYTOL, V195, P329, DOI 10.1111/j.1469-8137.2012.04169.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 1998, MYCORRHIZA, V7, P261, DOI 10.1007/s005720050190; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Narisawa K, 2004, PHYTOPATHOLOGY, V94, P412, DOI 10.1094/PHYTO.2004.94.5.412; Narisawa K, 2002, EUR J PLANT PATHOL, V108, P103, DOI 10.1023/A:1015080311041; Narisawa K, 1998, PLANT PATHOL, V47, P206, DOI 10.1046/j.1365-3059.1998.00225.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Priyadharsini P, 2012, ACTA BOT CROAT, V71, P159, DOI 10.2478/v10184-011-0058-1; Reeve JR, 2008, SOIL BIOL BIOCHEM, V40, P2547, DOI 10.1016/j.soilbio.2008.06.015; Rodrigues MA, 2006, EUR J AGRON, V25, P328, DOI 10.1016/j.eja.2006.07.002; ROY RY, 1962, LLOYD, V25, P164; Silvani VA, 2008, SOIL BIOL BIOCHEM, V40, P1259, DOI 10.1016/j.soilbio.2007.11.022; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Wilson BJ, 2004, CAN J BOT, V82, P607, DOI 10.1139/B04-030; Zubek S, 2012, APPL SOIL ECOL, V59, P106, DOI 10.1016/j.apsoil.2012.04.008	27	41	46	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78746	10.1371/journal.pone.0078746	http://dx.doi.org/10.1371/journal.pone.0078746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223848	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300033
J	Ruttermann, S; Trellenkamp, T; Bergmann, N; Beikler, T; Ritter, H; Janda, R				Ruettermann, Stefan; Trellenkamp, Taina; Bergmann, Nora; Beikler, Thomas; Ritter, Helmut; Janda, Ralf			Bacterial Viability and Physical Properties of Antibacterially Modified Experimental Dental Resin Composites	PLOS ONE			English	Article							SURFACE-FREE-ENERGY; ENAMEL IN-SITU; STREPTOCOCCUS-MUTANS ADHESION; RESTORATIVE MATERIALS; FILLING MATERIALS; PLAQUE-FORMATION; POLYETHYLENIMINE NANOPARTICLES; BIOFILM DEVELOPMENT; BIOCIDAL ACTIVITIES; AGED RESTORATIONS	Purpose: To investigate the antibacterial effect and the effect on the material properties of a novel delivery system with Irgasan as active agent and methacrylated polymerizable Irgasan when added to experimental dental resin composites. Materials and Methods: A delivery system based on novel polymeric hollow beads, loaded with Irgasan and methacrylated polymerizable Irgasan as active agents were used to manufacture three commonly formulated experimental resin composites. The non-modified resin was used as standard (ST). Material A contained the delivery system providing 4 % (m/m) Irgasan, material B contained 4 % (m/m) methacrylated Irgasan and material C 8 % (m/m) methacrylated Irgasan. Flexural strength (FS), flexural modulus (FM), water sorption (WS), solubility (SL), surface roughness R-a, polymerization shrinkage, contact angle Theta, total surface free energy Upsilon(S) and its apolar Upsilon(LW)(S), polar Upsilon(AB)(S), Lewis acid Upsilon(+)(S) and base Upsilon(-)(S) term as well as bacterial viability were determined. Significance was p < 0.05. Results: The materials A to C were not unacceptably influenced by the modifications and achieved the minimum values for FS, WS and SL as requested by EN ISO 4049 and did not differ from ST what was also found for R-a. Only A had lower FM than ST. Theta of A and C was higher and Upsilon(AB)(S) of A and B was lower than of ST. Materials A to C had higher Upsilon(+)(S) than ST. The antibacterial effect of materials A to C was significantly increased when compared with ST meaning that significantly less vital cells were found. Conclusion: Dental resin composites with small quantities of a novel antibacterially doped delivery system or with an antibacterial monomer provided acceptable physical properties and good antibacterial effectiveness. The sorption material being part of the delivery system can be used as a vehicle for any other active agent.	[Ruettermann, Stefan; Bergmann, Nora; Beikler, Thomas; Janda, Ralf] Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat Dent Periodontol & Endodont, Dusseldorf, Germany; [Trellenkamp, Taina; Ritter, Helmut] Univ Dusseldorf, Inst Organ Chem & Macromol Chem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ruttermann, S (corresponding author), Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat Dent Periodontol & Endodont, Dusseldorf, Germany.	stefan.ruettermann@uni-duesseldorf.de			DFG Deutsche Forschungsgemeinschaft, Bonn, Germany [RU 825/3-1]	DFG Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by the DFG Deutsche Forschungsgemeinschaft, Bonn, Germany (Project No. RU 825/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0; [Anonymous], 4288 DIN EN ISO; [Anonymous], 4049 EN ISO; Aykent F, 2010, J PROSTHET DENT, V103, P221, DOI 10.1016/S0022-3913(10)60034-0; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003; Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2; Buergers R, 2009, DENT MATER, V25, P269, DOI 10.1016/j.dental.2008.07.011; Cho E, 2011, DENT MATER, V27, P1070, DOI 10.1016/j.dental.2011.07.008; Choi SB, 2007, MACROMOL SYMP, V249, P660, DOI 10.1002/masy.200750452; da Silva EM, 2008, J APPL ORAL SCI, V16, P161, DOI 10.1590/S1678-77572008000200015; Feng L, 2006, J BIOMED MATER RES B, V76B, P196, DOI 10.1002/jbm.b.30355; Goncalves L, 2008, J BIOMED MATER RES B, V85B, P320, DOI 10.1002/jbm.b.30949; Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x; Gyo M, 2008, APPL ENVIRON MICROB, V74, P1428, DOI 10.1128/AEM.02039-07; Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7; Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003; Hahnel S, 2008, J DENT, V36, P977, DOI 10.1016/j.jdent.2008.08.004; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hannig C, 2010, J MED MICROBIOL, V59, P1, DOI 10.1099/jmm.0.015420-0; Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005; Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5; Imazato S, 2008, DENT MATER J, V27, P145, DOI 10.4012/dmj.27.145; Janda R, 2006, DENT MATER, V22, P1103, DOI 10.1016/j.dental.2005.09.005; Janda R, 2007, J BIOMED MATER RES B, V82B, P545, DOI 10.1002/jbm.b.30760; Jung DJ, 2010, J MICROBIOL METH, V81, P166, DOI 10.1016/j.mimet.2010.03.002; Kapoor M, 2004, BIOCHEM J, V381, P719, DOI 10.1042/BJ20031821; Knorr SD, 2005, DENT MATER, V21, P272, DOI 10.1016/j.dental.2004.06.002; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Konishi N, 2003, J ORAL REHABIL, V30, P790, DOI 10.1046/j.1365-2842.2003.01129.x; Lee SP, 2009, ANGLE ORTHOD, V79, P353, DOI 10.2319/021308-88.1; Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Namba N, 2009, DENT MATER, V25, P424, DOI 10.1016/j.dental.2008.08.012; Oh ST, 1996, J APPL POLYM SCI, V59, P1871, DOI 10.1002/(SICI)1097-4628(19960321)59:12<1871::AID-APP8>3.0.CO;2-N; OH ST, 1994, J APPL POLYM SCI, V54, P859, DOI 10.1002/app.1994.070540704; Persson A, 2005, CARIES RES, V39, P201, DOI 10.1159/000084799; Persson A, 2005, ACTA ODONTOL SCAND, V63, P21, DOI 10.1080/00016350510019649; QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x; QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Ruttermann S, 2007, J DENT, V35, P806, DOI 10.1016/j.jdent.2007.07.014; Ruttermann S, 2012, ARCH ORAL BIOL, V57, P1512, DOI 10.1016/j.archoralbio.2012.05.005; Ruttermann S, 2011, ACTA BIOMATER, V7, P1160, DOI 10.1016/j.actbio.2010.10.002; Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198; Sharifi S, 2008, J BIOMED MATER RES A, V84A, P545, DOI 10.1002/jbm.a.31384; Sharma S, 2003, ANTIMICROB AGENTS CH, V47, P3859, DOI 10.1128/AAC.47.12.3859-3866.2003; Sideridou ID, 2009, J BIOMAT SCI-POLYM E, V20, P1831, DOI 10.1163/156856208X386435; Silikas N, 2000, DENT MATER, V16, P292, DOI 10.1016/S0109-5641(00)00020-8; Sojka MS, 1998, US Patent No, Patent No. [US5830960, 5830960]; ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Thomas RZ, 2008, ORAL MICROBIOL IMMUN, V23, P7, DOI 10.1111/j.1399-302X.2007.00381.x; vanDijken JWV, 1997, CARIES RES, V31, P379, DOI 10.1159/000262422; VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; WEERKAMP AH, 1985, J DENT RES, V64, P1204, DOI 10.1177/00220345850640100501; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022	65	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79119	10.1371/journal.pone.0079119	http://dx.doi.org/10.1371/journal.pone.0079119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223890	Green Published, gold			2022-12-25	WOS:000326499300059
J	Hikiji, H; Endo, D; Horie, K; Harayama, T; Akahoshi, N; Igarashi, H; Kihara, Y; Yanagida, K; Takeda, J; Koji, T; Shimizu, T; Ishii, S				Hikiji, Hisako; Endo, Daisuke; Horie, Kyoji; Harayama, Takeshi; Akahoshi, Noriyuki; Igarashi, Hidemitsu; Kihara, Yasuyuki; Yanagida, Keisuke; Takeda, Junji; Koji, Takehiko; Shimizu, Takao; Ishii, Satoshi			TDAG8 activation inhibits osteoclastic bone resorption	FASEB JOURNAL			English	Article						proton-sensing receptor; GPR65; Rho; cell morphology; T-cell death-associated gene 8	PROTEIN-COUPLED RECEPTOR; INDUCED THYMOCYTE APOPTOSIS; EXTRACELLULAR ACIDIFICATION; CATION CHANNELS; GENE 8; OSTEOPOROSIS; ACID; MICE; LOCALIZATION; OVARIECTOMY	Although the roles of acids in bone metabolism are well characterized, the function of proton-sensing receptors in bone metabolism remains to be explored. In this study, we evaluated the role of proton-sensing receptor T-cell death-associated gene 8 (TDAG8) in osteoclastic activity during bone loss after ovariectomy. Through observations of bone mineral content, we found that pathological bone resorption was significantly exacerbated in mice homozygous for a gene trap mutation in the Tdag8 gene. Furthermore, osteoclasts from the homozygous mutant mice resorbed calcium in vitro more than the osteoclasts from the heterozygous mice did. Impaired osteoclast formation under acidic conditions was ameliorated in cultures of bone marrow cells by Tdag8 gene mutation. Extracellular acidification changed the cell morphology of osteoclasts via the TDAG8-Rho signaling pathway. These results suggest that the enhancement of TDAG8 function represents a new strategy for preventing bone resorption diseases, such as osteoporosis.Hikiji, H., Endo, D., Horie, K., Harayama, T., Akahoshi, N., Igarashi, H., Kihara, Y., Yanagida, K., Takeda, J., Koji, T., Shimizu, T., Satoshi, I. TDAG8 activation inhibits osteoclastic bone resorption.	[Hikiji, Hisako; Harayama, Takeshi; Kihara, Yasuyuki; Yanagida, Keisuke; Shimizu, Takao; Ishii, Satoshi] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Endo, Daisuke; Koji, Takehiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Histol & Cell Biol, Nagasaki 852, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Akahoshi, Noriyuki; Igarashi, Hidemitsu; Ishii, Satoshi] Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan	University of Tokyo; Nagasaki University; Osaka University; Akita University	Ishii, S (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, 1-1-1 Hondo, Akita 0108543, Japan.	satishii@med.akita-u.ac.jp	Harayama, Takeshi/AAD-8852-2022; Shimizu, Takao/AAV-7052-2021; Kihara, Yasuyuki/C-8801-2011	Harayama, Takeshi/0000-0003-2255-4197; Kihara, Yasuyuki/0000-0001-7462-3006; Horie, Kyoji/0000-0001-9036-8180	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Health and Labor Sciences research grant for the research on allergic disease and immunology from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23390467, 25116703] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences research grant for the research on allergic disease and immunology from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank K. Ohori, C. Kanokoda, and S. Kondo for technical assistance and all the members of their laboratory (Department of Biochemistry and Molecular Biology, University of Tokyo) for support and valuable suggestions. This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. S., S. I., and H. H.), a Health and Labor Sciences research grant for the research on allergic disease and immunology from the Ministry of Health, Labor, and Welfare of Japan (to S. I.), and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor, and Welfare of Japan (to S. I.). The authors declare no conflicts of interest.	ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horne WC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P221, DOI 10.1016/B978-0-12-373884-4.00031-8; Ihara Y, 2010, P NATL ACAD SCI USA, V107, P17309, DOI 10.1073/pnas.1001165107; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Iwai K, 2007, J BONE MINER RES, V22, P1612, DOI 10.1359/JBMR.070612; KOJI T, 1993, ENDOCRINOLOGY, V132, P382, DOI 10.1210/en.132.1.382; Kottyan LC, 2009, BLOOD, V114, P2774, DOI 10.1182/blood-2009-05-220681; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Shibata K, 2000, HISTOCHEM CELL BIOL, V113, P153, DOI 10.1007/s004180050434; Tosa N, 2003, INT IMMUNOL, V15, P741, DOI 10.1093/intimm/dxg070; Turner RT, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P855, DOI 10.1016/B978-0-12-373884-4.00057-4; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Vaananen HK, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P193, DOI 10.1016/B978-0-12-373884-4.00030-6; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; YOSHII A, 1995, J HISTOCHEM CYTOCHEM, V43, P321, DOI 10.1177/43.3.7532657	44	25	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					871	879		10.1096/fj.13-233106	http://dx.doi.org/10.1096/fj.13-233106			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24221084				2022-12-25	WOS:000331072200032
J	Jagirdar, K; Yin, K; Harrison, M; Lim, W; Muscat, GEO; Sturm, RA; Smith, AG				Jagirdar, Kasturee; Yin, Kelvin; Harrison, Matthew; Lim, Wen; Muscat, George E. O.; Sturm, Richard A.; Smith, Aaron G.			The NR4A2 Nuclear Receptor Is Recruited to Novel Nuclear Foci in Response to UV Irradiation and Participates in Nucleotide Excision Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; INDUCED DNA-DAMAGE; UBIQUITIN LIGASE; POLY(ADP-RIBOSE) POLYMERASE-1; H2AX PHOSPHORYLATION; IONIZING-RADIATION; ORPHAN RECEPTORS; MELANOMA-CELLS; DDB2; GAMMA-H2AX	Ultraviolet radiation (UVR) is one of the most common mutagens encountered by humans and induces the formation of cyclobutane pyrimidine dimers (CPDs) and pyrimidine-(6-4)-pyrimidone photoproduct (6-4PP) lesions in the genomic DNA. To prevent the accumulation of deleterious mutations these lesions must be efficiently repaired, primarily by nucleotide excision repair. We have previously demonstrated that the NR4A family of nuclear receptors are crucial mediators of the DNA repair function of the MC1R signalling pathway in melanocytes. Here we explore the role of the NR4A2 protein in the DNA repair process further. Using EYFP tagged-NR4A2 we have demonstrated a UVR induced recruitment to distinct nuclear foci where they co-localise with known DNA repair proteins. We reveal that the N-terminal domain of the receptor is required for this translocation and identify a role for p38 and PARP signalling in this process. Moreover disruption of the functional integrity of the Ligand Binding Domain of the receptor by deleting the terminal helix 12 effectively blocks co-localisation of the receptor with DNA repair factors. Restored co-localisation of the mutant receptor with DNA repair proteins in the presence of a Histone Deacetylase Inhibitor suggests that impaired chromatin accessibility underpins the mis-localisation observed. Finally NR4A2 over-expression facilitated a more efficient clearance of UVR induced CPD and 6-4PP lesions. Taken together these data uncover a novel role for the NR4A nuclear receptors as direct facilitators of nucleotide excision repair.	[Jagirdar, Kasturee; Harrison, Matthew; Lim, Wen; Muscat, George E. O.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Yin, Kelvin; Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Smith, AG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	aaron.smith@uq.edu.au	Jagirdar, Kasturee/J-1810-2014; Smith, Aaron/A-8329-2010; Sturm, Richard A/C-9943-2009; Muscat, George/A-6401-2017	Jagirdar, Kasturee/0000-0001-8761-132X; Sturm, Richard A/0000-0003-1301-0294; Muscat, George/0000-0002-5829-5695; Yin, Kelvin/0000-0003-2993-6374; Smith, Aaron/0000-0003-2937-1713	National Health and Medical Research Grant [631510]	National Health and Medical Research Grant	This work was funded by a National Health and Medical Research Grant (ID: 631510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; De Leseleuc L, 2006, EXP CELL RES, V312, P1507, DOI 10.1016/j.yexcr.2006.01.014; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; HUANG JC, 1994, J BIOL CHEM, V269, P19034; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Limoli CL, 2002, P NATL ACAD SCI USA, V99, P233, DOI 10.1073/pnas.231611798; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Luijsterburg MS, 2012, J CELL BIOL, V197, P267, DOI 10.1083/jcb.201106074; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Oh KS, 2007, DNA REPAIR, V6, P1359, DOI 10.1016/j.dnarep.2007.03.025; Ohkura N, 2008, J CELL BIOCHEM, V105, P785, DOI 10.1002/jcb.21876; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; PARSONS PG, 1986, BIOCHEM PHARMACOL, V35, P655, DOI 10.1016/0006-2952(86)90363-1; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Rebecca VW, 2012, MELANOMA RES, V22, P114, DOI 10.1097/CMR.0b013e328351fa4d; Robu M, 2013, P NATL ACAD SCI USA, V110, P1658, DOI 10.1073/pnas.1209507110; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Smith AG, 2011, PIGM CELL MELANOMA R, V24, P551, DOI 10.1111/j.1755-148X.2011.00843.x; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhao Q, 2008, J BIOL CHEM, V283, P32553, DOI 10.1074/jbc.M803963200	44	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78075	10.1371/journal.pone.0078075	http://dx.doi.org/10.1371/journal.pone.0078075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223135	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200027
J	Li, S; Shih, CK; Wang, C; Pang, H; Ren, D				Li, Shu; Shih, Chungkun; Wang, Chen; Pang, Hong; Ren, Dong			Forever Love: The Hitherto Earliest Record of Copulating Insects from the Middle Jurassic of China	PLOS ONE			English	Article							HOMOPTERA; EVOLUTION	Background: Mating behaviors have been widely studied for extant insects. However, cases of mating individuals are particularly rare in the fossil record of insects, and most of them involved preservation in amber while only in rare cases found in compression fossils. This considerably limits our knowledge of mating position and genitalia orientation during the Mesozoic, and hinders our understanding of the evolution of mating behaviors in this major component of modern ecosystems. Principal Finding: Here we report a pair of copulating froghoppers, Anthoscytina perpetua sp. nov., referable to the Procercopidae, from the Middle Jurassic of northeastern China. They exhibit belly-to-belly mating position as preserved, with male's aedeagus inserting into the female's bursa copulatrix. Abdominal segments 8 to 9 of male are disarticulated suggesting these segments were twisted and flexed during mating. Due to potential taphonomic effect, we cannot rule out that they might have taken side-by-side position, as in extant froghoppers. Genitalia of male and female, based on paratypes, show symmetric structures. Conclusions/Significance: Our findings, consistent with those of extant froghoppers, indicate froghoppers' genitalic symmetry and mating position have remained static for over 165 million years.	[Li, Shu; Shih, Chungkun; Wang, Chen; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Li, Shu] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Pang, Hong] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Pang, Hong] Sun Yat Sen Univ, Inst Entomol, Guangzhou 510275, Guangdong, Peoples R China	Capital Normal University; Beijing Academy of Agriculture & Forestry; Sun Yat Sen University; Sun Yat Sen University	Ren, D (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Pang, Hong/AAL-7785-2020; Pang, Hong/J-8710-2014	Pang, Hong/0000-0002-0585-3577; 	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31172143, 31230065, 31272352, 41272006]; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey)	This research is supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), the National Natural Science Foundation of China (grants 31172143, 31230065, 31272352 and 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education (grants KZ201310028033), and China Geological Survey (grant 1212011120115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RD, 1964, EVOLUTION MATING BEH, P78; Ansorge J, 1996, INSECTS UPPER LIAS P; ANUFRIEV G. A., 1988, OPREDELITELNASEKOMYK, V2, P12; Becker-Migdisova E. E, 1949, T PALEONTOLOGICHESKO, V22, P1; Biedermann R, 2002, J ETHOL, V20, P13, DOI 10.1007/s10164-002-0048-9; Boucot A. J., 2011, FOSSIL BEHAV COMPEND, P147; Boucot AJ, 1990, EVOLUTIONARY PALEOBI, P385; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; DWORAKOWSKA I, 1988, Entomologische Abhandlungen (Dresden), V52, P63; Evans JW, 1966, LEAFHOPPERS FROGHOPP; Hamilton K.G. Andrew, 2001, Biodiversity, V2, P15; Hong YC, 1983, MIDDLE JURASSIC FOSS, P61; Huber BA, 2007, BIOL REV, V82, P647, DOI 10.1111/j.1469-185X.2007.00029.x; Huber BA, 2010, GENETICA, V138, P19, DOI 10.1007/s10709-008-9339-6; HUNT RE, 1993, ANN ENTOMOL SOC AM, V86, P356, DOI 10.1093/aesa/86.3.356; Ji Qiang, 2005, Geological Review (Beijing), V51, P609; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Ma N, 2010, MICRON, V41, P931, DOI 10.1016/j.micron.2010.07.008; Nel A, 2012, J MORPHOL, V273, P480, DOI 10.1002/jmor.11036; Ren D, 1995, FAUNAE STRATIGRAPHY, V8, P222; Ren D, 2010, SILENT STORIES INSEC, P13; Ren Dong, 1998, Acta Zootaxonomica Sinica, V23, P281; Shcherbakov D. E., 1988, PALEONTOL J, V4, P52; Wang B, 2012, PALAEONTOLOGY, V55, P1223, DOI 10.1111/j.1475-4983.2012.01185.x; Wang RR, 2009, SYST ENTOMOL, V34, P434, DOI 10.1111/j.1365-3113.2009.00475.x; WEBER H., 1931, Biol. Tiere Deutschlands, P71; Yang W, 2004, S PETR GEOD CHIN HAI, P326	28	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78188	10.1371/journal.pone.0078188	http://dx.doi.org/10.1371/journal.pone.0078188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223138	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200030
J	Nakano, M; Nakashima, A; Nagano, T; Ishikawa, S; Kikkawa, U; Kamada, S				Nakano, Masayuki; Nakashima, Akio; Nagano, Taiki; Ishikawa, Shintaro; Kikkawa, Ushio; Kamada, Shinji			Branched-Chain Amino Acids Enhance Premature Senescence through Mammalian Target of Rapamycin Complex I-Mediated Upregulation of p21 Protein	PLOS ONE			English	Article							P53-DEPENDENT CELLULAR SENESCENCE; P70 S6 KINASE; HUMAN FIBROBLASTS; DNA-DAMAGE; TELOMERASE ACTIVITY; LIVER-CIRRHOSIS; HUMAN CANCER; G(1) ARREST; CELLS; VIVO	Branched-chain amino acids (BCAAs) have been applied as an oral supplementation to patients with liver cirrhosis. BCAAs not only improve nutritional status of patients but also decrease the incidence of liver cancer. Mammalian target of rapamycin (mTOR) links cellular metabolism with growth and proliferation in response to nutrients, energy, and growth factors. BCAAs, especially leucine, have been shown to regulate protein synthesis through mTOR activities. On the other hand, cellular senescence is suggested to function as tumor suppressor mechanisms, and induced by a variety of stimuli including DNA damage-inducing drugs. However, it is not clear how BCAA supplementation prevents the incidence of liver cancer in patients with cirrhosis. Here we showed that human cancer cells, HepG2 and U2OS, cultured in medium containing BCAAs with Fischer's ratio about 3, which was shown to have highest activities to synthesize and secrete of albumin, had higher activities to induce premature senescence and elevate mTORC1 activities. Furthermore, BCAAs themselves enhanced the execution of premature senescence induced by DNA damage-inducing drugs, which was effectively prevented by rapamycin. These results strongly suggested the contribution of the mTORC1 pathway to the regulation of premature senescence. Interestingly, the protein levels of p21, a p53 target and well-known gene essential for the execution of cellular senescence, were upregulated in the presence of BCAAs. These results suggested that BCAAs possibly contribute to tumor suppression by enhancing cellular senescence mediated through the mTOR signalling pathway.	[Nakano, Masayuki; Nakashima, Akio; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan; [Nakano, Masayuki; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Ishikawa, Shintaro] Otsuka Pharmaceut Co Ltd, Minato Ku, Tokyo, Japan	Kobe University; Kobe University; Otsuka Pharmaceutical	Kamada, S (corresponding author), Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan.	skamada@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P2413; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hasegawa J, 1996, CANCER RES, V56, P1713; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Marchesini G, 2005, J NUTR, V135, p1596S, DOI 10.1093/jn/135.6.1596S; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; MCCULLOUGH AJ, 1981, GASTROENTEROLOGY, V81, P645; Medcalf ASC, 1996, CANCER RES, V56, P4582; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; OKUNO M, 1995, BIOCHEM BIOPH RES CO, V214, P1045, DOI 10.1006/bbrc.1995.2391; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Roninson IB, 2003, CANCER RES, V63, P2705; Shigemitsu K, 1999, FEBS LETT, V447, P303, DOI 10.1016/S0014-5793(99)00304-X; te Poele RH, 2002, CANCER RES, V62, P1876; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YOSHIDA T, 1989, Gastroenterologia Japonica, V24, P692; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80411	10.1371/journal.pone.0080411	http://dx.doi.org/10.1371/journal.pone.0080411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223226	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200119
J	Zhang, XJ; Li, H; Mao, YQ; Li, ZX; Wang, R; Guo, TT; Jin, L; Song, RJ; Xu, W; Zhou, N; Zhang, YZ; Hu, RB; Wang, X; Huang, HK; Lei, Z; Niu, G; Irwin, DM; Tan, HR				Zhang, Xiaojing; Li, Hui; Mao, Yiqing; Li, Zhixin; Wang, Rong; Guo, Tingting; Jin, Ling; Song, Rongjing; Xu, Wei; Zhou, Na; Zhang, Yizhuang; Hu, Ruobi; Wang, Xi; Huang, Huakang; Lei, Zhen; Niu, Gang; Irwin, David M.; Tan, Huanran			An Over Expression APP Model for Anti-Alzheimer Disease Drug Screening Created by Zinc Finger Nuclease Technology	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; HOMOLOGOUS RECOMBINATION; GAMMA-SECRETASE; KNOCKOUT RATS; PROTEIN; CELLS; CYCLOOXYGENASE; INDUCTION; NSAIDS; ROAD	Zinc Finger Nucleases (ZFNs), famous for their ability to precisely and efficiently modify specific genomic loci, have been employed in numerous transgenic model organism and cell constructions. Here we employ the ZFNs technology, with homologous recombination (HR), to construct sequence-specific Amyloid Precursor Protein (APP) knock-in cells. With the use of ZFNs, we established APP knock in cell lines with gene-modification efficiencies of about 7%. We electroporated DNA fragment containing the promoter and the protein coding regions of the zinc finger nucleases into cells, instead of the plasmids, to avoid problems associated with off target homologous recombination, and adopted a pair of mutated FokI cleavage domains to reduce the toxic effects of the ZFNs on cell growth. Since over-expression of APP, or a subdomain of it, might lead to an immediately lethal effect, we used the Cre-LoxP System to regulate APP expression. Our genetically transformed cell lines, w5c1 and s12c8, showed detectable APP and Amyloid beta (A beta) production. The Swedish double mutation in the APP coding sequence enhanced APP and A beta abundance. What is more, the activity of the three key secretases in A beta formation could be modulated, indicating that these transgenic cells have potential for drug screening to modify amyloid metabolism in cells. Our transformed cells could readily be propagated in culture and should provide an excellent experimental medium for elucidating aspects of the molecular pathogenesis of Alzheimer's disease, especially those concerning the amyloidogenic pathways involving mutations in the APP coding sequence. The cellular models may also serve as a tool for deriving potentially useful therapeutic agents.	[Zhang, Xiaojing; Li, Hui; Mao, Yiqing; Li, Zhixin; Wang, Rong; Guo, Tingting; Jin, Ling; Song, Rongjing; Xu, Wei; Zhou, Na; Zhang, Yizhuang; Hu, Ruobi; Wang, Xi; Huang, Huakang; Irwin, David M.; Tan, Huanran] Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Niu, Gang] Beijing N&N Genetech Co, Beijing, Peoples R China; [Lei, Zhen] Ningxia Med Univ, Dept Pharmacol, Yinchuan, Peoples R China	Peking University; University of Toronto; Ningxia Medical University	Irwin, DM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China.	david.irwin@utoronto.ca; tanlab@bjmu.edu.cn		Irwin, David/0000-0001-6131-4933; Jin, Ling/0000-0002-0687-9234	National Natural Science Foundation of China (NSFC) [30772603]; National Key Technologies RD Program [2006BAF07B01, 2009BAK61B01, 2009BAK61B04?2012BAK25B01]; National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative [81061120525, CCI-109605]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the National Natural Science Foundation of China (NSFC) Grant Number 30772603, National Key Technologies R&D Program (Grant Numbers 2006BAF07B01, 2009BAK61B01, 2009BAK61B04?2012BAK25B01), and a grant from the National Science Foundation of China - Canadian Institutes of Health Research (NSFC-CIHR) China-Canada Joint Health Research Initiative (Grant Numbers 81061120525 and CCI-109605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarir-Bouhram J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028876; Asai M, 2010, J NEUROSCI RES, V88, P3588, DOI 10.1002/jnr.22503; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Forsyth E, 1998, PHYS THER, V78, P1325, DOI 10.1093/ptj/78.12.1325; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hampel H, 2012, ALZHEIMERS DEMENT, V8, P312, DOI 10.1016/j.jalz.2012.05.2116; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrill JA, 2011, TOXICOL IN VITRO, V25, P368, DOI 10.1016/j.tiv.2010.10.011; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Kane JM, 2010, J CLIN PSYCHIAT, V71, P1115, DOI 10.4088/JCP.10r06264yel; Karnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047389; Koob AO, 2012, ANAL BIOCHEM, V425, P120, DOI 10.1016/j.ab.2012.02.034; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Li QQ, 2010, EXP GERONTOL, V45, P842, DOI 10.1016/j.exger.2010.06.008; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ruminy P, 2001, J MOL BIOL, V310, P523, DOI 10.1006/jmbi.2001.4788; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Shaughnessy L, 2004, J MOL NEUROSCI, V24, P23, DOI 10.1385/JMN:24:1:023; Skovronsky DM, 2001, J BIOL CHEM, V276, P17036, DOI 10.1074/jbc.M006285200; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Tsuchiya H, 2005, J GENE MED, V7, P486, DOI 10.1002/jgm.673; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vasileva A, 2006, NUCLEIC ACIDS RES, V34, P3345, DOI 10.1093/nar/gkl455; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x	49	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e75493	10.1371/journal.pone.0075493	http://dx.doi.org/10.1371/journal.pone.0075493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223114	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200006
J	Barone, R; Macaluso, F; Catanese, P; Gammazza, AM; Rizzuto, L; Marozzi, P; Lo Giudice, G; Stampone, T; Cappello, F; Morici, G; Zummo, G; Farina, F; Di Felice, V				Barone, Rosario; Macaluso, Filippo; Catanese, Patrizia; Gammazza, Antonella Marino; Rizzuto, Luigi; Marozzi, Paola; Lo Giudice, Giuseppe; Stampone, Tomaso; Cappello, Francesco; Morici, Giuseppe; Zummo, Giovanni; Farina, Felicia; Di Felice, Valentina			Endurance Exercise and Conjugated Linoleic Acid (CLA) Supplementation Up-Regulate CYP17A1 and Stimulate Testosterone Biosynthesis	PLOS ONE			English	Article							RAT ADRENAL-CELLS; BODY-COMPOSITION; ANABOLIC-STEROIDS; SKELETAL-MUSCLE; GENE-EXPRESSION; RESISTANCE; INCREASE; BONE; PERFORMANCE; CAPACITY	A new role for fat supplements, in particular conjugated linoleic acid (CLA), has been delineated in steroidogenesis, although the underlying molecular mechanisms have not yet been elucidated. The aims of the present study were to identify the pathway stimulated by CLA supplementation using a cell culture model and to determine whether this same pathway is also stimulated in vivo by CLA supplementation associated with exercise. In vitro, Leydig tumour rat cells (R2C) supplemented with different concentrations of CLA exhibited increasing testosterone biosynthesis accompanied by increasing levels of CYP17A1 mRNA and protein. In vivo, trained mice showed an increase in free plasma testosterone and an up-regulation of CYP17A1 mRNA and protein. The effect of training on CYP17A1 expression and testosterone biosynthesis was significantly higher in the trained mice supplemented with CLA compared to the placebo. The results of the present study demonstrated that CLA stimulates testosterone biosynthesis via CYP17A1, and endurance training led to the synthesis of testosterone in vivo by inducing the overexpression of CYP17A1 mRNA and protein in the Leydig cells of the testis. This effect was enhanced by CLA supplementation. Therefore, CLA-associated physical activity may be used for its steroidogenic property in different fields, such as alimentary industry, human reproductive medicine, sport science, and anti-muscle wasting.	[Barone, Rosario; Macaluso, Filippo; Catanese, Patrizia; Gammazza, Antonella Marino; Rizzuto, Luigi; Cappello, Francesco; Morici, Giuseppe; Zummo, Giovanni; Farina, Felicia; Di Felice, Valentina] Univ Palermo, Dept Expt Biomed & Clin Neurosci BioNeC, Palermo, Italy; [Marozzi, Paola] Hosp OR Villa Sofia Cervello, Nucl Med Lab, Palermo, Italy; [Lo Giudice, Giuseppe; Stampone, Tomaso] Hosp OR Villa Sofia Cervello, Clin Pathol Lab, Palermo, Italy	University of Palermo	Macaluso, F (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci BioNeC, Palermo, Italy.	filippo.macaluso@unipa.it	Di Felice, Valentina/A-4457-2009; Barone, Rosario/ABD-8488-2020; Gammazza, Antonella Marino/AAV-3123-2020; barone, rosario/ABA-6758-2021; Di Felice, Valentina/AAG-3740-2021; Cappello, Francesco/F-9153-2012	Di Felice, Valentina/0000-0002-4132-1260; Di Felice, Valentina/0000-0002-4132-1260; Macaluso, Filippo/0000-0001-5109-2070; Marino Gammazza, Antonella/0000-0002-1683-3803; barone, rosario/0000-0002-8240-1240; Cappello, Francesco/0000-0001-9288-1148	Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN) [prot. 2009WBFZYM_003]	Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This Study was partly funded by the Ministero dell'Istruzione dell'Universita e della Ricerca; PRIN2009 - Prof. Zummo; prot. 2009WBFZYM_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu J, 2008, J BONE MINER METAB, V26, P436, DOI 10.1007/s00774-008-0863-3; Barone R, 2009, SCAND J MED SCI SPOR, V19, P782, DOI 10.1111/j.1600-0838.2008.00863.x; Bellafiore M, 2007, INT J SPORTS MED, V28, P749, DOI 10.1055/s-2007-964899; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Chimenti L, 2007, AM J RESP CRIT CARE, V175, P442, DOI 10.1164/rccm.200608-1086OC; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Clark AM, 1996, BIOL REPROD, V55, P347, DOI 10.1095/biolreprod55.2.347; Colakoglu S, 2006, J SPORT MED PHYS FIT, V46, P570; CRIVELLO JF, 1980, J BIOL CHEM, V255, P8144; Di Felice V, 2007, J STRENGTH COND RES, V21, P193, DOI 10.1519/00124278-200702000-00035; Di Felice V, 2009, J CELL PHYSIOL, V221, P729, DOI 10.1002/jcp.21912; DIFELICE V, 2013, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1739.PUBMED:23592297; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Enoki T, 2006, J PHYSIOL-LONDON, V577, P433, DOI 10.1113/jphysiol.2006.115436; FRINCHI M, 2013, INT J SPORTS MED MED, DOI DOI 10.1055/S-0033-1343405.PUBMED:23868681; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Jeukendrup AE, 2004, NUTRITION, V20, P678, DOI 10.1016/j.nut.2004.04.018; Keogh JWL, 2012, J PAIN SYMPTOM MANAG, V43, P96, DOI 10.1016/j.jpainsymman.2011.03.006; Kim JH, 2012, LIPIDS, V47, P855, DOI 10.1007/s11745-012-3698-6; Kim JH, 2010, J MED FOOD, V13, P1057, DOI 10.1089/jmf.2009.1358; Kim YC, 1997, STEROIDS, V62, P10, DOI 10.1016/S0039-128X(96)00153-5; KRAEMER WJ, 1991, INT J SPORTS MED, V12, P228, DOI 10.1055/s-2007-1024673; Kreider RB, 2002, J STRENGTH COND RES, V16, P325; Lin H, 2001, J CELL BIOCHEM, V83, P147, DOI 10.1002/jcb.1213; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macaluso F, 2012, J MUSCLE RES CELL M, V33, P187, DOI 10.1007/s10974-012-9302-0; Macaluso F, 2012, SCAND J MED SCI SPOR, V22, pE38, DOI 10.1111/j.1600-0838.2011.01389.x; Macaluso F, 2013, MUSCLE NERVE, V48, P109, DOI 10.1002/mus.23721; Macaluso F, 2013, NUTRIENTS, V5, P509, DOI 10.3390/nu5020509; Macaluso F, 2012, J STRENGTH COND RES, V26, P1667, DOI 10.1519/JSC.0b013e318231ab78; Maggio M, 2013, CURR OPIN CLIN NUTR, V16, P3, DOI 10.1097/MCO.0b013e32835b6044; Mirand PP, 2004, J NUTR, V134, P2263, DOI 10.1093/jn/134.9.2263; Serradifalco C, 2011, EUR J HISTOCHEM, V55, P229, DOI 10.4081/ejh.2011.e41; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Stojkov NJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1239, DOI 10.1152/ajpendo.00554.2011; Storey A, 2012, SPORTS MED, V42, P769, DOI 10.2165/11633000-000000000-00000; Svechnikov K, 2009, J APPL TOXICOL, V29, P673, DOI 10.1002/jat.1456; Tamaki T, 2001, AM J PHYSIOL-ENDOC M, V280, pE973; Weisser J, 2011, MOL CELL ENDOCRINOL, V341, P18, DOI 10.1016/j.mce.2011.03.008; Ye LP, 2011, MOLECULES, V16, P9983, DOI 10.3390/molecules16129983	43	38	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79686	10.1371/journal.pone.0079686	http://dx.doi.org/10.1371/journal.pone.0079686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223995	Green Published, gold			2022-12-25	WOS:000326597400081
J	Islam, S; Griffiths, CA; Blomstedt, CK; Le, TN; Gaff, DF; Hamill, JD; Neale, AD				Islam, Sharmin; Griffiths, Cara A.; Blomstedt, Cecilia K.; Tuan-Ngoc Le; Gaff, Donald F.; Hamill, John D.; Neale, Alan D.			Increased Biomass, Seed Yield and Stress Tolerance Is Conferred in Arabidopsis by a Novel Enzyme from the Resurrection Grass Sporobolus stapfianus That Glycosylates the Strigolactone Analogue GR24	PLOS ONE			English	Article							LEAF SENESCENCE; BIOCHEMICAL-CHARACTERIZATION; DESICCATION-TOLERANCE; PHOSPHATE DEFICIENCY; DROUGHT TOLERANCE; GENES; EXPRESSION; ACID; GLYCOSYLTRANSFERASES; INHIBITION	Isolation of gene transcripts from desiccated leaf tissues of the resurrection grass, Sporobolus stapfianus, resulted in the identification of a gene, SDG8i, encoding a Group 1 glycosyltransferase (UGT). Here, we examine the effects of introducing this gene, under control of the CaMV35S promoter, into the model plant Arabidopsis thaliana. Results show that Arabidopsis plants constitutively over-expressing SDG8i exhibit enhanced growth, reduced senescence, cold tolerance and a substantial improvement in protoplasmic drought tolerance. We hypothesise that expression of SDG8i in Arabidopsis negatively affects the bioactivity of metabolite/s that mediate/s environmentally-induced repression of cell division and expansion, both during normal development and in response to stress. The phenotype of transgenic plants over-expressing SDG8i suggests modulation in activities of both growth-and stress-related hormones. Plants overexpressing the UGT show evidence of elevated auxin levels, with the enzyme acting downstream of ABA to reduce drought-induced senescence. Analysis of the in vitro activity of the UGT recombinant protein product demonstrates that SDG8i can glycosylate the synthetic strigolactone analogue GR24, evoking a link with strigolactone-related processes in vivo. The large improvements observed in survival of transgenic Arabidopsis plants under cold-, salt-and drought-stress, as well as the substantial increases in growth rate and seed yield under non-stress conditions, indicates that overexpression of SDG8i in crop plants may provide a novel means of increasing plant productivity.	[Islam, Sharmin; Griffiths, Cara A.; Blomstedt, Cecilia K.; Tuan-Ngoc Le; Gaff, Donald F.; Neale, Alan D.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Tuan-Ngoc Le] Victorian AgriBiosci Ctr, Biosci Res Div, Melbourne, Vic, Australia; [Hamill, John D.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia	Monash University; University of Melbourne	Neale, AD (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	alan.neale@monash.edu		Blomstedt, Cecilia/0000-0003-1919-6982	Monash University Graduate Research Scholarship; Monash University Faculty of Science Dean's Postgraduate Research Scholarship	Monash University Graduate Research Scholarship; Monash University Faculty of Science Dean's Postgraduate Research Scholarship	Sharmin Islam was supported by a Monash University Graduate Research Scholarship and Cara Griffiths by a Monash University Faculty of Science Dean's Postgraduate Research Scholarship; URL;www.monash.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2006, ANN BOT-LONDON, V97, P925, DOI 10.1093/aob/mcl063; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bai F, 2008, AM J BOT, V95, P133, DOI 10.3732/ajb.95.2.133; Blomstedt CK, 2010, PLANT GROWTH REGUL, V62, P217, DOI 10.1007/s10725-010-9485-6; Bowles D, 2010, ENCY LIFE SCI CHICHE; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dubrovsky JG, 2009, ANN BOT-LONDON, V103, P807, DOI 10.1093/aob/mcn267; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Gaff DF, 2009, FUNCT PLANT BIOL, V36, P589, DOI 10.1071/FP08166; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Ghasempour HR, 2001, AUST J PLANT PHYSIOL, V28, P1115; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hajouj T, 2000, PLANT PHYSIOL, V124, P1305, DOI 10.1104/pp.124.3.1305; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jordi W, 2000, PLANT CELL ENVIRON, V23, P279, DOI 10.1046/j.1365-3040.2000.00544.x; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; Le TN, 2007, FUNCT PLANT BIOL, V34, P589, DOI 10.1071/FP06231; Levitt J, 1960, B RES COUNC ISRAEL D, V8D, P177; Leyser O, 2009, PLANT CELL ENVIRON, V32, P694, DOI 10.1111/j.1365-3040.2009.01930.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lopez-Raez JA, 2010, NEW PHYTOL, V187, P343, DOI 10.1111/j.1469-8137.2010.03291.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; Neale AD, 2000, PLANT CELL ENVIRON, V23, P265, DOI 10.1046/j.1365-3040.2000.00548.x; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; OWEN PC, 1952, J EXP BOT, V3, P188, DOI 10.1093/jxb/3.2.188; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Song JT, 2005, J PLANT BIOL, V48, P422, DOI 10.1007/BF03030584; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Sykorova B, 2008, J EXP BOT, V59, P377, DOI 10.1093/jxb/erm319; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Weigel D., 2002, ARABIDOPSIS LAB MANU; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	55	17	17	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80035	10.1371/journal.pone.0080035	http://dx.doi.org/10.1371/journal.pone.0080035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224034	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400106
J	Lynch, J; Meehan, MH; Crean, J; Copeland, J; Stallings, RL; Bray, IM				Lynch, Jennifer; Meehan, Maria H.; Crean, John; Copeland, John; Stallings, Raymond L.; Bray, Isabella M.			Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators	PLOS ONE			English	Article							CELL MOTILITY; LIM-KINASE; COFILIN; NEUROBLASTOMA; CANCER; CARCINOMA; PROTEINS; INVASION; FMNL2; DEPHOSPHORYLATION	MiRNAs can have pleiotropic effects by targeting multiple genes belonging to diverse signalling networks. Alternatively, miRNAs can enhance the potency of their cellular effects by targeting multiple genes within the same genetic pathway. Previously, we and others have demonstrated that miR-335 is a potent suppressor of tumour cell migration, invasion and metastasis, in part by targeting several genes involved in these cellular processes, including ROCK1, MAPK1, LRG1, SP1 and SOX4. Here, we demonstrate that direct targeting of multiple members of the formin family of actin nucleators contributes to the inhibitory effects of miR-335 in neuroblastoma cells. We demonstrate that miR-335 regulates the expression of at least five formin family members and validate three family members, FMNL3, FMN2 and DAAM2, as direct targets of miR-335. The contribution of the formin family genes to cancer progression and metastasis has recently begun to emerge and here we demonstrate for the first time the ability of FMN2 and DAAM2 to regulate tumour cell migration and invasion, using siRNA-mediated inhibition of each of these formin genes. Finally, we demonstrate that the formin genes, in particular FMNL3, are responsible for the protrusion of actin-rich filopodia structures that contribute to the enhanced migratory and invasive potential associated with reduced expression of miR-335. Thus, direct targeting of the formin family contributes to the metastasis suppressing abilities of miR-335 by providing a direct regulatory link to the actin assembly machinery of the cell. We conclude that miR-335 is a master regulator of tumour cell migration and invasion by directly targeting a plethora of genes that effectively control cell migratory processes.	[Lynch, Jennifer; Meehan, Maria H.; Stallings, Raymond L.; Bray, Isabella M.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Lynch, Jennifer; Meehan, Maria H.; Stallings, Raymond L.; Bray, Isabella M.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Crean, John] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Copeland, John] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Ottawa	Bray, IM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	ibray@rcsi.ie	Stallings, Raymond/A-7213-2008	/0000-0002-4337-6177				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; KANAMORI T, 1995, J BIOL CHEM, V270, P8061, DOI 10.1074/jbc.270.14.8061; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Liang L, 2013, GASTROENTEROLOGY; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meyer G, 2005, CELL MOL LIFE SCI, V62, P461, DOI 10.1007/s00018-004-4456-6; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Okada K, 1996, EXP CELL RES, V227, P116, DOI 10.1006/excr.1996.0256; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2; Zhu XL, 2011, J PATHOL, V224, P377, DOI 10.1002/path.2871	41	28	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78428	10.1371/journal.pone.0078428	http://dx.doi.org/10.1371/journal.pone.0078428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223803	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400026
J	Zhu, FF; Zhang, QL; Qiu, J				Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang			Relating Inter-Individual Differences in Verbal Creative Thinking to Cerebral Structures: An Optimal Voxel-Based Morphometry Study	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; TORRANCE TESTS; BROCAS AREA; INHIBITION; CORTEX; CONNECTIVITY; MECHANISMS; EEG; SEX	Creativity can be defined the capacity of an individual to produce something original and useful. An important measurable component of creativity is divergent thinking. Despite existing studies on creativity-related cerebral structural basis, no study has used a large sample to investigate the relationship between individual verbal creativity and regional gray matter volumes (GMVs) and white matter volumes (WMVs). In the present work, optimal voxel-based morphometry (VBM) was employed to identify the structure that correlates verbal creativity (measured by the verbal form of Torrance Tests of Creative Thinking) across the brain in young healthy subjects. Verbal creativity was found to be significantly positively correlated with regional GMV in the left inferior frontal gyrus (IFG), which is believed to be responsible for language production and comprehension, new semantic representation, and memory retrieval, and in the right IFG, which may involve inhibitory control and attention switching. A relationship between verbal creativity and regional WMV in the left and right IFG was also observed. Overall, a highly verbal creative individual with superior verbal skills may demonstrate a greater computational efficiency in the brain areas involved in high-level cognitive processes including language production, semantic representation and cognitive control.	[Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Southwest University - China	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	qiuj318@swu.edu.cn			National Natural Science Foundation of China [31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [TR201208-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (TR201208-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bechtereva NP, 2004, INT J PSYCHOPHYSIOL, V53, P11, DOI 10.1016/j.ijpsycho.2004.01.001; Caplan D, 2006, CORTEX, V42, P469, DOI 10.1016/S0010-9452(08)70379-4; CARSON DK, 1994, CREATIVITY RES J, V7, P145, DOI 10.1080/10400419409534520; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chrysikou EG, 2011, HUM BRAIN MAPP, V32, P665, DOI 10.1002/hbm.21056; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; DAN L, 1989, COMBINED REVENS TREA; de Souza LC, 2010, NEUROPSYCHOLOGIA, V48, P3733, DOI 10.1016/j.neuropsychologia.2010.09.010; DeHaan RL, 2009, CBE-LIFE SCI EDUC, V8, P172, DOI 10.1187/cbe.08-12-0081; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; FINK A, 2011, HUM BRAIN MAPP; FINK A, 2013, BRAIN STRUCT FUNCT, V218, P1; FINK A, 2012, NEUROSCI BIOBEHAV R, P46442; Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001; Fink A, 2011, INT J PSYCHOPHYSIOL, V82, P233, DOI 10.1016/j.ijpsycho.2011.09.003; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Gansier DA, 2011, NEUROPSYCHOLOGIA, V49, P2527, DOI 10.1016/j.neuropsychologia.2011.05.001; Vidorreta JG, 2011, HUM BRAIN MAPP, V32, P331, DOI 10.1002/hbm.21026; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Good CD, 2002, VOXEL BASED MORPHOME, P16; Grabner RH, 2007, BEHAV NEUROSCI, V121, P224, DOI 10.1037/0735-7044.121.1.224; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Grewe T, 2005, HUM BRAIN MAPP, V26, P178, DOI 10.1002/hbm.20154; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hampshire A, 2007, J NEUROSCI, V27, P6219, DOI 10.1523/JNEUROSCI.0851-07.2007; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HEAUSLER NL, 1988, EDUC PSYCHOL MEAS, V48, P463, DOI 10.1177/0013164488482021; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; HUANG P, 2012, HUM BRAIN MAPP; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009818; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kanai R, 2011, J NEUROSCI, V31, P6620, DOI 10.1523/JNEUROSCI.5864-10.2011; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim KH, 2006, EDUC PSYCHOL MEAS, V66, P459, DOI 10.1177/0013164405282456; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Ming W. D. Q., 1989, PSYCHOL SCI, V5; Moore DW, 2009, BRAIN COGNITION, V70, P267, DOI 10.1016/j.bandc.2009.02.011; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Razumnikova O. M., 2009, Human Physiology, V35, P285, DOI 10.1134/S0362119709030049; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Runco MA, 2010, CREATIVITY RES J, V22, P361, DOI 10.1080/10400419.2010.523393; Shamay-Tsoory SG, 2011, NEUROPSYCHOLOGIA, V49, P178, DOI 10.1016/j.neuropsychologia.2010.11.020; Silvia PJ, 2011, THINK SKILLS CREAT, V6, P24, DOI 10.1016/j.tsc.2010.06.001; Skipper JI, 2007, BRAIN LANG, V101, P260, DOI 10.1016/j.bandl.2007.02.008; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Taki Y, 2012, HUM BRAIN MAPP; Torrance E.P., 1987, FRONTIERS CREATIVITY, P189; Torrance EP., 1974, TEST CREATIVE THINKI; Zabelina DL, 2010, PSYCHOL AESTHET CREA, V4, P136, DOI 10.1037/a0017379; ZHANG H, 2013, CORTEX, P82377	69	41	42	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79272	10.1371/journal.pone.0079272	http://dx.doi.org/10.1371/journal.pone.0079272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223921	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400058
J	Bao, XQ; Li, N; Wang, T; Kong, XC; Tai, WJ; Sun, H; Zhang, D				Bao, Xiu-Qi; Li, Ning; Wang, Tao; Kong, Xiang-Chen; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan			FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer's Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation	PLOS ONE			English	Article							A-BETA; COMPOUND FLZ; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; ACCUMULATION; OLIGOMERS; MICE; PHOSPHORYLATION; SECRETASE; PATHOLOGY	Alzheimer's disease (AD) is the most common cause of dementia worldwide and mainly characterized by the aggregated beta-amyloid (A beta) and hyperphosphorylated tau. FLZ is a novel synthetic derivative of natural squamosamide and has been proved to improve memory deficits in dementia animal models. In this study, we aimed to investigate the mechanisms of FLZ's neuroprotective effect in APP/PS1 double transgenic mice and SH-SY5Y (APPwt/swe) cells. The results showed that treatment with FLZ significantly improved the memory deficits of APP/PS1 transgenic mice and decreased apoptosis of SH SY5Y (APPwt/swe) cells. FLZ markedly attenuated A beta accumulation and tau phosphorylation both in vivo and in vitro. Mechanistic study showed that FLZ interfered APP processing, i.e., FLZ decreased beta-amyloid precursor protein (APP) phosphorylation, APP-carboxy-terminal fragment (APP-CTF) production and b-amyloid precursor protein cleaving enzyme 1 (BACE1) expression. These results indicated that FLZ reduced Ab production through inhibiting amyloidogenic pathway. The mechanistic study about FLZ's inhibitory effect on tau phosphorylation revealed t the involvement of Akt/glycogen synthase kinase 3 beta (GSK3 beta) pathway. FLZ treatment increased Akt activity and inhibited GSK3 beta activity both in vivo and in vitro. The inhibitory effect of FLZ on GSK3 beta activity and tau phosphorylation was suppressed by inhibiting Akt activity, indicating that Akt/GSK3 beta pathway might be the possible mechanism involved in the inhibitory effect of FLZ on tau hyperphosphorylation. These results suggested FLZ might be a potential anti-AD drug as it not only reduced A beta production via inhibition amyloidogenic APP processing pathway, but also attenuated tau hyperphosphoylation mediated by Akt/GSK3 beta.	[Bao, Xiu-Qi; Li, Ning; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Bao, Xiu-Qi; Li, Ning; Tai, Wen-Jiao; Sun, Hua; Zhang, Dan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Tao] Chinese Peoples Armed Police Force, Beijing Municipal Corps Hosp, Beijing, Peoples R China; [Kong, Xiang-Chen] Shenzhen Univ, Sch Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shenzhen University	Zhang, D (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	danzhang@imm.ac.cn			National 973 Fundamental Project of China [2011CB504105]; Beijing NOVA Program [Z111102054511129]; PUMC Youth Fund [2012J19]; Fundamental Research Funds for the Central Universities [2012S08]; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study [BZ0150]	National 973 Fundamental Project of China(National Basic Research Program of China); Beijing NOVA Program(Beijing Municipal Science & Technology Commission); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study	This work was supported by grants from National 973 Fundamental Project of China (2011CB504105), Beijing NOVA Program (Z111102054511129), PUMC Youth Fund (2012J19) and Supported by the Fundamental Research Funds for the Central Universities (2012S08). This work was supported by Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study (NO.BZ0150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; [鲍秀琦 Bao Xiuqi], 2010, [中国新药杂志, Chinese Journal New Drugs], V19, P867; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fang F, 2008, ACTA PHARMACOL SIN, V29, P152, DOI 10.1111/j.1745-7254.2008.00714.x; Fang F, 2007, BASIC CLIN PHARMACOL, V101, P447, DOI 10.1111/j.1742-7843.2007.00138.x; Fang F, 2006, ACTA PHARMACOL SIN, V27, P651, DOI 10.1111/j.1745-7254.2006.00347.x; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Hou JF, 2012, J PHARMACEUT BIOMED, V66, P232, DOI 10.1016/j.jpba.2012.03.001; Hou Y, 2009, J ALZHEIMERS DIS, V18, P153, DOI 10.3233/JAD-2009-1133; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kulic L, 2006, NEUROBIOL DIS, V22, P50, DOI 10.1016/j.nbd.2005.10.002; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Luan KL, 2013, AGEING RES REV, V12, P174, DOI 10.1016/j.arr.2012.06.002; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; Zhang ZX, 2011, J NEUROSCI RES, V89, P437, DOI 10.1002/jnr.22563	31	32	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78033	10.1371/journal.pone.0078033	http://dx.doi.org/10.1371/journal.pone.0078033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223757	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400030
J	Hu, JW; Yang, ZL; Wang, J; Tang, YY; Liu, H; Zhang, B; Chen, H				Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu			Infusion of Trx-1-Overexpressing hucMSC Prolongs the Survival of Acutely Irradiated NOD/SCID Mice by Decreasing Excessive Inflammatory Injury	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXPRESSING INTERFERON-BETA; STROMAL CELLS; BONE-MARROW; MAMMALIAN THIOREDOXIN; DNA-DAMAGE; IN-VIVO; PROTECTION; OXIDATION; APOPTOSIS	A protective reagent for ARI should have the ability to repair injured tissue caused by radiation and prevent continuous damage from secondary risk factors. Trx-1 was explored as a candidate therapy for ARI, as it scavenges reactive oxygen species, regulates cell growth and differentiation, participates in immune reactions, and inhibits apoptosis by acting inside and/or outside cells. Trx-1 can also decrease excessive inflammation in ARI by regulating the creation of inflamed media, by inhibiting the activation of complement, and by reducing the chemotaxis, adhesion, and migration of inflammatory cells. As effectively and stably expressing exogenous genes in the long term and regulating immune inflammation and tissue repair, MSC are a good choice for Trx-1 gene therapy. In this study, Trx-1-overexpressing hucMSC-Trx-1 were obtained by adenoviral vector-mediated infection. We first measured the redox capacity of hucMSC-Trx-1 with an antioxidant capacity (T-AOC) assay, a hydrogen peroxide (H2O2) content determination assay in vivo, a H2O2-induced oxidation hemolysis assay, and a lipid peroxidation assay in vitro. Then, we measured survival time, the protection of the hematopoietic system, and the regulation of inflammation in important organs in three treatment groups of NOD/SCID mice (treated with hucMSC-Trx1, with hucMSC, and with saline) that were exposed to 4.5 Gy Co-60-gamma-ray radiation. The hucMSC-Trx-1 group achieved superior antioxidation results, protecting bone marrow hematopoietic stem cells (Lin(-)CD117(+): hucMSC-Trx-1 vs. hucMSC, P<0.05; hucMSC-Trx-1 vs. NS, P<0.01), promoting the formation of red blood cells and hemoglobin (hucMSC-Trx-1 vs. hucMSC or NS, P<0.05), reducing inflammation and damage in important organs (Bone marrow and lung: hucMSC-Trx-1 vs. NS, P<0.01; hucMSC-Trx-1 vs. hucMSC, P<0.05. Liver and intestine: hucMSC-Trx-1 vs. NS, P<0.05; hucMSC-Trx-1 vs. hucMSC, P<0.05), and prolonging survival (hucMSC-Trx-1 vs. hucMSC or NS, P<0.01). Therefore, hucMSC-Trx-1 combines the merits of gene and cell therapy as a multifunctional radioprotector for ARI.	[Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China; [Hu, JiangWei; Yang, ZaiLiang; Wang, Jun; Tang, YongYong; Liu, Hao; Zhang, Bin; Chen, Hu] Acad Mil Med Sci, Affiliated Hosp, Gene Therapy Ctr, Beijing, Peoples R China; [Yang, ZaiLiang] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing, Peoples R China; [Yang, ZaiLiang] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Army Medical University; Army Medical University	Zhang, B (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China.	zb307ctc@163.com; chenhu217@aliyun.com			"863 Projects'' of Ministry of Science and Technology of PR China [2011AA020114]; Military Clinical High-Tech Key Program [2010gxjs100]; Clinical Feature Application Research of Beijing [Z111107058811107]	"863 Projects'' of Ministry of Science and Technology of PR China; Military Clinical High-Tech Key Program; Clinical Feature Application Research of Beijing	This work was supported by the "863 Projects'' of Ministry of Science and Technology of PR China (No. 2011AA020114), Military Clinical High-Tech Key Program (No. 2010gxjs100) and the Clinical Feature Application Research of Beijing (Z111107058811107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; Arora R, 2005, PHYTOTHER RES, V19, P1, DOI 10.1002/ptr.1605; Besse A, 2000, CYTOKINE, V12, P522, DOI 10.1006/cyto.1999.0580; Cavarretta IT, 2010, MOL THER, V18, P223, DOI 10.1038/mt.2009.237; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fliedner TM, 2001, MED MANAGEMENT RAD A, P18; Fliedner TM., 2005, BRIT J RADIOL, V27, P1, DOI [10.1259/bjr/77700378, DOI 10.1259/BJR/77700378]; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Hirama T, 2003, BRIT J RADIOL, V76, P246, DOI 10.1259/bjr/82373369; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Kuter DJ, 2010, SEMIN HEMATOL, V47, P243, DOI 10.1053/j.seminhematol.2010.02.005; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Lomax ME, 2002, RADIAT PROT DOSIM, V99, P63, DOI 10.1093/oxfordjournals.rpd.a006840; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Nakamura H, 2005, ANTIOXID REDOX SIGN, V7, P823, DOI 10.1089/ars.2005.7.823; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; Nakamura H, 2008, NOVART FDN SYMP, V291, P221; Nakamura T, 2007, FREE RADICAL RES, V41, P1089, DOI 10.1080/10715760701487682; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Obermeier F, 2003, CLIN EXP IMMUNOL, V134, P217, DOI 10.1046/j.1365-2249.2003.02288.x; OKADA S, 1992, BLOOD, V80, P3044; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; POWIS G, 1994, ONCOL RES, V6, P539; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sak A, 2000, INT J RADIAT BIOL, V76, P749, DOI 10.1080/09553000050028896; Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; Srinivasan M, 2007, BBA-GEN SUBJECTS, V1770, P659, DOI 10.1016/j.bbagen.2006.11.008; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Tmyer DL, 2008, STEM CELLS, V26, P591; Turai I, 2004, BRIT MED J, V328, P568, DOI 10.1136/bmj.328.7439.568; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Valeyrie-Allanore L, 2008, RADIOTHER ONCOL, V87, P300, DOI 10.1016/j.radonc.2008.01.021; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xin H, 2007, STEM CELLS, V25, P1618, DOI 10.1634/stemcells.2006-0461	55	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78227	10.1371/journal.pone.0078227	http://dx.doi.org/10.1371/journal.pone.0078227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223778	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400041
J	van Roekel, E; Verhagen, M; Scholte, RHJ; Kleinjan, M; Goossens, L; Engels, RCME				van Roekel, Eeske; Verhagen, Maaike; Scholte, Ron H. J.; Kleinjan, Marloes; Goossens, Luc; Engels, Rutger C. M. E.			The Oxytocin Receptor Gene (OXTR) in Relation to State Levels of Loneliness in Adolescence: Evidence for Micro-Level Gene-Environment Interactions	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; 5-HTT GENES; HUMANS; ASSOCIATION; EXPRESSION; EXPERIENCE; CHILDHOOD; CONTEXT; STRESS; HEALTH	Previous research has shown that the rs53576 variant of the oxytocin receptor gene (OXTR) is associated with trait levels of loneliness, but results are inconsistent. The aim of the present study is to examine micro-level effects of the OXTR rs53576 variant on state levels of loneliness in early adolescents. In addition, gene-environment interactions are examined between this OXTR variant and positive and negative perceptions of company. Data were collected in 278 adolescents (58% girls), by means of the Experience Sampling Method (ESM). Sampling periods consisted of six days with nine assessments per day. A relation was found between the OXTR rs53576 variant and state loneliness, in girls only. Girls carrying an A allele had higher levels of state loneliness than girls carrying the GG genotype. In addition, adolescents with an A allele were more affected by negative perceptions of company than GG carriers, on weekend days only. No significant gene-environment interactions were found with positive company. Adolescents carrying an A allele were more susceptible to negative environments during weekend days than GG carriers. Our findings emphasize the importance of operationalizing the phenotype and the environment accurately.	[van Roekel, Eeske; Verhagen, Maaike; Scholte, Ron H. J.; Kleinjan, Marloes; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Goossens, Luc] KU Leuven Univ Leuven, Sch Psychol & Child & Adolescent Dev, Louvain, Belgium	Radboud University Nijmegen; KU Leuven	Goossens, L (corresponding author), KU Leuven Univ Leuven, Sch Psychol & Child & Adolescent Dev, Louvain, Belgium.	G.vanRoekel@pwo.ru.nl	van Roekel, Eeske/E-7889-2012; Kleinjan, Marloes/AAF-1128-2019	van Roekel, Eeske/0000-0002-0829-8089; Kleinjan, Marloes/0000-0002-4545-5549; Engels, Rutger/0000-0003-1944-9126; Goossens, Luc/0000-0003-3851-0412	Behavioural Science Institute, Radboud University Nijmegen	Behavioural Science Institute, Radboud University Nijmegen	This research was supported by a grant from the Behavioural Science Institute, Radboud University Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bartels M, 2008, AM J MED GENET B, V147B, P385, DOI 10.1002/ajmg.b.30608; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Chen FS, 2011, P NATL ACAD SCI US; Cornelis MC, 2012, MOL PSYCHIATR, V17, P1157, DOI 10.1038/mp.2011.178; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Costello DM, 2008, J CONSULT CLIN PSYCH, V76, P173, DOI 10.1037/0022-006X.76.2.173; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Feng M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1059, DOI 10.1152/ajpendo.90609.2008; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Kleinjan M, 2009, DRUG ALCOHOL DEPEN, V99, P204, DOI 10.1016/j.drugalcdep.2008.08.002; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; LARSON R, 1998, TEMPORAL RHYTHMS ADO, P37; LARSON RW, 1983, J MARRIAGE FAM, V45, P739, DOI 10.2307/351787; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Poulin MJ, 2013, HORM BEHAV, V63, P510, DOI 10.1016/j.yhbeh.2013.01.004; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Schneiders J, 2007, J RES ADOLESCENCE, V17, P697, DOI 10.1111/j.1532-7795.2007.00543.x; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Sturge-Apple ML, 2012, J FAM PSYCHOL, V26, P431, DOI 10.1037/a0028302; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; van Roekel E, PSYCHIATR GENET IN P; van Roekel E, 2014, J RES ADOLESCENCE, V24, P350, DOI 10.1111/jora.12061; Waaktaar T, 2012, AM J MED GENET B, V159B, P580, DOI 10.1002/ajmg.b.32064	35	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77689	10.1371/journal.pone.0077689	http://dx.doi.org/10.1371/journal.pone.0077689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223720	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400013
J	Benros, ME; Laursen, TM; Dalton, SO; Nordentoft, M; Mortensen, PB				Benros, Michael Eriksen; Laursen, Thomas Munk; Dalton, Susanne Oksbjerg; Nordentoft, Merete; Mortensen, Preben Bo			The Risk of Schizophrenia and Child Psychiatric Disorders in Offspring of Mothers with Lung Cancer and Other Types of Cancer: A Danish Nationwide Register Study	PLOS ONE			English	Article							HU ANTIBODIES; AUTOANTIBODIES; PARENTS; HYPERACTIVITY; INFECTIONS; IMPAIRMENT; PREGNANCY; PSYCHOSIS; EXPOSURE; HISTORY	Background: Maternal immune responses and brain-reactive antibodies have been proposed as possible causal mechanisms for schizophrenia and some child psychiatric disorders. According to this hypothesis maternal antibodies may cross the placenta and interact with the developing CNS of the fetus causing future neurodevelopmental disorders. Therefore, we investigated if children of mothers with cancer might be at higher risk of developing psychiatric disorders, with particular focus on small-cell lung cancer, which is known to induce production of antibodies binding to CNS elements. Methods: Nationwide population-based registers were linked, including the Danish Psychiatric Central Register and The Danish Cancer Registry. Data were analyzed as a cohort study using survival analysis techniques. Incidence rate ratios (IRRs) and accompanying 95% confidence intervals (CIs) were used as measures of relative risk. Results: In general, parental cancer was not associated with schizophrenia in the offspring (IRR, 0.98; 95% CI, 0.95-1.01). Furthermore, we found no temporal associations with maternal cancer in general; neither around the pregnancy period. However, maternal small-cell lung cancer increased the risk of early-onset schizophrenia and maternal small-cell lung cancer diagnosed within 20 years after childbirth increased the risk of schizophrenia. Parental cancer was not associated with child psychiatric disorders (IRR, 1.01; 95% CI, 0.98-1.05) except for the smoking related cancers. There was a significantly increased risk of child psychiatric disorders in offspring of both mothers (IRR, 1.35; 95% CI, 1.16-1.58) and fathers (IRR, 1.47; 95% CI, 1.30-1.66) with lung cancer of all types. Conclusions: In general, parental cancer did not increase the risk of schizophrenia nor of child psychiatric disorders. However, maternal small-cell lung cancer increased the risk of schizophrenia in subgroups; and lung cancer in general increased the risk of child psychiatric disorders, which could be due to risk factors associated with parental smoking.	[Benros, Michael Eriksen; Laursen, Thomas Munk; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Benros, Michael Eriksen; Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Benros, Michael Eriksen; Laursen, Thomas Munk; Nordentoft, Merete; Mortensen, Preben Bo] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dalton, Susanne Oksbjerg] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Danish Cancer Society	Benros, ME (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark.	Benros@ncrr.dk	Mortensen, Preben B/D-2358-2015; Laursen, Thomas Munk/AFQ-8066-2022; Nordentoft, Merete/AAH-3253-2019; Benros, Michael Eriksen/N-5868-2016	Mortensen, Preben B/0000-0002-5230-9865; Benros, Michael Eriksen/0000-0003-4939-9465; Laursen, Thomas Munk/0000-0001-6934-1784; Dalton, Susanne Oksbjerg/0000-0002-5485-2730	Stanley Medical Research Institute; ERC [294838]; Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH	Stanley Medical Research Institute; ERC(European Research Council (ERC)European Commission); Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH	The study was supported financially by a grant from the Stanley Medical Research Institute, ERC Advanced Grant Project no. 294838 and the Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Blatt J, 2010, PEDIATR BLOOD CANCER, V54, P144, DOI 10.1002/pbc.22303; Bo Mortensen P, 2007, BIOL PSYCHIAT, V61, P688, DOI 10.1016/j.biopsych.2006.05.024; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Carpentier AF, 1998, NEUROLOGY, V50, P1919, DOI 10.1212/WNL.50.6.1919; Connors SL, 2008, PEDIATR NEUROL, V38, P163, DOI 10.1016/j.pediatrneurol.2007.10.009; DALMAU J, 1995, CANCER, V75, P99, DOI 10.1002/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I; Dalton SO, 2005, AM J PSYCHIAT, V162, P1024, DOI 10.1176/appi.ajp.162.5.1024-a; Dalton SO, 2004, AM J PSYCHIAT, V161, P903, DOI 10.1176/appi.ajp.161.5.903; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; DENHOLLANDER AM, 1989, GEN HOSP PSYCHIAT, V11, P388, DOI 10.1016/0163-8343(89)90132-1; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Eaton WW, 2010, BIPOLAR DISORD, V12, P638, DOI 10.1111/j.1399-5618.2010.00853.x; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; Hills, 1993, STAT MODELS EPIDEMIO; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Ji JG, 2013, SCHIZOPHRENIA BULL, V39, P527, DOI 10.1093/schbul/sbs065; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; Karlsgodt KH, 2008, DEV PSYCHOPATHOL, V20, P1297, DOI 10.1017/S095457940800062X; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; Levav I, 2007, BRIT J PSYCHIAT, V190, P156, DOI 10.1192/bjp.bp.106.024943; Lichtermann D, 2001, ARCH GEN PSYCHIAT, V58, P573, DOI 10.1001/archpsyc.58.6.573; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; Margutti P, 2006, CURR NEUROVASC RES, V3, P149, DOI 10.2174/156720206776875894; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Monstad SE, 2004, J CLIN ONCOL, V22, P795, DOI 10.1200/JCO.2004.01.028; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nahmias AJ, 2006, CLIN DEV IMMUNOL, V13, P167, DOI 10.1080/17402520600801745; Nielsen PR, 2013, SCHIZOPHRENIA BULL, V39, P230, DOI 10.1093/schbul/sbr149; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; OLSEN JH, 1995, NEW ENGL J MED, V333, P1594, DOI 10.1056/NEJM199512143332403; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2001, BRIT J PSYCHIAT, V179, P46, DOI 10.1192/bjp.179.1.46; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; Storm HH, 1997, DAN MED BULL, V44, P535; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; SYSE A, 2012, J CLIN EPIDEMIOL, V4, P41; Verschuuren JJ, 1999, J NEUROL NEUROSUR PS, V67, P353, DOI 10.1136/jnnp.67.3.353; Vincent A, 2003, ANN NY ACAD SCI, V992, P48, DOI 10.1111/j.1749-6632.2003.tb03137.x; Wasserman EE, 2008, AM J EPIDEMIOL, V167, P701, DOI 10.1093/aje/kwm342; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zimmerman AW, 2007, BRAIN BEHAV IMMUN, V21, P351, DOI 10.1016/j.bbi.2006.08.005	56	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79031	10.1371/journal.pone.0079031	http://dx.doi.org/10.1371/journal.pone.0079031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223877	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300048
J	Ludwig, Y; Zhang, YX; Hochholdinger, F				Ludwig, Yvonne; Zhang, Yanxiang; Hochholdinger, Frank			The Maize (Zea mays L.) AUXIN/INDOLE-3-ACETIC ACID Gene Family: Phylogeny, Synteny, and Unique Root-Type and Tissue-Specific Expression Patterns during Development	PLOS ONE			English	Article							AUX/IAA PROTEINS; AUXIN; ARABIDOPSIS; INITIATION; ROLES	The plant hormone auxin plays a key role in the coordination of many aspects of growth and development. AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) genes encode instable primary auxin responsive regulators of plant development that display a protein structure with four characteristic domains. In the present study, a comprehensive analysis of the 34 members of the maize Aux/IAA gene family was performed. Phylogenetic reconstructions revealed two classes of Aux/IAA proteins that can be distinguished by alterations in their domain III. Seven pairs of paralogous maize Aux/IAA proteins were discovered. Comprehensive root-type and tissue-specific expression profiling revealed unique expression patterns of the diverse members of the gene family. Remarkably, five of seven pairs of paralogous genes displayed highly correlated expression patterns in roots. All but one (ZmIAA23) tested maize Aux/IAA genes were auxin inducible, displaying two types of auxin induction within three hours of treatment. Moreover, 51 of 55 (93%) differential Aux/IAA expression patterns between different root-types followed the expression tendency: crown roots > seminal roots > primary roots > lateral roots. This pattern might imply root-type-specific regulation of Aux/IAA transcript abundance. In summary, the detailed analysis of the maize Aux/IAA gene family provides novel insights in the evolution and developmental regulation and thus the function of these genes in different root-types and tissues.	[Ludwig, Yvonne; Zhang, Yanxiang; Hochholdinger, Frank] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany	University of Bonn	Hochholdinger, F (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany.	hochholdinger@uni-bonn.de		Hochholdinger, Frank/0000-0002-5155-0884	DFG (Deutsche Forschungsgemeinschaft); University of Bonn	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Bonn	This work was supported by a DFG (Deutsche Forschungsgemeinschaft) grant to F.H. and funding by the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; AINLEY WM, 1988, J BIOL CHEM, V263, P10658; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Berendzen KW, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-125; BLATT MR, 1993, ANNU REV PLANT PHYS, V44, P543, DOI 10.1146/annurev.pp.44.060193.002551; Cakir B, 2013, ACTA PHYSIOL PLANT, V35, P365, DOI 10.1007/s11738-012-1079-7; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; ESTELLE M, 1992, BIOESSAYS, V14, P439, DOI 10.1002/bies.950140703; Fahn A, 1990, PLANT ANATOMY; GUILFOYLE TJ, 1986, CRIT REV PLANT SCI, V4, P247, DOI 10.1080/07352688609382226; GUILFOYLE TJ, 1999, BIOCH MOL BIOL PLANT; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han XY, 2012, GENE, V503, P83, DOI 10.1016/j.gene.2012.03.069; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jansen L, 2012, PHILOS T R SOC B, V367, P1525, DOI 10.1098/rstb.2011.0239; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Lynch M, 2000, GENETICS, V154, P459; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THEOLOGIS A, 1986, ANNU REV PLANT PHYS, V37, P407, DOI 10.1146/annurev.arplant.37.1.407; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; von Behrens I, 2011, PLANT J, V66, P341, DOI 10.1111/j.1365-313X.2011.04495.x; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang YiJun, 2010, Acta Agronomica Sinica, V36, P688, DOI 10.3724/SP.J.1006.2010.00688; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Went F.W., 1937, PHYTOHORMONES; Woll K, 2005, PLANT PHYSIOL, V139, P1255, DOI 10.1104/pp.105.067330; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y	51	34	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78859	10.1371/journal.pone.0078859	http://dx.doi.org/10.1371/journal.pone.0078859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223858	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300037
J	Antonelli, A; Sfara, C; Battistelli, S; Canonico, B; Arcangeletti, M; Manuali, E; Salamida, S; Papa, S; Magnani, M				Antonelli, Antonella; Sfara, Carla; Battistelli, Serafina; Canonico, Barbara; Arcangeletti, Marcella; Manuali, Elisabetta; Salamida, Sonia; Papa, Stefano; Magnani, Mauro			New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI	PLOS ONE			English	Article							RED-BLOOD-CELLS; SUPERPARAMAGNETIC NANOPARTICLES; MAGNETIC NANOPARTICLES; BIOMEDICAL APPLICATIONS; MACROPHAGE APOPTOSIS; LOADED ERYTHROCYTES; OXIDE; CLODRONATE; ENCAPSULATION; REPOPULATION	Superparamagnetic iron oxide (SPIO) and ultra small superparamagnetic iron oxide (USPIO) nanoparticles have been developed as magnetic resonance imaging (MRI) contrast agents. Iron oxide nanoparticles, that become superparamagnetic if the core particle diameter is (similar to) 30nm or less, present R1 and R2 relaxivities which are much higher than those of conventional paramagnetic gadolinium chelates. Generally, these magnetic particles are coated with biocompatible polymers that prevent the agglomeration of the colloidal suspension and improve their blood distribution profile. In spite of their potential as MRI blood contrast agents, the biomedical application of iron oxide nanoparticles is still limited because of their intravascular half-life of only few hours; such nanoparticles are rapidly cleared from the bloodstream by macrophages of the reticulo-endothelial system (RES). To increase the life span of these MRI contrast agents in the bloodstream we proposed the encapsulation of SPIO nanoparticles in red blood cells (RBCs) through the transient opening of cell membrane pores. We have recently reported results obtained by applying our loading procedure to several SPIO nanoparticles with different chemical physical characteristics such as size and coating agent. In the current investigation we showed that the life span of iron-based contrast agents in the mice bloodstream was prolonged to 12 days after the intravenous injection of murine SPIO-loaded RBCs. Furthermore, we developed an animal model that implicates the pretreatment of animals with clodronate to induce a transient suppression of tissue macrophages, followed by the injection of human SPIO-loaded RBCs which make it possible to encapsulate nanoparticle concentrations (5.3-16.7mM Fe) higher than murine SPIO-loaded RBCs (1.4-3.55mM Fe). The data showed that, when human RBCs are used as more capable SPIO nanoparticle containers combined with a depletion of tissue macrophages, Fe concentration in animal blood is 2-3 times higher than iron concentration obtained by the use of murine SPIO-loaded RBCs.	[Antonelli, Antonella; Sfara, Carla; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Biochem & Mol Biol Sect, Urbino, Italy; [Battistelli, Serafina] Univ Urbino Carlo Bo, Dept Biomol Sci, Clin Biochem Sect, Urbino, Italy; [Canonico, Barbara] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy; [Arcangeletti, Marcella; Papa, Stefano] Univ Urbino Carlo Bo, Dept Biomol Sci, Pharmacol & Pharmacognosy Sect, Urbino, Italy; [Manuali, Elisabetta; Salamida, Sonia] Expt Zooprofilact Inst Umbria & Marche, Lab Elect Microscopy & Histopathol, Perugia, Italy	University of Urbino; University of Urbino; University of Urbino; University of Urbino; IZS Umbria e Marche	Antonelli, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Biochem & Mol Biol Sect, Urbino, Italy.	antonella.antonelli@uniurb.it	ANTONELLI, ANTONELLA/C-6238-2011; Magnani, Mauro/A-1919-2008; Manuali, Elisabetta/K-8491-2016	Manuali, Elisabetta/0000-0003-3680-0926; Canonico, Barbara/0000-0003-3383-715X; Magnani, Mauro/0000-0001-6456-6626	FIRB funds from the Italian Minister for University and Research [RBFR1299K0]	FIRB funds from the Italian Minister for University and Research	The authors have received support from FIRB funds with contract RBFR1299K0 from the Italian Minister for University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allkemper T, 2002, RADIOLOGY, V223, P432, DOI 10.1148/radiol.2232010241; Antonelli A, 2012, SPRINGER PROC PHYS, V140, P175; Antonelli A, 2008, J NANOSCI NANOTECHNO, V8, P2270, DOI 10.1166/jnn.2008.190; Antonelli A, 2011, NANOMEDICINE-UK, V6, P211, DOI 10.2217/NNM.10.163; Araujo L, 1999, J DRUG TARGET, V6, P373, DOI 10.3109/10611869908996844; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203; Boni A, 2013, CONTRAST ME IN PRESS; Brahler M, 2006, NANO LETT, V6, P2505, DOI 10.1021/nl0618501; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; CASTRO O, 1973, P NATL ACAD SCI USA, V70, P2356, DOI 10.1073/pnas.70.8.2356; Corot C, 2003, INVEST RADIOL, V38, P311, DOI 10.1097/01.rli.0000066814.82006.be; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6; DELOACH JR, 1987, METHOD ENZYMOL, V149, P235; Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E; Gadian DG, 1984, NUCL MAGNETIC RESONA; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Jun YW, 2008, ANGEW CHEM INT EDIT, V47, P5122, DOI 10.1002/anie.200701674; KREUTER J, 1994, EUR J DRUG METAB PH, V19, P253, DOI 10.1007/BF03188928; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Magnani M, 2012, THER DELIV, V3, P405, DOI 10.4155/TDE.12.6; Markov DE, 2010, PHYS MED BIOL, V55, P6461, DOI 10.1088/0031-9155/55/21/008; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Moghimi SM, 2001, PHARMACOL REV, V53, P283; MONKKONEN J, 1989, DRUG METAB DISPOS, V17, P690; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Rossi L, 2005, J DRUG TARGET, V13, P99, DOI 10.1080/10611860500064123; Rumenapp C, 2012, PHARM RES-DORDR, V29, P1165, DOI 10.1007/s11095-012-0711-y; Selander KS, 1996, MOL PHARMACOL, V50, P1127; SPRANDEL U, 1987, METHOD ENZYMOL, V149, P301; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; VYAS SP, 1994, J MICROENCAPSUL, V11, P19, DOI 10.3109/02652049409040435; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; Zhang C, 2010, MINI-REV MED CHEM, V10, P194, DOI 10.2174/138955710791185073; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158; Zhu HM, 2011, CRIT CARE MED, V39, P2478, DOI 10.1097/CCM.0b013e318225754f	47	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78542	10.1371/journal.pone.0078542	http://dx.doi.org/10.1371/journal.pone.0078542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24223101	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400084
J	Barcena-Uribarri, I; Thein, M; Maier, E; Bonde, M; Bergstrom, S; Benz, R				Barcena-Uribarri, Ivan; Thein, Marcus; Maier, Elke; Bonde, Mari; Bergstrom, Sven; Benz, Roland			Use of Nonelectrolytes Reveals the Channel Size and Oligomeric Constitution of the Borrelia burgdorferi P66 Porin	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CURRENT NOISE-ANALYSIS; SITE-DIRECTED MUTAGENESIS; LAMB MALTOPORIN CHANNEL; LIPID BILAYER-MEMBRANES; ESCHERICHIA-COLI; LYME-DISEASE; ION CHANNELS; BINDING-KINETICS; SUGAR-TRANSPORT	In the Lyme disease spirochete Borrelia burgdorferi, the outer membrane protein P66 is capable of pore formation with an atypical high single-channel conductance of 11 nS in 1 M KCl, which suggested that it could have a larger diameter than 'normal' Gram-negative bacterial porins. We studied the diameter of the P66 channel by analyzing its single-channel conductance in black lipid bilayers in the presence of different nonelectrolytes with known hydrodynamic radii. We calculated the filling of the channel with these nonelectrolytes and the results suggested that nonelectrolytes (NEs) with hydrodynamic radii of 0.34 nm or smaller pass through the pore, whereas neutral molecules with greater radii only partially filled the channel or were not able to enter it at all. The diameter of the entrance of the P66 channel was determined to be <= 1.9 nm and the channel has a central constriction of about 0.8 nm. The size of the channel appeared to be symmetrical as judged from one-sidedness of addition of NEs. Furthermore, the P66-induced membrane conductance could be blocked by 80-90% by the addition of the nonelectrolytes PEG 400, PEG 600 and maltohexaose to the aqueous phase in the low millimolar range. The analysis of the power density spectra of ion current through P66 after blockage with these NEs revealed no chemical reaction responsible for channel block. Interestingly, the blockage of the single-channel conductance of P66 by these NEs occurred in about eight subconductance states, indicating that the P66 channel could be an oligomer of about eight individual channels. The organization of P66 as a possible octamer was confirmed by Blue Native PAGE and immunoblot analysis, which both demonstrated that P66 forms a complex with a mass of approximately 460 kDa. Two dimension SDS PAGE revealed that P66 is the only polypeptide in the complex.	[Barcena-Uribarri, Ivan; Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Barcena-Uribarri, Ivan; Thein, Marcus; Maier, Elke; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Bonde, Mari; Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden	Jacobs University; German Research Foundation (DFG); University of Wurzburg; Umea University	Benz, R (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany.	r.benz@jacobs-university.de		Benz, Roland/0000-0002-9510-9265	Deutsche Forschungsgemeinschaft [Be 865/15-1]; Jacobs University; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jacobs University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Deutsche Forschungsgemeinschaft, http://www.dfg.de; Be 865/15-1, Jacobs University http://www.jacobs-university.de; Swedish Research Council, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1985, CRC CR REV BIOCH MOL, V19, P145, DOI 10.3109/10409238509082542; Berestovsky GN, 2001, J EXP BOT, V52, P1173, DOI 10.1093/jexbot/52.359.1173; Bezrukov SM, 2000, PHYS REV LETT, V85, P202, DOI 10.1103/PhysRevLett.85.202; BUNIKIS J, 1995, FEMS MICROBIOL LETT, V131, P139, DOI 10.1111/j.1574-6968.1995.tb07768.x; Bunikis J, 1996, INFECT IMMUN, V64, P5111, DOI 10.1128/IAI.64.12.5111-5116.1996; Coburn J, 2003, P NATL ACAD SCI USA, V100, P7301, DOI 10.1073/pnas.1131117100; Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x; Defoe G, 2001, INFECT IMMUN, V69, P3455, DOI 10.1128/IAI.69.5.3455-3459.2001; Denker K, 2005, J MOL BIOL, V352, P534, DOI 10.1016/j.jmb.2005.07.025; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; HOLZ R, 1970, J GEN PHYSIOL, V56, P125, DOI 10.1085/jgp.56.1.125; HOOGE FN, 1971, PHILIPS RES REP, V26, P77; Jordy M, 1996, J MOL BIOL, V259, P666, DOI 10.1006/jmbi.1996.0348; Kaulin YA, 1998, BIOPHYS J, V74, P2918, DOI 10.1016/S0006-3495(98)77999-8; KRASILNIKOV OV, 1995, BRAZ J MED BIOL RES, V28, P693; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KRASILNIKOV OV, 1992, FEMS MICROBIOL IMMUN, V105, P93; Krasilnikov OV, 2002, NATO SCI S PRT 3 HI, V87, P97; KROPINSKI AM, 1987, J BACTERIOL, V169, P172, DOI 10.1128/jb.169.1.172-179.1987; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; MARK JE, 1965, J AM CHEM SOC, V87, P1415, DOI 10.1021/ja01085a001; MARKIN VS, 1974, INDUCED ION TRANSPOR; MCKIM S, 1994, BBA-BIOMEMBRANES, V1193, P186, DOI 10.1016/0005-2736(94)90348-4; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; Rempp P., 1957, J CHIM PHYS PCB, V54, P432; Rostovtseva TK, 2002, BIOPHYS J, V82, P160, DOI 10.1016/S0006-3495(02)75383-6; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; SADZIENE A, 1992, J EXP MED, V176, P799, DOI 10.1084/jem.176.3.799; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Sizonenko VL, 1995, BIOFIZIKA+, V40, P1251; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VODYANOY I, 1992, BIOPHYS J, V62, P10, DOI 10.1016/S0006-3495(92)81762-9; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wohnsland F, 1997, J MEMBRANE BIOL, V158, P77, DOI 10.1007/s002329900245; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b	51	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78272	10.1371/journal.pone.0078272	http://dx.doi.org/10.1371/journal.pone.0078272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223145	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200037
J	Gaudio, E; Paduano, F; Spizzo, R; Ngankeu, A; Zanesi, N; Gaspari, M; Ortuso, F; Lovat, F; Rock, J; Hill, GA; Kaou, M; Cuda, G; Aqeilan, RI; Alcaro, S; Croce, CM; Trapasso, F				Gaudio, Eugenio; Paduano, Francesco; Spizzo, Riccardo; Ngankeu, Apollinaire; Zanesi, Nicola; Gaspari, Marco; Ortuso, Francesco; Lovat, Francesca; Rock, Jonathan; Hill, Grace A.; Kaou, Mohamed; Cuda, Giovanni; Aqeilan, Rami I.; Alcaro, Stefano; Croce, Carlo M.; Trapasso, Francesco			Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel	PLOS ONE			English	Article							DEFICIENT MICE; TUMOR-DEVELOPMENT; INDUCED APOPTOSIS; GENE; EXPRESSION; RESISTANCE; LINES; ANNEXINOPATHIES; TUMORIGENICITY; MALIGNANCIES	Fhit protein is lost or reduced in a large fraction of human tumors, and its restoration triggers apoptosis and suppresses tumor formation or progression in preclinical models. Here, we describe the identification of candidate Fhit-interacting proteins with cytosolic and plasma membrane localization. Among these, Annexin 4 (ANXA4) was validated by co-immunoprecipitation and confocal microscopy as a partner of this novel Fhit protein complex. Here we report that overexpression of Fhit prevents Annexin A4 translocation from cytosol to plasma membrane in A549 lung cancer cells treated with paclitaxel. Moreover, paclitaxel administration in combination with AdFHIT acts synergistically to increase the apoptotic rate of tumor cells both in vitro and in vivo experiments.	[Gaudio, Eugenio; Ngankeu, Apollinaire; Zanesi, Nicola; Lovat, Francesca; Hill, Grace A.; Kaou, Mohamed; Aqeilan, Rami I.; Croce, Carlo M.] Ohio State Univ, Dept Mol Immunol Virol & Med Genet, Columbus, OH 43210 USA; [Gaudio, Eugenio] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland; [Gaudio, Eugenio; Paduano, Francesco; Gaspari, Marco; Cuda, Giovanni; Trapasso, Francesco] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; [Spizzo, Riccardo] CRO, Div Expt Oncol 2, Aviano, Italy; [Ortuso, Francesco; Alcaro, Stefano] Magna Graecia Univ Catanzaro, Dipartimento Sci Salute, Catanzaro, Italy; [Rock, Jonathan] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Aqeilan, Rami I.] Hebrew Univ Jerusalem, Inst Med Res, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel	University System of Ohio; Ohio State University; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Magna Graecia University of Catanzaro; IRCCS Aviano (CRO); Magna Graecia University of Catanzaro; University System of Ohio; Ohio State University; Hebrew University of Jerusalem	Croce, CM (corresponding author), Ohio State Univ, Dept Mol Immunol Virol & Med Genet, Columbus, OH 43210 USA.	carlo.croce@osumc.edu; trapasso@unicz.it	Cuda, Giovanni/F-5359-2012; Cuda, Giovanni/AAC-2821-2019; Aqeilan, Rami/R-4443-2016; Gaspari, Marco/C-2756-2009; Gaspari, Marco/ABE-1539-2020; Aqeilan, Rami/AAT-7785-2020; Gaspari, Marco/HGB-2399-2022; Paduano, Francesco/A-2548-2015; Young, Richard A/F-6495-2012; Spizzo, Riccardo/V-1057-2019	Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; Aqeilan, Rami/0000-0002-6034-023X; Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Paduano, Francesco/0000-0003-0916-8101; Young, Richard A/0000-0001-8855-8647; Spizzo, Riccardo/0000-0001-7772-0960; ALCARO, Stefano/0000-0002-0437-358X; ORTUSO, Francesco/0000-0001-6235-8161	AIRC (Associazione Italiana Ricerca Cancro); National Institutes of Health (NIH) [CA152758]; NATIONAL CANCER INSTITUTE [U01CA152758, U01CA166905] Funding Source: NIH RePORTER	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AIRC (Associazione Italiana Ricerca Cancro) and National Institutes of Health (NIH) grant CA152758 (C. M. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani F, 2006, NEOPLASIA, V8, P9; Baffa R, 1998, CANCER RES, V58, P4708; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bianchi F, 2007, CELL CYCLE, V6, P643, DOI 10.4161/cc.6.6.4033; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Cortinovis DL, 2008, CURR CANCER DRUG TAR, V8, P342, DOI 10.2174/156800908785133204; D'Agostini F, 2006, CANCER RES, V66, P3936, DOI 10.1158/0008-5472.CAN-05-3666; Ding S, 2001, BRIT J CANCER, V85, P1175, DOI 10.1054/bjoc.2001.2044; Draganescu A, 2000, J BIOL CHEM, V275, P4555, DOI 10.1074/jbc.275.7.4555; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Dumon KR, 2001, CANCER RES, V61, P4827; Fong LYY, 2000, P NATL ACAD SCI USA, V97, P4742, DOI 10.1073/pnas.080063497; Gaudio E, 2013, BLOOD, V121, P351, DOI 10.1182/blood-2012-09-457374; Gaudio E, 2012, BLOOD, V119, P180, DOI 10.1182/blood-2011-08-374561; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Han EKH, 2000, BRIT J CANCER, V83, P83; Hayes M. J., 2007, V45, P1; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hendricks DT, 1997, CANCER RES, V57, P2112; Huebner K, 2011, ADV ENZYME REGUL, V51, P208, DOI 10.1016/j.advenzreg.2010.09.003; Ishii H, 2003, MOL CANCER RES, V1, P940; Ishii H, 2001, CANCER RES, V61, P1578; Ji L, 1999, CANCER RES, V59, P3333; Kim CH, 2006, INT J CANCER, V118, P1692, DOI 10.1002/ijc.21573; Matsuyama A, 2003, P NATL ACAD SCI USA, V100, P14988, DOI 10.1073/pnas.2336256100; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Pichiorri F, 2006, CLIN CANCER RES, V12, P3494, DOI 10.1158/1078-0432.CCR-05-2581; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rimessi A, 2009, P NATL ACAD SCI USA, V106, P12753, DOI 10.1073/pnas.0906484106; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Sevignani C, 2003, CANCER RES, V63, P1183; Song J, 2007, CLIN CANCER RES, V13, P6842, DOI 10.1158/1078-0432.CCR-07-0569; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200; Virgilio L, 1996, P NATL ACAD SCI USA, V93, P9770, DOI 10.1073/pnas.93.18.9770; Wang Y, 2004, BIOCHEM BIOPH RES CO, V314, P565, DOI 10.1016/j.bbrc.2003.12.117; Zanesi N, 2005, CANCER RES, V65, P6576, DOI 10.1158/0008-5472.CAN-05-1128; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898	42	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78610	10.1371/journal.pone.0078610	http://dx.doi.org/10.1371/journal.pone.0078610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223161	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200053
J	Iakoubov, L; Mossakowska, M; Szwed, M; Duan, ZB; Sesti, F; Puzianowska-Kuznicka, M				Iakoubov, Leonid; Mossakowska, Malgorzata; Szwed, Malgorzata; Duan, Zhibing; Sesti, Federico; Puzianowska-Kuznicka, Monika			A Common Copy Number Variation (CNV) Polymorphism in the CNTNAP4 Gene: Association with Aging in Females	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LONGEVITY; MORTALITY; DISEASE; HAPLOTYPES; SURVIVAL; FOXO1A; RISK	Background: Aging is a biological process strongly determined by genetics. However, only a few single nucleotide polymorphisms (SNPs) have been reported to be consistently associated with aging. While investigating whether copy number variations (CNVs) could fill this gap, we focused on CNVs that have not been studied in previous SNP-based searches via tagging SNPs. Methods: TaqMan qPCR assays were developed to quantify 20 common CNVs in 222 senior American Caucasians in order to reveal possible association with longevity. The replication study was comprised of 1283 community-dwelling senior European Caucasians. Replicated CNVs were further investigated for association with healthy aging and aging-related diseases, while association with longevity was additionally tested in Caenorhabditis elegans. Results: In the discovery study of >= 80 vs. <80 years old seniors, a homozygous intronic CNV deletion in the CNTNAP4 gene was inversely associated with survival to the age of 80 (OR=0.51, 95% CI 0.29-0.87, p=0.015 before correction for multiple testing). After stratification by sex, association remained significant in females (OR=0.41, 95% CI 0.21-0.77, p=0.007), but not in males (OR=0.97, 95% CI 0.33-2.79, p=1). The finding was validated in a replication study (OR=0.66, 95% CI 0.48-0.90, p=0.011 for females). CNTNAP4 association with longevity was supported by a marked 25% lifespan change in C. elegans after knocking down the ortholog gene. An inverse association of the CNV del/del variant with female healthy aging was observed (OR=0.39, 95% CI 0.19-0.76, p=0.006). A corresponding positive association with aging-related diseases was revealed for cognitive impairment (OR=2.17, 95% CI 1.11-4.22, p=0.024) and, in independent studies, for Alzheimer's (OR=4.07, 95% CI 1.17-14.14, p=0.036) and Parkinson's (OR=1.59, 95% CI 1.03-2.42, p=0.041) diseases. Conclusion: This is the first demonstration for association of the CNTNAP4 gene and one of its intronic CNV polymorphisms with aging. Association with particular aging-related diseases awaits replication and independent validation.	[Iakoubov, Leonid] GeneCona LLC, Vallejo, CA USA; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, PolSenior Project, Warsaw, Poland; [Szwed, Malgorzata; Puzianowska-Kuznicka, Monika] Mossakowski Med Res Ctr, Dept Human Epigenet, Warsaw, Poland; [Duan, Zhibing; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Puzianowska-Kuznicka, Monika] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centre of Postgraduate Medical Education - Poland	Iakoubov, L (corresponding author), GeneCona LLC, Vallejo, CA USA.	iakoubov@comcast.net; mpuzianowska@wum.edu.pl	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Duan, Zhibing/0000-0002-6241-7296; Iakoubov, Leonid/0000-0001-9666-2110; Puzianowska-Kuznicka, Monika/0000-0001-5295-3848	Polish Ministry of Science and Higher Education [PBZ-MEiN-9/2/2006 - K143/P01/2007/1]; NSF [1026958]; NATIONAL INSTITUTE ON AGING [U24AG021886] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	M.P-K., M. M., and M. S. were supported by the Polish Ministry of Science and Higher Education grant PBZ-MEiN-9/2/2006 - K143/P01/2007/1 ("PolSenior"). F. S. and Z.D. were supported by NSF award number 1026958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bledowski P, 2011, EXP GERONTOL, V46, P1003, DOI 10.1016/j.exger.2011.09.006; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dastani Z, 2010, EUR J HUM GENET, V18, P342, DOI 10.1038/ejhg.2009.157; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; Gamazon ER, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001292; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hart AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042646; He KW, 2009, NEUROSCI BULL, V25, P335, DOI 10.1007/s12264-009-6123-2; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Ji WD, 2013, PSYCHIAT RES, V207, P225, DOI 10.1016/j.psychres.2012.09.024; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kryspin-Exner I, 2011, GERONTOLOGY, V57, P539, DOI 10.1159/000323154; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Kuningas M, 2011, HUM MOL GENET, V20, P4290, DOI 10.1093/hmg/ddr340; Laslett Peter, 1995, AGING DEMOGRAPHY SOC, P4; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lord C, 2011, CELL, V147, P24, DOI 10.1016/j.cell.2011.09.017; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Perls T, 2002, J MOL NEUROSCI, V19, P233, DOI 10.1007/s12031-002-0039-x; Pilling LC, 2012, J GERONTOL A-BIOL, V67, P511, DOI 10.1093/gerona/gls091; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shi H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.014; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Ulmer M, 2012, INVEST OPHTH VIS SCI, V53, P4468, DOI 10.1167/iovs.12-9784; van Abel D, 2012, J ALZHEIMERS DIS, V31, P793, DOI 10.3233/JAD-2012-120472; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156	44	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79790	10.1371/journal.pone.0079790	http://dx.doi.org/10.1371/journal.pone.0079790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223195	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200088
J	Mi, D; Huang, YT; Kleinjan, DA; Mason, JO; Price, DJ				Mi, Da; Huang, Yu-Ting; Kleinjan, Dirk A.; Mason, John O.; Price, David J.			Identification of Genomic Regions Regulating Pax6 Expression in Embryonic Forebrain Using YAC Reporter Transgenic Mouse Lines	PLOS ONE			English	Article							CORTICAL PROGENITOR PROLIFERATION; PALLIAL-SUBPALLIAL BOUNDARY; RADIAL GLIA; DEVELOPING NEOCORTEX; NEURONAL DIVERSITY; NASAL DEVELOPMENT; CEREBRAL-CORTEX; LIMBIC SYSTEM; MUTANT MICE; CELL-CYCLE	The transcription factor Pax6 is a crucial regulator of eye and central nervous system development. Both the spatiotemporal patterns and the precise levels of Pax6 expression are subject to tight control, mediated by an extensive set of cis-regulatory elements. Previous studies have shown that a YAC reporter transgene containing 420Kb of genomic DNA spanning the human PAX6 locus drives expression of a tau-tagged GFP reporter in mice in a pattern that closely resembles that of endogenous Pax6. Here we have closely compared the pattern of tau-GFP reporter expression at the cellular level in the forebrains and eyes of transgenic mice carrying either complete or truncated versions of the YAC reporter transgene with endogenous Pax6 expression and found several areas where expression of tau-GFP and Pax6 diverge. Some discrepancies are due to differences between the intracellular localization or perdurance of tau-GFP and Pax6 proteins, while others are likely to be a consequence of transcriptional differences. We show that cis-regulatory elements that lie outside the 420kb fragment of PAX6 are required for correct expression around the pallial-subpallial boundary, in the amygdala and the prethalamus. Further, we found that the YAC reporter transgene effectively labels cells that contribute to the lateral cortical stream, including cells that arise from the pallium and subpallium, and therefore represents a useful tool for studying lateral cortical stream migration.	[Mi, Da; Huang, Yu-Ting; Mason, John O.; Price, David J.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Kleinjan, Dirk A.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Mi, D (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	D.Mi@sms.ed.ac.uk; David.Price@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400; Mi, Da/0000-0002-7829-1923; Price, David/0000-0002-5318-307X	Wellcome Trust [08420]; Medical Research Council (MRC) [G0800429]; Medical Research Council [MR/J003662/1, G0800429] Funding Source: researchfish; MRC [G0800429, MR/J003662/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from: 1. Wellcome Trust (08420), http://www.wellcome.ac.uk/index.htm. 2. Medical Research Council (MRC) (G0800429), http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2008, DEV NEUROSCI-BASEL, V30, P144, DOI 10.1159/000109859; Baumer N, 2002, DEVELOPMENT, V129, P4535; Caric D, 1997, DEVELOPMENT, V124, P5087; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123; Cocas LA, 2011, J NEUROSCI, V31, P5313, DOI 10.1523/JNEUROSCI.3867-10.2011; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dimanlig PV, 2001, DEVELOPMENT, V128, P4415; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FUKUSHIMA Y, 1993, HUM GENET, V91, P205; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Georgala PA, 2011, CEREB CORTEX, V21, P81, DOI 10.1093/cercor/bhq061; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kleinjan DA, 2002, MAMM GENOME, V13, P102, DOI 10.1007/s00335-001-3058-y; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McBride DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028616; Mi D, 2013, NEURON, V78, P269, DOI 10.1016/j.neuron.2013.02.012; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Morgan R, 2004, TRENDS GENET, V20, P283, DOI 10.1016/j.tig.2004.04.009; Plaza S, 1999, DEV GENES EVOL, V209, P165, DOI 10.1007/s004270050240; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Theil T, 2005, DEV BIOL, V286, P559, DOI 10.1016/j.ydbio.2005.08.033; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1997, DEVELOPMENT, V124, P1573; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Xu PX, 1999, DEVELOPMENT, V126, P383	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80208	10.1371/journal.pone.0080208	http://dx.doi.org/10.1371/journal.pone.0080208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223221	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200114
J	Skardhamar, T; Skirbekk, V				Skardhamar, Torbjorn; Skirbekk, Vegard			Relative Mortality among Criminals in Norway and the Relation to Drug and Alcohol Related Offenses	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; PRISON; DEATH; RELEASE; DELINQUENCY; DISORDERS; OFFENDERS; COUNTRIES; INMATES; COHORT	Background: Registered offenders are known to have a higher mortality rate, but given the high proportion of offenders with drug-addiction, particularly among offenders with a custodial sentence, higher mortality is expected. While the level of overall mortality compared to the non-criminal population is of interest in itself, we also estimate the risk of death by criminal records related to substance abuse and other types of criminal acts, and separate between those who receive a prison sentence or not. Methods: Age-adjusted relative risks of death for 2000-2008 were studied in a population based dataset. Our dataset comprise the total Norwegian population of 2.9 million individuals aged 15-69 years old in 1999, of whom 10% had a criminal record in the 1992-1999 period. Results: Individuals with a criminal record have twice the relative risk (RR) of death of the control group (non-offenders). Males with a record of use/possession of drugs and a prison record have an 11.9 RR (females, 15.6); males with a drug record but no prison record have a 6.9 RR (females 10.5). Males imprisoned for driving under the influence of substances have a 4.4 RR (females 5.6); males with a record of driving under the influence but no prison sentence have a 3.2 RR (females 6.5). Other male offenders with a prison record have a 2.8 RR (females 3.7); other male offenders with no prison record have a 1.7 RR (females 2.3). Conclusion: Significantly higher mortality was found for people with a criminal record, also for those without any record of drug use. Mortality is much higher for those convicted of substance-related crimes: more so for drug-than for alcohol-related crimes and for women.	[Skardhamar, Torbjorn] Stat Norway, Oslo, Norway; [Skirbekk, Vegard] Int Inst Appl Syst Anal, Age & Cohort Change Program ACC, A-2361 Laxenburg, Austria	Statistics Norway; International Institute for Applied Systems Analysis (IIASA)	Skirbekk, V (corresponding author), Int Inst Appl Syst Anal, Age & Cohort Change Program ACC, A-2361 Laxenburg, Austria.	skirbekk@iiasa.ac.at			European Research Council [241003-COHORT]; Norwegian Research Council [202453/S20]	European Research Council(European Research Council (ERC)European Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a Starting Grant of the European Research Council [241003-COHORT], and from the Norwegian Research Council, [202453/S20]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SA, 2000, ADDICT BEHAV, V25, P167, DOI 10.1016/S0306-4603(99)00053-2; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Bjorkenstam E, 2011, INT J EPIDEMIOL, V40, P1585, DOI 10.1093/ije/dyr127; Christensen PB, 2006, INT J PRISON HEALTH, V2, P13, DOI 10.1080/17449200600743644; Christophersen AS, 1999, FORENSIC SCI INT, V106, P173, DOI 10.1016/S0379-0738(99)00194-2; Darke S., 2007, MORTALITY ILLICIT DR; Dye MH, 2010, J CRIM JUST, V38, P796, DOI 10.1016/j.jcrimjus.2010.05.007; ETSC, 2008, DRINK DRIV FACT SHEE; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Galanter M, 1983, RECENT DEV ALCOHOLIS, V8; Giertsen H, 2012, NORD STUD ALCOHOL DR, V29, P589, DOI 10.2478/v10199-012-0049-0; Gjerde H, 2008, ACCIDENT ANAL PREV, V40, P1765, DOI 10.1016/j.aap.2008.06.015; Graham A, 2003, AUST NZ J CRIMINOL, V36, P94, DOI 10.1375/000486503764805365; Greenfield SF, 2009, PSYCHIAT SERV, V60, P880, DOI 10.1176/appi.ps.60.7.880; Haggard-Grann U, 2006, ADDICTION, V101, P100, DOI 10.1111/j.1360-0443.2005.01293.x; Hausken AM, 2005, DRUG ALCOHOL DEPEN, V79, P423, DOI 10.1016/j.drugalcdep.2005.03.014; Helsedirektoratet, 2013, HELS OMS FENGS; James D. J., 2006, HIGHLIGHTS MENTAL HL; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kjelsberg E, 2010, EUR J EPIDEMIOL, V25, P237, DOI 10.1007/s10654-010-9436-6; Lappi-Seppala T, 2011, CRIME JUSTICE, V40, P1, DOI 10.1086/660822; Laub JH, 2000, AM J PSYCHIAT, V157, P96, DOI 10.1176/ajp.157.1.96; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Little M, 2006, J RES CRIME DELINQ, V43, P357, DOI 10.1177/0022427806291260; Lyngstad TH, 2011, CRIME JUSTICE, V40, P613; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Nieuwbeerta P, 2008, J RES CRIME DELINQ, V45, P256, DOI 10.1177/0022427808317573; Nochajski TH, 2006, CLIN PSYCHOL REV, V26, P179, DOI 10.1016/j.cpr.2005.11.006; Norwegian Parhamentary, 2008, STRAFF SOM VIRK MIND; Nyhlen A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-122; Paula H, 2010, AM J GASTROENTEROL, V105, P1782, DOI 10.1038/ajg.2010.46; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/09595230500102434; Room R, 2001, J SUBST USE, V4, P218, DOI DOI 10.1080/146598901753325048; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Sailas ES, 2006, EUR J PUBLIC HEALTH, V16, P193, DOI 10.1093/eurpub/cki169; Singleton N, 2003, DRUG RELATED MORTALI; Skarohamar T., 2003, J SCANDINAVIAN STUDI, V4, P39, DOI [DOI 10.1080/14043850310012314, 10.1080/14043850310012314]; Stattin H., 1995, CRIM BEHAV MENT HEAL, V5, P279, DOI [10.1002/cbm.1995.5.4.279, DOI 10.1002/CBM.1995.5.4.279]; Steinman KJ, 2005, J ADOLESCENT HEALTH, V36, DOI [10.1016/j.jadohealth.2003.12.012, DOI 10.1016/J.JAD0HEALTH.2003.12.012]; Stenbacka M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-38; Sun F., 2002, PROPORTIONS CRIMES A; Unlu A., 2012, INT J HUMAN SCI, V9, P161; Verger P, 2003, J FORENSIC SCI, V48, P614; Waal H, 2013, LAR SOM VIL BLI FREM; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78893	10.1371/journal.pone.0078893	http://dx.doi.org/10.1371/journal.pone.0078893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247XD	24223171	Green Published, gold, Green Accepted			2022-12-25	WOS:000326656200063
J	Ilboudo, PGC; Russell, S; D'Exelle, B				Ilboudo, Patrick G. C.; Russell, Steve; D'Exelle, Ben			The Long Term Economic Impact of Severe Obstetric Complications for Women and Their Children in Burkina Faso	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; LOW-INCOME; CONSEQUENCES; ILLNESS; HOUSEHOLD; MORBIDITY; MORTALITY; SERVICES; DELIVERY; PROGRESS	This study investigates the long term economic impact of severe obstetric complications for women and their children in Burkina Faso, focusing on measures of food security, expenditures and related quality of life measures. It uses a hospital based cohort, first visited in 2004/2005 and followed up four years later. This cohort of 1014 women consisted of two main groups of comparison: 677 women who had an uncomplicated delivery and 337 women who experienced a severe obstetric complication which would have almost certainly caused death had they not received hospital care (labelled a "near miss" event). To analyze the impact of such near miss events as well as the possible interaction with the pregnancy outcome, we compared household and individual level indicators between women without a near miss event and women with a near miss event who either had a live birth, a perinatal death or an early pregnancy loss. We used propensity score matching to remove initial selection bias. Although we found limited effects for the whole group of near miss women, the results indicated negative impacts: a) for near miss women with a live birth, on child development and education, on relatively expensive food consumption and on women's quality of life; b) for near miss women with perinatal death, on relatively expensive foods consumption and children's education and c) for near miss women who had an early pregnancy loss, on overall food security. Our results showed that severe obstetric complications have long lasting consequences for different groups of women and their children and highlighted the need for carefully targeted interventions.	[Ilboudo, Patrick G. C.] Agence Format Rech & Expertise Sante Afrique AFRI, Bobo Dioulasso, Burkina Faso; [Ilboudo, Patrick G. C.] Univ Oslo, Dept Community Med, Oslo, Norway; [Russell, Steve; D'Exelle, Ben] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England	University of Oslo; University of East Anglia	Ilboudo, PGC (corresponding author), Agence Format Rech & Expertise Sante Afrique AFRI, Bobo Dioulasso, Burkina Faso.	g.p.c.ilboudo@studmed.uio.no			Immpact; DFID-funded research programme consortium; UK Economic and Social Research Council [RES-183-25-0011]; Hewlett Foundation [RES-183-25-0011]; Research Council of Norway's ECONPOP programme [199730/H30]; Economic and Social Research Council [ES/F038402/1] Funding Source: researchfish; ESRC [ES/F038402/1] Funding Source: UKRI	Immpact; DFID-funded research programme consortium; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Hewlett Foundation; Research Council of Norway's ECONPOP programme(Research Council of Norway); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The first wave was supported by Immpact (2005-2007) and a DFID-funded research programme consortium 'Towards 4 plus 5'. The second wave was supported by a joint UK Economic and Social Research Council and Hewlett Foundation grant (RES-183-25-0011; 2007-2010). Patrick G. C Ilboudo was funded by the Research Council of Norway's ECONPOP programme (Project number 199730/H30) during the analysis and writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalola S, 2011, J PAEDIATR CHILD H, V47, P276, DOI 10.1111/j.1440-1754.2010.01956.x; Baltes PB, 2001, INT ENCY SOCIAL BEHA, P14558; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Bhatia JC, 1996, SOC SCI MED, V43, P1507, DOI 10.1016/0277-9536(96)00105-0; BLOOM DE, 2009, INT PUBLIC HLTH DIS, P601; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; DOR A, 1987, J HEALTH ECON, V6, P291, DOI 10.1016/0167-6296(87)90017-8; Elo I T, 1992, Health Transit Rev, V2, P49; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; FORTNEY JA, 1996, BASE ICEBERG PREVALE; Fronczak N, 2005, INT J GYNECOL OBSTET, V91, P271, DOI 10.1016/j.ijgo.2005.09.006; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; GERTLER P, 1993, SOC SCI MED, V37, P199, DOI 10.1016/0277-9536(93)90455-D; GLICK P, 2000, ED HLTH SERVICES MAD; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; KRISHNA A, 2010, ONE ILLNESS AWAY WHY, V17, P229; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Powell-Jackson T, 2012, HEALTH ECON, V21, P796, DOI 10.1002/hec.1749; Ridde V, 2012, TROP MED INT HEALTH, V17, P782, DOI 10.1111/j.1365-3156.2012.02991.x; Ridde V, 2010, J EPIDEMIOL COMMUN H, V64, P10, DOI 10.1136/jech.2008.086793; Ridde V, 2008, SOC SCI MED, V66, P1368, DOI 10.1016/j.socscimed.2007.10.026; Ridde V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033082; Ridde V, 2011, SANTE PUBLIQUE, V23, P61, DOI 10.3917/spub.111.0061; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; RUGER JP, 1998, INT PUBLIC HLTH DIS; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Russell S, 2006, SOC SCI MED, V63, P1732, DOI 10.1016/j.socscimed.2006.04.017; *SANT MIN BURK FAS, 2006, STRAT NAT SUBV ACC S; *SANT MIN BURK FAS, 2010, ANN STAT 2009; Singh S, 2010, WOMENS HEALTH, V6, P849, DOI [10.2217/whe.10.70, 10.2217/WHE.10.70]; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Uzma A, 1999, SOC SCI MED, V48, P313, DOI 10.1016/S0277-9536(98)00319-0; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wagner KS, 2012, TROP MED INT HEALTH, V17, P9, DOI 10.1111/j.1365-3156.2011.02883.x; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; World Health Organization, 2004, WHO QUAL LIF WHOQOL; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Zere E, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-16	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80010	10.1371/journal.pone.0080010	http://dx.doi.org/10.1371/journal.pone.0080010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224028	Green Published, gold			2022-12-25	WOS:000326597400101
J	Sanchez-Gutierrez, D; Saez, A; Pascual, A; Escudero, LM				Sanchez-Gutierrez, Daniel; Saez, Aurora; Pascual, Alberto; Escudero, Luis M.			Topological Progression in Proliferating Epithelia Is Driven by a Unique Variation in Polygon Distribution	PLOS ONE			English	Article							CELL-SHAPE CHANGES; DROSOPHILA GASTRULATION; MORPHOGENESIS; POLARITY; CENTRALITY; NETWORKS; SHROOM; SIZE	Morphogenesis is consequence of lots of small coordinated variations that occur during development. In proliferating stages, tissue growth is coupled to changes in shape and organization. A number of studies have analyzed the topological properties of proliferating epithelia using the Drosophila wing disc as a model. These works are based in the existence of a fixed distribution of these epithelial cells according to their number of sides. Cell division, cell rearrangements or a combination of both mechanisms have been proposed to be responsible for this polygonal assembling. Here, we have used different system biology methods to compare images from two close proliferative stages that present high morphological similarity. This approach enables us to search for traces of epithelial organization. First, we show that geometrical and network characteristics of individual cells are mainly dependent on their number of sides. Second, we find a significant divergence between the distribution of polygons in epithelia from mid-third instar larva versus early prepupa. We show that this alteration propagates into changes in epithelial organization. Remarkably, only the variation in polygon distribution driven by morphogenesis leads to progression in epithelial organization. In addition, we identify the relevant features that characterize these rearrangements. Our results reveal signs of epithelial homogenization during the growing phase, before the planar cell polarity pathway leads to the hexagonal packing of the epithelium during pupal stages.	[Sanchez-Gutierrez, Daniel; Pascual, Alberto; Escudero, Luis M.] Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain; [Saez, Aurora] Univ Seville, Escuela Tecn Super Ingn, Seville, Spain; [Pascual, Alberto; Escudero, Luis M.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Sevilla; CIBERNED	Escudero, LM (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain.	lmescudero-ibis@us.es	Pascual, Alberto P/E-9609-2015; Pascual, Alberto/L-2014-2019; IBIS, NEURONAL/O-9910-2015; Saez, Aurora/L-1060-2017	Pascual, Alberto P/0000-0001-5459-6207; Pascual, Alberto/0000-0001-5459-6207; Saez, Aurora/0000-0003-2555-7123; Escudero, Luis M./0000-0001-8030-1820	Miguel Servet (Instituto Carlos III) program; Spanish Ministry of Science [BFU2011-25734]; Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia	Miguel Servet (Instituto Carlos III) program; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia)	LME is supported by the Miguel Servet (Instituto Carlos III) program that also funded the work. LME and DSG are funded by the Spanish Ministry of Science (BFU2011-25734). AS is funded by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Axelrod JD, 2006, CELL, V126, P643, DOI 10.1016/j.cell.2006.07.018; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2009, IMAGE PROCESS SER, P1; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Eaton S, 2011, CURR OPIN GENET DEV, V21, P747, DOI 10.1016/j.gde.2011.08.010; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Escudero LM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1536; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fukunaga K, 1990, INTRO STAT PATTERN R; Gho M, 1999, DEVELOPMENT, V126, P3573; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martinez-Arias M, 2002, MOL PRINCIPLES ANIMA; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Saez A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-77; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011	34	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79227	10.1371/journal.pone.0079227	http://dx.doi.org/10.1371/journal.pone.0079227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223910	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400053
J	Sun, CZ; Li, QL; Hu, ZD; He, JH; Li, C; Li, GJ; Tao, XF; Yang, AK				Sun, Chuanzheng; Li, Qiuli; Hu, Zedong; He, Jiehua; Li, Chao; Li, Guojun; Tao, Xiaofeng; Yang, Ankui			Treatment and Prognosis of Anaplastic Thyroid Carcinoma: Experience from a Single Institution in China	PLOS ONE			English	Article							TREATMENT OUTCOMES; SURVIVAL; CANCER; RADIOTHERAPY; SURGERY; NEUTROPHILIA; DOXORUBICIN; MANAGEMENT	Background: Anaplastic thyroid carcinoma (ATC), a highly aggressive malignancy, has a poor prognosis, and the consensus on the most effective treatment is needed. Methods: Clinical data from all ATC patients treated in our institution over a 30-year period (between May 1980 and May 2010) were analyzed retrospectively with regard to mortality and survival rates (Kaplan-Meier). Multivariate analysis was performed using a Cox proportional hazards model. Results: Sixty cases were analyzed. The overall 1- and 3-year survival rates were 35.0% and 22.9%, respectively. Univariate analysis showed that the best prognosis was seen in patients younger than 55 years, those without distant metastases, those with white blood cell (WBC) counts < 10.0 x 10(9)/L or blood platelet (PLT) counts < 300.0 x 10(9)/L at presentation, those who did not receive chemotherapy, and those who received radiotherapy doses >= 40 Gy or underwent surgery plus postoperative radiotherapy. According to multivariate analysis, the WBC count at first presentation and the type of therapeutic regimen independently influenced survival. Conclusions: We found that the elevated peripheral PLT count may be an adverse prognostic factor of ATC patients. The prognosis for ATC is especially poor for patients with distant metastasis, a WBC count >= 10.0x10(9)/L, a PLT count >= 300.0 x 10(9)/L, or age >= 55 years. WBC count at presentation and surgery with or without postoperative radiotherapy independently influenced the prognosis. Intensive treatment combining surgery with postoperative radiotherapy is recommended for ATC patients with stage IVA/B disease.	[Sun, Chuanzheng; Hu, Zedong] Kunming Med Univ, Affiliated Hosp 3, Dept Head & Neck Surg, Kunming, Yunnan, Peoples R China; [Li, Qiuli; Yang, Ankui] Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Qiuli; He, Jiehua; Yang, Ankui] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [He, Jiehua] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Chao] Tumor Hosp Sichuan Prov, Dept Head & Neck Surg, Chengdu, Sichuan, Peoples R China; [Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Tao, Xiaofeng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Kunming Medical University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Tao, XF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China.	cjr.taoxiaofeng.@vip.163.com; Yangak@sysucc.org.cn			National Natural Science Foundation of China [30960444, 81260402, 81272955]; Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province [D-201243]; Natural Science Foundation of Guangdong Province, China [9451008901002400, S2011010003997]; Science and Technology Planning Project of Guangdong Province, China [2012B031800089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (Numbers: 30960444, 81260402 and 81272955), Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province (No. D-201243), Natural Science Foundation of Guangdong Province, China (Numbers: 9451008901002400 and S2011010003997), and Science and Technology Planning Project of Guangdong Province, China (Number: 2012B031800089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi J, 2011, THYROID, V21, P1183, DOI 10.1089/thy.2010.0332; Besic N, 2005, LANGENBECK ARCH SURG, V390, P203, DOI 10.1007/s00423-004-0524-5; Chen J, 2008, AM J CLIN ONCOL-CANC, V31, P460, DOI 10.1097/COC.0b013e31816a61f3; Derbel O, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-469; Edge SB, 2010, AJCC CANC STAGING MA; ENOMOTO T, 1990, CANCER, V65, P1971, DOI 10.1002/1097-0142(19900501)65:9<1971::AID-CNCR2820650916>3.0.CO;2-V; Foote RL, 2011, THYROID, V21, P25, DOI 10.1089/thy.2010.0220; Goutsouliak V, 2005, CLIN ONCOL-UK, V17, P75, DOI 10.1016/j.clon.2004.07.013; Haigh PI, 2001, CANCER-AM CANCER SOC, V91, P2335, DOI 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.3.CO;2-T; HOLTING T, 1989, LANGENBECK ARCH CHIR, V374, P72, DOI 10.1007/BF01261613; HOLTING T, 1990, WIEN KLIN WOCHENSCHR, V102, P264; Ito K, 2012, HEAD NECK-J SCI SPEC, V34, P230, DOI 10.1002/hed.21721; Ito Y, 2009, ASIAN J SURG, V32, P47, DOI 10.1016/S1015-9584(09)60008-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kihara M, 2004, SURG TODAY, V34, P394, DOI 10.1007/s00595-003-2737-6; Lim SM, 2012, YONSEI MED J, V53, P352, DOI 10.3349/ymj.2012.53.2.352; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; Nakada T, 1996, INTERNAL MED, V35, P815, DOI 10.2169/internalmedicine.35.815; Noppen M, 2004, CHEST, V125, P723, DOI 10.1378/chest.125.2.723; Pasieka JL, 2003, CURR OPIN ONCOL, V15, P78, DOI 10.1097/00001622-200301000-00012; Perri F, 2011, WORLD J CLIN ONCOL, V2, P150, DOI 10.5306/wjco.v2.i3.150; Pierie JPEN, 2002, ANN SURG ONCOL, V9, P57, DOI 10.1245/aso.2002.9.1.57; Sato T, 2000, THYROID, V10, P1113, DOI 10.1089/thy.2000.10.1113; Segerhammar I, 2012, J SURG ONCOL, V106, P981, DOI 10.1002/jso.23177; Shaha AR, 2008, LARYNGOSCOPE, V118, P1195, DOI 10.1097/MLG.0b013e3181726d36; Sherman EJ, 2011, RADIOTHER ONCOL, V101, P425, DOI 10.1016/j.radonc.2011.09.004; SHIMAOKA K, 1985, CANCER, V56, P2155, DOI 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E; Siironen P, 2010, ONCOLOGY-BASEL, V79, P400, DOI 10.1159/000322640; Sugino K, 2002, SURGERY, V131, P245, DOI 10.1067/msy.2002.119936; Sugitani I, 2001, WORLD J SURG, V25, P617, DOI 10.1007/s002680020166; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Swaak-Kragten AT, 2009, RADIOTHER ONCOL, V92, P100, DOI 10.1016/j.radonc.2009.02.016; Tashima L, 2012, EUR ARCH OTO-RHINO-L, V269, P1251, DOI 10.1007/s00405-011-1762-0; Wein RO, 2011, CURR OPIN OTOLARYNGO, V19, P113, DOI 10.1097/MOO.0b013e328343af3d; Yau T, 2008, ANN SURG ONCOL, V15, P2500, DOI 10.1245/s10434-008-0005-0	36	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80011	10.1371/journal.pone.0080011	http://dx.doi.org/10.1371/journal.pone.0080011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224029	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400102
J	Bruggmann, R; Jagannathan, V; Braunschweig, M				Bruggmann, Remy; Jagannathan, Vidhya; Braunschweig, Martin			In Search of Epigenetic Marks in Testes and Sperm Cells of Differentially Fed Boars	PLOS ONE			English	Article							GENE-EXPRESSION; INHERITANCE; MOUSE; METHYLATION; MAMMALS; ALLELE	In search of transmittable epigenetic marks we investigated gene expression in testes and sperm cells of differentially fed F0 boars from a three generation pig feeding experiment that showed phenotypic differences in the F2 generation. RNA samples from 8 testes of boars that received either a diet enriched in methylating micronutrients or a control diet were analyzed by microarray analysis. We found moderate differential expression between testes of differentially fed boars with a high FDR of 0.82 indicating that most of the differentially expressed genes were false positives. Nevertheless, we performed a pathway analysis and found disparate pathway maps of development_A2B receptor: action via G-protein alpha s, cell adhesion_Tight junctions and cell adhesion_Endothelial cell contacts by junctional mechanisms which show inconclusive relation to epigenetic inheritance. Four RNA samples from sperm cells of these differentially fed boars were analyzed by RNA-Seq methodology. We found no differential gene expression in sperm cells of the two groups (adjusted P-value > 0.05). Nevertheless, we also explored gene expression in sperm by a pathway analysis showing that genes were enriched for the pathway maps of bacterial infections in cystic fibrosis (CF) airways, glycolysis and gluconeogenesis p. 3 and cell cycle_Initiation of mitosis. Again, these pathway maps are miscellaneous without an obvious relationship to epigenetic inheritance. It is concluded that the methylating micronutrients moderately if at all affects RNA expression in testes of differentially fed boars. Furthermore, gene expression in sperm cells is not significantly affected by extensive supplementation of methylating micronutrients and thus RNA molecules could not be established as the epigenetic mark in this feeding experiment.	[Bruggmann, Remy] Univ Bern, Dept Biol, Bern, Switzerland; [Jagannathan, Vidhya; Braunschweig, Martin] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland	University of Bern; University of Bern	Braunschweig, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	martin.braunschweig@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041; Bruggmann, Remy/0000-0001-5629-6363				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Gutzwiller A, 2009, VET REC, V165, P598, DOI 10.1136/vr.165.20.598; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009	19	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78691	10.1371/journal.pone.0078691	http://dx.doi.org/10.1371/journal.pone.0078691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223838	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400081
J	Del Barrio, MG; Bourane, S; Grossmann, K; Schule, R; Britsch, S; O'Leary, DDM; Goulding, M				Del Barrio, Marta Garcia; Bourane, Steeve; Grossmann, Katja; Schuele, Roland; Britsch, Stefan; O'Leary, Dennis D. M.; Goulding, Martyn			A Transcription Factor Code Defines Nine Sensory Interneuron Subtypes in the Mechanosensory Area of the Spinal Cord	PLOS ONE			English	Article							DORSAL-HORN NEURONS; VESICULAR GLUTAMATE TRANSPORTERS; LAMINAE III-V; HOMEOBOX GENES; C-MAF; EXPRESSION; LBX1; DIFFERENTIATION; TRANSMITTER; POPULATIONS	Interneurons in the dorsal spinal cord process and relay innocuous and nociceptive somatosensory information from cutaneous receptors that sense touch, temperature and pain. These neurons display a well-defined organization with respect to their afferent innervation. Nociceptive afferents innervate lamina I and II, while cutaneous mechanosensory afferents primarily innervate sensory interneurons that are located in lamina III-IV. In this study, we outline a combinatorial transcription factor code that defines nine different inhibitory and excitatory interneuron populations in laminae III-IV of the postnatal cord. This transcription factor code reveals a high degree of molecular diversity in the neurons that make up laminae III-IV, and it lays the foundation for systematically analyzing and manipulating these different neuronal populations to assess their function. In addition, we find that many of the transcription factors that are expressed in the dorsal spinal cord at early postnatal times continue to be expressed in the adult, raising questions about their function in mature neurons and opening the door to their genetic manipulation in adult animals.	[Del Barrio, Marta Garcia; Bourane, Steeve; Grossmann, Katja; O'Leary, Dennis D. M.; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Schuele, Roland] Univ Freiburg Klinikum, Frauenklin, Urol Klin, Freiburg, Germany; [Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, Freiburg, Germany; [Britsch, Stefan] Max Delbruck Ctr Mol Med, Dept Med Genet, Berlin, Germany; [Britsch, Stefan] Univ Ulm, Inst Mol & Cellular Anat, D-89069 Ulm, Germany	Salk Institute; University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ulm University	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	goulding@salk.edu	Bourane, Steeve/AAI-6143-2020	Bourane, Steeve/0000-0002-9805-2196	NIH [NS031978, NS080586, NS31558, R01 MH086147]; Hoffman Foundation; Spanish Instituto de Salud Carlos III [Salk-08-02]; Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt) [Schu688/12-1, Schu 688/9-1, SFB 850]; Dr. Oetker-Stiftung by DFG [SFB 497-A9]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080586, R01NS031978, R01NS031558, R37NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hoffman Foundation; Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt)(German Research Foundation (DFG)); Dr. Oetker-Stiftung by DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS031978 and NS080586 to MG, by the Hoffman Foundation and the Spanish Instituto de Salud Carlos III (Salk-08-02), by the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt Schu688/12-1, Schu 688/9-1, SFB 850) and by the Dr. Oetker-Stiftung to RS by a grant from the DFG (SFB 497-A9) to SB and by NIH NS31558 and R01 MH086147 grants to DDMO'L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; Altman J, 2001, DEV HUMAN SPINAL COR; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Brown AG, 1981, ORG SPINAL CORD; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; Han SI, 2011, J BIOL CHEM, V286, P10449, DOI 10.1074/jbc.M110.209510; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hochman S, 1997, BRAIN RES, V767, P214, DOI 10.1016/S0006-8993(97)00578-7; Hu J, 2012, J NEUROSCI, V32, P5362, DOI 10.1523/JNEUROSCI.6239-11.2012; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; JIANG MC, 1995, J NEUROPHYSIOL, V74, P1819, DOI 10.1152/jn.1995.74.5.1819; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Li Y, 2012, FRONT BIOSCI-LANDMRK, V17, P2391, DOI 10.2741/4060; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Ramon y Cajal S., 1909, HISTOLOGY NERVOUS SY; Rhinn M, 2004, DEV DYNAM, V229, P334, DOI 10.1002/dvdy.10435; Sakai M, 1997, ONCOGENE, V14, P745, DOI 10.1038/sj.onc.1200869; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P1746, DOI 10.1152/jn.1992.68.5.1746; Schneider SP, 2005, BRAIN RES, V1034, P71, DOI 10.1016/j.brainres.2004.11.046; Schneider SP, 2003, J NEUROPHYSIOL, V90, P245, DOI 10.1152/jn.01012.2002; Schouenborg J, 2008, BRAIN RES REV, V57, P111, DOI 10.1016/j.brainresrev.2007.08.007; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Waters ST, 2003, GENE EXPR PATTERNS, V3, P313, DOI 10.1016/S1567-133X(03)00041-3; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Xiang CX, 2010, MOL CELL NEUROSCI, V44, P394, DOI 10.1016/j.mcn.2010.05.005; Xu Y, 2008, J NEUROSCI, V28, P4037, DOI 10.1523/JNEUROSCI.4126-07.2008; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	66	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77928	10.1371/journal.pone.0077928	http://dx.doi.org/10.1371/journal.pone.0077928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223744	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326503400023
J	Ghulam, MM; Courtois, F; Lerbs-Mache, S; Merendino, L				Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia			Complex Processing Patterns of mRNAs of the Large ATP Synthase Operon in Arabidopsis Chloroplasts	PLOS ONE			English	Article							BINDING; TERMINI; NUCLEUS; GENES	Chloroplasts are photosynthetic cell organelles which have evolved from endosymbiosis of the cyanobacterial ancestor. In chloroplasts, genes are still organized into transcriptional units as in bacteria but the corresponding poly-cistronic mRNAs undergo complex processing events, including inter- genic cleavage and 5' and 3' end-definition. The current model for processing proposes that the 3' end of the upstream cistron transcripts and the 5' end of the downstream cistron transcripts are defined by the same RNA-binding protein and overlap at the level of the protein-binding site. We have investigated the processing mechanisms that operate within the large ATP synthase (atp) operon, in Arabidopsis thaliana chloroplasts. This operon is transcribed by the plastid-encoded RNA polymerase starting from two promoters, which are upstream and within the operon, respectively, and harbors four potential sites for RNA-binding proteins. In order to study the functional significance of the promoters and the protein-binding sites for the maturation processes, we have performed a detailed mapping of the atp transcript ends. Our data indicate that in contrast to maize, atpI and atpH transcripts with overlapping ends are very rare in Arabidopsis. In addition, atpA mRNAs, which overlap with atpF mRNAs, are even truncated at the 3' end, thus representing degradation products. We observe, instead, that the 5' ends of nascent poly-cistronic atp transcripts are defined at the first protein-binding site which follows either one of the two transcription initiation sites, while the 3' ends are defined at the subsequent protein-binding sites or at hairpin structures that are encountered by the progressing RNA polymerase. We conclude that the overlapping mechanisms of mRNA protection have only a limited role in obtaining stable processed atp mRNAs in Arabidopsis. Our findings suggest that during evolution of different plant species as maize and Arabidopsis, chloroplasts have evolved multiple strategies to produce mature transcripts suitable for translation.	[Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] CEA, DSV, iRTSV, Lab Physiol Cellulaire & Vegetale, Grenoble, France; [Ghulam, Mustafa Malik; Courtois, Florence; Lerbs-Mache, Silva; Merendino, Livia] INRA, Lab Physiol Cellulaire & Vegetale, USC1359, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Merendino, L (corresponding author), CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, Grenoble, France.	livia.merendino@cea.fr		Courtois, Florence/0000-0003-0357-9401	Centre National de la Recherche Scientifique; French Ministry of Education	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Education	The Centre National de la Recherche Scientifique and the French Ministry of Education have funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Demarsy E, 2012, J EXP BOT, V63, P925, DOI 10.1093/jxb/err322; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Ghulam MM, 2012, PLANT MOL BIOL, V79, P259, DOI 10.1007/s11103-012-9910-5; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Perrin R, 2004, J BIOL CHEM, V279, P25440, DOI 10.1074/jbc.M401182200; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; Zghidi W, 2007, NUCLEIC ACIDS RES, V35, P455, DOI 10.1093/nar/gkl1067; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	13	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78265	10.1371/journal.pone.0078265	http://dx.doi.org/10.1371/journal.pone.0078265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223785	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400047
J	Heinis, FI; Andersson, KB; Christensen, G; Metzger, JM				Heinis, Frazer I.; Andersson, Kristin B.; Christensen, Geir; Metzger, Joseph M.			Prominent Heart Organ-Level Performance Deficits in a Genetic Model of Targeted Severe and Progressive SERCA2 Deficiency	PLOS ONE			English	Article							DIASTOLIC DYSFUNCTION; CARDIAC-PERFORMANCE; FAILURE; MICE; DISRUPTION; EXPRESSION; KNOCKOUT; ATPASE	The cardiac SERCA2 Ca2+ pump is critical for maintaining normal Ca2+ handling in the heart. Reduced SERCA2a content and blunted Ca2+ reuptake are frequently observed in failing hearts and evidence implicates poor cardiac Ca2+ handling in the progression of heart failure. To gain insight into mechanism we investigated a novel genetic mouse model of inducible severe and progressive SERCA2 deficiency (inducible Serca2 knockout, SERCA2 KO). These mice eventually die from overt heart failure 7-10 weeks after knockout but as yet there have been no reports on intrinsic mechanical performance at the isolated whole heart organ level. Thus we studied whole-organ ex vivo function of hearts isolated from SERCA2 KO mice at one and four weeks post-knockout in adult animals. We found that isolated KO heart function was only modestly impaired one week post-knockout, when SERCA2a protein was 32% of normal. At four weeks post-knockout, function was severely impaired with near non-detectable levels of SERCA2. During perfusion with 10 mM caffeine, LV developed pressures were similar between 4-week KO and control hearts, and end-diastolic pressures were lower in KO. When hearts were subjected to ischemia-reperfusion injury, recovery was not different between control and KO hearts at either one or four weeks post-knockout. Our findings indicate that ex vivo function of isolated SERCA2 KO hearts is severely impaired long before symptoms appear in vivo, suggesting that physiologically relevant heart function in vivo can be sustained for weeks in the absence of robust SR Ca2+ flux.	[Heinis, Frazer I.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Heinis, Frazer I.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Ullevaal Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Oslo, Norway; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; University of Oslo; University of Oslo	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu			National Institutes of Health (NIH) [5R01HL059301-14]; NIA [5T32AG029796-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) 5R01HL059301-14 to JMM. FIH was supported by NIA training grant 5T32AG029796-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2009, CELL CALCIUM, V46, P219, DOI 10.1016/j.ceca.2009.07.004; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Elliott EB, 2012, CIRC RES, V110, P1618, DOI 10.1161/CIRCRESAHA.111.262337; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; Hiranandani N, 2007, AM J PHYSIOL-REG I, V293, pR30, DOI 10.1152/ajpregu.00508.2006; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; LOMPRE AM, 1991, CIRC RES, V69, P1380, DOI 10.1161/01.RES.69.5.1380; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Louch WE, 2010, J PHYSIOL-LONDON, V588, P465, DOI 10.1113/jphysiol.2009.183517; Mayosi BM, 2006, HEART, V92, P105, DOI 10.1136/hrt.2004.051037; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Pogwizd SM, 1999, CIRC RES, V85, P1009; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stokke MK, 2010, CARDIOVASC RES, V86, P63, DOI 10.1093/cvr/cvp401; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324	20	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79609	10.1371/journal.pone.0079609	http://dx.doi.org/10.1371/journal.pone.0079609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223976	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400127
J	Llorente-Berzal, A; Puighermanal, E; Burokas, A; Ozaita, A; Maldonado, R; Marco, EM; Viveros, MP				Llorente-Berzal, Alvaro; Puighermanal, Emma; Burokas, Aurelijus; Ozaita, Andres; Maldonado, Rafael; Marco, Eva M.; Viveros, Maria-Paz			Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption	PLOS ONE			English	Article							LONG-LASTING CONSEQUENCES; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; MATERNAL-DEPRIVATION; CHRONIC DELTA(9)-TETRAHYDROCANNABINOL; DIFFERENTIALLY AFFECTS; UNPREDICTABLE STRESS; INDUCED HYPERTHERMIA; PREPULSE INHIBITION; SYNAPTIC PLASTICITY; RECOGNITION MEMORY	Ecstasy is a drug that is usually consumed by young people at the weekends and frequently, in combination with cannabis. In the present study we have investigated the long-term effects of administering increasing doses of delta-9-tetrahydrocannabinol [THC; 2.5, 5, 10 mg/kg; i.p.] from postnatal day (pnd) 28 to 45, alone and/or in conjunction with 3,4-methylenedioxymethamphetamine [MDMA; two daily doses of 10 mg/kg every 5 days; s.c.] from pnd 30 to 45, in both male and female Wistar rats. When tested one day after the end of the pharmacological treatment (pnd 46), MDMA administration induced a reduction in directed exploration in the holeboard test and an increase in open-arm exploration in an elevated plus maze. In the long-term, cognitive functions in the novel object test were seen to be disrupted by THC administration to female but not male rats. In the prepulse inhibition test, MDMA-treated animals showed a decrease in prepulse inhibition at the most intense prepulse studied (80 dB), whereas in combination with THC it induced a similar decrease at 75 dB. THC decreased hippocampal Arc expression in both sexes, while in the frontal cortex this reduction was only evident in females. MDMA induced a reduction in ERK1/2 immunoreactivity in the frontal cortex of male but not female animals, and THC decreased prepro-orexin mRNA levels in the hypothalamus of males, although this effect was prevented when the animals also received MDMA. The results presented indicate that adolescent exposure to THC and/or MDMA induces long-term, sex-dependent psychophysiological alterations and they reveal functional interactions between the two drugs.	[Llorente-Berzal, Alvaro; Marco, Eva M.; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain; [Llorente-Berzal, Alvaro; Marco, Eva M.; Viveros, Maria-Paz] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Puighermanal, Emma; Burokas, Aurelijus; Ozaita, Andres; Maldonado, Rafael] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Pompeu Fabra University	Maldonado, R (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain.	rafael.maldonado@upf.edu; pazviver@bio.ucm.es	Llorente-Berzal, Alvaro/C-8232-2018; Burokas, Aurelijus/ABC-9268-2021; Marco, Eva M./Q-3870-2019; Marco, Eva M./ABH-3257-2020; Llorente-Berzal, Alvaro/GLQ-8115-2022; Maldonado, Rafael/F-5657-2014; Viveros, Maria-Paz/S-6855-2016; Puighermanal, Emma/J-4426-2019; Ozaita, Andres/H-3411-2015	Llorente-Berzal, Alvaro/0000-0002-9787-2619; Burokas, Aurelijus/0000-0002-0364-3496; Marco, Eva M./0000-0002-2457-475X; Llorente-Berzal, Alvaro/0000-0002-9787-2619; Maldonado, Rafael/0000-0002-4359-8773; Viveros, Maria-Paz/0000-0002-4119-4636; Puighermanal, Emma/0000-0003-4271-9104; Ozaita, Andres/0000-0002-2239-7403	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos [RD06/0001/1013, RD2012/0028/0021, RD06/001/001]; GRUPOS UCM-BSCH [GRUPO UCM 951579]; Plan Nacional sobre Drogas en la convocatoria de Orden [SAS/1250/2009]; Ministerio de Ciencia e Innovacion	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos; GRUPOS UCM-BSCH; Plan Nacional sobre Drogas en la convocatoria de Orden; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Instituto de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en salud (ISCIII y FEDER): Red de trastornos adictivos RD06/0001/1013, RD2012/0028/0021 and RD06/001/001; GRUPOS UCM-BSCH (GRUPO UCM 951579); Plan Nacional sobre Drogas en la convocatoria de Orden SAS/1250/2009. ALB has a FPU predoctoral grant from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat-Mendes C, 2003, NEUROPHARMACOLOGY, V45, P106, DOI 10.1016/S0028-3908(03)00135-7; Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; Allott K, 2007, NEUROSCI BIOBEHAV R, V31, P327, DOI 10.1016/j.neubiorev.2006.09.009; Anderson BM, 2010, J PSYCHOACTIVE DRUGS, V42, P413; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Beveridge TJR, 2004, PSYCHOPHARMACOLOGY, V173, P346, DOI 10.1007/s00213-003-1753-y; Biscaia M, 2003, PSYCHOPHARMACOLOGY, V170, P301, DOI 10.1007/s00213-003-1550-7; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bubenikova V, 2005, BEHAV PHARMACOL, V16, P127, DOI 10.1097/00008877-200503000-00009; Cai XJ, 1999, DIABETES, V48, P2132, DOI 10.2337/diabetes.48.11.2132; Carroll ME, 2004, TRENDS PHARMACOL SCI, V25, P273, DOI 10.1016/j.tips.2004.03.011; Cha YM, 2007, BEHAV PHARMACOL, V18, P563, DOI 10.1097/FBP.0b013e3282ee7b7e; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Cunningham JI, 2009, BEHAV NEUROSCI, V123, P1076, DOI 10.1037/a0016716; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; Di Benedetto M, 2011, N-S ARCH PHARMACOL, V383, P169, DOI 10.1007/s00210-010-0587-5; Dumont GJ, 2009, CLIN PHARMACOL THER, V86, P160, DOI 10.1038/clpt.2009.62; Einat H, 2003, J NEUROSCI, V23, P7311; EMCDDA, 2011, ANN REP 2011 STAT DR; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Gerra G, 2003, PSYCHIAT RES, V120, P115, DOI 10.1016/S0165-1781(03)00175-6; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gouzoulis-Mayfrank Euphrosyne, 2009, Dialogues Clin Neurosci, V11, P305; Graham DL, 2010, NEUROTOXICOL TERATOL, V32, P152, DOI 10.1016/j.ntt.2009.08.012; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hill MN, 2012, NEUROSCIENCE, V204, P5, DOI 10.1016/j.neuroscience.2011.12.030; Kobeissy FH, 2008, ADDICT BIOL, V13, P15, DOI 10.1111/j.1369-1600.2007.00083.x; Kolyaduke OV, 2012, PHARM BIOCH BEHAV, V103, P742; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lieb R, 2002, DRUG ALCOHOL DEPEN, V68, P195, DOI 10.1016/S0376-8716(02)00190-4; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Llorente R, 2007, PSYCHONEUROENDOCRINO, V32, P636, DOI 10.1016/j.psyneuen.2007.04.002; Llorente-Berzal A, 2011, ADDICT BIOL, V16, P624, DOI 10.1111/j.1369-1600.2011.00318.x; Lopez-Gallardo M, 2012, NEUROSCIENCE, V204, P90, DOI 10.1016/j.neuroscience.2011.09.063; Ludwig V, 2008, BEHAV BRAIN RES, V189, P52, DOI 10.1016/j.bbr.2007.12.008; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Malberg JE, 1998, J NEUROSCI, V18, P5086; Malone DT, 2010, BRIT J PHARMACOL, V160, P511, DOI 10.1111/j.1476-5381.2010.00721.x; Mateos B, 2011, J PSYCHOPHARMACOL, V25, P1676, DOI 10.1177/0269881110370503; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Montgomery C, 2005, PSYCHOPHARMACOLOGY, V180, P141, DOI 10.1007/s00213-004-2131-0; Montoya AG, 2002, HARVARD REV PSYCHIAT, V10, P212, DOI 10.1093/hrp/10.4.212; Morgan MJ, 2000, PSYCHOPHARMACOLOGY, V152, P230, DOI 10.1007/s002130000545; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; NASH JF, 1988, J PHARMACOL EXP THER, V245, P873; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Palenicek T, 2005, PHYSIOL BEHAV, V86, P546, DOI 10.1016/j.physbeh.2005.08.043; Parrott AC, 2007, J NEURAL TRANSM, V114, P959, DOI 10.1007/s00702-007-0715-7; Parrott AC, 2004, NEUROPSYCHOBIOLOGY, V50, P329, DOI 10.1159/000080961; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Piper BJ, 2007, NEUROTOXICOL TERATOL, V29, P288, DOI 10.1016/j.ntt.2006.10.002; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Quednow BB, 2007, PSYCHOPHARMACOLOGY, V189, P517, DOI 10.1007/s00213-005-0256-4; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Rao Y, 2013, J PHYSIOL-LONDON, V591, P1951, DOI 10.1113/jphysiol.2012.246983; Robledo P, 2007, PSYCHOPHARMACOLOGY, V195, P255, DOI 10.1007/s00213-007-0879-8; Robledo P, 2010, CURR DRUG TARGETS, V11, P429, DOI 10.2174/138945010790980330; Rodsiri R, 2011, PSYCHOPHARMACOLOGY, V213, P365, DOI 10.1007/s00213-010-1921-9; Rubino T, 2008, MOL CELL ENDOCRINOL, V286, pS108, DOI 10.1016/j.mce.2008.02.003; Rubino T, 2004, MOL CELL NEUROSCI, V25, P355, DOI 10.1016/j.mcn.2003.11.003; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Schneider M, 2008, ADDICT BIOL, V13, P345, DOI 10.1111/j.1369-1600.2008.00117.x; Schulz Sybille, 2011, Curr Drug Abuse Rev, V4, P81; Senn Ch, 2007, Ther Umsch, V64, P109, DOI 10.1024/0040-5930.64.2.109; Shen EY, 2011, NEUROPHARMACOLOGY, V61, P1183, DOI 10.1016/j.neuropharm.2011.07.002; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Shortall SE, 2012, EUR NEUROPS IN PRESS; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Skelton MR, 2008, BEHAV PHARMACOL, V19, P91, DOI 10.1097/FBP.0b013e3282f62c76; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Taffe MA, 2012, NEUROSCIENCE, V201, P125, DOI 10.1016/j.neuroscience.2011.11.040; Viveros MP, 2012, J PSYCHOPHARMACOL, V26, P164, DOI 10.1177/0269881111408956; Viveros M P, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS217, DOI 10.1016/j.psyneuen.2009.05.015; Viveros MP, 2006, NEUROSCI BIOBEHAV R, V30, P1161, DOI 10.1016/j.neubiorev.2006.08.002; Viveros MP, 2011, NEUROSCI BIOBEHAV R, V35, P1740, DOI 10.1016/j.neubiorev.2010.09.005; Vollenweider FX, 1999, PSYCHOPHARMACOLOGY, V143, P365, DOI 10.1007/s002130050960; Walker QD, 2007, PSYCHOPHARMACOLOGY, V189, P435, DOI 10.1007/s00213-006-0531-z; Wegener N, 2009, BRAIN RES, V1253, P81, DOI 10.1016/j.brainres.2008.11.081; Wish ED, 2006, J AM COLL HEALTH, V55, P99, DOI 10.3200/JACH.55.2.99-104; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Young JM, 2005, NEUROPSYCHOPHARMACOL, V30, P1475, DOI 10.1038/sj.npp.1300692	87	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78386	10.1371/journal.pone.0078386	http://dx.doi.org/10.1371/journal.pone.0078386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223797	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400057
J	Nicoli, F; Finessi, V; Sicurella, M; Rizzotto, L; Gallerani, E; Destro, F; Cafaro, A; Marconi, P; Caputo, A; Ensoli, B; Gavioli, R				Nicoli, Francesco; Finessi, Valentina; Sicurella, Mariaconcetta; Rizzotto, Lara; Gallerani, Eleonora; Destro, Federica; Cafaro, Aurelio; Marconi, Peggy; Caputo, Antonella; Ensoli, Barbara; Gavioli, Riccardo			The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPSTEIN-BARR-VIRUS; NF-KAPPA-B; DENDRITIC CELLS; TRANSACTIVATOR GENE; IMMUNE-RESPONSES; MEMORY; EXPRESSION; RECOMBINANT; APOPTOSIS	T cells are functionally compromised during HIV infection despite their increased activation and proliferation. Although T cell hyperactivation is one of the best predictive markers for disease progression, its causes are poorly understood. Anti-tat natural immunity as well as anti-tat antibodies induced by Tat immunization protect from progression to AIDS and reverse signs of immune activation in HIV-infected patients suggesting a role of Tat in T cell dysfunctionality. The Tat protein of HIV-1 is known to induce, in vitro, the activation of CD4(+) T lymphocytes, but its role on CD8(+) T cells and how these effects modulate, in vivo, the immune response to pathogens are not known. To characterize the role of Tat in T cell hyperactivation and dysfunction, we examined the effect of Tat on CD8(+) T cell responses and antiviral immunity in different ex vivo and in vivo models of antigenic stimulation, including HSV infection. We demonstrate for the first time that the presence of Tat during priming of CD8(+) T cells favors the activation of antigen-specific CTLs. Effector CD8(+) T cells generated in the presence of Tat undergo an enhanced and prolonged expansion that turns to a partial dysfunctionality at the peak of the response, and worsens HSV acute infection. Moreover, Tat favors the development of effector memory CD8(+) T cells and a transient loss of B cells, two hallmarks of the chronic immune activation observed in HIV-infected patients. Our data provide evidence that Tat affects CD8(+) T cell responses to co-pathogens and suggest that Tat may contribute to the CD8(+) T cell hyperactivation observed in HIV-infected individuals.	[Nicoli, Francesco; Finessi, Valentina; Sicurella, Mariaconcetta; Gallerani, Eleonora; Destro, Federica; Marconi, Peggy; Gavioli, Riccardo] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Sicurella, Mariaconcetta; Destro, Federica; Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Rizzotto, Lara] Azienda Osped Univ St Anna, Dept Biomed Sci, Ferrara, Italy; [Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy	University of Ferrara; University of Padua; University of Ferrara; Arcispedale Sant'Anna; Istituto Superiore di Sanita (ISS)	Gavioli, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy.	r.gavioli@unife.it	Destro, Federica/K-5904-2016; Cafaro, Aurelio/K-5314-2016; Ensoli, Barbara/J-9169-2016; Sicurella, Mariaconcetta/AAA-7030-2019; Caputo, Antonella/ABE-7851-2020; , Francesco/I-8040-2019; Gavioli, Riccardo/K-7594-2016; Marconi, Peggy/K-7733-2016	Destro, Federica/0000-0002-3014-0165; Ensoli, Barbara/0000-0002-0545-8737; Sicurella, Mariaconcetta/0000-0003-3996-3667; Caputo, Antonella/0000-0002-1241-0299; , Francesco/0000-0001-6327-5958; Gavioli, Riccardo/0000-0002-7805-4290; Cafaro, Aurelio/0000-0001-9675-6344; Rizzotto, Lara/0000-0002-2658-9103; Marconi, Peggy C. R./0000-0003-3488-0491	University of Ferrara; University of Padova; Italian National AIDS Program; Gilead Fellowship Program	University of Ferrara; University of Padova; Italian National AIDS Program; Gilead Fellowship Program(Gilead Sciences)	This work was supported by grants from the University of Ferrara and the University of Padova and the Italian National AIDS Program, and by the Gilead Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; [Anonymous], 2014, WORLD AIDS DAY 2014; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bullock TNJ, 2000, J IMMUNOL, V164, P2354, DOI 10.4049/jimmunol.164.5.2354; BUONAGURO L, 1994, J VIROL, V68, P2677, DOI 10.1128/JVI.68.4.2677-2682.1994; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Caputo A, 2009, INT REV IMMUNOL, V28, P285, DOI 10.1080/08830180903013026; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Cellini S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-81; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Colombrino E, 2004, EXP CELL RES, V295, P539, DOI 10.1016/j.yexcr.2004.01.018; Dabrowska A, 2008, J IMMUNOL, V181, P8460, DOI 10.4049/jimmunol.181.12.8460; Decman V, 2005, VIRAL IMMUNOL, V18, P466, DOI 10.1089/vim.2005.18.466; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Fraefel C, 2011, METHODS MOL BIOL, V737, P303, DOI 10.1007/978-1-61779-095-9_13; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; Hayes PJ, 1999, CLIN EXP IMMUNOL, V117, P331; Huang LL, 1997, BIOCHEM BIOPH RES CO, V237, P461, DOI 10.1006/bbrc.1997.7162; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Krisky DM, 1997, GENE THER, V4, P1120, DOI 10.1038/sj.gt.3300497; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; Lefevre EA, 1999, J IMMUNOL, V163, P1119; Leifert JA, 2003, GENE THER, V10, P2067, DOI 10.1038/sj.gt.3302115; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Minami R, 2006, CELL IMMUNOL, V243, P41, DOI 10.1016/j.cellimm.2006.11.003; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Secchiero P, 2000, P NATL ACAD SCI USA, V97, P14620, DOI 10.1073/pnas.011512398; Sgadari C, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/452729; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Slyker JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020375; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Sun Y, 2003, J IMMUNOL METHODS, V272, P23, DOI 10.1016/S0022-1759(02)00328-9; TOGNON M, 1985, INT OPHTHALMOL, V8, P13, DOI 10.1007/BF00136456; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Varbanov M, 2006, AIDS REV, V8, P221; Voltan R, 2009, VACCINE, V27, P4498, DOI 10.1016/j.vaccine.2009.05.031; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yang TC, 2003, J VIROL, V77, P13407, DOI 10.1128/JVI.77.24.13407-13411.2003; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; ZAULI G, 1995, BLOOD, V86, P3823, DOI 10.1182/blood.V86.10.3823.bloodjournal86103823; Zauli G, 1996, J IMMUNOL, V157, P2216	87	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77746	10.1371/journal.pone.0077746	http://dx.doi.org/10.1371/journal.pone.0077746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223723	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400015
J	Pandey, MK; Gowda, K; Doi, K; Sharma, AK; Wang, HG; Amin, S				Pandey, Manoj K.; Gowda, Krishne; Doi, Kenichiro; Sharma, Arun K.; Wang, Hong-Gang; Amin, Shantu			Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; SMALL-MOLECULE; TARGETING MCL-1; BH3-MIMETIC ABT-737; ANTISENSE THERAPY; DOWN-REGULATION; UP-REGULATION; LUNG-CANCER; RESISTANCE; PROTEINS	Background and purpose: Metastatic melanoma remains one of the most invasive and highly drug resistant cancers. The over expression of anti-apoptotic protein Mcl-1 has been associated with inferior survival, poor prognosis and chemoresistance of malignant melanoma. A BH3 mimetic, ABT-737, has demonstrated efficacy in several forms of cancers. However, the efficacy of ABT-737 depends on Mcl-1. Because the over expression of Mcl-1 is frequently observed in melanoma, specifically targeting of Mcl-1 may overcome the resistance of ABT-737. In this study, we investigated the effects of Maritoclax, a novel Mcl-1-selective inhibitor, alone and in combination with ABT-737, on the survival of human melanoma cells. Experimental approach: For cell viability assessment we performed MTT assay. Apoptosis was determined using western blot and flow cytometric analysis. Key results: The treatment of Maritoclax reduced the cell viability of melanoma cells with an IC50 of between 2.2-5.0 mu M. Further, treatment of melanoma cells with Maritoclax showed significant decrease in Mcl-1 expression. We found that Maritoclax was able to induce apoptosis in melanoma cells in a caspase-dependent manner. Moreover, Maritoclax induced Mcl-1 degradation via the proteasome system, which was associated with its pro-apoptotic activity. We also found that Maritoclax treatment increased mitochondrial translocation of Bim and Bmf. Importantly, Maritoclax markedly enhanced the efficacy of ABT-737 against melanoma cells in both two-and three-dimensional spheroids. Conclusions and implications: Taken together, these results suggest that targeting of Mcl-1 by Maritoclax may represent a new therapeutic strategy for melanoma treatment that warrants further investigation as a single therapy or in combination with other agents such as Bcl-2 inhibitors.	[Pandey, Manoj K.; Gowda, Krishne; Doi, Kenichiro; Sharma, Arun K.; Wang, Hong-Gang; Amin, Shantu] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Amin, S (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	huw11@psu.edu; sga3@psu.edu	Pandey, Manoj K/K-9706-2015; Wang, Hong-Gang/A-3018-2015	Pandey, Manoj K/0000-0002-2767-2929; Wang, Hong-Gang/0000-0003-0551-0571; Sharma, Arun/0000-0002-7679-7779; GOWDA, KRISHNE/0000-0002-6042-0520	Penn State Hershey Cancer Institute of the Penn State College of Medicine	Penn State Hershey Cancer Institute of the Penn State College of Medicine	The Penn State Hershey Cancer Institute of the Penn State College of Medicine supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan FT, 2009, BLOOD, V113, P535, DOI 10.1182/blood-2008-08-173450; Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Cory S, 2005, CANCER CELL, V8, P5, DOI 10.1016/j.ccr.2005.06.012; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Gomez-Bougie P, 2005, ONCOGENE, V24, P8076, DOI 10.1038/sj.onc.1208949; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hughes CC, 2009, J AM CHEM SOC, V131, P12094, DOI 10.1021/ja903149u; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu L, 2011, CANCER RES, V71, P3972, DOI 10.1158/0008-5472.CAN-10-3852; Liu Qiang, 2012, Commun Integr Biol, V5, P557, DOI 10.4161/cib.21554; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Ma YH, 2003, MOL CANCER THER, V2, P73; Munshi A, 2005, METH MOLEC MED, V110, P21; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sondak Vernon K, 2009, Pigment Cell Melanoma Res, V22, P386, DOI 10.1111/j.1755-148X.2009.00593.x; Thallinger C, 2003, J INVEST DERMATOL, V120, P1081, DOI 10.1046/j.1523-1747.2003.12252.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052483; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979	61	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78570	10.1371/journal.pone.0078570	http://dx.doi.org/10.1371/journal.pone.0078570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223823	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400073
J	Li, YX; Zhao, YL; Huang, X; Lin, XF; Guo, YL; Wang, DY; Li, CJ; Wang, DY				Li, Yinxia; Zhao, Yunli; Huang, Xu; Lin, Xingfeng; Guo, Yuling; Wang, Daoyong; Li, Chaojun; Wang, Dayong			Serotonin Control of Thermotaxis Memory Behavior in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; MODEL SYSTEM; TERM-MEMORY; TRANSPORTER; PLASTICITY; GENE; CHEMOTAXIS; NEURONS; PATHWAY; FOOD	Caenorhabditis elegans is as an ideal model system for the study of mechanisms underlying learning and memory. In the present study, we employed C. elegans assay system of thermotaxis memory to investigate the possible role of serotonin neurotransmitter in memory control. Our data showed that both mutations of tph-1, bas-1, and cat-4 genes, required for serotonin synthesis, and mutations of mod-5 gene, encoding a serotonin reuptake transporter, resulted in deficits in thermotaxis memory behavior. Exogenous treatment with serotonin effectively recovered the deficits in thermotaxis memory of tph-1 and bas-1 mutants to the level of wild-type N2. Neuron-specific activity assay of TPH-1 suggests that serotonin might regulate the thermotaxis memory behavior by release from the ADF sensory neurons. Ablation of ADF sensory neurons by expressing a cell-death activator gene egl-1 decreased the thermotaxis memory, whereas activation of ADF neurons by expression of a constitutively active protein kinase C homologue (pkc-1(gf)) increased the thermotaxis memory and rescued the deficits in thermotaxis memory in tph-1 mutants. Moreover, serotonin released from the ADF sensory neurons might act through the G-protein-coupled serotonin receptors of SER-4 and SER-7 to regulate the thermotaxis memory behavior. Genetic analysis implies that serotonin might further target the insulin signaling pathway to regulate the thermotaxis memory behavior. Thus, our results suggest the possible crucial role of serotonin and ADF sensory neurons in thermotaxis memory control in C. elegans.	[Li, Yinxia; Zhao, Yunli; Huang, Xu; Lin, Xingfeng; Guo, Yuling; Wang, Daoyong; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Southeast University - China; Nanjing University	Wang, DY (corresponding author), Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn		Li, Chaojun/0000-0001-9474-7321	National Natural Science Foundation of China [30870810, 30300062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30870810, 30300062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Braskie MN, 2011, HUM BRAIN MAPP, V32, P947, DOI 10.1002/hbm.21081; BRENNER S, 1974, GENETICS, V77, P71; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chase DL, 2007, BIOGENIC AMINE NEURO, DOI [10.1895/worm-book.1.132.1, DOI 10.1895/W0RM-B00K.1.132.1]; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Giles AC, 2009, NEUROBIOL LEARN MEM, V92, P139, DOI 10.1016/j.nlm.2008.08.004; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hartley CA, 2012, P NATL ACAD SCI USA, V109, P5493, DOI 10.1073/pnas.1202044109; Hu Ya-Ou, 2007, Neurosci Bull, V23, P9, DOI 10.1007/s12264-007-0002-5; Li Z, 2012, NAT COMMUN, DOI [10.1038/ncomms1780, DOI 10.1038/NC0MMS1780]; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; Loer CM, 1999, J NEUROGENET, V13, P157, DOI 10.3109/01677069909083472; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meneses A, 2012, REV NEUROSCIENCE, V23, P543, DOI 10.1515/revneuro-2012-0060; Meneses A, 2011, NEUROPHARMACOLOGY, V61, P355, DOI 10.1016/j.neuropharm.2011.01.018; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1997, BIOESSAYS, V19, P1055, DOI 10.1002/bies.950191204; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Sasakura H, 2013, CURR OPIN NEUROBIOL, V23, P92, DOI 10.1016/j.conb.2012.09.005; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Ye Hua-Yue, 2008, Neurosci Bull, V24, P49, DOI 10.1007/s12264-008-0808-9; Ye Hua-Yue, 2008, Neurosci Bull, V24, P1, DOI 10.1007/s12264-008-0920-x; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	38	7	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77779	10.1371/journal.pone.0077779	http://dx.doi.org/10.1371/journal.pone.0077779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223727	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300007
J	Nefs, G; Pop, VJM; Denollet, J; Pouwer, F				Nefs, Giesje; Pop, Victor J. M.; Denollet, Johan; Pouwer, Francois			The Longitudinal Association between Depressive Symptoms and Initiation of Insulin Therapy in People with Type 2 Diabetes in Primary Care	PLOS ONE			English	Article							CO-MORBID DEPRESSION; EUROPEAN DEPRESSION; COMORBID DEPRESSION; CLINICAL INERTIA; GLYCEMIC CONTROL; RESISTANCE; MELLITUS; ADULTS; HYPERGLYCEMIA; PREVALENCE	Objective: To examine whether depressive symptoms are associated with time to insulin initiation in insulin-naive people with type 2 diabetes in primary care. Methods: 1,389 participants completed the Edinburgh Depression Scale (EDS) in 2005 and were followed until: 1) insulin therapy was started, 2) death, 3) an oral antihyperglycemic drug (OAD) prescription gap >1 year, 4) last OAD prescription in 2010 or 5) the end of the study (December 31, 2010). Cox regression analyses were used to determine whether there was a difference in time to insulin initiation between people with a low versus a high depression score at baseline, adjusting for potential demographic and clinical confounders, including HbA(1c) levels. Results: The prevalence of depression (EDS >= 12) was 12% (n=168). After a mean follow-up of 1,597 +/- 537 days, 253 (18%) participants had started insulin therapy. The rate of insulin initiation did not differ between depressed and non-depressed participants. People with depression were not more likely to start insulin therapy earlier or later than their non-depressed counterparts (HR=0.98, 95% CI 0.66-1.45), also after adjustment for sex and age (HR=0.95, 0.64-1.42). The association remained non-significant when individual candidate confounders were added to the age-and sex-adjusted base model. Conclusions: In the present study, depression was not associated with time to insulin initiation. The hypothesis that depression is associated with delayed initiation of insulin therapy merits more thorough testing, preferably in studies where more information is available about patient-, provider-and health care system factors that may influence the decision to initiate insulin.	[Nefs, Giesje; Pop, Victor J. M.; Denollet, Johan; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, CORPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands	Tilburg University	Pouwer, F (corresponding author), Tilburg Univ, Dept Med & Clin Psychol, CORPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.	f.pouwer@tilburguniversity.edu	Nefs, Giesje/C-9992-2018	Pouwer, Frans/0000-0002-8172-9818	ZonMW grant from the Netherlands Organisation for Health Research and Development; Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands)	ZonMW grant from the Netherlands Organisation for Health Research and Development; Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands)	This study was supported by a ZonMW grant from the Netherlands Organisation for Health Research and Development, and by a Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; de Cock ESA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-141; De Grauw WJC, 2009, HUISARTS WET, V52, P586, DOI DOI 10.1007/BF03085802; Donnan PT, 2002, DIABETIC MED, V19, P606, DOI 10.1046/j.1464-5491.2002.00743.x; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Grant RW, 2007, DIABETES CARE, V30, P1448, DOI 10.2337/dc06-2499; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; HERINGS RMC, 1992, J EPIDEMIOL COMMUN H, V46, P136, DOI 10.1136/jech.46.2.136; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x; Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/0145721705285638; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nefs G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-388; Nichols GA, 2007, J GEN INTERN MED, V22, P453, DOI 10.1007/s11606-007-0139-y; Nyklicek I, 2004, PSYCHIAT RES, V128, P111, DOI 10.1016/j.psychres.2004.05.017; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Parchman ML, 2012, PRIM CARE DIABETES, V6, P19, DOI 10.1016/j.pcd.2011.06.006; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4; Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6; Ratanawongsa N, 2012, DIABETES EDUCATOR, V38, P94, DOI 10.1177/0145721711432649; Rubino A, 2007, DIABETIC MED, V24, P1412, DOI 10.1111/j.1464-5491.2007.02279.x; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Spoelstra JA, 2002, NETH J MED, V60, P243; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1995, DIABETES, V44, P1249; Twisk JWR., 2011, INLEIDING TOEGEPASTE; Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x	41	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78865	10.1371/journal.pone.0078865	http://dx.doi.org/10.1371/journal.pone.0078865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223860	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300038
J	Nemethova, A; Michel, K; Gomez-Pinilla, PJ; Boeckxstaens, GE; Schemann, M				Nemethova, Andrea; Michel, Klaus; Gomez-Pinilla, Pedro J.; Boeckxstaens, Guy E.; Schemann, Michael			Nicotine Attenuates Activation of Tissue Resident Macrophages in the Mouse Stomach through the beta 2 Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; INTRACELLULAR CA2+; STIMULATION; SURVIVAL; NEURONS	Background: The cholinergic anti-inflammatory pathway is an endogenous mechanism by which the autonomic nervous system attenuates macrophage activation via nicotinic acetylcholine receptors (nAChR). This concept has however not been demonstrated at a cellular level in intact tissue. To this end, we have studied the effect of nicotine on the activation of resident macrophages in a mouse stomach preparation by means of calcium imaging. Methods: Calcium transients ([Ca2+](i)) in resident macrophages were recorded in a mouse stomach preparation containing myenteric plexus and muscle layers by Fluo-4. Activation of macrophages was achieved by focal puff administration of ATP. The effects of nicotine on activation of macrophages were evaluated and the nAChR involved was pharmacologically characterized. The proximity of cholinergic nerves to macrophages was quantified by confocal microscopy. Expression of beta 2 and alpha 7 nAChR was evaluated by beta 2 immunohistochemistry and fluorophore-tagged alpha-bungarotoxin. Results: In 83% of macrophages cholinergic varicose nerve fibers were detected at distances <900nm. The ATP induced [Ca2+](i) increase was significantly inhibited in 65% or 55% of macrophages by 100 mu M or 10 mu M nicotine, respectively. This inhibitory effect was reversed by the beta 2 nAChR preferring antagonist dihydro-beta-eryhtroidine but not by hexamethonium (non-selective nAChR-antagonist), mecamylamine (alpha 3 beta 4 nAChR-preferring antagonist), alpha-bungarotoxin or methyllycaconitine (both alpha 7 nAChR-preferring antagonist). Macrophages in the stomach express beta 2 but not alpha 7 nAChR at protein level, while those in the intestine express both receptor subunits. Conclusion: This study is the first in situ demonstration of an inhibition of macrophage activation by nicotine suggesting functional signaling between cholinergic neurons and macrophages in the stomach. The data suggest that the beta 2 subunit of the nAChR is critically involved in the nicotine-induced inhibition of these resident macrophages.	[Nemethova, Andrea; Gomez-Pinilla, Pedro J.; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium; [Michel, Klaus; Schemann, Michael] Tech Univ Munich, Freising Weihenstephan, Germany	KU Leuven; Technical University of Munich	Schemann, M (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	schemann@wzw.tum.de	Boeckxstaens, Guy/AAP-2502-2020; Michel, Klaus/HDM-6232-2022	Michel, Klaus/0000-0003-2359-6428; Schemann, Michael/0000-0003-1007-9843	European Union; Deutsche Forschungsgemeinschaft [Sche267/9-1]; Research Foundation Flanders (FWO)	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Foundation Flanders (FWO)(FWO)	This work was supported by a grant from the European Union 7th Framework Program (IPODD), by Deutsche Forschungsgemeinschaft Sche267/9-1 to MS; by a grant of the Research Foundation Flanders (FWO, Odysseus and Hercules program) to GEB, and by a FWO postdoctoral research fellowship to PJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Breunig E, 2007, J PHYSIOL-LONDON, V583, P731, DOI 10.1113/jphysiol.2007.139352; Conley E.C., 1996, ION CHANNEL FACTSBOO; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Ghia JE, 2009, GASTROENTEROLOGY, V136, P2280, DOI 10.1053/j.gastro.2009.02.069; Giniatullin RA, 2000, MOL PHARMACOL, V58, P778, DOI 10.1124/mol.58.4.778; GURNEY AM, 1984, BRIT J PHARMACOL, V82, P623, DOI 10.1111/j.1476-5381.1984.tb10801.x; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Matteoli G, 2013, GUT             0808, V8, DOI [10.1136/gutjnl-2013-304676, DOI 10.1136/GUTJNL-2013-304676.PUBMED:23929694]; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; SCHEMANN M, 1992, AM J PHYSIOL, V263, pG709, DOI 10.1152/ajpgi.1992.263.5.G709; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Zoli M, 1999, TRENDS PHARMACOL SCI, V20, P142, DOI 10.1016/S0165-6147(99)01343-7	28	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79264	10.1371/journal.pone.0079264	http://dx.doi.org/10.1371/journal.pone.0079264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223920	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000326499300072
J	Zhou, TBT; King, GD; Chen, CD; Abraham, CR				Zhou, Tracey B. Tucker; King, Gwendalyn D.; Chen, CiDi; Abraham, Carmela R.			Biochemical and Functional Characterization of the Klotho-VS Polymorphism Implicated in Aging and Disease Risk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Cell Signaling; Fibroblast Growth Factor Receptor (FGFR); Genetic Polymorphism; Protein Complexes; Shedding; Dimerizaion	CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; AGED POSTMENOPAUSAL WOMEN; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; GENE POLYMORPHISMS; ENDOPLASMIC-RETICULUM; GLUCOSE-METABOLISM; HORMONE KLOTHO; BLOOD-PRESSURE	Background: The mechanism by which polymorphisms in the anti-aging protein klotho lead to increased disease risk is unknown. Results:In vitro, klotho-VS decreases homodimerization and increases heterodimerization with and activation of FGFR1c. Conclusion: Altered dimerization explains klotho-VS association with increased disease risk. Significance: Understanding how the VS variant leads to changes in klotho function will elucidate the role klotho plays in disease and lifespan. Klotho (KL) is an age-regulating protein named after the Greek goddess who spins the thread of life. Mice deficient in KL are normal throughout development, but rapidly degenerate and display a variety of aging-associated abnormalities that eventually lead to decreased life expectancy. While multiple genetic association studies have identified KL polymorphisms linked with changes in disease risk, there is a paucity of concrete mechanistic data to explain how these amino acid substitutions alter KL protein function. The KLVS polymorphism is suggested to lead to changes in protein trafficking although the mechanism is unclear. Our studies have sought to further investigate the functional differences in the KLVS variant that result in increased risk of many age-related diseases. Our findings suggest that the F352V and C370S substitutions lead to alterations in processing as seen by differences in shedding and half-life. Their co-expression in KLVS results in a phenotype resembling wild-type, but despite this intragenic complementation there are still changes in homodimerization and interactions with FGFR1c. Taken together, these studies suggest that KLVS leads to altered homodimerization that indirectly leads to changes in processing and FGFR1c interactions. These findings help elucidate the functional differences that result from the VS polymorphism, which will help clarify how alterations in KL function can lead to human disease and affect cognition and lifespan.	[Zhou, Tracey B. Tucker; King, Gwendalyn D.; Chen, CiDi; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Zhou, Tracey B. Tucker; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio O Conte Bldg K304, Boston, MA 02118 USA.	cabraham@bu.edu			National Institutes of Health-NIA [AG 00001, 5T32GM008541-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000001] Funding Source: NIH RePORTER	National Institutes of Health-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health-NIA Grants AG 00001 (to C. R. A.) and 5T32GM008541-15 (to T. B. T. Z.).	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brownstein CA, 2008, P NATL ACAD SCI USA, V105, P3455, DOI 10.1073/pnas.0712361105; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; FIMBEL S, 1995, STEROIDS, V60, P686, DOI 10.1016/0039-128X(95)00092-5; Freathy RM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-51; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Ichikawa S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P318; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Invidia L, 2010, BIOGERONTOLOGY, V11, P67, DOI 10.1007/s10522-009-9229-z; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Ko GJ, 2012, KIDNEY BLOOD PRESS R, V36, P191, DOI 10.1159/000343408; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Laitman Y, 2012, BREAST CANCER RES TR, V132, P1119, DOI 10.1007/s10549-011-1938-8; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Low AF, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-38; Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Majumdar V, 2011, CLIN CHIM ACTA, V412, P1116, DOI 10.1016/j.cca.2011.02.034; Majumdar V, 2010, BIOCHEM BIOPH RES CO, V403, P412, DOI 10.1016/j.bbrc.2010.11.045; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mullin BH, 2005, CALCIFIED TISSUE INT, V77, P145, DOI 10.1007/s00223-004-0291-x; Nolan VG, 2005, BRIT J HAEMATOL, V128, P266, DOI 10.1111/j.1365-2141.2004.05295.x; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Rhee EJ, 2006, J ENDOCRINOL INVEST, V29, P613, DOI 10.1007/BF03344160; Rhee EJ, 2006, METABOLISM, V55, P1344, DOI 10.1016/j.metabol.2006.05.020; Riancho JA, 2007, BIOGERONTOLOGY, V8, P121, DOI 10.1007/s10522-006-9039-5; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shimoyama Y, 2009, AM J NEPHROL, V30, P383, DOI 10.1159/000235686; Shimoyama Y, 2009, CLIN CHIM ACTA, V406, P134, DOI 10.1016/j.cca.2009.06.011; Sopjani M, 2011, FEBS LETT, V585, P1759, DOI 10.1016/j.febslet.2011.05.021; Tangri N, 2011, NEPHROL DIAL TRANSPL, V26, P3998, DOI 10.1093/ndt/gfr188; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zarrabeitia MT, 2007, CALCIFIED TISSUE INT, V80, P10, DOI 10.1007/s00223-006-0233-x	62	26	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36302	36311		10.1074/jbc.M113.490052	http://dx.doi.org/10.1074/jbc.M113.490052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217253	Green Published, hybrid			2022-12-25	WOS:000328883400013
J	Alemu, K; Worku, A; Berhane, Y				Alemu, Kassahun; Worku, Alemayehu; Berhane, Yemane			Malaria Infection Has Spatial, Temporal, and Spatiotemporal Heterogeneity in Unstable Malaria Transmission Areas in Northwest Ethiopia	PLOS ONE			English	Article							VILLAGE LEVEL; EPIDEMIC; PATTERNS; FALCIPARUM; CLUSTERS	Background: Malaria elimination requires successful nationwide control efforts. Detecting the spatiotemporal distribution and mapping high-risk areas are useful to effectively target pockets of malaria endemic regions for interventions. Objective: The aim of the study was to identify patterns of malaria distribution by space and time in unstable malaria transmission areas in northwest Ethiopia. Methods: Data were retrieved from the monthly reports stored in the district malaria offices for the period between 2003 and 2012. Eighteen districts in the highland and fringe malaria areas were included and geo-coded for the purpose of this study. The spatial data were created in ArcGIS10 for each district. The Poisson model was used by applying Kulldorff methods using the SaTScan (TM) software to analyze the purely temporal, spatial and space-time clusters of malaria at a district levels. Results: The study revealed that malaria case distribution has spatial, temporal, and spatiotemporal heterogeneity in unstable transmission areas. Most likely spatial malaria clusters were detected at Dera, Fogera, Farta, Libokemkem and Misrak Este districts (LLR = 197764.1, p<0.001). Significant spatiotemporal malaria clusters were detected at Dera, Fogera, Farta, Libokemkem and Misrak Este districts (LLR=197764.1, p<0.001) between 2003/1/1 and 2012/12/31. A temporal scan statistics identified two high risk periods from 2009/1/1 to 2010/12/31 (LLR=72490.5, p<0.001) and from 2003/1/1 to 2005/12/31 (LLR=26988.7, p<0.001). Conclusion: In unstable malaria transmission areas, detecting and considering the spatiotemporal heterogeneity would be useful to strengthen malaria control efforts and ultimately achieve elimination.	[Alemu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Addis Ababa, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	University of Gondar; Addis Ababa University; Addis Continental Institute of Public Health	Alemu, K (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia.	alemukass@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar	University of Gondar	University of Gondar is the source of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chowell G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-142; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; ESRI, 2011, ARCGIS DESKT REL 10; FDREMoH, 2009, ED DEM REP ETH MIN H; FMOH, 2012, PRES MAL IN MAL OP P; FONTAINE RE, 1961, AM J TROP MED HYG, V10, P795, DOI 10.4269/ajtmh.1961.10.795; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Haque U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-185; Hui FM, 2009, AM J TROP MED HYG, V81, P503; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2009, SER GUIDE VERSION 9; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Mboera LEG, 2010, GEOSPATIAL HEALTH, V4, P167, DOI 10.4081/gh.2010.198; Negash K, 2005, East Afr Med J, V82, P186; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	25	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79966	10.1371/journal.pone.0079966	http://dx.doi.org/10.1371/journal.pone.0079966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223209	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200102
J	Yao, LL; Kan, EM; Kaur, C; Dheen, ST; Hao, AJ; Lu, J; Ling, EA				Yao, Linli; Kan, Enci Mary; Kaur, Charanjit; Dheen, S. Thameem; Hao, Aijun; Lu, Jia; Ling, Eng-Ang			Notch-1 Signaling Regulates Microglia Activation via NF-kappa B Pathway after Hypoxic Exposure In Vivo and In Vitro	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; MURINE BV-2 CELLS; INNATE IMMUNITY; INFLAMMATORY RESPONSE; AMEBOID MICROGLIA; NITRIC-OXIDE; RAT-BRAIN; RECEPTOR; DIFFERENTIATION; EXPRESSION	Neuroinflammation mediated by the activated microglia is suggested to play a pivotal role in the pathogenesis of hypoxic brain injury; however, the underlying mechanism of microglia activation remains unclear. Here, we show that the canonical Notch signaling orchestrates microglia activation after hypoxic exposure which is closely associated with multiple pathological situations of the brain. Notch-1 and Delta-1 expression in primary microglia and BV-2 microglial cells was significantly elevated after hypoxia. Hypoxia-induced activation of Notch signaling was further confirmed by the concomitant increase in the expression and translocation of intracellular Notch receptor domain (NICD), together with RBPJk and target gene Hes-1 expression. Chemical inhibition of Notch signaling with N-[N-(3,5-difluorophenacetyl)-1-alany1-Sphenyglycine t-butyl ester (DAPT), a gamma-secretase inhibitor, effectively reduced hypoxia-induced upregulated expression of most inflammatory mediators. Notch inhibition also reduced NF-kappa B/p65 expression and translocation. Remarkably, Notch inhibition suppressed expression of TLR4/MyD88/TRAF6 pathways. In vivo, Notch signaling expression and activation in microglia were observed in the cerebrum of postnatal rats after hypoxic injury. Most interestingly, hypoxia-induced upregulation of NF-kappa B immunoexpression in microglia was prevented when the rats were given DAPT pretreatment underscoring the interrelationship between Notch signaling and NF-kappa B pathways. Taken together, we conclude that Notch signaling is involved in regulating microglia activation after hypoxia partly through the cross talk between TLR4/MyD88/TRAF6/NF-kappa B pathways. Therefore, Notch signaling may serve as a prospective target for inhibition of microglia activation known to be implicated in brain damage in the developing brain.	[Yao, Linli; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Key Lab Minist Educ Expt Teratol,Shandong Prov Ke, Jinan 250100, Shandong, Peoples R China; [Kan, Enci Mary; Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Yao, Linli; Kaur, Charanjit; Dheen, S. Thameem; Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore	Shandong University; National University of Singapore	Ling, EA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.	antlea@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	National University of Singapore [R-181-000-140-592]	National University of Singapore(National University of Singapore)	This study was supported by grant No. R-181-000-140-592 from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Basovich SN, 2010, BIOSCI TRENDS, V4, P288; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Cao Q, 2008, GLIA, V56, P1224, DOI 10.1002/glia.20692; Chen YP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030437, 10.1371/journal.pone.0046512, 10.1371/journal.pone.0036329]; Correia SC, 2013, CURR PHARM IN PRESS; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Cummins AG, 2013, DIGEST DIS SCI, V58, P678, DOI 10.1007/s10620-012-2422-y; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Grandbarbe L, 2007, GLIA, V55, P1519, DOI 10.1002/glia.20553; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Heyen JRR, 2000, MOL BRAIN RES, V77, P138, DOI 10.1016/S0169-328X(00)00042-5; Johnston MV, 1997, BRAIN DEV-JPN, V19, P235, DOI 10.1016/S0387-7604(96)00561-X; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kim MY, 2008, J CELL SCI, V121, P1466, DOI 10.1242/jcs.019018; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kopan R, 2002, J CELL SCI, V115, P1095; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Kramer H, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.29.pe1; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lanner F, 2013, STEM CELLS DEV, V22, P1360, DOI 10.1089/scd.2012.0259; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Li P, 2009, NEUROSCIENCE, V164, P948, DOI 10.1016/j.neuroscience.2009.08.044; Lutolf S, 2002, DEVELOPMENT, V129, P373; Marignol L, 2013, NAT REV UROL, V10, P405, DOI 10.1038/nrurol.2013.110; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Morga E, 2009, GLIA, V57, P1741, DOI 10.1002/glia.20887; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Outtz HH, 2011, BLOOD, V118, P3436, DOI 10.1182/blood-2010-12-327015; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Parer JT, 1998, COMP BIOCHEM PHYS A, V119, P711, DOI 10.1016/S1095-6433(98)01009-5; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; Valapala M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2624; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wearing HJ, 2000, B MATH BIOL, V62, P293, DOI 10.1006/bulm.1999.0152; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yonekura S, 2013, ANTICANCER RES, V33, P3099; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhou ZD, 2010, IUBMB LIFE, V62, P618, DOI 10.1002/iub.362	62	88	97	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78439	10.1371/journal.pone.0078439	http://dx.doi.org/10.1371/journal.pone.0078439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223152	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200044
J	Conraux, L; Pech, C; Guerraoui, H; Loyaux, D; Ferrara, P; Guillemot, JC; Meininger, V; Pradat, PF; Salachas, F; Bruneteau, G; Le Forestier, N; Lacomblez, L				Conraux, Laurence; Pech, Catherine; Guerraoui, Halim; Loyaux, Denis; Ferrara, Pascual; Guillemot, Jean-Claude; Meininger, Vincent; Pradat, Pierre-Francois; Salachas, Francois; Bruneteau, Gaelle; Le Forestier, Nadine; Lacomblez, Lucette			Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI -TOF Mass Spectrometry Profiling	PLOS ONE			English	Article							PLATELETS; INFLAMMATION; DIAGNOSIS; PLATELET-FACTOR-4	The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore, finding biomarkers with high sensitivity and specificity remains urgent. In our study, we looked for peptide biomarkers in plasma samples using reverse phase magnetic beads (C18 and C8) and MALDI-TOF mass spectrometry analysis. From a set of ALS patients (n=30) and healthy age-matched controls (n=30), C18- or C8-SVM-based models for ALS diagnostic were constructed on the base of the minimum of the most discriminant peaks. These two SVM-based models end up in excellent separations between the 2 groups of patients (recognition capability overall classes > 97%) and classify blinded samples (10 ALS and 10 healthy age-matched controls) with very high sensitivities and specificities (>90%). Some of these discriminant peaks have been identified by Mass Spectrometry (MS) analyses and correspond to (or are fragments of) major plasma proteins, partly linked to the blood coagulation.	[Conraux, Laurence; Pech, Catherine; Guerraoui, Halim; Loyaux, Denis; Ferrara, Pascual; Guillemot, Jean-Claude] Sanofi, Exploratory Unit, Toulouse, France; [Meininger, Vincent; Pradat, Pierre-Francois; Salachas, Francois; Bruneteau, Gaelle; Le Forestier, Nadine; Lacomblez, Lucette] UPMC, AP HP, La Salpetriere Hosp, Ctr Referent Malad Rares, Paris, France	Sanofi-Aventis; Sanofi France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Conraux, L (corresponding author), Sanofi, Exploratory Unit, Toulouse, France.	Laurence.conraux@sanofi.com		BRUNETEAU, GAELLE/0000-0002-1905-7985				Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; An YM, 2010, DIS MARKERS, V29, P11, DOI [10.1155/2010/681876, 10.3233/DMA-2010-0721]; Arhart RW, 2010, MED HYPOTHESES, V75, P341, DOI 10.1016/j.mehy.2010.03.017; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Behari M, 2013, INT J NEUROSCI, V123, P287, DOI 10.3109/00207454.2012.751534; Brettschneider J, 2010, NEUROSCI LETT, V468, P23, DOI 10.1016/j.neulet.2009.10.053; Dupuis L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013346; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Kaneshiro N, 2009, RAPID COMMUN MASS SP, V23, P3720, DOI 10.1002/rcm.4315; Kawashima Y, 2010, J PROTEOME RES, V9, P1694, DOI 10.1021/pr9008018; Khansari Parto S., 2012, Inflammopharmacology, V20, P103, DOI 10.1007/s10787-012-0124-x; Kim JY, 2013, RAPID COMMUN MASS SP, V27, P521, DOI 10.1002/rcm.6480; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Kruger T, 2012, PROTEOMICS IN PRESS; Li YH, 2011, EUR NEUROL, V65, P105, DOI 10.1159/000323427; Liang TT, 2010, PROTEOMICS, V10, P90, DOI 10.1002/pmic.200900513; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Nanni P, 2008, THESIS; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Shrivastava M, 2011, ULTRASTRUCT PATHOL, V35, P52, DOI 10.3109/01913123.2010.541985; Silani V, 2011, ARCH ITAL BIOL, V149, P5, DOI 10.4449/aib.v149i1.1260; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; von Neuhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044401; Zhang XX, 2012, CLIN EXP MED, V12, P145, DOI 10.1007/s10238-011-0154-5	36	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79733	10.1371/journal.pone.0079733	http://dx.doi.org/10.1371/journal.pone.0079733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224000	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400083
J	Melo, HPM; Franks, A; Moreira, AA; Diermeier, D; Andrade, JS; Amaral, LAN				Melo, Hygor Piaget M.; Franks, Alexander; Moreira, Andre A.; Diermeier, Daniel; Andrade, Jose S., Jr.; Amaral, Luis A. Nunes			A Solution to the Challenge of Optimization on "Golf-Course"-Like Fitness Landscapes	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EVOLUTION; NETWORKS	Genetic algorithms (GAs) have been used to find efficient solutions to numerous fundamental and applied problems. While GAs are a robust and flexible approach to solve complex problems, there are some situations under which they perform poorly. Here, we introduce a genetic algorithm approach that is able to solve complex tasks plagued by so-called ''golf-course''-like fitness landscapes. Our approach, which we denote variable environment genetic algorithms (VEGAs), is able to find highly efficient solutions by inducing environmental changes that require more complex solutions and thus creating an evolutionary drive. Using the density classification task, a paradigmatic computer science problem, as a case study, we show that more complex rules that preserve information about the solution to simpler tasks can adapt to more challenging environments. Interestingly, we find that conservative strategies, which have a bias toward the current state, evolve naturally as a highly efficient solution to the density classification task under noisy conditions.	[Melo, Hygor Piaget M.; Moreira, Andre A.; Andrade, Jose S., Jr.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [Franks, Alexander; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Franks, Alexander] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Diermeier, Daniel] Northwestern Univ, Kellogg Sch Management, MEDS, Evanston, IL USA; [Diermeier, Daniel; Amaral, Luis A. Nunes] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Diermeier, Daniel] Canadian Inst Adv Res, Toronto, ON, Canada; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Universidade Federal do Ceara; Northwestern University; Harvard University; Northwestern University; Northwestern University; Canadian Institute for Advanced Research (CIFAR); Howard Hughes Medical Institute; Northwestern University	Melo, HPM (corresponding author), Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil.	hygor@fisica.ufc.br	Amaral, LAN/A-4980-2008; Moreira, Andre Auto A/C-5290-2013; Amaral, Luis N./C-5485-2009; Andrade, José S/C-5451-2013	Amaral, LAN/0000-0002-3762-789X; Moreira, Andre Auto A/0000-0003-1046-5218; Andrade, José S/0000-0002-5571-7610; Franks, Alexander/0000-0002-9329-206X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP); Financiadora de Estudos e Projetos; National Institute of Science and Technology for Complex Systems in Brazil; National Institutes of Health [1-P50-GM081892]; FUNCAP/CNPq Pronex grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); National Institute of Science and Technology for Complex Systems in Brazil; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FUNCAP/CNPq Pronex grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) and Financiadora de Estudos e Projetos, the FUNCAP/CNPq Pronex grant, and the National Institute of Science and Technology for Complex Systems in Brazil for financial support and the National Institutes of Health grant number 1-P50-GM081892 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi A, 2010, INT J COMPUT INTELL, V9, P33, DOI 10.1142/S1469026810002756; Asch S. E., 1951, GROUPS LEADERSHIP ME, P177; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; Ferreira C, 2002, GENETIC PROGRAMMING, P123; Gashler M, 2011, IEEE T SYST MAN CY B, V41, P1458, DOI 10.1109/TSMCB.2011.2151187; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; Greulich P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.088101; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Hermsen R, 2012, P NATL ACAD SCI USA, V109, P10775, DOI 10.1073/pnas.1117716109; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Holland, 1975, ADAPTATION NATURAL A; Holland J. H., 1973, SIAM Journal on Computing, V2, P88, DOI 10.1137/0202009; Hoyle F., 1984, INTELLIGENT UNIVERSE; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Maynard Smith J, 1986, PROBLEMS BIOL, V144; Mitchell, 1996, INTRO GENETIC ALGORI; Moreira AA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218702; Moreira AA, 2004, P NATL ACAD SCI USA, V101, P12085, DOI 10.1073/pnas.0400672101; Ramon y Cajal S, 1999, ADVICE YOUNG INVESTI; Seaver SMD, 2009, EUR PHYS J B, V67, P369, DOI 10.1140/epjb/e2008-00406-4; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Werfel J, 2000, IEEE T EVOLUT COMPUT, V4, P388, DOI 10.1109/4235.887238; Wolpert DH, 2005, IEEE T EVOLUT COMPUT, V9, P721, DOI 10.1109/TEVC.2005.856205; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Wu ZJ, 1996, SIAM J OPTIMIZ, V6, P748, DOI 10.1137/S1052623493254698; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78401	10.1371/journal.pone.0078401	http://dx.doi.org/10.1371/journal.pone.0078401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223800	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400024
J	Pettay, DT; LaJeunesse, TC				Pettay, D. Tye; LaJeunesse, Todd C.			Long-Range Dispersal and High-Latitude Environments Influence the Population Structure of a "Stress-Tolerant" Dinoflagellate Endosymbiont	PLOS ONE			English	Article							CORAL POCILLOPORA-DAMICORNIS; SOUTHERN OSCILLATION EVENT; GREAT-BARRIER-REEF; GULF-OF-CALIFORNIA; EASTERN PACIFIC; GENETIC DIVERSITY; MICROSATELLITE LOCI; INDO-PACIFIC; SEA FAN; PATTERNS	The migration and dispersal of stress-tolerant symbiotic dinoflagellates (genus Symbiodinium) may influence the response of symbiotic reef-building corals to a warming climate. We analyzed the genetic structure of the stress-tolerant endosymbiont, Symbiodinium glynni nomen nudum (ITS2 - D1), obtained from Pocillopora colonies that dominate eastern Pacific coral communities. Eleven microsatellite loci identified genotypically diverse populations with minimal genetic subdivision throughout the Eastern Tropical Pacific, encompassing 1000's of square kilometers from mainland Mexico to the Galapagos Islands. The lack of population differentiation over these distances corresponds with extensive regional host connectivity and indicates that Pocillopora larvae, which maternally inherit their symbionts, aid in the dispersal of this symbiont. In contrast to its host, however, subtropical populations of S. glynni in the Gulf of California (Sea of Cortez) were strongly differentiated from populations in tropical eastern Pacific. Selection pressures related to large seasonal fluctuations in temperature and irradiance likely explain this abrupt genetic discontinuity. We infer that S. glynni genotypes harbored by host larvae arriving from more southern locations are rapidly replaced by genotypes adapted to more temperate environments. The strong population structure of S. glynni corresponds with fluctuating environmental conditions and suggests that these genetically diverse populations have the potential to evolve rapidly to changing environments and reveals the importance of environmental extremes in driving microbial eukaryote (e. g., plankton) speciation in marine ecosystems.	[Pettay, D. Tye; LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Pettay, D. Tye] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Delaware	Pettay, DT (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tpettay@udel.edu	LaJeunesse, Todd/B-1720-2009	LaJeunesse, Todd/0000-0001-7607-9358	Florida International University; The Pennsylvania State University; National Science Foundation [IOB 544854, OCE-09287664]; DHHS/NIH/NIEHS [ES11181]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [S11ES011181] Funding Source: NIH RePORTER	Florida International University; The Pennsylvania State University; National Science Foundation(National Science Foundation (NSF)); DHHS/NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded in part by Florida International University, The Pennsylvania State University, the National Science Foundation (IOB 544854 and OCE-09287664) and DHHS/NIH/NIEHS (ES11181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Byler KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059596; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Castro R, 2000, CIENC MAR, V26, P561; Chavez-Romo H, 2007, CIENC MAR, V33, P495, DOI 10.7773/cm.v33i4.1141; Chavez-Romo HE, 2008, P 11 INT COR REEF S, P429; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Earl DA, 2009, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FIEDLER PC, 1992, DEEP-SEA RES, V39, P199, DOI 10.1016/0198-0149(92)90105-3; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, CORAL REEFS, V15, P71; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2001, B MAR SCI, V69, P79; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurtado LA, 2007, MAR BIOL, V151, P1863, DOI 10.1007/s00227-007-0620-5; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lopez-Perez RA, 2005, EARTH-SCI REV, V72, P67, DOI 10.1016/j.earscirev.2005.04.002; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pettay DT, 2011, MOL ECOL, V20, P5197, DOI 10.1111/j.1365-294X.2011.05357.x; Pettay DT, 2009, MOL ECOL RESOUR, V9, P1022, DOI 10.1111/j.1755-0998.2009.02561.x; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pinzon JH, 2011, CONSERV GENET RESOUR, V3, P45, DOI 10.1007/s12686-010-9283-5; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOL, V143, P111, DOI 10.1007/s00227-003-1065-0; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shankle AM, 2004, J PHYCOL, V40, P239, DOI 10.1111/j.1529-8817.2004.03021.x; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Victor BC, 2001, B MAR SCI, V69, P279; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wham DC, 2011, CONSERV GENET RESOUR, V3, P541, DOI 10.1007/s12686-011-9399-2; Wintzingerode F., 1997, MICROBIOLOGY REV, V21, P213, DOI DOI 10.1111/J.1574-6976.1997.TB00351.X.PUBMED:9451814	65	33	33	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79208	10.1371/journal.pone.0079208	http://dx.doi.org/10.1371/journal.pone.0079208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223906	Green Published, gold			2022-12-25	WOS:000326597400052
J	Coursey, TG; Gandhi, NB; Volpe, EA; Pflugfelder, SC; de Paiva, CS				Coursey, Terry G.; Gandhi, Niral B.; Volpe, Eugene A.; Pflugfelder, Stephen C.; de Paiva, Cintia S.			Chemokine Receptors CCR6 and CXCR3 Are Necessary for CD4(+) T Cell Mediated Ocular Surface Disease in Experimental Dry Eye Disease	PLOS ONE			English	Article							TH17 CELLS; PREVALENCE; EXPRESSION; INFLAMMATION; DISTINCT; MIGRATION; CYTOKINES; RESPONSES; SUBSETS; LINEAGE	CD4(+) T cells are essential to pathogenesis of ocular surface disease in dry eye. Two subtypes of CD4(+) T cells, Th1 and Th17 cells, function concurrently in dry eye to mediate disease. This occurs in spite of the cross-regulation of IFN-gamma and IL-17A, the prototypical cytokines Th1 and Th17 cells, respectively. Essential to an effective immune response are chemokines that direct and summon lymphocytes to specific tissues. T cell trafficking has been extensively studied in other models, but this is the first study to examine the role of chemokine receptors in ocular immune responses. Here, we demonstrate that the chemokine receptors, CCR6 and CXCR3, which are expressed on Th17 and Th1 cells, respectively, are required for the pathogenesis of dry eye disease, as CCR6KO and CXCR3KO mice do not develop disease under desiccating stress. CD4(+) T cells from CCR6KO and CXCR3KO mice exposed to desiccating stress (DS) do not migrate to the ocular surface, but remain in the superficial cervical lymph nodes. In agreement with this, CD4(+) T cells from CCR6 and CXCR3 deficient donors exposed to DS, when adoptively transferred to T cell deficient recipients manifest minimal signs of dry eye disease, including significantly less T cell infiltration, goblet cell loss, and expression of inflammatory cytokine and matrix metalloproteinase expression compared to wild-type donors. These findings highlight the important interaction of chemokine receptors on T cells and chemokine ligand expression on epithelial cells of the cornea and conjunctiva in dry eye pathogenesis and reveal potential new therapeutic targets for dry eye disease.	[Coursey, Terry G.; Gandhi, Niral B.; Volpe, Eugene A.; Pflugfelder, Stephen C.; de Paiva, Cintia S.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA	Baylor College of Medicine	de Paiva, CS (corresponding author), Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA.	cintiadp@bcm.edu	Volpe, Eugene A./D-2000-2012; De Paiva, Cintia/AAH-8354-2021	Volpe, Eugene A./0000-0002-9128-754X; De Paiva, Cintia/0000-0002-9057-5494	NIH [EY018888, EY11915, EY018090, EY002520, EY020799]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH (NIAID) [P30AI036211]; NIH (NCI) [P30CA125123]; NIH (NCRR) [S10RR024574];  [2 T32 EY 7001-36]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018090, P30EY020799, R21EY018888, R01EY011915, P30EY002520, T32EY007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Training Grant- 2 T32 EY 7001-36 (TGC), NIH Grant EY018888 (CSDP), EY11915 (SCP), EY018090 (SCP), NIH Core Grants EY002520 & EY020799, Research to Prevent Blindness, the Oshman Foundation, William Stamps Farish Fund, the Hamill Foundation and by the Cytometry and Cell Sorting Core at Baylor College of Medicine which is funded by the NIH (NIAID P30AI036211, NCI P30CA125123, and NCRR S10RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Dursun D, 2002, ADV EXP MED BIOL, V506, P647; El Annan J, 2009, INVEST OPHTH VIS SCI, V50, P3802, DOI 10.1167/iovs.08-2417; Elhofy A, 2009, J NEUROIMMUNOL, V213, P91, DOI 10.1016/j.jneuroim.2009.05.011; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedrick MN, 2010, EXPERT OPIN THER TAR, V14, P911, DOI 10.1517/14728222.2010.504716; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schaumburg CS, 2011, J IMMUNOL, V187, P3653, DOI 10.4049/jimmunol.1101442; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Song XJ, 2003, INVEST OPHTH VIS SCI, V44, P4223, DOI 10.1167/iovs.02-1319; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Zhang XB, 2011, AM J PATHOL, V179, P1807, DOI 10.1016/j.ajpath.2011.06.030; Zheng XF, 2010, J CELL PHYSIOL, V222, P95, DOI 10.1002/jcp.21926	42	39	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78508	10.1371/journal.pone.0078508	http://dx.doi.org/10.1371/journal.pone.0078508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223818	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400070
J	Shi, L; Shu, XO; Li, HL; Cai, H; Liu, QL; Zheng, W; Xiang, YB; Villegas, R				Shi, Liang; Shu, Xiao-Ou; Li, Honglan; Cai, Hui; Liu, Qiaolan; Zheng, Wei; Xiang, Yong-Bing; Villegas, Raquel			Physical Activity, Smoking, and Alcohol Consumption in Association with Incidence of Type 2 Diabetes among Middle-Aged and Elderly Chinese Men	PLOS ONE			English	Article							RISK-FACTORS; HEALTH; REPRODUCIBILITY; PREVALENCE; VALIDITY; POPULATION; BEHAVIORS; EXERCISE; MELLITUS	Background: Type 2 diabetes mellitus (T2DM) is a prevalent chronic disease worldwide. The prevalence of T2DM is increasing rapidly in China. Understanding the contribution of modifiable lifestyle factors on T2DM risk is imperative to prevent the development of T2DM in China. Methods: We examined associations between lifestyle factors including physical activity, smoking and alcohol consumption with incidence of T2DM among middle-aged and elderly men in urban Shanghai. Information on socio-demographics, lifestyle habits, dietary habits, and disease history was collected via in-person interviews. Anthropometric measurements were taken. A total of 51 464 Chinese men aged 40-74 years free of T2DM, coronary heart disease (CHD), and stroke at baseline were included in the current study. Incident T2DM was identified through follow-up surveys conducted every 2-3 years. Cox proportional hazard analyses were conducted to evaluate associations between lifestyle risk factors and incidence of T2DM. Results: We documented 1304 new cases of T2DM during 276 929 person-years of follow-up (average: 5.4 years). Physical activity was inversely associated with T2DM risk. Daily living, commuting, and total physical activity METs had inverse negative dose-response relationships with T2DM (P-trend = 0.0033, 0.0022, and <0.0001, respectively). Regular participation in exercise or sports reduced T2DM risk (HR = 0.86, 95% CI: 0.76-0.98). Moderate alcohol intake (1-3 drinks/day) was inversely related to T2DM risk (HR = 0.80, 95% CI: 0.67-0.94). Cigarette smoking, on the other hand, was associated with increased T2DM risk; HRs were 1.25 (95% CI: 1.00-1.56) for smoking more than 20 cigarettes per day and 1.28 (95% CI: 1.04-1.57) for smoking more than 40 pack-years. Conclusions: Physical activity and moderate alcohol intake are inversely associated with T2DM risk, whereas smoking was positively associated with T2DM risk among middle-age and elderly Chinese men. Preventive measures should be developed to focus on these modifiable lifestyle habits to reduce the upward trend of T2DM.	[Shi, Liang; Shu, Xiao-Ou; Cai, Hui; Liu, Qiaolan; Zheng, Wei] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA; [Shi, Liang; Shu, Xiao-Ou; Cai, Hui; Liu, Qiaolan; Zheng, Wei; Villegas, Raquel] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN 37235 USA; [Shi, Liang] Shanghai Municipal Ctr Dis Control & Prevent, Dept Diabet Control & Prevent, Shanghai, Peoples R China; [Li, Honglan; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Liu, Qiaolan] Sichuan Univ, Huaxi Sch Publ Hlth, Chengdu 610064, Peoples R China; [Villegas, Raquel] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; Sichuan University; Vanderbilt University	Villegas, R (corresponding author), Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37212 USA.	raquel.villegas@vanderbilt.edu	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	US PHS from the National Cancer Institute [R01 CA082729]; Fogarty International Institute [D43 TX008313]; NATIONAL CANCER INSTITUTE [UM1CA173640, R01CA082729] Funding Source: NIH RePORTER	US PHS from the National Cancer Institute; Fogarty International Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by US PHS grant number R01 CA082729 (to Xiao-Ou Shu) from the National Cancer Institute. The work of Liang Shi was supported by a grant from the Fogarty International Institute (D43 TX008313 to Xiao-Ou Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Ansari RM, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/195285; Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Cullmann M, 2012, DIABETIC MED, V29, P441, DOI 10.1111/j.1464-5491.2011.03450.x; Esposito K, 2008, CURR ATHEROSCLER REP, V10, P523, DOI 10.1007/s11883-008-0081-4; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; Hu Gang, 2005, Metabolic Syndrome and Related Disorders, V3, P35, DOI 10.1089/met.2005.3.35; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; James SA, 1998, DIABETES CARE, V21, P555, DOI 10.2337/diacare.21.4.555; Jurj AL, 2007, AM J EPIDEMIOL, V165, P1124, DOI 10.1093/aje/kwk119; Kao WHL, 2001, AM J EPIDEMIOL, V154, P748, DOI 10.1093/aje/154.8.748; Koletsi-Kounari H, 2011, COMMUNITY DENT HLTH, V28, P47, DOI 10.1922/CDH_2474Kounari06; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Nagaya T, 2008, ANN EPIDEMIOL, V18, P113, DOI 10.1016/j.annepidem.2007.07.107; Narayan KMV, 2012, HEALTH AFFAIR, V31, P84, DOI 10.1377/hlthaff.2011.1040; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001; PULLEN E, 1992, J EPIDEMIOL COMMUN H, V46, P455, DOI 10.1136/jech.46.4.455; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Villegas R, 2006, INT J EPIDEMIOL, V35, P1553, DOI 10.1093/ije/dyl209; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108; Wei Ming, 2000, Comprehensive Therapy, V26, P176, DOI 10.1007/s12019-000-0006-9; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P420, DOI 10.1016/S0895-3988(11)60001-9; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	74	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77919	10.1371/journal.pone.0077919	http://dx.doi.org/10.1371/journal.pone.0077919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223743	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400022
J	Peltonen, HM; Haapasalo, A; Hiltunen, M; Kataja, V; Kosma, VM; Mannermaa, A				Peltonen, Hanna M.; Haapasalo, Annakaisa; Hiltunen, Mikko; Kataja, Vesa; Kosma, Veli-Matti; Mannermaa, Arto			Upsilon-Secretase Components as Predictors of Breast Cancer Outcome	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; ESTROGEN-RECEPTOR; PRESENILIN/GAMMA-SECRETASE; TUMOR-SUPPRESSOR; BETA-CATENIN; SIGNALING PATHWAY; COMPLEX-FORMATION; GENE-EXPRESSION; APH-1 INTERACTS	Upsilon-secretase is a large ubiquitously expressed protease complex composed of four core subunits: presenilin, Aph1, PEN-2, and nicastrin. The function of Upsilon-secretase in the cells is to proteolytically cleave various proteins within their transmembrane domains. Presenilin and Aph1 occur as alternative variants belonging to mutually exclusive Upsilon-secretase complexes and providing the complexes with heterogeneous biochemical and physiological properties.Upsilon-secretase is proposed to have a role in the development and progression of cancer and Upsilon-secretase inhibitors are intensively studied for their probable anti-tumor effects in various types of cancer models. Here, we for the first time determined mRNA expression levels of presenilin-1, presenilin-2, Aph1a, Aph1b, PEN-2, and nicastrin in a set of breast cancer tissue samples (N = 55) by quantitative real-time PCR in order to clarify the clinical significance of the expression of different Upsilon-secretase complex components in breast cancer. We found a high positive correlation between the subunit expression levels implying a common regulation of transcription. Our univariate Kaplan-Meier survival analyses established low expression level of Upsilon-secretase complex as a risk factor for breast cancer specific mortality. The tumors expressing low levels of Upsilon-secretase complex were characterized by high histopathological tumor grade, low or no expression of estrogen and progesterone receptors and consequently high probability to fall into the class of triple negative breast cancer tumors. These results may provide novel tools to further categorize breast cancer tumors, especially the highly aggressive and poorly treatable breast cancer type of triple negative cases, and suggest a significant role for Upsilon-secretase in breast cancer.	[Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, SF-70210 Kuopio, Finland; [Haapasalo, Annakaisa; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Peltonen, HM (corresponding author), Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland.	hanna.peltonen@uef.fi		Haapasalo, Annakaisa/0000-0003-0959-2957; Kataja, Vesa/0000-0003-4846-4843	Special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organisations; Sigrid Juselius Foundation; Health Research Council of the Academy of Finland; (UEF-Brain and Cancer Center of Eastern Finland)	Special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organisations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Health Research Council of the Academy of Finland(Academy of Finland); (UEF-Brain and Cancer Center of Eastern Finland)	This study was supported by grants from Special Government Funding (EVO) of Kuopio University Hospital (www.psshp.fi), the Cancer Fund of Northern Savo (www.pohjois-savonsyopayhdistys.fi), the Finnish Cancer Organisations (www.cancer.fi), Sigrid Juselius Foundation (www.sigridjuselius.fi), Health Research Council of the Academy of Finland (www.aka.fi), and the strategic funding of the University of Eastern Finland (UEF-Brain and Cancer Center of Eastern Finland; www.uef.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Bao JY, 2007, MOL CELL BIOL, V27, P1321, DOI 10.1128/MCB.01280-06; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Checler F, 2012, NEURODEGENER DIS, V10, P52, DOI 10.1159/000332935; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Coolen MW, 2006, MOL PSYCHIATR, V11, P787, DOI 10.1038/sj.mp.4001846; Coolen MW, 2005, FASEB J, V19, P175, DOI 10.1096/fj.05-4337fje; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Debeb BG, 2012, BREAST CANCER RES TR, V134, P495, DOI 10.1007/s10549-012-2075-8; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Howard EM, 2005, J CANCER RES CLIN, V131, P14, DOI 10.1007/s00432-004-0618-z; Ilaya NT, 2004, J NEUROCHEM, V91, P230, DOI 10.1111/j.1471-4159.2004.02718.x; Jayadev S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015743; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kondratyev M, 2012, ONCOGENE, V31, P93, DOI 10.1038/onc.2011.212; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lleo A, 2003, J BIOL CHEM, V278, P47370, DOI 10.1074/jbc.M308480200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Madsen LB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-72; Mannisto S, 1996, INT J CANCER, V68, P8, DOI 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V; Mitrunen K, 2000, CANCER EPIDEM BIOMAR, V9, P1343; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nykopp TK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-143; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rasul S, 2009, BRIT J CANCER, V100, P1879, DOI 10.1038/sj.bjc.6605034; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rizzo P, 2009, ADV ENZYME REGUL, V49, P134, DOI 10.1016/j.advenzreg.2009.01.008; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Saito S, 2005, BIOCHEM BIOPH RES CO, V327, P18, DOI 10.1016/j.bbrc.2004.11.130; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seo SJ, 2007, NEUROCHEM RES, V32, P1016, DOI 10.1007/s11064-006-9262-0; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Seveno C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3214; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thelu Jacques, 2002, BMC Dermatol, V2, P7, DOI 10.1186/1471-5945-2-7; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zardawi SJ, 2010, HISTOPATHOLOGY, V56, P286, DOI 10.1111/j.1365-2559.2009.03475.x; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	91	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79249	10.1371/journal.pone.0079249	http://dx.doi.org/10.1371/journal.pone.0079249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223915	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300069
J	Winck, FV; Arvidsson, S; Riano-Pachon, DM; Hempel, S; Koseska, A; Nikoloski, Z; Gomez, DAU; Rupprecht, J; Mueller-Roeber, B				Winck, Flavia Vischi; Arvidsson, Samuel; Mauricio Riano-Pachon, Diego; Hempel, Sabrina; Koseska, Aneta; Nikoloski, Zoran; Urbina Gomez, David Alejandro; Rupprecht, Jens; Mueller-Roeber, Bernd			Genome-Wide Identification of Regulatory Elements and Reconstruction of Gene Regulatory Networks of the Green Alga Chlamydomonas reinhardtii under Carbon Deprivation	PLOS ONE			English	Article							CONCENTRATING MECHANISM; TRANSCRIPTION FACTOR; HEAT-SHOCK; CO2-CONCENTRATING MECHANISM; BINDING PROTEINS; EXPRESSION; CHROMATIN; CO2; ACTIVATION; ANHYDRASE	The unicellular green alga Chlamydomonas reinhardtii is a long-established model organism for studies on photosynthesis and carbon metabolism-related physiology. Under conditions of air-level carbon dioxide concentration [CO2], a carbon concentrating mechanism (CCM) is induced to facilitate cellular carbon uptake. CCM increases the availability of carbon dioxide at the site of cellular carbon fixation. To improve our understanding of the transcriptional control of the CCM, we employed FAIRE-seq (formaldehyde-assisted Isolation of Regulatory Elements, followed by deep sequencing) to determine nucleosome-depleted chromatin regions of algal cells subjected to carbon deprivation. Our FAIRE data recapitulated the positions of known regulatory elements in the promoter of the periplasmic carbonic anhydrase (Cah1) gene, which is upregulated during CCM induction, and revealed new candidate regulatory elements at a genome-wide scale. In addition, time series expression patterns of 130 transcription factor (TF) and transcription regulator (TR) genes were obtained for cells cultured under photoautotrophic condition and subjected to a shift from high to low [CO2]. Groups of co-expressed genes were identified and a putative directed gene-regulatory network underlying the CCM was reconstructed from the gene expression data using the recently developed IOTA (inner composition alignment) method. Among the candidate regulatory genes, two members of the MYB-related TF family, Lcr1 (Low-CO2 response regulator 1) and Lcr2 (Low-CO2 response regulator 2), may play an important role in down-regulating the expression of a particular set of TF and TR genes in response to low [CO2]. The results obtained provide new insights into the transcriptional control of the CCM and revealed more than 60 new candidate regulatory genes. Deep sequencing of nucleosome-depleted genomic regions indicated the presence of new, previously unknown regulatory elements in the C. reinhardtii genome. Our work can serve as a basis for future functional studies of transcriptional regulator genes and genomic regulatory elements in Chlamydomonas.	[Winck, Flavia Vischi; Nikoloski, Zoran; Mueller-Roeber, Bernd] Univ Potsdam, GoFORSYS Res Unit Syst Biol, Inst Biochem & Biol, Potsdam, Germany; [Winck, Flavia Vischi; Arvidsson, Samuel; Rupprecht, Jens; Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, GoFORSYS Res Unit Syst Biol, Potsdam, Germany; [Mauricio Riano-Pachon, Diego; Urbina Gomez, David Alejandro] Univ Los Andes, Dept Biol Sci, Grp Computat & Evolutionary Biol, Bogota, Colombia; [Hempel, Sabrina; Koseska, Aneta] Univ Potsdam, Inst Phys, Potsdam, Germany; [Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany; [Hempel, Sabrina] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Hempel, Sabrina] Humboldt Univ, Dept Phys, Berlin, Germany	University of Potsdam; Max Planck Society; Universidad de los Andes (Colombia); University of Potsdam; Max Planck Society; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin	Mueller-Roeber, B (corresponding author), Univ Potsdam, GoFORSYS Res Unit Syst Biol, Inst Biochem & Biol, Potsdam, Germany.	bmr@uni-potsdam.de	Riaño-Pachón, Diego M/A-1755-2010; Riaño-Pachón, Diego Mauricio/B-4891-2014; Hempel, Sabrina/AAO-7482-2020; Winck, Flavia V/K-5568-2014; Mueller-Roeber, Bernd/Z-4052-2019; Winck, Flavia Vischi/AAC-2949-2021	Riaño-Pachón, Diego M/0000-0001-9803-3465; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Hempel, Sabrina/0000-0002-8398-4820; Winck, Flavia V/0000-0002-8399-4156; Urbina-Gomez, David/0000-0003-3678-6327; Nikoloski, Zoran/0000-0003-2671-6763	Federal Ministry of Education and Research (BMBF), Germany [FKZ 0313924]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	The research was funded by the Federal Ministry of Education and Research (BMBF), Germany, within the frame of the GoFORSYS Research Unit for Systems Biology (FKZ 0313924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai Y, 2010, P NATL ACAD SCI USA, V107, P8153, DOI 10.1073/pnas.0912509107; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BADGER MR, 1980, PLANT PHYSIOL, V66, P407, DOI 10.1104/pp.66.3.407; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; DIONISIOSESE ML, 1990, PLANT PHYSIOL, V94, P1103, DOI 10.1104/pp.94.3.1103; Erkine AM, 2003, J BIOL CHEM, V278, P7755, DOI 10.1074/jbc.M211703200; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; Gerhart LM, 2010, NEW PHYTOL, V188, P674, DOI 10.1111/j.1469-8137.2010.03441.x; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Hempel S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.054101; Hempel S, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31111-8; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Jiang WN, 1997, J BIOL CHEM, V272, P196; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Klutstein M, 2008, GENETICS, V178, P2389, DOI 10.1534/genetics.108.086777; Kucho K, 1999, PLANT PHYSIOL, V121, P1329, DOI 10.1104/pp.121.4.1329; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Louwers M, 2009, PLANT CELL, V21, P832, DOI 10.1105/tpc.108.064329; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Moseley JL, 2009, GENETICS, V181, P889, DOI 10.1534/genetics.108.099382; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pollock SV, 2004, PLANT MOL BIOL, V56, P125, DOI 10.1007/s11103-004-2650-4; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schulz-Raffelt M, 2007, PLANT J, V52, P286, DOI 10.1111/j.1365-313X.2007.03228.x; Spijkerman E, 2008, PHYSIOL PLANTARUM, V133, P41, DOI 10.1111/j.1399-3054.2008.01062.x; Spijkerman E, 2011, PHOTOSYNTH RES, V109, P179, DOI 10.1007/s11120-010-9607-z; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yamano T, 2009, J BASIC MICROB, V49, P42, DOI 10.1002/jobm.200800352; Yoshioka S, 2004, PLANT CELL, V16, P1466, DOI 10.1105/tpc.021162; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	15	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79909	10.1371/journal.pone.0079909	http://dx.doi.org/10.1371/journal.pone.0079909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224019	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300095
J	Kornblau, SM; Qutub, A; Yao, H; York, H; Qiu, YH; Graber, D; Ravandi, F; Cortes, J; Andreeff, M; Zhang, NX; Coombes, KR				Kornblau, Steven M.; Qutub, Amina; Yao, Hui; York, Heather; Qiu, Yi Hua; Graber, David; Ravandi, Farhad; Cortes, Jorge; Andreeff, Michael; Zhang, Nianxiang; Coombes, Kevin R.			Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38-Stem-Like Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ABILITY IN-VITRO; STEM-CELLS; EXPRESSION DATA; GENE; PROGENITORS; MICROARRAY; SIGNATURES; INDUCTION; HIERARCHY	Acute myeloid leukemia (AML) is believed to arise from leukemic stem-like cells (LSC) making understanding the biological differences between LSC and normal stem cells (HSC) or common myeloid progenitors (CMP) crucial to understanding AML biology. To determine if protein expression patterns were different in LSC compared to other AML and CD34+ populations, we measured the expression of 121 proteins by Reverse Phase Protein Arrays (RPPA) in 5 purified fractions from AML marrow and blood samples: Bulk (CD3/CD19 depleted), CD34-, CD34+(CMP), CD34+CD38+ and CD34+CD38-(LSC). LSC protein expression differed markedly from Bulk (n=31 cases, 93/121 proteins) and CD34+ cells (n= 30 cases, 88/121 proteins) with 54 proteins being significantly different (31 higher, 23 lower) in LSC than in either Bulk or CD34+ cells. Sixty-seven proteins differed significantly between CD34+ and Bulk blasts (n= 69 cases). Protein expression patterns in LSC and CD34+ differed markedly from normal CD34+ cells. LSC were distinct from CD34+ and Bulk cells by principal component and by protein signaling network analysis which confirmed individual protein analysis. Potential targetable submodules in LSC included the proteins PU.1(SP1), P27, Mcl1, HIF1 alpha, cMET, P53, Yap, and phospho-Stats 1, 5 and 6. Protein expression and activation in LSC differs markedly from other blast populations suggesting that studies of AML biology should be performed in LSC.	[Kornblau, Steven M.; Qiu, Yi Hua; Graber, David; Ravandi, Farhad; Cortes, Jorge; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Qutub, Amina; York, Heather] Rice Univ, Dept Bioengn, Houston, TX USA; [Yao, Hui; Zhang, Nianxiang; Coombes, Kevin R.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center	Kornblau, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	skornblau@mdanderson.org	Yao, Huiqin/AAX-3787-2020	Yao, Huiqin/0000-0003-4742-8971; Cortes, Jorge/0000-0002-8636-1071; Qutub, Amina/0000-0003-1737-9208	Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a translational research grant from the Leukemia and Lymphoma Society to SMK. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Blair A, 2000, EXP HEMATOL, V28, P660, DOI 10.1016/S0301-472X(00)00155-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Burger JA, 2003, BRIT J HAEMATOL, V122, P579, DOI 10.1046/j.1365-2141.2003.04466.x; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan WI, 2008, SEMIN ONCOL, V35, P326, DOI 10.1053/j.seminoncol.2008.04.003; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kornblau SM, 2008, BLOOD, V112, P281; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; LORD BI, 1990, INT J CELL CLONING, V8, P317, DOI 10.1002/stem.5530080501; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Moshaver B, 2008, STEM CELLS; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pabst T, 2007, ONCOGENE, V26, P6829, DOI 10.1038/sj.onc.1210765; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Ran D, 2009, EXP HEMATOL, V37, P1423, DOI 10.1016/j.exphem.2009.10.001; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Sutherland HJ, 1996, BLOOD, V87, P4754, DOI 10.1182/blood.V87.11.4754.bloodjournal87114754; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; York H, 2012, PROTEOMICS, V12, P2084, DOI 10.1002/pmic.201100491; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055	53	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78453	10.1371/journal.pone.0078453	http://dx.doi.org/10.1371/journal.pone.0078453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24223100	Green Submitted, Green Published, gold			2022-12-25	WOS:000326152300061
J	Beyth, N; Shvero, DK; Zaltsman, N; Houri-Haddad, Y; Abramovitz, I; Davidi, MP; Weiss, EI				Beyth, Nurit; Shvero, Dana Kesler; Zaltsman, Nathan; Houri-Haddad, Yael; Abramovitz, Itzhak; Davidi, Michael Perez; Weiss, Ervin I.			Rapid Kill-Novel Endodontic Sealer and Enterococcus faecalis	PLOS ONE			English	Article							PYRIDINIUM-TYPE POLYMERS; ROOT-CANAL SEALERS; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; IN-VITRO; POLYETHYLENEIMINE NANOPARTICLES; FUNCTIONAL POLYMERS; GUTTA-PERCHA; BACTERIA; SURFACES	With growing concern over bacterial resistance, the identification of new antimicrobial means is paramount. In the oral cavity microorganisms are essential to the development of periradicular diseases and are the major causative factors associated with endodontic treatment failure. As quaternary ammonium compounds have the ability to kill a wide array of bacteria through electrostatic interactions with multiple anionic targets on the bacterial surface, it is likely that they can overcome bacterial resistance. Melding these ideas, we investigated the potency of a novel endodontic sealer in limiting Enterococcus faecalis growth. We used a polyethyleneimine scaffold to synthesize nano-sized particles, optimized for incorporation into an epoxy-based endodontic sealer. The novel endodontic sealer was tested for its antimicrobial efficacy and evaluated for biocompatibility and physical eligibility. Our results show that the novel sealer foundation affixes the nanoparticles, achieving surface bactericidal properties, but at the same time impeding nanoparticle penetration into eukaryotic cells and thereby mitigating a possible toxic effect. Moreover, adequate physical properties are maintained. The nanosized quaternary amine particles interact within minutes with bacteria, triggering cell death across wide pH values. Throughout this study we demonstrate a new antibacterial perspective for endodontic sealers; a novel antibacterial, effective and safe antimicrobial means.	[Beyth, Nurit; Shvero, Dana Kesler; Zaltsman, Nathan; Houri-Haddad, Yael; Davidi, Michael Perez; Weiss, Ervin I.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Prosthodont, Jerusalem, Israel; [Abramovitz, Itzhak] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Endodont, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Beyth, N (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Dent, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		perez davidi, michael/0000-0002-8596-5025				Aal-Saraj AB, 2012, AUST ENDOD J, V38, P60, DOI 10.1111/j.1747-4477.2010.00241.x; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2007, J DENT, V35, P201, DOI 10.1016/j.jdent.2006.07.009; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Beyth N, 2010, QUINTESSENCE INT, V41, P827; Bouillaguet S, 2006, J ENDODONT, V32, P989, DOI 10.1016/j.joen.2006.05.006; EGUCHI DS, 1985, J ENDODONT, V11, P166, DOI 10.1016/S0099-2399(85)80141-2; Foschi F, 2005, ORAL MICROBIOL IMMUN, V20, P289, DOI 10.1111/j.1399-302X.2005.00227.x; Gao BJ, 2007, J BIOMAT SCI-POLYM E, V18, P531, DOI 10.1163/156856207780852523; Gatewood R Scott, 2007, Dent Clin North Am, V51, P695, DOI 10.1016/j.cden.2007.04.005; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hancock HH, 2001, ORAL SURG ORAL MED O, V91, P579, DOI 10.1067/moe.2001.113587; IKEDA T, 1990, BIOCHIM BIOPHYS ACTA, V1026, P105, DOI 10.1016/0005-2736(90)90339-P; ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859, DOI 10.1128/AEM.24.6.859-863.1972; KAWABATA N, 1988, APPL ENVIRON MICROB, V54, P2532, DOI 10.1128/AEM.54.10.2532-2535.1988; Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004; Li GJ, 2000, J APPL POLYM SCI, V78, P676, DOI 10.1002/1097-4628(20001017)78:3<676::AID-APP240>3.0.CO;2-E; Li GJ, 2000, J APPL POLYM SCI, V78, P668, DOI 10.1002/1097-4628(20001017)78:3<668::AID-APP230>3.0.CO;2-A; Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651; Lin J, 2002, BIOTECHNOL PROGR, V18, P1082, DOI 10.1021/bp025597w; Moradi Saeed, 2009, J Oral Sci, V51, P207; Morgental RD, 2011, INT ENDOD J, V44, P1128, DOI 10.1111/j.1365-2591.2011.01931.x; Neetakantan P, 2008, J CLIN PEDIATR DENT, V33, P117, DOI 10.17796/jcpd.33.2.d526512310970142; Nonaka T, 2000, J APPL POLYM SCI, V77, P1077, DOI 10.1002/1097-4628(20000801)77:5<1077::AID-APP15>3.3.CO;2-H; ORSTAVIK D, 1990, ENDOD DENT TRAUMATOL, V6, P6; Pasqualini D, 2010, J ENDODONT, V36, P1358, DOI 10.1016/j.joen.2010.03.035; Peters OA, 2001, INT ENDOD J, V34, P221, DOI 10.1046/j.1365-2591.2001.00373.x; Pizzo G, 2006, J DENT, V34, P35, DOI 10.1016/j.jdent.2005.03.001; Ricucci D, 2010, J ENDODONT, V36, P1, DOI 10.1016/j.joen.2009.09.038; Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004; Saha S, 2010, J Indian Soc Pedod Prev Dent, V28, P251, DOI 10.4103/0970-4388.76151; Senges C, 2011, J ENDODONT, V37, P1247, DOI 10.1016/j.joen.2011.05.034; Shen Y, 2009, J ENDODONT, V35, P981, DOI 10.1016/j.joen.2009.04.030; Shipper G, 2005, J ENDODONT, V31, P91, DOI 10.1097/01.don.0000140569.33867.bf; Siqueira JF, 2000, J ENDODONT, V26, P274, DOI 10.1097/00004770-200005000-00005; Siqueira JF, 2008, J ENDODONT, V34, P1291, DOI 10.1016/j.joen.2008.07.028; Slutzky-Goldberg I, 2008, J ENDODONT, V34, P735, DOI 10.1016/j.joen.2008.03.012; Tanomaru Juliane M G, 2008, Acta Odontol Latinoam, V21, P147; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; TOBIAS RS, 1988, INT ENDOD J, V21, P155, DOI 10.1111/j.1365-2591.1988.tb00969.x; Waltimo T, 2005, J ENDODONT, V31, P863, DOI 10.1097/01.don.0000164856.27920.85; Zhang H, 2009, J ENDODONT, V35, P1051, DOI 10.1016/j.joen.2009.04.022	44	16	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78586	10.1371/journal.pone.0078586	http://dx.doi.org/10.1371/journal.pone.0078586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223159	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200051
J	Bihari, V; Kesavachandran, CN; Mathur, N; Pangtey, BS; Kamal, R; Pathak, MK; Srivastava, AK				Bihari, Vipin; Kesavachandran, Chandrasekharan Nair; Mathur, Neeraj; Pangtey, Balram Singh; Kamal, Ritul; Pathak, Manoj Kumar; Srivastava, Anup Kumar			Mathematically Derived Body Volume and Risk of Musculoskeletal Pain among Housewives in North India	PLOS ONE			English	Article							LOW-BACK-PAIN; MASS INDEX; TRONDELAG HEALTH; LEISURE-TIME; OBESITY; WOMEN; ASSOCIATION; NETHERLANDS; PREVALENCE; DISABILITY	Background: Global Burden of Disease Study 2010 demonstrates the impact of musculoskeletal diseases as the second greatest cause of disability globally in all regions of the world. The study was conducted to determine the role of mathematically derived body volume (BV), body volume index (BVI), body mass index (BMI), body surface area (BSA) and body fat % (BF %) on musculoskeletal pain (MSP) among housewives in National Capital Region (NCR). Methods: A cross sectional study was undertaken among 495 housewives from Gurgaon and New Okhla Industrial Development Area (NOIDA) in National Capital Region (NCR), New Delhi, India. The study includes questionnaire survey, clinical examination and body composition monitoring among housewives. Results: A significantly higher BMI, BVI, BV and BSA were observed in subjects with MSP as compared to those who had no MSP. This was also true for subjects with pain in knee for BMI category for overweight. Subjects with pain in limbs had significantly high BMI and BVI as compared to subjects with no MSP. A significant positive correlation of age with BMI, BVI, BV and BSA was observed among subjects having no MSP denoting a direct relationship of age and these body factors. Conclusions: The prevalence of MSP among housewives is associated with increasing age, BMI and BVI. This can possibly be used for formulating a strategy for prevention of MSP.	[Bihari, Vipin; Kesavachandran, Chandrasekharan Nair; Mathur, Neeraj; Pangtey, Balram Singh; Kamal, Ritul; Pathak, Manoj Kumar; Srivastava, Anup Kumar] CSIR, Indian Inst Toxicol Res, Div Epidemiol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Srivastava, AK (corresponding author), CSIR, Indian Inst Toxicol Res, Div Epidemiol, Lucknow, Uttar Pradesh, India.	srianup1@yahoo.co.in		Kamal, Ritul/0000-0001-9741-1698; Srivastava, Anup Kumar/0000-0002-0211-7814	CSIR - Network Program [NWP - 17]	CSIR - Network Program	Financial support for the study was provided from CSIR - Network Program (NWP - 17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adera Tilahun, 1994, Annals of Epidemiology, V4, P416; Al-Awadhi AM, 2005, ANN SAUDI MED, V25, P459, DOI 10.5144/0256-4947.2005.459; Bigal ME, 2006, NEUROLOGY, V66, P545, DOI 10.1212/01.wnl.0000197218.05284.82; Bihari V, 2011, Indian J Occup Environ Med, V15, P59, DOI 10.4103/0019-5278.90375; Cardoso J.P., 2009, REV BRAS EPIDEMIOL, V12, P604, DOI [10.1590/S1415-790X2009000400010, DOI 10.1590/S1415-790X2009000400010]; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Escalante A, 2005, ARCH INTERN MED, V165, P1624, DOI 10.1001/archinte.165.14.1624; Haq SA, 2008, INT J RHEUM DIS, V11, P216, DOI 10.1111/j.1756-185X.2008.00364.x; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Koley S, 2009, LIFE SCI, V1, P129; Korkmaz NC, 2003, PAIN CLINIC, V15, P219; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LAU EMC, 1995, J EPIDEMIOL COMMUN H, V49, P492, DOI 10.1136/jech.49.5.492; Leavitt SB, 2012, SOARING BURDEN MUSCU; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Lohman TG, 1996, EXERCISE SPORT SCI R, V14, P325; Loshak VD, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI [10.1210/jc.87.4.1509, DOI 10.1210/JC.87.4.1509.PUBMED:11932273]; Marino PL, 2009, LITTLE ICU BOOK FACT, P106; Miranda H, 2002, OSTEOARTHR CARTILAGE, V10, P623, DOI 10.1053/joca.2002.0796; Moore R, 1999, EPIDEMIOL PAIN, P53; Mork PJ, 2010, ARTHRIT CARE RES, V62, P611, DOI 10.1002/acr.20118; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; SENDROY J, 1966, J APPL PHYSIOL, V21, P167, DOI 10.1152/jappl.1966.21.1.167; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sorensen MB, 2001, OBES RES, V9, P622, DOI 10.1038/oby.2001.81; Suryapani R., 1996, TRIBUNE, V6, P16; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Weevers HJA, 2005, FAM PRACT, V22, P197, DOI 10.1093/fampra/cmh727; *WHO SCI GROUP, 2003, WHO TECHN REP SER, V919; Woolf AD, 2001, BMJ-BRIT MED J, V322, P1079, DOI 10.1136/bmj.322.7294.1079; Yip YB, 2001, INT J OBESITY, V25, P887, DOI 10.1038/sj.ijo.0801557; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80133	10.1371/journal.pone.0080133	http://dx.doi.org/10.1371/journal.pone.0080133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223218	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200111
J	Lavelle, A; Lennon, G; Docherty, N; Balfe, A; Mulcahy, HE; Doherty, G; O'Donoghue, D; Hyland, JM; Shanahan, F; Sheahan, K; Coffey, JC; Winter, DC; O'Connell, PR				Lavelle, Aonghus; Lennon, Grainne; Docherty, Neil; Balfe, Aine; Mulcahy, Hugh E.; Doherty, Glen; O'Donoghue, Diarmuid; Hyland, John M.; Shanahan, Fergus; Sheahan, Kieran; Coffey, J. Calvin; Winter, Desmond C.; O'Connell, P. Ronan			Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; DIVERSITY; DISEASE; ENTEROTYPES; STABILITY; THERAPY; COLITIS; TRACT	Objective: The aims of this study were to develop techniques for spatial microbial assessment in humans and to establish colonic luminal and mucosal spatial ecology, encompassing longitudinal and cross-sectional axes. Design: A microbiological protected specimen brush was used in conjunction with a biopsy forceps to sample the colon in nine healthy volunteers undergoing colonoscopy. Terminal Restriction Fragment Length Polymorphism analysis was used to determine the major variables in the spatial organization of the colonic microbiota. Results: Protected Specimen Brush sampling retrieved region-specific, uncontaminated samples that were enriched for bacterial DNA and depleted in human DNA when compared to biopsy samples. Terminal Restriction Fragment Length Polymorphism analysis revealed a segmentation of bacterial communities between the luminal brush and biopsy-associated ecological niches with little variability across the longitudinal axis of the colon and reduced diversity in brush samples. Conclusion: These results support the concept of a microbiota with little longitudinal variability but with some degree of segregation between luminal and mucosal communities.	[Lavelle, Aonghus; Lennon, Grainne; Balfe, Aine; Winter, Desmond C.; O'Connell, P. Ronan] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Lavelle, Aonghus; Lennon, Grainne; Mulcahy, Hugh E.; Doherty, Glen; O'Donoghue, Diarmuid; Hyland, John M.; Sheahan, Kieran; Winter, Desmond C.; O'Connell, P. Ronan] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [Docherty, Neil] Trin Coll Dublin, Dept Physiol, Dublin, Ireland; [Coffey, J. Calvin] Univ Limerick, Grad Entry Med Sch, Ctr Intervent Inflammat Infect & Immun 4i, Limerick, Ireland; [Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University of Limerick; University College Cork	O'Connell, PR (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	Ronan.OConnell@ucd.ie	O'Connell, Patrick Ronan/H-6583-2019; Shanahan, Fergus/ABF-2390-2020	O'Connell, Patrick Ronan/0000-0002-1846-5629; Shanahan, Fergus/0000-0003-0467-0936; Docherty, Neil/0000-0002-0961-2607; Doherty, Glen/0000-0003-4384-5049; mulcahy, hugh/0000-0002-7087-6177	Science Foundation Ireland [09/IN.1/B2606]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Funding was provided by a Science Foundation Ireland grant (09/IN.1/B2606). www.sfi.ie. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler D, 2012, COMPREHENSIVE R ARCH; Araujo-Perez F, 2012, GUT MICROBES, V3, P530, DOI 10.4161/gmic.22157; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Dave M, 2011, GUT, V60, P1043, DOI 10.1136/gut.2010.224337; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jeffery IB, 2012, NAT REV MICROBIOL, V10, P591, DOI 10.1038/nrmicro2859; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815; Oksanen J, 2012, COMPREHENSIVE R ARCH; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2012, R LANG ENV STAT COMP; Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x; Rowan F, 2010, ANN SURG, V252, P869, DOI 10.1097/SLA.0b013e3181fdc54c; Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620; Shanahan F, 2011, CURR OPIN GASTROEN, V27, P61, DOI 10.1097/MOG.0b013e328340076f; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Fodor Lab, 2012, PEAKSTUDIO; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	45	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78835	10.1371/journal.pone.0078835	http://dx.doi.org/10.1371/journal.pone.0078835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223167	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200059
J	Su, HT; Kodiha, M; Lee, S; Stochaj, U				Su, Haitong; Kodiha, Mohamed; Lee, Sunghoon; Stochaj, Ursula			Identification of Novel Markers That Demarcate the Nucleolus during Severe Stress and Chemotherapeutic Treatment	PLOS ONE			English	Article							RIBOSOME BIOGENESIS; MESSENGER-RNA; SIGNALING EVENTS; PROTEINS; HUR; HETEROCHROMATIN; COMPONENTS; IMAGE	The nucleolus, the ribosomal factory of the cell, has emerged as a key player that regulates many aspects of cell biology. Several thousand proteins associate at least transiently with nucleoli, thereby generating a highly dynamic compartment with a protein profile which is sensitive to changes in cell physiology and pharmacological agents. Powerful tools that reliably demarcate the nucleoli are a prerequisite to measure their composition and activities. Previously, we developed quantitative methods to measure fluorescently labeled molecules in nucleoli. While these tools identify nucleoli under control and mild stress conditions, the accurate detection of nucleolar boundaries under harsh experimental conditions is complicated by the lack of appropriate markers for the nucleolar compartment. Using fluorescence microscopy we have now identified new marker proteins to detect nucleoli upon (a) severe stress and (b) drug treatments that trigger a pronounced reorganization of nucleoli. Our results demonstrate that nucleolin is an ideal marker to delimit nucleoli when cells are exposed to heat or oxidative stress. Furthermore, we show for the first time that cellular apoptosis susceptibility protein (CAS) and human antigen R protein (HuR) are excluded from nucleoli and can be employed to delimit these compartments under severe conditions that redistribute major nucleolar proteins. As proof-of-principle, we used these markers to demarcate nucleoli in cells treated with pharmacological compounds that disrupt the nucleolar organization. Furthermore, to gain new insights into the biology of the nucleolus, we applied our protocols and quantified stress-and drug-induced changes in nucleolar organization and function. Finally, we show that CAS, HuR and nucleolin not only identify nucleoli in optical sections, but are also suitable to demarcate the nucleolar border following 3D reconstruction. Taken together, our studies present novel marker proteins that delimit nucleoli with high confidence under a variety of experimental settings.	[Su, Haitong; Kodiha, Mohamed; Lee, Sunghoon; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	stochaj, ursula/AAC-1865-2021		Natural Sciences and Engineering Research Council (NSERC); Fonds de Recherche Nature et Technologies Quebec (FQRNT); Heart and Stroke Foundation of Canada (HSFC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Nature et Technologies Quebec (FQRNT); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This research was supported by grants and fellowships from Natural Sciences and Engineering Research Council (NSERC), Fonds de Recherche Nature et Technologies Quebec (FQRNT), and Heart and Stroke Foundation of Canada (HSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Avitabile D, 2011, P NATL ACAD SCI USA, V108, P6145, DOI 10.1073/pnas.1017935108; Banski P, 2010, TRENDS BIOCHEM SCI, V35, P361, DOI 10.1016/j.tibs.2010.02.010; Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bierne H, 2013, EMBO REP, V14, P663, DOI 10.1038/embor.2013.105; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Guetg C, 2012, EPIGENETICS-US, V7, P811, DOI 10.4161/epi.21072; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Kar B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-33; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Khandelwal N, 2011, CELL DEATH DIFFER, V18, P1889, DOI 10.1038/cdd.2011.79; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2013, CHAPERONES MULTITASK, P149; Kodiha M, 2012, J SIGNAL TRANSDUCTIO, V2012; Kodiha M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-25; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Lindenboim L, 2010, CELL DEATH DIFFER, V17, P346, DOI 10.1038/cdd.2009.145; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Louvet E, 2006, MOL BIOL CELL, V17, P2537, DOI 10.1091/mbc.E05-10-0923; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Mahboubi H, 2013, MICROSC MICROANAL, P1; Mahboubi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068356; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Politz JCR, 2005, MOL BIOL CELL, V16, P3401, DOI 10.1091/mbc.E05-02-0106; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Turner AJ, 2012, RNA BIOL, V9, DOI [10.4161/rna.18811, 10.4161/rna.9.2.18811]; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414	50	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80237	10.1371/journal.pone.0080237	http://dx.doi.org/10.1371/journal.pone.0080237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223222	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200115
J	Voss, MW; Wong, CN; Baniqued, PL; Burdette, JH; Erickson, KI; Prakash, RS; McAuley, E; Laurienti, PJ; Kramer, AF				Voss, Michelle W.; Wong, Chelsea N.; Baniqued, Pauline L.; Burdette, Jonathan H.; Erickson, Kirk I.; Prakash, Ruchika Shaurya; McAuley, Edward; Laurienti, Paul J.; Kramer, Arthur F.			Aging Brain from a Network Science Perspective: Something to Be Positive About?	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; CARDIORESPIRATORY FITNESS; AGE; FMRI; SYSTEMS; MOTION; ROBUST; LIFE	To better understand age differences in brain function and behavior, the current study applied network science to model functional interactions between brain regions. We observed a shift in network topology whereby for older adults subcortical and cerebellar structures overlapping with the Salience network had more connectivity to the rest of the brain, coupled with fragmentation of large-scale cortical networks such as the Default and Fronto-Parietal networks. Additionally, greater integration of the dorsal medial thalamus and red nucleus in the Salience network was associated with greater satisfaction with life for older adults, which is consistent with theoretical predictions of age-related increases in emotion regulation that are thought to help maintain well-being and life satisfaction in late adulthood. In regard to cognitive abilities, greater ventral medial prefrontal cortex coherence with its topological neighbors in the Default Network was associated with faster processing speed. Results suggest that large-scale organizing properties of the brain differ with normal aging, and this perspective may offer novel insight into understanding age-related differences in cognitive function and well-being.	[Voss, Michelle W.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Wong, Chelsea N.; Baniqued, Pauline L.; Kramer, Arthur F.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Wong, Chelsea N.; Baniqued, Pauline L.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Prakash, Ruchika Shaurya] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Univ, Wake Forest Sch Med, Winston Salem, NC 27109 USA	University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Wake Forest University	Voss, MW (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	michelle-voss@uiowa.edu	Prakash, Ruchika S/K-2030-2013; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging at the National Institutes of Health [R37 AG025667, RO1 AG25032]; NATIONAL INSTITUTE ON AGING [R01AG025032] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging at the National Institutes of Health (grant numbers R37 AG025667, RO1 AG25032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gana K, 2012, J GERONTOL B-PSYCHOL; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Madden DJ, 2010, NEUROIMAGE, V52, P643, DOI 10.1016/j.neuroimage.2010.04.249; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Nolte J, 2009, HUMAN BRAIN INTRO IT, P390; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prakash RS, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00229; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Urry HL, 2010, CURR DIR PSYCHOL SCI, V19, P352, DOI 10.1177/0963721410388395; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Voss MW, 2008, BRAIN RES, V1244, P121, DOI 10.1016/j.brainres.2008.09.051; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	58	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78345	10.1371/journal.pone.0078345	http://dx.doi.org/10.1371/journal.pone.0078345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223147	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200039
J	Boynak, NY; Rojas, F; D'Alessio, C; Larrea, SCV; Rodriguez, V; Ghiringhelli, PD; Tellez-Inon, MT				Boynak, Natalia Y.; Rojas, Federico; D'Alessio, Cecilia; Larrea, Salome C. Vilchez; Rodriguez, Vanina; Ghiringhelli, Pablo D.; Tellez-Inon, Maria T.			Identification of a Wee1-Like Kinase Gene Essential for Procyclic Trypanosoma brucei Survival	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; CELL-CYCLE REGULATION; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; CHECKPOINT KINASE; FISSION YEAST; WEE1; MITOSIS; CYTOKINESIS	Regulation of eukaryotic cell cycle progression requires sequential activation and inactivation of cyclin-dependent kinases (CDKs). Activation of the cyclin B-cdc2 kinase complex is a pivotal step in mitotic initiation and the tyrosine kinase Wee1 is a key regulator of cell cycle sequence during G2/M transition and inhibits mitotic entry by phosphorylating the inhibitory tyrosine 15 on the cdc2 M-phase-inducing kinase. Wee1 degradation is essential for the exit from the G2 phase. In trypanosomatids, little is known about the genes that regulate cyclin B-cdc2 complexes at the G2/M transition of their cell cycle. Although canonical tyrosine kinases are absent in the genome of trypanosomatids, phosphorylation on protein tyrosine residues has been reported in Trypanosoma brucei. Here, we characterized a Wee1-like protein kinase gene from T. brucei. Expression of TbWee1 in a Schizosaccharomyces pombe strain null for Wee1 inhibited cell division and caused cell elongation. This demonstrates the lengthening of G2, which provided cells with extra time to grow before dividing. The Wee1-like protein kinase was expressed in the procyclic and bloodstream proliferative slender forms of T. brucei and the role of Wee1 in cell cycle progression was analyzed by generating RNA interference cell lines. In the procyclic form of T. brucei, the knock-down of TbWee1 expression by RNAi led to inhibition of parasite growth. Abnormal phenotypes showing an increase in the percentage of cells with 1N0K, 0N1K and 2N1K were observed in these RNAi cell lines. Using parasites with a synchronized cell cycle, we demonstrated that TbWee1 is linked to the G2/M phase. We also showed that TbWee1 is an essential gene necessary for proper cell cycle progression and parasite growth in T. brucei. Our results provide evidence for the existence of a functional Wee1 in T. brucei with a potential role in cell division at G2/M.	[Boynak, Natalia Y.; Rojas, Federico; Larrea, Salome C. Vilchez; Tellez-Inon, Maria T.] Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, RA-1033 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Lab Glycobiol, RA-1033 Buenos Aires, DF, Argentina; [Rodriguez, Vanina; Ghiringhelli, Pablo D.] Univ Nacl Quilmes, Dept Sci & Technol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Tellez-Inon, MT (corresponding author), Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, RA-1033 Buenos Aires, DF, Argentina.	mtellez@dna.uba.ar	Ghiringhelli, Pablo D/N-8073-2017; Rojas, Federico/AAG-6220-2020	Ghiringhelli, Pablo D/0000-0002-2003-0106; Rojas, Federico/0000-0002-7018-2861; D'Alessio, Cecilia/0000-0001-7371-5080; Vilchez Larrea, Salome/0000-0001-8302-1509	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina. NYB, FR, VR, SV were Fellows and DG, CD and MTTI are Career Investigators of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligue R, 1997, J BIOL CHEM, V272, P13320, DOI 10.1074/jbc.272.20.13320; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Borup MT, 2006, CELL CYCLE, V5, P2138, DOI 10.4161/cc.5.18.3206; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cools T, 2011, PLANT CELL, V23, P1435, DOI 10.1105/tpc.110.082768; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; Enders GH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-12; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gomez EB, 1998, MOL BIOCHEM PARASIT, V91, P337, DOI 10.1016/S0166-6851(97)00218-1; Gonzalez N, 2004, PLANT MOL BIOL, V56, P849, DOI 10.1007/s11103-004-5110-2; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; HONDA R, 1995, CHROMOSOME RES, V3, P300, DOI 10.1007/BF00713068; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Li Y, 2003, MOL MICROBIOL, V49, P251, DOI 10.1046/j.1365-2958.2003.03575.x; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Lim HH, 2003, MOL CELL, V11, P845, DOI 10.1016/S1097-2765(03)00149-7; MacIntosh GC, 1996, PLANT PHYSIOL, V112, P1541, DOI 10.1104/pp.112.4.1541; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Monnerat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067327; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MOTTRAM JC, 1995, GENE, V162, P147, DOI 10.1016/0378-1119(95)00350-F; Mueller Paul R, 2005, Methods Mol Biol, V296, P299; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; Murakami MS, 2011, GENE DEV, V13, P620; Murrow LM, 2010, BREAST CANCER RES TR, V122, P347, DOI 10.1007/s10549-009-0571-2; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Okamoto K, 2007, P NATL ACAD SCI USA, V104, P3753, DOI 10.1073/pnas.0607357104; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Ploubidou A, 1999, J CELL SCI, V112, P4641; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sorrell DA, 2002, PLANTA, V215, P518, DOI 10.1007/s00425-002-0815-4; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P4180, DOI 10.1073/pnas.96.7.4180; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49	72	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79364	10.1371/journal.pone.0079364	http://dx.doi.org/10.1371/journal.pone.0079364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223931	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400062
J	Darbari, DS; Wang, ZY; Kwak, MJ; Hildesheim, M; Nichols, J; Allen, D; Seamon, C; Peters-Lawrence, M; Conrey, A; Hall, MK; Kato, GJ; Taylor, JG				Darbari, Deepika S.; Wang, Zhengyuan; Kwak, Minjung; Hildesheim, Mariana; Nichols, James; Allen, Darlene; Seamon, Catherine; Peters-Lawrence, Marlene; Conrey, Anna; Hall, Mary K.; Kato, Gregory J.; Taylor, James G.			Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort Study	PLOS ONE			English	Article							ACUTE CHEST SYNDROME; PULMONARY-HYPERTENSION; DISEASE; CHILDREN; RISK; HYDROXYUREA; PREVENTION; STROKE; DEATH; CARE	Background: Frequent painful vaso-occlusive crises (VOCs) were associated with mortality in the Cooperative Study of Sickle Cell Disease (CSSCD) over twenty years ago. Modern therapies for sickle cell anemia (SCA) like hydroxyurea are believed to have improved overall patient survival. The current study sought to determine the relevance of the association between more frequent VOCs and death and its relative impact upon overall mortality compared to other known risk factors in a contemporary adult SCA cohort. Methods: Two hundred sixty four SCA adults were assigned into two groups based on patient reported outcomes for emergency department (ED) visits or hospitalizations for painful VOC treatment during the 12 months prior to evaluation. Results: Higher baseline hematocrit (p = 0.0008), ferritin (p = 0.005), and HDL cholesterol (p = 0.01) were independently associated with 1 or more painful VOCs requiring an ED visit or hospitalization for acute pain. During a median follow-up of 5 years, mortality was higher in the ED visit/hospitalization group (relative risk [RR] 2.68, 95% CI 1.1-6.5, p = 0.03). Higher tricuspid regurgitatant jet velocity (TRV) (RR 2.41, 95% CI 1.5-3.9, p < 0.0001), elevated ferritin (RR 4.00, 95% CI 1.8-9.0, p = 0.001) and lower glomerular filtration rate (RR=2.73, 95% CI 1.6-4.6, p < 0.0001) were also independent risk factors for mortality. Conclusions: Severe painful VOCs remain a marker for SCA disease severity and premature mortality in a modern cohort along with other known risk factors for death including high TRV, high ferritin and lower renal function. The number of patient reported pain crises requiring healthcare utilization is an easily obtained outcome that could help to identify high risk patients for disease modifying therapies.	[Darbari, Deepika S.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Darbari, Deepika S.; Wang, Zhengyuan; Taylor, James G.] NHLBI, NIH, Hematol Branch, Genom Med Sect, Bethesda, MD 20892 USA; [Kwak, Minjung] Natl Heart Lung & Blood Inst, NIH, Off Biostat Res, Bethesda, MD USA; [Hildesheim, Mariana; Nichols, James; Allen, Darlene; Seamon, Catherine; Peters-Lawrence, Marlene; Conrey, Anna; Kato, Gregory J.] Natl Heart Lung & Blood Inst, NIH, Hematol Branch, Sickle Cell Dis Vasc Sect, Bethesda, MD USA; [Hall, Mary K.] NIH, Ctr Clin, Bethesda, MD 20892 USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Taylor, JG (corresponding author), NHLBI, NIH, Hematol Branch, Genom Med Sect, Bethesda, MD 20892 USA.	jamesta@mail.nih.gov	Kato, Gregory J/I-7615-2014; wang, zhengyuan/HGA-0435-2022; Wang, Zhengyuan/GWV-6069-2022; Taylor, James G./AAH-4782-2021	Kato, Gregory J/0000-0003-4465-3217; wang, zhengyuan/0000-0002-8447-9674; Taylor, James G./0000-0002-4421-1809	Division of Intramural Research, National Heart, Lung and Blood Institute [1ZIAHL006012-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006012] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Division of Intramural Research, National Heart, Lung and Blood Institute (project 1ZIAHL006012-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; BALLAS SK, 1988, BLOOD, V72, P1216; Bean CJ, 2012, BLOOD, V120, P3822, DOI 10.1182/blood-2011-06-361642; BILLETT HH, 1986, BLOOD, V68, P301; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1995, CONTROL CLIN TRIALS, V16, P432, DOI 10.1016/S0197-2456(95)00098-4; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hoots WK, 2012, PEDIATR BLOOD CANCER, V59, P353, DOI 10.1002/pbc.24180; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; LETTRE G, 2012, COLD SPRING HARBOR P, V2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Miller ST, 2001, J PEDIATR-US, V139, P785, DOI 10.1067/mpd.2001.119593; Minniti CP, 2009, BRIT J HAEMATOL, V147, P737, DOI 10.1111/j.1365-2141.2009.07906.x; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; SASAKI J, 1983, CLIN LAB HAEMATOL, V5, P35; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Zorca S, 2010, BRIT J HAEMATOL, V149, P436, DOI 10.1111/j.1365-2141.2010.08109.x	31	70	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79923	10.1371/journal.pone.0079923	http://dx.doi.org/10.1371/journal.pone.0079923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224021	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400095
J	Kato, H; Kira, S; Kawamukai, M				Kato, Hiroaki; Kira, Shintaro; Kawamukai, Makoto			The Transcription Factors Atf1 and Pcr1 Are Essential for Transcriptional Induction of the Extracellular Maltase Agl1 in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENE; KINASE; MEDIATOR; PROTEIN; DISTINCT; ACTIVATION; EXPRESSION; ENCODES; BINDING	The fission yeast Schizosaccharomyces pombe secretes the extracellular maltase Agl1, which hydrolyzes maltose into glucose, thereby utilizing maltose as a carbon source. Whether other maltases contribute to efficient utilization of maltose and how Agl1 expression is regulated in response to switching of carbon sources are unknown. In this study, we show that three other possible maltases and the maltose transporter Sut1 are not required for efficient utilization of maltose. Transcription of agl1 was induced when the carbon source was changed from glucose to maltose. This was dependent on Atf1 and Pcr1, which are highly conserved transcription factors that regulate stress-responsive genes in various stress conditions. Atf1 and Pcr1 generally bind the TGACGT motif as a heterodimer. The agl1 gene lacks the exact motif, but has many degenerate TGACGT motifs in its promoter and coding region. When the carbon source was switched from glucose to maltose, Atf1 and Pcr1 associated with the promoters and coding regions of agl1, fbp1, and gpx1, indicating that the Atf1-Pcr1 heteromer binds a variety of regions in its target genes to induce their transcription. In addition, the association of Mediator with these genes was dependent on Atf1 and Pcr1. These data indicate that Atf1 and Pcr1 induce the transcription of agl1, which allows efficient utilization of extracellular maltose.	[Kato, Hiroaki; Kira, Shintaro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Kato, Hiroaki] Shimane Univ, Sch Med, Dept Biochem, Izumo, Shimane, Japan; [Kato, Hiroaki] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Shimane University; Shimane University; Japan Science & Technology Agency (JST)	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Kato, Hiroaki/T-1674-2017	Kawamukai, Makoto/0000-0003-2929-8798; Kato, Hiroaki/0000-0001-9591-1875	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380056]; JSPS KAKENHI [24710229]; JST PRESTO program; Grants-in-Aid for Scientific Research [25660059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid (#24380056) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Makoto Kawamukai, by JSPS KAKENHI Number 24710229, and by a grant from the JST PRESTO program to Hiroaki Kato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chi ZM, 2008, MYCOL RES, V112, P983, DOI 10.1016/j.mycres.2008.01.024; Eshaghi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011620; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Jansen MLA, 2006, FEMS YEAST RES, V6, P888, DOI 10.1111/j.1567-1364.2006.00091.x; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Mehta SV, 1998, J BACTERIOL, V180, P674, DOI 10.1128/JB.180.3.674-679.1998; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Reinders A, 2001, MOL MICROBIOL, V39, P445, DOI 10.1046/j.1365-2958.2001.02237.x; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80572	10.1371/journal.pone.0080572	http://dx.doi.org/10.1371/journal.pone.0080572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224056	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400120
J	Lear, BC; Darrah, EJ; Aldrich, BT; Gebre, S; Scott, RL; Nash, HA; Allada, R				Lear, Bridget C.; Darrah, Eric J.; Aldrich, Benjamin T.; Gebre, Senetibeb; Scott, Robert L.; Nash, Howard A.; Allada, Ravi			UNC79 and UNC80, Putative Auxiliary Subunits of the NARROW ABDOMEN Ion Channel, Are Indispensable for Robust Circadian Locomotor Rhythms in Drosophila	PLOS ONE			English	Article							CATION CHANNEL; NEURONAL EXCITABILITY; GENE; EXPRESSION	In the fruit fly Drosophila melanogaster, a network of circadian pacemaker neurons drives daily rhythms in rest and activity. The ion channel NARROW ABDOMEN (NA), orthologous to the mammalian sodium leak channel NALCN, functions downstream of the molecular circadian clock in pacemaker neurons to promote behavioral rhythmicity. To better understand the function and regulation of the NA channel, we have characterized two putative auxiliary channel subunits in Drosophila, unc79 (aka dunc79) and unc80 (aka CG18437). We have generated novel unc79 and unc80 mutations that represent strong or complete loss-of-function alleles. These mutants display severe defects in circadian locomotor rhythmicity that are indistinguishable from na mutant phenotypes. Tissue-specific RNA interference and rescue analyses indicate that UNC79 and UNC80 likely function within pacemaker neurons, with similar anatomical requirements to NA. We observe an interdependent, post-transcriptional regulatory relationship among the three gene products, as loss of na, unc79, or unc80 gene function leads to decreased expression of all three proteins, with minimal effect on transcript levels. Yet despite this relationship, we find that the requirement for unc79 and unc80 in circadian rhythmicity cannot be bypassed by increasing NA protein expression, nor can these putative auxiliary subunits substitute for each other. These data indicate functional requirements for UNC79 and UNC80 beyond promoting channel subunit expression. Immunoprecipitation experiments also confirm that UNC79 and UNC80 form a complex with NA in the Drosophila brain. Taken together, these data suggest that Drosophila NA, UNC79, and UNC80 function together in circadian clock neurons to promote rhythmic behavior.	[Lear, Bridget C.; Darrah, Eric J.; Aldrich, Benjamin T.; Gebre, Senetibeb] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Scott, Robert L.; Nash, Howard A.] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA; [Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Northwestern University	Lear, BC (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bridget-lear@uiowa.edu			NIH [R00 GM080107, R01 NS052903]; NARSAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R00 GM080107 to B. C. L, NIH R01 NS052903 to R. A., and a NARSAD Young Investigator Award to B. C. L. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUBREUIL R, 1987, J CELL BIOL, V105, P2095, DOI 10.1083/jcb.105.5.2095; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lear BC, 2012, CIRCADIAN RHYTHMS EN, P1; LeSauter J, 2011, J NEUROPHYSIOL, V106, P576, DOI 10.1152/jn.00060.2011; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; MORGAN PG, 1988, ANESTHESIOLOGY, V69, P246, DOI 10.1097/00000542-198808000-00015; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Speca DJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001057; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Wang H, 2009, CHANNELS, V3, P161, DOI 10.4161/chan.3.3.8853; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	28	34	35	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78147	10.1371/journal.pone.0078147	http://dx.doi.org/10.1371/journal.pone.0078147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223770	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400018
J	Owen, EL; Bale, JS; Hayward, SAL				Owen, Emily L.; Bale, Jeffrey S.; Hayward, Scott A. L.			Can Winter-Active Bumblebees Survive the Cold? Assessing the Cold Tolerance of Bombus terrestris audax and the Effects of Pollen Feeding	PLOS ONE			English	Article							HYMENOPTERA APIDAE; L. HYMENOPTERA; HARDINESS; COLONIES; LIFE; FOOD; THERMOREGULATION; POLLINATOR; BEHAVIORS; DIAPAUSE	There is now considerable evidence that climate change is disrupting the phenology of key pollinator species. The recently reported UK winter activity of the bumblebee Bombus terrestris brings a novel set of thermal challenges to bumblebee workers that would typically only be exposed to summer conditions. Here we assess the ability of workers to survive acute and chronic cold stress (via lower lethal temperatures and lower lethal times at 0 degrees C), the capacity for rapid cold hardening (RCH) and the influence of diet (pollen versus nectar consumption) on supercooling points (SCP). Comparisons are made with chronic cold stress indices and SCPs in queen bumblebees. Results showed worker bees were able to survive acute temperatures likely to be experienced in a mild winter, with queens significantly more tolerant to chronic cold temperature stress. The first evidence of RCH in any Hymenoptera is shown. In addition, dietary manipulation indicated the consumption of pollen significantly increased SCP temperature. These results are discussed in the light of winter active bumblebees and climate change.	[Owen, Emily L.; Bale, Jeffrey S.; Hayward, Scott A. L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Owen, EL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	exo763@bham.ac.uk		Hayward, Scott/0000-0002-1899-6630	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a PhD studentship awarded to ELO by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD DV, 1969, J ANIM ECOL, V38, P149, DOI 10.2307/2743; Alford DV, 1975, BUMBLEBEES; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 1996, EUR J ENTOMOL, V93, P369; BALE JS, 1989, CRYOBIOLOGY, V26, P285, DOI 10.1016/0011-2240(89)90024-2; Beekman M, 1999, ENTOMOL EXP APPL, V93, P69, DOI 10.1023/A:1003886710659; Buttermore RE, 1997, AUST J ENTOMOL, V36, P251, DOI 10.1111/j.1440-6055.1997.tb01463.x; Cattiaux J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044613; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; COULSON SJ, 1990, J INSECT PHYSIOL, V36, P207, DOI 10.1016/0022-1910(90)90124-X; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diehl K, 2001, ATMOS RES, V58, P75, DOI 10.1016/S0169-8095(01)00091-6; DUMAN JG, 1978, COMP BIOCHEM PHYS A, V59, P69, DOI 10.1016/0300-9629(78)90308-0; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; Everatt MJ, 2012, J INSECT PHYSIOL, V58, P1104, DOI 10.1016/j.jinsphys.2012.05.009; Finney D.J., 1971, PROBIT ANAL; FREE J. B., 1955, INSECTES SOCIAUX, V2, P303, DOI 10.1007/BF02331508; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Gurel F, 2008, INSECT SOC, V55, P123, DOI 10.1007/s00040-008-0984-7; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hillstrom ML, 2008, INSECT CONSERV DIVER, V1, P233, DOI 10.1111/j.1752-4598.2008.00031.x; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Krunic MD, 2006, B ENTOMOL RES, V96, P323, DOI 10.1079/BER2006423; KRUNIC MD, 1971, CAN J ZOOLOG, V49, P863, DOI 10.1139/z71-129; LEE RE, 1989, BIOSCIENCE, V39, P308, DOI 10.2307/1311113; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee RE, 2006, J EXP BIOL, V209, P399, DOI 10.1242/jeb.02001; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Met Office, 2010, DEC 2010; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Musolin DL, 2003, ECOL ENTOMOL, V28, P694, DOI 10.1111/j.1365-2311.2003.00559.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Roberts Stuart P.M., 2011, BioRisk, V6, P1; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sheffield CS, 2008, J KANSAS ENTOMOL SOC, V81, P276, DOI 10.2317/JKES-710.23.1; Shreve SM, 2004, J EXP BIOL, V207, P1797, DOI 10.1242/jeb.00951; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; TASEI JN, 1994, ENTOMOL EXP APPL, V72, P273, DOI 10.1007/BF02383815; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Velthuis HHW, 2004, INT WORKSH SOL BEES; VOGT FD, 1986, PHYSIOL ZOOL, V59, P55, DOI 10.1086/physzool.59.1.30156090; VOGT FD, 1986, PHYSIOL ZOOL, V59, P60, DOI 10.1086/physzool.59.1.30156091; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Worland MR, 2001, FUNCT ECOL, V15, P515, DOI 10.1046/j.0269-8463.2001.00547.x; ZACHARIASSEN KE, 1982, COMP BIOCHEM PHYS A, V73, P557, DOI 10.1016/0300-9629(82)90262-6	55	33	34	5	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80061	10.1371/journal.pone.0080061	http://dx.doi.org/10.1371/journal.pone.0080061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224036	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400108
J	Palagi, E; Norscia, I				Palagi, Elisabetta; Norscia, Ivan			Bonobos Protect and Console Friends and Kin	PLOS ONE			English	Article							CAPTIVE CHIMPANZEES; PAN-TROGLODYTES; RECONCILIATION; EMPATHY; AFFILIATION; BEHAVIOR; 3RD-PARTY; HIERARCHY; COGNITION; PLAY	Post-conflict third-party affiliation has been reported to have different functional meanings, one of them being consolation. Here, we tested the main hypotheses that have been put forth to explain the presence of this phenomenon at a functional level in the bonobo: Self-Protection Hypothesis, Victim-Protection Hypothesis, Relationship-Repair or Substitute for Reconciliation Hypothesis, and Consolation Hypothesis. By analyzing the data collected over 10 years, we investigated what factors affected the distribution of both spontaneous third party affiliation (initiated by the bystander) and solicited third party affiliation (initiated by the victim). We considered factors related to the individual features (sex, rank, age) of victim and bystander, their relationship quality (kinship, affiliation), and the effect that third party affiliation had on the victim (such as protection against further attacks and anxiety reduction). Both spontaneous and solicited third party affiliation reduced the probability of further aggression by group members on the victim (Victim-Protection Hypothesis supported). Yet, only spontaneous affiliation reduced victim anxiety (measured via self-scratching), thus suggesting that the spontaneous gesture - more than the protection itself - works in calming the distressed subject. The victim may perceive the motivational autonomy of the bystander, who does not require an invitation to provide post-conflict affiliative contact. Moreover, spontaneous - but not solicited - third party affiliation was affected by the bond between consoler and victim, being the relationship between consoler and aggressor irrelevant to the phenomenon distribution (Consolation Hypothesis supported). Spontaneous affiliation followed the empathic gradient described for humans, being mostly offered to kin, then friends, then acquaintances. Overall, our findings do not only indicate the consolatory function of spontaneous third-party affiliation but they also suggest that consolation in the bonobo may be an empathy-based phenomenon.	[Palagi, Elisabetta; Norscia, Ivan] Univ Pisa, Museo Storia Nat & Terr, Calci Pisa, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognit, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat & Terr, Calci Pisa, Italy.	elisabetta.palagi@unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; BURLESON BR, 1983, HUM COMMUN RES, V10, P295, DOI 10.1111/j.1468-2958.1983.tb00019.x; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; Castellan NJ, 1988, NONPARAMETRIC STAT B; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; Darwin C., 1859, ORIGIN SPECIES MEANS; Davidov M, 2013, CHILD DEV PERSPECT, V7, P126, DOI 10.1111/cdep.12028; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2012, SO NEUROSCI SER, P87; De Waal Frans B. M., 1996, P80; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; DEWAAL FBM, 1981, BEHAVIOUR, V77, P164, DOI 10.1163/156853981X00211; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Eisenberg N., 1992, THE CARING CHILD; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Erlandsson K, 2007, BIRTH-ISS PERINAT C, V34, P105, DOI 10.1111/j.1523-536X.2007.00162.x; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; Fujisawa KK, 2006, J COMP PSYCHOL, V120, P48, DOI 10.1037/0735-7036.120.1.48; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Ganda AJ, 2011, CLIN PEDIATR, V50, P753, DOI 10.1177/0009922811405516; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Iacoboni M., 2012, PRIMATE MIND BUILT C, P32; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Jahromi LB, 2007, INFANCY, V11, P255, DOI 10.1111/j.1532-7078.2007.tb00226.x; Kano T., 1992, LAST APE; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Light S, 2012, SO NEUROSCI SER, P109; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Mallavarapu S, 2006, AM J PRIMATOL, V68, P789, DOI 10.1002/ajp.20279; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Palagi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052767; Palagi E, 2011, STRESS, V14, P93, DOI 10.3109/10253890.2010.505272; Paoli T, 2006, AM J PHYS ANTHROPOL, V130, P116, DOI 10.1002/ajpa.20345; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Paoli T, 2007, ANN ZOOL FENN, V44, P81; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rilling JK, 2011, SCAN, DOI [10.1093/scan/nsr017, DOI 10.1093/SCAN/NSR017)]; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038936; Sclafani V, 2012, PRIMATES, V53, P247, DOI 10.1007/s10329-012-0294-6; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Watts David P., 2000, P281; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Zahavi D, 2012, SO NEUROSCI SER, P3; ZAHNWAXLER C, 1990, MOTIV EMOTION, V14, P107, DOI 10.1007/BF00991639	79	39	39	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79290	10.1371/journal.pone.0079290	http://dx.doi.org/10.1371/journal.pone.0079290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223924	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400060
J	Hsieh, YT; Lin, MH; Ho, HY; Chen, LC; Chen, CC; Shu, JC				Hsieh, Yi-Ting; Lin, Mei-Hui; Ho, Hung-Yao; Chen, Lei-Chin; Chen, Chien-Cheng; Shu, Jwu-Ching			Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Epithelial Cells Are Less Tolerant to Infection by Staphylococcus aureus	PLOS ONE			English	Article							G6PD DEFICIENCY; APOPTOSIS; BACTERIAL; HEMOLYSIS; DNA	Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme in the pentose phosphate pathway and provides reducing energy to all cells by maintaining redox balance. The most common clinical manifestations in patients with G6PD deficiency are neonatal jaundice and acute hemolytic anemia. The effects of microbial infection in patients with G6PD deficiency primarily relate to the hemolytic anemia caused by Plasmodium or viral infections and the subsequent medication that is required. We are interested in studying the impact of bacterial infection in G6PD-deficient cells. G6PD knock down A549 lung carcinoma cells, together with the common pathogen Staphylococcus aureus, were employed in our cell infection model. Here, we demonstrate that a lower cell viability was observed among G6PD-deficient cells when compared to scramble controls upon bacterial infection using the MTT assay. A significant increase in the intracellular ROS was detected among S. aureus-infected G6PD-deficient cells by observing dichlorofluorescein (DCF) intensity within cells under a fluorescence microscope and quantifying this signal using flow cytometry. The impairment of ROS removal is predicted to enhance apoptotic activity in G6PD-deficient cells, and this enhanced apoptosis was observed by annexin V/PI staining under a confocal fluorescence microscope and quantified by flow cytometry. A higher expression level of the intrinsic apoptotic initiator caspase-9, as well as the downstream effector caspase-3, was detected by Western blotting analysis of G6PD-deficient cells following bacterial infection. In conclusion, we propose that bacterial infection, perhaps the secreted S. aureus a-hemolysin in this case, promotes the accumulation of intracellular ROS in G6PD-deficient cells. This would trigger a stronger apoptotic activity through the intrinsic pathway thereby reducing cell viability when compared to wild type cells.	[Hsieh, Yi-Ting; Lin, Mei-Hui; Ho, Hung-Yao; Shu, Jwu-Ching] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Taoyuan, Taiwan; [Ho, Hung-Yao] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Chen, Lei-Chin] I Shou Univ, Dept Nutr, Kaohsiung, Taiwan; [Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; I Shou University; National Kaohsiung Normal University	Chen, CC (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	cheng@nknu.edu.tw; shujc@mail.cgu.edu.tw		Lin, Mei-Hui/0000-0002-3498-9377; Shu, Jwu-Ching/0000-0003-4862-6056	Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1B0081similar to2]	Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan	This work was supported by the Research Program for Chang Gung Memorial Hospital (contract no. CMRPD1B0081 similar to 2), Taoyuan, Taiwan (http://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantsitohaina R, 2012, CLIN SCI, V123, P173, DOI 10.1042/CS20110643; Au WY, 2011, ANN HEMATOL, V90, P1237, DOI 10.1007/s00277-011-1167-6; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; BOGOMOLSKIYAHALOM V, 1995, BLOOD REV, V9, P183, DOI 10.1016/0268-960X(95)90024-1; Bonnefont CMD, 2012, PHYSIOL GENOMICS, V44, P403, DOI 10.1152/physiolgenomics.00155.2011; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chakraborty SP, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/942123; Chao YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001557; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024472; Cheng ML, 2004, FREE RADICAL BIO MED, V36, P580, DOI 10.1016/j.freeradbiomed.2003.11.031; CLARK M, 1979, YALE J BIOL MED, V52, P169; Dong J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002869; *DRUGS TMCGO, 2011, PLOS MED, V8, P402; EFFERTH T, 1995, J MOL MED-JMM, V73, P47, DOI 10.1007/BF00203619; Fico A, 2004, CELL DEATH DIFFER, V11, P823, DOI 10.1038/sj.cdd.4401420; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Hsu CY, 2011, FEMS IMMUNOL MED MIC, V63, P236, DOI 10.1111/j.1574-695X.2011.00846.x; Ikeda R, 2008, RES MICROBIOL, V159, P628, DOI 10.1016/j.resmic.2008.07.006; Krzyminska S, 2011, J MED MICROBIOL, V60, P889, DOI 10.1099/jmm.0.030833-0; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Liang XD, 2007, CELL MICROBIOL, V9, P1809, DOI 10.1111/j.1462-5822.2007.00917.x; Lodha A, 2008, J PERINATOL, V28, P77, DOI 10.1038/sj.jp.7211853; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Paek DS, 2009, J EMERG MED, V37, P273, DOI 10.1016/j.jemermed.2007.10.049; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Siddiqui T, 1998, MIL MED, V163, P434, DOI 10.1093/milmed/163.6.434; Sun GP, 2008, INFECT IMMUN, V76, P4405, DOI 10.1128/IAI.00575-08; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wilmanski J, 2007, CRIT CARE MED, V35, P510, DOI 10.1097/01.CCM.0000254337.50361.2E; Wolach B, 2004, PEDIATR RES, V55, P807, DOI 10.1203/01.PDR.0000120680.47846.47; Wu YH, 2008, J INFECT DIS, V197, P812, DOI 10.1086/528377; Yang CH, 1997, J INFECTION, V35, P316, DOI 10.1016/S0163-4453(97)93574-X; Youngster I, 2010, DRUG SAFETY, V33, P713, DOI 10.2165/11536520-000000000-00000	37	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79566	10.1371/journal.pone.0079566	http://dx.doi.org/10.1371/journal.pone.0079566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223971	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400126
J	Onwujekwe, O; Uguru, N; Etiaba, E; Chikezie, I; Uzochukwu, B; Adjagba, A				Onwujekwe, Obinna; Uguru, Nkoli; Etiaba, Enyi; Chikezie, Ifeanyi; Uzochukwu, Benjamin; Adjagba, Alex			The Economic Burden of Malaria on Households and the Health System in Enugu State Southeast Nigeria	PLOS ONE			English	Article							PAYMENT; ILLNESS	Background: Malaria is the number one public health problem in Nigeria, responsible for about 30% of deaths in under-fives and 25% of deaths in infants and 11% maternal mortality. This study estimated the economic burden of malaria in Nigeria using the cost of illness approach. Methods: A cross-sectional study was undertaken in two malaria holo-endemic communities in Nigeria, involving both community and hospital based surveys. A random sample of 500 households was interviewed using interviewer administered questionnaire. In addition, 125 exit interviews for inpatient department stays (IPD) and outpatient department visits (OPD) were conducted and these were complemented with data abstraction from 125 patient records. Results: From the household survey, over half of the households (57.6%) had an episode of malaria within one month to the date of the interview. The average household expenditure per case was 12.57US$ and 23.20US$ for OPD and IPD respectively. Indirect consumer costs of treatment were higher than direct consumer medical costs. From a health system perspective, the recurrent provider costs per case was 30.42 US$ and 48.02 US$ for OPD and IPD while non recurrent provider costs were 133.07US$ and 1857.15US$ for OPD and IPD. The mode of payment was mainly through out-of-pocket spending (OOPS). Conclusion: Private expenditure on treatment of malaria constitutes a high economic burden to households and to the health system. Removal of user fees and interventions that will decrease the use of OOPS for treatment of malaria will significantly decrease the economic burden of malaria to both households and the health system.	[Onwujekwe, Obinna; Uguru, Nkoli; Etiaba, Enyi; Chikezie, Ifeanyi; Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria; [Onwujekwe, Obinna; Etiaba, Enyi; Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Uguru, Nkoli] Univ Nigeria, Coll Med, Dept Prevent Dent, Enugu, Nigeria; [Uzochukwu, Benjamin] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Adjagba, Alex] Agence Med Prevent, SIVAC Supporting Natl Independent Immunizat & Vac, Paris, France	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria; Agence de Medecine Preventive	Etiaba, E (corresponding author), Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu Campus, Enugu, Nigeria.	enyietiaba@yahoo.co.uk	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285	Partnership for Transforming Health Systems (PATHS)	Partnership for Transforming Health Systems (PATHS)	Funding for this study was provided by the Partnership for Transforming Health Systems (PATHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedotun AA, 2010, J VECTOR DIS, V47, P155; AsensoOkyere WK, 1997, SOC SCI MED, V45, P659, DOI 10.1016/S0277-9536(96)00383-8; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Chuma JM, 2006, MALARIA J, V30, P5; Cleary SM, 2006, COST EFFECTIVENESS R, V4; Elden S, 2010, MALARIA BURDEN INTER; Erhun W. O., 2005, African Journal of Biomedical Research, V8, P25; Ezeoke OP, 2012, AM J TROP MED HYG, V86, P52, DOI 10.4269/ajtmh.2012.11-0090; Federal Ministry of Health Nigeria, 2005, NAT MAL CONTR PROGR; Federal Ministry of Health Nigeria, 2006, MAL EP; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Jimoh A, 2007, COST EFFECTIVENESS R; Meessen B, 2006, LANCET, V368, P2253, DOI 10.1016/S0140-6736(06)69899-1; National Population Commission, 2006, NAT CENS 2006; Okorosobo T, 2011, EUROPEAN J BUSINESS, V3; Oluka GP, 2008, PRESENTATION ROLL OU; Oluyole K. A., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P696; Onoka C, 2012, WHY STATES ADOPTING; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Onwujekwe O, 2006, AM J TROP MED HYG, V75, P421, DOI 10.4269/ajtmh.2006.75.421; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Uguru NP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-21; Uzochukwu BSC, 2004, INT J EQUITY HLTH, V3; WHO, 2010, WORLD MALARIA REPORT 2010, P1	25	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78362	10.1371/journal.pone.0078362	http://dx.doi.org/10.1371/journal.pone.0078362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223796	gold, Green Submitted, Green Published			2022-12-25	WOS:000326503400056
J	Rocha, M; Banuls, C; Bellod, L; Rovira-Llopis, S; Morillas, C; Sola, E; Victor, VM; Hernandez-Mijares, A				Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio			Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; CARDIOVASCULAR RISK; VISCERAL ADIPOSITY; RETINOL-BINDING-PROTEIN-4; CHOLESTEROL; FENRETINIDE; TAMOXIFEN; WOMEN	Retinol binding protein 4 (RBP4) is an adipokine that may contribute to the development of insulin resistance. However, how this adipokine is affected and its possible involvement in lipid metabolism in obese patients with varying degrees of insulin resistance is yet to be determined. A total of 299 middle-aged morbid obese patients (BMI>40 kg/m(2)) were divided in euglycemic, metabolic syndrome or type 2 diabetic. Anthropometric measurements, biochemical variables and systemic RBP4 levels were determined. RBP4 levels were significantly higher in patients with metabolic syndrome and type 2 diabetes than in euglycemic subjects (42.9 +/- 14.6; 42.3 +/- 17.0 and 37.4 +/- 11.7 mu g/ml, respectively) and correlated with triglycerides but not with those of HOMA-IR in the whole population. The multivariate regression model revealed that triglycerides were the strongest predictor of systemic RBP4 levels. Analysis of lipoprotein subfractions in a subpopulation of 80 subjects showed an altered profile of insulin resistant states characterized by higher VLDL, sdLDL and small HDL percentages and lower large HDL percentage. Although RBP4 levels correlated significantly with LDL particle size and small HDL percentage, the latter parameter was independently associated only with RBP4. Our study reveals that systemic RBP4 levels could play an important role in lipid metabolism in morbid obesity, increasing triglyceride levels and contributing to the formation of small HDL.	[Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Univ Hosp Dr Peset, Serv Endocrinol, Valencia, Spain; [Rocha, Milagros; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Fdn Promot Healthcare & Biomed Res Valencian Comm, Valencia, Spain; [Rocha, Milagros; Victor, Victor M.] Univ Valencia, Fac Med, CIBER Hepat & Digest Dis, CIBER Res Group CB06 04 0071, Valencia, Spain; [Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Inst Hlth Res INCLIVA, Valencia, Spain; [Banuls, Celia; Morillas, Carlos; Sola, Eva; Hernandez-Mijares, Antonio] Univ Valencia, Fac Med, Dept Med, Valencia, Spain; [Victor, Victor M.] Univ Valencia, Fac Med, Dept Physiol, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; University of Valencia; University of Valencia	Rocha, M (corresponding author), Univ Hosp Dr Peset, Serv Endocrinol, Valencia, Spain.	milagros.rocha@uv.es	BaÃuls, Celia/H-7359-2017; VICTOR, VICTOR M/I-3270-2015; Rovira-Llopis, Susana/AAX-8666-2021; Rocha, Milagros/ABE-4931-2020; Cerviño, Alejandro/L-5853-2014; Mijares, Antonio Hernandez/D-3411-2011; victor, victor/Q-4843-2019; Rocha, Milagros/I-4987-2015; Morillas, Carlos/ABF-3504-2020; Hernandez Mijares, Antonio/D-3411-2011	BaÃuls, Celia/0000-0001-8077-7642; Rovira-Llopis, Susana/0000-0002-8476-5128; Rocha, Milagros/0000-0003-2923-6546; Cerviño, Alejandro/0000-0001-8014-3279; Mijares, Antonio Hernandez/0000-0003-2197-0607; Rocha, Milagros/0000-0003-2923-6546; Morillas, Carlos/0000-0002-3745-4423; VICTOR, VICTOR/0000-0002-3027-3945; Hernandez Mijares, Antonio/0000-0003-4099-1905	FIS [PI10/1195, PS12/01984]; European Regional Development Fund of the European Union (FEDER); Regional Ministry of Education of Valencian Community [ACOMP/2013/061]; FIS contract [CP10/00360]	FIS(Instituto de Salud Carlos III); European Regional Development Fund of the European Union (FEDER); Regional Ministry of Education of Valencian Community; FIS contract	This work was supported by grants PI10/1195 and PS12/01984 from FIS and co-funded by the European Regional Development Fund of the European Union (FEDER) and and ACOMP/2013/061 from the Regional Ministry of Education of Valencian Community. Milagros Rocha is a recipient of a FIS contract (CP10/00360). Victor M. Victor is a recipient of Valencian Regional Ministry of Health and Carlos III Health Institute contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkharfy KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048612; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Cabre A, 2010, NUTR METAB CARDIOVAS, V20, P243, DOI 10.1016/j.numecd.2009.04.003; Chiba M, 2010, ENDOCR J, V57, P811, DOI 10.1507/endocrj.K10E-054; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Gavi S, 2007, J CLIN ENDOCR METAB, V92, P1886, DOI 10.1210/jc.2006-1815; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hermsdorff HHM, 2011, INFLAMMATION, V34, P161, DOI 10.1007/s10753-010-9219-y; Hoefner DM, 2001, CLIN CHEM, V47, P266; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koba Shinji, 2008, J Atheroscler Thromb, V15, P250; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Lazzeroni M, 2008, ECANCERMEDICALSCIENC, V2, DOI 10.3332/ecancer.2008.67; Lee JW, 2007, OBESITY, V15, P2225, DOI 10.1038/oby.2007.264; Lim S, 2010, OBESITY, V18, P826, DOI 10.1038/oby.2009.232; Lin CJ, 2013, CLIN PEDIATR, V52, P16, DOI 10.1177/0009922812459948; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Makino S, 2009, HORM METAB RES, V41, P221, DOI 10.1055/s-0028-1100411; Moon JY, 2007, CARDIOLOGY, V108, P282, DOI 10.1159/000099097; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Packard CJ, 2006, CURR OPIN LIPIDOL, V17, P412, DOI 10.1097/01.mol.0000236367.42755.c1; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Promintzer M, 2007, J CLIN ENDOCR METAB, V92, P4306, DOI 10.1210/jc.2006-2522; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Smith JD, 2010, J CLIN LIPIDOL, V4, P382, DOI 10.1016/j.jacl.2010.08.007; Staels B, 2001, J AM ACAD DERMATOL, V45, pS158, DOI 10.1067/mjd.2001.113718; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Takashima N, 2006, NEW ENGL J MED, V355, P1392; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Uelgen Fatma, 2010, Archives of Physiology and Biochemistry, V116, P57, DOI 10.3109/13813451003631421; Usui S, 2009, CLIN CHIM ACTA, V399, P45, DOI 10.1016/j.cca.2008.08.017; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; Verges B, 2012, ARTERIOSCL THROM VAS, V32, P3050, DOI 10.1161/ATVBAHA.112.255190; von Eynatten M, 2007, DIABETOLOGIA, V50, P1930, DOI 10.1007/s00125-007-0743-8; Wu J, 2012, CLIN BIOCHEM, V45, P619, DOI 10.1016/j.clinbiochem.2012.02.022; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yu ZJ, 2012, EUR J CLIN INVEST, V42, P1100, DOI 10.1111/j.1365-2362.2012.02702.x; Zujewski J, 1999, BREAST CANCER RES TR, V57, P277, DOI 10.1023/A:1006216409688	46	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78670	10.1371/journal.pone.0078670	http://dx.doi.org/10.1371/journal.pone.0078670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223837	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400080
J	Yang, SD; Ding, WY; Yang, DL; Gu, TX; Zhang, F; Zhang, D; Sun, YP; Ma, L; Song, YL				Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Gu, Tixin; Zhang, Feng; Zhang, Di; Sun, Yapeng; Ma, Lei; Song, Yanli			Epidemiology and Risk Factors of Cervical Spine Injury during Heating Season in the Patients with Cervical Trauma: A Cross-Sectional Study	PLOS ONE			English	Article							CORD-INJURY; HEAD-INJURIES; FRACTURES; CANADA	Purpose: The purpose of this study was to describe the epidemiology of cervical spine injury in the patients with cervical trauma and analyze its associated risk factors during the special heating season in North China. Methods: This cross-sectional study investigated predictors for cervical spine injury in cervical trauma patients using retrospectively collected data of Hebei Provincial Orthopaedic Hospital from 11/2011 to 02/2012, and 11/2012 to 02/2013. Binary logistic regression analysis was used to determine risk factors for cervical fractures/dislocations or cord injury. Results: A total of 106 patients were admitted into this study. Of all, 34 patients (32.1%) were treated from 11/2011 to 02/2012 and 72 patients (67.9%) from 11/2012 to 02/2013. The mean age was 41.9 +/- 13.3 years old; 85 patients (80.2%) were male and 82 (77.4%) from rural areas. Eighty patients (75.5%) were caused by fall including 45 (42.5%) by severe fall (>2 m). Sixty-five patients (61.3%) of all suffered injuries to other body regions and 32 (30.2%) got head injury. Thirty-one patients (29.2%) sustained cervical cord injury with cervical fractures/dislocations. Twenty-six (83.9%) of cervical cord injury patients were from rural areas and 24 (77.4%) of those resulted from fall including 15 (48.4%) from severe fall (>2 m). Logistic regression displayed that age (OR, 1.47; 95% CI, 1.05-2.07), head injury (OR, 5.63; 95% CI, 2.23-14.26), were risk factors for cervical cord injury and snowing (OR, 8.25; 95% CI, 2.26-30.15) was a risk factor for cervical spine injury due to severe fall (>2 m). Conclusions: The elder male patients and patients with head trauma are high-risk population for cervical cord injury. As a seasonal factor, snowing during heating season is of note a risk factor for cervical spine injury resulting from severe fall (>2 m) in the patients with cervical trauma in North China.	[Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Zhang, Di; Sun, Yapeng; Ma, Lei; Song, Yanli] Hebei Med Univ, Hosp 3, Dept Spine Surg, Shijiazhuang, Hebei, Peoples R China; [Gu, Tixin] Hebei Med Univ, Hosp 1, Dept VIP Ward, Shijiazhuang, Hebei, Peoples R China; [Zhang, Feng] Hebei Med Univ, Hosp 3, Dept Rehabil Med, Shijiazhuang, Hebei, Peoples R China; [Yang, Sidong; Ding, Wenyuan; Yang, Dalong; Zhang, Di; Sun, Yapeng; Ma, Lei] Hebei Prov Key Lab Orthoped Biomech, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Ding, WY (corresponding author), Hebei Med Univ, Hosp 3, Dept Spine Surg, Shijiazhuang, Hebei, Peoples R China.	dingwyster@126.com	zhang, feng/AAD-1724-2019; Yang, Sidong/AAP-5389-2021	zhang, feng/0000-0002-7845-7970; Yang, Sidong/0000-0003-2342-4714; Ding, Wenyuan/0000-0002-7257-4316	Department of Spine Surgery, The Third Hospital of Hebei Medical University	Department of Spine Surgery, The Third Hospital of Hebei Medical University	The authors were supported by the Department of Spine Surgery, The Third Hospital of Hebei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Gupta A, 2009, ANZ J SURG, V79, P898, DOI 10.1111/j.1445-2197.2009.05141.x; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; Ho CH, 2007, ARCH PHYS MED REHAB, V88, pS49, DOI 10.1016/j.apmr.2006.12.001; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Knop C, 1999, UNFALLCHIRURG, V102, P924, DOI 10.1007/s001130050507; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lenehan B, 2009, EUR SPINE J, V18, P938, DOI 10.1007/s00586-009-0923-y; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Mulford JS, 2001, AUST NZ J SURG, V71, P32, DOI 10.1046/j.1440-1622.2001.02021.x; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; RIGGINS RS, 1977, J TRAUMA, V17, P126, DOI 10.1097/00005373-197702000-00007; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Smith JA, 2005, J TRAUMA, V59, P117, DOI 10.1097/01.TA.0000171534.75347.52; SOICHER E, 1991, BRIT J SURG, V78, P1013, DOI 10.1002/bjs.1800780837; Tian HL, 2009, J TRAUMA, V67, P1305, DOI 10.1097/TA.0b013e31819db57c; World Health Organisation, 2009, WORLD HLTH REP; Zargar M, 2005, East Mediterr Health J, V11, P235	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78358	10.1371/journal.pone.0078358	http://dx.doi.org/10.1371/journal.pone.0078358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223795	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400055
J	Streja, E; Wu, CS; Uldall, P; Grove, J; Arah, O; Olsen, J				Streja, Elani; Wu, Chunsen; Uldall, Peter; Grove, Jakob; Arah, Onyebuchi; Olsen, Jorn			Congenital Cerebral Palsy, Child Sex and Parent Cardiovascular Risk	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; PREGNANCY COMPLICATIONS; PRIMARY CAREGIVERS; BIRTH-WEIGHT; LATER LIFE; MOTHERS; STROKE; WOMEN; AGE; PREECLAMPSIA	Objective: Genes associated with cardiovascular disease may also be risk factors for congenital cerebral palsy (CP) and these associations may be modified by sex, since there is an increased risk of CP in male children. We investigated the association between CP of the child with cardiovascular disease in parents, taking sex of the child into consideration. Methods: All parents of non-adopted singletons born in Denmark between 1973 and 2003 were included. Parents of a child with CP, confirmed by the Danish National CP registry, were considered exposed. Cox proportional hazards regressions were used to model risk of cardiovascular outcomes for exposed parents compared to all other parents beginning at the child's 10th birthday. Results: We identified 733,730 mothers and 666,652 fathers among whom 1,592 and 1,484, respectively, had a child with CP. The mean age for mothers at end of follow up was 50 +/- 8 years. After adjustment for maternal age, parental education, child's sex, child's residence, child being small for gestational age and maternal hypertensive disorder during pregnancy, mothers of CP male children had an excess risk of cardiovascular disease (HR: 1.52, 95% CI: 1.16-2.00), attributable mostly to an increased incidence of hypertension and cerebrovascular disease. After additional adjustment for preterm birth, the association was markedly attenuated for cardiovascular disease (1.34, 95% CI: 1.02 - 1.76), became nonsignificant for hypertension, but remained significant for cerebrovascular disease (HR: 2.73, 95% CI: 1.45-5.12). There was no increased risk of cardiovascular events in mothers of female CP children, or fathers of CP children of any sex. Conclusions: Women that have a male child with CP are at increased risk for premature cardiovascular disease. Part of this association may be related to risk factors for preterm births.	[Streja, Elani; Arah, Onyebuchi; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Wu, Chunsen; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Uldall, Peter] Southern Univ, Natl Inst Publ Hlth, Danish Cerebral Registry, Odense, Denmark; [Uldall, Peter] Univ Copenhagen, Rigshosp, Dept Pediat, DK-2100 Copenhagen, Denmark; [Grove, Jakob] Univ Aarhus, Inst Biomed, Aarhus, Denmark; [Grove, Jakob] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark	University of California System; University of California Los Angeles; Aarhus University; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University	Streja, E (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	elani@ucla.edu	; Grove, Jakob/K-8112-2015	Arah, Onyebuchi/0000-0002-9067-1697; Grove, Jakob/0000-0003-2284-5744				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2002, SAS 9 2; Arah OA, 2008, ANN EPIDEMIOL, V18, P637, DOI 10.1016/j.annepidem.2008.04.003; Arnadottir GA, 2005, BJOG-INT J OBSTET GY, V112, P286, DOI 10.1111/j.1471-0528.2004.00396.x; Bella GP, 2011, PSYCHONEUROENDOCRINO, V36, P834, DOI 10.1016/j.psyneuen.2010.11.005; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brehaut Jamie C, 2004, Pediatrics, V114, pe182, DOI 10.1542/peds.114.2.e182; Brey RL, 2005, J THROMB THROMBOLYS, V20, P105, DOI 10.1007/s11239-005-3204-6; Brown AS, 1997, EPIDEMIOLOGY, V8, P55, DOI 10.1097/00001648-199701000-00009; Catov JM, 2007, EPIDEMIOLOGY, V18, P733, DOI 10.1097/EDE.0b013e3181567f96; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Gu L, 2013, AM J MED SCI, V345, P227, DOI 10.1097/MAJ.0b013e31825f92da; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Hjern A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-49; Hubel CA, 2008, HYPERTENSION, V51, P1499, DOI 10.1161/HYPERTENSIONAHA.108.109934; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jorgensen FS, 1999, ACTA OBSTET GYN SCAN, V78, P305, DOI 10.1034/j.1600-0412.1999.780406.x; Khashan AS, 2011, J PSYCHIATR RES, V45, P879, DOI 10.1016/j.jpsychires.2010.12.005; Knudsen LB, 1998, DAN MED BULL, V45, P320; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Libby G, 2007, DIABETOLOGIA, V50, P523, DOI 10.1007/s00125-006-0558-z; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Lu M, 2008, CEREBROVASC DIS, V25, P517, DOI 10.1159/000131669; Lykke JA, 2010, PAEDIATR PERINAT EP, V24, P323, DOI 10.1111/j.1365-3016.2010.01120.x; Magnussen EB, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.016; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Manso H, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-40; Mekinian A, 2013, ANN RHEUM DIS, V72, P217, DOI 10.1136/annrheumdis-2011-201167; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Nilsson PM, 2009, ACTA PAEDIATR, V98, P985, DOI 10.1111/j.1651-2227.2009.01261.x; Palmer CGS, 2008, SCHIZOPHR RES, V104, P135, DOI 10.1016/j.schres.2008.06.022; POLANI PE, 1958, BMJ-BRIT MED J, V2, P1497, DOI 10.1136/bmj.2.5111.1497; Rana SA, 2012, HORM BEHAV, V62, P228, DOI 10.1016/j.yhbeh.2012.03.015; Ravn SH, 2010, EUR J PAEDIATR NEURO, V14, P214, DOI 10.1016/j.ejpn.2009.06.001; Ross G, 2003, ARCH PEDIAT ADOL MED, V157, P397, DOI 10.1001/archpedi.157.4.397; Schaefer GB, 2008, SEMIN PEDIATR NEUROL, V15, P21, DOI 10.1016/j.spen.2008.01.004; Sie MPS, 2006, STROKE, V37, P2667, DOI 10.1161/01.STR.0000244779.30070.1a; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Streja E, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.023; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Uldall P, 2001, DAN MED BULL, V48, P161; Wang H-Y, 2004, KAOHSIUNG J MED SCI, V20, P334, DOI [10.1016/S1607-551X(09)70167-6, DOI 10.1016/S1607-551X(09)70167-6]; Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wu YW, 2006, PEDIATRICS, V118, P690, DOI 10.1542/peds.2006-0278; Zetterstrom K, 2008, BJOG-INT J OBSTET GY, V115, P1436, DOI 10.1111/j.1471-0528.2008.01844.x	54	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79071	10.1371/journal.pone.0079071	http://dx.doi.org/10.1371/journal.pone.0079071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223882	Green Published, gold			2022-12-25	WOS:000326499300052
J	Castillo-Melendez, M; Baburamani, AA; Cabalag, C; Yawno, T; Witjaksono, A; Miller, SL; Walker, DW				Castillo-Melendez, Margie; Baburamani, Ana A.; Cabalag, Carlos; Yawno, Tamara; Witjaksono, Anissa; Miller, Suzie L.; Walker, David W.			Experimental Modelling of the Consequences of Brief Late Gestation Asphyxia on Newborn Lamb Behaviour and Brain Structure	PLOS ONE			English	Article							OVINE FETAL-BRAIN; UMBILICAL-CORD OCCLUSION; NEONATAL ENCEPHALOPATHY; CEREBRAL-PALSY; INTRAVENTRICULAR HEMORRHAGE; SHEEP; TERM; PRETERM; INJURY; HYPOXIA	Brief but severe asphyxia in late gestation or at the time of birth may lead to neonatal hypoxic ischemic encephalopathy and is associated with long-term neurodevelopmental impairment. We undertook this study to examine the consequences of transient in utero asphyxia in late gestation fetal sheep, on the newborn lamb after birth. Surgery was undertaken at 125 days gestation for implantation of fetal catheters and placement of a silastic cuff around the umbilical cord. At 132 days gestation (0.89 term), the cuff was inflated to induce umbilical cord occlusion (UCO), or sham (control). Fetal arterial blood samples were collected for assessment of fetal wellbeing and the pregnancy continued until birth. At birth, behavioral milestones for newborn lambs were recorded over 24 h, after which the lambs were euthanased for brain collection and histopathology assessments. After birth, UCO lambs displayed significant latencies to (i) use all four legs, (ii) attain a standing position, (iii) find the udder, and (iv) successfully suckle-compared to control lambs. Brains of UCO lambs showed widespread pathologies including cell death, white matter disruption, intra-parenchymal hemorrhage and inflammation, which were not observed in full term control brains. UCO resulted in some preterm births, but comparison with age-matched preterm non-UCO control lambs showed that prematurity per se was not responsible for the behavioral delays and brain structural abnormalities resulting from the in utero asphyxia. These results demonstrate that a single, brief fetal asphyxic episode in late gestation results in significant grey and white matter disruption in the developing brain, and causes significant behavioral delay in newborn lambs. These data are consistent with clinical observations that antenatal asphyxia is causal in the development of neonatal encephalopathy and provide an experimental model to advance our understanding of neuroprotective therapies.	[Castillo-Melendez, Margie; Baburamani, Ana A.; Cabalag, Carlos; Yawno, Tamara; Miller, Suzie L.; Walker, David W.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Witjaksono, Anissa; Miller, Suzie L.; Walker, David W.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Monash University; Monash University	Walker, DW (corresponding author), Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	david.walker@monash.edu	Castillo-Melendez, Margie/AAB-8383-2020; Baburamani, Ana/AGD-2259-2022; Baburamani, Ana/J-4920-2019	Baburamani, Ana/0000-0002-7537-6534; Miller, Suzanne/0000-0002-0451-8304	National Health & Medical Research Council of Australia (NHMRC); Cerebral Palsy Alliance Australia; Network in Genes, Environment and Development (NGED), an initiative of the NHMRC; Australia Research Council (ARC); Victorian Government	National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cerebral Palsy Alliance Australia; Network in Genes, Environment and Development (NGED), an initiative of the NHMRC; Australia Research Council (ARC)(Australian Research Council); Victorian Government	This study was supported by grants to DWW and MCM from the National Health & Medical Research Council of Australia (NHMRC), Cerebral Palsy Alliance Australia, and the Network in Genes, Environment and Development (NGED), an initiative of the NHMRC and Australia Research Council (ARC). The authors also gratefully acknowledge support from the Victorian Government's Operational Infrastucture Support Program to Monash Institute of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Baburamani AA, 2013, PEDIATR RES, V73, P310, DOI 10.1038/pr.2012.191; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BECK DW, 1984, J NEUROPATH EXP NEUR, V43, P219, DOI 10.1097/00005072-198405000-00001; Castillo-Melendez M, 2005, DEV NEUROSCI-BASEL, V27, P220, DOI 10.1159/000085995; Castillo-Melendez M, 2004, PEDIATR RES, V55, P864, DOI 10.1203/01.PDR.0000115679.86566.C4; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; De Matteo R, 2008, CLIN EXP PHARMACOL P, V35, P1426, DOI 10.1111/j.1440-1681.2008.05014.x; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Duncan JR, 2004, J SOC GYNECOL INVEST, V11, P369, DOI 10.1016/j.jsgi.2004.03.004; Dwyer CM, 2003, THERIOGENOLOGY, V59, P1027, DOI 10.1016/S0093-691X(02)01137-8; Dwyer CM, 1996, REPROD FERT DEVELOP, V8, P1123, DOI 10.1071/RD9961123; Dwyer CM, 1999, PHYSIOL BEHAV, V67, P443, DOI 10.1016/S0031-9384(99)00089-X; Dwyer CM, 2000, BEHAVIOUR, V137, P1629, DOI 10.1163/156853900502754; GARCIA JH, 1994, AM J PATHOL, V144, P188; GIBSON KJ, 1995, J PHYSIOL-LONDON, V485, P835, DOI 10.1113/jphysiol.1995.sp020773; Goursaud AP, 1999, PHYSIOL BEHAV, V67, P49, DOI 10.1016/S0031-9384(99)00037-2; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Huang AH, 2004, AM J NEURORADIOL, V25, P469; Ikeda T, 1999, INT J DEV NEUROSCI, V17, P1, DOI 10.1016/S0736-5748(98)00055-0; Juul S, 2007, SEMIN FETAL NEONAT M, V12, P250, DOI 10.1016/j.siny.2007.01.015; Juul SE, 2008, DEV NEUROSCI-BASEL, V30, P231, DOI 10.1159/000110348; Juul SE, 2007, DEV NEUROSCI-BASEL, V29, P311, DOI 10.1159/000105472; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kishimoto T K, 1994, Adv Pharmacol, V25, P117, DOI 10.1016/S1054-3589(08)60431-7; Leviton A, 2013, AM J OBSTET GYNECOL, V208, P176, DOI 10.1016/j.ajog.2012.07.020; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MALLARD EC, 1994, AM J OBSTET GYNECOL, V170, P206; Nishigori H, 2008, REPROD SCI, V15, P895, DOI 10.1177/1933719108324135; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Ohyu J, 1999, BRAIN DEV-JPN, V21, P248, DOI 10.1016/S0387-7604(99)00018-2; Pfister JA, 2006, SMALL RUMINANT RES, V65, P70, DOI 10.1016/j.smallrumres.2005.05.025; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Ramachandrappa A, 2009, PEDIATR CLIN N AM, V56, P565, DOI 10.1016/j.pcl.2009.03.009; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; Rocha E, 2004, AM J OBSTET GYNECOL, V191, P488, DOI 10.1016/j.ajog.2004.01.039; Roelants-van Rijn AM, 2001, NEUROPEDIATRICS, V32, P80, DOI 10.1055/s-2001-13875; ROLAND EH, 1990, PEDIATRICS, V85, P737; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; SILVER M, 1991, J DEV PHYSIOL, V15, P169; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Volpe JJ, 2012, ANN NEUROL, V72, P156, DOI 10.1002/ana.23647; WEHBERG K, 1992, PEDIATRICS, V89, P327; Yan EB, 2009, AM J PHYSIOL-REG I, V297, pR60, DOI 10.1152/ajpregu.00047.2009	49	34	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77377	10.1371/journal.pone.0077377	http://dx.doi.org/10.1371/journal.pone.0077377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223120	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200012
J	Huang, YZ; Li, MX; Wang, J; Zhan, ZY; Sun, YJ; Sun, JJ; Li, CJ; Lan, XY; Lei, CZ; Zhang, CL; Chen, H				Huang, Yong-Zhen; Li, Ming-Xun; Wang, Jing; Zhan, Zhao-Yang; Sun, Yu-Jia; Sun, Jia-Jie; Li, Cong-Jun; Lan, Xian-Yong; Lei, Chu-Zhao; Zhang, Chun-Lei; Chen, Hong			A 5 '-Regulatory Region and Two Coding Region Polymorphisms Modulate Promoter Activity and Gene Expression of the Growth Suppressor Gene ZBED6 in Cattle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MUSCLE MASS; TRAITS; INSULIN; BINDING; QTL; SKELETAL; PIT-1; MAPS; MICE	Zinc finger, BED-type containing 6 (ZBED6) is an important transcription factor in placental mammals, affecting development, cell proliferation and growth. Polymorphisms in its promoter and coding regions are likely to impact ZBED6 transcription and growth traits. In this study, rapid amplification of 5' cDNA ends (5'-RACE) analysis revealed two transcription start sites (TSS) for the bovine ZBED6 starting within exon 1 of the ZC3H11A gene (TSS-1) and upstream of the translation start codon of the ZBED6 gene (TSS-2). There was one SNP in the promoter and two missense mutations in the coding region of the bovine ZBED6 by sequencing of the pooled DNA samples (Pool-Seq, n = 100). The promoter and coding region are the key regions for gene function; polymorphisms in these regions can alter gene expression. Quantitative real-time PCR (qPCR) analysis showed that ZBED6 has a broad tissue distribution in cattle and is highly expressed in skeletal muscle. Eleven promoter-detection vectors were constructed, which enabled the cloning of putative promoter sequences and analysis of ZBED6 transcriptional activity by luciferase reporter gene assays. The core region of the basal promoter of bovine ZBED6 is located within region -866 to -556. The activity of WT-826G-pGL3 in driving reporter gene transcription is significantly higher than that of the M-826A-pGL3 construct (P < 0.01). Analysis of gene expression patterns in homozygous full-sibling Chinese Qinchuan cattle showed that the mutant-type Hap-AGG exhibited a lower mRNA level than the wild-type Hap-GCA (P < 0.05) in longissimus dorsi muscle (LDM). Moreover, ZBED6 mRNA expression was low in C2C12 cells overexpressing the mutant-type ZBED6 (pcDNA3.1(+)-Hap-GG) (P < 0.01). Our results suggest that the polymorphisms in the promoter and coding regions may modulate the promoter activity and gene expression of bovine ZBED6 in the skeletal muscles of these cattle breeds.	[Huang, Yong-Zhen; Li, Ming-Xun; Wang, Jing; Zhan, Zhao-Yang; Sun, Yu-Jia; Sun, Jia-Jie; Lan, Xian-Yong; Lei, Chu-Zhao; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Li, Cong-Jun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Zhang, Chun-Lei] Jiangsu Normal Univ, Inst Cellular & Mol Biol, Xuzhou, Jiangsu, Peoples R China	Northwest A&F University - China; United States Department of Agriculture (USDA); Jiangsu Normal University	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Li, Mingxun/Y-7161-2019; WANG, JINGYI/GSJ-1241-2022; Li, Cong-jun/J-8572-2014	Li, Cong-jun/0000-0003-1389-9820	National 863 Program of China [2013AA102505]; National Natural Science Foundation of China [31272408]; Agricultural Science and Technology Innovation Projects of Shaanxi Province [2012NKC01-13]; Program of National Beef Cattle and Yak Industrial Technology System [CARS-38]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Projects of Shaanxi Province; Program of National Beef Cattle and Yak Industrial Technology System	This study was supported by the National 863 Program of China (Grant No. 2013AA102505), National Natural Science Foundation of China (Grant No. 31272408), Agricultural Science and Technology Innovation Projects of Shaanxi Province (No. 2012NKC01-13), Program of National Beef Cattle and Yak Industrial Technology System (CARS-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Bahar B, 2011, ANIM GENET, V42, P270, DOI 10.1111/j.1365-2052.2010.02151.x; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bjornsdottir G, 2008, NUCLEIC ACIDS RES, V36, P2906, DOI 10.1093/nar/gkn130; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Hayward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059940; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Huang YZ, 2013, GENE, V526, P107, DOI 10.1016/j.gene.2013.04.049; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jia Xiang-Jie, 2011, Yichuan, V33, P1359, DOI 10.3724/SP.J.1005.2011.01359; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jonsen MD, 2009, MOL ENDOCRINOL, V23, P1371, DOI 10.1210/me.2008-0137; Kotaja N, 2004, NAT GENET, V36, P551, DOI 10.1038/ng0604-551; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Renaville R, 1997, J DAIRY SCI, V80, P3431, DOI 10.3168/jds.S0022-0302(97)76319-7; Sambrook J., 2002, MOL CLONING LAB MANU; Stancekova K, 1999, ANIM GENET, V30, P313, DOI 10.1046/j.1365-2052.1999.00484.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064	32	10	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79744	10.1371/journal.pone.0079744	http://dx.doi.org/10.1371/journal.pone.0079744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223190	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200083
J	Khalki, L; M'hamed, SB; Sokar, Z; Bennis, M; Vinay, L; Bras, H; Viemari, JC				Khalki, Loubna; M'hamed, Saadia Ba; Sokar, Zahra; Bennis, Mohamed; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles			Prenatal Exposure to Fenugreek Impairs Sensorimotor Development and the Operation of Spinal Cord Networks in Mice	PLOS ONE			English	Article							KCL COTRANSPORTER KCC2; GRAECUM SEED POWDER; GAIT ANALYSIS; LUMBAR MOTONEURONS; RAT; LOCOMOTION; SEROTONIN; TRANSECTION; POTENTIALS; TISSUES	Fenugreek is a medicinal plant whose seeds are widely used in traditional medicine, mainly for its laxative, galactagogue and antidiabetic effects. However, consumption of fenugreek seeds during pregnancy has been associated with a range of congenital malformations, including hydrocephalus, anencephaly and spina bifida in humans. The present study was conducted to evaluate the effects of prenatal treatment of fenugreek seeds on the development of sensorimotor functions from birth to young adults. Pregnant mice were treated by gavage with 1g/kg/day of lyophilized fenugreek seeds aqueous extract (FSAE) or distilled water during the gestational period. Behavioral tests revealed in prenatally treated mice a significant delay in righting, cliff avoidance, negative geotaxis responses and the swimming development. In addition, extracellular recording of motor output in spinal cord isolated from neonatal mice showed that the frequency of spontaneous activity and fictive locomotion was reduced in FSAE-exposed mice. On the other hand, the cross-correlation coefficient in control mice was significantly more negative than in treated animals indicating that alternating patterns are deteriorated in FSAE-treated animals. At advanced age, prenatally treated mice displayed altered locomotor coordination in the rotarod test and also changes in static and dynamic parameters assessed by the CatWalk automated gait analysis system. We conclude that FSAE impairs sensorimotor and coordination functions not only in neonates but also in adult mice. Moreover, spinal neuronal networks are less excitable in prenatally FSAE-exposed mice suggesting that modifications within the central nervous system are responsible, at least in part, for the motor impairments.	[Khalki, Loubna; M'hamed, Saadia Ba; Sokar, Zahra; Bennis, Mohamed] Cadi Ayyad Univ, Ctr Natl Rech Sci & Tech URAC 37, Lab Pharmacol Neurobiol & Comportement, Marrakech, Morocco; [Khalki, Loubna; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles] Aix Marseille Univ, CNRS, Team P3M, Inst Neurosci Timone, Marseille, France	Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Viemari, JC (corresponding author), Aix Marseille Univ, CNRS, Team P3M, Inst Neurosci Timone, Marseille, France.	jean-charles.viemari@univ-amu.fr	Bras, Helene/L-8915-2018	Viemari, Jean-Charles/0000-0001-6614-1461; sokar, zahra/0000-0002-8646-4660	Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM); NEUROMED project	Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM); NEUROMED project	The authors acknowledge support from the Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM) and the NEUROMED project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDANCE IND ESTIMAT; Aruga J, 1998, J NEUROSCI, V18, P284; ATSUTA Y, 1990, J NEUROPHYSIOL, V64, P727, DOI 10.1152/jn.1990.64.3.727; Bellakhdar J, 1997, EDITIONS FENNEC; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bin-Hafeez B, 2003, INT IMMUNOPHARMACOL, V3, P257, DOI 10.1016/S1567-5769(02)00292-8; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Brocard F, 1999, DEV BRAIN RES, V117, P81, DOI 10.1016/S0165-3806(99)00101-7; CAZALETS JR, 1990, BEHAV BRAIN RES, V40, P215, DOI 10.1016/0166-4328(90)90078-S; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Clarac F, 1998, BRAIN RES REV, V28, P35, DOI 10.1016/S0165-0173(98)00024-1; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Fellippa-Marques S, 2000, EUR J NEUROSCI, V12, P155, DOI 10.1046/j.1460-9568.2000.00895.x; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Geisler Hildegard C., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P517; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Jean-Xavier C, 2006, J NEUROPHYSIOL, V96, P2274, DOI 10.1152/jn.00328.2006; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; KALLMAN, 1994, ASSESSMENT MOTORIC E, P103; KAMAL R, 1993, PHYTOTHER RES, V7, P134, DOI 10.1002/ptr.2650070208; Kassem A, 2006, CONTRACEPTION, V73, P301, DOI 10.1016/j.contraception.2005.08.020; Khalki L, 2012, J ETHNOPHARMACOL, V139, P672, DOI 10.1016/j.jep.2011.12.011; Khalki L, 2010, J ETHNOPHARMACOL, V131, P321, DOI 10.1016/j.jep.2010.06.033; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kumar P, 2012, EUR REV MED PHARMACO, V16, P18; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Pearlstein E, 2005, EUR J NEUROSCI, V21, P1338, DOI 10.1111/j.1460-9568.2005.03971.x; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; Raju J, 2001, MOL CELL BIOCHEM, V224, P45, DOI 10.1023/A:1011974630828; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Sabiri N., 2013, J PEDIAT PUERICULT, V26, P198, DOI DOI 10.1016/J.JPP.2013.05.001; Sadlaoud K, 2010, J NEUROSCI, V30, P3358, DOI 10.1523/JNEUROSCI.6310-09.2010; Santillan ME, 2010, NUTRITION, V26, P423, DOI 10.1016/j.nut.2009.06.005; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Skalli S., 2006, B INFORM PHARMACOVIG, V3; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Stil A, 2011, EUR J NEUROSCI, V33, P1212, DOI 10.1111/j.1460-9568.2010.07592.x; Thakran S, 2004, MOL CELL BIOCHEM, V266, P151, DOI 10.1023/B:MCBI.0000049153.14295.0d; Vinay L, 2000, BRAIN RES BULL, V53, P635, DOI 10.1016/S0361-9230(00)00397-X; WESTERGA J, 1993, EARLY HUM DEV, V34, P89, DOI 10.1016/0378-3782(93)90044-U; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Ziskind-Conhaim L, 1998, PERSPECT DEV NEUROBI, V5, P279	54	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80013	10.1371/journal.pone.0080013	http://dx.doi.org/10.1371/journal.pone.0080013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224030	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400103
J	Qin, ZX; Kaufman, RS; Khoury, RN; Khoury, MK; Aswad, DW				Qin, Zhenxia; Kaufman, Rachel S.; Khoury, Rana N.; Khoury, Mitri K.; Aswad, Dana W.			Isoaspartate Accumulation in Mouse Brain Is Associated with Altered Patterns of Protein Phosphorylation and Acetylation, Some of Which Are Highly Sex-Dependent	PLOS ONE			English	Article							SYNAPSIN-I; CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; SYNAPTIC-TRANSMISSION; DEFICIENT MICE; REPAIR ENZYME; ASPARAGINE RESIDUES; ASPARTYL RESIDUES; DAMAGED PROTEINS; DEAMIDATION	Isoaspartate (isoAsp) formation is a major source of protein damage that is kept in check by the repair function of protein L-isoaspartyl methyltransferase (PIMT). Mice deficient in PIMT accumulate isoAsp-containing proteins, resulting in cognitive deficits, abnormal neuronal physiology and cytoarchitecture, and fatal epileptic seizures 30-60 days after birth. Synapsins I and II, dynamin-1, collapsin response mediator protein 2 (CRMP2), and alpha/beta-tubulin are major targets of PIMT in brain. To investigate links between isoAsp accumulation and the neurological phenotype of the KO mice, we used Western blotting to compare patterns of in vivo phosphorylation or acetylation of the major PIMT targets listed above. Phosphorylations of synapsins I and II at Ser-9 were increased in female KO vs. WT mice, and acetylation of tubulin at Lys-40 was decreased in male KO vs. WT mice. Average levels of dynamin-1 phosphorylation at Ser-778 and Ser-795 were higher in male KO vs. WT mice, but the statistical significance (P>0.1) was low. No changes in phosphorylation were found in synapsins I and II at Ser-603, in CRMP2 at Ser-522 or Thr-514, in DARPP-32 at Thr-34, or in PDK1 at Ser-241. General levels of phosphorylation assessed with Pro-Q Diamond stain, or an anti-phosphotyrosine antibody, appeared similar in the WT and KO mice. We conclude that isoAsp accumulation is associated with altered functional status of several neuronal proteins that are highly susceptible to this type of damage. We also uncovered unexpected differences in how male and female mice respond to isoAsp accumulation in the brain.	[Qin, Zhenxia; Kaufman, Rachel S.; Khoury, Rana N.; Khoury, Mitri K.; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded solely by National Institutes of Health grant NS-17269. http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASWAD DW, 1984, J BIOL CHEM, V259, P714; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; Bidinosti M, 2010, J BIOL CHEM, V285, P19402, DOI 10.1074/jbc.M110.120774; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Iwata SI, 1996, J PHARMACOL EXP THER, V278, P1428; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1985, BIOCHEMISTRY-US, V24, P2581, DOI 10.1021/bi00331a028; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; OHTA K, 1987, BIOCHIMIE, V69, P1227, DOI 10.1016/0300-9084(87)90150-7; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Sharma SK, 2002, ANAL BIOCHEM, V307, P187, DOI 10.1016/S0003-2697(02)00008-8; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; STROMBOM U, 1979, P NATL ACAD SCI USA, V76, P4687, DOI 10.1073/pnas.76.9.4687; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; YAMAGATA Y, 1995, NEUROSCIENCE, V64, P1, DOI 10.1016/0306-4522(94)00492-N; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	54	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80758	10.1371/journal.pone.0080758	http://dx.doi.org/10.1371/journal.pone.0080758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224061	Green Published, gold			2022-12-25	WOS:000326597400124
J	Ramsay, H; Kelleher, I; Flannery, P; Clarke, MC; Lynch, F; Harley, M; Connor, D; Fitzpatrick, C; Morris, DW; Cannon, M				Ramsay, Hugh; Kelleher, Ian; Flannery, Padraig; Clarke, Mary C.; Lynch, Fionnuala; Harley, Michelle; Connor, Dearbhla; Fitzpatrick, Carol; Morris, Derek W.; Cannon, Mary			Relationship between the COMT-Val158Met and BDNF-Val66Met Polymorphisms, Childhood Trauma and Psychotic Experiences in an Adolescent General Population Sample	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET MODERATION; HYPERACTIVITY DISORDER ADHD; DELUSIONAL-LIKE EXPERIENCES; ENVIRONMENT INTERACTIONS; ENZYME-ACTIVITY; MENTAL-HEALTH; CANNABIS USE; RISK-FACTOR; SYMPTOMS	Objective: Psychotic experiences occur at a much greater prevalence in the population than psychotic disorders. There has been little research to date, however, on genetic risk for this extended psychosis phenotype. We examined whether COMT or BDNF genotypes were associated with psychotic experiences or interacted with childhood trauma in predicting psychotic experiences. Method: Psychiatric interviews and genotyping for COMT-Val158Met and BDNF-Val66Met were carried out on two population-based samples of 237 individuals aged 11-15 years. Logistic regression was used to examine for main effects by genotype and childhood trauma, controlling for important covariates. This was then compared to a model with a term for interaction between genotype and childhood trauma. Where a possible interaction was detected, this was further explored in stratified analyses. Results: While childhood trauma showed a borderline association with psychotic experiences, COMT-Val158Met and BDNF-Val66Met genotypes were not directly associated with psychotic experiences in the population. Testing for gene x environment interaction was borderline significant in the case of COMT-Val158Met with individuals with the COMT-Val158Met Val-Val genotype, who had been exposed to childhood trauma borderline significantly more likely to report psychotic experiences than those with Val-Met or Met-Met genotypes. There was no similar interaction by BDNF-Val66Met genotype. Conclusion: The COMT-Val158Met Val-Val genotype may be a genetic moderator of risk for psychotic experiences in individuals exposed to childhood traumatic experiences.	[Ramsay, Hugh; Kelleher, Ian; Flannery, Padraig; Clarke, Mary C.; Harley, Michelle; Connor, Dearbhla; Cannon, Mary] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland; [Kelleher, Ian] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth 3, Stockholm, Sweden; [Lynch, Fionnuala] Lucena Clin, Dublin, Ireland; [Harley, Michelle] St Vincents Hosp, Dept Child & Adolescent Psychiat, Dublin 4, Ireland; [Fitzpatrick, Carol] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Morris, Derek W.] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Morris, Derek W.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	Royal College of Surgeons - Ireland; Karolinska Institutet; University College Dublin; Trinity College Dublin; Trinity College Dublin	Ramsay, H (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland.	drhughramsay@gmail.com	Flannery, Padraig/HCI-9510-2022; Cannon, Mary/D-8227-2012; Morris, Derek/AAW-8343-2021	Cannon, Mary/0000-0002-0910-299X; Morris, Derek/0000-0002-3413-570X; Kelleher, Ian/0000-0003-1484-651X	European Communities Seventh Framework Programme [HEALTH-F2-2010-241909]; Health Research Board (Ireland) [CSA/2004/1]; Friends of the Children's University Hospital (Dublin); American Foundation for Suicide Prevention; HSE Northern Area; Mater Misericordiae University Hospital	European Communities Seventh Framework Programme(European Commission); Health Research Board (Ireland); Friends of the Children's University Hospital (Dublin); American Foundation for Suicide Prevention; HSE Northern Area; Mater Misericordiae University Hospital	The research leading to these results has received funding from the European Communities Seventh Framework Programme under grant agreement HEALTH-F2-2010-241909 (Project EU-GEI); EU-GEI is the acronym of the project European Network of National Schizophrenia Networks Studying Gene-Environment Interactions. This work was supported by a Clinician Scientist Award to Dr Cannon (CSA/2004/1) from the Health Research Board (Ireland). The original Challenging Times study was funded by Friends of the Children's University Hospital (Dublin), the American Foundation for Suicide Prevention, HSE Northern Area and the Mater Misericordiae University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Binbay T, 2012, SCHIZOPHRENIA BULL, V38, P992, DOI 10.1093/schbul/sbr003; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Eisenberg J, 1999, AM J MED GENET, V88, P497, DOI 10.1002/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.3.CO;2-6; Fisher HL, 2013, PSYCHOL MED, V43, P2077, DOI 10.1017/S0033291712003091; Gale CK, 2011, ACTA PSYCHIAT SCAND, V124, P205, DOI 10.1111/j.1600-0447.2011.01707.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; HARLEY M, 2013, IR J MED SC IN PRESS; Hawi Z, 2000, AM J MED GENET, V96, P282, DOI 10.1002/1096-8628(20000612)96:3<282::AID-AJMG9>3.0.CO;2-R; Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kaufman J, 1996, SCHEDULE AFFECTIVE D; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Kelleher I, 2012, ARCH GEN PSYCHIAT, V69, P1277, DOI 10.1001/archgenpsychiatry.2012.164; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Kelleher I, 2010, BRIT J PSYCHIAT, V197, P167, DOI 10.1192/bjp.bp.109.076018; Kia-Keating BM, 2007, AM J MED GENET B, V144B, P1048, DOI 10.1002/ajmg.b.30551; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Kovacs M., 1992, CHILDRENS DEPRESSION; Lataster T, 2006, SOC PSYCH PSYCH EPID, V41, P423, DOI 10.1007/s00127-006-0060-4; Laurens KR, 2012, PSYCHOL MED, V42, P1495, DOI 10.1017/S0033291711002108; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Lynch F, 2006, J ADOLESCENCE, V29, P555, DOI 10.1016/j.adolescence.2005.08.011; MANDELLI L, 2013, NEUROSCI BIOBEHAV R, P86513; Meira-Lima I, 2004, GENES BRAIN BEHAV, V3, P75, DOI 10.1046/j.1601-1848.2003.0042.x; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Nishida A, 2010, ACTA PSYCHIAT SCAND, V121, P301, DOI 10.1111/j.1600-0447.2009.01439.x; Nurjono Milawaty, 2012, Clin Psychopharmacol Neurosci, V10, P61, DOI 10.9758/cpn.2012.10.2.61; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Saha S, 2011, SCHIZOPHR RES, V132, P197, DOI 10.1016/j.schres.2011.07.012; Savitz J, 2010, BEHAV GENET, V40, P415, DOI 10.1007/s10519-009-9323-7; Scott J, 2009, AM J PSYCHIAT, V166, P567, DOI 10.1176/appi.ajp.2008.08081182; Scott J, 2009, SCHIZOPHR RES, V107, P179, DOI 10.1016/j.schres.2008.11.002; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346; Stefanis NC, 2007, PSYCHOL MED, V37, P1651, DOI 10.1017/S0033291707001080; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Varghese D, 2013, ACTA PSYCHIAT SCAND, V127, P48, DOI 10.1111/j.1600-0447.2012.01905.x; VINKERS CH, 2013, SCHIZOPHR RES; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Wigman JTW, 2012, ACTA PSYCHIAT SCAND, V126, P266, DOI 10.1111/j.1600-0447.2012.01857.x; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019; Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421	70	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79741	10.1371/journal.pone.0079741	http://dx.doi.org/10.1371/journal.pone.0079741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224001	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400084
J	Teuber, L; Schukat, A; Hagen, W; Auel, H				Teuber, Lena; Schukat, Anna; Hagen, Wilhelm; Auel, Holger			Distribution and Ecophysiology of Calanoid Copepods in Relation to the Oxygen Minimum Zone in the Eastern Tropical Atlantic	PLOS ONE			English	Article							ELECTRON-TRANSPORT-SYSTEM; VERTICAL-DISTRIBUTION; METABOLIC SUPPRESSION; ZOOPLANKTON ECOLOGY; ARABIAN SEA; PACIFIC; HYPOXIA; RATES; RESPIRATION; COMMUNITIES	Oxygen minimum zones (OMZs) affect distribution patterns, community structure and metabolic processes of marine organisms. Due to the prominent role of zooplankton, especially copepods, in the marine carbon cycle and the predicted intensification and expansion of OMZs, it is essential to understand the effects of hypoxia on zooplankton distribution and ecophysiology. For this study, calanoid copepods were sampled from different depths (0-1800 m) at eight stations in the eastern tropical Atlantic (3 degrees 47'N to 18 degrees S) during three expeditions in 2010 and 2011. Their horizontal and vertical distribution was determined and related to the extent and intensity of the OMZ, which increased from north to south with minimum O-2 concentrations (12.7 mu mol kg(-1)) in the southern Angola Gyre. Calanoid copepod abundance was highest in the northeastern Angola Basin and decreased towards equatorial regions as well as with increasing depth. Maximum copepod biodiversity was observed in the deep waters of the central Angola Basin. Respiration rates and enzyme activities were measured to reveal species-specific physiological adaptations. Enzyme activities of the electron transport system (ETS) and lactate dehydrogenase (LDH) served as proxies for aerobic and anaerobic metabolic activity, respectively. Mass-specific respiration rates and ETS activities decreased with depth of occurrence, consistent with vertical changes in copepod body mass and ambient temperature. Copepods of the families Eucalanidae and Metridinidae dominated within the OMZ. Several of these species showed adaptive characteristics such as lower metabolic rates, additional anaerobic activity and diel vertical migration that enable them to successfully inhabit hypoxic zones.	[Teuber, Lena; Schukat, Anna; Hagen, Wilhelm; Auel, Holger] Univ Bremen, Bremen Marine Ecol, D-28359 Bremen, Germany	University of Bremen	Teuber, L (corresponding author), Univ Bremen, Bremen Marine Ecol, D-28359 Bremen, Germany.	teuber@uni-bremen.de		Hagen, Wilhelm/0000-0002-7462-9931	German Federal Ministry of Education and Research; University of Bremen	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); University of Bremen	This study was partly funded by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/index.php) in the framework of the GENUS "Geochemistry and Ecology of the Namibian Upwelling System" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional part of the funding was provided by the University of Bremen.	[Anonymous], 1994, CHANGES MARINE COMMU; Antezana T., 2002, OCEANOGRAPHY E PACIF, VII, P29; Auel H, 2007, J EXP MAR BIOL ECOL, V352, P234, DOI 10.1016/j.jembe.2007.07.020; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bode M, 2013, J EXP MAR BIOL ECOL, V444, P1, DOI 10.1016/j.jembe.2013.03.003; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bradford-Grieve Janet M., 1999, P869; Champalbert G, 2005, HYDROBIOLOGIA, V548, P251, DOI 10.1007/s10750-005-5194-y; CHILDRESS JJ, 1975, COMP BIOCHEM PHYS A, V50, P787, DOI 10.1016/0300-9629(75)90146-2; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CHILDRESS JJ, 1979, MAR BIOL, V52, P273, DOI 10.1007/BF00398141; Childress JJ, 1998, J EXP BIOL, V201, P1223; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Escribano Rubén, 2006, Gayana (Concepc.), V70, P19; Escribano R, 2009, DEEP-SEA RES PT II, V56, P1049, DOI 10.1016/j.dsr2.2008.09.009; FLINT MV, 1991, MAR BIOL, V111, P199, DOI 10.1007/BF01319701; Gonzalez RR, 2002, J PLANKTON RES, V24, P1349, DOI 10.1093/plankt/24.12.1349; GORDON AL, 1991, DEEP-SEA RES, V38, pS323, DOI 10.1016/S0198-0149(12)80015-X; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Ikeda T, 2001, MAR BIOL, V139, P587, DOI 10.1007/s002270100608; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Lass HU, 2008, J MARINE SYST, V74, P1, DOI 10.1016/j.jmarsys.2007.09.008; Le Borgne R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000745; Loick N, 2005, AFR J MAR SCI, V27, P597, DOI 10.2989/18142320509504120; LONGHURST AR, 1967, DEEP-SEA RES, V14, P51, DOI 10.1016/0011-7471(67)90028-9; Maas AE, 2012, MAR BIOL, V159, P1955, DOI 10.1007/s00227-012-1982-x; MAHNKEN CVW, 1969, B MAR SCI, V19, P550; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Ohman MD, 1998, DEEP-SEA RES PT II, V45, P1709, DOI 10.1016/S0967-0645(98)80014-3; OWENS TG, 1975, MAR BIOL, V30, P27, DOI 10.1007/BF00393750; PACKARD TT, 1971, J MAR RES, V29, P235; PACKARD TT, 1971, LIMNOL OCEANOGR, V16, P60, DOI 10.4319/lo.1971.16.1.0060; Parker-Stetter SL, 2009, ESTUAR COAST SHELF S, V81, P13, DOI 10.1016/j.ecss.2008.09.021; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Piontkovski SA, 2003, OCEANOL ACTA, V26, P255, DOI 10.1016/S0399-1784(03)00014-8; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P931, DOI 10.1016/S0967-0637(97)00006-X; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P907, DOI 10.1016/S0967-0637(97)00007-1; SCHALK PH, 1988, MAR ECOL PROG SER, V44, P25, DOI 10.3354/meps044025; Schnack-Schiel SB, 2008, J PLANKTON RES, V30, P655, DOI 10.1093/plankt/fbn029; Schnack-Schiel SB, 2010, DEEP-SEA RES PT II, V57, P2064, DOI 10.1016/j.dsr2.2010.09.010; Schukat A, 2013, J EXP MAR BIOL ECOL, V442, P1, DOI 10.1016/j.jembe.2013.01.024; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; Smith S, 1998, DEEP-SEA RES PT II, V45, P2369, DOI 10.1016/S0967-0645(98)00075-7; SOMERO GN, 1980, PHYSIOL ZOOL, V53, P322, DOI 10.1086/physzool.53.3.30155794; Stramma L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004369; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Stramma L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039593; Svetlichny LS, 2000, MAR BIOL, V137, P963, DOI 10.1007/s002270000405; TEAL JM, 1967, LIMNOL OCEANOGR, V12, P548, DOI 10.4319/lo.1967.12.3.0548; Teuber L, 2013, J EXP MAR BIOL ECOL, V448, P28, DOI 10.1016/j.jembe.2013.06.012; Thuesen EV, 1998, MAR ECOL PROG SER, V168, P95, DOI 10.3354/meps168095; VINOGRADOV ME, 1962, DEEP-SEA RES, V9, P523, DOI 10.1016/0011-7471(62)90105-5; WIEBE PH, 1985, MAR BIOL, V87, P313, DOI 10.1007/BF00397811; Wishner KF, 2008, PROG OCEANOGR, V78, P163, DOI 10.1016/j.pocean.2008.03.001; Wishner KF, 2013, DEEP-SEA RES PT I, V79, P122, DOI 10.1016/j.dsr.2013.05.012; WONG CK, 1988, J PLANKTON RES, V10, P1285, DOI 10.1093/plankt/10.6.1285; Woodd-Walker RS, 2001, HYDROBIOLOGIA, V453, P161, DOI 10.1023/A:1013140606293	63	29	29	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77590	10.1371/journal.pone.0077590	http://dx.doi.org/10.1371/journal.pone.0077590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223716	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400009
J	Ellis, ECS; Nauglers, S; Parini, P; Mork, LM; Jorns, C; Zemack, H; Sandblom, AL; Bjorkhem, I; Ericzon, BG; Wilson, EM; Strom, SC; Grompe, M				Ellis, Ewa C. S.; Nauglers, Scott; Parini, Paolo; Mork, Lisa-Mari; Jorns, Carl; Zemack, Helen; Sandblom, Anita Lovgren; Bjorkhem, Ingemar; Ericzon, Bo-Goran; Wilson, Elizabeth M.; Strom, Stephen C.; Grompe, Markus			Mice with Chimeric Livers Are an Improved Model for Human Lipoprotein Metabolism	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; HUMAN HEPATOCYTES; CONJUGATION; CULTURES; PLASMA; SIGNAL; RAT	Objective: Rodents are poor model for human hyperlipidemias because total cholesterol and low density lipoprotein levels are very low on a normal diet. Lipoprotein metabolism is primarily regulated by hepatocytes and we therefore assessed whether chimeric mice extensively repopulated with human cells can model human lipid and bile acid metabolism. Design: FRG [FahRag2(-/-)Il2rg(-/-)]) mice were repopulated with primary human hepatocytes. Serum lipoprotein lipid composition and distribution (VLDL, LDL, and HDL) was analyzed by size exclusion chromatography. Bile was analyzed by LC-MS or by GC-MS. RNA expression levels were measured by quantitative RT-PCR. Results: Chimeric mice displayed increased LDL and VLDL fractions and a lower HDL fraction compared to wild type, thus significantly shifting the ratio of LDL/HDL towards a human profile. Bile acid analysis revealed a human-like pattern with high amounts of cholic acid and deoxycholic acid (DCA). Control mice had only taurine-conjugated bile acids as expcted, but highly repopulated mice had glycine-conjugated cholic acid as found in human bile. RNA levels of human genes involved in bile acid synthesis including CYP7A1, and CYP27A1 were significantly upregulated as compared to human control liver. However, administration of recombinant hFGF19 restored human CYP7A1 levels to normal. Conclusion: Humanized-liver mice showed a typical human lipoprotein profile with LDL as the predominant lipoprotein fraction even on a normal diet. The bile acid profile confirmed presence of an intact enterohepatic circulation. Although bile acid synthesis was deregulated in this model, this could be fully normalized by FGF19 administration. Taken together these data indicate that chimeric FRG-mice are a useful new model for human lipoprotein and bile-acid metabolism.	[Ellis, Ewa C. S.; Mork, Lisa-Mari; Jorns, Carl; Zemack, Helen; Ericzon, Bo-Goran] Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg,Karolinska Inst, Stockholm, Sweden; [Nauglers, Scott; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Portland, OR USA; [Parini, Paolo; Sandblom, Anita Lovgren; Bjorkhem, Ingemar; Strom, Stephen C.] Karolinska Univ, Huddinge Hosp, Dept Lab Med, Stockholm, Sweden; [Wilson, Elizabeth M.] Yecuris Corp, Portland, OR USA	Karolinska Institutet; Karolinska University Hospital; Oregon Health & Science University; Karolinska Institutet; Karolinska University Hospital	Ellis, ECS (corresponding author), Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg,Karolinska Inst, Stockholm, Sweden.	Ewa.Ellis@ki.se	Ellis, Ewa C S/D-5370-2014; Jorns, Carl/AAE-6925-2021; Ericzon, Bo-Goran/AAH-5328-2020	Ellis, Ewa C S/0000-0002-3057-5337; Jorns, Carl/0000-0001-7727-8113; Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425; Grompe, Markus/0000-0002-6616-4345; Strom, Stephen/0000-0002-2889-3387	National Institute of Health [R01DK05192]; Swedish Research Council; Swedish Heart-Lung Foundation; Karolinska Institute	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institute(Karolinska Institutet)	Human hepatocytes were obtained from Pittsburgh, PA (to Stephen C. Strom), through the Liver Tissue and Cell Distribution system (N01-DK-7-0004/HHSN267200700004C). This work was supported by grants from the National Institute of Health to Markus Grompe (R01DK05192). The Swedish Research Council, the Swedish Heart-Lung Foundation, the Karolinska Institute to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bjorkhem I, 1997, Subcell Biochem, V28, P23; BJORKHEM I, 1983, SCAND J CLIN LAB INV, V43, P163, DOI 10.3109/00365518309168239; Chen Z, 2011, J CARDIOVASC TRANSL, V4, P801, DOI 10.1007/s12265-011-9309-8; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Ellis E, 1998, HEPATOLOGY, V27, P615, DOI 10.1002/hep.510270241; Ellis E, 2003, HEPATOLOGY, V38, P930, DOI 10.1053/jhep.2003.50394; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; Katoh M, 2008, TOXICOLOGY, V246, P9, DOI 10.1016/j.tox.2007.11.012; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; MATOBA N, 1986, J LIPID RES, V27, P1154; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; PRINCEN HMG, 1988, BIOCHEM BIOPH RES CO, V154, P1114, DOI 10.1016/0006-291X(88)90256-2; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Schwarz M, 1998, J LIPID RES, V39, P1833; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; SJOVALL J, 1959, P SOC EXP BIOL MED, V100, P676; Society TR, 2004, USE NONHUMAN ANIMALS; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; YOKOYAMA HO, 1953, CANCER RES, V13, P80; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	29	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78550	10.1371/journal.pone.0078550	http://dx.doi.org/10.1371/journal.pone.0078550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223822	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400072
J	Leyrat, C; Renner, M; Harlos, K; Grimes, JM				Leyrat, Cedric; Renner, Max; Harlos, Karl; Grimes, Jonathan M.			Solution and Crystallographic Structures of the Central Region of the Phosphoprotein from Human Metapneumovirus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; C-TERMINAL DOMAIN; BINDING DOMAIN; N-P; PROTEIN; NUCLEOPROTEIN; SCATTERING; DISORDER; IDENTIFICATION; PREDICTION	Human metapneumovirus (HMPV) of the family Paramyxoviridae is a major cause of respiratory illness worldwide. Phosphoproteins (P) from Paramyxoviridae are essential co-factors of the viral RNA polymerase that form tetramers and possess long intrinsically disordered regions (IDRs). We located the central region of HMPV P (P-ced) which is involved in tetramerization using disorder analysis and modeled its 3D structure ab initio using Rosetta fold-and-dock. We characterized the solution-structure of P-ced using small angle X-ray scattering (SAXS) and carried out direct fitting to the scattering data to filter out incorrect models. Molecular dynamics simulations (MDS) and ensemble optimization were employed to select correct models and capture the dynamic character of P-ced. Our analysis revealed that oligomerization involves a compact central core located between residues 169-194 (P-core), that is surrounded by flexible regions with a-helical propensity. We crystallized this fragment and solved its structure at 3.1 angstrom resolution by molecular replacement, using the folded core from our SAXS-validated ab initio model. The RMSD between modeled and experimental tetramers is as low as 0.9 angstrom, demonstrating the accuracy of the approach. A comparison of the structure of HMPV P to existing mononegavirales P-ced structures suggests that P-ced evolved under weak selective pressure. Finally, we discuss the advantages of using SAXS in combination with ab initio modeling and MDS to solve the structure of small, homo-oligomeric protein complexes.	[Leyrat, Cedric; Renner, Max; Harlos, Karl; Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Oxford, England; [Grimes, Jonathan M.] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England	University of Oxford; Diamond Light Source	Leyrat, C (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	cedric@strubi.ox.ac.uk	LEYRAT, Cédric/G-5559-2017	Leyrat, Cedric/0000-0003-0189-0562; Grimes, Jonathan Mark/0000-0001-9698-0389; Renner, Max/0000-0001-9885-8256	European Union [260644]; Wellcome trust [099667/Z/12/Z, 090532/Z/09/Z, 075491/Z/04]	European Union(European Commission); Wellcome trust(Wellcome TrustEuropean Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under SILVER grant agreement no 260644. Max Renner was supported by a Wellcome trust fellowship (099667/Z/12/Z). This work was also supported by the Wellcome Trust Core award (090532/Z/09/Z). Administrative support was provided by the Wellcome Trust (Grant 075491/Z/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERENDSEN HJC, 1984, MOL DYNAMICS SIMULAT, V135, P500; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Buchholz UJ, 2005, J VIROL, V79, P6588, DOI 10.1128/JVI.79.11.6588-6597.2005; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Communie G, 2013, J VIROL, V87, P7166, DOI 10.1128/JVI.00487-13; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Derdowski A, 2008, J GEN VIROL, V89, P2698, DOI 10.1099/vir.0.2008/004051-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Expert-Bezancon N, 2003, BIOPHYS CHEM, V100, P469, DOI 10.1016/S0301-4622(02)00299-5; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; GarciaBarreno B, 1996, J VIROL, V70, P801; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hyndman TH, 2012, INFECT GENET EVOL, V12, P1436, DOI 10.1016/j.meegid.2012.04.022; Jensen MR, 2010, PROTEIN PEPTIDE LETT, V17, P952; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Khattar SK, 2001, J GEN VIROL, V82, P775, DOI 10.1099/0022-1317-82-4-775; Khattar SK, 2001, VIROLOGY, V285, P253, DOI 10.1006/viro.2001.0960; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leyrat C, 2012, J MOL BIOL, V423, P182, DOI 10.1016/j.jmb.2012.07.003; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Leyrat C, 2011, PROTEIN SCI, V20, P542, DOI 10.1002/pro.587; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Llorente MT, 2008, PROTEINS, V72, P946, DOI 10.1002/prot.21988; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Longhi S, 2010, PROTEIN PEPTIDE LETT, V17, P961, DOI 10.2174/092986610791498894; Lu B, 2002, J VIROL, V76, P2871, DOI 10.1128/JVI.76.6.2871-2880.2002; Mallipeddi SK, 1996, J GEN VIROL, V77, P1019, DOI 10.1099/0022-1317-77-5-1019; Marriott AC, 1999, J VIROL, V73, P5162, DOI 10.1128/JVI.73.6.5162-5165.1999; Martinez N, 2013, J VIROL, V87, P9569, DOI 10.1128/JVI.00999-13; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Mavrakis M, 2004, J MOL BIOL, V343, P819, DOI 10.1016/j.jmb.2004.08.071; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pons C, 2010, J MOL BIOL, V403, P217, DOI 10.1016/j.jmb.2010.08.029; R_uhle V, 2008, PRESSURE COUPLING BA; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Retief J D, 2000, Methods Mol Biol, V132, P243; Ribeiro EA, 2008, J MOL BIOL, V382, P525, DOI 10.1016/j.jmb.2008.07.028; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schneidman-Duhovny D, 2011, J STRUCT BIOL, V173, P461, DOI 10.1016/j.jsb.2010.09.023; Slack MS, 1998, VIRUS RES, V55, P167, DOI 10.1016/S0168-1702(98)00042-2; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taly JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-6; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; WASSENAAR T, WENMR STRUCTURAL BIO, V10, P767; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012; Zheng WJ, 2005, PROTEIN ENG DES SEL, V18, P209, DOI 10.1093/protein/gzi026; Zheng WJ, 2002, J MOL BIOL, V316, P173, DOI 10.1006/jmbi.2001.5324	76	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80371	10.1371/journal.pone.0080371	http://dx.doi.org/10.1371/journal.pone.0080371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224051	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400155
J	Li, XY; Song, BA; Chen, X; Wang, ZC; Zeng, MJ; Yu, DD; Hu, DY; Chen, Z; Jin, LH; Yang, S; Yang, CG; Chen, BE				Li, Xiangyang; Song, Baoan; Chen, Xi; Wang, Zhenchao; Zeng, Mengjiao; Yu, Dandan; Hu, Deyu; Chen, Zhuo; Jin, Linhong; Yang, Song; Yang, Caiguang; Chen, Baoen			Crystal Structure of a Four-Layer Aggregate of Engineered TMV CP Implies the Importance of Terminal Residues for Oligomer Assembly	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ELECTRON-MICROSCOPY; COAT PROTEIN; RESOLUTION; RNA; MECHANISM; DISK; PURIFICATION; STRAIN; MODEL	Background: Crystal structures of the tobacco mosaic virus (TMV) coat protein (CP) in its helical and disk conformations have previously been determined at the atomic level. For the helical structure, interactions of proteins and nucleic acids in the main chains were clearly observed; however, the conformation of residues at the C-terminus was flexible and disordered. For the four-layer aggregate disk structure, interactions of the main chain residues could only be observed through water-mediated hydrogen bonding with protein residues. In this study, the effects of the C-terminal peptides on the interactions of TMV CP were investigated by crystal structure determination. Methodology/Principal Findings: The crystal structure of a genetically engineered TMV CP was resolved at 3.06 angstrom. For the genetically engineered TMV CP, a six-histidine (His) tag was introduced at the N-terminus, and the C-terminal residues 155 to 158 were truncated (N-His-TMV CP19). Overall, N-His-TMV CP19 protein self-assembled into the four-layer aggregate form. The conformations of residues Gln36, Thr59, Asp115 and Arg134 were carefully analyzed in the high radius and low radius regions of N-His-TMV CP19, which were found to be significantly different from those observed previously for the helical and four-layer aggregate forms. In addition, the aggregation of the N-His-TMV CP19 layers was found to primarily be mediated through direct hydrogen-bonding. Notably, this engineered protein also can package RNA effectively and assemble into an infectious virus particle. Conclusion: The terminal sequence of amino acids influences the conformation and interactions of the four-layer aggregate. Direct protein-protein interactions are observed in the major overlap region when residues Gly155 to Thr158 at the C-terminus are truncated. This engineered TMV CP is reassembled by direct protein-protein interaction and maintains the normal function of the four-layer aggregate of TMV CP in the presence of RNA.	[Li, Xiangyang; Song, Baoan; Chen, Xi; Wang, Zhenchao; Yu, Dandan; Hu, Deyu; Chen, Zhuo; Jin, Linhong; Yang, Song] Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China; [Zeng, Mengjiao] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou, Guangdong, Peoples R China; [Yang, Caiguang; Chen, Baoen] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Guizhou University; South China University of Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Song, BA (corresponding author), Guizhou Univ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Minist Educ, Guiyang 550003, Peoples R China.	basong@gzu.edu.cn; yangsdqj@126.com	Chen, Zhuo/AFX-0411-2022; Yang, Song/H-2765-2013	Yang, Song/0000-0003-1301-3030	National Basic Research Program of China [2010CB126105]; Key Technologies RD Program [2011BAE06B05-6]; National Natural Science Foundation of China [21132003]	National Basic Research Program of China(National Basic Research Program of China); Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No. 2010CB126105), the Key Technologies R&D Program (Grant No. 2011BAE06B05-6), and the National Natural Science Foundation of China (Grant No. 21132003). The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfors TE, 2009, PROTEIN CRYSTALLIZAT, P95; Bhyravbhatla B, 1998, BIOPHYS J, V74, P604, DOI 10.1016/S0006-3495(98)77819-1; BLOOMER AC, 1978, NATURE, V276, P362, DOI 10.1038/276362a0; Bloomer AC, 1986, TOBACCO MOSAIC VIRUS, P19; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruckman MA, 2011, ACS NANO, V5, P1606, DOI 10.1021/nn1025719; BUTLER PJG, 1984, J GEN VIROL, V65, P253, DOI 10.1099/0022-1317-65-2-253; Caspar D L, 1990, Adv Biophys, V26, P157, DOI 10.1016/0065-227X(90)90011-H; CastellanosSerra LR, 1996, ELECTROPHORESIS, V17, P1564, DOI 10.1002/elps.1150171012; Clare DK, 2010, J STRUCT BIOL, V171, P303, DOI 10.1016/j.jsb.2010.06.011; Dedeo MT, 2010, NANO LETT, V10, P181, DOI 10.1021/nl9032395; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRAENK.H, 1961, VIROLOGY, V14, P54, DOI 10.1016/0042-6822(61)90131-3; Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108; Geiger FC, 2013, NANOSCALE, V5, P3808, DOI 10.1039/c3nr33724c; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; HEBERT TT, 1963, PHYTOPATHOLOGY, V53, P362; Jonathan P, 1977, ADV PROTEIN CHEM, V31, P188; Kadri A, 2013, J VIROL METHODS, V189, P328, DOI 10.1016/j.jviromet.2013.02.017; Kadri A, 2011, VIRUS RES, V157, P35, DOI 10.1016/j.virusres.2011.01.014; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kegel WK, 2006, BIOPHYS J, V91, P1501, DOI 10.1529/biophysj.105.072603; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Li XY, 2012, VIROLOGY J IN PRESS; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mancini EJ, 2012, ADV EXP MED BIOL, V726, P609, DOI 10.1007/978-1-4614-0980-9_27; MANDELKOW E, 1976, J MOL BIOL, V102, P265, DOI 10.1016/S0022-2836(76)80053-8; MANDELKOW E, 1981, J MOL BIOL, V152, P375, DOI 10.1016/0022-2836(81)90248-5; Mueller A, 2010, J VIROL METHODS, V166, P77, DOI 10.1016/j.jviromet.2010.02.026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Okada Y, 1986, Adv Biophys, V22, P95, DOI 10.1016/0065-227X(86)90004-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTANAYEK R, 1992, J MOL BIOL, V228, P516, DOI 10.1016/0022-2836(92)90839-C; RAGHAVENDRA K, 1988, BIOCHEMISTRY-US, V27, P7583, DOI 10.1021/bi00420a002; RAGHAVENDRA K, 1985, BIOCHEMISTRY-US, V24, P3298, DOI 10.1021/bi00334a034; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; SCHUSTER TM, 1980, BIOPHYS J, V32, P313, DOI 10.1016/S0006-3495(80)84959-9; SHIRE SJ, 1979, P NATL ACAD SCI USA, V76, P2745, DOI 10.1073/pnas.76.6.2745; SHIRE SJ, 1979, J MOL BIOL, V127, P487, DOI 10.1016/0022-2836(79)90233-X; SPERLING R, 1975, J MOL BIOL, V96, P425, DOI 10.1016/0022-2836(75)90169-2; STUBBS G, 1977, NATURE, V267, P216, DOI 10.1038/267216a0; Stubbs G, 2012, ADV EXP MED BIOL, V726, P631, DOI 10.1007/978-1-4614-0980-9_28; WILCOCKSON J, 1974, J GEN VIROL, V23, P107, DOI 10.1099/0022-1317-23-1-107	50	24	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77717	10.1371/journal.pone.0077717	http://dx.doi.org/10.1371/journal.pone.0077717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223721	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400014
J	Romero, L; Trenor, B; Ferrero, JM; Starmer, CF				Romero, Lucia; Trenor, Beatriz; Ferrero, Jose M.; Starmer, C. Frank			Non-Uniform Dispersion of the Source-Sink Relationship Alters Wavefront Curvature	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; CARDIAC TISSUE; SAFETY FACTOR; VULNERABLE PERIOD; SLOW CONDUCTION; EXCITABILITY; MUSCLE; FIBRILLATION; ARRHYTHMIAS; MECHANISMS	The distribution of cellular source-sink relationships plays an important role in cardiac propagation. It can lead to conduction slowing and block as well as wave fractionation. It is of great interest to unravel the mechanisms underlying evolution in wavefront geometry. Our goal is to investigate the role of the source-sink relationship on wavefront geometry using computer simulations. We analyzed the role of variability in the microscopic source-sink relationship in driving changes in wavefront geometry. The electrophysiological activity of a homogeneous isotropic tissue was simulated using the ten Tusscher and Panfilov 2006 action potential model and the source-sink relationship was characterized using an improved version of the Romero et al. safety factor formulation (SFm2). Our simulations reveal that non-uniform dispersion of the cellular source-sink relationship (dispersion along the wavefront) leads to alterations in curvature. To better understand the role of the source-sink relationship in the process of wave formation, the electrophysiological activity at the initiation of excitation waves in a 1D strand was examined and the source-sink relationship was characterized using the two recently updated safety factor formulations: the SFm2 and the Boyle-Vigmond (SFVB) definitions. The electrophysiological activity at the initiation of excitation waves was intimately related to the SFm2 profiles, while the SFVB led to several counterintuitive observations. Importantly, with the SFm2 characterization, a critical source-sink relationship for initiation of excitation waves was identified, which was independent of the size of the electrode of excitation, membrane excitability, or tissue conductivity. In conclusion, our work suggests that non-uniform dispersion of the source-sink relationship alters wavefront curvature and a critical source-sink relationship profile separates wave expansion from collapse. Our study reinforces the idea that the safety factor represents a powerful tool to study the mechanisms of cardiac propagation in silico, providing a better understanding of cardiac arrhythmias and their therapy.	[Romero, Lucia; Trenor, Beatriz; Ferrero, Jose M.] Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain; [Starmer, C. Frank] Duke NUS Grad Med Sch, Singapore, Singapore; [Starmer, C. Frank] Duke Univ, Durham, NC USA	Universitat Politecnica de Valencia; National University of Singapore; Duke University	Romero, L (corresponding author), Univ Politecn Valencia, Inst Invest Interuniv Bioingn & Tecnol Orientada, E-46071 Valencia, Spain.	lurope@eln.upv.es	Romero, Lucia/H-6815-2015; Trenor, Beatriz/H-1716-2015; Ferrero, Jose M/I-2034-2015	Romero, Lucia/0000-0003-4605-8630; Trenor, Beatriz/0000-0001-9166-6112; Ferrero, Jose M/0000-0003-4200-9225; Starmer, C Frank/0000-0002-9877-1537	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain [TIN2012?37546?C03?01]; European Commission (European Regional Development Funds - ERDF ? FEDER); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain [TSI?020100?2010?469]; Programa de Apoyo a la Investigacion y Desarrollo [PAID?06?11?2002]; de la Universidad Politecnica de Valencia; Direccion General de Politica Cientifica de la Generalitat Valenciana [GV/2013/119]; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana [PROMETEO/2012/030]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds - ERDF ? FEDER); Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain; Programa de Apoyo a la Investigacion y Desarrollo; de la Universidad Politecnica de Valencia; Direccion General de Politica Cientifica de la Generalitat Valenciana; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana	This work was partially supported by the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from the Ministerio de Economia y Competitividad of Spain (TIN2012?37546?C03?01) and the European Commission (European Regional Development Funds - ERDF ? FEDER), Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Plan Avanza en el marco de la Accion Estrategica de Telecomunicaciones y Sociedad de la Informacion del Ministerio de Industria Turismo y Comercio of Spain (TSI?020100?2010?469), Programa de Apoyo a la Investigacion y Desarrollo (PAID?06?11?2002) de la Universidad Politecnica de Valencia, Direccion General de Politica Cientifica de la Generalitat Valenciana (GV/2013/119) and Programa Prometeo (PROMETEO/2012/030) de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1976, CIRC RES, V39, P168, DOI 10.1161/01.RES.39.2.168; Aslanidi OV, 2009, BIOPHYS J, V97, P20, DOI 10.1016/j.bpj.2009.03.061; Azene EM, 2001, ANN BIOMED ENG, V29, P35, DOI 10.1114/1.1332083; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; CABO C, 1994, CIRC RES, V75, P1014, DOI 10.1161/01.RES.75.6.1014; Clayton RH, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-11; Danse PW, 2000, J CARDIOVASC ELECTR, V11, P262, DOI 10.1111/j.1540-8167.2000.tb01795.x; DELGADO C, 1990, CIRC RES, V67, P97, DOI 10.1161/01.RES.67.1.97; Efimov IR, 1997, J CARDIOVASC ELECTR, V8, P1031, DOI 10.1111/j.1540-8167.1997.tb00627.x; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; Hubbard ML, 2010, AM J PHYSIOL-HEART C, V298, pH1209, DOI 10.1152/ajpheart.00689.2009; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kucera JP, 2001, CIRC RES, V89, P799, DOI 10.1161/hh2101.098442; LEON LJ, 1991, CIRC RES, V69, P378, DOI 10.1161/01.RES.69.2.378; ONG JJC, 1995, J CLIN INVEST, V96, P2284, DOI 10.1172/JCI118284; Romero L, 2005, COMPUT CARDIOL, V32, P873; Romero L, 2009, ANN BIOMED ENG, V37, P1560, DOI 10.1007/s10439-009-9721-2; RUSHTON WAH, 1937, P R SOC B, V124, P213; Sambelashvili AT, 2003, AM J PHYSIOL-HEART C, V284, pH2368, DOI 10.1152/ajpheart.00988.2002; SELFRIDGE O., 1948, ARCH INST CARDIOL [MEXICO], V18, P177; Shaw RM, 1997, CIRC RES, V81, P727; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; Starmer CF, 1997, PACE, V20, P445, DOI 10.1111/j.1540-8159.1997.tb06203.x; Starmer CF, 2003, CARDIOVASC RES, V57, P82, DOI 10.1016/S0008-6363(02)00613-2; Stein M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020310; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; VANCAPELLE FJL, 1980, CIRC RES, V47, P454, DOI 10.1161/01.RES.47.3.454; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Wang Y, 2000, AM J PHYSIOL-HEART C, V278, pH1019, DOI 10.1152/ajpheart.2000.278.4.H1019; Wellner M, 1997, PHYS REV E, V55, P7656, DOI 10.1103/PhysRevE.55.7656; Zhao JC, 2009, J CARDIOVASC ELECTR, V20, P675, DOI 10.1111/j.1540-8167.2008.01420.x; ZYKOV VS, 1980, BIOFIZIKA+, V25, P888	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78328	10.1371/journal.pone.0078328	http://dx.doi.org/10.1371/journal.pone.0078328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223791	Green Published, gold			2022-12-25	WOS:000326503400051
J	Fan, WH; Li, Q; Yang, XP; Zhang, L				Fan, Wenhong; Li, Qian; Yang, Xiuping; Zhang, Li			Zn Subcellular Distribution in Liver of Goldfish (Carassius Auratus) with Exposure to Zinc Oxide Nanoparticles and Mechanism of Hepatic Detoxification	PLOS ONE			English	Article							WATER RAINBOW-TROUT; HEAVY-METAL; FISH; TOXICITY; METALLOTHIONEIN; CADMIUM; COPPER; BIOACCUMULATION; ACCUMULATION; GILLS	Zinc Oxide Nanoparticles (ZnO NPs) have attracted increasing concerns because of their widespread use and toxic potential. In this study, Zn accumulations in different tissues (gills, liver, muscle, and gut) of goldfish (Carassius auratus) after exposure to ZnO NPs were studied in comparison with bulk ZnO and Zn2+. And the technique of subcellular partitioning was firstly used on the liver of goldfish to study the hepatic accumulation of ZnO NPs. The results showed that at sublethal Zn concentration (2 mg/L), bioaccumulation in goldfish was tissue-specific and dependent on the exposure materials. Compared with Zn2+, the particles of bulk ZnO and the ZnO NPs appeared to aggregate in the environmentally contacted tissues (gills and gut), rather than transport to the internal tissues (liver and muscle). The subcellular distributions of liver differed for the three exposure treatments. After ZnO NPs exposure, Zn percentage in metal-rich granule (MRG) increased significantly, and after Zn2+ exposure, it increased significantly in the organelles. Metallothionein-like proteins (MTLP) were the main target for Zn2+, while MRG played dominant role for ZnO NPs. The different results of subcellular distributions revealed that metal detoxification mechanisms of liver for ZnO NPs, bulk ZnO, and Zn2+ were different. Overall, subcellular partitioning provided an interesting start to better understanding of the toxicity of nano-and conventional materials.	[Fan, Wenhong; Li, Qian; Yang, Xiuping] Beihang Univ, Sch Chem & Environm, Dept Environm Sci & Engn, Beijing, Peoples R China; [Zhang, Li] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China	Beihang University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Fan, WH (corresponding author), Beihang Univ, Sch Chem & Environm, Dept Environm Sci & Engn, Beijing, Peoples R China.	fanwh@buaa.edu.cn	Zhang, Li/A-7762-2014; fan, wen hong/F-6415-2012	Zhang, Li/0000-0001-5705-6548; 	National Natural Science Foundation of China [51290283]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07501001]; China's National Basic Research Program [2011CB935700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China; China's National Basic Research Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (51290283), Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2012ZX07501001), and China's National Basic Research Program (No. 2011CB935700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; BOOTH JH, 1978, J EXP BIOL, V73, P119; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Collins D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042663; Dowling A., 2004, NANOSCIENCE NANOTECH, P61; Dural M, 2007, FOOD CHEM, V102, P415, DOI 10.1016/j.foodchem.2006.03.001; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Giguere A, 2006, AQUAT TOXICOL, V77, P178, DOI 10.1016/j.aquatox.2005.12.001; Glover CN, 2004, BBA-BIOMEMBRANES, V1663, P214, DOI 10.1016/j.bbamem.2004.03.008; Goto D, 2010, MAR ENVIRON RES, V69, P163, DOI 10.1016/j.marenvres.2009.09.008; Hariharan C, 2006, APPL CATAL A-GEN, V304, P55, DOI 10.1016/j.apcata.2006.02.020; Hogstrand C, 1996, AM J PHYSIOL-REG I, V270, pR1141; Jabeen F, 2010, ENVIRON MONIT ASSESS, V170, P645, DOI 10.1007/s10661-009-1263-4; Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025; Johnston BD, 2010, ENVIRON SCI TECHNOL, V44, P1144, DOI 10.1021/es901971a; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kotze P, 1999, WATER SA, V25, P99; Li LZ, 2011, ENVIRON INT, V37, P1098, DOI 10.1016/j.envint.2011.01.008; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Murugan SS, 2008, TURK J FISH AQUAT SC, V8, P55; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Papagiannis I, 2004, ENVIRON INT, V30, P357, DOI 10.1016/j.envint.2003.08.002; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; ROCH M, 1982, CAN J FISH AQUAT SCI, V39, P1596, DOI 10.1139/f82-215; ROESIJADI G, 1992, AQUAT TOXICOL, V22, P81, DOI 10.1016/0166-445X(92)90026-J; Sappal R, 2009, AQUAT TOXICOL, V91, P281, DOI 10.1016/j.aquatox.2008.10.007; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Urena R, 2007, ENVIRON INT, V33, P532, DOI 10.1016/j.envint.2006.10.007; Uysal K, 2011, INT J FOOD PROP, V14, P280, DOI 10.1080/10942910903176378; Wallace WG, 2003, MAR ECOL PROG SER, V249, P183, DOI 10.3354/meps249183; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Wang WX, 2010, ENVIRON TOXICOL CHEM, V29, P1841, DOI 10.1002/etc.229; Wang WX, 2010, COMP BIOCHEM PHYS C, V152, P1, DOI 10.1016/j.cbpc.2010.02.015; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Wu SM, 2006, B ENVIRON CONTAM TOX, V76, P595, DOI 10.1007/s00128-006-0961-7; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Yin H, 2010, LANGMUIR, V26, P15399, DOI 10.1021/la101033n	40	7	7	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78123	10.1371/journal.pone.0078123	http://dx.doi.org/10.1371/journal.pone.0078123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223767	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300024
J	Ohnesorge, H; Feng, ZY; Zitta, K; Steinfath, M; Albrecht, M; Bein, B				Ohnesorge, Henning; Feng, Zhiying; Zitta, Karina; Steinfath, Markus; Albrecht, Martin; Bein, Berthold			Influence of Clonidine and Ketamine on m-RNA Expression in a Model of Opioid-Induced Hyperalgesia in Mice	PLOS ONE			English	Article							ABNORMAL PAIN SENSITIVITY; LONG-LASTING HYPERALGESIA; MORPHINE ANALGESIA; BETA-ARRESTIN; MURINE MODEL; TOLERANCE; RECEPTOR; RATS; MECHANISMS; REMIFENTANIL	Background: We investigated the influence of morphine and ketamine or clonidine in mice on the expression of genes that may mediate pronociceptive opioid effects. Material and Methods: C57BL/6 mice received morphine injections thrice daily using increasing doses (5-20mg.kg(-1)) for 3 days (sub-acute, n=6) or 14 days (chronic, n=6) and additionally either s-ketamine (5mg.kg(-1), n=6) or clonidine (0.1mg.kg(-1), n=6). Tail flick test and the assessment of the mechanical withdrawal threshold of the hindpaw was performed during and 4 days after cessation of opioid treatment. Upon completion of the behavioural testing the mRNA-concentration of the NMDA receptor (NMDAR1) and beta-arrestin 2 (Arrb2) were measured by PCR. Results: Chronic opioid treatment resulted in a delay of the tail flick latency with a rapid on-and offset. Simultaneously the mice developed a static mechanical hyperalgesia with a delayed onset that that outlasted the morphine treatment. Sub-acute morphine administration resulted in a decrease of NMDAR1 and Arrb2 whereas during longer opioid treatment the expression NMDAR1 and Arrb2 mRNA increased again to baseline values. Coadministration of s-ketamine or clonidine resulted in a reversal of the mechanical hyperalgesia and inhibited the normalization of NMDAR1 mRNA expression but had no effect on the expression of Arrb2 mRNA. Conclusion: In the model of chronic morphine therapy the antinociceptive effects of morphine are represented by the thermal analgesia while the proniceptive effects are represented by the mechanical hyperalgesia. The results indicate that the regulation of the expression of NMDAR1 and Arrb2 may be associated to the development of OIH in mice. Perspective: The results indicate that co-administration of clonidine or ketamine may influence the underlying mechanisms of OIH.	[Ohnesorge, Henning; Zitta, Karina; Steinfath, Markus; Albrecht, Martin; Bein, Berthold] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Feng, Zhiying] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China	University of Kiel; Schleswig Holstein University Hospital; Zhejiang University	Ohnesorge, H (corresponding author), Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	ohnesorge@anaesthesie.uni-kiel.de	Albrecht, Martin/AAW-9303-2021	Albrecht, Martin/0000-0003-2580-768X	Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christian-Albrecht-University, Kiel, Germany	Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christian-Albrecht-University, Kiel, Germany	Work was supported by the Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany and the Christian-Albrecht-University, Kiel, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Angst MS, 2003, PAIN, V106, P49, DOI 10.1016/S0304-3959(03)00276-8; Appleyard SM, 1999, J BIOL CHEM, V274, P23802, DOI 10.1074/jbc.274.34.23802; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Celerier E, 2006, ANESTHESIOLOGY, V104, P546; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Celerier E, 1999, BRAIN RES, V847, P18, DOI 10.1016/S0006-8993(99)01998-8; CHANG SL, 1988, BIOCHEM BIOPH RES CO, V157, P698, DOI 10.1016/S0006-291X(88)80306-1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Crain SM, 2000, PAIN, V84, P121, DOI 10.1016/S0304-3959(99)00223-7; De Kock M, 2005, ANESTH ANALG, V101, P566, DOI 10.1213/01.ANE.0000157121.71808.04; Dupen A, 2007, PAIN MANAG NURS, V8, P113, DOI 10.1016/j.pmn.2007.02.004; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Gowing LR, 2002, ADDICTION, V97, P49, DOI 10.1046/j.1360-0443.2002.00037.x; Himmelseher S, 2005, ANESTHESIOLOGY, V102, P211, DOI 10.1097/00000542-200501000-00030; Hong D, 2008, ANESTH ANALG, V107, P1384, DOI 10.1213/ane.0b013e3181823efb; Jiang BH, 2006, NEUROSCI LETT, V400, P150, DOI 10.1016/j.neulet.2006.02.071; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Juni A, 2006, BRAIN RES, V1070, P35, DOI 10.1016/j.brainres.2005.11.054; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Koppert W, 2003, ANESTHESIOLOGY, V99, P152, DOI 10.1097/00000542-200307000-00025; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Laulin JP, 1998, EUR J NEUROSCI, V10, P782, DOI 10.1046/j.1460-9568.1998.00083.x; Le Bars D, 2001, PHARMACOL REV, V53, P597; Li XH, 2001, J PHARMACOL EXP THER, V299, P939; Li XQ, 2001, ANESTH ANALG, V93, P204; Li XQ, 2001, MOL BRAIN RES, V86, P56, DOI 10.1016/S0169-328X(00)00260-6; LICHTMAN AH, 1993, PAIN, V55, P283, DOI 10.1016/0304-3959(93)90003-8; MAO J, 1994, J NEUROSCI, V14, P2301; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Waxman AR, 2009, NEUROSCI LETT, V462, P68, DOI 10.1016/j.neulet.2009.06.061	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79567	10.1371/journal.pone.0079567	http://dx.doi.org/10.1371/journal.pone.0079567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223972	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300090
J	Linke-Winnebeck, C; Paterson, NG; Young, PG; Middleditch, MJ; Greenwood, DR; Witte, G; Baker, EN				Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Witte, Gregor; Baker, Edward N.			Structural Model for Covalent Adhesion of the Streptococcus pyogenes Pilus through a Thioester Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Crystal Structure; Mass Spectrometry (MS); Post-translational Modification; Protein Cross-linking; Protein Domains; Streptococcus pyogenes; Bacterial Pilus; Thioester Domain	COMPLEMENT COMPONENT C3; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; INTERNAL THIOESTER; BIOFILM FORMATION; ISOPEPTIDE BONDS; FCT REGION; PROTEIN; BINDING; MECHANISM	The human pathogen Streptococcus pyogenes produces pili that are essential for adhesion to host surface receptors. Cpa, the adhesin at the pilus tip, was recently shown to have a thioester-containing domain. The thioester bond is believed to be important in adhesion, implying a mechanism of covalent attachment analogous to that used by human complement factors. Here, we have characterized a second active thioester-containing domain on Cpa, the N-terminal domain of Cpa (CpaN). Expression of CpaN in Escherichia coli gave covalently linked dimers. These were shown by x-ray crystallography and mass spectrometry to comprise two CpaN molecules cross-linked by the polyamine spermidine following reaction with the thioester bonds. This cross-linked CpaN dimer provides a model for the covalent attachment of Cpa to target receptors and thus the streptococcal pilus to host cells. Similar thioester domains were identified in cell wall proteins of other Gram-positive pathogens, suggesting that thioester domains are more widely used and provide a mechanism of adhesion by covalent bonding to target molecules on host cells that mimics that used by the human complement system to eliminate pathogens.	[Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Witte, Gregor] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Witte, Gregor] Univ Munich, Gene Ctr, D-81377 Munich, Germany	University of Auckland; University of Auckland; University of Munich; University of Munich	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 921019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Linke-Winnebeck, Christian/F-4091-2010; Linke-Winnebeck, Christian/P-1585-2019; Greenwood, David R/D-2375-2016; Witte, Gregor/B-4635-2011	Linke-Winnebeck, Christian/0000-0002-2306-247X; Linke-Winnebeck, Christian/0000-0002-2306-247X; Greenwood, David R/0000-0001-5280-042X; Witte, Gregor/0000-0003-0313-0962; Paterson, Neil/0000-0003-4292-6971; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; German Research Council (Deutsche Forschungsgemeinschaft) [GRK1721]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported in part by the Marsden Fund of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by German Research Council (Deutsche Forschungsgemeinschaft) Grant GRK1721.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Blanc E., 2011, BUSTER VERSION 2 11; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Gadjeva M, 1998, J IMMUNOL, V161, P985; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koller T, 2010, J MED MICROBIOL, V59, P442, DOI 10.1099/jmm.0.013581-0; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Law SKA, 1997, PROTEIN SCI, V6, P263; Lebedev A. A., 2012, CCP4 NEWSLETTER COMP; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Sugiyama S, 1996, PROTEIN SCI, V5, P1984, DOI 10.1002/pro.5560051004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tholl D, 1998, WORLD J MICROB BIOT, V14, P857, DOI 10.1023/A:1008829008065; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walden M., 2013, PROTEINS, DOI 10.1002/prot.24420; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHATMORE AM, 1994, MOL MICROBIOL, V11, P363, DOI 10.1111/j.1365-2958.1994.tb00316.x; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791	60	36	37	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					177	189		10.1074/jbc.M113.523761	http://dx.doi.org/10.1074/jbc.M113.523761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220033	hybrid, Green Published			2022-12-25	WOS:000329370900016
J	Akiyama, H; Iwahana, Y; Suda, M; Yoshimura, A; Kogai, H; Nagashima, A; Ohtsuka, H; Komiya, Y; Tashiro, F				Akiyama, Hirotada; Iwahana, Yoshimasa; Suda, Mikiya; Yoshimura, Atsunori; Kogai, Hiroyuki; Nagashima, Ai; Ohtsuka, Hiroko; Komiya, Yuko; Tashiro, Fumio			The FBI1/Akirin2 Target Gene, BCAM, Acts as a Suppressive Oncogene	PLOS ONE			English	Article							CELL-ADHESION-MOLECULE; B-CAM; MATRIX METALLOPROTEINASES; EXPRESSION; LAMININ; LUTHERAN; GROWTH; DIFFERENTIATION; GLYCOPROTEIN; INVASION	Basal cell adhesion molecule (BCAM), known to be a splicing variant of Lutheran glycoprotein (LU), is an immunoglobulin superfamily membrane protein that acts as a laminin alpha 5 receptor. The high affinity of BCAM/LU for laminin alpha 5 is thought to contribute to the pathogenesis of sickle red blood cells and to various developmental processes. However, the function of BCAM in carcinogenesis is poorly understood. Based on microarray expression analysis, we found that BCAM was one of the target genes of the oncogenic 14-3-3 beta-FBI1/Akirin2 complex, which acts as a transcriptional repressor and suppresses MAPK phosphatase-1 gene expression. To elucidate the detailed function of BCAM in malignant tumors, we established BCAM-expressing hepatoma K2 cells. These cells lost the malignant characteristics of parental cells, such as anchorage-independent growth, migration, invasion, and tumorigenicity. Moreover, luciferase reporter assays and chromatin immunoprecipitation analysis revealed that the 14-3-3 beta-FBI1/Akirin2 complex bound to the BCAM promoter and repressed transcription. Thus, these data indicate that BCAM is a suppressive oncoprotein, and that FBI1/Akirin2 is involved in tumorigenicity and metastasis of hepatoma through the downregulation of suppressive oncogenes.	[Akiyama, Hirotada; Iwahana, Yoshimasa; Suda, Mikiya; Yoshimura, Atsunori; Kogai, Hiroyuki; Nagashima, Ai; Ohtsuka, Hiroko; Komiya, Yuko; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 162, Japan	Tokyo University of Science	Akiyama, H (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 162, Japan.	hakiyama@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [70089332, 23701104, 25870775]; Grants-in-Aid for Scientific Research [23501271] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research Grant Numbers 70089332, 23701104, 25870775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Bernemann TM, 2000, J CUTAN PATHOL, V27, P108, DOI 10.1034/j.1600-0560.2000.027003108.x; CAMPBELL IG, 1994, CANCER RES, V54, P5761; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; Drewniok C, 2004, ARCH DERMATOL RES, V296, P59, DOI 10.1007/s00403-004-0481-4; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Nemer W, 1998, J BIOL CHEM, V273, P16686; GARINCHESA P, 1994, INT J ONCOL, V5, P1261; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Komiya Y, 2005, MYCOTOXINS, V55, P107; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Latini FRM, 2013, BLOOD CELL MOL DIS, V50, P161, DOI 10.1016/j.bcmd.2012.10.009; MORIMURA S, 1990, CHEM PHARM BULL, V38, P460, DOI 10.1248/cpb.38.460; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Planaguma J, 2011, HUM PATHOL, V42, P57, DOI 10.1016/j.humpath.2010.01.025; Schon M, 2000, J INVEST DERMATOL, V115, P1047, DOI 10.1046/j.1523-1747.2000.00189.x; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Suda M, 2013, MYCOTOXINS IN PRESS, V64; Sugiyama A, 2003, CARCINOGENESIS, V24, P1549, DOI 10.1093/carcin/bgg113; Sugiyama A., 2000, Mycotoxins, V50, P83, DOI 10.2520/myco1975.50.83; Sugiyama A, 1999, MYCOTOXINS, V48, P59; TAKAI R, 1995, J BIOCHEM, V118, P1045, DOI 10.1093/jb/118.5.1045; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	32	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78716	10.1371/journal.pone.0078716	http://dx.doi.org/10.1371/journal.pone.0078716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223164	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200056
J	Chang, KC; Chang, WC; Chang, Y; Hung, LY; Lai, CH; Yeh, YM; Chou, YW; Chen, CH				Chang, Kung-Chao; Chang, Wei-Chao; Chang, Yao; Hung, Liang-Yi; Lai, Chien-Hsien; Yeh, Yu-Min; Chou, Yu-Wei; Chen, Chung-Hsuan			Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							SERUM LACTATE-DEHYDROGENASE; NON-HODGKINS-LYMPHOMA; PROGNOSTIC-FACTOR; CYSTATIN-C; RANGAP1; LEVEL; EXPRESSION; CYCLE; BETA-2-MICROGLOBULIN; DEREGULATION	Lymphoma-specific biomarkers contribute to therapeutic strategies and the study of tumorigenesis. Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma. However, only 50% of patients experience long-term survival after current treatment; therefore, developing novel therapeutic strategies is warranted. Comparative proteomic analysis of two DLBCL lines with a B-lymphoblastoid cell line (LCL) showed differential expression of Ran GTPase-activating protein 1 (RanGAP1) between them, which was confirmed using immunoblotting. Immunostaining showed that the majority of DLBCLs (92%, 46/50) were RanGAP1(+), while reactive lymphoid hyperplasia (n = 12) was RanGAP1+ predominantly in germinal centers. RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%). Interestingly, serum RanGAP1 level was higher in patients with high-grade BCL (1.71 +/- 2.28 ng/mL, n = 62) than in low-grade BCL (0.75 +/- 2.12 ng/mL, n = 52) and healthy controls (0.55 +/- 1.58 ng/mL, n = 75) (high-grade BCL vs. low-grade BCL, p = 0.002; high-grade BCL vs. control, p < 0.001, Mann-Whitney U test). In vitro, RNA interference of RanGAP1 showed no effect on LCL but enhanced DLBCL cell death (41% vs. 60%; p = 0.035) and cell-cycle arrest (G0/G1: 39% vs. 49%, G2/M: 19.0% vs. 7.5%; p = 0.030) along with decreased expression of TPX2 and Aurora kinases, the central regulators of mitotic cell division. Furthermore, ON 01910. Na (Estybon), a multikinase inhibitor induced cell death, mitotic cell arrest, and hyperphosphorylation of RanGAP1 in DLBCL cell lines but no effects in normal B and T cells. Therefore, RanGAP1 is a promising marker and therapeutic target for aggressive B-cell lymphoma, especially DLBCL.	[Chang, Kung-Chao; Chou, Yu-Wei] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pathol, Tainan, Taiwan; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chang, Yao] Natl Hlth Res Inst, Div Infect Dis, Tainan, Taiwan; [Hung, Liang-Yi; Lai, Chien-Hsien] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Yeh, Yu-Min] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Chang, KC (corresponding author), Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pathol, Tainan, Taiwan.	changkc@mail.ncku.edu.tw; winschen@gate.sinica.edu.tw	Chen, Chung-Hsuan/F-7940-2012; Hung, Liang-Yi/AAG-4174-2019; Chang, Yao/B-2653-2010; Lai, Chien-Hsien/ABD-9379-2020	, Liang-Yi/0000-0002-7284-2608	National Cheng Kung University Hospital [NCKUH-98-02004]; National Science Council, Taiwan [NSC100-2320-B-006-005-MY3];  [DOH101-TD-C-111-003]	National Cheng Kung University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); 	This work was supported by grants NCKUH-98-02004 from National Cheng Kung University Hospital, NSC100-2320-B-006-005-MY3 from the National Science Council, Taiwan, and DOH101-TD-C-111-003 (To establish centers of excellence for cancer research in Taiwan) to KC Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2005, IN VIVO, V19, P439; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Chang KC, 2004, LEUKEMIA LYMPHOMA, V45, P1375, DOI 10.1080/10428194042000198849; Chang KC, 2011, CANCER SCI, V102, P275, DOI 10.1111/j.1349-7006.2010.01765.x; Chang KC, 2009, AM J CLIN PATHOL, V132, P50, DOI 10.1309/AJCPBDFR5L5UOAUZ; Chang Wei-Chao, 2010, Int J Proteomics, V2010, P726968, DOI 10.1155/2010/726968; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; Chapman CM, 2012, CLIN CANCER RES, V18, P1979, DOI 10.1158/1078-0432.CCR-11-2113; Cimerman N, 2000, CLIN CHIM ACTA, V300, P83, DOI 10.1016/S0009-8981(00)00298-9; Coiffier B, 2003, SEMIN ONCOL, V30, P21, DOI 10.1053/sonc.2003.50021; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; Feng WQ, 1999, J CELL SCI, V112, P339; GEHAN EA, 1965, BIOMETRIKA, V52, P650, DOI 10.1093/biomet/52.3-4.650; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Goto N, 2006, EUR J HAEMATOL, V77, P217, DOI 10.1111/j.1600-0609.2006.00702.x; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; HAGBERG H, 1983, CANCER, V51, P2220, DOI 10.1002/1097-0142(19830615)51:12<2220::AID-CNCR2820511212>3.0.CO;2-A; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Kim JA, 2011, LEUKEMIA LYMPHOMA, V52, P205, DOI 10.3109/10428194.2010.542261; Konno R, 2000, CLIN CANCER RES, V6, P3576; Krejsek J, 1997, CLIN RHEUMATOL, V16, P149, DOI 10.1007/BF02247843; Maresca TJ, 2009, CURR BIOL, V19, P1210, DOI 10.1016/j.cub.2009.05.061; MCADAM B, 1993, MED ONCOL TUMOR PHAR, V10, P95; Mulaomerovic A, 2007, CANCER LETT, V248, P192, DOI 10.1016/j.canlet.2006.07.004; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Niitsu N, 1999, LEUKEMIA, V13, P1434, DOI 10.1038/sj.leu.2401502; Niitsu N, 2001, BLOOD, V97, P1202, DOI 10.1182/blood.V97.5.1202; Niitsu N, 2002, LEUKEMIA RES, V26, P241, DOI 10.1016/S0145-2126(01)00122-9; Oussenko IA, 2011, CANCER RES, V71, P4968, DOI 10.1158/0008-5472.CAN-10-1603; Paulli M, 1999, HUM PATHOL, V30, P178, DOI 10.1016/S0046-8177(99)90273-3; Pham LV, 2008, J BIOL CHEM, V283, P5081, DOI 10.1074/jbc.M706307200; Rentzos M, 2005, J NEUROL SCI, V228, P129, DOI 10.1016/j.jns.2004.11.001; Rodrigo-Peiris T, 2011, J EXP BOT, V62, P2705, DOI 10.1093/jxb/erq448; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; SARRIS AH, 1995, LEUKEMIA LYMPHOMA, V17, P473, DOI 10.3109/10428199509056860; SCHNEIDER RJ, 1980, CANCER, V46, P139, DOI 10.1002/1097-0142(19800701)46:1<139::AID-CNCR2820460122>3.0.CO;2-8; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Swerdlow E., 2008, WHO CLASSIFICATION T; Terol MJ, 2003, ANN ONCOL, V14, P467, DOI 10.1093/annonc/mdg057; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Tsou JH, 2011, J PATHOL, V225, P243, DOI 10.1002/path.2934; Yeh YM, 2010, HISTOPATHOLOGY, V57, P785, DOI 10.1111/j.1365-2559.2010.03709.x	51	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79863	10.1371/journal.pone.0079863	http://dx.doi.org/10.1371/journal.pone.0079863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223200	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200093
J	Coovadia, YM; Mahomed, S; Pillay, M; Werner, L; Mlisana, K				Coovadia, Yacoob Mahomed; Mahomed, Sharana; Pillay, Melendhran; Werner, Lise; Mlisana, Koleka			Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region	PLOS ONE			English	Article							LINE PROBE ASSAY; RISK-FACTORS; MONORESISTANT TUBERCULOSIS; DRUG-RESISTANCE; UNITED-KINGDOM; WESTERN CAPE; MUTATIONS	Setting: The dual epidemics of HIV-TB including MDR-TB are major contributors to high morbidity and mortality rates in South Africa. Rifampicin (RIF) resistance is regarded as a proxy for MDR-TB. Currently available molecular assays have the advantage of rapidly detecting resistant strains of MTB, but the GeneXpert does not detect isoniazid (INH) resistance and the GenoTypeMTBDRplus(LPA) assay may underestimate resistance to INH. Increasing proportions of rifampicin mono-resistance resistance (RMR) have recently been reported from South Africa and other countries. Objective: This laboratory based study was conducted at NHLS TB Laboratory, Durban, which is the reference laboratory for culture and susceptibility testing in KwaZulu-Natal. We retrospectively determined, for the period 2007 to 2009, the proportion of RMR amongst Mycobacterium tuberculosis (MTB) isolates, that were tested for both RIF and INH, using the gold standard of culture based phenotypic drug susceptibility testing (DST). Gender and age were also analysed to identify possible risk factors for RMR. Design: MTB culture positive sputum samples from 16,748 patients were analysed for susceptibility to RIF and INH during the period 2007 to 2009. RMR was defined as MTB resistant to RIF and susceptible to INH. For the purposes of this study, only the first specimen from each patient was included in the analysis. Results: RMR was observed throughout the study period. The proportion of RMR varied from a low of 7.3% to a high of 10.0% [overall 8.8%]. Overall, males had a 42% increased odds of being RMR as compared to females. In comparison to the 50 plus age group, RMR was 37% more likely to occur in the 25-29 year age category. Conclusion: We report higher proportions of RMR ranging from 7.3% to 10% [overall 8.8%] than previously reported in the literature. To avoid misclassification of RMR, detected by the GeneXpert, as MDR-TB, culture based phenotypic DST must be performed on a second specimen, as recommended by the SA NDOH TB guidelines as well as WHO. We suggest that two sputum samples should be obtained at the first visit. The second sputum sample should be stored at 4 degrees C. The latter sample is then readily available for performing additional DST (phenotypic or genotypic) for 2nd lines drugs, resulting in a decreased waiting period for DST results to become available.	[Coovadia, Yacoob Mahomed; Mahomed, Sharana; Pillay, Melendhran; Mlisana, Koleka] Univ KwaZulu Natal, Natl Hlth Lab Serv, Durban, South Africa; [Coovadia, Yacoob Mahomed; Mahomed, Sharana; Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa; [Werner, Lise] UKZN, CAPRISA, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Coovadia, YM (corresponding author), Univ KwaZulu Natal, Natl Hlth Lab Serv, Durban, South Africa.	coovadia@ukzn.ac.za	Mlisana, Koleka/N-6204-2013	Mlisana, Koleka/0000-0002-8436-3268				Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Austin JF, 2004, INT J TUBERC LUNG D, V8, P435; AZIZ MA, 2004, ANTITUBERCULOSIS DRU; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bishai WR, 1996, NEW ENGL J MED, V334, P1573, DOI 10.1056/NEJM199606133342404; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Dramowski A, 2012, INT J TUBERC LUNG D, V16, P76, DOI 10.5588/ijtld.11.0360; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Jaramillo E., 2008, GUIDELINES PROGRAMMA; Jarrin I, GUIDELINES PROGRAMMA; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; NOLAN CM, 1995, AM J RESP CRIT CARE, V152, P1067, DOI 10.1164/ajrccm.152.3.7663785; Organization WH, 2008, MOL LINE PROBE ASSAY; Organization WH, 2012, GLOBAL TUBERCULOSIS; ORMEROD LP, 1990, THORAX, V45, P403, DOI 10.1136/thx.45.5.403; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pietzka AT, 2009, J ANTIMICROB CHEMOTH, V63, P1121, DOI 10.1093/jac/dkp124; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ridzon R, 1998, AM J RESP CRIT CARE, V157, P1881, DOI 10.1164/ajrccm.157.6.9712009; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; South African Department of Health, 2011, MAN DRUG RES TUB POL; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WELTMAN AC, 1995, LANCET, V345, P1513, DOI 10.1016/S0140-6736(95)91074-3; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	33	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77712	10.1371/journal.pone.0077712	http://dx.doi.org/10.1371/journal.pone.0077712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223122	Green Published, gold			2022-12-25	WOS:000326656200014
J	Glusman, G; Caballero, J; Robinson, M; Kutlu, B; Hood, L				Glusman, Gustavo; Caballero, Juan; Robinson, Max; Kutlu, Burak; Hood, Leroy			Optimal Scaling of Digital Transcriptomes	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; DIFFERENTIAL EXPRESSION; NORMALIZATION; QUANTILE; MPSS	Deep sequencing of transcriptomes has become an indispensable tool for biology, enabling expression levels for thousands of genes to be compared across multiple samples. Since transcript counts scale with sequencing depth, counts from different samples must be normalized to a common scale prior to comparison. We analyzed fifteen existing and novel algorithms for normalizing transcript counts, and evaluated the effectiveness of the resulting normalizations. For this purpose we defined two novel and mutually independent metrics: (1) the number of "uniform'' genes (genes whose normalized expression levels have a sufficiently low coefficient of variation), and (2) low Spearman correlation between normalized expression profiles of gene pairs. We also define four novel algorithms, one of which explicitly maximizes the number of uniform genes, and compared the performance of all fifteen algorithms. The two most commonly used methods (scaling to a fixed total value, or equalizing the expression of certain 'housekeeping' genes) yielded particularly poor results, surpassed even by normalization based on randomly selected gene sets. Conversely, seven of the algorithms approached what appears to be optimal normalization. Three of these algorithms rely on the identification of "ubiquitous'' genes: genes expressed in all the samples studied, but never at very high or very low levels. We demonstrate that these include a "core'' of genes expressed in many tissues in a mutually consistent pattern, which is suitable for use as an internal normalization guide. The new methods yield robustly normalized expression values, which is a prerequisite for the identification of differentially expressed and tissue-specific genes as potential biomarkers.	[Glusman, Gustavo; Robinson, Max; Kutlu, Burak; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Caballero, Juan] Univ Autonoma Queretaro, Fac Ingn, Queretaro, Mexico	Institute for Systems Biology (ISB); Universidad Autonoma de Queretaro	Glusman, G (corresponding author), Inst Syst Biol, Seattle, WA USA.	Gustavo@SystemsBiology.org	Robinson, Max/AAS-5856-2021	Robinson, Max/0000-0003-0878-114X; Glusman, Gustavo/0000-0001-8060-5955; Caballero Perez, Juan/0000-0002-6160-3644	Edgewood Contracting Division, US Army [W911SR-09-C-0062]	Edgewood Contracting Division, US Army	This work was supported by contract W911SR-09-C-0062 from Edgewood Contracting Division, US Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dillies MA, 2012, BRIEF BIOINFORM; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hartemink AJ, 2001, SPIE BIOS 2001 SAN J; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kadota K, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-5; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110; Yang L, 2009, BIOINFORMATICS, V25, P2244, DOI 10.1093/bioinformatics/btp369; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77885	10.1371/journal.pone.0077885	http://dx.doi.org/10.1371/journal.pone.0077885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223126	gold, Green Published			2022-12-25	WOS:000326656200018
J	Hashiba, M; Ono, M; Hyogo, H; Ikeda, Y; Masuda, K; Yoshioka, R; Ishikawa, Y; Nagata, Y; Munekage, K; Ochi, T; Hirose, A; Nozaki-Fujimura, Y; Noguchi, S; Okamoto, N; Chayama, K; Suganuma, N; Saibara, T				Hashiba, Motoi; Ono, Masafumi; Hyogo, Hideyuki; Ikeda, Yukio; Masuda, Kosei; Yoshioka, Reiko; Ishikawa, Yoichi; Nagata, Yuri; Munekage, Kensuke; Ochi, Tsunehiro; Hirose, Akira; Nozaki-Fujimura, Yasuko; Noguchi, Shuhei; Okamoto, Nobuto; Chayama, Kazuaki; Suganuma, Narufumi; Saibara, Toshiji			Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE VARIABILITY; MONOCYTE ADHESION; OXIDATIVE STRESS; STEATOHEPATITIS; RISK; HYPERINSULINEMIA; HYPERGLYCEMIA; PROGRESSION; SEVERITY	Patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) often have metabolic disorders including insulin resistance and type 2 diabetes mellitus (T2DM). We clarified the predictive factors in glucose metabolism for progression of hepatic fibrosis in patients with NAFLD by the 75-g oral glucose tolerance test (75gOGTT) and a continuous glucose monitoring system (CGMS). One hundred sixty-nine patients (68 female and 101 male patients) with biopsy-proven NAFLD with performance with 75gOGTT were enrolled and divided into four groups according to the stage of hepatic fibrosis (F0-3). The proportion of patients with T2DM significantly gradually increased, HbA1c and the homeostasis model assessment of insulin resistance were significantly elevated, and 1,5-anhydroglucitol (1,5-AG) was remarkably decreased with the progression of fibrosis. In the 75gOGTT, both plasma glucose and insulin secretion were remarkably increased with the progression of fibrosis. The only factor significantly associated with advanced fibrosis was 1,5-AG (P = 0.008) as determined by multivariate logistic regression analysis. We next evaluated the changes in blood glucose during 24 hours by monitoring with the CGMS to confirm the relationship between glycemic variability and progression of fibrosis. Variability of median glucose, standard deviation of median glucose (P = 0.0022), maximum blood glucose (P = 0.0019), and Delta Min-max blood glucose (P = 0.0029) were remarkably higher in severe fibrosis than in mild fibrosis. Conclusion: Hyperinsulinemia and hyperglycemia, especially glycemic variability, are important predictive factors in glucose impairment for the progression of hepatic fibrosis in NAFLD.	[Hashiba, Motoi; Ono, Masafumi; Masuda, Kosei; Yoshioka, Reiko; Ishikawa, Yoichi; Nagata, Yuri; Munekage, Kensuke; Ochi, Tsunehiro; Hirose, Akira; Nozaki-Fujimura, Yasuko; Okamoto, Nobuto; Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Ikeda, Yukio] Kochi Mem Hosp, Ctr Diabet, Kochi, Japan; [Noguchi, Shuhei; Suganuma, Narufumi] Kochi Med Sch, Dept Environm Med, Kochi, Japan	Kochi University; Hiroshima University; Kochi University	Ono, M (corresponding author), Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan.	onom@kochi-u.ac.jp	Suganuma, Narufumi/E-4805-2012	Suganuma, Narufumi/0000-0003-1610-6216; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Culture, Sports, Science and Technology, Japan [23590979]; Grants-in-Aid for Scientific Research [25670369] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) 2011 Grant # 23590979, Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1111/j.1753-4887.2007.tb00329.x; Bialasiewicz P, 2009, DIABETIC MED, V26, P339, DOI 10.1111/j.1464-5491.2009.02684.x; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Jin WL, 2011, DIABETOLOGIA, V54, P1921, DOI 10.1007/s00125-011-2141-5; Kaji K, 2008, INT J MOL MED, V22, P801, DOI 10.3892/ijmm_00000088; Kilpatrick ES, 2010, DIABETIC MED, V27, P868, DOI 10.1111/j.1464-5491.2010.02929.x; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kimura Y, 2011, J GASTROEN HEPATOL, V26, P517, DOI 10.1111/j.1440-1746.2010.06567.x; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Koschinsky T, 2001, DIABETES-METAB RES, V17, P113, DOI 10.1002/dmrr.188; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; Ono M, 2006, J GASTROENTEROL, V41, P725, DOI 10.1007/s00535-006-1876-0; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Sonsuz A, 2002, AM J GASTROENTEROL, V97, P495; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Watada H, 2007, DIABETES RES CLIN PR, V77, pS58, DOI 10.1016/j.diabres.2007.01.034; WHALAN DJ, 1975, MED J AUSTRALIA, V1, P491, DOI 10.5694/j.1326-5377.1975.tb111524.x; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4	37	35	38	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76161	10.1371/journal.pone.0076161	http://dx.doi.org/10.1371/journal.pone.0076161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223115	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200007
J	van Nierop, M; Janssens, M; Bruggeman, R; Cahn, W; de Haan, L; Kahn, RS; Meijer, CJ; Myin-Germeys, I; van Os, J; Wiersma, D				van Nierop, Martine; Janssens, Mayke; Bruggeman, Richard; Cahn, Wiepke; de Haan, Lieuwe; Kahn, Rene S.; Meijer, Carin J.; Myin-Germeys, Inez; van Os, Jim; Wiersma, Durk		Genetic Risk OUtcome Psychosis GRP	Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk	PLOS ONE			English	Article							FAMILIAL LIABILITY; CHILDHOOD TRAUMA; PREMORBID ADJUSTMENT; NEGATIVE SYMPTOMS; CANNABIS USE; SCHIZOPHRENIA; METAANALYSIS; URBANICITY; EXPERIENCES; POPULATION	Background: In order to assess the importance of environmental and genetic risk on transition from health to psychotic disorder, a prospective study of individuals at average (n=462) and high genetic risk (n=810) was conducted. Method: A three-year cohort study examined the rate of transition to psychotic disorder. Binary measures indexing environmental exposure (combining urban birth, cannabis use, ethnicity and childhood trauma) and proxy genetic risk (high-risk sibling status) were used to model transition. Results: The majority of high-risk siblings (68%) and healthy comparison subjects (60%) had been exposed to one or more environmental risks. The risk of transition in siblings (n=9, 1.1%) was higher than the risk in healthy comparison subjects (n=2, 0.4%; ORadj=2.2,95% CI: 5-10.3). All transitions (100%) were associated with environmental exposure, compared to 65% of non-transitions (p=0.014), with the greatest effects for childhood trauma (ORadj=34.4,95% CI: 4.4-267.4), cannabis use (OR=4.1,95% CI: 1.1, 15.4), minority ethnic group (OR=3.8,95% CI: 1.2,12.8) and urban birth (OR=3.7,95% CI: 0.9,15.4). The proportion of transitions in the population attributable to environmental and genetic risk ranged from 28% for minority ethnic group, 45% for urban birth, 57% for cannabis use, 86% for childhood trauma, and 50% for high-risk sibling status. Nine out of 11 transitions (82%) were exposed to both genetic and environmental risk, compared to only 43% of non-transitions (p=0.03). Conclusion: Environmental risk associated with transition to psychotic disorder is semi-ubiquitous regardless of genetic high risk status. Careful prospective documentation suggests most transitions can be attributed to powerful environmental effects that become detectable when analysed against elevated background genetic risk, indicating gene-environment interaction.	[van Nierop, Martine; Janssens, Mayke; Myin-Germeys, Inez; van Os, Jim] Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands; [Bruggeman, Richard; Wiersma, Durk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Cahn, Wiepke; Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014	van Os, Jim/0000-0002-7245-1586; Bruggeman, Richard/0000-0002-3238-8471; Myin-Germeys, Inez/0000-0002-3731-4930; van Nierop, Martine/0000-0003-2734-0550	Dutch Health Research Council (ZON-MW) [10-000-1002]; Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Ingeest; Site Amsterdam: Arkin; Site Amsterdam: Dijk en Duin; Site Amsterdam: Rivierduinen; Site Amsterdam: Erasmus MC; Site Amsterdam: GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Utrecht: Altrecht; Site Utrecht: Symfora; Site Utrecht: Meerkanten; Site Utrecht: Riagg Amersfoort; Site Utrecht: Delta; Site Groningen: University Medical Centre Groningen; Site Groningen: Lentis; Site Groningen: GGZ Friesland; Site Groningen: GGZ Drenthe; Site Groningen: Dimence; Site Groningen: Mediant; Site Groningen: GGZ De Grote Rivieren; Site Groningen: Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre; Site Maastricht: GGZ Eindhoven; Site Maastricht: GGZ Midden-Brabant; Site Maastricht: GGZ Oost-Brabant; Site Maastricht: GGZ Noord- Midden Limburg; Site Maastricht: Mondriaan Zorggroep; Site Maastricht: Prins Clauscentrum Sittard; Site Maastricht: RIAGG Roermond; Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg; Site Maastricht: CAPRI University of Antwerp; Site Maastricht: PC Ziekeren Sint-Truiden; Site Maastricht: PZ Sancta Maria Sint-Truiden; Site Maastricht: GGZ Overpelt; Site Maastricht: OPZ Rekem; Jansen-Cilag; Eli Lilly and Company; Astra-Zeneca; Lundbeck; European Community [HEALTH-F2-2009-241909]	Dutch Health Research Council (ZON-MW)(Netherlands Organization for Health Research and Development); Site Amsterdam: Academic Psychiatric Centre AMC; Site Amsterdam: Ingeest; Site Amsterdam: Arkin; Site Amsterdam: Dijk en Duin; Site Amsterdam: Rivierduinen; Site Amsterdam: Erasmus MC; Site Amsterdam: GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht; Site Utrecht: Altrecht; Site Utrecht: Symfora; Site Utrecht: Meerkanten; Site Utrecht: Riagg Amersfoort; Site Utrecht: Delta; Site Groningen: University Medical Centre Groningen; Site Groningen: Lentis; Site Groningen: GGZ Friesland; Site Groningen: GGZ Drenthe; Site Groningen: Dimence; Site Groningen: Mediant; Site Groningen: GGZ De Grote Rivieren; Site Groningen: Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre; Site Maastricht: GGZ Eindhoven; Site Maastricht: GGZ Midden-Brabant; Site Maastricht: GGZ Oost-Brabant; Site Maastricht: GGZ Noord- Midden Limburg; Site Maastricht: Mondriaan Zorggroep; Site Maastricht: Prins Clauscentrum Sittard; Site Maastricht: RIAGG Roermond; Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg; Site Maastricht: CAPRI University of Antwerp; Site Maastricht: PC Ziekeren Sint-Truiden; Site Maastricht: PZ Sancta Maria Sint-Truiden; Site Maastricht: GGZ Overpelt; Site Maastricht: OPZ Rekem; Jansen-Cilag; Eli Lilly and Company(Eli Lilly); Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); European Community(European Commission)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002) and matching funds from participating universities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ Noord- Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants from Jansen-Cilag, Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brill N, 2008, SCHIZOPHRENIA BULL, V34, P981, DOI 10.1093/schbul/sbm128; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Cutajar MC, 2010, ARCH GEN PSYCHIAT, V67, P1114, DOI 10.1001/archgenpsychiatry.2010.147; Elklit A, 2011, SCHIZOPHRENIA BULL, V37, P1305, DOI 10.1093/schbul/sbq048; Fusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Johnstone EC, 2005, BRIT J PSYCHIAT, V186, P18, DOI 10.1192/bjp.186.1.18; Kahn RS, 2011, ARCH GEN PSYCHIAT, V68, P138, DOI 10.1001/archgenpsychiatry.2010.132; Kahn RS, JAMA IN PRESS; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; Kirkbride JB, 2012, EPIGENOMICS-UK, V4, P303, DOI [10.2217/EPI.12.20, 10.2217/epi.12.20]; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Marcelis M, 1999, PSYCHOL MED, V29, P1197, DOI 10.1017/S0033291799008983; Matheson SL, 2011, SCHIZOPHR RES, V133, P133, DOI 10.1016/j.schres.2011.09.020; McGorry P, 2013, LANCET, V381, P343, DOI 10.1016/S0140-6736(12)61268-9; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22; NIMH Genetics Initiative, 1992, FAM INT GEN STUD FIG; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Purcell SM, 2009, NATURE; Read J, 2012, BRIT J PSYCHIAT, V200, P89, DOI 10.1192/bjp.bp.111.096727; Russell AJ, 1997, AM J PSYCHIAT, V154, P635; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; SELTEN JPCJ, 1993, COMPR PSYCHIAT, V34, P192, DOI 10.1016/0010-440X(93)90047-8; SMALL NE, 1984, BIOL PSYCHIAT, V19, P203; StataCorp, 2011, STAT STAT SOFTW REL, P173; The WHOQOL Group, 1998, PSYCHOL MED, V28, P551; van Nierop M, 2012, SCHIZOPHRENIA BULL, V38, P231, DOI 10.1093/schbul/sbr129; van Os J, 2003, AM J PSYCHIAT, V160, P477, DOI 10.1176/appi.ajp.160.3.477; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vassos E, 2012, SCHIZOPHRENIA BULL, V38, P1118, DOI 10.1093/schbul/sbs096; Velthorst E, 2012, COGN NEUROPSYCHIATRY; Weiser M, 2007, BRIT J PSYCHIAT, V191, P320, DOI 10.1192/bjp.bp.106.031328; Welch KA, 2011, BRIT J PSYCHIAT, V199, P386, DOI 10.1192/bjp.bp.110.090175; Wicks S, 2005, AM J PSYCHIAT, V162, P1652, DOI 10.1176/appi.ajp.162.9.1652; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; World Health Organization, 1990, COMP INT DIAGN INT C	56	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e76690	10.1371/journal.pone.0076690	http://dx.doi.org/10.1371/journal.pone.0076690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223116	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200008
J	Welvaert, M; Rosseel, Y				Welvaert, Marijke; Rosseel, Yves			On the Definition of Signal-To-Noise Ratio and Contrast-To-Noise Ratio for fMRI Data	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; HEMODYNAMIC-RESPONSE FUNCTION; PHYSIOLOGICAL NOISE; FUNCTIONAL CONNECTIVITY; SPATIAL ICA; RESOLUTION; MOTION; MRI; SENSITIVITY; ENTROPY	Signal-to-noise ratio, the ratio between signal and noise, is a quantity that has been well established for MRI data but is still subject of ongoing debate and confusion when it comes to fMRI data. fMRI data are characterised by small activation fluctuations in a background of noise. Depending on how the signal of interest and the noise are identified, signal-to-noise ratio for fMRI data is reported by using many different definitions. Since each definition comes with a different scale, interpreting and comparing signal-to-noise ratio values for fMRI data can be a very challenging job. In this paper, we provide an overview of existing definitions. Further, the relationship with activation detection power is investigated. Reference tables and conversion formulae are provided to facilitate comparability between fMRI studies.	[Welvaert, Marijke; Rosseel, Yves] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium	Ghent University	Welvaert, M (corresponding author), Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium.	Marijke.Welvaert@Ugent.be	Welvaert, Marijke/GOE-6151-2022; Welvaert, Marijke/K-8486-2013	Welvaert, Marijke/0000-0002-0802-8134; Rosseel, Yves/0000-0002-4129-4477				[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Beckett A, 2012, NEUROIMAGE, V63, P1623, DOI 10.1016/j.neuroimage.2012.07.066; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bungert A, 2012, NEUROIMAGE, V59, P2167, DOI 10.1016/j.neuroimage.2011.10.013; Cabella BCT, 2009, PHYSICA A, V388, P41, DOI 10.1016/j.physa.2008.09.029; Calhoun VD, 2005, NEUROIMAGE, V25, P527, DOI 10.1016/j.neuroimage.2004.12.012; Casanova R, 2008, NEUROIMAGE, V40, P1606, DOI 10.1016/j.neuroimage.2008.01.011; Chen HF, 2004, MAGN RESON IMAGING, V22, P827, DOI 10.1016/j.mri.2003.12.003; Churchill NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031147; Conijn MMA, 2012, NEUROIMAGE, V59, P950, DOI 10.1016/j.neuroimage.2011.08.059; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; De Maziere PA, 2007, J MAGN RESON, V185, P138, DOI 10.1016/j.jmr.2006.12.001; den Dekker AJ, 2009, IEEE T MED IMAGING, V28, P287, DOI 10.1109/TMI.2008.2004427; Driver ID, 2012, NEUROIMAGE, V63, P1178, DOI 10.1016/j.neuroimage.2012.08.045; Duyn JH, 2012, NEUROIMAGE, V62, P1241, DOI 10.1016/j.neuroimage.2011.10.065; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hahn AD, 2012, NEUROIMAGE, V59, P2231, DOI 10.1016/j.neuroimage.2011.09.082; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Hughes BL, 2012, NEUROIMAGE, V61, P889, DOI 10.1016/j.neuroimage.2012.03.011; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Ing A, 2012, NEUROIMAGE, V63, P1487, DOI 10.1016/j.neuroimage.2012.07.042; Janssens T, 2012, NEUROIMAGE, V62, P1529, DOI 10.1016/j.neuroimage.2012.05.028; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Koush Y, 2012, NEUROIMAGE, V59, P478, DOI 10.1016/j.neuroimage.2011.07.076; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lee S, 2011, J AM STAT ASSOC, V106, P1009, DOI 10.1198/jasa.2011.tm10332; Lin QH, 2010, HUM BRAIN MAPP, V31, P1076, DOI 10.1002/hbm.20919; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Lopes R, 2012, NEUROIMAGE, V60, P1867, DOI 10.1016/j.neuroimage.2011.12.083; Marrelec G, 2003, HUM BRAIN MAPP, V19, P1, DOI 10.1002/hbm.10100; Nan FY, 1999, IEEE T MED IMAGING, V18, P320, DOI 10.1109/42.768841; Newton AT, 2012, NEUROIMAGE, V59, P2511, DOI 10.1016/j.neuroimage.2011.08.096; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Posse S, 2012, NEUROIMAGE, V61, P115, DOI 10.1016/j.neuroimage.2012.02.059; Redpath TW, 1998, BRIT J RADIOL, V71, P704, DOI 10.1259/bjr.71.847.9771379; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Sarkka S, 2012, NEUROIMAGE, V60, P1517, DOI 10.1016/j.neuroimage.2012.01.067; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Scholvinck ML, 2012, NEUROIMAGE, V59, P2700, DOI 10.1016/j.neuroimage.2011.10.066; Shen YJ, 2012, NEUROIMAGE, V59, P3450, DOI 10.1016/j.neuroimage.2011.10.097; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Sturzbecher MJ, 2009, PHYS MED BIOL, V54, P161, DOI 10.1088/0031-9155/54/1/011; Suckling J, 2004, HUM BRAIN MAPP, V22, P193, DOI 10.1002/hbm.20027; Tabelow K, 2009, J NEUROSCI METH, V178, P357, DOI 10.1016/j.jneumeth.2008.12.011; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Valente G, 2009, MAGN RESON IMAGING, V27, P1110, DOI 10.1016/j.mri.2009.05.036; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent T, 2010, IEEE T MED IMAGING, V29, P1059, DOI 10.1109/TMI.2010.2042064; Wald LL, 2012, NEUROIMAGE, V62, P1221, DOI 10.1016/j.neuroimage.2012.02.077; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; Zhang CM, 2010, J MULTIVARIATE ANAL, V101, P1574, DOI 10.1016/j.jmva.2010.02.009; Zotev V, 2012, NEUROIMAGE, V63, P698, DOI 10.1016/j.neuroimage.2012.07.031	61	254	255	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77089	10.1371/journal.pone.0077089	http://dx.doi.org/10.1371/journal.pone.0077089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223118	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200010
J	Li, P; Chen, Y; Mak, KK; Wong, CK; Wang, CC; Yuan, P				Li, Peng; Chen, Ying; Mak, Kinglun Kingston; Wong, Chun Kwok; Wang, Chi Chiu; Yuan, Ping			Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; PROMOTES APOPTOSIS; PROGENITOR CELLS; PRECURSOR CELLS; YAP ONCOPROTEIN; SIZE-CONTROL; CYCLE EXIT; ORGAN SIZE; PROLIFERATION; DROSOPHILA	The Hippo pathway is an evolutionary conserved pathway that involves cell proliferation, differentiation, apoptosis and organ size regulation. Mst1 and Mst2 are central components of this pathway that are essential for embryonic development, though their role in controlling embryonic stem cells (ES cells) has yet to be exploited. To further understand the Mst1/Mst2 function in ES cell pluripotency and differentiation, we derived Mst1/Mst2 double knockout (Mst-/-) ES cells to completely perturb Hippo signaling. We found that Mst-/- ES cells express higher level of Nanog than wild type ES cells and show differentiation resistance after LIF withdrawal. They also proliferate faster than wild type ES cells. Although Mst-/- ES cells can form embryoid bodies (EBs), their differentiation into tissues of three germ layers is distorted. Intriguingly, Mst-/- ES cells are unable to form teratoma. Mst-/- ES cells can differentiate into mesoderm lineage, but further differentiation to cardiac lineage cells is significantly affected. Microarray analysis revealed that ligands of non-canonical Wnt signaling, which is critical for cardiac progenitor specification, are significantly repressed in Mst-/- EBs. Taken together our results showed that Mst1/Mst2 are required for proper cardiac lineage cell development and teratoma formation.	[Li, Peng; Wong, Chun Kwok; Yuan, Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Chen, Ying; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Mak, Kinglun Kingston; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Mak, Kinglun Kingston; Wong, Chun Kwok; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Mak, Kinglun Kingston] Chinese Univ Hong Kong, Key Labs Regenerat Med, Minist Educ, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Yuan, P (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China.	pyuan@cuhk.edu.hk	Wong, CK/H-3256-2016; Wang, Ronald/C-6541-2014	Wong, CK/0000-0002-5637-8331; Wang, Ronald/0000-0002-3928-7278; Yuan, Ping/0000-0001-7243-3487; Mak, Kingston King-Lun/0000-0002-4733-9146				Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song JY, 2011, BIOCHEM BIOPH RES CO, V404, P728, DOI 10.1016/j.bbrc.2010.12.052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tokuzawa Yoshimi, 2006, V329, P223; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang H, 2012, CELL SIGNAL, V24, P224, DOI 10.1016/j.cellsig.2011.09.004; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao QS, 2011, STEM CELL REV REP, V7, P326, DOI 10.1007/s12015-010-9206-6; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	54	30	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79867	10.1371/journal.pone.0079867	http://dx.doi.org/10.1371/journal.pone.0079867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224013	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400092
J	Gotthard, G; Hiblot, J; Gonzalez, D; Elias, M; Chabriere, E				Gotthard, Guillaume; Hiblot, Julien; Gonzalez, Daniel; Elias, Mikael; Chabriere, Eric			Structural and Enzymatic Characterization of the Phosphotriesterase OPHC2 from Pseudomonas pseudoalcaligenes	PLOS ONE			English	Article							ORGANOPHOSPHORUS HYDROLASE OPHC2; METHYL PARATHION HYDROLASE; CATALYTIC-ACTIVITY; EVOLUTION; MECHANISMS; PESTICIDES; SYSTEM; FISH; SITE	Background: Organophosphates (OPs) are neurotoxic compounds for which current methods of elimination are unsatisfactory; thus bio-remediation is considered as a promising alternative. Here we provide the structural and enzymatic characterization of the recently identified enzyme isolated from Pseudomonas pseudoalcaligenes dubbed OPHC2. OPHC2 belongs to the metallo-beta-lactamase superfamily and exhibits an unusual thermal resistance and some OP degrading abilities. Principal findings: The X-ray structure of OPHC2 has been solved at 2.1 A resolution. The enzyme is roughly globular exhibiting a alpha beta/beta alpha topology typical of the metallo-beta-lactamase superfamily. Several structural determinants, such as an extended dimerization surface and an intramolecular disulfide bridge, common features in thermostable enzymes, are consistent with its high T-m (97.8 degrees C). Additionally, we provide the enzymatic characterization of OPHC2 against a wide range of OPs, esters and lactones. Significance: OPHC2 possesses a broad substrate activity spectrum, since it hydrolyzes various phosphotriesters, esters, and a lactone. Because of its organophosphorus hydrolase activity, and given its intrinsic thermostability, OPHC2 is an interesting candidate for the development of an OPs bio-decontaminant. Its X-ray structure shed light on its active site, and provides key information for the understanding of the substrate binding mode and catalysis.	[Gotthard, Guillaume; Hiblot, Julien; Gonzalez, Daniel; Chabriere, Eric] Univ Mediterranee, URMITE UMR CNRS IRD 6236, IFR48, Fac Med & Pharm, Marseille, France; [Elias, Mikael] Weizmann Inst Sci, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Weizmann Institute of Science	Elias, M (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	mikael.elias@weizmann.ac.il; eric.chabriere@univmed.fr	Hiblot, Julien/AAA-4452-2020; Elias, Mikael/AAH-9385-2021	Hiblot, Julien/0000-0002-7883-8079; Elias, Mikael/0000-0003-0406-7539	DGA, France [REI. 2009 34 0045]; DGA; APHM; IEF Marie Curie program [252836]	DGA, France; DGA; APHM; IEF Marie Curie program	This work was granted by DGA, France (REI. 2009 34 0045. J.H. and G.G. are PhD students granted by DGA. D.G. is a PhD student granted by APHM. M.E. is a fellow supported by the IEF Marie Curie program (grant No. 252836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Aravind L, 1999, In Silico Biol, V1, P69; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Bigley AN, 2012, BIOCH BIOPHYS ACTA; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; Cheng TC, 1999, CHEM-BIOL INTERACT, V119, P455, DOI 10.1016/S0009-2797(99)00058-7; Chu XY, 2006, PROTEIN EXPRES PURIF, V49, P9, DOI 10.1016/j.pep.2006.03.013; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; DELLUSGUR E, 2013, J MOL BIOL; Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldsmith M, 2012, CHEM BIOL, V19, P456, DOI 10.1016/j.chembiol.2012.01.017; Gotthard G, 2013, ACTA CRYSTALLOGR F, V69, P73, DOI 10.1107/S174430911205049X; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gupta RC, 2009, HANDBOOK OF TOXICOLOGY OF CHEMICAL WARFARE AGENTS, P1; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Jackson CJ, 2006, BIOCHEM J, V397, P501, DOI 10.1042/BJ20060276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim MH, 2005, P NATL ACAD SCI USA, V102, P17606, DOI 10.1073/pnas.0504996102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LeJeune KE, 1998, NATURE, V395, P27, DOI 10.1038/25634; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Monias BL, 1928, J INFECT DIS, V43, P330, DOI 10.1093/infdis/43.4.330; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Raushel FM, 2002, CURR OPIN MICROBIOL, V5, P288, DOI 10.1016/S1369-5274(02)00314-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sapozhnikova Y, 2005, CHEMOSPHERE, V60, P196, DOI 10.1016/j.chemosphere.2004.12.061; Sapozhnikova Y, 2004, CHEMOSPHERE, V55, P797, DOI 10.1016/j.chemosphere.2003.12.009; Schrodinger L., 2020, PYMOL; Shen YJ, 2010, BIODEGRADATION, V21, P785, DOI 10.1007/s10532-010-9343-2; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Su YD, 2011, APPL BIOCHEM BIOTECH, V165, P989, DOI 10.1007/s12010-011-9314-z; Toth-Petroczy A, 2013, MOL BIOL EVOL, V30, P761, DOI 10.1093/molbev/mst003; Velankar S, 2012, NUCLEIC ACIDS RES, V40, pD445, DOI 10.1093/nar/gkr998; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vyas NK, 2010, BIOCHEMISTRY-US, V49, P547, DOI 10.1021/bi9011989; Wilkins MR, 1999, METH MOL B, V112, P531	54	35	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77995	10.1371/journal.pone.0077995	http://dx.doi.org/10.1371/journal.pone.0077995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223749	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400026
J	Huang, KH; Wang, CH; Lee, KY; Lin, SM; Lin, CH; Kuo, HP				Huang, Kuo-Hsiung; Wang, Chun-Hua; Lee, Kang-Yun; Lin, Shu-Min; Lin, Chien-Huang; Kuo, Han-Pin			NF-kappa B Repressing Factor Inhibits Chemokine Synthesis by Peripheral Blood Mononuclear Cells and Alveolar Macrophages in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; MYCOBACTERIUM-TUBERCULOSIS; CXC CHEMOKINES; IFN-GAMMA; BASAL REPRESSION; NITRIC-OXIDE; IP-10; IL-8; SECRETION; INFLAMMATION	NF-kappa B repressing factor (NRF) is a transcriptional silencer implicated in the basal silencing of specific NF-kappa B targeting genes, including iNOS, IFN-beta and IL-8/CXCL8. IP-10/CXCL10 and IL-8/CXCL8 are involved in neutrophil and lymphocyte recruitment against M. tuberculosis (MTb) and disease progression of pulmonary tuberculosis (TB). Alveolar macrophages (AM) and peripheral blood mononuclear cells (PBMC) were used to study the regulatory role of NRF in pulmonary TB. AM and PBMC were purified from 19 TB patients and 15 normal subjects. To study the underlying mechanism, PBMC were exposed to heated TB bacilli. The regulation role of NRF in IP-10/CXCL10 and IL-8/CXCL8 was determined by NRF knock-down or overexpression. NRF binding capabilities in promoter sites were measured by chromatin immunoprecipitation (ChIP) assay. The levels of IP-10/CXCL10, IL-8/CXCL8 and NRF were significantly higher in AM and PBMC in patients with active TB. NRF played an inhibitory role in IP-10/CXCL10 and IL-8/CXCL8 inductions. We delineate the role of NRF in pulmonary TB, which inhibits the expressions of IP-10/CXCL10 and IL-8/CXCL8 in AM and PBMC of patients with high bacterial load. NRF may serve as an endogenous repressor to prevent robust increase in IP-10/CXCL10 and IL-8/CXCL8 when TB bacterial load is high.	[Huang, Kuo-Hsiung; Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Chun-Hua; Lee, Kang-Yun; Lin, Shu-Min; Kuo, Han-Pin] Chang Gung Mem Hosp, Pulm Med Res Ctr, Taipei 10591, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital	Lin, CH (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	chlin@tmu.edu.tw; q8828@ms11.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019	Wang, Chun-Hua/0000-0002-3514-9353; Lin, Chien-Huang/0000-0002-0916-8737	National Science Council, Taiwan [NSC97-2314-B-182A-095]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC97-2314-B-182A-095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; Chou PC, 2012, INT J TUBERC LUNG D, V16, P1674, DOI 10.5588/ijtld.11.0672; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; FRIEDLAND JS, 1992, EUR J IMMUNOL, V22, P1373, DOI 10.1002/eji.1830220607; Gangur V, 1998, FASEB J, V12, P705, DOI 10.1096/fasebj.12.9.705; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gupta R, 2004, SEMIN RESP CRIT CARE, V25, P245, DOI 10.1055/s-2004-829520; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Keane MP, 1997, J IMMUNOL, V159, P1437; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; LARSEN CG, 1995, J IMMUNOL, V155, P2151; Law KF, 1996, AM J RESP CRIT CARE, V153, P1377, DOI 10.1164/ajrccm.153.4.8616569; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7; Murray JF, 2004, AM J RESP CRIT CARE, V169, P1181, DOI 10.1164/rccm.200402-140OE; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Nolan A, 2013, INT J TUBERC LUNG D, V17, P922, DOI 10.5588/ijtld.12.0610; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; O'Kane CM, 2007, J IMMUNOL, V178, P3767, DOI 10.4049/jimmunol.178.6.3767; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Riedel DD, 1997, INFECT IMMUN, V65, P4620, DOI 10.1128/IAI.65.11.4620-4623.1997; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Sauty A, 1999, J IMMUNOL, V162, P3549; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Toossi Z, 1997, J IMMUNOL, V159, P4109; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; Wang XW, 2006, P NATL ACAD SCI USA, V103, P4204, DOI 10.1073/pnas.0507044103; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e77789	10.1371/journal.pone.0077789	http://dx.doi.org/10.1371/journal.pone.0077789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223729	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400016
J	Kulsantiwong, J; Prasopdee, S; Ruangsittichai, J; Ruangjirachuporn, W; Boonmars, T; Viyanant, V; Pierossi, P; Hebert, PDN; Tesana, S				Kulsantiwong, Jutharat; Prasopdee, Sattrachai; Ruangsittichai, Jiraporn; Ruangjirachuporn, Wipaporn; Boonmars, Thidarut; Viyanant, Vithoon; Pierossi, Paola; Hebert, Paul D. N.; Tesana, Smarn			DNA Barcode Identification of Freshwater Snails in the Family Bithyniidae from Thailand	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI; BRAZILIAN BIOMPHALARIA; CHOLANGIOCARCINOMA; DIPTERA; CAENOGASTROPODA; VARIABILITY; MORPHOLOGY; GASTROPODA; INFECTION; IDENTIFY	Freshwater snails in the family Bithyniidae are the first intermediate host for Southeast Asian liver fluke (Opisthorchis viverrini), the causative agent of opisthorchiasis. Unfortunately, the subtle morphological characters that differentiate species in this group are not easily discerned by non-specialists. This is a serious matter because the identification of bithyniid species is a fundamental prerequisite for better understanding of the epidemiology of this disease. Because DNA barcoding, the analysis of sequence diversity in the 5' region of the mitochondrial COI gene, has shown strong performance in other taxonomic groups, we decided to test its capacity to resolve 10 species/subspecies of bithyniids from Thailand. Our analysis of 217 specimens indicated that COI sequences delivered species-level identification for 9 of 10 currently recognized species. The mean intraspecific divergence of COI was 2.3% (range 0-9.2 %), whereas sequence divergences between congeneric species averaged 8.7% (range 0-22.2 %). Although our results indicate that DNA barcoding can differentiate species of these medically-important snails, we also detected evidence for the presence of one overlooked species and one possible case of synonymy.	[Kulsantiwong, Jutharat; Prasopdee, Sattrachai; Ruangjirachuporn, Wipaporn; Boonmars, Thidarut; Tesana, Smarn] Khon Kaen Univ, Fac Med, Dept Parasitol, Food Borne Parasite Res Grp, Khon Kaen 40002, Thailand; [Ruangsittichai, Jiraporn] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand; [Viyanant, Vithoon] Thammasat Univ, Ctr Excellence Res Biomed Sci, Klongluang, Pathumthani, Thailand; [Viyanant, Vithoon] Thammasat Univ, Thailand Ctr Excellence Drug Discovery & Dev, Klongluang, Pathumthani, Thailand; [Pierossi, Paola; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Khon Kaen University; Mahidol University; Thammasat University; Thammasat University; University of Guelph	Tesana, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Food Borne Parasite Res Grp, Khon Kaen 40002, Thailand.	smarn_te@kku.ac.th	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Prasopdee, Sattrachai/0000-0003-0175-9679	Higher Education Research Promotion and National Research University Project (NRU) of Thailand; Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission	Higher Education Research Promotion and National Research University Project (NRU) of Thailand; Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission	The study was supported by the Higher Education Research Promotion and National Research University Project (NRU) of Thailand, and the Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand. Jutharat Kulsantiwong thanks the Office of the Higher Education Commission for supporting her PhD program (CHE) in the Department of Parasitology, Faculty of Medicine, Khon Kaen University, Thammasat University, and UdonThani Rajabhat University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P121; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; Caldeira RL, 2009, ACTA TROP, V111, P1, DOI 10.1016/j.actatropica.2009.02.004; Canadian Centre for DNA Barcoding (CCDB), 2008, ADV SPEC ID DISC; Carvalho OS, 2001, PARASITOLOGY, V123, pS197, DOI 10.1017/S0031182001008058; Chitramvong Y.P., 1992, Malacological Review, V25, P21; Chitramvong Yaowaluk Prayoonhong, 1991, Walkerana, V5, P161; Davis GM, 1998, MALACOLOGIA, V40, P251; Delicado D, 2012, ZOOKEYS, P55, DOI 10.3897/zookeys.190.2555; Duangprompo W, 2007, THESIS KHON KAEN U K; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibbs J, 2009, ZOOTAXA, P1; Hall T, 2008, BIOEDIT SEQUENCE ALI; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1167; HASWELLELKINS MR, 1992, PARASITOL TODAY, V8, P86, DOI 10.1016/0169-4758(92)90241-S; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; Ivanova N, 2006, INCREASED DNA BARCOD; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova NV, 2005, PROTOCOLS HIGH VOLUM; Jones CS, 2001, PARASITOLOGY, V123, pS277, DOI 10.1017/S0031182001008381; Jorgensen A, 2007, ZOOL J LINN SOC-LOND, V151, P337, DOI 10.1111/j.1096-3642.2007.00330.x; Kiatsopit N, 2011, ACTA TROP, V118, P136, DOI 10.1016/j.actatropica.2011.02.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodcharin P, 2006, THESIS KHON KAEN U K; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Locke SA, 2010, INT J PARASITOL, V40, P333, DOI 10.1016/j.ijpara.2009.08.012; Mairiang E, 2003, ACTA TROP, V88, P221, DOI 10.1016/j.actatropica.2003.03.001; McCarthy C, 2008, CHROMAS; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller K, 2005, TLS-TIMES LIT SUPPL, P30; Osman M, 1998, DIGEST SURG, V15, P287, DOI 10.1159/000018640; Prayoonhong Chitramvong Y., 1990, Walkerana, V3, P179; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rojo S, 2006, EUR J ENTOMOL, V103, P443, DOI 10.14411/eje.2006.058; Rollinson D, 1998, MEM I OSWALDO CRUZ, V93, P111, DOI 10.1590/S0074-02761998000700015; Shufran KA, 2011, ANN ENTOMOL SOC AM, V104, P39, DOI 10.1603/AN10129; SITHITHAWORN P, 1994, INT J PARASITOL, V24, P833, DOI 10.1016/0020-7519(94)90009-4; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Sri-Aroon Pusadee, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P294; Sri-aroon Pusadee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P653; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THAMAVIT W, 1978, CANCER RES, V38, P4634; Tropmed Technical Group, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P282; UPATHAM E S, 1983, Malacological Review, V16, P107; Vatanasapt V, 2000, LIVER CANC THAILAND, P3; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wilke T, 2000, ACTA TROP, V77, P215, DOI 10.1016/S0001-706X(00)00143-1; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; WYKOFF DE, 1965, J PARASITOL, V51, P207, DOI 10.2307/3276083	58	20	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79144	10.1371/journal.pone.0079144	http://dx.doi.org/10.1371/journal.pone.0079144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223896	Green Published, gold			2022-12-25	WOS:000326503400099
J	Moriya, K; Nagatoshi, K; Noriyasu, Y; Okamura, T; Takamitsu, E; Suzuki, T; Utsumi, T				Moriya, Koko; Nagatoshi, Kei; Noriyasu, Yoshimi; Okamura, Tsuyoshi; Takamitsu, Emi; Suzuki, Takashi; Utsumi, Toshihiko			Protein N-Myristoylation Plays a Critical Role in the Endoplasmic Reticulum Morphological Change Induced by Overexpression of Protein Lunapark, an Integral Membrane Protein of the Endoplasmic Reticulum	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CYTOCHROME B(5) REDUCTASE; MYRISTIC ACID; OUTER MITOCHONDRIAL; ER; IDENTIFICATION; REQUIRES; MYRISTYLATION; TERMINUS; SEQUENCE	N-myristoylation of eukaryotic cellular proteins has been recognized as a modification that occurs mainly on cytoplasmic proteins. In this study, we examined the membrane localization, membrane integration, and intracellular localization of four recently identified human N-myristoylated proteins with predicted transmembrane domains. As a result, it was found that protein Lunapark, the human ortholog of yeast protein Lnp1p that has recently been found to be involved in network formation of the endoplasmic reticulum (ER), is an N-myristoylated polytopic integral membrane protein. Analysis of tumor necrosis factor-fusion proteins with each of the two putative transmembrane domains and their flanking regions of protein Lunapark revealed that transmembrane domain 1 and 2 functioned as type II signal anchor sequence and stop transfer sequence, respectively, and together generated a double-spanning integral membrane protein with an N-/C-terminal cytoplasmic orientation. Immunofluorescence staining of HEK293T cells transfected with a cDNA encoding protein Lunapark tagged with FLAG-tag at its C-terminus revealed that overexpressed protein Lunapark localized mainly to the peripheral ER and induced the formation of large polygonal tubular structures. Morphological changes in the ER induced by overexpressed protein Lunapark were significantly inhibited by the inhibition of protein N-myristoylation by means of replacing Gly2 with Ala. These results indicated that protein N-myristoylation plays a critical role in the ER morphological change induced by overexpression of protein Lunapark.	[Moriya, Koko; Nagatoshi, Kei; Noriyasu, Yoshimi; Okamura, Tsuyoshi; Takamitsu, Emi; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan; [Suzuki, Takashi] Shimadzu Co Ltd, Clin & Biotechnol Business Unit, Kyoto, Japan	Yamaguchi University; Yamaguchi University; Shimadzu Corporation	Utsumi, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan.	utsumi@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23580136]; YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23580136) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TU). This work was also supported in part by a research grant (The YU "Pump-Priming Program'' for Fostering Research Activities) from Yamaguchi University (to TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Beauchamp E, 2007, BIOCHIMIE, V89, P1553, DOI 10.1016/j.biochi.2007.07.001; Beauchamp E, 2009, BIOCHIMIE, V91, P1411, DOI 10.1016/j.biochi.2009.07.014; Bitar M, 2013, J MOL GRAPH MODEL, V39, P29, DOI 10.1016/j.jmgm.2012.10.004; BORGESE N, 1990, BIOCHEM J, V266, P341, DOI 10.1042/bj2660341; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Chen S, 2013, CURR OPIN CELL BIOL, V25, P1; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Ezanno H, 2012, LIPIDS, V47, P117, DOI 10.1007/s11745-011-3638-x; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; GRIPON P, 1995, VIROLOGY, V213, P292, DOI 10.1006/viro.1995.0002; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Ishisaka R, 1999, J BIOCHEM-TOKYO, V126, P413, DOI 10.1093/oxfordjournals.jbchem.a022466; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; OSTAPCHUK P, 1994, EMBO J, V13, P1048, DOI 10.1002/j.1460-2075.1994.tb06353.x; OZOLS J, 1984, J BIOL CHEM, V259, P3349; PERSING DH, 1987, J VIROL, V61, P1672, DOI 10.1128/JVI.61.5.1672-1677.1987; PRANGE R, 1991, J VIROL, V65, P3919, DOI 10.1128/JVI.65.7.3919-3923.1991; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Sakurai N, 2007, ANAL BIOCHEM, V362, P236, DOI 10.1016/j.ab.2006.12.030; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki T, 2006, PROTEOMICS, V6, P4486, DOI 10.1002/pmic.200600126; Suzuki T, 2010, PROTEOMICS, V10, P1780, DOI 10.1002/pmic.200900783; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	50	40	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78235	10.1371/journal.pone.0078235	http://dx.doi.org/10.1371/journal.pone.0078235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223779	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400042
J	Qiu, YW; Lv, XF; Su, HH; Jiang, GH; Tian, JZ; Zhuo, FZ; Han, LJ; Zhang, XL				Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang; Zhuo, Fuzhen; Han, Lujun; Zhang, Xuelin			Reduced Regional Homogeneity in Bilateral Frontostriatal System Relates to Higher Impulsivity Behavior in Codeine-Containing Cough Syrups Dependent Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL MRI; MONKEY VISUAL-CORTEX; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; ACTIVITY FLUCTUATIONS; PREFRONTAL CORTEX; NEURAL ACTIVITY; COCAINE USERS; HEROIN USERS; FMRI	Background: In the past twenty years, codeine-containing cough syrups (CCS) was recognized as a new type of addictive drugs. However, the exact neurobiologic mechanisms underlying CCS-dependence are still ill-defined. The aims of this study are to identify CCS-related modulations of neural activity during the resting-state in CCS-dependent individuals and to investigate whether these changes of neural activity can be related to duration of CCS use, the first age of CCS use and impulse control deficits in CCS-dependent individuals. We also want to observe the impact of gray matter deficits on these functional results. Methodology/Principal Findings: Thirty CCS-dependent individuals and 30 control subjects participated. Resting-state functional MRI was performed by using gradient-echo echo-planar imaging sequence. Regional homogeneity (ReHo) was calculated by using REST software. Voxel-based analysis of the ReHo maps between controls and CCS-dependent groups was performed using two-sample t tests (p<0.05, corrected for multiple comparisons). The Barratt Impulsiveness Scale 11 (BIS.11) was surveyed to assess participants' impulsivity trait soon after MR examination. Abnormal clusters revealed by group comparison were extracted and correlated with impulsivity, duration of CCS use, and age of first CCS use. ReHo was diminished in the bilateral medial orbitofrontal cortex (mOFC) and left dorsal striatum in CCS-dependent individuals. There were negative correlations between mean ReHo in the bilateral medial OFC, left dorsal striatum and duration of CCS use, BIS.11 total scores, and the subscale of attentional impulsivity in CCS-dependent individuals. There was a significantly positive correlation between mean ReHo in the left dorsal striatum and age of first CCS use in CCS-dependent individuals. Importantly, these results still remain significant after statistically controlling for the regional gray matter deficits. Conclusion: Resting-state abnormalities in CCS-dependent individuals revealed in the present study may further improve our understanding about the neural substrates of impulse control dysfunction in CCS-dependent individuals.	[Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei; Han, Lujun] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiaofei; Han, Lujun] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xuelin] Southern Medial Univ, NanFang Hosp, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Zhuo, Fuzhen] Guangdong 2 Prov Peoples Hosp, Addict Med Div, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com; jiangguihua177@163.com; tianjz2010@163.com		Qiu, Yingwei/0000-0003-1298-8506; Tian, Junzhang/0000-0002-6212-1882	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 81201084 for Yingwei Qiu], and the Planned Science and Technology Project of Guangdong Province, China [Grant No. 2011B031800044 for Guihua Jiang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio S, 2010, SYNAPSE, V64, P397, DOI 10.1002/syn.20741; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Botelho MF, 2006, ANN NY ACAD SCI, V1074, P466, DOI 10.1196/annals.1369.047; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hou HF, 2011, DRUG ALCOHOL DEPEN, V118, P148, DOI 10.1016/j.drugalcdep.2011.03.011; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; Mattoo SK, 1997, ADDICTION, V92, P1783, DOI 10.1111/j.1360-0443.1997.tb02898.x; Moeller FG, 2001, J SUBST ABUSE TREAT, V21, P193, DOI 10.1016/S0740-5472(01)00202-1; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Remy F, 2005, NEUROIMAGE, V25, P253, DOI 10.1016/j.neuroimage.2004.10.045; Shek DTL, 2008, SOC BEHAV PERSONAL, V36, P135, DOI 10.2224/sbp.2008.36.1.135; Shek Daniel T L, 2006, Int J Adolesc Med Health, V18, P493; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Vree TB, 2000, INT J CLIN PRACT, V54, P395; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Wang XL, 2011, CHIN J SOC MED, V28, P190; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Wilson W, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n01_01; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Yang Y, 2008, CHINESE J DRUG ABUSE, V14, P143; Yang Z, 2009, HUM BRAIN MAPP, V30, P766, DOI 10.1002/hbm.20542; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	60	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78738	10.1371/journal.pone.0078738	http://dx.doi.org/10.1371/journal.pone.0078738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223847	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400087
J	Shehzad, SA; Alsaedi, A; Hayat, T; Alhuthali, MS				Shehzad, Sabir Ali; Alsaedi, Ahmed; Hayat, Tasawar; Alhuthali, M. Shahab			Three-Dimensional Flow of an Oldroyd-B Fluid with Variable Thermal Conductivity and Heat Generation/Absorption	PLOS ONE			English	Article							STAGNATION-POINT FLOW; BOUNDARY-LAYER-FLOW; STRETCHING SHEET; MICROPOLAR FLUID; MIXED CONVECTION; HELICAL FLOWS; POROUS-MEDIUM; RADIATION	This paper looks at the series solutions of three dimensional boundary layer flow. An Oldroyd-B fluid with variable thermal conductivity is considered. The flow is induced due to stretching of a surface. Analysis has been carried out in the presence of heat generation/absorption. Homotopy analysis is implemented in developing the series solutions to the governing flow and energy equations. Graphs are presented and discussed for various parameters of interest. Comparison of present study with the existing limiting solution is shown and examined.	[Shehzad, Sabir Ali; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Alsaedi, Ahmed; Hayat, Tasawar; Alhuthali, M. Shahab] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shehzad, SA (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	ali_qau@yahoo.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922	Deanship of Scientific Research (DSR); King Abdulaziz University; Jeddah [10-130/1433HiCi]	Deanship of Scientific Research (DSR); King Abdulaziz University; Jeddah	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant no. (10-130/1433HiCi). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel PD, 2007, COMPUT MATH APPL, V54, P920, DOI 10.1016/j.camwa.2006.12.066; Bararnia H, 2012, CURR SCI INDIA, V103, P169; Bhattacharyya K, 2011, INT COMMUN HEAT MASS, V38, P917, DOI 10.1016/j.icheatmasstransfer.2011.04.020; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P308, DOI 10.1016/j.ijheatmasstransfer.2010.09.041; Chen CH, 2010, INT J HEAT MASS TRAN, V53, P4264, DOI 10.1016/j.ijheatmasstransfer.2010.05.053; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Hayat T, 2012, NUCL ENG DES, V243, P15, DOI 10.1016/j.nucengdes.2011.11.005; Hayat T, 2011, ARAB J SCI ENG, V36, P1113, DOI 10.1007/s13369-011-0066-4; Hayat T, 2011, INT J NUMER METH FL, V67, P1418, DOI 10.1002/fld.2424; Hayat T, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2655; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201201; Kazem S, 2012, COMMUN NUMER ANAL, V2012; Li CR, 2012, COMMUN NONLINEAR SCI, V17, P5026, DOI 10.1016/j.cnsns.2012.04.012; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Makinde OD, 2010, INT J THERM SCI, V49, P1813, DOI 10.1016/j.ijthermalsci.2010.05.015; Mukhopadhyay S, 2009, INT J HEAT MASS TRAN, V52, P3261, DOI 10.1016/j.ijheatmasstransfer.2008.12.029; Nofal T.A., 2011, APPL MATH SCI, V5, P2603; Qi D, 2009, CHINESE PHYS LETT, V26; Qi HT, 2009, APPL MATH MODEL, V33, P4184, DOI 10.1016/j.apm.2009.03.002; Rashidi MM, 2010, NONLINEAR ANAL-MODEL, V15, P83, DOI 10.15388/NA.2010.15.1.14366; Sahoo B, 2011, COMPUT MATH APPL, V61, P1442, DOI 10.1016/j.camwa.2011.01.017; Sajid M, 2010, CAN J PHYS, V88, P635, DOI 10.1139/P10-049; Si XY, 2011, APPL MATH MECH-ENGL, V32, P859, DOI 10.1007/s10483-011-1465-6; Tong DK, 2009, J NON-NEWTON FLUID, V156, P75, DOI 10.1016/j.jnnfm.2008.07.004; Vosughi H, 2011, MATH METHOD APPL SCI, V34, P1243, DOI 10.1002/mma.1436; Yao BH, 2009, COMMUN NONLINEAR SCI, V14, P3320, DOI 10.1016/j.cnsns.2009.01.014; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016; Zheng LC, 2011, COMMUN NONLINEAR SCI, V16, P731, DOI 10.1016/j.cnsns.2010.05.022	30	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78240	10.1371/journal.pone.0078240	http://dx.doi.org/10.1371/journal.pone.0078240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223780	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400043
J	Cha, JH; Bae, SH; Kim, HL; Park, NR; Choi, ES; Jung, ES; Choi, JY; Yoon, SK				Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Jung, Eun Sun; Choi, Jong Young; Yoon, Seung Kew			Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis	PLOS ONE			English	Article							HEPATIC-FIBROSIS; C57BL/KSJ-DB/DB MICE; INSULIN-RESISTANCE; COLON-CANCER; FACTOR-BETA; SUPPLEMENTATION; ANGIOGENESIS; ASSOCIATION; DISEASE; RISK	Purpose: Recent studies have revealed that branched-chain amino acids (BCAA) reduce the development of hepatocellular carcinoma (HCC) in patients with obesity and hepatitis C virus infection by improving insulin resistance (IR). The aim of this study was to examine the anti-cancer and anti-fibrotic effects of BCAA on the development of diethylnitrosamine (DEN)induced HCC and liver cirrhosis in a rat model. Methods: Male SD rats received weekly intraperitoneal injections of DEN (50 mg/kg of body weight) for 16 weeks to induce HCC. They were fed a diet containing 3% casein, 3% or 6% BCAA for 13 weeks beginning 6 weeks after DEN administration. DEN was used to induce HCC through stepwise development from cirrhosis to HCC. The effect of BCAA was evaluated in tumor tissues by histopathologic analyses, reverse transcription-polymerase chain reaction, and Western blotting. Results: The mean area and number of dysplastic nodules (DNs) and tumors in the casein group tended to be larger than those in the BCAA group 16 weeks after DEN administration. The mean fibrotic area in the BCAA group was smaller than that in the casein group. The BCAA group showed decreased mRNA levels for markers of fibrosis, angiogenesis, and apoptosis inhibition. Compared with the casein group, the BCAA group had lower levels of a-smooth muscle actin, vascular endothelial growth factor, p-b-catenin, p-p38 mitogen-activated protein kinase, proliferating cell nuclear antigen, and caspase-3 protein expression, as well as a higher level of cleaved caspase-3 protein expression. Conclusions: BCAA supplementation of the diet ameliorated liver fibrosis and HCC development in a DEN-induced rat model of HCC with liver cirrhosis, but not in the IR model. These results provide a rationale for anti-fibrosis and chemoprevention using BCAA treatment for HCC with liver cirrhosis, as well as decreasing the ammonia level.	[Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea; [Cha, Jung Hoon; Bae, Si Hyun; Kim, Hye Lim; Park, Na Ri; Choi, Eun Suk; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Jung, Eun Sun] Catholic Univ Korea, Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Bae, SH (corresponding author), Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea.	baesh@catholic.ac.kr			Samil Pharm. Co., Ltd., Korea	Samil Pharm. Co., Ltd., Korea	This study was supported by research funds from the Samil Pharm. Co., Ltd., Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; Donadon V, 2008, WORLD J GASTROENTERO, V14, P5695, DOI 10.3748/wjg.14.5695; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Giavazzi R, 1999, Forum (Genova), V9, P261; Hagiwara A, 2011, J CELL PHYSL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holecek M, 2010, NUTRITION, V26, P482, DOI 10.1016/j.nut.2009.06.027; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kawaguchi T, 2007, LIVER INT, V27, P1287, DOI 10.1111/j.1478-3231.2007.01559.x; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208; Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8; Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016; Murata K, 2007, CANCER RES, V67, P3263, DOI 10.1158/0008-5472.CAN-06-3739; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713; Nakanishi C, 2010, TOHOKU J EXP MED, V221, P151, DOI 10.1620/tjem.221.151; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nie QH, 2002, WORLD J GASTROENTERO, V8, P282; Park ST, 2010, CANCER CHEMOTH PHARM, V65, P1029, DOI 10.1007/s00280-009-1108-4; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schiel R, 2006, METHOD FIND EXP CLIN, V28, P169, DOI 10.1358/mf.2006.28.3.985230; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Shimizu M, 2009, CLIN CANCER RES, V15, P3068, DOI 10.1158/1078-0432.CCR-08-2093; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Yoshiji H, 2009, J GASTROENTEROL, V44, P483, DOI 10.1007/s00535-009-0031-0; Zhou XW, 1996, INT J BIOCHEM CELL B, V28, P787, DOI 10.1016/1357-2725(96)00019-2	42	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77899	10.1371/journal.pone.0077899	http://dx.doi.org/10.1371/journal.pone.0077899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223741	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300014
J	Cordina-Duverger, E; Truong, T; Anger, A; Sanchez, M; Arveux, P; Kerbrat, P; Guenel, P				Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Arveux, Patrick; Kerbrat, Pierre; Guenel, Pascal			Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France	PLOS ONE			English	Article							REPLACEMENT THERAPY; ENDOMETRIAL CARCINOMA; DIFFERENT REGIMENS; ESTROGEN; PROGESTINS; PROGESTERONE; MORTALITY	Background: There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast cancer risk, particularly combinations of estrogen and progestagen (EP). We investigated the effects of the specific formulations and types of therapies used by French women. Progestagen constituents, regimen (continuous or sequential treatment by the progestagen), and time interval between onset of menopause and start of MHT were examined. Methods: We conducted a population-based case-control study in France in 1555 menopausal women (739 cases and 816 controls). Detailed information on MHT use was obtained during in-person interviews. Odds ratios and 95% confidence interval adjusted for breast cancer risk factors were calculated. Results: We found that breast cancer risk differed by type of progestagen among current users of EP therapies. No increased risk was apparent among EP therapy users treated with natural micronized progesterone. Among users of EP therapy containing a synthetic progestin, the odds ratio was 1.57 (0.99-2.49) for progesterone-derived and 3.35 (1.07-10.4) for testosterone-derived progestagen. Women with continuous regimen were at greater risk than women treated sequentially, but regimen and type of progestagen could not be investigated independently, as almost all EP combinations containing a testosterone-derivative were administered continuously and vice-versa. Tibolone was also associated with an increased risk of breast cancer. Early users of MHT after onset of menopause were at greater risk than users who delayed treatment. Conclusion: This study confirms differential effects on breast cancer risk of progestagens and regimens specifically used in France. Formulation of EP therapies containing natural progesterone, frequently prescribed in France, was not associated with increased risk of breast cancer but may poorly protect against endometrial cancer.	[Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Guenel, Pascal] Ctr Rech Epidemiol & Sante Populat, CESP, INSERM, U1018, Villejuif, France; [Cordina-Duverger, Emilie; Truong, Therese; Anger, Antoinette; Sanchez, Marie; Guenel, Pascal] Univ Paris 11, UMRS 1018, Villejuif, France; [Arveux, Patrick] Breast Canc Registry Cote dOr, Ctr Georges Francois Leclerc, Dijon, France; [Kerbrat, Pierre] Ctr Eugene Marquis, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Centre Georges-Francois Leclerc; UNICANCER; Centre Eugene Marquis	Guenel, P (corresponding author), Ctr Rech Epidemiol & Sante Populat, CESP, INSERM, U1018, Villejuif, France.	pascal.guenel@inserm.fr	Guenel, Pascal/AAS-7688-2021; truong, therese/A-2837-2013; Guenel, Pascal/H-3728-2018	Guenel, Pascal/0000-0002-8359-518X; truong, therese/0000-0002-2943-6786; Guenel, Pascal/0000-0002-8359-518X	French National Institute of Cancer (INCa); Fondation de France; French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET); French National Research Agency (ANR); League against Cancer (Grand Ouest)	French National Institute of Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET); French National Research Agency (ANR)(French National Research Agency (ANR)); League against Cancer (Grand Ouest)	The CECILE study was supported by grants from the French National Institute of Cancer (INCa), Fondation de France, the French Agency for Environmental and Occupational Health Safety (ANSES - ex-AFSSET), the French National Research Agency (ANR), the League against Cancer (Grand Ouest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2010, AM J EPIDEMIOL, V172, P1394, DOI 10.1093/aje/kwq300; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Bakken K, 2011, INT J CANCER, V128, P144, DOI 10.1002/ijc.25314; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Campagnoli C, 2005, J STEROID BIOCHEM, V96, P95, DOI 10.1016/j.jsbmb.2005.02.014; Campagnoli C, 2005, J STEROID BIOCHEM, V97, P441, DOI 10.1016/j.jsbmb.2005.08.015; Daubisse-Marliac L, 2011, ANN ONCOL, V22, P329, DOI 10.1093/annonc/mdq396; Dinger Juergen C, 2006, BMC Womens Health, V6, P13, DOI 10.1186/1472-6874-6-13; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Fournier A, 2008, J CLIN ONCOL, V26, P1260, DOI 10.1200/JCO.2007.13.4338; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Fournier A, 2011, MENOPAUSE, V18, P219, DOI 10.1097/gme.0b013e3181ecf3ec; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; IARC (International Agency for Research on Cancer), 2012, IARC MON, V100F; Kuhl H, 2005, MATURITAS, V51, P83, DOI 10.1016/j.maturitas.2005.02.018; Lee SA, 2005, BRIT J CANCER, V92, P2049, DOI 10.1038/sj.bjc.6602617; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Lyytinen HK, 2010, INT J CANCER, V126, P483, DOI 10.1002/ijc.24738; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Opatrny L, 2008, BJOG-INT J OBSTET GY, V115, P169, DOI 10.1111/j.1471-0528.2007.01520.x; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schindler AE, 2008, MATURITAS, V61, P171, DOI 10.1016/j.maturitas.2008.11.013; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; THOM MH, 1979, LANCET, V2, P455; von Euler-Chelpin M, 2010, CANCER CAUSE CONTROL; WHITEHEAD MI, 1981, NEW ENGL J MED, V305, P1599, DOI 10.1056/NEJM198112313052701; ZIEL HK, 1975, NEW ENGL J MED, V293, P1167, DOI 10.1056/NEJM197512042932303	36	87	91	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78016	10.1371/journal.pone.0078016	http://dx.doi.org/10.1371/journal.pone.0078016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223752	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300017
J	Ferreira, JC; Icimoto, MY; Marcondes, MF; Oliveira, V; Nascimento, OR; Nantes, IL				Ferreira, Juliana C.; Icimoto, Marcelo Y.; Marcondes, Marcelo F.; Oliveira, Vitor; Nascimento, Otaciro R.; Nantes, Iseli L.			Recycling of the High Valence States of Heme Proteins by Cysteine Residues of Thimet-Oligopeptidase	PLOS ONE			English	Article							CYTOCHROME-C; EC 3.4.24.15; SELF-PEROXIDATION; HUMAN NEUROGLOBIN; ELECTRON-TRANSFER; PZ-PEPTIDASE; MYOGLOBIN; SPECIFICITY; RAT; METALLOENDOPEPTIDASE	The peptidolytic enzyme THIMET-oligopeptidase (TOP) is able to act as a reducing agent in the peroxidase cycle of myoglobin (Mb) and horseradish peroxidase (HRP). The TOP-promoted recycling of the high valence states of the peroxidases to the respective resting form was accompanied by a significant decrease in the thiol content of the peptidolytic enzyme. EPR (electron paramagnetic resonance) analysis using DBNBS spin trapping revealed that TOP also prevented the formation of tryptophanyl radical in Mb challenged by H2O2. The oxidation of TOP thiol groups by peroxidases did not promote the inactivating oligomerization observed in the oxidation promoted by the enzyme aging. These findings are discussed towards a possible occurrence of these reactions in cells.	[Ferreira, Juliana C.; Icimoto, Marcelo Y.; Marcondes, Marcelo F.; Oliveira, Vitor] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Nascimento, Otaciro R.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Ferreira, Juliana C.; Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Nantes, IL (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	ilnantes@gmail.com	Oliveira, Vitor/L-3709-2013; Marcondes, Marcelo FM/I-2234-2013; Ferreira, Juliana/O-7542-2014; Icimoto, Marcelo Yudi/L-6275-2016; Nantes, Iseli Lourenço/B-9517-2012; Oliveira, Vitor/AAT-5981-2020	Oliveira, Vitor/0000-0002-4662-1377; Icimoto, Marcelo Yudi/0000-0002-0746-5279; Nantes, Iseli Lourenço/0000-0003-1434-3154; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/04948-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We are grateful for financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Projeto Tematico Proc. 2008/04948-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Universidade Federal de Sao Paulo (UNIFESP), Universidade Federal do ABC (UFABC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; CAMARGO ACM, 1987, J NEUROCHEM, V48, P1258, DOI 10.1111/j.1471-4159.1987.tb05655.x; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Figueiredo KM, 2005, J PHOTOCH PHOTOBIO B, V79, P1, DOI 10.1016/j.jphotobiol.2004.11.011; GALARIS D, 1989, FREE RADICAL BIO MED, V6, P473, DOI 10.1016/0891-5849(89)90039-7; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; GUNTHER MR, 1995, J BIOL CHEM, V270, P16075, DOI 10.1074/jbc.270.27.16075; Gunther MR, 1998, BIOCHEM J, V330, P1293; Gunther MR, 2003, CHEM RES TOXICOL, V16, P652, DOI 10.1021/tx0256580; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; HOLM L, 1993, FEBS LETT, V315, P301, DOI 10.1016/0014-5793(93)81183-Z; Hunter CL, 2003, P NATL ACAD SCI USA, V100, P3647, DOI 10.1073/pnas.0636702100; Kundu S, 2003, TRENDS PLANT SCI, V8, P387, DOI 10.1016/S1360-1385(03)00163-8; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lepeshkevich SV, 2009, BBA-PROTEINS PROTEOM, V1794, P103, DOI 10.1016/j.bbapap.2008.09.024; LEW RA, 1995, BIOCHEM BIOPH RES CO, V209, P788, DOI 10.1006/bbrc.1995.1569; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; Malvezzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039408; Mano CM, 2009, FREE RADICAL BIO MED, V47, P841, DOI 10.1016/j.freeradbiomed.2009.06.028; Matsui T, 1999, J BIOL CHEM, V274, P2838, DOI 10.1074/jbc.274.5.2838; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; MILLER VP, 1992, J BIOL CHEM, V267, P8936; Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2011, J BIOENERG BIOMEMBR, V43, P11, DOI 10.1007/s10863-011-9328-9; NAZHAT NB, 1990, BIOCHEM BIOPH RES CO, V166, P807, DOI 10.1016/0006-291X(90)90881-M; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; OLLIKKA P, 1993, APPL ENVIRON MICROB, V59, P4010, DOI 10.1128/AEM.59.12.4010-4016.1993; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Pessoto FS, 2007, CHEM RES TOXICOL, V20, P1453, DOI 10.1021/tx700092r; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Smith AI, 2000, BIOCHEM SOC T, V28, P430, DOI 10.1042/0300-5127:0280430; TISLJAR U, 1989, ARCH BIOCHEM BIOPHYS, V274, P138, DOI 10.1016/0003-9861(89)90424-4; TISLJAR U, 1990, BIOCHEM J, V267, P531, DOI 10.1042/bj2670531; Tullai JW, 2000, J BIOL CHEM, V275, P36514, DOI 10.1074/jbc.M001843200; Vincent B, 1997, EUR J PHARMACOL, V334, P49, DOI 10.1016/S0014-2999(97)01209-0; WELINDER KG, 1979, EUR J BIOCHEM, V96, P483, DOI 10.1111/j.1432-1033.1979.tb13061.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777; Zhang H, 2005, J BIOL CHEM, V280, P40684, DOI 10.1074/jbc.M504503200; Zucchi MR, 2003, BIOCHEM J, V370, P671, DOI 10.1042/BJ20021521	55	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79102	10.1371/journal.pone.0079102	http://dx.doi.org/10.1371/journal.pone.0079102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223886	Green Submitted, gold, Green Published			2022-12-25	WOS:000326499300055
J	Ku, WL; Girvan, M; Yuan, GC; Sorrentino, F; Ott, E				Ku, Wai Lim; Girvan, Michelle; Yuan, Guo-Cheng; Sorrentino, Francesco; Ott, Edward			Modeling the Dynamics of Bivalent Histone Modifications	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENOME; MEMORY; DIFFERENTIATION; DEMETHYLASES; PLURIPOTENT; PROPAGATION; METHYLATION; INHERITANCE; ACTIVATION	Epigenetic modifications to histones may promote either activation or repression of the transcription of nearby genes. Recent experimental studies show that the promoters of many lineage-control genes in stem cells have "bivalent domains" in which the nucleosomes contain both active (H3K4me3) and repressive (H3K27me3) marks. It is generally agreed that bivalent domains play an important role in stem cell differentiation, but the underlying mechanisms remain unclear. Here we formulate a mathematical model to investigate the dynamic properties of histone modification patterns. We then illustrate that our modeling framework can be used to capture key features of experimentally observed combinatorial chromatin states.	[Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Ku, Wai Lim; Girvan, Michelle; Ott, Edward] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA; [Girvan, Michelle] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Sorrentino, Francesco] Univ New Mexico, Dept Mech Engn, Albuquerque, NM 87131 USA; [Ott, Edward] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of New Mexico; University System of Maryland; University of Maryland College Park	Ku, WL (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	wlku@umd.edu	Ott, Edward/F-5609-2017; Ku, Wai Lim/R-7170-2016; Girvan, Michelle/E-3982-2016; O, E/F-1630-2015	Ott, Edward/0000-0002-9395-5062; Ku, Wai Lim/0000-0002-8859-6771; Girvan, Michelle/0000-0003-0299-0784; Girvan, Michelle/0000-0001-7519-2842	Office of Naval Research [N000140710734]; United States National Institutes of Health [HG005085]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Office of Naval Research grant N000140710734 and United States National Institutes of Health grant HG005085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Binder H, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026006; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Chakravarthy H, 2011, FASEB J, V25, P206, DOI 10.1096/fj.10-166926; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hodges C, 2012, P NATL ACAD SCI USA, V109, P13296, DOI 10.1073/pnas.1211172109; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orlando DA, 2012, GENOMICS, V100, P320, DOI 10.1016/j.ygeno.2012.07.006; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Sneppen K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002643; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yuan GC, 2012, WIRES SYST BIOL MED, V4, P297, DOI 10.1002/wsbm.1165; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	38	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77944	10.1371/journal.pone.0077944	http://dx.doi.org/10.1371/journal.pone.0077944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223747	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300016
J	Morgan, JP; Magee, H; Wong, A; Nelson, T; Koch, B; Cooper, JD; Weimer, JM				Morgan, Jeremy P.; Magee, Helen; Wong, Andrew; Nelson, Tarah; Koch, Bettina; Cooper, Jonathan D.; Weimer, Jill M.			A Murine Model of Variant Late Infantile Ceroid Lipofuscinosis Recapitulates Behavioral and Pathological Phenotypes of Human Disease	PLOS ONE			English	Article							SOUTH HAMPSHIRE SHEEP; THALAMOCORTICAL NEURON LOSS; LYSOSOMAL STORAGE DISEASE; BATTEN-DISEASE; MOUSE MODEL; GLIAL ACTIVATION; TRANSMEMBRANE PROTEIN; GENE-EXPRESSION; CLN6 MUTATIONS; DEFICIENT MICE	Neuronal ceroid lipofuscinoses (NCLs; also known collectively as Batten Disease) are a family of autosomal recessive lysosomal storage disorders. Mutations in as many as 13 genes give rise to similar to 10 variants of NCL, all with overlapping clinical symptomatology including visual impairment, motor and cognitive dysfunction, seizures, and premature death. Mutations in CLN6 result in both a variant late infantile onset neuronal ceroid lipofuscinosis (vLINCL) as well as an adult-onset form of the disease called Type A Kufs. CLN6 is a non-glycosylated membrane protein of unknown function localized to the endoplasmic reticulum (ER). In this study, we perform a detailed characterization of a naturally occurring Cln6 mutant (Cln6(nclf)) mouse line to validate its utility for translational research. We demonstrate that this Cln6(nclf) mutation leads to deficits in motor coordination, vision, memory, and learning. Pathologically, we demonstrate loss of neurons within specific subregions and lamina of the cortex that correlate to behavioral phenotypes. As in other NCL models, this model displays selective loss of GABAergic interneuron sub-populations in the cortex and the hippocampus with profound, early-onset glial activation. Finally, we demonstrate a novel deficit in memory and learning, including a dramatic reduction in dendritic spine density in the cerebral cortex, which suggests a reduction in synaptic strength following disruption in CLN6. Together, these findings highlight the behavioral and pathological similarities between the Cln6(nclf) mouse model and human NCL patients, validating this model as a reliable format for screening potential therapeutics.	[Morgan, Jeremy P.; Magee, Helen] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Weimer, Jill M.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA; [Morgan, Jeremy P.; Magee, Helen; Nelson, Tarah; Weimer, Jill M.] Sanford Res USD, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Wong, Andrew; Cooper, Jonathan D.] Kings Coll London, James Black Ctr, Inst Psychiat, London WC2R 2LS, England; [Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, London WC2R 2LS, England; [Koch, Bettina] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany	University of South Dakota; University of South Dakota; Sanford Health; University of London; King's College London; University of London; King's College London; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weimer, JM (corresponding author), Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.	jill.weimer@sanfordhealth.org	Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750	Deutsche Forschungsgemeinshaft [FOR885]; Wellcome Trust [GR079491MA]; NIH-NINDS [NS41930]; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041930] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinshaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Deutsche Forschungsgemeinshaft (FOR885), Wellcome Trust Grant (GR079491MA), NIH-NINDS (NS41930), the Batten Disease Support and Research Association, Batten Disease Family Association, and The Natalie Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Benedict JW, 2009, J NEUROSCI RES, V87, P2157, DOI 10.1002/jnr.22032; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Blom T, 2013, DIS MODEL MECH, V6, P342, DOI 10.1242/dmm.010140; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; BOUSTANY RMN, 1989, REV NEUROL, V145, P105; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Broom MF, 1998, J MED GENET, V35, P717, DOI 10.1136/jmg.35.9.717; Buff H, 2007, GENETICS, V176, P209, DOI 10.1534/genetics.106.067983; Cannelli N, 2009, BIOCHEM BIOPH RES CO, V379, P892, DOI 10.1016/j.bbrc.2008.12.159; Chattopadhyay S, 2004, INVEST OPHTH VIS SCI, V45, P2893, DOI 10.1167/iovs.04-0143; Cook RW, 2002, AUST VET J, V80, P292, DOI 10.1111/j.1751-0813.2002.tb10847.x; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Cooper JD, 1999, J NEUROSCI, V19, P2556; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cooper JD, 2010, BIOCHEM SOC T, V38, P1448, DOI 10.1042/BST0381448; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Di Cristo G, 2007, CLIN GENET, V72, P1, DOI 10.1111/j.1399-0004.2007.00822.x; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602; GOEBEL HH, 1992, AM J MED GENET, V42, P605, DOI 10.1002/ajmg.1320420435; GOEBEL HH, 1990, OPHTHALMIC PAED GEN, V11, P61, DOI 10.3109/13816819009012949; Guarneri R, 2004, BRAIN RES, V1014, P209, DOI 10.1016/j.brainres.2004.04.040; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; JOLLY RD, 1993, J INHERIT METAB DIS, V16, P280, DOI 10.1007/BF00710265; JOLLY RD, 1989, NEUROPATH APPL NEURO, V15, P371, DOI 10.1111/j.1365-2990.1989.tb01236.x; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; Kanninen KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058644; Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042; Kay C, 2011, CLIN GENET, V80, P505, DOI 10.1111/j.1399-0004.2011.01761.x; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kay GW, 2009, NEUROCHEM INT, V55, P783, DOI 10.1016/j.neuint.2009.07.012; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Korey CA, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-30; Kovacs AD, 2006, NEUROBIOL DIS, V22, P575, DOI 10.1016/j.nbd.2005.12.018; Kovacs AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02116; Kuronen M, 2012, NEUROBIOL DIS, V47, P444, DOI 10.1016/j.nbd.2012.04.018; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Narfstrom K, 2007, VET OPHTHALMOL, V10, P111, DOI 10.1111/j.1463-5224.2007.00527.x; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Oswald M J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P135, DOI 10.1053/ejpn.2000.0450; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; Palmer DN, 1997, NEUROPEDIATRICS, V28, P45, DOI 10.1055/s-2007-973666; Palmer DN, 2002, ARCH GERONTOL GERIAT, V34, P343, DOI 10.1016/S0167-4943(02)00011-0; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Pears MR, 2007, J NEUROSCI RES, V85, P3494, DOI 10.1002/jnr.21343; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Rider JA, 1999, MOL GENET METAB, V66, P231, DOI 10.1006/mgme.1999.2827; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Ros-Simo C, 2013, J NEUROCHEM, V125, P736, DOI 10.1111/jnc.12247; Sanders DN, 2010, MOL GENET METAB, V100, P349, DOI 10.1016/j.ymgme.2010.04.009; SANTAVUORI P, 1991, NEUROPEDIATRICS, V22, P92, DOI 10.1055/s-2008-1071423; Seigel GM, 2002, MOL CELL NEUROSCI, V19, P515, DOI 10.1006/mcne.2001.1099; Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227; Siintola E, 2005, CLIN GENET, V68, P167, DOI 10.1111/j.1399-0004.2005.00471.x; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Tammen I, 2001, Eur J Paediatr Neurol, V5 Suppl A, P37, DOI 10.1053/ejpn.2000.0432; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Teixeira C, 2003, J NEUROL, V250, P661, DOI 10.1007/s00415-003-1050-z; Teixeira CAF, 2006, BBA-MOL BASIS DIS, V1762, P637, DOI 10.1016/j.bbadis.2006.06.002; Teixeira CA, 2003, HUM MUTAT, V21, P502, DOI 10.1002/humu.10207; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Tyynela J, 1997, J NEUROPATH EXP NEUR, V56, P369, DOI 10.1097/00005072-199704000-00005; Url A, 2001, ACTA NEUROPATHOL, V101, P410; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; von Schantz C, 2009, NEUROBIOL DIS, V34, P308, DOI 10.1016/j.nbd.2009.02.001; Weimer JM, 2007, BRAIN RES, V1162, P98, DOI 10.1016/j.brainres.2007.05.018; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009; Weimer JM, 2006, NEUROBIOL DIS, V22, P284, DOI 10.1016/j.nbd.2005.11.008; Weimer JM, 2005, ALTERATIONS ST UNPUB; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; WILLIAMS RS, 1977, ARCH NEUROL-CHICAGO, V34, P298, DOI 10.1001/archneur.1977.00500170052010	92	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78694	10.1371/journal.pone.0078694	http://dx.doi.org/10.1371/journal.pone.0078694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223841	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300030
J	Tibbles, KL; Sarkar, S; Novak, B; Arumugam, P				Tibbles, Katherine Louise; Sarkar, Sourav; Novak, Bela; Arumugam, Prakash			CDK-Dependent Nuclear Localization of B-Cyclin Clb1 Promotes FEAR Activation during Meiosis I in Budding Yeast	PLOS ONE			English	Article							MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; CDC14 PHOSPHATASE; CHROMOSOME SEGREGATION; EARLY ANAPHASE; KINASE CDC5; RENT COMPLEX; CELL-CYCLE; PHOSPHORYLATION; REPLICATION	Cyclin-dependent kinases (CDK) are master regulators of the cell cycle in eukaryotes. CDK activity is regulated by the presence, post-translational modification and spatial localization of its regulatory subunit cyclin. In budding yeast, the B-cyclin Clb1 is phosphorylated and localizes to the nucleus during meiosis I. However the functional significance of Clb1's phosphorylation and nuclear localization and their mutual dependency is unknown. In this paper, we demonstrate that meiosis-specific phosphorylation of Clb1 requires its import to the nucleus but not vice versa. While Clb1 phosphorylation is dependent on activity of both CDK and polo-like kinase Cdc5, its nuclear localization requires CDK but not Cdc5 activity. Furthermore we show that increased nuclear localization of Clb1 during meiosis enhances activation of FEAR (Cdc Fourteen Early Anaphase Release) pathway. We discuss the significance of our results in relation to regulation of exit from meiosis I.	[Tibbles, Katherine Louise; Sarkar, Sourav; Arumugam, Prakash] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Novak, Bela] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Warwick; University of Oxford	Tibbles, KL (corresponding author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.	katetibbles@yahoo.co.uk; prakash.arumugam@warwick.ac.uk	Novak, Bela/D-5365-2009; Arumugam, Prakash/AAZ-6422-2020	Novak, Bela/0000-0002-6961-1366; Arumugam, Prakash/0000-0001-6217-8128	BBSRC [BB/G00353X/1]; Biotechnology and Biological Sciences Research Council [BB/G00353X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a BBSRC grant (BB/G00353X/1) awarded to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bizzari F, 2011, J CELL BIOL, V193, P1213, DOI 10.1083/jcb.201103076; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Diffley JFX, 1995, J CELL SCI, P67; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; Kamieniecki RJ, 2005, CELL CYCLE, V4, P1093; Kerr GW, 2011, J CELL BIOL, V193, P1157, DOI 10.1083/jcb.201103019; Kerr GW, 2012, CELL MOL LIFE SCI, V69, P3037, DOI 10.1007/s00018-012-0974-9; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Liang FS, 2009, MOL BIOL CELL, V20, P3671, DOI 10.1091/mbc.E08-10-1049; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Moore M, 2007, BIOCHEMISTRY-US, V46, P271, DOI 10.1021/bi061858p; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Porter ACG, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-3; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Sawarynski KE, 2007, BBA-MOL CELL RES, V1773, P450, DOI 10.1016/j.bbamcr.2006.10.003; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79001	10.1371/journal.pone.0079001	http://dx.doi.org/10.1371/journal.pone.0079001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223874	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300046
J	Hirata, R; Nihei, C; Nakano, A				Hirata, Ryogo; Nihei, Coh-ichi; Nakano, Akihiko			Isoform-selective Oligomer Formation of Saccharomyces cerevisiae p24 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Golgi; Membrane Trafficking; Protein Assembly; Protein Sorting; Yeast	COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RETRIEVAL RECEPTOR; GOLGI-APPARATUS; QUALITY-CONTROL; CARGO BINDING; TRANSPORT; IDENTIFICATION; COMPLEX	p24 family proteins are evolutionarily conserved transmembrane proteins involved in the early secretory pathway. Saccharomyces cerevisiae has 8 known p24 proteins that are classified into four subfamilies (p24, -, -, and -). Emp24 and Erv25 are the sole members of p24 and -, respectively, and deletion of either destabilizes the remaining p24 proteins, resulting in p24 null phenotype (p24). We studied genetic and physical interactions of p24 (Erp1, -5, and -6) and (Erp2, -3, and -4). Deletion of the major p24 (Erp1) partially inhibited p24 activity as reported previously. A second mutation in either Erp5 or Erp6 aggravated the erp1 phenotype, and the triple mutation gave a full p24 phenotype. Similar genetic interactions were observed among the major p24 (Erp2) and the other two members. All the p24/ isoforms interacted with both p24 and -. Interaction between p24 and - was isoform-selective, and five major / pairs were detected. These results suggest that the yeast p24 proteins form functionally redundant complexes. We also identified Rrt6 as a novel p24 isoform. Rrt6 shows only limited sequence identity (approximate to 15%) to known p24 proteins but was found to have structural properties characteristic of p24. Rrt6 was induced when cells were grown on glycerol and form an additional complex with Erp3, Erp5, and Emp24. This complex was mainly localized to the Golgi, whereas the p24 complex containing Erv25, instead of Rrt6 but otherwise with the same isoform composition, was found mostly in the ER.	[Hirata, Ryogo; Nihei, Coh-ichi; Nakano, Akihiko] RIKEN, Ctr Adv Photon, Live Cell Mol Imaging Res Team, Wako, Saitama 3510198, Japan; [Hirata, Ryogo] RIKEN, Biol Chem Lab, Wako, Saitama 3510198, Japan; [Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; University of Tokyo	Hirata, R (corresponding author), RIKEN, Biol Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	rhirata@riken.jp	Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/A-6420-2016; Hirata, Ryogo/C-7424-2017	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bioarchitect Project of RIKEN; Extreme Photonics Project of RIKEN; Cellular Systems Biology Project of RIKEN; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bioarchitect Project of RIKEN; Extreme Photonics Project of RIKEN; Cellular Systems Biology Project of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Specially Promoted Research, grants-in-aid for Scientific Research, and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Bioarchitect, the Extreme Photonics, and the Cellular Systems Biology Projects of RIKEN.	Anantharaman V, 2002, GENOME BIOL, V3; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Bouw G, 2004, MOL BIOL CELL, V15, P1244, DOI 10.1091/mbc.E03-08-0600; Brachmann CB, 1998, YEAST, V14, P115; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Burke D., 2000, METHODS YEAST GENETI, P171; Montesinos JC, 2012, J EXP BOT, V63, P4243, DOI 10.1093/jxb/ers112; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Ciufo LF, 2000, J BIOL CHEM, V275, P8382, DOI 10.1074/jbc.275.12.8382; Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Finnigan GC, 2011, MOL BIOL CELL, V22, P3176, DOI 10.1091/mbc.E11-03-0244; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Herzig Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001329; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hontz RD, 2009, GENETICS, V182, P105, DOI 10.1534/genetics.108.100313; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lavieu G, 2013, ELIFE, V2, DOI 10.7554/eLife.00558; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Luo WB, 2011, J NEUROCHEM, V117, P71, DOI 10.1111/j.1471-4159.2011.07173.x; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Noda Y, 2010, J BIOL CHEM, V285, P15420, DOI 10.1074/jbc.M109.086272; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popoff V., 2011, COLD SPRING HARB PER, V3; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Rizzo R, 2013, J CELL BIOL, V201, P1027, DOI 10.1083/jcb.201211147; Roberts GG, 2009, YEAST, V26, P95, DOI 10.1002/yea.1655; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rotter J, 2002, J CELL SCI, V115, P1049; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; SIKORSKI RS, 1989, GENETICS, V122, P19; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Strating JRPM, 2009, MOL BIOL EVOL, V26, P1707, DOI 10.1093/molbev/msp099; Strating JRPM, 2009, BIOL CELL, V101, P207, DOI 10.1042/BC20080075; Strating JRPM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000704; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Weidler M, 2000, BIOCHEM BIOPH RES CO, V271, P401, DOI 10.1006/bbrc.2000.2511; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zhang LL, 2010, FEBS LETT, V584, P2298, DOI 10.1016/j.febslet.2010.03.041; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434	79	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37057	37070		10.1074/jbc.M113.518340	http://dx.doi.org/10.1074/jbc.M113.518340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217251	hybrid, Green Published			2022-12-25	WOS:000329189700026
J	Crivat, G; Lizunov, VA; Li, CR; Stenkula, KG; Zimmerberg, J; Cushman, SW; Pick, L				Crivat, Georgeta; Lizunov, Vladimir A.; Li, Caroline R.; Stenkula, Karin G.; Zimmerberg, Joshua; Cushman, Samuel W.; Pick, Leslie			Insulin Stimulates Translocation of Human GLUT4 to the Membrane in Fat Bodies of Transgenic Drosophila melanogaster	PLOS ONE			English	Article							GLUCOSE-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; RAT ADIPOCYTES; ADIPOSE-CELLS; GROWTH; TRAFFICKING; RECEPTOR; PROTEIN; KINASE; GLUCOSE-TRANSPORTER-4	The fruit fly Drosophila melanogaster is an excellent model system for studies of genes controlling development and disease. However, its applicability to physiological systems is less clear because of metabolic differences between insects and mammals. Insulin signaling has been studied in mammals because of relevance to diabetes and other diseases but there are many parallels between mammalian and insect pathways. For example, deletion of Drosophila Insulin-Like Peptides resulted in 'diabetic' flies with elevated circulating sugar levels. Whether this situation reflects failure of sugar uptake into peripheral tissues as seen in mammals is unclear and depends upon whether flies harbor the machinery to mount mammalian-like insulin-dependent sugar uptake responses. Here we asked whether Drosophila fat cells are competent to respond to insulin with mammalian-like regulated trafficking of sugar transporters. Transgenic Drosophila expressing human glucose transporter-4 (GLUT4), the sugar transporter expressed primarily in insulin-responsive tissues, were generated. After expression in fat bodies, GLUT4 intracellular trafficking and localization were monitored by confocal and total internal reflection fluorescence microscopy (TIRFM). We found that fat body cells responded to insulin with increased GLUT4 trafficking and translocation to the plasma membrane. While the amplitude of these responses was relatively weak in animals reared on a standard diet, it was greatly enhanced in animals reared on sugar-restricted diets, suggesting that flies fed standard diets are insulin resistant. Our findings demonstrate that flies are competent to mobilize translocation of sugar transporters to the cell surface in response to insulin. They suggest that Drosophila fat cells are primed for a response to insulin and that these pathways are down-regulated when animals are exposed to constant, high levels of sugar. Finally, these studies are the first to use TIRFM to monitor insulin-signaling pathways in Drosophila, demonstrating the utility of TIRFM of tagged sugar transporters to monitor signaling pathways in insects.	[Crivat, Georgeta; Li, Caroline R.; Pick, Leslie] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Lizunov, Vladimir A.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin G.; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pick, L (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	lpick@umd.edu	Crivat, Georgeta/AAJ-5714-2020; Tsai, Yu-Chen/B-5852-2008; Bai, Li/N-8311-2013	Stenkula, Karin/0000-0002-0739-1150	March of Dimes Birth Defects Foundation [1-FY-10-368]; NICHD; NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the March of Dimes Birth Defects Foundation (grant # 1-FY-10-368 to L. P., http://www.marchofdimes.com/research/research-grants.aspx) and Intramural Research Programs of NICHD and NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani H, 1999, FEBS LETT, V460, P338, DOI 10.1016/S0014-5793(99)01369-1; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DAHLMAN DL, 1973, ANN ENTOMOL SOC AM, V66, P1023, DOI 10.1093/aesa/66.5.1023; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; GARVEY WT, 1987, J BIOL CHEM, V262, P189; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Henquin JC, 2005, JOSLINS DIABETES MEL; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Lee W, 1999, J BIOL CHEM, V274, P37755, DOI 10.1074/jbc.274.53.37755; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; OHARAIMAIZUMI M, 1992, BIOCHEM BIOPH RES CO, V185, P1016, DOI 10.1016/0006-291X(92)91728-9; OKADA T, 1994, J BIOL CHEM, V269, P3568; Oldham S, 2002, DEVELOPMENT, V129, P4103; Pasco MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036583; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; Powis KV, 2011, CELL SIGNAL, V23, P1153, DOI 10.1016/j.cellsig.2011.02.010; Renstrom F, 2007, METABOLISM, V56, P190, DOI 10.1016/j.metabol.2006.09.012; RICORT JM, 1995, DIABETOLOGIA, V38, P1148, DOI 10.1007/s001250050406; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sajid W, 2011, J BIOL CHEM, V286, P661, DOI 10.1074/jbc.M110.156018; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; SATOH S, 1993, J BIOL CHEM, V268, P17820; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Suga J, 1997, DIABETES, V46, P735, DOI 10.2337/diabetes.46.5.735; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Thompson SN, 1997, BIOCHEM BIOPH RES CO, V237, P702, DOI 10.1006/bbrc.1997.7211; Thompson SN, 2003, J COMP PHYSIOL B, V173, P149, DOI 10.1007/s00360-002-0322-8; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; WOODRING J, 1993, J INSECT PHYSIOL, V39, P89, DOI 10.1016/0022-1910(93)90022-J; Wyatt G.R., 1967, ADV INSECT PHYSIOL, V4, P287, DOI DOI 10.1016/S0065-2806(08)60210-6; WYATT GR, 1957, J GEN PHYSIOL, V40, P833, DOI 10.1085/jgp.40.6.833; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429	67	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77953	10.1371/journal.pone.0077953	http://dx.doi.org/10.1371/journal.pone.0077953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223128	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200020
J	Ohara, S; Sato, S; Tsutsui, KI; Witter, MP; Iijima, T				Ohara, Shinya; Sato, Sho; Tsutsui, Ken-Ichiro; Witter, Menno P.; Iijima, Toshio			Organization of Multisynaptic Inputs to the Dorsal and Ventral Dentate Gyrus: Retrograde Trans-Synaptic Tracing with Rabies Virus Vector in the Rat	PLOS ONE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL FIELD CA1; DIAGONAL BAND COMPLEX; PARAHIPPOCAMPAL REGION; INTERPEDUNCULAR NUCLEUS; LAMINAR ORGANIZATION; PRINCIPAL NEURONS; TOPOGRAPHIC ORGANIZATION; SUPRAMAMMILLARY NUCLEUS; RECIPROCAL CONNECTIONS	Behavioral, anatomical, and gene expression studies have shown functional dissociations between the dorsal and ventral hippocampus with regard to their involvement in spatial cognition, emotion, and stress. In this study we examined the difference of the multisynaptic inputs to the dorsal and ventral dentate gyrus (DG) in the rat by using retrograde trans-synaptic tracing of recombinant rabies virus vectors. Three days after the vectors were injected into the dorsal or ventral DG, monosynaptic neuronal labeling was present in the entorhinal cortex, medial septum, diagonal band, and supramammillary nucleus, each of which is known to project to the DG directly. As in previous tracing studies, topographical patterns related to the dorsal and ventral DG were seen in these regions. Five days after infection, more of the neurons in these regions were labeled and labeled neurons were also seen in cortical and subcortical regions, including the piriform and medial prefrontal cortices, the endopiriform nucleus, the claustrum, the cortical amygdala, the medial raphe nucleus, the medial habenular nucleus, the interpeduncular nucleus, and the lateral septum. As in the monosynaptically labeled regions, a topographical distribution of labeled neurons was evident in most of these disynaptically labeled regions. These data indicate that the cortical and subcortical inputs to the dorsal and ventral DG are conveyed through parallel disynaptic pathways. This second-order input difference in the dorsal and ventral DG is likely to contribute to the functional differentiation of the hippocampus along the dorsoventral axis.	[Ohara, Shinya; Sato, Sho; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan; [Witter, Menno P.] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Witter, Menno P.] Norwegian Univ Sci & Technol NTNU, Ctr Neural Computat, Trondheim, Norway	Tohoku University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by the Kavli Foundation and the Norwegian Research Council to MPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARNISALO AA, 1995, NEUROSCIENCE, V65, P175, DOI 10.1016/0306-4522(94)00459-I; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2001, EXP BRAIN RES, V139, P39, DOI 10.1007/s002210100746; Behan M, 1999, J COMP NEUROL, V408, P532; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Canto CB, 2012, J NEUROSCI, V32, P17620, DOI 10.1523/JNEUROSCI.3526-12.2012; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; CULLINAN WE, 1991, J COMP NEUROL, V306, P631, DOI 10.1002/cne.903060408; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; Eichenbaum H, 2013, J COGNITIVE NEUROSCI, V25, P14, DOI 10.1162/jocn_a_00285; Eid T, 1996, EXP BRAIN RES, V109, P209; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HAYAKAWA T, 1993, ANAT EMBRYOL, V188, P139; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; JACKSON AC, 1989, ACTA NEUROPATHOL, V78, P159, DOI 10.1007/BF00688204; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Jinno S, 2010, HIPPOCAMPUS, V20, P829, DOI 10.1002/hipo.20685; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kloosterman F, 2003, J COMP NEUROL, V455, P156, DOI 10.1002/cne.10472; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; LUSKIN MB, 1983, J COMP NEUROL, V216, P292, DOI 10.1002/cne.902160306; Majak K, 2004, J COMP NEUROL, V476, P414, DOI 10.1002/cne.20233; MONTONE KT, 1988, BRAIN RES BULL, V20, P233, DOI 10.1016/0361-9230(88)90183-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; NADEL L, 1968, PHYSIOL BEHAV, V3, P891, DOI 10.1016/0031-9384(68)90174-1; NYAKAS C, 1987, BRAIN RES BULL, V18, P533, DOI 10.1016/0361-9230(87)90117-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly KC, 2012, SOC NEUR ABSTR, V702.02; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Prasad JA, 2013, J NEUROSCI, V33, P8494, DOI 10.1523/JNEUROSCI.5072-12.2013; Risold P.Y., 2004, RAT NERVOUS SYSTEM, P605, DOI DOI 10.1016/B978-012547638-6/50021-3; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEGAL M, 1974, BRAIN RES, V82, P263, DOI 10.1016/0006-8993(74)90603-9; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Soussi R, 2010, EUR J NEUROSCI, V32, P771, DOI 10.1111/j.1460-9568.2010.07329.x; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; VERTES RP, 1992, J COMP NEUROL, V326, P595, DOI 10.1002/cne.903260408; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1988, EXP BRAIN RES, V73, P23, DOI 10.1007/BF00279657; Watson C, 2006, RAT BRAIN STEREOTAXI; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; WITTER MP, 1988, NEUROSCIENCE, V24, P519, DOI 10.1016/0306-4522(88)90347-8; WITTER MP, 1992, NEUROSCI LETT, V148, P164, DOI 10.1016/0304-3940(92)90830-Z; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 1989, HIPPOCAMPUS NEW VIST, P53; Witter MP, 1988, NEUROSCI RES COMMUN, V2, P61; WYSS JM, 1979, NEUROSCIENCE, V4, P463, DOI 10.1016/0306-4522(79)90124-6; YOSHIDA K, 1995, NEUROSCI RES, V21, P199, DOI 10.1016/0168-0102(94)00852-7	87	28	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78928	10.1371/journal.pone.0078928	http://dx.doi.org/10.1371/journal.pone.0078928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223172	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200064
J	Rousseau, S; Iannuccelli, N; Mercat, MJ; Naylies, C; Thouly, JC; Servin, B; Milan, D; Pailhoux, E; Riquet, J				Rousseau, Sarah; Iannuccelli, Nathalie; Mercat, Marie-Jose; Naylies, Claire; Thouly, Jean-Claude; Servin, Bertrand; Milan, Denis; Pailhoux, Eric; Riquet, Juliette			A Genome-Wide Association Study Points out the Causal Implication of SOX9 in the Sex-Reversal Phenotype in XX Pigs	PLOS ONE			English	Article							COPY NUMBER VARIATION; CAMPOMELIC DYSPLASIA; GONADAL DIFFERENTIATION; SRY; GENE; INTERSEXUALITY; EXPRESSION; TRANSLOCATION; DUPLICATION; DISORDERS	Among farm animals, pigs are known to show XX sex-reversal. In such cases the individuals are genetically female but exhibit a hermaphroditism, or a male phenotype. While the frequency of this congenital disease is quite low (less than 1%), the economic losses are significant for pig breeders. These losses result from sterility, urogenital infections and the carcasses being downgraded because of the risk of boar taint. It has been clearly demonstrated that the SRY gene is not involved in most cases of sex-reversal in pigs, and that autosomal recessive mutations remain to be discovered. A whole-genome scan analysis was performed in the French Large-White population to identify candidate genes: 38 families comprising the two non-affected parents and 1 to 11 sex-reversed full-sib piglets were genotyped with the PorcineSNP60 BeadChip. A Transmission Disequilibrium Test revealed a highly significant candidate region on SSC12 (most significant p-value<4.65.10(-10)) containing the SOX9 gene. SOX9, one of the master genes involved in testis differentiation, was sequenced together with one of its main regulatory region Tesco. However, no causal mutations could be identified in either of the two sequenced regions. Further haplotype analyses did not identify a shared homozygous segment between the affected pigs, suggesting either a lack of power due to the SNP properties of the chip, or a second causative locus. Together with information from humans and mice, this study in pigs adds to the field of knowledge, which will lead to characterization of novel molecular mechanisms regulating sexual differentiation and dysregulation in cases of sex reversal.	[Rousseau, Sarah; Iannuccelli, Nathalie; Naylies, Claire; Servin, Bertrand; Milan, Denis; Riquet, Juliette] INRA, LGC UMR444, F-31326 Castanet Tolosan, France; [Mercat, Marie-Jose] IFIP, Pole Genet Motte Vicomte, Le Rheu, France; [Thouly, Jean-Claude] INRA, UE Domaine Galles 0332, F-31326 Castanet Tolosan, France; [Pailhoux, Eric] INRA, BDR UMR1198, Jouy En Josas, France	INRAE; INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Riquet, J (corresponding author), INRA, LGC UMR444, F-31326 Castanet Tolosan, France.	juliette.riquet@toulouse.inra.fr	Servin, Bertrand/B-2206-2008	Servin, Bertrand/0000-0001-5141-0913; Iannuccelli, Nathalie/0000-0002-7822-3250	French National Research Agency (Agence Nationale de la Recherche) [ANR-08-GENM-040 SwAn]; BIOPORC; LABOGENA; Research Ministry (CIFFRE grant)	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); BIOPORC; LABOGENA; Research Ministry (CIFFRE grant)	The project was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR-08-GENM-040 SwAn project) and by BIOPORC. SR PhD is funded by LABOGENA and the Research Ministry (CIFFRE grant). The ANR and LABOGENA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BIOPORC has contributed to the construction of the collection used for the design; BIOPORC had no role in the analysis and the preparation of the manuscript.	Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bagheri-Fam S, 2012, CHROMOSOME RES, V20, P191, DOI 10.1007/s10577-011-9269-5; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Dupuis MC, 2011, MAMM GENOME, V22, P613, DOI 10.1007/s00335-011-9337-3; Eggers S, 2012, CHROMOSOME RES, V20, P215, DOI 10.1007/s10577-012-9274-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Hughes IA., 2006, J PEDIATR UROL, V2, P148, DOI [DOI 10.1016/J.JPUROL.2006.03.004, 10.1101/gr.247007.118]; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; Jakubiczka S, 2010, SEX DEV, V4, P143, DOI 10.1159/000302403; JIMENEZ R, 1993, DEVELOPMENT, V118, P1303; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARZUL C, 2008, 40 JOURN RECH PORC P, V40, P141; Lavery R, 2011, DEV BIOL, V354, P111, DOI 10.1016/j.ydbio.2011.03.029; Lear TL, 2012, SEX DEV, V6, P61, DOI 10.1159/000334048; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Meyers-Wallen VN, 2012, SEX DEV, V6, P46, DOI 10.1159/000332740; Meyers-Wallen VN, 1999, MOL REPROD DEV, V53, P266, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;266::AID-MRD2&gt;3.0.CO;2-6; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Pailhoux E, 1997, THERIOGENOLOGY, V47, P93, DOI 10.1016/S0093-691X(96)00343-3; Pailhoux E, 2001, J REP FER S, P65; Pailhoux E, 2001, J EXP ZOOL, V290, P700, DOI 10.1002/jez.1120; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2012, SEX DEV, V6, P33, DOI 10.1159/000334056; Parma P, 1999, BIOL REPROD, V61, P741, DOI 10.1095/biolreprod61.3.741; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Vetro A, 2011, J MED GENET, V48, P710, DOI 10.1136/jmedgenet-2011-100036; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; White S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017793; Whitworth DJ, 1996, DEVELOPMENT, V122, P4057	49	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79882	10.1371/journal.pone.0079882	http://dx.doi.org/10.1371/journal.pone.0079882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223201	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200094
J	Trucco, MM; Awad, O; Wilky, BA; Goldstein, SD; Huang, RL; Walker, RL; Shah, P; Katuri, V; Gul, N; Zhu, YLJ; McCarthy, EF; Paz-Priel, I; Meltzer, PS; Austin, CP; Xia, MH; Loeb, DM				Trucco, Matteo M.; Awad, Ola; Wilky, Breelyn A.; Goldstein, Seth D.; Huang, Ruili; Walker, Robert L.; Shah, Preeti; Katuri, Varalakshmi; Gul, Naheed; Zhu, Yuelin J.; McCarthy, Edward F.; Paz-Priel, Ido; Meltzer, Paul S.; Austin, Christopher P.; Xia, Menghang; Loeb, David M.			A Novel Chordoma Xenograft Allows In Vivo Drug Testing and Reveals the Importance of NF-kappa B Signaling in Chordoma Biology	PLOS ONE			English	Article							CELL-LINE; GENE-EXPRESSION; PHASE-II; BRACHYURY; IDENTIFICATION; ESTABLISHMENT; ACTIVATION; INDUCTION	Chordoma is a rare primary bone malignancy that arises in the skull base, spine and sacrum and originates from remnants of the notochord. These tumors are typically resistant to conventional chemotherapy, and to date there are no FDA-approved agents to treat chordoma. The lack of in vivo models of chordoma has impeded the development of new therapies for this tumor. Primary tumor from a sacral chordoma was xenografted into NOD/SCID/IL-2R gamma-null mice. The xenograft is serially transplantable and was characterized by both gene expression analysis and whole genome SNP genotyping. The NIH Chemical Genomics Center performed high-throughput screening of 2,816 compounds using two established chordoma cell lines, U-CH1 and U-CH2B. The screen yielded several compounds that showed activity and two, sunitinib and bortezomib, were tested in the xenograft. Both agents slowed the growth of the xenograft tumor. Sensitivity to an inhibitor of I kappa B, as well as inhibition of an NF-kappa B gene expression signature demonstrated the importance of NF-kappa B signaling for chordoma growth. This serially transplantable chordoma xenograft is thus a practical model to study chordomas and perform in vivo preclinical drug testing.	[Trucco, Matteo M.; Awad, Ola; Wilky, Breelyn A.; Goldstein, Seth D.; Shah, Preeti; Katuri, Varalakshmi; Gul, Naheed; Paz-Priel, Ido; Loeb, David M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Huang, Ruili; Austin, Christopher P.; Xia, Menghang] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Walker, Robert L.; Zhu, Yuelin J.; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [McCarthy, Edward F.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Loeb, DM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	loebda@jhmi.edu	Zhu, Yuelin/ABD-5743-2021	Zhu, Yuelin/0000-0003-2762-0755; Walker, Robert/0000-0001-8235-4686; Wilky, Breelyn/0000-0001-5080-497X; Goldstein, Seth/0000-0001-7806-4109	The Chordoma Foundation; Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE [P30CA006973, ZIABC010759, T32CA009071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	The Chordoma Foundation; Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was funded by grants from The Chordoma Foundation and from Sarcoma Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Dewaele B, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-4; George S, 2009, J CLIN ONCOL, V27, P3154, DOI 10.1200/JCO.2008.20.9890; Hallor KH, 2008, BRIT J CANCER, V98, P434, DOI 10.1038/sj.bjc.6604130; Hsu W, 2011, J NEUROSURG, V115, P760, DOI 10.3171/2011.5.JNS11185; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Jambhekar NA, 2010, ARCH PATHOL LAB MED, V134, P1181, DOI 10.1043/2009-0476-OA.1; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Liu XZ, 2012, J ORTHOP RES, V30, P1666, DOI 10.1002/jor.22113; Lo PK, 2013, EXP MOL PATHOL, V94, P262, DOI 10.1016/j.yexmp.2012.10.014; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Siu IM, 2012, J NEUROSURG, V116, P801, DOI 10.3171/2011.12.JNS111123; Stacchiotti S, 2012, J CLIN ONCOL, V30, P914, DOI 10.1200/JCO.2011.35.3656; Stacchiotti S, 2011, CURR ONCOL REP, V13, P323, DOI 10.1007/s11912-011-0176-x; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	29	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79950	10.1371/journal.pone.0079950	http://dx.doi.org/10.1371/journal.pone.0079950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223206	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200099
J	van der Graaf, AM; Wiegman, MJ; Plosch, T; Zeeman, GG; van Buiten, A; Henning, RH; Buikema, H; Faas, MM				van der Graaf, Anne Marijn; Wiegman, Marjon J.; Plosch, Torsten; Zeeman, Gerda G.; van Buiten, Azuwerus; Henning, Robert H.; Buikema, Hendrik; Faas, Marijke M.			Endothelium-Dependent Relaxation and Angiotensin II Sensitivity in Experimental Preeclampsia	PLOS ONE			English	Article							LOW-DOSE-ENDOTOXIN; ACETYLCHOLINE-INDUCED RELAXATION; NITRIC-OXIDE; HYPERPOLARIZING FACTOR; VASCULAR REACTIVITY; MESENTERIC-ARTERIES; PREGNANT RATS; URINARY-EXCRETION; ANIMAL-MODEL; RECEPTOR	Objective: We investigated endothelial dysfunction and the role of angiotensin (Ang)-II type I (AT1-R) and type II (AT2-R) receptor in the changes in the Ang-II sensitivity in experimental preeclampsia in the rat. Methods: Aortic rings were isolated from low dose lipopolysaccharide (LPS) infused pregnant rats (experimental preeclampsia; n=9), saline-infused pregnant rats (n=8), and saline (n=8) and LPS (n=8) infused non-pregnant rats. Endothelium-dependent acetylcholine--mediated relaxation was studied in phenylephrine-preconstricted aortic rings in the presence of vehicle, N-G-nitro-L-arginine methyl ester and/or indomethacin. To evaluate the role for AT1-R and AT2-R in Ang-II sensitivity, full concentration response curves were obtained for Ang-II in the presence of losartan or PD123319. mRNA expression of the AT1-R and AT2-R, eNOS and iNOS, COX1 and COX2 in aorta were evaluated using real-time RT-PCR. Results: The role of vasodilator prostaglandins in the aorta was increased and the role of endothelium-derived hyperpolarizing factor and response of the AT1-R and AT2-R to Ang-II was decreased in pregnant saline infused rats as compared with non-pregnant rats. These changes were not observed during preeclampsia. Conclusion: Pregnancy induced adaptations in endothelial function, which were not observed in the rat model for preeclampsia. This role of lack of pregnancy induced endothelial adaptation in the pathophysiology of experimental preeclampsia needs further investigation.	[van der Graaf, Anne Marijn; Wiegman, Marjon J.; Zeeman, Gerda G.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab, Groningen, Netherlands; [van Buiten, Azuwerus; Henning, Robert H.; Buikema, Hendrik] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [van der Graaf, Anne Marijn; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Graaf, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.	a.m.van.der.graaf@umcg.nl	Plösch, Torsten/X-6808-2019; Henning, Robert H/AAY-5222-2020	Plösch, Torsten/0000-0002-9305-4045; Henning, Robert/0000-0002-5135-4621				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; ALOAMAKA CP, 1993, EXP PHYSIOL, V78, P403, DOI 10.1113/expphysiol.1993.sp003694; ALOAMAKA CP, 1993, RES EXP MED, V193, P407, DOI 10.1007/BF02576249; Anderson CM, 2006, EXP BIOL MED, V231, P1398, DOI 10.1177/153537020623100813; Anton L, 2009, ENDOCRINOLOGY, V150, P4316, DOI 10.1210/en.2009-0076; Ballejo G, 2002, LIFE SCI, V70, P3131, DOI 10.1016/S0024-3205(02)01576-X; BENJAMIN N, 1991, BRIT J CLIN PHARMACO, V32, P523, DOI 10.1111/j.1365-2125.1991.tb03944.x; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Bobadilla RA, 2005, CLIN EXP PHARMACOL P, V32, P202, DOI 10.1111/j.1440-1681.2005.04172.x; Bobadilla RA, 1997, HYPERTENSION, V30, P596, DOI 10.1161/01.HYP.30.3.596; Bobadilla RA, 2001, HYPERTENS PREGNANCY, V20, P143, DOI 10.1081/PRG-100106964; Brown MA, 1997, CLIN EXP HYPERTENS, V19, P713, DOI 10.3109/10641969709083181; Buikema H, 2000, BRIT J PHARMACOL, V130, P1999, DOI 10.1038/sj.bjp.0703498; BUIKEMA H, 1993, CARDIOVASC RES, V27, P2118, DOI 10.1093/cvr/27.12.2118; Buikema H, 1996, EUR HEART J, V17, P787; CHU ZM, 1993, BRIT J PHARMACOL, V109, P322, DOI 10.1111/j.1476-5381.1993.tb13573.x; Cockell AP, 1996, J PHYSIOL-LONDON, V495, P545, DOI 10.1113/jphysiol.1996.sp021614; Cockell AP, 1997, HYPERTENSION, V30, P247, DOI 10.1161/01.HYP.30.2.247; CONRAD KP, 1993, FASEB J, V7, P566, DOI 10.1096/fasebj.7.6.7682524; Cosentino F, 2005, AM J HYPERTENS, V18, P493, DOI 10.1016/j.amjhyper.2004.11.007; Davis JR, 2002, AM J PHYSIOL-REG I, V282, pR390, DOI 10.1152/ajpregu.00270.2001; Delemarre FMC, 2000, PROSTAG LEUKOTR ESS, V63, P209, DOI 10.1054/plef.2000.0211; Doering TP, 1998, AM J OBSTET GYNECOL, V178, P1307, DOI 10.1016/S0002-9378(98)70337-0; EASTERLING TR, 1990, OBSTET GYNECOL, V76, P1061; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Faas MM, 2004, AM J OBSTET GYNECOL, V191, P1192, DOI 10.1016/j.ajog.2004.03.041; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; FAAS MM, 1995, AM J PATHOL, V147, P1510; Faas MM, 2000, AM J OBSTET GYNECOL, V182, P351, DOI 10.1016/S0002-9378(00)70223-7; Faas MM, 1999, AM J REPROD IMMUNOL, V41, P224; Faas MM, 1997, J LAB CLIN MED, V130, P496, DOI 10.1016/S0022-2143(97)90126-8; Faas MM, 2000, AM J REPROD IMMUNOL, V44, P178, DOI 10.1111/j.8755-8920.2000.440308.x; Fraga-Silva RA, 2013, CURR HYPERTENS REP, V15, P31, DOI 10.1007/s11906-012-0324-1; FRIEDMAN SA, 1988, OBSTET GYNECOL, V71, P122; GANT NF, 1987, AM J KIDNEY DIS, V9, P303, DOI 10.1016/S0272-6386(87)80126-9; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; Gerber RT, 1998, BRIT J PHARMACOL, V125, P455, DOI 10.1038/sj.bjp.0702099; Gillham JC, 2003, EUR J OBSTET GYN R B, V109, P2, DOI 10.1016/S0301-2115(03)00044-7; GOETZ RM, 1994, BIOCHEM BIOPH RES CO, V205, P905, DOI 10.1006/bbrc.1994.2750; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; JASPERS WJM, 1981, EUR J OBSTET GYN R B, V11, P379, DOI 10.1016/0028-2243(81)90087-3; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kenny LC, 2002, CLIN SCI, V103, P67; KNOCK GA, 1994, J PHARMACOL EXP THER, V271, P1007; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Laskowska M, 2003, GYNECOL OBSTET INVES, V56, P55, DOI 10.1159/000072704; Leung PS, 2001, MOL CELL ENDOCRINOL, V184, P95, DOI 10.1016/S0303-7207(01)00637-2; Lewis DF, 2010, AM J REPROD IMMUNOL, V64, P376, DOI 10.1111/j.1600-0897.2010.00861.x; Li CB, 2000, HYPERTENSION, V36, P159, DOI 10.1161/01.HYP.36.2.159; Lopez-Jaramillo Patricio, 2008, Ther Adv Cardiovasc Dis, V2, P261, DOI 10.1177/1753944708092277; Lubarsky SL, 1997, AM J OBSTET GYNECOL, V176, P1069, DOI 10.1016/S0002-9378(97)70404-6; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Malatyalioglu E, 2000, J Matern Fetal Med, V9, P173; Martinez-Orgado J, 2003, J SOC GYNECOL INVEST, V10, P74, DOI 10.1016/S1071-5576(02)00220-4; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Mills JL, 1999, JAMA-J AM MED ASSOC, V282, P356, DOI 10.1001/jama.282.4.356; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; NATHAN L, 1995, BRIT J PHARMACOL, V114, P955, DOI 10.1111/j.1476-5381.1995.tb13297.x; Nielsen AH, 2000, PLACENTA, V21, P468, DOI 10.1053/plac.2000.0535; Oosterga M, 2000, CARDIOVASC DRUG THER, V14, P55, DOI 10.1023/A:1007843205311; Orshal JM, 2004, HYPERTENSION, V43, P434, DOI 10.1161/01.HYP.0000113044.46326.98; Plosch T, 2010, PLACENTA, V31, P910, DOI 10.1016/j.placenta.2010.07.009; Ralevic V, 1996, BRIT J PHARMACOL, V117, P1463, DOI 10.1111/j.1476-5381.1996.tb15307.x; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Saito T, 2004, FASEB J, V18, pA935; Schaefer WR, 1996, PROSTAGLANDINS, V52, P1, DOI 10.1016/0090-6980(96)00049-4; SCHAFER W, 1993, PROSTAGLANDINS, V46, P167, DOI 10.1016/0090-6980(93)90042-6; Schmitt M, 2005, HYPERTENSION, V46, P227, DOI 10.1161/01.HYP.0000164581.39811.bd; Serreau R, 2005, BJOG-INT J OBSTET GY, V112, P710, DOI 10.1111/j.1471-0528.2004.00525.x; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stennett AK, 2009, AM J PHYSIOL-HEART C, V296, pH745, DOI 10.1152/ajpheart.00861.2008; STLOUIS J, 1992, AM J OBSTET GYNECOL, V166, P684, DOI 10.1016/0002-9378(92)91698-A; Takiuti N H, 1999, Sao Paulo Med J, V117, P197; Ulu N, 2008, NEPHROL DIAL TRANSPL, V23, P1854, DOI 10.1093/ndt/gfm911; Vainio M, 2004, ACTA OBSTET GYN SCAN, V83, P1119, DOI 10.1111/j.0001-6349.2004.00396.x; Valdes G, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-79; van Drongelen J, 2012, AM J PHYSIOL-HEART C, V303, pH639, DOI 10.1152/ajpheart.00617.2011; vanderWeiden RMF, 1996, AM J OBSTET GYNECOL, V174, P1614, DOI 10.1016/S0002-9378(96)70616-6; Voors AA, 2005, J RENIN-ANGIO-ALDO S, V6, P145, DOI 10.3317/jraas.2005.021; Wang XM, 2003, AM J PHYSIOL-RENAL, V285, pF540, DOI 10.1152/ajprenal.00127.2003; Wang ZJ, 2012, J MATERN-FETAL NEO M, V25, P855, DOI 10.3109/14767058.2011.599077; Wilkinson IB, 2004, HYPERTENSION, V44, P112, DOI 10.1161/01.HYP.0000138068.03893.40; Xu Y, 2007, LIFE SCI, V80, P1678, DOI 10.1016/j.lfs.2007.01.041	85	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79884	10.1371/journal.pone.0079884	http://dx.doi.org/10.1371/journal.pone.0079884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223202	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200095
J	Beauchesne, D; Jaeger, JAG; St-Laurent, MH				Beauchesne, David; Jaeger, Jochen A. G.; St-Laurent, Martin-Hugues			Disentangling Woodland Caribou Movements in Response to Clearcuts and Roads across Temporal Scales	PLOS ONE			English	Article							FOREST-DWELLING CARIBOU; CONDITIONAL LOGISTIC-REGRESSION; MOOSE HABITAT SELECTION; FUNCTIONAL-RESPONSES; THREATENED CARIBOU; LARGE HERBIVORES; MODEL SELECTION; TRADE-OFFS; BOREAL; CONSERVATION	Although prey species typically respond to the most limiting factors at coarse spatiotemporal scales while addressing biological requirements at finer scales, such behaviour may become challenging for species inhabiting human altered landscapes. We investigated how woodland caribou, a threatened species inhabiting North-American boreal forests, modified their fine-scale movements when confronted with forest management features (i.e. clearcuts and roads). We used GPS telemetry data collected between 2004 and 2010 on 49 female caribou in a managed area in Quebec, Canada. Movements were studied using a use - availability design contrasting observed steps (i.e. line connecting two consecutive locations) with random steps (i.e. proxy of immediate habitat availability). Although caribou mostly avoided disturbances, individuals nonetheless modulated their fine-scale response to disturbances on a daily and annual basis, potentially compromising between risk avoidance in periods of higher vulnerability (i.e. calving, early and late winter) during the day and foraging activities in periods of higher energy requirements (i.e. spring, summer and rut) during dusk/dawn and at night. The local context in which females moved was shown to influence their decision to cross clearcut edges and roads. Indeed, although females typically avoided crossing clearcut edges and roads at low densities, crossing rates were found to rapidly increase in greater disturbance densities. In some instance, however, females were less likely to cross edges and roads as densities increased. Females may then be trapped and forced to use disturbed habitats, known to be associated with higher predation risk. We believe that further increases in anthropogenic disturbances could exacerbate such behavioural responses and ultimately lead to population level consequences.	[Beauchesne, David; Jaeger, Jochen A. G.] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ, Canada; [Beauchesne, David] Concordia Univ, Ctr Northern Studies, Montreal, PQ, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Northern Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Forest Res, Rimouski, PQ G5L 3A1, Canada	Concordia University - Canada; Concordia University - Canada; University of Quebec; University of Quebec	St-Laurent, MH (corresponding author), Univ Quebec, Ctr Northern Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	martin-hugues_st-laurent@uqar.ca		Beauchesne, David/0000-0002-3590-8161	AbitibiBowater Inc.; Canada Economic Development; Concordia University; Conseil de l'industrie forestiere du Quebec; Fondation de la faune du Quebec; Fonds quebecois de la recherche sur la nature et les technologies; Fonds de recherche forestiere du Saguenay-Lac-St-Jean; Ministere des Ressources naturelles et de la Faune; Natural Sciences and Engineering Research Council of Canada; Universite du Quebec a Rimouski; World Wildlife Fund for Nature	AbitibiBowater Inc.; Canada Economic Development; Concordia University; Conseil de l'industrie forestiere du Quebec; Fondation de la faune du Quebec; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Fonds de recherche forestiere du Saguenay-Lac-St-Jean; Ministere des Ressources naturelles et de la Faune; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Universite du Quebec a Rimouski; World Wildlife Fund for Nature	This project was funded by the following partners: AbitibiBowater Inc., Canada Economic Development, Concordia University, Conseil de l'industrie forestiere du Quebec, Fondation de la faune du Quebec, Fonds quebecois de la recherche sur la nature et les technologies, Fonds de recherche forestiere du Saguenay-Lac-St-Jean, Ministere des Ressources naturelles et de la Faune, Natural Sciences and Engineering Research Council of Canada (Discovery Grant to M.-H. St-Laurent), Universite du Quebec a Rimouski and World Wildlife Fund for Nature. The authors also thank the Essipit First Nation and A. Chabot for providing access to their caribou telemetry data, via the Aboriginal Funds for Species at Risk (Environment Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; Barten NL, 2001, J WILDLIFE MANAGE, V65, P77, DOI 10.2307/3803279; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Bastille-Rousseau G, 2011, ECOGRAPHY, V34, P588, DOI 10.1111/j.1600-0587.2010.06517.x; BERGERUD AT, 1987, CAN J ZOOL, V65, P1597, DOI 10.1139/z87-249; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Bjorneraas K, 2011, WILDLIFE BIOL, V17, P44, DOI 10.2981/10-073; Briand Y, 2009, ECOSCIENCE, V16, P330, DOI 10.2980/16-3-3248; Brodeur V, 2008, CAN J ZOOL, V86, P1307, DOI 10.1139/Z08-118; Burton PJ, 1999, FOREST CHRON, V75, P623, DOI 10.5558/tfc75623-4; COSEWIC, 2011, CAN WILDL SPEC RISK; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Courtois R., 1998, ALCES, V34, P210; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Dussault C, 2006, CAN J FOREST RES, V36, P1097, DOI 10.1139/X05-310; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Environment Canada, 2011, SCI ASS INF ID CRIT; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frid A, 2002, CONSERV ECOL, V6; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gurarie E, 2011, OECOLOGIA, V165, P891, DOI 10.1007/s00442-010-1883-y; Gustine DD, 2008, CAN J ZOOL, V86, P812, DOI 10.1139/Z08-047; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Hins C, 2009, FOREST ECOL MANAG, V257, P636, DOI 10.1016/j.foreco.2008.09.049; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; Leblond M, 2011, LANDSCAPE ECOL, V26, P1433, DOI 10.1007/s10980-011-9647-6; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lesmerises R, 2013, ECOL EVOL, V3, P2880, DOI 10.1002/ece3.695; Lykkja Odd N., 2009, Alces, V45, P109; Mabille G, 2012, OECOLOGIA, V170, P965, DOI 10.1007/s00442-012-2382-0; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Peterson Rolf O., 2003, P104; Pinard V, 2012, J WILDLIFE MANAGE, V76, P189, DOI 10.1002/jwmg.217; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robitaille A., 1998, PAYSAGES REGIONAUX Q; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Skarin A, 2010, POLAR BIOL, V33, P1263, DOI 10.1007/s00300-010-0815-y; St-Laurent Martin-Hugues, 2012, Rangifer, V32, P127; TREMBLAYGENDRON S, 2012, THESIS U QUEBEC RIMO; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.5061/DRYAD.N3C2F; [No title captured]	64	20	20	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77514	10.1371/journal.pone.0077514	http://dx.doi.org/10.1371/journal.pone.0077514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223713	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400007
J	Frump, AL; Lowery, JW; Hamid, R; Austin, ED; de Caestecker, M				Frump, Andrea L.; Lowery, Jonathan W.; Hamid, Rizwan; Austin, Eric D.; de Caestecker, Mark			Abnormal Trafficking of Endogenously Expressed BMPR2 Mutant Allelic Products in Patients with Heritable Pulmonary Arterial Hypertension	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; II RECEPTOR; SODIUM 4-PHENYLBUTYRATE; ENDOPLASMIC-RETICULUM; CYSTIC-FIBROSIS; MUTATIONS; GENE; SUSCEPTIBILITY; SPECIFICITY; ENDOTHELIUM	More than 200 heterozygous mutations in the type 2 BMP receptor gene, BMPR2, have been identified in patients with Heritable Pulmonary Arterial Hypertension (HPAH). More severe clinical outcomes occur in patients with BMPR2 mutations by-passing nonsense-mediated mRNA decay (NMD negative mutations). These comprise 40% of HPAH mutations and are predicted to express BMPR2 mutant products. However expression of endogenous NMD negative BMPR2 mutant products and their effect on protein trafficking and signaling function have never been described. Here, we characterize the expression and trafficking of an HPAH-associated NMD negative BMPR2 mutation that results in an in-frame deletion of BMPR2 EXON2 (BMPR2.Ex2) in HPAH patient-derived lymphocytes and in pulmonary endothelial cells (PECs) from mice carrying the same in-frame deletion of Exon 2 (Bmpr2(Ex2/+) mice). The endogenous BMPR2 Delta Ex2 mutant product does not reach the cell surface and is retained in the endoplasmic reticulum. Moreover, chemical chaperones 4-PBA and TUDCA partially restore cell surface expression of Bmpr2.Ex2 in PECs, suggesting that the mutant product is mis-folded. We also show that PECs from Bmpr(2 Delta Ex2/+) mice have defects in the BMP-induced Smad1/5/8 and Id1 signaling axis, and that addition of chemical chaperones restores expression of the Smad1/5/8 target Id1. These data indicate that the endogenous NMD negative BMPR.Ex2 mutant product is expressed but has a folding defect resulting in ER retention. Partial correction of this folding defect and restoration of defective BMP signaling using chemical chaperones suggests that protein-folding agents could be used therapeutically in patients with these NMD negative BMPR2 mutations.	[Frump, Andrea L.; de Caestecker, Mark] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA; [Lowery, Jonathan W.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Hamid, Rizwan] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Mol Genet & Genom Med, Nashville, TN 37232 USA; [Austin, Eric D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Pulm Med, Nashville, TN 37232 USA; [de Caestecker, Mark] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Harvard University; Harvard School of Dental Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University	de Caestecker, M (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA.	mark.de.caestecker@vanderbilt.edu	Frump, Andrea/W-5043-2019	Frump, Andrea/0000-0002-5972-5079	National Institutes of Health/NIH Heart, Lung and Blood Institute [HL093057, HL095797]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095797, R01HL102020, R01HL093057] Funding Source: NIH RePORTER	National Institutes of Health/NIH Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health/NIH Heart, Lung and Blood Institute grants HL093057 and HL095797, URL http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin Eric D, 2011, Pulm Circ, V1, P389, DOI 10.4103/2045-8932.87308; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bulleid NJ, 2012, COLD SPRING HARB PER, V4; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; da-Silva WS, 2011, FEBS LETT, V585, P539, DOI 10.1016/j.febslet.2010.12.044; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Drake KM, 2013, AM J RESP CELL MOL, V49, P403, DOI 10.1165/rcmb.2013-0100OC; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Freeze HH, 2008, CURR PROTOC IMMUNOL, P15; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Hua YA, 2010, J CARDIOVASC PHARM, V55, P49, DOI 10.1097/FJC.0b013e3181c37d86; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; LODISH HF, 1988, J BIOL CHEM, V263, P2107; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483; Lowery JW, 2010, AM J PHYSIOL-REG I, V299, pR1463, DOI 10.1152/ajpregu.00866.2009; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Loyd James E, 2011, Proc Am Thorac Soc, V8, P154, DOI 10.1513/pats.201007-047MS; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Miyazono K, 2002, SCI STKE, V2002, ppe40; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Obici L, 2012, AMYLOID, V19, P34, DOI 10.3109/13506129.2012.678508; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; Roque T, 2008, J PHARMACOL EXP THER, V326, P949, DOI 10.1124/jpet.107.135186; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; West J, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-45; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Yeh LCC, 2012, BIOCHEMISTRY-US, V51, P6968, DOI 10.1021/bi3003023; Yin HR, 2008, J MOL BIOL, V378, P191, DOI 10.1016/j.jmb.2008.02.031; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	52	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80319	10.1371/journal.pone.0080319	http://dx.doi.org/10.1371/journal.pone.0080319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224048	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400116
J	Mischke, M; Pruis, MGM; Boekschoten, MV; Groen, AK; Fitri, AR; van de Heijning, BJM; Verkade, HJ; Muller, M; Plosch, T; Steegenga, WT				Mischke, Mona; Pruis, Maurien G. M.; Boekschoten, Mark V.; Groen, Albert K.; Fitri, Aditia R.; van de Heijning, Bert J. M.; Verkade, Henkjan J.; Muller, Michael; Plosch, Torsten; Steegenga, Wilma T.			Maternal Western-Style High Fat Diet Induces Sex-Specific Physiological and Molecular Changes in Two-Week-Old Mouse Offspring	PLOS ONE			English	Article							HYPOTHALAMIC GENE-EXPRESSION; AORTIC VASCULAR FUNCTION; BETA-CATENIN; LIPID-METABOLISM; ESTROGEN-RECEPTOR; ECONOMIC BURDEN; C57BL/6 MICE; FOOD-INTAKE; X-RECEPTOR; LIVER	Maternal diet is associated with the development of metabolism-related and other non-communicable diseases in offspring. Underlying mechanisms, functional profiles, and molecular markers are only starting to be revealed. Here, we explored the physiological and molecular impact of maternal Western-style diet on the liver of male and female offspring. C57BL/6 dams were exposed to either a low fat/low cholesterol diet (LFD) or a Western-style high fat/high cholesterol diet (WSD) for six weeks before mating, as well as during gestation and lactation. Dams and offspring were sacrificed at postnatal day 14, and body, liver, and blood parameters were assessed. The impact of maternal WSD on the pups' liver gene expression was characterised by whole-transcriptome microarray analysis. Exclusively male offspring had significantly higher body weight upon maternal WSD. In offspring of both sexes of WSD dams, liver and blood parameters, as well as hepatic gene expression profiles were changed. In total, 686 and 604 genes were differentially expressed in liver (p <= 0.01) of males and females, respectively. Only 10% of these significantly changed genes overlapped in both sexes. In males, in particular alterations of gene expression with respect to developmental functions and processes were observed, such as Wnt/beta-catenin signalling. In females, mainly genes important for lipid metabolism, including cholesterol synthesis, were changed. We conclude that maternal WSD affects physiological parameters and induces substantial changes in the molecular profile of the liver in two-week-old pups. Remarkably, the observed biological responses of the offspring reveal pronounced sex-specificity.	[Mischke, Mona; Boekschoten, Mark V.; Fitri, Aditia R.; Muller, Michael; Steegenga, Wilma T.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands; [Pruis, Maurien G. M.; Groen, Albert K.; Verkade, Henkjan J.; Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [van de Heijning, Bert J. M.] Danone Res, Ctr Specialised Nutr, Wageningen, Netherlands	Wageningen University & Research; University of Groningen; University of Groningen; Danone Nutricia	Steegenga, WT (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands.	wilma.steegenga@wur.nl	Muller, Michael/B-5795-2008; Plösch, Torsten/X-6808-2019; Muller, Michael/M-5724-2019; Boekschoten, Mark/AAS-4597-2021	Muller, Michael/0000-0002-5930-9905; Plösch, Torsten/0000-0002-9305-4045; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; Verkade, Henkjan J/0000-0002-7034-2861	Dutch Technology Foundation STW , which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	Dutch Technology Foundation STW , which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This research is supported by the Dutch Technology Foundation STW (www.stw.nl), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and is supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2009, AM J PHYSIOL-REG I, V296, pR1027, DOI 10.1152/ajpregu.00104.2009; Aounallah-Skhiri H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-38; Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Behari J, 2010, EXPERT REV GASTROENT, V4, P745, DOI [10.1586/egh.10.74, 10.1586/EGH.10.74]; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Chafey P, 2009, PROTEOMICS, V9, P3889, DOI 10.1002/pmic.200800609; Chechi K, 2009, AM J PHYSIOL-REG I, V296, pR1029, DOI 10.1152/ajpregu.90932.2008; Cheng TO, 2003, J AM COLL CARDIOL, V42, P773, DOI 10.1016/S0735-1097(03)00792-7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins TG, 2012, REPRODUCTION, V143, P727, DOI 10.1530/REP-11-0450; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; Koletzko B, 2012, P NUTR SOC, V71, P371, DOI 10.1017/S0029665112000596; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Muller-Riemenschneider F, 2008, EUR J EPIDEMIOL, V23, P499, DOI 10.1007/s10654-008-9239-1; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Pruis M, 2011, J DEV ORIG HLTH DIS, V2, pS35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; Silverman BL, 1998, DIABETES CARE, V21, pB142; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Wang HH, 2006, J LIPID RES, V47, P778, DOI 10.1194/jlr.M500454-JLR200; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Zhang JL, 2005, AM J PHYSIOL-REG I, V288, pR112, DOI 10.1152/ajpregu.00351.2004; Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576	59	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78623	10.1371/journal.pone.0078623	http://dx.doi.org/10.1371/journal.pone.0078623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223833	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400037
J	Nuss, AM; Adnan, F; Weber, L; Berghoff, BA; Glaeser, J; Klug, G				Nuss, Aaron M.; Adnan, Fazal; Weber, Lennart; Berghoff, Bork A.; Glaeser, Jens; Klug, Gabriele			DegS and RseP Homologous Proteases Are Involved in Singlet Oxygen Dependent Activation of RpoE in Rhodobacter sphaeroides	PLOS ONE			English	Article							ESCHERICHIA-COLI SIGMA(E); ENVELOPE STRESS-RESPONSE; PHOTOOXIDATIVE STRESS; TRANSCRIPTIONAL RESPONSE; CRYSTAL-STRUCTURE; SIGNALS; CAROTENOIDS; PROTEOLYSIS; EXPRESSION; RESISTANCE	Singlet oxygen (O-1(2)) is the main agent of photooxidative stress and is generated by photosensitizers as (bacterio) chlorophylls. It leads to the damage of cellular macromolecules and therefore photosynthetic organisms have to mount an adaptive response to O-1(2) formation. A major player of the photooxidative stress response in Rhodobacter sphaeroides is the alternative sigma factor RpoE, which is inactivated under non-stress conditions by its cognate anti-sigma factor ChrR. By using random mutagenesis we identified RSP_1090 to be required for full activation of the RpoE response under O-1(2) stress, but not under organic peroxide stress. In this study we show that both RSP_1090 and RSP_1091 are required for full resistance towards O-1(2). Moreover, we revealed that the DegS and RseP homologs RSP_3242 and RSP_2710 contribute to O-1(2) resistance and promote ChrR proteolysis. The RpoE signaling pathway in R. sphaeroides is therefore highly similar to that of Escherichia coli, although very different anti-sigma factors control RpoE activity. Based on the acquired results, the current model for RpoE activation in response to O-1(2) exposure in R. sphaeroides was extended.	[Nuss, Aaron M.; Adnan, Fazal; Weber, Lennart; Berghoff, Bork A.; Glaeser, Jens; Klug, Gabriele] Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany; [Nuss, Aaron M.] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany; [Berghoff, Bork A.] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden	Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center for Infection Research; Uppsala University	Klug, G (corresponding author), Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de; jens.glaeser@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093	Deutsche Forschungsgemeinschaft [Kl 563/ 20-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft grant Kl 563/ 20-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Anthony JR, 2004, J MOL BIOL, V341, P345, DOI 10.1016/j.jmb.2004.06.018; Anthony JR, 2003, METHOD ENZYMOL, V370, P54; Berghoff BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003576; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2011, ENVIRON MICROBIOL, V13, P775, DOI 10.1111/j.1462-2920.2010.02381.x; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Cogdell RJ, 2000, PHILOS T ROY SOC B, V355, P1345, DOI 10.1098/rstb.2000.0696; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Drews G, 1983, MIKROBIOLOGISCHES PR; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Greenwell R, 2011, J MOL BIOL, V407, P477, DOI 10.1016/j.jmb.2011.01.055; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; HUBNER P, 1991, J BACTERIOL, V173, P2993; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Nam TW, 2013, MBIO, V4, DOI 10.1128/mBio.00541-12; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHILKE BA, 1995, J BACTERIOL, V177, P1929, DOI 10.1128/jb.177.8.1929-1937.1995; SIMON R, 1986, METHOD ENZYMOL, V118, P640; van Niel CB, 1944, BACTERIOL REV, V8, P1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	44	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79520	10.1371/journal.pone.0079520	http://dx.doi.org/10.1371/journal.pone.0079520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223961	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400070
J	Zhuchkova, E; Remme, MWH; Schreiber, S				Zhuchkova, Ekaterina; Remme, Michiel W. H.; Schreiber, Susanne			Somatic versus Dendritic Resonance: Differential Filtering of Inputs through Non-Uniform Distributions of Active Conductances	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; CORTEX LAYER-II; SUBTHRESHOLD MEMBRANE RESONANCE; MEDIAL ENTORHINAL CORTEX; RAT HIPPOCAMPAL-NEURONS; SQUID GIANT AXON; STELLATE CELLS; H-CURRENT; IN-VITRO; POTENTIAL OSCILLATIONS	Synaptic inputs to neurons are processed in a frequency-dependent manner, with either low-pass or resonant response characteristics. These types of filtering play a key role in the frequency-specific information flow in neuronal networks. While the generation of resonance by specific ionic conductances is well investigated, less attention has been paid to the spatial distribution of the resonance-generating conductances across a neuron. In pyramidal neurons - one of the major excitatory cell-types in the mammalian brain - a steep gradient of resonance-generating h-conductances with a 60-fold increase towards distal dendrites has been demonstrated experimentally. Because the dendritic trees of these cells are large, spatial compartmentalization of resonant properties can be expected. Here, we use mathematical descriptions of spatially extended neurons to investigate the consequences of such a distal, dendritic localization of h-conductances for signal processing. While neurons with short dendrites do not exhibit a pronounced compartmentalization of resonance, i.e. the filter properties of dendrites and soma are similar, we find that neurons with longer dendrites (similar to 1 space constant) can show distinct filtering of dendritic and somatic inputs due to electrotonic segregation. Moreover, we show that for such neurons, experimental classification as resonant versus nonresonant can be misleading when based on somatic recordings, because for these morphologies a dendritic resonance could easily be undetectable when using somatic input. Nevertheless, noise-driven membrane-potential oscillations caused by dendritic resonance can propagate to the soma where they can be recorded, hence contrasting with the low-pass filtering at the soma. We conclude that non-uniform distributions of active conductances can underlie differential filtering of synaptic input in neurons with spatially extended dendrites, like pyramidal neurons, bearing relevance for the localization-dependent targeting of synaptic input pathways to these cells.	[Zhuchkova, Ekaterina; Remme, Michiel W. H.; Schreiber, Susanne] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany	Humboldt University of Berlin	Schreiber, S (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	s.schreiber@hu-berlin.de		Remme, Michiel/0000-0003-0400-6074	German Federal Ministry of Education and Research [01GQ0901, 01GQ1001A, 01GQ0972]; Deutsche Forschungsgemeinschaft [SFB 618/B1, GK1589]; Einstein Foundation Berlin	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Einstein Foundation Berlin	This work was funded by the German Federal Ministry of Education and Research (01GQ0901, 01GQ1001A, 01GQ0972), Deutsche Forschungsgemeinschaft (SFB 618/B1 and GK1589), and the Einstein Foundation Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Coombes S, 2007, BIOL CYBERN, V97, P137, DOI 10.1007/s00422-007-0161-5; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Gastrein P, 2011, J PHYSIOL-LONDON, V589, P3753, DOI 10.1113/jphysiol.2011.209148; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Jack J.J.B., 1975, ELECT CURRENT FLOW E; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Rall W, 1964, NEURAL THEORY MODELI, P73; Remme MWH, 2011, J COMPUT NEUROSCI, V31, P13, DOI 10.1007/s10827-010-0295-7; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; SABAH NH, 1969, BIOPHYS J, V9, P1206, DOI 10.1016/S0006-3495(69)86446-5; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; SPAIN WJ, 1987, J NEUROPHYSIOL, V57, P1555, DOI 10.1152/jn.1987.57.5.1555; Stuart G, 1998, J NEUROSCI, V18, P3501; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wang WT, 2006, NEUROSCIENCE, V140, P45, DOI 10.1016/j.neuroscience.2006.01.033; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zhuchkova E, 2014, COMPUTING DENDRITE	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78908	10.1371/journal.pone.0078908	http://dx.doi.org/10.1371/journal.pone.0078908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223864	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400042
J	Zou, RY; Zhou, K; Stephanopoulos, G; Too, HP				Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Heng Phon Too			Combinatorial Engineering of 1-Deoxy-D-Xylulose 5-Phosphate Pathway Using Cross-Lapping In Vitro Assembly (CLIVA) Method	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; REACTION-AMPLIFIED DNA; ESCHERICHIA-COLI; CHEMICAL-SYNTHESIS; SYNTHETIC BIOLOGY; OXIDATIVE STRESS; NATURAL-PRODUCTS; 2-C-METHYL-D-ERYTHRITOL-2,4-CYCLOPYROPHOSPHATE; BIOSYNTHESIS; ARTEMISININ	The ability to assemble multiple fragments of DNA into a plasmid in a single step is invaluable to studies in metabolic engineering and synthetic biology. Using phosphorothioate chemistry for high efficiency and site specific cleavage of sequences, a novel ligase independent cloning method (cross-lapping in vitro assembly, CLIVA) was systematically and rationally optimized in E. coli. A series of 16 constructs combinatorially expressing genes encoding enzymes in the 1-deoxy-D-xylulose 5-phosphate (DXP) pathway were assembled using multiple DNA modules. A plasmid (21.6 kb) containing 16 pathway genes, was successfully assembled from 7 modules with high efficiency (2.0 x 10(3) cfu/ mu g input DNA) within 2 days. Overexpressions of these constructs revealed the unanticipated inhibitory effects of certain combinations of genes on the production of amorphadiene. Interestingly, the inhibitory effects were correlated to the increase in the accumulation of intracellular methylerythritol cyclodiphosphate (MEC), an intermediate metabolite in the DXP pathway. The overexpression of the iron sulfur cluster operon was found to modestly increase the production of amorphadiene. This study demonstrated the utility of CLIVA in the assembly of multiple fragments of DNA into a plasmid which enabled the rapid exploration of biological pathways.	[Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Heng Phon Too] Singapore MIT Alliance, Singapore, Singapore; [Heng Phon Too] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Too, HP (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	heng-phon_too@nuhs.edu.sg	Zhou, Kang/AAI-9969-2021; Zhou, Kang/AAQ-5730-2021	Zhou, Kang/0000-0003-0606-7030	Singapore-MIT Alliance [CPE program grant]	Singapore-MIT Alliance [CPE program grant](Singapore-MIT Alliance for Research & Technology Centre (SMART))	Funding provided by Singapore-MIT Alliance http://web.mit.edu/sma/ [CPE program grant]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Carlsen S, 2013, APPL MICROBIOL BIOT, V97, P5753, DOI 10.1007/s00253-013-4877-y; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Grey BN, 2001, APPL ENVIRON MICROB, V67, P5325, DOI 10.1128/AEM.67.11.5325-5327.2001; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; Huang M, 2012, EXPERT OPIN INV DRUG, V21, P1801, DOI 10.1517/13543784.2012.727395; KALUZ S, 1992, NUCLEIC ACIDS RES, V20, P4369, DOI 10.1093/nar/20.16.4369; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Lang BE, 2007, BIOPHYS CHEM, V131, P96, DOI 10.1016/j.bpc.2007.09.007; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu CZ, 2006, APPL MICROBIOL BIOT, V72, P11, DOI 10.1007/s00253-006-0452-0; Liu XP, 2010, PROTEIN SCI, V19, P967, DOI 10.1002/pro.374; Lutz S, 2001, P NATL ACAD SCI USA, V98, P11248, DOI 10.1073/pnas.201413698; Marienhagen J., 2012, BIOTECHNIQUES, P1, DOI [10.2144/000113865, DOI 10.2144/000113865]; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; NAKAMAYE KL, 1988, NUCLEIC ACIDS RES, V16, P9947, DOI 10.1093/nar/16.21.9947; Nisson P E, 1991, PCR Methods Appl, V1, P120; Ogrel' O D, 1996, Biokhimiia, V61, P1294; Ogrel OD, 1996, CURR MICROBIOL, V32, P225, DOI 10.1007/s002849900040; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Ostrovsky D, 1998, ARCH MICROBIOL, V171, P69, DOI 10.1007/s002030050680; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; RASHTCHIAN A, 1992, ANAL BIOCHEM, V206, P91, DOI 10.1016/S0003-2697(05)80015-6; Rodriguez-Villalon A, 2008, J BIOTECHNOL, V135, P78, DOI 10.1016/j.jbiotec.2008.02.023; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Villiers BRM, 2010, PROTEIN ENG DES SEL, V23, P1, DOI 10.1093/protein/gzp063; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; ZHOU MX, 1995, NUCLEIC ACIDS RES, V23, P1089, DOI 10.1093/nar/23.6.1089	48	43	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79557	10.1371/journal.pone.0079557	http://dx.doi.org/10.1371/journal.pone.0079557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223968	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400072
J	Murakoshi, M; Saiki, K; Urayama, K; Sato, TN				Murakoshi, Motoaki; Saiki, Kyohei; Urayama, Kyoji; Sato, Thomas N.			An Anthelmintic Drug, Pyrvinium Pamoate, Thwarts Fibrosis and Ameliorates Myocardial Contractile Dysfunction in a Mouse Model of Myocardial Infarction	PLOS ONE			English	Article							FUMARATE REDUCTASE; ANTITUMOR-ACTIVITY; CARDIAC FIBROSIS; ANGIOTENSIN; INHIBITION; METABOLISM; ACTIVATION; TARGETS; GROWTH; CELLS	Metabolic adaptation to limited supplies of oxygen and nutrients plays a pivotal role in health and disease. Heart attack results from insufficient delivery of oxygen and nutrients to the heart, where cardiomyocytes die and cardiac fibroblasts proliferate - the latter causing scar formation, which impedes regeneration and impairs contractility of the heart. We postulated that cardiac fibroblasts survive metabolic stress by adapting their intracellular metabolism to low oxygen and nutrients, and impeding this metabolic adaptation would thwart their survival and facilitate the repair of scarred heart. Herein, we show that an anthelmintic drug, Pyrvinium pamoate, which has been previously shown to compromise cancer cell survival under glucose starvation condition, also disables cardiac fibroblast survival specifically under glucose deficient condition. Furthermore, Pyrvinium pamoate reduces scar formation and improves cardiac contractility in a mouse model of myocardial infarction. As Pyrvinium pamoate is an FDA-approved drug, our results suggest a therapeutic use of this or other related drugs to repair scarred heart and possibly other organs.	[Murakoshi, Motoaki; Saiki, Kyohei; Urayama, Kyoji; Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Sato, Thomas N.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Sato, Thomas N.] Centenary Inst, Sydney, NSW, Australia	Nara Institute of Science & Technology; Cornell University; University of Sydney; Centenary Institute	Sato, TN (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	island1005@bs.naist.jp			JSPS [22229007, 24790758]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24790758] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI S Grant Number 22229007 (T.N.S.), Takeda Science Foundation (T.N.S.), JSPS KAKENHI Young Scientists (B) Grant Number 24790758 (K.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chun MGH, 2013, NAT BIOTECHNOL, V31, P505, DOI 10.1038/nbt.2611; De Mello WC, 2006, J RENIN-ANGIO-ALDO S, V7, P201, DOI 10.3317/jraas.2006.038; Deng L, 2013, DROSOPHILA INF SERV, V4, pe614; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Harada Y, 2012, CANCER LETT, V319, P83, DOI 10.1016/j.canlet.2011.12.034; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ishii I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00137; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Shibasaki Y, 2005, HYPERTENS RES, V28, P787, DOI 10.1291/hypres.28.787; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951	22	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79374	10.1371/journal.pone.0079374	http://dx.doi.org/10.1371/journal.pone.0079374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223934	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400108
J	Ryan, MA; Whisson, DA; Holland, GJ; Arnould, JPY				Ryan, Michelle A.; Whisson, Desley A.; Holland, Greg J.; Arnould, John P. Y.			Activity Patterns of Free-Ranging Koalas (Phascolarctos cinereus) Revealed by Accelerometry	PLOS ONE			English	Article							METABOLIC-RATE; BEHAVIOR; CAPTIVITY; GOLDFUSS; TIME; ACCELERATION; POPULATIONS; CONSUMPTION; WATER; SIZE	An understanding of koala activity patterns is important for measuring the behavioral response of this species to environmental change, but to date has been limited by the logistical challenges of traditional field methodologies. We addressed this knowledge gap by using tri-axial accelerometer data loggers attached to VHF radio collars to examine activity patterns of adult male and female koalas in a high-density population at Cape Otway, Victoria, Australia. Data were obtained from 27 adult koalas over two 7-d periods during the breeding season: 12 in the early-breeding season in November 2010, and 15 in the late-breeding season in January 2011. Multiple 15 minute observation blocks on each animal were used for validation of activity patterns determined from the accelerometer data loggers. Accelerometry was effective in distinguishing between inactive (sleeping, resting) and active (grooming, feeding and moving) behaviors. Koalas were more active during the early-breeding season with a higher index of movement (overall dynamic body acceleration [ODBA]) for both males and females. Koalas showed a distinct temporal pattern of behavior, with most activity occurring from mid-afternoon to early morning. Accelerometry has potential for examining fine-scale behavior of a wide range of arboreal and terrestrial species.	[Ryan, Michelle A.; Whisson, Desley A.; Holland, Greg J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia	Deakin University	Whisson, DA (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	desley.whisson@deakin.edu.au	Whisson, Desley/V-9422-2019; Holland, Greg/K-9303-2013; Whisson, Desley A/H-9578-2013	Whisson, Desley/0000-0002-4221-0706; Whisson, Desley A/0000-0002-4221-0706				Benesch AR, 2010, BIOL RHYTHM RES, V41, P289, DOI 10.1080/09291010903018164; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; Core R Team, 2012, R LANG ENV STAT COMP; CORK SJ, 1983, J COMP PHYSIOL, V153, P181, DOI 10.1007/BF00689622; DEGABRIELE R, 1979, J COMP PHYSIOL, V134, P293, DOI 10.1007/BF00709996; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis W., 2010, Australian Zoologist, V35, P369; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; Jackson S., 1994, KOALA PHASCOLARCTOS; Jacobi D, 2009, EUR J EPIDEMIOL, V24, P171, DOI 10.1007/s10654-009-9329-8; Johansson HP, 2006, BRIT J NUTR, V95, P631, DOI 10.1079/BJN20051527; Kokubun N, 2011, J EXP BIOL, V214, P3760, DOI 10.1242/jeb.058263; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Larrucea ES, 2009, J MAMMAL, V90, P1176, DOI 10.1644/08-MAMM-A-272.1; Logan M, 2003, AUST J ZOOL, V51, P415, DOI 10.1071/ZO03017; Logan M, 2002, AUST J ZOOL, V50, P281, DOI 10.1071/ZO01022; Marsh KJ, 2007, OECOLOGIA, V154, P283, DOI 10.1007/s00442-007-0828-6; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Mitchell P., 1990, P151; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Papailiou A, 2008, AM J PRIMATOL, V70, P185, DOI 10.1002/ajp.20476; SMITH M, 1980, AUST WILDLIFE RES, V7, P41; SMITH M, 1979, AUST WILDLIFE RES, V6, P117; SMITH M, 1979, AUST WILDLIFE RES, V6, P131; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; SMITH M, 1980, AUST WILDLIFE RES, V7, P35; Stephens D.W., 1986, pi; Taborsky M, 2010, ETHOLOGY, V116, P185, DOI 10.1111/j.1439-0310.2010.01751.x; Takahashi M, 2009, ZOO BIOL, V28, P59, DOI 10.1002/zoo.20212; ULLREY DE, 1981, AUST J ZOOL, V29, P847, DOI 10.1071/ZO9810847; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Whisson DA, 2010, J MAMMAL, V91, P1160, DOI 10.1644/09-MAMM-A-384.1; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	43	20	20	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80366	10.1371/journal.pone.0080366	http://dx.doi.org/10.1371/journal.pone.0080366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224050	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400154
J	Xu, CH; Wang, M; Zhou, L; Quan, TY; Xia, GM				Xu, Chunhui; Wang, Meng; Zhou, Li; Quan, Taiyong; Xia, Guangmin			Heterologous Expression of the Wheat Aquaporin Gene TaTIP2;2 Compromises the Abiotic Stress Tolerance of Arabidopsis thaliana	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; INTRINSIC PROTEINS MIPS; ABSCISIC-ACID; SALT TOLERANCE; FUNCTIONAL-ANALYSIS; PLANT AQUAPORINS; RESPONSIVE GENE; CROSS-TALK; DROUGHT; FAMILY	Aquaporins are channel proteins which transport water across cell membranes. We show that the bread wheat aquaporin gene TaTIP2;2 maps to the long arm of chromosome 7b and that its product localizes to the endomembrane system. The gene is expressed constitutively in both the root and the leaf, and is down-regulated by salinity and drought stress. Salinity stress induced an increased level of C-methylation within the CNG trinucleotides in the TaTIP2; 2 promoter region. The heterologous expression of TaTIP2; 2 in Arabidopsis thaliana compromised its drought and salinity tolerance, suggesting that TaTIP2; 2 may be a negative regulator of abiotic stress. The proline content of transgenic A. thaliana plants fell, consistent with the down-regulation of P5CS1, while the expression of SOS1, SOS2, SOS3, CBF3 and DREB2A, which are all stress tolerance-related genes acting in an ABA-independent fashion, was also down-regulated. The supply of exogenous ABA had little effect either on TaTIP2; 2 expression in wheat or on the phenotype of transgenic A. thaliana. The expression level of the ABA signalling genes ABI1, ABI2 and ABF3 remained unaltered in the transgenic A. thaliana plants. Thus TaTIP2; 2 probably regulates the response to stress via an ABA-independent pathway(s).	[Xu, Chunhui; Wang, Meng; Zhou, Li; Quan, Taiyong; Xia, Guangmin] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan, Shandong, Peoples R China	Shandong University	Xia, GM (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan, Shandong, Peoples R China.	xiagm@sdu.edu.cn			National Transgenic Project of China [20011ZX08002-002]; National Basic Research 973 Program of China [2012CB114200]; Natural Science Foundation of China [30530480]; National Science Foundation of China [91117006]	National Transgenic Project of China; National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Transgenic Project (20011ZX08002-002) of China, National Basic Research 973 Program of China (2012CB114200), the funds of the Major Program of the Natural Science Foundation of China (no. 30530480), and National Science Foundation of China (grant no. 91117006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; De Amicis F, 2007, TRANSGENIC RES, V16, P731, DOI 10.1007/s11248-006-9063-x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Gao YP, 1999, PLANT MOL BIOL, V40, P635, DOI 10.1023/A:1006212216876; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hoagland DR, 1938, WATER CULTURE METHOD, P7; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kawaura Kanako, 2006, Functional & Integrative Genomics, V6, P132, DOI 10.1007/s10142-005-0010-3; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li SO, 2010, PLANT CELL ENVIRON, V33, P117, DOI 10.1111/j.1365-3040.2009.02063.x; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Liu C, 2012, PLANT MOL BIOL, V78, P159, DOI 10.1007/s11103-011-9854-1; Liu JP, 1997, P NATL ACAD SCI USA, V94, P14960, DOI 10.1073/pnas.94.26.14960; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Nongpiur R, 2012, PLANT SIGNAL BEHAV, V7, P1230, DOI 10.4161/psb.21516; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Peng YH, 2007, PLANTA, V226, P729, DOI 10.1007/s00425-007-0520-4; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schussler MD, 2008, PLANT J, V56, P756, DOI 10.1111/j.1365-313X.2008.03632.x; Sears E.R., 1954, MISSOURI AGR EXP STA, V572, P1; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; STEINITZSEARS LM, 1957, GENETICS, V42, P623; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; TROLL W, 1955, J BIOL CHEM, V215, P655; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Xia GM, 2003, THEOR APPL GENET, V107, P299, DOI 10.1007/s00122-003-1247-7; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang J, 2006, FIELD CROPS RES, V97, P9; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P104, DOI 10.1093/abbs/gms096; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	68	44	50	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79618	10.1371/journal.pone.0079618	http://dx.doi.org/10.1371/journal.pone.0079618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223981	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400131
J	Chen, W; Wang, W; Zhu, BB; Guo, H; Sun, Y; Ming, J; Shen, N; Li, Z; Wang, ZL; Liu, LF; Cai, BX; Duan, JY; Li, JY; Liu, C; Zhong, R; Hu, WG; Huang, T; Miao, XP				Chen, Wei; Wang, Wei; Zhu, Beibei; Guo, Hui; Sun, Yu; Ming, Jie; Shen, Na; Li, Zhi; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Hu, Weiguo; Huang, Tao; Miao, Xiaoping			A Functional Variant rs1820453 in YAP1 and Breast Cancer Risk in Chinese Population	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; P73; HETEROZYGOSITY; SUSCEPTIBILITY	Background: To investigate the association between rs1820453 which located in the promoter region of yes-associated protein 1 (YAP1) gene and breast cancer (BC) risk. Method and Findings: We conducted a hospital-based case-control study including a total of 480 BC cases and 545 cancer-free controls in Chinese population. Then the expression quantitative trait locus (e-QTL) analysis was performed to explore the possible function of rs1820453 to the YAP1 gene expression. The association between rs1820453 and BC risk was significantly identified with the odds ratio (OR) was 1.27 (95 % confidence interval (CI)=1.03-1.57) under allelic model when adjusted by age and menopausal status. In addition, the correlation analysis of rs1820453 and YAP1 expression level found that this variant was significantly associated with the gene expression in Chinese population. When compared with level of mRNA expression of the AA genotype (6.011 +/- 0.046), the mRNA expression level in CC genotype (5.903 +/- 0.026) was statistically lower (P=0.024). Conclusion: The results from this study suggested that rs1820453 A>C change may affect the gene expression and contribute to the risk of developing BC in Chinese population though larger sample-size studies along with functional experiments were anticipated to warrant the results.	[Chen, Wei; Zhu, Beibei; Sun, Yu; Shen, Na; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Minist Environm Protect, Minist Educ,Key Lab Environm & Hlth, State Key Lab Environm Hlth Incubat,Key Lab Envir, Wuhan 430074, Peoples R China; [Chen, Wei; Zhu, Beibei; Sun, Yu; Shen, Na; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wang, Wei; Guo, Hui; Ming, Jie; Li, Zhi; Huang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Breast & Thyroid Surg, Wuhan 430074, Peoples R China; [Wang, Wei] Hubei Canc Hosp, Dept Breast Surg, Wuhan, Peoples R China; [Hu, Weiguo] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Minist Environm Protect, Minist Educ,Key Lab Environm & Hlth, State Key Lab Environm Hlth Incubat,Key Lab Envir, Wuhan 430074, Peoples R China.	huangtaowh@163.com; miaoxp@mail.hust.edu.cn	Duan, Jiayu/HCI-7247-2022; 李, 娇元/GVS-6952-2022; miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; Duan, Jiayu/0000-0001-6311-5938	National Natural Science Foundation of China [81001171, 81202094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81001171 and 81202094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; CARTER SL, 1994, CANCER RES, V54, P6270; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; TOMLINSON IPM, 1995, J CLIN PATHOL, V48, P424, DOI 10.1136/jcp.48.5.424; Wu C, 2010, CANCER RES, V70, P9721, DOI 10.1158/0008-5472.CAN-10-1493; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108	20	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79056	10.1371/journal.pone.0079056	http://dx.doi.org/10.1371/journal.pone.0079056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223879	gold, Green Submitted, Green Published			2022-12-25	WOS:000326499300049
J	Robert, MC; Furlan, G; Rosso, N; Gambaro, SE; Apitsionak, F; Vianello, E; Tiribelli, C; Gazzin, S				Robert, Maria Celeste; Furlan, Giulia; Rosso, Natalia; Gambaro, Sabrina Eliana; Apitsionak, Faina; Vianello, Eleonora; Tiribelli, Claudio; Gazzin, Silvia			Alterations in the Cell Cycle in the Cerebellum of Hyperbilirubinemic Gunn Rat: A Possible Link with Apoptosis?	PLOS ONE			English	Article							BILIRUBIN INDUCES APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE; PROTEOLYTIC CLEAVAGE; CORTICAL-NEURONS; NERVOUS-SYSTEM; ANIMAL-MODEL; HYPOPLASIA; TOXICITY; ENCEPHALOPATHY; KERNICTERUS	Severe hyperbilirubinemia causes neurological damage both in humans and rodents. The hyperbilirubinemic Gunn rat shows a marked cerebellar hypoplasia. More recently bilirubin ability to arrest the cell cycle progression in vascular smooth muscle, tumour cells, and, more importantly, cultured neurons has been demonstrated. However, the involvement of cell cycle perturbation in the development of cerebellar hypoplasia was never investigated before. We explored the effect of sustained spontaneous hyperbilirubinemia on cell cycle progression and apoptosis in whole cerebella dissected from 9 day old Gunn rat by Real Time PCR, Western blot and FACS analysis. The cerebellum of the hyperbilirubinemic Gunn rats exhibits an increased cell cycle arrest in the late G0/G1 phase (p < 0.001), characterized by a decrease in the protein expression of cyclin D1 (15%, p < 0.05), cyclin A/A1 (20 and 30%, p < 0.05 and 0.01, respectively) and cyclin dependent kinases2 (25%, p < 0.001). This was associated with a marked increase in the 18 kDa fragment of cyclin E (67%, p < 0.001) which amplifies the apoptotic pathway. In line with this was the increase of the cleaved form of Poly (ADP-ribose) polymerase (54%, p < 0.01) and active Caspase3 (two fold, p < 0.01). These data indicate that the characteristic cerebellar alteration in this developing brain structure of the hyperbilirubinemic Gunn rat may be partly due to cell cycle perturbation and apoptosis related to the high bilirubin concentration in cerebellar tissue mainly affecting granular cells. These two phenomena might be intimately connected.	[Robert, Maria Celeste; Furlan, Giulia; Rosso, Natalia; Gambaro, Sabrina Eliana; Apitsionak, Faina; Vianello, Eleonora; Tiribelli, Claudio; Gazzin, Silvia] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	University of Trieste	Gazzin, S (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy.	silvia.gazzin@csf.units.it	Rosso, Natalia/K-9035-2016; Tiribelli, Claudio/A-4716-2014; Vianello, Eleonora/Y-2458-2018	Rosso, Natalia/0000-0002-4251-3547; Tiribelli, Claudio/0000-0001-6596-7595; Vianello, Eleonora/0000-0003-0342-4055	Italian Ministry of Foreign Affairs, Rome, Italy; Italian Liver Foundation; Regione Friuli Venezia Giulia [Fondo Regionale FVG LR26/2005]; Telethon [GGP10051]	Italian Ministry of Foreign Affairs, Rome, Italy; Italian Liver Foundation; Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Telethon(Fondazione Telethon)	MCR and SEG were supported by a PhD fellowship from the Italian Ministry of Foreign Affairs, Rome, Italy. SG, NR were supported by a in house grant of the Italian Liver Foundation. The work was supported by grants from Regione Friuli Venezia Giulia [Fondo Regionale FVG LR26/2005] and from Telethon (GGP10051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Ahlfors CE, 2001, BIOL NEONATE, V80, P158, DOI 10.1159/000047136; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2012, J CHILD NEUROL, V27, P615, DOI 10.1177/0883073811423975; Bulmer AC, 2013, PROG LIPID RES, V52, P193, DOI 10.1016/j.plipres.2012.11.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Calligaris S, 2006, FEBS LETT, V580, P1355, DOI 10.1016/j.febslet.2006.01.056; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; Clarke DJ, 1997, CLIN CHIM ACTA, V266, P63, DOI 10.1016/S0009-8981(97)00167-8; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; Daood MJ, 2006, PEDIATR RES, V60, P44, DOI 10.1203/01.pdr.0000219561.07550.04; Deganuto M, 2010, PROTEOMICS, V10, P1645, DOI 10.1002/pmic.200900579; EHRLICH P, 1883, CENTR KLIN MED, V4, P721; Falcao AS, 2007, J NEUROSCI RES, V85, P1229, DOI 10.1002/jnr.21227; Falcao AS, 2006, ACTA NEUROPATHOL, V112, P95, DOI 10.1007/s00401-006-0078-4; Falcao AS, 2013, NEUROCHEM RES, V38, P644, DOI 10.1007/s11064-012-0963-2; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; GAZZIN S, 2012, PEDIAT RES UNPUB; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Giraudi PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029078; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Heinlein C., 2011, CURR PROTOC CYTOM, V7, DOI DOI 10.1002/0471142956.CY0739S56.PUBMED:21455969; Heinlein C, 2010, CELL CYCLE, V9, P3584, DOI 10.4161/cc.9.17.12831; HUANG PWH, 1970, ARCH PATHOL, V90, P536; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lee YK, 2009, PEDIATR INT, V51, P795, DOI 10.1111/j.1442-200X.2009.02878.x; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Mazumder S, 2007, CELL CYCLE, V6, P1437; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MIKOSHIBA K, 1982, J NEUROCHEM, V39, P1028, DOI 10.1111/j.1471-4159.1982.tb11492.x; MIKOSHIBA K, 1980, J NEUROCHEM, V35, P1309, DOI 10.1111/j.1471-4159.1980.tb09003.x; Mitchell PJ, 2007, J NEUROSCI METH, V164, P350, DOI 10.1016/j.jneumeth.2007.04.021; Ollinger R, 2007, CELL CYCLE, V6, P3078, DOI 10.4161/cc.6.24.5022; Ollinger R, 2007, CELL CYCLE, V6, P39, DOI 10.4161/cc.6.1.3700; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Ostrow JD, 2007, TRANSL RES, V149, P37, DOI 10.1016/j.trsl.2006.07.006; Ostrow JD, 2003, PEDIATR RES, V54, P926, DOI 10.1203/01.PDR.0000103388.01854.91; Peyton KJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00048; Plesca D, 2008, J BIOL CHEM, V283, P30796, DOI 10.1074/jbc.M804642200; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Rao P, 2006, BIOCHEM BIOPH RES CO, V342, P1279, DOI 10.1016/j.bbrc.2006.02.074; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, J LIPID RES, V43, P885; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rodrigues CMP, 2002, PEDIATR RES, V51, P112, DOI 10.1203/00006450-200201000-00020; SAWASAKI Y, 1973, P JPN ACAD, V49, P840, DOI 10.2183/pjab1945.49.840; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; Servedio V, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9322; Shapiro SM, 2010, SEMIN FETAL NEONAT M, V15, P157, DOI 10.1016/j.siny.2009.12.004; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Stoeckius M, 2012, J BIOL CHEM, V287, P15418, DOI 10.1074/jbc.M111.266510; Tabarki B, 2002, PEDIATR NEUROL, V27, P234, DOI 10.1016/S0887-8994(02)00425-3; TAKAGISHI Y, 1989, BRAIN RES, V492, P116, DOI 10.1016/0006-8993(89)90894-9; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wallner M, 2013, CLIN SCI, V125, P257, DOI 10.1042/CS20120661; Wingate H, 2003, CELL CYCLE, V2, P461, DOI 10.4161/cc.2.5.464; Yamamura H, 1993, Nagoya J Med Sci, V55, P11; YEARY RA, 1971, LAB ANIM SCI, V21, P362; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005	76	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79073	10.1371/journal.pone.0079073	http://dx.doi.org/10.1371/journal.pone.0079073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223883	gold, Green Published, Green Submitted			2022-12-25	WOS:000326499300053
J	Sun, HW; Leng, TD; Zeng, Z; Gao, XR; Inoue, K; Xiong, ZG				Sun, Huawei; Leng, Tiandong; Zeng, Zhao; Gao, Xiuren; Inoue, Koichi; Xiong, Zhi-Gang			Role of TRPM7 Channels in Hyperglycemia-Mediated Injury of Vascular Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HIGH GLUCOSE; OXIDATIVE STRESS; NEURONAL DEATH; SMOOTH-MUSCLE; KEY ROLE; DYSFUNCTION; EXPRESSION; DISEASE; KINASE	This study investigated the change of transient receptor potential melastatin 7 (TRPM7) expression by high glucose and its role in hyperglycemia induced injury of vascular endothelial cells. Human umbilical vein endothelial cells (HUVECs) were incubated in the presence or absence of high concentrations of D-glucose (HG) for 72h. RT-PCR, Real-time PCR, Western blotting, Immunofluorescence staining and whole-cell patch-clamp recordings showed that TRPM7 mRNA, TRPM7 protein expression and TRPM7-like currents were increased in HUVECs following exposure to HG. In contrast to D-glucose, exposure of HUVECs to high concentrations of L-glucose had no effect. HG increased reactive oxygen species (ROS) generation, cytotoxicity and decreased endothelial nitric oxide synthase protein expression, which could be attenuated by knockdown of TRPM7 with TRPM7 siRNA. The protective effect of silencing TRPM7 against HG induced endothelial injury was abolished by U0126, an inhibitor of the extracellular signal-regulated kinase signaling pathway. These observations suggest that TRPM7 channels play an important role in hyperglycemia-induced injury of vascular endothelial cells.	[Sun, Huawei; Gao, Xiuren] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Huawei; Leng, Tiandong; Zeng, Zhao; Inoue, Koichi; Xiong, Zhi-Gang] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	Sun Yat Sen University; Morehouse School of Medicine	Gao, XR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	xiurengao@163.com; ZXiong@msm.edu			National Institute of Health [R01NS066027]; National Institute on Minority Health and Health Disparities [S21MD000101, U54RR026137]; American Heart Association [0840132N]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066027] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (R01NS066027), The National Institute on Minority Health and Health Disparities (S21MD000101, U54RR026137), and American Heart Association (0840132N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Ametov AS, 2012, TERAPEVT ARKH, V84, P91; Baldoli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059891; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Brinkmann C, 2011, WIEN MED WOCHENSCHR, V161, P305, DOI 10.1007/s10354-011-0868-8; BUSCONI L, 1995, MOL PHARMACOL, V47, P655; Cheang WS, 2011, CARDIOVASC RES, V92, P267, DOI 10.1093/cvr/cvr233; Chen HC, 2012, BIOCHEM J, V445, P441, DOI 10.1042/BJ20120248; Dhar I, 2012, J PHARMACOL EXP THER, V342, P196, DOI 10.1124/jpet.112.192112; Dietrich A, 2006, PHARMACOL THERAPEUT, V112, P744, DOI 10.1016/j.pharmthera.2006.05.013; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x; Hecquet CM, 2010, ADV EXP MED BIOL, V661, P155, DOI 10.1007/978-1-60761-500-2_10; Heikkinen M, 2007, EUR J VASC ENDOVASC, V33, P583, DOI 10.1016/j.ejvs.2007.01.012; Ho FM, 1999, J CELL BIOCHEM, V75, P258, DOI 10.1002/(SICI)1097-4644(19991101)75:2<258::AID-JCB8>3.0.CO;2-3; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Noyman I, 2002, NITRIC OXIDE-BIOL CH, V7, P187, DOI 10.1016/S1089-8603(02)00106-4; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sansbury BE, 2012, CIRC RES, V111, P1176, DOI [10.1161/circresaha.112.266395, 10.1161/CIRCRESAHA.112.266395]; Sasaki S, 2012, DIABETES METAB J, V36, P255, DOI 10.4093/dmj.2012.36.4.255; Shehata M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-7; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Sun JX, 2002, P NATL ACAD SCI USA, V99, P13108, DOI 10.1073/pnas.202260999; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhu MM, 2012, ANESTH ANALG, V114, P303, DOI 10.1213/ANE.0b013e31823f0c42	43	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79540	10.1371/journal.pone.0079540	http://dx.doi.org/10.1371/journal.pone.0079540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223965	Green Submitted, gold, Green Published			2022-12-25	WOS:000326499300088
J	Casey, MF; Neidell, M				Casey, Martin F.; Neidell, Matthew			Disconcordance in Statistical Models of Bisphenol A and Chronic Disease Outcomes in NHANES 2003-08	PLOS ONE			English	Article							HUMAN EXPOSURE; ENDOCRINE DISRUPTORS; NATIONAL-HEALTH; US POPULATION; URINARY; ASSOCIATION; VARIABILITY; SAMPLES; ADULTS	Background: Bisphenol A (BPA), a high production chemical commonly found in plastics, has drawn great attention from researchers due to the substance's potential toxicity. Using data from three National Health and Nutrition Examination Survey (NHANES) cycles, we explored the consistency and robustness of BPA's reported effects on coronary heart disease and diabetes. Methods And Findings: We report the use of three different statistical models in the analysis of BPA: (1) logistic regression, (2) log-linear regression, and (3) dose-response logistic regression. In each variation, confounders were added in six blocks to account for demographics, urinary creatinine, source of BPA exposure, healthy behaviours, and phthalate exposure. Results were sensitive to the variations in functional form of our statistical models, but no single model yielded consistent results across NHANES cycles. Reported ORs were also found to be sensitive to inclusion/exclusion criteria. Further, observed effects, which were most pronounced in NHANES 2003-04, could not be explained away by confounding. Conclusions: Limitations in the NHANES data and a poor understanding of the mode of action of BPA have made it difficult to develop informative statistical models. Given the sensitivity of effect estimates to functional form, researchers should report results using multiple specifications with different assumptions about BPA measurement, thus allowing for the identification of potential discrepancies in the data.	[Casey, Martin F.; Neidell, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Casey, Martin F.] Icahn Sch Med Mt Sinai, New York, NY USA	Columbia University; Icahn School of Medicine at Mount Sinai	Casey, MF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	martin.casey@mssm.edu		Casey, Martin/0000-0002-5049-012X				Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; [Anonymous], 2008, NBC NEWS; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BICK J, 2006, NY TIMES; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bolt HM, 2011, ARCH TOXICOL, V85, P1491, DOI 10.1007/s00204-011-0785-z; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat A. M., 2010, LAB PROCEDURE MANUAL; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; *CDC, 2005, AN REP GUID NAT HLTH; CDC, 2011, NATL HLTH NUTR EXAMI; Cooper JE, 2011, CHEMOSPHERE, V85, P943, DOI 10.1016/j.chemosphere.2011.06.060; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Hu WY, 2012, MOL CELL ENDOCRINOL, V354, P63, DOI 10.1016/j.mce.2011.08.032; Kelland K., 2010, REUTERS; Koch HM, 2012, J EXPO SCI ENV EPID, V22, P610, DOI 10.1038/jes.2012.39; LaKind JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051086; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Mariscal-Arcas M, 2009, FOOD CHEM TOXICOL, V47, P506, DOI 10.1016/j.fct.2008.12.011; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; *NAT CTR HLTH STAT, 2009, DAT DOC COD FREQ UR, P2007; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Noonan GO, 2011, J AGR FOOD CHEM, V59, P7178, DOI 10.1021/jf201076f; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; SEABROOK A, 2007, IS CHEM PLASTIC BOTT; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Spivey A, 2009, ENVIRON HEALTH PERSP, V117, pA541, DOI 10.1289/ehp.117-a541; Steenland K, 2011, ENVIRON HEALTH PERSP, V119, P831, DOI 10.1289/ehp.1002521; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teppala S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/598180; Vaidya SV, 2012, J ASTHMA, V49, P800, DOI 10.3109/02770903.2012.721041; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Whitcomb BW, 2008, PAEDIATR PERINAT EP, V22, P597, DOI 10.1111/j.1365-3016.2008.00969.x; Yan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025455; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	50	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79944	10.1371/journal.pone.0079944	http://dx.doi.org/10.1371/journal.pone.0079944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223205	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200098
J	Wang, ZJ; Lakes, RS; Golob, M; Eickhoff, JC; Chesler, NC				Wang, Zhijie; Lakes, Roderic S.; Golob, Mark; Eickhoff, Jens C.; Chesler, Naomi C.			Changes in Large Pulmonary Arterial Viscoelasticity in Chronic Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC HYPOXIA; MECHANICAL-PROPERTIES; VENTRICULAR-FUNCTION; ELASTIC PROPERTIES; COLLAGEN-FIBERS; WAVE REFLECTION; CONSCIOUS DOGS; IN-VIVO; WALL; PRESSURE	Conduit pulmonary artery (PA) stiffening is characteristic of pulmonary arterial hypertension (PAH) and is an excellent predictor of mortality due to right ventricular (RV) overload. To better understand the impact of conduit PA stiffening on RV afterload, it is critical to examine the arterial viscoelastic properties, which require measurements of elasticity (energy storage behavior) and viscosity (energy dissipation behavior). Here we hypothesize that PAH leads to frequency-dependent changes in arterial stiffness (related to elasticity) and damping ratio (related to viscosity) in large PAs. To test our hypothesis, PAH was induced by the combination of chronic hypoxia and an antiangiogenic compound (SU5416) treatment in mice. Static and sinusoidal pressure-inflation tests were performed on isolated conduit PAs at various frequencies (0.01-20 Hz) to obtain the mechanical properties in the absence of smooth muscle contraction. Static mechanical tests showed significant stiffening of large PAs with PAH, as expected. In dynamic mechanical tests, structural stiffness (kappa) increased and damping ratio (D) decreased at a physiologically relevant frequency (10 Hz) in hypertensive PAs. The dynamic elastic modulus (E), a material stiffness, did not increase significantly with PAH. All dynamic mechanical properties were strong functions of frequency. In particular, kappa, E and D increased with increasing frequency in control PAs. While this behavior remained for D in hypertensive PAs, it reversed for kappa and E. Since these novel dynamic mechanical property changes were found in the absence of changes in smooth muscle cell content or contraction, changes in collagen and proteoglycans and their interactions are likely critical to arterial viscoelasticity in a way that has not been previously described. The impact of these changes in PA viscoelasticity on RV afterload in PAH awaits further investigation.	[Wang, Zhijie; Lakes, Roderic S.; Chesler, Naomi C.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA; [Lakes, Roderic S.] Univ Wisconsin, Dept Engn Phys, Madison, WI USA; [Lakes, Roderic S.; Golob, Mark] Univ Wisconsin, Dept Mat Sci, Madison, WI USA; [Eickhoff, Jens C.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chesler, NC (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA.	chesler@engr.wisc.edu	; Stefanadis, Christodoulos/ABH-2232-2020	Chesler, Naomi/0000-0002-7612-5796; Stefanadis, Christodoulos/0000-0001-5974-6454	NIH [R01 HL086939]; AHA Midwest Affiliate Postdoctoral Fellowship [10POST2640148]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Midwest Affiliate Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by NIH R01 HL086939 (NCC) and AHA Midwest Affiliate Postdoctoral Fellowship 10POST2640148 (ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshima D, 2009, J PHARMACOL SCI, V110, P182, DOI 10.1254/jphs.09059FP; Armentano RL, 2007, IEEE ENG MED BIOL, V26, P62, DOI 10.1109/MEMB.2007.289123; Armentano RL, 2006, HYPERTENSION, V47, P384, DOI 10.1161/01.HYP.0000205915.15940.15; ARMENTANO RL, 1995, CIRC RES, V76, P468, DOI 10.1161/01.RES.76.3.468; Armentano RL, 1998, HYPERTENSION, V31, P534, DOI 10.1161/01.HYP.31.1.534; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P458, DOI 10.1113/jphysiol.1961.sp006687; BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686; Bhatia A, 2005, P ANN INT IEEE EMBS, P2979, DOI 10.1109/IEMBS.2005.1617099; BRODT M, 1995, REV SCI INSTRUM, V66, P5292, DOI 10.1063/1.1146101; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; COX RH, 1984, AM J PHYSIOL, V246, pH90, DOI 10.1152/ajpheart.1984.246.1.H90; Danpinid A, 2010, ULTRASONICS, V50, P654, DOI 10.1016/j.ultras.2010.01.003; Dourte LM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006200; Elliott DM, 2003, ANN BIOMED ENG, V31, P599, DOI 10.1114/1.1567282; FOURIE PR, 1992, CARDIOVASC RES, V26, P839, DOI 10.1093/cvr/26.9.839; Gamero LG, 2001, EXP PHYSIOL, V86, P519, DOI 10.1113/eph8602172; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Gomez-Arroyo J, 2012, AM J PHYSIOL-LUNG C, V302, pL977, DOI 10.1152/ajplung.00362.2011; Grignola JC, 2007, INT J CARDIOL, V115, P171, DOI 10.1016/j.ijcard.2006.03.007; Hunter KS, 2010, J APPL PHYSIOL, V108, P968, DOI 10.1152/japplphysiol.01173.2009; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Kawut SM, 2005, AM J CARDIOL, V95, P199, DOI 10.1016/j.amjcard.2004.09.006; Kobs RW, 2005, AM J PHYSIOL-HEART C, V288, pH1209, DOI 10.1152/ajpheart.01129.2003; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lammers SR, 2008, AM J PHYSIOL-HEART C, V295, pH1451, DOI 10.1152/ajpheart.00127.2008; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; Lee T, 2000, REV SCI INSTRUM, V71, P2855, DOI 10.1063/1.1150703; Li LP, 2004, BIORHEOLOGY, V41, P181; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Lichtenstein O, 1998, HYPERTENSION, V32, P346, DOI 10.1161/01.HYP.32.2.346; Liu Q, 2012, J BIOMECH, V45, P1192, DOI 10.1016/j.jbiomech.2012.01.035; Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; Mangoni AA, 1996, J HYPERTENS, V14, P897, DOI 10.1097/00004872-199607000-00013; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Naeije R, 2007, REV MAL RESPIR, V24, P481, DOI 10.1016/S0761-8425(07)91571-5; Naeije Robert, 2005, Ital Heart J, V6, P784; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Ooi CY, 2010, AM J PHYSIOL-HEART C, V299, pH1823, DOI 10.1152/ajpheart.00493.2009; OROURKE MF, 1993, J HYPERTENS, V11, P327, DOI 10.1097/00004872-199304000-00001; Pagnamenta A, 2010, J APPL PHYSIOL, V109, P1080, DOI 10.1152/japplphysiol.00467.2010; Quarck R, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-27; Robinson PS, 2004, J BIOMECH ENG-T ASME, V126, P252, DOI 10.1115/1.1695570; Sakao S, 2011, RESPIRATION, V81, P253, DOI 10.1159/000322011; Santana DB, 2005, J APPL PHYSIOL, V98, P605, DOI 10.1152/japplphysiol.00361.2004; Silver FH, 2002, CONNECT TISSUE RES, V43, P569, DOI 10.1080/03008200290001302; Stefanadis C, 1997, CIRCULATION, V96, P1853, DOI 10.1161/01.CIR.96.6.1853; Tabima DM, 2012, J BIOMECH, V45, P799, DOI 10.1016/j.jbiomech.2011.11.020; Tabima DM, 2010, AM J PHYSIOL-HEART C, V299, pH2069, DOI 10.1152/ajpheart.00805.2010; Tabima DM, 2010, J BIOMECH, V43, P1864, DOI 10.1016/j.jbiomech.2010.03.033; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; TAYLOR MG, 1966, BIOPHYS J, V6, P697, DOI 10.1016/S0006-3495(66)86689-4; Tian L, 2012, ANN BIOMED ENG, V40, P1419, DOI 10.1007/s10439-012-0509-4; Tian L, 2011, AM J PHYSIOL-HEART C, V301, pH1810, DOI 10.1152/ajpheart.00025.2011; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Wang Z, 2012, EFFECTS COL IN PRESS; Wang ZJ, 2012, BIOMECH MODEL MECHAN, V11, P279, DOI 10.1007/s10237-011-0309-z; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yuan XJ, 2011, TXB PULMONARY VASCUL; Zhao JB, 2002, AM J PHYSIOL-HEART C, V282, pH622, DOI 10.1152/ajpheart.00620.2000	66	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78569	10.1371/journal.pone.0078569	http://dx.doi.org/10.1371/journal.pone.0078569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223157	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200049
J	Xu, YF; Li, H; Chen, W; Yao, XM; Xing, Y; Wang, X; Zhong, J; Meng, GX				Xu, Yongfen; Li, Hua; Chen, Wei; Yao, Xiaomin; Xing, Yue; Wang, Xun; Zhong, Jin; Meng, Guangxun			Mycoplasma hyorhinis Activates the NLRP3 Inflammasome and Promotes Migration and Invasion of Gastric Cancer Cells	PLOS ONE			English	Article							MALIGNANT-TRANSFORMATION; MEMBRANE LIPOPROTEINS; INTERLEUKIN-18; P37; INFECTIONS; INVASIVENESS; METASTASIS; CARCINOMA; GROWTH; SERUM	Background: Mycoplasma hyorhinis (M.hyorhinis, M.hy) is associated with development of gastric and prostate cancers. The NLRP3 inflammasome, a protein complex controlling maturation of important pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18, is also involved in tumorigenesis and metastasis of various cancers. Methodology/Principal Findings: To clarify whether M.hy promoted tumor development via inflammasome activation, we analyzed monocytes for IL-1 beta and IL-18 production upon M.hy challenge. When exposed to M.hy, human monocytes exhibited rapid and robust IL-1 beta and IL-18 secretion. We further identified that lipid-associated membrane protein (LAMP) from M.hy was responsible for IL-1 beta induction. Applying competitive inhibitors, gene specific shRNA and gene targeted mice, we verified that M.hy induced IL-1 beta secretion was NLRP3-dependent in vitro and in vivo. Cathepsin B activity, K+ efflux, Ca2+ influx and ROS production were all required for the NLRP3 inflammasome activation by M.hy. Importantly, it is IL-1 beta but not IL-18 produced from macrophages challenged with M.hy promoted gastric cancer cell migration and invasion. Conclusions: Our data suggest that activation of the NLRP3 inflammasome by M.hy may be associated with its promotion of gastric cancer metastasis, and anti-M.hy therapy or limiting NLRP3 signaling could be effective approach for control of gastric cancer progress.	[Xu, Yongfen; Li, Hua; Chen, Wei; Yao, Xiaomin; Xing, Yue; Zhong, Jin; Meng, Guangxun] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wang, Xun] Shanghai Blood Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	jzhong@sibs.ac.cn; gxmeng@sibs.ac.cn	Xu, Yongfen/CAF-5582-2022; li, hua/I-1881-2016; Zhong, Jin/M-6859-2018	Xu, Yongfen/0000-0002-2845-7753; li, hua/0000-0001-6367-4764; xing, yue/0000-0001-5845-2286; Zhong, Jin/0000-0002-3554-1275	Chinese Academy of Sciences; Natural Science Foundation of China [91029707, 31170868]; Shanghai Natural Science foundation [11ZR1442600]; Novo Nordisk-CAS Research Foundation; SA-SIBS Scholarship Program; National Key Programs on Infectious Disease [2012ZX10002007-003]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science foundation(Natural Science Foundation of Shanghai); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); SA-SIBS Scholarship Program; National Key Programs on Infectious Disease	This work was supported by grants from 100 Talent Program of the Chinese Academy of Sciences, Natural Science Foundation of China (91029707, 31170868), Shanghai Natural Science foundation (11ZR1442600), Novo Nordisk-CAS Research Foundation, SA-SIBS Scholarship Program, as well as grants from the National Key Programs on Infectious Disease (2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chow MT, 2012, IMMUNOL CELL BIOL; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Hernandez L, 2009, METHODS MOL BIOL, V571, P227, DOI 10.1007/978-1-60761-198-1_15; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kang JS, 2009, CARCINOGENESIS, V30, P1987, DOI 10.1093/carcin/bgp158; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Kornspan JD, 2012, FEMS MICROBIOL LETT; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lebel-Binay S, 2000, EUR CYTOKINE NETW, V11, P15; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lei G, 2013, CELL RES; Liu WB, 2007, CAN J MICROBIOL, V53, P270, DOI 10.1139/W06-120; Lo SC, 1992, AM SOC MICROBIOL, P525; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; NOELLE RJ, 1992, ADV EXP MED BIOL, V323, P131; Osawa R, 2011, J INFECTION, V62, P119, DOI 10.1016/j.jinf.2010.10.002; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rawadi G, 1996, INFECT IMMUN, V64, P637, DOI 10.1128/IAI.64.2.637-643.1996; Rawadi G, 1998, J IMMUNOL, V160, P1330; ROBERTS ED, 1962, CORNELL VET, V52, P306; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sung HR, 2006, J MICROBIOL, V44, P42; Tanaka F, 2000, CANCER RES, V60, P4838; Thong-Ngam D, 2006, WORLD J GASTROENTERO, V12, P4473, DOI 10.3748/wjg.v12.i28.4473; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; WAITES KB, 1999, MANUAL CLIN MICROBIO, pCH56; Yamanaka N, 2004, CLIN CANCER RES, V10, P1853, DOI 10.1158/1078-0432.CCR-03-0300; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yang J, 2003, MICROB PATHOGENESIS, V34, P17, DOI 10.1016/S0882-4010(02)00190-0; Zhang B, 2004, LEUKEMIA RES, V28, P91, DOI 10.1016/S0145-2126(03)00121-8; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	62	58	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77955	10.1371/journal.pone.0077955	http://dx.doi.org/10.1371/journal.pone.0077955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223129	Green Published, Green Submitted, gold			2022-12-25	WOS:000326656200021
J	Aboul-Enein, F; Seifert-Held, T; Mader, S; Kuenz, B; Lutterotti, A; Rauschka, H; Rommer, P; Leutmezer, F; Vass, K; Flamm-Horak, A; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Heller, T; Eggers, C; Safoschnik, G; Fuchs, S; Kraus, J; Assar, H; Guggenberger, S; Reisz, M; Schnabl, P; Komposch, M; Simschitz, P; Skrobal, A; Moser, A; Jeschow, M; Stadlbauer, D; Freimuueller, M; Guger, M; Schmidegg, S; Franta, C; Weiser, V; Koppi, S; Niederkorn-Duft, M; Raber, B; Schmeissner, I; Jecel, J; Tinchon, A; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W				Aboul-Enein, Fahmy; Seifert-Held, Thomas; Mader, Simone; Kuenz, Bettina; Lutterotti, Andreas; Rauschka, Helmut; Rommer, Paulus; Leutmezer, Fritz; Vass, Karl; Flamm-Horak, Agathe; Stepansky, Robert; Lang, Wilfried; Fertl, Elisabeth; Schlager, Thomas; Heller, Thomas; Eggers, Christian; Safoschnik, Georg; Fuchs, Siegrid; Kraus, Joerg; Assar, Hamid; Guggenberger, Stefan; Reisz, Martin; Schnabl, Peter; Komposch, Martina; Simschitz, Philipp; Skrobal, Alena; Moser, Alexander; Jeschow, Mario; Stadlbauer, Dorothea; Freimueller, Manfred; Guger, Michael; Schmidegg, Susanne; Franta, Claudia; Weiser, Vera; Koppi, Stefan; Niederkorn-Duft, Margret; Raber, Bettina; Schmeissner, Iris; Jecel, Julia; Tinchon, Alexander; Storch, Maria K.; Reindl, Markus; Berger, Thomas; Kristoferitsch, Wolfgang			Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People	PLOS ONE			English	Article							EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; DIFFERENTIAL-DIAGNOSIS; CEREBROSPINAL-FLUID; MYASTHENIA-GRAVIS; CLINICAL-COURSE; ANTIBODY; MRI; MULTICENTER; AQUAPORIN-4	Background:In 2008 the Austrian Task Force for Neuromyelitis Optica (NMO) started a nation-wide network for information exchange and multi-centre collaboration. Their aim was to detect all patients with NMO or NMO spectrum disorders (NMO-SD) in Austria and to analyse their disease courses and response to treatment. Methods:(1) As of March 2008, 1957 serum samples (of 1557 patients) have been tested with an established cell based immunofluorescence aquaporin-4 antibody (AQP4-ab) assay with a high sensitivity and specificity (both >95%). All tests were performed in a single reference laboratory (Clinical Dept. of Neurology of the Innsbruck Medical University). (2) A nation-wide survey with several calls for participation (via email newsletters, articles in the official journal of the Austrian Society of Neurology, and workshops) was initiated in 2008. All collected data will be presented in a way that allows that every individual patient can be traced back in order to ensure transparency and to avoid any data distortion in future meta-analyses. The careful and detailed presentation allows the visualization and comparison of the different disease courses in real time span. Failure and response to treatment are made visible at one glance. Database closure was 31 December 2011. All co-operators were offered co-authorship. Results:All 71 NMO- or NMO-SD patients with AQP4-ab positivity (age range 12.3 to 79.6 years) were analysed in detail. Sex ratio (m:f = 1:7) and the proportion of patients without oligoclonal bands in cerebrospinal fluid (86.6%) were in line with previously published results. All identified patients were Caucasians. Conclusions:A nationwide collaboration amongst Austrian neurologists with good network communications made it possible to establish a database of 71 AQP4-ab positive patients with NMO/NMO-SD. This database is presented in detail and provides the basis for further studies and international cooperation in order to investigate this rare disease.	[Aboul-Enein, Fahmy; Rauschka, Helmut; Jecel, Julia; Kristoferitsch, Wolfgang] Donauspital, Sozial Med Zentrum Ost, Dept Neurol, Vienna, Austria; [Aboul-Enein, Fahmy; Rauschka, Helmut; Kristoferitsch, Wolfgang] Karl Landsteiner Inst Neuroimmunol & Neurodegener, Dept Neurol, Vienna, Austria; [Seifert-Held, Thomas; Fuchs, Siegrid; Storch, Maria K.] Med Univ Graz, Dept Neurol, Graz, Austria; [Mader, Simone; Kuenz, Bettina; Lutterotti, Andreas; Reindl, Markus; Berger, Thomas] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria; [Rommer, Paulus; Leutmezer, Fritz; Vass, Karl] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Flamm-Horak, Agathe; Stepansky, Robert; Lang, Wilfried] Krankenhaus Barmherzigen Bruder, Dept Neurol, Vienna, Austria; [Fertl, Elisabeth; Schlager, Thomas; Heller, Thomas] Krankenanstalt Rudolfstiftung Wien, Dept Neurol, Vienna, Austria; [Eggers, Christian] Konventspital Barmherzige Bruder, Dept Neurol, Linz, Austria; [Safoschnik, Georg] Krankenhaus Hietzing, Neurologischem Zentrum Rosenhugel, Dept Neurol, Vienna, Austria; [Kraus, Joerg] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Assar, Hamid; Guggenberger, Stefan] Landes Nervenklin Wagner Jauregg, Dept Neurol, Linz, Austria; [Reisz, Martin] Landeskrankenhaus Steyr, Dept Neurol, Steyr, Austria; [Schnabl, Peter] Hosp Mariahilf, Humanomed Hosp, Private Hosp Mariahilf, Dept Neurol, Klagenfurt, Austria; [Komposch, Martina; Simschitz, Philipp] Klinikum Klagenfurt, Dept Neurol, Klagenfurt, Austria; [Skrobal, Alena] Landesklinikum Horn, Dept Neurol, Horn, Austria; [Moser, Alexander] Neurol Therapiezentrum Kapfenberg, Dept Neurol, Kapfenberg, Austria; [Jeschow, Mario; Stadlbauer, Dorothea] Krankenhaus Barmherzigen Schwestern Ried, Dept Neurol, Ried, Austria; [Freimueller, Manfred] Gailtal Klin Hermagor, Dept Neurol, Hermagor, Austria; [Guger, Michael; Schmidegg, Susanne] Allgemeines Krankenhaus Stadt Linz, Dept Neurol, Linz, Austria; [Franta, Claudia] Landesklinikum St Polten, Dept Neurol, St Polten, Austria; [Weiser, Vera; Koppi, Stefan] Landeskrankenhaus Rankweil, Dept Neurol, Rankweil, Austria; [Niederkorn-Duft, Margret; Raber, Bettina] Landeskrankenhaus Judenburg Knittelfeld, Dept Neurol, Knittelfeld, Austria; [Schmeissner, Iris] Landeskrankenhaus Vocklabruck, Dept Neurol, Vocklabruck, Austria; [Tinchon, Alexander] Sud Kaiser Franz Josef Spital, Sozialmed Zentrum, Dept Neurol, Vienna, Austria	Donauspital; Medical University of Graz; Medical University of Innsbruck; Medical University of Vienna; Konventhospital Der Barmherzigen Bruder; Rudolfstiftung Hospital; Konventhospital Der Barmherzigen Bruder; Hietzing Hospital; Paracelsus Private Medical University; Kepler University Hospital; Konventhospital Der Barmherzigen Bruder; Kepler University Hospital	Aboul-Enein, F (corresponding author), Donauspital, Sozial Med Zentrum Ost, Dept Neurol, Vienna, Austria.	fahmy.aboulenein@meduniwien.ac.at	Reindl, Markus/ABE-5880-2020	Mader, Simone/0000-0002-2844-9091; Berger, Thomas/0000-0001-5626-1144; Reindl, Markus/0000-0003-2817-1402; Tinchon, Alexander/0000-0001-6665-2990	Austrian Multiple Sclerosis Research Society	Austrian Multiple Sclerosis Research Society	This study was supported by research grants of the Austrian Multiple Sclerosis Research Society in 2010 and 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; About-Enein F, 2008, MULT SCLER, V14, pS268; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; Cossburn M, 2012, EUR J NEUROL, V19, P655, DOI 10.1111/j.1468-1331.2011.03529.x; Feigin V, 2009, NEUROEPIDEMIOLOGY, V33, P296, DOI 10.1159/000252942; Rivera JF, 2008, J NEUROL, V255, P710, DOI 10.1007/s00415-008-0781-2; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2013, J NEUROL, V260, P663, DOI 10.1007/s00415-012-6755-4; Jarius S, 2012, MULT SCLER J, V18, P1135, DOI 10.1177/1352458511431728; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Kawazoe T, 2012, INTERNAL MED, V51, P2625, DOI 10.2169/internalmedicine.51.7771; Kim W, 2013, MULT SCLER INT, V2012; Kitley JL, 2012, MULT SCLER J, V18, P271, DOI 10.1177/1352458511406165; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; Mckeon A, 2009, MUSCLE NERVE, V39, P87, DOI 10.1002/mus.21197; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P1176, DOI 10.1001/archneurol.2012.314; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Nakamura M, 2008, J NEUROL, V255, P163, DOI 10.1007/s00415-008-0545-z; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; Serbecic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019843; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Trebst C, 2011, NAT REV NEUROL, V7, P688, DOI 10.1038/nrneurol.2011.176; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	37	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79649	10.1371/journal.pone.0079649	http://dx.doi.org/10.1371/journal.pone.0079649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223985	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400078
J	Liu, K; Zhu, W; Shi, JG; Jia, LS; Shi, GD; Wang, Y; Liu, N				Liu, Kun; Zhu, Wei; Shi, Jiangang; Jia, Lianshun; Shi, Guodong; Wang, Yuan; Liu, Ning			Foot Drop Caused by Lumbar Degenerative Disease: Clinical Features, Prognostic Factors of Surgical Outcome and Clinical Stage	PLOS ONE			English	Article							PERONEAL NERVE; SURGERY; PATIENT	Objective: The purpose of this study was to analyze the clinical features and prognostic factors of surgical outcome of foot drop caused by lumbar degenerative disease and put forward the clinical stage. Methods: We retrospectively reviewed 135 patients with foot drop due to lumbar degenerative disease. The clinical features and mechanism were analyzed. Age, sex, duration of palsy, preoperative muscle strength of tibialis anterior (TA), sensation defect of affected lower limb, affected foot, diagnosis and compressed nerve roots were recorded and compared with surgical outcome. Results: Foot drop was observed in 8.1% of all inpatients of lumbar degenerative disease. L5 nerve root compression was observed in 126 of all 135 patients (93.3%). Single, double and triple roots compression was observed respectively in 43, 83, and 9 patients (31.9%, 61.5%, and 6.6%). But there was no significant relationship between preoperative muscle strength of TA and the number of compressed roots. The muscle strength of TA was improved in 113 (83.7%) patients after surgery, but it reached to >=4 in only 21 (15.6%) patients. Improvement of the muscle strength of TA was almost stable at the 6-month follow-up. At the last follow-up, the muscle strength of TA was 1, 2, 3, 4, 5 respectively in 28, 24, 62, 13, 8 patients. Multivariate logistic regression showed duration of palsy (p=0.0360, OR=2.543), preoperative muscle strength of TA (p=0.0064, OR=5.528) and age (p=0.0309, OR=3.208) were factors that influenced recovery following an operation. Conclusions: L5 nerve root was most frequently affected. The muscle strength of TA improved in most patients after surgery, but few patients can get a good recovery from foot drop. Patients of shorter duration of palsy, better preoperative muscle strength of TA and younger age showed a better surgical outcome.	[Liu, Kun] Second Artillery Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Zhu, Wei; Shi, Jiangang; Jia, Lianshun; Shi, Guodong; Wang, Yuan; Liu, Ning] Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Orthoped Surg, Shanghai, Peoples R China	Naval Medical University	Shi, JG (corresponding author), Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Orthoped Surg, Shanghai, Peoples R China.	shijiangang616@163.com						Ahmad FU, 2006, INT J OBSTET ANESTH, V15, P233, DOI 10.1016/j.ijoa.2005.11.002; Aono H, 2007, SPINE, V32, pE262, DOI 10.1097/01.brs.0000259922.82413.72; Bobba RK, 2006, EUR J INTERN MED, V17, P572, DOI 10.1016/j.ejim.2006.07.010; Campbell WW, 2020, DEJONGS NEUROLOGIC E; Ferraresi S, 2010, J NEUROSURG-PEDIATR, V6, P506, DOI 10.3171/2010.8.PEDS10214; Ghahreman A, 2009, J CLIN NEUROSCI, V16, P1024, DOI 10.1016/j.jocn.2008.10.017; Girardi FP, 2002, J SPINAL DISORD TECH, V15, P490, DOI 10.1097/00024720-200212000-00010; Hans SS, 2011, J VASC SURG, V53, P407, DOI 10.1016/j.jvs.2010.08.084; Hoppenfeld S, 1976, PHYS EXAMINATION SPI; Iizuka Y, 2009, J NEUROSURG-SPINE, V10, P260, DOI 10.3171/2008.12.SPINE08500; Ji JH, 2007, KNEE, V14, P249, DOI 10.1016/j.knee.2007.01.003; Karaoglan A, 2009, TURK NEUROSURG, V19, P208; Masakado Yoshihisa, 2008, Keio Journal of Medicine, V57, P84, DOI 10.2302/kjm.57.84; MCCULLOCH JA, 1980, J BONE JOINT SURG BR, V62, P475, DOI 10.1302/0301-620X.62B4.7430228; Okuda S, 2006, J NEUROSURG-SPINE, V4, P304, DOI 10.3171/spi.2006.4.4.304; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Voermans NC, 2006, ACTA NEUROCHIR, V148, P809, DOI 10.1007/s00701-006-0754-0	17	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80375	10.1371/journal.pone.0080375	http://dx.doi.org/10.1371/journal.pone.0080375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224052	Green Submitted, gold, Green Published			2022-12-25	WOS:000326597400118
J	Matos, LA; Hilf, ME; Chen, JC; Folimonova, SY				Matos, Luis A.; Hilf, Mark E.; Chen, Jianchi; Folimonova, Svetlana Y.			Validation of 'Variable Number of Tandem Repeat'-Based Approach for Examination of 'Candidatus Liberibacter asiaticus' Diversity and Its Applications for the Analysis of the Pathogen Populations in the Areas of Recent Introduction	PLOS ONE			English	Article							CITRUS SEED COATS; 1ST REPORT; SEQUENCE; BACTERIUM; DISEASE; TRANSMISSION; PCR	Citrus greening (Huanglongbing, HLB) is one of the most destructive diseases of citrus worldwide. In South Asia HLB has been known for more than a century, while in Americas the disease was found relatively recently. HLB is associated with three species of 'Candidatus Liberibacter' among which 'Ca. Liberibacter asiaticus' (CLas) has most wide distribution. Recently, a number of studies identified different regions in the CLas genome with variable number of tandem repeats (VNTRs) that could be used for examination of CLas diversity. One of the objectives of the work presented here was to further validate the VNTR analysis-based approach by assessing the stability of these repeats upon multiplication of the pathogen in a host over an extended period of time and upon its passaging from a host to a host using CLas populations from Florida. Our results showed that the numbers of tandem repeats in the four loci tested display very distinguishable "signature profiles" for the two Florida-type CLas haplotype groups. Remarkably, the profiles do not change upon passage of the pathogen in citrus and psyllid hosts as well as after its presence within a host over a period of five years, suggesting that VNTR analysis-based approach represents a valid methodology for examination of the pathogen populations in various geographical regions. Interestingly, an extended analysis of CLas populations in different locations throughout Florida and in several countries in the Caribbean and Central America regions and in Mexico where the pathogen has been introduced recently demonstrated the dispersion of the same haplotypes of CLas. On the other hand, these CLas populations appeared to differ significantly from those obtained from locations where the disease has been present for a much longer time.	[Matos, Luis A.; Folimonova, Svetlana Y.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Matos, Luis A.] Inst Dominicano Invest Agr Forestales, Santo Domingo, Dominican Rep; [Hilf, Mark E.] USDA ARS, Ft Pierce, FL USA; [Chen, Jianchi] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Folimonova, SY (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	svetlana@ufl.edu	Folimonova, Svetlana/T-2592-2019; Matos, Luis/HDL-7321-2022					Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bastianel C, 2005, APPL ENVIRON MICROB, V71, P6473, DOI 10.1128/AEM.71.11.6473-6478.2005; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brown S. E., 2011, New Disease Reports, V24, P25; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; De Jensen CE, 2010, PHYTOPATHOLOGY, V100, pS34; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Garnsey S. M., 2002, Proceedings of the Fifteenth Conference of the International Organization of Citrus Virologists, Paphos, Cyprus, 11-16 November 2001, P219; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Hilf ME, 2013, PHYTOPATHOLOGY, V103, P545, DOI 10.1094/PHYTO-09-12-0226-R; Hilf ME, 2011, PHYTOPATHOLOGY, V101, P1242, DOI 10.1094/PHYTO-11-10-0323; Irey M.S., 2006, P FLA STATE HORTIC S, V42, P17; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Johnson E, 2012, PHYTOPATHOLOGY, V102, P59; Katoh H, 2012, ANN APPL BIOL, V160, P291, DOI 10.1111/j.1744-7348.2012.00541.x; Katoh H, 2011, APPL ENVIRON MICROB, V77, P1910, DOI 10.1128/AEM.01571-10; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Manjunath KL, 2010, PLANT DIS, V94, P781, DOI 10.1094/PDIS-94-6-0781A; Martinez Y, 2008, BS PLANT PATHOLOGY, V18, P7; Matos L, 2009, PLANT DIS, V93, P668, DOI 10.1094/PDIS-93-6-0668B; MATSUMOTO T., 1961, Proceedings of the Second Conference of the International Organization of Citrus Virologists., P121; MCCLEAN A. P. D., 1965, South African Journal of Agricultural Science, V8, P253; MIYAKAWA T, 1989, Annals of the Phytopathological Society of Japan, V55, P667, DOI 10.3186/jjphytopath.55.667; Miyata S, 2011, J GEN PLANT PATHOL, V77, P43, DOI 10.1007/s10327-010-0284-8; Oberholzer P.C.J., 1965, P 3 C IOCV, P213; OIRSA (Organismo Internacional Regional de Sanidad Agropecuaria), 2011, TALL SENS CERT PROD; Ramadugu C, 2010, PHYTOPATHOLOGY, V100, pS107; RAYCHAUDHURI S. P., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V3, P1433; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, INT J SYST EVOL MICR, V58, P1414, DOI 10.1099/ijs.0.65641-0; TIRTAWIDJAJA S, 1965, P AM SOC HORTIC SCI, V86, P235; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Trujillo-Arriaga J, 2010, TALL INT HUANGL PSIL; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	46	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78994	10.1371/journal.pone.0078994	http://dx.doi.org/10.1371/journal.pone.0078994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223873	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400045
J	Mori, N; Ohwashi, M; Yoshinaga, K; Mitsuhashi, K; Tanaka, N; Teramura, M; Okada, M; Shiseki, M; Tanaka, J; Motoji, T				Mori, Naoki; Ohwashi, Mari; Yoshinaga, Kentaro; Mitsuhashi, Kenjiro; Tanaka, Norina; Teramura, Masanao; Okada, Michiko; Shiseki, Masayuki; Tanaka, Junji; Motoji, Toshiko			L265P Mutation of the MYD88 Gene Is Frequent in Waldenstrom's Macroglobulinemia and Its Absence in Myeloma	PLOS ONE			English	Article							SOMATIC MUTATIONS; KAPPA-B; LYMPHOMAS; CARCINOMA; TIME; BCR	L265P mutation in the MYD88 gene has recently been reported in Waldenstrom's macroglobulinemia; however the incidence has been different according to the methods used. To determine the relevance and compare the incidence by different methods, we analyzed the L265P mutation in bone marrow mononuclear cells from lymphoid neoplasms. We first performed cloning and sequencing in 10 patients: 8 Waldenstrm's macroglobulinemia; 1 non-IgM-secreting lymphoplasmacytic lymphoma; and 1 low grade B-cell lymphoma with monoclonal IgG protein. The L265P mutation was detected in only 1/8 Waldenstrm's macroglobulinemia patients (2 of 9 clones). To confirm these results, direct sequencing was performed in the 10 patients and an additional 17 Waldenstrm's macroglobulinemia patients and 1 lymphoplasmacytic lymphoma patient. Nine of 28 patients (7/25 Waldenstrm's macroglobulinemia, 1/2 lymphoplasmacytic lymphoma, and B-cell lymphoma) harbored the mutation. We next tested for the mutation with BSiE1 digestion and allele-specific polymerase chain reaction in the 28 patients and 38 patients with myeloma. Aberrant bands corresponding to the mutation were detected by BSiE1 digestion in 19/25 patients with Waldenstrm's macroglobulinemia (76%), 1/2 lymphoplasmacytic lymphoma and B-cell lymphoma, but not in the 38 myeloma patients. The L265P mutation was more frequent in patients with Waldenstrm's macroglobulinemia than in those with myeloma (p= 1.3x10(-10)). The mutation was detected by allele-specific polymerase chain reaction in 18/25 Waldenstrm's macroglobulinemia patients (72%). In the 25 Waldenstrm's macroglobulinemia patients, the L265P was more frequently detected by BSiE1 digestion than by direct sequencing (p= 5.3x10(-4)), and in males (15/16, 94%) than in females (4/9, 44%) (p= 1.2x10(-2)). No siginificant difference was observed in the incidence of the L265P mutation between BSiE1 digestion and allele-specific polymerase chain reaction (p= 0.32). These results suggest that the L265P mutation is involved in the majority of Waldenstrm's macroglobulinemia. BSiE1 digestion and allelespecific polymerase chain reaction may detect a small fraction of mutated cells in some cases.	[Mori, Naoki; Ohwashi, Mari; Yoshinaga, Kentaro; Mitsuhashi, Kenjiro; Tanaka, Norina; Teramura, Masanao; Okada, Michiko; Shiseki, Masayuki; Tanaka, Junji; Motoji, Toshiko] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan	Tokyo Women's Medical University	Mori, N (corresponding author), Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan.	mori@dh.twmu.ac.jp		Mitsuhashi, Kenjiro/0000-0002-4103-7681				Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Gachard N, 2013, LEUKEMIA, V27, P183, DOI 10.1038/leu.2012.257; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; James C, 2006, LEUKEMIA, V20, P350, DOI 10.1038/sj.leu.2404069; Johnson SA, 2006, BRIT J HAEMATOL, V132, P683, DOI 10.1111/j.1365-2141.2005.05948.x; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Lasho TL, 2006, BRIT J HAEMATOL, V135, P683, DOI 10.1111/j.1365-2141.2006.06348.x; Leleu X, 2008, BLOOD, V111, P5068, DOI 10.1182/blood-2007-09-115170; Li ZM, 2012, BRIT J HAEMATOL, V158, P662, DOI 10.1111/j.1365-2141.2012.09176.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; MORI N, 1990, ONCOGENE, V5, P1713; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Yan QG, 2012, HAEMATOL-HEMATOL J, V97, P595, DOI 10.3324/haematol.2011.054080	22	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80088	10.1371/journal.pone.0080088	http://dx.doi.org/10.1371/journal.pone.0080088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224040	gold, Green Submitted, Green Published			2022-12-25	WOS:000326597400112
J	Noszticzius, Z; Wittmann, M; Kaly-Kullai, K; Beregvari, Z; Kiss, I; Rosivall, L; Szegedi, J				Noszticzius, Zoltan; Wittmann, Maria; Kaly-Kullai, Kristof; Beregvari, Zoltan; Kiss, Istvan; Rosivall, Laszlo; Szegedi, Janos			Chlorine Dioxide Is a Size-Selective Antimicrobial Agent	PLOS ONE			English	Article							MYELOPEROXIDASE-DERIVED OXIDANTS; HYPOCHLOROUS ACID; GLUTATHIONE SULFONAMIDE; HYDROGEN-PEROXIDE; OXIDATION; DISINFECTANTS; MECHANISMS; TOXICITY; PROTEIN; ANTISEPTICS	Background / Aims: ClO2, the so-called "ideal biocide", could also be applied as an antiseptic if it was understood why the solution killing microbes rapidly does not cause any harm to humans or to animals. Our aim was to find the source of that selectivity by studying its reaction-diffusion mechanism both theoretically and experimentally. Methods: ClO2 permeation measurements through protein membranes were performed and the time delay of ClO2 transport due to reaction and diffusion was determined. To calculate ClO2 penetration depths and estimate bacterial killing times, approximate solutions of the reaction-diffusion equation were derived. In these calculations evaporation rates of ClO2 were also measured and taken into account. Results: The rate law of the reaction-diffusion model predicts that the killing time is proportional to the square of the characteristic size (e. g. diameter) of a body, thus, small ones will be killed extremely fast. For example, the killing time for a bacterium is on the order of milliseconds in a 300 ppm ClO2 solution. Thus, a few minutes of contact time (limited by the volatility of ClO2) is quite enough to kill all bacteria, but short enough to keep ClO2 penetration into the living tissues of a greater organism safely below 0.1 mm, minimizing cytotoxic effects when applying it as an antiseptic. Additional properties of ClO2, advantageous for an antiseptic, are also discussed. Most importantly, that bacteria are not able to develop resistance against ClO2 as it reacts with biological thiols which play a vital role in all living organisms. Conclusion: Selectivity of ClO2 between humans and bacteria is based not on their different biochemistry, but on their different size. We hope initiating clinical applications of this promising local antiseptic.	[Noszticzius, Zoltan; Wittmann, Maria; Kaly-Kullai, Kristof] Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary; [Beregvari, Zoltan; Szegedi, Janos] Josa Andras Hosp, Nyiregyhaza, Hungary; [Kiss, Istvan] St Imre Hosp, Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, H-1085 Budapest, Hungary	Budapest University of Technology & Economics; Semmelweis University	Wittmann, M (corresponding author), Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary.	wittmann@eik.bme.hu	Wittmann, Maria/AAN-5276-2021	Wittmann, Maria/0000-0003-4786-7712	OTKA [77908]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by OTKA Grant 77908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes SGB, 2010, ANTIBACTERIAL CHEMOT; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; Crank J., 1975, MATH DIFFUSION; Csikany Cs, 2009, DENT HIREK, P36; DANIEL FB, 1990, J AM WATER WORKS ASS, V82, P61; Das S, 2011, REV IND J DENT ADV, V3, P538; EASTOE JE, 1955, BIOCHEM J, V61, P589, DOI 10.1042/bj0610589; EPA Guidance Manual, ALT DIS OX 4 4 3 2 P; Evans BA, 2013, CURR PHARM DESIGN, V19, P223; Harris AG, 2002, MICROBIOL-SGM, V148, P3813, DOI 10.1099/00221287-148-12-3813; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; Herczegh A, 2013, ACTA MICROBIOL IMM H, V60, P63, DOI 10.1556/AMicr.60.2013.1.7; Ison A, 2006, INORG CHEM, V45, P8768, DOI 10.1021/ic0609554; Junli Huang, 1997, Water Research, V31, P455, DOI 10.1016/S0043-1354(96)00276-X; Koburger T, 2010, J ANTIMICROB CHEMOTH, V65, P1712, DOI 10.1093/jac/dkq212; Lansdown ABG, 2010, ISSUES TOXICOL, V6, P1; Loginova IV, 2008, CHEM NAT COMPD+, V44, P752, DOI 10.1007/s10600-009-9182-8; LUBBERS JR, 1982, ENVIRON HEALTH PERSP, V46, P57, DOI 10.2307/3429422; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mehra P, 2000, J AM DENT ASSOC, V131, P67, DOI 10.14219/jada.archive.2000.0021; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Muller G, 2006, DERMATOLOGY, V212, P91, DOI 10.1159/000090102; Muller G, 2007, GMS KRANKENHAUSHYG I, V2; Napolitano MJ, 2005, CHEM RES TOXICOL, V18, P501, DOI 10.1021/tx049697i; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Noszticzius Z, 2006, PERMEATION METHOD AP; Ogata N, 2007, BIOCHEMISTRY-US, V46, P4898, DOI 10.1021/bi061827u; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200; Robson M.C., 2007, J BURNS WOUNDS, V6, P80; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sanekata T, 2010, BIOCONTROL SCI, V15, P45, DOI 10.4265/bio.15.45; Simpson GD, 1993, CORR 93 NEW ORL LA M; SMIT MJ, 1992, AGENTS ACTIONS, V36, P58, DOI 10.1007/BF01991229; Spellberg B., 2009, RISING PLAGUE GLOBAL; Stewart DJ, 2008, INORG CHEM, V47, P1639, DOI 10.1021/ic701761p; TANNER RS, 1989, J IND MICROBIOL, V4, P145, DOI 10.1007/BF01569799; Wang L., 2007, J BURNS WOUNDS, V6, P65	43	48	49	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79157	10.1371/journal.pone.0079157	http://dx.doi.org/10.1371/journal.pone.0079157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223899	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400049
J	Singh, R; Avliyakulov, NK; Braga, M; Haykinson, MJ; Martinez, L; Singh, V; Parveen, M; Chaudhuri, G; Pervin, S				Singh, Rajan; Avliyakulov, Nuraly K.; Braga, Melissa; Haykinson, Michael J.; Martinez, Luis; Singh, Vikash; Parveen, Meher; Chaudhuri, Gautam; Pervin, Shehla			Proteomic Identification of Mitochondrial Targets of Arginase in Human Breast Cancer	PLOS ONE			English	Article							HYDROXY-L-ARGININE; NITRIC-OXIDE; MDA-MB-468 CELLS; SERINE HYDROXYMETHYLTRANSFERASE; MYOGENIC DIFFERENTIATION; INDUCED APOPTOSIS; POTENTIAL ROLE; COLON-CANCER; METABOLISM; INHIBITOR	We have previously reported arginase expression in human breast cancer cells and demonstrated that the inhibition of arginase by N-omega hydroxy L-arginine (NOHA) in MDA-MB-468 cells induces apoptosis. However, arginase expression and its possible molecular targets in human breast tumor samples and potential clinical implications have not been fully elucidated. Here, we demonstrate arginase expression in human breast tumor samples, and several established breast cancer cell lines, in which NOHA treatment selectively inhibits cell proliferation. The overexpression of Bcl2 in MDA-MB-468 cells abolished NOHA-induced apoptosis, suggesting that the mitochondria may be the main site of NOHA's action. We, therefore, undertook a proteomics approach to identify key mitochondrial targets of arginase in MDA-MB-468 cells. We identified 54 non-mitochondrial and 13 mitochondrial proteins that were differentially expressed in control and NOHA treated groups. Mitochondrial serine hydroxymethyltransferase (mSHMT) was identified as one of the most promising targets of arginase. Both arginase II (Arg II) and mSHMT expressions were higher in human breast tumor tissues compared to the matched normal and there was a strong correlation between Arg II and mSHMT protein expression. MDA-MB-468 xenografts had significant upregulation of Arg II expression that preceded the induction of mSHMT expression. Small inhibitory RNA (siRNA)-mediated inhibition of Arg II in MDA-MB-468 and HCC-1806 cells led to significant inhibition of both the mSHMT gene and protein expression. As mSHMT is a key player in folate metabolism, our data provides a novel link between arginine and folate metabolism in human breast cancer, both of which are critical for tumor cell proliferation.	[Singh, Rajan; Braga, Melissa; Martinez, Luis; Singh, Vikash; Parveen, Meher; Pervin, Shehla] Charles Drew Univ Med & Sci, Los Angeles, CA 90059 USA; [Singh, Rajan; Chaudhuri, Gautam; Pervin, Shehla] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Singh, Rajan; Chaudhuri, Gautam; Pervin, Shehla] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Avliyakulov, Nuraly K.; Haykinson, Michael J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Singh, R (corresponding author), Charles Drew Univ Med & Sci, Los Angeles, CA 90059 USA.	rajansingh@mednet.ucla.edu			NIH [SC1 AG033407-01A1, 1SC1 CA165865-01A1]; CDU/UCLA Cancer Partnership [5U54CA143931]; NATIONAL CANCER INSTITUTE [U54CA143931, SC1CA165865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [SC1AG033407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDU/UCLA Cancer Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by NIH grants SC1 AG033407-01A1 (R. S.); 1SC1 CA165865-01A1 (S. P.) and in part by CDU/UCLA Cancer Partnership 5U54CA143931. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; Chang CI, 2001, CANCER RES, V61, P1100; Chang WN, 2007, DRUG METAB DISPOS, V35, P2127, DOI 10.1124/dmd.107.016840; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; CYBULSKI RL, 1976, BIOCHEMISTRY-US, V15, P3183, DOI 10.1021/bi00660a004; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Jung EJ, 2007, PROTEOMICS, V7, P3906, DOI 10.1002/pmic.200700377; Komlosi V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-525; Leamon CP, 2008, CANCER RES, V68, P9839, DOI 10.1158/0008-5472.CAN-08-2341; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; MALT RA, 1985, ADV ENZYME REGUL, V24, P93, DOI 10.1016/0065-2571(85)90071-8; Mayr M, 2009, J MOL CELL CARDIOL, V46, P268, DOI 10.1016/j.yjmcc.2008.10.008; Meulemans A, 2000, NEUROSCI LETT, V294, P125, DOI 10.1016/S0304-3940(00)01548-2; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Muller C, 2012, CURR PHARM DESIGN, V18, P1058, DOI 10.2174/138161212799315777; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Pervin S, 2013, BRIT J CANCER, V108, P848, DOI 10.1038/bjc.2013.40; Pervin S, 2003, CANCER RES, V63, P5470; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pervin S, 2001, CANCER RES, V61, P4701; Pervin S, 2008, NITRIC OXIDE-BIOL CH, V19, P103, DOI 10.1016/j.niox.2008.04.016; Pervin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053287; Polat MF, 2003, SURG TODAY, V33, P655, DOI 10.1007/s00595-002-2563-2; Porembska Z, 2003, CLIN CHIM ACTA, V328, P105, DOI 10.1016/S0009-8981(02)00391-1; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Shin H, 2004, J AM CHEM SOC, V126, P10278, DOI 10.1021/ja047788w; Singh R, 2006, J CELL BIOCHEM, V99, P146, DOI 10.1002/jcb.20908; Singh R, 2000, CANCER RES, V60, P3305; Singh R, 2002, J BIOL CHEM, V277, P37630, DOI 10.1074/jbc.M203648200; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; SNELL K, 1988, BRIT J CANCER, V57, P87, DOI 10.1038/bjc.1988.15; SNELL K, 1989, CANCER LETT, V44, P217, DOI 10.1016/0304-3835(89)90064-5; STRAUS B, 1992, CLIN CHIM ACTA, V210, P5, DOI 10.1016/0009-8981(92)90040-W; Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Weigert A, 2008, NITRIC OXIDE-BIOL CH, V19, P95, DOI 10.1016/j.niox.2008.04.021; Xia W, 2010, J MED CHEM, V53, P6811, DOI 10.1021/jm100509v	45	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79242	10.1371/journal.pone.0079242	http://dx.doi.org/10.1371/journal.pone.0079242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223914	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400055
J	Sakakibara, M; Uenoyama, Y; Minabe, S; Watanabe, Y; Deura, C; Nakamura, S; Suzuki, G; Maeda, K; Tsukamura, H				Sakakibara, Mototsugu; Uenoyama, Yoshihisa; Minabe, Shiori; Watanabe, Youki; Deura, Chikaya; Nakamura, Sho; Suzuki, Genki; Maeda, Kei-ichiro; Tsukamura, Hiroko			Microarray Analysis of Perinatal-Estrogen-Induced Changes in Gene Expression Related to Brain Sexual Differentiation in Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE SURGE; FEMALE RATS; PREOPTIC AREA; NEONATAL TREATMENT; BEHAVIOR; NEURONS; ESTRADIOL; MOUSE; DIFFERENCE; FOREBRAIN	Sexual dimorphism of the behaviors or physiological functions in mammals is mainly due to the sex difference of the brain. A number of studies have suggested that the brain is masculinized or defeminized by estradiol converted from testicular androgens in perinatal period in rodents. However, the mechanisms of estrogen action resulting in masculinization/defeminization of the brain have not been clarified yet. The large-scale analysis with microarray in the present study is an attempt to obtain the candidate gene(s) mediating the perinatal estrogen effect causing the brain sexual differentiation. Female mice were injected with estradiol benzoate (EB) or vehicle on the day of birth, and the hypothalamus was collected at either 1, 3, 6, 12, or 24 h after the EB injection. More than one hundred genes down-regulated by the EB treatment in a biphasic manner peaked at 3 h and 12-24 h after the EB treatment, while forty to seventy genes were constantly up-regulated after it. Twelve genes, including Ptgds, Hcrt, Tmed2, Klc1, and Nedd4, whose mRNA expressions were down-regulated by the neonatal EB treatment, were chosen for further examination by semiquantitative RT-PCR in the hypothalamus of perinatal intact male and female mice. We selected the genes based on the known profiles of their potential roles in brain development. mRNA expression levels of Ptgds, Hcrt, Tmed2, and Nedd4 were significantly lower in male mice than females at the day of birth, suggesting that the genes are down-regulated by estrogen converted from testicular androgen in perinatal male mice. Some genes, such as Ptgds encoding prostaglandin D2 production enzyme and Hcrt encording orexin, have been reported to have a role in neuroprotection. Thus, Ptgds and Hcrt could be possible candidate genes, which may mediate the effect of perinatal estrogen responsible for brain sexual differentiation.	[Sakakibara, Mototsugu; Uenoyama, Yoshihisa; Minabe, Shiori; Watanabe, Youki; Deura, Chikaya; Tsukamura, Hiroko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Sakakibara, Mototsugu] Mitsubishi Chem Medience Corp, Adv Med Sci Res Dept, Ibaraki, Japan; [Suzuki, Genki] Mitsubishi Chem Medience Corp, Mol Genet Res & Anal Dept, Tokyo, Japan; [Nakamura, Sho; Maeda, Kei-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan	Nagoya University; University of Tokyo	Tsukamura, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	htsukamura@nagoya-u.jp	Minabe, Shiori/AAJ-7486-2021; Tsukamura, Hiroko/AAC-5632-2022	Minabe, Shiori/0000-0001-7902-925X; Uenoyama, Yoshihisa/0000-0002-8272-2781	Japan Society for the Promotion Sciences (JSPS) [23380163, 23580402, 24380157]; Grants-in-Aid for Scientific Research [12J05310] Funding Source: KAKEN	Japan Society for the Promotion Sciences (JSPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development to H. T., Grants-in Aid No. 23380163 to H. T., No. 23580402 to Y.U., and No. 24380157 to K. M. from the Japan Society for the Promotion Sciences (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Baxter KK, 2009, ASN NEURO, V1, DOI 10.1042/AN20090036; Berridge CW, 2010, BRAIN RES, V1314, P91, DOI 10.1016/j.brainres.2009.09.019; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; CORBIER P, 1983, PHYSIOL BEHAV, V30, P613, DOI 10.1016/0031-9384(83)90229-9; Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950; Diao JK, 2010, THEOR CHEM ACC, V125, P397, DOI 10.1007/s00214-009-0677-y; DIAZ DR, 1995, DEV BRAIN RES, V86, P227; Forger NG, 2004, P NATL ACAD SCI USA, V101, P13666, DOI 10.1073/pnas.0404644101; GERALL AA, 1967, ANAT REC, V157, P97, DOI 10.1002/ar.1091570114; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; Gorski RA, 1971, FRONT NEUROENDOCRIN, P237; Hadjimarkou MM, 2008, EUR J NEUROSCI, V27, P1780, DOI 10.1111/j.1460-9568.2008.06142.x; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Jerome-Majewska LA, 2010, DEV BIOL, V341, P154, DOI 10.1016/j.ydbio.2010.02.019; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; KONDO Y, 1986, PHYSIOL BEHAV, V37, P495, DOI 10.1016/0031-9384(86)90212-X; Kouki T, 2003, HORM BEHAV, V44, P140, DOI 10.1016/S0018-506X(03)00122-3; Kouki T, 2005, BRAIN RES BULL, V64, P449, DOI 10.1016/j.brainresbull.2004.10.002; Lenz KM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00026; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Matsuda KI, 2012, REV ENDOCR METAB DIS, V13, P163, DOI 10.1007/s11154-012-9202-z; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MCEWEN BS, 1977, HORM BEHAV, V9, P249, DOI 10.1016/0018-506X(77)90060-5; Mong JA, 2004, MOL PSYCHIATR, V9, P550, DOI 10.1038/sj.mp.4001493; Mong JA, 2003, P NATL ACAD SCI USA, V100, P318, DOI 10.1073/pnas.262663799; MULLINS RF, 1968, PHYSIOL BEHAV, V3, P333, DOI 10.1016/0031-9384(68)90110-8; PFAFF DW, 1971, NEUROENDOCRINOLOGY, V7, P129, DOI 10.1159/000121961; Poling MC, 2012, ENDOCRINOLOGY, V153, P782, DOI 10.1210/en.2011-1838; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reik W, 2000, INT J DEV BIOL, V44, P145; Sakakibara M, 2013, J NEUROENDOCRINOL, V25, P251, DOI 10.1111/j.1365-2826.2012.02389.x; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Sokolowska P, 2012, NEUROSCI LETT, V506, P303, DOI 10.1016/j.neulet.2011.11.028; Takahashi K, 2008, J COMP NEUROL, V509, P180, DOI 10.1002/cne.21740; THOMAS CN, 1969, PSYCHON SCI, V16, P19; Tsukamura H, 2010, ANN NY ACAD SCI, V1200, P95, DOI 10.1111/j.1749-6632.2010.05645.x; Urade Y, 1999, BBA-MOL CELL BIOL L, V1436, P606, DOI 10.1016/S0005-2760(98)00163-5; VREEBURG JTM, 1977, J ENDOCRINOL, V74, P375, DOI 10.1677/joe.0.0740375; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; Waite MR, 2011, DEV DYNAM, V240, P333, DOI 10.1002/dvdy.22532; WHALEN RE, 1963, SCIENCE, V141, P273, DOI 10.1126/science.141.3577.273; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84	48	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79437	10.1371/journal.pone.0079437	http://dx.doi.org/10.1371/journal.pone.0079437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223949	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400114
J	Chih, PC; Yang, YC; Wu, JS; Chang, YF; Lu, FH; Chang, CJ				Chih, Pei-Chi; Yang, Yi-Ching; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Chang, Chih-Jen			Overweight Associated with Increased Risk of Erosive Esophagitis in a Non-Obese Taiwanese Population	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; METABOLIC SYNDROME; ADIPOSE-TISSUE; ESOPHAGOGASTRIC JUNCTION; BARRETTS-ESOPHAGUS; HIATAL-HERNIA; LIFE-STYLE; OBESITY; EPIDEMIOLOGY	Objective: To investigate the relationship between overweight and erosive esophagitis (EE) in a non-obese Taiwanese population. Design and Methods: A total of 7,352 subjects (non-obese, 5,826; obese, 1,526) from a health examination center at National Cheng Kung University Hospital were enrolled. Central obesity was defined by a waist circumference (WC) >= 90 cm in male and 80 cm in female. Overweight was defined as body mass index (BMI) of 24-26.9 kg/m(2), and general obesity as BMI >= 27 kg/m(2). The Los Angeles classification was adopted to determine the presence of EE. Results: There were significant differences in the prevalence of central obesity and different BMI status between subjects with and without EE in total and non-obese population. In total population, multivariate analyses revealed central obesity (OR, 1.17, 95% CI, 1.02-1.34, p = 0.021) and being obese (OR, 1.28, 95% CI, 1.07-1.52, p = 0.007)/overweight (OR, 1.25, 95% CI, 1.08-1.45, p = 0.003) had positive associations with EE in different model, respectively. When considering the joint effect of central obesity and BMI status, overweight (OR, 1.22; 95% CI, 1.04-1.44; p = 0.016) remained as an independent associated factor of EE but central obesity (OR, 1.06; 95% CI, 0.89-1.26; p = 0.549)/being obese (OR, 1.22; 95% CI, 0.98-1.53; p = 0.082) did not. As for non-obese group, separate model showed central obesity (OR, 1.19, 95% CI, 1.00-1.40, p = 0.046) and overweight (OR, 1.24; 95% CI, 1.07-1.44, p = 0.005) was positively associated with EE, respectively. However, being overweight (OR, 1.20; 95% CI, 1.02-1.42, p = 0.030) but not central obesity (OR, 1.08; 95% CI, 0.90-1.31; p = 0.398) was positively related to EE with considering the effect of overweight and central obesity simultaneously. Conclusion: Overweight effect on EE was more detrimental than central obesity in non-obese subjects. In addition, male gender, hiatus hernia and alcohol use were also associated with increased risk of EE.	[Chih, Pei-Chi] Madou Sin Lau Hosp, Dept Family Med, Tainan, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Yang, Yi-Ching; Wu, Jin-Shang; Lu, Feng-Hwa; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Wu, JS (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	z8508014@email.ncku.edu.tw; em75210@email.ncku.edu.tw	Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-005]	Department of Family Medicine, National Cheng-Kung University Hospital	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-58; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Bertin E, 2000, DIABETES METAB, V26, P178; Boguradzka A, 2011, POL ARCH MED WEWN, V121, P230, DOI 10.20452/pamw.1063; Bor S, 1999, DIGEST DIS SCI, V44, P290, DOI 10.1023/A:1026646215879; Cai N, 2012, WORLD J GASTROENTERO, V18, P2545, DOI 10.3748/wjg.v18.i20.2545; Cao WB, 2004, AM J PHYSIOL-GASTR L, V287, pG1131, DOI 10.1152/ajpgi.00216.2004; Chang CY, 2011, J GASTROEN HEPATOL, V26, P240, DOI 10.1111/j.1440-1746.2010.06529.x; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collings KL, 2003, MED SCI SPORT EXER, V35, P730, DOI 10.1249/01.MSS.0000064937.99001.56; de Vries DR, 2008, AM J GASTROENTEROL, V103, P1349, DOI 10.1111/j.1572-0241.2008.01909.x; Du J, 2007, WORLD J GASTROENTERO, V13, P6009, DOI 10.3748/wjg.13.6009; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Festi D, 2009, WORLD J GASTROENTERO, V15, P1690, DOI 10.3748/wjg.15.1690; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Genuth S, 2003, DIABETES CARE, V26, P3160; Goh KL, 2011, J GASTROEN HEPATOL, V26, P2, DOI 10.1111/j.1440-1746.2010.06534.x; Gudlaugsdottir Sunna, 2002, Eur J Intern Med, V13, P369, DOI 10.1016/S0953-6205(02)00090-0; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Kang MS, 2007, J GASTROEN HEPATOL, V22, P1656, DOI 10.1111/j.1440-1746.2006.04518.x; Kato M, 2011, J GASTROENTEROL, V46, P1361, DOI 10.1007/s00535-011-0453-3; KEKKI M, 1982, SCAND J GASTROENTERO, V17, P737, DOI 10.3109/00365528209181087; Labenz J, 2004, AM J GASTROENTEROL, V99, P1652, DOI 10.1111/j.1572-0241.2004.30390.x; Lee HL, 2009, J CLIN GASTROENTEROL, V43, P240, DOI 10.1097/MCG.0b013e318167b88a; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; Miles MP, 2012, MED SCI SPORT EXER, V44, P2290, DOI 10.1249/MSS.0b013e318267b209; Mittal RK, 1997, NEW ENGL J MED, V336, P924, DOI 10.1056/NEJM199703273361306; Moayyedi P, 2005, ALIMENT PHARM THER, V22, P11, DOI 10.1111/j.1365-2036.2005.02605.x; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Moki F, 2007, ALIMENT PHARM THER, V26, P1069, DOI 10.1111/j.1365-2036.2007.03454.x; Nam SY, 2009, ALIMENT PHARM THER, V29, P1042, DOI 10.1111/j.1365-2036.2009.03965.x; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Orlando RC, 2011, ANN NY ACAD SCI, V1232, P369, DOI 10.1111/j.1749-6632.2011.06064.x; Ou JL, 2012, J CHIN MED ASSOC, V75, P60, DOI 10.1016/j.jcma.2011.12.008; Pan WH, 2008, OBES REV, V9, P22, DOI 10.1111/j.1467-789X.2007.00434.x; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Park JH, 2008, WORLD J GASTROENTERO, V14, P5442, DOI 10.3748/wjg.14.5442; Ronkainen J, 2011, AM J GASTROENTEROL, V106, P1946, DOI 10.1038/ajg.2011.326; Selthofer-Relatic K, 2012, MED GLAS, V9, P198; Sopasakis VR, 2005, INT J OBESITY, V29, P1144, DOI 10.1038/sj.ijo.0803002; Tilg H, 2010, GASTROENTEROLOGY, V139, P1823, DOI 10.1053/j.gastro.2010.10.038; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Tseng PH, 2012, DIABETES CARE, V35, P1053, DOI 10.2337/dc11-1596; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z; Whaley M., 2006, ACSMS GUIDELINES EXE; Wilson LJ, 1999, AM J GASTROENTEROL, V94, P2840, DOI 10.1111/j.1572-0241.1999.01426.x; Wong BCY, 2006, CLIN GASTROENTEROL H, V4, P398, DOI 10.1016/j.cgh.2005.10.011; World Health Organization Western Pacific Region, 2000, AS PAC PERSP RED OB; Wu JCY, 2007, GASTROENTEROLOGY, V132, P883, DOI 10.1053/j.gastro.2006.12.032; Wu P, 2011, NEUROGASTROENT MOTIL, V23, P989, DOI 10.1111/j.1365-2982.2011.01786.x; You TJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE741, DOI 10.1152/ajpendo.00419.2004	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e77932	10.1371/journal.pone.0077932	http://dx.doi.org/10.1371/journal.pone.0077932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223746	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300015
J	Harper, DM; Verdenius, I; Ratnaraj, F; Arey, AM; Rosemergey, B; Malnar, GJ; Wall, J				Harper, Diane M.; Verdenius, Inge; Ratnaraj, Felicia; Arey, Anne M.; Rosemergey, Beth; Malnar, Gerard J.; Wall, Jeffrey			Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; CERVICAL-CANCER PREVENTION; COST-EFFECTIVENESS; PATIENT ADHERENCE; YOUNG-WOMEN; COMPLETION; ADOLESCENTS; SERIES; IMMUNOGENICITY; INITIATION	Purpose: HPV4 is the most expensive vaccine requiring three appropriately timed doses to provide maximal efficacy against two oncogenic HPV types. The primary purpose of this study is to quantify the use of HPV4 vaccine in a safety net health care system in terms of its inefficiencies. Methods: A retrospective study of HPV4 dosing from 2006-2009, among females 10-26 years old who sought care in a safety net health care system was conducted to determine dose usage patterns among those at highest risk for cervical cancer. Dose descriptors abstracted from the electronic medical record (EMR) included timing and number in series as well as characteristics of the person to whom and visit at which the dose was given. Dose inefficiencies were separated into "less than three doses'' and "mistimed doses'' for analysis. Results: The majority (66%) of HPV4 doses administered were insufficient to induce the maximal immune response necessary for HPV infection prevention. Among on-time doses, 58% were singleton or doublet doses. Mistimed doses accounted for 19% of all doses administered with late intervals being more common than early intervals among those receiving more than one dose (9% vs. 4%, p<0.001). Third doses were mistimed twice as often as second doses (10% vs. 5%, p<0.001). Black women were more likely to have a mistimed second dose and Hispanic women more likely to have a mistimed third dose compared to white women (OR = 1.70 (95% CI: 1.11, 2.61 and 2.44 (1.19, 5.00), respectively). The HPV4-only visit type at which HPV4 was initiated was the most significant predictor of on-time doublet completion. Conclusions: In a safety net health care system the large inefficiencies associated with HPV4 vaccination must be addressed in order to maximize our patient's cervical cancer prevention.	[Harper, Diane M.] Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Harper, Diane M.; Ratnaraj, Felicia; Malnar, Gerard J.; Wall, Jeffrey] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.; Arey, Anne M.; Rosemergey, Beth] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Verdenius, Inge] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen	Harper, DM (corresponding author), Univ Missouri, Sch Med, Ctr Excellence, Kansas City, MO 64108 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				[Anonymous], 2008, FDA NEWS; Brisson M, 2011, SEX TRANSM INFECT, V87, P41, DOI 10.1136/sti.2010.044412; CDC, 2013, VACC PRIC LIST; Chao C, 2009, MAYO CLIN PROC, V84, P864, DOI 10.1016/S0025-6196(11)60503-X; Chou B, 2011, OBSTET GYNECOL, V118, P14, DOI 10.1097/AOG.0b013e318220ebf3; Cook RL, 2010, J ADOLESCENT HEALTH, V47, P596, DOI 10.1016/j.jadohealth.2010.09.015; Dempsey A, 2011, VACCINE, V29, P528, DOI 10.1016/j.vaccine.2010.10.051; Dempsey A, 2010, VACCINE, V28, P989, DOI 10.1016/j.vaccine.2009.10.133; *DEP HLTH HUM SERV, 2009, ADV COMM IMM PRACT A; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Dorell CG, 2011, PEDIATRICS, V128, P830, DOI 10.1542/peds.2011-0950; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; FDA Approval Letter, 2006, FDA APPROVAL LETT; Freeman HP, 2005, NIH PUB; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Gold R, 2011, PREV MED, V52, P456, DOI 10.1016/j.ypmed.2011.04.010; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Grant D, 2012, VACCINES CHILDREN PR; Harper D. M., 2010, J VACCINES VACCIN, V1, P107, DOI [10.4172/2157-7560.1000107, DOI 10.4172/2157-7560.1000107]; Harper DM, 2010, DISCOV MED, V10, P7; Harper Diane M, 2011, ISRN Obstet Gynecol, V2011, P457204, DOI 10.5402/2011/457204; Hirth JM, 2012, CANCER-AM CANCER SOC, V118, P5623, DOI 10.1002/cncr.27598; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V306, P1643, DOI 10.1001/jama.2011.1480; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Neubrand TPL, 2009, CLIN PEDIATR, V48, P966, DOI 10.1177/0009922809337534; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Niccolai LM, 2011, AM J PREV MED, V41, P428, DOI 10.1016/j.amepre.2011.06.032; Perkins RB, 2012, J WOMENS HEALTH, V21, P813, DOI 10.1089/jwh.2011.3364; Romanowski B, 2011, HUM VACCINES, V7, P1374, DOI 10.4161/hv.7.12.18322; Rosen AB, 2009, AM J MANAG CARE, V15, P626; Rouzier R, 2010, J ADOLESCENT HEALTH, V47, P237, DOI 10.1016/j.jadohealth.2010.04.006; Rubin RF, 2012, J COMMUN HEALTH, V37, P1145, DOI 10.1007/s10900-012-9581-9; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Schluterman NH, 2011, VACCINE, V29, P3767, DOI 10.1016/j.vaccine.2011.03.032; Setia S, 2002, VACCINE, V20, P1148, DOI 10.1016/S0264-410X(01)00433-9; Smith LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-645; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; StatSoft Inc, 2010, STATISTICA DAT AN SO; Tan WY, 2011, VACCINE, V29, P2548, DOI 10.1016/j.vaccine.2011.01.066; Tiro JA, 2012, VACCINE, V30, P2368, DOI 10.1016/j.vaccine.2011.11.031; United States Securities and Exchange Commission, 2011, MERCK CO STRAT NAT S; United States Securities and Exchange Commission, 2012, MERCK CO INC ANN SEC, P51; United States Securities and Exchange Commission, 2012, MERCK CO INC Q SEC R, P47; Verdenius I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071295; Widdice LE, 2011, PEDIATRICS, V127, P77, DOI 10.1542/peds.2010-0812; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258; Zimmerman RK, 2010, J WOMENS HEALTH, V19, P1441, DOI 10.1089/jwh.2009.1753	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e77961	10.1371/journal.pone.0077961	http://dx.doi.org/10.1371/journal.pone.0077961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223131	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200023
J	Heenan, A; Williams, ID				Heenan, Adel; Williams, Ivor D.			Monitoring Herbivorous Fishes as Indicators of Coral Reef Resilience in American Samoa	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ACANTHURUS-NIGROFUSCUS; COMMUNITY STRUCTURE; MACROALGAL COVER; TROPHIC STATUS; PHASE-SHIFTS; SCALE; BIOMASS; ALGAL; DEPTH	Resilience-based management aims to promote or protect processes and species that underpin an ecosystem's capacity to withstand and recover from disturbance. The management of ecological processes is a developing field that requires reliable indicators that can be monitored over time. Herbivory is a key ecological process on coral reefs, and pooling herbivorous fishes into functional groups based on their feeding mode is increasingly used as it may quantify herbivory in ways that indicate resilience. Here we evaluate whether the biomass estimates of these herbivore functional groups are good predictors of reef benthic assemblages, using data from 240 sites from five island groups in American Samoa. Using an information theoretic approach, we assembled a candidate set of linear and nonlinear models to identify the relations between benthic cover and total herbivore and non-herbivore biomass and the biomass of the aforementioned functional groups. For each benthic substrate type considered (encrusting algae, fleshy macroalgae, hard coral and turf algae), the biomass of herbivorous fishes were important explanatory variables in predicting benthic cover, whereas biomass of all fishes combined generally was not. Also, in all four cases, variation in cover was best explained by the biomass of specific functional groups rather than by all herbivores combined. Specifically: 1) macroalgal and turf algal cover decreased with increasing biomass of 'grazers/detritivores'; and 2) cover of encrusting algae increased with increasing biomass of 'grazers/detritivores' and browsers. Furthermore, hard coral cover increased with the biomass of large excavators/bio-eroders (made up of large-bodied parrotfishes). Collectively, these findings emphasize the link between herbivorous fishes and the benthic community and demonstrate support for the use of functional groups of herbivores as indicators for resilience-based monitoring.	[Heenan, Adel] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Williams, Ivor D.] Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Heenan, A (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	adel.heenan@gmail.com		Williams, Ivor/0000-0002-9444-1020; Heenan, Adel/0000-0002-8307-5352	United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program; Pacific Islands Fisheries Science Center	United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program; Pacific Islands Fisheries Science Center	Financial support was provided by the United States National Oceanic Atmospheric Administration (NOAA) Coral Reef Conservation Program (http://coralreef.noaa.gov/) and the Pacific Islands Fisheries Science Center (http://www.pifsc.noaa.gov/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Ayotte P., 2011, H1108 NOAA PAC ISL F, P24; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P259, DOI 10.1007/s00338-010-0669-3; Bunnefeld N, 2012, ECOGRAPHY, V35, P15, DOI 10.1111/j.1600-0587.2011.07078.x; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Chateau O, 2009, ICES J MAR SCI, V66, P50, DOI 10.1093/icesjms/fsn165; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Choat JH, 2003, MONITORING CORAL REE, P68; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Froese R., 2014, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; Gust N, 2002, ENVIRON BIOL FISH, V64, P353, DOI 10.1023/A:1016112312009; Hart AM, 1996, MAR ECOL PROG SER, V132, P11, DOI 10.3354/meps132011; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 1985, P 5 INT COR REEF S T, V4, P3539; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; Marshell A, 2012, CORAL REEFS, V31, P1093, DOI 10.1007/s00338-012-0931-y; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; O'Leary JK, 2012, CORAL REEFS, V31, P547, DOI 10.1007/s00338-012-0872-5; Ohman MC, 1998, ENVIRON BIOL FISH, V53, P19, DOI 10.1023/A:1007445226928; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Sabater MG, 2007, PAC SCI, V61, P503, DOI 10.2984/1534-6188(2007)61[503:SABCEO]2.0.CO;2; Steneck R.S, 1988, HERBIVORY CORAL REEF; Tolimieri N, 1998, MAR ECOL PROG SER, V167, P227, DOI 10.3354/meps167227; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Travers MJ, 2010, J BIOGEOGR, V37, P148, DOI 10.1111/j.1365-2699.2009.02183.x; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Willliams I, 2011, J MARINE BIOL, V2011; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Zuur Alain F., 2009, P1	70	38	39	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79604	10.1371/journal.pone.0079604	http://dx.doi.org/10.1371/journal.pone.0079604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223183	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200076
J	O'Hanlon, DE; Moench, TR; Cone, RA				O'Hanlon, Deirdre E.; Moench, Thomas R.; Cone, Richard A.			Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; FEMALE GENITAL-TRACT; BACTERIAL VAGINOSIS; HYDROGEN-PEROXIDE; H2O2-PRODUCING LACTOBACILLI; NEISSERIA-GONORRHOEAE; IN-VITRO; OXYGEN; WOMEN	Lactic acid at sufficiently acidic pH is a potent microbicide, and lactic acid produced by vaginal lactobacilli may help protect against reproductive tract infections. However, previous observations likely underestimated healthy vaginal acidity and total lactate concentration since they failed to exclude women without a lactobacillus-dominated vaginal microbiota, and also did not account for the high carbon dioxide, low oxygen environment of the vagina. Fifty-six women with low (0-3) Nugent scores (indicating a lactobacillus-dominated vaginal microbiota) and no symptoms of reproductive tract disease or infection, provided a total of 64 cervicovaginal fluid samples using a collection method that avoided the need for sample dilution and rigorously minimized aerobic exposure. The pH of samples was measured by microelectrode immediately after collection and under a physiological vaginal concentration of CO2. Commercial enzymatic assays of total lactate and total acetate concentrations were validated for use in CVF, and compared to the more usual HPLC method. The average pH of the CVF samples was 3.5 +/- 0.3 (mean +/- SD), range 2.8-4.2, and the average total lactate was 1.0% +/- 0.2% w/v; this is a five-fold higher average hydrogen ion concentration (lower pH) and a fivefold higher total lactate concentration than in the prior literature. The microbicidal form of lactic acid (protonated lactic acid) was therefore eleven-fold more concentrated, and a markedly more potent microbicide, than indicated by prior research. This suggests that when lactobacilli dominate the vaginal microbiota, women have significantly more lactic acid-mediated protection against infections than currently believed. Our results invite further evaluations of the prophylactic and therapeutic actions of vaginal lactic acid, whether provided in situ by endogenous lactobacilli, by probiotic lactobacilli, or by products that reinforce vaginal lactic acid.	[O'Hanlon, Deirdre E.; Cone, Richard A.] Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Moench, Thomas R.; Cone, Richard A.] ReProtect Inc, Baltimore, MD USA	Johns Hopkins University	O'Hanlon, DE (corresponding author), Johns Hopkins Univ, Thomas C Jenkins Dept Biophys, Baltimore, MD 21218 USA.	eohanlon@jhu.edu			National Institutes of Health [AI45967, AI60598, AI66726, AI096398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060598, P01AI045967, U01AI066726, U19AI096398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institutes of Health [grants number AI45967, AI60598, AI66726, and AI096398]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldunate M, 2013, J ANTIMICROB CHEMOTH; Allsworth JE, 2001, AM J OBSTET GYNECOL, V205, P113; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Connor RI, 2006, JAIDS-J ACQ IMM DEF, V43, P499, DOI 10.1097/01.qai.0000243048.50451.18; Conti C, 2009, J PHYSIOL PHARMACOL, V60, P19; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; HUNTER CA, 1958, AM J OBSTET GYNECOL, V75, P872, DOI 10.1016/0002-9378(58)90669-0; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lusk MJ, 2008, CURR OPIN INFECT DIS, V21, P49, DOI 10.1097/QCO.0b013e3282f3d988; Mane A, 2013, DIAGN MICR INFEC DIS, V75, P112, DOI 10.1016/j.diagmicrobio.2012.09.009; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Martin R, 2010, APPL ENVIRON MICROB, V76, P400, DOI 10.1128/AEM.01631-09; Mijac VD, 2006, EUR J OBSTET GYN R B, V129, P69, DOI 10.1016/j.ejogrb.2005.11.036; MURPHY MG, 1985, ARCH MICROBIOL, V141, P75, DOI 10.1007/BF00446743; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Ocana VS, 1999, FEMS IMMUNOL MED MIC, V23, P87, DOI 10.1016/S0928-8244(98)00116-3; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pastorek JG, 1996, CLIN INFECT DIS, V23, P1075, DOI 10.1093/clinids/23.5.1075; Pavletic Adriana J, 2004, Infect Dis Obstet Gynecol, V12, P63, DOI 10.1080/10647440400009839; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sewankambo N, 1997, LANCET, V350, P1036; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; SOBEL JD, 1990, BRIT J CLIN PRACT, V44, P65; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STANEK R, 1992, BIOMED CHROMATOGR, V6, P231, DOI 10.1002/bmc.1130060506; Strus M, 2006, FEMS IMMUNOL MED MIC, V48, P56, DOI 10.1111/j.1574-695X.2006.00120.x; Tanton C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017480; Tomas MSJ, 2003, J MED MICROBIOL, V52, P1117, DOI 10.1099/jmm.0.05155-0; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; WAGNER G, 1984, AM J OBSTET GYNECOL, V148, P147, DOI 10.1016/S0002-9378(84)80165-9; WAGNER G, 1988, AM J OBSTET GYNECOL, V158, P1040, DOI 10.1016/0002-9378(88)90214-1; WAGNER G, 1978, FERTIL STERIL, V30, P50; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zuck TT, 1939, AM J OBSTET GYNECOL, V38, P310, DOI 10.1016/S0002-9378(39)90833-1	53	243	256	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80074	10.1371/journal.pone.0080074	http://dx.doi.org/10.1371/journal.pone.0080074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223212	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200105
J	Thomson, ELS; Dennis, JJ				Thomson, Euan L. S.; Dennis, Jonathan J.			Common Duckweed (Lemna minor) Is a Versatile High-Throughput Infection Model For the Burkholderia cepacia Complex and Other Pathogenic Bacteria	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; GALLERIA-MELLONELLA; COLONY MORPHOLOGY; BIOFILM FORMATION; CENOCEPACIA; VIRULENCE; PLANT; GENES; SECRETION	Members of the Burkholderia cepacia complex (Bcc) have emerged in recent decades as problematic pulmonary pathogens of cystic fibrosis (CF) patients, with severe infections progressing to acute necrotizing pneumonia and sepsis. This study presents evidence that Lemna minor (Common duckweed) is useful as a plant model for the Bcc infectious process, and has potential as a model system for bacterial pathogenesis in general. To investigate the relationship between Bcc virulence in duckweed and Galleria mellonella (Greater wax moth) larvae, a previously established Bcc infection model, a duckweed survival assay was developed and used to determine LD50 values. A strong correlation (R-2 = 0.81) was found between the strains' virulence ranks in the two infection models, suggesting conserved pathways in these vastly different hosts. To broaden the application of the duckweed model, enteropathogenic Escherichia coli (EPEC) and five isogenic mutants with previously established LD50 values in the larval model were tested against duckweed, and a strong correlation (R-2 = 0.93) was found between their raw LD50 values. Potential virulence factors in B. cenocepacia K56-2 were identified using a high-throughput screen against single duckweed plants. In addition to the previously characterized antifungal compound (AFC) cluster genes, several uncharacterized genes were discovered including a novel lysR regulator, a histidine biosynthesis gene hisG, and a gene located near the gene encoding the recently characterized virulence factor SuhB(Bc). Finally, to demonstrate the utility of this model in therapeutic applications, duckweed was rescued from Bcc infection by treating with bacteriophage at 6-h intervals. It was observed that phage application became ineffective at a timepoint that coincided with a sharp increase in bacterial invasion of plant tissue. These results indicate that common duckweed can serve as an effective infection model for the investigation of bacterial virulence factors and therapeutic strategies to combat them.	[Thomson, Euan L. S.; Dennis, Jonathan J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Dennis, JJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jon.dennis@ualberta.ca	Dennis, Jonathan/E-8515-2014	Dennis, Jonathan/0000-0001-9288-6555; Dennis, Jonathan/0000-0002-3925-9533	Natural Sciences and Engineering Council of Canada; Cystic Fibrosis Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Natural Sciences and Engineering Council of Canada, Cystic Fibrosis Canada, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Bernier SP, 2008, INFECT IMMUN, V76, P38, DOI 10.1128/IAI.00874-07; BURKHOLDER WALTER H., 1950, PHYTOPATH, V40, P115; Burns JL, 1996, ANTIMICROB AGENTS CH, V40, P307, DOI 10.1128/AAC.40.2.307; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Castonguay-Vanier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011467; Champion OL, 2010, J INFECT DIS, V201, P776, DOI 10.1086/650494; Chiu CH, 2001, J MED MICROBIOL, V50, P594, DOI 10.1099/0022-1317-50-7-594; Chu KK, 2004, INFECT IMMUN, V72, P6142, DOI 10.1128/IAI.72.10.6142-6147.2004; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Dennis JJ, 2008, APPL ENVIRON MICROB, V64, P2710; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Iriti M, 2007, MYCOPATHOLOGIA, V164, P57, DOI 10.1007/s11046-007-9026-7; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Kang YW, 1998, APPL ENVIRON MICROB, V64, P3939; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Leuko S, 2012, INFECT IMMUN, V80, P3077, DOI 10.1128/IAI.00081-12; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Randhawa Muhammad Akram, 2009, J Ayub Med Coll Abbottabad, V21, P184; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rosales-Reyes R, 2012, MICROBIOL-SGM, V158, P2315, DOI 10.1099/mic.0.060988-0; Schikora A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024112; Schikora M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-171; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Seed KD, 2009, ANTIMICROB AGENTS CH, V53, P2205, DOI 10.1128/AAC.01166-08; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; Stotz HU, 2013, ANTIMICROBIAL PEPTID; Subramoni S, 2013, MICROBIOL-SGM, V159, P603, DOI 10.1099/mic.0.064683-0; Subramoni S, 2011, INFECT IMMUN, V79, P2984, DOI 10.1128/IAI.00170-11; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Yohalem DS, 1997, ANN APPL BIOL, V130, P467, DOI 10.1111/j.1744-7348.1997.tb07675.x; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	51	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80102	10.1371/journal.pone.0080102	http://dx.doi.org/10.1371/journal.pone.0080102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223216	Green Submitted, Green Published, gold			2022-12-25	WOS:000326656200109
J	Bodewes, R; Garcia, AR; Wiersma, LCM; Getu, S; Beukers, M; Schapendonk, CME; van Run, PRWA; van de Bildt, MWG; Poen, MJ; Osinga, N; Contreras, GJS; Kuiken, T; Smits, SL; Osterhaus, ADME				Bodewes, Rogier; Garcia, Ana Rubio; Wiersma, Lidewij C. M.; Getu, Sarah; Beukers, Martijn; Schapendonk, Claudia M. E.; van Run, Peter R. W. A.; van de Bildt, Marco W. G.; Poen, Marjolein J.; Osinga, Nynke; Contreras, Guillermo J. Sanchez; Kuiken, Thijs; Smits, Saskia L.; Osterhaus, Albert D. M. E.			Novel B19-Like Parvovirus in the Brain of a Harbor Seal	PLOS ONE			English	Article							CYNOMOLGUS MONKEYS; PHOCA-VITULINA; B19 PARVOVIRUS; IDENTIFICATION; INFECTION; VIRUS; MENINGOENCEPHALITIS; COINFECTION; DISEASE; ANEMIA	Using random PCR in combination with next-generation sequencing, a novel parvovirus was detected in the brain of a young harbor seal (Phoca vitulina) with chronic non-suppurative meningo-encephalitis that was rehabilitated at the Seal Rehabilitation and Research Centre (SRRC) in the Netherlands. In addition, two novel viruses belonging to the family Anelloviridae were detected in the lungs of this animal. Phylogenetic analysis of the coding sequence of the novel parvovirus, tentatively called Seal parvovirus, indicated that this virus belonged to the genus Erythrovirus, to which human parvovirus B19 also belongs. Although no other seals with similar signs were rehabilitated in SRRC in recent years, a prevalence study of tissues of seals from the same area collected in the period 2008-2012 indicated that the Seal parvovirus has circulated in the harbor seal population at least since 2008. The presence of the Seal parvovirus in the brain was confirmed by real-time PCR and in vitro replication. Using in situ hybridization, we showed for the first time that a parvovirus of the genus Erythrovirus was present in the Virchow-Robin space and in cerebral parenchyma adjacent to the meninges. These findings showed that a parvovirus of the genus Erythrovirus can be involved in central nervous system infection and inflammation, as has also been suspected but not proven for human parvovirus B19 infection.	[Bodewes, Rogier; Wiersma, Lidewij C. M.; Getu, Sarah; Schapendonk, Claudia M. E.; van Run, Peter R. W. A.; van de Bildt, Marco W. G.; Poen, Marjolein J.; Kuiken, Thijs; Smits, Saskia L.; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Osinga, Nynke; Contreras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Beukers, Martijn] Univ Utrecht, Fac Vet Med, Div Diagnost Imaging, Utrecht, Netherlands; [Smits, Saskia L.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl	Smits, Saskia/A-2953-2014	Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Kuiken, Thijs/0000-0001-5501-9049; Bodewes, Rogier/0000-0002-0689-7889	European Community [223498]; Dutch Virgo Consortium	European Community(European Commission); Dutch Virgo Consortium	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE; EC grant agreement number 223498) and the Dutch Virgo Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; BARRETT T, 1993, VIROLOGY, V193, P1010, DOI 10.1006/viro.1993.1217; Bodewes R, 2013, VIROLOGY, V440, P84, DOI 10.1016/j.virol.2013.02.011; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Bonvicini F, 2008, CLIN INFECT DIS, V47, P385, DOI 10.1086/589863; BORST GHA, 1986, J WILDLIFE DIS, V22, P1; Burns K, 2007, FIELDS VIROLOGY, P2437; Coskun O, 2008, CLIN MICROBIOL INFEC, V14, P1188, DOI 10.1111/j.1469-0691.2008.02110.x; Das Neves C, 2011, HERPESVIRUS INFECT M; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Douvoyiannis M, 2009, CLIN INFECT DIS, V48, P1713, DOI 10.1086/599042; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Greer LL, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P729, DOI 10.1201/9781420041637.ch32; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; ICTV, 2012, VIRUS TAXONOMY; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Koraka P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002682; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Maness HTD, 2011, VET MICROBIOL, V149, P23, DOI 10.1016/j.vetmic.2010.09.035; Morinet F, 2011, STEM CELLS, V29, P1656, DOI 10.1002/stem.725; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Nolan RC, 2003, CLIN INFECT DIS, V36, P1191, DOI 10.1086/374603; Osinga N, 2012, J COMP PATHOL, V147, P550, DOI 10.1016/j.jcpa.2012.04.001; Osinga Nynke, 2010, NAMMCO Scientific Publications, V8, P355; OSTERHAUS ADME, 1988, NATURE, V335, P403, DOI 10.1038/335403a0; OSullivan MG, 1997, J VIROL, V71, P4517, DOI 10.1128/JVI.71.6.4517-4521.1997; OSULLIVAN MG, 1994, J CLIN INVEST, V93, P1571, DOI 10.1172/JCI117136; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Rohayem J, 2001, J CLIN MICROBIOL, V39, P4585, DOI 10.1128/JCM.39.12.4585-4587.2001; Rommel SA, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P129; Servant-Delmas A, 2010, J VIROL, V84, P9658, DOI 10.1128/JVI.00684-10; Servey JT, 2007, AM FAM PHYSICIAN, V75, P373; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toan NL, 2006, J HEPATOL, V45, P361, DOI 10.1016/j.jhep.2006.03.013; Toan NL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-375; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; WILSON TM, 1972, J AM VET MED ASSOC, V161, P611; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518	45	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79259	10.1371/journal.pone.0079259	http://dx.doi.org/10.1371/journal.pone.0079259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223918	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400056
J	Sanderson, TH; Mahapatra, G; Pecina, P; Ji, QQ; Yu, KB; Sinkler, C; Varughese, A; Kumar, R; Bukowski, MJ; Tousignant, RN; Salomon, AR; Lee, I; Huttemann, M				Sanderson, Thomas H.; Mahapatra, Gargi; Pecina, Petr; Ji, Qinqin; Yu, Kebing; Sinkler, Christopher; Varughese, Ashwathy; Kumar, Rita; Bukowski, Melissa J.; Tousignant, Renee N.; Salomon, Arthur R.; Lee, Icksoo; Huttemann, Maik			Cytochrome c Is Tyrosine 97 Phosphorylated by Neuroprotective Insulin Treatment	PLOS ONE			English	Article							ISCHEMIC BRAIN-DAMAGE; CEREBRAL-ISCHEMIA; FOREBRAIN ISCHEMIA; APOPTOSIS; RELEASE; CARDIOLIPIN; DEATH; CELL; RESPIRATION; MECHANISMS	Recent advancements in isolation techniques for cytochrome c (Cytc) have allowed us to discover post-translational modifications of this protein. We previously identified two distinct tyrosine phosphorylated residues on Cytc in mammalian liver and heart that alter its electron transfer kinetics and the ability to induce apoptosis. Here we investigated the phosphorylation status of Cytc in ischemic brain and sought to determine if insulin-induced neuroprotection and inhibition of Cytc release was associated with phosphorylation of Cytc. Using an animal model of global brain ischemia, we found a similar to 50% decrease in neuronal death in the CA1 hippocampal region with post-ischemic insulin administration. This insulin-mediated increase in neuronal survival was associated with inhibition of Cytc release at 24 hours of reperfusion. To investigate possible changes in the phosphorylation state of Cytc we first isolated the protein from ischemic pig brain and brain that was treated with insulin. Ischemic brains demonstrated no detectable tyrosine phosphorylation. In contrast Cytc isolated from brains treated with insulin showed robust phosphorylation of Cytc, and the phosphorylation site was unambiguously identified as Tyr97 by immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry. We next confirmed these results in rats by in vivo application of insulin in the absence or presence of global brain ischemia and determined that Cytc Tyr97-phosphorylation is strongly induced under both conditions but cannot be detected in untreated controls. These data suggest a mechanism whereby Cytc is targeted for phosphorylation by insulin signaling, which may prevent its release from the mitochondria and the induction of apoptosis.	[Sanderson, Thomas H.; Kumar, Rita; Bukowski, Melissa J.; Tousignant, Renee N.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Sanderson, Thomas H.; Kumar, Rita; Bukowski, Melissa J.; Huttemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Mahapatra, Gargi; Pecina, Petr; Sinkler, Christopher; Varughese, Ashwathy; Huttemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Mahapatra, Gargi; Huttemann, Maik] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Pecina, Petr] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Pecina, Petr] Acad Sci Czech Republ, Ctr Appl Genom, Prague, Czech Republic; [Ji, Qinqin; Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, Chungcheongnam, South Korea	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Brown University; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48202 USA.	mhuttema@med.wayne.edu	Pecina, Petr/A-9396-2010; Yu, Kebing/D-4585-2014; Sanderson, Thomas H/K-6656-2012; Mahapatra, Gargi/ABC-9107-2020	Pecina, Petr/0000-0003-0641-2834; Sanderson, Thomas H/0000-0003-0112-8164; Mahapatra, Gargi/0000-0003-2363-4092; Huttemann, Maik/0000-0001-6310-7081; Kumar, Rita/0000-0002-9573-7667	National Institutes of Health [GM089900, NS076715, AI083636, AI083908]; Cardiovascular Research Institute; Department of Emergency Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636, R21AI083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Research Institute; Department of Emergency Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research described in this article was supported by grants GM089900 (MH), NS076715 (THS, RK), AI083636, and AI083908 (ARS) from the National Institutes of Health, the Cardiovascular Research Institute (MH, THS), the Department of Emergency Medicine, and the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao GD, 2004, J NEUROSCI, V24, P6189, DOI 10.1523/JNEUROSCI.1426-04.2004; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Matapurkar A, 2006, CELL DEATH DIFFER, V13, P2062, DOI 10.1038/sj.cdd.4401968; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Rodriguez-Roldan V, 2008, BIOCHEMISTRY-US, V47, P12371, DOI [10.1021/bi801329s, 10.1021/bi800910v]; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sanderson TH, 2008, J NEUROCHEM, V106, P1248, DOI 10.1111/j.1471-4159.2008.05473.x; Sanderson TH, 2013, JOVE-J VIS EXP, DOI 10.3791/50173; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Traub ML, 2009, J NEUROENDOCRINOL, V21, P1038, DOI 10.1111/j.1365-2826.2009.01927.x; VOLL CL, 1989, STROKE, V20, P646, DOI 10.1161/01.STR.20.5.646; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zhao X, 2010, MOL CELL PROTEOMICS	32	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78627	10.1371/journal.pone.0078627	http://dx.doi.org/10.1371/journal.pone.0078627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223835	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400038
J	Chen, R; Feng, LQ; Ruan, M; Liu, XH; Adriouch, S; Liao, H				Chen, Rong; Feng, Liqiang; Ruan, Mo; Liu, Xinghui; Adriouch, Sahil; Liao, Hua			Mechanical-Stretch of C2C12 Myoblasts Inhibits Expression of Toll-Like Receptor 3 (TLR3) and of Autoantigens Associated with Inflammatory Myopathies	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE; NITRIC-OXIDE; INDUCED ACTIVATION; REGENERATING MUSCLE; P38 MAPK; MYOSITIS; DIFFERENTIATION; DERMATOMYOSITIS	Recent studies in patients suffering from inflammatory autoimmune myopathies suggested that moderate exercise training improves or at least stabilizes muscle strength and function without inducing disease flares. However, the precise mechanisms involved in this beneficial effect have not been extensively studied. Here we used a model of in vitro stretched C2C12 myoblasts to investigate whether mechanical stretch could influence myoblast proliferation or the expression of proinflammatory genes. Our results demonstrated that cyclic mechanical stretch stimulated C2C12 cell cycling and early up-regulation of the molecules related to mechanical-stretch pathway in muscle (calmodulin, nNOS, MMP-2, HGF and c-Met). Unexpectedly, mechanical stretch also reduced the expression of TLR3 and of proteins known to represent autoantigens in inflammatory autoimmune myopathies (Mi-2, HRS, DNA-PKcs, U1-70). Interestingly, stimulation or inhibition of calmodulin, NOS, HGF or c-Met molecules in vitro affected the expression of autoantigens and TLR3 proteins confirming their role in the inhibition of autoantigens and TLR3 during mechanical stretch. Overall, this study demonstrates for the first time that mechanical stretch could be beneficial by reducing expression of muscle autoantigens and of pro-inflammatory TLR3 and may provide new insight to understand how resistance training can reduce the symptoms associated with myositis.	[Chen, Rong; Liu, Xinghui; Liao, Hua] Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Feng, Liqiang] NingXia Med Univ, Dept Anat, Ningxia, Peoples R China; [Ruan, Mo] KunMing Gen Hosp ChengDu Mil Command, Affiliated Orthoped Hosp, Kunming, Peoples R China; [Adriouch, Sahil] Univ Rouen, Inst Res & Innovat Biomed, INSERM, U905, Normandy, France	Southern Medical University - China; Ningxia Medical University; Kunming General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Liao, H (corresponding author), Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China.	hua-liao@163.com	ADRIOUCH, Sahil/G-8999-2012	ADRIOUCH, Sahil/0000-0002-0265-7773	National Natural Science Foundation of China [81171724, 81371924]; National Basic Research Program of China [2012CB619104]; Guang Dong Provincial Science and Technology Program [2012B031800146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Guang Dong Provincial Science and Technology Program	This study has been supported by grants from the National Natural Science Foundation of China (81171724) and (81371924), National Basic Research Program of China (Grant No. 2012CB619104), and Guang Dong Provincial Science and Technology Program (2012B031800146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexanderson H, 2007, ARTHRIT RHEUM-ARTHR, V57, P768, DOI 10.1002/art.22780; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Betteridge ZE, 2009, CURR OPIN RHEUMATOL, V21, P604, DOI 10.1097/BOR.0b013e328331638a; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Fluck M, 2000, J APPL PHYSIOL, V88, P352, DOI 10.1152/jappl.2000.88.1.352; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Hengstman GJD, 2001, CURR OPIN RHEUMATOL, V13, P476, DOI 10.1097/00002281-200111000-00004; Kook SH, 2008, MOL CELLS, V25, P479; Kook SH, 2008, MOL CELL BIOCHEM, V309, P133, DOI 10.1007/s11010-007-9651-y; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Mammen AL, 2009, ARTHRITIS RHEUM, V60, P3784, DOI 10.1002/art.24977; Nader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Okunishi K, 2007, J IMMUNOL, V179, P5504, DOI 10.4049/jimmunol.179.8.5504; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Tatsumi R., 2002, Animal Science Journal, V73, P235, DOI 10.1046/j.1344-3941.2002.00033.x; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x; Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V296, pC922, DOI 10.1152/ajpcell.00471.2008; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; VazquezAbad D, 1996, ARTHRITIS RHEUM, V39, P292, DOI 10.1002/art.1780390218; Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Yamada M, 2008, INT J BIOCHEM CELL B, V40, P2183, DOI 10.1016/j.biocel.2008.02.017; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372	29	12	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79930	10.1371/journal.pone.0079930	http://dx.doi.org/10.1371/journal.pone.0079930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224022	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400148
J	Ge, HT; Yin, XT; Xu, JH; Tang, YC; Han, Y; Xu, WJ; Pang, ZC; Meng, HW; Liu, SW				Ge, Haitao; Yin, Xuntao; Xu, Junhai; Tang, Yuchun; Han, Yan; Xu, Wenjian; Pang, Zengchang; Meng, Haiwei; Liu, Shuwei			Fiber Pathways of Attention Subnetworks Revealed with Tract-Based Spatial Statistics (TBSS) and Probabilistic Tractography	PLOS ONE			English	Article							WORKING-MEMORY; VISUOSPATIAL ATTENTION; EXECUTIVE ATTENTION; CORTICAL THICKNESS; PREFRONTAL CORTEX; BRAIN; NETWORKS; INDEPENDENCE; CEREBELLUM; MATURATION	It has been widely accepted that attention can be divided into three subnetworks - alerting, orienting and executive control (EC), and the subnetworks of attention are linked to distinct brain regions. However, the association between specific white matter fibers and the subnetworks of attention is not clear enough. Using diffusion tensor imaging (DTI), the white matter connectivity related to the performance of attention was assessed by attention network test (ANT) in 85 healthy adolescents. Tract-based spatial statistics (TBSS) and probabilistic diffusion tractography analysis demonstrated that cerebellothalamic tract was involved in alerting, while orienting depended upon the superior longitudinal fasciculus (SLF). In addition, EC was under the control of anterior corona radiata (ACR). Our findings suggest that different fiber pathways are involved in the three distinct subnetworks of attention. The current study will yield more precise information about the structural substrates of attention function and may aid the efforts to understand the neurophysiology of several attention disorders.	[Ge, Haitao; Yin, Xuntao; Xu, Junhai; Tang, Yuchun; Meng, Haiwei; Liu, Shuwei] Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China; [Han, Yan; Xu, Wenjian] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China; [Pang, Zengchang] Qingdao Municipal Ctr Dis Control & Prevent, Dept Epidemiol, Qingdao, Shandong, Peoples R China	Shandong University; Qingdao University	Liu, SW (corresponding author), Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China.	liusw@sdu.edu.cn		Yin, Xuntao/0000-0002-8228-6908; Xu, Junhai/0000-0002-4289-647X	National Natural Science Foundation of China [30871305, 81371533]; Graduate Independent Innovation Foundation of Shandong University [yzc12151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Independent Innovation Foundation of Shandong University	This study was supported by National Natural Science Foundation of China (No. 30871305, 81371533) and the Graduate Independent Innovation Foundation of Shandong University (No. yzc12151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Gallay MN, 2008, BRAIN STRUCT FUNCT, V212, P443, DOI 10.1007/s00429-007-0170-0; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Hatta T, 2004, APPL NEUROPSYCHOL, V11, P153, DOI 10.1207/s15324826an1103_3; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Klarborg B, 2012, HUM BRAIN MAPP; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; Nestor PG, 2007, SCHIZOPHR RES, V90, P308, DOI 10.1016/j.schres.2006.10.005; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Penke L., 2012, MOL PSYCHIAT; Petrides M, 2006, J COMP NEUROL, V498, P227, DOI 10.1002/cne.21048; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; SAKAI ST, 1993, J COMP NEUROL, V330, P183, DOI 10.1002/cne.903300204; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Suchan J, 2013, HUM BRAIN MAPP, DOI 10.1002/hbm.22232; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Takeuchi H, 2011, HUM BRAIN MAPP; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thimm M, 2011, PSYCHOL MED, V41, P1551, DOI 10.1017/S0033291710002217; Thimm M, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-54; Troster AI, 2002, EUR J NEUROL, V9, P143; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477	60	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78831	10.1371/journal.pone.0078831	http://dx.doi.org/10.1371/journal.pone.0078831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223852	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400090
J	Malhotra, U; Zaidi, AH; Kosovec, JE; Kasi, PM; Komatsu, Y; Rotoloni, CL; Davison, JM; Irvin, CR; Hoppo, T; Nason, KS; Kelly, LA; Gibson, MK; Jobe, BA				Malhotra, Usha; Zaidi, Ali H.; Kosovec, Juliann E.; Kasi, Pashtoon M.; Komatsu, Yoshihiro; Rotoloni, Christina L.; Davison, Jon M.; Irvin, Clint R.; Hoppo, Toshitaka; Nason, Katie S.; Kelly, Lori A.; Gibson, Michael K.; Jobe, Blair A.			Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium	PLOS ONE			English	Article							CELL CARCINOMA; APOPTOSIS; GENE; PREDICTORS; BLOOD; P53	Background: Survivin is an inhibitor of apoptosis and its over expression is associated with poor prognosis in several malignancies. While several studies have analyzed survivin expression in esophageal squamous cell carcinoma, few have focused on esophageal adenocarcinoma (EAC) and/or cancer-adjacent squamous epithelium (CASE). The purpose of this study was 1) to determine the degree of survivin up regulation in samples of EAC and CASE, 2) to evaluate if survivin expression in EAC and CASE correlates with recurrence and/or death, and 3) to examine the effect of survivin inhibition on apoptosis in EAC cells. Methods: Fresh frozen samples of EAC and CASE from the same patient were used for qRT-PCR and Western blot analysis, and formalin-fixed, paraffin-embedded tissue was used for immunohistochemistry. EAC cell lines, OE19 and OE33, were transfected with small interfering RNAs (siRNAs) to knockdown survivin expression. This was confirmed by qRT-PCR for survivin expression and Western blot analysis of cleaved PARP, cleaved caspase 3 and survivin. Survivin expression data was correlated with clinical outcome. Results: Survivin expression was significantly higher in EAC tumor samples compared to the CASE from the same patient. Patients with high expression of survivin in EAC tumor had an increased risk of death. Survivin expression was also noted in CASE and correlated with increased risk of distant recurrence. Cell line evaluation demonstrated that inhibition of survivin resulted in an increase in apoptosis. Conclusion: Higher expression of survivin in tumor tissue was associated with increased risk of death; while survivin expression in CASE was a superior predictor of recurrence. Inhibition of survivin in EAC cell lines further showed increased apoptosis, supporting the potential benefits of therapeutic strategies targeted to this marker.	[Malhotra, Usha] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Kasi, Pashtoon M.; Gibson, Michael K.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Zaidi, Ali H.; Kosovec, Juliann E.; Komatsu, Yoshihiro; Rotoloni, Christina L.; Irvin, Clint R.; Kelly, Lori A.] Allegheny Hlth Network, Allegheny Singer Res Inst, Pittsburgh, PA USA; [Davison, Jon M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Hoppo, Toshitaka; Jobe, Blair A.] Allegheny Hlth Network, Dept Surg, Pittsburgh, PA USA; [Nason, Katie S.] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jobe, BA (corresponding author), Allegheny Hlth Network, Dept Surg, Pittsburgh, PA USA.	bjobe1@wpahs.org	Kasi, Pashtoon Murtaza/M-2569-2019	Kasi, Pashtoon Murtaza/0000-0002-5169-7085	NCI NIH HHS [K07 CA151613] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA151613] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Beardsmore DA, 2003, J GASTROINTEST SURG, V7, P77, DOI 10.1016/S1091-255X(02)00141-5; Cao M, 2009, CLIN EXP METASTAS, V26, P751, DOI 10.1007/s10585-009-9274-7; Chang E, 2010, J THORAC CARDIOV SUR, V140, P225, DOI 10.1016/j.jtcvs.2009.11.038; Chiou SK, 2003, BIOCHEM BIOPH RES CO, V305, P374, DOI 10.1016/S0006-291X(03)00724-1; Dhir R, 2008, CANCER-AM CANCER SOC, V113, P1705, DOI 10.1002/cncr.23768; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grimminger P, 2009, J SURG ONCOL, V100, P447, DOI 10.1002/jso.21355; Hamoui N, 2004, ARCH SURG-CHICAGO, V139, P712, DOI 10.1001/archsurg.139.7.712; Hoffmann AC, 2010, PHARMACOGENOMICS, V11, P341, DOI [10.2217/pgs.09.164, 10.2217/PGS.09.164]; Kato J, 2001, INT J CANCER, V95, P92; Kaur P, 2004, ARCH PATHOL LAB MED, V128, P39; Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Ngan CY, 2008, CANCER SCI, V99, P129, DOI 10.1111/j.1349-7006.2007.00637.x; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Rosato A, 2006, INT J CANCER, V119, P1717, DOI 10.1002/ijc.21923; Shen X, 2012, AM J MED SCI, V344, P52, DOI 10.1097/MAJ.0b013e318239c4ee; Tamm I, 1998, CANCER RES, V58, P5315; Upadhyay R, 2011, ANN SURG ONCOL, V18, P880, DOI 10.1245/s10434-010-1371-y; Vallbohmer D, 2005, SURGERY, V138, P701, DOI 10.1016/j.surg.2005.06.051; Vetter CS, 2005, ARCH DERMATOL RES, V297, P26, DOI 10.1007/s00403-005-0572-x; Wani S, 2011, CLIN GASTROENTEROL H, V9, P220, DOI 10.1016/j.cgh.2010.11.008; Zhu HX, 2011, TUMOR BIOL, V32, P1147, DOI 10.1007/s13277-011-0217-y	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78343	10.1371/journal.pone.0078343	http://dx.doi.org/10.1371/journal.pone.0078343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223792	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326503400052
J	Streijger, F; Plunet, WT; Lee, JHT; Liu, J; Lam, CK; Park, S; Hilton, BJ; Fransen, BL; Matheson, KAJ; Assinck, P; Kwon, BK; Tetzlaff, W				Streijger, Femke; Plunet, Ward T.; Lee, Jae H. T.; Liu, Jie; Lam, Clarrie K.; Park, Soeyun; Hilton, Brett J.; Fransen, Bas L.; Matheson, Keely A. J.; Assinck, Peggy; Kwon, Brian K.; Tetzlaff, Wolfram			Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT1; ACTIVATED PROTEIN-KINASE; BETA-HYDROXYBUTYRATE; RAT-BRAIN; NEURONAL DAMAGE; STAIRCASE TEST; SYNAPTIC PLASTICITY; MOUSE-BRAIN; LEPTIN; ADULT	High fat, low carbohydrate ketogenic diets (KD) are validated non-pharmacological treatments for some forms of drug-resistant epilepsy. Ketones reduce neuronal excitation and promote neuroprotection. Here, we investigated the efficacy of KD as a treatment for acute cervical spinal cord injury (SCI) in rats. Starting 4 hours following C5 hemi-contusion injury animals were fed either a standard carbohydrate based diet or a KD formulation with lipid to carbohydrate plus protein ratio of 3: 1. The forelimb functional recovery was evaluated for 14 weeks, followed by quantitative histopathology. Post-injury 3: 1 KD treatment resulted in increased usage and range of motion of the affected forepaw. Furthermore, KD improved pellet retrieval with recovery of wrist and digit movements. Importantly, after returning to a standard diet after 12 weeks of KD treatment, the improved forelimb function remained stable. Histologically, the spinal cords of KD treated animals displayed smaller lesion areas and more grey matter sparing. In addition, KD treatment increased the number of glucose transporter-1 positive blood vessels in the lesion penumbra and monocarboxylate transporter-1 (MCT1) expression. Pharmacological inhibition of MCTs with 4-CIN (alpha-cyano-4-hydroxycinnamate) prevented the KD-induced neuroprotection after SCI, In conclusion, post-injury KD effectively promotes functional recovery and is neuroprotective after cervical SCI. These beneficial effects require the function of monocarboxylate transporters responsible for ketone uptake and link the observed neuroprotection directly to the function of ketones, which are known to exert neuroprotection by multiple mechanisms. Our data suggest that current clinical nutritional guidelines, which include relatively high carbohydrate contents, should be revisited.	[Streijger, Femke; Plunet, Ward T.; Lee, Jae H. T.; Liu, Jie; Lam, Clarrie K.; Park, Soeyun; Hilton, Brett J.; Fransen, Bas L.; Matheson, Keely A. J.; Assinck, Peggy; Kwon, Brian K.; Tetzlaff, Wolfram] Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Kwon, Brian K.; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Combined Neurosurg & Orthopaed Spine Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Tetzlaff, W (corresponding author), Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.	tetzlaff@icord.org	Hilton, Brett/N-9290-2019; Tetzlaff, Wolfram/AAY-4430-2020; Fransen, Bas/AAC-1020-2020; Assinck, Peggy/ABA-9634-2020; Assinck, Peggy/ABD-5333-2020	Hilton, Brett/0000-0003-2813-2294; Assinck, Peggy/0000-0001-6085-8162; Assinck, Peggy/0000-0001-6085-8162; Fransen, Bas/0000-0001-8865-8656	Craig Neilsen Foundation; Christopher and Dana Reeve Foundation; Canadian Institutes for Health Research; Rick Hansen Foundation	Craig Neilsen Foundation; Christopher and Dana Reeve Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Rick Hansen Foundation	This research was supported by The Craig Neilsen Foundation (to WT; www.chnfoundation.org), The Christopher and Dana Reeve Foundation (to FS; www.christopherreeve.org), and the Canadian Institutes for Health Research (to WT; www.cihr-irsc.gc.ca). WT holds the Edie Ehlers Chair in Spinal Cord Research funded by the Rick Hansen Foundation (www.rickhansen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Blazquez C, 1999, J NEUROCHEM, V73, P1674, DOI 10.1046/j.1471-4159.1999.731674.x; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; *CNS, 2002, NEUROSURGERY, V50, DOI DOI 10.1097/00006123-200203001-00015.PUBMED:12431291; Cruse JM, 2000, EXP MOL PATHOL, V68, P38, DOI 10.1006/exmp.1999.2292; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Duelli R, 1999, BRAIN RES, V831, P254, DOI 10.1016/S0006-8993(99)01463-8; Duelli R, 2001, NEWS PHYSIOL SCI, V16, P71; DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459; ELWOOD JC, 1960, J BIOL CHEM, V235, P573; Enerson BE, 2003, J PHARM SCI-US, V92, P1531, DOI 10.1002/jps.10389; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Genovese T, 2007, NEUROSCI LETT, V423, P41, DOI 10.1016/j.neulet.2007.05.058; Genovese T, 2006, SHOCK, V25, P608, DOI 10.1097/01.shk.0000209560.54328.69; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; ITOH T, 1970, BIOCHEM J, V116, P641, DOI 10.1042/bj1160641; Jaerve A, 2012, INT J BIOCHEM CELL B, V44, P452, DOI 10.1016/j.biocel.2011.11.023; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kloth V, 2006, BRAIN RES BULL, V70, P68, DOI 10.1016/j.brainresbull.2006.04.006; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; KWON BK, 2011, J NEUROTRAUMA; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018; Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu Y, 1999, J NEUROSCI, V19, P4370; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Makuc J, 2004, FEMS YEAST RES, V4, P795, DOI 10.1016/j.femsyr.2004.06.003; Massieu L, 2003, NEUROSCIENCE, V120, P365, DOI 10.1016/S0306-4522(03)00266-5; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Nikkhah G, 1998, BEHAV BRAIN RES, V92, P85, DOI 10.1016/S0166-4328(97)00128-9; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; Noh HS, 2004, MOL BRAIN RES, V129, P80, DOI 10.1016/j.molbrainres.2004.06.020; O'Malley D, 2007, MOL CELL NEUROSCI, V35, P559, DOI 10.1016/j.mcn.2007.05.001; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Pan JW, 2002, J CEREBR BLOOD F MET, V22, P890, DOI 10.1097/00004647-200207000-00014; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Plunet WT, 2010, ANN NY ACAD SCI, V1198, pE1, DOI 10.1111/j.1749-6632.2010.05564.x; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Puchowicz MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1607, DOI 10.1152/ajpendo.00512.2006; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; RILEY KO, 2001, NEUROLOGICAL INJURY; RODRIGUEZ DJ, 1999, NUTR SUPPORT; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Streijger F, 2013, J NEUROTRAUM, V30, P869, DOI 10.1089/neu.2012.2405; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Tai KK, 2007, NEUROSCI LETT, V425, P34, DOI 10.1016/j.neulet.2007.08.007; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WHISHAW IQ, 1994, BEHAV BRAIN RES, V61, P65, DOI 10.1016/0166-4328(94)90009-4; Xiaowei H, 2006, SPINAL CORD, V44, P35, DOI 10.1038/sj.sc.3101813; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722	98	67	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78765	10.1371/journal.pone.0078765	http://dx.doi.org/10.1371/journal.pone.0078765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223849	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400088
J	Szkandera, J; Stotz, M; Eisner, F; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; AlZoughbi, W; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M				Szkandera, Joanna; Stotz, Michael; Eisner, Florian; Absenger, Gudrun; Stojakovic, Tatjana; Samonigg, Hellmut; Kornprat, Peter; Schaberl-Moser, Renate; AlZoughbi, Wael; Ress, Anna Lena; Seggewies, Friederike Sophia; Gerger, Armin; Hoefler, Gerald; Pichler, Martin			External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; CIRCULATING NUMBERS; HEAD; INFLAMMATION; FOLFIRINOX; CARCINOMA; SURVIVAL; INVASION; TUMORS	Background: With growing evidence on the role of inflammation in cancer biology, the presence of a systemic inflammatory response has been postulated as having prognostic significance in a wide range of cancer types. The derived neutrophil to lymphocyte ratio (dNLR), which represents an easily determinable potential prognostic marker in daily practise and clinical trials, has never been externally validated in pancreatic cancer (PC) patients. Methods: Data from 474 consecutive PC patients, treated between 2004 and 2012 at a single centre, were evaluated retrospectively. Cancer-specific survival (CSS) was assessed using the Kaplan-Meier method. To evaluate the prognostic relevance of dNLR, univariate and multivariate Cox regression models were applied. Results: We calculated by ROC analysis a cut-off value of 2.3 for the dNLR to be ideal to discriminate between patients' survival in the whole cohort. Kaplan-Meier curve reveals a dNLR >= 2.3 as a factor for decreased CSS in PC patients (p<0.001, log-rank test). An independent significant association between high dNLR >= 2.3 and poor clinical outcome in multivariate analysis (HR = 1.24, CI95% = 1.01-1.51, p = 0.041) was identified. Conclusion: In the present study we confirmed elevated pre-treatment dNLR as an independent prognostic factor for clinical outcome in PC patients. Our data encourage independent replication in other series and settings of this easily available parameter as well as stratified analysis according to tumor resectability.	[Szkandera, Joanna; Stotz, Michael; Eisner, Florian; Absenger, Gudrun; Samonigg, Hellmut; Schaberl-Moser, Renate; Ress, Anna Lena; Seggewies, Friederike Sophia; Gerger, Armin; Pichler, Martin] Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria; [Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Kornprat, Peter] Med Univ Graz, Dept Surg, Div Gen Surg, Graz, Austria; [AlZoughbi, Wael; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Pichler, M (corresponding author), Med Univ Graz, Dept Med, Div Clin Oncol, Graz, Austria.	martin.pichler@medunigraz.at	, Kornprat/AAH-6353-2019; Hoefler, Gerald/H-1796-2016	Szkandera, Joanna/0000-0002-2217-893X; Hoefler, Gerald/0000-0002-9056-3063; Pichler, Martin/0000-0002-8701-9462	Oesterreichische Nationalbank'' (Anniversary Fund) [14320]	Oesterreichische Nationalbank'' (Anniversary Fund)	This study was supported by funds of the "Oesterreichische Nationalbank'' (Anniversary Fund, project number: 14320 to Gerald Hoefler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CUBILLA AL, 1978, CANCER, V41, P880, DOI 10.1002/1097-0142(197803)41:3<880::AID-CNCR2820410315>3.0.CO;2-J; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Fortner JG, 1996, ANN SURG, V223, P147, DOI 10.1097/00000658-199602000-00006; GRIFFANTIBARTOLI F, 1994, ANTICANCER RES, V14, P657; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; NAGAKAWA T, 1991, INT J PANCREATOL, V10, P113; Ozaki H, 1999, SURG TODAY, V29, P16; PETRIE HT, 1985, J IMMUNOL, V134, P230; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; RABINOWICH H, 1987, CANCER RES, V47, P173; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; SHAU H, 1988, J IMMUNOL, V141, P4395; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Stotz M, 2013, J CLIN PATH IN PRESS; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tinchon C, 2013, ACTA ONCOL, V52, P1231, DOI 10.3109/0284186X.2013.771821; ULICH TR, 1987, J IMMUNOL, V139, P3406; ULICH TR, 1989, BLOOD, V73, P108; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; Zikos TA, 2011, CANCER IMMUNOL IMMUN, V60, P819, DOI 10.1007/s00262-011-0996-4	36	78	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78225	10.1371/journal.pone.0078225	http://dx.doi.org/10.1371/journal.pone.0078225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223776	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400039
J	Baez-Saldana, R; Lopez-Arteaga, Y; Bizarron-Muro, A; Ferreira-Guerrero, E; Ferreyra-Reyes, L; Delgado-Sanchez, G; Cruz-Hervert, LP; Mongua-Rodriguez, N; Garcia-Garcia, L				Baez-Saldana, Renata; Lopez-Arteaga, Yesenia; Bizarron-Muro, Alma; Ferreira-Guerrero, Elizabeth; Ferreyra-Reyes, Leticia; Delgado-Sanchez, Guadalupe; Pablo Cruz-Hervert, Luis; Mongua-Rodriguez, Norma; Garcia-Garcia, Lourdes			A Novel Scoring System to Measure Radiographic Abnormalities and Related Spirometric Values in Cured Pulmonary Tuberculosis	PLOS ONE			English	Article							DISEASE; BURDEN; STANDARDIZATION; PREVALENCE; RISK; COPD	Background: Despite chemotherapy, patients with cured pulmonary tuberculosis may result in lung functional impairment. Objective: To evaluate a novel scoring system based on the degree of radiographic abnormalities and related spirometric values in patients with cured pulmonary tuberculosis. Methods: One hundred and twenty seven patients with cured pulmonary tuberculosis were prospectively enrolled in a referral hospital specializing in respiratory diseases. Spirometry was performed and the extent of radiographic abnormalities was evaluated twice by each of two readers to generate a novel quantitative score. Scoring reproducibility was analyzed by the intra-class correlation coefficient (ICC) and the Bland-Altman method. Multiple linear regression models were performed to assess the association of the extent of radiographic abnormalities with spirometric values. Results: The intra-observer agreement for scoring of radiographic abnormalities (SRA) showed an ICC of 0.81 (CI: 95%, 0.67-0.95) and 0.78 (CI: 95%, 0.65-0.92), for reader 1 and 2, respectively. Inter-observer reproducibility for the first measurement was 0.83 (CI: 95%, 0.71-0.95), and for the second measurement was 0.74 (CI: 95%, 0.58-0.90). The Bland-Altman analysis of the intra-observer agreement showed a mean bias of 0.87% and -0.55% and an inter-observer agreement of -0.35% and -1.78%, indicating a minor average systematic variability. After adjustment for age, gender, height, smoking status, pack-years of smoking, and degree of dyspnea, the scoring degree of radiographic abnormalities was significantly and negatively associated with absolute and percent predicted values of FVC: -0.07 (CI: 95%, -0.01 to -0.04); -2.48 (CI: 95%, -3.45 to -1.50); and FEV1-0.07 (CI: 95%, -0.10 to -0.05); -2.92 (CI: 95%, -3.87 to -1.97) respectively, in the patients studied. Conclusion: The extent of radiographic abnormalities, as evaluated through our novel scoring system, was inversely associated with spirometric values, and exhibited good reliability and reproducibility. As intra-observer and inter-observer agreement of the SRA varied from good to excellent, the use of SRA in this setting appears acceptable.	[Baez-Saldana, Renata; Lopez-Arteaga, Yesenia; Bizarron-Muro, Alma] INER, Mexico City, DF, Mexico; [Baez-Saldana, Renata; Ferreira-Guerrero, Elizabeth; Ferreyra-Reyes, Leticia; Delgado-Sanchez, Guadalupe; Pablo Cruz-Hervert, Luis; Mongua-Rodriguez, Norma; Garcia-Garcia, Lourdes] INSP, Cuernavaca, Morelos, Mexico		Baez-Saldana, R (corresponding author), INER, Mexico City, DF, Mexico.	baezrd@unam.mx	Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019	Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157	Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City	Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City	The study was sponsored by the Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1991, AM REV RESPIR DIS, V144, P1201; [Anonymous], 2009, PLAT UN INF MOD TUB; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Ehrlich RI, 2011, INT J TUBERC LUNG D, V15, P886, DOI 10.5588/ijtld.10.0526; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; ENRIGHT PL, 1991, AM REV RESPIR DIS, V143, P1215, DOI 10.1164/ajrccm/143.6.1215; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; JIMÉNEZ P PATRICIO, 2006, Rev. chil. enferm. respir., V22, P98; Kim SJ, 2006, INT J TUBERC LUNG D, V10, P1393; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oficial Norma Mexicana, 1993, NOM006SSA21993 OF NO; Organization WH, GLOB TUB REP 2012; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perez Rafael L, 2003, Semin Respir Infect, V18, P23, DOI 10.1053/srin.2003.50005; Perez-Padilla JR, 2001, SALUD PUBLICA MEXICO, V43, P113; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010; Vecino Mauricio, 2011, J Infect Public Health, V4, P244, DOI 10.1016/j.jiph.2011.08.005; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9	27	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78926	10.1371/journal.pone.0078926	http://dx.doi.org/10.1371/journal.pone.0078926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223865	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300042
J	Dias-Lopes, C; Neshich, IAP; Neshich, G; Ortega, JM; Granier, C; Chavez-Olortegui, C; Molina, F; Felicori, L				Dias-Lopes, Camila; Neshich, Izabella A. P.; Neshich, Goran; Ortega, Jose Miguel; Granier, Claude; Chavez-Olortegui, Carlos; Molina, Franck; Felicori, Liza			Identification of New Sphingomyelinases D in Pathogenic Fungi and Other Pathogenic Organisms	PLOS ONE			English	Article							WEB-BASED APPLICATION; DERMONECROTIC TOXIN; ARCANOBACTERIUM-HAEMOLYTICUM; LOXOSCELES-INTERMEDIA; PROTEIN-STRUCTURE; GENE FAMILY; SPIDER; SEQUENCE; VENOM; VIRULENCE	Sphingomyelinases D (SMases D) or dermonecrotic toxins are well characterized in Loxosceles spider venoms and have been described in some strains of pathogenic microorganisms, such as Corynebacterium sp. After spider bites, the SMase D molecules cause skin necrosis and occasional severe systemic manifestations, such as acute renal failure. In this paper, we identified new SMase D amino acid sequences from various organisms belonging to 24 distinct genera, of which, 19 are new. These SMases D share a conserved active site and a C-terminal motif. We suggest that the C-terminal tail is responsible for stabilizing the entire internal structure of the SMase D Tim barrel and that it can be considered an SMase D hallmark in combination with the amino acid residues from the active site. Most of these enzyme sequences were discovered from fungi and the SMase D activity was experimentally confirmed in the fungus Aspergillus flavus. Because most of these novel SMases D are from organisms that are endowed with pathogenic properties similar to those evoked by these enzymes alone, they might be associated with their pathogenic mechanisms.	[Dias-Lopes, Camila; Ortega, Jose Miguel; Chavez-Olortegui, Carlos; Felicori, Liza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim Imunol, Belo Horizonte, MG, Brazil; [Neshich, Izabella A. P.] Univ Estadual Campinas UNICAMP, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Neshich, Goran] Embrapa Informat Technol, Campinas, SP, Brazil; [Granier, Claude; Molina, Franck] BioRad, CNRS, SysDiag UMR 3145, Montpellier, France	Universidade Federal de Minas Gerais; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Centre National de la Recherche Scientifique (CNRS)	Felicori, L (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim Imunol, Belo Horizonte, MG, Brazil.	liza@icb.ufmg.br	Ortega, J Miguel/E-8272-2011; Felicori, Liza F/I-6683-2013; Pena, Izabella/P-6345-2017; Chavez-Olortegui, Carlos/F-9227-2019	Ortega, J Miguel/0000-0002-8047-9191; Pena, Izabella/0000-0001-5242-3724; Chavez-Olortegui, Carlos/0000-0001-9390-7207	INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Centre national de la recherche scientifique (CNRS) [2474]; Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES [23038000825/2011-63]; FAPESP [12/00235-5, 2009/16376-4]	INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Centre national de la recherche scientifique (CNRS) - Projet International de Cooperation Scientifique [PICS no. 2474] and Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES (Toxinologia no. 23038000825/2011-63). Izabella Pena Neshich received a PhD fellowship from FAPESP- 12/00235-5 and Goran Neshich received support from FAPESP (research project number 2009/16376-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2009, PARASITE IMMUNOL, V31, P210, DOI 10.1111/j.1365-3024.2009.01095.x; Albermann S, 2013, APPL MICROBIOL BIOT, V97, P2979, DOI 10.1007/s00253-012-4377-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameen M, 2010, CLIN EXP DERMATOL, V35, P576, DOI 10.1111/j.1365-2230.2009.03647.x; Ampel Neil M, 2010, Proc Am Thorac Soc, V7, P181, DOI 10.1513/pats.200907-080AL; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Barthelmes J, 2007, NUCLEIC ACIDS RES, V35, pD511, DOI 10.1093/nar/gkl972; Bazzini S, 2011, APPL MICROBIOL BIOT, V92, P887, DOI 10.1007/s00253-011-3616-5; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Bramwell PA, 1998, LETT APPL MICROBIOL, V27, P255, DOI 10.1046/j.1472-765X.1998.00439.x; Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Dighe NS, 2009, ARLING S DIS REV, V1, P88; Edwards KT, 2011, VET PARASITOL, V183, P1, DOI 10.1016/j.vetpar.2011.09.038; Fernandes JH, 2003, BIOCHEM BIOPH RES CO, V308, P533; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Health TC for FS and P Biologics I for IC in A, 2005, DERMATOPHYTOSIS, P1; Health TC for FS and P Biologics I for IC in A, 2009, REV REP ACT SUBST MA, P1; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Horta CCR, 2013, J INVEST DERMATOL, V133, P1682, DOI 10.1038/jid.2013.40; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurgenson JE, 2002, APPL ENVIRON MICROB, V68, P1972, DOI 10.1128/AEM.68.4.1972-1979.2002; Kiss T, 2012, VET PARASITOL, V187, P357, DOI 10.1016/j.vetpar.2012.02.010; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Li XP, 2012, INFECT IMMUN, V80, P429, DOI 10.1128/IAI.05830-11; Lucas EA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-270; Mancini AL, 2004, BIOINFORMATICS, V20, P2145, DOI 10.1093/bioinformatics/bth203; Marcellino LH, 1996, FEBS LETT, V385, P154, DOI 10.1016/0014-5793(96)00375-4; MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Neshich G, 2006, GENET MOL RES, V5, P717; Neshich G, 2004, NUCLEIC ACIDS RES, V32, pW595, DOI 10.1093/nar/gkh480; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Ribeiro C, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-36; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	54	19	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79240	10.1371/journal.pone.0079240	http://dx.doi.org/10.1371/journal.pone.0079240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223912	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300068
J	Jonas, JB; Holbach, L; Panda-Jonas, S				Jonas, Jost B.; Holbach, Leonard; Panda-Jonas, Songhomitra			Peripapillary Arterial Circle of Zinn-Haller: Location and Spatial Relationships with Myopia	PLOS ONE			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; OPTIC-NERVE HEAD; FUNDUS FLUORESCEIN ANGIOGRAPHY; ANGLE-CLOSURE GLAUCOMA; BEIJING EYE; COHERENCE TOMOGRAPHY; LAMINA-CRIBROSA; IN-VIVO; VASCULATURE; RING	Purpose: To measure histomorphometrically the location of the peripapillary arterial circle of Zinn-Haller (ZHAC) and assess its associations with axial length. Methods: Using a light microscope, we measured the distance from the ZHAC to the peripapillary ring (optic disc border), the merging point of the dura mater with the posterior sclera ("dura-sclera point"), and the inner scleral surface. In the parapapillary region, we differentiated between beta zone (presence of Bruch's membrane, absence of retinal pigment epithelium) and gamma zone (absence of Bruch's membrane). The peripapillary scleral flange as roof of the orbital cerebrospinal fluid space was the connection between the end of the lamina cribrosa and the posterior full-thickness sclera starting at the dura-sclera point. Results: The study included 101 human globes (101 patients) with a mean axial length of 26.7 +/- 3.7 mm (range: 20.0-39.0 mm). The distance between the ZHAC and the peripapillary ring increased significantly with longer axial length (P<0.001; correlation coefficient r=0.49), longer parapapillary gamma zone (P<0.001; r=0.85), longer (P<0.001; r=0.73) land thinner (P<0.001; r=-0.45) peripapillary scleral flange, and thinner sclera posterior to the equator (P<0.001). ZHAC distance to the peripapillary ring was not significantly associated with length of parapapillary beta zone (P=0.33). Including only non-highly myopic eyes (axial length <26.5 mm), the ZHAC distance to the disc border was not related with axial length (P=0.84). In non-highly myopic eyes, the ZHAC was located close to the dura-sclera point. With increasing axial length and decreasing thickness of the peripapillary scleral flange, the ZHAC was located closer to the inner scleral surface. Conclusions: The distance between the ZHAC and the optic disc border is markedly enlarged in highly myopic eyes. Since the ZHAC is the main arterial source for the lamina cribrosa blood supply, the finding may be of interest for the pathogenesis of the increased glaucoma susceptibility in highly myopic eyes.	[Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Holbach, Leonard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.	Jost.Jonas@medma.uni-heidelberg.de						ANDERSON DR, 1976, AM J OPHTHALMOL, V82, P165, DOI 10.1016/0002-9394(76)90414-1; Haller A, 1754, A HALLERS PHYSL; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; HAYREH SS, 1985, DOC OPHTHALMOL, V59, P217, DOI 10.1007/BF00159262; HAYREH SS, 1974, T AM ACAD OPHTHALMOL, V78, P240; HENKIND P, 1969, AM J OPHTHALMOL, V68, P979, DOI 10.1016/0002-9394(69)93437-0; Hollo G, 1998, BRIT J OPHTHALMOL, V82, P332; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P134, DOI 10.1007/BF00164651; Jonas JB, 2012, PLOS ONE, V7; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe317, DOI 10.1111/j.1755-3768.2010.02022.x; Ko MK, 1999, BRIT J OPHTHALMOL, V83, P862, DOI 10.1136/bjo.83.7.862; Ko MK, 1997, BRIT J OPHTHALMOL, V81, P663, DOI 10.1136/bjo.81.8.663; LEVITZKY M, 1969, AM J OPHTHALMOL, V68, P986, DOI 10.1016/0002-9394(69)93438-2; LIEBERMAN MF, 1976, AM J OPHTHALMOL, V82, P405, DOI 10.1016/0002-9394(76)90489-X; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Ohno-Matsui K, 1998, BRIT J OPHTHALMOL, V82, P1357, DOI 10.1136/bjo.82.12.1357; Ohno-Matsui K, 2013, AM J OPHTHALMOL, V155, P920, DOI 10.1016/j.ajo.2012.12.010; OhnoMatsui K, 1997, AM J OPHTHALMOL, V123, P494, DOI 10.1016/S0002-9394(14)70175-8; OLVER JM, 1994, INVEST OPHTH VIS SCI, V35, P3858; ONDA E, 1995, AM J OPHTHALMOL, V120, P92, DOI 10.1016/S0002-9394(14)73763-8; Park KH, 1996, AM J OPHTHALMOL, V122, P905, DOI 10.1016/S0002-9394(14)70398-8; Povazay B, 2009, INVEST OPHTH VIS SCI, V50, P1856, DOI 10.1167/iovs.08-2869; QUIGLEY HA, 1977, AM J OPHTHALMOL, V84, P358, DOI 10.1016/0002-9394(77)90680-8; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu LA, 2010, ACTA OPHTHALMOL, V88, pe350, DOI 10.1111/j.1755-3768.2009.01770.x; Yasuzumi K, 2003, BRIT J OPHTHALMOL, V87, P1088, DOI 10.1136/bjo.87.9.1088; ZHAO Y, 1987, JPN J OPHTHALMOL, V31, P147; Zinn J, 1755, DESCRIPTIO ANATOMICA	35	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78867	10.1371/journal.pone.0078867	http://dx.doi.org/10.1371/journal.pone.0078867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223862	Green Submitted, Green Published, gold			2022-12-25	WOS:000326499300040
J	Mahande, MJ; Daltveit, AK; Mmbaga, BT; Masenga, G; Obure, J; Manongi, R; Lie, RT				Mahande, Michael J.; Daltveit, Anne K.; Mmbaga, Blandina T.; Masenga, Gileard; Obure, Joseph; Manongi, Rachel; Lie, Rolv T.			Recurrence of Preeclampsia in Northern Tanzania: A Registry-Based Cohort Study	PLOS ONE			English	Article							SUBSEQUENT PREGNANCY; 2ND PREGNANCY; RISK-FACTORS; WOMEN; 1ST; OUTCOMES; COMPLICATIONS	Objective: Preeclampsia occurs in about 4 per cent of pregnancies worldwide, and may have particularly serious consequences for women in Africa. Studies in western countries have shown that women with preeclampsia in one pregnancy have a substantially increased risk of preeclampsia in subsequent pregnancies. We estimate the recurrence risks of preeclampsia in data from Northern Tanzania. Methods: A prospective cohort study was designed using 19,811 women who delivered singleton infants at a hospital in Northern Tanzania between 2000 and 2008. A total of 3,909 women were recorded with subsequent deliveries in the hospital with follow up through 2010. Adjusted recurrence risks of preeclampsia were computed using regression models. Results: The absolute recurrence risk of preeclampsia was 25%, which was 9.2-fold (95% CI: 6.4 - 13.2) compared with the risk for women without prior preeclampsia. When there were signs that the preeclampsia in a previous pregnancy had been serious either because the baby was delivered preterm or had died in the perinatal period, the recurrence risk of preeclampsia was even higher. Women who had preeclampsia had increased risk of a series of adverse pregnancy outcomes in future pregnancies. These include perinatal death (RR = 4.3), a baby with low birth weight (RR = 3.5), or a preterm birth (RR = 2.5). These risks were only partly explained by recurrence of preeclampsia. Conclusions: Preeclampsia in one pregnancy is a strong predictor for preeclampsia and other adverse pregnancy outcomes in subsequent pregnancies in Tanzania. Women with previous preeclampsia may benefit from close follow-up during their pregnancies.	[Mahande, Michael J.; Obure, Joseph; Manongi, Rachel] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mahande, Michael J.; Daltveit, Anne K.; Mmbaga, Blandina T.; Lie, Rolv T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Mahande, Michael J.; Mmbaga, Blandina T.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Daltveit, Anne K.; Lie, Rolv T.] Norwegian Inst Publ Hlth, Oslo, Norway; [Masenga, Gileard; Obure, Joseph] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynaecol, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Dept Pediat, Moshi, Tanzania	University of Bergen; University of Bergen; Norwegian Institute of Public Health (NIPH); Kilimanjaro Christian Medical Centre; Kilimanjaro Christian Medical Centre	Mahande, MJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.	jmmahande@yahoo.com	Mahande, Michael Johnson J/I-6359-2015; Mmbaga, Blandina Theophil/AAR-8707-2021	Mahande, Michael Johnson J/0000-0002-7750-7657; Mmbaga, Blandina Theophil/0000-0002-5550-1916	Norwegian Council for Higher Education; Quota scholarship scheme	Norwegian Council for Higher Education; Quota scholarship scheme	The birth registry was supported by the Norwegian Council for Higher Education's Program for Development Research or Nasjonalt program for Utvikling, Forskning og Utdanning (NUFU) and Quota scholarship scheme as part of MJM PhD training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56; Bhattacharya S, 2009, OBSTET GYNECOL SURV, V64, P577, DOI 10.1097/01.ogx.0000358026.53650.5a; Bramham K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.014; Brown MA, 2007, BJOG-INT J OBSTET GY, V114, P984, DOI 10.1111/j.1471-0528.2007.01376.x; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Dildy GA, 2007, SEMIN PERINATOL, V31, P135, DOI 10.1053/j.semperi.2007.03.005; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Macdonald-Wallis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022115; Mahomed K, 1998, PAEDIATR PERINAT EP, V12, P253, DOI 10.1046/j.1365-3016.1998.00116.x; Mahomed K., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P218; Majoko F, 2005, TROP DOCT, V35, P195, DOI 10.1258/004947505774938710; Makkonen N, 2000, HYPERTENS PREGNANCY, V19, P173, DOI 10.1081/PRG-100100133; Mbah AK, 2011, EUR J OBSTET GYN R B, V156, P23, DOI 10.1016/j.ejogrb.2010.12.036; Melamed N, 2012, J MATERN-FETAL NEO M, V25, P2248, DOI 10.3109/14767058.2012.684174; Mmbaga BT, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-68; Obed Sa, 2007, Ghana Med J, V41, P139; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; van Rijn BB, 2006, AM J OBSTET GYNECOL, V195, P723, DOI 10.1016/j.ajog.2006.06.044; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Williams D, 2011, SEMIN NEPHROL, V31, P111, DOI 10.1016/j.semnephrol.2010.10.010	23	10	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79116	10.1371/journal.pone.0079116	http://dx.doi.org/10.1371/journal.pone.0079116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223889	Green Published, gold, Green Submitted			2022-12-25	WOS:000326499300058
J	Rolls, DA; Sacks-Davis, R; Jenkinson, R; McBryde, E; Pattison, P; Robins, G; Hellard, M				Rolls, David A.; Sacks-Davis, Rachel; Jenkinson, Rebecca; McBryde, Emma; Pattison, Philippa; Robins, Garry; Hellard, Margaret			Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject Drugs	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; SPONTANEOUS VIRAL CLEARANCE; P-ASTERISK MODELS; VIRUS-INFECTION; COST-EFFECTIVENESS; PLUS RIBAVIRIN; SOCIAL NETWORK; REINFECTION; USERS; HIV	Hepatitis C virus (HCV) chronically infects over 180 million people worldwide, with over 350,000 estimated deaths attributed yearly to HCV-related liver diseases. It disproportionally affects people who inject drugs (PWID). Currently there is no preventative vaccine and interventions feature long treatment durations with severe side-effects. Upcoming treatments will improve this situation, making possible large-scale treatment interventions. How these strategies should target HCV-infected PWID remains an important unanswered question. Previous models of HCV have lacked empirically grounded contact models of PWID. Here we report results on HCV transmission and treatment using simulated contact networks generated from an empirically grounded network model using recently developed statistical approaches in social network analysis. Our HCV transmission model is a detailed, stochastic, individual-based model including spontaneously clearing nodes. On transmission we investigate the role of number of contacts and injecting frequency on time to primary infection and the role of spontaneously clearing nodes on incidence rates. On treatment we investigate the effect of nine network-based treatment strategies on chronic prevalence and incidence rates of primary infection and re-infection. Both numbers of contacts and injecting frequency play key roles in reducing time to primary infection. The change from "less-" to "more-frequent" injector is roughly similar to having one additional network contact. Nodes that spontaneously clear their HCV infection have a local effect on infection risk and the total number of such nodes (but not their locations) has a network wide effect on the incidence of both primary and re-infection with HCV. Re-infection plays a large role in the effectiveness of treatment interventions. Strategies that choose PWID and treat all their contacts (analogous to ring vaccination) are most effective in reducing the incidence rates of re-infection and combined infection. A strategy targeting infected PWID with the most contacts (analogous to targeted vaccination) is the least effective.	[Rolls, David A.; Pattison, Philippa; Robins, Garry] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia; [McBryde, Emma] Univ Melbourne, Dept Med RMH, Melbourne, Vic, Australia	University of Melbourne; Burnet Institute; Monash University; Burnet Institute; University of Melbourne	Rolls, DA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	drolls@unimelb.edu.au	Sacks-Davis, Rachel/H-3277-2019; Rolls, David/C-2886-2012; McBryde, Emma/D-2220-2018	Rolls, David/0000-0003-0397-9923; Sacks-Davis, Rachel/0000-0003-0860-2762; McBryde, Emma/0000-0002-9570-9172; Pattison, Philippa/0000-0001-9626-2897; Robins, Garry/0000-0001-7538-5804	Australian Research Council [0987730]; Australian National Health and Medical Research Council [331312]; Victorian Medical Research Operational Infrastructure Program	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Medical Research Operational Infrastructure Program	This work was supported in part by the Australian Research Council (Discovery project grant 0987730, http://www.arc.gov.au/ncgp/dp/dp_default.htm), the Australian National Health and Medical Research Council (project grant 331312, postgraduate scholarship to RSD, Senior Research Fellowship to MH, http://www.nhmrc.gov.au/) and funding from the Victorian Medical Research Operational Infrastructure Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program) to the Burnet Institute (http://www.burnet.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Aitken CK, 2004, J INFECT DIS, V190, P1586, DOI 10.1086/424678; ANDERSON R M, 1991; [Anonymous], 2012, MATLAB VERS 7 14 0 R; [Anonymous], 2008, STUDY CHARACTERIZE E; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Backmund M, 2004, CLIN INFECT DIS, V39, P1540, DOI 10.1086/425361; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2011, PAJEK PROGRAM LARGE; Bate JP, 2010, J GASTROEN HEPATOL, V25, P1276, DOI 10.1111/j.1440-1746.2010.06295.x; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; Caruntu Florin Alexandru, 2006, J Gastrointestin Liver Dis, V15, P249; Centers for Disease Control and Prevention, 2003, GUID SMALL IN PRESS; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Currie SL, 2008, DRUG ALCOHOL DEPEN, V93, P148, DOI 10.1016/j.drugalcdep.2007.09.011; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; De P, 2007, JAIDS-J ACQ IMM DEF, V46, P355, DOI 10.1097/QAI.0b013e3181565dde; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Esposito N, 2004, MATH BIOSCI, V188, P29, DOI 10.1016/j.mbs.2003.11.001; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Friedman SR, 1998, ADDICTION, V93, P1403, DOI 10.1046/j.1360-0443.1998.939140311.x; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Grady BPX, 2012, EUR J GASTROEN HEPAT, V24, P1302, DOI 10.1097/MEG.0b013e32835702a8; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn JA, 2009, EPIDEMICS-NETH, V1, P47, DOI 10.1016/j.epidem.2008.10.002; Hartvigsen G, 2007, J THEOR BIOL, V246, P205, DOI 10.1016/j.jtbi.2006.12.027; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Hutchinson SJ, 2006, INT J DRUG POLICY, V17, P211, DOI 10.1016/j.drugpo.2006.02.008; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Khan B, 2012, MODELING DYNAMIC RIS; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; Mather D, 1999, EUR J EPIDEMIOL, V15, P5, DOI 10.1023/A:1007548307196; McDonald SA, 2012, INT J DRUG POLICY, V23, P353, DOI 10.1016/j.drugpo.2012.02.003; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Murray JM, 2003, INT J EPIDEMIOL, V32, P708, DOI 10.1093/ije/dyg102; National Centre in HIV Epidemiology and Clinical Research (NCHECR), 2006, HEP C VIR PROJ WORK; NCHECR, 2009, RET INV 2 EV COST EF; Neaigus A, 1995, NIDA Res Monogr, V151, P20; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pattison PE, 2013, J MATH PSYC IN PRESS; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Rolls DA, 2013, SOC NETWORK IN PRESS; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Vickerman P, 2007, INT J EPIDEMIOL, V36, P396, DOI 10.1093/ije/dyl276; Vickerman P, 2009, SEX TRANSM INFECT, V85, P23, DOI 10.1136/sti.2008.034660; Vickerman P, 2012, J INFECT DIS, V205, P1342, DOI 10.1093/infdis/jis213; Vidondo B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-51; Wang P., 2006, PNET PROGRAM SIMULAT; Wasley A, 2008, MMWR SURVEILL SUMM, V57, P124; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watanabe H, 2003, J MED VIROL, V71, P56, DOI 10.1002/jmv.10448; Welch D, 2011, EPIDEMICS-NETH, V3, P38, DOI 10.1016/j.epidem.2011.01.002; World Health Organization, 2012, PREV CONTR VIR HEP I; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229	81	44	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78286	10.1371/journal.pone.0078286	http://dx.doi.org/10.1371/journal.pone.0078286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223787	gold, Green Published, Green Accepted			2022-12-25	WOS:000326499300027
J	Muller, PAJ; Trinidad, AG; Caswell, PT; Norman, JC; Vousden, KH				Muller, Patricia A. J.; Trinidad, Antonio G.; Caswell, Patrick T.; Norman, Jim C.; Vousden, Karen H.			Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Motility; Dicer; MicroRNA; p63; Cell Scattering; Mutant p53	CELL-MIGRATION; DOWN-REGULATION; TAP63; P63; METASTASIS; INTEGRIN; CANCER; PROLIFERATION; MODULATION; EXPRESSION	The control and processing of microRNAs (miRs) is critical in the regulation of all cellular responses. Previous studies have suggested that a reduction in the expression of certain miRs, or an overall decrease in miR processing through the partial depletion of Dicer, can promote enhanced metastatic potential. We show here that Dicer depletion can promote the invasive behavior of cells that is reflected in enhanced recycling and activation of the growth factor receptors Met and EGF receptor. These responses are also seen in response to the expression of tumor-derived mutant p53s, and we show that mutant p53 can down-regulate Dicer expression through both direct inhibition of the TAp63-mediated transcriptional activation of Dicer and a TAp63-independent control of Dicer protein expression. Our results delineate a clear relationship between mutant p53, TAp63, and Dicer that might contribute to the metastatic function of mutant p53 but, interestingly, also reveal TAp63-independent functions of mutant p53 in controlling Dicer activity.	[Muller, Patricia A. J.; Trinidad, Antonio G.; Norman, Jim C.; Vousden, Karen H.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Caswell, Patrick T.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Beatson Institute; University of Manchester	Muller, PAJ (corresponding author), MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	PM292@le.ac.uk	Muller, Patricia AJ/AAH-1888-2019; Caswell, Patrick/N-3063-2015	Muller, Patricia AJ/0000-0002-0926-1499; Caswell, Patrick/0000-0002-2633-2324; NORMAN, Jim/0000-0002-0098-3014	Cancer Research UK; AICR (Association For International Cancer Research); Breast Cancer Campaign; Wellcome Trust/The Royal Society; Medical Research Council; MRC [MC_UP_1203/3] Funding Source: UKRI; Cancer Research UK [18274] Funding Source: researchfish; Medical Research Council [MC_UP_1203/3] Funding Source: researchfish; Wellcome Trust [101242/A/13/Z] Funding Source: researchfish; Breast Cancer Campaign [2011NovPR12] Funding Source: researchfish; Worldwide Cancer Research [11-0626] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR (Association For International Cancer Research); Breast Cancer Campaign; Wellcome Trust/The Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Campaign; Worldwide Cancer Research	This work was supported by Cancer Research UK and the AICR (Association For International Cancer Research) and Breast Cancer Campaign (to K. H. V. and J. C. N.) and by the Wellcome Trust/The Royal Society and the Medical Research Council to (P. A. J. M.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chang L, 2012, RNA BIOL, V9, P1247, DOI 10.4161/rna.21821; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; Damiani MT, 2004, TRAFFIC, V5, P785, DOI 10.1111/j.1600-0854.2004.00220.x; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Kuang Y, 2013, ONCOL LETT, V5, P1149, DOI 10.3892/ol.2013.1158; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.97; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	50	56	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					122	132		10.1074/jbc.M113.502138	http://dx.doi.org/10.1074/jbc.M113.502138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220032	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000329370900011
J	Feinberg, H; Rowntree, TJW; Tan, SLW; Drickamer, K; Weis, WI; Taylor, ME				Feinberg, Hadar; Rowntree, Thomas J. W.; Tan, Shawn L. W.; Drickamer, Kurt; Weis, William I.; Taylor, Maureen E.			Common Polymorphisms in Human Langerin Change Specificity for Glycan Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Crystal Structure; Genetic Polymorphism; Glycobiology; Lectin; CD207; Sulfated Glycans	C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; HIV-1 TRANSMISSION; STRUCTURAL BASIS; DC-SIGN; CELLS; BIOSYNTHESIS; ANTIGENS; RECEPTOR; VIRUS	Langerin, a C-type lectin on Langerhans cells, mediates carbohydrate-dependent uptake of pathogens in the first step of antigen presentation to the adaptive immune system. Langerin binds a diverse range of carbohydrates including high mannose structures, fucosylated blood group antigens, and glycans with terminal 6-sulfated galactose. Mutagenesis and quantitative binding assays indicate that salt bridges between the sulfate group and two lysine residues compensate for the nonoptimal binding of galactose at the primary Ca2+ site. A commonly occurring single nucleotide polymorphism (SNP) in human langerin results in change of one of these lysine residues, Lys-313, to isoleucine. Glycan array screening reveals that this amino acid change abolishes binding to oligosaccharides with terminal 6SO(4)-Gal and enhances binding to oligosaccharides with terminal GlcNAc residues. Structural analysis shows that enhanced binding to GlcNAc may result from Ile-313 packing against the N-acetyl group. The K313I polymorphism is tightly linked to another SNP that results in the change N288D, which reduces affinity for glycan ligands by destabilizing the Ca2+-binding site. Langerin with Asp-288 and Ile-313 shows no binding to 6SO(4)-Gal-terminated glycans and increased binding to GlcNAc-terminated structures, but overall decreased binding to glycans. Altered langerin function in individuals with the linked N288D and K313I polymorphisms may affect susceptibility to infection by microorganisms.	[Rowntree, Thomas J. W.; Tan, Shawn L. W.; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94306 USA	Imperial College London; Stanford University; Stanford University	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Drickamer, Kurt/0000-0001-5026-5996	National Institutes of Health [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Consortium for Functional Glycomics was supported by Grant GM62116 from the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSSON M, 1989, CARBOHYD RES, V185, P211, DOI 10.1016/0008-6215(89)80036-9; Chabrol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050722; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; de Jong MAWP, 2010, J LEUKOCYTE BIOL, V87, P637, DOI 10.1189/jlb.0809577; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Hiraoka N, 2007, GLYCOBIOLOGY, V17, P277, DOI 10.1093/glycob/cwl077; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stoitzner P, 2011, EUR J IMMUNOL, V41, P2526, DOI 10.1002/eji.201141934; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Varki A., 2009, ESSENTIALS GLYCOBIOL; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	30	38	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36762	36771		10.1074/jbc.M113.528000	http://dx.doi.org/10.1074/jbc.M113.528000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217250	hybrid, Green Published			2022-12-25	WOS:000329189700001
J	Chua, ACG; Klopcic, BRS; Ho, DS; Fu, K; Forrest, CH; Croft, KD; Olynyk, JK; Lawrance, IC; Trinder, D				Chua, Anita C. G.; Klopcic, Borut R. S.; Ho, Desiree S.; Fu, Kristine; Forrest, Cynthia H.; Croft, Kevin D.; Olynyk, John K.; Lawrance, Ian C.; Trinder, Debbie			Dietary Iron Enhances Colonic Inflammation and IL-6/IL-11-Stat3 Signaling Promoting Colonic Tumor Development in Mice	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; CELL-CYCLE PROGRESSION; MUTANT MOUSE MODEL; NF-KAPPA-B; ULCERATIVE-COLITIS; BOWEL-DISEASE; INTESTINAL INFLAMMATION; OXIDATIVE STRESS; EPITHELIAL-CELLS; CROHNS-DISEASE	Chronic intestinal inflammation and high dietary iron are associated with colorectal cancer development. The role of Stat3 activation in iron-induced colonic inflammation and tumorigenesis was investigated in a mouse model of inflammation-associated colorectal cancer. Mice, fed either an iron-supplemented or control diet, were treated with azoxymethane and dextran sodium sulfate (DSS). Intestinal inflammation and tumor development were assessed by endoscopy and histology, gene expression by real-time PCR, Stat3 phosphorylation by immunoblot, cytokines by ELISA and apoptosis by TUNEL assay. Colonic inflammation was more severe in mice fed an iron-supplemented compared with a control diet one week post-DSS treatment, with enhanced colonic IL-6 and IL-11 release and Stat3 phosphorylation. Both IL-6 and ferritin, the iron storage protein, co-localized with macrophages suggesting iron may act directly on IL-6 producing-macrophages. Iron increased DSS-induced colonic epithelial cell proliferation and apoptosis consistent with enhanced mucosal damage. DSS-treated mice developed anemia that was not alleviated by dietary iron supplementation. Six weeks post-DSS treatment, iron-supplemented mice developed more and larger colonic tumors compared with control mice. Intratumoral IL-6 and IL-11 expression increased in DSS-treated mice and IL-6, and possibly IL-11, were enhanced by dietary iron. Gene expression of iron importers, divalent metal transporter 1 and transferrin receptor 1, increased and iron exporter, ferroportin, decreased in colonic tumors suggesting increased iron uptake. Dietary iron and colonic inflammation synergistically activated colonic IL-6/IL-11-Stat3 signaling promoting tumorigenesis. Oral iron therapy may be detrimental in inflammatory bowel disease since it may exacerbate colonic inflammation and increase colorectal cancer risk.	[Chua, Anita C. G.; Klopcic, Borut R. S.; Ho, Desiree S.; Fu, Kristine; Lawrance, Ian C.; Trinder, Debbie] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia; [Chua, Anita C. G.; Ho, Desiree S.; Trinder, Debbie] Western Australian Inst Med Res, Perth, WA, Australia; [Klopcic, Borut R. S.; Fu, Kristine] Fremantle Hosp, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Forrest, Cynthia H.] Fremantle Hosp, Dept Histopathol, Fremantle, WA, Australia; [Forrest, Cynthia H.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Croft, Kevin D.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Olynyk, John K.] Fremantle Hosp, Dept Gastroenterol, Fremantle, WA, Australia; [Olynyk, John K.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Olynyk, John K.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Murdoch University; Curtin University	Chua, ACG (corresponding author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.	anita.chua@uwa.edu.au	Chua, Anita CG/D-3718-2016; Lawrance, Ian C/H-5252-2014	Chua, Anita CG/0000-0003-1075-5901; Croft, Kevin/0000-0003-1596-4913; Olynyk, John/0000-0003-0417-3411	National Health and Medical Research Council, Australia (NHMRC) [APP1007769]; Cancer Council of Western Australia; Fremantle Hospital Medical Research Foundation; Raine Medical Research Foundation; Gastroenterological Society of Australia; NHMRC [APP1042370, APP1020437]	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Fremantle Hospital Medical Research Foundation; Raine Medical Research Foundation; Gastroenterological Society of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council, Australia (NHMRC; APP1007769 to DT, JKO, ACGC, ICL), Cancer Council of Western Australia (to DT, JKO, ICL, ACGC, BRSK), Fremantle Hospital Medical Research Foundation (to ACGC, BRSK, ICL, DSH) and Raine Medical Research Foundation (to ACGC). ACGC is a recipient of a Bushell Postdoctoral Fellowship from the Gastroenterological Society of Australia. DT is a recipient of a Senior Research Fellowship (APP1020437) and JKO is a recipient of a Practitioner Fellowship (APP1042370) from NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Carrier J, 2002, J NUTR, V132, P3146, DOI 10.1093/jn/131.10.3146; Carrier J, 2001, ALIMENT PHARM THER, V15, P1989, DOI 10.1046/j.1365-2036.2001.01113.x; Carrier JC, 2006, INT J COLORECTAL DIS, V21, P381, DOI 10.1007/s00384-005-0011-7; Chua ACG, 2010, J HEPATOL, V52, P425, DOI 10.1016/j.jhep.2009.12.010; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; GASCHE C, 1994, DIGEST DIS SCI, V39, P1930, DOI 10.1007/BF02088127; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Gearry RB, 2006, INFLAMM BOWEL DIS, V12, P936, DOI 10.1097/01.mib.0000231572.88806.b9; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hagiwara C, 2002, J GASTROEN HEPATOL, V17, P758, DOI 10.1046/j.1440-1746.2002.02791.x; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iwamoto M, 1996, J PATHOL, V180, P152; KESHAVARZIAN A, 1992, DIGEST DIS SCI, V37, P1866; KESHAVARZIAN A, 1990, GUT, V31, P786, DOI 10.1136/gut.31.7.786; Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Lakatos L, 2003, WORLD J GASTROENTERO, V9, P2300; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Millar AD, 2000, ALIMENT PHARM THERAP, V14, P1163; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Neufert C, 2010, CELL CYCLE, V9, P652, DOI 10.4161/cc.9.4.10615; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Pillai RB, 1999, DIGEST DIS SCI, V44, P1565, DOI 10.1023/A:1026654725101; Pinnix ZK, 2010, SCI TRANSL MED, V2; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Seril DN, 2002, DIGEST DIS SCI, V47, P1266, DOI 10.1023/A:1015362228659; Seril DN, 2005, DIGEST DIS SCI, V50, P696, DOI 10.1007/s10620-005-2560-6; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Wurzelmann JI, 1996, CANCER EPIDEM BIOMAR, V5, P503; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209	61	49	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78850	10.1371/journal.pone.0078850	http://dx.doi.org/10.1371/journal.pone.0078850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223168	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200060
J	Han, YY; Zhang, X; Wang, YF; Ming, F				Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng			The Suppression of WRKY44 by GIGANTEA-miR172 Pathway Is Involved in Drought Response of Arabidopsis thaliana	PLOS ONE			English	Article							FLOWERING-TIME; GENE-EXPRESSION; PLANT DEVELOPMENT; CIRCADIAN CLOCK; ACID CONTENT; STRESS; SUGAR; IDENTIFICATION; SENSITIVITY; MODULATION	Water availability is an important environmental factor that controls flowering time. Many plants accelerate flowering under drought conditions, a phenomenon called drought escape. Four pathways are involved in controlling flowering time, but which ones participate in drought escape is not yet known. In this study, plants with loss-of-function mutations of GIGANTEA (GI) and CONSTANS (CO) exhibited abnormal drought-escape phenotypes. The peak mRNA levels of GI and FKF1 (Flavin-binding Kelch domain F box protein 1) and the mRNA levels of CO and FT (Flowering locus T) changed under drought stress. The microRNA factor miRNA172E was up-regulated by drought stress, and its up-regulation was dependent on GI, while other miRNA172s were not. Water-loss analyses indicated that gi mutants were more sensitive while miRNA172 over-expressing (miRNA172-OX) plants were less so to drought stress than wild-type plants. Digital gene expression and real-time PCR analyses showed that WRKY44 was down-regulated by GI and miRNA172. The WRKY44 protein could interact with TOE1 (a target of miRNA172) in a yeast two-hybrid system. We proposed that GI-miRNA172-WRKY44 may regulate drought escape and drought tolerance by affecting sugar signaling in Arabidopsis.	[Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Han, Yingying; Zhang, Xuan; Wang, Yaofeng; Ming, Feng] Fudan Univ, Sch Life Sci, Inst Plant Biol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ming, F (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	fming@fudan.edu.cn			National Natural Science Foundation of China [30900782]; Ministry of Agriculture of China [2008ZX08009-001-008]; Natural Science Foundation of Shanghai [12ZR1402300square]; Foundation of Chinese Post-doctor [20080440580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Foundation of Chinese Post-doctor	This work was supported by grants from National Natural Science Foundation of China (No. 30900782), the Ministry of Agriculture of China (2008ZX08009-001-008, Natural Science Foundation of Shanghai (No. 12ZR1402300 square), Foundation of Chinese Post-doctor (No. 20080440580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; BYRNE PF, 1995, CROP SCI, V35, P63, DOI 10.2135/cropsci1995.0011183X003500010011x; Cao SQ, 2007, BIOL PLANTARUM, V51, P359, DOI 10.1007/s10535-007-0073-1; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Galvez DA, 2011, TREE PHYSIOL, V31, P250, DOI 10.1093/treephys/tpr012; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Hwang EW, 2011, GENES GENOM, V33, P105, DOI 10.1007/s13258-010-0135-1; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; LEONARD M, 1981, PLANT PHYSIOL, V67, P1245, DOI 10.1104/pp.67.6.1245; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; McLaughlin JE, 2004, ANN BOT-LONDON, V94, P675, DOI 10.1093/aob/mch193; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas B., 1997, PHOTOPERIODISM PLANT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; ZEEVAART JA, 1971, PLANT PHYSIOL, V48, P86, DOI 10.1104/pp.48.1.86; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	62	59	74	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e73541	10.1371/journal.pone.0073541	http://dx.doi.org/10.1371/journal.pone.0073541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223111	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200003
J	Ma, JD; Jiang, Z; He, S; Liu, YK; Chen, L; Long, KR; Jin, L; Jiang, AA; Zhu, L; Wang, JY; Li, MZ; Li, XW				Ma, Jideng; Jiang, Zhi; He, Shen; Liu, Yingkai; Chen, Lei; Long, Keren; Jin, Long; Jiang, An'an; Zhu, Li; Wang, Jinyong; Li, Mingzhou; Li, Xuewei			Intrinsic Features in MicroRNA Transcriptomes Link Porcine Visceral Rather than Subcutaneous Adipose Tissues to Metabolic Risk	PLOS ONE			English	Article							DOWN-REGULATION; INFLAMMATION; EXPRESSION; OBESITY; ADIPOGENESIS; INVASION; PROFILE; GENES; MACROPHAGES; ACTIVATION	MicroRNAs (miRNAs) are non-coding small RNA similar to 22 nucleotides in length that can regulate the expression of a wide range of coding genes at the post-transcriptional level. Visceral adipose tissues (VATs) and subcutaneous adipose tissues (SATs), the two main fat compartments in mammals, are anatomically, physiologically, metabolically, and clinically distinct. Various studies of adipose tissues have focused mainly on DNA methylation, and mRNA and protein expression, nonetheless little research sheds directly light on the miRNA transcriptome differences between these two distinct adipose tissue types. Here, we present a comprehensive investigation of miRNA transcriptomes across six variant porcine adipose tissues by small RNA-sequencing. We identified 219 known porcine miRNAs, 97 novel miRNA*s, and 124 miRNAs that are conserved to other mammals. A set of universally abundant miRNAs (i.e., miR-148a-3p, miR-143-3p, miR-27b-3p, miR-let-7a-1-5p, and miR-let-7f-5p) across the distinct adipose tissues was found. This set of miRNAs may play important housekeeping roles that are involved in adipogenesis. Clustering analysis indicated significant variations in miRNA expression between the VATs and SATs, and highlighted the role of the greater omentum in responding to potential metabolic risk because of the observed enrichment in this tissue of the immune-and inflammation-related miRNAs, such as the members of miR-17-92 cluster and miR-181 family. Differential expression of the miRNAs between the VATs and SATs, and miRNA target prediction analysis revealed that the VATs-specific enriched miRNAs were associated mainly with immune and inflammation responses. In summary, the differences of miRNA expression between the VATs and SATs revealed some of their intrinsic differences and indicated that the VATs might be closely associated with increased risk of metabolic disorders.	[Ma, Jideng; He, Shen; Liu, Yingkai; Long, Keren; Jin, Long; Jiang, An'an; Zhu, Li; Li, Mingzhou; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Jiang, Zhi] Novogene Bioinformat Inst, Beijing, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China	Sichuan Agricultural University	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	mingzhou.li@163.com; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684	National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Specialized Research Fund of Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; National Special Foundation for Transgenic Species of China [2011ZX08006-003]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund of Ministry of Agriculture of China; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; National Special Foundation for Transgenic Species of China	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502) to M. L., the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), and the National Special Foundation for Transgenic Species of China (2011ZX08006-003) to X. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; Arner P, 2005, CURR MOL MED, V5, P333, DOI 10.2174/1566524053766022; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Carlow DA, 2009, J IMMUNOL, V183, P1155, DOI 10.4049/jimmunol.0900409; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Clement K, 2007, J INTERN MED, V262, P422, DOI 10.1111/j.1365-2796.2007.01851.x; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lafontan M, 2013, DIFFERENCES SUBCUTAN, P329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Pan S., 2012, BOUND VALUE PROBL, V1, P1; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P94, DOI 10.1002/ibd.21742; Piche ME, 2008, METABOLISM, V57, P1101, DOI 10.1016/j.metabol.2008.03.015; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sam S, 2008, DIABETES, V57, P2022, DOI 10.2337/db08-0157; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yildirim A, 2010, ROM J MORPHOL EMBRYO, V51, P759; Zhou CW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-75; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	73	9	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80041	10.1371/journal.pone.0080041	http://dx.doi.org/10.1371/journal.pone.0080041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223210	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200103
J	Adler, NRL; Dean, RE; Saint, RJ; Stevens, MP; Prior, JL; Atkins, TP; Galyov, EE				Adler, Natalie R. Lazar; Dean, Rachel E.; Saint, Richard J.; Stevens, Mark P.; Prior, Joann L.; Atkins, Timothy P.; Galyov, Edouard E.			Identification of a Predicted Trimeric Autotransporter Adhesin Required for Biofilm Formation of Burkholderia pseudomallei	PLOS ONE			English	Article							PROTEIN SECRETION; STRESS TOLERANCE; VIRULENCE; MELIOIDOSIS; KNOCKOUT; MOTILITY; INSIGHTS; VECTORS; OPERON; MUTANT	The autotransporters are a large and diverse family of bacterial secreted and outer membrane proteins, which are present in many Gram-negative bacterial pathogens and play a role in numerous environmental and virulence-associated interactions. As part of a larger systematic study on the autotransporters of Burkholderia pseudomallei, the causative agent of the severe tropical disease melioidosis, we have constructed an insertion mutant in the bpss1439 gene encoding an unstudied predicted trimeric autotransporter adhesin. The bpss1439 mutant demonstrated a significant reduction in biofilm formation at 48 hours in comparison to its parent 10276 wild-type strain. This phenotype was complemented to wild-type levels by the introduction of a full-length copy of the bpss1439 gene in trans. Examination of the wild-type and bpss1439 mutant strains under biofilm-inducing conditions by microscopy after 48 hours confirmed that the bpss1439 mutant produced less biofilm compared to wild-type. Additionally, it was observed that this phenotype was due to low levels of bacterial adhesion to the abiotic surface as well as reduced microcolony formation. In a murine melioidosis model, the bpss1439 mutant strain demonstrated a moderate attenuation for virulence compared to the wild-type strain. This attenuation was abrogated by in trans complementation, suggesting that bpss1439 plays a subtle role in the pathogenesis of B. pseudomallei. Taken together, these studies indicate that BPSS1439 is a novel predicted autotransporter involved in biofilm formation of B. pseudomallei; hence, this factor was named BbfA, Burkholderia biofilm factor A.	[Adler, Natalie R. Lazar; Galyov, Edouard E.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Stevens, Mark P.] Def Sci & Technol Lab, Porton Down, England; [Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, England; [Atkins, Timothy P.] Univ Exeter, Sch Biosci, Exeter, Devon, England	University of Leicester; Defence Science & Technology Laboratory; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Exeter	Galyov, EE (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	eg98@leicester.ac.uk	Lazar Adler, Natalie/I-2099-2014	Lazar Adler, Natalie/0000-0001-5775-7627; Galyov, Edouard/0000-0003-2609-0748; Stevens, Mark/0000-0003-2174-5039	Wellcome Trust Research [085972]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001116, BB/E021212/1, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BB/E021212/1, BBS/E/D/20231761] Funding Source: UKRI	Wellcome Trust Research(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Wellcome Trust Research Grant #085972 (http://www.wellcome.ac.uk/Funding/Biomedical-science/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00151; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; Balder R, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-1110-1250, DOI 10.1186/1471-2180-1110-1250]; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gamage AM, 2011, MICROBIOL-SGM, V157, P1176, DOI 10.1099/mic.0.046540-0; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Korbsrisate S, 2005, FEMS MICROBIOL LETT, V252, P243, DOI 10.1016/j.femsle.2005.09.002; Lazar Adler NR, 2011, FRONTIERS MICROBIOLO, P2; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Mack K, 1996, ANAL BIOCHEM, V242, P73, DOI 10.1006/abio.1996.0430; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mil-Homens D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041747; Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Songsri J, 2012, SE ASIAN J TROP MED, V43, P124; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Thongboonkerd V, 2007, J PROTEOME RES, V6, P1334, DOI 10.1021/pr060457t; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Vorachit M, 1995, J TROP MED HYG, V98, P379; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; Yuen CW, 2012, J MICROBIOL BIOTECHN, V22, P1336, DOI 10.4014/jmb.1203.03059	36	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79461	10.1371/journal.pone.0079461	http://dx.doi.org/10.1371/journal.pone.0079461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223950	Green Submitted, Green Published, gold			2022-12-25	WOS:000326597400067
J	Barak, MM; Lieberman, DE; Raichlen, D; Pontzer, H; Warrener, AG; Hublin, JJ				Barak, Meir M.; Lieberman, Daniel E.; Raichlen, David; Pontzer, Herman; Warrener, Anna G.; Hublin, Jean-Jacques			Trabecular Evidence for a Human-Like Gait in Australopithecus africanus	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; BENT-KNEE WALKING; CANCELLOUS BONE; ARDIPITHECUS-RAMIDUS; LAETOLI FOOTPRINTS; HUMAN BIPEDALISM; EARLY HOMININS; FEMORAL-HEAD; AFARENSIS; EVOLUTION	Although the earliest known hominins were apparently upright bipeds, there has been mixed evidence whether particular species of hominins including those in the genus Australopithecus walked with relatively extended hips, knees and ankles like modern humans, or with more flexed lower limb joints like apes when bipedal. Here we demonstrate in chimpanzees and humans a highly predictable and sensitive relationship between the orientation of the ankle joint during loading and the principal orientation of trabecular bone struts in the distal tibia that function to withstand compressive forces within the joint. Analyses of the orientation of these struts using microCT scans in a sample of fossil tibiae from the site of Sterkfontein, of which two are assigned to Australopithecus africanus, indicate that these hominins primarily loaded their ankles in a relatively extended posture like modern humans and unlike chimpanzees. In other respects, however, trabecular properties in Au africanus are distinctive, with values that mostly fall between those of chimpanzees and humans. These results indicate that Au. africanus, like Homo, walked with an efficient, extended lower limb.	[Barak, Meir M.; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Barak, Meir M.; Lieberman, Daniel E.; Warrener, Anna G.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Raichlen, David] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY USA	Max Planck Society; Harvard University; University of Arizona; City University of New York (CUNY) System; Hunter College (CUNY)	Barak, MM (corresponding author), Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA.	barakm@winthrop.edu; danlieb@fas.harvard.edu	Barak, Meir/C-9957-2010; Warrener, Anna/AAC-5225-2020	Barak, Meir/0000-0003-4953-4380; Pontzer, Herman/0000-0003-2397-6543	American School of Prehistoric Research (Harvard University); Hintze Family Charitable Foundation; Minerva Stiftung Gesellschaft fur die Forschung mbH; LSB Leakey Foundation; National Science Foundation [ECS-0335765]	American School of Prehistoric Research (Harvard University); Hintze Family Charitable Foundation; Minerva Stiftung Gesellschaft fur die Forschung mbH; LSB Leakey Foundation; National Science Foundation(National Science Foundation (NSF))	For funding, the authors thank the American School of Prehistoric Research (Harvard University), the Hintze Family Charitable Foundation, the Minerva Stiftung Gesellschaft fur die Forschung mbH, and the LSB Leakey Foundation. The human and chimpanzee microCT scans were performed in the Center for Nanoscale Systems, Harvard University, a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MORPH PAR MEAS SKYSC; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Berger LR, 1996, J HUM EVOL, V30, P343, DOI 10.1006/jhev.1996.0027; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Carey TS, 2005, J HUM EVOL, V48, P25, DOI 10.1016/j.jhevol.2004.10.001; Christen P, 2012, BIOMECH MODEL MECHAN, V11, P483, DOI 10.1007/s10237-011-0327-x; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; Darwin Charles, 1871, DESCENT MAN; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; DeSilva JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014432; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Haraguchi N, 2009, FOOT ANKLE INT, V30, P177, DOI 10.3113/FAI.2009.0177; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HARRIGAN TP, 1988, J BIOMECH, V21, P269, DOI 10.1016/0021-9290(88)90257-6; HUNT KD, 1992, AM J PHYS ANTHROPOL, V87, P83, DOI 10.1002/ajpa.1330870108; Kabel J, 1999, BONE, V24, P115, DOI 10.1016/S8756-3282(98)00164-1; KIMIZUKA M, 1980, ARCH ORTHOP TRAUM SU, V96, P45, DOI 10.1007/BF01246141; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; LANYON LE, 1974, J BONE JOINT SURG BR, VB 56, P160; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lovejoy CO, 2010, PHILOS T R SOC B, V365, P3289, DOI 10.1098/rstb.2010.0112; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Raichlen DA, 2008, J HUM EVOL, V54, P112, DOI 10.1016/j.jhevol.2007.07.005; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Rook L, 1999, P NATL ACAD SCI USA, V96, P8795, DOI 10.1073/pnas.96.15.8795; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Saparin P, 2011, ANAT REC, V294, P55, DOI 10.1002/ar.21285; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schiff A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P224; Schmitt D, 2003, J EXP BIOL, V206, P1437, DOI 10.1242/jeb.00279; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Su A, 2013, J HUM EVOL, V64, P667, DOI 10.1016/j.jhevol.2013.03.003; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; TARDIEU C, 1994, AM J PHYS ANTHROPOL, V95, P183, DOI 10.1002/ajpa.1330950206; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; Volpato V, 2008, PRIMATES, V49, P16, DOI 10.1007/s10329-007-0053-2; Wang WJ, 2003, J HUM EVOL, V44, P563, DOI 10.1016/S0047-2484(03)00045-9; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wolff J, 1892, GESETZ TRANSFORMATIO; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	65	67	67	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e77687	10.1371/journal.pone.0077687	http://dx.doi.org/10.1371/journal.pone.0077687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223719	Green Published, gold			2022-12-25	WOS:000326597400010
J	Cheng, KC; Pratt, J; Maki, BE				Cheng, Kenneth C.; Pratt, Jay; Maki, Brian E.			Do Aging and Dual-Tasking Impair the Capacity to Store and Retrieve Visuospatial Information Needed to Guide Perturbation-Evoked Reach-To-Grasp Reactions?	PLOS ONE			English	Article							ONLINE VISUAL CONTROL; AGE-RELATED-CHANGES; BALANCE-RECOVERY; WORKING-MEMORY; POSTURAL STABILITY; SPATIAL-MEMORY; ATTENTIONAL DEMANDS; STEPPING REACTIONS; COGNITIVE DEMANDS; NORMATIVE DATA	A recent study involving young adults showed that rapid perturbation-evoked reach-to-grasp balance-recovery reactions can be guided successfully with visuospatial-information (VSI) retained in memory despite: 1) a reduction in endpoint accuracy due to recall-delay (time between visual occlusion and perturbation-onset, PO) and 2) slowing of the reaction when performing a concurrent cognitive task during the recall-delay interval. The present study aimed to determine whether this capacity is compromised by effects of aging. Ten healthy older adults were tested with the previous protocol and compared with the previously-tested young adults. Reactions to recover balance by grasping a small handhold were evoked by unpredictable antero-posterior platform-translation (barriers deterred stepping reactions), while using liquid-crystal goggles to occlude vision post-PO and for varying recall-delay times (0-10s) prior to PO (the handhold was moved unpredictably to one of four locations 2s prior to vision-occlusion). Subjects also performed a spatial-or non-spatial-memory cognitive task during the delay-time in a subset of trials. Results showed that older adults had slower reactions than the young across all experimental conditions. Both age groups showed similar reduction in medio-lateral end-point accuracy when recall-delay was longest (10s), but differed in the effect of recall delay on vertical hand elevation. For both age groups, engaging in either the non-spatial or spatial-memory task had similar (slowing) effects on the arm reactions; however, the older adults also showed a dual-task interference effect (poorer cognitive-task performance) that was specific to the spatial-memory task. This provides new evidence that spatial working memory plays a role in the control of perturbation-evoked balance-recovery reactions. The delays in completing the reaction that occurred when performing either cognitive task suggest that such dual-task situations in daily life could increase risk of falling in seniors, particularly when combined with the general age-related slowing that was observed across all experimental conditions.	[Cheng, Kenneth C.; Pratt, Jay; Maki, Brian E.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Cheng, Kenneth C.; Maki, Brian E.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Cheng, Kenneth C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Pratt, Jay] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Maki, Brian E.] Univ Toronto, Inst Biomaterials & Biomed Engn, Toronto, ON, Canada; [Maki, Brian E.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Maki, BE (corresponding author), Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada.	brian.maki@uhn.ca		Pratt, Jay/0000-0002-4902-5095	Canadian Institutes of Health Research (CIHR) [MOP-13355]; CIHR; Ontario Neurotrauma Foundation; Vision Science Research Program; Ontario Graduate Scholarship Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Vision Science Research Program; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship)	The work was upported by grant #MOP-13355 from the Canadian Institutes of Health Research (CIHR) and by scholarships from CIHR, the Ontario Neurotrauma Foundation, the Vision Science Research Program and the Ontario Graduate Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRITAS MG, 1994, J AM STAT ASSOC, V89, P336, DOI 10.2307/2291230; Bradshaw MF, 2002, NEUROPSYCHOLOGIA, V40, P1766, DOI 10.1016/S0028-3932(02)00039-8; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Brown LA, 2002, J GERONTOL A-BIOL, V57, pM785, DOI 10.1093/gerona/57.12.M785; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Chen HC, 1996, J GERONTOL A-BIOL, V51, pM116, DOI 10.1093/gerona/51A.3.M116; Cheng KC, 2013, HUM MOVEMENT SCI, V32, P328, DOI 10.1016/j.humov.2012.11.001; Cheng KC, 2012, J GERONTOL A-BIOL, V67, P1238, DOI 10.1093/gerona/gls116; Cheng KC, 2012, EXP BRAIN RES, V218, P589, DOI 10.1007/s00221-012-3051-6; Cheng KC, 2009, GAIT POSTURE, V29, P339, DOI 10.1016/j.gaitpost.2008.08.011; CHERRY KE, 1993, EXP AGING RES, V19, P333, DOI 10.1080/03610739308253942; CHERRY KE, 1989, J GERONTOL, V44, pP16, DOI 10.1093/geronj/44.1.P16; Chieffi S, 1999, NEUROPSYCHOLOGIA, V37, P495, DOI 10.1016/S0028-3932(98)00082-7; Christopoulos VN, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000538; Christou EA, 2003, J APPL PHYSIOL, V95, P373, DOI 10.1152/japplphysiol.00060.2003; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Desrocher M, 1998, BRAIN COGNITION, V37, P91; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; ELLIOTT D, 1988, CAN J PSYCHOL, V42, P57, DOI 10.1037/h0084172; ELLIOTT D, 1987, Q J EXP PSYCHOL-A, V39, P541, DOI 10.1080/14640748708401802; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; FLICKER C, 1984, NEUROBIOL AGING, V5, P275, DOI 10.1016/0197-4580(84)90003-4; Fougnie D, 2009, ATTEN PERCEPT PSYCHO, V71, P1831, DOI 10.3758/APP.71.8.1831; Fougnie D, 2009, VIS COGN, V17, P48, DOI 10.1080/13506280802281337; Gage WH, 2007, EXP BRAIN RES, V181, P627, DOI 10.1007/s00221-007-0959-3; Ghafouri M, 2004, EXP BRAIN RES, V155, P532, DOI 10.1007/s00221-004-1855-8; GITTINGS NS, 1986, EXP GERONTOL, V21, P423, DOI 10.1016/0531-5565(86)90047-1; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hesse C, 2009, NEUROPSYCHOLOGIA, V47, P1532, DOI 10.1016/j.neuropsychologia.2008.08.012; Hu Y, 1999, EXP BRAIN RES, V126, P109, DOI 10.1007/s002210050720; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; Khan MA, 2003, MOTOR CONTROL, V7, P290, DOI 10.1123/mcj.7.3.290; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; King EC, 2009, J OPTOM, V2, P119, DOI [10.3921/joptom.2009.119, DOI 10.3921/J0PT0M.2009.119]; King EC, 2011, HUM MOVEMENT SCI, V30, P368, DOI 10.1016/j.humov.2010.07.005; King EC, 2010, EXP BRAIN RES, V207, P105, DOI 10.1007/s00221-010-2434-9; Korsnes MS, 1996, ACTA PSYCHOL, V94, P133, DOI 10.1016/0001-6918(95)00056-9; Lemay M, 2004, EXP AGING RES, V30, P391, DOI 10.1080/03610730490484443; Lemay M, 2002, J MOTOR BEHAV, V34, P11, DOI 10.1080/00222890209601927; Lemay M, 2001, EXP BRAIN RES, V140, P357, DOI 10.1007/s002210100834; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; Lustig C, 2001, J EXP PSYCHOL GEN, V130, P199, DOI 10.1037//0096-3445.130.2.199; Maki B, 2001, CONTROL POSTURE GAIT, P126; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; Maki BE, 1996, J BIOMECH, V29, P343, DOI 10.1016/0021-9290(95)00053-4; Maki BE, 2001, NEUROREPORT, V12, P3583, DOI 10.1097/00001756-200111160-00042; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; MCILROY WE, 1993, BRAIN RES, V631, P203, DOI 10.1016/0006-8993(93)91536-2; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; Norrie RG, 2002, EXP BRAIN RES, V146, P315, DOI 10.1007/s00221-002-1172-z; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; PATLA AE, 1996, CHANGES SENSORY MOTO, P257; QUANT S, 2000, PHYSIOTHERAPY CANA S, V52, P98; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Rapp MA, 2006, AM J GERIAT PSYCHIAT, V14, P52, DOI 10.1097/01.JGP.0000192490.43179.e7; Redfern MS, 2002, J GERONTOL A-BIOL, V57, pB298, DOI 10.1093/gerona/57.8.B298; Sarlegna F, 2004, EXP BRAIN RES, V157, P468, DOI 10.1007/s00221-004-1860-y; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Scovil CY, 2008, NEUROSCI LETT, V445, P108, DOI 10.1016/j.neulet.2008.08.062; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; THOMPSON GL, 1991, J AM STAT ASSOC, V86, P410, DOI 10.2307/2290586; THOMPSON GL, 1991, BIOMETRIKA, V78, P697; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; WATANABE K, 1994, INT CONGR SER, V1070, P195; Westwood DA, 2003, J MOTOR BEHAV, V35, P127, DOI 10.1080/00222890309602128; Westwood DA, 2001, CAN J EXP PSYCHOL, V55, P304, DOI 10.1037/h0087377; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zettel JL, 2005, EXP BRAIN RES, V165, P392, DOI 10.1007/s00221-005-2310-1; Zettel JL, 2008, J GERONTOL A-BIOL, V63, P1370, DOI 10.1093/gerona/63.12.1370	80	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79401	10.1371/journal.pone.0079401	http://dx.doi.org/10.1371/journal.pone.0079401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223942	Green Published, gold			2022-12-25	WOS:000326597400063
J	Kim, EC; Morgan, IG; Kakizaki, H; Kang, S; Jee, D				Kim, Eun Chul; Morgan, Ian G.; Kakizaki, Hirohiko; Kang, Seungbum; Jee, Donghyun			Prevalence and Risk Factors for Refractive Errors: Korean National Health and Nutrition Examination Survey 2008-2011	PLOS ONE			English	Article							OUTDOOR ACTIVITY; UNITED-STATES; MYOPIA; SINGAPORE; EYE; CHILDREN; POPULATION; CHINESE; ASSOCIATION; EDUCATION	Purpose: To examine the prevalence and risk factors of refractive errors in a representative Korean population aged 20 years old or older. Methods: A total of 23,392 people aged 20(+) years were selected for the Korean National Health and Nutrition Survey 2008-2011, using stratified, multistage, clustered sampling. Refractive error was measured by autorefraction without cycloplegia, and interviews were performed regarding associated risk factors including gender, age, height, education level, parent's education level, economic status, light exposure time, and current smoking history. Results: Of 23,392 participants, refractive errors were examined in 22,562 persons, including 21,356 subjects with phakic eyes. The overall prevalences of myopia (< -0.5 D), high myopia (< -6.0 D), and hyperopia (> 0.5 D) were 48.1% (95% confidence interval [CI], 47.4-48.8), 4.0% (CI, 3.7-4.3), and 24.2% (CI, 23.6-24.8), respectively. The prevalence of myopia sharply decreased from 78.9% (CI, 77.4-80.4) in 20-29 year olds to 16.1% (CI, 14.9-17.3) in 60-69 year olds. In multivariable logistic regression analyses restricted to subjects aged 40(+) years, myopia was associated with younger age (odds ratio [OR], 0.94; 95% Confidence Interval [CI], 0.93-0.94, p < 0.001), education level of university or higher (OR, 2.31; CI, 1.97-2.71, p < 0.001), and shorter sunlight exposure time (OR, 0.84; CI, 0.76-0.93, p = 0.002). Conclusions: This study provides the first representative population-based data on refractive error for Korean adults. The prevalence of myopia in Korean adults in 40+ years (34.7%) was comparable to that in other Asian countries. These results show that the younger generations in Korea are much more myopic than previous generations, and that important factors associated with this increase are increased education levels and reduced sunlight exposures.	[Kim, Eun Chul] Catholic Univ Korea, Coll Med, Buchon St Marys Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Morgan, Ian G.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia; [Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 48011, Japan; [Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejon St Marys Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jee, Donghyun] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea	Catholic University of Korea; Australian National University; Aichi Medical University; Catholic University of Korea; Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	donghyunjee@catholic.ac.kr	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574				Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Choo V, 2003, LANCET, V361, P1622, DOI 10.1016/S0140-6736(03)13315-6; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fotouhi A, 2012, ACTA OPHTHALMOL, V90, P380, DOI 10.1111/j.1755-3768.2010.01983.x; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; HOLT D, 1991, J R STAT SOC D-STAT, V40, P333; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; KATZ B, 1993, AM J OPHTHALMOL, V116, P754, DOI 10.1016/S0002-9394(14)73477-4; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Krishnaiah S, 2009, CLIN OPHTHALMOL, V3, P17; LEE DA, 1984, ARCH OPHTHALMOL-CHIC, V102, P46; LEE JH, 2013, INVEST OPHTHALMOL VI; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim MCC, 2009, EYE, V23, P1086, DOI 10.1038/eye.2008.225; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; SO CH, 2007, KOREA KNOWLEDGE EC E, P5; SORSBY A, 1960, BRIT MED J, V1, P1394, DOI 10.1136/bmj.1.5183.1394; Tarczy-Hornoch K, 2006, INVEST OPHTH VIS SCI, V47, P1845, DOI 10.1167/iovs.05-1153; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012	39	52	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80361	10.1371/journal.pone.0080361	http://dx.doi.org/10.1371/journal.pone.0080361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224049	Green Published, gold, Green Submitted			2022-12-25	WOS:000326597400117
J	Olivier, M; Foret, B; Le Vern, Y; Kerboeuf, D; Guilloteau, LA				Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Kerboeuf, Dominique; Guilloteau, Laurence A.			Plasticity of Migrating CD1b(+) and CD1b(-) Lymph Dendritic Cells in the Promotion of Th1, Th2 and Th17 in Response to Salmonella and Helminth Secretions	PLOS ONE			English	Article							DELTA-T-CELLS; IMMUNE-RESPONSE; INFECTION; POLARIZATION	Dendritic cells (DCs) are pivotal in the development of specific T-cell responses to control pathogens, as they govern both the initiation and the polarization of adaptive immunity. To investigate the capacities of migrating DCs to respond to pathogens, we used physiologically generated lymph DCs (L-DCs). The flexible polarization of L-DCs was analysed in response to Salmonella or helminth secretions known to induce different T cell responses. Mature conventional CD1b(+) L-DCs showed a predisposition to promote pro-inflammatory (IL-6), pro-Th1 (IL-12p40) and anti-inflammatory (IL-10) responses which were amplified by Salmonella, and limited to only IL-6 induction by helminth secretions. The other major population of L-DCs did not express the CD1b molecule and displayed phenotypic features of immaturity compared to CD1b(+) L-DCs. Salmonella infection reduced the constitutive expression of TNF-alpha and IL-4 mRNA in CD1b(-) L-DCs, whereas this expression was not affected by helminth secretions. The cytokine response of T cells promoted by L-DCs was analysed in T cell subsets after co-culture with Salmonella or helminth secretion-driven CD1b(+) or CD1b(-) L-DCs. T cells preferentially expressed the IL-17 gene, and to a lesser extent the IFN-gamma and IL-10 genes, in response to Salmonella-driven CD1b(+) L-DCs, whereas a preferential IL-10, IFN-gamma and IL-17 gene expression was observed in response to Salmonella-driven CD1b(-) L-DCs. In contrast, a predominant IL-4 and IL-13 gene expression by CD4(+) and CD8(+) T cells was observed after stimulation of CD1b(+) and CD1b(-) L-DCs with helminth secretions. These results show that mature conventional CD1b(+) L-DCs maintain a flexible capacity to respond differently to pathogens, that the predisposition of CD1b(-) L-DCs to promote a Th2 response can be oriented towards other Th responses, and finally that the modulation of migrating L-DCs responses is controlled more by the pathogen encountered than the L-DC subsets.	[Olivier, Michel; Foret, Benjamin; Kerboeuf, Dominique; Guilloteau, Laurence A.] INRA, Infectiol & Sante Publ UR1282, Nouzilly, France; [Le Vern, Yves] INRA, Lab Cytometrie, F-37380 Nouzilly, France	INRAE; INRAE	Guilloteau, LA (corresponding author), INRA, Infectiol & Sante Publ UR1282, Nouzilly, France.	Laurence.Guilloteau@tours.inra.fr			Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Brunner E, 2002, NONPARAMETRIC ANAL W; BUJDOSO R, 1990, International Reviews of Immunology, V6, P177, DOI 10.3109/08830189009056628; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Ferret-Bernard S, 2008, PROTEOMICS, V8, P980, DOI 10.1002/pmic.200700538; Gohin I, 1997, VET IMMUNOL IMMUNOP, V60, P111, DOI 10.1016/S0165-2427(97)00090-1; Hegde VL, 2008, J LEUKOCYTE BIOL, V84, P134, DOI 10.1189/jlb.1107752; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Hwang YY, 2013, ADV EXP MED BIOL, V785, P9, DOI 10.1007/978-1-4614-6217-0_2; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Knight JS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-51; Liotta F, 2008, J ALLERGY CLIN IMMUN, V121, P1000, DOI 10.1016/j.jaci.2008.01.004; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Olivier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030430; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Ryan S, 2000, J VIROL, V74, P10096, DOI 10.1128/JVI.74.21.10096-10103.2000; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79537	10.1371/journal.pone.0079537	http://dx.doi.org/10.1371/journal.pone.0079537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223964	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400071
J	Zhao, JL; Solis-Montero, L; Lou, A; Vallejo-Marin, M				Zhao, Jiali; Solis-Montero, Lislie; Lou, Anru; Vallejo-Marin, Mario			Population Structure and Genetic Diversity of Native and Invasive Populations of Solanum rostratum (Solanaceae)	PLOS ONE			English	Article							PLANT; INFERENCE; BIOLOGY	Aims: We investigate native and introduced populations of Solanum rostratum, an annual, self-compatible plant that has been introduced around the globe. This study is the first to compare the genetic diversity of Solanum rostratum between native and introduced populations. We aim to (1) determine the level of genetic diversity across the studied regions; (2) explore the likely origins of invasive populations in China; and (3) investigate whether there is the evidence of multiple introductions into China. Methods: We genotyped 329 individuals at 10 microsatellite loci to determine the levels of genetic diversity and to investigate population structure of native and introduced populations of S. rostratum. We studied five populations in each of three regions across two continents: Mexico, the U.S.A. and China. Important Findings: We found the highest genetic diversity among Mexican populations of S. rostratum. Genetic diversity was significantly lower in Chinese and U.S.A. populations, but we found no regional difference in inbreeding coefficients (F-IS) or population differentiation (F-ST). Population structure analyses indicate that Chinese and U.S.A. populations are more closely related to each other than to sampled Mexican populations, revealing that introduced populations in China share an origin with the sampled U.S.A. populations. The distinctiveness between some introduced populations indicates multiple introductions of S. rostratum into China.	[Zhao, Jiali; Lou, Anru] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China; [Solis-Montero, Lislie; Vallejo-Marin, Mario] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	Beijing Normal University; University of Stirling	Lou, A (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China.	louanru@bnu.edu.cn; mario.vallejo@stir.ac.uk	Solis-Montero, Lislie/N-2556-2014; Vallejo-Marin, Mario/G-4186-2011	Solis-Montero, Lislie/0000-0002-5793-3376; Vallejo-Marin, Mario/0000-0002-5663-8025	Royal Society of Edinburgh-Chinese National Science Foundation; National Natural Science Foundation of China [31070374]; Royal Society of London [RG2010R1]; University of Stirling	Royal Society of Edinburgh-Chinese National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society of London(Royal Society of London); University of Stirling	Support for this study was provided by a Royal Society of Edinburgh-Chinese National Science Foundation Joint Project to MVM and AL, a grant by the National Natural Science Foundation of China (Project 31070374) to AL, a Royal Society of London research grant (RG2010R1) to MVM, and a Horizon Ph.D. fellowship from the University of Stirling to LSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, TFPGA TOOLS POPULATI; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BARRELL J, 1975, RED HILLS KANSAS CRO; Barrett SCH, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P195; BASSETT IJ, 1986, CAN J PLANT SCI, V66, P977, DOI 10.4141/cjps86-120; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Cho Young-Ho, 1997, Korean Journal of Plant Taxonomy, V27, P277; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; [高芳 Gao Fang], 2005, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V41, P420; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUAN G, 1984, PLANT QUAR, V4, P25; Henry P, 2009, MOL ECOL, V18, P2819, DOI 10.1111/j.1365-294X.2009.04237.x; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Langella O, 1999, POPULATIONS 1 2 30; Lin Y, 2007, ACTA PHYTOTAXON SIN, V45, P675, DOI 10.1360/aps07010; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Stern SR, 2010, SYST BOT, V35, P885, DOI 10.1600/036364410X539934; Tower W.L., 1906, INVESTIGATION EVOLUT, V2, P13; USDA NRCS, 2012, PLANTS DAT; Vallejo-Marin M, 2013, PLANT BIOLOGY, V15, P948, DOI 10.1111/j.1438-8677.2012.00715.x; Vallejo-Marin M, 2009, J EVOLUTION BIOL, V22, P828, DOI 10.1111/j.1420-9101.2009.01693.x; Vallejo-Marin M, 2011, AM J BOT, V98, pE296, DOI 10.3732/ajb.1100159; Voss N, 2012, ANN BOT-LONDON, V110, P585, DOI 10.1093/aob/mcs117; Wang WS, 2005, PLANTS QUARANTINE, V19, P247; Whalen MD, 1979, GENTES HERBARIUM, V11, P359; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Zhang S. M., 1997, J LIAONING NORMAL U, V20, P323; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x; [赵晓英 ZHAO Xiaoying], 2007, [地球科学进展, Advance in Earth Sciences], V22, P167; Zhong Gen-ping, 2009, Shengtaixue Zazhi, V28, P162	45	26	28	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79807	10.1371/journal.pone.0079807	http://dx.doi.org/10.1371/journal.pone.0079807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224008	Green Published, Green Submitted, gold			2022-12-25	WOS:000326597400089
J	Jia, PY; Zhao, Y; Wu, SP; Wu, JH; Gao, S; Tong, Y; Wang, YX				Jia, Peiyuan; Zhao, Yu; Wu, Shaoping; Wu, Junhua; Gao, Shan; Tong, Ying; Wang, Yuxia			The Novel Fusion Proteins, GnRH-p53 and GnRHIII-p53, Expression and Their Anti-Tumor Effect	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; LH-RH RECEPTORS; ANALOGS; CANCERS; BREAST; CELLS; P53; DERIVATIVES; PROSTATE; THERAPY	p53, one of the most well studied tumor suppressor factor, is responsible to a variety of damage owing to the induction of apoptosis and cell cycle arrest in the tumor cells. More than 50% of human tumors contain mutation or deletion of p53. Gonadotrophin-releasing hormone (GnRH), as the ligand of Gonadotrophin-releasing hormone receptor (GnRH-R), was used to deliver p53 into tumor cells. The p53 fusion proteins GnRH-p53 and GnRH iii-p53 were expressed and their targeted anti-tumor effects were determined. GnRH mediates its fusion proteins transformation into cancer cells. The intracellular delivery of p53 fusion proteins exerted the inhibition of the growth of H1299 cells in vitro and the reduction of tumor volume in vivo. Their anti-tumor effect was functioned by the apoptosis and cell cycle arrest induced by p53. Hence, the fusion protein could be a novel protein drug for anti-tumor therapy.	[Jia, Peiyuan; Zhao, Yu; Wu, Junhua; Wang, Yuxia] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Wu, Shaoping; Gao, Shan; Tong, Ying] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wang, YX (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.	wangyuxia1962@hotmail.com		Zhao, Yu/0000-0002-4919-1341	National Natural Science Foundation of China [30973562]; National Basic Research Program of China [2010CB933904]; Ministry of Science and Technology of China [2009ZX09103-614]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 30973562), the National Basic Research Program of China (No. 2010CB933904) and the Ministry of Science and Technology of China (No. 2009ZX09103-614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FRIESS H, 1991, INT J PANCREATOL, V10, P151; Gho YS, 1999, MOL CELLS, V9, P31; Gunthert AR, 2005, EUR J ENDOCRINOL, V153, P613, DOI 10.1530/eje.1.01996; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HAZUM E, 1985, CELL TISSUE RES, V239, P3, DOI 10.1007/BF00214895; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kovacs M, 2007, PEPTIDES, V28, P821, DOI 10.1016/j.peptides.2007.01.003; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lovas S, 1998, J PEPT RES, V52, P384; Mezo G, 2007, PEPTIDES, V28, P806, DOI 10.1016/j.peptides.2006.12.014; Mezo G, 2010, EXPERT OPIN DRUG DEL, V7, P79, DOI 10.1517/17425240903418410; Mezo G, 2008, CURR MED CHEM, V15, P2366, DOI 10.2174/092986708785909157; Nagy A, 2005, BIOL REPROD, V73, P851, DOI 10.1095/biolreprod.105.043489; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Nechushtan A, 1997, J BIOL CHEM, V272, P11597; Orban E, 2011, AMINO ACIDS, V41, P469, DOI 10.1007/s00726-010-0766-1; PINSKI J, 1995, INT J PEPT PROT RES, V45, P410; Saad M, 2008, J CONTROL RELEASE, V130, P107, DOI 10.1016/j.jconrel.2008.05.024; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Schally AV, 2004, TRENDS ENDOCRIN MET, V15, P300, DOI 10.1016/j.tem.2004.07.002; SOWER SA, 1993, ENDOCRINOLOGY, V132, P1125, DOI 10.1210/en.132.3.1125; Szepeshazi K, 2007, INT J ONCOL, V30, P1485; Wu SP, 2006, BIOCHEM BIOPH RES CO, V346, P1, DOI 10.1016/j.bbrc.2006.03.247; Zhao Y, 2011, CANCER BIOL THER, V11, P95, DOI 10.4161/cbt.11.1.13960; Zhao Y, 2009, CANCER LETT, V279, P101, DOI 10.1016/j.canlet.2009.01.030	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79384	10.1371/journal.pone.0079384	http://dx.doi.org/10.1371/journal.pone.0079384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223939	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400112
J	Lee, KB; Park, KE; Kwon, IK; Tripurani, SK; Kim, KJ; Lee, JH; Niwa, K; Kim, MK				Lee, Kyung-Bon; Park, Ki-Eun; Kwon, In-Kiu; Tripurani, Swamy K.; Kim, Keun Jung; Lee, Ji Hye; Niwa, Koji; Kim, Min Kyu			Develop to Term Rat Oocytes Injected with Heat-Dried Sperm Heads	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; INTRACYTOPLASMIC INJECTION; MOUSE SPERMATOZOA; DESICCATION TOLERANCE; PRONUCLEAR FORMATION; HAMSTER OOCYTES; PLASMA-MEMBRANE; FERTILIZATION; ACTIVATION; MICROINJECTION	This study investigated the development of rat oocytes in vitro and in vivo following intracytoplasmic injection of heads from spermatozoa heat-dried at 50 degrees C for 8 h and stored at 4 degrees C in different gas phases. Sperm membrane and chromosome are damaged by the process of heat-drying. Oocyte activation and cleavage of oocytes were worse in oocytes injected with spermatozoa heat-dried and stored for 1 week than unheated, fresh spermatozoa, but in heat-dried spermatozoa, there were no differences in these abilities of oocytes between the samples stored in nitrogen gas and in air. The oocytes injected with heat-dried spermatozoa stored for 1 week could develop to the morula and blastocyst stages without difference between the samples stored in nitrogen gas and in air after artificial stimulation. Cleavage of oocytes and development of cleaved embryos were higher when heat-dried spermatozoa were stored for 3 and 6 months in nitrogen gas than in air. However, the ability of injected oocytes to develop to the morula and blastocyst stages was not inhibited even when heat-dried spermatozoa stored in both atmosphere conditions for as long as 6 months were used. When 2-cell embryos derived from oocytes injected with heads from spermatozoa heat-dried and stored for 1 week and 1 month were transferred, each 1 of 4 recipients was conceived, and the conceived recipients delivered 1 live young each. These results demonstrate that rat oocytes can be fertilized with heat-dried spermatozoa and that the fertilized oocytes can develop to term.	[Lee, Kyung-Bon; Park, Ki-Eun; Kwon, In-Kiu; Niwa, Koji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Tripurani, Swamy K.] W Virginia Univ, Div Anim & Nutr Sci, Lab Anim Biotechnol & Genom, Morgantown, WV 26506 USA; [Kim, Keun Jung; Lee, Ji Hye; Kim, Min Kyu] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim Sci & Biotechnol, Taejon, South Korea	Okayama University; West Virginia University; Chungnam National University	Lee, KB (corresponding author), Chungnam Natl Univ, Inst Agr Sci, Taejon, South Korea.	kblee20@cnu.ac.kr; kminkyu@cnu.ac.kr		Kim, Keun Jung/0000-0003-2340-8319; KIM, MINKYU/0000-0001-7099-9735	Japan Society for the Promotion of Science [13GS0008]; Next-Generation BioGreen 21 program [PJ008148]; Rural Development Administration, Korea	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Next-Generation BioGreen 21 program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported in part by a grant-in Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (13GS0008) and by a grant from the Next-Generation BioGreen 21 program (No. PJ008148), Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi A, 1999, ARCH ANDROLOGY, V42, P1; Akutsu H, 2001, BIOL REPROD, V64, P249, DOI 10.1095/biolreprod64.1.249; Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407; Cozzi J, 2001, BIOL REPROD, V65, P1518, DOI 10.1095/biolreprod65.5.1518; Dozortsev D, 1998, ZYGOTE, V6, P143, DOI 10.1017/S0967199498000069; Elmoazzen HY, 2009, CRYOBIOLOGY, V59, P113, DOI 10.1016/j.cryobiol.2009.03.005; Hamano K, 1999, BIOL REPROD, V60, P1194, DOI 10.1095/biolreprod60.5.1194; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Hirabayashi M, 2002, TRANSGENIC RES, V11, P221, DOI 10.1023/A:1015210604906; Hochi S, 2008, MOL REPROD DEV, V75, P890, DOI 10.1002/mrd.20825; HOSHI K, 1992, ARCH ANDROLOGY, V29, P233, DOI 10.3109/01485019208987730; Jiang JY, 2002, MOL REPROD DEV, V61, P120, DOI 10.1002/mrd.1138; Kaneko T, 2003, BIOL REPROD, V69, P1859, DOI 10.1095/biolreprod.103.019729; Kasai T, 1999, ZYGOTE, V7, P187, DOI 10.1017/S0967199499000568; KEEFER CL, 1982, J EXP ZOOL, V224, P371, DOI 10.1002/jez.1402240310; Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260; Lee JW, 2004, MOL REPROD DEV, V68, P96, DOI 10.1002/mrd.20044; Lee KB, 2006, BIOL REPROD, V74, P146, DOI 10.1095/biolreprod.105.044743; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Morozumi K, 2006, P NATL ACAD SCI USA, V103, P17661, DOI 10.1073/pnas.0608183103; Nakai M, 2003, BIOL REPROD, V68, P1003, DOI 10.1095/biolreprod.102.009506; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Said S, 2003, THERIOGENOLOGY, V60, P359, DOI 10.1016/S0093-691X(03)00028-1; Seita Y, 2009, J REPROD DEVELOP, V55, P475, DOI 10.1262/jrd.20216; Sutovsky P, 1996, HUM REPROD, V11, P1703; THADANI VM, 1980, J EXP ZOOL, V212, P435, DOI 10.1002/jez.1402120316; THADANI VM, 1979, J EXP ZOOL, V210, P161, DOI 10.1002/jez.1402100118; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Ward MA, 2003, BIOL REPROD, V69, P2100, DOI 10.1095/biolreprod.103.020529; Yamauchi Y, 2002, BIOL REPROD, V67, P534, DOI 10.1095/biolreprod67.2.534; YANAGIDA K, 1991, BIOL REPROD, V44, P440, DOI 10.1095/biolreprod44.3.440; Yanagimachi R, 1998, HUM REPROD, V13, P87, DOI 10.1093/humrep/13.suppl_1.87	38	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78260	10.1371/journal.pone.0078260	http://dx.doi.org/10.1371/journal.pone.0078260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223784	Green Published, Green Submitted, gold			2022-12-25	WOS:000326503400046
J	Ozdemir, B; Abd-Almageed, W; Roessler, S; Wang, XW				Ozdemir, Bahadir; Abd-Almageed, Wael; Roessler, Stephanie; Wang, Xin Wei			iSubgraph: Integrative Genomics for Subgroup Discovery in Hepatocellular Carcinoma Using Graph Mining and Mixture Models	PLOS ONE			English	Article							REGULATORY MODULES; MICRORNA; PREDICTION; IDENTIFICATION; CLASSIFICATION; GENES	The high tumor heterogeneity makes it very challenging to identify key tumorigenic pathways as therapeutic targets. The integration of multiple omics data is a promising approach to identify driving regulatory networks in patient subgroups. Here, we propose a novel conceptual framework to discover patterns of miRNA-gene networks, observed frequently up-or down-regulated in a group of patients and to use such networks for patient stratification in hepatocellular carcinoma (HCC). We developed an integrative subgraph mining approach, called iSubgraph, and identified altered regulatory networks frequently observed in HCC patients. The miRNA and gene expression profiles were jointly analyzed in a graph structure. We defined a method to transform microarray data into graph representation that encodes miRNA and gene expression levels and the interactions between them as well. The iSubgraph algorithm was capable to detect cooperative regulation of miRNAs and genes even if it occurred only in some patients. Next, the miRNA-mRNA modules were used in an unsupervised class prediction model to discover HCC subgroups via patient clustering by mixture models. The robustness analysis of the mixture model showed that the class predictions are highly stable. Moreover, the Kaplan-Meier survival analysis revealed that the HCC subgroups identified by the algorithm have different survival characteristics. The pathway analyses of the miRNA-mRNA co-modules identified by the algorithm demonstrate key roles of Myc, E2F1, let-7, TGFB1, TNF and EGFR in HCC subgroups. Thus, our method can integrate various omics data derived from different platforms and with different dynamic scales to better define molecular tumor subtypes. iSubgraph is available as MATLAB code at http://www.cs.umd.edu/similar to ozdemir/isubgraph/.	[Ozdemir, Bahadir] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Ozdemir, Bahadir; Roessler, Stephanie; Wang, Xin Wei] Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Liver Carcinogenesis Sect, Bethesda, MD USA; [Abd-Almageed, Wael] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Roessler, Stephanie] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Ruprecht Karls University Heidelberg	Roessler, S (corresponding author), Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Liver Carcinogenesis Sect, Bethesda, MD USA.	stephanie.roessler@med.uni-heidelberg.de; xw3u@nih.gov	Wang, Xin Wei/B-6162-2009; Roessler, Stephanie/J-8432-2019	Wang, Xin Wei/0000-0001-9735-606X; Roessler, Stephanie/0000-0002-5333-5942	UMD-NCI Partnership for Cancer Technology; Intramural Research Program of the Center for Cancer Research, the National Cancer Institute [Z01-BC 010313]; NATIONAL CANCER INSTITUTE [ZIABC010313] Funding Source: NIH RePORTER	UMD-NCI Partnership for Cancer Technology; Intramural Research Program of the Center for Cancer Research, the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.O. was supported by the UMD-NCI Partnership for Cancer Technology. This work was supported in part by grants (Z01-BC 010313) from the Intramural Research Program of the Center for Cancer Research, the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bishop C.M., 2006, PATTERN RECOGNITION; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Burrage K, 2006, BRIEF BIOINFORM, V7, P390, DOI 10.1093/bib/bbl033; Cook DJ, 2006, MINING GRAPH DATA; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fiedler M., 2007, P IEEE INT WORKSH MI, P399; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harrington D, 2005, LINEAR RANK TESTS SU; Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027; Huang JC, 2006, LECT NOTES COMPUT SC, V3909, P114; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kim SJ, 2010, ESEM 10 P 2010 ACM I, P1; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Pekalska E, 2005, DISSIMILARITY REPRES; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Riesen K, 2009, IEEE T SYST MAN CY B, V39, P1472, DOI 10.1109/TSMCB.2009.2019264; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saint-Jean C, 2000, LECT NOTES COMPUT SC, V1876, P872; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Yan X., 2003, P 9 ACM SIGKDD INT C, P286, DOI [DOI 10.1145/956750.956784, 10.1145/956750.956784]; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhang SH, 2011, BIOINFORMATICS, V27, pI401, DOI 10.1093/bioinformatics/btr206	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78624	10.1371/journal.pone.0078624	http://dx.doi.org/10.1371/journal.pone.0078624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223834	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400079
J	Sumiyoshi, M; Nakamura, A; Nakamura, H; Hakata, M; Ichikawa, H; Hirochika, H; Ishii, T; Satoh, S; Iwai, H				Sumiyoshi, Minako; Nakamura, Atsuko; Nakamura, Hidemitsu; Hakata, Makoto; Ichikawa, Hiroaki; Hirochika, Hirohiko; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki			Increase in Cellulose Accumulation and Improvement of Saccharification by Overexpression of Arabinofuranosidase in Rice	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; CELL-WALL; D-XYLOSIDASE; HETEROLOGOUS EXPRESSION; PECTIC POLYSACCHARIDES; SIDE-CHAINS; BARLEY; PURIFICATION; SPECIFICITY; PLANTS	Cellulosic biomass is available for the production of biofuel, with saccharification of the cell wall being a key process. We investigated whether alteration of arabinoxylan, a major hemicellulose in monocots, causes an increase in saccharification efficiency. Arabinoxylans have beta-1,4-D-xylopyranosyl backbones and 1,3- or 1,4-alpha-L-arabinofuranosyl residues linked to O-2 and/or O-3 of xylopyranosyl residues as side chains. Arabinose side chains interrupt the hydrogen bond between arabinoxylan and cellulose and carry an ester- linked feruloyl substituent. Arabinose side chains are the base point for diferuloyl cross- links and lignification. We analyzed rice plants overexpressing arabinofuranosidase (ARAF) to study the role of arabinose residues in the cell wall and their effects on saccharification. Arabinose content in the cell wall of transgenic rice plants overexpressing individual ARAF full- length cDNA (OsARAF1-FOX and OsARAF3-FOX) decreased 25% and 20% compared to the control and the amount of glucose increased by 28.2% and 34.2%, respectively. We studied modifications of cell wall polysaccharides at the cellular level by comparing histochemical cellulose staining patterns and immunolocalization patterns using antibodies raised against alpha-(1,5)-linked L-Ara (LM6) and beta-(1,4)-linked D-Xyl (LM10 and LM11) residues. However, they showed no visible phenotype. Our results suggest that the balance between arabinoxylan and cellulose might maintain the cell wall network. Moreover, ARAF overexpression in rice effectively leads to an increase in cellulose accumulation and saccharification efficiency, which can be used to produce bioethanol.	[Sumiyoshi, Minako; Nakamura, Atsuko; Ishii, Tadashi; Satoh, Shinobu; Iwai, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Hidemitsu; Hakata, Makoto; Ichikawa, Hiroaki; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Agrobiological Sciences - Japan	Iwai, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	iwai.hiroaki.gb@u.tsukuba.ac.jp	Iwai, Hiroaki/B-3171-2014; Ichikawa, Hiroaki/AAB-3127-2019	Ichikawa, Hiroaki/0000-0002-1898-8235	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMA0007];  [18075004];  [24114006];  [AMR0001];  [EF1004]	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); ; ; ; 	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (18075004 to H. Iwai), a Grant-in-Aid for Scientific Research on Innovative Areas (24114006 to S. Satoh and H. Iwai) and grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, GMA0007 to S. Satoh) and AMR0001 to H. Ichikawa, and Green Technology Project, EF1004 to H. Ichikawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba K, 2009, MOL PLANT, V2, P893, DOI 10.1093/mp/ssp054; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brendel O, 2000, PHYTOCHEM ANALYSIS, V11, P7, DOI 10.1002/(SICI)1099-1565(200001/02)11:1&lt;7::AID-PCA488&gt;3.0.CO;2-U; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1984, PLANT PHYSIOL, V76, P205, DOI 10.1104/pp.76.1.205; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Coutinho PM, 1999, ROY SOC CH, P3; Drakakaki G, 2006, PLANT PHYSIOL, V142, P1480, DOI 10.1104/pp.106.086363; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Fulton LM, 2003, J EXP BOT, V54, P2467, DOI 10.1093/jxb/erg269; Gibeaut DM, 2005, PLANTA, V221, P729, DOI 10.1007/s00425-005-1481-0; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Hoije A, 2008, BIOMACROMOLECULES, V9, P2042, DOI 10.1021/bm800290m; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; ISHII T, 1991, CARBOHYD RES, V219, P15, DOI 10.1016/0008-6215(91)89039-I; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; Konishi T, 2011, PHYTOCHEMISTRY, V72, P1962, DOI 10.1016/j.phytochem.2011.07.012; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; Laidlaw HKC, 2012, J EXP BOT, V63, P3031, DOI 10.1093/jxb/ers019; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Lee RC, 2001, BIOCHEM J, V356, P181, DOI 10.1042/0264-6021:3560181; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Minic Z, 2004, PLANT PHYSIOL, V135, P867, DOI 10.1104/pp.104.041269; Minic Z, 2006, J EXP BOT, V57, P2339, DOI 10.1093/jxb/erj205; Montes RAC, 2008, PLANT PHYSIOL, V147, P63, DOI 10.1104/pp.107.110023; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Nakamura H, 2007, PLANT MOL BIOL, V65, P357, DOI 10.1007/s11103-007-9243-y; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Suzuki S, 2009, PLANT BIOTECHNOL-NAR, V26, P337, DOI 10.5511/plantbiotechnology.26.337; Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002; Willats WGT, 1999, PLANT J, V20, P619, DOI 10.1046/j.1365-313X.1999.00629.x; WOOD PJ, 1983, J CEREAL SCI, V1, P95, DOI 10.1016/S0733-5210(83)80027-7; Xiong JS, 2007, J EXP BOT, V58, P2799, DOI 10.1093/jxb/erm133; Yazaki J, 2004, NUCLEIC ACIDS RES, V32, pD383, DOI 10.1093/nar/gkh001	44	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78269	10.1371/journal.pone.0078269	http://dx.doi.org/10.1371/journal.pone.0078269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223786	Green Submitted, Green Published, gold			2022-12-25	WOS:000326503400048
J	Jaffre, M; Beaugrand, G; Goberville, E; Jiguet, F; Kjellen, N; Troost, G; Dubois, PJ; Lepretre, A; Luczak, C				Jaffre, Mikael; Beaugrand, Gregory; Goberville, Eric; Jiguet, Frederic; Kjellen, Nils; Troost, Gerard; Dubois, Philippe J.; Lepretre, Alain; Luczak, Christophe			Long-Term Phenological Shifts in Raptor Migration and Climate	PLOS ONE			English	Article							ARRIVAL; REPRODUCTION; SELECTION; PATTERNS; MIGRANTS; PLANKTON; IMPACT; BIRDS; DATES	Climate change is having a discernible effect on many biological and ecological processes. Among observed changes, modifications in bird phenology have been widely documented. However, most studies have interpreted phenological shifts as gradual biological adjustments in response to the alteration of the thermal regime. Here we analysed a long-term dataset (1980-2010) of short-distance migratory raptors in five European regions. We revealed that the responses of these birds to climate-induced changes in autumn temperatures are abrupt and synchronous at a continental scale. We found that when the temperatures increased, birds delayed their mean passage date of autumn migration. Such delay, in addition to an earlier spring migration, suggests that a significant warming may induce an extension of the breeding-area residence time of migratory raptors, which may eventually lead to residency.	[Jaffre, Mikael; Beaugrand, Gregory; Goberville, Eric; Luczak, Christophe] Univ Lille 1, Stn Marine Wimereux, CNRS, Lab Oceanol & Geosci,LOG,UMR 8187, Wimereux, France; [Jiguet, Frederic] UPMC, MNHN, Ctr Rech Biol Populat Oiseaux, CNRS,UMR 7204, Paris, France; [Kjellen, Nils] Lund Univ, Dept Biol, Lund, Sweden; [Dubois, Philippe J.] Trektellen Org, SOVON Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Dubois, Philippe J.] Ligue Protect Oiseaux, Rochefort, France; [Lepretre, Alain] Univ Lille 1, UPRES, EA 4515, F-59655 Villeneuve Dascq, France; [Luczak, Christophe] Univ Artois, IUFM, Gravelines, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Lund University; Universite de Lille - ISITE; Universite de Lille; Universite d'Artois; Universite de Bretagne Occidentale	Jaffre, M (corresponding author), Univ Lille 1, Stn Marine Wimereux, CNRS, Lab Oceanol & Geosci,LOG,UMR 8187, Wimereux, France.	mikael.jaffre@univ-lille1.fr	Goberville, Eric/A-2621-2017	Goberville, Eric/0000-0002-1843-7855; BEAUGRAND, GREGORY/0000-0002-0712-5223	Region Ile de France/LPO - PICRI (LPO/Universite Lille research fund) [SASS9045]	Region Ile de France/LPO - PICRI (LPO/Universite Lille research fund)(Region Ile-de-France)	This research was partly supported by a grant from Region Ile de France/LPO - PICRI project to M. Jaffre (LPO/Universite Lille 1 research fund SASS9045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2006, ENTOMOL REV, DOI DOI 10.1134/S0013873806100058; Beaugrand G, 2000, MAR ECOL PROG SER, V200, P93, DOI 10.3354/meps200093; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BERTHOLD P, 1994, P ROY SOC B-BIOL SCI, V257, P311, DOI 10.1098/rspb.1994.0131; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Coppack T, 2002, ARDEA, V90, P369; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Filippi-Codaccioni O, 2010, J ORNITHOL, V151, P687, DOI 10.1007/s10336-010-0500-5; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Hohn ME, 1993, COMPUTERS GEOLOGY 25, P181; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Hussell David J.T., 2005, North American Bird Bander, V30, P6; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lehikoinen A, 2009, OIKOS, V118, P829, DOI 10.1111/j.1600-0706.2008.17440.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Louchart A, 2008, NATURWISSENSCHAFTEN, V95, P1109, DOI 10.1007/s00114-008-0435-3; Luczak C, 2011, BIOL LETTERS, V7, P702, DOI 10.1098/rsbl.2011.0225; Mihoub JB, 2012, J AVIAN BIOL, V43, P472, DOI 10.1111/j.1600-048X.2012.05529.x; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peron G, 2007, CLIM RES, V35, P147, DOI 10.3354/cr00721; Porter R.F., 1985, International Council for Bird Preservation Technical Publication, P237; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Rodionov SN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025904; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Sergio F, 2003, J AVIAN BIOL, V34, P144, DOI 10.1034/j.1600-048X.2003.03104.x; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8	37	23	23	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79112	10.1371/journal.pone.0079112	http://dx.doi.org/10.1371/journal.pone.0079112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223888	Green Published, gold			2022-12-25	WOS:000326499300057
J	Gall, MG; Chen, YQ; de Ribeiro, AJV; Zhang, H; Bailey, CG; Spielman, DS; Yu, DMT; Gorrell, MD				Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Spielman, Derek S.; Yu, Denise M. T.; Gorrell, Mark D.			Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; CELL-ADHESION; SUBSTANCE-P; DPP-IV; EXPRESSION; MICE; INHIBITION; GENE; LOCALIZATION; APOPTOSIS	Dipeptidyl Peptidase (DPP) 4 and related dipeptidyl peptidases are emerging as current and potential therapeutic targets. DPP9 is an intracellular protease that is regulated by redox status and by SUMO1. DPP9 can influence antigen processing, epidermal growth factor (EGF)-mediated signaling and tumor biology. We made the first gene knock-in (gki) mouse with a serine to alanine point mutation at the DPP9 active site (S729A). Weaned heterozygote DPP9(wt/S729A) pups from 110 intercrosses were indistinguishable from wild-type littermates. No homozygote DPP9(S729A/S729A) weaned mice were detected. DPP9(S729A/S729A) homozygote embryos, which were morphologically indistinguishable from their wild-type littermate embryos at embryonic day (ED) 12.5 to ED 17.5, were born live but these neonates died within 8 to 24 hours of birth. All neonates suckled and contained milk spots and were of similar body weight. No gender differences were seen. No histological or DPP9 immunostaining pattern differences were seen between genotypes in embryos and neonates. Mouse embryonic fibroblasts (MEFs) from DPP9(S729A/S729A) ED13.5 embryos and neonate DPP9(S729A/S729A) mouse livers collected within 6 hours after birth had levels of DPP9 protein and DPP9-related proteases that were similar to wild-type but had less DPP9/DPP8-derived activity. These data confirmed the absence of DPP9 enzymatic activity due to the presence of the serine to alanine mutation and no compensation from related proteases. These novel findings suggest that DPP9 enzymatic activity is essential for early neonatal survival in mice.	[Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Yu, Denise M. T.; Gorrell, Mark D.] Centenary Inst, Camperdown, NSW, Australia; [Gall, Margaret G.; Chen, Yiqian; de Ribeiro, Ana Julia Vieira; Zhang, Hui; Bailey, Charles G.; Yu, Denise M. T.; Gorrell, Mark D.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Spielman, Derek S.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney	Gorrell, MD (corresponding author), Centenary Inst, Camperdown, NSW, Australia.	m.gorrell@centenary.usyd.edu.au	Zhang, Hui Emma/J-6888-2019; Gorrell, Mark Douglas/H-7231-2019; Gorrell, Mark/AAX-6394-2021	Zhang, Hui Emma/0000-0002-4699-4237; Gorrell, Mark Douglas/0000-0002-0528-2604; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council of Australia [512218]; Rebecca L. Cooper Foundation; Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney; University of Sydney; Australian Postgraduate Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation; Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney; University of Sydney(University of Sydney); Australian Postgraduate Award(Australian Government)	This work was funded by National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/grants/types-funding) grant 512218 and Rebecca L. Cooper Foundation (http://www.cooperfoundation.org.au/funding.html) grants to MDG. MGG holds a Sydney Medical School Foundation/Francis M. Hooper Scholarship for Medical Research through the University of Sydney (http://sydney.edu.au/medicine/scholawards/postgrad/research.php#francishooper). YC holds a University of Sydney international student scholarship (http://sydney.edu.au/scholarships/prospective/international_postgraduate_scholarships.shtml#usi). HZ holds an Australian Postgraduate Award (http://sydney.edu.au/scholarships/research/postgraduate_awards.shtml#APAUPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Abbott CA, 1999, FEBS LETT, V458, P278, DOI 10.1016/S0014-5793(99)01166-7; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Ajami K, 2003, BIOCHEMISTRY-US, V42, P694, DOI 10.1021/bi026846s; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury S, 2013, WORLD J GASTROENTERO, V19, P2883, DOI 10.3748/wjg.v19.i19.2883; Christiansen VJ, 2013, NEOPLASIA, V15, P348, DOI 10.1593/neo.121850; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Dubois V, 2010, BBA-PROTEINS PROTEOM, V1804, P781, DOI 10.1016/j.bbapap.2009.11.022; Dubois V, 2009, J HISTOCHEM CYTOCHEM, V57, P531, DOI 10.1369/jhc.2009.952739; ERICKSON RH, 1992, J BIOL CHEM, V267, P21623; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hardy ICW, 1997, APPL ANIM BEHAV SCI, V51, P217, DOI 10.1016/S0168-1591(96)01106-9; Harstad EB, 2013, REGUL PEPTIDES, V186, P26, DOI 10.1016/j.regpep.2013.07.003; HEYMANN E, 1978, FEBS LETT, V91, P360, DOI 10.1016/0014-5793(78)81210-1; Keane F. M., 2012, PROTEINASES DRUG TAR, P119; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lu C, 2011, CANC RES, V187; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reinhold D, 2009, CLIN CHEM LAB MED, V47, P268, DOI 10.1515/CCLM.2009.062; RUGH R, 1968, MOUSE ITS REPROD DEV; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SCHLAGER G, 1968, J HERED, V59, P363, DOI 10.1093/oxfordjournals.jhered.a107747; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Stremenova J, 2010, INT J ONCOL, V36, P351, DOI 10.3892/ijo_00000506; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walsh MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058860; Wang Aiying, 2012, BMC Pharmacology, V12, P2, DOI 10.1186/1471-2210-12-2; Wang XM, 2007, HEPATOLOGY, V46, p299A; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wilson CH, 2013, J BIOL CHEM, V288, P13936, DOI 10.1074/jbc.M112.445841; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Wu WG, 2012, BIOORG MED CHEM LETT, V22, P5536, DOI 10.1016/j.bmcl.2012.07.033; Xu J, 2005, CURRENT PROTOCOLS S, V70; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zhang H, 2013, MOL CANC RE IN PRESS	57	34	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e78378	10.1371/journal.pone.0078378	http://dx.doi.org/10.1371/journal.pone.0078378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223149	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200041
J	Goff, PH; Eggink, D; Seibert, CW; Hai, R; Martinez-Gil, L; Krammer, F; Palese, P				Goff, Peter H.; Eggink, Dirk; Seibert, Christopher W.; Hai, Rong; Martinez-Gil, Luis; Krammer, Florian; Palese, Peter			Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies	PLOS ONE			English	Article							VIRAL-INFECTION; VACCINE; IGA; MECHANISM; RESPONSES; IMMUNITY	The global population remains vulnerable in the face of the next pandemic influenza virus outbreak, and reformulated vaccinations are administered annually to manage seasonal epidemics. Therefore, development of a new generation of vaccines is needed to generate broad and persistent immunity to influenza viruses. Here, we describe three adjuvants that enhance the induction of stalk-directed antibodies against heterologous and heterosubtypic influenza viruses when administered with chimeric HA proteins. Addavax, an MF59-like nanoemulsion, poly(I: C), and an RNA hairpin derived from Sendai virus (SeV) Cantell were efficacious intramuscularly. The SeV RNA and poly(I: C) also proved to be effective respiratory mucosal adjuvants. Although the quantity and quality of antibodies induced by the adjuvants varied, immunized mice demonstrated comparable levels of protection against challenge with influenza A viruses on the basis of HA stalk reactivity. Finally, we present that intranasally, but not intramuscularly, administered chimeric HA proteins induce mucosal IgA antibodies directed at the HA stalk.	[Goff, Peter H.; Eggink, Dirk; Seibert, Christopher W.; Hai, Rong; Martinez-Gil, Luis; Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Goff, Peter H.; Seibert, Christopher W.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu	Martinez-Gil, Luis/M-7422-2014; Krammer, Florian/H-3237-2019	Martinez-Gil, Luis/0000-0002-9076-7760; Krammer, Florian/0000-0003-4121-776X; Palese, Peter/0000-0002-0337-5823; Goff, Peter/0000-0002-3488-4997; Eggink, Dirk/0000-0002-4248-6008	National Institutes of Health [HHSN272200900032C, 1P01AI097092-353 01A1]; Austrian Science Fund (FWF) [J 3232]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by a National Institutes of Health adjuvant development contract (HHSN272200900032C) and grant (1P01AI097092-353 01A1). Florian Krammer was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Cox RJ, 2013, HUM VACC IMMUNOTHER, V9, P405, DOI 10.4161/hv.22908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.03183-13, 10.1128/JVI.00641-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Miller MS, 2013, J INFECT DIS, V207, P98, DOI 10.1093/infdis/jis652; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Palese P, 2006, FIELDS VIROLOGY; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; Schaffner W, 2006, US INFFECT DIS, P28; Seibert CW, 2013, J VIROL, V87, P7793, DOI 10.1128/JVI.00979-13; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	25	50	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e79194	10.1371/journal.pone.0079194	http://dx.doi.org/10.1371/journal.pone.0079194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223176	gold, Green Submitted, Green Published			2022-12-25	WOS:000326656200068
J	Jung, SK; Kim, MK; Lee, YH; Shin, DH; Shin, MH; Chun, BY; Choi, BY				Jung, Su Kyoung; Kim, Mi-Kyung; Lee, Young-Hoon; Shin, Dong Hoon; Shin, Min-Ho; Chun, Byung-Yeol; Choi, Bo Youl			Lower Zinc Bioavailability May Be Related to Higher Risk of Subclinical Atherosclerosis in Korean Adults	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; PHYTATE INTAKE; MOLAR RATIOS; HUMAN HEALTH; DIETARY; MICRONUTRIENT; THICKNESS; ARTERY; REPRODUCIBILITY; NUTRITION	Background: There is a proposed link between dietary zinc intake and atherosclerosis, but this relationship remains unclear. Phytate may contribute to this relationship by influencing zinc bioavailability. Objective: The aim of this study is to examine the relationship between zinc bioavailability and subclinical atherosclerosis in healthy Korean adults. Materials and Methods: The present cross-sectional analysis used baseline data from the Korean multi-Rural Communities Cohort Study (MRCohort), which is a part of The Korean Genome Epidemiology Study (KoGES). A total of 5,532 subjects (2,116 men and 3,416 women) aged 40 years and older were recruited from rural communities in South Korea between 2005 and 2010. Phytate: zinc molar ratio, estimated from a food-based food frequency questionnaire (FFQ) of 106 food items, was used to determine zinc bioavailability, and carotid intima media thickness (cIMT) and pulse wave velocity (PWV) were measured to calculate the subclinical atherosclerotic index. Results: We found that phytate: zinc molar ratio is positively related to cIMT in men. A higher phytate: zinc molar ratio was significantly related to an increased risk of atherosclerosis in men, defined as the 80th percentile value of cIMT (5th vs. 1st quintile, OR = 2.11, 95% CI 1.42-3.15, P for trend = 0.0009), and especially in elderly men (5th vs. 1st quintile, OR = 2.58, 95% CI 1.52-4.37, P for trend = 0.0021). We found a positive relationship between phytate: zinc molar ratio and atherosclerosis risk among women aged 65 years or younger. Phytate: zinc molar ratio was not found to be related to PWV. Conclusions: Lower zinc bioavailability may be related to higher atherosclerosis risk.	[Jung, Su Kyoung; Kim, Mi-Kyung; Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Jung, Su Kyoung; Kim, Mi-Kyung; Choi, Bo Youl] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Dept Prevent Med, Iksan, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Coll Med, Inst Wonkwang Med Sci, Iksan, South Korea; [Shin, Dong Hoon] Keimyung Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea; [Chun, Byung-Yeol] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Chun, Byung-Yeol] Kyungpook Natl Univ, Hlth Promot Res Ctr, Daegu, South Korea	Hanyang University; Hanyang University; Wonkwang University; Wonkwang University; Keimyung University; Chonnam National University; Kyungpook National University; Kyungpook National University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr		Jung, Sukyoung/0000-0001-9200-2158; Shin, Min-Ho/0000-0002-2217-5624	National Research Foundation of Korea [NRF-2012R1A1A2001930]; Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Centers for Disease Control and Prevention	This study was supported by the National Research Foundation of Korea (grant NRF-2012R1A1A2001930) and partially supported by the Korea Centers for Disease Control and Prevention (grants 2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, and 2009-E71006-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Amirabdollahian F, 2010, PUBLIC HEALTH NUTR, V13, P1380, DOI 10.1017/S1368980010000704; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1430S, DOI 10.3945/ajcn.2010.28674B; Harland B F, 1987, World Rev Nutr Diet, V52, P235; He K, 2008, AM J CLIN NUTR, V88, P1111, DOI 10.1093/ajcn/88.4.1111; Health Canada, 2010, DIETARY REFERENCE IN; Hess SY, 2009, FOOD NUTR BULL, V30, pS5, DOI 10.1177/15648265090301S102; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Joung H, 2004, J FOOD COMPOS ANAL, V17, P713, DOI 10.1016/j.jfca.2003.10.002; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Kwun IS, 2000, BIOL TRACE ELEM RES, V75, P29, DOI 10.1385/BTER:75:1-3:29; 신진호, 2005, Korean Circulation Journal, V35, P683; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Ma G, 2007, EUR J CLIN NUTR, V61, P368, DOI 10.1038/sj.ejcn.1602513; MACKEY RH, 2007, CALCIFICATIONS ARTER, P75212; MILLS C, 1996, TRACE ELEMENTS HUMAN; Mitani S, 2012, BLOOD PRESSURE, V21, P338, DOI 10.3109/08037051.2012.686176; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; MORRIS ER, 1989, BIOL TRACE ELEM RES, V19, P107, DOI 10.1007/BF02925452; Otto MCCD, 2011, J NUTR, V141, P1508, DOI 10.3945/jn.111.138115; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Ouyang P, 2009, ATHEROSCLEROSIS, V204, P255, DOI 10.1016/j.atherosclerosis.2008.08.037; Perez-Lopez FR, 2010, REPROD SCI, V17, P511, DOI 10.1177/1933719110367829; Persson H, 1998, J AGR FOOD CHEM, V46, P3194, DOI 10.1021/jf971055w; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780; Prasad AS, 2009, NUTR CANCER, V61, P879, DOI 10.1080/01635580903285122; Roohani N, 2013, J RES MED SCI, V18, P144; Salgueiro MJ, 2000, NUTR RES, V20, P737, DOI 10.1016/S0271-5317(00)00163-9; Stensland-Bugge E, 2001, ATHEROSCLEROSIS, V154, P437, DOI 10.1016/S0021-9150(00)00486-X; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Willett W., 2012, NUTR EPIDEMIOLOGY; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yang YJ, 2010, BRIT J NUTR, V104, P1202, DOI 10.1017/S0007114510001893	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80115	10.1371/journal.pone.0080115	http://dx.doi.org/10.1371/journal.pone.0080115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223217	Green Submitted, gold, Green Published			2022-12-25	WOS:000326656200110
J	Vaughan, G; Xia, GL; Forbi, JC; Purdy, MA; Rossi, LMG; Spradling, PR; Khudyakov, YE				Vaughan, Gilberto; Xia, Guoliang; Forbi, Joseph C.; Purdy, Michael A.; Rossi, Livia Maria Goncalves; Spradling, Philip R.; Khudyakov, Yury E.			Genetic Relatedness among Hepatitis A Virus Strains Associated with Food-Borne Outbreaks	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; UNITED-STATES; C VIRUS; INFECTION; SOFTWARE; DNA	The genetic characterization of hepatitis A virus (HAV) strains is commonly accomplished by sequencing subgenomic regions, such as the VP1/P2B junction. HAV genome is not extensively variable, thus presenting opportunity for sharing sequences of subgenomic regions among genetically unrelated isolates. The degree of misrepresentation of phylogenetic relationships by subgenomic regions is especially important for tracking transmissions. Here, we analyzed whole-genome (WG) sequences of 101 HAV strains identified from 4 major multi-state, food-borne outbreaks of hepatitis A in the Unites States and from 14 non-outbreak-related HAV strains that shared identical VP1/P2B sequences with the outbreak strains. Although HAV strains with an identical VP1/P2B sequence were specific to each outbreak, WG were different, with genetic diversity reaching 0.31% (mean 0.09%). Evaluation of different subgenomic regions did not identify any other section of the HAV genome that could accurately represent phylogenetic relationships observed using WG sequences. The identification of 2-3 dominant HAV strains in 3 out of 4 outbreaks indicates contamination of the implicated food items with a heterogeneous HAV population. However, analysis of intra-host HAV variants from eight patients involved in one outbreak showed that only a single sequence variant established infection in each patient. Four non-outbreak strains were found closely related to strains from 2 outbreaks, whereas ten were genetically different from the outbreak strains. Thus, accurate tracking of HAV strains can be accomplished using HAV WG sequences, while short subgenomic regions are useful for identification of transmissions only among cases with known epidemiological association.	[Vaughan, Gilberto; Xia, Guoliang; Forbi, Joseph C.; Purdy, Michael A.; Rossi, Livia Maria Goncalves; Spradling, Philip R.; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Vaughan, G (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30329 USA.	GVaughan@cdc.gov			Division of Viral Hepatitis	Division of Viral Hepatitis	This work was supported by Division of Viral Hepatitis Intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon JJ, 2005, J INFECT DIS, V192, P1323, DOI 10.1086/462425; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bialek SR, 2007, CLIN INFECT DIS, V44, P838, DOI 10.1086/511874; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Craig AS, 2007, AM J MED SCI, V334, P180, DOI 10.1097/MAJ.0b013e3181425411; Cuthbert JA, 2001, CLIN MICROBIOL REV, V14, P38, DOI 10.1128/CMR.14.1.38-58.2001; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Fujiwara K, 2001, J HEPATOL, V35, P112, DOI 10.1016/S0168-8278(01)00074-5; Hollinger FB., 2001, FIELDS VIROLOGY, P799; JANSEN RW, 1990, P NATL ACAD SCI USA, V87, P2867, DOI 10.1073/pnas.87.8.2867; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Laird DT, 2011, FOOD MICROBIOL, V28, P998, DOI 10.1016/j.fm.2011.01.011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NAINAN OV, 1991, J GEN VIROL, V72, P1685, DOI 10.1099/0022-1317-72-7-1685; Purcell RH, 2002, J INFECT DIS, V185, P1668, DOI 10.1086/340520; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Rivera-Osorio P, 2011, J CLIN MICROBIOLOGY; ROBERTSON BH, 1991, J INFECT DIS, V163, P286, DOI 10.1093/infdis/163.2.286; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Russi JC, 2003, AM J TROP MED HYG, V68, P716, DOI 10.4269/ajtmh.2003.68.716; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Schiodt FV, 1999, LIVER TRANSPLANT SUR, V5, P29, DOI 10.1002/lt.500050102; Shieh YC, 2007, J FOOD PROTECT, V70, P145, DOI 10.4315/0362-028X-70.1.145; Shieh YC, 2009, J FOOD PROTECT, V72, P2390, DOI 10.4315/0362-028X-72.11.2390; Takahashi Y, 1993, Indian J Gastroenterol, V12 Suppl 3, P19; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855	29	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e74546	10.1371/journal.pone.0074546	http://dx.doi.org/10.1371/journal.pone.0074546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223112	gold, Green Published, Green Submitted			2022-12-25	WOS:000326656200004
J	Simon, O; Williams, T; Cerutti, M; Caballero, P; Lopez-Ferber, M				Simon, Oihane; Williams, Trevor; Cerutti, Martine; Caballero, Primitivo; Lopez-Ferber, Miguel			Expression of a Peroral Infection Factor Determines Pathogenicity and Population Structure in an Insect Virus	PLOS ONE			English	Article							JUVENILE-HORMONE ESTERASE; PER-OS INFECTIVITY; RECOMBINANT BACULOVIRUS; GENETIC-STRUCTURE; P10 PROTEIN; NUCLEOPOLYHEDROVIRUS; GENOTYPES; DELETION; PIF; PROMOTER	A Nicaraguan isolate of Spodoptera frugiperda multiple nucleopolyhedrovirus is being studied as a possible biological insecticide. This virus exists as a mixture of complete and deletion genotypes; the latter depend on the former for the production of an essential per os transmission factor (pif1) in coinfected cells. We hypothesized that the virus population was structured to account for the prevalence of pif1 defector genotypes, so that increasing the abundance of pif1 produced by a cooperator genotype in infected cells would favor an increased prevalence of the defector genotype. We tested this hypothesis using recombinant viruses with pif1 expression reprogrammed at its native locus using two exogenous promoters (egt, p10) in the pif2/pif1 intergenic region. Reprogrammed viruses killed their hosts markedly faster than the wild-type and rescue viruses, possibly due to an earlier onset of systemic infection. Group success (transmission) depended on expression of pif1, but overexpression was prejudicial to group-specific transmissibility, both in terms of reduced pathogenicity and reduced production of virus progeny from each infected insect. The presence of pif1-overproducing genotypes in the population was predicted to favor a shift in the prevalence of defector genotypes lacking pif1-expressing capabilities, to compensate for the modification in pif1 availability at the population level. As a result, defectors increased the overall pathogenicity of the virus population by diluting pif1 produced by overexpressing genotypes. These results offer a new and unexpected perspective on cooperative behavior between viral genomes in response to the abundance of an essential public good that is detrimental in excess.	[Simon, Oihane; Caballero, Primitivo] Consejo Super Invest Cient Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Cerutti, Martine] CNRS, Lab Baculovirus & Therapie, St Christol Les Ales, France; [Caballero, Primitivo] Univ Publ Navarra, Dept Agr Prod, Pamplona, Spain; [Lopez-Ferber, Miguel] Ecole Mines Ales, Lab Genie Environm Ind, Ales, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Instituto de Ecologia - Mexico; Centre National de la Recherche Scientifique (CNRS); Universidad Publica de Navarra; IMT - Institut Mines-Telecom; IMT Mines Ales	Lopez-Ferber, M (corresponding author), Ecole Mines Ales, Lab Genie Environm Ind, Ales, France.	miguel.lopez-ferber@mines-ales.fr	Simon, Oihane/G-5703-2014; Lopez-Ferber, Miguel/F-5465-2012; Williams, Trevor/ABG-3961-2020; Caballero, Primitivo/D-5063-2009; Williams, Trevor/F-1447-2011; GUO, Zhaoyu/AAS-5699-2020; Williams, Trevor/J-4239-2013	Simon, Oihane/0000-0003-1239-1486; Lopez-Ferber, Miguel/0000-0002-3850-1703; Caballero, Primitivo/0000-0003-0065-9625; Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440	Spanish Ministry for Science and Technology [AGL2005-07909-CO3-01, AGL2008-05456-CO3-01/AGR]; Jose Castillejo grant for postdoctoral mobility	Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Jose Castillejo grant for postdoctoral mobility	This study received financial support from the Spanish Ministry for Science and Technology projects AGL2005-07909-CO3-01 and AGL2008-05456-CO3-01/AGR. O.S. received a Jose Castillejo grant for postdoctoral mobility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNING BC, 1995, ARCH INSECT BIOCHEM, V30, P177, DOI 10.1002/arch.940300208; BONNING BC, 1994, J GEN VIROL, V75, P1551, DOI 10.1099/0022-1317-75-7-1551; Bull JC, 2001, APPL ENVIRON MICROB, V67, P5204, DOI 10.1128/AEM.67.11.5204-5209.2001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caballero P, 2009, REV COLOMB ENTOMOL, V35, P105; Clavijo G, 2010, P ROY SOC B-BIOL SCI, V277, P943, DOI 10.1098/rspb.2009.1838; Clavijo G, 2009, J VIROL, V83, P5127, DOI 10.1128/JVI.02020-08; Cory JS, 2005, J INVERTEBR PATHOL, V89, P101, DOI 10.1016/j.jip.2005.03.008; Crawley M.J., 1993, GLIM ECOLOGISTS; Evans OP, 1999, J GEN VIROL, V80, P485, DOI 10.1099/0022-1317-80-2-485; Frank SA, 2010, J EVOLUTION BIOL, V23, P1245, DOI 10.1111/j.1420-9101.2010.01986.x; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Gutierrez S, 2005, J BIOTECHNOL, V116, P135, DOI 10.1016/j.jbiotec.2004.10.007; Gutierrez S, 2004, J GEN VIROL, V85, P331, DOI 10.1099/vir.0.19623-0; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hernandez-Crespo P, 2001, APPL ENVIRON MICROB, V67, P1140, DOI 10.1128/AEM.67.3.1140-1146.2001; Hodgson DJ, 2004, J EVOLUTION BIOL, V17, P1018, DOI 10.1111/j.1420-9101.2004.00750.x; Hodgson DJ, 2001, EVOL ECOL RES, V3, P687; Hodgson JJ, 2007, J GEN VIROL, V88, P2479, DOI 10.1099/vir.0.82863-0; HORTON HM, 1993, J VIROL, V67, P1860, DOI 10.1128/JVI.67.4.1860-1868.1993; Hughes PR, 1987, BIOL BACULOVIRUSES, P1; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KnebelMorsdorf D, 1996, J GEN VIROL, V77, P815, DOI 10.1099/0022-1317-77-5-815; LeOra Software, 1987, POL PC US GUID PROB; Lopez-Ferber M, 2003, P ROY SOC B-BIOL SCI, V270, P2249, DOI 10.1098/rspb.2003.2498; LYNN DE, 1992, BIOTECHNIQUES, V13, P282; MacLean RC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000486; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; McNeil J, 2010, J GEN VIROL, V91, P1590, DOI 10.1099/vir.0.018952-0; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1991, BIO-TECHNOL, V9, P1086, DOI 10.1038/nbt1191-1086; Peng K, 2012, J VIROL, V86, P4981, DOI 10.1128/JVI.06801-11; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Simon O, 2006, P ROY SOC B-BIOL SCI, V273, P783, DOI 10.1098/rspb.2005.3394; Simon O, 2005, APPL ENVIRON MICROB, V71, P4254, DOI 10.1128/AEM.71.8.4254-4262.2005; Simon O, 2004, APPL ENVIRON MICROB, V70, P5579, DOI 10.1128/AEM.70.9.5579-5588.2004; Simon O, 2008, BIOL CONTROL, V44, P321, DOI 10.1016/j.biocontrol.2007.12.005; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; VANOERS MM, 1993, J GEN VIROL, V74, P563, DOI 10.1099/0022-1317-74-4-563; Washburn JO, 2003, J VIROL, V77, P280, DOI 10.1128/JVI.77.1.280-290.2003; Washburn JO, 1999, J VIROL, V73, P411, DOI 10.1128/JVI.73.1.411-416.1999; WEYER U, 1989, J GEN VIROL, V70, P203, DOI 10.1099/0022-1317-70-1-203	51	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78834	10.1371/journal.pone.0078834	http://dx.doi.org/10.1371/journal.pone.0078834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223853	gold, Green Published, Green Submitted			2022-12-25	WOS:000326597400040
J	Connes, P; Lamarre, Y; Hardy-Dessources, MD; Lemonne, N; Waltz, X; Mougenel, D; Mukisi-Mukaza, M; Lalanne-Mistrih, ML; Tarer, V; Tressieres, B; Etienne-Julan, M; Romana, M				Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Lemonne, Nathalie; Waltz, Xavier; Mougenel, Daniele; Mukisi-Mukaza, Martin; Lalanne-Mistrih, Marie-Laure; Tarer, Vanessa; Tressieres, Benoit; Etienne-Julan, Maryse; Romana, Marc			Decreased Hematocrit-To-Viscosity Ratio and Increased Lactate Dehydrogenase Level in Patients with Sickle Cell Anemia and Recurrent Leg Ulcers	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; BLOOD RHEOLOGY; HEMOLYSIS; DISEASE; TRANSFUSION; RISK	Leg ulcer is a disabling complication in patients with sickle cell anemia (SCA) but the exact pathophysiological mechanisms are unknown. The aim of this study was to identify the hematological and hemorheological alterations associated with recurrent leg ulcers. Sixty-two SCA patients who never experienced leg ulcers (ULC-) and 13 SCA patients with a positive history of recurrent leg ulcers (ULC+) - but with no leg ulcers at the time of the study - were recruited. All patients were in steady state condition. Blood was sampled to perform hematological, biochemical (hemolytic markers) and hemorheological analyses (blood viscosity, red blood cell deformability and aggregation properties). The hematocrit-to-viscosity ratio (HVR), which reflects the red blood cell oxygen transport efficiency, was calculated for each subject. Patients from the ULC+ group were older than patients from the ULC- group. Anemia (red blood cell count, hematocrit and hemoglobin levels) was more pronounced in the ULC+ group. Lactate dehydrogenase level was higher in the ULC+ group than in the ULC-group. Neither blood viscosity, nor RBC aggregation properties differed between the two groups. HVR was lower and RBC deformability tended to be reduced in the ULC+ group. Our study confirmed increased hemolytic rate and anemia in SCA patients with leg ulcers recurrence. Furthermore, our data suggest that although systemic blood viscosity is not a major factor involved in the pathophysiology of this complication, decreased red blood cell oxygen transport efficiency (i.e., low hematocrit/viscosity ratio) may play a role.	[Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Waltz, Xavier; Lalanne-Mistrih, Marie-Laure; Romana, Marc] Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Waltz, Xavier; Romana, Marc] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES, EA 3596, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Mukisi-Mukaza, Martin; Etienne-Julan, Maryse] Ctr Hosp, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Mukisi-Mukaza, Martin; Tarer, Vanessa; Etienne-Julan, Maryse] Univ Pointe A Pitre, Pointe A Pitre, Guadeloupe, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp Univ Pointe A Pitre, INSERM, CICEC 802, Pointe A Pitre, Guadeloupe, France; [Tarer, Vanessa; Etienne-Julan, Maryse] Ctr Hosp, Ctr Refrence Malad Rares Drepanocytose Antilles G, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe	Connes, P (corresponding author), Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Romana, Marc/K-6442-2017; , Hardy-dessources/K-9189-2017; Lamarre, Yann/ABC-2074-2020; WALTZ, Xavier/M-3606-2016; Connes, Philippe/J-7835-2019; TRESSIERES, Benoit/ABH-1085-2020	Romana, Marc/0000-0002-8715-9836; , Hardy-dessources/0000-0003-0861-3648; WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; ETIENNE-JULAN, Maryse/0000-0003-1339-6545; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998				Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x; BALLAS SK, 1989, AM J HEMATOL, V32, P104, DOI 10.1002/ajh.2830320206; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V53, P23, DOI 10.3233/CH-2012-1573; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Bowers AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068929; Cumming V, 2008, BRIT J HAEMATOL, V142, P119, DOI 10.1111/j.1365-2141.2008.07115.x; Delaney KMH, 2013, HEMOGLOBIN, V37, P325, DOI 10.3109/03630269.2013.789968; Detterich J, 2013, TRANSFUSION, V53, P297, DOI 10.1111/j.1537-2995.2012.03822.x; DUPUYFONS C, 1995, CLIN HEMORHEOL, V15, P191; Eckman JR, 1996, HEMATOL ONCOL CLIN N, V10, P1333, DOI 10.1016/S0889-8588(05)70404-4; Giraldi S, 2003, PEDIATR DERMATOL, V20, P427, DOI 10.1046/j.1525-1470.2003.20512.x; GUERI M, 1970, TROP GEOGR MED, V22, P155; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KOSHY M, 1989, BLOOD, V74, P1403; LAMARRE Y, 2013, CLIN HEMORHEOL MICRO, P4554; Lamarre Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066004; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; Minniti CP, 2014, AM J HEMATOL, V89, P1, DOI 10.1002/ajh.23571; Minniti CP, 2011, AM J HEMATOL, V86, P705, DOI 10.1002/ajh.22065; Minniti Caterina P, 2010, Am J Hematol, V85, P831, DOI 10.1002/ajh.21838; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; WALTZ X, 2013, CLIN HEMORHEOL MICRO; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200	29	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79680	10.1371/journal.pone.0079680	http://dx.doi.org/10.1371/journal.pone.0079680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223994	Green Published, gold			2022-12-25	WOS:000326503400138
J	Harada, K; Itoh, H; Kawazoe, Y; Miyazaki, S; Doi, K; Kubo, T; Akagawa, Y; Shiba, T				Harada, Kana; Itoh, Hiromichi; Kawazoe, Yumi; Miyazaki, Shuichi; Doi, Kazuya; Kubo, Takayasu; Akagawa, Yasumasa; Shiba, Toshikazu			Polyphosphate-Mediated Inhibition of Tartrate-Resistant Acid Phosphatase and Suppression of Bone Resorption of Osteoclasts	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; IN-VITRO; CELLS; EXOPOLYPHOSPHATASE; ACIDOCALCISOMES; REGENERATION; RECOMBINANT; MODULATION; ACTIVATION; INDUCTION	Inorganic polyphosphate (poly(P)) has recently been found to play an important role in bone formation. In this study, we found that tartrate-resistant acid phosphatase (TRAP), which is abundantly expressed in osteoclasts, has polyphosphatase activity that degrades poly(P) and yields Pi as well as shorter poly(P) chains. Since the TRAP protein that coprecipitated with anti-TRAP monoclonal antibodies exhibited both polyphosphatase and the original phosphatase activity, poly(P) degradation activity is dependent on TRAP and not on other contaminating enzymes. The ferrous chelator alpha, alpha'-bipyridyl, which inhibits the TRAP-mediated production of reactive oxygen species (ROS), had no effect on such poly(P) degradation, suggesting that the degradation is not dependent on ROS. In addition, shorter chain length poly(P) molecules were better substrates than longer chains for TRAP, and poly(P) inhibited the phosphatase activity of TRAP depending on its chain length. The IC50 of poly(P) against the original phosphatase activity of TRAP was 9.8 mu M with an average chain length more than 300 phosphate residues, whereas the IC50 of poly(P) with a shorter average chain length of 15 phosphate residues was 8.3 mM. Finally, the pit formation activity of cultured rat osteoclasts differentiated by RANKL and M-CSF were markedly inhibited by poly(P), while no obvious decrease in cell number or differentiation efficiency was observed for poly(P). In particular, the inhibition of pit formation by long chain poly(P) with 300 phosphate residues was stronger than that of shorter chain poly(P). Thus, poly(P) may play an important regulatory role in osteoclastic bone resorption by inhibiting TRAP activity, which is dependent on its chain length.	[Harada, Kana; Doi, Kazuya; Kubo, Takayasu; Akagawa, Yasumasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Itoh, Hiromichi; Kawazoe, Yumi; Shiba, Toshikazu] Regenetiss Inc, Koganei, Tokyo, Japan; [Miyazaki, Shuichi] YAMASA Corp, Diagnost Dept, Choshi, Chiba, Japan; [Shiba, Toshikazu] Kitasato Univ, Kitasato Inst, Kitasato Inst Life Sci, Tokyo, Japan	Hiroshima University; Kitasato University	Shiba, T (corresponding author), Regenetiss Inc, Koganei, Tokyo, Japan.	shiba@regenetiss.com	Doi, Kazuya/J-6554-2016	Doi, Kazuya/0000-0001-9452-4750	Regenetiss Inc.	Regenetiss Inc.	This work was supported by basic research fund of Regenetiss Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; [Anonymous], J BIOL CHEM, V274, P22907; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Halleen JM, 2003, J BONE MINER RES, V18, P1908, DOI 10.1359/jbmr.2003.18.10.1908; Halleen JM, 1999, PLOS ONE; Hayman AR, 1996, DEVELOPMENT, V122, P3151; HAYMAN AR, 1994, J BIOL CHEM, V269, P1294; Itoh H, 2006, J MICROBIOL METH, V64, P241, DOI 10.1016/j.mimet.2005.05.003; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Kawazoe Y, 2004, J DENT RES, V83, P613, DOI 10.1177/154405910408300806; Kawazoe Y, 2008, INT J BIOL SCI, V4, P37, DOI 10.7150/ijbs.4.37; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; LING P, 1993, J BIOL CHEM, V268, P6896; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Lorenz B, 1997, BBA-GEN SUBJECTS, V1335, P51, DOI 10.1016/S0304-4165(96)00121-3; McInerney P, 2006, MOL MICROBIOL, V60, P438, DOI 10.1111/j.1365-2958.2006.05103.x; Miyazaki S, 2001, METHOD FIND EXP CLIN, V23, P433, DOI 10.1358/mf.2001.23.8.662130; MOONGA BS, 1990, J PHYSIOL-LONDON, V429, P29, DOI 10.1113/jphysiol.1990.sp018242; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; REINHOLT FP, 1990, J BONE MINER RES, V5, P1055; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Schroder HC, 2000, BIOCHEMISTRY-MOSCOW+, V65, P296; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Yuan Q, 2009, ACTA BIOMATER, V5, P1716, DOI 10.1016/j.actbio.2009.01.034; ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V159, P68, DOI 10.1016/0006-291X(89)92405-4	40	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78612	10.1371/journal.pone.0078612	http://dx.doi.org/10.1371/journal.pone.0078612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223830	Green Submitted, gold, Green Published			2022-12-25	WOS:000326503400078
J	Trape, JF; Diatta, G; Arnathau, C; Bitam, I; Sarih, M; Belghyti, D; Bouattour, A; Elguero, E; Vial, L; Mane, Y; Balde, C; Pugnolle, F; Chauvancy, G; Mahe, G; Granjon, L; Duplantier, JM; Durand, P; Renaud, F				Trape, Jean-Francois; Diatta, Georges; Arnathau, Celine; Bitam, Idir; Sarih, M'hammed; Belghyti, Driss; Bouattour, Ali; Elguero, Eric; Vial, Laurence; Mane, Youssouph; Balde, Cellou; Pugnolle, Franck; Chauvancy, Gilles; Mahe, Gil; Granjon, Laurent; Duplantier, Jean-Marc; Durand, Patrick; Renaud, Francois			The Epidemiology and Geographic Distribution of Relapsing Fever Borreliosis in West and North Africa, with a Review of the Ornithodoros erraticus Complex (Acari: Ixodida)	PLOS ONE			English	Article							TICK-BORNE BORRELIOSIS; RODENTS; MALARIA; PART	Background: Relapsing fever is the most frequent bacterial disease in Africa. Four main vector / pathogen complexes are classically recognized, with the louse Pediculus humanus acting as vector for B. recurrentis and the soft ticks Ornithodoros sonrai, O. erraticus and O. moubata acting as vectors for Borrelia crocidurae, B. hispanica and B. duttonii, respectively. Our aim was to investigate the epidemiology of the disease in West, North and Central Africa. Methods And Findings: From 2002 to 2012, we conducted field surveys in 17 African countries and in Spain. We investigated the occurrence of Ornithodoros ticks in rodent burrows in 282 study sites. We collected 1,629 small mammals that may act as reservoir for Borrelia infections. Using molecular methods we studied genetic diversity among Ornithodoros ticks and Borrelia infections in ticks and small mammals. Of 9,870 burrows investigated, 1,196 (12.1%) were inhabited by Ornithodoros ticks. In West Africa, the southern and eastern limits of the vectors and Borrelia infections in ticks and small mammals were 13 degrees N and 01 degrees E, respectively. Molecular studies revealed the occurrence of nine different Ornithodoros species, including five species new for science, with six of them harboring Borrelia infections. Only B. crocidurae was found in West Africa and three Borrelia species were identified in North Africa: B. crocidurae, B. hispanica, and B. merionesi. Conclusions: Borrelia Spirochetes responsible for relapsing fever in humans are highly prevalent both in Ornithodoros ticks and small mammals in North and West Africa but Ornithodoros ticks seem absent south of 13 degrees N and small mammals are not infected in these regions. The number of Ornithodoros species acting as vector of relapsing fever is much higher than previously known.	[Trape, Jean-Francois; Diatta, Georges; Vial, Laurence; Mane, Youssouph; Chauvancy, Gilles] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Arnathau, Celine; Elguero, Eric; Vial, Laurence; Pugnolle, Franck; Durand, Patrick; Renaud, Francois] CNRS, Inst Rech Dev, IRD, MIVEGEC,UMR, Montpellier, France; [Bitam, Idir] Inst Pasteur, Lab Ecol Syst Vectoriels, Algiers, Algeria; [Sarih, M'hammed] Inst Pasteur, Lab Malad Vectorielles, Casablanca, Morocco; [Belghyti, Driss] Univ Ibn Tofail, Dept Biol, Fac Sci, Kenitra, Morocco; [Bouattour, Ali] Inst Pasteur, Serv Entomol Med, Tunis, Tunisia; [Balde, Cellou] Inst Pasteur, Lab Entomol Med & Venimol, Kindia, Guinea; [Mahe, Gil] Inst Rech Dev, UMR Hydrosci, Montpellier, France; [Granjon, Laurent; Duplantier, Jean-Marc] Ctr Biol & Gest Populat, Inst Rech Dev, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ibn Tofail University of Kenitra; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal.	jean-francois.trape@ird.fr	Granjon, Laurent/K-2111-2016; Driss, BELGHYTI/E-6963-2014; BELGHYTI, Driss/AAK-8888-2020; Mahe, Gil/AAY-9002-2021	Granjon, Laurent/0000-0003-1182-3793; Driss, BELGHYTI/0000-0002-2465-8742; Mahe, Gil/0000-0002-0081-750X; Prugnolle, Franck/0000-0001-8519-1253	GICC programme of the French Ministry of Ecology [CV02000201]; Agence Nationale de la Recherche [3215AO-3R077-STEV]; IRD special programme "Evolution Climatique et Sante" [IRD-ATI-ECS]	GICC programme of the French Ministry of Ecology; Agence Nationale de la Recherche(French National Research Agency (ANR)); IRD special programme "Evolution Climatique et Sante"	The study received grants from the GICC programme of the French Ministry of Ecology (ref: CV02000201), the programmes "Sante-Environnement" and "Sante-Travail" of the Agence Nationale de la Recherche (ref: 3215AO-3R077-STEV), and the IRD special programme "Evolution Climatique et Sante" (ref: IRD-ATI-ECS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1935, ARCH I PASTEUR TUNIS, V22, P350; Baltazard M., 1950, Bulletin de la Societe de Pathologie Exotique Paris, V43, P595; BARCLAY AJG, 1990, T ROY SOC TROP MED H, V84, P852, DOI 10.1016/0035-9203(90)90106-O; BERGERET C., 1946, Bulletin Medical de l'Afrique-Occidentale Francaise, V3, P29; BLANC G., 1948, BULL SOC PATH EXOT, V41, P139; BOIRON H., 1949, BULL SOC PATH EXOT, V42, P62; Bouattour A, 2010, VECTOR-BORNE ZOONOT, V10, P825, DOI 10.1089/vbz.2009.0151; BRYCESON AD, 1970, Q J MED, V39, P129; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; Camicas JL, 1998, PARIS ORSTOM, P233; CHABAUD ALAIN, 1954, ANN PARASITOL HUMAINE ET COMP, V29, P89; Chausov E.V., 2010, ENTOMOL REV, V90, P240, DOI DOI 10.1134/S0013873810020090; Colangelo P, 2007, MOL PHYLOGENET EVOL, V42, P797, DOI 10.1016/j.ympev.2006.10.001; Colas Belcour J, 1930, ARCH I PASTEUR TUNIS, V19, P1; Cutler SJ, 2009, CLIN MICROBIOL INFEC, V15, P400, DOI 10.1111/j.1469-0691.2009.02819.x; Cutler SJ, 2006, EMERG INFECT DIS, V12, P369, DOI 10.3201/eid1203.050899; de BUEN SADI, 1926, ANN PARASITOL HUM ET COMP, V4, P185; DIATTA G, 1994, T ROY SOC TROP MED H, V88, P423, DOI 10.1016/0035-9203(94)90412-X; Diatta G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001810; Dobigny G, 2005, HEREDITY, V95, P358, DOI 10.1038/sj.hdy.6800730; Dobigny G, 2011, MAMM BIOL, V76, P417, DOI 10.1016/j.mambio.2010.10.002; Dutton JE, 1905, BRIT MED J, V1905, P1259; Eguale Tewdros., 2002, ETHIOP J HLTH SCI, V12, P103; Fukunaga M, 2001, VECTOR-BORNE ZOONOT, V1, P331, DOI 10.1089/15303660160025949; GARNHAM PCC, 1947, T ROY SOC TROP MED H, V41, P141, DOI 10.1016/S0035-9203(47)90209-5; Gaud M, 1947, B ORG MOND SANTE, V1, P75; Gaud M, 1947, B ORG MOND SANTE, V1, P99; GOUBAU PF, 1984, ANN SOC BELG MED TR, V64, P335; GOUBAU PFJ, 1983, ANN SOC BELG MED TR, V63, P347; Granjon L, 2003, MAMMAL REV, V33, P77, DOI 10.1046/j.1365-2907.2003.00007.x; Granjon L, 2009, RONGEURS AFRIQUE SAH, P215; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoogstraal H, 1956, 0050502907 NM, P113; Hornus P, 1928, NOTE SUJET FIEVRE RE, V17, P327; Kisinza WN, 2003, LANCET, V362, P1283, DOI 10.1016/S0140-6736(03)14609-0; Larrouse F., 1923, Annales de Parasitologie Paris, V1, P170; Lecompte F, 2005, MOL PHYLOGENET EVOL, V37, P899, DOI 10.1016/j.ympev.2005.06.018; LEESON HS, 1952, B ENTOMOL RES, V43, P407, DOI 10.1017/S000748530004058X; LEESON HS, 1953, B ENTOMOL RES, V44, P517, DOI 10.1017/S0007485300025591; Lucas H, 1849, EXPLORATION SCI ALGE, P316; Mackie FP, 1907, BRIT MED J, V1907, P1706, DOI 10.1136/bmj.2.2450.1706; Mahe G, 2012, CARTE PLUIES ANN AF; Mathis C., 1934, Ann Inst Pasteur Paris T, V52, P166; Mathis C, 1932, B SOC PATHOL EXOT, V21, P472; Mathis Constant, 1946, OEUVRE PASTORIENS AF; Morel P. C., 1959, Revue d'Elevage, V12, P53; Morel P.-C., 2003, B ACAD VET FR, DOI DOI 10.4267/2042/66807; Neumann G, 1896, MEM SOC ZOOL FRANCE, V9, P25; Nicolle C, 1928, PRESENCE MAROC SPIRO, V17, P83; Nordstrand A, 2007, EMERG INFECT DIS, V13, P117, DOI 10.3201/eid1301.060670; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramos JM, 2008, ANN TROP MED PARASIT, V102, P467, DOI 10.1179/136485908X300887; RODHAIN F, 1976, B I PASTEUR, V74, P173; Ross PH, 1904, BRIT MED J, V1904, P1453, DOI 10.1136/bmj.2.2291.1453; Sarih M, 2009, EMERG INFECT DIS, V15, P1626, DOI 10.3201/eid1510.090403; SAUTET J., 1944, BULL SOC PATH EXOT, V37, P182; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; SERGENT A., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P906; Sergent Edm., 1908, Bulletin de la Societe de Pathologie Exotique Paris, V1; SOUTHERN PM, 1969, MEDICINE, V48, P129, DOI 10.1097/00005792-196903000-00002; SPARROW H, 1958, Bull World Health Organ, V19, P673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Trape JF, 1996, AM J TROP MED HYG, V54, P289, DOI 10.4269/ajtmh.1996.54.289; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W; VELU H., 1919, Bulletin de la Societe de Pathologie Exotique, V12, P99; Venzal JM, 2008, J MED ENTOMOL, V45, P832, DOI 10.1603/0022-2585(2008)45[832:TOATSG]2.0.CO;2; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; WALTON GERALD A., 1962, SYMPOSIA ZOOL SOC LONDON, V6, P83; Weldon ED, 1955, WORLD DISTRIBUTION S, V2; Wilson DE, 2005, MAMMALS WORLD TAXONI, V1	77	83	86	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78473	10.1371/journal.pone.0078473	http://dx.doi.org/10.1371/journal.pone.0078473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223812	Green Published, gold			2022-12-25	WOS:000326503400065
J	Wang, MC; Hashimoto, M; Hashidoko, Y				Wang, Mengcen; Hashimoto, Makoto; Hashidoko, Yasuyuki			Repression of Tropolone Production and Induction of a Burkholderia plantarii Pseudo-Biofilm by Carot-4-en-9, 10-diol, a Cell-to-Cell Signaling Disrupter Produced by Trichoderma virens	PLOS ONE			English	Article							SECONDARY METABOLITES; CAROTANE SESQUITERPENE; GENE-EXPRESSION; QUORUM; BACTERIA; PROTEIN; BIOSYNTHESIS; SUBSTANCES; AERUGINOSA; BEHAVIORS	Background: The tropolone-tolerant Trichoderma virens PS1-7 is a biocontrol agent against Burkholderia plantarii, causative of rice seedling blight. When exposed to catechol, this fungus dose-dependently produced carot-4-en-9,10-diol,a sesquiterpene-type autoregulatory signal molecule that promotes self-conidiation of T. virens PS1-7 mycelia. It was, however, uncertain why T. virens PS1-7 attenuates the symptom development of the rice seedlings infested with B. plantarii. Methodology/Principal Findings: To reveal the antagonism by T. virens PS1-7 against B. plantarii leading to repression of tropolone production in a coculture system, bioassay-guided screening for active compounds from a 3-d culture of T. virens PS1-7 was conducted. As a result, carot-4-en-9,10-diol was identified and found to repress tropolone production of B. plantarii from 10 to 200 mu M in a dose-dependent manner as well as attenuate virulence of B. plantarii on rice seedlings. Quantitative RT-PCR analysis revealed that transcriptional suppression of N-acyl-L-homoserine lactone synthase plaI in B. plantarii was the main mode of action by which carot-4-en-9,10-diol mediated the quorum quenching responsible for repression of tropolone production. In addition, the unique response of B. plantarii to carot-4-en-9,10-diol in the biofilm formed in the static culture system was also found. Although the initial stage of B. plantarii biofilm formation was induced by both tropolone and carot-4-en-9,10-diol, it was induced in different states. Moreover, the B. plantarii biofilm that was induced by carot-4-en-9,10-diol at the late stage showed defects not only in matrix structure but also cell viability. Conclusions/Significance: Our findings demonstrate that carot-4-en-9,10-diol released by T. virens PS1-7 acts as an interkingdom cell-to-cell signaling molecule against B. plantarii to repress tropolone production and induces pseudo-biofilm to the cells. This observation also led to another discovery that tropolone is an autoregulatory cell-to-cell signaling molecule of B. plantarii that induces a functional biofilm other than a simple B. plantarii virulence factor.	[Hashidoko, Yasuyuki] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hashidoko, Y (corresponding author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	yasu-h@abs.agr.hokudai.ac.jp	Hashimoto, Makoto/B-7837-2012; Wang, Mengcen/AAP-6051-2021; Wang, Mengcen/AAN-3975-2021	Hashimoto, Makoto/0000-0002-5526-8835; Wang, Mengcen/0000-0001-7169-6779	Ministry of Economy, Trade and Industry, Japan for the METI Project; Chinese Scholarship Council for the Scholarship [CSC 2010632028];  [485 20240833]	Ministry of Economy, Trade and Industry, Japan for the METI Project; Chinese Scholarship Council for the Scholarship; 	The authors are grateful to the Ministry of Economy, Trade and Industry, Japan for the METI Project (Highly efficient gene design for microbial production of innovative biomaterials to Y.H.) and Chinese Scholarship Council for the Scholarship (CSC 2010632028 to M.W.). This research work was also financially supported by a Grant-in-aid for Scientific Research A (no. 485 20240833 to Y.H.). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitha R, 2005, J BASIC MICROB, V45, P12, DOI 10.1002/jobm.200410451; AZEGAMI K, 1985, Annals of the Phytopathological Society of Japan, V51, P315, DOI 10.3186/jjphytopath.51.315; AZEGAMI K, 1988, APPL ENVIRON MICROB, V54, P844, DOI 10.1128/AEM.54.3.844-847.1988; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Cataldi TRI, 2013, ANAL BIOANAL CHEM, V405, P493, DOI 10.1007/s00216-012-6371-2; Chernin L, 2011, ENV MICROBIOL REP, V3, P698, DOI 10.1111/j.1758-2229.2011.00284.x; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Dandurishvili N, 2011, J APPL MICROBIOL, V110, P341, DOI 10.1111/j.1365-2672.2010.04891.x; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P2486, DOI 10.1111/j.1462-2920.2007.01367.x; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Dufour N, 2011, FEMS MICROBIOL LETT, V314, P10, DOI 10.1111/j.1574-6968.2010.02154.x; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gao MS, 2003, MOL PLANT MICROBE IN, V16, P827, DOI 10.1094/MPMI.2003.16.9.827; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Gram L, 1996, APPL ENVIRON MICROB, V62, P4284, DOI 10.1128/AEM.62.11.4284-4287.1996; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Howell CR, 2004, PHYTOPATHOLOGY, V94, pS138; Jarosz LM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002312; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Koh CL, 2013, SENSORS-BASEL, V13, P6217, DOI 10.3390/s130506217; Lee SH, 1995, J NAT PROD, V58, P1822, DOI 10.1021/np50126a004; Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P35, DOI 10.1099/mic.0.053629-0; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Okajima Y, 2006, INVEST OPHTH VIS SCI, V47, P2971, DOI 10.1167/iovs.05-1172; Okegbe C, 2012, ANTIOXID REDOX SIGN, V16, P658, DOI 10.1089/ars.2011.4249; ONDEYKA JG, 1995, BIOORG MED CHEM LETT, V5, P733, DOI 10.1016/0960-894X(95)00104-2; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Ponnusamy K, 2010, BRAZ J MICROBIOL, V41, P227, DOI 10.1590/S1517-838220100001000032; Popat R, 2008, BRIT MED BULL, V87, P63, DOI 10.1093/bmb/ldn030; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Shinohara M, 2008, J PESTIC SCI, V33, P90, DOI 10.1584/jpestics.33.90; Solis R, 2006, FEMS MICROBIOL LETT, V259, P106, DOI 10.1111/j.1574-6968.2006.00254.x; Stanley NR, 2004, MOL MICROBIOL, V52, P917, DOI 10.1111/j.1365-2958.2004.04036.x; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Teplitski M, 2000, MOL PLANT MICROBE IN, V13, P637, DOI 10.1094/MPMI.2000.13.6.637; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang MC, 2013, APPL ENVIRON MICROB, V79, P1906, DOI 10.1128/AEM.03531-12; WATANABE N, 1990, J NAT PROD, V53, P1176, DOI 10.1021/np50071a006; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Zhu H, 2011, LETT APPL MICROBIOL, V52, P269, DOI 10.1111/j.1472-765X.2010.02993.x	59	12	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78024	10.1371/journal.pone.0078024	http://dx.doi.org/10.1371/journal.pone.0078024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223754	Green Published, gold			2022-12-25	WOS:000326503400029
J	Adams, RI; Miletto, M; Taylor, JW; Bruns, TD				Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.			The Diversity and Distribution of Fungi on Residential Surfaces	PLOS ONE			English	Article							QUANTITATIVE PCR; BACTERIAL; AIRBORNE; COMMUNITY; WORLD; DUST	The predominant hypothesis regarding the composition of microbial assemblages in indoor environments is that fungal assemblages are structured by outdoor air with a moderate contribution by surface growth, whereas indoor bacterial assemblages represent a mixture of bacteria entered from outdoor air, shed by building inhabitants, and grown on surfaces. To test the fungal aspect of this hypothesis, we sampled fungi from three surface types likely to support growth and therefore possible contributors of fungi to indoor air: drains in kitchens and bathrooms, sills beneath condensation-prone windows, and skin of human inhabitants. Sampling was done in replicated units of a university-housing complex without reported mold problems, and sequences were analyzed using both QIIME and the new UPARSE approach to OTU-binning, to the same result. Surfaces demonstrated a mycological profile similar to that of outdoor air from the same locality, and assemblages clustered by surface type. "Weedy" genera typical of indoor air, such as Cladosporium and Cryptococcus, were abundant on sills, as were a diverse set of fungi of likely outdoor origin. Drains supported more depauperate assemblages than the other surfaces and contained thermotolerant genera such as Exophiala, Candida, and Fusarium. Most surprising was the composition detected on residents' foreheads. In addition to harboring Malassezia, a known human commensal, skin also possessed a surprising richness of non-resident fungi, including plant pathogens such as ergot (Claviceps purperea). Overall, fungal richness across indoor surfaces was high, but based on known autecologies, most of these fungi were unlikely to be growing on surfaces. We conclude that while some endogenous fungal growth on typical household surfaces does occur, particularly on drains and skin, all residential surfaces appear - to varying degrees - to be passive collectors of airborne fungi of putative outdoor origin, a view of the origins of the indoor microbiome quite different from bacteria.	[Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	adamsri@berkeley.edu		Adams, Rachel/0000-0003-4499-5743	Alfred P. Sloan Foundation [2010-10-03]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded with a grant from the Alfred P. Sloan Foundation (http://www.sloan.org), grant number 2010-10-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abe N, 2011, BIOCONTROL SCI, V16, P139, DOI 10.4265/bio.16.139; Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Ara Katsutoshi, 2004, Allergology International, V53, P369, DOI 10.1111/j.1440-1592.2004.00356.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2013, NAT METHODS ADV; Edgar RC, 2013, UPARSE PIPELINE; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher AJ, 2007, PLANT DIS, V91, P380, DOI 10.1094/PDIS-91-4-0380; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; Hamada N, 2009, MYCOSCIENCE, V50, P421, DOI 10.1007/s10267-009-0500-6; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Karvala K, 2010, INT ARCH OCC ENV HEA, V83, P855, DOI 10.1007/s00420-010-0507-5; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kuhn DM, 2003, CLIN MICROBIOL REV, V16, P144, DOI 10.1128/CMR.16.1.144-172.2003; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; R Development Core Team, 2012, R LANG ENV STAT COMP; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; SAMSON RA, 2001, MICROORGANISMS HOME, P287, DOI DOI 10.1201/9780203302934; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Zhou G, 2000, MOL CELL PROBE, V14, P339, DOI 10.1006/mcpr.2000.0324	52	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78866	10.1371/journal.pone.0078866	http://dx.doi.org/10.1371/journal.pone.0078866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	23936296	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300039
J	Yeh, CB; Hsieh, MJ; Lin, CW; Chiou, HL; Lin, PY; Chen, TY; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Lin, Chiao-Wen; Chiou, Hui-Ling; Lin, Pen-Yuan; Chen, Tzy-Yen; Yang, Shun-Fa			The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; ORAL-CANCER; SIGNALING PATHWAY; KAPPA-B; EXPRESSION; INVASION; CELLS; INHIBITION; ANGIOGENESIS; APOPTOSIS	Background: The mortality and morbidity rates from cancer metastasis have not declined in Taiwan, especially because of hepatocellular carcinoma (HCC). Resveratrol has been shown to have benefits such as cardioprotection, providing antioxidative, anti-inflammatory, anti-cancer properties in previous studies. Therefore, HCC cells were subjected to treatment with resveratrol and then analyzed to determine the effects of resveratrol on the migration and invasion. Methodology and Principal Findings: Modified Boyden chamber assays revealed that resveratrol treatment significantly inhibited cell migration and invasion capacities of Huh7 cell lines that have low cytotoxicity in vitro, even at a high concentration of 100 mu M. The results of casein zymography and western blotting revealed that the activities and protein levels of the urokinase-type plasminogen activator (u-PA) were inhibited by resveratrol. Western blot analysis also showed that resveratrol inhibits phosphorylation of JNK1/2. Tests of the mRNA level, real-time PCR, and promoter assays evaluated the inhibitory effects of resveratrol on u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay showed that reactive in transcription protein of nuclear factor SP-1 was inhibited by resveratrol. Conclusions: Resveratrol inhibits u-PA expression and the metastasis of HCC cells and is a powerful chemopreventive agent. The inhibitory effects were associated with the downregulation of the transcription factors of SP-1 signaling pathways.	[Yeh, Chao-Bin; Chen, Tzy-Yen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Pen-Yuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chen, Tzy-Yen] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, TY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy042@csh.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576; Ryu, Soojin/0000-0002-7059-0160; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2012-C-006]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2012-C-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bae S, 2011, MOL CELLS, V32, P243, DOI 10.1007/s10059-011-1037-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Freeman MR, 2011, CANCER BIOL THER, V12, P966, DOI 10.4161/cbt.12.11.18136; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hsu WH, 2012, J CELL PHYSIOL, V227, P697, DOI 10.1002/jcp.22777; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Kunimasa K, 2011, MOL NUTR FOOD RES, V55, P1730, DOI 10.1002/mnfr.201100098; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Liu M, 2011, COMMUN INTEGR BIOL, P4382; Mohapatra P, 2011, ONCOL RES, V19, P311, DOI 10.3727/096504011X13079697132844; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Piotrowska H., 2011, MUTAT RES, V750, P60; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roy S, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/703676; Ryu J, 2011, ANTICANCER RES, V31, P4223; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Szekeres T, 2010, PHARM RES-DORDR, V27, P1042, DOI 10.1007/s11095-010-0090-1; Thummarati P, 2012, WORLD J GASTROENTERO, V18, P244, DOI 10.3748/wjg.v18.i3.244; VONDERAHE D, 1988, NUCLEIC ACIDS RES, V16, P7527, DOI 10.1093/nar/16.15.7527; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5235, DOI 10.1021/jf900531m; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	36	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56661	10.1371/journal.pone.0056661	http://dx.doi.org/10.1371/journal.pone.0056661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24223943	Green Published, gold			2022-12-25	WOS:000315184200133
J	Zhou, XY; Barsky, LW; Adams, GB				Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.			Placental Growth Factor Expression Is Required for Bone Marrow Endothelial Cell Support of Primitive Murine Hematopoietic Cells	PLOS ONE			English	Article							STEM-CELL; PROGENITOR CELLS; VASCULAR NICHE; IN-VIVO; THERAPEUTIC NEOVASCULARIZATION; SELF-RENEWAL; TRANSPLANTATION; RECONSTITUTION; TISSUE; MOUSE	Two distinct microenvironmental niches that regulate hematopoietic stem/progenitor cell physiology in the adult bone marrow have been proposed; the endosteal and the vascular niche. While extensive studies have been performed relating to molecular interactions in the endosteal niche, the mechanisms that regulate hematopoietic stem/progenitor cell interaction with bone marrow endothelial cells are less well defined. Here we demonstrate that endothelial cells derived from the bone marrow supported hematopoietic stem/progenitor cells to a higher degree than other endothelial or stromal cell populations. This support was dependant upon placental growth factor expression, as genetic knockdown of mRNA levels reduced the ability of endothelial cells to support hematopoietic stem/progenitor cells in vitro. Furthermore, using an in vivo model of recovery from radiation induced myelosuppression, we demonstrate that bone marrow endothelial cells were able to augment the recovery of the hematopoietic stem/progenitor cells. However, this effect was diminished when the same cells with reduced placental growth factor expression were administered, possibly owing to a reduced homing of the cells to the bone marrow vasculature. Our data suggest that placental growth factor elaborated from bone marrow endothelial cells mediates the regulatory effects of the vascular niche on hematopoietic stem/progenitor cell physiology.	[Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Adams, GB (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	gregorad@med.usc.edu		Adams, Rachel/0000-0003-4499-5743	California Institute for Regenerative Medicine	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute for Regenerative Medicine (XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Ewing P, 2003, J IMMUNOL METHODS, V283, P307, DOI 10.1016/j.jim.2003.08.004; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grassinger J, 2012, CYTOKINE, V58, P218, DOI 10.1016/j.cyto.2012.01.014; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; LAMBERTSEN RH, 1984, BLOOD, V63, P287; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Larrivee B, 2006, EXP HEMATOL, V34, P1741, DOI 10.1016/j.exphem.2006.08.006; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miyamoto Y, 2007, J MOL CELL CARDIOL, V43, P627, DOI 10.1016/j.yjmcc.2007.08.001; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; PLOEMACHER RE, 1991, BLOOD, V78, P2527; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yan Z, 2013, TRANSPL P, V45, P427, DOI 10.1016/j.transproceed.2012.03.064; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	53	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e67861	10.1371/journal.pone.0067861	http://dx.doi.org/10.1371/journal.pone.0067861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936296	Green Published, Green Submitted, gold			2022-12-25	WOS:000324545800001
J	Wang, FM; Xu, X; Zou, B; Guo, ZH; Li, ZA; Zhu, WX				Wang, Faming; Xu, Xin; Zou, Bi; Guo, Zhihua; Li, Zhian; Zhu, Weixing			Biomass Accumulation and Carbon Sequestration in Four Different Aged Casuarina equisetifolia Coastal Shelterbelt Plantations in South China	PLOS ONE			English	Article							FINE-ROOT BIOMASS; SOIL CARBON; SECONDARY FORESTS; STAND DEVELOPMENT; DRY TROPICS; NITROGEN; DYNAMICS; CHRONOSEQUENCE; EUCALYPTUS; FIXATION	Thousands of kilometers of shelterbelt plantations of Casuarina equisetifolia have been planted to protect the southeast coastline of China. These plantations also play an important role in the regional carbon (C) cycling. In this study, we examined plant biomass increment and C accumulation in four different aged C. equisetifolia plantations in sandy beaches in South China. The C accumulated in the C. equisetifolia plant biomass increased markedly with stand age. The annual rate of C accumulation in the C. equisetifolia plant biomass during 0-3, 3-6, 6-13 and 13-18 years stage was 2.9, 8.2, 4.2 and 1.0 Mg C ha(-1) yr(-1), respectively. Soil organic C (SOC) at the top 1 m soil layer in these plantations was 17.74, 5.14, 6.93, and 11.87 Mg C ha(-1), respectively, with SOC density decreasing with increasing soil depth. Total C storage in the plantation ecosystem averaged 26.57, 38.50, 69.78, and 79.79 Mg C ha(-1) in the 3, 6, 13 and 18-yrs plantation, with most of the C accumulated in the aboveground biomass rather than in the belowground root biomass and soil organic C. Though our results suggest that C. equisetifolia plantations have the characteristics of fast growth, high biomass accumulation, and the potential of high C sequestration despite planting in poor soil conditions, the interactive effects of soil condition, natural disturbance, and human policies on the ecosystem health of the plantation need to be further studied to fully realize the ecological and social benefits of the C equisetifolia shelterbelt forests in South China.	[Wang, Faming; Xu, Xin; Zou, Bi; Li, Zhian; Zhu, Weixing] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Guo, Zhihua] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Zhu, Weixing] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Forestry; Institute of Wetland Research, CAF; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Li, ZA (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn; wxzhu@binghamton.edu	Wang, Faming/J-9342-2014	Wang, Faming/0000-0002-7543-6779; Zhu, Weixing/0000-0002-4274-6973	National Basic Research Program of China [2011CB403200]; NSFC [U1131001]; Natural Science Foundation of China [31300419]; Chinese Academy of Sciences [KSCX2-EW-J-28, XDA05070307]; National Science and Technology Pillar program [2009BAD2B0604]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Pillar program	This work was funded by National Basic Research Program of China (2011CB403200), NSFC-Guangdong Joint Project (U1131001), Natural Science Foundation of China (31300419), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-28), the "Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (XDA05070307) and the key projects in the National Science and Technology Pillar program (2009BAD2B0604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borja I, 2008, TREE PHYSIOL, V28, P773, DOI 10.1093/treephys/28.5.773; Campo J, 2001, BIOGEOCHEMISTRY, V53, P161, DOI 10.1023/A:1010663516029; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; Clements F.E., 1916, PLANT SUCCESSION ANA; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; El-Lankany M, 1990, ADV CASUARINA RES UT; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; GAUTHIER D, 1985, SOIL BIOL BIOCHEM, V17, P375, DOI 10.1016/0038-0717(85)90076-8; Goulden ML, 2011, GLOBAL CHANGE BIOL, V17, P855, DOI 10.1111/j.1365-2486.2010.02274.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hardman CJ, 2012, ORYX, V46, P204, DOI 10.1017/S0030605311000251; Harmand JM, 2004, FOREST ECOL MANAG, V188, P249, DOI 10.1016/j.foreco.2003.07.026; HARRISON AF, 1995, FORESTRY, V68, P335, DOI 10.1093/forestry/68.4.335; Hong YuanCheng, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P66; Hughes RF, 1999, ECOLOGY, V80, P1892; Johnston MH, 1996, FOREST ECOL MANAG, V83, P17, DOI 10.1016/0378-1127(96)03704-8; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Usuga JCL, 2010, FOREST ECOL MANAG, V260, P1906, DOI 10.1016/j.foreco.2010.08.040; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Mascarenhas A, 2008, J ENVIRON MANAGE, V89, P24, DOI 10.1016/j.jenvman.2007.01.053; Mather A, 2003, LAND USE POLICY, V20, P195, DOI 10.1016/S0264-8377(03)00003-6; Miao S.Y., 1998, GUIHAIA, V18, P16; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Muthukumar T, 2010, NEW FOREST, V40, P101, DOI 10.1007/s11056-009-9186-z; Parrotta JA, 1996, CAN J FOREST RES, V26, P1684, DOI 10.1139/x26-190; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rokityanskiy D, 2007, TECHNOL FORECAST SOC, V74, P1057, DOI 10.1016/j.techfore.2006.05.022; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; Srivastava AK, 1995, BIOMASS BIOENERG, V9, P465, DOI 10.1016/0961-9534(95)00048-8; State Forestry Administration (SFA), 2009, CHIN FOR STAT YB 200; TROUVE C, 1994, SOIL BIOL BIOCHEM, V26, P287, DOI 10.1016/0038-0717(94)90169-4; WILDE SERGIUS A., 1964, SOIL SCI, V97, P276, DOI 10.1097/00010694-196404000-00009; WILLIAMSLINERA G, 1983, BIOTROPICA, V15, P275, DOI 10.2307/2387652; [杨昆 YANG Kun], 2006, [生态环境, Ecology and Environment], V15, P84; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; Zhang H.L., 1996, CHINESE ECOSYSTEM RE, P1; Zhong C., 2003, CHINA FOREST SCI TEC, V17, P3, DOI DOI 10.3969/J.ISSN.1000-8101.2003.02.001; Zhong CL, 2010, SYMBIOSIS, V50, P107, DOI 10.1007/s13199-009-0039-5; Zoysa M. de, 2008, Small-scale Forestry, V7, P17, DOI 10.1007/s11842-008-9038-2	46	18	20	8	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77449	10.1371/journal.pone.0077449	http://dx.doi.org/10.1371/journal.pone.0077449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143236	Green Published, Green Submitted, gold			2022-12-25	WOS:000325894100073
J	Abada, YSK; Nguyen, HP; Schreiber, R; Ellenbroek, B				Abada, Yah-se K.; Nguyen, Huu Phuc; Schreiber, Rudy; Ellenbroek, Bart			Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease	PLOS ONE			English	Article							YAC128 MOUSE MODEL; COGNITIVE DEFICITS; NEUROPATHOLOGICAL FEATURES; PREPULSE INHIBITION; MUTANT HUNTINGTIN; GENE; SYMPTOMS; MICE; HD; ABNORMALITIES	Rationale: Huntington disease (HD) is frequently first diagnosed by the appearance of motor symptoms; the diagnosis is subsequently confirmed by the presence of expanded CAG repeats (> 35) in the HUNTINGTIN (HTT) gene. A BACHD rat model for HD carrying the human full length mutated HTT with 97 CAG-CAA repeats has been established recently. Behavioral phenotyping of BACHD rats will help to determine the validity of this model and its potential use in preclinical drug discovery studies. Objectives: The present study seeks to characterize the progressive emergence of motor, sensorimotor and cognitive deficits in BACHD rats. Materials and Methods: Wild type and transgenic rats were tested from 1 till 12 months of age. Motor tests were selected to measure spontaneous locomotor activity (open field) and gait coordination. Sensorimotor gating was assessed in acoustic startle response paradigms and recognition memory was evaluated in an object recognition test. Results: Transgenic rats showed hyperactivity at 1 month and hypoactivity starting at 4 months of age. Motor coordination imbalance in a Rotarod test was present at 2 months and gait abnormalities were seen in a Catwalk test at 12 months. Subtle sensorimotor changes were observed, whereas object recognition was unimpaired in BACHD rats up to 12 months of age. Conclusion: The current BACHD rat model recapitulates certain symptoms from HD patients, especially the marked motor deficits. A subtle neuropsychological phenotype was found and further studies are needed to fully address the sensorimotor phenotype and the potential use of BACHD rats for drug discovery purposes.	[Abada, Yah-se K.] EVOTEC AG, Neuropharmacol, Hamburg, Germany; [Abada, Yah-se K.] Univ Bremen, Brain Res Inst, Dept Neuropharmacol, D-28359 Bremen, Germany; [Nguyen, Huu Phuc] Univ Tubingen, Inst Med Genet & Appl Gen, Tubingen, Germany; [Schreiber, Rudy] Univ Groningen, Groningen, Netherlands; [Ellenbroek, Bart] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	Evotec; University of Bremen; Eberhard Karls University of Tubingen; University of Groningen; Victoria University Wellington	Abada, YSK (corresponding author), EVOTEC AG, Neuropharmacol, Hamburg, Germany.	yah-se.abada@evotec.com	Nguyen, Huu Phuc/F-5390-2015; Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Ellenbroek, Bart/0000-0003-1996-4873; abada, komla yah-se/0000-0003-0085-8747	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union [215618-2]	Neuromodel, an Initial Training Network through the people programme FP7 of the European Union	This work was supported by grant no. 215618-2 from Neuromodel, an Initial Training Network funded through the people programme FP7 of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bowles KR, 2012, BRAIN RES BULL, V88, P276, DOI 10.1016/j.brainresbull.2011.07.021; Brooks S, 2009, BRAIN RES BULL, V79, P310, DOI 10.1016/j.brainresbull.2009.03.003; Carter RJ, 1999, J NEUROSCI, V19, P3248; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; CHABOT CC, 1992, BEHAV NEUROSCI, V106, P846, DOI 10.1037/0735-7044.106.5.846; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; DIMAIO L, 1993, J MED GENET, V30, P289, DOI 10.1136/jmg.30.4.289; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Ellenbroek BA, 2004, BIOL PSYCHIAT, V55, P701, DOI 10.1016/j.biopsych.2003.10.024; ESTEBAN A, 1981, J NEUROL NEUROSUR PS, V44, P43, DOI 10.1136/jnnp.44.1.43; Fink KD, 2012, BEHAV NEUROSCI, V126, P479, DOI 10.1037/a0028028; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Hahn-Barma V, 1998, J NEUROL NEUROSUR PS, V64, P172, DOI 10.1136/jnnp.64.2.172; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huntington G., 1872, MED SURG REP, V26, P320; Jones L, 2011, INT REV NEUROBIOL, V98, P373, DOI 10.1016/B978-0-12-381328-2.00015-8; Kirch RD, 2013, BEHAV BRAIN RES, V239, P15, DOI 10.1016/j.bbr.2012.10.048; Kodsi MH, 1997, BRAIN RES, V773, P45, DOI 10.1016/S0006-8993(97)00869-X; KOLLER WC, 1985, NEUROLOGY, V35, P1450, DOI 10.1212/WNL.35.10.1450; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 2000, BRAIN, V123, P1349, DOI 10.1093/brain/123.7.1349; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Montoya A, 2006, NEUROPSYCHOLOGIA, V44, P1984, DOI 10.1016/j.neuropsychologia.2006.01.015; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; ROSENBERG NK, 1995, J MED GENET, V32, P600, DOI 10.1136/jmg.32.8.600; Seaman RL, 2000, NEUROSCI LETT, V280, P183, DOI 10.1016/S0304-3940(00)00790-4; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zeef DH, 2012, BEHAV BRAIN RES, V227, P194, DOI 10.1016/j.bbr.2011.11.009; Zeef DH, 2012, BEHAV BRAIN RES, V226, P435, DOI 10.1016/j.bbr.2011.09.041; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2	58	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e68584	10.1371/journal.pone.0068584	http://dx.doi.org/10.1371/journal.pone.0068584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23874679	Green Published, Green Submitted, gold			2022-12-25	WOS:000322218800037
J	Di, L; Zhang, H; Gu, WJ; Liu, YQ; Zhang, MG				Liu, Di; Zhang, Hong; Gu, Wenjuan; Liu, Yuqin; Zhang, Mengren			Neuroprotective Effects of Ginsenoside Rb1 on High Glucose-Induced Neurotoxicity in Primary Cultured Rat Hippocampal Neurons	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-PROLIFERATION; PYRAMIDAL NEURONS; OXIDATIVE STRESS; DIABETIC-RATS; NADPH OXIDASE; ER STRESS; APOPTOSIS; MICE	Ginsenoside Rb1 is one of the main active principles in traditional herb ginseng and has been reported to have a wide variety of neuroprotective effects. Endoplasmic reticulum (ER) stress has been implicated in neurodegenerative diseases, so the present study aimed to observe the effects of ginsenoside Rb1 on ER stress signaling pathways in high glucose-treated hippocampal neurons. The results from MTT, TUNEL labeling and Annexin V-FITC/PI/Hoechst assays showed that incubating neurons with 50 mM high glucose for 72h decreased cell viability and increased the number of apoptotic cells whereas treating neurons with 1 mu M Rb1 for 72h protected the neurons against high glucose-induced cell damage. Further molecular mechanism study demonstrated that Rb1 suppressed the activation of ER stress-associated proteins including protein kinase RNA (PKR)-like ER kinase (PERK) and C/EBP homology protein (CHOP) and downregulation of Bcl-2 induced by high glucose. Moreover, Rb1 inhibited both the elevation of intracellular reactive oxygen species (ROS) and the disruption of mitochondrial membrane potential induced by high glucose. In addition, the high glucose-induced cell apoptosis, activation of ER stress, ROS accumulation and mitochondrial dysfunction can also be attenuated by the inhibitor of ER stress 4-phenylbutyric acid (4-PBA) and anti-oxidant N-acetylcysteine(NAC). In conclusion, these results suggest that Rb1 may protect neurons against high glucose-induced cell injury through inhibiting CHOP signaling pathway as well as oxidative stress and mitochondrial dysfunction.	[Liu, Di; Gu, Wenjuan; Zhang, Mengren] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100021, Peoples R China; [Liu, Di; Zhang, Hong; Gu, Wenjuan; Liu, Yuqin; Zhang, Mengren] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Hong; Liu, Yuqin] Peking Union Med Coll, Inst Basic Med Sci, Dept Cell Resource Ctr, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, MG (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100021, Peoples R China.	xh02742@163.com	Vieira, Fernando/L-6246-2013	Vieira, Fernando/0000-0003-2996-6418	NIAID NIH HHS [K02-AI-060701, K02 AI060701] Funding Source: Medline; NIA NIH HHS [P30 AG013846, AG013846] Funding Source: Medline; BLRD VA [I01 BX001428] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BLRD VA		Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Arduino DM, 2009, NEUROCHEM INT, V55, P341, DOI 10.1016/j.neuint.2009.04.004; Bravo R, 2012, INT J BIOCHEM CELL B, V44, P16, DOI 10.1016/j.biocel.2011.10.012; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Chen ZY, 2010, NEUROSCI LETT, V482, P264, DOI 10.1016/j.neulet.2010.07.052; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Gaspar JM, 2010, NEUROSCIENCE, V171, P981, DOI 10.1016/j.neuroscience.2010.10.019; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Guo J, 2010, NEUROSCI RES, V68, P329, DOI 10.1016/j.neures.2010.08.012; Hashimoto R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/693717; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hou Y, 2012, NEUROSCIENCE, V200, P120, DOI 10.1016/j.neuroscience.2011.10.030; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Liu D, 2013, INT J NEUROSCI, V123, P155, DOI 10.3109/00207454.2012.746974; Liu L, 2011, BRAIN RES, V1382, P147, DOI 10.1016/j.brainres.2011.01.051; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sims-Robinson C, 2012, DIABETOLOGIA, V55, P2276, DOI 10.1007/s00125-012-2573-6; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Srinivasan K, 2011, BEHAV BRAIN RES, V225, P110, DOI 10.1016/j.bbr.2011.07.004; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tekkok S, 1999, NEUROSCIENCE, V91, P185, DOI 10.1016/S0306-4522(98)00662-9; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Verkhratsky A, 2008, CELL CALCIUM, V44, P112, DOI 10.1016/j.ceca.2007.11.010; Wang SH, 2009, TOXICOL SCI, V111, P72, DOI 10.1093/toxsci/kfp126; Wang WW, 2013, BRAIN INJURY, V27, P924, DOI 10.3109/02699052.2013.793397; Xue JF, 2006, BRAIN RES, V1106, P91, DOI 10.1016/j.brainres.2006.05.106; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Ye L, 2011, BRAIN RES, V1411, P57, DOI 10.1016/j.brainres.2011.07.011; Yi SS, 2011, NEUROCHEM RES, V36, P117, DOI 10.1007/s11064-010-0280-6; Yoshikawa T, 2008, J PHARMACOL SCI, V107, P32, DOI 10.1254/jphs.FP0071297; Zhang XM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924327; Zhao CH, 2012, BRAIN RES, V1457, P33, DOI 10.1016/j.brainres.2012.03.067	46	56	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79399	10.1371/journal.pone.0079399	http://dx.doi.org/10.1371/journal.pone.0079399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223941	Green Published, Green Submitted, gold			2022-12-25	WOS:000326499300081
J	Hodgson, AB; Randell, RK; Jeukendrup, AE				Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.			The Metabolic and Performance Effects of Caffeine Compared to Coffee during Endurance Exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; INTERMITTENT EXERCISE; PERCEIVED EXERTION; PROLONGED EXERCISE; FAT-METABOLISM; INGESTION; RESPONSES; HUMANS; CARBOHYDRATE; METAANALYSIS	There is consistent evidence supporting the ergogenic effects of caffeine for endurance based exercise. However, whether caffeine ingested through coffee has the same effects is still subject to debate. The primary aim of the study was to investigate the performance enhancing effects of caffeine and coffee using a time trial performance test, while also investigating the metabolic effects of caffeine and coffee. In a single-blind, crossover, randomised counter-balanced study design, eight trained male cyclists/triathletes (Mean +/- SD: Age 41 +/- 7y, Height 1.80 +/- 0.04 m, Weight 78.9 +/- 4.1 kg, VO2 max 58 +/- 3 ml.kg(-1).min(-1)) completed 30 min of steady-state (SS) cycling at approximately 55% VO(2)max followed by a 45 min energy based target time trial (TT). One hour prior to exercise each athlete consumed drinks consisting of caffeine (5 mg CAF/kg BW), instant coffee (5 mg CAF/kg BW), instant decaffeinated coffee or placebo. The set workloads produced similar relative exercise intensities during the SS for all drinks, with no observed difference in carbohydrate or fat oxidation. Performance times during the TT were significantly faster (similar to 5.0%) for both caffeine and coffee when compared to placebo and decaf (38.35 +/- 1.53, 38.27 +/- 1.80, 40.23 +/- 1.98, 40.31 +/- 1.22 min respectively, p<0.05). The significantly faster performance times were similar for both caffeine and coffee. Average power for caffeine and coffee during the TT was significantly greater when compared to placebo and decaf (294 +/- 21 W, 291 +/- 22 W, 277 +/- 14 W, 276 +/- 23 W respectively, p<0.05). No significant differences were observed between placebo and decaf during the TT. The present study illustrates that both caffeine (5 mg/kg/BW) and coffee (5 mg/kg/BW) consumed 1 h prior to exercise can improve endurance exercise performance.	[Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Jeukendrup, Asker E.] PepsiCo, Gatorade Sport Sci Inst, Barrington, IL USA	University of Birmingham; PepsiCo	Jeukendrup, AE (corresponding author), Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	a.e.jeukendrup@bham.ac.uk		Hodgson, Amanda/0000-0002-9479-3018; Kelly, Nat/0000-0002-9664-354X				Beaudoin Marie-Soleil, 2011, Handb Exp Pharmacol, P509, DOI 10.1007/978-3-642-13443-2_21; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUTTS NK, 1985, RES Q EXERCISE SPORT, V56, P301, DOI 10.1080/02701367.1985.10605333; Chesley A, 1998, AM J PHYSIOL-REG I, V275, pR596, DOI 10.1152/ajpregu.1998.275.2.R596; COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6; Desbrow B, 2006, INT J SPORT NUTR EXE, V16, P545, DOI 10.1123/ijsnem.16.5.545; Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a; Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; GRAHAM TE, 1991, J APPL PHYSIOL, V71, P2292, DOI 10.1152/jappl.1991.71.6.2292; Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x; Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; KATHER H, 1985, J CLIN INVEST, V76, P1559, DOI 10.1172/JCI112137; Lamina S, 2009, AFR HEALTH SCI, V9, P270; McLellan TM, 2004, INT J SPORT NUTR EXE, V14, P698, DOI 10.1123/ijsnem.14.6.698; Mohr M, 2011, J APPL PHYSIOL, V111, P1372, DOI 10.1152/japplphysiol.01028.2010; Mohr T, 1998, J APPL PHYSIOL, V85, P979, DOI 10.1152/jappl.1998.85.3.979; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Raguso CA, 1996, METABOLISM, V45, P1153, DOI 10.1016/S0026-0495(96)90016-5; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Stalmach A, 2012, COFFEE EMERGING HLTH; Tallis J, 2012, J APPL PHYSIOL, V112, P64, DOI 10.1152/japplphysiol.00801.2011; Tarnopolsky M, 2000, J APPL PHYSIOL, V89, P1719, DOI 10.1152/jappl.2000.89.5.1719; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121; TRICE I, 1995, INT J SPORT NUTR, V5, P37, DOI 10.1123/ijsn.5.1.37; TSE SYH, 1992, J PHARM SCI, V81, P449, DOI 10.1002/jps.2600810512; Tsuda S, 2012, J NUTR BIOCH; vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999; VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104; WAHLBERG G, 1992, SCAND J CLIN LAB INV, V52, P547, DOI 10.3109/00365519209090132; Wiles J D, 1992, Br J Sports Med, V26, P116	42	195	202	2	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59561	10.1371/journal.pone.0059561	http://dx.doi.org/10.1371/journal.pone.0059561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573201	gold, Green Published, Green Submitted			2022-12-25	WOS:000318840100020
J	Chen, X; Zhang, Z; Visser, RGF; Broekgaarden, C; Vosman, B				Chen, Xi; Zhang, Zhao; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben			Overexpression of IRM1 Enhances Resistance to Aphids in Arabidopsis thaliana	PLOS ONE			English	Article							GREEN PEACH APHID; INSECT-RESISTANCE; DEFENSE RESPONSES; XYLEM INGESTION; MYZUS-PERSICAE; PLANT DEFENSE; ACTIVATION; PENETRATION; GENE; PATHOGEN	Aphids are insects that cause direct damage to crops by the removal of phloem sap, but more importantly they spread devastating viruses. Aphids use their sophisticated mouthpart (i.e. stylet) to feed from the phloem sieve elements of the host plant. To identify genes that affect host plant resistance to aphids, we previously screened an Arabidopsis thaliana activation tag mutant collection. In such mutants, tagged genes are overexpressed by a strong 35S enhancer adjacent to the natural promoter, resulting in a dominant gain-of-function phenotype. We previously identified several of these mutants on which the aphid Myzus persicae showed a reduced population development compared with wild type. In the present study we show that the gene responsible for the phenotype of one of the mutants is At5g65040 and named this gene Increased Resistance to Myzus persicae 1 (IRM1). Overexpression of the cloned IRM1 gene conferred a phenotype identical to that of the original mutant. Conversely, an IRM1 knockout mutant promoted aphid population development compared to the wild type. We performed Electrical Penetration Graph analysis to investigate how probing and feeding behaviour of aphids was affected on plants that either overexpressed IRM1 or contained a knockout mutation in this gene. The EPG results indicated that the aphids encounter resistance factors while reaching for the phloem on the overexpressing line. This resistance mechanism also affected other aphid species and is suggested to be of mechanical nature. Interestingly, genetic variation for IRM1 expression in response to aphid attack was observed. Upon aphid attack the expression of IRM1 was initially (after 6 hours) induced in ecotype Wassilewskija followed by suppression. In Columbia-0, IRM1 expression was already suppressed six hours after the start of the infestation. The resistance conferred by the overexpression of IRM1 in A. thaliana trades off with plant growth.	[Chen, Xi; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Zhang, Zhao] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Broekgaarden, C (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	colette.broekgaarden@wur.nl	Zhang, Zhao/J-1615-2019; Vosman, Ben/C-5494-2013; Visser, Richard GF/B-3423-2012; Wang, Cheng/O-7206-2016	Zhang, Zhao/0000-0002-7323-5500; Vosman, Ben/0000-0003-4942-8342; Visser, Richard GF/0000-0002-0213-4016; Zhang, Chunni/0000-0002-7329-7162; Wang, Cheng/0000-0002-1834-2119	Chinese scholarship council; Wageningen UR Plant Breeding	Chinese scholarship council(China Scholarship Council); Wageningen UR Plant Breeding	The work was financially supported by the Chinese scholarship council (http://en.csc.edu.cn/). The work was additionally funded by Wageningen UR Plant Breeding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, PLANT CELL ENVIRON, V34, P1191, DOI 10.1111/j.1365-3040.2011.02317.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Chen X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-33; Civolani S, 2010, B INSECTOL, V63, P265; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couldridge C, 2007, B ENTOMOL RES, V97, P523, DOI 10.1017/S0007485307005160; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Firdaus S, 2011, PLANT BREEDING, V130, P708, DOI 10.1111/j.1439-0523.2011.01894.x; Halarewicz A, 2012, B INSECTOL, V65, P77; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ichikawa T, 2003, PLANT J, V36, P421, DOI 10.1046/j.1365-313X.2003.01876.x; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Karam GN, 2005, ANN BOT-LONDON, V95, P1179, DOI 10.1093/aob/mci130; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Nalam VJ, 2012, PLANT CELL, V24, P1643, DOI 10.1105/tpc.111.094110; Pegadaraju V, 2007, PLANT J, V52, P332, DOI 10.1111/j.1365-313X.2007.03241.x; Powell G, 2002, ENTOMOL EXP APPL, V104, P103, DOI 10.1023/A:1021234412475; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Simmons AT, 2005, EUPHYTICA, V144, P313, DOI 10.1007/s10681-005-8002-x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Stafford Candice A., 2012, Communicative & Integrative Biology, V5, P43; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tjallingii W.F., 1990, P89; Tjallingii WF, 2010, ENTOMOL EXP APPL, V135, P193, DOI 10.1111/j.1570-7458.2010.00983.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhu LC, 2011, J ECON ENTOMOL, V104, P2068, DOI 10.1603/EC11203	47	43	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70914	10.1371/journal.pone.0070914	http://dx.doi.org/10.1371/journal.pone.0070914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951039	Green Published, Green Submitted, gold			2022-12-25	WOS:000323097300067
J	Yu, QF; Ye, W; Wang, W; Chen, HF				Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng			Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP	PLOS ONE			English	Article							DYNAMIC ENERGY LANDSCAPE; CREB-BINDING-PROTEIN; TRANSITION-STATE; MOLECULAR-DYNAMICS; TRANSCRIPTIONAL ACTIVATION; CHYMOTRYPSIN INHIBITOR-2; TRANSACTIVATION DOMAIN; COUPLED BINDING; MECHANISM; COACTIVATOR	The transactivation domain (TAD) of tumor suppressor p53 can bind with the nuclear coactivator binding domain (NCBD) of cyclic-AMP response element binding protein (CBP) and activate transcription. NMR experiments demonstrate that both apo-NCBD and TAD are intrinsic disordered and bound NCBD/TAD undergoes a transition to well folded. The recognition mechanism between intrinsic disordered proteins is still hotly debated. Molecular dynamics (MD) simulations in explicit solvent are used to study the recognition mechanism between intrinsic disordered TAD and NCBD. The average RMSD values between bound and corresponding apo states and Kolmogorov-Smirnov P test analysis indicate that TAD and NCBD may follow an induced fit mechanism. Quantitative analysis indicates there is also a global conformational selection. In summary, the recognition of TAD and NCBD might obey a local induced fit and global conformational selection. These conclusions are further supported by high-temperature unbinding kinetics and room temperature landscape analysis. These methods can be used to study the recognition mechanism of other intrinsic disordered proteins.	[Yu, Qingfen; Ye, Wei; Wang, Wei; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Chen, HF (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020	Li, Haizhou/0000-0001-9158-9401	Ministry of Science and Technology China [2012CB721003]; National High-tech Research & Development Program of China (863 Program) [2012AA020403]; National Natural Science Foundation of China [31271403]; Shanghai Education Committee [12ZZ023]; Shanghai Pujiang Program [10PJD010]; Natural Science Foundation of Shanghai from China [10ZR1414500]; Medical Engineering Cross Fund of Shanghai Jiaotong University [YG2010MS67]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National High-tech Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Education Committee; Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai from China; Medical Engineering Cross Fund of Shanghai Jiaotong University	This work was sponsored by grants from Ministry of Science and Technology China(2012CB721003), by National High-tech Research & Development Program of China (863 Program)(2012AA020403), by National Natural Science Foundation of China (31271403), by Innovation Program of Shanghai Education Committee (Grants No. 12ZZ023), by Shanghai Pujiang Program (10PJD010), by the Natural Science Foundation of Shanghai from China (Grants No. 10ZR1414500), and by Medical Engineering Cross Fund of Shanghai Jiaotong University (YG2010MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agakishiev G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.072302; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; CAFLISCH A, 1994, P NATL ACAD SCI USA, V91, P1746, DOI 10.1073/pnas.91.5.1746; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case D.A., 2022, AMBER 2020; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fernandez-Escamilla AM, 2004, P NATL ACAD SCI USA, V101, P2834, DOI 10.1073/pnas.0304180101; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gsponer J, 2002, P NATL ACAD SCI USA, V99, P6719, DOI 10.1073/pnas.092686399; Henkels CH, 2006, J AM CHEM SOC, V128, P7772, DOI 10.1021/ja057279+; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; Petsko GA, 2003, CURR PROTOC BIOINFOR; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Ritort F, 2002, P NATL ACAD SCI USA, V99, P13544, DOI 10.1073/pnas.172525099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Turjanski AG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000060; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043788; Ye W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036382	64	87	90	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59627	10.1371/journal.pone.0059627	http://dx.doi.org/10.1371/journal.pone.0059627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	24223789	Green Submitted, Green Published, gold			2022-12-25	WOS:000317418500067
J	Chen, YX; Zhu, LQ; Chen, Z				Chen, Yongxiang; Zhu, Liqi; Chen, Zhe			Family Income Affects Children's Altruistic Behavior in the Dictator Game	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; CATEGORIZATION; EVOLUTION	This study aimed to examine how family income and social distance influence young rural Chinese children's altruistic behavior in the dictator game (DG). A total of 469 four-year-old children from eight rural areas in China, including many children left behind by parents who had migrated to urban areas for work, played the DG. Stickers comprised the resource, while recipients in the game were assumed to be either their friends or strangers, with the social distance (i.e., strangers compared to friends) as a between-subjects variable. Children donated significantly more stickers to their friends than to strangers. Moreover, children from lower income families donated more stickers than children from higher income families. However, no gender and parental migrant status differences in children's prosocial behaviors were evident in this sample. Findings of this study suggest that children's altruistic behaviours to peers are influenced by family characteristics since preschool age. The probable influence of local socialization practices on development and the possible adaptive significance were discussed.	[Chen, Yongxiang; Zhu, Liqi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Yongxiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Zhe] Univ Calif Davis, Dept Human & Community Dev, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Zhu, LQ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhulq@psych.ac.cn		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	Chinese Academy of Sciences [KJZD-EW-L04, Y1CX012Y01]; 973 program [2010CB8339004]; National Science Foundation of China [30970911]	Chinese Academy of Sciences(Chinese Academy of Sciences); 973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences (KJZD-EW-L04 and Y1CX012Y01), the 973 program(2010CB8339004) and National Science Foundation of China (30970911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN VL, 1975, J PERS SOC PSYCHOL, V32, P971, DOI 10.1037/0022-3514.32.6.971; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Asis, 2006, ASIAN POPULATION STU, V2, P45, DOI [10.1080/17441730600700556, DOI 10.1080/17441730600700556]; Ben-Ner A, 2009, J ECON BEHAV ORGAN, V72, P153, DOI 10.1016/j.jebo.2009.05.007; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Chu SM, 2012, PERS INDIV DIFFER, V52, P691, DOI 10.1016/j.paid.2011.12.029; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; ENGEL C, 2010, WORKING PAPER SERIES, P1; *FED CWS, 2008, NAT SURV LEFT BEH CH; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Friesen J, 2012, J ECON PSYCHOL, V33, P1156, DOI 10.1016/j.joep.2012.08.003; Froiland JM, 2013, SCHOOL PSYCHOL INT, V34, P33, DOI 10.1177/0143034312454361; Fujisawa KK, 2008, INT J BEHAV DEV, V32, P89, DOI 10.1177/0165025407084055; Gueguen N, 2012, SWISS J PSYCHOL, V71, P157, DOI 10.1024/1421-0185/a000083; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hesketh T, 2011, SOC PSYCH PSYCH EPID, V46, P733, DOI 10.1007/s00127-010-0240-0; HOFFMAN ML, 1975, J PERS SOC PSYCHOL, V31, P937, DOI 10.1037/h0076825; JIAO SL, 1986, CHILD DEV, V57, P357, DOI 10.2307/1130591; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kwan YK, 2009, CHILD INDIC RES, V2, P375, DOI 10.1007/s12187-009-9041-y; LI JL, 1995, POPUL DEV REV, V21, P563, DOI 10.2307/2137750; Milonoff M, 2012, ANN ZOOL FENN, V49, P378, DOI 10.5735/086.049.0512; Ng R, 2011, DEV PSYCHOL, V47, P1230, DOI 10.1037/a0024923; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rao LL, 2011, EVOL HUM BEHAV, V32, P63, DOI 10.1016/j.evolhumbehav.2010.07.002; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Rutte C, 2009, CURR SCI INDIA, V97, P1573; Shen JP, 1999, J PSYCHOL, V133, P115, DOI 10.1080/00223989909599726; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Y, 2009, J AM ACAD CHILD PSY, V48, P1137, DOI 10.1097/CHI.0b013e3181bc72f8; Wen M, 2012, CHILD DEV, V83, P120, DOI 10.1111/j.1467-8624.2011.01698.x; YU J, 2010, DEV CHILDRENS FAIR B; Zheng HM, 2010, NEUROPSYCHOLOGIA, V48, P3198, DOI 10.1016/j.neuropsychologia.2010.06.031; Zhou F., 2006, POPULATION J, V3, P60	41	92	96	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80419	10.1371/journal.pone.0080419	http://dx.doi.org/10.1371/journal.pone.0080419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24260499	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100156
J	Chen, Y; Xin, XX; Li, J; Xu, JF; Yu, XX; Li, TY; Mo, ZN; Hu, YL				Chen, Yang; Xin, Xianxiang; Li, Jie; Xu, Jianfeng; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling			RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer	PLOS ONE			English	Article							FOCAL ADHESION KINASE; POSITIVE SELECTION; ACQUIRED-RESISTANCE; CELL-MIGRATION; GENOME; STATISTICS; PROTEIN; MUTATIONS; GENES; EGFR	Prostate cancer (PCa) is a global disease causing large numbers of deaths every year. Recent studies have indicated the RTK/ERK pathway might be a key pathway in the development of PCa. However, the exact association and evolution-based mechanism remain unclear. This study was conducted by combining genotypic and phenotypic data from the Chinese Consortium for Prostate Cancer Genetics (ChinaPCa) with related databases such as the HapMap Project and Genevar. In this analysis, expression of quantitative trait loci (eQTLs) analysis, natural selection and gene-based pathway analysis were involved. The pathway analysis confirmed the positive relationship between PCa risk and several key genes. In addition, combined with the natural selection, it seems that 4 genes (EGFR, ERBB2, PTK2, and RAF1) with five SNPs (rs11238349, rs17172438, rs984654, rs11773818, and rs17172432) especially rs17172432, might be pivotal factors in the development of PCa. The results indicate that the RTK/ERK pathway under natural selection is a key link in PCa risk. The joint effect of the genes and loci with positive selection might be one reason for the development of PCa. Dealing with all the factors simultaneously might give insight into prevention and aid in predicting the success of potential therapies for PCa.	[Chen, Yang; Xin, Xianxiang; Li, Jie; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Xin, Xianxiang; Hu, Yanling] Guangxi Med Univ, Med Res Ctr, Nanning, Guangxi, Peoples R China; [Chen, Yang; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China; [Li, Jie] Guangxi Med Univ, Affiliated Hosp 1, Res Ctr Guangxi Reprod Med, Nanning, Guangxi Zhuang, Peoples R China; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center	Mo, ZN (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com; ylhupost@163.com		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	National Program on Key Basic Research Project (973 Program) [2012CB518303]; National Natural Science Foundation of China [81060213, 81272853]; Guangxi Natural Science Foundation [2011GXNSFB018100]; Postdoctoral Sustentation Fund of China [2012M511886]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Postdoctoral Sustentation Fund of China	This study was supported by grants from National Program on Key Basic Research Project (973 Program) (2012CB518303), the National Natural Science Foundation of China (81060213, 81272853), Guangxi Natural Science Foundation (2011GXNSFB018100) and Postdoctoral Sustentation Fund of China (2012M511886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arteaga CL, 2002, SEMIN ONCOL, V29, P4, DOI 10.1053/sonc.2002.34047; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Chen LQ, 2011, CLIN CANCER RES, V17, P6218, DOI 10.1158/1078-0432.CCR-11-1548; Choi BK, 2012, CANCER MED-US, V1, P28, DOI 10.1002/cam4.10; Dong LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004895; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hong YS, 2009, CANCER EPIDEM BIOMAR, V18, P680, DOI 10.1158/1055-9965.EPI-08-0961; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung HY, 2012, CANCER RES TREAT, V44, P251, DOI 10.4143/crt.2012.44.4.251; Keller Evan T, 2011, For Immunopathol Dis Therap, V2, P89; Kelley JL, 2009, HUM MOL GENET, V18, P779, DOI 10.1093/hmg/ddn399; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lacoste J, 2005, MOL CELL ENDOCRINOL, V235, P51, DOI 10.1016/j.mce.2004.06.014; Lamy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053240; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Ning QY, 2011, GENET MOL RES, V10, P3855, DOI 10.4238/2011.December.14.10; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peng L, 2013, CURR MOL MED, V13, P333; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Ren GP, 2012, GENE CHROMOSOME CANC, V51, P1014, DOI 10.1002/gcc.21984; Rezaiemanesh Alireza, 2010, Human Antibodies, V19, P63, DOI 10.3233/HAB-2010-0229; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906	52	92	96	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78254	10.1371/journal.pone.0078254	http://dx.doi.org/10.1371/journal.pone.0078254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24260499	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400044
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600038
J	Li, X; Yao, XP; Wang, YB; Hu, FL; Wang, F; Jiang, LY; Liu, YP; Wang, D; Sun, GZ; Zhao, YS				Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Wang, Da; Sun, Guizhi; Zhao, Yashuang			MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF MUTATION; HEREDITARY; HYPERMETHYLATION	Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis. Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively). Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.	[Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China; [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; Zhao, Yashuang/I-6145-2019; li, xia/HHZ-7468-2022; Li, Xiaobing/B-1267-2019; Liu, YuPeng/P-3181-2018	Wang, Fan/0000-0002-9869-9504; Liu, Guowen/0000-0002-2672-6104; Li, Xiaobing/0000-0001-9105-6365; Liu, YuPeng/0000-0002-8652-1987	National Natural Science Foundation of China for Priority Areas [NSFC 30972538]; Education Bureau of Heilongjiang Province [11531100]; Graduate Foundation; Scientific Research of Heilongjiang Province [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]	National Natural Science Foundation of China for Priority Areas; Education Bureau of Heilongjiang Province; Graduate Foundation; Scientific Research of Heilongjiang Province; Harbin Medical University	This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boland CR, 1998, CANCER RES, V58, P5248; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cunningham JM, 1998, CANCER RES, V58, P3455; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deng GR, 1999, CANCER RES, V59, P2029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Garagnani P, 2012, CURR PHARM DES; Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987; Gazzoli I, 2002, CANCER RES, V62, P3925; GLOBOCAN, 2008, CANC FACT SHEET; Grady WM, 2001, CANCER RES, V61, P900; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kane MF, 1997, CANCER RES, V57, P808; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mathers JC, ADV GENET, V71, P3; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Mirchev M, 2007, J IMAB ANN P SCI PAP, P95; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nakagawa H, 2001, CANCER RES, V61, P6991; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1; Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Strazzullo M, 2003, CANCER-AM CANCER SOC, V98, P1540, DOI 10.1002/cncr.11651; Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.2004.05.007; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0; Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329	78	84	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59064	10.1371/journal.pone.0059064	http://dx.doi.org/10.1371/journal.pone.0059064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23861826	gold, Green Published, Green Submitted			2022-12-25	WOS:000317263900009
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300065
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	23658832	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700121
